<SEC-DOCUMENT>0001140361-22-027000.txt : 20220726
<SEC-HEADER>0001140361-22-027000.hdr.sgml : 20220726
<ACCEPTANCE-DATETIME>20220726164531
ACCESSION NUMBER:		0001140361-22-027000
CONFORMED SUBMISSION TYPE:	S-4/A
PUBLIC DOCUMENT COUNT:		125
FILED AS OF DATE:		20220726
DATE AS OF CHANGE:		20220726

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CALADRIUS BIOSCIENCES, INC.
		CENTRAL INDEX KEY:			0000320017
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				222343568
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-265638
		FILM NUMBER:		221107616

	BUSINESS ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920
		BUSINESS PHONE:		908-229-2590

	MAIL ADDRESS:	
		STREET 1:		110 ALLEN ROAD
		STREET 2:		SECOND FLOOR
		CITY:			BASKING RIDGE
		STATE:			NJ
		ZIP:			07920

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Caladrius Biosciences, Inc.
		DATE OF NAME CHANGE:	20150608

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NeoStem, Inc.
		DATE OF NAME CHANGE:	20060906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHASE III MEDICAL INC/DE
		DATE OF NAME CHANGE:	20030819
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4/A
<SEQUENCE>1
<FILENAME>ny20004343x2_s4a.htm
<DESCRIPTION>S-4/A
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:clbs="http://caladrius.com/20220726" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="background-color: #ffffff; color: #000000;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:DocumentType" id="Fact_574737c10f394a5e9755cec5ab7de35d" contextRef="c20220101to20220331">S-4/A</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_238daff061ab46d2b2b8895981147e5d" contextRef="c20220101to20220331" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_1e5a71510c134de08f66144992d105ec" contextRef="c20220101to20220331">CALADRIUS BIOSCIENCES, INC.</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_45344d3f03804fa3b37d56200e0fd1d6" contextRef="c20220101to20220331">0000320017</ix:nonNumeric><ix:nonNumeric name="dei:EntityFilerCategory" id="Fact_007e9f44cc7f42e49d97494af57fd318" contextRef="c20220101to20220331">Non-accelerated Filer</ix:nonNumeric><ix:nonNumeric name="dei:EntitySmallBusiness" id="Fact_930baf0bc2aa4049af949a4c079e0d95" contextRef="c20220101to20220331" format="ixt:booleantrue">true</ix:nonNumeric><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_38b1318e52f545ca93da974d8d454a22" contextRef="c20220101to20220331" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="Fact_ce1d736a988a4564aff92c00256cdd92" contextRef="c20211231">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="Fact_02a6f0c3111348a5b2e0df82b435956e" contextRef="c20211231">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="Fact_6c255ea4f7c24c48b604a925c0f5819f" contextRef="c20201231">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="Fact_394d33db98754a5dbaa2063579daa0be" contextRef="c20211231">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="Fact_f6a138b4447e4c69840c11bceb8fe65d" contextRef="c20211231">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="Fact_d2023c19465a459a9ecb0fec411ae9c3" contextRef="c20201231">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="Fact_646cbb0a67a54f629dc6c425eb143706" contextRef="c20211231">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="Fact_3980d08cb35e4c0087f62256aa859a67" contextRef="c20211231">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="Fact_b65fe760104b4546b3abaa579a18c88c" contextRef="c20201231">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_b33f9ae5fcb543bd9c7f792ce5439476" contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember">P5Y6M</ix:nonNumeric><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_71e638d2f8944c3b8762be6c9f077488" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMember">P1Y</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="Fact_2bb6a876105046b48a849d6ac8adfc37" contextRef="c20220331">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="Fact_01cbbf57a5d5461f83158b26769ed161" contextRef="c20220331">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="Fact_52d14b2a09d54c84bb4a3b7e7f351e66" contextRef="c20220331">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_09a53c4a1103459dacf922bb1b50b09c" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMember">P1Y</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="clbs-20220726.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220101to20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_PreferredStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331_StatementEquityComponentsAxis_TreasuryStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20171231_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_CLBS16TreatmentOfCMDMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">clbs:CLBS16TreatmentOfCMDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_SoftwareAndSoftwareDevelopmentCostsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_BalanceSheetLocationAxis_MarketableSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clbs:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_BalanceSheetLocationAxis_MarketableSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clbs:MarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200630_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2017AmendedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20200630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20170531_PlanNameAxis_EmployeeStockPurchasePlan2017Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20130101_PlanNameAxis_EmployeeStockPurchasePlan2012Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2012Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2013-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheThreeMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_PlanNameAxis_EquityIncentiveCompensationPlan2018Member"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2017AmendedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_PlanNameAxis_EmployeeStockPurchasePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2017AmendedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210604_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180831_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210201to20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:InstitutionalPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:January2021PurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210201to20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AdditionalPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:January2021PurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AdditionalPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:InstitutionalPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20180801to20180831_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180201to20210212_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2021-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210201to20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20170228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20170501to20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20170501to20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20171201to20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20180301to20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20190501to20190531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-05-01</xbrli:startDate><xbrli:endDate>2019-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20200901to20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_IncomeTaxAuthorityAxis_DomesticCountryMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20210412to20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-12</xbrli:startDate><xbrli:endDate>2021-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clbs:AgreementAndPlanOfMergerAndReorganizationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:CendTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220331_AwardTypeAxis_RestrictedStockMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220222to20220222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-22</xbrli:startDate><xbrli:endDate>2022-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220426to20220426_StatementClassOfStockAxis_SeriesDPreferredStockCendMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">clbs:SeriesDPreferredStockCendMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-26</xbrli:startDate><xbrli:endDate>2022-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220426_StatementClassOfStockAxis_SeriesDPreferredStockCendMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">clbs:SeriesDPreferredStockCendMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220426to20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-26</xbrli:startDate><xbrli:endDate>2022-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c20220426to20220426_LegalEntityAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000320017</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CendTherapeuticsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-26</xbrli:startDate><xbrli:endDate>2022-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U001"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="U002"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U003"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U004"><xbrli:measure>clbs:office</xbrli:measure></xbrli:unit><xbrli:unit id="U005"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U006"><xbrli:measure>clbs:offering_period</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>


  <div style="color: #000000;">
    <!--Begin Page 1-->
    <div style="text-align: left; margin: auto; position: relative; width: 540pt;" class="page"><!--Anchor-->
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 540pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 25pt; text-align: center;" class="h1">As filed with the Securities and Exchange Commission on July&#160;26, 2022</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 1pt; text-align: right;" class="regno">Registration No. 333-265638</div>

        </div>

      </div>

      <div style="width: 540pt; margin-left: 0pt;" class="block-frill">
        <div>
          <div style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;" class="rule-full"> </div>

          <div style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;" class="rule-full"> </div>

        </div>

      </div>

      <div style="width: 540pt; margin-left: 0pt;" class="block-main">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 9.5pt; text-align: center;" class="h1">UNITED STATES<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">SECURITIES AND EXCHANGE COMMISSION<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 14pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-size: 11pt;">Washington, D.C. 20549</span></div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 5pt; text-align: center;" class="h1">Amendment No.&#160;1<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">to<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-size: 18pt;">FORM S-4</span><br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-size: 18pt;">REGISTRATION STATEMENT</span><br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-style: italic;">UNDER</span><br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-style: italic;">THE SECURITIES ACT OF 1933</span></div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 24pt; font-weight: bold; margin-top: 5.5pt; text-align: center;" class="h1">CALADRIUS BIOSCIENCES, INC.<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 24pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-size: 9.5pt;">(Exact name of Registrant as specified in its charter) </span></div>

        <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 540pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Delaware</div>
              </td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.85%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">8090</div>
              </td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.85%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">22-2343568</div>
              </td>

  </tr>

  <tr>

    <td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(State or other jurisdiction of<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">incorporation or organization)</div>
              </td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.85%; text-align: center; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(Primary Standard Industrial Classification Code Number)</div>
              </td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.85%; text-align: center; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(I.R.S. Employer<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Identification Number)</div>
              </td>

  </tr>

  <tr>

    <td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold;" class="fpara">&#160;</div>
              </td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.85%; text-align: center; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">110 Allen Road, 2nd Floor<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Basking Ridge, New Jersey 07920<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(908) 842-0100</div>
              </td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.85%; text-align: center; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold;" class="fpara">&#160;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 100%; text-align: center; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;" colspan="7">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(Address including zip code, and telephone number, including area code, of
                  Registrant&#8217;s principal executive offices)</div>
              </td>

  </tr>


</table>
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 3.5pt; text-align: center;" class="h1">David J. Mazzo, Ph.D.<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">President and Chief Executive Officer<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">Caladrius Biosciences, Inc.<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">110 Allen Road, 2<sup>nd</sup> Floor<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">Basking Ridge, New Jersey 07920<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(908) 842-0100<br />
        </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(Name, address, including zip code, and telephone number, including area code, of agent
          for service)</div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-style: italic; font-weight: bold; margin-top: 3.5pt; text-align: center;" class="h1">Copies to:<span style="font-style: normal; font-weight: normal;">
          </span></div>

        <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 540pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Jeffrey P. Schultz, Esq.<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Daniel A. Bagliebter, Esq.<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Mintz Levin Cohn Ferris Glovsky &amp;<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Popeo, P.C.<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Chrysler Center<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">666 Third Avenue<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">New York, New York 10017<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(212) 935-3000</div>
              </td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">David Slack<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">President &amp; Chief Executive Officer<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend Therapeutics, Inc.<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">12544 High Bluff Drive, Suite 400<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">San Diego, California 92130<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(858) 795-5123</div>
              </td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.11%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.85%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Paul Johnson, Esq.<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Christopher L. Tinen, Esq.<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Procopio, Cory, Hargreaves &amp; <br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Savitch LLP<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">12544 High Bluff Drive, Suite 400<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">San Diego, California 92130<br />
                </div>
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(619) 525-3866</div>
              </td>

  </tr>


</table>
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">Approximate date of commencement of proposed sale to the public: As
          soon as practicable after the effectiveness of this registration statement and the satisfaction or waiver of all other conditions under the Merger Agreement described herein.</div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">If the securities being registered on this Form are being offered in connection with the
          formation of a holding company and there is compliance with General Instruction G, please check the following box. <span style="font-size: 1pt;">&#8201;</span>&#9744; </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">If this Form is filed to register additional securities for an offering pursuant to Rule
          462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <span style="font-size: 1pt;">&#8201;</span>&#9744; </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the
          Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <span style="font-size: 1pt;">&#8201;</span>&#9744; </div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">Indicate by check mark whether the registrant is a large accelerated filer, an
          accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check
          one): </div>

        <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 540pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 17.78%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Large accelerated filer</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 2.22%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8201;<span style="font-size: 9.5pt;">&#9744;</span></div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 17.78%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt;" class="fpara">&#160;</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 22.22%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Accelerated filer</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 2.22%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8201;<span style="font-size: 9.5pt;">&#9744;</span></div>
              </td>

  </tr>

  <tr>

    <td style="width: 17.78%; text-align: left; vertical-align: top; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Non-accelerated filer</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 2.22%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#9746;</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 17.78%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt;" class="fpara">&#160;</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 22.22%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Smaller reporting company</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 2.22%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#9746;</div>
              </td>

  </tr>

  <tr>

    <td style="width: 17.78%; text-align: left; vertical-align: top; padding-top: 2.5pt; padding-bottom: 3pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt;" class="fpara">&#160;</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.22%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt;" class="fpara">&#160;</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.78%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt;" class="fpara">&#160;</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.22%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Emerging Growth Company</div>
              </td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.22%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3pt;">
                <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8201;<span style="font-size: 9.5pt;">&#9744;</span></div>
              </td>

  </tr>


</table>
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 2pt; margin-left: 0pt; text-align: left;" class="fpara">If an emerging growth company, indicate by check mark if the registrant has elected not
          to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act <span style="font-size: 1pt;">&#8201;</span>&#9744;</div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">If applicable, place an X in the box to designate the appropriate rule provision relied
          upon in conducting this transaction:</div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">Exchange Act Rule 13(e)-4(i) (Cross-Border Issuer Tender Offer) <span style="font-size: 1pt;">&#8201;</span>&#9744;</div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">Exchange Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) <span style="font-size: 1pt;">&#8201;</span>&#9744;</div>

        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.5pt; font-weight: bold; margin-top: 5pt; margin-left: 0pt; text-align: left;" class="fpara">The Registrant hereby amends this registration statement on such date
          or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the
          Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</div>

      </div>

      <div style="width: 540pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div>
          <div style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;" class="rule-full"> </div>

          <div style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;" class="rule-full"> </div>

        </div>

      </div>

    </div>

    <!--End Page 1-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 2-->
    <div style="text-align: left; margin: auto; position: relative; width: 528pt;" class="page"><a id="ny20004343x2_s4a_101-cov_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 528pt; margin-left: 0pt;" class="block-main">
          <div style="color: #FC0014; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">
            <div style="font-family: Arial, Helvetica, sans-serif; text-align: left; margin-bottom: 12pt;">The information in this proxy statement/prospectus/information statement is not complete and may be changed. Caladrius Biosciences, Inc. may not
                sell its securities pursuant to the proposed transactions until the Registration Statement filed with the Securities and Exchange Commission is effective. This proxy statement/prospectus/information statement is not an offer to sell these
                securities and is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</div>
<div>Subject to completion, dated July&#160;26, 2022
            <span style="color: #000000;"> </span></div>
</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 528pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 48.86%; text-align: center; vertical-align: top; padding-top: 6pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><img src="logo_caladrius.jpg" style="height: 52px; width: 149px;" alt="graphic" /><br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">&#8201;</div>
                </td>

    <td style="width: 1.14%; border-bottom: none; font-size: 2pt; padding-top: 6pt;" class="gutter">&#8203;</td>

    <td style="width: 1.14%; border-bottom: none; font-size: 2pt; padding-top: 6pt;" class="gutter">&#8203;</td>

    <td style="width: 48.86%; text-align: center; vertical-align: bottom; padding-top: 6pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><img src="logo_cend.jpg" style="height: 52px; width: 111px;" alt="graphic" /><br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8201;</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.5pt; text-align: center;" class="h1">PROPOSED MERGER<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">YOUR VOTE IS VERY IMPORTANT</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">To the Stockholders of Caladrius Biosciences, Inc. and Cend Therapeutics, Inc.:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;) and Cend Therapeutics,
            Inc. (&#8220;Cend&#8221;) have entered into an Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;) pursuant to which a wholly owned subsidiary of Caladrius will merge with and into Cend, with Cend surviving as a wholly owned subsidiary
            of Caladrius (the &#8220;Merger&#8221;). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">At the effective time of the Merger (the &#8220;Effective Time&#8221;), each
            share of Cend&#8217;s common stock, par value $0.00001 per share (&#8220;Cend Common Stock&#8221;), and each share of Cend&#8217;s preferred stock, par value $0.00001 per share (&#8220;Cend Preferred Stock,&#8221; together with the Cend Common Stock, the &#8220;Cend Capital Stock&#8221;),
            outstanding immediately prior to the Effective Time will be converted into the right to receive approximately 8.5623 shares of Caladrius&#8217; common stock, par value $0.001 per share (&#8220;Caladrius Common Stock&#8221;), subject to adjustment to account for
            the effect of a reverse stock split of Caladrius Common Stock, at a ratio mutually agreed to by Caladrius and Cend in the range of one new share for every five to fifteen shares outstanding (or any number in between) (the &#8220;Reverse Stock
            Split&#8221;), to be implemented prior to the consummation of the Merger as discussed in this proxy statement/prospectus/information statement, and further adjusted based on Caladrius&#8217; net cash and Cend&#8217;s unpaid transaction costs immediately prior to
            the closing of the Merger (the &#8220;Exchange Ratio&#8221;). Because Caladrius&#8217; net cash balance and Cend&#8217;s unpaid transaction costs will not be determined until immediately prior to the closing of the Merger, and because the number of shares of Caladrius
            Common Stock issuable to Cend is determined based on Caladrius&#8217; net cash balance and Cend&#8217;s unpaid transaction costs immediately prior to the closing of the Merger, Caladrius&#8217; stockholders cannot be certain of the exact number of shares of
            Caladrius Common Stock that will be issued to Cend stockholders when Caladrius&#8217; stockholders vote on the proposals at the Annual Meeting of Caladrius stockholders. Caladrius will assume outstanding and unexercised options to purchase shares of
            Cend Common Stock granted under Cend&#8217;s 2016 Equity Incentive Plan, and each such option will be converted into an option to purchase shares of Caladrius Common Stock, with the number of shares of Caladrius Common Stock subject to such option
            and the exercise price being appropriately adjusted to reflect the Exchange Ratio. Caladrius stockholders will continue to own and hold their existing shares of Caladrius Common Stock. At the Effective Time, each (i)&#160;option or other right to
            purchase shares of Caladrius Common Stock issued by Caladrius (a &#8220;Caladrius Option&#8221;), (ii)&#160;restricted stock unit covering shares of Caladrius Common Stock issued or granted by Caladrius, which for the avoidance of doubt, shall include a
            performance stock unit covering shares of Caladrius Common Stock issued or granted by Caladrius and (iii)&#160;award of shares of Caladrius Common Stock subject to forfeiture and certain vesting criteria, in each case, that is outstanding and
            unexercised immediately prior to the Effective Time, whether or not vested, shall survive the closing of the Merger and remain outstanding in accordance with its terms.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11pt;" class="fpara">Immediately following the consummation of the Merger, Cend&#8217;s
            stockholders are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock, and Caladrius&#8217; stockholders are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock, subject to adjustment
            of the Exchange Ratio as set forth in the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11pt;" class="fpara">Shares of Caladrius Common Stock are currently listed on The
              Nasdaq Capital Market under the symbol &#8220;CLBS.&#8221; Prior to consummation of the Merger, Caladrius intends to file a notification form with the Nasdaq Stock Market, LLC (&#8220;Nasdaq&#8221;) for the listing of additional shares with respect to the shares of
              Caladrius Common Stock to be issued to the holders of Cend Capital Stock in the Merger. After completion of the Merger, Caladrius will be renamed &#8220;Lisata Therapeutics, Inc.&#8221; and expects to trade on The Nasdaq Capital Market under the symbol
              &#8220;LSTA.&#8221; On July&#160;25, 2022, the last trading day before the date of this proxy statement/prospectus/information statement, the closing sale price of Caladrius Common Stock was $0.51 per share.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11pt;" class="fpara">Caladrius is holding an annual meeting of stockholders (the
              &#8220;Annual Meeting&#8221;) in order to obtain the stockholder approvals necessary to complete the Merger and related matters, hold an election of directors, hold a &#8220;say-on-pay&#8221; vote, and ratify the selection of an independent registered public
              accounting firm. At the Annual Meeting, which will be held at 9:00 a.m., New York time, on September&#160;13, 2022, via live webcast on the internet where you will be able to participate in the Annual Meeting, vote and submit your questions during
              the Annual Meeting by visiting www.virtualshareholdermeeting.com/CLBS2022SM, unless postponed or adjourned to a later date, Caladrius will ask Caladrius&#8217; stockholders to, among other things, (i)&#160;adopt the Merger Agreement thereby approving
              the Merger and the issuance of Caladrius Common Stock pursuant to the Merger Agreement, (ii)&#160;approve an amendment to Caladrius&#8217; amended and restated certificate of incorporation effecting the Reverse Stock Split, (iii)&#160;approve an amendment to
              Caladrius&#8217; amended and restated certificate of incorporation changing Caladrius&#8217; corporate name from &#8220;Caladrius Biosciences, Inc.&#8221; to &#8220;Lisata Therapeutics, Inc.,&#8221; (iv)&#160;elect three Class&#160;III directors to hold office until the 2025 annual
              meeting of Caladrius&#8217; stockholders or until their successors are elected (provided, however, that if the Merger is completed, Caladrius&#8217; board of directors will be reconstituted as provided in the Merger Agreement), (v)&#160;ratify the selection
              by the audit committee of the Caladrius board of directors of Grant Thornton LLP as the independent registered public accounting firm of Caladrius for its calendar year ending December&#160;31, 2022, (vi)&#160;approve, on a non-binding advisory basis,
              the executive compensation of Caladrius&#8217; named executive officers as disclosed in this proxy statement/prospectus/information statement and (vii)&#160;approve an amendment to the Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan
              (the &#8220;Plan&#8221;) that increases the number of shares of common stock that may be issued under the Plan by 5,000,000, each as described in this proxy statement/prospectus/information statement.</div>

        </div>

      </div>

    </div>

    <!--End Page 2-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 3-->
    <div style="text-align: left; margin: auto; position: relative; width: 528pt;" class="page"><a id="ny20004343x2_s4a_101-cov_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 528pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">As described in this proxy statement/prospectus/information
            statement, certain of Cend&#8217;s stockholders who in the aggregate own 100% of the outstanding shares of Cend Series A Preferred Stock, approximately 88.8% of the outstanding shares of Cend Series B Preferred Stock and approximately 77.5% of the
            outstanding shares of Cend Capital Stock on an as converted to common stock basis (excluding shares held by Caladrius), and certain Caladrius stockholders who in the aggregate own approximately 1.8% of the outstanding shares of Caladrius Common
            Stock, are parties to support agreements with Caladrius and Cend, respectively, whereby such stockholders have agreed to vote in favor of the adoption or approval of the Merger Agreement, as applicable, and the approval of the transactions
            contemplated therein, including the Merger and the issuance of Caladrius Common Stock in the Merger pursuant to the Merger Agreement, respectively, subject to the terms of the support agreements. In addition, following the registration
            statement on Form S-4, of which this proxy statement/prospectus/information statement is a part, being declared effective by the U.S. Securities and Exchange Commission and pursuant to the conditions of the Merger Agreement, Cend&#8217;s stockholders
            who are party to the support agreements will each execute an action by written consent of Cend&#8217;s stockholders, referred to herein as the written consent, adopting the Merger Agreement, thereby approving the Merger and related transactions.
            Therefore, holders of a sufficient number of shares of Cend Capital Stock required to adopt the Merger Agreement will adopt the Merger Agreement, and no meeting of Cend stockholders is required to adopt the Merger Agreement and approve the
            Merger and related transactions and no meeting of Cend&#8217;s stockholders will be held. Nevertheless, all of Cend&#8217;s stockholders will have the opportunity to elect to adopt the Merger Agreement, thereby approving the Merger and related
            transactions, by signing and returning to Cend a written consent.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">After careful consideration, the respective boards of directors of
            Caladrius and Cend have (i)&#160;determined that the transactions contemplated by the Merger Agreement are fair to, advisable and in the best interests of Caladrius or Cend, as applicable, and their respective stockholders, (ii)&#160;approved and
            declared advisable the Merger Agreement and the transactions contemplated thereby and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in the Merger Agreement, that its stockholders vote to adopt or approve,
            as applicable, the Merger Agreement and, therefore, approve the transactions contemplated therein. Caladrius&#8217; board of directors recommends that its stockholders vote &#8220;FOR&#8221; the proposals described in this proxy statement/prospectus/information
            statement, and Cend&#8217;s board of directors recommends that its stockholders sign and return to Cend the written consent indicating their approval of the Merger and adoption of the Merger Agreement and related transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">More information about Caladrius, Cend and the proposed
            transaction is contained in this proxy statement/prospectus/information statement. Caladrius and Cend urge you to read this proxy statement/prospectus/information statement carefully and in its entirety. IN PARTICULAR, YOU SHOULD CAREFULLY
            CONSIDER THE MATTERS DISCUSSED UNDER THE SECTION ENTITLED &#8220;<span style="font-style: italic;">RISK FACTORS</span>&#8221; IN THIS PROXY STATEMENT/PROSPECTUS/INFORMATION STATEMENT.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">Caladrius and Cend are excited about the opportunities the Merger
            brings to both Caladrius&#8217; and Cend&#8217;s respective stockholders, and thank you for your consideration and continued support. </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 528pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 48.86%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D. <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="font-style: italic;">President and Chief Executive Officer</span>
                    <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc.</div>
                </td>

    <td style="width: 1.14%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.14%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.86%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="font-style: italic;">President and Chief Executive Officer</span>
                    <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Therapeutics, Inc.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">Neither the Securities and Exchange Commission
            nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this proxy statement/prospectus/information statement. Any representation to the contrary is a criminal offense.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">This proxy statement/prospectus/information statement is dated
              &#8195;&#8195;&#8195; , 2022, and is first being mailed to Caladrius&#8217; and Cend&#8217;s respective stockholders on or about August&#160;2, 2022.</div>

        </div>

      </div>

    </div>

    <!--End Page 3-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 4-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_102-notice_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; text-align: center;" class="fpara"><img src="logo_caladriusx1.jpg" style="height: 69px; width: 198px;" alt="graphic" /><br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8201;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;" class="h1">CALADRIUS BIOSCIENCES, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">110 Allen Road, 2<sup>nd</sup> Floor<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">Basking Ridge, New Jersey 07920<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(908) 842-0100</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;" class="h1">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">TO BE HELD ON SEPTEMBER&#160;13, 2022</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Dear Stockholders of Caladrius:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On behalf of the board of directors of Caladrius Biosciences, Inc., a Delaware
              corporation (&#8220;Caladrius&#8221;), we are pleased to deliver this proxy statement/prospectus/information statement for the proposed merger between Caladrius and Cend Therapeutics, Inc., a Delaware corporation (&#8220;Cend&#8221;), pursuant to which CS Cedar
              Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Caladrius, will merge with and into Cend, with Cend surviving as a wholly owned subsidiary of Caladrius (the &#8220;Merger&#8221;). The annual meeting of stockholders of Caladrius
              (the &#8220;Annual Meeting&#8221;) will be held on September&#160;13, 2022, at 9:00 a.m., New York time. The Annual Meeting will be held via live webcast on the internet. You will be able to participate in the Annual Meeting, vote and submit your questions
              during the Annual Meeting by visiting www.virtualshareholdermeeting.com/CLBS2022SM. You will not be able to attend the Annual Meeting in person. The Annual Meeting is being held for the following purposes: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and vote upon a proposal to approve the Agreement and Plan of Merger and Reorganization, dated as of April&#160;26, 2022,
                    by and among Caladrius, CS Cedar Merger Sub, Inc. and Cend, a copy of which is attached as <span style="font-style: italic;">Annex&#160;A</span> to this proxy statement/prospectus/information statement (the &#8220;Merger Agreement&#8221;), and the
                    transactions contemplated thereby, including the Merger and the issuance of shares of Caladrius&#8217; common stock to Cend&#8217;s stockholders pursuant to the terms of the Merger Agreement. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To approve an amendment to the amended and restated certificate of incorporation of Caladrius to effect a reverse stock split of
                    Caladrius&#8217; common stock, at a ratio mutually agreed to by Caladrius and Cend in the range of one new share for every five to fifteen shares outstanding (or any number in between), in the form attached as <span style="font-style: italic;">Annex&#160;D</span> to this proxy statement/prospectus/information statement. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To approve an amendment to the amended and restated certificate of incorporation of Caladrius to change the corporate name of
                    Caladrius from &#8220;Caladrius Biosciences, Inc.&#8221; to &#8220;Lisata Therapeutics, Inc.&#8221; in the form attached as <span style="font-style: italic;">Annex&#160;E</span> to this proxy statement/prospectus/information statement. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To elect three Class&#160;III directors to hold office until the 2025 annual meeting of Caladrius&#8217; stockholders or until their
                    successors are elected (provided, however, that if the Merger is completed, Caladrius&#8217; board of directors will be reconstituted as provided in the Merger Agreement). </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To ratify the selection by the audit committee of the Caladrius board of directors of Grant Thornton LLP as the independent
                    registered public accounting firm of Caladrius for its calendar year ending December&#160;31, 2022.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To approve, on a non-binding advisory basis, the executive compensation of Caladrius&#8217; named executive officers as disclosed in
                    this proxy statement/prospectus/information statement.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">7.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To approve an amendment to the Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan (the &#8220;Plan&#8221;) that increases
                    the number of shares of common stock that may be issued under the Plan by 5,000,000.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and vote upon an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not
                    sufficient votes in favor of Proposal No. 1 or 2. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">9.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To transact such other business as may properly come before the stockholders at the Annual Meeting or any adjournment or
                    postponement thereof. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

    </div>

    <!--End Page 4-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 5-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_102-notice_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; board of directors has fixed July&#160;25, 2022, as the record date (the
              &#8220;Record Date&#8221;) for the determination of stockholders entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. Only holders of record of shares of Caladrius&#8217; common stock at the close of business
              on the Record Date are entitled to notice of, and to vote at, the Annual Meeting. At the close of business on the Record Date, there were 60,583,249 shares of Caladrius&#8217; common stock outstanding and entitled to vote.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Your vote is important. The affirmative vote of the holders of a
            majority of the shares of Caladrius&#8217; common stock having voting power present in person or represented by proxy at the Annual Meeting is required for approval of Proposal Nos. 1, 5, 6, 7 and 8. The affirmative vote of the holders of a majority
            of shares of Caladrius&#8217; common stock having voting power outstanding on the Record Date for the Annual Meeting is required for approval of Proposal Nos. 2 and 3. With respect to Proposal No. 4, the three nominees receiving the most &#8220;FOR&#8221; votes
            (from the votes of shares present in person or represented by proxy and entitled to vote on the election of directors) will be elected. The approval of Proposal No. 1 is a condition to the completion of the Merger. Therefore, the Merger cannot
            be consummated without the approval of Proposal No. 1.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">All Caladrius stockholders are cordially invited to participate in
            the online, live Annual Meeting. However, even if you plan to participate in the webcast Annual Meeting, we request that you vote by following the instructions in the Notice of Internet Availability of Proxy Materials that you previously
            received and submit your proxy by telephone or through the Internet or by mail as promptly as possible prior to the Annual Meeting to ensure that your shares of Caladrius stock will be represented at the Annual Meeting. Please note, however,
            that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the Annual Meeting, you must obtain a proxy issued in your name from the record holder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">By Order of Caladrius&#8217; board of directors,</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basking Ridge, New Jersey<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195;&#8195;&#8195;&#8195;, 2022</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">CALADRIUS&#8217; BOARD OF DIRECTORS HAS DETERMINED AND BELIEVES THAT EACH
            OF THE PROPOSALS OUTLINED ABOVE IS ADVISABLE TO, AND IN THE BEST INTERESTS OF, CALADRIUS AND ITS STOCKHOLDERS AND HAS APPROVED EACH SUCH PROPOSAL. CALADRIUS&#8217; BOARD OF DIRECTORS RECOMMENDS THAT CALADRIUS STOCKHOLDERS VOTE &#8220;FOR&#8221; EACH SUCH
            PROPOSAL.</div>

        </div>

      </div>

    </div>

    <!--End Page 5-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 6-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_102-notice_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">REFERENCES TO ADDITIONAL INFORMATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This proxy statement/prospectus/information statement incorporates important business
            and financial information about Caladrius that is not included in or delivered with this document. You may obtain this information without charge through the Securities and Exchange Commission (&#8220;SEC&#8221;) website (www.sec.gov) or upon your written
            or oral request by contacting Caladrius&#8217; Corporate Secretary at Caladrius Biosciences, Inc., 110 Allen Road, 2<sup>nd</sup> Floor, Basking Ridge, New Jersey 07920 or by calling (908) 842-0100.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To ensure timely delivery of these documents, any request should
              be made no later than September&#160;6, 2022, to receive them before the Annual Meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For additional details about where you can find information about Caladrius, please see
            the section entitled <span style="font-style: italic;">&#8220;Where You Can Find More Information&#8221;</span> in this proxy statement/prospectus/information statement.</div>

        </div>

      </div>

    </div>

    <!--End Page 6-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 7-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_103-toc_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">TABLE OF CONTENTS</div>

          <a id="TOC"><!--Anchor--></a>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tQA">QUESTIONS AND ANSWERS ABOUT THE MERGER</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tQA"><span style="padding-left: 10pt;">1</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPSUM">PROSPECTUS SUMMARY</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPSUM"><span style="padding-left: 5pt;">12</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCOMP1">The Companies</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCOMP1"><span style="padding-left: 5pt;">12</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tTMERG">The Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTMERG"><span style="padding-left: 5pt;">13</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRFM">Reasons for the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRFM"><span style="padding-left: 5pt;">14</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tOCF">Opinion of the Caladrius Financial Advisor</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tOCF"><span style="padding-left: 5pt;">15</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tOMA">Overview of the Merger Agreement</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tOMA"><span style="padding-left: 5pt;">15</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tSAGR">Support Agreements</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tSAGR"><span style="padding-left: 5pt;">17</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tLUP">Lock-up Agreements</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tLUP"><span style="padding-left: 5pt;">18</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCOLAG">Collaboration Agreement</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCOLAG"><span style="padding-left: 5pt;">18</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tMANAGEF">Management Following the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tMANAGEF"><span style="padding-left: 5pt;">19</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tICD">Interests of Certain Directors, Officers and Affiliates of
                      Caladrius and Cend</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tICD"><span style="padding-left: 5pt;">19</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tMUS">Material U.S. Federal Income Tax Consequences of the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tMUS"><span style="padding-left: 5pt;">19</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRISKF">Risk Factors</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRISKF"><span style="padding-left: 5pt;">20</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tREGU">Regulatory Approvals</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tREGU"><span style="padding-left: 5pt;">20</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tLIST">Nasdaq Capital Market Listing</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tLIST"><span style="padding-left: 5pt;">20</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tATREAT">Anticipated Accounting Treatment</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tATREAT"><span style="padding-left: 5pt;">21</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tAPPRD">Appraisal Rights and Dissenters&#8217; Rights</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tAPPRD"><span style="padding-left: 5pt;">21</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCSRI">Comparison of Stockholder Rights</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCSRI"><span style="padding-left: 5pt;">21</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tSHUP">SUMMARY HISTORICAL AND UNAUDITED PRO
                      FORMA CONDENSED COMBINED FINANCIAL DATA</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tSHUP"><span style="padding-left: 5pt;">22</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRF">RISK FACTORS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRF"><span style="padding-left: 5pt;">27</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRRM">Risks Related to the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRRM"><span style="padding-left: 5pt;">27</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRRC">Risks Related to Caladrius</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRRC"><span style="padding-left: 5pt;">31</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRRTC">Risks Related to Cend</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRRTC"><span style="padding-left: 5pt;">58</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRRTTCC">Risks Related to the Combined Company</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRRTTCC">100 </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tFLS">FORWARD-LOOKING STATEMENTS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tFLS">105</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tAMS">THE ANNUAL MEETING OF CALADRIUS STOCKHOLDERS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tAMS">106</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tDTP">Date, Time and Place</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tDTP">106</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPAM">Purposes of the Annual Meeting</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPAM">106</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRCBD">Recommendation of the Caladrius Board of Directors</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRCBD">106</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRDVP">Record Date and Voting Power</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRDVP">107</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tVRP">Voting and Revocation of Proxies</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tVRP">107</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRV">Required Vote</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRV">108</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tSP">Solicitation of Proxies</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tSP">109</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tOM">Other Matters</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tOM">109</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTHEME">THE MERGER</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTHEME"><span style="padding-left: 0.37pt;">110</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tBACKOM">Background of the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tBACKOM"><span style="padding-left: 0.37pt;">110</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRFTM">Caladrius Reasons for the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRFTM"><span style="padding-left: 0.37pt;">116</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCENDRFM">Cend Reasons for the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCENDRFM"><span style="padding-left: 0.37pt;">118</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tOOTC">Opinion of the Caladrius Financial Advisor</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tOOTC">120</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tIOTCD">Interests of the Caladrius Directors and Executive Officers
                      in the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tIOTCD">131</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCDEOM">Interests of the Cend Directors and Executive Officers in
                      the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCDEOM">134</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tFORM1">Form of the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tFORM1">137</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tMERGCAA">Merger Consideration and Adjustment</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tMERGCAA">137</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tDCNC">Determination of Caladrius&#8217; Net Cash</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tDCNC">139</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPECSE">Procedures for Exchanging Cend Stock Certificates</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPECSE">140</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tETOT">Effective Time of the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tETOT">141</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tREGAPP">Regulatory Approvals</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tREGAPP">141</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tTAXTM">Tax Treatment of the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTAXTM">141</a></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">i<br />
        </div>

      </div>

    </div>

    <!--End Page 7-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 8-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_103-toc_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tMATE1">Material U.S. Federal Income Tax Consequences of the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tMATE1">141</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tNASD">Nasdaq Capital Market Listing</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tNASD">143</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tANTIAT">Anticipated Accounting Treatment</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANTIAT">144</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tAPPRDR">Appraisal Rights and Dissenters&#8217; Rights</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tAPPRDR">144</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTMA">THE MERGER AGREEMENT</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tTMA">148</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tGEN">General</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tGEN">148</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tTCO">Treatment of Caladrius Options</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTCO">148</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tTCS">Treatment of Cend Options</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTCS">148</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tDOCF">Directors and Officers of Caladrius Following the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tDOCF">148</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tCIAC">Amended and Restated Certificate of
                      Incorporation and Amendments to the Amended and Restated Certificate of Incorporation of Caladrius</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCIAC">149</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCCM">Conditions to the Completion of the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCM">149</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tRW">Representations and Warranties</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tRW">152</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tNS">No Solicitation</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tNS">153</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tMOS">Meetings of Stockholders</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tMOS">155</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCCBP">Covenants; Conduct of Business Pending the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCBP">155</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tOA">Other Agreements</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tOA">158</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tTERM">Termination</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTERM">158</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tTFE">Termination Fee</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTFE">160</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tAME">Amendment</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tAME">162</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tARM">AGREEMENTS RELATED TO THE MERGER</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tARM">163</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tSUPP">Support Agreements</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tSUPP">163</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tLOCK">Lock-up Agreements</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tLOCK">163</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tSPA">Stock Purchase Agreement</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tSPA">164</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCOLLA">Collaboration Agreement</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCOLLA">164</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCDO">CALADRIUS DIRECTORS, OFFICERS AND CORPORATE GOVERNANCE</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tCDO">165</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tEOC">Executive Officers of Caladrius</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tEOC">165</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tDOC">Directors of Caladrius</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tDOC">166</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tBC">Board Composition</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tBC">169</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tBLSR">Board Leadership Structure and Role in Risk Oversight</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tBLSR">169</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tBOARD">Board Committees</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tBOARD">170</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tDIR">Director Compensation</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tDIR">175</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCCI">Compensation Committee Interlocks and Insider Participation</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCI">176</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tREPORT">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tREPORT">177</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCEC">CALADRIUS EXECUTIVE COMPENSATION</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tCEC">178</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCEND">CEND EXECUTIVE COMPENSATION</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tCEND">183</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCENDDC">CEND DIRECTOR COMPENSATION</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tCENDDC">188</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tMBS">MATTERS BEING SUBMITTED TO A VOTE OF CALADRIUS STOCKHOLDERS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tMBS">189</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPROP1">Proposal No. 1: Approval of the Merger and the Issuance of
                      Common Stock in the Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPROP1">189</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tPROP2">Proposal No. 2: Approval of an Amendment
                      to the Amended and Restated Certificate of Incorporation of Caladrius Effecting the Reverse Stock Split</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPROP2">190</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tPROP3">Proposal No. 3: Approval of an Amendment
                      to the Amended and Restated Certificate of Incorporation of Caladrius Effecting the Caladrius Name Change</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPROP3">196</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPROP4">Proposal No. 4: Election of Directors</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPROP4">197</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPROP5">Proposal No. 5: Ratification of Selection of Independent
                      Registered Public Accounting Firm</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPROP5">198</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPROP6">Proposal No. 6: The Non-Binding, Advisory Vote on Named
                      Executive Officer Compensation</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPROP6">199</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPROP7">Proposal No. 7: Approval of an Amendment to the 2018 Equity
                      Incentive Compensation Plan</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPROP7">200</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPROP8">Proposal No. 8: Approval of Possible Adjournment of the
                      Annual Meeting</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPROP8">205</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tEPT">EQUITY PLAN TABLE</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tEPT">206</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tECPI">Equity Compensation Plan Information</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tECPI">206</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCBUS">CALADRIUS BUSINESS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;" class="fpara"><a href="#tCBUS">207</a></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">ii<br />
        </div>

      </div>

    </div>

    <!--End Page 8-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 9-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_103-toc_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCEBUS">CEND BUSINESS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tCEBUS"><span style="padding-left: 4.44pt;">220</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tCMDAF">CALADRIUS MANAGEMENT&#8217;S DISCUSSION AND
                      ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tCMDAF"><span style="padding-left: 4.44pt;">231</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tCENDOP">CEND MANAGEMENT&#8217;S DISCUSSION AND
                      ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tCENDOP"><span style="padding-left: 4.44pt;">241</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tMFTM">MANAGEMENT FOLLOWING THE MERGER</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tMFTM"><span style="padding-left: 4.44pt;">253</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tEOAD">Executive Officers and Directors</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tEOAD"><span style="padding-left: 4.44pt;">253</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCOMP">Composition of the Board of Directors</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tCOMP"><span style="padding-left: 4.44pt;">257</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCOMMI">Committees of the Board of Directors</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tCOMMI"><span style="padding-left: 4.44pt;">257</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tPARTY">RELATED PARTY TRANSACTIONS OF DIRECTORS
                      AND EXECUTIVE OFFICERS OF THE COMBINED ORGANIZATION</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tPARTY"><span style="padding-left: 4.44pt;">260</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCALA">Caladrius Transactions</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tCALA"><span style="padding-left: 4.44pt;">260</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tTRANS">Cend Transactions</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tTRANS"><span style="padding-left: 4.44pt;">260</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPRO">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tPRO"><span style="padding-left: 4.44pt;">262</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tSTOCK">DESCRIPTION OF CALADRIUS CAPITAL STOCK</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tSTOCK"><span style="padding-left: 4.44pt;">274</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCRHCF">COMPARISON OF RIGHTS OF HOLDERS OF CALADRIUS STOCK AND CEND
                      STOCK</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tCRHCF"><span style="padding-left: 4.44pt;">277</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tPOSTM">Current Cend Rights Versus Caladrius Rights Post-Merger</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tPOSTM"><span style="padding-left: 4.44pt;">277</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tIOOA">Indemnification of Officers and Directors
                      and Advancement of Expenses; Limitation on Personal Liability</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tIOOA"><span style="padding-left: 4.44pt;">285</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tATCO">Amendments to Certificate of Incorporation or Bylaws</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tATCO"><span style="padding-left: 4.44pt;">286</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPSOC">PRINCIPAL STOCKHOLDERS OF CALADRIUS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tPSOC"><span style="padding-left: 4.44pt;">288</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPSCEND">PRINCIPAL STOCKHOLDERS OF CEND</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tPSCEND"><span style="padding-left: 4.44pt;">290</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tPRINC">PRINCIPAL STOCKHOLDERS OF THE COMBINED ORGANIZATION</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tPRINC"><span style="padding-left: 4.44pt;">292</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tLEGAL">LEGAL MATTERS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tLEGAL"><span style="padding-left: 4.44pt;">294</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tEXPER">EXPERTS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tEXPER"><span style="padding-left: 4.44pt;">294</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tWHERE">WHERE YOU CAN FIND MORE INFORMATION</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tWHERE"><span style="padding-left: 4.44pt;">294</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tTRADEN">TRADEMARK NOTICE</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tTRADEN"><span style="padding-left: 4.44pt;">295</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tOMS">OTHER MATTERS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tOMS"><span style="padding-left: 4.44pt;">295</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tSHP">Stockholder Proposals</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tSHP"><span style="padding-left: 4.44pt;">295</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCOMM">Stockholder Communications with the Caladrius Board of
                      Directors</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tCOMM"><span style="padding-left: 4.44pt;">295</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tHOUSE">Householding of Proxy Materials</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tHOUSE"><span style="padding-left: 4.44pt;">295</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tAREPORT">Annual Reports</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tAREPORT"><span style="padding-left: 4.44pt;">295</span></a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tINDEX1">INDEX TO CALADRIUS FINANCIAL STATEMENTS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tINDEX1">FS-1</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tINDEX2">INDEX TO CEND FINANCIAL STATEMENTS</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tINDEX2">FS-1</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANNEXA">ANNEX A&#8212;AGREEMENT AND PLAN OF MERGER AND REORGANIZATION </a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tANNEXA"><span style="padding-left: 3.89pt;">A-</span>1 </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANNEXB">ANNEX B&#8212;OPINION OF BACK BAY LIFE SCIENCES ADVISORS, LLC</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tANNEXB"><span style="padding-left: 4.45pt;">B-</span>1</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANNEXC">ANNEX C&#8212;GENERAL CORPORATION LAW OF THE STATE OF DELAWARE </a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tANNEXC"><span style="padding-left: 4.45pt;">C-</span>1</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANNEXD">ANNEX D&#8212;CERTIFICATE OF AMENDMENT FOR THE REVERSE STOCK SPLIT</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: justify;" class="fpara"><a href="#tANNEXD"><span style="padding-left: 3.89pt;">D-</span>1</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANNEXE">ANNEX E&#8212;CERTIFICATE OF AMENDMENT FOR THE CALADRIUS NAME
                      CHANGE</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tANNEXE"><span style="padding-left: 5pt;">E-</span>1</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANNEXF">ANNEX F&#8212;2018 EQUITY INCENTIVE COMPENSATION PLAN, AS AMENDED</a></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -4.44pt; text-align: left;" class="fpara"><a href="#tANNEXF"><span style="padding-left: 5.56pt;">F-</span>1</a></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">iii<br />
        </div>

      </div>

    </div>

    <!--End Page 9-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 10-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tQA"><!--Anchor--></a>QUESTIONS AND ANSWERS ABOUT THE MERGER</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Except where specifically noted, the following information and all other information
            contained in this proxy statement/prospectus/information statement does not give effect to the proposed reverse stock split described in Proposal No. 2, beginning on page&#160;<a href="#tPROP2">190</a> in this proxy statement/prospectus/information
            statement (the &#8220;Reverse Stock Split&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following section provides answers to frequently asked questions about the Merger
            (as defined below). This section, however, provides only summary information. For a more complete response to these questions and for additional information, please refer to the cross-referenced sections. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What is the Merger? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;) and Cend Therapeutics, Inc.
                      (&#8220;Cend&#8221;) have entered into an Agreement and Plan of Merger and Reorganization, dated as of April&#160;26, 2022 (the &#8220;Merger Agreement&#8221;). The Merger Agreement contains the terms and conditions of the proposed business combination of
                      Caladrius and Cend. Under the Merger Agreement, CS Cedar Merger Sub, Inc., a wholly owned subsidiary of Caladrius (&#8220;Merger Sub&#8221;) will merge with and into Cend, with Cend surviving as a wholly owned subsidiary of Caladrius (the
                      &#8220;Merger&#8221;).</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">At the effective time of the Merger (the &#8220;Effective Time&#8221;), each share of Cend&#8217;s
            common stock, par value $0.00001 per share (&#8220;Cend Common Stock&#8221;), and each share of Cend&#8217;s preferred stock, par value $0.00001 per share (&#8220;Cend Preferred Stock,&#8221; and together with Cend Common Stock, &#8220;Cend Capital Stock&#8221;) outstanding immediately
            prior to the Effective Time (excluding certain shares to be canceled pursuant to the Merger Agreement, and shares held by stockholders who have exercised and perfected appraisal rights or dissenters&#8217; rights as more fully described in the
            section of this proxy statement/prospectus/information statement entitled <span style="font-style: italic;">&#8220;The Merger&#8212;Appraisal Rights and Dissenters&#8217; Rights&#8221;</span>) will be converted into the right to receive approximately 8.5623 shares of
            Caladrius&#8217; common stock, par value $0.001 per share (&#8220;Caladrius Common Stock&#8221;), subject to adjustment to account for the Reverse Stock Split, and further adjusted based on Caladrius&#8217; net cash and Cend&#8217;s unpaid transaction costs immediately
            prior to the closing (the &#8220;Closing&#8221;) of the Merger (the&#160;&#8220;Exchange Ratio&#8221;). Because Caladrius&#8217; net cash balance and Cend&#8217;s unpaid transaction costs will not be determined until the Closing, and because the number of shares of Caladrius Common
            Stock issuable to Cend is determined based on Caladrius&#8217; net cash balance and Cend&#8217;s unpaid transaction costs at Closing, Caladrius Stockholders (as defined below) cannot be certain of the exact number of shares that will be issued to Cend&#8217;s
            stockholders when Caladrius&#8217; stockholders vote on the proposals at the annual meeting of stockholders of Caladrius Stockholders (the &#8220;Annual Meeting&#8221;). The Exchange Ratio is an estimate only and the final Exchange Ratio will be determined
            pursuant to a formula described in more detail in the Merger Agreement and in the attached proxy statement/prospectus/information statement. As a result of the Merger, current holders of shares of Cend Capital Stock (each holder of Cend Capital
            Stock, a &#8220;Cend Stockholder&#8221;) are expected to own, or hold rights to acquire, in the aggregate approximately 50% of the outstanding shares of Caladrius Common Stock and current stockholders of Caladrius (&#8220;Caladrius Stockholders&#8221;) are expected to
            own in the aggregate approximately 50% of the outstanding shares of Caladrius Common Stock and, in each case, following the Effective Time and subject to adjustment of the Exchange Ratio. After the consummation of the Merger, and assuming
            Caladrius Stockholders approve Proposal No. 3, Caladrius will change its corporate name to &#8220;Lisata Therapeutics, Inc.&#8221; as required by the Merger Agreement (the &#8220;Caladrius Name Change&#8221;). </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What will happen to Caladrius if, for any reason, the Merger does not close? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">If, for any reason, the Merger does not close, the board of directors of
                      Caladrius (the &#8220;Caladrius Board of Directors&#8221;) will continue to operate the existing business of Caladrius and may seek to continue to seek strategic transactions to diversify its pipeline of development product candidates. </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Why are the two companies proposing to merge? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Cend and Caladrius believe that the Merger will result in a drug discovery
                      and development company aiming to diversify the indication and technology risk associated with its development pipeline and to increase opportunity for value creation of its shareholders. For a discussion of Caladrius&#8217; and Cend&#8217;s
                      reasons for the Merger, please see the section entitled </span><span style="font-style: italic; font-weight: normal;">&#8220;The Merger&#8212;Caladrius Reasons for the Merger&#8221;</span><span style="font-weight: normal;"> and </span><span style="font-style: italic; font-weight: normal;">&#8220;The Merger&#8212;Cend Reasons for the Merger&#8221;</span><span style="font-weight: normal;"> in this proxy statement/prospectus/information statement.</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">1<br />
        </div>

      </div>

    </div>

    <!--End Page 10-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 11-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Why am I receiving this proxy statement/prospectus/information statement? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">You are receiving this proxy statement/prospectus/information statement
                      because you have been identified as a Caladrius Stockholder or Cend Stockholder as of the applicable Record Date (as defined below), and you are entitled, as applicable, to (i)&#160;vote at the Annual Meeting to approve the Merger
                      Agreement and the transactions contemplated thereby, including the Merger and the issuance of shares of Caladrius Common Stock pursuant to the Merger Agreement, or (ii)&#160;sign and return the Cend written consent to adopt the Merger
                      Agreement and approve the transactions contemplated thereby, including the Merger. The Annual Meeting will be held via live webcast on the internet. You will be able to participate in the Annual Meeting, vote and submit your questions
                      during the Annual Meeting by visiting www.virtualshareholdermeeting.com/CLBS2022SM. You will not be able to attend the Annual Meeting in person. This document serves as:</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a proxy statement of Caladrius used to solicit proxies for the Annual Meeting; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a prospectus of Caladrius used to offer shares of Caladrius Common Stock in exchange for shares of Cend Capital Stock in the
                    Merger and issuable upon exercise of options to purchase Caladrius Common Stock, as applicable; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an information statement of Cend used to solicit the written consent of Cend Stockholders for the adoption of the Merger
                    Agreement and the approval of the Merger and related transactions. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What is required to consummate the Merger? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To consummate the Merger, Caladrius Stockholders must approve the Merger
                      and the issuance of Caladrius Common Stock pursuant to the Merger Agreement (Proposal No. 1) and Cend Stockholders must adopt the Merger Agreement and, thereby, approve the Merger and the other transactions contemplated by the Merger
                      Agreement.</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The approval of the Merger and the issuance of Caladrius Common Stock pursuant to the
            Merger Agreement by the Caladrius Stockholders requires the affirmative vote of the holders of a majority of the shares of Caladrius Common Stock having voting power present in person or represented by proxy at the Annual Meeting. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The adoption of the Merger Agreement and the approval of the Merger and related
            transactions by the Cend Stockholders requires the affirmative vote (or written consent) of the holders of a majority of (a) the outstanding shares of Cend Common Stock and Cend Preferred Stock, voting together as one class, (b) the holders of
            a majority of the outstanding shares of Cend Series A Preferred Stock, voting as a separate class, (c) the holders of a majority of the outstanding shares of Cend Series B Preferred Stock, voting as a separate class and (d) holders of a
            majority of the outstanding shares of Cend Series D Preferred Stock, voting as a separate class. In addition to the requirement of obtaining such stockholder approvals and appropriate regulatory approvals, each of the other closing conditions
            set forth in the Merger Agreement must be satisfied or waived.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The presence, in person or represented by proxy, at the Annual Meeting of the holders
            of a majority of the shares of Caladrius Common Stock outstanding and entitled to vote at the Annual Meeting is necessary to constitute a quorum at the meeting. Abstentions and broker non-votes will be counted toward a quorum. The affirmative
            vote of a majority of the votes cast in person or by proxy at the Annual Meeting, assuming a quorum is present, is required for approval of Proposal No. 1. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The approval of Proposal No. 1 is a condition to the completion of the Merger.
            Therefore, the Merger cannot be consummated without the approval of Proposal No. 1.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">Votes will be counted by the inspector of election appointed for the meeting, who will
            separately count &#8220;FOR,&#8221; &#8220;AGAINST&#8221; and &#8220;WITHHOLD&#8221; votes, abstentions and broker non-votes. Abstentions and broker non-votes will be treated as shares present for the purpose of determining the presence of a quorum for the transaction of business
            at the Annual Meeting. Abstentions and broker non-votes will not, however, be considered votes cast at the Annual Meeting and will therefore not have any effect with respect to Proposal No. 1. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">As of June&#160;13, 2022, certain Cend Stockholders who in the aggregate own 100% of the
            outstanding shares of Cend Series A Preferred Stock, approximately 88.8% of the outstanding shares of Cend Series B </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">2<br />
        </div>

      </div>

    </div>

    <!--End Page 11-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 12-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="fpara">Preferred Stock and approximately 77.5% of the outstanding shares of Cend Capital
            Stock on an as converted to common stock basis (excluding shares held by Caladrius), and certain Caladrius Stockholders who in the aggregate own approximately 1.8% of the outstanding shares of Caladrius Common Stock, are parties to support
            agreements with Caladrius and Cend, respectively, whereby such stockholders have agreed to vote their shares in favor of the adoption or approval, as applicable, of the Merger Agreement and the transactions contemplated therein, including the
            Merger and the issuance of Caladrius Common Stock to Cend Stockholders pursuant to the Merger Agreement, subject to the terms of the support agreements. In addition, following the registration statement on Form S-4, of which this proxy
            statement/prospectus/information statement is a part, being declared effective by the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) and pursuant to the conditions of the Merger Agreement, Cend Stockholders who are party to the support
            agreements will each execute written consents approving the Merger and related transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">Therefore, holders of a sufficient number of shares of Cend Capital Stock required to
            adopt the Merger Agreement, thereby approving the Merger, have agreed to adopt the Merger Agreement via written consent. Cend Stockholders, including those who are parties to support agreements, are being requested to execute written consents
            providing such approvals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">For a more complete description of the closing conditions under the Merger Agreement,
            Caladrius urges you to read the section entitled <span style="font-style: italic;">&#8220;The Merger Agreement&#8212;Conditions to the Completion of the Merger&#8221;</span> in this proxy statement/prospectus/information statement. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What proposals are to be voted on at the Annual Meeting, other than the proposals required in connection with
                    the Merger? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">At the Annual Meeting, the Caladrius Stockholders will also be asked to
                      consider the following proposals, along with any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof: </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Proposal No. 2 to approve an amendment to the amended and restated certificate of incorporation of Caladrius to effect the
                    Reverse Stock Split;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Proposal No. 3 to approve an amendment to the amended and restated certificate of incorporation of Caladrius to effect the
                    Caladrius Name Change;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Proposal No. 4 to elect three Class&#160;III directors to hold office until the 2025 annual meeting of Caladrius Stockholders or
                    until their successors are elected (provided, however, that if the Merger is completed, the Caladrius Board of Directors will be reconstituted as provided in the Merger Agreement); </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Proposal No. 5 to ratify the selection of Grant Thornton LLP as Caladrius&#8217; independent registered public accounting firm for the
                    calendar year ending December&#160;31, 2022; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Proposal No. 6 to approve, on a non-binding, advisory basis, the executive compensation of Caladrius&#8217; named executive officers
                    as described in this proxy statement/prospectus/information statement;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Proposal No. 7 to approve an amendment to the Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan that increases
                    the number of shares of common stock that may be issued under the Plan by 5,000,000; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Proposal No. 8 to approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not
                    sufficient votes in favor of Proposal No. 1 or 2. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The approval of Proposal Nos. 2, 3, 4, 5, 6, 7 and 8 are not conditions to the Merger.
            Such proposals, together with Proposal No. 1, are referred to collectively in this proxy statement/prospectus/information statement as the proposals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The approval of the Reverse Stock Split (Proposal No. 2) is required in order to avoid
            a potential delisting of Caladrius Common Stock from The Nasdaq Capital Market. However, the approval of the Reverse Stock Split (Proposal No. 2) is not a condition to closing the Merger and is also not conditioned upon the consummation of the
            Merger, and as such the Reverse Stock Split may be implemented by the Caladrius Board of Directors even if the Merger does not take place.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">3<br />
        </div>

      </div>

    </div>

    <!--End Page 12-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 13-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="fpara">Caladrius Stockholders should understand, however, that if the Merger is completed,
            the effect of the approval of Proposal No. 4 will be limited since the composition of the Caladrius Board of Directors will be changed upon completion of the Merger in accordance with the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The election of Class&#160;III directors to the Caladrius Board of Directors requires a
            plurality of the votes cast at the Annual Meeting. The approval of the proposal to ratify the selection of an independent registered public accounting firm for the calendar year ending December&#160;31, 2022 requires the affirmative vote of a
            majority of the votes cast in person or by proxy (not counting &#8220;abstentions&#8221; or &#8220;broker non-votes&#8221; as votes cast), assuming a quorum is present, at the Annual Meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The presence, in person or represented by proxy, at the Annual Meeting of the
              holders of a majority of the shares of Caladrius Common Stock outstanding and entitled to vote at the Annual Meeting is necessary to constitute a quorum at the meeting. Abstentions and broker non-votes will be counted toward a quorum. The
              affirmative vote of a majority of the votes cast in person or by proxy at the Annual Meeting, assuming a quorum is present, is required for approval of Proposal Nos. 5, 6, 7 and 8. The affirmative vote of the holders of a majority of shares
              of Caladrius Common Stock having voting power outstanding on July&#160;25, 2022 (the &#8220;Record Date&#8221;) is required for approval of Proposal Nos. 2 and 3. Broker non-votes will not be counted towards the vote total for Proposal Nos. 5, 6, 7 and 8.
              Abstentions and broker non-votes will have the same effect as a vote &#8220;AGAINST&#8221; Proposal Nos. 2 and 3. With respect to Proposal No. 4, the three nominees receiving the most &#8220;FOR&#8221; votes (from the votes of shares present in person or represented
              by proxy and entitled to vote on the election of directors) will be elected. Broker non-votes will not be counted towards the vote total for Proposal No. 4.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">Votes will be counted by the inspector of election appointed for the Annual Meeting,
            who will separately count &#8220;FOR,&#8221; &#8220;AGAINST&#8221; and &#8220;WITHHOLD&#8221; votes, abstentions and broker non-votes. &#8220;WITHHOLD&#8221; votes with respect to the election of one or more nominees for director pursuant to Proposal No. 4 will not be voted with respect to
            the director or directors indicated, although they will be counted for purposes of determining the presence of a quorum for the transaction of business at the Annual Meeting. Abstentions and broker non-votes will also be treated as shares
            present for the purpose of determining the presence of a quorum for the transaction of business at the Annual Meeting. Abstentions and broker non-votes will not, however, be considered votes cast at the Annual Meeting and will therefore not
            have any effect with respect to Proposal Nos. 5, 6, 7 and 8. Abstentions and broker non-votes will have the same effect as &#8220;AGAINST&#8221; votes for Proposal Nos. 2 and 3.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">As of June&#160;13, 2022, the directors and executive officers of Caladrius beneficially
            owned approximately 1.8% of the outstanding shares of Caladrius Common Stock entitled to vote at the Annual Meeting. As of June&#160;13, 2022, Caladrius is not aware of any affiliate of Cend owning any shares of Caladrius Common Stock entitled to
            vote at the Annual Meeting. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What will Cend Stockholders and holders of Cend Options receive in the Merger? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">As a result of the Merger, Cend Stockholders will become entitled to
                      receive shares, or rights to acquire shares, of Caladrius Common Stock equal to, in the aggregate, approximately 50% of the outstanding shares of Caladrius Common Stock. Following the Closing, holders of options or other rights to
                      purchase Cend Capital Stock (&#8220;Cend Options&#8221;) will have their Cend Options converted into options to purchase shares of Caladrius Common Stock, with the number of shares of Caladrius Common Stock subject to such option and the exercise
                      price being appropriately adjusted to reflect the Exchange Ratio between Caladrius Common Stock and Cend Capital Stock determined in accordance with the Merger Agreement. </span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">For a more complete description of what Cend Stockholders and holders of Cend Options
            will receive in the Merger, please see the section entitled <span style="font-style: italic;">&#8220;The Merger&#8212;Merger Consideration and Adjustment&#8221;</span> in this proxy statement/prospectus/information statement. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">4<br />
        </div>

      </div>

    </div>

    <!--End Page 13-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 14-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who will be the directors of Caladrius following the Merger? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Following the consummation of the Merger, the size of the Caladrius
                        Board of Directors will be maintained to include a total of up to nine directors. Pursuant to the terms of the Merger Agreement, the Caladrius Board of Directors will be reconstituted such that four of directors will
                        be designated by Cend and four directors will be designated by Caladrius. Following the Closing, the eight Caladrius and Cend designees may mutually select a ninth director, though
                      there are no current plans to do so. It is anticipated that, following the Closing, the Caladrius Board of Directors will be constituted as follows: </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;" class="txttab">


  <tr class="header">

    <td style="width: 42.86%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 2.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Current Principal Affiliation</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.</div>
                </td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc., President and Chief <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Executive Officer and Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D.</div>
                </td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc., Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk</div>
                </td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc., Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers</div>
                </td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc., Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack</div>
                </td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Therapeutics, Inc., President and Chief Executive <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Officer and Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Heidi Henson</div>
                </td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Therapeutics, Inc., Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Erkki Ruoslahti, M.D., Ph.D.</div>
                </td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Therapeutics, Inc., Scientific Founder &amp; Chairman</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mohammad Azab, MD, MBA </div>
                </td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">DURECT Corporation, Director</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who will be the executive officers of Caladrius immediately following the Merger? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Immediately following the consummation of the Merger, the executive
                      management team of Caladrius is expected to be composed of the following executive officers: </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 448pt; margin-left: 20pt;" class="txttab">


  <tr class="header">

    <td style="width: 42.86%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.97%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.97%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 53.21%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Title</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.</div>
                </td>

    <td style="width: 1.97%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.97%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 53.21%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Chief Executive Officer</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack</div>
                </td>

    <td style="width: 1.97%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.97%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 53.21%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President &amp; Chief Business Officer</div>
                </td>

  </tr>

  <tr>

    <td style="width: 42.86%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D.</div>
                </td>

    <td style="width: 1.97%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.97%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 53.21%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Executive Vice President R&amp;D and Chief Medical Officer</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What are the material U.S. federal income tax consequences of the Reverse Stock Split? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Reverse Stock Split should constitute a &#8220;recapitalization&#8221; for U.S. federal income tax purposes. As a result, a U.S. holder
                    (as defined in the section of this proxy statement/prospectus/information statement entitled &#8220;<span style="font-style: italic;">Matters Being Submitted to a Vote of Caladrius Stockholders&#8212;Caladrius Proposal No. 2: Approval of an
                      Amendment to the Amended and Restated Certificate of Incorporation of Caladrius Effecting the Reverse Stock Split&#8212;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</span>&#8221;) of Caladrius Common Stock generally
                    should not recognize gain or loss upon the Reverse Stock Split, except with respect to cash received in lieu of a fractional share of Caladrius Common Stock, as discussed in the section of this proxy statement/prospectus/information
                    statement entitled &#8220;<span style="font-style: italic;">Matters Being Submitted to a Vote of Caladrius Stockholders&#8212;Caladrius Proposal No. 2: Approval of an Amendment to the Amended and Restated Certificate of Incorporation of Caladrius
                      Effecting the Reverse Stock Split&#8212;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split.</span>&#8221; A U.S. holder&#8217;s aggregate tax basis in the shares of Caladrius Common Stock received pursuant to the Reverse Stock
                    Split should equal the aggregate tax basis of the shares of the Caladrius Common Stock surrendered (excluding any portion of such basis that is allocated to any fractional share of Caladrius Common Stock), and such U.S. holder&#8217;s holding
                    period in the shares of Caladrius Common Stock received should include the holding period in the shares of Caladrius Common Stock surrendered. Treasury Regulations provide detailed rules for allocating the tax basis and holding period
                    of the shares of Caladrius Common Stock surrendered to the shares of Caladrius Common Stock received in a recapitalization pursuant to the Reverse Stock Split. U.S. holders of shares of Caladrius Common Stock acquired on different dates
                    and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such shares. For more information, please see the section of this proxy statement/prospectus/information statement
                    entitled &#8220;<span style="font-style: italic;">Matters Being Submitted to a Vote of Caladrius Stockholders&#8212;Caladrius Proposal No. 2: Approval of an Amendment to the Amended and Restated Certificate of Incorporation of Caladrius Effecting
                      the Reverse Stock Split&#8212;Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</span>.&#8221; </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">5<br />
        </div>

      </div>

    </div>

    <!--End Page 14-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 15-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What are the material U.S. federal income tax consequences of the Merger?</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius and Cend intend the Merger to qualify as a reorganization within the meaning of Section 368(a) of the Internal Revenue
                    Code of 1986, as amended (the &#8220;Code&#8221;), as described in the section entitled <span style="font-style: italic;">&#8220;The Merger&#8212;Material U.S. Federal Income Tax Consequences of the Merger&#8221;</span> in this proxy
                    statement/prospectus/information statement. Assuming the Merger constitutes a reorganization, subject to the limitations and qualifications described in the section entitled <span style="font-style: italic;">&#8220;The Merger&#8212;Material U.S.
                      Federal Income Tax Consequences of the Merger&#8221;</span> in this proxy statement/prospectus/information statement, Cend Stockholders generally should not recognize gain or loss for U.S. federal income tax purposes on the receipt of
                    shares of Caladrius Common Stock issued in connection with the Merger (other than in respect of cash received in lieu of fractional shares). Each Cend Stockholder who receives cash in lieu of a fractional share of Caladrius Common Stock
                    will be treated for U.S. federal income tax purposes as having received such fractional share pursuant to the Merger and then as having exchanged such fractional share for cash in a redemption by Caladrius. A Cend Stockholder should
                    generally recognize gain or loss on such a deemed exchange of the fractional share.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">If the Merger is not treated as a reorganization under Section 368(a) of the Code,
            then, subject to the limitations and qualifications described in the section entitled <span style="font-style: italic;">&#8220;The Merger&#8212;Material U.S. Federal Income Tax Consequences of the Merger&#8221;</span> in this proxy
            statement/prospectus/information statement, each Cend Stockholder will generally recognize gain or loss, for U.S. federal income tax purposes, on the receipt of shares of Caladrius Common Stock issued to such Cend Stockholder and on any cash
            received in lieu of fractional shares in connection with the Merger. The tax consequences to each Cend Stockholder will depend on that stockholder&#8217;s particular circumstances. Each Cend Stockholder should consult with his, her or its tax advisor
            for a full understanding of the tax consequences of the Merger to that stockholder. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">As a Caladrius Stockholder, how does the Caladrius Board of Directors recommend that I vote? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">After careful consideration, the Caladrius Board of Directors recommends
                      that Caladrius Stockholders vote: </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;FOR&#8221; Proposal No. 1 to approve the Merger Agreement and the transactions contemplated thereby, including the Merger and the
                    issuance of shares of Caladrius Common Stock to Cend Stockholders in the Merger; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;FOR&#8221; Proposal No. 2 to approve an amendment to the amended and restated certificate of incorporation of Caladrius to effect the
                    Reverse Stock Split; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;FOR&#8221; Proposal No. 3 to approve an amendment to the amended and restated certificate of incorporation of Caladrius to effect the
                    Caladrius Name Change; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;FOR&#8221; Proposal No. 4 to elect each of the Class&#160;III nominees for director to hold office until the 2025 annual meeting of
                    Caladrius Stockholders or until their successors are elected; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;FOR&#8221; Proposal No. 5 to ratify the selection by the audit committee of the Caladrius Board of Directors of Grant Thornton LLP as
                    the independent registered public accounting firm of Caladrius for its calendar year ending December&#160;31, 2022; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;FOR&#8221; Proposal No. 6 to approve, on a non-binding, advisory basis, the executive compensation of Caladrius&#8217; named executive
                    officers as described in this proxy statement/prospectus/information statement;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;FOR&#8221; Proposal No. 7 to approve an amendment to the Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan that
                    increases the number of shares of common stock that may be issued under the Plan by 5,000,000; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;FOR&#8221; Proposal No. 8 to adjourn the Annual Meeting, if necessary, if a quorum is present, to solicit additional proxies if there
                    are not sufficient votes in favor of Proposal No. 1 or 2. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">As a Cend Stockholder, how does the Cend Board of Directors recommend that I vote? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">After careful consideration, the board of directors of Cend (the &#8220;Cend
                      Board of Directors&#8221;) recommends that Cend Stockholders execute the written consent indicating their vote in favor of the adoption of the Merger Agreement and the approval of the Merger and the transactions contemplated by the Merger
                      Agreement. </span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">6<br />
        </div>

      </div>

    </div>

    <!--End Page 15-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 16-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What risks should I consider in deciding whether to vote in favor of the Merger or to execute and return the
                    written consent, as applicable? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">You should carefully review the section of this proxy
                      statement/prospectus/information statement entitled </span><span style="font-style: italic; font-weight: normal;">&#8220;Risk Factors,&#8221;</span><span style="font-weight: normal;"> which sets forth certain risks and uncertainties related to
                      the Merger, risks and uncertainties to which the combined organization&#8217;s business will be subject, and risks and uncertainties to which each of Caladrius and Cend, as independent companies, are subject. </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who can vote at the Annual Meeting? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Only Caladrius Stockholders of record at the close of business on the
                        Record Date, July&#160;25, 2022, will be entitled to vote at the Annual Meeting. As of July&#160;25, 2022, there were 60,583,249 shares of Caladrius Common Stock outstanding and
                        entitled to vote. </span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 20pt; text-align: left;" class="h3">Stockholder of Record: Shares Registered in Your
            Name</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">If, at the close of business on the Record Date, your shares of Caladrius Common Stock
            were registered directly in your name with Caladrius&#8217; transfer agent, Continental Stock Transfer &amp; Trust Company, then you are a Caladrius Stockholder of record. As a Caladrius Stockholder of record, you may vote virtually at the Annual
            Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, please vote as soon as possible by completing and returning the enclosed proxy card or vote by proxy over the telephone or on the internet as instructed below to
            ensure your vote is counted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 20pt; text-align: left;" class="h3">Beneficial Owner: Shares Registered in the Name
            of a Broker or Bank</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">If, at the close of business on the Record Date, your shares of Caladrius Common Stock
            were not held in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in &#8220;street name&#8221; and these proxy materials are being forwarded to you by that
            organization. The organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent how to vote the
            shares in your account. You are also invited to attend the Annual Meeting. However, because you are not the stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy from
            your broker or other agent. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How many votes do I have? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">On each matter to be voted upon, you have one vote for each share of
                      Caladrius Common Stock you own as of the Record Date. </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What is the quorum requirement? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">A quorum of stockholders is necessary to hold a valid meeting. A quorum
                        will be present if stockholders holding at least a majority of the outstanding shares entitled to vote are present at the Annual Meeting. On July 25, 2022, there were 60,583,249 shares
                        of Caladrius Common Stock outstanding and entitled to vote. Accordingly, Caladrius expects that the holders of at least 30,291,625 shares of Caladrius Common Stock must be present at the Annual
                        Meeting for a quorum to exist. Your shares of Caladrius Common Stock will be counted toward the quorum at the Annual Meeting only if you attend the Annual Meeting in person or are represented at the Annual Meeting by
                        proxy. </span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">Abstentions and broker non-votes (as described below) will be counted towards the
            quorum requirement. If there is no quorum, the holders of a majority of shares present and entitled to vote at the meeting in person or represented by proxy may adjourn the Annual Meeting to another date. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What are &#8220;broker non-votes&#8221;? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">If you hold shares beneficially in street name and do not provide your
                      broker or other agent with voting instructions, your shares may constitute &#8220;broker non-votes.&#8221; Broker non-votes occur on a matter when a broker is not permitted to vote on that matter without instructions from the beneficial owner and
                      instructions are not given. These matters are referred to as &#8220;non-routine&#8221; matters. Proposals Nos. 1, 3, 4, 6, 7 and 8 are </span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">7<br />
        </div>

      </div>

    </div>

    <!--End Page 16-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 17-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="fpara">anticipated to be &#8220;non-routine&#8221; matters, but Proposal No. 2 regarding the Reverse
            Stock Split and Proposal No. 5 regarding the ratification of the selection of the independent registered public accounting firm are anticipated to be &#8220;routine&#8221; matters. Broker non-votes will not be counted toward the vote total for any proposal
            at the Annual Meeting. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How can I find out the results of the voting at the Annual Meeting? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Caladrius will disclose final voting results in a Current Report on Form
                      8-K filed with the SEC within four business days after the Annual Meeting. If final voting results are unavailable at that time, then Caladrius intends to file a Current Report on Form 8-K to disclose preliminary voting results and
                      file an amended Current Report on Form 8-K within four business days after the date the final voting results are available. </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">When are stockholder proposals due for next year&#8217;s annual meeting? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To be considered for inclusion in the proxy materials for the 2023
                        annual meeting of Caladrius Stockholders, your proposal must be submitted in writing by April&#160;4, 2023 to Caladrius&#8217; Corporate Secretary at Caladrius Biosciences, Inc., 110 Allen Road, 2<sup>nd</sup>
                        Floor, Basking Ridge, New Jersey 07920. However, if the meeting is more than 30 days from September&#160;13, 2023, then the deadline for stockholder proposals will be a reasonable time before Caladrius
                        begins to print and mail the proxy materials before the meeting. </span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">If you wish to submit a proposal before the stockholders or nominate a director at
              the 2023 annual meeting of Caladrius Stockholders, but you are not requesting that your proposal or nomination be included in the proxy materials for that meeting, then you must follow the procedures set forth in Caladrius&#8217; bylaws and, among
              other things, notify Caladrius&#8217; Corporate Secretary in writing between May&#160;16, 2023 and June&#160;15, 2023. However, if the date of the 2023 annual meeting of Caladrius Stockholders is more than 30 days before or more than 60 days after September
              13, 2023, then you must give notice no later than the 90th day prior to that meeting or, if later, the 10th day following the day on which public disclosure of that annual meeting date is first made. You are also advised to review Caladrius&#8217;
              bylaws, which contain additional requirements regarding advance notice of stockholder proposals and director nominations. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">When do you expect the Merger to be consummated? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Caladrius and Cend anticipate that the Merger will occur sometime soon
                        after the Annual Meeting to be held on September&#160;13, 2022, but the companies cannot predict the exact timing. For more information, please see the section entitled </span><span style="font-style: italic; font-weight: normal;">&#8220;The Merger Agreement&#8212;Conditions to the Completion of the Merger&#8221;</span><span style="font-weight: normal;"> in this proxy statement/prospectus/information statement. </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What do I need to do now? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Caladrius and Cend urge you to read this proxy
                      statement/prospectus/information statement carefully, including its annexes, and to consider how the Merger affects you. </span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">If you are a Caladrius Stockholder of record, you may provide your proxy instructions
            in one of two different ways. First, you can mail your signed proxy card in the enclosed return envelope. You may also provide your proxy instructions via telephone or via the Internet by following the instructions on your proxy card or voting
            instruction form. Please provide your proxy instructions only once, unless you are revoking a previously delivered proxy instruction, and as soon as possible so that your shares can be voted at the Annual Meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">If you are a Cend Stockholder, you may execute and return your written consent to Cend
            in accordance with the instructions provided. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What happens if I do not return a proxy card or otherwise provide proxy instructions, as applicable? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">If you are a Caladrius Stockholder, the failure to return your proxy card
                      or otherwise provide proxy instructions will reduce the aggregate number of votes required to approve Proposal Nos. 1, 4, 5 and 8 and will have the same effect as voting against Proposal Nos. 2 and 3 and your shares will not be
                      counted for purposes of determining whether a quorum is present at the Annual Meeting. </span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">8<br />
        </div>

      </div>

    </div>

    <!--End Page 17-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 18-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">When and where is the Annual Meeting? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">The Annual Meeting will be held at 9:00 a.m., New York
                        time, on September&#160;13, 2022 via live webcast at www.virtualshareholdermeeting.com/CLBS2022SM. You will not be able to attend the Annual Meeting in person.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Why are you holding a virtual Annual Meeting?</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">This year&#8217;s Annual Meeting will be held in a virtual meeting format only.
                      We have designed our virtual format to enhance, rather than constrain, stockholder access, participation and communication. For example, the virtual format allows stockholders to communicate with us in advance of, and during, the
                      Annual Meeting so that they can ask questions of the Caladrius Board of Directors or management, as time permits.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What happens if there are technical difficulties during the Annual Meeting?</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">We will have technicians ready to assist you with any technical
                      difficulties you may have accessing the virtual Annual Meeting, voting at the Annual Meeting or submitting questions at the Annual Meeting. If you encounter any difficulties accessing the virtual Annual Meeting during the check-in or
                      meeting time, please call the technical support number that will be posted on the virtual Annual Meeting login page.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What do I need to do now and how do I vote?</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Caladrius urges you to read this proxy statement carefully, including its
                      appendices, as the actions contemplated by each of the Proposals may affect you.</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">If your shares of Caladrius stock are registered directly in your name with our
            transfer agent, you are considered, with respect to those shares, to be the &#8220;stockholder of record,&#8221; and the proxy materials and proxy card are being sent directly to you by Caladrius. There are four methods by which you may vote your shares at
            the Annual Meeting:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic; font-weight: bold;">By Internet</span>. You may vote your shares 24 hours a day by
                      logging onto the secure website indicated in the instructions that are included in the Notice, or if you received printed materials, on the proxy card and following the instructions provided any time up until 11:59 pm, New York time,
                      on September&#160;12, 2022.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic; font-weight: bold;">By Telephone</span>. You may vote your shares 24 hours a day by
                      calling the telephone number listed in the instructions that are included in the Notice, or if you received printed materials, on the proxy card and following the instructions provided by the recorded message any time up until 11:59
                      pm, New York time, on September&#160;12, 2022.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic; font-weight: bold;">By Mail</span>. If you received a proxy card by mail, you may vote by
                    completing, signing, dating and promptly returning the proxy card in the postage-paid return envelope provided with the proxy materials for receipt prior to the Annual Meeting.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic; font-weight: bold;">At the Virtual Meeting</span>. You may vote your shares electronically
                    through the portal at the virtual Annual Meeting (if you satisfy the admission requirements, as described below). Even if you plan to attend the Annual Meeting virtually, we encourage you to vote in advance by telephone, through the
                    Internet or by mail so that your vote will be counted in the event you later decide not to attend virtually the Annual Meeting.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">The Annual Meeting will be a virtual meeting of stockholders conducted via a live
            webcast that provides stockholders the same rights and opportunities to participate as they would have at an in-person meeting. We believe that a virtual meeting will provide expanded stockholder access and participation and improved
            communications. You will be able to vote your shares electronically at the virtual meeting. To attend and submit your questions during the virtual meeting, please visit www.virtualshareholdermeeting.com/CLBS2022SM. To participate and vote
            during the Annual Meeting, you will need the 16-digit control number included on your Internet Notice or on your proxy card. Beneficial shareholders who do not have a control number may gain access to and vote at the meeting by logging in to
            their broker, brokerage firm, bank or other nominee&#8217;s website and selecting the stockholder communications mailbox to access the meeting; instructions should also be provided on the voting instruction card provided </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">9<br />
        </div>

      </div>

    </div>

    <!--End Page 18-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 19-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="fpara">by your broker, bank, or other nominee. If you encounter any difficulties accessing
            the virtual meeting during check-in or the meeting, please call the technical support number that will be posted on the virtual shareholder meeting log-in page.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What happens if I do not sign and return my proxy card or vote by telephone, through the Internet before or
                    during the Annual Meeting?</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">If you are a stockholder of record of Caladrius and you do not sign and
                      return your proxy card or vote by telephone, through the Internet or during the virtual meeting, your shares will not be voted at the Annual Meeting and will not be counted as present for the purpose of determining the presence of a
                      quorum, which is required to transact business at the Annual Meeting. Assuming the presence of a quorum, the failure to return your proxy card or otherwise vote your shares during the Annual Meeting will have no effect on any of the
                      Proposals.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">If my Caladrius shares are held in &#8220;street name&#8221; by my broker, will my broker vote my shares for me? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Unless your broker has discretionary authority to vote on certain matters,
                      your broker will not be able to vote your shares of Caladrius Common Stock without instructions from you. Brokers are not expected to have discretionary authority to vote for Proposal No. 1, 2, 3, 4, 6 or 7. To make sure that your
                      vote is counted, you should instruct your broker to vote your shares, following the procedures provided by your broker. </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">May I change my vote after I have submitted a proxy or provided proxy instructions? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Caladrius Stockholders of record, other than those Caladrius Stockholders
                      who are parties to support agreements, may change their vote at any time before their proxy is voted at the Annual Meeting in one of three ways. First, a Caladrius Stockholder of record can send a written notice to the Secretary of
                      Caladrius stating that it would like to revoke its proxy. Second, a Caladrius Stockholder of record can submit new proxy instructions either on a new proxy card or via the Internet. Third, a Caladrius Stockholder of record can attend
                      the Annual Meeting and vote virtually. Attendance alone will not revoke a proxy. If a Caladrius Stockholder of record or a stockholder who owns shares of Caladrius Common Stock in &#8220;street name&#8221; has instructed a broker to vote its
                      shares of Caladrius Common Stock, the stockholder must follow directions received from its broker to change those instructions. </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who is paying for this proxy solicitation? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Caladrius will be responsible for the cost of printing and filing this
                      proxy statement/prospectus/information statement and the proxy card. Arrangements will also be made with brokerage firms and other custodians, nominees and fiduciaries who are record holders of Caladrius Common Stock for the
                      forwarding of solicitation materials to the beneficial owners of Caladrius Common Stock. Caladrius will reimburse these brokers, custodians, nominees and fiduciaries for the reasonable out-of-pocket expenses they incur in connection
                      with the forwarding of solicitation materials. </span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">10<br />
        </div>

      </div>

    </div>

    <!--End Page 19-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 20-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_104-qa_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who can help answer my questions? </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">If you are a Caladrius Stockholder and would like additional copies,
                      without charge, of this proxy statement/prospectus/information statement or if you have questions about the Merger, including the procedures for voting your shares, you should contact: </span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;" class="fpara">110 Allen Road, 2<sup>nd</sup> Floor<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Basking Ridge, New Jersey 07920<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Tel: (908) 842-0100<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Attn: David J. Mazzo, Ph.D., President and Chief Executive Officer</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">If you are a Cend Stockholder, and would like additional copies, without charge, of
            this proxy statement/prospectus/information statement or if you have questions about the Merger, including the procedures for voting your shares, you should contact:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-align: left;" class="fpara">Cend Therapeutics, Inc.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">12544 High Bluff Drive, Suite 400<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">San Diego, California 92130<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Tel: (858) 795-5123 <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Attn: David Slack, President and Chief Executive Officer</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">11<br />
        </div>

      </div>

    </div>

    <!--End Page 20-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 21-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPSUM"><!--Anchor--></a>PROSPECTUS SUMMARY</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This summary highlights selected information from this proxy
              statement/prospectus/information statement and may not contain all of the information that is important to you. To better understand the Merger, the proposals being considered at the Annual Meeting and Cend Stockholder actions that are the
              subject of the written consent, you should read this entire proxy statement/prospectus/information statement carefully, including the Merger Agreement attached as Annex&#160;A, the opinion of Back Bay Life Science Advisors, LLC. (&#8220;Back Bay&#8221;)
              attached as Annex&#160;B and the other annexes to which you are referred herein. For more information, please see the section entitled &#8220;Where You Can Find More Information&#8221; in this proxy statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCOMP1"><!--Anchor--></a>The Companies</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Caladrius Biosciences, Inc.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc.<br />
            </div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">110 Allen Road, 2<sup>nd</sup> Floor<br />
            </div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basking Ridge, New Jersey 07920</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius is a clinical-stage biopharmaceutical company dedicated to the development
              and commercialization of therapies to treat and/or reverse disease. Caladrius is developing what are intended to be first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their ability to stimulate the
              growth of new microvasculature. Caladrius&#8217; technology is intended to leverage these cells to enable the body&#8217;s natural repair mechanisms using formulations unique to each medical indication.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; leadership team has decades of collective biopharmaceutical product
              development experience in a variety of therapeutic categories. Caladrius&#8217; goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. Caladrius&#8217; current
              product candidates include:</div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA&#174; (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow-on Phase 2b study
                      (the &#8220;FREEDOM Trial&#8221;) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA&#174; (CLBS12), recipient of SAKIGAKE designation and eligible for early conditional approval in Japan for the treatment of
                      critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan; and</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, the subject of a study designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients
                      with chronic kidney disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h3">Cend Therapeutics, Inc.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Therapeutics, Inc.<br />
            </div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12544 High Bluff Drive, Suite 400<br />
            </div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">San Diego, California 92130</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend is a clinical stage biotech company focused on a tumor microenvironment
              (&#8220;TME&#8221;)-modifying approach to enable more effective treatment for a range of solid tumor cancers. Cend is advancing a pipeline of product and partnering opportunities based on the CendR Platform&#8482; to potentially improve outcomes for patients
              with a range of solid tumor cancers that are currently poorly treated, representing high unmet medical needs.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s management team is comprised of a number of professionals who have decades of
              experience working with biotech, pharmaceutical and medical companies, many of which are publicly traded. Cend&#8217;s lead investigational drug, CEND-1, modifies the TME by targeting tumor vasculature by its affinity for alpha-v integrins that are
              selectively expressed in tumor, but not healthy tissue vasculature. CEND-1 is a cyclic peptide that, once bound to these integrins, is cleaved by proteases expressed in tumors to release a peptide fragment, called a CendR fragment, which
              binds to a second receptor, called neuropilin-1, to activate a novel uptake pathway that allows anticancer drugs to more selectively penetrate solid tumors. The ability of CEND-1 to modify the TME to enhance delivery and efficacy of
              co-administered drugs has been demonstrated in models, including tumor cell line models, multiple mouse xenograft models with human tumor cell lines and </div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">12<br />
        </div>

      </div>

    </div>

    <!--End Page 21-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 22-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">patient-derived tumors, and genetically engineered and syngeneic mouse models, of
              a range of solid tumors. Based on results from multiple pre-clinical mouse xenograft models of pancreatic and other human cancers, CEND-1 has also been shown in unpublished preclinical models of human tumors in xenograft mouse models as well
              as in genetically engineered and syngeneic mouse models to selectively deplete certain immunosuppressive cell types in tumors wherein the TME is dominated by such immunosuppressive cells, hampering the patients&#8217; immune systems&#8217; and
              immunotherapies&#8217; abilities to fight disease. Cend plans to explore its potential for combination therapy with immunotherapies. As part of the CendR Platform&#8482;, Cend is also conducting preclinical research on a tumor-penetrating nanocomplex
              (&#8220;TPN&#8221;) technology that may enable nucleic acid-based drugs, such as antisense, small interfering RNA (&#8220;siRNA&#8221;) or messenger RNA (&#8220;mRNA&#8221;), to more effectively treat solid tumor cancers, which could potentially result in earlier stage product
              and partnership opportunities.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In February 2021, Cend entered an exclusive license and collaboration agreement with
              a major pharmaceutical company in China, Qilu Pharmaceutical Co., Ltd. (&#8220;Qilu&#8221;), in which Qilu gained rights to CEND-1 for development and commercialization in Greater China. Under the terms of the agreement, Cend received $10&#160;million in
              up-front license fees and is eligible to receive development and commercial milestone payments up to $100&#160;million and $125&#160;million, respectively, tiered royalties on net sales in the Qilu territory ranging from 10% to 15%, and tiered
              sublicensing revenues ranging from 12% to 35%. The parties also have an active collaboration in which Qilu provides funding for development and regulatory activities within China.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s current product candidate development activities include:</div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CEND-1/gemcitabine/nab-paclitaxel, which is currently the subject of a Phase 2b clinical trial for pancreatic cancer;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CEND-1/FOLFIRINOX, which is currently the subject of a Phase 1b/2 clinical trial for pancreatic cancer;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CEND-1/FOLFIRINOX/ panitumumab (non-Ras mutated pts), which is currently the subject of a Phase&#160;1b/2 clinical trial for
                      colorectal and appendiceal cancers;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CEND1/gemcitabine/nab-paclitaxel +/- anti-PD(L)1, for which Cend expects to commence a Phase 1b/2 clinical trial for
                      pancreatic cancer during either the fourth quarter of 2022 or the first quarter of 2023;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CEND-1/standard of care (SoC) for selected solid tumor cancers, which Cend expects to commence a Phase 1b/2 clinical trial
                      during the first half of 2023; and</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Potential development candidate(s) based on TPN.</div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">CS Cedar Merger Sub, Inc.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Merger Sub is a wholly owned subsidiary of Caladrius and was formed solely for the
              purposes of carrying out the Merger.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tTMERG"><!--Anchor--></a>The Merger<span style="font-weight: normal;"> (see page&#160;<a href="#tTHEME">110</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Merger is completed, Merger Sub will merge with and into Cend, with Cend
              surviving as a wholly owned subsidiary of Caladrius.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Effective Time, each outstanding share of Cend Capital Stock (excluding any
              shares of capital stock held by Caladrius) outstanding immediately prior to the Effective Time will automatically be converted solely into the right to receive a number of shares of Caladrius Common Stock equal to the Exchange Ratio, subject
              to adjustment to account for the Reverse Stock Split, for Caladrius&#8217; net cash immediately prior to the Closing, for Cend&#8217;s unpaid transaction costs immediately prior to the Closing and in accordance with the Merger Agreement; each Cend Option
              outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, will be assumed by Caladrius and will become an option, subject to vesting (with acceleration of vesting triggered by the Merger in some
              instances), to purchase shares of Caladrius Common Stock, and, immediately after the Merger, based on the Exchange Ratio, current Cend Stockholders are expected to own, or hold rights to acquire, approximately 50% of the outstanding shares of
              Caladrius Common Stock with current Caladrius Stockholders expected to own approximately 50% of the outstanding shares of Caladrius Common </div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">13<br />
        </div>

      </div>

    </div>

    <!--End Page 22-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 23-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Stock. The approximate post-Closing ownership will be subject to adjustment based
              on Caladrius&#8217; net cash immediately prior to Closing and the amount of any unpaid transaction costs of Cend in excess of $250,000 immediately prior to Closing. Accordingly, such percentages are subject to change based upon the final Exchange
              Ratio as set forth in the Merger Agreement</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For a more complete description of the Merger and the Exchange Ratio please see the
              section entitled &#8220;<span style="font-style: italic;">The Merger Agreement</span>&#8221; in this proxy statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Closing will occur no later than the second business day after the last of the
              conditions to the Merger has been satisfied or waived (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of each such conditions), or at such other time as Caladrius
              and Cend agree. Caladrius and Cend anticipate that the consummation of the Merger will occur in the third quarter of the calendar year. However, because the Merger is subject to a number of conditions, neither Caladrius nor Cend can predict
              exactly when the Closing will occur or if it will occur at all. After completion of the Merger, assuming that Caladrius receives the required stockholder approval of Proposal No. 3, Caladrius will be renamed &#8220;Lisata Therapeutics, Inc.&#8221;</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tRFM"><!--Anchor--></a>Reasons for the Merger</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following the Merger, the combined organization will be a drug discovery and
              development company focused on its diverse product development pipeline, including the advancement of product and partnering opportunities based on the CendR Platform&#8482; technology. Caladrius and Cend believe that the combined organization will
              have the following potential advantages:</div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Emerging Development-Stage Company</span>. Cend is a clinical-stage drug discovery and
                      development company focused on a novel approach to enable more effective treatments for solid tumor cancers. The CendR Platform&#8482; provides a tumor-targeted tissue penetration capability to specifically enhance drug delivery to tumors.
                      Cend is also applying its technology to alter immunosuppression selectively within the tumor microenvironment to enable a patient&#8217;s immune system and immunotherapies to fight cancer with greater effectiveness. Caladrius and Cend
                      believe that Cend&#8217;s development programs will diversify Caladrius&#8217; product portfolio pipeline. Cend&#8217;s TPN technology platform holds significant potential to enable RNA-based drugs to work effectively in treating solid tumor cancers,
                      which could potentially result in product and partnership opportunities.</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Management Team</span>. It is expected that the combined organization will be led by the
                      existing experienced senior management team from Caladrius and David Slack from Cend and a board of directors of up to nine members with equal representation from each of Caladrius and Cend.</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Cash Resources</span>. The combined organization is expected to have at least $63.8&#160;million
                      in cash and cash equivalents at the Closing, assuming a Closing on September&#160;30, 2022, which Caladrius and Cend believe is sufficient to enable Caladrius to pursue its near-term clinical trials for Cend&#8217;s technology and Caladrius&#8217;
                      ongoing clinical trials and business plans. </div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Each of the boards of directors of Caladrius and Cend also considered other reasons
              for the Merger, as described herein. For example, the Caladrius Board of Directors considered, among other things: </div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the strategic alternatives to the Merger available to Caladrius to expand and diversify its product candidate portfolio
                      pipeline, including the discussions that Caladrius&#8217; management and the Caladrius Board of Directors previously conducted with other potential target companies and licensing partners;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the fact that the stock market was not currently giving any value to Caladrius&#8217; current product development programs;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the opportunity as a result of the Merger for Caladrius Stockholders to participate in the potential value of Cend&#8217;s product
                      candidate portfolio and the potential growth of the combined organization following the Merger. </div>
                  </td>

  </tr>


</table>
          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">14<br />
        </div>

      </div>

    </div>

    <!--End Page 23-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 24-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, the Cend Board of Directors approved the Merger based on a number of
              factors, including the following:</div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the potential increased access to sources of capital and a broader range of investors to support the clinical development of
                      its products than it could otherwise obtain if it continued to operate as a privately held company;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the potential to provide its current stockholders with greater liquidity by owning stock in a public company;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Cend Board of Directors&#8217; belief that no alternatives to the Merger were reasonably likely to create greater value for Cend
                      Stockholders after reviewing the various strategic options to enhance stockholder value that were considered by the Cend Board of Directors and the likelihood of achieving any alternative transaction compared to the likelihood of
                      completing the Merger;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the $10&#160;million of cash resources provided to Cend by Caladrius pursuant to the Purchase Agreement (as defined below) and the
                      cash resources of the combined organization expected to be available at the Closing relative to the anticipated burn rate of the combined organization; and</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the expectation that the Merger will be treated as a reorganization for U.S. federal income tax purposes.</div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tOCF"><!--Anchor--></a>Opinion of the Caladrius Financial
              Advisor <span style="font-weight: normal;">(see page&#160;<a href="#tOOTC">120</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors engaged Back Bay to provide strategic advisory and
              investment banking services in connection with evaluating and considering various strategic alternatives, and ultimately requested that Back Bay render an opinion as to whether the consideration to be paid by Caladrius in the Merger, as
              provided in the Merger Agreement, was fair, from a financial point of view, to Caladrius. At the April&#160;25, 2022 meeting of the Caladrius Board of Directors, Back Bay rendered its oral opinion, subsequently confirmed by delivery of a written
              opinion dated April&#160;25, 2022, to the Caladrius Board of Directors that, as of the date of such opinion, and based upon the assumptions made, procedures followed, matters considered, and qualifications and limitations of the review set forth
              in its written opinion, the consideration to be paid by Caladrius in the Merger was fair, from a financial point of view, to Caladrius. For purposes of Back Bay&#8217;s opinion, the term &#8220;consideration&#8221; means (i)&#160;the cancellation of 1,135,650
              shares of Cend Series D Preferred Stock, $0.00001 par value per share, which were issued to Caladrius for an aggregate purchase price of $10.0&#160;million pursuant to the Stock Purchase Agreement that was entered into by Caladrius and Cend
              concurrently with their entry into the Merger Agreement and (ii)&#160;the shares of Caladrius Common Stock to be issued to holders of Cend Capital Stock in the Merger.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The full text of Back Bay&#8217;s written opinion, which sets forth the
              procedures followed, assumptions made, matters considered, and qualifications and limitations of the review undertaken in connection with the opinion, is attached to this proxy statement/prospectus/information statement as <span style="font-style: italic;">Annex&#160;B</span> and is incorporated by reference in its entirety to this proxy statement/prospectus/information statement. Back Bay&#8217;s opinion was intended solely for the benefit and use of the Caladrius Board of
              Directors (in its capacity as such) in connection with its consideration of the Merger. Back Bay&#8217;s opinion was not intended to be used for any other purpose without Back Bay&#8217;s prior written consent in each instance, except as expressly
              provided for in the engagement letter between Caladrius and Back Bay. Back Bay has consented to the use of Back Bay&#8217;s opinion in this proxy statement/prospectus/information statement. Back Bay&#8217;s opinion did not address Caladrius&#8217; underlying
              business decision to enter into the Merger Agreement or complete the Merger or the merits of the Merger as compared to any alternative transactions that were or may be available to Caladrius, and did not constitute a recommendation to the
              Caladrius Board of Directors or to any Caladrius Stockholder as to how such stockholder should vote with respect to the Merger or otherwise.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tOMA"><!--Anchor--></a>Overview of the Merger Agreement</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Merger Consideration<span style="font-style: normal; font-weight: normal;"> (see page&#160;<a href="#tMERGCAA">137</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Effective Time, all outstanding shares of Cend Capital Stock shall convert
              into the right to receive Caladrius Common Stock as follows: </div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each share of Cend Capital Stock (excluding any shares of capital stock held by Caladrius) outstanding immediately prior to
                      the Effective Time will automatically be converted solely into the right to receive </div>
                  </td>

  </tr>


</table>
          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">15<br />
        </div>

      </div>

    </div>

    <!--End Page 24-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 25-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="bl">a number of shares of Caladrius Common Stock equal to the Exchange Ratio, subject to
              adjustment to account for the Reverse Stock Split, for Caladrius&#8217; net cash immediately prior to the Closing, for Cend&#8217;s unpaid transaction costs immediately prior to the Closing and in accordance with the Merger Agreement; </div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each Cend Option outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, will be
                      assumed by Caladrius and will become an option, subject to vesting (with acceleration of vesting triggered by the Merger in some instances), to purchase shares of Caladrius Common Stock; and </div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">immediately after the Merger, based on the Exchange Ratio, current Cend Stockholders are expected to own, or hold rights to
                      acquire, approximately 50% of the outstanding shares of Caladrius Common Stock with current Caladrius Stockholders expected to own approximately 50% of the outstanding shares of Caladrius Common Stock. The approximate post-closing
                      ownership will be subject to adjustment based on Caladrius&#8217; net cash immediately prior to Closing and the amount of any unpaid transaction costs of Cend in excess of $250,000 immediately prior to Closing. Accordingly, such percentages
                      are subject to change based upon the final Exchange Ratio as set forth in the Merger Agreement. </div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Treatment of Cend Options<span style="font-style: normal; font-weight: normal;"> (see page&#160;<a href="#tTCS">148</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the Merger Agreement, at the Effective Time, each Cend Option that is
              outstanding and unexercised immediately prior to the Effective Time granted under the Cend 2016 Equity Incentive Plan, whether or not vested, will be assumed by Caladrius and will become an option to purchase that number of shares of
              Caladrius Common Stock equal to the product obtained by multiplying (i)&#160;the number of shares of Cend Common Stock that were subject to such Cend Option immediately prior to the Effective Time by (ii)&#160;the Exchange Ratio, and rounding the
              resulting number down to the nearest whole number of shares of Caladrius Common Stock. The per share exercise price for Caladrius Common Stock issuable upon exercise of each Cend Option assumed by Caladrius shall be determined by dividing (a)
              the per share exercise price of Cend Common Stock subject to such Cend Option, as in effect immediately prior to the Effective Time, by (b) the Exchange Ratio, and rounding the resulting exercise price up to the nearest whole cent. Any
              restriction on the exercise of any Cend Option assumed by Caladrius will continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Cend Option shall otherwise remain unchanged.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Treatment of Caladrius Options<span style="font-style: normal; font-weight: normal;"> (see page&#160;<a href="#tTCO">148</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Effective Time, each Caladrius Option that is outstanding and unexercised
              immediately prior to the Effective Time, whether or not vested, shall survive the Closing and remain outstanding in accordance with its terms.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Conditions to the Completion of the Merger<span style="font-style: normal; font-weight: normal;"> (see page&#160;<a href="#tCCM">149</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To consummate the Merger, Caladrius Stockholders must approve (a) the Merger
              Agreement and the transactions contemplated thereby, including the Merger and the issuance of shares of Caladrius Common Stock to Cend Stockholders in the Merger, and (b) an amendment to the certificate of incorporation of Caladrius effecting
              the Reverse Stock Split. Additionally, Cend Stockholders must adopt the Merger Agreement thereby approving the Merger and the other transactions contemplated by the Merger Agreement. In addition to obtaining such stockholder approvals, each
              of the other closing conditions set forth in the Merger Agreement must be satisfied or waived.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">No Solicitation<span style="font-style: normal; font-weight: normal;"> (see page&#160;<a href="#tNS">153</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Each of Caladrius and Cend have agreed that, except as described below, Caladrius and
              Cend and any of their respective subsidiaries will not, nor will either party or any of its subsidiaries authorize any of the directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors or representatives
              retained by it or any of its subsidiaries to, directly or indirectly: </div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of, any
                      &#8220;Acquisition Proposal&#8221; (as defined in the section of this proxy </div>
                  </td>

  </tr>


</table>
          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">16<br />
        </div>

      </div>

    </div>

    <!--End Page 25-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 26-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="bl">statement/prospectus/information statement entitled &#8220;<span style="font-style: italic;">The Merger Agreement&#8212;No Solicitation</span>&#8221;), or &#8220;Acquisition Inquiry&#8221; (as defined in the section of this proxy statement/prospectus/information statement entitled &#8220;<span style="font-style: italic;">The Merger Agreement&#8212;No
                Solicitation</span>&#8221;); </div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">furnish any non-public information with respect to it to any person in connection with or in response to an Acquisition
                      Proposal or Acquisition Inquiry; </div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">engage in discussions or negotiations with any person with respect to any Acquisition Proposal or Acquisition Inquiry; </div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approve, endorse or recommend an Acquisition Proposal; or </div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">execute or enter into any letter of intent or similar document or any contract contemplating or otherwise relating to an
                      Acquisition Transaction (as defined in the section of this proxy statement/prospectus/information statement entitled &#8220;<span style="font-style: italic;">The Merger Agreement&#8212;No Solicitation</span>&#8221;). </div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Termination<span style="font-style: normal; font-weight: normal;"> (see page&#160;<a href="#tTERM">158</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Either Caladrius or Cend can terminate the Merger Agreement under certain
              circumstances, which would prevent the Merger from being consummated.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Termination Fee<span style="font-style: normal; font-weight: normal;"> (see page&#160;<a href="#tTFE">160</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Merger Agreement is terminated under certain circumstances, Caladrius will be
              required to pay Cend a termination fee of $1.0&#160;million, and, if the Merger Agreement is terminated under certain separate circumstances, Cend will be required to pay Caladrius a termination fee of $4.0&#160;million. In some circumstances,
              Caladrius or Cend will be required to reimburse the other party for expenses incurred in connection with the Merger, up to a maximum of $1.0&#160;million.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tSAGR"><!--Anchor--></a>Support Agreements<span style="font-weight: normal;"> (see page&#160;<a href="#tSUPP">163</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Certain Cend Stockholders are party to a support agreement with Caladrius pursuant to
              which, among other things, each of these stockholders agreed, solely in his, her or its capacity as a Cend Stockholder, to vote all of his, her or its shares of Cend Capital Stock in favor of the adoption of the Merger Agreement, the approval
              of the transactions contemplated thereby, including the Merger, and the approval of any other matter necessary to consummate the transactions contemplated by the Merger Agreement that are considered and voted upon by the Cend Stockholders and
              against any Acquisition Proposal. The parties to the support agreements with Caladrius include all directors and executive officers of Cend and certain major stockholders of Cend, including ER Trust 2/18/11, Innovation 2016 Kyoto Investment
              Limited Partnership, Leading Choice International Limited, Sanford Burnham Prebys Medical Discovery Institute, Kazuki Sugahara and Tambet Teesalu.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, the Cend Stockholders that are party to a support agreement with
              Caladrius owned an aggregate of 3,823,674 shares of Cend Common Stock, 371,396 shares of Cend Series A Preferred Stock and 951,637 shares of Cend Series B Preferred Stock, representing approximately 77.5% of the outstanding shares of Cend
              Capital Stock on an as converted to common stock basis (excluding shares held by Caladrius). These stockholders include executive officers and directors of Cend and certain stockholders owning a significant portion of the outstanding shares
              of Cend Capital Stock. Following the effectiveness of the registration statement of which this proxy statement/prospectus/information statement is a part and pursuant to the Merger Agreement, Cend Stockholders holding a sufficient number of
              shares of Cend Capital Stock to adopt the Merger Agreement and approve the Merger and related transactions will execute written consents providing for such adoption and approval.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; directors and executive officers are party to a support agreement with
              Cend pursuant to which, among other things, such individuals have agreed, solely in his or her capacity as a Caladrius Stockholder, to vote all of his or her shares of Caladrius Common Stock in favor of (i)&#160;the Merger Agreement and the
              transactions contemplated thereby, including the Merger and the issuance of Caladrius Common Stock to Cend Stockholders, (ii)&#160;an amendment to the certificate of incorporation of Caladrius to effect the Reverse Stock Split, (iii)&#160;an amendment
              to the certificate of incorporation of Caladrius to effect the Caladrius Name Change, (iv)&#160;any proposal to adjourn or postpone the meeting to a later date, if there are not sufficient votes for the approval of </div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">17<br />
        </div>

      </div>

    </div>

    <!--End Page 26-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 27-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the other matters to be approved on date of the Annual Meeting, and (v)&#160;any other
              matter necessary to consummate the transactions contemplated by the Merger Agreement that are considered and voted upon by Caladrius Stockholders at the Annual Meeting and against any Acquisition Proposal.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, the Caladrius Stockholders that are party to a support agreement
              with Cend beneficially owned an aggregate of 1,099,314 shares of Caladrius Common Stock, representing approximately 1.8% of the outstanding shares of Caladrius Common Stock. </div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The support agreements are discussed in greater detail in the section entitled &#8220;<span style="font-style: italic;">Agreements Related to the Merger&#8212;Support Agreements</span>&#8221; in this proxy statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tLUP"><!--Anchor--></a>Lock-up Agreements<span style="font-weight: normal;"> (see page&#160;<a href="#tLOCK">163</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As a condition to the Closing, certain Caladrius Stockholders and Cend Stockholders
              have entered into lock-up agreements, pursuant to which such parties have agreed not to, except in limited circumstances, sell or transfer, or engage in swap or similar transactions with respect to, shares of Caladrius Common Stock,
              including, as applicable, shares received in the Merger and issuable upon exercise of certain options, in each case from the Closing until the date that is 120 days from the Closing.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, Caladrius Stockholders who have executed lock-up agreements
              beneficially owned in the aggregate approximately 1.8% of the outstanding shares of Caladrius Common Stock.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Stockholders who have executed lock-up agreements as of June&#160;13, 2022 owned in
              the aggregate approximately 77.5% of the outstanding shares of Cend Capital Stock on an as if converted into common stock basis (excluding shares held by Caladrius).</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The lock-up agreements are discussed in greater detail in the section entitled &#8220;<span style="font-style: italic;">Agreements Related to the Merger&#8212;Lock-up Agreements</span>&#8221; in this proxy statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Purchase Agreement <span style="font-weight: normal;">(see

                page&#160;<a href="#tSPA">164</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Concurrently with the execution of the Merger Agreement and in order to provide Cend
              with capital for its development programs prior to the closing of the Merger, Caladrius and Cend entered into a Series D Preferred Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which Caladrius agreed to purchase from Cend
              1,135,628 shares of Series D Preferred Stock, $0.00001 par value per share (the &#8220;Series D Preferred Stock&#8221;), of Cend at a purchase price per share equal to $8.8057 per share (the &#8220;Series D Original Issue Price&#8221;), or approximately $10,000,000
              in the aggregate. The Purchase Agreement contains customary representations, warranties and agreements by Caladrius and Cend and customary conditions to Closing. The Series D Preferred Stock ranks senior to Cend&#8217;s common stock and the other
              series of preferred stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of Cend. The Series D Preferred Stock has a liquidation preference equal to the Series D
              Original Issue Price plus an amount equal to any accrued and unpaid dividends to the date of payment and will participate with Cend&#8217;s common stockholders and other preferred stockholders thereafter on an as-converted basis, except in
              connection with the Merger. The Series D Preferred Stock shall vote with the shares of Caladrius Common Stock on an as-converted basis on any matters presented to the Cend Stockholders. Each share of Series D Preferred Stock is convertible,
              at the option of the holder thereof, into such number of shares of Cend Common Stock as is determined by dividing the Series&#160;D Original Issue Price by the conversion price in effect at the time of conversion, which conversion price shall be
              the Series D Original Issue Price as appropriately adjusted for stock splits, stock dividends, combinations, and subdivisions of Cend common stock, and as adjusted pursuant to a weighted-average antidilution adjustment. The Series D Preferred
              Stock will automatically convert into shares of Cend common stock upon the closing of a firm-commitment underwritten initial public offering implying a pre-equity offering value of at least $250&#160;million, resulting in at least $50&#160;million of
              gross proceeds to Cend.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tCOLAG"><!--Anchor--></a>Collaboration Agreement <span style="font-weight: normal;">(see page&#160;<a href="#tCOLLA">164</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Concurrently with the execution of the Merger Agreement, Caladrius and Cend entered
              into a Collaboration Agreement (the &#8220;Collaboration Agreement&#8221;), pursuant to which Caladrius and Cend agreed to collaborate on certain developmental and clinical activities prior to the closing of the Merger. Under the Collaboration Agreement,
              Caladrius and Cend agreed to form a joint steering committee (the &#8220;Committee&#8221;) comprised of </div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">18<br />
        </div>

      </div>

    </div>

    <!--End Page 27-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 28-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">individuals from both entities. The Committee will meet regularly and be
              responsible for monitoring ongoing studies and making recommendations for development activity and trial planning. Cend has agreed to pay each member of the Committee from Caladrius an hourly consulting fee for such service.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tMANAGEF"><!--Anchor--></a>Management Following the
              Merger<span style="font-weight: normal;"> (see page&#160;<a href="#tMFTM">253</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Effective as of the Closing, Caladrius&#8217; officers are expected to include: </div>

            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 46.5%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                  </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 50.94%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Title</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 46.5%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.</div>
                  </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.94%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Chief Executive Officer</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 46.5%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack</div>
                  </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.94%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President &amp; Chief Business Officer</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 46.5%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D.</div>
                  </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.94%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Executive Vice President R&amp;D and Chief Medical Officer</div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tICD"><!--Anchor--></a>Interests of Certain Directors,
              Officers and Affiliates of Caladrius and Cend<span style="font-weight: normal;"> (see page&#160;<a href="#tIOTCD">131</a>, <a href="#tCDEOM">134</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In considering the recommendation of the Caladrius Board of Directors with respect to
              issuing shares of Caladrius Common Stock pursuant to the Merger Agreement and the other matters to be acted upon by Caladrius Stockholders at the Annual Meeting, Caladrius Stockholders should be aware that certain members of the Caladrius
              Board of Directors and executive officers of Caladrius have interests in the Merger that may be different from, or in addition to, interests they have as Caladrius Stockholders. For example, all of Caladrius&#8217; executive officers and four of
              Caladrius&#8217; directors will remain in their positions immediately following the Merger. </div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, the directors and executive officers of Caladrius beneficially
              owned, in the aggregate approximately 4.3% of the outstanding shares of Caladrius Common Stock.Certain of Caladrius&#8217; officers and directors, and their affiliates, have also entered into support agreements in connection with the Merger. The
              support agreements are discussed in greater detail in the section entitled &#8220;<span style="font-style: italic;">Agreements Related to the Merger&#8212;Support Agreements</span>&#8221; in this proxy statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In considering the recommendation of the Cend Board of Directors with respect to
              approving the Merger and related transactions by written consent, Cend Stockholders should be aware that certain members of the Cend Board of Directors and certain executive officers of Cend have interests in the Merger that may be different
              from, or in addition to, interests they have as Cend Stockholders. For example, certain of Cend&#8217;s directors and executive officers have options, subject to vesting (with acceleration of vesting triggered by the Merger in some instances), to
              purchase shares of Cend Common Stock which, at Closing, shall be converted into and become options to purchase shares of Caladrius Common Stock; certain of Cend&#8217;s directors and executive officers are expected to become directors and executive
              officers of Caladrius upon the Closing; and all of Cend&#8217;s directors and executive officers are entitled to certain indemnification and liability insurance coverage pursuant to the terms of the Merger Agreement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, all directors and executive officers of Cend, together with
              their affiliates, owned approximately 47.1% of the outstanding shares of Cend Capital Stock, on an as converted to common stock basis. Certain of Cend&#8217;s officers and directors, and their affiliates, have also entered into support agreements
              in connection with the Merger. The support agreements are discussed in greater detail in the section entitled &#8220;<span style="font-style: italic;">Agreements Related to the Merger&#8212;Support Agreements</span>&#8221; in this proxy
              statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tMUS"><!--Anchor--></a>Material U.S. Federal Income Tax
              Consequences of the Merger<span style="font-weight: normal;"> (see page&#160;<a href="#tMATE1">141</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As discussed in detail in the section entitled <span style="font-style: italic;">&#8220;The

                Merger&#8212;Material U.S. Federal Income Tax Consequences of the Merger&#8221;</span> in this proxy statement/prospectus/information statement, Caladrius and Cend intend the Merger to qualify as a reorganization within the meaning of Section 368(a) of
              the Code. If the Merger is not treated as a reorganization within the meaning of Section 368(a) of the Code, then each U.S. holder generally will be treated as exchanging its shares of Cend Capital Stock in a fully taxable transaction in
              exchange for shares of Caladrius Common Stock. Cend Stockholders will generally recognize gain or loss in such exchange equal to the amount that such Cend Stockholder&#8217;s adjusted tax basis in the shares of Cend Capital Stock surrendered is
              less or more than the fair market value of the shares of Caladrius Common Stock (and cash in lieu of a fractional share) </div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">19<br />
        </div>

      </div>

    </div>

    <!--End Page 28-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 29-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">received in exchange therefor. Determining the actual tax consequences of the
              Merger to you may be complex and will depend on the facts of your own situation. You should consult your tax advisors to fully understand the tax consequences to you of the Merger, including estate, gift, state, local or non-U.S. tax
              consequences of the Merger.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tRISKF"><!--Anchor--></a>Risk Factors<span style="font-weight: normal;"> (see page&#160;<a href="#tRF">27</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Both Caladrius and Cend are subject to various risks associated with their businesses
              and their industries. In addition, the Merger poses a number of risks to each company and its respective stockholders, including the possibility that the Merger may not be completed and the following risks: </div>

            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Exchange Ratio is not adjustable based on the market price of Caladrius Common Stock, so the merger consideration at the
                      Closing may have a greater or lesser value than at the time the Merger Agreement was signed; failure to complete the Merger may result in Caladrius or Cend paying a termination fee or expenses to the other and could harm the per share
                      price of Caladrius Common Stock and future business and operations of each company;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger may be completed even though material adverse changes may result solely from the announcement of the Merger,
                      general economic or political conditions or conditions generally affecting the industries in which Caladrius and Cend operate and other causes;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">some Caladrius and Cend officers and directors have interests that are different from or in addition to those considered by
                      stockholders of Caladrius and Cend and which may influence them to support or approve the Merger;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the market price of Caladrius Common Stock may decline as a result of the Merger;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius Stockholders and Cend Stockholders may not realize a benefit from the Merger commensurate with the ownership
                      dilution they will experience in connection with the Merger;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">during the pendency of the Merger, Caladrius and Cend may not be able to enter into a business combination with another party
                      under certain circumstances because of restrictions in the Merger Agreement, which could adversely affect their respective businesses;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">certain provisions of the Merger Agreement may discourage third parties from submitting alternative takeover proposals,
                      including proposals that may be superior to the arrangements contemplated by the Merger Agreement;</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">because the lack of a public market for shares of Cend Capital Stock makes it difficult to evaluate the fairness of the
                      Merger, the Cend Stockholders may receive consideration in the Merger that is less than the fair market value of the shares of Cend Capital Stock and/or Caladrius may pay more than the fair market value of the shares of Cend Capital
                      Stock; and</div>
                  </td>

  </tr>


</table>
            <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                  </td>

    <td style="vertical-align: top;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the conditions to the Merger are not met, the Merger will not occur.</div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">These risks and other risks are discussed in greater detail under the section
              entitled &#8220;<span style="font-style: italic;">Risk Factors</span>&#8221; in this proxy statement/prospectus/information statement. Caladrius and Cend both encourage you to read and consider all of these risks carefully.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tREGU"><!--Anchor--></a>Regulatory Approvals<span style="font-weight: normal;"> (see page&#160;<a href="#tREGAPP">141</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the United States, Caladrius must comply with applicable federal and state
              securities laws and the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) in connection with the issuance of shares of Caladrius Common Stock and the filing of this proxy statement/prospectus/information statement with the SEC.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tLIST"><!--Anchor--></a>Nasdaq Capital Market Listing<span style="font-weight: normal;"> (see page&#160;<a href="#tNASD">143</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Prior to consummation of the Merger, Caladrius intends to file a notification form
                with Nasdaq for the listing of additional shares with respect to the shares of Caladrius Common Stock to be issued to the holders of Cend Capital Stock in the Merger. Caladrius anticipates that shares of Caladrius Common Stock will be
                listed on The Nasdaq Capital Market following the Closing under the trading symbol &#8220;LSTA.&#8221;</div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">20<br />
        </div>

      </div>

    </div>

    <!--End Page 29-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 30-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tATREAT"><!--Anchor--></a>Anticipated Accounting
              Treatment<span style="font-weight: normal;"> (see page&#160;<a href="#tANTIAT">144</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger is expected to be treated by Caladrius as an asset acquisition by
              Caladrius in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). To determine the accounting for this transaction under U.S. GAAP, a company must assess whether an integrated set of assets and activities should be
              accounted for as an acquisition of a business or an asset acquisition. The guidance requires an initial screen test to determine if substantially all of the fair value of the gross assets acquired is concentrated in a single asset or group of
              similar assets. If that screen is met, the set is not a business. In connection with the acquisition of Cend, substantially all the fair value is included in in-process research and development of CEND-1 and, as such, the acquisition is
              expected to be treated as an asset acquisition. For accounting purposes, Caladrius is considered to be acquiring Cend in the Merger.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tAPPRD"><!--Anchor--></a>Appraisal Rights and
              Dissenters&#8217; Rights<span style="font-weight: normal;"> (see page&#160;<a href="#tAPPRDR">144</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Holders of shares of Caladrius Common Stock are not entitled to appraisal rights in
              connection with the Merger. Cend Stockholders are entitled to appraisal rights in connection with the Merger under Delaware law. For more information about such rights, see the provisions of Section 262 of the General Corporation Law of the
              State of Delaware (the &#8220;DGCL&#8221;) attached hereto as <span style="font-style: italic;">Annex&#160;C</span>, and the section entitled &#8220;<span style="font-style: italic;">The Merger&#8212;Appraisal Rights and Dissenters&#8217; Rights</span>&#8221; in this proxy
              statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tCSRI"><!--Anchor--></a>Comparison of Stockholder Right<span style="font-weight: normal;">s (see page <a href="#tCRHCF">277</a>)</span></div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Both Caladrius and Cend are incorporated under the laws of the State of Delaware and,
              accordingly, the rights of the stockholders of each are currently, and will continue to be, governed by the DGCL. If the Merger is completed, Cend Stockholders will become Caladrius Stockholders, and their rights will be governed by the DGCL,
              the bylaws of Caladrius and, assuming Proposals No. 2 and 3 are approved by Caladrius Stockholders at the Annual Meeting, the amended and restated certificate of incorporation of Caladrius. The rights of Caladrius Stockholders contained in
              the amended and restated certificate of incorporation and bylaws of Caladrius differ from the rights of Cend Stockholders under the amended and restated certificate of incorporation and bylaws of Cend, as more fully described under the
              section entitled &#8220;<span style="font-style: italic;">Comparison of Rights of Holders of Caladrius Stock and Cend Stock</span>&#8221; in this proxy statement/prospectus/information statement.</div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">21<br />
        </div>

      </div>

    </div>

    <!--End Page 30-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 31-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tSHUP"><!--Anchor--></a>SUMMARY HISTORICAL AND UNAUDITED PRO FORMA <br />
            </div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONDENSED COMBINED FINANCIAL DATA</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following tables present summary historical financial data
              for Caladrius and Cend, summary unaudited pro forma condensed combined financial data for Caladrius and Cend, and comparative historical and unaudited pro forma per share data for Caladrius and Cend.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;" class="h1">Selected Historical Financial Data of Caladrius</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The selected statement of operations data for the years ended December&#160;31, 2021, 2020
              and 2019 and the selected balance sheet data as of December&#160;31, 2021 and 2020 are derived from Caladrius&#8217; audited financial statements prepared using U.S. GAAP, which are included in this proxy statement/prospectus/information statement. The
              selected statement of operations data for the years ended December&#160;31, 2018 and 2017 and the selected balance sheet data as of December&#160;31, 2019, 2018 and 2017 are derived from Caladrius&#8217; audited financial statements, which are not included
              in this proxy statement/prospectus/information statement. The selected financial data for the three months ended March&#160;31, 2022 and 2021, are derived from Caladrius&#8217; unaudited condensed financial statements included in this proxy
              statement/prospectus/information statement. The financial data should be read in conjunction with <span style="font-style: italic;">&#8220;Caladrius Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</span> and
              Caladrius&#8217; condensed financial statements and related notes appearing elsewhere in this proxy statement/prospectus/information statement. The historical results are not necessarily indicative of results to be expected in any future period.</div>

            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 43.96%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.35pt;" colspan="13">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Years Ended December&#160;31,</div>
                  </td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 22.43%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.35pt;" colspan="4">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended Mar 31,</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                  </td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2019</div>
                  </td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2018</div>
                  </td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2017</div>
                  </td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                  </td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: center; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(unaudited)</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: center; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(unaudited)</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Statement of Operations Data:<br />
                    </div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 67.81%; text-align: center; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;" colspan="19">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in thousands, except per share data)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">17,680</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">9,253</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">10,797</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">7,594</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">15,843</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">3,278</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara">$<span style="padding-left: 4.63pt;">5,076</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.7pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">11,370</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">9,892</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">9,295</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">9,393</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.7pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">11,750</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">3,342</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;">3,010</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Operating expenses</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">29,050</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">19,145</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">20,092</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">16,987</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">27,593</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">6,620</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt;">8,086</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Operating loss</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(29,050)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(19,145)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(20,092)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(16,987)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(27,593)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(6,620)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(8,086)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense):<br />
                    </div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Investment income, net</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">151</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">132</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">740</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">824</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">273</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">63</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt;">23</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other (expense), net</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(75</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(5</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(378</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(148</span><span style="min-width: 32.5pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;">&#8212;</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">76</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">132</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">740</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">819</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(105</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(85</span><span style="min-width: 32.5pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;">23</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Loss before taxes and noncontrolling interests</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(28,974)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(19,013)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(19,352)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(16,168)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(27,698)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(6,705)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(8,063)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Benefit from income taxes</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(1,508</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,872</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5.37pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(11,527</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(2,479</span><span style="min-width: 32.5pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;">&#8212;</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Net loss from continuing operations</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(27,466)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(8,141)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(19,352)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(16,168)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(16,171)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(4,226)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(8,063)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Discontinued operations - net</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">38,399</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;">&#8212;</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net (loss) income</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(27,466)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(8,141)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(19,352)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(16,168)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">22,228</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(4,226)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(8,063)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Less - net income attributable to noncontrolling
                      interests</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">9</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">9</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">(1)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">(182)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt;">&#8212;</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Less - net loss from discontinued operations
                      attributable to noncontrolling interests</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(569</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3.35pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;">&#8212;</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3.35pt; padding-bottom: 4.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Net loss attributable to Caladrius Biosciences, Inc.
                      common shareholders</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 4.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(27,466</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 4.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">(8,150</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 4.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(19,361</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 4.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(16,167</span><span style="min-width: 35.83pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 4.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">22,979</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 4.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 1.67pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(4,226</span><span style="min-width: 32.5pt;">)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3.35pt; padding-bottom: 4.35pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.35pt; padding-bottom: 4.35pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.13pt;">$</span><span style="padding-left: 1.3pt; border-bottom: 3pt double #000000; min-width: 32.13pt;">(8,063</span><span style="min-width: 32.13pt;">)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Basic and diluted (loss) income per
                      share<br />
                    </div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.35pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc. common shareholders</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 10pt;">(0.50)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 10pt;">(0.53)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 10pt;">(1.88)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 10pt;">(1.67)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 13.33pt;">2.56</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara">$<span style="padding-left: 6.67pt;">(0.07)</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara">$<span style="padding-left: 6.3pt;">(0.19)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Weighted average common shares
                      outstanding:<br />
                    </div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 2.1pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 2.1pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic and diluted shares</div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">55,313</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">15,440</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">10,325</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">9,689</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">8,969</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.33pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">60,560</span></div>
                  </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 2.1pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.1pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.52pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">42,117</span></div>
                  </td>

  </tr>


</table>
          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">22<br />
        </div>

      </div>

    </div>

    <!--End Page 31-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 32-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 54.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="13">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">At December&#160;31,</div>
                  </td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">At Mar 31,</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                  </td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2019</div>
                  </td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2018</div>
                  </td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2017</div>
                  </td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Balance Sheet Data:<br />
                    </div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 54.88%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;" colspan="13">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in thousands)</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash and cash equivalents</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">24,647</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">16,512</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">14,032</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">10,299</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">29,163</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">12,747</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Restricted cash</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">5,005</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Marketable securities</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">70,323</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">18,061</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.7pt;">11,125</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">32,754</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">25,917</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">75,772</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total current assets</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">96,182</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">35,331</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">25,972</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">44,106</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">61,397</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">90,700</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total assets</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">97,008</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">36,002</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">27,153</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">44,580</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">63,376</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">91,463</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total current liabilities</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">4,523</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">3,506</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">5,976</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">5,619</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">9,314</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">2,801</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total liabilities</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">5,008</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">3,760</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">6,600</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">7,126</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">13,187</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">3,222</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Accumulated deficit</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(453,016)</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(425,550)</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(417,400)</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(397,977)</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(381,810)</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(457,242)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total equity</div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">92,000</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">32,242</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">20,553</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">37,454</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">50,189</span></div>
                  </td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">88,241</span></div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.75pt; text-align: center;" class="h1">Selected Historical Financial Data of Cend</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The selected financial data as of December&#160;31, 2021 and 2020 and for the years ended
              December&#160;31, 2021 and 2020 are derived from Cend&#8217;s audited consolidated financial statements prepared using U.S. GAAP, which are included in this proxy statement/prospectus/information statement. The statement of operations data for the three
              months ended March&#160;31, 2022 and 2021, as well as the balance sheet data as of March&#160;31, 2022, are derived from Cend&#8217;s unaudited condensed consolidated financial statements included in this proxy statement/prospectus/information statement. In
              the opinion of management of Cend, the unaudited condensed consolidated financial statements reflect all adjustments, which include normal recurring adjustments, necessary to state fairly Cend&#8217;s results of operations and financial position.
              These historical results are not necessarily indicative of results to be expected in any future period. The selected financial data should be read in conjunction with &#8220;<span style="font-style: italic;">Cend Management&#8217;s Discussion and
                Analysis of Financial Condition and Results of Operations</span>&#8221; and Cend&#8217;s financial statements and the related notes to those statements appearing elsewhere in this proxy statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h4">Summary Consolidated Balance Sheet</div>

            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Ended March 31,</div>
                  </td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 22.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                  </td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.53pt; text-align: left;" class="fpara">$<span style="padding-left: 7.96pt;">4,716</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">6,288</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">684 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Working capital</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.53pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">5,332</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">6,627</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,052 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total assets</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.53pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">6,432</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">7,487</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,529 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total liabilities</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.53pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">1,316</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,076</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">477 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Accumulated deficit</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.53pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(11,636)</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(10,207)</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(13,946)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total stockholders' equity (deficit)</div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.53pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">75</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,370</span></div>
                  </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(3,989)</span></div>
                  </td>

  </tr>


</table>
          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">23<br />
        </div>

      </div>

    </div>

    <!--End Page 32-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 33-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h4">Summary Consolidated Statement of Operations</div>

            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;" colspan="4">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Ended March&#160;31,</div>
                  </td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 21.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;" colspan="4">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                  </td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">(in thousands)</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(unaudited)</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(unaudited)</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net revenues</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara">$<span style="padding-left: 10.83pt;">178</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">9,736</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara">$14,787</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">&#8212; </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating expenses:<br />
                    </div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Research and development</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">1,291</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">3,200</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">8,148</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">1,555 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Acquired in process research &amp; development</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">520</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1,584</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">6,572 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">General and administrative</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">316</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">237</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">1,150</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">598 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total operating expenses</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">1,607</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">3,957</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">10,882</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">8,725 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating income (loss)</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,429)</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">5,779</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">3,905</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(8,725)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense)<br />
                    </div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Interest income</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">4</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">5</span> </div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total other income (expense), net</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">4</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">5 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) before taxes</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara">$(1,429)</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">5,779</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">3,909</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara">$(8,720)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Income tax expense</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">192</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">170</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212; </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consolidated net income (loss)</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,429</span><span style="min-width: 30.83pt;">)</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">5,587</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">3,739</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(8,720</span><span style="min-width: 30.83pt;">)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Income allocable to participating securities</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(2,166</span><span style="min-width: 30.83pt;">)</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(1,466</span><span style="min-width: 32.5pt;">)</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212; </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders</div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.59pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,429</span><span style="min-width: 30.83pt;">)</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">3,421</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.31pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">2,273</span></div>
                  </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(8,720</span><span style="min-width: 30.83pt;">)</span></div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;" class="h1">Selected Unaudited Pro Forma Condensed Combined Financial Data of Caladrius and
              Cend</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h4">The following information does not give effect to the Reverse
              Stock Split of Caladrius Common Stock.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following selected unaudited pro forma condensed combined financial data was
              prepared using the acquisition method of accounting under U.S. GAAP. For accounting purposes, Caladrius is considered to be acquiring Cend in the Merger. The Caladrius and Cend unaudited pro forma combined balance sheet data assume that the
              Merger took place on March&#160;31, 2022, and combines the Caladrius and Cend historical balance sheets as of March&#160;31, 2022. The Caladrius and Cend unaudited pro forma condensed combined statements of operations data assume that the Merger took
              place on January&#160;1, 2021, and combines the historical results of Caladrius and Cend for the three months ended March&#160;31, 2022 and the year ended December&#160;31, 2021. </div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The selected unaudited pro forma condensed combined financial data are presented for
              illustrative purposes only and are not necessarily indicative of the combined financial position or results of operations of future periods or the results that actually would have been realized had the entities been a single entity during
              these periods. The selected unaudited pro forma condensed combined financial data as of and for the three months ended March&#160;31, 2022 and for the year ended December&#160;31, 2021 are derived from the unaudited pro forma condensed combined
              financial information and should be read in conjunction with that information. For more information, please see the section entitled &#8220;<span style="font-style: italic;">Unaudited Pro Forma Condensed Combined Financial Statements</span>&#8221; in
              this proxy statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma condensed combined financial information assumes that, at the
              Effective Time, each share of Cend Capital Stock will be converted into the right to receive shares of Caladrius Common Stock such that, immediately after the Merger, Caladrius Stockholders are expected to own approximately 50% of the
              outstanding common stock of the combined organization and Cend Stockholders are expected to own approximately 50% of the outstanding common stock of the combined organization, and is subject to adjustment to account for the occurrence of
              certain events discussed elsewhere in this proxy statement/prospectus/information statement.</div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">24<br />
        </div>

      </div>

    </div>

    <!--End Page 33-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 34-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Unaudited Pro Forma Condensed Combined
              Statements of Operations Data</div>

            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Mar 31,</div>
                  </td>

    <td style="width: 3.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December 31,</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                  </td>

    <td style="width: 3.06%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(unaudited)</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(unaudited)</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 32.35%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;" colspan="4">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in thousands, except per share data)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net revenues</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara">$<span style="padding-left: 17.5pt;">178</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara">$<span style="padding-left: 4.63pt;">14,787</span> </div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Expenses:<br />
                    </div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Research and development</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 15pt;">4,569</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt;">25,828</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">In-process research and development</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt;">36,595</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">General and administrative</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 15pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">3,700</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;">18,837</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Operating expenses</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 15pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">8,269</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;">81,260</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Operating loss</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 11.67pt;">(8,091)</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(66,473)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense):<br />
                    </div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Investment income, net</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">63</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt;">151</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other expense, net</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt;">(148)</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 23.8pt;">(75)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Interest income</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">&#8212;</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 32.13pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;">4</span><span style="border-bottom: 1pt solid #000000; min-width: 37.13pt;"> </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total other (expense) income</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 24.17pt;">(85)</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 27.13pt;">80</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss before benefit from income taxes</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 11.67pt;">(8,176)</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(66,393)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Benefit from income taxes</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 11.67pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">(2,479</span><span style="min-width: 37.5pt;">)</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 11.3pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;">(1,338</span><span style="min-width: 37.13pt;">)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 6.67pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">(5,697</span><span style="min-width: 37.5pt;">)</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$</span><span style="padding-left: 1.3pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">(65,055</span><span style="min-width: 37.13pt;">)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss per share attributable to common shareholders:<br />
                    </div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 11.67pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">(0.05</span><span style="min-width: 37.5pt;">)</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$</span><span style="padding-left: 11.3pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">(0.56</span><span style="min-width: 37.13pt;">)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 11.67pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">(0.05</span><span style="min-width: 37.5pt;">)</span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$</span><span style="padding-left: 11.3pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">(0.56</span><span style="min-width: 37.13pt;">)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding:<br />
                    </div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">121,081</span><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"> </span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">115,243</span><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;"> </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted</div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.66pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">121,081</span><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"> </span></div>
                  </td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.06%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.24%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.4pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">115,243</span></div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h3">Unaudited Pro Forma Condensed Combined Balance
              Sheet Data</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

            <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">At Mar 31,</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                  </td>

  </tr>

  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(unaudited)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Balance Sheet Data (in thousands):<br />
                    </div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Cash and cash equivalents</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">17,463 </span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Marketable securities</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">75,772</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total current assets</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">97,132</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total assets</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">100,195</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total current liabilities</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">9,856</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total liabilities</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">10,493</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accumulated deficit</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(495,320)</span></div>
                  </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total stockholders' equity (deficit)</div>
                  </td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.05%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">89,702</span></div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;" class="h1">Comparative Historical and Unaudited Pro Forma Per Share Data</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The information below reflects the historical net loss and book value per share of
              Caladrius Common Stock and the historical net loss and book value per share of Cend Common Stock in comparison with the unaudited pro forma net loss and book value per share after giving effect to the Merger on a purchase basis. The unaudited
              pro forma net loss and book value per share does not give effect to the proposed Reverse Stock Split.</div>

          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">25<br />
        </div>

      </div>

    </div>

    <!--End Page 34-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 35-->
    <div style="text-align: left; margin: auto; position: relative; width: 492pt;" class="page"><a id="ny20004343x2_s4a_105-sum_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;" class="border-box">
        <div style="margin-left: 12pt;" class="page-content">
          <div style="width: 468pt; margin-left: 0pt;" class="block-main">
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">You should read the tables below in conjunction with the audited and unaudited
              consolidated financial statements of Caladrius included in this proxy statement/prospectus/information statement and the audited and unaudited financial statements of Cend included in this proxy statement/prospectus/information statement and
              the related notes and the unaudited pro forma condensed combined financial information and notes related to such financial statements included elsewhere in this proxy statement/prospectus/information statement.</div>

            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Caladrius</div>

            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Ended <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31, 2022</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Historical Per Common Share Data:<br />
                    </div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic and diluted net loss per share</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara">$(0.50)</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.22pt; text-align: left;" class="fpara">$(0.07)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Book value per share</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">1.54</span></div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.22pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">1.46</span></div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h3">Cend</div>

            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Ended <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31, 2022</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Historical Per Common Share Data:<br />
                    </div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic net loss per share</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.33pt; text-align: left;" class="fpara">$0.54</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.22pt; text-align: left;" class="fpara">$(0.33)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Diluted net loss per share</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.33pt; text-align: left;" class="fpara">$0.48</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.22pt; text-align: left;" class="fpara">$(0.33)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Book value per share</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.33pt; text-align: left;" class="fpara">$0.32</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.22pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">0.02</span></div>
                  </td>

  </tr>


</table>
            <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h3">Caladrius and Cend</div>

            <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                  </td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Ended <br />
                    </div>
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31, 2022</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Pro Forma Per Common Share Data:<br />
                    </div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic net loss per share</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara">$(0.56)</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.22pt; text-align: left;" class="fpara">$(0.05)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Diluted net loss per share</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara">$(0.56)</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.22pt; text-align: left;" class="fpara">$(0.05)</div>
                  </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Book value per share</div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">1.56</span></div>
                  </td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.63%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                    <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.22pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">1.46</span></div>
                  </td>

  </tr>


</table>
          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 12pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">26<br />
        </div>

      </div>

    </div>

    <!--End Page 35-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 36-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tRF"><!--Anchor--></a>RISK FACTORS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The combined organization will be faced with a market environment
            that cannot be predicted and that involves significant risks, many of which will be beyond its control. In addition to the other information contained in this proxy statement/prospectus/information statement, you should carefully consider the
            material risks described below before deciding how to vote your shares of stock. In addition, you should read and consider the risks associated with the business of Caladrius because these risks may also affect the combined organization&#8212;these
            risks can be found in Caladrius&#8217; Annual Report on Form 10-K, as updated by subsequent Quarterly Reports on Form 10-Q, all of which are filed with the SEC and incorporated by reference into this proxy statement/prospectus/information statement.
            You should also read and consider the other information in this proxy statement/prospectus/information statement and the other documents incorporated by reference into this proxy statement/prospectus/information statement. Please see the
            section entitled &#8220;Where You Can Find More Information&#8221; in this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; text-align: center;" class="h1"><a id="tRRM"><!--Anchor--></a><span style="text-decoration: underline;">Risks Related to the Merger</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The Exchange Ratio is not adjustable based on
            the market price of Caladrius Common Stock so the merger consideration at the Closing may have a greater or lesser value than the market price at the time the Merger Agreement was signed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement has set the Exchange Ratio formula for Cend Capital Stock, and the
            Exchange Ratio is adjustable upward or downward based on Caladrius&#8217; net cash and Cend&#8217;s unpaid transaction costs at the closing of the Merger and changes in the outstanding Cend Capital Stock or the outstanding Caladrius Common Stock, including
            in connection with the proposed Reverse Stock Split prior to completion of the Merger as described in the section entitled &#8220;<span style="font-style: italic;">The Merger&#8212;Merger Consideration and Adjustment</span>&#8221; in this proxy
            statement/prospectus/information statement. Any changes in the market price of Caladrius Common Stock before the completion of the Merger will not affect the number of shares Cend Stockholders will be entitled to receive pursuant to the Merger
            Agreement. Therefore, if before the completion of the Merger, the market price of Caladrius Common Stock declines from the market price on the date of the Merger Agreement, then Cend Stockholders could receive merger consideration with
            substantially lower value. Similarly, if before the completion of the Merger, the market price of Caladrius Common Stock increases from the market price on the date of the Merger Agreement, then Cend Stockholders could receive merger
            consideration with substantially more value for their shares of Cend Capital Stock than the parties had negotiated in the establishment of the Exchange Ratio. The Merger Agreement does not include a price-based termination right. Because the
            Exchange Ratio does not adjust as a result of changes in the value of Caladrius Common Stock, for each one percentage point that the market value of Caladrius Common Stock rises or declines, there is a corresponding one percentage point rise or
            decline, respectively, in the value of the total merger consideration issued to Cend Stockholders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; net cash may be less than a range
            between $61.076&#160;million and $73.579&#160;million at the closing of the Merger, which, depending on when the closing of the Merger occurs, could result in Caladrius Stockholders owning a smaller percentage of the combined organization and could even
            result in the conditions to the closing of the Merger not being satisfied.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For purposes of the Merger Agreement, cash is subject to certain reductions, including,
            without limitation, accounts payable, accrued expenses (except those related to the Merger), current liabilities payable in cash, unpaid expenses related to the Merger and certain other unpaid obligations, including declared but unpaid
            dividends. In the event the amount of Caladrius&#8217; cash is smaller or such reductions are greater than anticipated, Caladrius Stockholders could hold a significantly smaller portion of the combined organization. Additionally, the Merger Agreement
            includes a closing condition based upon a minimum net cash balance depending on when the closing of the Merger occurs. In the event that Caladrius&#8217; net cash falls below this threshold, Cend would not be obligated to consummate the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend&#8217;s unpaid transaction costs may exceed
            $250,000 at the closing of the Merger, or Caladrius&#8217; net cash may be in excess of certain targets in the Merger Agreement, both of which could result in Cend Stockholders owning a smaller percentage of the combined organization. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the event the amount of Cend&#8217;s unpaid transaction costs exceed $250,000, Cend
            Stockholders could hold a significantly smaller portion of the combined organization. In addition, the provisions of the Merger Agreement </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">27<br />
        </div>

      </div>

    </div>

    <!--End Page 36-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 37-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">providing for a reduction in the ownership of Caladrius Stockholders for cash
            shortfalls also provide for an increase in the ownership of Caladrius Stockholders in the even the amount of Caladrius&#8217; cash is greater than certain other thresholds. These factors could combine to materially reduce the Cend Stockholders&#8217;
            ownership of the combined organization. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Failure to complete the Merger may result in
            Caladrius and Cend paying a termination fee or expenses to the other party and could harm the price of Caladrius Common Stock and the future business and operations of each company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">If the Merger is not completed, Caladrius and Cend are subject to the following risks:
          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Merger Agreement is terminated under certain circumstances, Caladrius or Cend will be required to pay certain transaction
                    expenses of the other party, up to a maximum of $1.0&#160;million; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Merger Agreement is terminated under certain circumstances, Cend will be required to pay Caladrius a termination fee of
                    $4.0&#160;million, plus certain transaction expenses of Caladrius; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Merger Agreement is terminated under certain circumstances, Caladrius will be required to pay Cend a termination fee of
                    $1.0&#160;million, plus certain transaction expenses of Cend; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the price of Caladrius Common Stock may decline and remain volatile; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">some costs related to the Merger, such as certain portions of legal and accounting fees, must be paid even if the Merger is not
                    completed. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, if the Merger Agreement is terminated and the Caladrius Board of Directors
            or the Cend Board of Directors determines to seek another business combination, there can be no assurance that either Caladrius or Cend will be able to find a partner willing to provide equivalent or more attractive consideration than the
            consideration to be provided by each party in the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The Merger may be completed even though
            material adverse changes may result from the announcement of the Merger, industry-wide changes and other causes.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In general, either Caladrius or Cend can refuse to complete the Merger if there is a
            material adverse change affecting the other party between the date of the Merger Agreement, and the Closing. However, certain types of changes do not permit either party to refuse to complete the Merger, even if such change could be said to
            have a material adverse effect on Caladrius or Cend, including: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to Caladrius, any rejection or non-acceptance by a governmental body of a registration statement or filing by
                    Caladrius relating to certain intellectual property rights of Caladrius; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the taking of any action, or the failure to take any action, by either Caladrius or Cend required to comply with the terms of
                    the Merger Agreement; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any effect resulting from the announcement or pendency of the Merger or any related transactions; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">continued losses from operations or decreases in cash balances of Caladrius or Cend;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any natural disaster or any act or threat of terrorism or war anywhere in the world, any armed hostilities or terrorist
                    activities anywhere in the world, any threat or escalation or armed hostilities or terrorist activities anywhere in the world or any governmental or other response or reaction to any of the foregoing; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any change in accounting requirements or principles of any change in applicable laws, rules or regulations or the interpretation
                    thereof; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any general economic or political conditions or conditions generally affecting the industries in which the Caladrius or Cend
                    operate;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any epidemics, pandemics, disease outbreaks, or other public health emergencies or the escalation or worsening thereof,
                    including COVID-19 or Caladrius&#8217; or Cend&#8217;s compliance with any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; social distancing, shut down, closure, sequester, safety or similar law, guidelines or recommendations promulgated by any
                    governmental body, the Centers for Disease Control and Prevention or the World Health Organization, in each case, in connection with, related to, or in response to COVID-19, including the CARES Act and Families First Coronavirus
                    Response Act;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">28<br />
        </div>

      </div>

    </div>

    <!--End Page 37-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 38-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to Caladrius, any changes in or affecting research and development, clinical trials or other drug development
                    activities conducted by or on behalf of Caladrius;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to Caladrius, any change in the stock price or trading volume of Caladrius Common Stock excluding any underlying
                    effect that may have caused such change; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to Cend, any change in the cash position of Cend that results from operations in the ordinary course of business. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If adverse changes occur and Caladrius and Cend still complete the Merger, the price of
            Caladrius Common Stock may suffer. This in turn may reduce the value of the Merger to the Caladrius Stockholders, the Cend Stockholders or both.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Some Caladrius and Cend officers and directors
            have interests in the Merger that are different from yours and that may influence them to support or approve the Merger without regard to your interests.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Certain officers and directors of Caladrius and Cend participate in arrangements that
            provide them with interests in the Merger that are different from yours, including, among others, the continued service as an officer or director of the combined organization, severance benefits, continued indemnification and the potential
            ability to sell an increased number of shares of common stock of the combined organization in accordance with Rule 144 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). For example, Caladrius has entered into certain
            employment and severance benefits agreements with each of its current executive officers that may result in the receipt by such executive officers of cash severance payments and other benefits with a total value of approximately $3.0 million
            (collectively, not individually), based on data available as of June&#160;13, 2022 and assuming a covered termination of employment of each executive officer&#8217;s employment as of such date. For more information concerning the treatment of Caladrius
            options in connection with the Merger, see the section entitled &#8220;<span style="font-style: italic;">The Merger Agreement&#8212;Treatment of Caladrius Options</span>&#8221; in this proxy statement/prospectus/information statement. In addition, and for
            example, certain of Cend&#8217;s directors and executive officers have options, subject to vesting (with acceleration of vesting triggered by the Merger in some instances), to purchase shares of Cend Common Stock which, at the Closing, shall be
            converted into and become options to purchase shares of Caladrius Common Stock; certain of Cend&#8217;s directors and executive officers are expected to become directors and executive officers of Caladrius upon the Closing; and all of Cend&#8217;s
            directors and executive officers are entitled to certain indemnification and liability insurance coverage pursuant to the terms of the Merger Agreement. For more information concerning the interests of Caladrius and Cend executive officers and
            directors, see the sections entitled &#8220;<span style="font-style: italic;">The Merger&#8212;Interests of the Caladrius Directors and Executive Officers in the Merger</span>&#8221; and &#8220;<span style="font-style: italic;">The Merger&#8212;Interests of the Cend
              Directors and Executive Officers in the Merger</span>&#8221; in this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;" class="frisk">The market price of Caladrius Common Stock
            following the Merger may decline as a result of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">The market price of Caladrius Common Stock may decline as a result of the Merger for a
            number of reasons if: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">investors react negatively to the prospects of the combined organization&#8217;s business and prospects from the Merger; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the effect of the Merger on the combined organization&#8217;s business and prospects is not consistent with the expectations of
                    financial or industry analysts; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the combined organization does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by
                    financial or industry analysts. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius Stockholders may not realize a
            benefit from the Merger commensurate with the ownership dilution they will experience in connection with the Merger, and Cend Stockholders may likewise receive less value than anticipated in the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the combined organization is unable to realize the full strategic and financial
            benefits currently anticipated from the Merger, Caladrius Stockholders will have experienced substantial dilution of their ownership interests without receiving any commensurate benefit, or only receiving part of the commensurate benefit, and
            likewise the value of the shares in the combined organization received by Cend Stockholders may be of significantly less value than anticipated, to the extent the combined organization is able to realize only part of the strategic and financial
            benefits currently anticipated from the Merger.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">29<br />
        </div>

      </div>

    </div>

    <!--End Page 38-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 39-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius Stockholders and Cend Stockholders
            will have a reduced ownership and voting interest in, and will exercise less influence over the management of, the combined organization following the completion of the Merger as compared to their current ownership and voting interests in the
            respective companies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">After the completion of the Merger, the current Caladrius Stockholders and Cend
            Stockholders will own a smaller percentage of the combined organization than their ownership of their respective companies prior to the Merger. Immediately after the Merger, Caladrius Stockholders, whose shares of Caladrius Common Stock will
            remain outstanding after the Merger, will own approximately 50% of the outstanding Caladrius Common Stock and Cend Stockholders will own approximately 50% of the outstanding Caladrius Common Stock, in each case, excluding securities convertible
            or exercisable into shares of Caladrius Common Stock. These estimates are based on the anticipated Exchange Ratio and are subject to adjustment.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">During the pendency of the Merger, Caladrius
            and Cend may not be able to enter into a business combination with another party at a favorable price because of restrictions in the Merger Agreement, which could adversely affect their respective businesses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Covenants in the Merger Agreement impede the ability of Caladrius and Cend to make
            acquisitions, subject to certain exceptions relating to fiduciary duties, as set forth below, or to complete other transactions that are not in the ordinary course of business pending completion of the Merger. As a result, if the Merger is not
            completed, the parties may be at a disadvantage to their competitors during such period. In addition, while the Merger Agreement is in effect, each party is generally prohibited from soliciting, initiating, encouraging or entering into certain
            extraordinary transactions, such as merger, sale of assets or other business combination outside the ordinary course of business with any third party, subject to certain exceptions relating to fiduciary duties, as set forth below. Any such
            transactions could be favorable to such party&#8217;s stockholders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Certain provisions of the Merger Agreement may
            discourage third parties from submitting alternative takeover proposals, including proposals that may be superior to the arrangements contemplated by the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The terms of the Merger Agreement prohibit each of Caladrius and Cend from soliciting
            alternative takeover proposals or cooperating with persons making unsolicited takeover proposals, except in limited circumstances when such party&#8217;s board of directors determines in good faith that an unsolicited alternative takeover proposal is
            or is reasonably likely to be inconsistent with the board&#8217;s fiduciary duties. Moreover, even if a party receives what the party&#8217;s board of directors determine is a superior proposal, the Merger Agreement does not permit either party to
            terminate the Merger Agreement to enter into a superior proposal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Because the lack of a public market for Cend
            Capital Stock makes it difficult to evaluate the value of Cend of Capital Stock, the Cend Stockholders may receive shares of Caladrius Common Stock in the Merger that have a value that is less than, or greater than, the fair market value of
            Cend Capital Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The outstanding Cend Capital Stock is privately held and is not traded in any public
            market. The lack of a public market makes it extremely difficult to determine the fair market value of Cend Capital Stock. Because the percentage of Caladrius equity to be issued to Cend Stockholders was determined based on negotiations between
            the parties, it is possible that the value of the Caladrius Common Stock to be received by Cend Stockholders will be less than the fair market value of Cend Capital Stock, or Caladrius may pay more than the aggregate fair market value of Cend
            Capital Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">If the conditions of the Merger are not met,
            the Merger will not occur.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even if the Merger is approved by Caladrius Stockholders and Cend Stockholders,
            specified conditions must be satisfied or waived to complete the Merger. These conditions are set forth in the Merger Agreement and described in the section entitled &#8220;<span style="font-style: italic;">The Merger Agreement&#8212;Conditions to the
              Completion of the Merger</span>&#8221; in this proxy statement/prospectus/information statement. Caladrius and Cend cannot assure you that all of the conditions will be satisfied or waived. If the conditions are not satisfied or waived, the Merger
            will not occur or will be delayed, and Caladrius and Cend each may lose some or all of the intended benefits of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The Merger may fail to qualify as a
            reorganization for U.S. federal income tax purposes, resulting in recognition of taxable gain or loss by Cend Stockholders in respect of their Cend Capital Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius and Cend intend for the Merger to qualify as a reorganization within the
            meaning of Section 368(a) of the Code, as described in the section entitled &#8220;<span style="font-style: italic;">The Merger&#8212;Material U.S. Federal Income Tax Consequences of the Merger</span>&#8221; in this proxy statement/prospectus/information
            statement. In the event that the Merger does not </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">30<br />
        </div>

      </div>

    </div>

    <!--End Page 39-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 40-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">qualify as a reorganization, the Merger would result in taxable gain or loss for
            each Cend Stockholder, with the amount of such gain or loss determined by the amount that each Cend Stockholder&#8217;s adjusted tax basis in the Cend Capital Stock surrendered is less or more than the fair market value of the Caladrius Common Stock
            and any cash in lieu of a fractional share received in exchange therefor. Each holder of Cend Capital Stock is urged to consult with his, her or its own tax advisor with respect to the tax consequences of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; text-align: center;" class="h1"><span style="text-decoration: underline;">Risks Related to the Proposed Reverse Stock Split</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The proposed Reverse Stock Split may not
            increase the combined organization&#8217;s stock price over the long-term.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The principal purpose of the proposed Reverse Stock Split is to increase the per-share
            market price of Caladrius Common Stock. It cannot be assured, however, that the proposed Reverse Stock Split will accomplish this objective for any meaningful period of time. While it is expected that the reduction in the number of outstanding
            shares of Caladrius Common Stock will proportionally increase the market price of Caladrius Common Stock, it cannot be assured that the proposed Reverse Stock Split will increase the market price of Caladrius Common Stock by a multiple of the
            proposed Reverse Stock Split ratio, or result in any permanent or sustained increase in the market price of Caladrius Common Stock, which is dependent upon many factors, including the combined organization&#8217;s business and financial performance,
            general market conditions and prospects for future success. Thus, while the stock price of the combined organization might meet the continued listing requirements for The Nasdaq Capital Market initially, it cannot be assured that it will
            continue to do so.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="frisk">The proposed Reverse Stock Split may decrease
            the liquidity of the combined organization&#8217;s common stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Although the Caladrius Board of Directors believes that the anticipated increase in the
            market price of the combined organization&#8217;s common stock could encourage interest in its common stock and possibly promote greater liquidity for its stockholders, such liquidity could also be adversely affected by the reduced number of shares
            outstanding after the proposed Reverse Stock Split. The reduction in the number of outstanding shares may lead to reduced trading and a smaller number of market makers for Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The proposed Reverse Stock Split may lead to a
            decrease in the combined organization&#8217;s overall market capitalization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Should the market price of the combined organization&#8217;s common stock decline after the
            proposed Reverse Stock Split, the percentage decline may be greater, due to the smaller number of shares outstanding, than it would have been prior to the proposed Reverse Stock Split. A reverse stock split may be viewed negatively by the
            market and, consequently, can lead to a decrease in the combined organization&#8217;s overall market capitalization. If the per share market price does not increase in proportion to the proposed Reverse Stock Split ratio, then the value of the
            combined organization, as measured by its stock capitalization, will be reduced. In some cases, the per-share stock price of companies that have effected reverse stock splits subsequently declined back to pre-reverse split levels, and
            accordingly, it cannot be assured that the total market value of Caladrius Common Stock will remain the same after the proposed Reverse Stock Split is effected, or that the proposed Reverse Stock Split will not have an adverse effect on the
            stock price of Caladrius Common Stock due to the reduced number of shares outstanding after the proposed Reverse Stock Split.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; text-align: center;" class="h1"><a id="tRRC"><!--Anchor--></a><span style="text-decoration: underline;">Risks Related to Caladrius</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h2">Risks Related to Caladrius&#8217; Financial Condition and Capital
            Requirements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius has incurred substantial losses and
            negative cash flow from operations in the past and expect to continue to incur losses and negative cash flow for the foreseeable future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has a limited operating history, limited capital, and limited sources of
            revenue. Since Caladrius&#8217; inception in 1980 through December&#160;31, 2021, Caladrius has incurred aggregate net losses of approximately $453.0&#160;million. Caladrius&#8217; net losses from continuing operations attributable to common stockholders for the
            years ended December&#160;31, 2021 and December&#160;31, 2020 were approximately $27.5&#160;million and $8.2&#160;million, respectively. As of December&#160;31, 2021, Caladrius&#8217; cash and cash equivalents and marketable securities were $95.0&#160;million. Caladrius&#8217; current
            business has not generated revenues in the past and for the foreseeable future it does not expect it to generate revenue to be sufficient to cover costs attributable to that business or to Caladrius&#8217; </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">31<br />
        </div>

      </div>

    </div>

    <!--End Page 40-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 41-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">operations as a whole, including Caladrius&#8217; development activities associated with
            our product candidates. Ultimately, Caladrius may never generate sufficient revenue from its business to reach profitability, generate positive cash flow or sustain, on an ongoing basis, its current or projected levels of product development
            and other operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius anticipates that it will need
            substantial additional financing to continue its operations; if it is unable to raise additional capital, it may be forced to delay, reduce or eliminate one or more of our product development programs, and its business will be harmed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; current operating plan will require significant levels of additional capital
            to fund the continued development of its cell therapy product candidates and its clinical development activities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; clinical activities are expected to continue to grow as its programs are
            advanced and they will require significant investment over a period of several years before they could potentially be approved by the U.S. Food and Drug Administration (&#8220;FDA&#8221;) and commercialized by it or a partner, if ever. Even if data from
            Caladrius&#8217; current clinical trials for its product candidates were deemed positive, it may be required to conduct additional clinical trials of the product candidates, including larger and more expensive pivotal Phase 3 trials, to pursue
            commercialization of the candidates. To do so, Caladrius will need to raise additional capital, enter into collaboration agreements with third parties or undertake any combination thereof. If Caladrius is unsuccessful in its efforts to raise
            capital or find collaborative partners, it will likely need to otherwise delay or abandon the trials. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The amount and timing of Caladrius&#8217; future capital requirements also will likely depend
            on many other factors, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the scope, progress, results, costs, timing and outcomes of Caladrius&#8217; cell therapy research and development programs and
                    product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius&#8217; ability to enter into any collaboration agreements with third parties for its product candidates and the timing and
                    terms of any such agreements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs associated with the consummation of one or more strategic transactions;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing of, and the costs involved in obtaining, regulatory approvals for our product candidates, a process which could be
                    particularly lengthy, or complex given the FDA&#8217;s limited experience with marketing approval for cell therapy products;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs of maintaining, expanding and protecting Caladrius&#8217; intellectual property portfolio, including potential litigation
                    costs and liabilities relating thereto;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the cost of expansion of Caladrius&#8217; development operations and personnel; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the availability of, or Caladrius&#8217; access to, state or federal government awards.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To both fund our clinical trials and support Caladrius&#8217; future operations, it would
            likely seek to raise capital through a variety of different public and/or private financings vehicles. This could include, but not be limited to, utilization of Caladrius&#8217; at-the-market (&#8220;ATM&#8221;) offering agreement with H.C. Wainwright &amp; Co.,
            LLC (&#8220;HCW&#8221;) potential issuances of other debt or equity securities in public or private financings and/or sale or licensing of assets. If Caladrius raises capital through the sale of equity, or securities convertible into equity, it will result
            in dilution to our then-existing stockholders. Servicing the interest and principal repayment obligations under debt Caladrius incurs, or whether any such debt is called, would divert funds that might otherwise be available to support research
            and development, clinical or commercialization activities. In addition, debt financing involves covenants that restrict Caladrius&#8217; ability to operate its business. In certain cases, Caladrius also may seek funding through collaborative
            arrangements that would likely require it to relinquish certain rights to its technology or product candidates and diminish its share in the future revenues associated with the partnered product.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Ultimately, Caladrius may be unable to raise capital or enter into collaborative
            relationships on terms that are acceptable to it, if at all. Caladrius&#8217; inability to obtain necessary capital or financing to fund our future operating needs could adversely affect its business, results of operations and financial condition.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">32<br />
        </div>

      </div>

    </div>

    <!--End Page 41-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 42-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius has never generated any revenue
            from product sales and its ability to generate revenue from product sales and become profitable depends significantly on its success in a number of factors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has no products approved for commercial sale, has not generated any revenue
            from product sales, and does not anticipate generating any revenue from product sales until sometime after it has received regulatory approval for the commercial sale of a product candidate, which may never occur. Caladrius&#8217; ability to generate
            revenue from product sales and achieve profitability depends significantly on its success in many factors, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">completing research regarding, and nonclinical and clinical development of, Caladrius&#8217; current and future product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining regulatory approvals and marketing authorizations for product candidates for which Caladrius completes clinical
                    trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">developing a sustainable and scalable manufacturing process for Caladrius&#8217; product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identifying and contracting with contract manufacturers that have the ability and capacity to manufacture Caladrius&#8217; development
                    products and make them at an acceptable cost;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">launching and commercializing product candidates for which Caladrius obtains regulatory approvals and marketing authorizations,
                    either directly or with a collaborator or distributor;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining market acceptance of Caladrius&#8217; product candidates as viable treatment options;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ensuring ongoing regulatory compliance post-approval and with respect to sales and marketing of future products;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">addressing any competing technological and market developments;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identifying, assessing, acquiring and/or developing new product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">negotiating favorable terms in any collaboration, licensing, or other arrangements into which Caladrius may enter;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">maintaining, protecting, and expanding Caladrius&#8217; portfolio of intellectual property rights, including patents, trade secrets,
                    and know-how; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">attracting, hiring, and retaining qualified personnel.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even if one or more of the product candidates that Caladrius develops is approved for
            commercial sale, it anticipates incurring significant costs associated with commercializing any approved product candidate. Caladrius&#8217; expenses could increase beyond expectations if we are required by the FDA, or other regulatory agencies,
            domestic or foreign, to change its manufacturing processes or assays, or to perform clinical, nonclinical, or other types of studies in addition to those that it currently anticipates. If Caladrius is successful in obtaining regulatory
            approvals to market one or more of its product candidates, its revenue will depend, in part, upon the size of the markets in the territories for which it obtains regulatory approval, the accepted price for the product, the ability to receive
            reimbursement at any price, and whether it owns the commercial rights for that territory. If the number of Caladrius&#8217; addressable disease patients is not as significant as it estimates, the indication approved by regulatory authorities is
            narrower than it expects, or the reasonably accepted population for treatment is narrowed by competition, physician choice or treatment guidelines, it may not generate significant revenue from sales of such products, even if approved. If
            Caladrius is not able to generate revenue from the sale of any approved products, it may never become profitable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">If Caladrius&#8217; status as a smaller reporting
            company changes, Section 404(b) of the Sarbanes-Oxley Act of 2002 may require an independent registered public accounting firm to report on the effectiveness of its internal control over financial reporting. Any delays or difficulty in
            satisfying these requirements could adversely affect Caladrius&#8217; future results of operations and its stock price.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Section 404(b) of the Sarbanes-Oxley Act of 2002 requires an independent registered
            public accounting firm to test the internal control over financial reporting of public companies, and to report on the effectiveness of such controls, for each fiscal year ending after June&#160;15, 2010. Under the Dodd Frank Wall Street Reform and
          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">33<br />
        </div>

      </div>

    </div>

    <!--End Page 42-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 43-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Consumer Protection Act of 2010 (the &#8220;Dodd Frank Act&#8221;), Caladrius is exempt from
            Section 404(b) as long as it remains a smaller reporting company or a non-accelerated filer. If Caladrius&#8217; status as a smaller reporting company changes, it may be required to comply with this auditor attestation requirement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, Caladrius may in the future discover areas of its internal controls that
            need improvement, particularly with respect to businesses that it may acquire. If so, we cannot be certain that any remedial measure Caladrius takes will ensure that it have adequate internal controls over its financial processes and reporting
            in the future. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could harm Caladrius&#8217; operating results or cause it to fail to meet its reporting obligations. If Caladrius is unable
            to conclude that it has effective internal controls over financial reporting, or if it becomes necessary for its independent registered public accounting firm to provide it with an unqualified report regarding the effectiveness of our internal
            control over financial reporting and it is unable to do so, investors could lose confidence in the reliability of its financial statements. This could result in a decrease in the value of Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Risks Related to Caladrius&#8217; Cell Therapy Product Development Efforts</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; future success may be dependent on
            the timely and successful continued development and commercialization of HONEDRA&#174;, its experimental product candidate for CLI and Buerger&#8217;s Disease that has been in clinical development in Japan, XOWNA&#174; or CLBS16 for CMD, and CLBS201 for DKD,
            and if Caladrius encounters delays or further difficulties in the development of these product candidates, its business prospects would be significantly harmed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius is dependent upon the successful development, approval and commercialization
            of its product candidates. Before Caladrius is able to seek regulatory approval of its product candidates, it must conduct and complete extensive clinical trials to demonstrate their safety and efficacy in humans. Caladrius has never taken a
            product through the regulatory approval process or successfully to U.S. or international commercialization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In early 2018, Caladrius treated the first patient in a clinical trial in Japan for
            HONEDRA&#174; for use in CLI taking advantage of the paradigm of potential conditional approval for regenerative medicine products established by new regulations in Japan for products that show sufficient safety evidence and some evidence of
            efficacy. Because of difficulty enrolling the remaining patients in the trial and the costs of continued delays in such, Caladrius suspended enrollment of the trial at the end of 2021 and commenced talks with development partners as well as
            with Japan&#8217;s Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) to consider paths forward. There can be no assurance that Caladrius will find a partner or that PMDA will consider the drug for approval without completing enrollment of the
            trial, such that HONEDRA&#174; may be delayed indefinitely or never commercialized.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In late 2020 Caladrius began enrolling patients in the FREEDOM Trial using CD34+ cells
            to treat CMD (CLBS16). That trial also has been delayed significantly by COVID-19-related challenges to enrollment and supply chain issues. Additionally, Caladrius currently has an open investigational new drug application (&#8220;IND&#8221;) for CLBS201
            in a pilot study examining the effectiveness of CD34+ cells to treat diabetic kidney disease.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Clinical testing is expensive, difficult to design and implement, and can take many
            years to complete. Importantly, a failure of one or more of these or any other clinical trials can occur at any stage of testing. Caladrius may experience numerous unforeseen events during, or as a result of clinical trials that could delay or
            prevent its ability to complete its clinical trials, receive regulatory approval or commercialize its cell therapy product candidates, including the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">suspensions, delays or changes in the design, initiation, enrollment, implementation or completion of required clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">adverse changes in its financial position or significant and unexpected increases in the cost of its clinical development
                    program;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes or uncertainties in, or additions to, the regulatory approval process that require Caladrius to alter its current
                    development strategy;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">clinical trial results that are negative, inconclusive or even less than desired as to safety and/or efficacy, which could
                    result in the need for additional clinical trials or the termination of the product&#8217;s development;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">34<br />
        </div>

      </div>

    </div>

    <!--End Page 43-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 44-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in its ability to manufacture its product candidates in quantities or in a form that is suitable for any required
                    clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">intellectual property constraints that prevent Caladrius from making, using, or commercializing any of its cell therapy product
                    candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the supply or quality of its product candidates or other materials or equipment necessary to conduct clinical trials of these
                    product candidates may be no longer available for purchase, insufficient or inadequate;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inability to generate sufficient preclinical, toxicology, or other in vivo or in vitro data to support the initiation of
                    clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in reaching agreement on acceptable terms with prospective contract research organizations (&#8220;CROs&#8221;), contract
                    manufacturing organizations (&#8220;CMOs&#8221;), and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs, CMOs and clinical trial sites;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in obtaining required institutional review board (&#8220;IRB&#8221;) approval at each clinical trial site;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inability to file INDs with the FDA for its development candidates or comparable clinical trial applications with other
                    regulatory authorities outside of the United States;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">imposition of a temporary or permanent clinical hold by the FDA or similar restrictions by other regulatory agencies for a
                    number of reasons, including after review of an IND or amendment, or equivalent application or amendment; as a result of a new safety finding that presents unreasonable risk to clinical trial participants; a negative finding from an
                    inspection of its clinical trial operations or clinical trial sites; developments on trials conducted by competitors or approved products post-market for related technology that raises FDA concerns about risk to patients of the
                    technology broadly; or if the FDA finds that the investigational protocol or plan is clearly deficient to meet its stated objectives;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">difficulty collaborating with patient groups and investigators;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure by its CROs, CMOs other third parties, or Caladrius to adhere to clinical trial requirements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to perform in accordance with the FDA or international good clinic practice (&#8220;GCP&#8221;) requirements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to reach agreement with the FDA on a satisfactory development path of its development candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in having patients qualify for or complete participation in a trial or return for post-treatment follow-up;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">patients dropping out of a clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">occurrence of adverse events associated with the product candidate;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in the standard of care on which a clinical development plan was based, which may require new or additional trials or
                    abandoning existing trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">transfer of manufacturing processes from its academic collaborators to larger-scale facilities operated by either a contract
                    manufacturing organization, or CMO, or by us, and delays or failure by its CMOs or Caladrius to make any necessary changes to such manufacturing process;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in manufacturing, testing, releasing, validating, or importing/exporting sufficient stable quantities of its product
                    candidates for use in clinical trials or the inability to do any of the foregoing; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA may not accept clinical data from trials that are conducted in countries where the standard of care is potentially
                    different from the United States.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any inability to successfully complete nonclinical and clinical development could
            result in additional costs to Caladrius or impair its ability to generate revenue. In addition, if Caladrius makes manufacturing or formulation changes to its product candidates, it may be required to, or it may elect to, conduct bridging
            studies to demonstrate the equivalence of its modified product candidates to earlier versions. Clinical trial delays could also </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">35<br />
        </div>

      </div>

    </div>

    <!--End Page 44-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 45-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">shorten any periods during which its products have patent protection and may allow
            its competitors to bring products to market before it does, which could impair its ability to successfully commercialize its product candidates and may harm its business and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; business has been and may continue
            to be adversely affected by the COVID-19 pandemic.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The COVID-19 pandemic has affected Caladrius&#8217; operations and may materially affect its
            business. In response to the pandemic, Caladrius has limited in-office operations, including implementing work from home and social distancing policies. Caladrius risks a delay, default and/or nonperformance under its existing agreements
            arising from force majeure.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, COVID-19 has resulted in significant governmental measures being
            implemented to control the spread of the virus, including quarantines, travel restrictions, social distancing and business shutdowns. Caladrius has taken temporary precautionary measures intended to help minimize the risk of the virus to its
            employees, including temporarily allowing all employees to work remotely. These measures could negatively affect its business. For instance, temporarily requiring all employees to work remotely may induce absenteeism, disrupt its operations, or
            increase the risk of a cybersecurity incident. COVID-19 has also caused volatility in the global financial markets and threatened a slowdown in the global economy, which may negatively affect Caladrius&#8217; ability to raise additional capital on
            attractive terms or at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; clinical trials have suffered and may continue to suffer from delays and
            lower than anticipated patient recruitment or enrollment. Caladrius&#8217; clinical study of HONEDRA&#174; in Japan has experienced significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 and re-implemented from
            January&#160;7, 2021 through March&#160;21, 2021 covering Tokyo and other regions in response to an increased number of COVID-19 infections. Due to reported increases in COVID-19 cases and a low rate of vaccination in Japan, States of Emergency were
            renewed on April&#160;25, 2021 through May&#160;11, 2021 and then re-implemented in Tokyo from July&#160;12, 2021 through September&#160;30, 2021. With Caladrius&#8217; expectation that COVID-19 in Japan would continue to impact negatively enrollment of patients in the
            HONEDRA&#174; clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory authorities regarding the submission of patient data already accrued. In addition, Caladrius&#8217; Phase 2b trial of
            XOWNA&#174; in the United States has experienced delays in enrolling patients as a result of COVID-19. In May 2022, Caladrius suspended enrollment in the Phase 2b trial pending results from an interim analysis, and there can be no assurance that
            enrollment will be resumed or that if resumed, that it will be successful.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">COVID-19 could continue to disrupt production and cause delays in the supply and
            delivery of products used in our clinical trials, may affect our operations, including the conduct of clinical studies, or the ability of regulatory bodies to grant approvals, may further divert the attention and efforts of the medical
            community to coping with COVID-19 and disrupt the marketplace in which we operate and may have a material adverse effects on our operations. The extent to which COVID-19 will continue to impact our business will depend on future developments,
            which are highly uncertain and cannot be predicted with confidence, such as the duration of the pandemic, the severity of COVID-19 or new variants or the effectiveness of actions to contain and treat COVID-19 and its variants, particularly in
            the geographies where Caladrius or its third party suppliers, contract manufacturers, or contract research organizations operate. Caladrius cannot presently predict the scope and severity of any potential business shutdowns or disruptions. If
            Caladrius or any of the third parties with whom it engages, however, were to experience shutdowns or other business disruptions, its ability to conduct its business in the manner and on the timelines presently planned could be materially and
            negatively affected, which could have a material adverse impact on its business and its results of operations and financial condition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Even if Caladrius is able to successfully
            complete its clinical development programs for its product candidates and receive regulatory approval to market one or more of the products, if the commercial opportunities are smaller than it anticipates, its future revenues may be adversely
            affected, and its business may suffer.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the size of the commercial opportunities in any of Caladrius&#8217; target indications is
            smaller than it anticipates, or if the FDA grants its candidates approval to treat only specific subpopulations or otherwise approves the products for more narrow indications for use than Caladrius is seeking, it may not be able to achieve
            profitability and growth.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">36<br />
        </div>

      </div>

    </div>

    <!--End Page 45-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 46-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Even if Caladrius is able to successfully complete its clinical development program
            for its product candidates, and ultimately receive regulatory approval to market one or more of the products, it may, among other things:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtain approval for indications that are not as broad as the indications it sought;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">have the product removed from the market after obtaining marketing approval;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">encounter problems with respect to the manufacturing of commercial supplies;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">be subject to additional post-marketing testing requirements; and/or</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">be subject to restrictions on how the product is distributed or used.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may experience delays in enrolling
            patients in its clinical trials, which could delay or prevent the receipt of necessary regulatory approvals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius may not be able to initiate or complete as planned any clinical trials if it
            is unable to identify and enroll a sufficient number of eligible patients to participate in the clinical trials required by the FDA or other regulatory authorities. Caladrius also may be unable to engage a sufficient number of clinical trial
            sites to conduct its trials. Moreover, Caladrius&#8217; ability to conduct trials outside of the United States may be constrained by its inability to transport trial materials to foreign destinations within the expiry period of such materials unless
            and until it commences operation outside of the United States or find another source of supply.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius may face continuing challenges in enrolling patients to participate in its
            clinical trials due to the novelty of its cell-based therapies, the size of the patient populations, the eligibility criteria for enrollment in the trial and COVID-19 impact. Due, in whole or in part, to delays in enrolling patients as a result
            of COVID-19, Caladrius has suspended trial enrollment for its clinical study of HONEDRA&#174; in Japan and its Phase 2b trial of XOWNA&#174; in the United States. Moreover, changes to enrollment criteria may be prohibited by regulating agencies, may have
            no impact on enrollment rates and may change or harm the outcome of the study. In addition, some patients may have concerns or negative perceptions regarding cell therapy that may affect their decision to enroll in the trials. Furthermore,
            patients suffering from diseases within target indications may enroll in competing clinical trials, which could negatively affect its ability to complete enrollment of its trials. Enrollment challenges in clinical trials often result in
            increased development costs for a product candidate, significant delays and potentially the abandonment of the clinical trial.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Outside of the unique aspects of conducting a clinical trial for a cell therapy
            candidate, patient enrollment in general is affected by many factors, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">size of the target patient population;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">severity of the disease or disorder under investigation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">eligibility criteria for the clinical trial in question;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">other clinical trials being conducted at the same time involving patients who have the disease or disorder under investigation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">perceived risks and benefits of the product candidate under study;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approval and availability of other therapies to treat the disease or disorder that is being investigated in the clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">willingness or unwillingness to participate in a placebo controlled clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">efforts to facilitate timely enrollment in clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">patient referral practices of physicians;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ability to monitor patients adequately during and after treatment; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">proximity and availability of clinical trial sites for prospective patients.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; inability to enroll a sufficient number of patients in any of its planned
            clinical trials would result in significant delays or may require it to abandon one or more clinical trials altogether.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">37<br />
        </div>

      </div>

    </div>

    <!--End Page 46-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 47-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may have other delays in completing
            its clinical trials and it may not complete them at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has not completed the clinical trials necessary to obtain FDA approval to
            market HONEDRA&#174;, XOWNA&#174; or CLBS201 or any of its other product candidates in development. Caladrius&#8217; operational team lacks significant experience in completing Phase 3 pivotal clinical trials and bringing a drug or biological product through
            commercialization. Clinical trials for products in development may be delayed or terminated as a result of many factors, including the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">patients failing to complete clinical trials due to dissatisfaction with the treatment, side effects or other reasons;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure by regulators, IRBs, or independent ethics committees to authorize Caladrius or its investigators at individual sites to
                    commence a clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">suspension or termination by regulators of clinical research for many reasons, including concerns about patient safety or
                    failure of Caladrius&#8217; contract manufacturers to comply with applicable current Good Manufacturing Practice (&#8220;cGMP&#8221;) or current Good Tissue Practice (&#8220;cGTP&#8221;) requirements for the clinical supplies of the cell therapy candidate;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays or failure to obtain clinical supply for Caladrius&#8217; product candidates necessary to conduct clinical trials from contract
                    manufacturers, including commercial grade clinical supply for its trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius&#8217; third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to
                    Caladrius in a timely manner, or at all;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">treatment candidates demonstrating a lack of efficacy during clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inability to continue to fund clinical trials or to find a partner to fund the clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">competition with ongoing clinical trials and scheduling conflicts with participating clinicians; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in completing data collection and analysis for clinical trials.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any delay or failure to complete clinical trials and obtain FDA approval for Caladrius&#8217;
            product candidates could have a material adverse effect on its cost to develop and commercialize, and its ability to generate revenue from, a particular product candidate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may be unable to manage multiple late
            stage clinical trials for a variety of product candidates simultaneously.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As Caladrius&#8217; current clinical trials progress, it may need to manage multiple late
            stage clinical trials simultaneously in order to continue developing all of its current product candidates. Caladrius&#8217; management team does not have significant experience in completing late stage clinical trials and the management of late
            stage clinical trials is more complex and time consuming than early stage trials. Typically, early stage trials involve several hundred patients in no more than 30 clinical sites. Late stage (Phase 3) trials may involve up to several thousand
            patients in up to several hundred clinical sites and may require facilities in several countries. Therefore, the project management required to supervise and control such an extensive program is substantially larger than early stage programs.
            As the need for these resources is not known until some months before the trials begin, it is necessary to recruit large numbers of experienced and talented individuals very quickly. If the labor market does not allow this team to be recruited
            quickly, the sponsor is faced with a decision to delay the program or to initiate it with inadequate management resources. This may result in recruitment of inappropriate patients, inadequate monitoring of clinical investigators and
            inappropriate handling of data or data analysis. Consequently, it is possible that conclusions of efficacy or safety may not be acceptable to permit submission of a Biological Licensing Application (&#8220;BLA&#8221;) for any one of the above reasons or a
            combination of several.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">The development of Caladrius&#8217; cell therapy
            product candidates is subject to uncertainty because autologous cell therapy is inherently variable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">When manufacturing an autologous cell therapy, the number and the composition of the
            cell population varies from patient to patient. Such variability in the number and composition of these cells could adversely affect its ability to manufacture autologous cell therapies in a cost-effective or profitable manner and meet
            acceptable product release specifications for use in a clinical trial or, if approved, for commercial sale. As a consequence, </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">38<br />
        </div>

      </div>

    </div>

    <!--End Page 47-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 48-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the development and regulatory approval process for autologous cell therapy products
            could be delayed or may never be completed. Caladrius&#8217; product development costs will also increase if manufacturing processes and controls require unexpected investments, which could harm its business and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Any disruption to Caladrius&#8217; access to the
            reagents, devices, material or equipment it is using in the clinical development of its cell therapy product candidates could adversely affect its ability to perform clinical trials and seek future regulatory submissions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Reagents, devices, materials and systems that Caladrius is using in its clinical
            trials, that it intends to use in its planned clinical trials and that it may need or use in commercial production, are provided by unaffiliated third parties. Any lack of continued availability of these reagents, devices, materials and systems
            for any reason would have a material adverse effect on its ability to complete these studies and could adversely impact its ability to achieve commercial manufacture of its planned therapeutic products. Although other available sources for
            these reagents, devices, materials and systems may exist in the marketplace, Caladrius has not evaluated its cost, effectiveness, or intellectual property foundation and therefore cannot guarantee the suitability or availability of such other
            potential sources. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The initiation of pivotal Phase 3 clinical
            trials for cell therapy product candidates requires the validation and establishment of manufacturing controls that may delay product development timelines.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To conduct pivotal Phase 3 clinical trials, Caladrius is required to have certain
            validated and established manufacturing controls with respect to the safety, purity and potency of its product candidates when administered to patients. If Caladrius determines that the results of any Phase 2 clinical trial it may conduct
            supports Phase 3 development, it expects to initiate and complete one or more pivotal Phase 3 clinical trials for such programs and would need to address any outstanding chemistry, manufacturing and control (&#8220;CMC&#8221;) issues raised by the FDA
            prior to initiating such trials. Caladrius may not be successful in its efforts to address any CMC issues raised by the FDA. If Caladrius cannot initiate, or if it is delayed in initiating, a pivotal Phase 3 clinical program as a result of its
            failure to satisfy the FDA&#8217;s CMC concerns or otherwise, the timing of regulatory submission for commercialization of its product candidates would be delayed, or it may be unable to seek regulatory approval to commercialize its products at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Product candidates that appear promising in
            research and development may be delayed or may fail to reach later stages of clinical development.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The successful development of pharmaceutical product candidates is highly uncertain.
            Product candidates that appear promising in research and development and early clinical trials may be delayed or fail to reach later stages of development. Decisions regarding the further development of product candidates must be made with
            limited and incomplete data, which makes it difficult to ensure or even accurately predict whether the allocation of limited resources and the expenditure of additional capital on specific product candidates will result in desired outcomes.
            Preclinical and clinical data can be interpreted in different ways, and negative or inconclusive results or adverse events during a clinical trial could delay, limit or prevent the development of a product candidate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Clinical testing is expensive and can take many years to complete, and its outcome is
            inherently uncertain. Failure can occur at any time during the clinical trial process. The results of preclinical studies and early clinical trials of its product candidates may not be predictive of the results of later-stage clinical trials.
            Exploratory trends and results observed in earlier stage clinical trials, particularly trends and results observed for small subsets that were not pre-specified, may not be replicated in later stage clinical trials. Product candidates in Phase
            3 clinical trials may fail to demonstrate sufficient efficacy despite having progressed through initial clinical trials, even if certain exploratory subset analyses of primary or secondary endpoints in those early trials showed trends toward
            efficacy or, in some analyses, nominal statistical significance. The results of clinical trials in one set of patients or line of treatment may not be predictive of those obtained in another.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">If serious or unacceptable side effects are
            identified during the development of any of Caladrius&#8217; product candidates, it may need to abandon or limit its development of that product candidate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">All of Caladrius&#8217; product candidates are in clinical development and their risk of
            failure is high. It is impossible to predict when or if any of Caladrius&#8217; product candidates will prove effective or safe in humans or will receive marketing approval. If Caladrius&#8217; product candidates are associated with undesirable side
            effects or have other unexpected, unacceptable characteristics, it may need to abandon its development or limit development to certain </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">39<br />
        </div>

      </div>

    </div>

    <!--End Page 48-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 49-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">uses or subpopulations in which the undesirable side effects or other
            characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. Many investigational products that initially showed promise in clinical or earlier stage testing have later been found to cause side effects or
            other safety issues that prevented further development. Even if Caladrius receives regulatory approval for a candidate with a known safety risk, such an approved product may not achieve market acceptance by physicians, patients, third-party
            payors or others in the medical community, which would materially and adversely affect its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">A Fast Track designation by the FDA and other
            similar regulatory designations may not lead to a faster development, regulatory review or approval process.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius was granted SAKIGAKE designation in Japan and Advanced Therapeutic Medicinal
            Product (&#8220;ATMP&#8221;) designation in Europe for HONEDRA&#174; for the treatment of CLI and Buerger&#8217;s Disease. However, SAKIGAKE and ATMP designations do not ensure that Caladrius will experience a faster development, regulatory review or approval process
            compared to conventional FDA or Japan&#8217;s PMDA procedures. Additionally, a regulatory authority may withdraw a designation if it believes that the designation is no longer supported by data from the clinical development program. Moreover, award
            of a particular designation does not imply a higher probability of success of a product in the approval process.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; clinical trials may fail to
            demonstrate adequately the safety and efficacy of its product candidates, which would prevent or delay regulatory approval and commercialization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The clinical trials of Caladrius&#8217; product candidates are, and the manufacturing and
            marketing of its products will be, subject to extensive and rigorous review and regulation by numerous government authorities in the United States and in other countries where it intends to test and market its product candidates. Before
            obtaining regulatory approvals for the commercial sale of any of its product candidates, Caladrius must demonstrate through lengthy, complex and expensive preclinical testing and clinical trials that its product candidates are both safe and
            effective for use in each target indication. In particular, because Caladrius&#8217; cell therapy candidates are subject to regulation as biological drug products, it will need to demonstrate that they are safe, pure, and potent for use in their
            target indications. Each product candidate must demonstrate an adequate risk versus benefit profile in its intended patient population and for its intended use. The risk/benefit profile required for product licensure will vary depending on
            these factors and may include adequate duration of response, a delay in the progression of the disease, and/or an improvement in survival. For example, response rates from the use of its product candidates may not be sufficient to obtain
            regulatory approval unless Caladrius can also show an adequate duration of response.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius expects there may be greater variability in results for products processed
            and administered on a patient-by-patient basis, as anticipated for its product candidates, than for &#8220;off-the-shelf&#8221; products, like many other drugs. There is typically an extremely high rate of attrition from the failure of product candidates
            proceeding through clinical trials. Product candidates in later stages of clinical trials may fail to show the desired safety and efficacy profile despite having progressed through preclinical studies and initial clinical trials. A number of
            companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or unacceptable safety issues, notwithstanding promising results in earlier trials. Most product candidates that
            begin clinical trials are never approved by regulatory authorities for commercialization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Data from earlier studies conducted by the third-party research institutions should not
            be relied upon as evidence that later or larger-scale clinical trials will succeed. Some future trials may have different patient populations than current studies and will test Caladrius&#8217; product candidates in different indications, among other
            differences. In addition, Caladrius&#8217; proposed manufacturing processes for its product candidates include what it believes will be process improvements that are not part of the production processes that were previously used in the earlier
            conducted clinical trials being conducted by the research institutions. Accordingly, Caladrius&#8217; results with its product candidates may not be consistent with the results of the clinical trials.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, even if such trials are successfully completed, Caladrius cannot guarantee
            that the FDA or foreign regulatory authorities will interpret the results as do it, and more trials could be required before it submits its product candidates for approval. To the extent that the results of the trials are not satisfactory to
            the FDA or foreign regulatory authorities for support of a marketing application, Caladrius may be required to expend significant resources, which may not be available to it, to conduct additional trials in support of potential approval of its
            product candidates.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">40<br />
        </div>

      </div>

    </div>

    <!--End Page 49-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 50-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius presently relies on contract
            manufacturing organizations to produce its product candidates at development and commercial scale quantities and has not yet qualified an alternate manufacturing supply, which could negatively impact its ability to meet any future demand for
            the products.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius currently relies on one contract manufacturer, Cognate Bioservices, a Charles
            River Company (&#8220;Cognate&#8221;), to provide the cell processing services necessary for clinical production for its various CD34+ cell therapy product candidates. To date, Cognate has not produced any products at commercial scale quantities and
            Caladrius expects that Cognate would need to significantly expand its manufacturing capabilities to meet potential commercial demand for XOWNA&#174; and CLBS201 and any other of its product candidates, if approved, as well as any of its other
            product candidates that might attain regulatory approval. Such expansion would require additional regulatory approvals. Even if they increase their manufacturing capabilities, it is possible that they may still lack sufficient capacity to meet
            demand. At present Caladrius has no contract manufacturer for the production of HONEDRA&#174; in Japan. Ultimately, if Caladrius is unable to supply its products to meet commercial demand, whether because of processing constraints or other
            disruptions, delays or difficulties that it experiences, sales of the products and their long-term commercial prospects could be significantly damaged.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius does not presently have redundant suppliers for any of its product
            candidates. If the facilities where Caladrius&#8217; product candidates are being manufactured and/or the associated equipment were significantly damaged or destroyed, or if there were other disruptions, delays or difficulties affecting manufacturing
            capacity, its planned and future clinical trials and commercial production for these product candidates would likely be significantly disrupted and delayed. It would be both time consuming and expensive to replace this capacity with third
            parties, particularly since any new facility would need to comply with regulatory requirements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Ultimately, if Caladrius is unable to supply its cell therapy product candidates to
            meet commercial demand, were commercial approval to be obtained, whether because of processing constraints or other disruptions, delays or difficulties that it experiences, its production costs could increase dramatically, and sales of the
            product and its long-term commercial prospects could be significantly damaged.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Also, as a result of the current geopolitical tensions and the conflict between Russia
            and Ukraine following the recent and ongoing Russian invasion of Ukraine, the governments of the United States, the European Union, Japan and other jurisdictions have recently announced the imposition of sanctions on certain industry sectors
            and parties in Russia, as well as enhanced export controls on certain products and industries. These and any additional sanctions and export controls, as well as any counter responses by the governments of Russia or other jurisdictions, could
            adversely affect, directly or indirectly, the global supply chain, with negative implications on the availability and prices of raw materials, energy prices, and its customers, as well as the global financial markets and financial services
            industry.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The commercial potential and profitability of
            Caladrius&#8217; product candidates are unknown and subject to significant risk and uncertainty.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even if Caladrius successfully develops and obtains regulatory approval for its cell
            therapy product candidates, the market may not understand or accept the products, which could adversely affect both the timing and level of future sales. Ultimately, the degree of market acceptance of Caladrius&#8217; product candidates (or any of
            its future product candidates) will depend on a number of factors, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the efficacy and potential advantages compared to alternative treatments or competitive products;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the prevalence and severity of any side effects;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">physician acceptance of its cell therapy approach to its target disease indications, include the ease or difficulty of
                    administering the future products;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">restrictions on how the product is distributed or used;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the strength of its marketing and distribution support, including whether it receives support from any patient advocacy groups;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the adequacy of product supply in light of complex manufacturing and distribution processes;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to distinguish its products (which involve adult cells) from any ethical and political controversies associated with
                    stem cell products derived from human embryonic or fetal tissue; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the cost of the product, the reimbursement policies of government and third-party payors and its ability to obtain sufficient
                    third-party coverage or reimbursement.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">41<br />
        </div>

      </div>

    </div>

    <!--End Page 50-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 51-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg16"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Even if Caladrius is successful in achieving sales of its product candidates, it is
            not clear to what extent, if any, the products will be profitable. The costs of goods associated with production of cell therapy products are significant. While Caladrius is working to improve the speed and efficiency and lower the cost of its
            manufacturing processes, there can be no assurance that Caladrius will be successful in these efforts. In addition, some changes in manufacturing processes or procedures generally require FDA or foreign regulatory authority review and approval
            prior to implementation. Thus, Caladrius may need to conduct additional nonclinical studies and clinical trials to support approval of any such changes. Furthermore, this review process could be costly and time-consuming and could delay or
            prevent the commercialization of product candidates. Even if a product is approved and has a medical benefit, it may not be widely adopted if insurers do not provide coverage or reimbursement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may enter into collaborations,
            strategic alliances, additional licensing arrangements, acquisitions, business combinations or other strategic transactions in the future, any of which could require it to issue securities that could significantly dilute the shares of its
            existing stockholders, and it may not realize the benefits of such alliances or licensing arrangements, acquisitions, business combinations or strategic transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius may enter into collaborations, strategic alliances, additional licensing
            arrangements, acquisitions, business combinations or other strategic transactions with third parties that it believes are essential to product commercialization or will complement or augment its development and commercialization efforts with
            respect to its product candidates and any future product candidates that it may develop. Any of these relationships may require Caladrius to incur non-recurring and other charges, increase its near and long-term expenditures, issue securities
            that could significantly dilute the shares of its existing stockholders, or disrupt its management and business. In addition, Caladrius faces significant competition in seeking appropriate strategic partners and/or acquisition candidates and
            the negotiation process can be time-consuming and complex. Moreover, Caladrius may not be successful in its efforts to establish a strategic partnership or other alternative arrangements for its product candidates because they may be deemed to
            be at too early of a stage of development for collaborative effort and third parties may not view its product candidates as having the requisite potential to demonstrate safety and efficacy. Furthermore, there can be no assurance that
            Caladrius&#8217; exploration of potential acquisitions, business combinations or strategic alternatives will result in Caladrius entering or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Further, collaborations involving its product candidates, such as its collaborations
            with third-party research institutions, are subject to numerous risks, which may include the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators have significant discretion in determining the efforts and resources that they will apply to a collaboration;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators may not pursue development and commercialization of its product candidates or may elect not to continue or renew
                    development or commercialization programs based on clinical trial results, changes in their strategic focus due to the acquisition of competitive products, availability of funding, or other external factors, such as a business
                    combination that diverts resources or creates competing priorities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial, abandon a
                    product candidate, repeat or conduct new clinical trials, or require a new formulation of a product candidate for clinical testing;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with its
                    products or product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a collaborator with marketing and distribution rights to one or more products may not commit sufficient resources to their
                    marketing and distribution;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators may not properly maintain or defend its intellectual property rights or may use its intellectual property or
                    proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate its intellectual property or proprietary information or expose Caladrius to potential liability;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">42<br />
        </div>

      </div>

    </div>

    <!--End Page 51-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 52-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg17"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disputes may arise between Caladrius and a collaborator that cause the delay or termination of the research, development or
                    commercialization of its product candidates, or that result in costly litigation or arbitration that diverts management attention and resources;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development
                    or commercialization of the applicable product candidates; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators may own or co-own intellectual property covering its products that results from its collaborating with them, and
                    in such cases, Caladrius would not have the exclusive right to commercialize such intellectual property.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As a result, if Caladrius enters into collaboration agreements and strategic
            partnerships or license its products or businesses, it may not be able to realize the benefit of such transactions if Caladrius is unable to successfully integrate them with its existing operations and company culture, which could delay its
            timelines or otherwise adversely affect its business. Caladrius also cannot be certain that, following a strategic transaction or license, it will achieve the revenue or specific net income that justifies such transaction. Any delays in
            entering into new collaborations or strategic partnership agreements related to Caladrius&#8217; product candidates could delay the development and commercialization of its product candidates in certain geographies for certain indications, which
            would harm its business prospects, financial condition and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius has limited experience in the
            development and marketing of cell therapies and may be unsuccessful in its efforts to establish a profitable business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has limited experience in the areas of cell therapy product development and
            marketing, and in the related regulatory issues and processes. Although Caladrius has recruited a team that has experience with designing and conducting clinical trials, as a company it has limited experience in conducting clinical trials and
            no experience in conducting clinical trials through to regulatory approval of any product candidate. In part because of this lack of experience, Caladrius cannot be certain that ongoing or planned clinical trials will begin or be completed on
            time, if at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; cell therapy business is based on
            novel technologies that are inherently expensive, risky and may not be understood by or accepted in the marketplace, which could adversely affect its future value.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The clinical development, commercialization and marketing of cell and tissue-based
            therapies are at an early stage, substantially research-oriented and financially speculative. To date, very few companies have been successful in their efforts to develop and commercialize a cell therapy product. In general, cell-based or
            tissue-based products may be susceptible to various risks, including undesirable and unintended side effects, unintended immune system responses, inadequate therapeutic efficacy, or other characteristics that may prevent or limit their approval
            or commercial use. Regulatory approval of novel product candidates such as HONEDRA&#174;, XOWNA&#174; and CLBS201, which are each manufactured having novel and proprietary formulations, can be more complex and expensive and take longer than other, more
            well-known or extensively studied pharmaceutical or biopharmaceutical products, due to the FDA&#8217;s lack of experience with them. To Caladrius&#8217; knowledge, the FDA has only approved five autologous cell therapy products to date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This lack of experience may lengthen the regulatory review process, require Caladrius
            to conduct additional studies or clinical trials, which would increase its development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of these product candidates or lead to
            significant post-approval limitations or restrictions. Furthermore, the number of people who may use cell or tissue-based therapies is difficult to forecast with accuracy. Caladrius&#8217; future success is dependent on the establishment of a large
            global market for cell and tissue-based therapies and its ability to capture a share of this market with its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">If competitors develop and market products that
            are more effective, safer, or less expensive than Caladrius&#8217; product candidates or offer other advantages, its commercial prospects will be limited.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; cell therapy development programs now face, and will continue to face,
            intense competition from pharmaceutical, biopharmaceutical and biotechnology companies, as well as numerous academic and research institutions and governmental agencies engaged in drug discovery activities or funding, both in the United States
            and abroad. Some of these competitors are pursuing the development of drugs and other therapies that target the same diseases and conditions that Caladrius is targeting with its product candidates.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">43<br />
        </div>

      </div>

    </div>

    <!--End Page 52-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 53-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg18"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">As a general matter, Caladrius also faces competition from many other companies that
            are researching and developing cell therapies. Many of these companies have financial and other resources substantially greater than ours. In addition, many of these competitors have significantly greater experience in testing pharmaceutical
            and other therapeutic products, obtaining FDA and other regulatory approvals, and marketing and selling FDA-approved products in highly regulated commercial health care markets. If Caladrius ultimately obtains regulatory approval for any of its
            product candidates, it also will be competing with respect to manufacturing efficiency and marketing capabilities, areas in which it has limited or no commercial-scale experience. Mergers and acquisitions in the pharmaceutical and biotechnology
            industries may result in resources being even more concentrated by its competitors. Competition may increase further as a result of advances made in the commercial applicability of Caladrius&#8217; technologies and greater availability of capital for
            investment in these fields.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; cell therapy product candidates for
            which it intends to seek approval as biologic products may face competition sooner than anticipated.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Biologics Price Competition and Innovation Act of 2009, or BPCIA, created an
            abbreviated pathway for licensure of so-called biosimilar and interchangeable biological products, both of which have specific defined meanings under the law. The abbreviated regulatory pathway establishes legal authority for the FDA to review
            and approve biosimilar biologics, including the possible designation of a biosimilar as &#8220;interchangeable&#8221; based on its similarity to an existing reference product. Under the BPCIA, an application for a biosimilar product cannot be approved by
            the FDA until 12&#160;years after the original reference product is approved for marketing in the United States a stand-alone BLA. The law is complex and is still being interpreted and implemented by the FDA. While it is uncertain when such
            processes intended to implement BPCIA may be fully adopted by the FDA, any such processes could have a material adverse effect on the future commercial prospects for Caladrius&#8217; biological products.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There is a risk that the FDA will not consider any of Caladrius&#8217; therapeutic candidates
            to be reference products for competing products, potentially creating the opportunity for generic competition sooner than anticipated. Additionally, this period of regulatory exclusivity does not apply to companies pursuing regulatory approval
            via their own traditional BLA, rather than via the abbreviated pathway. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of its reference products in a way that is similar to traditional generic
            substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing, as well as unique state laws and government/private policies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may be subject to significant product
            liability claims and litigation, including potential exposure from the use of its product candidates in human subjects, and its insurance may be inadequate to cover claims that may arise.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; business exposes it to potential product liability risks inherent in the
            testing, processing and marketing of cell therapy products. Such liability claims may be expensive to defend and result in large judgments against us. Caladrius faces an inherent risk of product liability exposure related to the testing of its
            current and any future product candidates in human clinical trials and will face an even greater risk with respect to any commercial sales of its products should they be approved. None of Caladrius&#8217; product candidates have been widely used over
            an extended period of time, and therefore relevant safety data are limited. Cell therapy companies also derive the raw materials for manufacturing of product candidates from human cell sources, and therefore the manufacturing process and
            handling requirements, including ensuring compliance with cGTPs, are extensive, which increases the risk of quality failures and subsequent product liability claims. Caladrius presently has product liability insurance limited to $10&#160;million per
            incident and $10&#160;million in annual aggregate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius will need to increase its insurance coverage when it begins commercializing
            product candidates, if ever. At that time, Caladrius may not be able to obtain or maintain product liability insurance on acceptable terms with adequate coverage or at all, or if claims against it substantially exceed its coverage, then its
            financial position could be significantly impaired.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Whether or not Caladrius is ultimately successful in any product liability litigation
            that may arise, such litigation could consume substantial amounts of its financial and managerial resources, decrease demand for its products and injure its reputation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius seeks to maintain errors and omissions, directors and officers, workers&#8217;
            compensation and other insurance at levels it believes to be appropriate to its business activities. If, however, Caladrius were subject to a </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">44<br />
        </div>

      </div>

    </div>

    <!--End Page 53-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 54-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg19"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">claim in excess of this coverage or to a claim not covered by its insurance and the
            claim succeeded, it would be required to pay the claim from its own limited resources, which could have a material adverse effect on its financial condition, results of operations and business. Additionally, liability or alleged liability could
            harm Caladrius&#8217; business by diverting the attention and resources of its management and damaging its reputation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may be unable to retain key officers
            or employees or hire new key officers or employees needed to implement its business strategy and develop its products and businesses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Given the specialized nature of cell therapy and that it is a relatively new field,
            there is an inherent scarcity of experienced personnel in the field. Caladrius is substantially dependent on the skills and efforts of current senior management for their management and operations, as well as for the implementation of its
            business strategy. In addition, Caladrius&#8217; future success depends upon its ability to attract and retain additional qualified personnel (including medical, scientific, technical, commercial, business and administrative personnel) necessary to
            support its anticipated growth, develop its business, perform its contractual obligations to third parties and maintain appropriate licensure. There can be no assurance that Caladrius will be successful in attracting or retaining personnel
            required by it to continue to grow its operations. The loss of a key employee, the failure of a key employee to perform in his or her current position or its inability to attract and/or retain skilled employees, as needed, could result in its
            inability to continue to grow its business or to implement its business strategy, or may have a material adverse effect on Caladrius&#8217; business, financial condition and operating results.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; internal computer systems, or those
            used by its clinical investigators, clinical research organizations or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of development programs for its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius relies on information technology systems to keep financial records, maintain
            laboratory and corporate records, communicate with staff and external parties and operate other critical functions. Any significant insufficiency degradation or failure of these computer systems could cause Caladrius to inaccurately calculate
            or lose its data. Despite the implementation of security measures, these internal computer systems and those used by Caladrius&#8217; clinical investigators, clinical research organizations, and other contractors and consultants are vulnerable to
            damage from computer viruses, unauthorized access, natural disasters, terrorism, war, and telecommunication and electrical failures. The techniques that could be used by criminal elements or foreign governments to attack these computer systems
            are sophisticated, change frequently and may originate from less regulated and remote areas of the world. Furthermore, there is an increased risk of cybersecurity attacks by state actors due to the current conflict between Russia and Ukraine.
            Recently, Russian ransomware gangs have threatened to increase hacking activity against critical infrastructure of any nation or organization that retaliates against Russia for its invasion of Ukraine. Any such increase in such attacks on
            Caladrius&#8217; third-party provider or other systems could adversely affect its network systems or other operations. While Caladrius has not experienced any such system failure, theft of information, accident or security breach to date, if such an
            event were to occur and cause interruptions in its operations, it could result in a material disruption of its clinical development activities. For example, the loss of clinical trial data from historical or future clinical trials could result
            in delays in regulatory approval efforts and significantly increase costs to recover or reproduce the data. To the extent that any disruption, theft of information, or security breach were to result in a loss of or damage to data or
            applications, or inappropriate disclosure of confidential or proprietary information, Caladrius could incur liability and the clinical development, and the future development of its product candidates could be delayed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="frisk">The increasing use of social media platforms
            presents new risks and challenges.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Social media is increasingly being used to communicate information about its product
            candidates and the diseases that Caladrius&#8217; therapies are designed to treat. Social media practices in its industry continue to evolve and regulations related to such use are not always clear. This evolution creates uncertainty and risk of
            noncompliance with regulations applicable to its business. For example, patients and others may use social media channels to comment on the effectiveness of a product candidate or to report an alleged adverse event. When such disclosures occur,
            Caladrius may fail to monitor and comply with applicable adverse event reporting obligations or it may not be able to defend against political and market pressures generated by social media due to restrictions on what it may say about its
            product candidates. There is also a risk of inappropriate disclosure of sensitive information or negative or inaccurate comments about Caladrius on any social networking website. If any of these events were to occur or Caladrius otherwise fails
            to comply with applicable regulations, it could incur liability, face overly restrictive regulatory actions or incur other harm to its business.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">45<br />
        </div>

      </div>

    </div>

    <!--End Page 54-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 55-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg20"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Risks Related to Manufacturing Caladrius&#8217; Development Product
            Candidates</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has no internal capacity to manufacture its development product candidates
            and has no assurance that it will continue to have access to manufacturers in its industry that can effectively make its development products or make them at an affordable, salable or otherwise commercially reasonable price or quantity.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Contract development and manufacturing
            organizations have a finite cell manufacturing capacity, which could inhibit the long-term growth prospects of our business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius currently has minimal manufacturing contracts to produce materials for its
            clinical trials in the United States. It is possible that the demand for Caladrius&#8217; products could exceed existing manufacturing capacity. Caladrius expects that, as its own cell therapy development programs progress and demand for cell therapy
            services in the industry expand, it may become necessary or desirable for it to expand its manufacturing vendors for cell therapy services and products in the future, which may require it to invest significant amounts of capital and to obtain
            regulatory approvals. If manufacturers are unable to meet Caladrius&#8217; rising demand for products and services on a timely basis or unable to maintain cGMP/cGTP compliance standards, then it is likely that the progress of its own programs will be
            impaired which could materially and adversely affect the overall success of its development programs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Components of therapeutic products approved for commercial sale or used in late-stage
            clinical trials must be manufactured in accordance with cGMPs and manufacturers of cell-based product candidates must comply with cGTPs. In addition, manufacturers of therapeutic products may be required to modify their manufacturing processes
            from time to time in response to regulatory requests. The manufacture of live cellular-based products is complex and imposes significant regulatory burdens that may change over time. Caladrius may encounter difficulties in the production of its
            product candidates due to its limited manufacturing experience.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius will need to improve manufacturing
            efficiency at its contract manufacturers in order to establish cost of goods levels that will permit approved products to succeed commercially.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">CMOs cannot provide assurances that they will be able to develop process enhancements
            that are acceptable to regulators or other comparable regulatory authorities, on a timely basis, on commercially reasonable terms, or at all, or that any expected improvement in profitability will be realized. If they are unsuccessful in their
            efforts to develop necessary improvements, Caladrius may be unable to develop commercially viable products, which would impair its ability to continue its operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Lack of access to safe, reliable, and effective
            transportation options could adversely affect Caladrius&#8217; ability to meet its needs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To effectively and efficiently deliver its cell therapy product, Caladrius also needs
            to establish and maintain cost-effective relationships with reliable and experienced transportation carriers. Most existing transportation carriers are not optimally designed for the transportation of cell therapy products. For example, these
            carriers generally lack a true point-to-point chain of control, may have non-controlled X-ray and inspection, do not guarantee package orientation, handling or storage conditions and, in many cases, lack a standard, documented and tracked
            operating procedures. While reliable ground carriers with experience in the transport of blood products exist in major U.S. metropolitan areas, air carriers meeting such needs are limited. If carriers we currently use should cease medical
            shipping operations or otherwise become unable to properly meet our transportation needs or comply with applicable customs and import regulations, the lack of access to safe, reliable and effective transportation options could adversely affect
            our ability to meet our needs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;" class="h2">Risks Related to Government Regulation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">The development and commercialization of
            Caladrius&#8217; product candidates are subject to extensive regulation by the FDA and other regulatory agencies in the United States and abroad, and the failure to receive regulatory approvals for our cell therapy product candidates would likely
            have a material and adverse effect on its business and prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Government authorities in the United States, at the federal, state and local level, and
            in other countries, extensively regulate, among other things, the research, development, testing, manufacture, including any manufacturing changes, packaging, storage, recordkeeping, labeling, advertising and promotion, distribution, marketing,
            import and export of pharmaceutical and biological products, such as HONEDRA&#174;, XOWNA&#174; and </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">46<br />
        </div>

      </div>

    </div>

    <!--End Page 55-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 56-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg21"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">CLBS201. The process of obtaining required regulatory approvals and the subsequent
            compliance with appropriate statutes and regulations requires the expenditure of substantial time and money, and there is no guarantee that Caladrius will successfully complete the steps needed to obtain regulatory approval of HONEDRA&#174;, XOWNA&#174;
            and CLBS201 or any future product candidates. There also are extensive and ongoing post-marketing compliance obligations to which Caladrius would be subject following FDA approval of any of our product candidates. In addition, these federal
            regulations may change, and Caladrius&#8217; product candidates may be subject to new laws or regulations due to the rapid advancement of the regenerative medicine field and legislators&#8217;/regulators&#8217; interest in it.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To date, Caladrius has not received regulatory approval to market any of its product
            candidates in any jurisdiction. If Caladrius seeks approval of any of its cell therapy product candidates, it will be required to submit to FDA, Japan&#8217;s PMDA, and potentially other regulatory authorities, extensive preclinical and clinical data
            supporting the safety and efficacy of such product candidates, as well as information about the manufacturing process and to undergo inspection of manufacturing facilities, among other things. The process of obtaining FDA and other regulatory
            approvals is expensive, typically takes many years and is subject to numerous risks and uncertainties, particularly with complex and/or novel product candidates such as our cell-based product candidates. Changes in regulatory approval policies
            during the clinical research and development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted product application, may cause delays in the approval or rejection of an
            application or may make it easier for Caladrius&#8217; competitors to gain regulatory approval to enter the marketplace. Ultimately, the FDA and other regulatory agencies have substantial discretion in the approval/licensure process and may refuse to
            accept any application or may decide that our product candidate data are insufficient for approval without the submission of additional preclinical, clinical or other time-consuming studies. In addition, varying agency interpretations of the
            data obtained from preclinical and clinical testing could delay, limit or prevent regulatory approval of a product candidate. Any regulatory approval we ultimately obtain may be limited or subject to restrictions or post-approval commitments
            that render the approved product not commercially viable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any of the following factors, among others, could cause regulatory approval for our
            product candidates to be delayed, limited or denied:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the product candidates require significant clinical testing to demonstrate safety and effectiveness before applications for
                    marketing approval can be submitted to the FDA and other regulatory authorities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">data obtained from animal testing and other nonclinical testing and clinical trials can be interpreted in different ways, and
                    regulatory authorities may not agree with our respective interpretations or may require Caladrius to conduct additional testing;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">negative or inconclusive results or the occurrence of serious or unexpected adverse events during a clinical trial could cause
                    Caladrius to delay and/or terminate development efforts for a product candidate; and/or</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA and other regulatory authorities may require expansion of the size and scope of the clinical trials.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any difficulties or failures that we encounter in securing regulatory approval for our
            product candidates would likely have a substantial adverse impact on Caladrius&#8217; ability to generate product sales and could make any search for a collaborative partner more difficult.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may be unsuccessful in its efforts
            to comply with applicable federal, state and international laws and regulations, which could result in loss of licensure, certification or accreditation or other government enforcement actions or impact its ability to secure regulatory approval
            of its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Although Caladrius seeks to conduct its business in compliance with applicable laws and
            regulations, these laws and regulations are exceedingly complex and often subject to varying interpretations. The cell therapy industry is the topic of significant government interest, and thus the laws and regulations applicable to Caladrius&#8217;
            business are subject to frequent change and/or reinterpretation. As such, there can be no assurance that Caladrius will be able, or will have the resources, to maintain compliance with all applicable biopharmaceutical and health care laws and
            regulations. Failure to comply with such biopharmaceutical and health care laws and regulations could </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">47<br />
        </div>

      </div>

    </div>

    <!--End Page 56-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 57-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg22"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">result in significant enforcement actions, civil or criminal penalties, which along
            with the costs associated with such compliance or with enforcement of such biopharmaceutical and health care laws and regulations, may have a material adverse effect on Caladrius&#8217; operations or may require restructuring of its operations or
            impair its ability to operate profitably.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Facilities engaged in the recovery, processing, storage, labeling, packaging or
            distribution of any human cells, tissues or cellular- and tissue-based products, or the screening or testing of a donor, are required to register with the applicable regulatory agencies. Any third party retained by Caladrius to process its
            samples must be similarly registered with regulators and comply with applicable regulations as well as applicable cGTP regulations and any failure to comply with these requirements could adversely affect its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition to cGTPs, cGMP regulations govern the manufacture, processing, packaging
            and holding of cell therapy products that are regulated as drugs. Any third-party manufacturers that prepare Caladrius&#8217; products must comply with cGMP requirements including quality control, quality assurance and the maintenance of records and
            documentation for certain products. They may be unable to comply with these cGMP requirements and with other national regulators and state and local regulatory requirements. These requirements may change over time and Caladrius or third-party
            manufacturers may be unable to comply with the revised requirements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">If Caladrius is unable to conduct clinical
            trials in accordance with regulations and accepted standards, it may be delayed in receiving, or may never receive, regulatory approvals of our product candidates from the FDA and other regulatory authorities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To obtain marketing approvals for Caladrius&#8217; product candidates in the United States
            and abroad, it must, among other requirements, complete adequate and well-controlled clinical trials sufficient to demonstrate to the FDA and other regulatory bodies that the product candidate is safe and effective for each indication for which
            approval is sought. If the FDA finds that patients enrolled in the trial are or would be exposed to an unreasonable and significant risk of illness or injury due to, among other things, occurrence of one or more serious adverse events in an
            ongoing clinical trial, the FDA can place one or more of Caladrius&#8217; clinical trials on partial or full clinical hold. If safety concerns develop, we may, or the FDA, a foreign regulatory authority, or an IRB may require Caladrius to pause or
            stop the affected trials before completion.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The completion of Caladrius&#8217; clinical trials also may be delayed or terminated for a
            number of other reasons, including if:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">third-party clinical investigators do not perform the clinical trials on the anticipated schedule or consistent with the
                    clinical trial protocol, GCPs required by the FDA and other regulatory requirements, or other third parties do not perform data collection and analysis in a timely or accurate manner;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">inspections of clinical trial sites by the FDA or by IRBs of research institutions participating in the clinical trials, reveal
                    regulatory violations that require the sponsor of the trial to undertake corrective action, suspend or terminate one or more sites, or prohibit use of some or all of the data in support of marketing applications; or</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA or one or more IRBs suspends or terminates the trial at an investigational site or precludes enrollment of additional
                    subjects.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; development costs will increase if there are material delays in its clinical
            trials, or if it is required to modify, suspend, terminate, or repeat a clinical trial. If Caladrius is unable to conduct its clinical trials properly, it may never receive regulatory approval to market its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may be subject to numerous and
            varying privacy and security laws, and its failure to comply could result in penalties and reputational damage.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius is subject to laws and regulations covering data privacy and the protection
            of personal information including health information. The legislative and regulatory landscape for privacy and data protection continues to evolve, and there has been an increasing focus on privacy and data protection issues which may affect
            Caladrius&#8217; business. In the United States, Caladrius may be subject to state security breach notification laws, state health information privacy laws and federal and state consumer protections laws which impose requirements for the collection,
            use, disclosure and transmission of personal information. Each of these laws are subject to varying interpretations by courts and government agencies, creating complex compliance issues for us. If Caladrius fails </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">48<br />
        </div>

      </div>

    </div>

    <!--End Page 57-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 58-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg23"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">to comply with applicable laws and regulations we could be subject to penalties or
            sanctions, including criminal penalties if Caladrius knowingly obtains individually identifiable health information from a covered entity in a manner that is not authorized or permitted by the federal Health Insurance Portability and
            Accountability Act of 1996 &#8220;HIPAA&#8221;) or for aiding and abetting the violation of HIPAA.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Numerous other countries have, or are developing, laws governing the collection, use
            and transmission of personal information as well. EU member states and other jurisdictions have adopted data protection laws and regulations, which impose significant compliance obligations. In May 2016, the European Union formally adopted the
            General Data Protection Regulation (&#8220;GDPR&#8221;), which applies to all EU member states from May&#160;25, 2018 and replaced the EU Data Protection Directive. The regulation introduces stringent new data protection requirements in the European Union and
            substantial fines for breaches of the data protection rules. It has increased Caladrius&#8217; responsibility and liability in relation to personal data that we process and we may be required to put in place additional mechanisms ensuring compliance
            with the new EU data protection rules. The GDPR is a complex law and the regulatory guidance is still evolving, including with respect to how the GDPR should be applied in the context of clinical studies. Furthermore, many of the countries
            within the European Union are still in the process of drafting supplementary data protection legislation in key fields where the GDPR allows for national variation, including the fields of clinical study and other health-related information.
            These variations in the law may raise Caladrius&#8217; costs of compliance and result in greater legal risks.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius will continue to be subject to
            extensive regulation following any product approvals, and if it fails to comply with these regulations, it may suffer a significant setback in its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even if Caladrius is successful in obtaining regulatory approval of our product
            candidates, it will continue to be subject to the requirements of and review by, the FDA and comparable regulatory authorities in the areas of manufacturing processes, quality assurance, post-approval clinical data, adverse event reporting,
            labeling, advertising and promotional activities, among other things. In addition, any marketing approval Caladrius receives may be limited in terms of the approved product indication or require costly post-marketing testing and surveillance.
            Discovery after approval of previously unknown problems with a product, manufacturer or manufacturing process, or a failure to comply with regulatory requirements, may result in actions such as:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">warning letters or untitled letters or other actions requiring changes in product manufacturing processes or restrictions on
                    product marketing or distribution;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">product recalls or seizures or the temporary or permanent withdrawal of a product from the market; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fines, restitution, or disgorgement of profits or revenue, the imposition of civil penalties or criminal prosecution.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The occurrence of any of these actions would likely cause a material adverse effect on
            Caladrius&#8217; business, financial condition and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Additionally, if Caladrius or others identify undesirable side effects, or other
            previously unknown problems, caused by Caladrius&#8217; product candidates after obtaining U.S. or foreign regulatory approval or other products with the same or related active ingredients, a number of potential consequences could result, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory authorities may withdraw their approval of the product;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory authorities may require a recall of the product or Caladrius may voluntarily recall a product;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory authorities may require the addition of warnings or contradictions in the product labeling, narrowing of the
                    indication in the product label or issuance of field alerts to physicians and pharmacies;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius may be required to create a medication guide outlining the risks of such side effects for distribution to patients or
                    institute a risk evaluation and mitigation strategy (&#8220;REMS&#8221;);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius may be subject to limitation as to how we promote the product;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius may be required to change the way the product is administered or modify the product in some other way;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA or applicable foreign regulatory authority may require additional clinical trials or costly post-marketing testing and
                    surveillance to monitor the safety or efficacy of the product;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">49<br />
        </div>

      </div>

    </div>

    <!--End Page 58-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 59-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg24"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">sales of the product may decrease significantly;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius could be sued and held liable for harm caused to patients; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius brand and reputation may suffer.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="frisk">Health care companies have been the subject
            of federal and state investigations, and Caladrius could become subject to investigations in the future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Both federal and state government agencies have heightened civil and criminal
            enforcement efforts. There are numerous ongoing investigations of health care companies, including drug, biologic and medical device companies, as well as their executives and managers. In addition, amendments to the Federal False Claims Act,
            including under health care reform, have made it easier for private parties to bring &#8220;<span style="font-style: italic;">qui tam</span>&#8221; (whistleblower) lawsuits against companies under which the whistleblower may be entitled to receive a
            percentage of any money paid to the government. The Federal False Claims Act provides, in part, that an action can be brought against any person or entity that has knowingly presented, or caused to be presented, a false or fraudulent request
            for payment from the federal government, or who has made a false statement or used a false record to get a claim approved. The government has taken the position that claims presented in violation of the federal anti-kickback law, Stark Law or
            other health care-related laws, including laws enforced by the FDA, may be considered a violation of the Federal False Claims Act. Penalties include substantial fines for each false claim, plus three times the amount of damages that the federal
            government sustained because of the act of that person or entity and/or exclusion from the Medicare program. In addition, a majority of states have adopted similar state whistleblower and false claims provisions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius is not aware of any government investigations involving any of its facilities
            or management. While Caladrius believes that it is in material compliance with applicable governmental health care laws and regulations, any future investigations of our business or executives could cause it to incur substantial costs, and
            result in significant liabilities or penalties, as well as damage to its reputation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="frisk">It is uncertain to what extent government,
            private health insurers and third-party payors will approve coverage or provide reimbursement for the therapies and products to which Caladrius&#8217; research and development relate. Availability for such reimbursement may be further limited by an
            increasing uninsured population and reductions in Medicare and Medicaid funding in the United States.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To the extent that health care providers cannot obtain coverage or reimbursement for
            our therapies and products, they may elect not to provide such therapies and products to their patients and, thus, may not need our services. Further, as cost containment pressures are increasing in the health care industry, government and
            private payors may adopt strategies designed to limit the amount of reimbursement paid to health care providers.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Similarly, the trend toward managed health care and bundled pricing for health care
            services in the United States, could significantly influence the purchase of health care services and products, resulting in lower prices and reduced demand for our therapeutic products under development.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius may receive a portion of its revenues from services rendered to patients
            enrolled in federal health care programs, such as Medicare, and it may also directly or indirectly receive revenues from federal health care programs. Federal health care programs are subject to changes in coverage and reimbursement rules and
            procedures, including retroactive rate adjustments. These contingencies could materially decrease the range of services covered by such programs or the reimbursement rates paid directly or indirectly for our products and services. To the extent
            that any health care reform favors the reimbursement of other therapies over our therapeutic products under development, such reform could affect our ability to sell our services, which may have a material adverse effect on our revenues.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The limitation on reimbursement available from private and government payors may reduce
            the demand for, or the price of, our services, which could have a material adverse effect on our revenues. Additional legislation or regulation relating to the health care industry or third-party coverage and reimbursement may be enacted in the
            future which could adversely affect the revenues generated from the sale of Caladrius&#8217; products and services.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Furthermore, there has been a trend in recent years towards reductions in overall
            funding for Medicare and Medicaid. There has also been an increase in the number of people who do not have any form of health care coverage in recent years and who are not eligible for or enrolled in Medicare, Medicaid or other governmental </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">50<br />
        </div>

      </div>

    </div>

    <!--End Page 59-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 60-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg25"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">programs. The extent to which the reforms brought about under health care reform may
            be successful in reducing the number of such uninsured is unclear, and the reduced funding of governmental programs and increase in uninsured populations could have a negative impact on the demand for Caladrius&#8217; services to the extent they
            relate to products and services which are reimbursed by government and private payors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Unintended consequences of health care reform
            legislation in the United States may adversely affect Caladrius&#8217; business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The health care industry is undergoing fundamental changes resulting from political,
            economic and regulatory influences. In the United States, comprehensive programs are under consideration that seek to, among other things, increase access to health care for the uninsured and control the escalation of health care expenditures
            within the economy. In March 2010, the Patient Protection and Affordable Care Act (&#8220;PPACA&#8221;), as amended by the Health Care and Education Reconciliation Act, or the Affordable Care Act, was passed, which substantially changes the way health care
            is financed by both governmental and private insurers, and significantly impacts the U.S. pharmaceutical industry. While Caladrius does not believe this legislation will have a direct impact on its business, the legislation requires the
            adoption of implementing regulations, which may have unintended consequences or indirectly impact its business. For instance, the scope and implications of the amendments pursuant to the Fraud Enforcement and Recovery Act of 2009, have yet to
            be fully determined or adjudicated and as a result it is difficult to predict how future enforcement initiatives may impact Caladrius&#8217; business. Also, in some instances our clients may be health insurers that will be subject to limitations on
            their administrative expenses and federal review of &#8220;unreasonable&#8221; rate increases that could impact the prices they pay for Caladrius&#8217; services. If the legislation causes such unintended consequences or indirect impact, it could have a material
            adverse effect on Caladrius&#8217; business, financial condition and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, other legislative changes have been proposed and adopted since the PPACA
            was enacted. On August&#160;2, 2011, the Budget Control Act of 2011 was signed into law, which, among other things, creates the Joint Select Committee on Deficit Reduction to recommend proposals in spending reductions to Congress. The Joint Select
            Committee did not achieve a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, triggering the legislation&#8217;s automatic reduction to several government programs. This included aggregate reductions to Medicare
            payments to providers of up to 2% per fiscal year, which went into effect on April&#160;1, 2013. On January&#160;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to
            several providers, including hospitals, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. Strong, partisan disagreement in Congress has prevented implementation of
            various PPACA provisions, and the Trump Administration had made the repeal of the PPACA a priority. One of the first executive orders of the Trump administration granted federal agencies broad powers to unwind regulations under the PPACA. On
            January&#160;11, 2017, the Senate voted to approve a &#8220;budget blueprint&#8221; allowing Republicans to repeal parts of the law while avoiding Democrat filibuster. The &#8220;Obamacare Repeal Resolution&#8221; passed 51-48. Certain legislators are continuing their
            efforts to repeal the PPACA, although there is little clarity on how such a repeal would be implemented and what a PPACA replacement might look like. For the immediate future, there is significant uncertainty regarding the health care, health
            care coverage and health care insurance markets.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The U.S. government has in the past considered, is currently considering and may in the
            future consider health care policies and proposals intended to curb rising health care costs, including those that could significantly affect both private and public reimbursement for health care services. State and local governments, as well
            as a number of foreign governments, are also considering or have adopted similar types of policies. Future significant changes in the health care systems in the United States or elsewhere, and current uncertainty about whether and how changes
            may be implemented, could have a negative impact on the demand for our products. Caladrius is unable to predict whether other health care policies, including policies stemming from legislation or regulations affecting its business, may be
            proposed or enacted in the future; what effect such policies would have on its business; or the effect ongoing uncertainty about these matters will have on the purchasing decisions of its customers.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius expects that additional state and federal health care reform measures will be
            adopted in the future, any of which could limit the amounts that federal and state governments will pay for health care products and services, which could result in reduced demand for its products or additional pricing pressures.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">51<br />
        </div>

      </div>

    </div>

    <!--End Page 60-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 61-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg26"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Governments outside the United States tend to
            impose strict price controls, which may adversely affect Caladrius&#8217; revenues, if any.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In some countries, particularly the member states of the European Union, the pricing of
            prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a product. In addition, there can be
            considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures. Political, economic and regulatory developments may further complicate pricing negotiations, and
            pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various EU member states and parallel distribution, or arbitrage between low-priced and high-priced member states, can further reduce prices. In
            some countries where we may seek to market our product candidates in the future, we may be required to conduct a clinical trial or other studies that compare the cost-effectiveness of our product candidate to other available therapies in order
            to obtain or maintain reimbursement or pricing approval. Publication of discounts by third-party payors or authorities may lead to further pressure on prices or reimbursement levels within the country of publication and other countries. If
            reimbursement of our products is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, Caladrius&#8217; business could be adversely affected.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Inadequate funding for the FDA, the SEC and
            other government agencies could hinder Caladrius&#8217; ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies
            from performing normal business functions on which the operation of Caladrius&#8217; business may rely, which could negatively impact its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The ability of the FDA to review and approve new products can be affected by a variety
            of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in
            recent years as a result. In addition, government funding of the SEC and other government agencies on which our operations may rely, including those that fund research and development activities is subject to the political process, which is
            inherently fluid and unpredictable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Disruptions at the FDA and other agencies may also slow the time necessary for new
            drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including beginning on December&#160;22, 2018, the U.S. government has shut down several
            times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the
            ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on Caladrius&#8217; business. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="frisk">Competitor companies or hospitals may be able
            to take advantage of EU rules permitting sales of unlicensed medicines for individual patients to sell competing products without a marketing authorization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The EU medicines rules allow individual member states to permit the supply of a
            medicinal product without a marketing authorization to fulfill special needs, where the product is supplied in response to a bona fide unsolicited order, formulated in accordance with the specifications of a health care professional and for use
            by an individual patient under his direct personal responsibility. This may in certain countries also apply to products manufactured in a country outside the EU and imported to treat specific patients or small groups of patients. In addition,
            designated advanced therapy medicinal products do not need a marketing authorization if they are prepared on a non-routine basis and are used within the same EU member state in a hospital in accordance with a medical prescription for an
            individual patient.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">These exemptions could allow Caladrius&#8217; competitors to make sales in the EU without
            having obtained a marketing authorization and without undergoing the expense of clinical trials, especially if those competitors have cell processing facilities in the relevant EU member state. Similarly, certain hospitals may be able to
            compete with Caladrius on the basis of these rules. Because any such sales would be made without a marketing authorization, there would be no need for the competitor company or hospital to refer to the clinical data in our marketing
            authorization dossiers, and so any data exclusivity protection that we may obtain for Caladrius&#8217; products would not prevent such competing sales.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">52<br />
        </div>

      </div>

    </div>

    <!--End Page 61-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 62-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg27"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">A variety of risks associated with operating
            Caladrius&#8217; business internationally could materially adversely affect its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius plans to seek regulatory approval of our product candidates outside of the
            United States and, accordingly, we expect that we, and any potential collaborators in those jurisdictions, will be subject to additional risks related to operating in foreign countries, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">differing regulatory requirements in foreign countries;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">differing coverage and reimbursement requirements in foreign countries;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">unexpected changes in tariffs, trade barriers, price and exchange controls, and other regulatory requirements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">economic weakness, including inflation, or political instability in particular foreign economies and markets;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">compliance with tax, employment, immigration, and labor laws for employees living or traveling abroad;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">foreign taxes, including withholding of payroll taxes;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations
                    incident to doing business in another country;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">difficulties staffing and managing foreign operations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">workforce uncertainty in countries where labor unrest is more common than in the United States;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable foreign laws, such as the U.K. Anti-Bribery
                    Act;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">challenges enforcing our contractual and intellectual property rights, especially in those foreign countries that do not respect
                    and protect intellectual property rights to the same extent as the United States;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the continued threat of terrorism and the impact of military and other action, including military actions involving Russia and
                    Ukraine;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad, including as
                    a result of COVID-19 or the recent military actions involving Russia and Ukraine; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">business interruptions resulting from geo-political actions, including war and terrorism.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">These and other risks associated with Caladrius&#8217; planned international operations may
            materially adversely affect our ability to attain or maintain profitable operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h2">Risks Related to Caladrius&#8217; Intellectual Property</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may be unable to obtain or maintain
            patent protection for its products and product candidates, which could have a material adverse effect on its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; commercial success will depend, in part, on obtaining and maintaining patent
            protection for new technologies, product candidates, products and processes and successfully defending such patents against third-party challenges. To that end, Caladrius files patent applications, and have been issued patents, that are
            intended to cover certain methods and uses of human cells as well as compositions and methods relating to hematopoietic stem cells. These patent applications may never result in the issuance of patents.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The patent positions of biotechnology companies can be highly uncertain and involve
            complex legal, scientific and factual questions and recent court decisions have introduced significant uncertainty regarding the strength of patents in the industry. Moreover, the legal systems of some foreign countries do not favor the
            aggressive enforcement of patents and may not protect our intellectual property rights to the same extent as the laws of the United States. Any of the issued patents Caladrius owns or licenses may be challenged by third parties and held to be
            invalid, unenforceable or with a narrower or different scope of coverage than what we currently believe, effectively reducing or eliminating protection Caladrius believed it had against competitors with similar products </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">53<br />
        </div>

      </div>

    </div>

    <!--End Page 62-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 63-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg28"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">or technologies. If Caladrius ultimately engages in and loses any such patent
            disputes, it could be subject to competition and/or significant liabilities, it could be required to enter into third-party licenses or it could be required to cease using the disputed technology or product. In addition, even if such licenses
            are available, the terms of any license requested by a third party could be unacceptable or unaffordable to Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Product development and approval timelines in the biotechnology industry are very
            lengthy. As such, it is possible that any patents that may cover an approved product may have expired at the time of commercialization or only have a short remaining period of exclusivity, thereby reducing the commercial advantages of the
            patent. In such case, Caladrius would then rely solely on other forms of exclusivity, such as regulatory exclusivity provided by the Federal Food, Drug, and Cosmetic Act (&#8220;FD&amp;C Act&#8221;), which may provide less protection to its competitive
            position.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Litigation relating to intellectual property
            is expensive, time-consuming and uncertain, and Caladrius may be unsuccessful in its efforts to protect against infringement by third parties or defend itself against claims of infringement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To protect its intellectual property, Caladrius may initiate litigation or other
            proceedings. In general, intellectual property litigation is costly, time-consuming, diverts the attention of management and technical personnel and could result in substantial uncertainty regarding our future viability, even if Caladrius
            ultimately prevails. Some of Caladrius&#8217; competitors may be able to sustain the costs of such litigation or other proceedings more effectively than can Caladrius because of their substantially greater financial resources. The loss or narrowing
            of our intellectual property protection, the inability to secure or enforce our intellectual property rights or a finding that Caladrius has infringed the intellectual property rights of a third party could limit Caladrius&#8217; ability to develop
            or market its products and services in the future or adversely affect its revenues. Furthermore, any public announcements related to such litigation or regulatory proceedings could adversely affect the price of Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Third parties may allege that the research, development and commercialization
            activities Caladrius conducts infringe patents or other proprietary rights owned by such parties. While Caladrius does not believe any of its current activities infringe the rights of others, it has not conducted an exhaustive search or
            analysis of third-party patent rights to determine whether its pre-clinical or clinical research and development or activities may infringe or be alleged to infringe any third-party patent rights. If Caladrius is found to have infringed the
            patents of a third party, it may be required to pay substantial damages; it also may be required to seek from such party a license, which may not be available on acceptable terms, if at all, to continue its activities. A judicial finding or
            infringement or the failure to obtain necessary licenses could prevent Caladrius from commercializing its products, which would have a material adverse effect on its business, operating results and financial condition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="frisk">If Caladrius is unable to maintain its
            licenses, patents or other intellectual property, it could lose important protections that are material to continuing its operations and its future prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To obtain and maintain patent protection and licensing rights under certain of our
            license agreement, Caladrius must, among other things, ensure the timely payment of all applicable filing and maintenance fees. Any failure to do so could result in the loss of some or all of Caladrius&#8217; rights to proprietary technology or the
            inability to secure or enforce intellectual property protection.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Additionally, Caladrius&#8217; license agreements require it to meet certain diligence
            obligations in the development of the licensed products. Caladrius&#8217; failure to meet these diligence obligations could result in the loss of some or all of its rights, which could materially and adversely affect its business and future
            prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="frisk">If Caladrius is unable to protect the
            confidentiality of trade secrets, its competitive position could be impaired.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A significant amount of Caladrius&#8217; technology, especially regarding manufacturing
            processes, is unpatented and is maintained as trade secrets and/or know-how. Caladrius expends significant energy, resources and know-how in an effort to protect these trade secrets and know-how, including through the use of confidentiality
            agreements. Even so, improper use or disclosure of Caladrius&#8217; confidential information could occur, and in such case, adequate remedies may not exist. The disclosure of trade secrets and know-how could impair Caladrius&#8217; competitive position.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">54<br />
        </div>

      </div>

    </div>

    <!--End Page 63-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 64-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg29"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">In certain countries, patent holders may be
            required to grant compulsory licenses, which would likely have a significant and detrimental effect on any future revenues in such country.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Many countries, including some countries in Europe, have compulsory licensing laws
            under which a patent owner may be compelled to grant licenses to third parties. In addition, most countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may be
            limited to monetary relief and may be unable to enjoin infringement, which could materially diminish the value of the patent. Compulsory licensing of life-saving products is also becoming increasingly common in developing countries, either
            through direct legislation or international initiatives. Such compulsory licenses could be extended to Caladrius&#8217; product candidates, which may limit its potential revenue opportunities, including with respect to any future revenues that may
            result from its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">Changes to U.S. patent law may have a material
            adverse effect on Caladrius&#8217; intellectual property rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As is the case with other biopharmaceutical companies, Caladrius&#8217; success is heavily
            dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involves both technological and legal complexity and is therefore costly, time consuming and inherently uncertain.
            Changes in either the patent laws or interpretation of the patent laws in the United States could increase the uncertainties and costs, and may diminish Caladrius&#8217; ability to protect its inventions, obtain, maintain, and enforce its
            intellectual property rights and, more generally, could affect the value of its intellectual property or narrow the scope of our owned and any licensed patents. Patent reform legislation in the United States and other countries, including the
            Leahy-Smith America Invents Act (the Leahy-Smith Act), signed into law on September&#160;16, 2011, could increase those uncertainties and costs surrounding the prosecution of Caladrius&#8217; patent applications and the enforcement or defense of its
            issued patents. In addition, the patent positions of companies in the development and commercialization of pharmaceuticals are particularly uncertain. The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing
            the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. Depending on future actions by the U.S. Congress, the U.S. courts, the U.S. Patent and Trade Office (the &#8220;USPTO&#8221;)
            and the relevant law-making bodies in other countries, the laws and regulations governing patents could change in unpredictable ways that would weaken Caladrius&#8217; ability to obtain new patents or to enforce Caladrius&#8217; existing patents and
            patents that it might obtain in the future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">Third-party claims of intellectual property
            infringement may prevent or delay Caladrius&#8217; development and commercialization efforts.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; commercial success depends in part on its avoiding infringement of the
            patents, trademarks and proprietary rights of third parties. There have been many lawsuits and other proceedings involving patent and other intellectual property rights in the biotechnology and pharmaceutical industries, including patent
            infringement lawsuits, interferences, oppositions, and reexamination proceedings before the USPTO and corresponding foreign patent offices and trademark violations. Numerous U.S. and foreign issued patents and pending patent applications, which
            are owned by third parties, exist in the fields in which we are developing products and services. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that Caladrius&#8217; products and services
            may be subject to claims of infringement of the patent rights of third parties.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Third parties may assert that we are employing their proprietary technology without
            authorization. There may be third-party patents or patent applications with claims to devices, materials, formulations, methods of manufacture, or methods for treatment related to the use or manufacture of Caladrius&#8217; products and services.
            Caladrius has conducted freedom to operate analyses with respect to only certain of its products and services, and therefore it does not know whether there are any third-party patents that would impair its ability to commercialize these
            products and services. Caladrius also cannot guarantee that any of its analyses are complete and thorough, nor can it be sure that it has identified each and every patent and pending application in the United States and abroad that is relevant
            or necessary to the commercialization of our products and services. Because patent applications can take many years to issue, there may be currently pending patent applications that may later result in issued patents that Caladrius&#8217; products or
            services may infringe upon.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, third parties may obtain patents in the future and claim that use of
            Caladrius&#8217; technologies infringes upon these patents. If any third-party patents were held by a court of competent jurisdiction to cover aspects of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">55<br />
        </div>

      </div>

    </div>

    <!--End Page 64-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 65-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg30"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; products or services, the holders of any such patents may be able to
            block our ability to commercialize such products or services unless Caladrius obtained a license under the applicable patents, or until such patents expire or are finally determined to be invalid or unenforceable. Such a license may not be
            available on commercially reasonable terms or at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Parties making claims against Caladrius may obtain injunctive or other equitable
            relief, which could effectively block Caladrius&#8217; ability to further develop and commercialize one or more of our products or services. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be
            a substantial diversion of employee resources from Caladrius&#8217; business. In the event of a successful claim of infringement against Caladrius, Caladrius may have to pay substantial damages, including treble damages and attorneys&#8217; fees for
            willful infringement, pay royalties, redesign our infringing products or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="h2">Risks Related to Caladrius&#8217; Capital Stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; stock price has been, and will likely
            continue to be, highly volatile.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The market price of Caladrius Common Stock has been, and in the future may continue to
            be, highly volatile. For example, from January&#160;1, 2021 through June&#160;13, 2022, Caladrius Common Stock traded as low as $0.40 per share and as high as $4.89 per share.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The market price for Caladrius Common Stock is highly dependent on, among other things,
            stock market conditions in general, Caladrius&#8217; clinical development efforts and the growth of Caladrius&#8217; business in general, the amount of Caladrius&#8217; available cash and investments and Caladrius&#8217; level of cash utilization. Future events could
            increase the volatility seen in Caladrius Common Stock and ultimately cause a significant decline in the price of Caladrius Common Stock and ultimately impact its ability to raise additional capital in the future. These events could include the
            following, among others:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">low levels of trading volume for Caladrius&#8217; shares;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">capital-raising or other transactions that are, or may in the future be, dilutive to existing stockholders or that involve the
                    issuance of debt securities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in our clinical trials, negative clinical trial results or adverse regulatory decisions relating to Caladrius&#8217; product
                    candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">adverse fluctuations in Caladrius&#8217; revenues or operating results or financial results that otherwise fall below the market&#8217;s
                    expectations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disappointing developments concerning Caladrius&#8217; cell therapy product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">positive developments concerning Caladrius&#8217; cell therapy product candidates that lead to the need for additional capital to
                    complete the development process; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">legal challenges, disputes and/or other adverse developments impacting Caladrius&#8217; patents or other proprietary rights that
                    protect its products.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, broader external events, such as news concerning economic or market
            conditions in the general economy or within Caladrius&#8217; industry, the activities of our competitors, changes (or the threat of changes) in U.S. or foreign government regulations impacting the life sciences industry or the movement of capital
            into or out of our industry, are likely to affect the price of Caladrius Common Stock. Geopolitical events, including the continued threat of terrorism and the impact of military and other action, including military actions involving Russia and
            Ukraine, could impact Caladrius&#8217; stock price as well. There can be no assurance that the market price of Caladrius Common Stock will not continue to fluctuate or decline significantly in the future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius may fail to comply with the continued
            listing requirements of The Nasdaq Capital Market, such that the Caladrius Common Stock may be delisted and the price of the Caladrius Common Stock and our ability to access the capital markets could be negatively impacted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Common Stock is listed for trading on The Nasdaq Capital Market. Caladrius
            must satisfy Nasdaq&#8217;s continued listing requirements, including, among other things, a minimum closing bid price requirement of $1.00&#160;per share for 30 consecutive business days (the &#8220;Minimum Bid Price Requirement&#8221;). If a company trades </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">56<br />
        </div>

      </div>

    </div>

    <!--End Page 65-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 66-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg31"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">for 30 consecutive business days below the $1.00 minimum closing bid price
            requirement, Nasdaq will send a deficiency notice to the company advising that it has been afforded a &#8220;compliance period&#8221; of 180 calendar days to regain compliance with the applicable requirements. Caladrius received such notice on February&#160;18,
            2022 and thus risks delisting unless it is able to regain compliance in a timely fashion.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In accordance with Nasdaq Listing Rule 5810(c)(3)(A), Caladrius has a grace period of
            180 calendar days, or until August&#160;17, 2022, to regain compliance with the Minimum Bid Price Requirement. Compliance can be achieved automatically and without further action if the closing bid price of our stock is at or above $1.00 for a
            minimum of 10 consecutive business days at any time during the 180-day compliance period, in which case Nasdaq will notify Caladrius of its compliance and the matter will be closed. If, however, Caladrius does not achieve compliance with the
            Minimum Bid Price Requirement by August&#160;17, 2022, it may be eligible for additional time to comply. In order to be eligible for such additional time, Caladrius will be required to meet the continued listing requirement for market value of
            publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and must notify Nasdaq in writing of its intention to cure the deficiency during the second
            compliance period. There can be no assurance that Caladrius will regain compliance with the Minimum Bid Price Requirement, that it will maintain compliant with other Nasdaq listing requirements or that it will be granted a second compliance
            period.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A delisting of Caladrius Common Stock from Nasdaq could materially reduce the liquidity
            of Caladrius Common Stock and result in a corresponding material reduction in the price of Caladrius Common Stock. In addition, delisting could harm Caladrius&#8217; ability to raise capital through alternative financing sources on terms acceptable
            to it, or at all, and may result in the potential loss of confidence by investors, employees and fewer business development opportunities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors has approved the Reverse Stock Split, to be
            implemented prior to the consummation of the Merger as discussed in this proxy statement/prospectus/information statement, and further adjusted based on the Exchange Ratio, but there can be no assurance that the Caladrius Stockholders will
            approve such Reverse Stock Split, that such Reverse Stock Split will be implemented or that such Reverse Stock Split, if implemented, will bring Caladrius into compliance with the Minimum Bid Price Requirement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">In addition to potential dilution associated
            with potential future fundraising and strategic transactions, Caladrius currently has significant numbers of securities outstanding that are exercisable for Caladrius Common Stock, which could result in significant additional dilution and
            downward pressure on its stock price.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, there were 60,518,478 shares of Caladrius Common Stock
            outstanding. In addition, there were outstanding stock options, restricted stock units and warrants representing the potential issuance of an additional 25,433,68 shares of Caladrius Common Stock. The issuance of these shares in the future
            would result in significant dilution to Caladrius&#8217; current stockholders and could adversely affect the price of Caladrius Common Stock and the terms on which Caladrius could raise additional capital. In addition, the issuance and subsequent
            trading of shares could cause the supply of Caladrius Common Stock available for purchase in the market to exceed the purchase demand for Caladrius Common Stock. Such supply in excess of demand could cause the market price of Caladrius Common
            Stock to decline.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Provisions in Caladrius&#8217; amended and restated
            certificate of incorporation and by-laws and Delaware law may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for Caladrius Common Stock and could entrench management.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; amended and restated certificate of incorporation and by-laws contain
            provisions that may discourage unsolicited takeover proposals that stockholders may consider to be in their best interests. The Caladrius Board of Directors is divided into three classes, each of which will generally serve for a term of three
            years with only one class of directors being elected in each year. As a result, at a given annual meeting only a minority of the Caladrius Board of Directors may be considered for election. Since Caladrius&#8217; staggered board of directors may
            prevent our stockholders from replacing a majority of the Caladrius Board of Directors at any given annual meeting, it may entrench management and discourage unsolicited stockholder proposals that may be in the best interests of stockholders.
            Moreover, the Caladrius Board of Directors has the ability to designate the terms of and issue new series of preferred stock without stockholder approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius is also subject to anti-takeover provisions under Delaware law, which could
            delay or prevent a change of control. Together, these provisions may make more difficult the removal of management and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for Caladrius&#8217;
            securities.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">57<br />
        </div>

      </div>

    </div>

    <!--End Page 66-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 67-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg32"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Failure to maintain effective internal
            control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on Caladrius&#8217; business and stock price.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">During the course of testing Caladrius&#8217; disclosure controls and procedures and internal
            control over financial reporting, Caladrius may identify and disclose material weaknesses or significant deficiencies in internal control over financial reporting that will have to be remedied. Implementing any appropriate changes to Caladrius&#8217;
            internal control may require specific compliance training of its directors, officers and employees, entail substantial costs to modify our existing accounting systems, and take a significant period of time to complete. Such changes may not,
            however, be effective in maintaining the adequacy of our internal control over financial reporting, and any failure to maintain that adequacy or inability to produce accurate financial statements on a timely basis could result in Caladrius&#8217;
            financial statements being unreliable, increase its operating costs and materially impair its ability to operate its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Failure to achieve and maintain effective internal control over financial reporting
            could result in a loss of investor confidence in Caladrius&#8217; financial reports and could have a material adverse effect on its stock price. Additionally, failure to maintain effective internal control over Caladrius&#8217; financial reporting could
            result in government investigation or sanctions by regulatory authorities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;" class="h1"><a id="tRRTC"><!--Anchor--></a><span style="text-decoration: underline;">Risks Related to Cend</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2">Risks Related to Cend&#8217;s Business</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend has incurred net losses for all but one
            year since inception and anticipates that it will continue to incur losses for the foreseeable future and may never achieve or maintain profitability.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend is a development-stage drug discovery and development company with a limited
            operating history, and, with the exception of the year ended December&#160;31, 2021 in which Cend did have net income as a result of a one-time license payment, Cend has not yet generated consistent revenues from the sales or licensing of its
            product candidates. Investment in drug discovery and development companies is highly speculative because it entails substantial upfront capital expenditures and significant risk that the product candidate(s) will fail to obtain regulatory
            approval or become commercially viable. Cend has not advanced product candidates to obtain marketing approvals, manufacture a commercial-scale product or conduct sales and marketing activities necessary for successful commercialization. Cend
            anticipates incurring significant expenses related to research and development, and other operations leading to partnering and commercialization of its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend expects that it could be several years, if ever, before it has a commercialized
            product candidate. Cend expects to continue to incur significant expenses and increasing operating losses for the foreseeable future. The net losses it incurs may fluctuate significantly from quarter to quarter. Cend anticipates that its
            expenses will increase substantially if, and as, it:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">licenses foundational intellectual property, or IP, and continues development of CEND-1, including conducting additional
                    clinical trials for pancreatic and other cancers;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">initiates preclinical studies for additional product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">continues its process research and development activities, as well as establishes its research-grade, clinical- and
                    commercial-scale manufacturing capabilities (should it choose to do so directly);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">seeks collaboration agreements (geographic licensing agreements, or co-development and -commercialization agreements) involving
                    CEND-1 and other product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">completes additional clinical trials for CEND-1, following acceptance by the FDA;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identifies additional diseases for treatment with CEND-1 and other product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">seeks partnering agreements (sub-licensing or asset divestitures) for continued clinical development and/or commercialization
                    and market support;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">maintains, expands and protects its intellectual property portfolio; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identifies, acquires or in-licenses other product candidates and/or enabling technologies.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">58<br />
        </div>

      </div>

    </div>

    <!--End Page 67-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 68-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg33"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">To become and remain profitable, Cend must develop and eventually realize, either
            through its own efforts or those of its collaboration partners, commercialized product candidates with significant market potential, which will require it to be successful in a range of challenging activities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">These activities can include completing formulation and delivery approaches to meet
            target product profiles, completing preclinical studies, conducting early stage clinical trials, and securing partnering agreements to advance programs to late-stage clinical development and/or commercialization. Cend may never succeed in any
            or all of these activities and, even if it does, Cend may never generate revenues significant or large enough to achieve profitability. If it does achieve profitability, Cend may not be able to sustain or increase profitability. Cend&#8217;s failure
            to become and remain profitable would decrease the value of Cend and could impair its ability to raise capital, maintain its research and development efforts, expand its business or continue its operations, any of which could cause you to lose
            all or part of your investment.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may not be able to generate sufficient
            revenue from the commercialization of product candidates and may never be profitable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s ability to generate revenue and achieve profitability depends on its ability,
            alone or with its collaborative partners, to successfully complete the development of, and obtain the regulatory approvals necessary to commercialize, current and future product candidates. CEND-1 has advanced into Phase 2 clinical trials, but
            is still in a pre-commercial stage, and Cend does not anticipate generating revenues from commercial sales for the next several years, and it may never succeed in doing so. Cend&#8217;s ability to generate future revenues from product sales or
            licensing revenues depends heavily on its and its collaborators' success in:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">completing clinical development of product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s partners may not complete clinical development or commercialization of product candidates, which could reduce Cend
                    revenues from such partnerships;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">seeking and obtaining regulatory and marketing approvals for product candidates for which clinical trials are completed;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">launching and commercializing product candidates, including those for which Cend obtains regulatory and marketing approval, by
                    collaborating with a commercialization partner(s);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">qualifying for adequate coverage, coding and payment, where applicable, by government and third-party payors for product
                    candidates if and when approved;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">maintaining and enhancing a sustainable, scalable, reproducible and transferable manufacturing process for Cend&#8217;s product
                    candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establishing and maintaining supply and manufacturing relationships with third parties that can provide adequate, in both amount
                    and quality, products and services to support development and commercial demand for product candidates, if approved;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining market acceptance of product candidates as a viable treatment option;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">addressing any competing technological and market developments;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">implementing additional internal systems and infrastructure, as needed;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">negotiating favorable terms in any collaboration, licensing or other arrangements into which Cend may enter and performing its
                    obligations in such collaborations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">maintaining, protecting and expanding Cend&#8217;s portfolio of intellectual property rights, including patents, trade secrets and
                    know-how;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">avoiding and defending against third-party interference or infringement claims; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">attracting and retaining qualified personnel.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s expenses could increase beyond expectations if Cend is required by the FDA, or
            other regulatory authorities to perform preclinical studies and/or clinical trials in addition to those that it currently anticipates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even if Cend is able to generate revenues from the licensing or sale of product
            candidates, it may not become profitable and may need to obtain additional funding to continue operations.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">59<br />
        </div>

      </div>

    </div>

    <!--End Page 68-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 69-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg34"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Cend is involved in a litigation matter that
            may consume resources and management time, and an adverse resolution could require us to pay damages or otherwise adversely impact its business, financial condition or results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend is currently involved in one litigation matter alleging breach of contract and
            fraud against Cend and Harri J&#228;rvel&#228;inen, Cend&#8217;s chief operating officer. See the section titled &#8220;<span style="font-style: italic;">Cend Business &#8211; Legal Proceedings</span>&#8221; beginning on page&#160;<a href="#tLP">230</a> of this proxy
            statement/prospectus/information statement. Resolving this matter could require Cend to incur substantial costs and divert the attention of management and technical personnel. Any adverse ruling or perception of an adverse ruling could have an
            adverse impact on Cend&#8217;s business, financial condition or results of operations. Cend could incur substantial costs and expenses which could negatively affect its gross margins and earnings per share. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Cend conducts significant operations through
            its Australian wholly-owned subsidiary. If it loses its ability to operate in Australia, or if that subsidiary is unable to receive the research and development tax credit allowed by Australian regulations, Cend's business and results of
            operations will suffer.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend develops its programs in part through its wholly-owned Australian subsidiary,
            DrugCendR Australia Pty Ltd. Due to the geographical distance and limited employees currently in Australia, as well as Cend's limited of experience operating in Australia, Cend may not be able to efficiently or successfully monitor, develop or
            commercialize its products or programs in Australia, including conducting clinical trials. Furthermore, Cend has no assurance that the results of any clinical trials that it conducts for its product candidates in Australia will be accepted by
            the FDA or foreign regulatory authorities for development and commercialization approvals. In addition, current Australian tax regulations provide for a refundable research and development tax credit equal to 43.5% of qualified expenditures. If
            Cend is ineligible or unable to receive the research and development tax credit, or past credits are determined ineligible upon audit, or if it loses its ability to operate DrugCendR Australia Pty Ltd. in Australia, or the Australian government
            significantly reduces or eliminates the tax credit, Cend's business and results of operation would be adversely affected. In the event Cend determined it advisable to stop operating through this subsidiary, Cend may be required to migrate such
            operations, employees and intellectual property from this subsidiary to Cend. Any such action may be difficult and cause Cend to incur additional expenses, as well as give rise to tax liabilities for Cend or erode Cend's tax attributes (such as
            tax credits or net operating losses).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Risks Related to Cend Intellectual Property</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend&#8217;s rights to develop and commercialize
            product candidates are subject to, in part, the terms and conditions of licenses granted to Cend by others.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;1, 2015, Cend Therapeutics, Inc. entered into an Exclusive License
            Agreement (the &#8220;SBP License Agreement&#8221;) with the Sanford Burnham Prebys Medical Discovery Institute (&#8220;SBP&#8221;), a California not-for-profit, public benefit corporation based in San Diego, California. Pursuant to the SBP License Agreement, SBP
            licensed to Cend the exclusive right to use certain patents to further Cend&#8217;s research and development efforts. Because Cend does not have the right to control the preparation, filing and prosecution of all of the patent applications, or to
            maintain the patents, covering CEND-1, Cend cannot be certain that these patents and applications will be prosecuted, maintained and enforced in a manner consistent with the best interests of its business. If Cend&#8217;s licensors fail to maintain
            such patents, or lose rights to those patents or patent applications, the rights Cend has licensed may be reduced or eliminated and its right to develop and commercialize any products that are the subject of such licensed rights could be
            adversely affected. In addition to the foregoing, the risks associated with patent rights that Cend licenses from third parties will also apply to patent rights it may own in the future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Further, in Cend&#8217;s license agreements it may be held responsible for bringing actions
            against infringers. Certain of Cend&#8217;s license agreements could also require it to meet development thresholds to maintain the license, including establishing a set timeline for developing and commercializing products and minimum yearly
            diligence obligations in developing and commercializing the product. Disputes may also arise regarding intellectual property subject to a licensing agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If disputes over intellectual property that Cend has licensed prevent or impair Cend&#8217;s
            ability to maintain its current licensing arrangements on acceptable terms, Cend may be unable to successfully develop and commercialize the affected product candidates.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">60<br />
        </div>

      </div>

    </div>

    <!--End Page 69-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 70-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg35"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend fails to comply with its obligations under these license agreements, or Cend
            is subject to a bankruptcy, the licensor may have the right to terminate the license, in which event Cend would not be able to market products covered by the license.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend is unable to obtain and maintain patent protection for its products and
            technology, or if the scope of the patent protection obtained is not sufficiently broad, Cend&#8217;s competitors could develop and commercialize products and technology similar or identical to Cend&#8217;s, and its ability to successfully partner and
            commercialize its products and technology may be adversely affected.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s success depends on its ability to obtain and maintain patent protection in the
            United States and other countries with respect to proprietary product candidates and manufacturing technology. Cend&#8217;s proposed licensors have sought and Cend intends to seek to protect proprietary position by filing patent applications in the
            United States and abroad related to the novel technologies and product candidates that are important to its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The patent prosecution process is expensive, time-consuming and complex, and Cend may
            not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. For example, in some cases, the work of certain academic researchers in the field of
            oncology could enter the public domain, which may compromise Cend&#8217;s ability to obtain patent protection for certain inventions related to or building upon such prior work. Consequently, Cend may not be able to obtain any such patent rights to
            prevent others from using its technology for, and developing and marketing competing products to treat, these indications. It is also possible that Cend will fail to identify patentable aspects of its research and development output before it
            is too late to obtain patent protection.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The patent position of biotechnology and pharmaceutical companies generally is highly
            uncertain, involves complex legal and factual questions and has, in recent years, been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of patent rights are highly uncertain. Any
            pending and future patent applications may not result in patents being issued which protect the related technology or product candidates or which effectively prevent others from commercializing competitive technologies and product candidates.
            Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of patents or narrow the scope of patent protection.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may not be aware of all third-party intellectual property rights potentially
            relating to its targeted product candidates. Publications of discoveries in the scientific literature often lag the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18
            months after filing or, in some cases, not at all. Therefore, Cend cannot be certain that it was the first to make the inventions claimed in any owned or any licensed patents or pending patent applications, or that it was the first to file for
            patent protection of such inventions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even if the patent applications Cend licenses or may own in the future do issue as
            patents, they may not issue in a form that will provide Cend with any meaningful protection, prevent competitors or other third parties from competing with Cend or otherwise provide Cend with any competitive advantage. Cend&#8217;s competitors or
            other third parties may be able to circumvent key patents by developing similar or alternative technologies or products in a non-infringing manner.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The issuance of a patent is not conclusive as to its inventorship, scope, validity or
            enforceability, and key patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated or held unenforceable, which
            could limit Cend&#8217;s ability to stop others from using or commercializing similar or identical technology and products; or limit the duration of the patent protection of its technology and product candidates. Given the amount of time required for
            the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, Cend&#8217;s intellectual property may not provide Cend
            with sufficient rights to exclude others from commercializing products similar or identical to Cend&#8217;s.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Further, in the event Cend breaches the terms of the SBP License Agreement, Cend could
            lose the ability to continue the development and potential commercialization of CEND-1, and Cend&#8217;s operations and profitability will be significantly negatively impacted. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">61<br />
        </div>

      </div>

    </div>

    <!--End Page 70-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 71-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg36"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">If Cend fails to comply with its obligations
            in any future agreements under which it may license intellectual property rights from third parties or otherwise experience disruptions to its business relationships with future licensors, Cend could lose license rights that are important to
            its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the future, Cend may be party to license or collaboration agreements with third
            parties to advance its research or allow commercialization of product candidates. Such future agreements may impose numerous obligations, such as development, diligence, payment, commercialization, funding, milestone, royalty, sublicensing,
            insurance, patent prosecution, enforcement and other obligations on Cend and may require it to meet development timelines, or to exercise commercially reasonable efforts to develop and commercialize licensed products, in order to maintain the
            licenses. In spite of Cend&#8217;s best efforts, future licensors might conclude that Cend has materially breached future license agreements and might therefore terminate the license agreements, thereby removing or limiting Cend&#8217;s ability to develop
            and commercialize products and technologies covered by these license agreements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any termination of these licenses, or if the underlying patents fail to provide the
            intended exclusivity, could result in the loss of significant rights and could harm Cend&#8217;s ability to commercialize its product candidates, and competitors or other third parties would have the freedom to seek regulatory approval of, and to
            market, products identical to Cend&#8217;s and it may be required to cease its development and commercialization of certain of its product candidates. Any of the foregoing could have a material adverse effect on Cend&#8217;s competitive position, business,
            financial conditions, results of operations, and prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Disputes may also arise between Cend and its future licensors regarding intellectual
            property subject to a license agreement, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the scope of rights granted under the license agreement and other interpretation-related issues;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">whether and the extent to which Cend&#8217;s technology and processes infringe, misappropriate or otherwise violate intellectual
                    property rights of the licensor that is not subject to the licensing agreement;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s right to sublicense patent and other rights to third parties under collaborative development relationships;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s diligence obligations with respect to the use of the licensed technology in relation to its development and
                    commercialization of its product candidates, and what activities satisfy those diligence obligations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the priority of invention of any patented technology; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ownership of inventions and know-how resulting from the joint creation or use of intellectual property by Cend&#8217;s future
                    licensors and Cend and its partners.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, the agreements under which Cend may license intellectual property or
            technology from third parties in the future are likely to be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could
            narrow what Cend believes to be the scope of its rights to the relevant intellectual property or technology, or increase what Cend believes to be its financial or other obligations under the relevant agreement, either of which could have a
            material adverse effect on Cend&#8217;s business, financial condition, results of operations and prospects. Moreover, if disputes over intellectual property that Cend may license in the future prevent or impair its ability to maintain future
            licensing arrangements on acceptable terms, Cend may be unable to successfully develop and commercialize the affected product candidates, which could have a material adverse effect on Cend&#8217;s business, financial conditions, results of operations
            and prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may not be successful in obtaining
            necessary additional rights to its product candidates through acquisitions and in-licenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may discover that it needs to obtain additional rights to the foundational IP
            associated with the product candidates it plans to develop, manufacture and market. If this occurs, Cend intends to license or purchase the rights to those candidates, which may nor may not prove successful at all, or on acceptable terms. If
            Cend&#8217;s programs require the use of proprietary rights held by third parties, such as academic institutions, the growth of Cend&#8217;s business will critically depend on its ability to acquire, in-license or use these proprietary rights, which may
            not prove possible on acceptable terms. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">62<br />
        </div>

      </div>

    </div>

    <!--End Page 71-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 72-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg37"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">third-party intellectual property rights that Cend may consider attractive. These
            established companies may have a competitive advantage over Cend due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive Cend to be a competitor may be
            unwilling to assign or license rights to us. If Cend is unable to license or acquire third-party intellectual property rights on terms that would allow it to execute its business plan, your investment may be lost.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may collaborate with non-profit and academic institutions to accelerate its
            preclinical research or development under written agreements with these institutions. Typically, these institutions would provide Cend with an option to negotiate a license to any of the institution's rights in technology resulting from the
            collaboration. Regardless of such option, Cend may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to it. If Cend is unable to do so, the institution may offer the intellectual property rights
            to other parties, potentially blocking Cend&#8217;s ability to pursue its program.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend is unable to successfully obtain rights to required third-party intellectual
            property rights or maintain the existing intellectual property rights it has, it may be required to expend significant time and resources to redesign its product candidates, identify other candidates, or to develop or license replacement
            technology, none of which may be feasible on a technical or commercial basis, especially with Cend&#8217;s limited resources. If Cend is unable to do so, it may be unable to develop or commercialize the affected product candidates, which could
            critically harm Cend&#8217;s business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">Obtaining and maintaining Cend&#8217;s patent
            protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by government patent agencies, and Cend&#8217;s patent protection could be reduced or eliminated for non-compliance with these
            requirements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Periodic maintenance fees, renewal fees, annuity fees and various other government fees
            on patents and/or applications will be due to be paid to the USPTO and various government patent agencies outside of the United States over the lifetime of Cend&#8217;s licensed patents and/or applications and any patent rights it may own in the
            future. Cend may rely on its outside counsel or licensing partners to pay these fees due to non-U.S. patent agencies. The USPTO and various non-U.S. government patent agencies require compliance with several procedural, documentary, fee payment
            and other similar provisions during the patent application process. Cend will employ reputable law firms and other professionals to help it comply, but it will also be dependent on its licensors to take the necessary action to comply with these
            requirements with respect to their licensed intellectual property. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. There are situations, however, in which non-
            compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, potential competitors might be able to enter the market
            and this circumstance could harm Cend&#8217;s business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may not be able to protect intellectual
            property rights throughout the world, including but not limited to China.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Filing, prosecuting and defending patents on product candidates in all countries
            throughout the world, including China, would be prohibitively expensive, and intellectual property rights in some countries outside the United States could be less extensive than those in the United States. In addition, the laws of some foreign
            countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, Cend may not be able to prevent third parties from practicing any of its inventions in all countries outside
            the United States, or from selling or importing products made using any of its inventions in and into the United States or other jurisdictions. Competitors may use Cend&#8217;s technologies in jurisdictions where Cend has not obtained patent
            protection to develop their own products and, further, may export otherwise infringing products to territories where Cend has patent protection, but enforcement is not as strong as that in the United States. These products may compete with
            Cend&#8217;s products and Cend&#8217;s patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Many companies have encountered significant problems in protecting and defending
            intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection,
            particularly those relating to life sciences products, which could make it difficult for Cend to stop the infringement of patents or marketing of competing products in violation of proprietary rights generally. Proceedings to enforce patent
            rights </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">63<br />
        </div>

      </div>

    </div>

    <!--End Page 72-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 73-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg38"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">in foreign jurisdictions could result in substantial costs and divert Cend&#8217;s efforts
            and attention from other aspects of Cend&#8217;s business, could put Cend&#8217;s patents at risk of being invalidated or interpreted narrowly and Cend&#8217;s patent applications at risk of not issuing and could provoke third parties to assert claims against
            Cend. Cend may not prevail in any lawsuits that it initiates and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, Cend&#8217;s efforts to enforce intellectual property rights around the world may be
            inadequate to obtain a significant commercial advantage from the intellectual property that Cend develops or licenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition to the protection afforded by patents, Cend will rely on trade secret
            protection and confidentiality agreements to protect proprietary know-how that is not patentable or that Cend elects not to patent, processes for which patents are difficult to enforce and any other elements of Cend&#8217;s product candidate
            discovery and development processes that involve proprietary know-how, information or technology that is not covered by patents. However, trade secrets can be difficult to protect and some courts inside and outside the United States are less
            willing or unwilling to protect trade secrets. Cend seeks to protect its proprietary technology and processes, in part, by entering into confidentiality agreements with its employees, consultants, scientific advisors and contractors. Cend
            cannot guarantee that it has entered into such agreements with each party that may have or have had access to Cend&#8217;s trade secrets or proprietary technology and processes. Agreements or security measures may be breached, and Cend may not have
            adequate remedies for any breach. In addition, Cend&#8217;s trade secrets may otherwise become known or be independently discovered by competitors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Changes to patent law in the United States and
            in foreign jurisdictions could diminish the value of patents in general, thereby impairing Cend&#8217;s ability to protect its products.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As is the case with other drug discovery and development companies, Cend&#8217;s success is
            heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the pharmaceutical industry involve both technological and legal complexity, and is therefore costly, time-consuming and inherently uncertain.
            Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to Cend&#8217;s
            ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents once obtained. Depending on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and
            regulations governing patents could change in unpredictable ways that would weaken Cend&#8217;s ability to obtain new patents or to enforce patents that Cend might obtain in the future. For example, in the case <span style="font-style: italic;">Assoc.
              for Molecular Pathology v. Myriad Genetics, Inc., </span>the U.S. Supreme Court held that certain claims to DNA molecules are not patentable. Any adverse changes in the patent laws of other jurisdictions could have a material adverse effect
            on Cend&#8217;s business and financial condition. Changes in the laws and regulations governing patents in other jurisdictions could similarly have an adverse effect on Cend&#8217;s ability to obtain and effectively enforce any rights it may have in its
            patent applications or any patents Cend may own or in-license in the future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Recent or future patent reform legislation could also increase the uncertainties and
            costs surrounding the prosecution of Cend&#8217;s patent applications and the enforcement or defense of any patents Cend may own or in-license in the future. The United States has enacted and implemented wide-ranging patent reform legislation. On
            September&#160;16, 2011, the Leahy-Smith America Invents Act, or America Invents Act, was signed into law, which includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are
            prosecuted, redefine prior art, may affect patent litigation, establish a new post-grant review system and switch the U.S. patent system from a &#8220;first-to-invent&#8221; system to a &#8220;first-to-file&#8221; system. Under a &#8220;first-to-file&#8221; system, assuming the
            other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to a patent on the invention regardless of whether another inventor had made the invention earlier. Since patent
            applications in the United States and most other countries are confidential for a period of time after filing or until issuance, Cend cannot be certain that it was the first to either (i)&#160;file any patent application related to its product
            candidates or other technologies or (ii)&#160;invent any of the inventions claimed in its patent applications or any patents it may own or in-license. These changes also allow third party submission of prior art to the USPTO during patent
            prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, <span style="font-style: italic;">inter partes</span> review, and derivation proceedings.
            Because of a lower evidentiary standard in USPTO proceedings compared to the evidentiary standard in United States federal courts necessary to invalidate a patent claim, a third party could potentially provide evidence in a USPTO proceeding
            sufficient for the USPTO to hold a claim invalid even though the same evidence would be insufficient to invalidate the claim if first presented in a district court action. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">64<br />
        </div>

      </div>

    </div>

    <!--End Page 73-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 74-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg39"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Accordingly, a third party may attempt to use the USPTO procedures to invalidate
            Cend&#8217;s patent claims that would not have been invalidated if first challenged by the third party as a defendant in a district court action. An adverse determination in any such proceeding could reduce the scope of, or invalidate, Cend&#8217;s patent
            rights, allow third parties to commercialize its technology or products and compete directly with Cend, without payment to Cend, or result in Cend&#8217;s inability to manufacture or commercialize products without infringing third-party patent
            rights. Accordingly, the America Invents Act and its implementation interjects uncertainties and costs surrounding the prosecution of Cend&#8217;s patent applications and the enforcement or defense of any issued patents Cend may own or in-license in
            the future, all of which could have a material adverse effect on Cend&#8217;s business and financial condition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may be subject to claims asserting that
            its employees, consultants or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers or claims asserting ownership of what Cend regards as its own intellectual property.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend anticipates that many of its consultants or advisors will currently be, or were
            previously, employed at universities, industry service providers (e.g., CDMOs, CROs, CDOs, etc.), or other biotechnology or pharmaceutical companies, including Cend&#8217;s competitors or potential competitors. Although Cend tries to ensure that its
            employees, consultants and advisors do not use the proprietary information or know-how of others in their work for Cend, Cend may be subject to claims that these individuals or Cend has used or disclosed intellectual property, including trade
            secrets or other proprietary information, of any such individual's current or former employer. Litigation may be necessary to defend against these claims. If Cend fails in defending any such claims, in addition to paying monetary damages, Cend
            may lose valuable intellectual property rights or personnel. Even if Cend is successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">If Cend is unable to protect the
            confidentiality of its trade secrets, its business and competitive position would be harmed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition to the protection afforded by patents Cend may own or in-license in the
            future, Cend seeks to rely on trade secret protection, confidentiality agreements, and license agreements to protect proprietary know-how that is not patentable, processes for which patents are difficult to enforce and any other elements of
            Cend&#8217;s product discovery and development processes, that involve proprietary know-how, information, or technology that is not covered by patents. Although Cend requires all of its employees, consultants, advisors and any third parties who have
            access to Cend proprietary know-how, information, or technology to enter into confidentiality agreements, trade secrets can be difficult to protect and Cend has limited the protection of trade secrets used by its collaborators and suppliers.
            Cend cannot be certain that it has or will obtain these agreements in all circumstances and cannot guarantee that it has entered into such agreements with each party that may have or have had access to Cend&#8217;s trade secrets or proprietary
            information.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Moreover, any of these parties might breach the agreements and intentionally or
            inadvertently disclose Cend trade secret information and Cend may not be able to obtain adequate remedies for such breaches. In addition, competitors may otherwise gain access to Cend&#8217;s trade secrets or independently develop substantially
            equivalent information and techniques. Furthermore, the laws of some foreign countries do not protect proprietary rights and trade secrets to the same extent or in the same manner as the laws of the United States. As a result, Cend may
            encounter significant problems in protecting and defending its intellectual property both in the United States and abroad. If Cend is unable to prevent unauthorized material disclosure of its intellectual property to third parties, Cend will
            not be able to establish or maintain a competitive advantage in its market, which could materially adversely affect Cend&#8217;s business, financial condition, results of operations and future prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is
            difficult, expensive and time-consuming, and the outcome is unpredictable. If Cend chooses to go to court to stop a third party from using any of its trade secrets, it may incur substantial costs. These lawsuits may consume Cend&#8217;s time and
            other resources even if it is successful. For example, significant elements, including aspects of drug manufacturing processes, experiments to validate mechanisms and pharmacology, drug design, and related processes, are based on unpatented
            trade secrets that are not publicly disclosed. Although Cend takes steps to protect its proprietary information and trade secrets, including through contractual means with its employees and consultants, third parties may independently develop
            substantially equivalent proprietary information and techniques or otherwise gain access to Cend&#8217;s trade secrets or disclose its technology. If any of Cend&#8217;s trade secrets were to be lawfully </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">65<br />
        </div>

      </div>

    </div>

    <!--End Page 74-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 75-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg40"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">obtained or independently developed by a competitor or other third party, Cend would
            have no right to prevent them from using that technology or information to compete with Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Thus, Cend may not be able to meaningfully protect its trade secrets. It is Cend&#8217;s
            policy to require its employees, consultants, outside scientific collaborators, sponsored researchers and other advisors to execute confidentiality agreements upon the commencement of employment or consulting relationships with Cend. These
            agreements provide that all confidential information concerning Cend&#8217;s business or financial affairs developed or made known to the individual or entity during the course of the party&#8217;s relationship with Cend is to be kept confidential and not
            disclosed to third parties except in specific circumstances. In addition, Cend takes other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of Cend&#8217;s proprietary technology by
            third parties. In the case of employees, the agreements provide that all inventions conceived by the individual, and which are related to Cend&#8217;s current or planned business or research and development or made during normal working hours, on
            Cend&#8217;s premises or using Cend&#8217;s equipment or proprietary information, are Cend&#8217;s exclusive property. Although Cend requires all of its employees to assign their inventions to it, Cend may be unsuccessful in executing such an agreement with each
            party who, in fact, conceives or develops intellectual property that Cend regards as its own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and Cend may be forced to
            bring claims against third parties, or defend claims that they may bring against Cend, to determine the ownership of what Cend regards as its intellectual property. Such claims could have a material adverse effect on Cend&#8217;s business, financial
            condition, results of operations, and prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may not be successful in obtaining or
            maintaining necessary rights to product components and processes for its development pipeline through acquisitions and in-licenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Presently Cend has seven pending patent applications in the United States. Because
            additional product candidates may require the use of proprietary rights held by third parties, the growth of Cend&#8217;s business will likely depend in part on its ability to acquire, in-license or use these proprietary rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s product candidates may also require specific formulations to work effectively
            and efficiently and these rights may be held by others. Similarly, efficient production or delivery of Cend product candidates may also require specific compositions or methods, and the rights to these may be owned by third parties. Cend may be
            unable to acquire or in-license any compositions, methods of use, processes or other third-party intellectual property rights from third parties that Cend identifies as necessary or important to its business operations. Cend may fail to obtain
            any of these licenses at a reasonable cost or on reasonable terms, if at all, which would harm its business. Cend may need to cease use of the compositions or methods covered by such third-party intellectual property rights, and may need to
            seek to develop alternative approaches that do not infringe on such intellectual property rights which may entail additional costs and development delays, even if Cend was able to develop such alternatives, which may not be feasible. Even if
            Cend is able to obtain a license, it may be nonexclusive, thereby giving Cend competitors access to the same technologies licensed to it. In that event, Cend may be required to expend significant time and resources to develop or license
            replacement technology. Moreover, the molecules that will be used with Cend&#8217;s product candidates may be covered by the intellectual property rights of others.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Additionally, Cend sometimes collaborated with academic institutions to accelerate its
            clinical research or development under written agreements with these institutions. In certain cases, these institutions provide Cend with an option to negotiate a license to any of the institution&#8217;s rights in technology resulting from the
            collaboration. Regardless of such option, Cend may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to it. If it is unable to do so, the institution may offer the intellectual property rights to
            others, potentially blocking Cend&#8217;s ability to pursue its program and allowing third parties to compete with it. If Cend is unable to successfully obtain rights to required third-party intellectual property or to maintain the existing
            intellectual property rights Cend has, Cend may have to abandon development of such program and its business and financial condition could suffer.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The licensing and acquisition of third-party intellectual property rights is a
            competitive area, and companies that are more established, or have greater resources than Cend does, may also be pursuing strategies to license or acquire third-party intellectual property rights that Cend may consider necessary or attractive
            in order to commercialize its product candidates. More established companies may have a competitive advantage over Cend due to their size, cash resources and greater clinical development and commercialization capabilities. In addition,
            companies that perceive Cend to be a competitor may be unwilling to assign or license rights to it. Cend also may be unable to license or acquire third-party intellectual property rights on terms that would allow it to make </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">66<br />
        </div>

      </div>

    </div>

    <!--End Page 75-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 76-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg41"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">an appropriate return on its investment or at all. There can be no assurance that
            Cend will be able to successfully complete such negotiations and ultimately acquire the rights to the intellectual property surrounding the additional product candidates that it may seek to acquire. If Cend is unable to successfully obtain
            rights to required third-party intellectual property or to maintain the existing intellectual property rights it has, to may have to abandon development of such program and its business, results of operations, financial condition and prospects
            could suffer.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">If Cend does not obtain patent term extension
            and data exclusivity for any of its current or future product candidates it may develop, its business may be materially harmed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Depending upon the timing, duration and specifics of any FDA marketing approval of any
            of its current or future product candidates Cend may develop, one or more U.S. patents Cend may own or in-license in the future may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act
            of 1984, or the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent term extension of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the
            remaining term of a patent beyond a total of 14&#160;years from the date of product approval, only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended.
            However, Cend may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration
            of relevant patents, or otherwise failing to satisfy applicable requirements. Moreover, the applicable time period or the scope of patent protection afforded could be less than Cend requests. If Cend is unable to obtain patent term extension or
            the term of any such extension is shorter than what Cend requests, its competitors may obtain approval of competing products following expiration of any patents that issue from Cend&#8217;s patent applications, and Cend&#8217;s business, financial
            condition, results of operations, and prospects could be materially harmed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">If Cend&#8217;s trademarks and trade names are not
            adequately protected, then it may not be able to build name recognition in its marks of interest and its business may be adversely affected.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s trademarks or trade names may be challenged, infringed, diluted, circumvented or
            declared generic or determined to be infringing on other marks. Cend intends to rely on both registration and common law protection for its trademarks. Cend may not be able to protect its rights to these trademarks and trade names or may be
            forced to stop using these names, which it needs for name recognition by potential partners or customers in its markets of interest. During the trademark registration process, Cend may receive Office Actions from the USPTO objecting to the
            registration of its trademarks. Although Cend would be given an opportunity to respond to those objections, it may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third
            parties are given an opportunity to oppose pending trademark applications and/or to seek the cancellation of registered trademarks. Opposition or cancellation proceedings may be filed against Cend&#8217;s trademarks, and its trademarks may not
            survive such proceedings. If Cend is unable to obtain a registered trademark or establish name recognition based on its trademarks and trade names, it may not be able to compete effectively and its business may be adversely affected.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Third-party claims of intellectual property
            infringement, misappropriation or other violations may be costly and time consuming and may prevent or delay Cend&#8217;s product discovery and development efforts.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The intellectual property landscape around precision medicine is crowded, and third
            parties may initiate legal proceedings alleging that Cend is infringing, misappropriating, or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the
            success of Cend&#8217;s business. Cend&#8217;s commercial success depends upon its ability to develop, manufacture, market and sell its current and future product candidates and use its proprietary technologies without infringing, misappropriating or
            otherwise violating the intellectual property rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries, as well as
            administrative proceedings for challenging patents, including derivation, interference, reexamination, <span style="font-style: italic;">inter partes</span> review, and post grant review proceedings before the USPTO or oppositions and other
            comparable proceedings in foreign jurisdictions. Cend or any of its future licensors or strategic partners may be party to, exposed to, or threatened with, future adversarial proceedings or litigation by third parties having patent or other
            intellectual property rights alleging that its current or future product candidates and/or proprietary technologies </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">67<br />
        </div>

      </div>

    </div>

    <!--End Page 76-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 77-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg42"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">infringe, misappropriate or otherwise violate their intellectual property rights.
            Cend cannot assure you that its product candidates and other technologies that it has developed, are developing or may develop in the future do not or will not infringe, misappropriate or otherwise violate existing or future patents or other
            intellectual property rights owned by third parties. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which Cend is developing product candidates. As the
            biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that Cend&#8217;s product candidates may give rise to claims of infringement of the patent rights of others. Moreover, it is not always clear to
            industry participants, including Cend, which patents cover various types of drugs, products or their methods of use or manufacture. Thus, because of the large number of patents issued and patent applications filed in Cend&#8217;s fields, there may be
            a risk that third parties may allege they have patent rights encompassing Cend&#8217;s product candidates, technologies or methods.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If a third party claims that Cend infringes, misappropriates or otherwise violates its
            intellectual property rights, Cend may face a number of issues, including, but not limited to:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">infringement, misappropriation and other intellectual property claims which, regardless of merit, may be expensive and
                    time-consuming to litigate and may divert management&#8217;s attention from Cend&#8217;s core business and may impact its reputation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">substantial damages for infringement, misappropriation or other violations, which Cend may have to pay if a court decides that
                    the product candidate or technology at issue infringes, misappropriates or violates the third party&#8217;s rights, and, if the court finds that the infringement was willful, Cend could be ordered to pay treble damages and the patent owner&#8217;s
                    attorneys&#8217; fees;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a court prohibiting Cend from developing, manufacturing, marketing or selling its product candidates, including CEND-1, or from
                    using its proprietary technologies, unless the third party licenses its product rights to Cend, which it is not required to do, on commercially reasonable terms or at all;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if a license is available from a third party, Cend may have to pay substantial royalties, upfront fees and other amounts, and/or
                    grant cross-licenses to intellectual property rights for its products, or the license to Cend may be non-exclusive, which would permit third parties to use the same intellectual property to compete with Cend;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">redesigning Cend&#8217;s product candidates or processes so they do not infringe, misappropriate or violate third party intellectual
                    property rights, which may not be possible or may require substantial monetary expenditures and time; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and, if
                    securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of Cend&#8217;s common stock.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Some of Cend&#8217;s competitors may be able to sustain the costs of complex patent
            litigation more effectively than Cend can because they have substantially greater resources. In addition, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on Cend&#8217;s ability
            to raise the funds necessary to continue Cend&#8217;s operations or could otherwise have a material adverse effect on Cend&#8217;s business, results of operations, financial condition and prospects. The occurrence of any of the foregoing could have a
            material adverse effect on Cend&#8217;s business, financial condition, results of operations or prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may choose to challenge the patentability of claims in a third party&#8217;s U.S. patent
            by requesting that the USPTO review the patent claims in an <span style="font-style: italic;">ex-parte</span> re-exam, <span style="font-style: italic;">inter partes</span> review or post-grant review proceedings. These proceedings are
            expensive and may consume Cend&#8217;s time or other resources. Cend may choose to challenge a third party&#8217;s patent in patent opposition proceedings in the EPO, or other foreign patent office. The costs of these opposition proceedings could be
            substantial, and may consume Cend&#8217;s time or other resources. If Cend fails to obtain a favorable result at the USPTO, EPO or other patent office then Cend may be exposed to litigation by a third party alleging that the patent may be infringed
            by Cend&#8217;s product candidates or proprietary technologies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Third parties may assert that Cend is employing their proprietary technology without
            authorization. Patents issued in the United States by law enjoy a presumption of validity that can be rebutted only with evidence that is &#8220;clear and convincing,&#8221; a heightened standard of proof. There may be issued third-party patents of which
            Cend is </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">68<br />
        </div>

      </div>

    </div>

    <!--End Page 77-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 78-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg43"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">currently unaware with claims to compositions, formulations, methods of manufacture
            or methods for treatment related to the use or manufacture of Cend&#8217;s product candidates. Patent applications can take many years to issue. In addition, because some patent applications in the United States may be maintained in secrecy until the
            patents are issued, patent applications in the United States and many foreign jurisdictions are typically not published until 18 months after filing, and publications in the scientific literature often lag behind actual discoveries, Cend cannot
            be certain that others have not filed patent applications covering Cend&#8217;s product candidates or technology. If any such patent applications issue as patents, and if such patents have priority over Cend&#8217;s patent applications or patents Cend may
            own or in-license, Cend may be required to obtain rights to such patents owned by third parties which may not be available on commercially reasonable terms or at all, or may only be available on a non-exclusive basis. There may be currently
            pending patent applications which may later result in issued patents that Cend&#8217;s product candidates may infringe. It is also possible that patents owned by third parties of which Cend is aware, but which it does not believe are relevant to
            Cend&#8217;s product candidates or other technologies, could be found to be infringed by Cend&#8217;s product candidates or other technologies. In addition, third parties may obtain patents in the future and claim that use of Cend&#8217;s technologies infringes
            upon these patents. Moreover, Cend may fail to identify relevant patents or incorrectly conclude that a patent is invalid, not enforceable, exhausted, or not infringed by Cend&#8217;s activities. If any third-party patents were held by a court of
            competent jurisdiction to cover the manufacturing process of Cend&#8217;s product candidates, molecules used in or formed during the manufacturing process, or any final product itself, the holders of any such patents may be able to block Cend&#8217;s
            ability to commercialize the product candidate unless it obtained a license under the applicable patents, or until such patents expire or they are finally determined to be held invalid or unenforceable. Similarly, if any third-party patent were
            held by a court of competent jurisdiction to cover aspects of Cend&#8217;s formulations, processes for manufacture or methods of use, including combination therapy or patient selection methods, the holders of any such patent may be able to block
            Cend&#8217;s ability to develop and commercialize the product candidate unless Cend obtained a license or until such patent expires or is finally determined to be held invalid or unenforceable. In either case, such a license may not be available on
            commercially reasonable terms or at all. If Cend is unable to obtain a necessary license to a third-party patent on commercially reasonable terms, or at all, its ability to commercialize its product candidates may be impaired or delayed, which
            could in turn significantly harm its business. Even if Cend obtains a license, it may be nonexclusive, thereby giving Cend&#8217;s competitors access to the same technologies licensed to Cend. In addition, if the breadth or strength of protection
            provided by Cend&#8217;s patent applications or any patents it may own or in-license in the future is threatened, it could dissuade companies from collaborating with Cend to license, develop or commercialize current or future product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Parties making claims against Cend may seek and obtain injunctive or other equitable
            relief, which could effectively block Cend&#8217;s ability to further develop and commercialize its product candidates. Defense of these claims, regardless of their merit, could involve substantial litigation expense and would be a substantial
            diversion of employee resources from Cend&#8217;s business. In the event of a successful claim of infringement, misappropriation or other violation against Cend, Cend may have to pay substantial damages, including treble damages and attorneys&#8217; fees
            for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign its infringing products, which may be impossible or require substantial time and monetary expenditure. Cend cannot predict whether any such
            license would be available at all or whether it would be available on commercially reasonable terms. Furthermore, even in the absence of litigation, Cend may need or may choose to obtain licenses from third parties to advance its research or
            allow commercialization of its product candidates. Cend may fail to obtain any of these licenses at a reasonable cost or on reasonable terms, if at all. In that event, Cend would be unable to further develop and commercialize its product
            candidates, which could harm its business significantly.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may become involved in lawsuits to protect
            or enforce its intellectual property rights, including any patents it may own or in-license in the future, which could be expensive, time-consuming and unsuccessful.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Competitors may infringe any patents Cend may own or in-license in the future. In
            addition, any patents Cend may own or in-license also may become involved in inventorship, priority, validity or unenforceability disputes. To counter infringement or unauthorized use, Cend may be required to file infringement claims, which can
            be expensive and time-consuming. Cend may not prevail in any lawsuits that it initiates, and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition, in an infringement proceeding, a court may decide that
            one or more of any patents Cend may own or in-license in the future is not valid or is unenforceable or that the other party&#8217;s use of Cend&#8217;s technology that may be patented falls under the safe harbor </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">69<br />
        </div>

      </div>

    </div>

    <!--End Page 78-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 79-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg44"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">to patent infringement under 35 U.S.C. &#167;271(e)(1). There is also the risk that, even
            if the validity of these patents is upheld, the court may refuse to stop the other party from using the technology at issue on the grounds that any patents Cend may own or in-license in the future do not cover the technology in question or that
            such third party&#8217;s activities do not infringe Cend&#8217;s patent applications or any patents it may own or in-license in the future. An adverse result in any litigation or defense proceedings could put one or more of any patents Cend may own or
            in-license in the future at risk of being invalidated, held unenforceable, or interpreted narrowly and could put Cend&#8217;s patent applications at risk of not issuing. Defense of these claims, regardless of their merit, would involve substantial
            litigation expense and would be a substantial diversion of employee resources from Cend&#8217;s business. In the event of a successful claim of infringement against Cend, Cend may have to pay substantial damages, including treble damages and
            attorneys&#8217; fees for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign Cend&#8217;s infringing products, which may be impossible or require substantial time and monetary expenditure. Such litigation or
            proceedings could substantially increase Cend&#8217;s operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. Cend may not have sufficient financial or other resources
            to conduct such litigation or proceedings adequately. Some of Cend&#8217;s competitors may be able to sustain the costs of such litigation or proceedings more effectively than Cend can because of their greater financial resources and more mature and
            developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on Cend&#8217;s ability to compete in the marketplace.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Post-grant proceedings provoked by third parties or brought by the USPTO may be
            necessary to determine the validity or priority of inventions with respect to Cend&#8217;s patent applications or any patents Cend may own or in-license in the future. These proceedings are expensive and an unfavorable outcome could result in a loss
            Cend&#8217;s current patent rights and could require Cend to cease using the related technology or to attempt to license rights to it from the prevailing party. Cend&#8217;s business could be harmed if the prevailing party does not offer Cend a license on
            commercially reasonable terms. In addition to potential USPTO review proceedings, Cend may become a party to patent opposition proceedings in the European Patent Office or similar proceedings in other foreign patent offices, where either Cend&#8217;s
            foreign patents are challenged. The costs of these opposition or similar proceedings could be substantial, and may result in a loss of scope of some claims or a loss of the entire patent. An unfavorable result at the USPTO, EPO or other patent
            office may result in the loss of Cend&#8217;s right to exclude others from practicing one or more of its inventions in the relevant country or jurisdiction, which could have a material adverse effect on Cend&#8217;s business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Litigation or post-grant proceedings may result in a decision adverse to Cend&#8217;s
            interests and, even if Cend is successful, may result in substantial costs and distract its management and other employees. Cend may not be able to prevent, misappropriation of its trade secrets or confidential information, particularly in
            countries where the laws may not protect those rights as fully as in the United States.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Furthermore, because of the substantial amount of discovery required in connection with
            intellectual property litigation, there is a risk that some of Cend&#8217;s confidential information could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings,
            motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of Cend&#8217;s common stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may not be able to detect infringement against any patents it may own or
            in-license in the future. Even if Cend detects infringement by a third party of any patents it may own or in-license in the future, Cend may choose not to pursue litigation against or settlement with the third party. If Cend later sues such
            third party for patent infringement, the third party may have certain legal defenses available to it, which otherwise would not be available except for the delay between when the infringement was first detected and when the suit was brought.
            Such legal defenses may make it impossible for Cend to enforce any patents it may own or in-license against such third party.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">70<br />
        </div>

      </div>

    </div>

    <!--End Page 79-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 80-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg45"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to the development of Cend&#8217;s product candidates</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend is early in its development efforts and is
            substantially dependent on its lead product candidate, CEND-1. If Cend is unable to advance CEND-1 or any of its other product candidates through clinical development, obtain regulatory approval and ultimately commercialize CEND-1 or any of its
            other product candidates, or experience significant delays in doing so, Cend&#8217;s business will be materially harmed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend is early in its development efforts. Cend&#8217;s lead product candidate is still in
            clinical development. Cend&#8217;s earlier stage drug discovery and development programs have not yet resulted in product candidates that have been tested in human subjects. Cend&#8217;s ability to generate product revenues, which it does not expect will
            occur for many years, if ever, will depend heavily on the successful clinical development and eventual commercialization of CEND-1 and one or more of its other product candidates. The success of Cend&#8217;s product candidates will depend on several
            factors, including the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">successful completion of preclinical and clinical studies;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approval of INDs for Cend&#8217;s planned clinical trials or future clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">FDA acceptance of Cend&#8217;s development strategy and resultant clinical data;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">successful initiation of clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">successful patient enrollment in and completion of clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">safety, tolerability and efficacy profiles for Cend&#8217;s product candidates that are satisfactory to the FDA or any foreign
                    regulatory authority for marketing approval;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">receipt of marketing approvals for Cend&#8217;s product candidates from applicable regulatory authorities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the extent of any required post-marketing approval commitments to applicable regulatory authorities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining and maintaining patent and trade secret protection and regulatory exclusivity for Cend&#8217;s product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">making arrangements with third-party manufacturers, or establishing manufacturing capabilities, for both clinical and commercial
                    supplies of Cend&#8217;s product candidates, if any product candidates are approved;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establishing sales, marketing and distribution capabilities and launching commercial sales of Cend&#8217;s products, if and when
                    approved, whether alone or in collaboration with others;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">acceptance of Cend&#8217;s products, if and when approved, by patients, the medical community and third-party payors;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">effectively competing with other cancer therapies;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining and maintaining third-party coverage and adequate reimbursement;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">maintaining a continued acceptable safety profile of Cend&#8217;s products following approval; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">factors Cend may not be able to control, such as current or potential pandemics that may limit patients, principal investigators
                    or staff or clinical site availability (e.g. the COVID-19 pandemic).</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There is no guarantee that the results obtained in current clinical studies will be
            sufficient to obtain regulatory approval or marketing authorization for such product candidate. Negative results in the development of Cend&#8217;s lead product candidate may also impact its ability to obtain regulatory approval for its other product
            candidates, either at all or within anticipated timeframes because, although other product candidates may target different indications, the underlying technology platform, manufacturing process and development process is the same for all of
            Cend&#8217;s product candidates. Accordingly, a failure in any one program may affect the ability to obtain regulatory approval to continue or conduct clinical programs for other product candidates. For example, although Cend believes based on its
            clinical studies that a combination of CEND-1 with certain anti-cancer therapeutics is more effective than the use of those therapeutics in alone, this may not prove true in clinical testing of CEND-1 for all or any of the targeted tumors or
            types of cancer. Anti-tumor activity may prove different in each of the different tumor and cancer types Cend plans on evaluating in the clinical trial. Therefore, even though Cend plans on pursuing tumor-agnostic clinical development of
            CEND-1, the tumor response may be low in patients </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">71<br />
        </div>

      </div>

    </div>

    <!--End Page 80-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 81-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg46"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">with some cancers compared to others. This may result in discontinuation of
            development of CEND-1 for patients with these tumor types and/or mutations due to insufficient clinical benefit while continuing development for a more limited population of patients more likely to benefit. As a consequence, Cend may have to
            negotiate with the FDA to reach agreement on defining the optimal patient population, study design and size in order to obtain regulatory approval, any of which may require significant additional resources and delay the timing of Cend&#8217;s
            clinical trials and ultimately the approval, if any, of any of Cend&#8217;s product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, because Cend has limited financial and personnel resources and is placing
            significant focus on the development of its lead product candidate, Cend may forego or delay pursuit of opportunities with other future product candidates that later prove to have greater commercial potential. Cend&#8217;s resource allocation
            decisions may cause it to fail to capitalize on viable commercial products or profitable market opportunities. Cend&#8217;s spending on current and future research and development programs and other future product candidates for specific indications
            may not yield any commercially viable future product candidates. If Cend does not accurately evaluate the commercial potential or target market for a particular future product candidate, it may relinquish valuable rights to those future product
            candidates through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for it to retain sole development and commercialization rights to such future product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="frisk">Difficulty in enrolling patients could delay or
            prevent clinical trials of Cend&#8217;s product candidates. Cend may find it difficult to enroll patients in its clinical trial for CEND-1 with the tumor cancers that CEND-1 is designed to target.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Identifying and qualifying patients to participate in clinical studies of Cend&#8217;s
            product candidates is critical to Cend&#8217;s success. The timing of completion of Cend&#8217;s clinical studies depends in part on the speed at which it can recruit patients to participate in testing its product candidates, and Cend may experience delays
            in its clinical trials if it encounters difficulties in enrollment. Cend may not be able to initiate or continue clinical trials for its product candidates if it is unable to locate and enroll a sufficient number of eligible patients to
            participate in these trials as required by the FDA or similar regulatory authorities outside the United States. In particular, because Cend is focused on patients with specific solid tumor cancers, Cend&#8217;s ability to enroll eligible patients may
            be limited or may result in slower enrollment than it anticipates. For example, with respect to CEND-1, Cend cannot be certain how many patients will have each of the solid tumor cancers that CEND-1 is designed to target or that the number of
            patients enrolled will suffice for regulatory approval and inclusion of each such mutation in the approved label. In addition, some of Cend&#8217;s competitors have ongoing clinical trials for product candidates that treat the same indications as
            Cend&#8217;s product candidates, and patients who would otherwise be eligible for Cend&#8217;s clinical trials may instead enroll in clinical trials of Cend&#8217;s competitors&#8217; product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The eligibility criteria of Cend&#8217;s planned clinical trials will limit the pool of
            available study participants as Cend will require that patients have specific characteristics that it can measure to assure their disease is either severe enough or not too advanced to include them in a study. Additionally, the process of
            finding and diagnosing patients may prove costly. Cend also may not be able to identify, recruit and enroll a sufficient number of patients to complete its clinical studies because of the perceived risks and benefits of the product candidate
            under study, the availability and efficacy of competing therapies and clinical trials, the proximity and availability of clinical study sites for prospective patients, the availability of genetic sequencing information for patient tumors so
            that Cend can identify patients with the targeted conditions, and the patient referral practices of physicians. If patients are unwilling to participate in Cend&#8217;s studies for any reason, the timeline for recruiting patients, conducting studies
            and obtaining regulatory approval of potential products may be delayed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Further, if Cend is unable to include patients with the targeted conditions, this could
            compromise its ability to seek participation in FDA&#8217;s expedited review and development programs, or otherwise seek to accelerate clinical development and regulatory timelines.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">The enrollment of patients further depends on many factors, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the proximity of patients to clinical trial sites;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the design of the clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s ability to recruit clinical trial investigators with the appropriate competencies and experience;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s ability to obtain and maintain patient consents;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">72<br />
        </div>

      </div>

    </div>

    <!--End Page 81-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 82-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg47"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reporting of the preliminary results of any of Cend&#8217;s clinical trials; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the risk that patients enrolled in clinical trials will drop out of the clinical trials before clinical trial completion; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">other unforeseeable conditions, such as COVID-19, which had a significantly negative impact on the availability of enrollment in
                    clinical trials.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, Cend&#8217;s clinical trials will compete with other clinical trials for product
            candidates that are in the same therapeutic areas as its product candidates, and this competition will reduce the number and types of patients available to Cend because some patients who might have opted to enroll in Cend&#8217;s clinical trials may
            instead opt to enroll in a clinical trial being conducted by one of Cend&#8217;s competitors. Since the number of qualified clinical investigators is limited, Cend may conduct some of its clinical trials at the same clinical trial sites that some of
            its competitors use, which could reduce the number of patients who are available for Cend&#8217;s clinical trials at such clinical trial sites. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend experiences delays in the completion of, or termination of, any clinical trial
            of its product candidates, the commercial prospects of Cend&#8217;s product candidates will be harmed, and Cend&#8217;s ability to generate product revenue from any of these product candidates could be delayed or prevented.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;" class="frisk">Cend has limited experience as a company in
            conducting clinical trials.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has limited experience as a company in conducting clinical trials. In part because
            of this lack of experience, Cend cannot be certain that its ongoing preclinical and clinical studies will be completed on time or if the planned preclinical studies and clinical trials will begin or be completed on time, if at all. Large-scale
            clinical trials would require significant additional financial and management resources and reliance on third-party clinical investigators, contract research organizations, or CROs, and consultants. Relying on third-party clinical
            investigators, CROs and consultants may force Cend to encounter delays that are outside of its control. Cend may be unable to identify and contract with sufficient investigators, CROs and consultants on a timely basis or at all. There can be no
            assurance that Cend will be able to negotiate and enter into any additional master services agreement with other CROs, as necessary, on terms that are acceptable to Cend on a timely basis or at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend&#8217;s non-clinical studies and clinical trials
            may fail to demonstrate adequately the safety, potency, purity and efficacy of any of its product candidates, which would prevent or delay development, regulatory approval and commercialization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Before obtaining regulatory approvals for the commercial license or sale of Cend&#8217;s
            product candidates, including CEND-1, Cend must demonstrate through lengthy, complex and expensive preclinical studies and clinical trials that its product candidates are both safe and effective for use in each target indication. Preclinical
            and clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the preclinical study and clinical trial processes, and, because Cend&#8217;s product candidates are
            in an early stage of development, there is a high risk of failure and Cend may never succeed in developing marketable products.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The results of preclinical studies and early clinical trials of Cend&#8217;s product
            candidates may not be predictive of the results of later-stage clinical trials. Although product candidates may demonstrate promising results in preclinical studies and early clinical trials, they may not prove to be effective in subsequent
            clinical trials. For example, testing on animals occurs under different conditions than testing in humans and therefore the results of animal studies may not accurately predict human experience. There is typically an extremely high rate of
            attrition from the failure of product candidates proceeding through preclinical studies and clinical trials. Product candidates in later stages of clinical trials may fail to show the desired safety, potency, purity and efficacy profile despite
            having progressed through preclinical studies and initial clinical trials. Likewise, early, smaller-scale clinical trials may not be predictive of eventual safety or effectiveness in large-scale pivotal clinical trials. A number of companies in
            the pharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of potency or efficacy, insufficient durability of potency or efficacy or unacceptable safety issues, notwithstanding promising results in
            earlier trials. Most product candidates that commence preclinical studies and clinical trials are never approved as products.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any preclinical studies or clinical trials that Cend may conduct may not demonstrate
            the safety, potency, purity and efficacy necessary to obtain regulatory approval to market Cend&#8217;s product candidates. If the results of Cend&#8217;s </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">73<br />
        </div>

      </div>

    </div>

    <!--End Page 82-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 83-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg48"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">ongoing or future preclinical studies and clinical trials are inconclusive with
            respect to the safety, potency, purity and efficacy of its product candidates, if Cend does not meet the clinical endpoints with statistical and clinically meaningful significance, or if there are safety concerns associated with Cend&#8217;s product
            candidates, Cend may be prevented or delayed in obtaining marketing approval for such product candidates. In some instances, there can be significant variability in safety, potency, purity or efficacy results between different preclinical
            studies and clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the
            clinical trial protocols and the rate of dropout among clinical trial participants. As is the case with all oncology drugs, it is likely that there may be side effects associated with their use. Results of Cend&#8217;s trials could reveal a high and
            unacceptable severity and prevalence of these or other side effects. In such an event, Cend&#8217;s trials could be suspended or terminated and the FDA or comparable foreign regulatory authorities could order us to cease further development of or
            deny approval of Cend&#8217;s product candidates for any or all targeted indications. Drug-related side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability
            claims. Any of these occurrences may harm Cend&#8217;s business, financial condition and prospects significantly.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may not be able to file INDs or IND
            amendments to commence additional clinical trials on the timelines it expects, and even if Cend is able to, the FDA may not permit it to proceed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend submitted an IND for CEND-1 on April&#160;14, 2021, which was allowed by the FDA on
            May&#160;14, 2021 but Cend may not be able to file INDs for its other product candidates on the timelines it expects. For example, Cend may experience manufacturing delays or other delays with IND-enabling studies. Moreover, Cend cannot be sure that
            submission of an IND will result in the FDA allowing further clinical trials to begin, or that, once begun, issues will not arise that suspend or terminate clinical trials. Additionally, even if such regulatory authorities agree with the design
            and implementation of the clinical trials set forth in an IND, Cend cannot guarantee that such regulatory authorities will not change their requirements in the future. These considerations also apply to new clinical trials Cend may submit as
            amendments to existing INDs or to a new IND. Any failure to file INDs on the timelines Cend expects or to obtain regulatory approvals for Cend&#8217;s trials may prevent Cend from completing its clinical trials or commercializing its products on a
            timely basis, if at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Since the number of patients that Cend plans to
            dose in its Phase 2b clinical trial of CEND-1 is small, the results from such a clinical trial, once completed, may be less reliable than results achieved in larger clinical trials, which may hinder Cend&#8217;s efforts to obtain regulatory approval
            for its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the current, ongoing Phase 2b clinical trial of CEND-1, Cend is evaluating the
            safety and anti-tumor activity profile of CEND-1 at the recommended Phase 2b dose in combination with standard-of-care chemotherapy in patients with pancreatic cancer. The Phase 2b portion of the trial is expected to enroll up to 125 patients.
            The Phase 2b portion may have to evaluate different dosing schedules if the pharmacokinetic or safety data suggest once daily dosing is suboptimal. The preliminary results of clinical trials with smaller sample sizes, such as Cend&#8217;s previous
            Phase 1b clinical trial of CEND-1, can be disproportionately influenced by various biases associated with the conduct of small clinical trials, such as the potential failure of the smaller sample size to accurately depict the features of the
            broader patient population, which limits the ability to generalize the results across a broader community, thus making the clinical trial results less reliable than clinical trials with a larger number of patients. As a result, there may be
            less certainty that such product candidates would achieve a statistically significant effect in any future clinical trials. If Cend conducts any future clinical trials of CEND-1, it may not achieve a statistically significant result or the same
            level of statistical significance, if any, that it might have anticipated based on the results observed in Cend&#8217;s initial clinical trial.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Further, clinical trials by their nature utilize a sample of the potential patient
            population. With a limited number of patients and limited duration of exposure, rare and severe side effects of Cend&#8217;s product candidates may only be uncovered with a significantly larger number of patients exposed to the drug candidate. If
            Cend&#8217;s product candidates receive marketing approval and Cend or others identify undesirable side effects caused by such product candidates (or any other similar drugs) after such approval, a number of potentially significant negative
            consequences could result, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory authorities may withdraw or limit their approval of such product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory authorities may require the addition of labeling statements, such as a &#8220;boxed&#8221; warning or a contraindication;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">74<br />
        </div>

      </div>

    </div>

    <!--End Page 83-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 84-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg49"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend may be required to change the way such product candidates are distributed or administered, conduct additional clinical
                    trials or change the labeling of the product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory authorities may require a REMS plan to mitigate risks, which could include medication guides, physician communication
                    plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend may be subject to regulatory investigations and government enforcement actions;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend may decide to remove such product candidates from the marketplace;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend could be sued and held liable for injury caused to individuals exposed to or taking its product candidates; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s reputation may suffer.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend believes that any of these events could prevent it from achieving or maintaining
            market acceptance of the affected product candidates and could substantially increase the costs of commercializing Cend&#8217;s product candidates, if approved, and significantly impact Cend&#8217;s ability to successfully commercialize its product
            candidates and generate revenues.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Clinical development involves a lengthy and
            expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future clinical trial results. Cend may encounter substantial delays in clinical trials, or may not be able to conduct or complete
            clinical trials on the expected timelines, if at all. If Cend&#8217;s preclinical studies and clinical trials are not sufficient to support regulatory approval of any of its product candidates, it may incur additional costs or experience delays in
            completing, or ultimately be unable to complete, the development of such product candidate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s lead product candidate is in clinical studies, and additional product candidates
            are at earlier stages of development, and their risk of failure is high. It is impossible to predict when or if any of Cend&#8217;s product candidates will prove effective and safe in humans or will receive regulatory approval. Before obtaining
            marketing approval from regulatory authorities for the sale of any drug candidate, Cend must complete preclinical studies and then conduct extensive clinical trials to demonstrate the safety and efficacy of its product candidates in humans. A
            failure of one or more clinical trials can occur at any stage of testing. The outcome of preclinical development testing and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical
            trial do not necessarily predict final results. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in
            preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates. Cend&#8217;s preclinical studies and future clinical trials may not be successful.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend cannot be certain that its non-clinical study and clinical trial results will be
            sufficient to support regulatory approval of its product candidates. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Human clinical trials are expensive and difficult to design and
            implement, in part because they are subject to rigorous regulatory requirements. Failure or delay can occur at any time during the clinical trial process.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Additionally, some of the clinical trials Cend conducts may be open-label in study
            design and may be conducted at a limited number of clinical sites on a limited number of patients. An &#8220;open-label&#8221; clinical trial is one where both the patient and investigator know whether the patient is receiving the investigational product
            candidate or either an existing approved drug or placebo. Most typically, open-label clinical trials test only the investigational product candidate and sometimes may do so at different dose levels. Open-label clinical trials are subject to
            various limitations that may exaggerate any therapeutic effect as patients in open-label clinical trials are aware when they are receiving treatment. Open-label clinical trials may be subject to a &#8220;patient bias&#8221; where patients perceive their
            symptoms to have improved merely due to their awareness of receiving an experimental treatment. Moreover, patients selected for early clinical studies often include the most severe sufferers and their symptoms may have been bound to improve
            notwithstanding the new treatment. In addition, open-label clinical trials may be subject to an &#8220;investigator bias&#8221; where those assessing and reviewing the physiological outcomes of the clinical trials are aware of which patients have received
            treatment and may interpret the information of the treated group more favorably given this knowledge. Cend&#8217;s Phase 2b and additional later stage clinical trials are planned to be conducted as controlled, blinded studies.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">75<br />
        </div>

      </div>

    </div>

    <!--End Page 84-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 85-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg50"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may experience delays in obtaining the FDA&#8217;s authorization to initiate clinical
            trials under future INDs, completing ongoing preclinical studies of Cend&#8217;s other product candidates, and initiating Cend&#8217;s planned preclinical studies and clinical trials. Additionally, Cend cannot be certain that non-clinical studies or
            clinical trials for its product candidates will begin on time, not require redesign, enroll an adequate number of subjects on time, or be completed on schedule, if at all. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Clinical trials can be delayed or terminated for a variety of reasons, including
            delays or failures related to:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation of Cend&#8217;s clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA or comparable foreign regulatory authorities disagreeing with Cend&#8217;s tumor-agnostic development strategy;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays in obtaining regulatory approval to commence a clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be subject to
                    extensive negotiation and may vary significantly among different CROs and clinical trial sites;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining IRB approval at each clinical trial site;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">recruiting an adequate number of suitable patients to participate in a clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of patients required for clinical trials of Cend&#8217;s product candidates may be larger than it anticipates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">having subjects complete a clinical trial or return for post-treatment follow-up;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">clinical trial sites deviating from clinical trial protocol or dropping out of a clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">addressing subject safety concerns that arise during the course of a clinical trial;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">adding a sufficient number of clinical trial sites; or</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining sufficient product supply of product candidate for use in non-clinical studies or clinical trials from third-party
                    suppliers.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may experience numerous adverse or unforeseen events during, or as a result of,
            preclinical studies and clinical trials that could delay or prevent Cend&#8217;s ability to receive marketing approval or commercialize Cend&#8217;s product candidates, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend may receive feedback from regulatory authorities that requires it to modify the design of its clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">clinical trials of Cend&#8217;s product candidates may produce negative or inconclusive results, and Cend may decide, or regulators
                    may require it, to conduct additional clinical trials or abandon its research efforts for its other product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">clinical trials of Cend&#8217;s product candidates may not produce differentiated or clinically significant results across tumor types
                    or indications;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the number of patients required for clinical trials of Cend&#8217;s product candidates may be larger than it anticipates, enrollment
                    in these clinical trials may be slower than it anticipates or participants may drop out of its clinical trials at a higher rate than it anticipates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s third-party contractors may fail to comply with regulatory requirements, fail to maintain adequate quality controls or be
                    unable to provide it with sufficient product supply to conduct and complete preclinical studies or clinical trials of Cend&#8217;s product candidates in a timely manner, or at all;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend or its investigators might have to suspend or terminate clinical trials of Cend&#8217;s product candidates for various reasons,
                    including non-compliance with regulatory requirements, a finding that Cend&#8217;s product candidates have undesirable side effects or other unexpected characteristics or a finding that the participants are being exposed to unacceptable
                    health risks;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">76<br />
        </div>

      </div>

    </div>

    <!--End Page 85-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 86-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg51"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the cost of clinical trials of Cend&#8217;s product candidates may be greater than it anticipates, for example, if it experiences
                    delays or challenges in identifying patients with the mutations required for its clinical trials, it may have to reimburse sites for genetic sequencing costs in order to encourage sequencing of additional patients;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the quality of Cend&#8217;s product candidates or other materials necessary to conduct preclinical studies or clinical trials of
                    Cend&#8217;s product candidates may be insufficient or inadequate, and any transfer of manufacturing activities may require unforeseen manufacturing or formulation changes;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulators may revise the requirements for approving Cend&#8217;s product candidates, or such requirements may not be as it
                    anticipates; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">future collaborators may conduct clinical trials in ways they view as advantageous to them but that are suboptimal for Cend.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend is required to conduct additional clinical trials or other testing of Cend&#8217;s
            product candidates beyond those that it currently contemplates, if Cend is unable to successfully complete clinical trials of Cend&#8217;s product candidates or other testing, if the results of these trials or tests are not positive or are only
            moderately positive or if there are safety concerns, Cend&#8217;s business and results of operations may be adversely affected and it may incur significant additional costs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend could also encounter delays if a clinical trial is suspended or terminated by it,
            by the IRBs of the institutions in which such clinical trials are being conducted, by the Data Safety Monitoring Board, if any, for such clinical trial or by the FDA or other regulatory authorities. Such authorities may suspend or terminate a
            clinical trial due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or Cend&#8217;s clinical trial protocols, inspection of the clinical trial operations or trial site by the FDA or
            other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from the product candidates, changes in governmental regulations or administrative
            actions or lack of adequate funding to continue the clinical trial.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Moreover, principal investigators for Cend&#8217;s future clinical trials may serve as
            scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, Cend may be required to report some of these relationships to the FDA or comparable foreign
            regulatory authorities. The FDA or comparable foreign regulatory authority may conclude that a financial relationship between Cend and a principal investigator has created a conflict of interest or otherwise affected interpretation of the
            study. The FDA or comparable foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a
            delay in approval, or rejection, of Cend&#8217;s marketing applications by the FDA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of one or more of Cend&#8217;s product
            candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend experiences delays in the completion, or termination, of any preclinical study
            or clinical trial of Cend&#8217;s product candidates, the commercial prospects of Cend&#8217;s product candidates may be harmed, and Cend&#8217;s ability to generate revenues from any of these product candidates will be delayed or not realized at all. In
            addition, any delays in completing Cend&#8217;s preclinical studies or clinical trials may increase its costs, slow down its product candidate development and approval process and jeopardize its ability to commence product sales and generate
            revenues. Any of these occurrences may significantly harm Cend&#8217;s business, financial condition and prospects. In addition, many of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also
            ultimately lead to the denial of regulatory approval of Cend&#8217;s product candidates. If one or more of Cend&#8217;s product candidates generally prove to be ineffective, unsafe or commercially unviable, Cend&#8217;s entire pipeline could have little, if any,
            value, which would have a material and adverse effect on Cend&#8217;s business, financial condition, results of operations and prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend and its partners are conducting clinical
            trials for product candidates outside the United States, and the FDA and comparable foreign regulatory authorities may not accept data from such trials.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may in the future choose to conduct one or more clinical trials outside the United
            States, including in Australia or Europe. The acceptance of study data from clinical trials conducted outside the United States or another jurisdiction by the FDA or comparable foreign regulatory authority may be subject to certain conditions
            or may not be accepted at all. In cases where data from foreign clinical trials are intended to serve as the basis </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">77<br />
        </div>

      </div>

    </div>

    <!--End Page 86-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 87-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg52"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">for marketing approval in the United States, the FDA will generally not approve the
            application on the basis of foreign data alone unless (i)&#160;the data are applicable to the U.S. population and U.S. medical practice; and (ii)&#160;the trials were performed by clinical investigators of recognized competence and pursuant to GCP
            regulations. Additionally, the FDA&#8217;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory authorities have similar approval requirements. In addition, such
            foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA or any comparable foreign regulatory authority will accept data from trials
            conducted outside of the United States or the applicable jurisdiction. If the FDA or any comparable foreign regulatory authority does not accept such data, it would result in the need for additional trials, which could be costly and
            time-consuming, and which may result in product candidates that Cend may develop not receiving approval for commercialization in the applicable jurisdiction.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to the COVID-19 pandemic</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Business or economic disruptions or global
            health concerns could seriously harm Cend&#8217;s development efforts and increase its costs and expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Broad-based business or economic disruptions could adversely affect Cend&#8217;s ongoing or
            planned research and development activities. For example, in December 2019, an outbreak of a novel strain of a virus named SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), or coronavirus, which causes coronavirus disease (COVID-19)
            was reported to have surfaced in Wuhan, China, and has since spread to other regions and countries worldwide. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. Almost all U.S. states and many local
            jurisdictions issued &#8220;shelter-in-place&#8221; orders, quarantines, executive orders and similar government orders, restrictions, and recommendations for their residents to control the spread of COVID-19. Such orders, restrictions and recommendations,
            and the perception that additional orders, restrictions or recommendations could occur, resulted in widespread closures of businesses not deemed &#8220;essential,&#8221; work stoppages, slowdowns and delays, work-from-home policies, travel restrictions and
            cancellation of events, as well as volatility in stock prices, among other effects. There is a risk that government actions will not be effective at containing such infectious diseases, and that government actions will have a negative impact on
            the world economy at large, in which case the risks to Cend&#8217;s operating results and financial condition described herein would be elevated significantly.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The continued spread of COVID-19 or other global health matters, has impacted and may
            continue to impact Cend&#8217;s target patient populations as well as the hospitals and clinical sites in which Cend conducts any of its clinical trials, which could lead to delays in completing enrollment of Cend&#8217;s clinical trials. For instance, the
            COVID-19 outbreak may continue to impair Cend&#8217;s ability to recruit and retain patients and engage principal investigators and site staff who, as healthcare providers, may have heightened exposure to COVID-19 if an outbreak occurs in their
            geography or due to prioritization of hospital resources toward the outbreak and restrictions on travel. Furthermore, some patients may be unwilling to enroll in Cend&#8217;s trials or be unable to comply with clinical trial protocols if quarantines
            or travel restrictions impede patient movement or interrupt healthcare services. COVID-19 already has affected and may further negatively affect the operations of third party contract research organizations that Cend relies upon to carry out
            its discovery work, clinical trials or the operations of its third party manufacturers, which could result in delays or disruptions in the supply of Cend&#8217;s product candidates and the conduct of experiments and studies. Any negative impact
            COVID-19 has to patient enrollment or treatment or the timing and execution of Cend&#8217;s preclinical studies or clinical trials could cause costly delays to Cend&#8217;s development programs, which could adversely affect Cend&#8217;s ability to obtain
            regulatory approval for and to commercialize Cend&#8217;s product candidates, increase Cend&#8217;s operating expenses and have a material adverse effect on Cend&#8217;s business and financial results. COVID-19 has also caused, and may continue to cause for an
            extended period, volatility in the global financial markets and threatened a slowdown in the global economy, which would reduce Cend&#8217;s ability to access capital and could negatively affect its liquidity.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Although states have, in the past, implemented &#8220;shelter-in-place&#8221; orders, quarantines
            and similar restrictions, the regulations vary on a state by state basis and the effectiveness of those restrictions on controlling the spread of COVID-19 varies. Cend&#8217;s office-based employees continue to work primarily from hybrid and Cend
            expects this to continue for an extended period. Furthermore, resurgence of COVID-19 cases could possibly prompt a reinstatement of certain &#8220;shelter-in-place&#8221; orders and restrictions at the state and local levels, impacting Cend&#8217;s reentry to
            the workplace and causing hospital and clinical sites to suspend Cend&#8217;s clinical trials or deterring patients from continuing to participate in Cend&#8217;s trials.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">78<br />
        </div>

      </div>

    </div>

    <!--End Page 87-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 88-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg53"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to manufacturing and supply</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend will rely on third parties to manufacture
            its clinical product supplies, and it may rely on third parties to produce and process its product candidates, if approved.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend does not currently own any facility that may be used as its clinical scale
            manufacturing facility and expects to rely on outside vendors to manufacture supplies of its product candidates. Cend will need to negotiate and maintain contractual arrangements with these outside vendors for the supply of its product
            candidates and Cend may not be able to do so on favorable terms. Cend has not yet caused any product candidates to be manufactured on a commercial scale and may not be able to do so for any of its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The facilities used by Cend&#8217;s contract manufacturers to manufacture its product
            candidates must be approved by the FDA or other foreign regulatory authorities following inspections that will be conducted after Cend submits an application to the FDA or other foreign regulatory authorities. Cend may not control the
            manufacturing process of, and may be completely dependent on, Cend&#8217;s contract manufacturing partners for compliance with cGMPs and any other regulatory requirements of the FDA or other regulatory authorities for the manufacture of its product
            candidates. Beyond periodic audits, Cend has no control over the ability of its contract manufacturers to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority does
            not approve these facilities for the manufacture of Cend&#8217;s product candidates or if it withdraws any approval in the future, Cend may need to find alternative manufacturing facilities, which would require the incurrence of significant
            additional costs and significantly impact its ability to develop, obtain regulatory approval for or market its product candidates, if approved. Similarly, if any third-party manufacturers on which Cend will rely fail to manufacture quantities
            of its product candidates at quality levels necessary to meet regulatory requirements and at a scale sufficient to meet anticipated demand at a cost that allows Cend to achieve profitability, Cend&#8217;s business, financial condition and prospects
            could be materially and adversely affected.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Manufacturing Cend&#8217;s product candidates is
            complex and it may encounter difficulties in production. If Cend encounters such difficulties, its ability to provide supply of its product candidates for preclinical studies and clinical trials or for commercial purposes could be delayed or
            stopped.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">The process of manufacturing of Cend&#8217;s product candidates is complex and highly
            regulated.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend relies on third parties for the manufacture of its product candidates. These
            third-party manufacturers may incorporate their own proprietary processes into Cend&#8217;s product candidate manufacturing processes. Cend has limited control and oversight of a third party&#8217;s proprietary process, and a third party may elect to
            modify its process without Cend&#8217;s consent or knowledge. These modifications could negatively impact Cend&#8217;s manufacturing, including product loss or failure that requires additional manufacturing runs or a change in manufacturer, both of which
            could significantly increase the cost of and significantly delay the manufacture of Cend&#8217;s product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As Cend&#8217;s product candidates progress through preclinical studies and clinical trials
            toward approval and commercialization, it is expected that various aspects of the manufacturing process will be altered in an effort to optimize processes and results. Such changes may require amendments to be made to regulatory applications
            which may further delay the timeframes under which modified manufacturing processes can be used for any of Cend&#8217;s product candidates and additional bridging studies or trials may be required.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend does not have its own clinical-scale manufacturing facility and is currently
            reliant on a limited number of manufacturers for its product candidates. These third-party manufacturing providers may not be able to provide adequate resources or capacity to meet Cend&#8217;s needs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to sales, marketing, and competition</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend currently has no marketing and sales
            organization and has no experience in marketing products. If Cend is unable to establish marketing and sales capabilities or enter into agreements with third parties to market and sell its product candidates, if approved, it may not be able to
            generate product revenue.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend currently has no sales, marketing or distribution capabilities and has no
            experience in marketing products. Cend intends to develop an in-house marketing organization and sales force, which will require significant capital expenditures, management resources and time. Cend will have to compete with other
            pharmaceutical and biotechnology companies to recruit, hire, train and retain marketing and sales personnel.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">79<br />
        </div>

      </div>

    </div>

    <!--End Page 88-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 89-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg54"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend is unable or decides not to establish internal sales, marketing and
            distribution capabilities, it will pursue arrangements with third-party sales, marketing, and distribution collaborators regarding the sales and marketing of its products, if approved. However, there can be no assurance that Cend will be able
            to establish or maintain such arrangements on favorable terms or if at all, or if Cend is able to do so, that these third-party arrangements will provide effective sales forces or marketing and distribution capabilities. Any revenue Cend
            receives will depend upon the efforts of such third parties, which may not be successful. Cend may have little or no control over the marketing and sales efforts of such third parties and its revenue from product sales may be lower than if Cend
            had commercialized its product candidates itself. Cend also faces competition in its search for third parties to assist it with the sales and marketing efforts of its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There can be no assurance that Cend will be able to develop in-house sales and
            distribution capabilities or establish or maintain relationships with third-party collaborators to commercialize any product in the United States or overseas.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">A variety of risks associated with marketing
            Cend&#8217;s product candidates internationally could materially adversely affect its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend and its partners plan to seek regulatory approval of Cend&#8217;s product candidates
            outside of the United States and, accordingly, Cend expects that it will be subject to additional risks related to operating in foreign countries if it obtains the necessary approvals, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">differing regulatory requirements in foreign countries, for example, no country other than the United States has a pathway for
                    accelerated drug approval and so obtaining regulatory approvals outside of the United States will take longer and be more costly than obtaining approval in the United States;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">unexpected changes in tariffs, trade barriers, price and exchange controls and other regulatory requirements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">economic weakness, including inflation, or political instability in particular foreign economies and markets;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">foreign taxes, including withholding of payroll taxes;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations
                    incident to doing business in another country;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">difficulties staffing and managing foreign operations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">workforce uncertainty in countries where labor unrest is more common than in the United States;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential liability under the Foreign Corrupt Practices Act of 1977 or comparable foreign regulations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">challenges enforcing Cend&#8217;s contractual and intellectual property rights, especially in those foreign countries that do not
                    respect and protect intellectual property rights to the same extent as the United States;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">business interruptions resulting from geo-political actions, including war and terrorism.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">These and other risks associated with international operations may materially adversely
            affect Cend&#8217;s ability to attain or maintain profitable operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Even if Cend obtains regulatory approval of its
            product candidates, the products may not gain market acceptance among physicians, patients, hospitals, cancer treatment centers and others in the medical community.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The use of Cend&#8217;s product candidates as a potential cancer treatment is a recent
            development and may not become broadly accepted by physicians, patients, hospitals, cancer treatment centers and others in the medical community. Various factors will influence whether Cend&#8217;s product candidates are accepted in the market,
            including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the clinical indications for which Cend&#8217;s product candidates are licensed;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">80<br />
        </div>

      </div>

    </div>

    <!--End Page 89-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 90-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg55"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">physicians, hospitals, cancer treatment centers and patients considering Cend&#8217;s product candidates as a safe and effective
                    treatment;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the potential and perceived advantages of Cend&#8217;s product candidates over alternative treatments;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s ability to demonstrate the advantages of its product candidates over other cancer medicines;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the prevalence and severity of any side effects;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the prevalence and severity of any side effects for other precision medicines and public perception of other precision
                    medicines;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">product labeling or product insert requirements of the FDA or other regulatory authorities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">limitations or warnings contained in the labeling approved by the FDA;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing of market introduction of Cend&#8217;s product candidates as well as competitive products;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the cost of treatment in relation to alternative treatments;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the availability of adequate coverage, reimbursement and pricing by third-party payors and government authorities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the willingness of patients to pay out-of-pocket in the absence of coverage by third-party payors and government authorities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">relative convenience and ease of administration, including as compared to alternative treatments and competitive therapies; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the effectiveness of Cend&#8217;s sales and marketing efforts.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend&#8217;s product candidates are licensed but fail to achieve market acceptance among
            physicians, patients, hospitals, cancer treatment centers or others in the medical community, Cend will not be able to generate significant revenue.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, although Cend&#8217;s product candidates differ in certain ways from other
            approaches, serious adverse events or deaths in other clinical trials involving precision medicines, even if not ultimately attributable to Cend&#8217;s product or product candidates, could result in increased government regulation, unfavorable
            public perception and publicity, potential regulatory delays in the testing or licensing of Cend&#8217;s product candidates, stricter labeling requirements for those product candidates that are licensed, and a decrease in demand for any such product
            candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even if Cend&#8217;s products achieve market acceptance, it may not be able to maintain that
            market acceptance over time if new products or technologies are introduced that are more favorably received than its products, are more cost effective or render its products obsolete.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="frisk">Cend faces substantial competition, which may
            result in others discovering, developing or commercializing products before or more successfully than it does.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The biotechnology and pharmaceutical industries utilize rapidly advancing technologies
            and are characterized by intense competition. While Cend believes that its scientific knowledge, technology and development expertise provide it with competitive advantages, it faces potential competition from many different sources, including
            major pharmaceuticals, specialty pharmaceuticals and biotechnology companies, academic institutions and government agencies, and public and private research institutes that conduct research, development, manufacturing and commercialization.
            Many of Cend&#8217;s competitors have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, regulatory approvals and product marketing than it does. Cend&#8217;s competitors may compete
            with it in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for,
            Cend&#8217;s programs. As a result, Cend&#8217;s competitors may discover, develop, license or commercialize products before or more successfully than it does.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Product candidates that Cend successfully develops and commercializes may compete with
            existing therapies and new therapies that may become available in the future. Specifically, other EnduRx and potentially other companies are conducting pre-clinical research with an alternative integrin-targeted peptides.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">81<br />
        </div>

      </div>

    </div>

    <!--End Page 90-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 91-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg56"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend&#8217;s drug candidates are approved for the indications for which Cend is
            currently planning clinical trials, they will likely compete with existing drugs and other drugs that are currently in development. Key product features that would affect Cend&#8217;s ability to effectively compete with other therapeutics include the
            efficacy, safety and convenience of its products. Cend&#8217;s competitors may obtain patent protection or other intellectual property rights that limit its ability to develop or commercialize its product candidates. The availability of reimbursement
            from government and other third-party payors will also significantly affect the pricing and competitiveness of Cend&#8217;s products. Cend&#8217;s competitors may also obtain FDA or other regulatory approval for their products more rapidly than Cend may
            obtain approval for its products, which could result in Cend&#8217;s competitors establishing a strong market position before Cend is able to enter the market. For additional information regarding Cend&#8217;s competition, see &#8220;<span style="font-style: italic;">Business&#8212;Competition</span>.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to Cend&#8217;s financial position and capital requirements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend&#8217;s limited operating history may make it
            difficult for you to evaluate the success of Cend&#8217;s business to date and to assess Cend&#8217;s future viability.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend is a drug discovery and development company with a limited operating history. Cend
            commenced operations in October 2015, and its operations to date have been limited to organizing and staffing its company, business planning, raising capital, conducting discovery and research activities, filing patent applications, identifying
            potential product candidates, undertaking preclinical studies and establishing arrangements with third parties for the manufacture of initial quantities of its product candidates and component materials. CEND-1 is currently the subject of Phase
            2b clinical studies. Cend has not fully demonstrated its ability to successfully conduct or complete clinical trials, obtain marketing approvals, manufacture a commercial-scale product or arrange for a third party to do so on its behalf, or
            conduct sales, marketing and distribution activities necessary for successful product commercialization. Consequently, any predictions you make about Cend&#8217;s future success or viability may not be as accurate as they could be if Cend had a
            longer operating history.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, as a young business, Cend may encounter unforeseen expenses, difficulties,
            complications, delays and other known and unknown factors. Cend will need to transition at some point from a company with a research and development focus to a company capable of supporting commercial activities. Cend may not be successful in
            such a transition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="frisk">Cend has incurred significant losses since
            inception, and it expects to incur losses over the next several years and may not be able to achieve or sustain revenues or profitability in the future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Investment in pharmaceutical product development is a highly speculative undertaking
            and entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate efficacy or an acceptable safety profile, gain regulatory approval and become commercially viable.
            Cend is still in the early stages of development of its product candidates. CEND-1 is currently the subject of clinical Phase 2b studies. Cend has no products approved for commercial sale and has not generated any revenue from product sales to
            date, and Cend continues to incur significant research and development and other expenses related to its ongoing operations. Cend has financed its operations primarily through private placements of its preferred stock and its one outbound
            license relationship. There can be no assurance Cend will be successful at future fund-raising efforts. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has incurred significant net losses in each period since it commenced operations,
            aside from the year ended December&#160;31, 2021, as a result of a one-time license payment and a milestone payment from the Exclusive License and Collaboration Agreement with Qilu. For the years ended December&#160;31, 2020 and 2021, Cend reported a net
            loss of $8.7&#160;million and $3.7&#160;million, respectively. As of December&#160;31, 2021, Cend had an accumulated deficit of $10.2&#160;million. Cend expects to continue to incur significant losses for the foreseeable future, and it expects these losses to
            increase substantially if and as it:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">continues its research and development efforts and submits INDs for its lead product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">conducts preclinical studies and clinical trials for its current and future product candidates </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">seeks marketing approvals for any product candidates that successfully complete clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">experiences any delays or encounter any issues with any of the above, including but not limited to failed studies, complex
                    results, safety issues or other regulatory challenges;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">82<br />
        </div>

      </div>

    </div>

    <!--End Page 91-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 92-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg57"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establishes a sales, marketing and distribution infrastructure and scale-up manufacturing capabilities, whether alone or with
                    third parties, to commercialize any product candidates for which it may obtain regulatory approval, if any;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtains, expands, maintains, enforces and protects its intellectual property portfolio; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">hires additional clinical, regulatory and scientific personnel.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Because of the numerous risks and uncertainties associated with pharmaceutical product
            development, Cend is unable to accurately predict the timing or amount of increased expenses it will incur or when, if ever, it will be able to achieve profitability. Even if Cend succeeds in commercializing one or more of its product
            candidates, Cend will continue to incur substantial research and development and other expenditures to develop, seek regulatory approval for and market additional product candidates. Cend may encounter unforeseen expenses, difficulties,
            complications, delays and other unknown factors that may adversely affect its business. The size of Cend&#8217;s future net losses will depend, in part, on the rate of future growth of its expenses and its ability to generate revenue. Cend&#8217;s prior
            losses and expected future losses have had and will continue to have an adverse effect on its stockholders&#8217; equity and working capital.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to government regulation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend&#8217;s clinical trials may fail to demonstrate
            adequately the safety and efficacy of any of its product candidates, which would prevent or delay regulatory approval and commercialization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To obtain the requisite regulatory approvals to market and sell any of its product
            candidates, including CEND-1 and any other future product candidates, Cend must demonstrate through extensive preclinical studies and clinical trials that its products are safe and effective in humans. Cend&#8217;s product candidates may fail to
            demonstrate efficacy in humans, and particularly across tumor types. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process and
            Cend&#8217;s future clinical trial results may not be successful. Further, the process of obtaining regulatory approval is expensive, often takes many years following the commencement of clinical trials and can vary substantially based upon the type,
            complexity and novelty of the product candidates involved, as well as the target indications, patient population and regulatory agency. Prior to obtaining approval to commercialize a product candidate in the United States or abroad, Cend or its
            potential future collaborators must demonstrate with substantial evidence from adequate and well-controlled clinical trials, and to the satisfaction of the FDA, the European Medicines Agency (&#8220;EMA&#8221;) or other comparable foreign regulatory
            authorities, that such product candidates are safe and effective for their intended uses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Clinical trials that Cend conducts may not demonstrate the efficacy and safety
            necessary to obtain regulatory approval to market Cend&#8217;s product candidates. In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same product candidate due to numerous
            factors, including changes in trial procedures set forth in protocols, differences in the size and type of the patient populations, changes in and adherence to the clinical trial protocols and the rate of dropout among clinical trial
            participants. If the results of Cend&#8217;s ongoing or future clinical trials are inconclusive with respect to the efficacy of Cend&#8217;s product candidates, if Cend does not meet the clinical endpoints with statistical and clinically meaningful
            significance, or if there are safety concerns associated with Cend&#8217;s product candidates, Cend may be delayed in obtaining marketing approval, if at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even if the trials are successfully completed, clinical data are often susceptible to
            varying interpretations and analyses, and Cend cannot guarantee that the FDA, or other comparable foreign regulatory authorities will interpret the results as Cend does, and more trials could be required before Cend submits its product
            candidates for approval. Cend cannot guarantee that the FDA, or other comparable foreign regulatory authorities will view its product candidates as having sufficient efficacy to support a tumor-agnostic indication even if positive results are
            observed in clinical trials. To the extent that the results of the trials are not satisfactory to the FDA, the EMA or other comparable foreign regulatory authorities for support of a marketing application, approval of Cend&#8217;s product candidates
            may be significantly delayed, or Cend may be required to expend significant additional resources, which may not be available to Cend, to conduct additional trials in support of potential approval of Cend&#8217;s product candidates. Additionally, any
            safety or efficacy concerns observed in any tumor-specific subgroup of Cend&#8217;s clinical trials could limit the prospects for regulatory approval of its product candidates for a tumor-agnostic indication, which could have a material adverse
            effect on Cend&#8217;s business, financial condition and results of operations.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">83<br />
        </div>

      </div>

    </div>

    <!--End Page 92-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 93-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg58"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">A Breakthrough Therapy designation by the
            FDA, even if granted for any of Cend&#8217;s product candidates, may not lead to a faster development or regulatory review or approval process and it does not increase the likelihood that Cend&#8217;s product candidates will receive marketing approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may seek Breakthrough Therapy designation for CEND-1 and some or all of its future
            product candidates. A breakthrough therapy is defined as a drug or biologic that is intended, alone or in combination with one or more other drugs or biologics, to treat a serious or life-threatening disease or condition and preliminary
            clinical evidence indicates that the drug or biologic may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development.
            For product candidates that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the
            number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA may also be eligible for other expedited approval programs, including accelerated approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly,
            even if Cend believes one of its product candidates meets the criteria for designation as a breakthrough therapy, the FDA may disagree and instead determine not to make such designation. In any event, the receipt of a Breakthrough Therapy
            designation for a product candidate may not result in a faster development process, review or approval compared to candidate products considered for approval under non-expedited FDA review procedures and does not assure ultimate approval by the
            FDA. In addition, even if one or more of Cend&#8217;s product candidates qualify as breakthrough therapies, the FDA may later decide that the product no longer meets the conditions for qualification. Thus, even though Cend intends to seek
            Breakthrough Therapy designation for CEND-1 and some or all of its future product candidates for the treatment of various cancers, there can be no assurance that it will receive breakthrough therapy designation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">A Fast Track designation by the FDA may not
            lead to a faster development or regulatory review or approval process, and does not increase the likelihood that Cend&#8217;s product candidates will receive marketing approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If a drug is intended for the treatment of a serious or life-threatening condition and
            the drug demonstrates the potential to address unmet medical needs for this condition, the drug sponsor may apply for FDA Fast Track designation for a particular indication. Cend has been granted Fast Track designation for CEND-1 for pancreatic
            cancer. Cend may seek Fast Track designation for other indications or for certain of Cend&#8217;s future product candidates, but there is no assurance that the FDA will grant this status to any of Cend&#8217;s other proposed product candidates. Marketing
            applications filed by sponsors of products in Fast Track development may qualify for priority review under the policies and procedures offered by the FDA, but the Fast Track designation does not assure any such qualification or ultimate
            marketing approval by the FDA. The FDA has broad discretion whether or not to grant Fast Track designation, so even if Cend believes a particular product candidate is eligible for this designation, there can be no assurance that the FDA would
            decide to grant it. Even if Cend does receive Fast Track designation, it may not experience a faster development process, review or approval compared to conventional FDA procedures, and receiving a Fast Track designation does not provide
            assurance of ultimate FDA approval. In addition, the FDA may withdraw Fast Track designation if it believes that the designation is no longer supported by data from Cend&#8217;s clinical development program. In addition, the FDA may withdraw any Fast
            Track designation at any time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Accelerated approval by the FDA, even if
            granted for CEND-1 or any other future product candidates, may not lead to a faster development or regulatory review or approval process and it does not increase the likelihood that Cend&#8217;s product candidates will receive marketing approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend plans to seek approval of CEND-1 and may seek approval of future product
            candidates using the FDA&#8217;s accelerated approval pathway. A product may be eligible for accelerated approval if it treats a serious or life-threatening condition and generally provides a meaningful advantage over available therapies. In
            addition, it must demonstrate an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit. As a condition of approval, the FDA may require that a sponsor of a drug receiving accelerated approval perform adequate and
            well-controlled post-marketing clinical trials. These confirmatory trials must be completed with due diligence. In addition, the FDA currently requires as a condition for accelerated approval pre-approval of promotional materials, which could
            adversely impact the timing of the commercial launch of the product. Even if Cend does receive accelerated approval, it may not experience a faster development or regulatory review or approval process, and receiving accelerated approval does
            not provide assurance of ultimate full FDA approval.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">84<br />
        </div>

      </div>

    </div>

    <!--End Page 93-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 94-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg59"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Obtaining and maintaining regulatory approval
            of Cend&#8217;s product candidates in one jurisdiction does not mean that it will be successful in obtaining regulatory approval of its product candidates in other jurisdictions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Obtaining and maintaining regulatory approval of Cend&#8217;s product candidates in one
            jurisdiction does not guarantee that it will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative effect on the regulatory
            approval process in others. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and promotion of the product
            candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, including additional non-clinical studies or
            clinical trials as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement
            before it can be approved for sale in that jurisdiction. In some cases, the price that Cend intends to charge for its products is also subject to approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may also submit marketing applications in other countries. Regulatory authorities
            in jurisdictions outside of the United States have requirements for approval of product candidates with which Cend must comply prior to marketing in those jurisdictions. Obtaining foreign regulatory approvals and compliance with foreign
            regulatory requirements could result in significant delays, difficulties and costs for Cend and could delay or prevent the introduction of its products in certain countries. If Cend fails to comply with the regulatory requirements in
            international markets and/or receive applicable marketing approvals, its target market will be reduced and its ability to realize the full market potential of its product candidates will be harmed. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to ongoing regulatory obligations</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Even if Cend receives regulatory approval of its
            product candidates, it will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and Cend may be subject to penalties if it fails to comply with regulatory requirements
            or experience unanticipated problems with its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any regulatory approvals that Cend receives for its product candidates will require
            surveillance to monitor the safety and efficacy of the product candidate. The FDA may also require a REMS in order to approve Cend&#8217;s product candidates, which could entail requirements for a medication guide, physician communication plans or
            additional elements to ensure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. In addition, if the FDA or a comparable foreign regulatory authority approves Cend&#8217;s product candidates, the
            manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion, import, export and recordkeeping for Cend&#8217;s product candidates will be subject to extensive and ongoing regulatory
            requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with applicable cGMP, GLP and GCP requirements, for any clinical trials that Cend
            conducts post-approval. Later discovery of previously unknown problems with Cend&#8217;s product candidates, including adverse events of unanticipated severity or frequency, or with Cend&#8217;s third-party manufacturers or manufacturing processes, or
            failure to comply with regulatory requirements, may result in, among other things:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">restrictions on the marketing or manufacturing of Cend&#8217;s product candidates, withdrawal of the product from the market or
                    voluntary or mandatory product recalls;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">manufacturing delays and supply disruptions where regulatory inspections identify observations of noncompliance requiring
                    remediation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">revisions to the labeling, including limitation on approved uses or the addition of additional warnings, contraindications or
                    other safety information, including boxed warnings;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">imposition of a REMS, which may include distribution or use restrictions;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">requirements to conduct additional post-market clinical trials to assess the safety of the product;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fines, warning letters or holds on clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">refusal by the FDA to approve pending applications or supplements to approved applications filed by Cend or suspension or
                    revocation of approvals;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">85<br />
        </div>

      </div>

    </div>

    <!--End Page 94-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 95-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg60"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">product seizure or detention, or refusal to permit the import or export of Cend&#8217;s product candidates; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">injunctions or the imposition of civil or criminal penalties.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional
            government regulations may be enacted that could prevent, limit or delay regulatory approval of Cend&#8217;s product candidates. Cend cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or
            administrative action, either in the United States or abroad. If Cend is slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if Cend is not able to maintain regulatory compliance, it
            may lose any marketing approval that it may have obtained and it may not achieve or sustain profitability.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The FDA and other regulatory agencies actively
            enforce the laws and regulations prohibiting the promotion of off-label uses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If any of Cend&#8217;s product candidates are approved and Cend is found to have improperly
            promoted off-label uses of those products, it may become subject to significant liability. The FDA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription products, if approved. In particular,
            while the FDA permits the dissemination of truthful and non-misleading information about an approved product, a manufacturer may not promote a product for uses that are not approved by the FDA or such other regulatory agencies as reflected in
            the product&#8217;s approved labeling. If Cend is found to have promoted such off-label uses, it may become subject to significant liability. The federal government has levied large civil and criminal fines against companies for alleged improper
            promotion of off-label use and has enjoined several companies from engaging in off-label promotion. The FDA has also requested that companies enter into consent decrees, corporate integrity agreements or permanent injunctions under which
            specified promotional conduct must be changed or curtailed. If Cend cannot successfully manage the promotion of its product candidates, if approved, Cend could become subject to significant liability, which would materially adversely affect its
            business and financial condition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The insurance coverage and reimbursement status
            of newly-approved products is uncertain. Cend&#8217;s product candidates may become subject to unfavorable pricing regulations, third-party coverage and reimbursement practices, or healthcare reform initiatives, which would harm Cend&#8217;s business.
            Failure to obtain or maintain adequate coverage and reimbursement for new or current products could limit Cend&#8217;s ability to market those products and decrease its ability to generate revenue.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The regulations that govern marketing approvals, pricing, coverage and reimbursement
            for new drugs vary widely from country to country. In the United States, recently enacted legislation may significantly change the approval requirements in ways that could involve additional costs and cause delays in obtaining approvals. Some
            countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical
            pricing remains subject to continuing governmental control even after initial approval is granted. As a result, Cend might obtain marketing approval for a product in a particular country, but then be subject to price regulations that delay its
            commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenue it is able to generate from the sale of the product in that country. Adverse pricing limitations may hinder Cend&#8217;s ability to recoup its
            investment in one or more product candidates, even if any product candidates it may develop obtain marketing approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the United States and markets in other countries, patients generally rely on
            third-party payors to reimburse all or part of the costs associated with their treatment. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid, and commercial payors is critical to new product
            acceptance. Cend&#8217;s ability to successfully commercialize its product candidates will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from government health
            administration authorities, private health insurers and other organizations. Government authorities and other third-party payors, such as private health insurers and health maintenance organizations, decide which medications they will pay for
            and establish reimbursement levels. The availability of coverage and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford treatments such as gene therapy products. Sales of these or
            other product candidates that Cend may identify will depend substantially, both domestically and abroad, on the extent to which the costs of Cend&#8217;s product candidates </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">86<br />
        </div>

      </div>

    </div>

    <!--End Page 95-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 96-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg61"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">will be paid by health maintenance, managed care, pharmacy benefit and similar
            healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. If coverage and adequate reimbursement is not available, or is available only to
            limited levels, Cend may not be able to successfully commercialize its product candidates. Even if coverage is provided, the approved reimbursement amount may not be high enough to allow Cend to establish or maintain pricing sufficient to
            realize a sufficient return on its investment.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Reimbursement by a third-party payor may depend upon a number of factors, including,
            but not limited to, the third-party payor&#8217;s determination that use of a product is:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a covered benefit under its health plan;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">safe, effective and medically necessary;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">appropriate for the specific patient;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">cost-effective; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">neither experimental nor investigational.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A primary trend in the U.S. healthcare industry and elsewhere is cost containment.
            Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. In many countries, the prices of medical products are subject to varying price
            control mechanisms as part of national health systems. In general, the prices of medicines under such systems are substantially lower than in the United States. Other countries allow companies to fix their own prices for medicines, but monitor
            and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that Cend is able to charge for its product candidates. Accordingly, in markets outside the United States, the
            reimbursement for products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenues and profits.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There is also significant uncertainty related to the insurance coverage and
            reimbursement of newly approved products and coverage may be more limited than the purposes for which the medicine is approved by the FDA or comparable foreign regulatory authorities. In the United States, the principal decisions about
            reimbursement for new medicines are typically made by the Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), an agency within the U.S. Department of Health and Human Services (&#8220;HHS&#8221;). CMS decides whether and to what extent a new medicine
            will be covered and reimbursed under Medicare and private payors tend to follow CMS to a substantial degree. No uniform policy of coverage and reimbursement for products exists among third-party payors and coverage and reimbursement levels for
            products can differ significantly from payor to payor. As a result, the coverage determination process is often a time consuming and costly process that may require Cend to provide scientific and clinical support for the use of its products to
            each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. It is difficult to predict what CMS will decide with respect to reimbursement for fundamentally
            novel products such as Cend&#8217;s. Reimbursement agencies in Europe may be more conservative than CMS. For example, a number of cancer drugs have been approved for reimbursement in the United States and have not been approved for reimbursement in
            certain European countries. Moreover, eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers Cend&#8217;s costs, including research, development, manufacture, sale, and distribution. Interim
            reimbursement levels for new drugs, if applicable, may also not be sufficient to cover Cend&#8217;s costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may
            be based on reimbursement levels already set for lower cost drugs and may be incorporated into existing payments for other services. Cend&#8217;s inability to promptly obtain coverage and profitable payment rates from both government-funded and
            private payors for any approved products Cend may develop could have a material adverse effect on Cend&#8217;s operating results, its ability to raise capital needed to commercialize product candidates, and its overall financial condition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Net prices for drugs may be reduced by mandatory discounts or rebates required by
            government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. Cend&#8217;s inability to promptly obtain
            coverage and profitable reimbursement rates third-party payors for any approved products that Cend develops could have a material adverse effect on its operating results, its ability to raise capital needed to commercialize products and its
            overall financial condition.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">87<br />
        </div>

      </div>

    </div>

    <!--End Page 96-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 97-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg62"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Increasingly, third-party payors are requiring that drug companies provide them with
            predetermined discounts from list prices and are challenging the prices charged for medical products. Cend cannot be sure that reimbursement will be available for any product candidate that it commercializes and, if reimbursement is available,
            the level of reimbursement. Reimbursement may impact the demand for, or the price of, any product candidate for which Cend obtains marketing approval. In order to obtain reimbursement, physicians may need to show that patients have superior
            treatment outcomes with Cend&#8217;s products compared to standard of care drugs, including lower-priced generic versions of standard of care drugs. Cend expects to experience pricing pressures in connection with the sale of any of its product
            candidates due to the trend toward managed healthcare, the increasing influence of health maintenance organizations and additional legislative changes. The downward pressure on healthcare costs in general, particularly prescription drugs and
            surgical procedures and other treatments, has become very intense. As a result, increasingly high barriers are being erected to the entry of new products.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Additionally, Cend and/or collaborators may develop companion diagnostic tests for use
            with Cend&#8217;s product candidates. Cend, or its collaborators, may be required to obtain coverage and reimbursement for these tests separate and apart from the coverage and reimbursement Cend seeks for its product candidates, once approved. Even
            if Cend obtains regulatory approval or clearance for such companion diagnostics, there is significant uncertainty regarding its ability to obtain coverage and adequate reimbursement for the same reasons applicable to its product candidates.
            Medicare reimbursement methodologies, whether under Part A, Part B, or clinical laboratory fee schedule may be amended from time to time, and Cend cannot predict what effect any change to these methodologies would have on any product candidate
            or companion diagnostic for which it receives approval. Cend&#8217;s inability to promptly obtain coverage and adequate reimbursement from both third-party payors for the companion diagnostic tests that it develops and for which it obtains regulatory
            approval could have a material and adverse effect on Cend&#8217;s business, financial condition, results of operations and prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Healthcare legislative measures aimed at
            reducing healthcare costs may have a material adverse effect on Cend&#8217;s business and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The United States and many foreign jurisdictions have enacted or proposed legislative
            and regulatory changes affecting the healthcare system that could prevent or delay marketing approval of our current product candidates and any future product candidates, restrict or regulate post-approval activities and affect our ability to
            profitably sell a product for which we obtain marketing approval. Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example, changes to our manufacturing
            arrangements, additions or modifications to product labeling, the recall or discontinuation of our products, or additional record-keeping or reporting requirements. If any such changes were to be imposed, they could adversely affect the
            operation of our business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the United States, there have been and continue to be a number of legislative
            initiatives to contain healthcare costs. For example, the Affordable Care Act substantially changed the way healthcare is financed by both governmental and private insurers, and significantly impacted the U.S. pharmaceutical industry. The ACA,
            among other things, subjected biological products to potential competition by lower-cost biosimilars, addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs and
            biologics that are inhaled, infused, instilled, implanted or injected, increased the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate Program and extended the rebate program to individuals enrolled in Medicaid
            managed care organizations, established annual fees and taxes on manufacturers of certain branded prescription drugs and biologics, and created a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 70%
            (increased from 50% pursuant to the Bipartisan Budget Act of 2018, effective as of 2019) point-of-sale discounts off negotiated prices of applicable brand drugs and biologics to eligible beneficiaries during their coverage gap period, as a
            condition for the manufacturer&#8217;s outpatient drugs or biologics to be covered under Medicare Part D.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Since its enactment, there have been judicial, executive and Congressional challenges
            to certain aspects of the ACA. On June&#160;17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme
            Court&#8217;s decision, President Biden issued an executive order to initiate a special enrollment period from February&#160;15, 2021 through August&#160;15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive
            order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, re-examining Medicaid </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">88<br />
        </div>

      </div>

    </div>

    <!--End Page 97-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 98-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg63"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">demonstration projects and waiver programs that include work requirements, and
            policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how other healthcare reform measures of the Biden administration or other efforts, if any, to challenge,
            repeal or replace the ACA will impact the ACA or our business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, other legislative changes have been proposed and adopted since the ACA was
            enacted. On August&#160;2, 2011, the Budget Control Act of 2011 was signed into law, which, among other things, resulted in reductions to Medicare payments to providers of 2% per fiscal year, which went into effect on April&#160;1, 2013 and, due to
            subsequent legislative amendments to the statute, will remain in effect through 2030, with the exception of a temporary suspension from May&#160;1, 2020 through June&#160;30, 2022 (a 1% sequester will apply from April&#160;1, 2022 through June&#160;30, 2022) due
            to the COVID-19 pandemic, unless additional Congressional action is taken. On January&#160;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, reduced Medicare payments to several providers, including
            hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. As another example, the 2021 Consolidated Appropriations Act signed into
            law on December&#160;27, 2020 incorporated extensive healthcare provisions and amendments to existing laws, including a requirement that all manufacturers of drugs and biological products covered under Medicare Part B report the product&#8217;s average
            sales price, or ASP, to HHS beginning on January&#160;1, 2022, subject to enforcement via civil money penalties.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Further, there has been heightened governmental scrutiny in the United States of
            pharmaceutical pricing practices in light of the rising cost of prescription drugs. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things,
            bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. Although a number of these and other measures may
            require additional authorization to become effective, Congress and the current U.S. administration have each indicated that it will continue to seek new legislative and/or administrative measures to control drug costs. Any reduction in
            reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. Moreover, in July 2021, President Biden issued a sweeping executive order on promoting competition in the American
            economy that includes several mandates pertaining to the pharmaceutical and health care insurance industries. Among other things, the executive order directs the FDA to work towards implementing a system for importing drugs from Canada
            (following on a Trump administration notice-and-comment rulemaking on Canadian drug importation that was finalized in October 2020). The Biden order also called on HHS to release a comprehensive plan to combat high prescription drug prices, and
            it includes several directives regarding the Federal Trade Commission&#8217;s oversight of potentially anticompetitive practices within the pharmaceutical industry. The drug pricing plan released by HHS in September 2021 in response to the executive
            order makes clear that the Biden Administration supports aggressive action to address rising drug prices, including allowing HHS to negotiate the cost of Medicare Part B and D drugs, but such significant changes will require either new
            legislation to be passed by Congress or time-consuming administrative actions. Accordingly, there remains a large amount of uncertainty regarding the federal government&#8217;s approach to making pharmaceutical treatment costs more affordable for
            patients.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the state level, legislatures have increasingly passed legislation and implemented
            regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and,
            in some cases, designed to encourage importation from other countries and bulk purchasing. For example, California requires pharmaceutical manufacturers to notify certain purchasers, including health insurers and government health plans at
            least 60 days before any scheduled increase in the wholesale acquisition cost (WAC), of their product if the increase exceeds 16%, and further requires pharmaceutical manufacturers to explain whether a change or improvement in the product
            necessitates such an increase. Similarly, Vermont requires pharmaceutical manufacturers to disclose price information on certain prescription drugs, and to provide notification to the state if introducing a new drug with a WAC in excess of the
            Medicare Part D specialty drug threshold. In December 2020, the U.S. Supreme Court also held unanimously that federal law does not preempt the states&#8217; ability to regulate pharmaceutical benefit managers, or PBMs, and other members of the
            healthcare and pharmaceutical supply chain, an important decision that may lead to further and more aggressive efforts by states in this area. Legally mandated price controls on payment amounts by third-party payors or other restrictions could
            harm our business, results of operations, financial condition and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">89<br />
        </div>

      </div>

    </div>

    <!--End Page 98-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 99-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg64"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">pharmaceutical products and which suppliers will be included in their prescription
            drug and other healthcare programs. This could reduce the ultimate demand for our product candidates, if approved, or put pressure on our product pricing, which could negatively affect our business, results of operations, financial condition
            and prospects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend expects that the ACA, the recent laws described above, and other healthcare reform
            measures that may be adopted in the future may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, new payment methodologies and additional downward pressure on the price that Cend receives
            for any approved product. Further, it is possible that additional governmental action will be taken in response to the COVID-19 pandemic. Cend cannot predict the initiatives that may be adopted in the future. The continuing efforts of the
            government, insurance companies, managed care organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the demand for our product candidates, if Cend obtains regulatory approval;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s ability to receive or set a price that it believes is fair for its products;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s ability to generate revenue and achieve or maintain profitability;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s ability to enjoy or maintain market exclusivity;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the level of taxes that Cend is required to pay; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the availability of capital.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any reduction in reimbursement from Medicare or other government programs may result in
            a similar reduction in payments from private payors, which may adversely affect Cend&#8217;s future profitability.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Inadequate funding for the FDA, the SEC and
            other government agencies could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner or otherwise prevent those agencies from
            performing normal business functions on which the operation of Cend&#8217;s business may rely, which could negatively impact Cend&#8217;s business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The ability of the FDA to review and approve new products can be affected by a variety
            of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory and policy changes. Average review times at the agency have fluctuated in recent
            years as a result. Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed and/or approved by necessary government agencies, which would adversely affect Cend&#8217;s business. In addition, government
            funding of the SEC and other government agencies on which Cend&#8217;s operations may rely, including those that fund research and development activities, is subject to the political process, which is inherently fluid and unpredictable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For example, over the last several years, including for 35 days beginning on
            December&#160;22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA and the SEC, have had to furlough critical FDA, SEC and other government employees and stop critical activities. Additionally,
            as of June&#160;23, 2020, the FDA noted it is continuing to ensure timely reviews of applications for medical products during the COVID-19 pandemic in line with its user fee performance goals; however, FDA may not be able to continue its current
            pace and approval timelines could be extended, including where a pre-approval manufacturing inspection or an inspection of clinical sites is required and due to the COVID-19 pandemic and travel restrictions FDA is unable to complete such
            required inspections during the review period. The FDA has developed a rating system to assist in determining when and where it is safest to conduct prioritized domestic inspections. Should FDA determine that an inspection is necessary for
            approval and an inspection cannot be completed during the review cycle due to restrictions on travel, FDA has stated that it generally intends to issue a complete response letter. Further, if there is inadequate information to make a
            determination on the acceptability of a facility, FDA may defer action on the application until an inspection can be completed. In 2020, several companies announced receipt of complete response letters due to the FDA&#8217;s inability to complete
            required inspections for their applications. Regulatory authorities outside the U.S. may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic and may experience delays in their regulatory activities. If a
            prolonged government shutdown occurs again, it could significantly impact the ability of the FDA </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">90<br />
        </div>

      </div>

    </div>

    <!--End Page 99-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 100-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg65"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">to timely review and process Cend&#8217;s regulatory submissions, which could have a
            material adverse effect on its business. Further, future government shutdowns could impact Cend&#8217;s ability to access the public markets and obtain necessary capital in order to properly capitalize and continue its operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend&#8217;s employees, independent contractors,
            consultants, commercial partners and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend is exposed to the risk of fraud or other illegal activity by its employees,
            independent contractors, consultants, commercial partners and vendors. Misconduct by these parties could include intentional, reckless and/or negligent conduct that fails to: comply with the regulations of the FDA and other similar foreign
            regulatory authorities, provide true, complete and accurate information to the FDA and other similar foreign regulatory authorities, comply with manufacturing standards Cend has established, comply with healthcare fraud and abuse laws in the
            United States and similar foreign fraudulent misconduct laws or report financial information or data accurately or to disclose unauthorized activities to Cend. If Cend obtains FDA approval of any of its product candidates and begins
            commercializing those products in the United States, Cend&#8217;s potential exposure under such laws and regulations will increase significantly, and its costs associated with compliance with such laws and regulations are also likely to increase.
            These laws may impact, among other things, Cend&#8217;s current activities with principal investigators and research patients, as well as proposed and future sales, marketing and education programs. In particular, the promotion, sales and marketing
            of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws designed to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may
            restrict or prohibit a wide range of pricing, discounting, marketing and promotion, structuring and commission(s), certain customer incentive programs and other business arrangements generally. Activities subject to these laws also involve the
            improper use of information obtained in the course of patient recruitment for clinical trials. The laws that may affect Cend&#8217;s ability to operate include, but are not limited to:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting,
                    receiving, offering or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce, or in return for, either the referral of an individual, or the
                    purchase, lease, order or recommendation of any good, facility, item or service for which payment may be made, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. A person or entity does
                    not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. Violations are subject to civil and criminal fines and penalties for each violation, plus up to three times the
                    remuneration involved, imprisonment, and exclusion from government healthcare programs. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute
                    constitutes a false or fraudulent claim for purposes of the Federal False Claims Act. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">federal civil and criminal false claims laws and civil monetary penalty laws, including the Federal False Claims Act, which
                    impose criminal and civil penalties, including through civil &#8220;qui tam&#8221; or &#8220;whistleblower&#8221; actions, against individuals or entities for, among other things, knowingly presenting, or causing to be presented, claims for payment or approval
                    from Medicare, Medicaid, or other federal health care programs that are false or fraudulent; knowingly making or causing a false statement material to a false or fraudulent claim or an obligation to pay money to the federal government;
                    or knowingly concealing or knowingly and improperly avoiding or decreasing such an obligation. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to
                    &#8220;cause&#8221; the submission of false or fraudulent claims. The FCA also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary
                    recovery. When an entity is determined to have violated the Federal False Claims Act, the government may impose civil fines and penalties for each false claim, plus treble damages, and exclude the entity from participation in Medicare,
                    Medicaid and other federal healthcare programs;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HIPAA, which created new federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a
                    scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">91<br />
        </div>

      </div>

    </div>

    <!--End Page 100-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 101-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg66"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="bl">the custody or control of, any healthcare benefit program, regardless of the payor
            (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially false statements in connection with the delivery of, or payment for, healthcare
            benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity can be found guilty of violating HIPAA without actual knowledge of the statute or specific intent to violate it;</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their
                    respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans, and healthcare clearinghouses as well as their respective business associates that perform services for them that
                    involve the use, or disclosure of, individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization. HITECH also created
                    new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in
                    federal courts to enforce the federal HIPAA laws and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the federal Physician Payment Sunshine Act, created under the ACA and its implementing regulations, which require manufacturers
                    of drugs, devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to HHS information related to payments
                    or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests held by physicians and their
                    immediate family members. Effective January&#160;1, 2022, these reporting obligations extend to include transfers of value made to certain non-physician providers such as physician assistants and nurse practitioners;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that
                    potentially harm consumers; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">analogous state and foreign laws and regulations, such as state and foreign anti-kickback, false claims, consumer protection and
                    unfair competition laws which may apply to pharmaceutical business practices, including but not limited to, research, distribution, sales and marketing arrangements as well as submitting claims involving healthcare items or services
                    reimbursed by any third-party payor, including commercial insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance
                    promulgated by the federal government that otherwise restricts payments that may be made to healthcare providers and other potential referral sources; state laws that require drug manufacturers to file reports with states regarding
                    pricing and marketing information, such as the tracking and reporting of gifts, compensations and other remuneration and items of value provided to healthcare professionals and entities; state and local laws requiring the registration
                    of pharmaceutical sales representatives; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same
                    effect, thus complicating compliance efforts.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has adopted a code of business conduct and ethics, but it is not always possible
            to identify and deter employee misconduct, and the precautions Cend takes to detect and prevent inappropriate conduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting it from governmental investigations
            or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Efforts to ensure that Cend&#8217;s business arrangements with third parties will comply with
            applicable healthcare laws and regulations will involve substantial costs. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of Cend&#8217;s business activities
            could be subject to challenge under one or more of such laws. It is possible that governmental authorities will conclude that Cend&#8217;s business practices may not comply with current or future statutes, regulations or case law involving applicable
            fraud and abuse or other healthcare laws and regulations. If Cend&#8217;s operations are found to be in </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">92<br />
        </div>

      </div>

    </div>

    <!--End Page 101-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 102-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg67"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">violation of any of these laws or any other governmental regulations that may apply
            to Cend, it may be subject to significant criminal, civil and administrative sanctions including monetary penalties, damages, fines, disgorgement, individual imprisonment, and exclusion from participation in government funded healthcare
            programs, such as Medicare and Medicaid, additional reporting requirements and oversight if it becomes subject to a corporate integrity agreement or similar agreement to resolve allegations of noncompliance with these laws, contractual damages,
            reputational harm, diminished profits and future earnings, and it may be required to curtail or restructure its operations, any of which could adversely affect its ability to operate its business and its results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any action against Cend for violation of these laws, even if Cend successfully defends
            against it, could cause Cend to incur significant legal expenses and divert its management&#8217;s attention from the operation of its business. The shifting compliance environment and the need to build and maintain robust and expandable systems to
            comply with multiple jurisdictions with different compliance and/or reporting requirements increases the possibility that a healthcare company may run afoul of one or more of the requirements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Moreover, agreements with physicians often must be the subject of prior notification
            and approval by the physician&#8217;s employer, his or her competent professional organization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Failure to comply with these requirements could result in reputational risk, public
            reprimands, administrative penalties, fines or imprisonment.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">If Cend fails to comply with environmental,
            health and safety laws and regulations, it could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend is subject to numerous environmental, health and safety laws and regulations,
            including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Cend&#8217;s operations involve the use of hazardous and flammable materials, including chemicals and biological
            and radioactive materials. Cend&#8217;s operations also produce hazardous waste products. Cend generally contracts with third parties for the disposal of these materials and wastes. Cend cannot eliminate the risk of contamination or injury from these
            materials. In the event of contamination or injury resulting from Cend&#8217;s use of hazardous materials, it could be held liable for any resulting damages, and any liability could exceed its resources. Cend also could incur significant costs
            associated with civil or criminal fines and penalties.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Although Cend maintains workers&#8217; compensation insurance to cover it for costs and
            expenses it may incur due to injuries to its employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. Cend does not maintain insurance for environmental liability
            or toxic tort claims that may be asserted against it in connection with its storage or disposal of biological, hazardous or radioactive materials.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to Cend&#8217;s reliance on third parties</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may form or seek collaborations or
            strategic alliances or enter into additional licensing arrangements in the future, and it may not realize the benefits of such collaborations, alliances or licensing arrangements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend may form or seek strategic alliances, create joint ventures or collaborations, or
            enter into additional licensing arrangements with third parties that it believes will complement or augment its development and commercialization efforts with respect to its product candidates and any future product candidates that it may
            develop. Any of these relationships may require Cend to incur non-recurring and other charges, increase its near and long-term expenditures, issue securities that dilute its existing stockholders or disrupt its management and business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, Cend faces significant competition in seeking appropriate strategic
            partners and the negotiation process is time-consuming and complex. Moreover, Cend may not be successful in its efforts to establish a strategic partnership or other alternative arrangements for its product candidates because they may be deemed
            to be at too early of a stage of development for collaborative effort and third parties may not view Cend&#8217;s product candidates as having the requisite potential to demonstrate safety, potency, purity and efficacy and obtain marketing approval.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">93<br />
        </div>

      </div>

    </div>

    <!--End Page 102-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 103-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg68"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Further, collaborations involving Cend&#8217;s product candidates are subject to numerous
            risks, which may include the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators have significant discretion in determining the efforts and resources that they will apply to a collaboration;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators may not pursue development and commercialization of Cend&#8217;s product candidates or may elect not to continue or
                    renew development or commercialization of Cend&#8217;s product candidates based on clinical trial results, changes in their strategic focus due to the acquisition of competitive products, availability of funding or other external factors,
                    such as a business combination that diverts resources or creates competing priorities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators may delay clinical trials, provide insufficient funding for a clinical trial, stop a clinical trial, abandon a
                    product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with
                    Cend&#8217;s product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a collaborator with marketing and distribution rights to one or more products may not commit sufficient resources to their
                    marketing and distribution;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators may not properly maintain or defend Cend&#8217;s intellectual property rights or may use Cend&#8217;s intellectual property or
                    proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate Cend&#8217;s intellectual property or proprietary information or expose Cend to potential liability;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disputes may arise between Cend and a collaborator that cause the delay or termination of the research, development or
                    commercialization of Cend&#8217;s product candidates, or that result in costly litigation or arbitration that diverts management attention and resources;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development
                    or commercialization of the applicable product candidates; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">collaborators may own or co-own intellectual property covering Cend&#8217;s products that results from Cend&#8217;s collaborating with them,
                    and in such cases, Cend would not have the exclusive right to commercialize such intellectual property.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As a result, if Cend enters into additional collaboration agreements and strategic
            partnerships or licenses its product candidates, it may not be able to realize the benefit of such transactions if it is unable to successfully integrate them with its existing operations and company culture, which could delay its timelines or
            otherwise adversely affect its business. Cend also cannot be certain that, following a strategic transaction or license, it will achieve the revenue or specific net income that justifies such transaction. Any delays in entering into new
            collaborations or strategic partnership agreements related to Cend&#8217;s product candidates could delay the development and commercialization of its product candidates in certain geographies for certain indications, which would harm its business
            prospects, financial condition and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend plans to rely on third parties to conduct
            its preclinical studies and clinical trials. If these third parties do not properly and successfully carry out their contractual duties or meet expected deadlines, Cend may not be able to obtain regulatory approval of or commercialize its
            product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend plans to utilize and depend upon independent investigators and collaborators, such
            as medical institutions, CROs, contract manufacturing organizations, or CMOs, and strategic partners to conduct and support its preclinical studies and clinical trials under agreements with it. For example, Cend contracts with Bachem Americas
            for Drug Substance manufacture, and Alcami for Drug Product manufacture. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend expects to have to negotiate budgets and contracts with CROs, trial sites and CMOs
            and may not be able to do so on favorable terms, which may result in delays to Cend&#8217;s development timelines and increased costs. Cend will rely heavily on these third parties over the course of its preclinical studies and clinical trials, and
            Cend controls only certain aspects of their activities. As a result, Cend will have less direct control over the conduct, timing and completion of these preclinical studies and clinical trials and the management of data developed through
            preclinical studies and clinical trials than would be the case if it were relying entirely upon its own staff. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">94<br />
        </div>

      </div>

    </div>

    <!--End Page 103-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 104-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg69"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Nevertheless, Cend is responsible for ensuring that each of its studies is conducted
            in accordance with applicable protocol, legal and regulatory requirements and scientific standards, and its reliance on third parties does not relieve Cend of its regulatory responsibilities. Cend and these third parties are required to comply
            with GCPs, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for product candidates in clinical development. Regulatory authorities enforce these GCPs through periodic inspections of trial
            sponsors, principal investigators and trial sites. If Cend or any of these third parties fail to comply with applicable GCP regulations, the clinical data generated in Cend&#8217;s clinical trials may be deemed unreliable and the FDA or comparable
            foreign regulatory authorities may require Cend to perform additional clinical trials before approving Cend&#8217;s marketing applications. Cend cannot assure you that, upon inspection, such regulatory authorities will determine that any of its
            clinical trials comply with the GCP regulations. In addition, Cend&#8217;s clinical trials must be conducted with pharmaceutical product produced under cGMP regulations and will require a large number of test patients. Cend&#8217;s failure or any failure
            by these third parties to comply with these regulations or to recruit a sufficient number of patients may require us to repeat clinical trials, which would delay the regulatory approval process. Moreover, Cend&#8217;s business may be implicated if
            any of these third parties violates federal or state fraud and abuse or false claims laws and regulations or healthcare privacy and security laws.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Any third parties conducting Cend&#8217;s clinical trials are not and will not be Cend&#8217;s
            employees and, except for remedies available to Cend under its agreements with such third parties, Cend cannot control whether or not they devote sufficient time and resources to Cend&#8217;s ongoing, clinical and non-clinical product candidates.
            These third parties may also have relationships with other commercial entities, including Cend&#8217;s competitors, for whom they may also be conducting clinical trials or other drug development activities, which could affect their performance on
            Cend&#8217;s behalf. If these third parties do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised
            due to the failure to adhere to Cend&#8217;s clinical protocols or regulatory requirements or for other reasons, Cend&#8217;s clinical trials may be extended, delayed or terminated and Cend may not be able to complete development of, obtain regulatory
            approval of or successfully commercialize its product candidates. As a result, Cend&#8217;s financial results and the commercial prospects for Cend&#8217;s product candidates would be harmed, Cend&#8217;s costs could increase and Cend&#8217;s ability to generate
            revenue could be delayed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Switching or adding third parties to conduct Cend&#8217;s preclinical studies and clinical
            trials involves substantial cost and requires extensive management time and focus. In addition, there is a natural transition period when a new third party commences work. As a result, delays occur, which can materially impact Cend&#8217;s ability to
            meet its desired clinical development timelines.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Cend&#8217;s manufacturing process needs to comply
            with FDA regulations relating to the quality and reliability of such processes. Any failure to comply with relevant regulations could result in delays in or termination of Cend&#8217;s clinical programs and suspension or withdrawal of any regulatory
            approvals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In order to commercially produce Cend&#8217;s products either at Cend&#8217;s own facility or at a
            third party&#8217;s facility, Cend will need to comply with the FDA&#8217;s cGMP regulations and guidelines. Cend may encounter difficulties in achieving quality control and quality assurance and may experience shortages in qualified personnel. Cend is
            subject to inspections by the FDA and comparable foreign regulatory authorities to confirm compliance with applicable regulatory requirements. Any failure to follow cGMP or other regulatory requirements or delay, interruption or other issues
            that arise in the manufacture, fill-finish, packaging, or storage of Cend&#8217;s precision medicines as a result of a failure of Cend&#8217;s facilities or the facilities or operations of third parties to comply with regulatory requirements or pass any
            regulatory authority inspection could significantly impair Cend&#8217;s ability to develop and commercialize Cend&#8217;s product candidates, including leading to significant delays in the availability of Cend&#8217;s precision medicines for Cend&#8217;s clinical
            trials or the termination of or suspension of a clinical trial, or the delay or prevention of a filing or approval of marketing applications for Cend&#8217;s product candidates. Significant non-compliance could also result in the imposition of
            sanctions, including warning or untitled letters, fines, injunctions, civil penalties, failure of regulatory authorities to grant marketing approvals for Cend&#8217;s product candidates, delays, suspension or withdrawal of approvals, license
            revocation, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could damage Cend&#8217;s reputation and Cend&#8217;s business.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">95<br />
        </div>

      </div>

    </div>

    <!--End Page 104-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 105-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg70"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">If Cend&#8217;s third-party manufacturers use
            hazardous and biological materials in a manner that causes injury or violates applicable law, Cend may be liable for damages.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s research and development activities involve the controlled use of potentially
            hazardous substances, including chemical and biological materials, by Cend&#8217;s third-party manufacturers. Cend&#8217;s manufacturers are subject to federal, state and local laws and regulations in the United States governing the use, manufacture,
            storage, handling and disposal of medical and hazardous materials. Although Cend believes that its manufacturers&#8217; procedures for using, handling, storing and disposing of these materials comply with legally prescribed standards, Cend cannot
            completely eliminate the risk of contamination or injury resulting from medical or hazardous materials. As a result of any such contamination or injury, Cend may incur liability or local, city, state or federal authorities may curtail the use
            of these materials and interrupt Cend&#8217;s business operations. In the event of an accident, Cend could be held liable for damages or penalized with fines, and the liability could exceed Cend&#8217;s resources. Cend does not have any insurance for
            liabilities arising from medical or hazardous materials. Compliance with applicable environmental laws and regulations is expensive, and current or future environmental regulations may impair Cend&#8217;s research, development and production efforts,
            which could harm its business, prospects, financial condition or results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h2">Risks related to managing growth and employee matters</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Cend is highly dependent on its key personnel
            and anticipate hiring new key personnel. If Cend is not successful in attracting and retaining highly qualified personnel, it may not be able to successfully implement its business strategy.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s ability to compete in the highly competitive biotechnology and pharmaceutical
            industries depends upon its ability to attract and retain highly qualified managerial, scientific and medical personnel. Cend is highly dependent on its management, scientific and medical personnel, including Cend&#8217;s Scientific Founder and
            Chairman, Erkki Ruoslahti, MD, David Slack, Cend&#8217;s President and CEO, and Harri J&#228;rvel&#228;inen, our Chief Operating Officer. Erkki Ruoslahti, MD is not Cend&#8217;s employee and provides services primarily as a consultant and a member of the Cend Board
            of Directors. In addition, the loss of the services of any of Cend&#8217;s executive officers, other key employees and other scientific and medical advisors, and an inability to find suitable replacements could result in delays in product development
            and harm Cend&#8217;s business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="frisk">Cend will need to grow the size of its
            organization, and may experience difficulties in managing this growth.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of December&#160;31, 2021 Cend had three full-time employees. Cend intends to hire new
            employees to conduct its research and development activities/administrative/scientific in the future. Any delay in hiring such new employees could result in delays in Cend&#8217;s research and development activities and would harm Cend&#8217;s business. As
            Cend&#8217;s development and commercialization plans and strategies develop, and as Cend transitions into operating as a public company, Cend expects to need additional managerial, operational, sales, marketing, financial and other personnel, as well
            as additional facilities to expand its operations. Future growth would impose significant added responsibilities on members of management, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identifying, recruiting, integrating, maintaining and motivating additional employees;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Advance applications of Cend&#8217;s drug discovery and development platform;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">managing Cend&#8217;s internal development efforts effectively, including the clinical and FDA review process for Cend&#8217;s product
                    candidates, while complying with Cend&#8217;s contractual obligations to contractors and other third parties; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">improving Cend&#8217;s operational, financial and management controls, reporting systems and procedures.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s future financial performance and Cend&#8217;s ability to commercialize Cend&#8217;s product
            candidates will depend, in part, on its ability to effectively manage any future growth, and Cend&#8217;s management may also have to divert a disproportionate amount of its attention away from day-to-day activities in order to devote a substantial
            amount of time to managing these growth activities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend currently relies, and for the foreseeable future will continue to rely, in
            substantial part on certain independent organizations, advisors and consultants to provide certain services, including substantially all aspects of regulatory approval, clinical trial management and manufacturing. There can be no assurance that
            the services of independent organizations, advisors and consultants will continue to be available to Cend on a timely basis </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">96<br />
        </div>

      </div>

    </div>

    <!--End Page 105-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 106-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg71"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">when needed, or that Cend can find qualified replacements. In addition, if Cend is
            unable to effectively manage Cend&#8217;s outsourced activities or if the quality or accuracy of the services provided by consultants is compromised for any reason, Cend&#8217;s clinical trials may be extended, delayed or terminated, and it may not be able
            to obtain regulatory approval of its product candidates or otherwise advance its business. There can be no assurance that Cend will be able to manage its existing consultants or find other competent outside contractors and consultants on
            economically reasonable terms, or at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend is not able to effectively expand its organization by hiring new employees and
            expanding its groups of consultants and contractors, or it is not able to effectively build out new facilities to accommodate this expansion, it may not be able to successfully implement the tasks necessary to further develop and commercialize
            its product candidates and, accordingly, may not achieve its research, development and commercialization goals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">If product liability lawsuits are brought
            against Cend, it may incur substantial liabilities and may be required to limit commercialization of its product candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend faces an inherent risk of product liability as a result of the planned clinical
            testing of its product candidates and will face an even greater risk if it commercializes any products. For example, Cend may be sued if its product candidates cause or are perceived to cause injury or are found to be otherwise unsuitable
            during clinical testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict
            liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. If Cend cannot successfully defend itself against product liability claims, it may incur substantial liabilities or be required to limit
            commercialization of its product candidates. Even successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">decreased demand for Cend&#8217;s product candidates or products that it may develop;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">injury to Cend&#8217;s reputation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">withdrawal of clinical trial participants;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">initiation of investigations by regulators;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">costs to defend the related litigation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a diversion of management&#8217;s time and Cend&#8217;s resources;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">substantial monetary awards to trial participants or patients;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">product recalls, withdrawals or labeling, marketing or promotional restrictions;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">loss of revenue;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">exhaustion of any available insurance and Cend&#8217;s capital resources;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the inability to commercialize any product candidate; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a decline in share price.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Failure to obtain or retain sufficient product liability insurance at an acceptable
            cost to protect against potential product liability claims could prevent or inhibit the commercialization of products Cend develops, alone or with corporate collaborators. Although Cend has clinical trial insurance, Cend&#8217;s insurance policies
            also have various exclusions, and it may be subject to a product liability claim for which it has no coverage. Cend may have to pay any amounts awarded by a court or negotiated in a settlement that exceed its coverage limitations or that are
            not covered by its insurance, and it may not have, or be able to obtain, sufficient capital to pay such amounts. Even if Cend&#8217;s agreements with any future corporate collaborators entitle it to indemnification against losses, such
            indemnification may not be available or adequate should any claim arise.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">97<br />
        </div>

      </div>

    </div>

    <!--End Page 106-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 107-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg72"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">General risk factors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="frisk">Data collection is governed by restrictive
            regulations governing the use, storage, processing and transfer of personal information.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the event Cend decides to conduct clinical trials or continue to enroll subjects in
            its ongoing or future clinical trials, it may be subject to additional privacy restrictions. The collection, use, storage, disclosure, transfer, or other processing of personal data is subject to the California Consumer Privacy Act, or CCPA,
            which creates new individual privacy rights for California consumers (as defined in the law) and places increased privacy and security obligations on entities handling personal data of consumers or households. The CCPA requires covered
            companies to provide new disclosure to consumers about such companies&#8217; data collection, use and sharing practices, provide such consumers new ways to opt-out of certain sales or transfers of personal information, and provide consumers with
            additional causes of action. The CCPA went into effect on January&#160;1, 2020, and the California Attorney General commenced enforcement actions for violations beginning July&#160;1, 2020. The CCPA was amended on September&#160;23, 2018, and it remains
            unclear what, if any, further modifications will be made to this legislation or how it will be interpreted. As currently written, the CCPA may impact Cend&#8217;s business activities and exemplifies the vulnerability of Cend&#8217;s business to the
            evolving regulatory environment related to personal data and protected health information.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Compliance with U.S. and international data protection laws and regulations could
            require Cend to take on more onerous obligations in its contracts, restrict its ability to collect, use and disclose data, or in some cases, impact its ability to operate in certain jurisdictions. Failure to comply with U.S. and international
            data protection laws and regulations could result in government enforcement actions (which could include civil or criminal penalties), private litigation or adverse publicity and could negatively affect Cend&#8217;s operating results and business.
            Moreover, clinical trial subjects about whom Cend or its potential collaborators obtain information, as well as the providers who share this information with Cend, may contractually limit Cend&#8217;s ability to use and disclose the information.
            Claims that Cend has violated individuals&#8217; privacy rights, failed to comply with data protection laws, or breached Cend&#8217;s contractual obligations, even if Cend is not found liable, could be expensive and time consuming to defend and could
            result in adverse publicity that could harm Cend&#8217;s business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">Cend may be unable to adequately protect its
            information systems from cyberattacks, which could result in the disclosure of confidential or proprietary information, including personal data, damage Cend&#8217;s reputation, and subject Cend to significant financial and legal exposure.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend relies on information technology systems that it or its third-party providers
            operate to process, transmit and store electronic information in Cend&#8217;s day-to-day operations. In connection with Cend&#8217;s product discovery efforts, Cend may collect and use a variety of personal data, such as name, mailing address, email
            addresses, phone number and clinical trial information. A successful cyberattack could result in the theft or destruction of intellectual property, data, or other misappropriation of assets, or otherwise compromise Cend&#8217;s confidential or
            proprietary information and disrupt Cend&#8217;s operations. Cyberattacks are increasing in their frequency, sophistication and intensity, and have become increasingly difficult to detect. Cyberattacks could include wrongful conduct by hostile
            foreign governments, industrial espionage, wire fraud and other forms of cyber fraud, the deployment of harmful malware, denial-of-service, social engineering fraud or other means to threaten data security, confidentiality, integrity and
            availability. A successful cyberattack could cause serious negative consequences for us, including, without limitation, the disruption of operations, the misappropriation of confidential business information, including financial information,
            trade secrets, financial loss and the disclosure of corporate strategic plans. Although Cend devotes resources to protect its information systems, Cend realizes that cyberattacks are a threat, and there can be no assurance that its efforts will
            prevent information security breaches that would result in business, legal, financial or reputational harm to Cend, or would have a material adverse effect on its results of operations and financial condition. Any failure to prevent or mitigate
            security breaches or improper access to, use of, or disclosure of Cend&#8217;s clinical data or patients&#8217; personal data could result in significant liability under state (<span style="font-style: italic;">e.g.</span>, state breach notification laws),
            federal (<span style="font-style: italic;">e.g.</span>, HIPAA, as amended by HITECH), and international law (<span style="font-style: italic;">e.g.</span>, the GDPR) and may cause a material adverse impact to Cend&#8217;s reputation, affect Cend&#8217;s
            ability to conduct new studies and potentially disrupt Cend&#8217;s business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, the computer systems of various third parties on which Cend relies, and
            other contractors, consultants and law and accounting firms, may sustain damage from computer viruses, unauthorized access, data breaches, phishing attacks, cybercriminals, natural disasters (including hurricanes and earthquakes), terrorism,
            war and telecommunication and electrical failures. Cend relies on its third-party providers to implement effective </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">98<br />
        </div>

      </div>

    </div>

    <!--End Page 107-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 108-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg73"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">security measures and identify and correct for any such failures, deficiencies or
            breaches. If Cend or its third-party providers fail to maintain or protect Cend&#8217;s information technology systems and data integrity effectively or fail to anticipate, plan for or manage significant disruptions to Cend&#8217;s information technology
            systems, Cend or its third-party providers could have difficulty preventing, detecting and controlling such cyber-attacks and any such attacks could result in losses described above as well as disputes with physicians, patients and Cend&#8217;s
            partners, regulatory sanctions or penalties, increases in operating expenses, expenses or lost revenues or other adverse consequences, any of which could have a material adverse effect on Cend&#8217;s business, results of operations, financial
            condition, prospects and cash flows. Any failure by such third parties to prevent or mitigate security breaches or improper access to or disclosure of such information could have similarly adverse consequences for us. If Cend is unable to
            prevent or mitigate the impact of such security or data privacy breaches, it could be exposed to litigation and governmental investigations, which could lead to a potential disruption to its business.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">99<br />
        </div>

      </div>

    </div>

    <!--End Page 108-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 109-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg74"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tRRTTCC"><!--Anchor--></a><span style="text-decoration: underline;">Risks Related to the Combined Company</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In determining whether you should approve the issuance of shares of
            Caladrius Common Stock and other matters related to the Merger, as applicable, you should carefully read the following risk factors in addition to the risks described above.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="frisk">The market price of the Caladrius Common Stock
            is expected to be volatile, and the market price of the Caladrius Common Stock may drop following the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The market price of the Caladrius Common Stock following the Merger could be subject to
            significant fluctuations. Some of the factors that may cause the market price of the Caladrius Common Stock to fluctuate include:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">results of clinical trials and preclinical studies of the combined company&#8217;s product candidates, or those of the combined
                    company&#8217;s competitors or the combined company&#8217;s existing or future collaborators;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to meet or exceed financial and development projections the combined company may provide to the public;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failure to meet or exceed the financial and development projections of the investment community;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the combined company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by
                    financial or industry analysts;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">announcements of significant acquisitions, strategic collaborations, joint ventures or capital commitments by the combined
                    company or its competitors;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actions taken by regulatory agencies with respect to the combined company&#8217;s product candidates, clinical studies, manufacturing
                    process or sales and marketing terms;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">disputes or other developments relating to proprietary rights, including patents, litigation matters, and the combined company&#8217;s
                    ability to obtain patent protection for its technologies;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">additions or departures of key personnel;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">significant lawsuits, including patent or stockholder litigation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if securities or industry analysts do not publish research or reports about the combined company&#8217;s business, or if they issue
                    adverse or misleading opinions regarding its business and stock;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in the market valuations of similar companies;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">general market or macroeconomic conditions or market conditions in the pharmaceutical and biotechnology sectors;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">sales of securities by the combined company or its securityholders in the future;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the combined company fails to raise an adequate amount of capital to fund its operations and continued development of its
                    product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">trading volume of the Caladrius Common Stock;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">announcements by competitors of new commercial products, clinical progress or lack thereof, significant contracts, commercial
                    relationships or capital commitments;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">adverse publicity relating to precision medicine product candidates, including with respect to other products in such markets;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the introduction of technological innovations or new therapies that compete with the products and services of the combined
                    company; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">period-to-period fluctuations in the combined company&#8217;s financial results.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Moreover, the stock markets in general have experienced substantial volatility that has
            often been unrelated to the operating performance of individual companies. These broad market fluctuations may also adversely affect the trading price of the Caladrius Common Stock. In addition, a recession, depression or other sustained
            adverse market event resulting from the spread of COVID-19 or otherwise could materially and adversely affect the </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">100<br />
        </div>

      </div>

    </div>

    <!--End Page 109-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 110-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg75"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">combined company&#8217;s business and the value of its common stock. In the past,
            following periods of volatility in the market price of a company&#8217;s securities, stockholders have often instituted class action securities litigation against such companies. Furthermore, market volatility may lead to increased shareholder
            activism if the combined company experiences a market valuation that activists believe is not reflective of its intrinsic value. Activist campaigns that contest or conflict with the combined company&#8217;s strategic direction or seek changes in the
            composition of its board of directors could have an adverse effect on its operating results and financial condition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="frisk">Following the Merger, the combined company
            may be unable to integrate successfully and realize the anticipated benefits of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger involves the combination of two companies which currently operate as
            independent companies. The combined company may fail to realize some or all of the anticipated benefits of the Merger if the integration process takes longer than expected or is more costly than expected. In addition, Caladrius and Cend have
            operated and, until the completion of the Merger, will continue to operate, independently. It is possible that the integration process also could result in the diversion of each company&#8217;s management&#8217;s attention, the disruption or interruption
            of, or the loss of momentum in, each company&#8217;s ongoing businesses or inconsistencies in standards, controls, procedures and policies, any of which could adversely affect the combined company&#8217;s ability to maintain relationships with customers,
            suppliers and employees or the ability to achieve the anticipated benefits of the Merger, or could otherwise adversely affect the business and financial results of the combined company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="frisk">The combined company will need substantial
            additional funding before it can complete the development of its product candidates. If the combined company is unable to obtain such additional capital on favorable terms, on a timely basis or at all, it would be forced to delay, reduce or
            eliminate its product development and clinical programs and may not have the capital required to otherwise operate its business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Developing cancer therapies and cell therapy products, including conducting
            pre-clinical studies and clinical trials and establishing manufacturing capabilities, is expensive. The combined company has not generated any revenues from the commercial sale of products and will not be able to generate any product revenues
            until, and only if, the combined company receives approval to sell its product candidates from the FDA or other regulatory authorities. The cash expected from both Caladrius and Cend at closing are expected to fund the further development of
            the combined company&#8217;s programs and operate the combined company into early 2023. However, as the combined company has not generated any revenue from commercial sales to date and does not expect to generate any revenue for several years, if
            ever, the combined company will need to raise substantial additional capital in order to fund its general corporate activities and to fund its research and development, including its currently planned clinical trials and plans for new clinical
            trials and product development.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The combined company may seek to raise additional funds through various potential
            sources, such as equity and debt financings, or through strategic collaborations and license agreements. The combined company can give no assurances that it will be able to secure such additional sources of funds to support its operations or,
            if such funds are available, that such additional financing will be sufficient to meet its needs. Moreover, to the extent that the combined company raises additional funds by issuing equity securities, its stockholders may experience additional
            significant dilution, and debt financing, if available, may involve restrictive covenants. To the extent that the combined company raises additional funds through collaboration and licensing arrangements, it may be necessary to relinquish some
            rights to its technologies or product candidates, or grant licenses on terms that may not be favorable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Given the combined company&#8217;s capital constraints, it will need to prioritize spending
            on its clinical and pre-clinical programs. If the combined company is unable to raise sufficient funds to support its current and planned operations, it may elect to discontinue certain of its ongoing activities or programs. The combined
            company&#8217;s inability to raise additional funds could also prevent it from taking advantage of opportunities to pursue promising new or existing programs in the future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The combined company&#8217;s forecasts regarding its beliefs in the sufficiency of its
            financial resources to support its current and planned operations are forward-looking statements and involve significant risks and uncertainties, and actual results could vary as a result of a number of factors, including the factors discussed
            elsewhere in this &#8220;<span style="font-style: italic;">Risk Factors</span>&#8221; section. These estimates are based on assumptions that may prove to be wrong, and the combined company could utilize its available capital resources sooner than currently
            expected.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">101<br />
        </div>

      </div>

    </div>

    <!--End Page 110-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 111-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg76"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">The combined company may be exposed to
            increased litigation, including stockholder litigation, which could have an adverse effect on the combined company&#8217;s business and operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The combined company may be exposed to increased litigation from stockholders,
            customers, suppliers, consumers and other third parties due to the combination of Caladrius&#8217; business and Cend&#8217;s business following the Merger. Such litigation may have an adverse impact on the combined company&#8217;s business and results of
            operations or may cause disruptions to the combined company&#8217;s operations. In addition, in the past, stockholders have initiated class action lawsuits against biotechnology companies following periods of volatility in the market prices of these
            companies&#8217; stock. Such litigation, if instituted against the combined company, could cause the combined company to incur substantial costs and divert management&#8217;s attention and resources, which could have a material adverse effect on the
            combined company&#8217;s business, financial condition and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The combined company may be exposed to continued litigation resulting from the
            proceeding described above in the section titled &#8220;<span style="font-style: italic;">Cend Business &#8211; Legal Proceedings</span>&#8221; beginning on page&#160;<a href="#tLP">230</a> of this proxy statement/prospectus/information statement. Such lawsuits, if
            remaining outstanding following the closing, could cause the combined company to incur substantial costs and divert management&#8217;s attention and resources, which could have a material adverse effect on the combined company&#8217;s business, financial
            condition and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">The unaudited pro forma condensed combined
            financial data for Caladrius and Cend included in this proxy statement/prospectus/information statement is preliminary, and the combined company&#8217;s actual financial position and operations after the Merger may differ materially from the
            unaudited pro forma financial data included in this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma financial data for Caladrius and Cend included in this proxy
            statement/prospectus/information statement is presented for illustrative purposes only and is not necessarily indicative of the combined company&#8217;s actual financial condition or results of operations of future periods, or the financial condition
            or results of operations that would have been realized had the entities been combined during the periods presented. The unaudited pro forma financial statements have been derived from the historical financial statements of Caladrius and Cend
            and adjustments and assumptions have been made regarding the combined company after giving effect to the transaction. The information upon which these adjustments and assumptions have been made is preliminary, and these kinds of adjustments and
            assumptions are difficult to make with accuracy. Moreover, the unaudited pro forma financial statements do not reflect all costs that are expected to be incurred by the combined company in connection with the transactions or that have been
            incurred since the date of such unaudited pro forma financial statements. The assumptions used in preparing the unaudited pro forma financial information may not prove to be accurate, and other factors may affect the combined company&#8217;s
            financial condition following the transaction. For more information see the section titled &#8220;<span style="font-style: italic;">Unaudited Pro Forma Condensed Combined Financial Statements</span>.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Anti-takeover provisions in the combined
            organization&#8217;s charter documents and under Delaware law could make the acquisition of the combined organization more difficult and may prevent attempts by the combined organization&#8217;s stockholders to replace or remove the combined organization&#8217;s
            management.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Provisions in the combined organization&#8217;s certificate of incorporation and bylaws may
            delay or prevent an acquisition or a change in management. These provisions include a classified board of directors, a prohibition on actions by written consent of the combined organization&#8217;s stockholders, and the ability of the board of
            directors to issue preferred stock without stockholder approval. In addition, because the combined organization will be incorporated in Delaware, it is governed by the provisions of Section 203 of the DGCL, which prohibits stockholders owning
            in excess of 15% of the outstanding combined organization&#8217;s voting stock from merging or combining with the combined organization. Although Caladrius and Cend believe these provisions collectively will provide for an opportunity to receive
            higher bids by requiring potential acquirers to negotiate with the combined organization&#8217;s board of directors, they would apply even if the offer may be considered beneficial by some stockholders. In addition, these provisions may frustrate or
            prevent any attempts by the combined organization&#8217;s stockholders to replace or remove then current management by making it more difficult for stockholders to replace members of the board of directors, which is responsible for appointing the
            members of management.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">102<br />
        </div>

      </div>

    </div>

    <!--End Page 111-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 112-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg77"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius and Cend do not anticipate the
            combined organization will pay any cash dividends in the foreseeable future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The current expectation is the combined organization will retain its future earnings to
            fund the development and growth of the combined organization&#8217;s business. As a result, capital appreciation, if any, of the Caladrius Common Stock will be your sole source of gain, if any, for the foreseeable future.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Future sales of shares by existing
            stockholders could cause the Caladrius Common Stock price to decline.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If existing securityholders of Caladrius and Cend sell, or indicate an intention to
            sell, substantial amounts of the Caladrius Common Stock in the public market after legal restrictions on resale discussed in this proxy statement/prospectus/information statement lapse, the trading price of the Caladrius Common Stock could
            decline. Based on shares outstanding as of June&#160;13, 2022 and approximately 60,518,478 shares of Caladrius Common Stock expected to be issued upon completion of the Merger, the combined company is expected to have outstanding, a total of
            approximately 121,036,956 shares of Caladrius Common Stock immediately following the completion of the Merger. Of the shares of Caladrius Common Stock, approximately 19,747,081 shares will be available for sale in the public market beginning
            120 days after the closing of the Merger as a result of the expiration of lock-up agreements between Caladrius and Cend on the one hand and certain securityholders of Caladrius and Cend on the other hand. All other outstanding shares of
            Caladrius Common Stock, other than shares held by affiliates of the combined company, will be freely tradable, without restriction, in the public market. In addition, shares of Caladrius Common Stock that are subject to outstanding options of
            Cend will become eligible for sale in the public market to the extent permitted by the provisions of various vesting agreements and Rules 144 and 701 under the Securities Act. If these shares are sold, the trading price of the Caladrius Common
            Stock could decline.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">If the ownership of the Caladrius Common
            Stock is highly concentrated, it may prevent you and other stockholders from influencing significant corporate decisions and may result in conflicts of interest that could cause the combined organization&#8217;s stock price to decline.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Executive officers and directors of the combined organization, and affiliates of
            executive officers and directors of the combined organization, are expected to beneficially own or control approximately 21.6% of the outstanding shares of the Caladrius Common Stock following the completion of the Merger. Accordingly, these
            executive officers, directors, and their affiliates, acting as a group, will have substantial influence over the outcome of corporate actions requiring stockholder approval, including the election of directors, any merger, consolidation, or
            sale of all or substantially all of the combined organization&#8217;s assets or any other significant corporate transactions. These stockholders may also delay or prevent a change of control of the combined organization, even if such a change of
            control would benefit the other stockholders of the combined organization. The significant concentration of stock ownership may adversely affect the trading price of Caladrius Common Stock due to investors&#8217; perception that conflicts of interest
            may exist or arise.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="frisk">If the combined organization fails to maintain
            proper and effective internal controls, the combined organization&#8217;s ability to produce accurate and timely financial statements could be impaired, which could harm its operating results, its ability to operate its business and investors&#8217; views
            of the combined organization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The combined organization will be required to comply with Section 404 of the
            Sarbanes-Oxley Act. Section 404 of the Sarbanes-Oxley Act requires public companies to conduct an annual review and evaluation of their internal controls and attestations of the effectiveness of internal controls by independent auditors.
            Ensuring that the combined organization has adequate internal financial and accounting controls and procedures in place so that it can produce accurate financial statements on a timely basis is a costly and time-consuming effort that will need
            to be evaluated frequently. The combined organization&#8217;s failure to maintain the effectiveness of its internal controls in accordance with the requirements of the Sarbanes-Oxley Act could have a material adverse effect on its business. The
            combined organization could lose investor confidence in the accuracy and completeness of its financial reports, which could have an adverse effect on the price of its common stock. In addition, if the combined organization&#8217;s efforts to comply
            with new or changed laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to practice, regulatory authorities may initiate legal proceedings against the combined
            organization and its business may be harmed.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">103<br />
        </div>

      </div>

    </div>

    <!--End Page 112-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 113-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_106-risk_pg78"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="frisk">If securities or industry analysts do not
            publish, or cease publishing, research or reports about the combined organization, its business or its market, or if they change their recommendations regarding the Caladrius Common Stock adversely, the Caladrius Common Stock price and trading
            volume could decline.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If a trading market for the combined organization&#8217;s Caladrius Common Stock develops,
            the trading market for its Caladrius Common Stock will be influenced by whether industry or securities analysts publish research and reports about the combined organization, its business, its market or its competitors and, if any analysts do
            publish such reports, what they publish in those reports. The combined organization may not obtain analyst coverage in the future. Any analysts that do cover the combined organization may make adverse recommendations regarding the Caladrius
            Common Stock, adversely change their recommendations from time to time, and/or provide more favorable relative recommendations about the combined organization&#8217;s competitors. If any analyst who may cover the combined organization in the future
            were to cease coverage of the combined organization or fail to regularly publish reports on the combined organization, or if analysts fail to cover the combined organization or publish reports about the combined organization at all, the
            combined organization could lose, or never gain, visibility in the financial markets, which in turn could cause the stock price or trading volume of the Caladrius Common Stock to decline.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="frisk">Caladrius&#8217; ability to utilize its net
            operating loss carryforwards and tax credit carryforwards may be subject to limitations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; ability to use its federal and state net operating losses (&#8220;NOLs&#8221;) to offset
            potential future taxable income and related income taxes that would otherwise be due is dependent upon the combined company&#8217;s generation of future taxable income, and Caladrius and Cend cannot predict with certainty when, or whether, the
            combined company will generate sufficient taxable income to use all of its NOLs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under Section 382 and Section 383 of the Code and corresponding provisions of state
            law, if a corporation undergoes an &#8220;ownership change,&#8221; its ability to use its pre-change NOL carryforwards and other pre-change tax attributes (such as research tax credits) to offset its post-change income may be limited. A Section 382
            &#8220;ownership change&#8221; is generally defined as a greater than 50 percentage point change (by value) in its equity ownership by certain stockholders over a three-year period. Cend may have experienced ownership changes in the past, may experience an
            ownership change as a result of the Merger, and may experience ownership changes in the future due to subsequent shifts in the combined company&#8217;s stock ownership (some of which are outside of its control). Furthermore, the Merger, if
            consummated, may constitute an ownership change (within the meaning of Section 382 of the Code) of Caladrius which could eliminate or otherwise substantially limit the combined company&#8217;s ability to use Caladrius&#8217; federal and state NOLs to
            offset its future taxable income. Consequently, even if the combined company achieves profitability, it may not be able to utilize a material portion of Cend&#8217;s, Caladrius&#8217; or the combined company&#8217;s NOL carryforwards and other tax attributes,
            which could have a material adverse effect on cash flow and results of operations. Similar provisions of state tax law may also apply to limit the combined company&#8217;s use of accumulated state tax attributes. There is also a risk that due to
            regulatory changes, such as suspensions on the use of NOLs, or other unforeseen reasons, the combined company&#8217;s existing NOLs could expire or otherwise be unavailable to offset future income tax liabilities.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">104<br />
        </div>

      </div>

    </div>

    <!--End Page 113-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 114-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_107-fls_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tFLS"><!--Anchor--></a>FORWARD-LOOKING STATEMENTS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This proxy statement/prospectus/information statement and the documents incorporated by
            reference into this proxy statement/prospectus/information statement contain forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and
            Section 27A of the Securities Act) concerning Caladrius, Cend, the proposed Merger and other matters. These statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial
            condition, or otherwise, based on current beliefs of the management of Caladrius, as well as assumptions made by, and information currently available to, management. Forward-looking statements generally include statements that are predictive in
            nature and depend upon or refer to future events or conditions, and include words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;intend,&#8221; &#8220;look forward,&#8221; and other similar expressions among others. Statements that are
            not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ
            materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the risk that the conditions to the Closing are not satisfied, including the failure to timely or at all obtain
            stockholder approval for the Merger; uncertainties as to the timing of the consummation of the Merger and the ability of each of Caladrius and Cend to consummate the Merger; risks related to Caladrius&#8217; ability to correctly estimate its
            operating expenses and its expenses associated with the Merger; risks related to the changes in market price of the Caladrius Common Stock relative to the Exchange Ratio; the ability of Caladrius or Cend to protect their respective intellectual
            property rights; competitive responses to the Merger; unexpected costs, charges or expenses resulting from the Merger; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Merger;
            and legislative, regulatory, political and economic developments. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with
            statements that are included herein and elsewhere. Caladrius can give no assurance that the conditions to the Merger will be satisfied. Except as required by applicable law, Caladrius undertakes no obligation to revise or update any
            forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For a discussion of the factors that may cause Caladrius, Cend or the combined
            organization&#8217;s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied in such forward-looking statements, or for a discussion of risks associated with the
            ability of Caladrius and Cend to complete the Merger and the effect of the Merger on the business of Caladrius, Cend and the combined organization, see the section entitled &#8220;<span style="font-style: italic;">Risk Factors</span>&#8221; in this proxy
            statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Additional factors that could cause actual results to differ materially from those
            expressed in the forward-looking statements are discussed in reports filed with the SEC by Caladrius. See the section entitled &#8220;<span style="font-style: italic;">Where You Can Find More Information</span>&#8221; in this proxy
            statement/prospectus/information statement. There can be no assurance that the Merger will be completed, or if it is completed, that it will be completed within the anticipated time period or that the expected benefits of the Merger will be
            realized.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If any of these risks or uncertainties materialize or any of these
            assumptions prove incorrect, the results of operations of Caladrius, Cend or the combined organization could differ materially from the forward-looking statements. All forward-looking statements in this proxy statement/prospectus/information
            statement are current only as of the date on which the statements were made. Caladrius and Cend do not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any
            statement is made, the occurrence of unanticipated events or any new information that becomes available in the future.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">105<br />
        </div>

      </div>

    </div>

    <!--End Page 114-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 115-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_108-meeting_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tAMS"><!--Anchor--></a>THE ANNUAL MEETING OF CALADRIUS STOCKHOLDERS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tDTP"><!--Anchor--></a>Date, Time and Place</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Annual Meeting will be held on September&#160;13, 2022 commencing at 9:00 a.m. New
              York time. This year&#8217;s meeting will be held via live webcast on the internet. You will be able to participate in the Annual Meeting, vote and submit your questions during the Annual Meeting by visiting
              www.virtualshareholdermeeting.com/CLBS2022SM. You will not be able to attend the Annual Meeting in person. Caladrius is delivering this proxy statement/prospectus/information statement to its stockholders in connection with the solicitation
              of proxies by the Caladrius Board of Directors for use at the Annual Meeting and any adjournments or postponements of the Annual Meeting. This proxy statement/prospectus/information statement is first being furnished to Caladrius Stockholders
              on or about August 2, 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tPAM"><!--Anchor--></a>Purposes of the Annual Meeting</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">The purposes of the Annual Meeting are: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and vote upon a proposal to approve the Merger Agreement, a copy of which is attached to this proxy
                    statement/prospectus/information statement as <span style="font-style: italic;">Annex&#160;A</span>, and the transactions contemplated thereby, including the Merger and the issuance of shares of Caladrius Common Stock to Cend Stockholders
                    pursuant to the terms of the Merger Agreement. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and vote upon a proposal to approve an amendment to the amended and restated certificate of incorporation of
                    Caladrius to effect the Reverse Stock Split, in the form attached to this proxy statement/prospectus/information statement as <span style="font-style: italic;">Annex&#160;D</span>. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and vote upon a proposal to approve an amendment to the amended and restated certificate of incorporation of
                    Caladrius to effect the Caladrius Name Change, in the form attached to this proxy statement/prospectus/information statement as <span style="font-style: italic;">Annex&#160;E</span>. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and vote upon a proposal to elect three Class&#160;III directors to hold office until the 2025 annual meeting of
                    stockholders or until their successors are elected (provided, however, that if the Merger is completed, the Caladrius Board of Directors will be reconstituted as provided in the Merger Agreement). </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and vote upon a proposal to ratify the selection by the audit committee of the Caladrius Board of Directors of Grant
                    Thornton LLP as the independent registered public accounting firm of Caladrius for its calendar year ending December&#160;31, 2022. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and approve, on a non-binding, advisory basis, the executive compensation of Caladrius&#8217; named executive officers as
                    described in this proxy statement/prospectus/information statement.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">7.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and approve an amendment to the Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan that increases
                    the number of shares of common stock that may be issued under the Plan by 5,000,000.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To consider and vote upon a proposal to approve an adjournment of the Annual Meeting, if necessary, to solicit additional
                    proxies if there are not sufficient votes in favor of Proposal No.&#160;1 or 2. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">9.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tRCBD"><!--Anchor--></a>Recommendation of the Caladrius Board
            of Directors </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors has determined that the transactions contemplated by the Merger Agreement are fair to,
                    advisable and in the best interests of Caladrius and Caladrius Stockholders and has approved and declared advisable the Merger Agreement and such transactions, including the issuance of shares of Caladrius Common Stock to the Cend
                    Stockholders pursuant to the terms of the Merger Agreement. The Caladrius Board of Directors recommends that Caladrius Stockholders vote &#8220;FOR&#8221; Proposal No.&#160;1 to approve the Merger Agreement and the transactions contemplated thereby,
                    including the issuance of shares of Caladrius Common Stock pursuant to the terms of the Merger Agreement and the amendment to Caladrius&#8217; certificate of incorporation to effect a change in the name of Caladrius to Cend. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">106<br />
        </div>

      </div>

    </div>

    <!--End Page 115-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 116-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_108-meeting_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors has determined that the Reverse Stock Split is fair to, advisable and in the best interests of
                    Caladrius and Caladrius Stockholders and has approved and declared advisable the Reverse Stock Split. The Caladrius Board of Directors recommends that Caladrius Stockholders vote &#8220;FOR&#8221; Proposal No.&#160;2 to approve an amendment to the
                    amended and restated certificate of incorporation of Caladrius effecting the Reverse Stock Split. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors has determined that the Caladrius Name Change is fair to, advisable and in the best interests
                    of Caladrius and Caladrius Stockholders and has approved and declared advisable the Caladrius Name Change. The Caladrius Board of Directors recommends that Caladrius Stockholders vote &#8220;FOR&#8221; Proposal No.&#160;3 to approve an amendment to the
                    amended and restated certificate of incorporation of Caladrius to effect the Caladrius Name Change. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors recommends that Caladrius Stockholders vote &#8220;FOR&#8221; Proposal No.&#160;4 to elect each of Steven M.
                    Klosk, Steven S. Myers and Michael H. Davidson, M.D., as Class&#160;III directors. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors recommends that Caladrius Stockholders vote &#8220;FOR&#8221; Proposal No.&#160;5 to ratify the selection of
                    Grant Thornton LLP as Caladrius&#8217; independent registered public accounting firm for the calendar year ending December&#160;31, 2022. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors recommends that Caladrius Stockholders vote &#8220;FOR&#8221; Proposal No.&#160;6 to approve, on a non-binding
                    advisory basis, the executive compensation of Caladrius&#8217; named executive officers as disclosed in this proxy statement/prospectus/information statement.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors recommends that Caladrius Stockholders vote &#8220;FOR&#8221; Proposal No.&#160;7 to approve an amendment to the
                    Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan (the &#8220;Plan&#8221;) that increases the number of shares of common stock that may be issued under the Plan by 5,000,000.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors has determined and believes that adjourning the Annual Meeting, if necessary, to solicit
                    additional proxies if there are not sufficient votes in favor of Proposal No.&#160;1 or 2 is advisable to, and in the best interests of, Caladrius and Caladrius Stockholders. The Caladrius Board of Directors recommends that Caladrius
                    Stockholders vote &#8220;FOR&#8221; Proposal No.&#160;8 to adjourn the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal No.&#160;1 or 2. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Stockholders should understand, however, that if the Merger is completed, the
            effect of the approval of Proposal No.&#160;4 may be limited since the composition of the Caladrius Board of Directors will be changed upon completion of the Merger in accordance with the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tRDVP"><!--Anchor--></a>Record Date and Voting Power</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Only holders of record of Caladrius Common Stock at the close of business on the
              Record Date, July&#160;25, 2022, are entitled to notice of, and to vote at, the Annual Meeting. There were approximately 533 holders of record of Caladrius Common Stock at the close of business on the Record Date. At the close of business on the
              Record Date, 60,583,249&#160;shares of Caladrius Common Stock were issued and outstanding. Each share of Caladrius Common Stock entitles the holder thereof to one vote on each matter submitted for stockholder approval at the Annual Meeting. See
              the section entitled &#8220;<span style="font-style: italic;">Principal Stockholders of Caladrius</span>&#8221; in this proxy statement/prospectus/information statement for information regarding persons known to the management of Caladrius
              to be the beneficial owners of more than 5% of the outstanding shares of Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tVRP"><!--Anchor--></a>Voting and Revocation of Proxies</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The proxy accompanying this proxy statement/prospectus/information statement is
            solicited on behalf of the Caladrius Board of Directors for use at the Annual Meeting.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">107<br />
        </div>

      </div>

    </div>

    <!--End Page 116-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 117-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_108-meeting_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">If you are a stockholder of record of Caladrius as of the Record Date referred to
            above, you may vote virtually at the Annual Meeting or vote by proxy using the enclosed proxy card. Whether or not you plan to attend the Annual Meeting, Caladrius urges you to vote by proxy to ensure your vote is counted. You may still attend
            the Annual Meeting and vote virtually if you have already voted by proxy. As a stockholder of record: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">to vote virtually</span>, attend the virtual Annual Meeting and you may vote your shares
                    electronically through the portal; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">to vote using the proxy card</span>, simply mark, sign and date your proxy card and return it
                    promptly in the postage-paid envelope provided; if you return your signed proxy card to Caladrius before the Annual Meeting, Caladrius will vote your shares as you direct; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">to vote by telephone or on the Internet</span>, dial the phone number on the proxy
                      card or voting instruction form or visit the website on the proxy card or voting instruction form to complete an electronic proxy card; you will be asked to provide the company number and control number from the enclosed proxy card
                      and your vote must be received by 11:59 p.m. Eastern time on September&#160;12, 2022, to be counted. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If your shares of Caladrius Common Stock are held in an account at a brokerage firm,
            bank, dealer or other similar organization, that is, in &#8220;street name,&#8221; you should receive voting instructions from the organization that holds your shares. If you do not give instructions to such organization, as your nominee, such nominee can
            vote your shares of Caladrius Common Stock with respect to &#8220;discretionary&#8221; items but not with respect to &#8220;non-discretionary&#8221; items. Discretionary items are proposals considered routine under Rule 452 of the New York Stock Exchange for which
            your broker or other agent may vote shares held in &#8220;street name&#8221; in the absence of your voting instructions. On non-discretionary items for which you do not give your broker or other agent instructions, the shares of Caladrius Common Stock will
            be treated as broker non-votes. It is anticipated that all proposals other than Proposal Nos. 2 and 5 will be non-discretionary items.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">All properly executed proxies that are not revoked will be voted at the Annual Meeting
            and at any adjournments or postponements of the Annual Meeting in accordance with the instructions contained in the proxy. If a holder of shares of Caladrius Common Stock executes and returns a proxy and does not specify otherwise, the shares
            of Caladrius Common Stock represented by that proxy will be voted &#8220;FOR&#8221; all of the proposals in accordance with the recommendation of the Caladrius Board of Directors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Stockholders of record, other than those Caladrius Stockholders who have
            executed support agreements, may change their vote at any time before their proxy is voted at the Annual Meeting in one of three ways: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">send timely written notice to Caladrius&#8217; Corporate Secretary stating that the stockholder would like to revoke its proxy; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">submit new proxy instructions either on a new proxy card or via phone or the Internet; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">attend the Annual Meeting and vote virtually. Simply attending the Annual Meeting will not, by itself, revoke your proxy. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If a Caladrius Stockholder of record who owns shares of Caladrius Common Stock in
            &#8220;street name&#8221; has instructed a broker to vote its shares of Caladrius Common Stock, the stockholder must follow the directions received from its broker to change those instructions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tRV"><!--Anchor--></a>Required Vote</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The presence, in person or represented by proxy, at the Annual Meeting of the holders
            of a majority of the shares of Caladrius Common Stock outstanding and entitled to vote at the Annual Meeting is necessary to constitute a quorum at the Annual Meeting. Abstentions and broker non-votes will be counted toward a quorum. The
            affirmative vote of a majority of the votes cast in person or by proxy at the Annual Meeting, assuming a quorum is present, is required for approval of Proposal Nos. 1, 5, 6, 7 and 8. The affirmative vote of the holders of a majority of shares
            of Caladrius Common Stock having voting power outstanding on the Record Date is required for approval of Proposal Nos. 2 and 3. Broker non-votes will not be counted towards the vote total for Proposal Nos. 1, 5, 6, 7 and 8. Abstentions and
            broker non-votes will have the same effect as a vote &#8220;AGAINST&#8221; Proposal Nos. 2 and 3. With respect to Proposal No.&#160;4, the three nominees receiving the most &#8220;FOR&#8221; votes (from the votes of shares present in person or represented by proxy and
            entitled to vote on the election of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">108<br />
        </div>

      </div>

    </div>

    <!--End Page 117-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 118-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_108-meeting_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">directors) will be elected. Broker non-votes will not be counted towards the vote
            total for Proposal No.&#160;4. The approval of Proposal No.&#160;1 is a condition to the completion of the Merger. Therefore, the Merger cannot be consummated without the approval of Proposal No.&#160;1. The approval of the Reverse Stock Split (Proposal
            No.&#160;2) is required in order to avoid a potential delisting of Caladrius Common Stock from The Nasdaq Capital Market. However, the approval of the Reverse Stock Split (Proposal No.&#160;2) is not a condition to closing the Merger and is also not
            conditioned upon the consummation of the Merger, and as such the Reverse Stock Split may be implemented by the Caladrius Board of Directors even if the Merger does not take place. Proposal No.&#160;3 is conditioned upon the consummation of the
            Merger. If the Merger is not completed, Proposal No.&#160;3 will not be implemented, and Caladrius&#8217; name will not be changed pursuant to this proposal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Votes will be counted by the inspector of election appointed for the Annual Meeting,
            who will separately count &#8220;FOR,&#8221; &#8220;AGAINST&#8221; and &#8220;WITHHOLD&#8221; votes, abstentions and broker non-votes. &#8220;WITHHOLD&#8221; votes with respect to the election of one or more nominees for director pursuant to Proposal No.&#160;4 will not be voted with respect to
            the director or directors indicated, although they will be counted for purposes of determining the presence of a quorum for the transaction of business at the Annual Meeting. Abstentions and broker non-votes will also be treated as shares
            present for the purpose of determining the presence of a quorum for the transaction of business at the Annual Meeting. Abstentions and broker non-votes will not, however, be considered votes cast at the Annual Meeting and will therefore not
            have any effect with respect to Proposal Nos. 1, 4, 5, 6, 7 and 8. Abstentions and broker non-votes will have the same effect as &#8220;AGAINST&#8221; votes for Proposal Nos. 2 and 3.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, the directors and executive officers of Caladrius beneficially
            owned approximately 1.8% of the outstanding shares of Caladrius Common Stock entitled to vote at the Annual Meeting. Certain of the directors and executive officers of Caladrius are subject to support agreements. Each Caladrius Stockholder that
            entered into a support agreement has agreed to vote all shares of Caladrius Common Stock owned by such holder as of the Record Date (a) in favor of (i)&#160;the approval of the Merger Agreement, (ii)&#160;the approval of the transactions contemplated
            therein, including the issuance of shares of Caladrius Common Stock pursuant to the Merger Agreement, (iii)&#160;the adoption of an amendment to Caladrius&#8217; amended and restated certificate of incorporation to effect the Reverse Stock Split, (iv)&#160;the
            adoption of an amendment to Caladrius&#8217; amended and restated certificate of incorporation to effect the Caladrius Name Change, (v)&#160;any proposal to adjourn or postpone the Annual Meeting to a later date, if there are not sufficient votes for the
            approval of the Merger Agreement and the transactions contemplated therein, including the issuance of Caladrius Common Stock pursuant to the Merger Agreement on the date on which such meeting is held, and (vi)&#160;any other proposal included in the
            proxy statement in connection with, or related to, the consummation of the Merger for which the Caladrius Board of Directors has recommended that Caladrius Stockholders vote in favor; and (b) against any competing Acquisition Proposal with
            respect to Caladrius. As of June&#160;13, 2022, Caladrius is not aware of any affiliate of Cend owning any shares of Caladrius Common Stock entitled to vote at the Annual Meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tSP"><!--Anchor--></a>Solicitation of Proxies</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition to solicitation by mail, the directors, officers, employees and agents of
            Caladrius may solicit proxies from Caladrius Stockholders by personal interview, telephone, telegram or otherwise. Caladrius and Cend will share equally the costs of printing and filing this proxy statement/prospectus/information statement and
            proxy card. Arrangements will also be made with brokerage firms and other custodians, nominees and fiduciaries who are record holders of Caladrius Common Stock for the forwarding of solicitation materials to the beneficial owners of Caladrius
            Common Stock. Caladrius will reimburse these brokers, custodians, nominees and fiduciaries for the reasonable out-of-pocket expenses they incur in connection with the forwarding of solicitation materials. Caladrius has retained Alliance
            Advisors to assist it in soliciting proxies using the means referred to above. Caladrius will pay the fees of Alliance Advisors, which Caladrius expects to be approximately $200,000 to $300,000, plus reimbursement of out-of-pocket expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tOM"><!--Anchor--></a>Other Matters</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of the date of this proxy statement/prospectus/information statement, the Caladrius
            Board of Directors does not know of any business to be presented at the Annual Meeting other than as set forth in the notice accompanying this proxy statement/prospectus/information statement. If any other matters should properly come before
            the Annual Meeting, it is intended that the shares represented by proxies will be voted with respect to such matters in accordance with the judgment of the persons voting the proxies.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">109<br />
        </div>

      </div>

    </div>

    <!--End Page 118-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 119-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tTHEME"><!--Anchor--></a>THE MERGER</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This section and the section entitled &#8220;The Merger Agreement&#8221; in
            this proxy statement/prospectus/information statement describe the material aspects of the Merger, including the Merger Agreement. While Caladrius and Cend believe that this description covers the material terms of the Merger and the Merger
            Agreement, it may not contain all of the information that is important to you. You should read carefully this entire proxy statement/prospectus/information statement for a more complete understanding of the Merger and the Merger Agreement,
            including the Merger Agreement attached to this proxy statement/prospectus/information statement as Annex&#160;A, the opinion of Back Bay attached as Annex&#160;B, and the other documents to which you are referred herein. See the section entitled &#8220;Where
            You Can Find More Information&#8221; in this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tBACKOM"><!--Anchor--></a>Background of the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors and Caladrius&#8217; management team regularly review
            Caladrius&#8217; operating and strategic plans, both near-term and long-term, as well as various strategic alternatives in an effort to enhance stockholder value. As noted in its prior Annual Reports on Form 10-K, the Caladrius Board of Directors and
            management team have focused on, among other things, the opportunities and risks associated with Caladrius&#8217; business and financial condition, potential partnering opportunities and strategic relationships, and other strategic options. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The terms of the Merger Agreement with Cend are the result of extensive arm&#8217;s-length
            negotiations among members of the Caladrius management team, and the management team of Cend, along with their respective advisors and under the guidance of each company&#8217;s board of directors. Caladrius followed a careful process assisted by
            experienced outside financial, scientific and legal advisors to rigorously examine potential transactions and transaction candidates through broad outreach to life sciences companies and a thorough process of evaluation of prospective strategic
            partners. The following is a summary of the background of the process undertaken by Caladrius, the identification and evaluation of strategic alternatives and the negotiation of the Merger Agreement with Cend. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On January&#160;25, 2021, Caladrius announced that it had closed on a private placement sale
            of its common stock and warrants to purchase common stock, gross proceeds of which totaled approximately $25&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On February&#160;12, 2021, Caladrius announced that it had entered into securities purchase
            agreements with several institutional investors to purchase shares and warrants, in a registered direct offering, gross proceeds of which totaled approximately $65&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following these announcements, Caladrius&#8217; management, along with its then engaged
            financial advisor, engaged in discussions relating to potential measures to preserve its cash while maximizing stockholder value.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On February&#160;18, 2021, Dr. David J. Mazzo, Ph.D., Caladrius&#8217; chief executive officer
              and president, received a telephone call from a board member and majority shareholder of Company A, a clinical-stage specialty pharmaceutical company developing treatments for pulmonary arterial hypertension and related diseases, a company of
              which Caladrius had performed a prior review in 2018. During such call, the representative of Company A expressed to Dr. Mazzo that Company A may be interested in exploring a strategic transaction with Caladrius whereby Caladrius would
              acquire all outstanding shares of Company A using Caladrius Common Stock as consideration for such acquisition. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;1, 2021, Caladrius and Company A executed a mutual nondisclosure agreement
            which did not include a standstill provision. Following execution of the nondisclosure agreement, members of Caladrius&#8217; management team held an introductory meeting, on March&#160;2, 2021, with Company A to discuss Company A&#8217;s business and a
            potential strategic transaction involving Caladrius. During such introductory meeting, the chief executive officer of Company A indicated to Caladrius&#8217; management team that Company A was already reviewing two other potential strategic
            transactions of its own such that, if Caladrius&#8217; management team and the Caladrius Board of Directors were interested in pursuing a transaction with Company A, any diligence and negotiation towards such a transaction would likely have to be on
            an accelerated timeline. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;3, 2021, both Caladrius and Company A provided one another access to the
            other&#8217;s virtual data room. Access to Company A&#8217;s data room was provided to members of the Caladrius clinical team, certain members of the Caladrius Board of Directors and a scientific KOL, a cardiologist, with whom Caladrius had engaged on
            prior diligence exercises.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">110<br />
        </div>

      </div>

    </div>

    <!--End Page 119-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 120-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;15, 2021, Company A presented its programs to the Caladrius management
            team. Among the items presented were preclinical findings of a revised formulation of Company A&#8217;s lead asset as well as a timeline of both near and long-term news flow which Company A predicted as its assets move through the clinic.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;14, 2021, Caladrius&#8217; management team held a meeting with members of the
            Caladrius Board of Directors and its then engaged financial advisor to discuss competing assets under evaluation, timing and any associated financial implications thereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;15, 2021, Caladrius held a meeting with members of the Caladrius Board of
            Directors to discuss updates of its review of Company A, along with other assets and companies under evaluation. Caladrius executed a consulting agreement with a second scientific KOL, a pulmonary disease specialist, to perform diligence of
            Company A. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;16, 2021, Dr. Mazzo had a telephonic meeting with a board member of Company A,
            whereby Company A reaffirmed its intent to complete a transaction with Caladrius, in favor of the two other companies actively performing diligence. Dr. Mazzo made clear that diligence of Company A remained underway, and that Caladrius, with
            the guidance of the Caladrius Board of Directors, would have a conclusive decision upon completion of the required due diligence.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On May&#160;19, 2021, Caladrius formally engaged Back Bay to provide financial and technical
            advisory services, including conducting a broad market search to identify and begin outreach to suitable merger and licensing candidates, as well as providing additional diligence of existing asset and company targets.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On May&#160;21, 2021, certain members of the Caladrius Board of Directors and its management
            team participated in a videoconference with the Chief Medical Officer of Company A to discuss outstanding technical diligence-related questions as well as addressing key concerns which had arisen from the review by Caladrius&#8217; engaged KOLs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On June&#160;7, 2021, at the direction of the Caladrius Board of Directors, Dr. Mazzo
            delivered an indication of interest for a business combination transaction involving Caladrius and Company A to Company A&#8217;s chairman of its board of directors and chief executive officer by email. The indication of interest contemplated
            Caladrius&#8217; acquisition of all outstanding shares of Company A using Caladrius&#8217; Common Stock as consideration for such acquisition at a fixed exchange ratio. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On June&#160;15, 2021, Dr. Mazzo, Dr. Gregory Brown, Chairman of Caladrius&#8217; Board of
            Directors, representatives of Caladrius&#8217; then engaged financial advisor, and members of Company A&#8217;s board held a meeting regarding the terms within Caladrius&#8217; indication of interest to gauge timing and the proposed consideration.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On June&#160;24, 2021, a board member of Company A, and chair of a special committee
            reviewing Caladrius&#8217; proposal informed Dr. Mazzo via email that, although Company A appreciated receiving the offer, its board considered the consideration contemplated by Caladrius&#8217; indication of interest to be inadequate and that a
            counterproposal would not be forthcoming. Dr. Mazzo responded by considering Caladrius&#8217; indication of interest withdrawn.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On June&#160;25, 2021, Caladrius commenced its weekly meetings with Back Bay to identify
              and evaluate opportunities and targets suitable for a merger, acquisition and/or licensing transaction. In its capacity as an advisor, cumulatively over time, Back Bay presented Caladrius with hundreds of potential opportunities for review
              which resulted in approximately ten executed non-disclosure agreements, none of which included a standstill provision. Upon the execution of a non-disclosure agreement, members of the Caladrius management and development team engaged in more
              profound technical and, in some cases, corporate due diligence of the corresponding target as a supplement to the initial screening diligence performed by Back Bay.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On October&#160;4, 2021, Back Bay provided a non-confidential presentation of Company B, a
            therapeutics company targeting primary mitochondrial diseases, and encouraged Caladrius to review the literature and proposed proceeding to having company-to-company discussions following execution of a nondisclosure agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On October&#160;5, 2021, the Caladrius Board of Directors voted to establish the
            Transactions Committee, consisting of directors Gregory B. Brown, M.D., Cynthia L. Flowers, Steven M. Klosk and David J. Mazzo, Ph.D. The purpose of the Transactions Committee was to review, and potentially to assist with negotiations of,
            transactions that Caladrius&#8217; management team believed may be suitable for future consideration by the Caladrius Board of Directors.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">111<br />
        </div>

      </div>

    </div>

    <!--End Page 120-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 121-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">On October&#160;8, 2021, during a weekly meeting with Back Bay, members of Caladrius&#8217;
            management team asked Back Bay to contact Cend as a potential target, citing the news flow of its published data presented at the European Society for Medical Oncology meeting in September 2020, and subsequent announcement of receiving FDA&#8217;s
            Fast Track Designation for treatment of pancreatic cancer on June&#160;29, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On October&#160;12, 2021, a nondisclosure agreement was executed between Caladrius and
              Company B, which did not include a standstill provision.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On October&#160;15, 2021, an introductory meeting was held between Caladrius&#8217; management
            team, Back Bay and the chief executive officer of Company B, a meeting in which the chief executive officer of Company B made clear that due to governing rules of Company B&#8217;s corporate domicile, Caladrius must provide a formal indication of
            interest, absent any specific considerations, prior to commencing due diligence and obtaining access to Company B&#8217;s data room.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">On October&#160;20, 2021, Back Bay delivered Caladrius&#8217; formal indication of interest to
            Company B.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">On November&#160;1, 2021, both Caladrius and Company B provided one another access to the
            other&#8217;s virtual data room.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On November&#160;2, 2021, Back Bay emailed David Slack, president and chief executive
            officer of Cend to set up a meeting. A meeting between representatives of Back Bay and Mr.&#160;Slack transpired on November&#160;4, 2021, introducing Caladrius, without making specific mention of Caladrius. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On November&#160;15, 2021, Caladrius discovered that the lead program of Company B was on a
            full clinical hold, information not previously disclosed by Company B. Dr. Mazzo instructed Caladrius&#8217; management team and Back Bay to halt the ongoing diligence until the matter was adequately resolved.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On November&#160;16, 2021, a nondisclosure agreement was executed between Caladrius and
              Cend, which did not include a standstill provision.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">On November&#160;17, 2021, Dr. Mazzo and Mr.&#160;Slack had an introductory meeting over
            videoconference.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On November&#160;24, 2021, the chief executive officer of Company B notified Dr. Mazzo that
            the clinical hold had been lifted and its IND approved, thereby ensuring that diligence could resume.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;1, 2021, Dr. Mazzo and Mr.&#160;Slack held an in-person meeting in Boston,
            Massachusetts, to discuss the businesses of Caladrius and Cend, respectively, and Caladrius&#8217; potential interest in pursuing a strategic transaction with Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;6, 2021, Dr. Mazzo requested certain diligence items of Company B&#8217;s chief
            executive officer that were either unknown, had gone unanswered or were unable to be found within Company B&#8217;s data room.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;8, 2021, during Caladrius&#8217; regularly scheduled quarterly Caladrius Board of
            Directors meeting, members of the Caladrius team and Back Bay presented its findings of Company B, outstanding items from diligence and gating factors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;15, 2021, Caladrius&#8217; management and Back Bay participated in an
            introductory call with management of Cend and its scientific founder, Erkki Ruoslahti, MD, PhD. During the call, Dr. Mazzo provided an overview of Caladrius, its technology and pipeline activities. In kind, Mr.&#160;Slack presented an overview of
            Cend, its technology and pipeline activities. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;16, 2021, Dr. Mazzo had a telephonic meeting with the chairman of Company
            B&#8217;s board of directors and expressed Caladrius&#8217; willingness to proceed with diligence with the hopes of concluding a transaction; however, he indicated that Caladrius could not proceed with due diligence until the open diligence items were
            provided and addressed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;17, 2021, Mr.&#160;Slack delivered to representatives of Back Bay responses to
            certain due diligence questions previously delivered to Cend by Back Bay. Back Bay circulated such responses to Caladrius&#8217; management team.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;20, 2021, Mr.&#160;Slack called Dr. Mazzo and reaffirmed Cend&#8217;s interest in
            pursuing a transaction with Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On January&#160;6, 2022, Mr.&#160;Slack delivered a non-binding indication of interest for a
            business combination transaction involving Caladrius and Cend to Dr. Mazzo by email.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">112<br />
        </div>

      </div>

    </div>

    <!--End Page 121-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 122-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Between January 12 and January&#160;20, 2022, Back Bay arranged and hosted five
            independent calls with pancreatic cancer physicians and KOLs, and presented, in a blinded manner, Cend&#8217;s technology and clinical findings; feedback of which was largely met with optimism. Members of Caladrius management team participated in
            each of the calls.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Throughout January and into March, representatives from Caladrius, their advisors and
            Cend continued to perform due diligence on one another. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On January&#160;12, 2022, the Transactions Committee, as well as members of Caladrius&#8217;
            management team, Back Bay and representatives of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., outside legal counsel to Caladrius (&#8220;Mintz&#8221;), held a meeting via videoconference to discuss Cend&#8217;s non-binding indication of interest and the
            desired response.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On January&#160;17, 2022, Caladrius held a meeting to discuss a counterproposal to Cend&#8217;s
            indication of interest with members of its management team, Dr. Brown, Back Bay, and Mintz.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On January&#160;18, 2022, following a call between the two; Dr. Mazzo provided Mr.&#160;Slack,
            via email, a counterproposal to Cend&#8217;s indication of interest. In addition, on January&#160;18, 2022, Mr.&#160;Slack delivered to representatives of Back Bay responses to certain due diligence questions previously delivered to Cend by Back Bay. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On January&#160;21, 2022, Cend formally engaged Evercore Group LLC (&#8220;Evercore&#8221;) to advise on
            potential strategic transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">From January&#160;31, 2022, through February&#160;4, 2022, Dr. Mazzo had a series of introductory
            meetings with members of the Cend Board of Directors; with director, Dr. Mike Sailor on January&#160;31, with scientific founder and chairman, Dr. Erkki Ruoslahti on February&#160;2, and with director, Ms.&#160;Heidi Henson on February&#160;4, respectively.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On February&#160;9, 2022, Mr.&#160;Slack notified Dr. Mazzo, via email, that Cend was exploring a
            transaction with another party, and though each party remained far apart on relative valuation, that a definitive decision with the other party would be made clear in a matter of weeks, if not days.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On February&#160;15, 2022, Caladrius&#8217; management team held a meeting to discuss strategy and
            other opportunities in the event a transaction with Cend did not materialize. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On February&#160;22, 2022, Mr.&#160;Slack notified Dr. Mazzo by email, that Cend&#8217;s discussions
            with the other party had ceased, thereby ensuring that Caladrius and Cend could resume discussions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Between February&#160;23, 2022, and March&#160;1, 2022, Dr. Mazzo participated in several
            telephonic meetings with Mr.&#160;Slack to discuss Caladrius&#8217; interest in pursuing a strategic transaction with Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;1, 2022, Dr. Mazzo and Mr.&#160;Slack met for dinner in San Diego, California,
              followed by a full day of meetings, on March&#160;2, 2022, at Cend&#8217;s offices. Among other things, Dr. Mazzo and Mr. Slack discussed the potential management structure of a combined entity.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;9, 2022, Mr.&#160;Slack presented an overview of Cend, its technology and rationale
            for a transaction to the Caladrius Board of Directors during Caladrius&#8217; regularly scheduled quarterly Caladrius Board of Directors meeting. Also on that day, Dr. Mazzo presented an overview of Caladrius, its technology and rationale for a
            transaction to the Cend Board of Directors during Cend&#8217;s regularly scheduled quarterly board meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;13, 2022, Caladrius and Cend executed a non-binding term sheet with a 90-day
            period of exclusivity. Also, following execution of the term sheet, the parties corresponded, via email, regarding the concept of having a development agreement in place, whereby Caladrius would invest into Cend an undetermined sum to fund
            Cend&#8217;s clinical efforts in advance of a merger closing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;14, 2022, members of Caladrius, Back Bay and Mintz discussed the scope of the
            proposed Merger Agreement concomitant with a joint development agreement and investment in Cend. Also on March&#160;14, 2022, Dr. Brown, held a videoconference with Dr. Ruoslahti. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;21, 2022, representatives of Mintz, delivered to Caladrius and Back Bay, a
            draft of the proposed Merger Agreement.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">113<br />
        </div>

      </div>

    </div>

    <!--End Page 122-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 123-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Between March&#160;23, 2022, and March&#160;30, 2022, members of Caladrius, Mintz and Back Bay
            participated in several videoconferences to discuss the proposed joint development agreement and investment in Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On March&#160;29, 2022, following the inputs of Caladrius management and Back Bay,
            representatives of Mintz, delivered to Cend and Procopio, Cory, Hargreaves &amp; Savitch LLP (&#8220;Procopio&#8221;), outside legal counsel to Cend, a draft of the proposed Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;1, 2022, Procopio provided Mintz with a &#8220;high-level&#8221; issues list, including,
            among other things, a discussion of fiduciary outs and break-up fees and the introduction of a minimum cash closing condition. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;4, 2022, members of Caladrius&#8217; management team, Back Bay and Mintz held a
            meeting to discuss the status and timing of the proposed joint development agreement with Mr.&#160;Slack and representatives of Procopio.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;6, 2022, Dr. Mazzo and Dr. Kristen K. Buck, Caladrius&#8217; EVP of R&amp;D and
            Chief Medical Officer, participated in meetings with Mr.&#160;Slack and Dr. Andrew Dorr, Cend&#8217;s consulting Chief Medical Officer, at Cend&#8217;s offices. Also on April&#160;6, representatives of Procopio delivered via email, a proposal in which terms of the
            joint development agreement would be bifurcated into two separate agreements: a follow-on investment round of funding, comprised of broad provisions and rights therewith, along with a technical collaboration agreement, governed via a joint
            steering committee with equal participants from both Caladrius and Cend. Also on April&#160;6, Procopio provided Mintz with an updated term sheet related to the proposed investment by Caladrius in Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;7, 2022, members of Caladrius&#8217; management team, representatives of Mintz and
            Back Bay held a meeting to discuss terms of the proposed investment agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;8, 2022, members of Caladrius and Back Bay held a meeting on items related to
            Caladrius&#8217; balance sheet and any impact thereto, of its investment in Cend. Also on April&#160;8, Mintz provided Procopio with responses to the term sheet related to the proposed investment by Caladrius in Cend, including a discussion of voting
            rights and anti-dilution protection.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;11, 2022, the Transactions Committee, as well as members of Caladrius&#8217;
            management team and representatives of Mintz, held a meeting via videoconference to outline terms of each the Merger Agreement, Purchase Agreement and Collaboration Agreement. With Mintz&#8217;s guidance, the Transaction Committee provided its input
            on certain covenants and provisions of the Merger Agreement, specifically, termination fees payable by each party in the event of termination in certain circumstances, closing conditions, deal-related fees and expenses and rights provided to
            Caladrius within the Purchase Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;12, 2022, representatives of Caladrius and Mintz held a meeting to discuss
            Caladrius&#8217; representations and warranties. Also on April&#160;12, a representative of Caladrius, its outside patent counsel of McCarter &amp; English, Mr.&#160;Slack, and a representative of Procopio had a meeting, via videoconference, to discuss Cend&#8217;s
            intellectual property representations and warranties.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;13, 2022, members of Caladrius&#8217; management team, representatives of Mintz and
            Back Bay held a meeting to discuss terms of the Merger Agreement, specifically the provision regarding Caladrius&#8217; net cash at closing. Also on April&#160;13, Dr. Mazzo, Dr. Buck, Mr.&#160;Slack, Dr. Ruoslahti, and Dr. Dorr, had a meeting, via
            videoconference, to discuss Cend&#8217;s proposed upcoming clinical studies and Mintz had a meeting with Procopio to discuss open items in the Merger Agreement, including termination fees and closing conditions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;14, 2022, Mintz provided Procopio with the forms of support agreement and
            lock-up agreements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;18, 2022, representatives of Caladrius and Mintz held a meeting to discuss
            open points, specifically with respect to the disclosure schedules to be attached to the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;20, 2022, the Transactions Committee, members of Caladrius&#8217; management team
            and representatives of Mintz, held a meeting via videoconference, seeking guidance and resolution of key issues respective to the Merger Agreement. Also on April&#160;20, 2022, members of Caladrius&#8217; management team, representatives from Mintz,
            representatives of Back Bay, Mr.&#160;Slack, representatives of Procopio, and representatives of Evercore, held a meeting to discuss remaining issues associated with the Merger Agreement, including the exchange ratio, Caladrius&#8217; anticipated cash at
            closing, Cend&#8217;s transaction-related expenses, capital allocation, and Caladrius&#8217; fully-diluted cap table, including warrants, outstanding equity awards and equity plan reserves. In addition, on April&#160;20, Procopio provided Mintz with a revised
            draft of the Merger Agreement.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">114<br />
        </div>

      </div>

    </div>

    <!--End Page 123-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 124-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;21, 2022, representatives of Caladrius, Mintz and Procopio held a meeting
            to review both parties&#8217; respective capitalization tables. Also on April&#160;21, Mintz provided Procopio with a revised draft of the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;22, 2022, representatives of Caladrius and Mintz held a meeting to discuss
            specifics of Caladrius&#8217; assumptions of net cash at closing and discussions regarding the structure of the proposed investment by Caladrius in Cend. Also on April&#160;22, Procopio provided Mintz with a revised draft of the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;23, 2022, Dr. Mazzo, representatives of Mintz, Mr.&#160;Slack, and representatives
            at Procopio held a meeting to resolve all remaining issues associated with the Purchase Agreement and the Merger Agreement, specifically regarding Caladrius&#8217; anticipated cash at closing, the targeted closing date of the transaction and
            anti-dilution rights of potential future down-rounds. Following this meeting, Mintz provided Procopio with a revised draft of the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;24, 2022, members of Caladrius, representatives of Mintz, representatives of
            Procopio, and representatives of Evercore held a meeting, by videoconference, to discuss adjustments to net cash at the closing and the definition and calculations of the exchange ratio. Later on April&#160;24, Mintz circulated the final executable
            copy of the Merger Agreement to each of Caladrius, Back Bay, Cend, Procopio, and Evercore.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;25, 2022, the Caladrius Board of Directors held a videoconference meeting for
            the purpose of reviewing and discussing the final terms of the Merger Agreement, including consideration of the fairness analysis by Back Bay with respect to the merger consideration and receiving an update as to timing of the merger.
            Participants included all members of the Caladrius Board of Directors, and representatives from Caladrius&#8217; management team, Back Bay, and Mintz. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Mintz representative provided a detailed review of the material terms of the Merger
            Agreement, Collaboration Agreement and Purchase Agreement. Representatives of Mintz also reviewed with the Caladrius Board of Directors the final forms of the Voting Agreement and lock-up agreement to be entered into by the directors and
            officers. During this review, several areas where Caladrius was successful in negotiating concessions or better outcomes than were originally advanced by Cend (including with respect to termination provisions and fees and deal structuring
            provisions that increased deal certainty from Caladrius' perspective) were discussed, as well as other negotiated points. During this presentation, questions from the directors were addressed, including a detailed discussion about the minimum
            cash closing requirement and Caladrius' comfort level of satisfying that condition under various scenarios. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Representatives from Back Bay provided a detailed fairness presentation, during which
            directors' questions were asked and answered. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Mintz representative also provided a review of the Caladrius Board of Directors&#8217;
            fiduciary duties and other legal aspects of the transaction. The Caladrius Board of Directors expressed consensus and satisfaction that a full and complete process had been run and that the appropriate corporate governance steps had been taken.
            The Caladrius Board of Directors reiterated its view that the proposed transaction was the best opportunity for maximizing Caladrius stockholder value, noting the objective merits of both the process that had been engaged in, the ultimate
            selection of Cend based on scientific, clinical, and probability-of-success rationale, along with the deal terms. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">After it was confirmed that there were no material changes to the Merger Agreement from
            the version it had previously reviewed, Back Bay orally presented its fairness opinion, which was confirmed by delivery of a written opinion dated April&#160;25, 2022, that, as of that date, and based upon the assumptions, qualifications and
            limitations set forth in its opinion, the Exchange Ratio was fair, from a financial point of view, to the Caladrius Stockholders. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following these presentations and discussions, representatives of Mintz reviewed with
            the Caladrius Board of Directors the proposed resolutions that had been provided in advance of the meeting. Following review and discussion among the participants, the Caladrius Board of Directors unanimously determined that the transactions
            contemplated by the Merger Agreement, including the Merger and the issuance of shares of Caladrius Common Stock to the Cend Stockholders pursuant to the Merger Agreement, were fair to, advisable and in the best interest of Caladrius and the
            Caladrius Stockholders; approved and declared advisable the Merger Agreement and the transactions contemplated therein, including the Merger and the issuance of shares of Caladrius Common Stock to the Cend Stockholders; and determined to
            recommend, upon the terms and subject to the conditions of the </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">115<br />
        </div>

      </div>

    </div>

    <!--End Page 124-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 125-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Merger Agreement, that the Caladrius Stockholders vote to approve the Merger
            Agreement and the transactions contemplated therein, including the Merger and the issuance of shares of Caladrius Common Stock to the Cend Stockholders. In the evening of April&#160;26, 2022, the Merger Agreement and related signing agreements were
            signed. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;27, 2022, at 8:30 A.M. Eastern Time, Caladrius and Cend issued a joint press
            release publicly announcing the signing of the definitive Merger Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tRFTM"><!--Anchor--></a>Caladrius Reasons for the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors considered the following factors in reaching its
            conclusion to approve the Merger Agreement and the transactions contemplated thereby and to recommend that Caladrius Stockholders approve the Merger Agreement, and thereby approve the Merger and the other transactions contemplated by the Merger
            Agreement, including the issuance of shares of Caladrius Common Stock in the Merger, all of which the Caladrius Board of Directors viewed as supporting its decision to approve the business combination with Cend: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors and its financial advisor undertook a comprehensive and thorough process of reviewing and
                    analyzing potential merger candidates to identify the opportunity that would, in the Caladrius Board of Directors&#8217; opinion, create the most value for Caladrius Stockholders;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors believes that, as a result of arm&#8217;s length negotiations with Cend, Caladrius and its
                    representatives negotiated the highest exchange ratio that Cend was willing to agree to and that the terms of the Merger Agreement include the most favorable terms to Caladrius in the aggregate to which Cend was willing to agree;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors believes that, after a thorough review of strategic alternatives and discussions with
                    Caladrius&#8217; senior management, financial advisors and legal counsel, the Merger is more favorable to Caladrius Stockholders than the potential value that might have resulted from other strategic options available to Caladrius;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors believes, based in part on scientific diligence and analysis of Cend&#8217;s product pipeline, its
                    therapeutic discovery capabilities, the potential market opportunity for its products and the expertise of its scientific team, which was conducted over several weeks by Caladrius&#8217; management and reviewed with the Caladrius Board of
                    Directors, that Cend&#8217;s potential product candidates represent a sizeable market opportunity, and may thereby create value for the stockholders of the combined organization and an opportunity for Caladrius Stockholders to participate in
                    the potential growth of the combined organization;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors also reviewed with the management of Caladrius and the management of Cend the current plans of
                    Cend for developing CEND-1 to confirm the likelihood that the combined organization would possess sufficient financial resources to allow the management team to focus on the continued development and anticipated commercialization of
                    those development candidates, and also considered the possibility that the combined organization would be able to take advantage of the potential benefits resulting from the combination of Caladrius&#8217; public company structure with Cend&#8217;s
                    business to raise additional funds in the future, if necessary;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors also considered the strength of the balance sheet of the combined organization, in addition to
                    the approximately $69.9&#160;million of net cash that Caladrius is expected to have immediately prior to the consummation of the Merger, assuming for this purpose a closing date of September&#160;30, 2022;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors also considered that the combined organization will be led by an experienced senior management
                    team and a board of directors with representation from each of the current boards of directors of Caladrius and Cend; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors considered the financial analyses of Back Bay, including its opinion to the Caladrius Board of
                    Directors as to the fairness to Caladrius Stockholders, from a financial point of view as of the date of the opinion, of the Exchange Ratio, as more fully described below under the caption &#8220;<span style="font-style: italic;">The
                      Merger&#8212;Opinion of the Caladrius Financial Advisor</span>.&#8221;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">116<br />
        </div>

      </div>

    </div>

    <!--End Page 125-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 126-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors also reviewed various factors impacting the
            financial condition, results of operations and prospects for Caladrius, including: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the strategic alternatives to the Merger, including potential transactions that could have resulted from discussions that
                    Caladrius&#8217; management conducted with other potential merger, acquisition and licensing partners;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the risks associated with continuing to operate Caladrius drug development programs on a stand-alone basis without diversifying
                    its pipeline of development product candidates; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius&#8217; potential inability to maintain its listing on The Nasdaq Capital Market without completing the Merger and the
                    Reverse Stock Split.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors also reviewed the terms and conditions of the Merger
            Agreement and associated transactions, as well as the safeguards and protective provisions included therein intended to mitigate risks, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the initial Exchange Ratio used to establish the number of shares of Caladrius Common Stock to be issued to Cend Stockholders in
                    the Merger was determined based on the relative valuations of the companies, and thus the relative percentage ownership of Caladrius Stockholders and Cend Stockholders immediately following the completion of the Merger is subject to
                    adjustment based on the amount of Caladrius&#8217; net cash immediately prior to Closing and Cend&#8217;s unpaid transaction costs;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the limited number and nature of the conditions to Cend&#8217;s obligation to consummate the Merger and the limited risk of
                    non-satisfaction of such conditions as well as the likelihood that the Merger will be consummated on a timely basis;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the respective rights of, and limitations on, Caladrius and Cend under the Merger Agreement to consider certain unsolicited
                    Acquisition Proposals under certain circumstances should Caladrius or Cend receive a superior offer;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the reasonableness of the potential termination fee of $1.0&#160;million or $4.0&#160;million, as applicable, and related reimbursement of
                    certain transaction expenses of up to $1.0&#160;million, which could become payable by either Caladrius or Cend if the Merger Agreement is terminated in certain circumstances;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the support agreements, pursuant to which the directors and officers of Caladrius and the directors, officers and certain
                    stockholders of Cend have agreed, solely in their capacity as stockholders of Caladrius and Cend, respectively, to vote all of their shares of Caladrius Common Stock or Cend Capital Stock in favor of the approval or adoption,
                    respectively, of the Merger Agreement;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the agreement of Cend to provide the written consent of Cend Stockholders necessary to adopt the Merger Agreement thereby
                    approving the Merger and related transactions within two business days of the registration statement on Form S-4, of which this proxy statement/prospectus/information statement is a part, becoming effective; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the belief that the terms of the Merger Agreement, including the parties&#8217; representations, warranties and covenants, and the
                    conditions to their respective obligations, are reasonable under the circumstances.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the course of its deliberations, the Caladrius Board of Directors also considered a
            variety of risks and other countervailing factors related to entering into the Merger, including: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the $1.0&#160;million termination fee and up to $1.0&#160;million in related expense reimbursement obligations payable by Caladrius to
                    Cend upon the occurrence of certain events and the potential effect of such fees in deterring other potential acquirers from proposing an alternative transaction that may be more advantageous to Caladrius Stockholders;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the substantial expenses to be incurred in connection with the Merger, including the costs associated with any related
                    litigation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the possible volatility, at least in the short term, of the trading price of Caladrius Common Stock resulting from the
                    announcement of the Merger;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">117<br />
        </div>

      </div>

    </div>

    <!--End Page 126-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 127-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the risk that the Merger might not be consummated in a timely manner or at all and the potential adverse effect on the
                    reputation of Caladrius of the public announcement of the Merger or delay or failure to complete the Merger;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the likely detrimental effect on Caladrius&#8217; cash position, stock price and ability to initiate another process and to
                    successfully complete an alternative transaction should the Merger not be completed;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the risk to Caladrius&#8217; business, operations and financial results in the event that the Merger is not consummated, including the
                    diminution of Caladrius&#8217; cash and its possible inability to raise additional capital through the public or private sale of equity securities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the likelihood of disruptive stockholder litigation following announcement of the Merger;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the unproven, early-stage nature of Cend&#8217;s product candidates, which may not be successfully developed into products that are
                    marketed and sold;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the strategic direction of the combined organization following the completion of the Merger; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">various other risks associated with the combined organization and the Merger, including those described in the section entitled
                    &#8220;<span style="font-style: italic;">Risk Factors</span>&#8221; in this proxy statement/prospectus/information statement.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The foregoing information and factors considered by the Caladrius Board of Directors
            are not intended to be exhaustive but are believed to include all of the material factors considered by the Caladrius Board of Directors. In view of the wide variety of factors considered in connection with its evaluation of the Merger and the
            complexity of these matters, the Caladrius Board of Directors did not find it useful to attempt, and did not attempt, to quantify, rank or otherwise assign relative weights to these factors. In considering the factors described above,
            individual members of the Caladrius Board of Directors may have given different weight to different factors. The Caladrius Board of Directors conducted an overall analysis of the factors described above, including thorough discussions with, and
            questioning of, Caladrius&#8217; management team, members of the Strategy Committee and the legal and financial advisors of Caladrius, and considered the factors overall to be favorable to, and to support, its determination.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCENDRFM"><!--Anchor--></a>Cend Reasons for the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following discussion sets forth material factors considered by the Cend Board of
            Directors in reaching its determination to approve the Merger Agreement and approve the Merger; however, it may not include all of the factors considered by the Cend Board of Directors. In light of the number and wide variety of factors
            considered in connection with its evaluation of the Merger Agreement and the Merger, the Cend Board of Directors did not consider it practicable to, and did not attempt to, quantify or otherwise assign relative weights to the specific factors
            it considered in reaching its determination. The Cend Board of Directors viewed its position and determinations as being based on all of the information available and the factors presented to and considered by it. In addition, individual
            directors may have given different weight to different factors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the course of reaching its decision to approve the Merger, the Cend Board of
            Directors engaged Evercore to represent it in negotiations and provide guidance in determining whether a proposed merger was favorable. Cend also consulted with Cend&#8217;s senior management, financial and tax advisors and legal counsel, reviewed a
            significant amount of information and considered a number of factors, including, among others: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">historical and current information concerning Cend&#8217;s business, including its financial performance and condition, operations,
                    management and competitive position;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the potential increased access to sources of capital and a broader range of investors to support the clinical development of its
                    therapeutic candidates following consummation of the transaction compared to if Cend continued to operate as a privately held company;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the potential to provide current Cend Stockholders with greater liquidity by owning stock in a public company;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Cend Board of Directors&#8217; belief that no alternatives to the Merger were reasonably likely to create greater value for Cend
                    Stockholders, after reviewing the various financing and other strategic options to enhance stockholder value that were considered by the Cend Board of Directors;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">118<br />
        </div>

      </div>

    </div>

    <!--End Page 127-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 128-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the $10&#160;million of cash resources provided to Cend by Caladrius pursuant to the Purchase Agreement and the cash resources of the
                    combined organization expected to be available at the Closing relative to the anticipated burn rate of the combined organization;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the availability of appraisal rights under the DGCL to Cend Stockholders who comply with the required procedures under the DGCL,
                    which allow such Cend Stockholders to seek appraisal of the fair value of their shares of Cend Capital Stock as determined by the Delaware Court of Chancery;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the expectation that the Merger would be a higher probability and more cost-effective means to access capital than other options
                    considered by the Cend Board of Directors, including additional private financings or an initial public offering;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the terms and conditions of the Merger Agreement, including, without limitation, the following:</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the determination that the expected relative percentage ownership of Caladrius Stockholders and Cend Stockholders in the
                    combined organization was appropriate, in the judgment of the Cend Board of Directors, based on the Cend Board of Directors&#8217; assessment of the approximate valuations of Caladrius (including the value of the net cash Caladrius is
                    expected to provide to the combined organization) and Cend (including the value of the net cash Cend is expected to provide to the combined organization);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the expectation that the Merger will be treated as a reorganization for U.S. federal income tax purposes;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the limited number and nature of the conditions to the obligation of Caladrius to consummate the Merger;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the rights of Cend under the Merger Agreement to consider certain unsolicited Acquisition Proposals under certain circumstances
                    should Cend receive a superior proposal;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the conclusion of the Cend Board of Directors that the potential termination fee of $1.0&#160;million payable by Caladrius and
                    $4.0&#160;million payable by Cend and related reimbursement of certain transaction expenses of up to $1.0&#160;million, which could become payable by either Caladrius or Cend if the Merger Agreement is terminated in certain circumstances, were
                    reasonable; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the belief that the other terms of the Merger Agreement, including the parties&#8217; representations, warranties and covenants, and
                    the conditions to their respective obligations, were reasonable in light of the entire transaction;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the fact that shares of Caladrius Common Stock issued to Cend Stockholders will be registered on a Form S-4 registration
                    statement and will become freely tradable for Cend Stockholders who are not affiliates of Cend and who are not parties to lock-up agreements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the support agreements, pursuant to which certain directors, officers and stockholders of Caladrius and Cend, respectively, have
                    agreed, solely in their capacity as stockholders of Caladrius and Cend, respectively, to vote all of their shares of Cend Capital Stock or Caladrius Common Stock in favor of the adoption or approval, respectively, of the Merger
                    Agreement;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ability to obtain a Nasdaq listing and the fact that Caladrius will, subject to approval by Caladrius Stockholders of
                    Proposal No. 3, change its name to &#8220;Lisata Therapeutics, Inc.&#8221; upon the Closing;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the fact that the proposed Merger may enable certain stockholders of Caladrius and Cend to increase the value of their current
                    shareholding; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the likelihood that the Merger will be consummated on a timely basis.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend Board of Directors also considered a number of uncertainties and risks in its
            deliberations concerning the Merger and the other transactions contemplated by the Merger Agreement, including the following: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the possibility that the Merger might not be completed and the potential adverse effect of the public announcement of the Merger
                    on the reputation of Cend and the ability of Cend to obtain financing in the future in the event the Merger is not completed;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the fact that the Exchange Ratio is not subject to adjustment based on the price of Caladrius Common Stock, which the Cend Board
                    of Directors determined is appropriate to determine relative percentage ownership of Caladrius&#8217; and Cend&#8217;s security holders;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">119<br />
        </div>

      </div>

    </div>

    <!--End Page 128-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 129-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the termination fee of $4.0&#160;million, or in some situations the reimbursement of certain transaction expenses incurred in
                    connection with the Merger of up to $1.0&#160;million, payable by Cend to Caladrius upon the occurrence of certain events, and the potential effect of such fees in deterring other potential acquirers from proposing an alternative transaction
                    that may be more advantageous to Cend Stockholders;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the risk that the Merger might not be consummated in a timely manner or at all;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the expenses to be incurred in connection with the Merger and related administrative challenges associated with combining the
                    companies;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the additional expenses and obligations Cend&#8217;s business will be subject to following the Merger that Cend has not previously
                    been subject to, and the operational changes to Cend&#8217;s business, in each case that may result from being a public company;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the fact that the representations and warranties in the Merger Agreement do not survive the Closing and the potential risk of
                    liabilities that may arise post-Closing; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">various other risks associated with the combined organization and the Merger, including the risks described in the section
                    entitled &#8220;<span style="font-style: italic;">Risk Factors</span>&#8221; in this proxy statement/prospectus/information statement.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend Board of Directors weighed the benefits, advantages and opportunities of a
            potential transaction against the uncertainties and risks described above, as well as the possible diversion of Cend&#8217;s management&#8217;s attention for an extended period of time. After taking into account these and other factors, the Cend Board of
            Directors approved and authorized the Merger Agreement and the transactions contemplated thereby, including the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tOOTC"><!--Anchor--></a>Opinion of the Caladrius Financial
            Advisor</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius engaged Back Bay to advise the Caladrius Board of Directors with respect to
            ongoing strategic planning and the consideration of alternative strategies, including a possible merger, pursuant to an engagement letter dated May&#160;21, 2021. As part of this engagement and at the request of the Caladrius Board of Directors,
            Back Bay delivered an opinion, dated April&#160;25, 2022, to the Caladrius Board of Directors to the effect that, as of that date and based on and subject to various assumptions, qualifications, matters considered and limitations described in the
            opinion, the consideration provided for in the Merger was fair, from a financial point of view, to Caladrius. For purposes of Back Bay&#8217;s analyses and opinion, the term consideration refers to (i)&#160;the cancellation of 1,135,650 shares of Cend
            Series D Preferred Stock, $0.00001 par value per share, which were issued to Caladrius for an aggregate purchase price of $10.0&#160;million pursuant to the Purchase Agreement that was entered into by Caladrius and Cend concurrently with their entry
            into the Merger Agreement and (ii)&#160;the shares of Caladrius Common Stock to be issued to holders of Cend Capital Stock in the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay&#8217;s opinion was provided solely for the benefit of the
            Caladrius Board of Directors (in its capacity as such) in connection with, and for the purposes of, its evaluation of the Merger. Back Bay&#8217;s opinion addressed only the fairness, from a financial point of view and as of the date of such opinion,
            of the consideration (as expressly specified in such opinion) and did not address any other aspect of the Merger. Back Bay&#8217;s opinion did not address the relative merits of the Merger as compared to other business strategies or transactions that
            might be available to Caladrius or Caladrius&#8217; underlying business decision to effect the Merger. Back Bay does not express any opinion and does not make any recommendation to any stockholder as to how such stockholder should vote or act with
            respect to the Merger or any proposal to be voted upon in connection with the Merger or otherwise.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay&#8217;s opinion does not address the relative merits of the Merger as compared to
            alternative transactions or strategies that might have been available to Caladrius, nor does it address the underlying business decision of Caladrius or the Caladrius Board of Directors to pursue, structure, approve, recommend or proceed with
            the Merger. Back Bay does not express any view on, and its opinion does not address, any other term or aspect of the Merger Agreement or the transactions contemplated thereby or any term or aspect of any other agreement or instrument
            contemplated by the Merger Agreement or entered into or amended in connection the entry into the Merger Agreement. No opinion, counsel or interpretation is intended in matters that require legal, regulatory, accounting, insurance, tax, or other
            similar professional advice. Back Bay relied, with the Caladrius Board of Directors&#8217; consent, on the advice of the outside counsel and independent accountants of Caladrius, and on the assumptions of the management of Caladrius, as to all legal,
            regulatory, accounting, insurance, and tax matters with respect to Caladrius, Cend, and the Merger. In addition, Back Bay expressed no opinion on, and its opinion </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">120<br />
        </div>

      </div>

    </div>

    <!--End Page 129-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 130-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">does not in any manner address, the fairness of the amount or the nature of any
            compensation to be paid to any officers, directors, or employees of any parties to the Merger, or any class of such persons, relative to the consideration paid in the Merger or otherwise. No limitations were imposed by the Caladrius Board of
            Directors upon Back Bay with respect to the investigations made or procedures followed by it in rendering its opinion. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In connection with its opinion, Back Bay among other things: (i)&#160;reviewed the draft
            Merger Agreement, dated April&#160;24, 2022, and other related documentation, including the Collaboration Agreement and the Purchase Agreement; (ii)&#160;reviewed certain publicly available historic financials, operating data, and other business
            information regarding Caladrius; (iii)&#160;reviewed financial and operating information with respect to the business, operations and prospects of Caladrius furnished to Back Bay by Caladrius, including financial projections of Caladrius prepared by
            management of Caladrius, which are referred to herein as the Caladrius projections, (iv)&#160;reviewed financials, operating data, capitalization, pro formas, other internal documents, trading information of Caladrius stock, and other business
            information regarding Cend, prepared by and furnished to Back Bay by the management of Cend, including financial projections of Cend prepared by management of Cend, which are referred to herein as Cend projections, (v)&#160;held discussions with
            members of senior management of Caladrius and Cend, regarding past and current operations, financial condition and prospects; (vi)&#160;reviewed certain financial and stock market data of Caladrius and other selected publicly held companies Back Bay
            deemed to be comparable to Caladrius and Cend; (vii)&#160;reviewed the financial terms, to the extent publicly available, of certain announced acquisitions and corporate transactions Back Bay deemed to be comparable to the Merger; (viii)&#160;performed a
            discounted cash flow analysis of Cend on a stand-alone basis; and (ix)&#160;took into account such other quantitative analyses and other matters Back Bay deemed relevant and necessary, including an assessment of general economic, market and monetary
            conditions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In conducting its review and analysis and in arriving at its opinion, Back Bay, with
            consent of the Caladrius Board of Directors, assumed and relied, without independent investigation, upon the accuracy and completeness of all financial and other information provided to Back Bay or publicly available. Back Bay did not undertake
            any responsibility for independently verifying, and did not independently verify the accuracy, completeness, or reasonableness of any such information and further relied upon the assurances of the management of Caladrius that they are not aware
            of any facts or circumstances that would make such information inaccurate or misleading. Back Bay did not make or obtain any independent evaluations, valuations or appraisals of the assets or liabilities (contingent or otherwise) of Caladrius
            or Cend, nor was Back Bay furnished with such materials. Back Bay made no independent investigation of any legal, accounting or tax matters relating to Caladrius, Cend, or the Merger, and assumed the correctness and adequacy of all legal,
            accounting and tax advice given. With respect to the Caladrius projections, upon the advice of the Caladrius Board of Directors, Back Bay assumed that such projections were reasonably prepared on a basis reflecting the best currently available
            estimates and judgments of the management of Caladrius as to the future financial performance of Caladrius and that Caladrius will perform substantially in accordance with such projections and relied on the Caladrius projections in arriving at
            its opinion. With respect to Cend projections, upon the advice and at the direction of the Caladrius Board of Directors, Back Bay assumed that such projections were reasonably prepared on a basis reflecting the best currently available
            estimates and judgments of the management of Cend as to the future financial performance of Cend and that Cend will perform substantially in accordance with such projections and relied on Cend projections in arriving at its opinion. Back Bay
            assumed in its analysis that Caladrius will be deemed to be the acquiring party for accounting purposes. For purposes of rendering its opinion, Back Bay assumed in all respects material to its analysis, that the consideration was determined
            through arm&#8217;s-length negotiations between the appropriate parties, that the representations and warranties of each party contained in the Merger Agreement are true and correct, that each party will perform all of the covenants and agreements
            required to be performed by it under the Merger Agreement without material alteration or waiver thereof, that all estimated financial forecasts will be realized, that all governmental, regulatory, shareholder or other consents and approvals
            necessary for the consummation of the Merger will be obtained without any adverse effect on the expected benefits of the Merger or in any way meaningful to its analysis, and that all conditions to the consummation of the proposed transaction
            will be satisfied without material alteration. Back Bay also assumed, with the consent of the Caladrius Board of Directors, that the final form of the Merger Agreement was substantially the same as the last draft reviewed by it.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, Back Bay assumed, with the consent of the Caladrius Board of Directors,
            that the historical financial statements of Caladrius reviewed by Back Bay were prepared and fairly presented in accordance with U.S. GAAP consistently applied. Back Bay understood that Cend historical financial statements reviewed by Back Bay
            were not prepared in accordance with U.S. GAAP. Back Bay assumed, with the consent of the Caladrius Board of Directors, that Cend historical financial statements reviewed by its are materially complete and fairly present the financial condition
            and results of operations of Cend as of and for the dates and periods indicated therein.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">121<br />
        </div>

      </div>

    </div>

    <!--End Page 130-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 131-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay further assumed, with the consent of the Caladrius Board of Directors, that
            as of the date of its opinion, there had been no material adverse change in Caladrius&#8217; or Cend&#8217;s assets, financial condition, results of operations, business, or prospects since the date of the last financial statements made available to Back
            Bay which change was not disclosed to Back Bay prior to the date of its opinion. Back Bay did not express any opinion as to (i)&#160;the value of any other arrangement entered into in connection with the Merger, or (ii)&#160;any tax or other consequences
            that might result from the proposed transaction. Back Bay did not express any opinion as to the impact of the Merger on the solvency or viability of the combined company. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay&#8217;s opinion does not address the relative merits of the Merger or any related
            transaction as compared to other business strategies or transactions that might be available to Caladrius or Caladrius&#8217; underlying business decision to effect the Merger or any related transaction. Back Bay&#8217;s opinion does not constitute a
            recommendation to any stockholder as to how such stockholder should vote or act with respect to the Merger or any related transaction. At the Caladrius Board of Directors&#8217; direction, Back Bay has not been asked to, nor has Back Bay, offered any
            opinion as to (i)&#160;the terms, other than the combined consideration to the extent expressly specified in its opinion, of the Merger Agreement or any related documents or the form of the Merger or any related transaction, (ii)&#160;the Cend Series D
            Preferred Stock private placement transaction in any respect, including the impact, terms and form of, and any documents relating to, the private placement transaction and the ability of the private placement transaction to be consummated. Back
            Bay expressed no opinion as to what the value of the Caladrius Common Stock will be when issued pursuant to the Merger or any related transaction or the price at which the Caladrius Common Stock will trade at any time. In addition, Back Bay
            expressed no opinion as to any adjustment, or the effect of any adjustment, to the amount of the exercise price of any warrant or option issued by Caladrius. In rendering its opinion, Back Bay assumed, with the consent of the Caladrius Board of
            Directors, that (i)&#160;the final executed form of the Merger Agreement would not differ in any material respect from the draft that Back Bay reviewed, (ii)&#160;Caladrius and Cend would comply with all material terms of the Merger Agreement, and
            (iii)&#160;the Merger would be consummated in accordance with the terms of the Merger Agreement without any adverse waiver or amendment of any material term or condition thereof. Back Bay also assumed that all governmental, regulatory, or other
            consents and approvals necessary for the consummation of the Merger would be obtained without any adverse effect on Caladrius, Cend or the expected benefits of the Merger in any way meaningful to Back Bay&#8217;s analysis. Back Bay is not a legal,
            regulatory, tax or accounting expert and relied on the assessments made by Caladrius and its advisors with respect to such issues. Back Bay was not authorized to solicit and did not solicit indications of interests in a business combination
            with Caladrius from any other party.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay&#8217;s opinion was for the sole benefit and use of the Caladrius Board of Directors
            in its consideration of the aggregate consideration to be paid in the Merger, and the opinion should not be construed as a recommendation or investment advice to any holders of Caladrius securities with respect to how such securityholders
            should vote or otherwise act with respect to the Merger. Back Bay&#8217;s opinion was approved by an authorized internal committee of Back Bay and is necessarily based upon information made available to it and market, economic and other conditions as
            they existed on, and can be evaluated as of the date of the opinion. Back Bay expressed no opinion as to the prices at which shares of Caladrius Common Stock would trade following the announcement or consummation of the Transaction. Other than
            in connection with the delivery to the Caladrius Board of Directors of an updated or modified opinion, or an affirmation of its original opinion, in each case as may be requested by the Caladrius Board of Directors, Back Bay does not undertake
            any obligation to update, revise, reaffirm or withdraw its opinion, or otherwise comment on or consider events occurring hereafter.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In preparing its opinion, Back Bay performed a variety of valuation analyses, including
            those described above. The summary of Back Bay&#8217;s analyses is not a complete description of the analyses underlying Back Bay&#8217;s opinion. The preparation of a fairness opinion is a complex process involving various quantitative and qualitative
            judgments and determinations with respect to the financial, comparative and other analytic methods employed and the adaptation and application of those methods to the unique facts and circumstances presented. As a consequence, neither Back
            Bay&#8217;s opinion nor the analyses underlying that opinion are readily susceptible to partial analysis or summary description. Back Bay arrived at its opinion based on the results of all analyses undertaken by it and assessed as a whole and did not
            draw, in isolation, conclusions from or with regard to any individual analysis, analytic method or factor. Accordingly, Back Bay believes that its analyses must be considered as a whole and that selecting portions of its analyses, analytic
            methods and factors, without considering all analyses and factors or the narrative description of the analyses, could create a misleading or incomplete view of the processes underlying its analyses and opinion.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">122<br />
        </div>

      </div>

    </div>

    <!--End Page 131-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 132-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">In performing its analyses, Back Bay considered industry factors (such as the
            probability of success of a drug), general business and economic conditions and other matters, many of which are beyond the control of Caladrius and Cend. The estimates of the future performance of Caladrius and Cend in or underlying Back Bay&#8217;s
            analyses are not necessarily indicative of actual values or actual future results, which may be significantly more or less favorable than those estimates or those suggested by Back Bay&#8217;s analyses. The analyses do not purport to be appraisals or
            to reflect the prices at which a company or business might actually be sold or acquired or the prices at which any securities have traded or may trade at any time in the future. Accordingly, the estimates used in, and the ranges of valuations
            resulting from, any particular analysis described below are inherently subject to substantial uncertainty and should not be taken as Back Bay&#8217;s view of the actual value of Caladrius or Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The combined consideration to be paid by Caladrius pursuant to the Merger Agreement was
            determined through negotiations between Caladrius and Cend and was approved by the Caladrius Board of Directors. The decision to enter into the Merger Agreement and any related agreements was solely that of the Caladrius Board of Directors.
            Back Bay&#8217;s opinion and analyses were only one of many factors considered by the Caladrius Board of Directors in its evaluation of the Merger and should not be viewed as determinative of the views of the Caladrius Board of Directors, management
            or any other party with respect to the Merger or related transactions or the consideration payable in the Merger or related transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h3">Financial Analyses</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The summary of the financial analyses described below under this heading &#8220;<span style="font-style: italic;">&#8212;Financial Analyses</span>&#8221; is a summary of the financial analyses provided by Back Bay to the Caladrius Board of Directors in connection with Back Bay&#8217;s opinion, dated April&#160;25, 2022. <span style="font-weight: bold;">The financial analyses summarized below include information presented in tabular format. In order to fully understand the financial analyses performed by Back Bay, the tables must be read together with the text of each summary. The
              tables alone do not constitute a complete description of the financial analyses. Selecting portions of Back Bay&#8217;s financial analyses or factors considered or focusing on the data set forth in the tables below without considering all analyses
              or factors or the full narrative description of such analyses or factors, including the methodologies and assumptions underlying the analyses, could create a misleading or incomplete view of Back Bay&#8217;s financial analyses.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h3">Comparable Transaction Analysis</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="h2">Mergers &amp; Acquisitions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay analyzed certain publicly available information in the following
              transactions, which involved acquisitions of biotech or biotechnology firms with oncology products in Phase I and Phase II stage of clinical trials announced between January 2017 and March 2022: </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 15.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Date Announced</div>
                </td>

    <td style="width: 0.52%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Target</div>
                </td>

    <td style="width: 0.52%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Acquiror</div>
                </td>

    <td style="width: 0.52%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Upfront Payment<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(millions)</div>
                </td>

    <td style="width: 0.52%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Closing Date</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">December 2021</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">VCN Biosciences, S.L.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Synthetic Biologics, Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$5.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">March 10, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">October 2021</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Takeda Pharmaceutical <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Company Limited</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Calithera Biosciences, Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$45.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">October 18, 2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">August 2020</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Forbius</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Bristol Myers Squibb</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$185.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">September 21, 2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July 2020</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Dynavax Technologies <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Corporation</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">TriSalus Life Sciences</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$9.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">August 3, 2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July 2020</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Kiq Bio LLC</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Unum Therapeutics Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$104.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July 6, 2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">December 2019</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Synthorx, Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Sanofi S.A.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$2,500.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">January 23, 2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">May 2019</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Peloton Therapeutics, Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Merck &amp; Co., Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$1,000.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">May 21, 2019</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">March 2019</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">FameWave Ltd.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Kitov Pharma Ltd.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$10.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">January 8, 2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">February 2019</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Immune Design Corp.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Merck &amp; Co., Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$300.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">April 2, 2019</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">May 2018</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">AurKa Pharma, Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Eli Lilly and Company</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$110.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">June 2018</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">January 2018</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cascadian Therapeutics, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Seagen Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$614.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">March 9, 2018</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">December 2017</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Ignyta, Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Roche Holding AG</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$1,700.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">January 10, 2018</div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.38%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">March 2017</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 22.75%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cerulean Pharma Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 27.29%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">BlueLink Pharmaceuticals, Inc.</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.88%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$2.0</div>
                </td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.52%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.51%; text-align: center; vertical-align: middle; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">March 19, 2017</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">123<br />
        </div>

      </div>

    </div>

    <!--End Page 132-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 133-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay reviewed the purchase price paid in each such transaction, comprised of an
            upfront payment and other deferred consideration (e.g., milestone payments) and derived a valuation of Cend based on the adjusted median (excluding highs and lows) upfront and milestone payments in each such transaction. This analysis
            demonstrated the following median and mean transaction payment values:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Transaction Payment<sup>(1)</sup></div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in US$ millions)</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Upfront</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Milestone</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: $110</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: $465 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: $371</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: $550</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Minimum and maximum values were excluded prior to calculating the mean and median values. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2">Licensing Transactions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Back Bay analyzed certain publicly available information in the
            following transactions, which involved licensing of biotech or biotechnology firms with oncology (solid tumors) products in Phase I stage of clinical trials announced between January 2017 and March 2022: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -3pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Date Announced</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Target</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Acquiror </div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">April 2021 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Pfizer Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Celcuity</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">March 2021 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Ipsen </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Fusion Pharmaceutials, Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">March 2021 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Kazia Therapeutics Limited </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Oasmia Pharmaceutical AB</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">January 2021 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Medivir AB </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">IGM Biosciences, Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">December 2020 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Relay Therapeutics, Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Genentech</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">October 2020 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">CTxONE </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Pfizer Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">May 2020 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">ACEA Therapeutics Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Sorrento Therapeutics, Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">December 2018</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Boehringer Ingelheim<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">International GmbH</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Xynomic Pharmaceuticals, Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">December 2017 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">UCB Biopharma </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Stemline Therapeutics Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">December 2017 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Ono Pharmaceutical Co., Ltd. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Bristol Myers-Squibb K.K.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">December 2017 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Bristol Myers-Squibb </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Ayala Therapeutics</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">January 2017 </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Calithera Biosciences, Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: middle; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Incyte Corp.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Back Bay reviewed the purchase price paid in each such transaction
            comprised of an upfront payment and other deferred consideration (e.g., milestone payments) paid in each transaction and derived a valuation of the Company based on the adjusted mean and median (excluding minimum and maximum values) upfront and
            milestone payments in each such transaction. This analysis demonstrated the following median and mean transaction payment values: </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 2pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Transaction Payment<sup>(1)</sup></div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 2pt; padding-bottom: 3.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in US$ millions)</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Upfront</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.25pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Milestone </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: $9</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: $352 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: $15</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: $363</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Minimum and maximum values were excluded prior to calculating the mean and median values.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">124<br />
        </div>

      </div>

    </div>

    <!--End Page 133-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 134-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg16"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Comparable Companies Analyses</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius<span style="font-style: normal;">. Back Bay
                performed a comparable company analysis with respect to Caladrius. Back Bay reviewed and compared Caladrius to certain publicly traded companies, each of which, similar to Caladrius, has a market capitalization that is lower
                than its cash holdings net of liabilities, which is not a rare occurrence in biotechnology with high cash burn rates and uncertain returns. The companies are Phase&#160;II clinical-stage oncology firms focused on developing
                treatments for various forms of cancer. Back Bay used publicly available information and current and historical financial information for each such comparable company in its analysis. The companies selected, as well as their
                respective market capitalization as of April&#160;25, 2022, were: </span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Company</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Market Capitalization (millions)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">ARCA Biopharma, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$35.2</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">BioaAtla,Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$14.8</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Bellicum Pharmaceuticals, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$137.6</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Calithera Biosciences, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$21.6</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Elevation Oncology, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$56.4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">IMARA Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$37.9</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">PharmaCyte Biotech, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$46.8</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Protara Therapeutics, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$48.4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Salarius Pharmaceuticals, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$12.7</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Syros Pharmaceuticals, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$59.5</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">These companies were selected on the basis of their financial and operating metrics
              and characteristics, including products in pre-clinical and clinical trials, risk profile, size and type of operations. Back Bay calculated the enterprise values of each comparable company as of the close of market on April&#160;25, 2022 and
              derived an equity valuation of Caladrius based on the mean and median enterprise values of such companies, which valuation assumed that Caladrius had a cash balance of&#8201;$94.9&#160;million based on Caladrius&#8217; public filings as of April&#160;25, 2022.
              This analysis demonstrated the following median and mean transaction value of the comparable companies:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Comparable Companies &#8211; Caladrius Biosciences</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in US$ millions)</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Market Capitalization</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Enterprise Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: $42</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: ($25)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: $47</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: ($30)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">High: $138</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">High: $48</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Low: $13</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Low: ($108)</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend. <span style="font-style: normal;">Back Bay
                performed a comparable company analysis with respect to Cend. Back Bay reviewed and compared Cend to certain publicly traded companies that, similar to Cend, are Phase I to Phase I/II clinical-stage oncology firms focused on
                developing treatments for solid tumors. Back Bay used publicly available information and current and historical financial information for each such comparable company in its analysis. The companies selected, as well
                as their respective market capitalization as of April 25, 2022, were:</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Company</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Market Capitalization (millions)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cyclacel Pharmaceuticals, Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$20.0</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Immix Biopharma, Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$20.1</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Neoleukin Therapeutics, Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$56.9</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Onconova Therapeutics, Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$30.3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Salarius Pharmaceuticals, Inc. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$12.7</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">125<br />
        </div>

      </div>

    </div>

    <!--End Page 134-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 135-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg17"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">These companies were selected on the basis of their financial and operating metrics
            and characteristics, including products in clinical trials, risk profile, size and type of operations. Back Bay calculated the enterprise values of each comparable company as of the close of market on April&#160;25, 2022 and derived an enterprise
            value range for Cend based on the range of enterprise values of such companies. This analysis indicated the following median and mean transaction values for the comparable companies:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Comparable Companies &#8211; Cend Therapeutics</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in US$ millions)</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Market Capitalization</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Enterprise Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: $20</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: ($17)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: $28</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: ($26)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">High: $57</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">High: $2.5</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Low: $13</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 21.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Low: ($73)</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h3">Recent Biotech IPOs</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay reviewed and compared Cend to biotechnology companies that were in the
              Phase I or Phase II trial stage of drug development in the oncology therapeutic area and modalities inclusive of antibodies, small molecules, biologics, and peptides and underwent initial public offerings between January 2019 and March 2022.
              Back Bay used publicly available information and current and historical financial information for each such company in its analysis. The companies for this analysis, as well as their respective pricing dates and IPO pre-money valuations,
              were:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Company</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Pricing Date</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">IPO Pre-Money Valuation (Millions)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Xilio Therapeutics, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">October 2021</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$309.0</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Adagene Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">February 2021</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$661.7</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Olema Pharmaceuticals, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">November 2020</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$522.9</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Codiak BioSciences, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">October 2020</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$196.4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Shattuck Labs, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">October 2020</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$477.4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Immunome Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">October 2020</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$81.4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Prelude Therapeutics Incorporated</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">September 2020</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$648.5</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">ALX Oncology Holdings Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July 2020</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$507.5</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Revolution Medicines, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">February 2020</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$729.3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Bicycle Therapeutics plc</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">May 2019</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$187.1</div>
                </td>

  </tr>

  <tr>

    <td style="width: 31.62%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Turning Point Therapeutics, Inc.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">April 2019</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 31.62%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$385.0</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In this analysis, Back Bay reviewed, among other things, the median and mean
            pre-initial public offering (IPO) valuation of each such company, which was derived by applying an illiquidity discount of 25.0% to reflect Cend&#8217;s private company status. This analysis indicated the following median and mean pre-IPO pre-money
            valuation for Cend:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">IPO Pre-Money Valuation<sup>(1,2)</sup></div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in US$ millions)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Median: $358</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 42.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mean: $325</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 42.31%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Minimum and maximum values were excluded prior to calculating the mean and median values.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 25.0% illiquidity Discount rate for lack of marketability based on &#8220;Discounts involved in Purchases of Common Stock
                    (1966-1969),&#8221; Institutional Investor Study Report of the Securities and Exchange Commission, H.R. Doc. No. 64, Part 5, 92nd Congress, 1st Session, 1971, pp. 2444-56.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="h3">Discounted Cash Flow Analysis</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Company.<span style="font-style: normal;"> Back Bay performed a
              discounted cash flow analysis of Cend by calculating the estimated present values of the unlevered free cash flows that Cend was forecasted to generate during the period from January&#160;1, 2022 to December&#160;31, 2025 based on Cend projections. </span></div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">126<br />
        </div>

      </div>

    </div>

    <!--End Page 135-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 136-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg18"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay discounted Cend&#8217;s unlevered free cash flow to present value as of
            January&#160;1, 2022 using a selected discount rate range of 12.0% to 20.0% based on Back Bay&#8217;s estimation of Cend&#8217;s then current weighted average cost of capital of 16.0%, in line with Caladrius&#8217; weighted-average cost of capital and assumed a
            CEND-1 product launch in the U.S. and Ex-U.S. in 2025 and 2026, respectively. Based on feedback Back Bay received from key opinion leaders (&#8220;KOLs&#8221;), Back Bay created a sensitized model by applying a 2.80% probability of success adjustment for
            the obtaining of regulatory approval of a Phase II clinical-stage solid tumor and pancreatic cancer asset and assumed the product launch would be delayed until 2027 and 2028 in the U.S. and Ex-U.S., respectively. Back Bay then calculated Cend&#8217;s
            implied equity valuation using company management assumptions and the sensitized assumptions. This analysis indicated the following risk-adjusted net present value ranges for Cend in these two scenarios:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 2pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Risk-Adjusted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Net Present Value Range</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in US$ millions)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Company Management</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 42.31%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Sensitized Assumptions</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Assumptions</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 42.31%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(probability of success adjusted) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$108 to $211</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 42.31%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">$39 to $105</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;" class="h3">Methodology for Estimating Probability of
            Success (POS) Adjustments</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In order for a therapy to reach the market, that therapy must successfully complete
            various phases of clinical trials and then must be approved by a regulatory agency (such as the FDA) for marketing. Typically, a therapy progresses from preclinical (non-human) testing into and through clinical (human) testing in a serial
            manner culminating in the regulatory review and potential approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In order to calculate the probability of success for a therapy to gain regulatory
            approval, one must consider both the probability of achieving individual clinical milestones as well as the total cumulative probability of the therapy progressing from the current phase of clinical development through approval. Because each
            phase of development has its own individual probability of success, in order to calculate the total cumulative probability of success through approval at any given point in development, one typically uses the product of multiplying all of the
            probabilities of success of each individual phase to be completed to arrive at a total cumulative probability of success for marketing approval. Collectively, these likelihoods of achieving certain outcomes on both an individual and collective
            basis are referred to as the therapy&#8217;s probability of success. The cumulative probability of success for an individual product is applied directly to all future revenues and is similarly applied to expenses that are projected to occur
            post-marketing approval if the existence of such expenses is dependent upon the future approval of the product. For any expenses that are projected to occur before marketing approval, expenses associated with the completion of ongoing
            activities devoted to progressing to the next phase are considered sunk costs and are not adjusted. For expenses that occur in the phase following the current phase of an individual product, the appropriate cumulative probability from the
            current phase to the appropriate projected stage of development is applied to the expense.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2">Unaudited Pro Forma Condensed Combined Financial Information </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following unaudited pro forma condensed combined financial statements are based on
            Caladrius&#8217; forecasted financial statements and Cend&#8217;s forecasted financial statements, as adjusted to give effect to the Merger. The unaudited pro forma condensed combined balance sheet as of September&#160;30, 2022 gives effect to the Merger as if
            it had occurred on September&#160;30, 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma condensed combined financial information does not give effect
            to the potential impact of current financial conditions, regulatory matters, operating efficiencies or other savings or expenses that may be associated with the integration of the two companies. The unaudited pro forma condensed combined
            financial information is preliminary and has been prepared for illustrative purposes only and is not necessarily indicative of the financial position or results of operations in future periods or the results that actually would have been
            realized had Caladrius and Cend been a combined company during the specified periods. The actual results reported in periods following the transaction may differ significantly from those reflected in the pro forma financial information
            presented herein for a number of reasons, including, but not limited to, differences between the assumptions used to prepare this pro forma financial information. The unaudited pro forma condensed combined financial statements should be read
            together with Caladrius&#8217; historical financial statements, which are included in Caladrius&#8217; latest annual report on Form 10-K filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March&#160;22, 2022.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">127<br />
        </div>

      </div>

    </div>

    <!--End Page 136-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 137-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg19"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">Pro Forma Condensed Combined Balance Sheet as of September&#160;30, 2022<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(in US$ thousands)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 73.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="19">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Merger-Related Adjustments </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Caladrius <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">9/30/2022E (1) </div>
                </td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">9/30/2022E (2) </div>
                </td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend Debt <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Adjustment <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">-3 </div>
                </td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Pro-Forma <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Equity <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Adjustments <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">-4 </div>
                </td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Caladrius Pro- <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Forma Equity <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Adjustments <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">-5 </div>
                </td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Deal Costs <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">-6 </div>
                </td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Pro Forma <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Combined As <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Adjusted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">9/30/2022E </div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">Assets</span><span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Cash, Cash Equivalents &amp; Marketable Securities </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$66,136.6 </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$1,698.8 </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara">$<span style="padding-left: 19.36pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$(4,000.0) </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 4.65pt;">63,835.4 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Marketable Securities </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 37.18pt;">$</span><span style="padding-left: 16.26pt; border-bottom: 1pt solid #000000; min-width: 37.18pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 32.53pt;">$</span><span style="padding-left: 11.62pt; border-bottom: 1pt solid #000000; min-width: 32.53pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.63pt;">$</span><span style="padding-left: 14.71pt; border-bottom: 1pt solid #000000; min-width: 35.63pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara"></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara"></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara"></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Cash &amp; Cash Equivalents &amp; Marketable Securities </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$66,136.6 </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$1,698.8 </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$(4,000.0) </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 4.65pt;">63,835.4 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other Current Assets </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 4.65pt;">1,584.1 </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$1,095.9 </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara">$<span style="padding-left: 19.36pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 9.3pt;">2,680.0 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accounts Receivable </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$<span style="padding-left: 11.62pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara">$<span style="padding-left: 19.36pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 20.91pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Intangible Assets </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$<span style="padding-left: 11.62pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$36,883.7 </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara">$<span style="padding-left: 19.36pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 4.65pt;">36,883.7 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other Non-Current Assets </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 37.18pt;">$10,830.4

                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 32.53pt;">$</span><span style="padding-left: 11.62pt; border-bottom: 1pt solid #000000; min-width: 32.53pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.63pt;">$</span><span style="padding-left: 14.71pt; border-bottom: 1pt solid #000000; min-width: 35.63pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 37.18pt;">$</span><span style="padding-left: 16.26pt; border-bottom: 1pt solid #000000; min-width: 37.18pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40.28pt;">$(10,000.0</span><span style="min-width: 40.28pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.63pt;">$</span><span style="padding-left: 14.71pt; border-bottom: 1pt solid #000000; min-width: 35.63pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 41.83pt;">$</span><span style="padding-left: 16.27pt; border-bottom: 1pt solid #000000; min-width: 41.83pt;">830.4 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Assets<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.18pt;">$78,551.1

                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.53pt;">$2,794.7

                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.63pt;">$</span><span style="padding-left: 14.71pt; border-bottom: 3pt double #000000; min-width: 35.63pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.18pt;">$36,883.7




                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40.28pt;">$(10,000.0</span><span style="min-width: 40.28pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.63pt;">$(4,000.0</span><span style="min-width: 35.63pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 41.83pt;">$104,229.6




                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; margin-left: 9.3pt; text-indent: -9.3pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">Liabilities &amp; Shareholders' </span><span style="text-decoration: underline;">Equity</span><span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Current Liabilities </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 4.65pt;">3,974.2 </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$<span style="padding-left: 6.97pt;">937.3 </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara">$<span style="padding-left: 19.36pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 9.64pt;">4,911.4 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Long-Term Debt/Notes Payable </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$<span style="padding-left: 11.62pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara">$<span style="padding-left: 19.36pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 20.91pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Other Non-Current Liabilities </div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 11.62pt;">344.8 </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$<span style="padding-left: 11.62pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara">$<span style="padding-left: 19.36pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 16.27pt;">344.8 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Liabilities<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 4.65pt;">4,319.0 </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara">$<span style="padding-left: 6.97pt;">937.3 </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 16.26pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara">$<span style="padding-left: 19.36pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara">$<span style="padding-left: 14.71pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara">$<span style="padding-left: 9.3pt;">5,256.2 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Shareholders' Equity<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 37.18pt;">$74,232.2

                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 32.53pt;">$1,857.4

                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.63pt;">$(1,857.4</span><span style="min-width: 35.63pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 37.18pt;">$38,741.2

                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40.28pt;">$(10,000.0</span><span style="min-width: 40.28pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.63pt;">$(4,000.0</span><span style="min-width: 35.63pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 41.83pt;">$</span><span style="padding-left: 4.65pt; border-bottom: 1pt solid #000000; min-width: 41.83pt;">98,973.3 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; font-weight: bold; margin-top: 0pt; margin-left: 9.3pt; text-indent: -9.3pt; text-align: left;" class="fpara">Total Liabilities and Shareholders'
                    Equity<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.18pt;">$78,551.1

                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.63%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 8.62pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.53pt;">$2,794.7

                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.64%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.4pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.63pt;">$(1,857.4</span><span style="min-width: 35.63pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.18pt;">$38,741.2




                    </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 5.57pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40.28pt;">$(10,000.0</span><span style="min-width: 40.28pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 0.62pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.63pt;">$(4,000.0</span><span style="min-width: 35.63pt;">) </span></div>
                </td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.97%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.3pt; margin-top: 0pt; margin-left: 2.42pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 41.83pt;">$104,229.6</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h3">52 Week Share Price Performance of Caladrius
            Biosciences</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay performed a valuation analysis of the total enterprise value of Caladrius
            Common Stock (i)&#160;as of April&#160;25, 2022 and (ii)&#160;based on the share price performance of the Caladrius Common Stock in the 52 weeks ended April&#160;25, 2022, in each case in which Back Bay reviewed certain financial and stock information of
            Caladrius. Back Bay observed that the price of Caladrius Common Stock as of the close of market on April&#160;25, 2022 was $0.64 per share and that the low and high prices of shares of Caladrius Common Stock for the 52 week period ended April&#160;25,
            2022 were $0.63 and $1.68 per share, respectively.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay calculated the total enterprise value of Caladrius by multiplying such per
            share prices by the total number of fully diluted shares of Caladrius Common Stock using the treasury method and based on Caladrius&#8217; public filings as of March&#160;22, 2022 and subtracting Caladrius&#8217; total cash and cash equivalents on hand as of
            that date. This analysis yielded the following total enterprise values:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total Enterprise Value</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 100%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in US$ millions)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">As of April&#160;25, 2022</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Based on Low and High for 52 Week </div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Period Ended on April&#160;25, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">($56)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">($57) to $65</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">128<br />
        </div>

      </div>

    </div>

    <!--End Page 137-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 138-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg20"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Miscellaneous</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2">Certain Financial Projections</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">While Caladrius has from time to time provided limited quarterly and full-year
            financial guidance in its regular earnings press release and other investor materials, which may have covered, among other items, research and development and general and administrative expenses, Caladrius&#8217; management team has not, as a matter
            of course, otherwise publicly disclosed internal projections as to future performance, earnings or other results due to the unpredictability of the underlying assumptions and estimates. This this proxy statement/prospectus/information statement
            includes unaudited standalone financial projections of Caladrius management&#8217;s estimates of Caladrius and Cend that were made available to the Caladrius Board of Directors in connection with its consideration of the Merger. The projections
            reviewed by the Caladrius Board of Directors were adjusted by Caladrius to reflect probability of success assumptions based on Caladrius management&#8217;s analysis of a number of factors, including management&#8217;s experience and judgment as informed by
            historical precedents and, in some cases, industry guidelines. Caladrius provided its projections of Cend with probability of success adjustments reflected, as described further below. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following are a series of financial projections on Caladrius&#8217; and Cend&#8217;s potential
            sales and earnings before interest and taxes which were provided to the Caladrius Board of Directors on April&#160;25, 2022, based on the most current assumptions at that time. Readers should refer to &#8220;<span style="font-style: italic;">Important
              Information about the Financial Projections</span>&#8221; for further cautionary statements regarding the financial projections.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The estimates of EBIT and unlevered free cash flow, or FCF, included in the following
            financial projections of Caladrius and Cend, or the financial projections, were calculated by Caladrius management using U.S. GAAP and other measures which are derived from U.S. GAAP, but such estimates constitute non- U.S. GAAP financial
            measures within the meaning of applicable rules and regulations of the SEC. These non- U.S. GAAP financial measures do not include estimates for non-cash stock compensation and include adjustments to reflect Caladrius management&#8217;s estimates for
            the probability of success related to clinical approval, as described below. The non- U.S. GAAP financial measures used in the financial projections were provided to and relied upon by Back Bay for purposes of its financial analyses and its
            fairness opinion (to the extent described in the section entitled &#8220;<span style="font-style: italic;">The Merger&#8201;&#8212;&#8201;Opinion of Caladrius&#8217; Financial Advisor</span>&#8221; beginning on page&#160;<a href="#tOOTC">120</a>) and by the Caladrius Board of
            Directors in connection with its consideration of the Merger (to the extent described below). Additionally, the non- U.S. GAAP financial measures were used in the financial projections provided to Cend in connection with its consideration of a
            potential strategic transaction with Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Caladrius Projections</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius management provided a preliminarily updated forecast to the Caladrius Board
            of Directors, on a non-probability of success adjusted basis, for the period from December&#160;31, 2022 to December&#160;31, 2025 for feedback from the Caladrius Board of Directors on the underlying assumptions&#8201;&#8212;&#8201;See Figure 1 below.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Figure 1: Financial Projections - Caladrius Biosciences</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 69.23%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022E</div>
                </td>

    <td style="width: 1.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2023E</div>
                </td>

    <td style="width: 1.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2024E</div>
                </td>

    <td style="width: 1.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2025E</div>
                </td>

  </tr>

  <tr>

    <td style="width: 69.23%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Sales</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">0</span></div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">0</span></div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">0</span></div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">0</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 69.23%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">OpEx</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$28</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$26</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$19</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$19</div>
                </td>

  </tr>

  <tr>

    <td style="width: 69.23%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">EBIT<sup>(1)</sup></div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($28)</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($26)</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($19)</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($19)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 69.23%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">FCF<sup>(2)</sup></div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($24)</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($23)</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($16)</div>
                </td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($16)</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">OpEx denotes operating expenses.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">EBIT denotes earnings before interest and taxes. EBIT is a non-U.S. GAAP financial measure.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">FCF denotes unlevered free cash flow. FCF is a non-U.S. GAAP financial measure.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">129<br />
        </div>

      </div>

    </div>

    <!--End Page 138-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 139-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg21"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Cend Projections</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend management provided forecast estimates which included revenue projections for the
            period from December&#160;31, 2022 to December&#160;31, 2030. See Figure 2 below.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Figure 2: Financial Projections - Cend Therapeutics<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="h2"><span style="font-weight: normal;">(in US$ millions)</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 20.51%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022E</div>
                </td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2023E</div>
                </td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2024E</div>
                </td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2025E</div>
                </td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2026E</div>
                </td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2027E</div>
                </td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2028E</div>
                </td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2029E</div>
                </td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2030E</div>
                </td>

  </tr>

  <tr>

    <td style="width: 20.51%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Sales<sup>(1)</sup></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$12</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.16pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">1</span></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.16pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">0</span></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.67pt; text-align: left;" class="fpara">$234</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$1,054</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$2,509</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$4,528</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$7,227</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$10,564 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 20.51%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">OpEx<sup>(2)</sup></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$31</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.16pt; text-align: left;" class="fpara">$69</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.16pt; text-align: left;" class="fpara">$97</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.67pt; text-align: left;" class="fpara">$161</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;">484</span></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$1,016</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$1,798</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$2,848</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">4,133 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 20.51%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">EBIT<sup>(3)</sup></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">($19)</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.16pt; text-align: left;" class="fpara">($68)</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.16pt; text-align: left;" class="fpara">($97)</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.67pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">73</span></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;">570</span></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$1,493</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$2,731</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$4,379</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">6,431 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 20.51%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">FCF<sup>(4)</sup></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;" class="fpara">$51</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.16pt; text-align: left;" class="fpara">$32</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.16pt; text-align: left;" class="fpara">$53</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.67pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">73</span></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;">570</span></div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$1,493</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$2,731</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$4,379</div>
                </td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">6,431</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes revenues from Qilu partnership in the form of royalties and milestones.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">OpEx denotes operating expenses.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">EBIT denotes earnings before interest and taxes. EBIT is a non-U.S. GAAP financial measure. Includes any projected amortization.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">FCF denotes unlevered free cash flow. Includes financing assumption of $70M in 2022, $100M in 2023, and $150M in 2024. FCF is a
                    non-U.S. GAAP financial measure.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">While the financial projections summarized above were prepared in good faith and based
            on information available at the time of preparation, no assurance can be made regarding future events. The estimates and assumptions underlying the financial projections involve judgments with respect to, among other things, future economic,
            competitive, regulatory and financial market conditions and future business decisions that may not be realized and that are inherently subject to significant business, economic, competitive and regulatory uncertainties and contingencies,
            including, among others, risks and uncertainties described in this proxy statement under the sections captioned &#8220;<span style="font-style: italic;">Risk Factors</span>&#8221; and &#8220;<span style="font-style: italic;">Forward-Looking Statements</span>&#8221;
            and information in Caladrius&#8217; consolidated financial statements and notes thereto included in Caladrius&#8217; most recent filings on Form 10-K and 10-Q, all of which are difficult to predict and many of which are beyond the control of Caladrius.
            There can be no assurance that the underlying assumptions will prove to be accurate or that the projected results will be realized, and actual results will likely differ, and may differ materially, from those reflected in the financial
            projections, whether or not the Merger is completed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The financial projections summarized above also reflect numerous variables,
            expectations and assumptions available at the time they were prepared as to certain business decisions that are subject to change. These projections do not reflect revised prospects for Caladrius&#8217; or Cend&#8217;s business, changes in general business
            or economic conditions, or any other transaction or event that has occurred or that may occur and that was not anticipated at the time the financial projections were prepared. Caladrius has not prepared revised financial projections to take
            into account variables or views of management that have changed since the dates on which the relevant projections were finalized. If the financial projections were prepared as of the date of this proxy statement, certain of the information
            would be materially different.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As a result, the financial projections cannot be considered a reliable predictor of
            future operating results, and this information should not be relied on as such. This prospective financial information was not prepared with a view toward compliance with published guidelines of the SEC or the guidelines established by the
            American Institute of Certified Public Accountants for preparation, presentation of prospective financial information, published guidelines of the SEC regarding forward-looking statements and the use of non-U.S. GAAP measures or U.S. GAAP. In
            the view of Caladrius&#8217; management, each set of projections prepared by them was prepared on a reasonable basis based on the best information available to Caladrius&#8217; management at the time of preparation taking into account the assumptions
            underlying the relevant alternative scenario for such financial projections. The financial projections, however, are not fact and should not be relied upon as being necessarily indicative of future results of Caladrius, Cend or, following the
            completion of the Merger, the combined company, and readers of this proxy statement are cautioned not to place undue reliance on this information. The inclusion of the financial projections in this proxy statement shall not be deemed an
            admission or representation by Caladrius that such information is material. None of the financial projections reflects any impact of the Merger. The prospective financial information included in this proxy has been prepared by, and is the
            responsibility of, Caladrius&#8217; management. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">130<br />
        </div>

      </div>

    </div>

    <!--End Page 139-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 140-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg22"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">None of Caladrius, Cend or any of their respective affiliates, advisors, officers,
            directors, or representatives has made or makes any representation to any person regarding the ultimate performance of Caladrius, Cend or the combined company compared to the financial projections. Caladrius has made no representation to Cend,
            and Cend has made no representation to Caladrius, in the Merger Agreement or otherwise concerning these financial projections. The financial projections cover multiple years, and such information by its nature becomes subject to greater
            uncertainty with each successive year. Neither Cend nor any of its stockholders, officers, or directors participated in the preparation of the financial projections.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The inclusion of a summary of these financial projections in this proxy statement
            should not be regarded as an indication that any of Caladrius, Cend or their respective affiliates, advisors, officers, directors or representatives considered these financial projections to be predictive of actual future events, and these
            financial projections should not be relied upon as such nor should the information contained in these financial projections be considered appropriate for other purposes. None of Caladrius, Cend or their respective affiliates, advisors,
            officers, directors or representatives can give you any assurance that actual results will not differ materially from these financial projections, and none of them undertakes any obligation, except as required by law, to update or otherwise
            revise the financial projections contained in this proxy statement to reflect circumstances existing since their preparation or to reflect the occurrence of unanticipated events or to reflect changes in general economic or industry conditions,
            even in the event that any or all of the underlying assumptions are shown to be in error.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The summary of the financial projections is not included in this this proxy
            statement/prospectus/information statement in order to induce any Caladrius Stockholder to vote in favor of any of the proposals necessary to consummate the Merger or the adjournment proposal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">General </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay is a life science dedicated management consulting and investment banking firm
            and, as part of its investment banking activities, is regularly engaged in the valuation of businesses and their securities in connection with mergers and acquisitions. The Caladrius Board of Directors selected Back Bay because of its
            familiarity with Caladrius and its qualifications, reputation, and experience in the valuation of businesses and securities in connection with mergers and acquisitions generally, as well as substantial experience in transactions comparable to
            the Merger. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Back Bay is acting as financial advisor to Caladrius in connection with the Merger.
              As compensation for its services in connection with the Merger, Caladrius is obliged to pay Back Bay an opinion fee of $250,000, which is referred to as the opinion fee, payable upon the delivery of Back Bay&#8217;s opinion. The opinion fee is not
              contingent upon the conclusion of Back Bay&#8217;s opinion or the consummation of the Merger. In addition, Caladrius has agreed to reimburse Back Bay for a portion of its reasonable expenses incurred in connection with the Merger and to indemnify
              Back Bay for certain liabilities that may arise out of its engagement by Caladrius and the rendering of Back Bay&#8217;s opinion. In the two years preceding the date of Back Bay's opinion, Back Bay performed various investment banking and financial
              services for Caladrius and has received approximately $1.01&#160;million in fees from Caladrius other than the payment for its opinion. Back Bay expects to perform such services in the future and expects to receive customary fees for such
              services. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the ordinary course of its business, Back Bay and affiliates may actively trade and
            effect transactions in the equity, debt and/or other securities (and any derivatives thereof) and financial instruments (including loans and other obligations) of Caladrius and Cend for its own account and for the accounts of its customers and,
            accordingly, may at any time hold long or short positions and investments in such securities and financial instruments. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tIOTCD"><!--Anchor--></a>Interests of the Caladrius Directors
            and Executive Officers in the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In considering the recommendation of the Caladrius Board of Directors with respect to
            issuing shares of Caladrius Common Stock as contemplated by the Merger Agreement and the other matters to be acted upon by the Caladrius Stockholders at the Annual Meeting, the Caladrius Stockholders should be aware that certain members of the
            Caladrius Board of Directors and executive officers of Caladrius have interests in the Merger that may be different from, or in addition to, the interests of the Caladrius Stockholders. These interests relate to or arise from, among other
            things: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">bonus payments which certain of Caladrius&#8217; officers may receive in connection with the consummation of the Merger;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">131<br />
        </div>

      </div>

    </div>

    <!--End Page 140-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 141-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg23"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">severance benefits to which each of Caladrius&#8217; executive officers would become entitled in the event of a change of control of
                    Caladrius and his or her covered termination of employment within 12 months following the consummation of the Merger;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the accelerated vesting of Caladrius Options held by Caladrius&#8217; executive officers and board members in connection with the
                    consummation of the Merger and his or her covered termination of employment within 12 months following the consummation of the Merger; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the agreement that four of Caladrius&#8217; directors will serve on the board of directors of the combined organization following the
                    consummation of the Merger.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The board of directors of each of Caladrius and Cend was aware of these potential
            conflicts of interest and considered them, among other matters, in reaching their respective decisions to approve the Merger Agreement and the Merger, and to recommend, as applicable, that the Caladrius Stockholders approve the proposals to be
            presented to the Caladrius Stockholders for consideration at the Annual Meeting as contemplated by this proxy statement/prospectus/information statement, and that the Cend Stockholders sign and return the written consent as contemplated by this
            proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Although Todd Girolamo is no longer an executive officer of Caladrius due to his
            ceasing employment in March 2022, included in this section is information with respect to Mr.&#160;Girolamo because he was an executive officer during 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Ownership Interests</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, all directors and current executive officers of Caladrius,
            together with all former named executive officers who were named executive officers during Caladrius&#8217; fiscal year ending December&#160;31, 2021, beneficially owned approximately 1.9% of the outstanding shares of Caladrius Common Stock. The
            affirmative vote of the holders of a majority of the shares of Caladrius Common Stock having voting power present in person or represented by proxy at the Annual Meeting is required for approval of Proposal Nos. 1, 4, 5 and 8. The affirmative
            vote of the holders of a majority of shares of Caladrius Common Stock having voting power outstanding on the Record Date for the Annual Meeting is required for approval of Proposal Nos. 2 and 3. Certain of Caladrius&#8217; officers and directors, and
            their affiliates, have also entered into support agreements in connection with the Merger. For a more detailed discussion of the support agreements see the section entitled &#8220;<span style="font-style: italic;">Agreements Related to the
              Merger&#8212;Support Agreements</span>&#8221; in this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Caladrius Options</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, Caladrius&#8217; directors and current executive officers, together with
            all former named executive officers who were named executive officers during Caladrius&#8217; fiscal year ending December&#160;31, 2021, collectively owned unvested Caladrius Options covering 984,029 shares of Caladrius Common Stock and vested Caladrius
            Options covering 1,028,478 shares of Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Effective Time, each Caladrius Option that is outstanding and unexercised
            immediately prior to the Effective Time, whether or not vested, shall survive the Closing and remain outstanding in accordance with its terms.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Vested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options Held</div>
                </td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Price of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Vested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options</div>
                </td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Unvested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options Held</div>
                </td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Price of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Unvested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Executive Officers<br />
                  </div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.<sup>(1)</sup></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.86pt; text-align: left;" class="fpara">428,669</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;" class="fpara">$6.64</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.86pt; text-align: left;" class="fpara">197,250</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;" class="fpara">$1.23</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D.<sup>(2)</sup></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.86pt; text-align: left;" class="fpara">383,636</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;" class="fpara">$1.27</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.86pt; text-align: left;" class="fpara">786,779</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;" class="fpara">$1.27</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Todd Girolamo (Former Chief Legal Officer)</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.86pt; text-align: left;" class="fpara">188,103</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;" class="fpara">$2.77</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.86pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">&#8212;</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">132<br />
        </div>

      </div>

    </div>

    <!--End Page 141-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 142-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg24"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Vested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options Held</div>
                </td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Price of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Vested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options</div>
                </td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Unvested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options Held</div>
                </td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Price of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Unvested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Non-Employee Directors<br />
                  </div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D.</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.86pt; text-align: left;" class="fpara">6,900</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.48pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">4.21</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.11pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.23pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Michael H. Davidson, M.D.</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.86pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.48pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.11pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.23pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.86pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.48pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.11pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.86pt; text-align: left;" class="fpara">7,370</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.48pt; text-align: left;" class="fpara">$18.65</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.11pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven S. Myers</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.86pt; text-align: left;" class="fpara">5,500</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.48pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">4.66</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.11pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.23pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Peter G. Traber, M.D.</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.86pt; text-align: left;" class="fpara">8,300</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.48pt; text-align: left;" class="fpara">$15.10</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.11pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.23pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Anne Whitaker</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.86pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.48pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.88%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.11pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.93%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.23pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 16pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Unvested options vest 50,000 on 01/10/2023, 15,000 on 01/11/2023, 17,250 on 01/13/2023, 50,000 on 01/10/2024, 15,000 on
                    01/11/2024 and 50,000 on 01/10/2025 </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Unvested options vest 375,512 on 09/01/2022, 8,125 on 01/10/2023, 386,892 on 09/01/2023, 8,125 on 01/10/2024 and 8,125 on
                    01/10/2025</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Generally, in the event of a &#8220;Change in Control&#8221; of Caladrius (as defined in the 2009
            Plan, the 2015 Plan and the Plan) and either (i)&#160;the failure of Caladrius&#8217; successor to assume a participant&#8217;s awards or (ii)&#160;such assumption of awards is followed by the participant&#8217;s termination without cause on or within the one-year period
            following the Change in Control, (a) all outstanding options and stock appreciation rights of each participant granted prior to the change in control shall be fully vested and immediately exercisable in their entirety, and (b)&#160;all unvested
            stock awards, restricted stock units, restricted stock, performance-based awards, and other awards shall become fully vested, including without limitation, the following: (i)&#160;the restrictions to which any shares of restricted stock granted
            prior to the change in control are subject shall lapse as if the applicable restriction period had ended upon such change in control, and (ii)&#160;the conditions required for vesting of any unvested performance-based awards shall be deemed to be
            satisfied upon such change in control.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Potential Payments upon Termination</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth the information required by Item 402(t) of Regulation
            S-K regarding certain compensation which each of Caladrius&#8217; &#8220;named executive officers&#8221; may receive that is based on or that otherwise relates to the Merger. This compensation is referred to as &#8220;golden parachute&#8221; compensation in Item&#160;402(t) of
            Regulation S-K. For additional details regarding the terms of the payments quantified below, see &#8220;<span style="font-style: italic;">&#8212;Interests of the Caladrius Directors and Executive Officers in the Merger&#8221;</span> above. Note that while
            Todd&#160;Girolamo is included in the table below as required by Item 402(t) of Regulation S-K, he no longer serves as an executive officer of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The amounts indicated below are estimates based on multiple assumptions that may or may
            not actually occur or be accurate on the relevant date, including the assumptions described below. The actual value to be received by Caladrius&#8217; named executive officers may be greater or less than the amounts presented below. It is currently
            contemplated that Dr. Mazzo and Dr. Buck will continue to serve in their executive positions at Caladrius and will not be terminated. For purposes of calculating such amounts, Caladrius has assumed, among other things: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">September&#160;30, 2022 as the closing date of the Merger; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the value of the vesting acceleration of the named executive officers&#8217; equity awards is calculated assuming a price per share of
                    Caladrius Common Stock of $0.552, which represents the average closing market price of Caladrius Common Stock over the first five business days following the first public announcement of the transactions contemplated by the Merger
                    Agreement; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the termination of Caladrius&#8217; Current Executive Officers&#8217; employment by Caladrius without &#8220;cause&#8221; or by the executive with &#8220;good
                    reason&#8221; immediately following the Closing.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">133<br />
        </div>

      </div>

    </div>

    <!--End Page 142-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 143-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg25"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">&#8220;Golden Parachute&#8221; Compensation </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cash <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">($)<sup>(1)</sup></div>
                </td>

    <td style="width: 1.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Equity <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">($)<sup>(2)</sup></div>
                </td>

    <td style="width: 1.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Perquisites/ <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Benefits <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">($)<sup>(3)</sup></div>
                </td>

    <td style="width: 1.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">($)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D. </div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">1,515,953</div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">205,206</div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.17pt; text-align: left;" class="fpara">52,168</div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">1,773,327</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D. </div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">1,038,984</div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">142,278</div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.17pt; text-align: left;" class="fpara">22,064</div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">1,203,326</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Todd Girolamo</div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 35pt;">0</span></div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">0</span></div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.51%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.17pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">0</span></div>
                </td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.06%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 35pt;">0</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents severance payments entitled under employment agreements</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents equity award acceleration entitled under employment agreements</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents medical premium payments entitled under employment agreements</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h2">2018 Equity Incentive Compensation Plan</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Plan provides for the grant of incentive stock options, non-statutory stock
            options, stock appreciation rights, restricted stock awards and other stock-based or cash awards. All of Caladrius&#8217; employees, non-employee directors and consultants are eligible participants under the Plan. As of June&#160;13, 2022, a total of
            3,504,420 shares of Caladrius Common Stock were available for future issuance under the Plan. The Plan is administered by the Caladrius Board of Directors, which has delegated concurrent authority to administer the Plan to Caladrius&#8217;
            compensation committee, including for purposes of approving equity award grants to Caladrius&#8217; named executive officers. Please see the section of this proxy statement/prospectus/information statement entitled &#8220;<span style="font-style: italic;">Matters
              Being Submitted to a Vote of Caladrius Stockholders&#8212;Caladrius Proposal No. 7: Approval of an Amendment to the 2018 Equity Incentive Compensation Plan</span>&#8221; for an explanation of the material features of the Plan. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h2">Director Compensation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Directors&#8217; Compensation Plan provides for cash and equity compensation
            for Caladrius non-employee directors and imposes an annual limit on the aggregate cash and equity compensation that may be awarded to non-employee directors. The Caladrius Directors&#8217; Compensation Plan provides that each non-employee director
            shall be entitled to the payments described below while serving as a director of Caladrius.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual cash retainer for each non-employee director of $40,000;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an additional annual cash compensation retainer of $30,000 for the non-executive chair;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual cash retainer for serving as chairperson of a committee as follows: Audit ($18,000); Compensation ($12,000);
                    Nominating and Governance ($9,000); Science and Technology ($9,000);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual cash retainer for serving as a member of a committee as follows: Audit ($8,000); Compensation ($6,000); Nominating and
                    Governance ($4,500); and Science and Technology ($4,500);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">new non-employee directors receive an initial grant of restricted stock units with a value of 2x the annual grant with the
                    number of shares to be issued on the grant date calculated based on the grant date fair value with one-third vesting annually on each of the first, second and third anniversaries of the grant date; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual equity grant on the second Monday in January a grant of restricted stock units with a value of $60,000, vesting at one
                    year from the grant date.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The effective date for any annual equity grants to employees and non-employee directors
            is the second Monday in January, with the exercise price of options granted set at the closing price of our common stock on the date of grant.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCDEOM"><!--Anchor--></a>Interests of the Cend Directors and
            Executive Officers in the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In considering the recommendation of the Cend Board of Directors with respect to
            adopting the Merger Agreement, Cend Stockholders should be aware that certain members of the Cend Board of Directors and certain executive officers of Cend may have interests in the Merger that may be different from, or in addition to, the
            interests of Cend Stockholders. Each of the Caladrius Board of Directors and the Cend Board of Directors was aware of these potential conflicts of interest and considered them, among other matters, in reaching their </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">134<br />
        </div>

      </div>

    </div>

    <!--End Page 143-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 144-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg26"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">respective decisions to approve the Merger Agreement and the Merger, and to
            recommend, as applicable, that Caladrius Stockholders approve the proposals to be presented to Caladrius Stockholders for consideration at the Annual Meeting as contemplated by this proxy statement/prospectus/information statement, and that
            Cend Stockholders sign and return the written consent as contemplated by this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h3">Ownership Interests</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Certain of Cend&#8217;s directors and executive officers currently hold shares of Cend
            Capital Stock. The table below sets forth the anticipated ownership of Cend Capital Stock by Cend&#8217;s directors and executive officers immediately prior to the Closing based on their ownership of Cend&#8217;s Capital Stock as of June&#160;13, 2022.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Directors and Executive Officers</div>
                </td>

    <td style="width: 1.22%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of Shares of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend Capital <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock Held <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Immediately Prior <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">to the Closing</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Erkki Ruoslahti, MD, PhD, Scientific Founder and Chairman</div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30.66pt; text-align: left;" class="fpara">0<sup>(1)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack, MBA, President and Chief Executive Officer, Director</div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30.66pt; text-align: left;" class="fpara">0<sup>(2)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Hari Jarvelainen, PhD, DVM, Chief Operating Officer</div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30.66pt; text-align: left;" class="fpara">0<sup>(3)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">F. Andrew Dorr, MD, Chief Medical Officer</div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30.66pt; text-align: left;" class="fpara">0<sup>(4)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Jun (James) Xiao, EMBA, Director</div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30.66pt; text-align: left;" class="fpara">0<sup>(5)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Heidi Henson, CPA, CFO, Director</div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30.66pt; text-align: left;" class="fpara">0<sup>(6)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 1pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mike Sailor, PhD, Director</div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 1pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30.66pt; text-align: left;" class="fpara">0<sup>(7)</sup></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As discussed below, Dr. Ruoslahti holds options to purchase 308,727 shares of Cend Common Stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As discussed below, Mr.&#160;Slack holds options to purchase 477,500 shares of Common Stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As discussed below, Dr. Jarvelainen holds options to purchase 614,018 shares of Common Stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As discussed below, Dr. Dorr holds an option to purchase 44,000 shares of Common Stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As discussed below, Mr.&#160;Xiao holds options to purchase 40,000 shares of Common Stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As discussed below, Ms.&#160;Henson holds options to purchase 40,000 shares of Common Stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As discussed below, Dr. Sailor holds an option to purchase 111,000 shares of Common Stock.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Certain Cend Stockholders affiliated with Cend&#8217;s directors also currently hold shares
            of Cend Capital Stock. The table below sets forth the anticipated ownership of Cend Capital Stock by affiliates of Cend&#8217;s directors immediately prior to the Closing based on their ownership of Cend Capital Stock as of June&#160;13, 2022.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stockholder Name</div>
                </td>

    <td style="width: 1.22%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of Shares of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend Capital <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock Held <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Immediately Prior <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">to the Closing</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">ER Trust 2/18/11<sup>(1)</sup></div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.16pt; text-align: left;" class="fpara">2,194,062<sup>(2)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Sailor Cheung Trust, 10 March 2000<sup>(3)</sup></div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.16pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">341,980</span><sup>(4)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 1pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Leading Choice International Limited<sup>(5)</sup></div>
                </td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.22%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 1pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.5%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 1pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.16pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">793,066</span><sup>(6)</sup></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Erkki Ruoslahti, Cend Scientific Founder and Chairman, is the Trustee of ER Trust 2/18/1.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This amount includes (i) 1,808,263 shares of Cend Common Stock, (ii) 54,691 shares of Series B Preferred Stock, and (iii) 331,108
                    Series C Preferred Stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Mike Sailor, Cend Director is the Trustee of Sailor Cheung Trust, 10 March 2000. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This amount includes (i) 10,872 shares of Series B Preferred Stock and (ii) 331,108 shares of Series C Preferred Stock. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Jun (James) Xiao, Cend Director, is the Managing Director of Leading Choice International Limited. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This amount includes (i) 340,124 shares of Cend Common Stock, (ii) 371,396 shares of Series A Preferred Stock, and (iii) 81,546
                    shares of Series B Preferred Stock.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Treatment of Cend Options</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Merger Agreement, at the Effective Time, each Cend Option outstanding and
            unexercised as of immediately prior to the Effective Time, whether or not vested, shall be converted into and become an option to purchase that number of shares of Caladrius Common Stock equal to the product obtained by multiplying (i)&#160;the </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">135<br />
        </div>

      </div>

    </div>

    <!--End Page 144-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 145-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg27"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">number of shares of Cend Common Stock that were subject to such Cend Option
            immediately prior to the Effective Time by (ii)&#160;the Exchange Ratio, and rounding the resulting number down to the nearest whole number of shares of Caladrius Common Stock. The per share exercise price for shares of Caladrius Common Stock
            issuable upon exercise of each Cend Option assumed by Caladrius shall be determined by dividing (a) the per share exercise price of Cend Common Stock subject to such Cend Option, as in effect immediately prior to the Effective Time, by (b) the
            Exchange Ratio, and rounding the resulting exercise price up to the nearest whole cent. Any restriction on the exercise of any Cend Option assumed by Caladrius will continue in full force and effect and the term, exercisability, vesting
            schedule and other provisions of such Cend Option shall otherwise remain unchanged. Certain of Cend&#8217;s directors and executive officers currently hold Cend Options. The table below sets forth certain information with respect to such Cend
            Options.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Optionholder Name</div>
                </td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Grant Date</div>
                </td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Expiration <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Date</div>
                </td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Price <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">($)</div>
                </td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Common <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Underlying <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option as <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">of May&#160;31, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number Shares <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">of Cend <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Common Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Underlying <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option Vested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">as of May&#160;31, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">F. Andrew Dorr, M.D. </div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/15/2021</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/15/2031</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">3.82</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">44,000</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">22,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack, MBA</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/03/2019</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/03/2029</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">2.25</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/29/2020</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/29/2030</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1.92</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara">457,500</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara">219,219</div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Harri J&#228;rvel&#228;inen, Ph.D., DVM</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="4" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">10/20/2017</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">10/20/2027</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara">0.9993</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara">189,604</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara">189,604</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">10/20/2017</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">10/20/2027</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara">0.9993</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara">134,414</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara">134,414</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">04/08/2019</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">04/08/2029</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">2.25</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara">250,000</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara">250,000</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2020</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2030</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1.92</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">40,000</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">40,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;" rowspan="3">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Erkki Ruoslahti, M.D., Ph.D. </div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" rowspan="3" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">08/31/2019</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">08/31/2029</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">2.25</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara">100,000</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara">100,000</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">08/31/2019</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">08/31/2029</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">2.25</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara">108,727</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara">108,727</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2020</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2030</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1.92</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara">100,000</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara">100,000</div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Jun (James) Xiao</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">04/08/2019</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">04/08/2029</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">2.25</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2020</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2030</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1.92</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Heidi Henson, CPA, CFO</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">04/08/2019</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">04/08/2029</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">2.25</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2020</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2030</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1.92</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mike Sailor, Ph.D. </div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2020</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2030</div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.61pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1.92</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;" class="fpara"><span style="padding-left: 0.73pt;">111,000</span></div>
                </td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.52%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.71pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">46,250</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">All of the option awards listed in the table above were granted under Cend&#8217;s 2016
            Equity Incentive Plan, as amended, or the 2016 Plan, the terms of which are described herein under &#8220;<span style="font-style: italic;">&#8212;Equity Incentive Plans</span>.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Management Following the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As described elsewhere in this proxy statement/prospectus/information statement,
            including in the section captioned &#8220;<span style="font-style: italic;">Management Following the Merger</span>,&#8221; certain of Cend&#8217;s directors and executive officers are expected to become the directors and executive officers of Caladrius upon the
            Closing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Indemnification and Insurance</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Merger Agreement, from the Effective Time through the sixth anniversary of
            the date on which the Effective Time occurs, Caladrius and Cend, as the surviving corporation in the Merger, shall indemnify and hold harmless each person who is or has served as a director or officer of Cend against all claims, losses,
            liabilities, damages, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal,
            administrative or investigative, arising out of or pertaining to the fact that such person is or was a director or officer of Cend, to the fullest extent permitted under the DGCL for directors or officers of Delaware corporations. In addition,
            each such director and officer, or former director and officer, is entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Merger Agreement, the provisions of Caladrius&#8217; or Cend&#8217;s certificate of
            incorporation and bylaws with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">136<br />
        </div>

      </div>

    </div>

    <!--End Page 145-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 146-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg28"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">of Caladrius or Cend, respectively, shall not be amended, modified or repealed for a
            period of six years from the Effective Time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the Effective Time, were officers or directors of Caladrius or Cend, respectively. The certificate of
            incorporation and bylaws of Cend, as the surviving corporation in the Merger, shall contain provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of former and present directors and officers that
            are presently set forth in the certificate of incorporation and bylaws of Caladrius and Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement also provides that Caladrius shall maintain directors&#8217; and
            officers&#8217; liability insurance policies commencing at the Closing, on commercially available terms and conditions with coverage limits customary for U.S. public companies similar situated to Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tFORM1"><!--Anchor--></a>Form of the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement provides that at the Effective Time, Merger Sub will be merged
            with and into Cend and Cend will continue as the surviving corporation and will be a wholly owned subsidiary of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">After completion of the Merger, assuming Proposal No. 3 is approved by Caladrius
            Stockholders at the Annual Meeting, Caladrius will be renamed &#8220;Lisata Therapeutics, Inc.&#8221; and expects to trade on The Nasdaq Capital Market under the symbol &#8220;LSTA.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tMERGCAA"><!--Anchor--></a>Merger Consideration and
            Adjustment</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">At the Effective Time: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each share of Cend Capital Stock (excluding any shares of capital stock held by Caladrius) outstanding immediately prior to the
                    Effective Time will automatically be converted solely into the right to receive a number of shares of Caladrius Common Stock equal to the Exchange Ratio, subject to adjustment to account for the Reverse Stock Split, for Caladrius&#8217; net
                    cash immediately prior to the Closing, for Cend&#8217;s unpaid transaction costs immediately prior to the Closing and in accordance with the Merger Agreement; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each Cend Option outstanding and unexercised immediately prior to the Effective Time, whether vested or unvested, will be
                    assumed by Caladrius and will become an option, subject to vesting (with acceleration of vesting triggered by the Merger in some instances), to purchase shares of Caladrius Common Stock.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Exchange Ratio is calculated using a formula intended to allocate to existing Cend
            Stockholders a percentage of the combined organization. Based on Cend&#8217;s and Caladrius&#8217; capitalization as of June&#160;13, 2022, the Exchange Ratio is currently estimated to be approximately 8.5623 pre-split shares of Caladrius Common Stock for each
            share of Cend Capital Stock, subject to (i)&#160;adjustment to account for the effect of the Reverse Stock Split, (ii)&#160;adjustments to account for the issuance of any additional shares of Cend Capital Stock or Caladrius Common Stock, as applicable,
            prior to the consummation of the Merger, (iii)&#160;an adjustment to the extent that Cend&#8217;s unpaid transaction costs are greater than $250,000, and (iv)&#160;an upward or downward adjustment to the extent that Caladrius&#8217; net cash immediately prior to the
            Closing is greater or less than a certain threshold based on when the Closing occurs, as further detailed in the Merger Agreement and in the section entitled &#8220;<span style="font-style: italic;">Merger Agreement</span>&#8221; below (and as a result,
            Caladrius Stockholders could own less, and Cend Stockholders could own more, of the combined organization).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Immediately after the consummation of the Merger, based on the Exchange Ratio, it is
            expected that existing Cend Stockholders are expected to own, or hold rights to acquire, approximately 50% of the outstanding shares of Caladrius Common Stock and existing Caladrius Stockholders are expected to own approximately 50% of the
            outstanding shares of Caladrius Common Stock. Such percentages are subject to adjustment based on the final Exchange Ratio as set forth in the Merger Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Exchange Ratio formula is the quotient obtained by dividing the number of Cend
            merger shares by the Cend outstanding shares, where:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend merger shares is the product determined by multiplying (i)&#160;the post-closing Caladrius shares by (ii)&#160;the Cend allocation
                    percentage;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">137<br />
        </div>

      </div>

    </div>

    <!--End Page 146-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 147-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg29"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend outstanding shares is the total number of shares of Cend Capital Stock issued and outstanding immediately prior to the
                    Effective Time after the effectiveness of the conversion of Cend Preferred Stock (excluding any Cend Preferred Stock owned by Caladrius) into Cend Common Stock (the &#8220;Preferred Stock Conversion&#8221;);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">post-closing Caladrius shares is the quotient determined by dividing (i)&#160;the Caladrius outstanding shares by (ii)&#160;the Caladrius
                    allocation percentage;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius outstanding shares is the total number of shares of Caladrius Common Stock issued and outstanding immediately prior to
                    the Effective Time;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend allocation percentage means 0.5; provided, however, that, to the extent that Cend&#8217;s unpaid transaction costs are greater
                    than $250,000, then 0.5 shall be reduced by 0.000056 for each $10,000 (rounded down to the next nearest $10,000 increment) that Cend&#8217;s unpaid transaction costs as so determined are greater than $250,000; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius allocation percentage means 1.00 minus the Cend allocation percentage; provided, however, that the Caladrius
                    allocation percentage is subject to adjustment to the extent that Caladrius&#8217; net cash immediately prior to the Closing is greater or less than a certain threshold based on when the Closing occurs.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For illustrative purposes only, four example scenarios calculating the Exchange Ratio
            are described below. These example scenarios have assumed that: (i)&#160;the Effective Time occurs on September&#160;30, 2022, (ii)&#160;Caladrius outstanding shares is equal to 60,518,478, and (iii)&#160;Cend outstanding shares is equal to 7,068,037. Further, the
            below illustrations do not give effect to any adjustment for the Reverse Stock Split and are rounded.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h4">Case 1: Caladrius&#8217; net cash is $70.0&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">In this case, the Caladrius allocation percentage will be 0.5. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend allocation percentage will be 1.00 &#8211; 0.5 = 0.5. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The post-closing Caladrius shares is equal to the quotient determined by dividing
            (i)&#160;the Caladrius outstanding shares by (ii)&#160;the Caladrius allocation percentage: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">60,518,478 / 0.5 = 121,036,956</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend merger shares is equal to the product determined by multiplying (i)&#160;the
            post-closing Caladrius shares by (ii)&#160;the Cend allocation percentage: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">121,036,956 x 0.5 = 60,518,478</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Exchange Ratio will thus be the quotient obtained by dividing the number of Cend
            merger shares by the number of Cend outstanding shares: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">60,518,478 / 7,068,037 = 8.5623 </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h4">Case 2: Caladrius&#8217; net cash is $75.0&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">In this case, the Caladrius allocation percentage will be 0.5091. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend allocation percentage will be 1.00 &#8211; 0.5091 = 0.4909. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The post-closing Caladrius shares is equal to the quotient determined by dividing
            (i)&#160;the Caladrius outstanding shares by (ii)&#160;the Caladrius allocation percentage: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">60,518,478 / 0.5091 = 118,873,459</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend merger shares is equal to the product determined by multiplying (i)&#160;the
            post-closing Caladrius shares by (ii)&#160;the Cend allocation percentage: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">118,873,459 x 0.4909 = 58,354,981</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Exchange Ratio will thus be the quotient obtained by dividing the number of Cend
            merger shares by the number of Cend outstanding shares: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">58,354,981 / 7,068,037 = 8.2562</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">138<br />
        </div>

      </div>

    </div>

    <!--End Page 147-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 148-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg30"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h4">Case 3: Caladrius&#8217; net cash is $67.0&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">In this case, the Caladrius allocation percentage will be 0.4937. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend allocation percentage will be 1.00 &#8211; 0.4937 = 0.5063. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The post-closing Caladrius shares is equal to the quotient determined by dividing
            (i)&#160;the Caladrius outstanding shares by (ii)&#160;the Caladrius allocation percentage: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">60,518,478 / 0.4937 = 122,581,483</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend merger shares is equal to the product determined by multiplying (i)&#160;the
            post-closing Caladrius shares by (ii)&#160;the Cend allocation percentage: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">122,581,483 x 0.5063 = 62,063,005</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Exchange Ratio will thus be the quotient obtained by dividing the number of Cend
            merger shares by the number of Cend outstanding shares: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">62,063,005 / 7,068,037 = 8.7808</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h4">Case 4: Caladrius&#8217; net cash is $70.0&#160;million and Cend&#8217;s unpaid
            transaction costs is $1.25&#160;million</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">In this case, the Caladrius allocation percentage will be 0.5056.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend allocation percentage will be 1.00-0.5056 = 0.4944.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The post-closing Caladrius shares is equal to the quotient determined by dividing
            (i)&#160;the Caladrius outstanding shares by (ii)&#160;the Caladrius allocation percentage:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">60,518,478 / 0.5056 = 119,696,357</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend merger shares is equal to the product determined by multiplying (i)&#160;the
            post-closing Caladrius shares by (ii)&#160;the Cend allocation percentage:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">119,696,357 x 0.4944 = 59,177,879</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Exchange Ratio will thus be the quotient obtained by dividing the number of Cend
            merger shares by the number of Cend outstanding shares:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">59,177,879 / 7,068,037 = 8.3726</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement does not include a price-based termination right, and there will
            be no adjustment to the total number of shares of Caladrius Common Stock that Cend Stockholders will be entitled to receive for changes in the market price of Caladrius Common Stock. Accordingly, the market value of the shares of Caladrius
            Common Stock issued pursuant to the Merger will depend on the market value of the shares of Caladrius Common Stock at Closing, and could vary significantly from the market value of Caladrius Common Stock on the date of this proxy
            statement/prospectus/information statement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">No fractional shares of Caladrius Common Stock will be issuable to Cend Stockholders
            pursuant to the Merger Agreement. Instead, each Cend Stockholder who would otherwise be entitled to receive a fraction of a share of Caladrius Common Stock, after aggregating all fractional shares of Caladrius Common Stock issuable to such
            stockholder, will be entitled to receive in cash the dollar amount, rounded to the nearest whole cent, without interest, determined by multiplying such fraction by the closing price of a share of Caladrius Common Stock on Nasdaq on the date the
            Merger becomes effective. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tDCNC"><!--Anchor--></a>Determination of Caladrius&#8217; Net Cash</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement includes a condition to Cend&#8217;s obligation to close the Merger that
            requires Caladrius to have a minimum net cash balance based on the date of the Closing as follows:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Closing occurs in June of 2022, net cash shall be greater than or equal $70,465,000;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Closing occurs in July of 2022, net cash shall be greater than or equal $68,697,000;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Closing occurs in August of 2022, net cash shall be greater than or equal $66,976,000;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Closing occurs in September of 2022, net cash shall be greater than or equal $64,872,000;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">139<br />
        </div>

      </div>

    </div>

    <!--End Page 148-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 149-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg31"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Closing occurs in October of 2022, net cash shall be greater than or equal $63,134,000;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Closing occurs in November of 2022, net cash shall be greater than or equal $61,400,000;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Closing occurs in December of 2022, net cash shall be greater than or equal $59,709,000; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">if the Closing occurs in January of 2023, net cash shall be greater than or equal $57,642,000.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Merger Agreement, Caladrius&#8217; &#8220;net cash&#8221; is defined as (i)&#160;the sum of, in each
            case as of the cash determination time set forth in the Merger Agreement, (a) Caladrius&#8217; cash and cash equivalents, marketable securities, prepaid and other current assets, accounts receivable, interest and other receivables, cash determination
            time determined in a manner consistent with the manner in which such items were historically determined and in accordance with U.S. GAAP and Caladrius&#8217; audited financial statements, (b) expenses paid, or liabilities incurred, prior to the
            Closing, that are approved and guaranteed in writing (without conditions) to be paid to Caladrius pursuant to any directors&#8217; and officers&#8217; insurance policy, and (c) amounts invested in the Series D Preferred Stock of Cend, <span style="font-style: italic;">minus</span> (ii)&#160;the sum of, in each case as of such cash determination time, (a) Caladrius&#8217; accounts payable and accrued liabilities (without duplication of any expenses accounted for below and other than accrued
            liabilities that are Caladrius transaction costs under the Merger Agreement), cash determination time in each case determined in a manner consistent with the manner in which such items were historically determined and in accordance with U.S.
            GAAP and Caladrius&#8217; audited financial statements, (b) any unpaid Caladrius transaction costs, and (c) any declared but unpaid Caladrius cash dividends. Notwithstanding the foregoing, in no case shall Caladrius&#8217; net cash be reduced for any costs
            or expenses, including attorney&#8217;s fees or settlement costs, incurred in connection with any dissenting shares described in the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; net cash balance at the cash determination time is subject to numerous
            factors, many of which are outside of Caladrius&#8217; control. If Caladrius&#8217; net cash immediately prior to the Closing is less than the applicable threshold based on when the Closing occurs, based on the manner of calculating net cash pursuant to
            the Merger Agreement, Caladrius would be unable to satisfy a closing condition for the Merger, in which case Cend could elect to waive the condition or choose to not consummate the Merger. Furthermore, the Exchange Ratio at the Closing will be
            subject to adjustment to the extent that Caladrius&#8217; net cash immediately prior to the Closing is less than or greater than the applicable threshold based on when the Closing occurs (and as a result, Caladrius Stockholders and Cend Stockholders
            could own more or less of the combined organization), as described under &#8220;<span style="font-style: italic;">The Merger&#8212;Merger Consideration and Adjustment</span>.&#8221; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tPECSE"><!--Anchor--></a>Procedures for Exchanging Cend Stock
            Certificates</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement provides that, at the Effective Time, Caladrius will deposit with
            an exchange agent acceptable to Caladrius and Cend evidence of book-entry shares representing the shares of Caladrius Common Stock issuable to Cend Stockholders and a sufficient amount of cash to make payments in lieu of fractional shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement provides that, promptly after the Effective Time, the exchange
            agent will mail to each record holder of shares of Cend Capital Stock immediately prior to the Effective Time a letter of transmittal and instructions for surrendering and exchanging Cend stock certificates held by such record holder in
            exchange for book-entry shares of Caladrius Common Stock. Upon surrender of a Cend stock certificate for exchange to the exchange agent, together with a duly signed letter of transmittal and such other documents as the exchange agent or
            Caladrius may reasonably require, the Cend stock certificate surrendered will be cancelled and the holder of such Cend stock certificate will be entitled to receive the following: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">book-entry shares representing the number of whole shares of Caladrius Common Stock that such holder has the right to receive
                    pursuant to the provisions of the Merger Agreement; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">cash in lieu of any fractional share of Caladrius Common Stock. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">From and after the Effective Time, until it is surrendered, each certificate that
            previously evidenced shares of Cend Capital Stock will be deemed to represent only the right to receive book-entry shares of Caladrius Common Stock, and cash in lieu of any fractional share of Caladrius Common Stock. Caladrius will not pay
            dividends or other distributions on any shares of Caladrius Common Stock to be issued in exchange for any unsurrendered Cend stock certificate until such Cend stock certificate is surrendered as provided in the Merger Agreement.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">140<br />
        </div>

      </div>

    </div>

    <!--End Page 149-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 150-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg32"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">If any Cend stock certificate has been lost, stolen or destroyed, Caladrius may, in
            its discretion, and as a condition precedent to the delivery of any book-entry shares of Caladrius Common Stock, require the owner of such lost, stolen or destroyed certificate to provide an affidavit claiming such certificate has been lost,
            stolen or destroyed and post a bond indemnifying Caladrius against any claim suffered by Caladrius related to the lost, stolen or destroyed certificate or any Caladrius Common Stock issued in exchange for such certificate as Caladrius may
            reasonably request.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tETOT"><!--Anchor--></a>Effective Time of the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement requires the parties to consummate the Merger as promptly as
            practicable (and in any event within two business days) after all of the conditions to the consummation of the Merger contained in the Merger Agreement are satisfied or waived, including the adoption of the Merger Agreement by the Cend
            Stockholders and the approval by the Caladrius Stockholders of the issuance of Caladrius Common Stock, the amendment to the amended and restated certificate of incorporation of Caladrius effecting the Reverse Stock Split and the other
            transactions contemplated by the Merger Agreement. The Merger will become effective upon the filing of a certificate of merger with the Secretary of State of the State of Delaware or at such later time as is agreed by Caladrius and Cend and
            specified in the certificate of merger. Neither Caladrius nor Cend can predict the exact timing of the consummation of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tREGAPP"><!--Anchor--></a>Regulatory Approvals</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the United States, Caladrius must comply with applicable federal and state
            securities laws and the rules and regulations of Nasdaq in connection with the issuance of shares of Caladrius Common Stock and the filing of this proxy statement/prospectus/information statement with the SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tTAXTM"><!--Anchor--></a>Tax Treatment of the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius and Cend intend for the Merger to qualify as a reorganization within the
            meaning of Section 368(a) of the Code. Each of Caladrius and Cend will use its commercially reasonable efforts to cause the Merger to qualify as a reorganization within the meaning of Section 368(a) of the Code, and not to permit or cause any
            affiliate or any subsidiary of Caladrius or Cend to, take any action or cause any action to be taken which would reasonably be expected to prevent the Merger from qualifying as a reorganization within the meaning Section 368(a) of the Code.
            Specifically, Caladrius will use its commercially reasonable efforts to operate the surviving corporation so as to meet the &#8220;continuity of business enterprise&#8221; requirement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tMATE1"><!--Anchor--></a>Material U.S. Federal Income Tax
            Consequences of the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following discussion summarizes the material U.S. federal income tax consequences
            of the Merger that are expected to apply generally to each Cend Stockholder upon the exchange of shares of Cend Capital Stock for shares of Caladrius Common Stock upon the consummation of the Merger. This summary is based upon current
            provisions of the Code, existing Treasury Regulations and current administrative rulings and court decisions, all in effect as of the date hereof and all of which are subject to change. Any change, which may be retroactive, could alter the tax
            consequences to Caladrius, Cend or the Cend Stockholders as described in this summary.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">No attempt has been made to comment on all of the U.S. federal income tax consequences
            of the Merger that may be relevant to particular holders, including holders who do not hold their shares as capital assets; holders subject to special treatment under the Code such as dealers in securities; banks; insurance companies; other
            financial institutions; mutual funds; real estate investment trusts; regulated investment companies; tax-exempt organizations; pass-through entities such as partnerships, S corporations, disregarded entities for federal income tax purposes and
            limited liability companies (and investors therein); persons who are not U.S. holders (as defined below); stockholders who are subject to the alternative minimum tax provisions of the Code; Cend Stockholders who hold their shares as part of a
            hedge, wash sale, synthetic security, conversion transaction, or other integrated transaction; persons that have a functional currency other than the U.S. dollar; traders in securities who elect to apply a mark-to-market method of accounting;
            persons who hold shares of Cend Capital Stock that may constitute &#8220;qualified small business stock&#8221; under Section 1202 of the Code or as &#8220;Section 1244 stock&#8221; for purposes of Section 1244 of the Code; Cend Stockholders who acquired their shares
            of stock in a transaction subject to the gain rollover provisions of Section 1045 of the Code; Cend Stockholders who acquired their shares of stock pursuant to the exercise of options or otherwise as compensation or through a tax-qualified
            retirement </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">141<br />
        </div>

      </div>

    </div>

    <!--End Page 150-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 151-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg33"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">plan or through the exercise of a warrant or conversion rights under convertible
            instruments; and certain expatriates or former citizens or long-term residents of the United States. Stockholders described in this paragraph are urged to consult their own tax advisors regarding the consequences to them of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the case of a stockholder that is a partnership, the U.S. federal income tax
            treatment of a partner in the partnership will generally depend upon the status of the partner, the activities of the partnership and certain determinations made at the partner level. Partnerships that are holders of Cend Capital Stock and
            partners in such partnerships are urged to consult their own tax advisors regarding the tax consequences to them of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, the following discussion does not address the tax consequences of the
            Merger under state, local or non-U.S. tax laws or federal tax laws other than income tax laws. Furthermore, the following discussion does not address: (a) the tax consequences of transactions effectuated before, after or at the same time as the
            Merger, whether or not they are in connection with the Merger, including, without limitation, transactions in which shares of Cend Capital Stock are acquired or disposed of other than in exchange for shares of Caladrius Common Stock in the
            Merger; (b) the tax consequences to holders of options or warrants issued by Cend which are assumed in connection with the Merger; (c) the tax consequences of the receipt of shares of Caladrius Common Stock other than in exchange for shares of
            Cend Capital Stock pursuant to the Merger Agreement; (d) any U.S. federal non-income tax consequences of the Merger, including estate, gift or other tax consequences; (e) any state, local or non-U.S. tax consequences of the Merger; or (f) the
            Medicare contribution tax on net investment income. No ruling from the Internal Revenue Service (the &#8220;IRS&#8221;) or opinion of counsel, has been or will be requested in connection with the Merger, and Cend Stockholders should be aware that the IRS
            could adopt a position which could be sustained by a court contrary to that set forth in this discussion.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Holders of Cend Capital Stock are urged to consult their tax
            advisors regarding the U.S. federal income tax consequences of the Merger in light of their personal circumstances and the consequences under state, local and non-U.S. tax laws and other federal tax laws.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">Treatment of the Merger as a &#8220;Reorganization&#8221;
            under Section 368(a)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius and Cend intend the Merger to qualify as a reorganization within the meaning
            of Section 368(a) of the Code, but the Merger may not so qualify. The Merger is not conditioned on the receipt of a tax opinion, or any other condition, relating to the qualification of the Merger as such a reorganization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">Definition of &#8220;U.S. Holder&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">For purposes of this discussion, a &#8220;U.S. holder&#8221; is a beneficial owner of Cend Capital
            Stock that is: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an individual who is a citizen or resident of the United States; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a corporation or any other entity taxable as a corporation created or organized in or under the laws of the United States or of
                    a state of the United States, any state thereof or the District of Columbia; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a trust if either (i)&#160;a court within the United States is able to exercise primary supervision over the administration of such
                    trust, and one or more United States persons (within the meaning of Section&#160;7701(a)(30) of the Code) are authorized or have the authority to control all substantial decisions of such trust, or (ii)&#160;the trust was in existence on
                    August&#160;20, 1996 and has a valid election in effect under applicable Treasury Regulations to be treated as a United States person for U.S. federal income tax purposes; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an estate, the income of which is subject to U.S. federal income tax regardless of its source. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Treatment of U.S. Holders in the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Merger qualifies as a reorganization within the meaning of Section 368(a) of the
            Code, Cend Stockholders generally will not recognize gain or loss upon the exchange of their Cend Capital Stock for Caladrius Common Stock, except to the extent of cash received in lieu of a fractional share of Caladrius Common Stock as
            described below. Cend Stockholders generally will obtain a basis in the Caladrius Common Stock they receive in the Merger equal to their basis in the exchanged Cend Capital Stock. The holding period of the shares of Caladrius Common Stock
            received by a Cend Stockholder in the Merger will include the holding period of the shares of Cend Capital Stock surrendered in exchange therefor. A U.S. holder who receives cash in lieu of a fractional share of Caladrius Common Stock will be
            treated for U.S. federal income tax purposes as having received such </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">142<br />
        </div>

      </div>

    </div>

    <!--End Page 151-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 152-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg34"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">fractional share pursuant to the Merger and then as having exchanged such fractional
            share for cash in a redemption by Caladrius. Such U.S. holder will recognize gain or loss equal to the difference, if any, between such stockholder&#8217;s basis in the fractional share and the amount of cash received. Such gain or loss will be a
            long-term capital gain or loss, if the U.S. holder&#8217;s holding period is greater than one year as of the date of the Closing. The deductibility of capital losses is subject to limitations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Merger is not treated as a reorganization within the meaning of Section 368(a)
            of the Code, then each U.S. holder generally will be treated as exchanging its Cend Capital Stock in a fully taxable transaction in exchange for Caladrius Common Stock and any cash received in lieu of a fractional share. Cend Stockholders will
            generally recognize gain or loss in such exchange equal to the amount that such Cend Stockholder&#8217;s adjusted tax basis in the Cend Capital Stock surrendered is less or more than the fair market value of the Caladrius Common Stock and any cash in
            lieu of a fractional share received in exchange therefor. Gain or loss recognized upon such an exchange generally will be capital gain or capital loss. Any recognized capital gain or capital loss will be long-term capital gain or capital loss,
            if the U.S. holder has held the shares of Cend Capital Stock for more than one year. The deductibility of capital losses is subject to limitations. In addition, for purposes of the above discussion of the bases and holding periods for shares of
            Cend Capital Stock and Caladrius Common Stock, U.S. holders who acquired different blocks of Cend Capital Stock at different times for different prices must calculate their gains and losses and holding periods separately for each identifiable
            block of such stock exchanged in the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Reporting Requirements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Merger is a reorganization within the meaning of Section 368(a) of the Code,
            each U.S. holder who receives shares of Caladrius Common Stock in the Merger is required to retain permanent records pertaining to the Merger, and make such records available to any authorized IRS officers and employees. Such records should
            specifically include information regarding the amount, basis, and fair market value of all transferred property, and relevant facts regarding any liabilities assumed or extinguished as part of such reorganization. Additionally, U.S. holders who
            owned immediately before the Merger at least one percent (by vote or value) of the total outstanding stock of Cend are required to attach a statement to their tax returns for the year in which the Merger is consummated that contains the
            information listed in Treasury Regulation Section 1.368-3(b). Such statement must include the U.S. holder&#8217;s tax basis in such holder&#8217;s Cend Capital Stock surrendered in the Merger, the fair market value of such stock, the date of the Merger and
            the name and employer identification number of each of Cend and Caladrius. U.S. holders are urged to consult with their tax advisors to comply with these rules.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Information Reporting and Backup Withholding</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A U.S. holder of Cend Capital Stock may be subject to information reporting and backup
            withholding for U.S. federal income tax purposes on cash paid in lieu of fractional shares in connection with the Merger. Backup withholding will not apply, however, to a holder who (i)&#160;furnishes a correct taxpayer identification number and
            certifies the holder is not subject to backup withholding on IRS Form W-9 or a substantially similar form, (ii)&#160;provides a certification of foreign status on an appropriate IRS Form W-8 or successor form or (iii)&#160;certifies the holder is
            otherwise exempt from backup withholding. If a U.S. holder does not provide a correct taxpayer identification number on IRS Form W-9 or other proper certification, the stockholder may be subject to penalties imposed by the IRS. Any amounts
            withheld under the backup withholding rules may be refunded or allowed as a credit against the federal income tax liability of a U.S. holder of Cend Capital Stock, if any, provided the required information is timely furnished to the IRS. U.S.
            holders of Cend Capital Stock should consult their tax advisors regarding their qualification for an exemption from backup withholding, the procedures for obtaining such an exemption, and in the event backup withholding is applied, to determine
            if any tax credit, tax refund or other tax benefit may be obtained.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The foregoing summary is of a general nature only and is not
            intended to be, and should not be construed to be, legal, business or tax advice to any particular Cend Stockholder. This summary does not take into account your particular circumstances and does not address consequences that may be particular
            to you. Therefore, you should consult your tax advisor regarding the particular consequences of the Merger to you.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tNASD"><!--Anchor--></a>Nasdaq Capital Market Listing</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Common Stock is currently listed on The Nasdaq Capital Market under the
            symbol &#8220;CLBS.&#8221; Caladrius has agreed to use commercially reasonable efforts to maintain its existing listing on The Nasdaq Capital Market, </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">143<br />
        </div>

      </div>

    </div>

    <!--End Page 152-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 153-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg35"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">and to obtain approval for listing on The Nasdaq Capital Market of the shares of
            Caladrius Common Stock that Cend Stockholders will be entitled to receive pursuant to the Merger. In addition, under the Merger Agreement, each party&#8217;s obligation to complete the Merger is subject to the satisfaction or waiver by each of the
            parties, at or prior to the Closing, of various conditions, including that the existing shares of Caladrius Common Stock must have been continually listed on The Nasdaq Capital Market, and Caladrius must have caused the shares of Caladrius
            Common Stock to be issued in the Merger to be approved for listing on The Nasdaq Capital Market as of the Closing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Prior to consummation of the Merger, Caladrius intends to file a notification form
              with Nasdaq for the listing of additional shares with respect to the shares of Caladrius Common Stock to be issued to the holders of Cend Capital Stock in the Merger. If such application is accepted, Caladrius anticipates that Caladrius
              Common Stock will be listed on The Nasdaq Capital Market following the Closing under the trading symbol &#8220;LSTA&#8221;.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tANTIAT"><!--Anchor--></a>Anticipated Accounting Treatment</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger is expected to be treated by Caladrius as an asset acquisition by Caladrius
            in accordance with U.S. GAAP. To determine the accounting for this transaction under U.S. GAAP, a company must assess whether an integrated set of assets and activities should be accounted for as an acquisition of a business or an asset
            acquisition. The guidance requires an initial screen test to determine if substantially all of the fair value of the gross assets acquired is concentrated in a single asset or group of similar assets. If that screen is met, the set is not a
            business. In connection with the acquisition of Cend, substantially all the fair value is included in in-process research and development of CEND-1 and, as such, the acquisition is expected to be treated as an asset acquisition. For accounting
            purposes, Caladrius is considered to be acquiring Cend in the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tAPPRDR"><!--Anchor--></a>Appraisal Rights and Dissenters&#8217;
            Rights</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Delaware Law</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Merger is completed, Cend Stockholders who do not deliver a written consent
            approving the Merger are entitled to appraisal rights under Section 262 of the DGCL (&#8220;Section 262&#8221;), <span style="font-style: italic;">provided</span> that they comply with the conditions established by Section 262. Holders of Caladrius Common
            Stock are not entitled to appraisal rights under Delaware law in connection with the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The discussion below is not a complete summary regarding a Cend Stockholders&#8217; appraisal
            rights under Delaware law and is qualified in its entirety by reference to the text of the relevant provisions of Delaware law, which are attached to this proxy statement/prospectus/information statement as <span style="font-style: italic;">Annex&#160;C</span>.
            Cend Stockholders intending to exercise appraisal rights should carefully review <span style="font-style: italic;">Annex&#160;C</span>. Failure to follow precisely any of the statutory procedures set forth in <span style="font-style: italic;">Annex&#160;C</span>
            may result in a termination or waiver of these rights. This summary does not constitute legal or other advice, nor does it constitute a recommendation that Cend Stockholders exercise their appraisal rights under Delaware law.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under Section 262, where a merger is adopted by stockholders by written consent in lieu
            of a meeting of stockholders pursuant to Section 228 of the DGCL, either the constituent corporation, before the effective date of the merger, or the surviving corporation, within 10 days after the effective date of the merger, must notify each
            stockholder of the constituent corporation entitled to appraisal rights of the approval of the merger, the effective date of the merger and that appraisal rights are available.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Merger is completed, within 10 days after the effective date of the Merger, Cend
            will notify its stockholders that the Merger has been approved, the effective date of the Merger and that appraisal rights are available to any stockholder who has not approved the Merger. Holders of shares of Cend Capital Stock who desire to
            exercise their appraisal rights must deliver a written demand for appraisal to Cend within 20 days after the date of mailing of that notice, and that stockholder must not have delivered a written consent approving the Merger. A demand for
            appraisal must reasonably inform Cend of the identity of the stockholder and that such stockholder intends thereby to demand appraisal of the shares of Cend Capital Stock held by such stockholder. Failure to deliver a written consent approving
            the Merger will not in and of itself constitute a written demand for appraisal satisfying the requirements of Section 262. All demands for appraisal should be addressed to Cend Therapeutics, Inc., 12544 High Bluff Drive, Suite 400, San Diego,
            California 92130, Attention: David Slack, and should be executed by, or on behalf of, the record holder of shares of Cend Capital Stock. ALL DEMANDS MUST BE RECEIVED BY CEND WITHIN TWENTY (20) DAYS AFTER THE DATE CEND MAILS A </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">144<br />
        </div>

      </div>

    </div>

    <!--End Page 153-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 154-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg36"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">NOTICE TO ITS STOCKHOLDERS NOTIFYING THEM THAT THE MERGER HAS BEEN APPROVED, THE
            EFFECTIVE DATE OF THE MERGER AND THAT APPRAISAL RIGHTS ARE AVAILABLE TO ANY STOCKHOLDER WHO HAS NOT APPROVED THE MERGER.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If a holder of shares of Cend Capital Stock fails to deliver a written demand for
            appraisal within the time period specified above, such holder will be entitled to receive the merger consideration for such holder&#8217;s shares of Cend Capital Stock as provided for in the Merger Agreement, but will have no appraisal rights with
            respect to such holder&#8217;s shares of Cend Capital Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To be effective, a demand for appraisal by a holder of shares of Cend Capital Stock
            must be made by, or in the name of, the registered stockholder, fully and correctly, as the stockholder&#8217;s name appears on the stockholder&#8217;s stock certificate(s). Beneficial owners who do not also hold the shares of record may not directly make
            appraisal demands to Cend. The beneficial owner must, in these cases, have the registered owner, such as a broker, bank or other custodian, submit the required demand in respect of those shares. If shares are owned of record in a fiduciary
            capacity, such as by a trustee, guardian or custodian, execution of a demand for appraisal should be made by or for the fiduciary; and if the shares are owned of record by more than one person, as in a joint tenancy or tenancy in common, the
            demand should be executed by or for all joint owners. An authorized agent, including an authorized agent for two or more joint owners, may execute the demand for appraisal for a stockholder of record; however, the agent must identify the record
            owner or owners and expressly disclose the fact that, in executing the demand, he or she is acting as agent for the record owner. A record owner, such as a broker, who holds shares as a custodian for others, may exercise the record owner&#8217;s
            right of appraisal with respect to the shares held for one or more beneficial owners, while not exercising this right for other beneficial owners. In that case, the written demand should state the number of shares as to which appraisal is
            sought. Where no number of shares is expressly mentioned, the demand will be presumed to cover all shares held in the name of the record owner. In addition, the stockholder must continuously hold the shares of record from the date of making the
            demand through the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If a holder of shares of Cend Capital Stock holds shares of Cend Capital Stock in a
            brokerage account or in other custodian form and such holder wishes to exercise appraisal rights, such holder should consult with such holder&#8217;s bank, broker or other custodian to determine the appropriate procedures for the making of a demand
            for appraisal by the custodian.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At any time within 60 days after the Effective Time of the Merger, any stockholder who
            has demanded an appraisal, but has neither commenced an appraisal proceeding or joined an appraisal proceeding as a named party, has the right to withdraw such stockholder&#8217;s demand and accept the terms of the Merger by delivering a written
            withdrawal to Cend. If, following a demand for appraisal, a holder of shares of Cend Capital Stock who has demanded an appraisal has withdrawn such holder&#8217;s demand for appraisal in accordance with Section 262, such holder will have the right to
            receive the merger consideration for such holder&#8217;s shares of Cend Capital Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Within 120 days after the effective date of the Merger, any stockholder who has
            delivered a demand for appraisal in accordance with Section 262 will, upon written request to the surviving corporation, be entitled to receive a written statement setting forth the aggregate number of shares not voted in favor of the Merger
            Agreement and with respect to which demands for appraisal rights have been received and the aggregate number of holders of such shares. This written statement will be mailed to the requesting stockholder within 10 days after the stockholder&#8217;s
            written request is received by the surviving corporation or within 10 days after expiration of the period for delivery of demands for appraisal, whichever is later. Within 120 days after the effective date of the Merger, either the surviving
            corporation or any stockholder who has delivered a demand for appraisal in accordance with Section 262 may file a petition in the Delaware Court of Chancery demanding a determination of the fair value of the shares held by all such
            stockholders. Upon the filing of the petition by a stockholder, service of a copy of the petition must be made upon the surviving corporation. The surviving corporation has no obligation to file a petition in the Delaware Court of Chancery in
            the event there are dissenting stockholders, and Cend, which is expected to be the surviving corporation, has no present intent to file a petition in the Delaware Court of Chancery. Accordingly, the failure of a stockholder to file a petition
            within the period specified could nullify the stockholder&#8217;s previously written demand for appraisal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If a petition for appraisal is duly filed by a stockholder and a copy of the petition
            is delivered to the surviving corporation, the surviving corporation will then be obligated, within 20 days after receiving service of a copy of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">145<br />
        </div>

      </div>

    </div>

    <!--End Page 154-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 155-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg37"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the petition, to provide the Delaware Court of Chancery with a duly verified list
            containing the names and addresses of all stockholders who have demanded an appraisal of their shares and with whom agreements as to the value of their shares have not been reached by the surviving corporation. After notice to dissenting
            stockholders who demanded appraisal of their shares, the Delaware Court of Chancery is empowered to conduct a hearing upon the petition, and to determine those stockholders who have complied with Section 262 and who have become entitled to the
            appraisal rights provided thereby. The Delaware Court of Chancery may require the stockholders who have demanded appraisal for their shares to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of
            the appraisal proceedings; and if any stockholder fails to comply with that direction, the Delaware Court of Chancery may dismiss the proceedings as to that stockholder. If immediately before the Merger the shares of a class or series of stock
            as to which appraisal rights are available were listed on a national securities exchange, the Delaware Court of Chancery will dismiss the proceedings as to all holders of such shares who are otherwise entitled to appraisal rights unless (1) the
            total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the class or series eligible for appraisal, (2) the value of the consideration provided in the Merger for such total number of shares exceeds $1.0&#160;million or
            (3) the Merger was approved pursuant to Sections 253 or 267 of the DGCL.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">After determination of the stockholders entitled to appraisal of their shares, the
            Delaware Court of Chancery will appraise the &#8220;fair value&#8221; of the shares owned by those stockholders. This value will be exclusive of any element of value arising from the accomplishment or expectation of the Merger, but may include a fair rate
            of interest, if any, upon the amount determined to be the fair value. At any time before the entry of judgment in the proceedings, the surviving corporation may pay to each shareowner entitled to appraisal an amount in cash, in which case
            interest shall accrue thereafter only upon the sum of (1) the difference, if any, between the amount paid and the fair value of the shares determined by the Delaware Court of Chancery, and (2) interest theretofore accrued, unless paid at that
            time. When the value is determined, the Delaware Court of Chancery will direct the payment of the value, with interest thereon accrued during the pendency of the proceeding, if the Delaware Court of Chancery so determines, to the stockholders
            entitled to receive the same, upon surrender by the holders of the certificates representing those shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In determining fair value, and, if applicable, a fair rate of interest, the Delaware
            Court of Chancery is required to take into account all relevant factors. In <span style="font-style: italic;">Weinberger v. UOP, Inc.</span>, the Delaware Supreme Court discussed the factors that could be considered in determining fair value
            in an appraisal proceeding, stating that &#8220;proof of value by any techniques or methods which are generally considered acceptable in the financial community and otherwise admissible in court&#8221; should be considered, and that &#8220;fair price obviously
            requires consideration of all relevant factors involving the value of a company.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Section 262 provides that fair value is to be &#8220;exclusive of any element of value
            arising from the accomplishment or expectation of the Merger.&#8221; In <span style="font-style: italic;">Cede &amp; Co. v. Technicolor, Inc.</span>, the Delaware Supreme Court stated that this exclusion is a &#8220;narrow exclusion [that] does not
            encompass known elements of value,&#8221; but which rather applies only to the speculative elements of value arising from such accomplishment or expectation. In <span style="font-style: italic;">Weinberger</span>, the Delaware Supreme Court
            construed Section 262 to mean that &#8220;elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the Merger and not the product of speculation, may be considered.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Holders of shares of Cend Capital Stock should be aware that the fair value of such
            holder&#8217;s shares as determined under Section 262 could be more than, the same as, or less than the value that such holder is entitled to receive under the terms of the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Costs of the appraisal proceeding may be imposed upon the surviving corporation and the
            stockholders participating in the appraisal proceeding by the Delaware Court of Chancery as the Court deems equitable in the circumstances. Upon the application of a stockholder, the Delaware Court of Chancery may order all or a portion of the
            expenses incurred by any stockholder in connection with the appraisal proceeding, including, without limitation, reasonable attorneys&#8217; fees and the fees and expenses of experts, to be charged pro rata against the value of all shares entitled to
            appraisal. In the absence of such a determination of assessment, each party bears its own expenses. Any stockholder who had demanded appraisal rights will not, after the Effective Time, be entitled to vote shares subject to that demand for any
            purpose or to receive payments of dividends or any other distribution with respect to those shares, other than with respect to payment as of a Record Date prior to the Effective Time; however, if no petition for appraisal is filed within 120
            days after the Effective Time, or if the stockholder delivers a written withdrawal of his or her demand for appraisal and an acceptance of the terms of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">146<br />
        </div>

      </div>

    </div>

    <!--End Page 155-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 156-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_109-merger_pg38"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the Merger within 60 days after the Effective Time, then the right of that
            stockholder to appraisal will cease and that stockholder will be entitled to receive the merger consideration for shares of his or her Caladrius capital stock pursuant to the Merger Agreement. Any withdrawal of a demand for appraisal made more
            than 60 days after the Effective Time may only be made with the written approval of the surviving corporation. No appraisal proceeding in the Delaware Court of Chancery will be dismissed as to any stockholder without the approval of the court.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Failure to follow the steps required by Section 262 for perfecting appraisal rights may
            result in the loss of appraisal rights. In view of the complexity of Section 262, stockholders who may wish to dissent from the Merger and pursue appraisal rights should consult their legal advisors.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">147<br />
        </div>

      </div>

    </div>

    <!--End Page 156-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 157-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tTMA"><!--Anchor--></a>THE MERGER AGREEMENT</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following is a summary of the material terms of the Merger
            Agreement. A copy of the Merger Agreement is attached to this proxy statement/prospectus/information statement as Annex&#160;A and is incorporated by reference into this proxy statement/prospectus/information statement. The Merger Agreement has been
            attached to this proxy statement/prospectus/information statement to provide you with information regarding its terms. It is not intended to provide any other factual information about Caladrius, Cend or Merger Sub. The following description
            does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement. You should refer to the full text of the Merger Agreement for details of the Merger and the terms and conditions of the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement contains representations and warranties that
            Caladrius and Merger Sub, on the one hand, and Cend, on the other hand, have made to one another as of specific dates. These representations and warranties have been made for the benefit of the other parties to the Merger Agreement and may be
            intended not as statements of fact but rather as a way of allocating the risk to one of the parties if those statements prove to be incorrect. In addition, the assertions embodied in the representations and warranties are qualified by
            information in confidential disclosure schedules exchanged by the parties in connection with signing the Merger Agreement. While Caladrius and Cend do not believe that these disclosure schedules contain information required to be publicly
            disclosed under the applicable securities laws, other than information that has already been so disclosed, the disclosure schedules do contain information that modifies, qualifies and creates exceptions to the representations and warranties set
            forth in the attached Merger Agreement. Accordingly, you should not rely on the representations and warranties as current characterizations of factual information about Caladrius or Cend, because they were made as of specific dates, may be
            intended merely as a risk allocation mechanism between Caladrius, Merger Sub and Cend and are modified by the disclosure schedules.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tGEN"><!--Anchor--></a>General </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Merger Agreement, at the Effective Time, Merger Sub will merge with and into
            Cend, with Cend surviving as a wholly owned subsidiary of Caladrius. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tTCO"><!--Anchor--></a>Treatment of Caladrius Options </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Effective Time, each Caladrius Option that is outstanding and unexercised
            immediately prior to the Effective Time, whether or not vested, shall survive the Closing and remain outstanding in accordance with its terms. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tTCS"><!--Anchor--></a>Treatment of Cend Options </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the Merger Agreement, at the Effective Time, each Cend Option that is
            outstanding and unexercised immediately prior to the Effective Time granted under the Cend 2016 Equity Incentive Plan, whether or not vested, will be assumed by Caladrius and will become an option to purchase that number of shares of Caladrius
            Common Stock equal to the product obtained by multiplying (i)&#160;the number of shares of Cend Common Stock that were subject to such Cend Option immediately prior to the Effective Time by (ii)&#160;the Exchange Ratio, and rounding the resulting number
            down to the nearest whole number of shares of Caladrius Common Stock. The per share exercise price for Caladrius Common Stock issuable upon exercise of each Cend Option assumed by Caladrius shall be determined by dividing (a) the per share
            exercise price of Cend Common Stock subject to such Cend Option, as in effect immediately prior to the Effective Time, by (b) the Exchange Ratio, and rounding the resulting exercise price up to the nearest whole cent. Any restriction on the
            exercise of any Cend Option assumed by Caladrius will continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such Cend Option shall otherwise remain unchanged. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tDOCF"><!--Anchor--></a>Directors and Officers of Caladrius
            Following the Merger </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the Merger Agreement, each of the directors and officers of Caladrius
              who will not continue as directors or officers of Caladrius following the consummation of the Merger, will resign immediately prior to the Effective Time. Following the consummation of the Merger, the Caladrius Board of Directors will include
              a total nine directors. Pursuant to the terms of the Merger Agreement, four of such directors will be designated by Cend and four of such directors will be designated by Caladrius. Following the Closing, the eight Caladrius and Cend designees
              may mutually select a ninth director, though there are no current plans to do so. Effective as of the Effective Time, it is </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">148<br />
        </div>

      </div>

    </div>

    <!--End Page 157-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 158-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">anticipated that Dr. David J. Mazzo, Ph.D., Dr. Gregory Brown, Steven Klosk and
              Cynthia Flowers will remain as directors of Caladrius and Dr. David J. Mazzo, Dr. Gregory Brown, Steven Klosk and Cynthia Flowers will elect David Slack, Dr. Erkki Ruoslahti, Heidi Henson and Dr.&#160;Mohammad Azab to the Caladrius Board of
              Directors. It is anticipated that the executive officers of Caladrius upon the Closing will be David J. Mazzo, Ph.D., Chief Executive Officer, David Slack, President and Chief Business Officer and Dr. Kristen Buck, the Company&#8217;s current
              Executive Vice President of R&amp;D and Chief Medical Officer.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCIAC"><!--Anchor--></a>Certificate of Incorporation and
            Amendments to the Certificate of Incorporation of Caladrius </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Stockholders of record on the Record Date will also be asked to approve
            amendments to the certificate of incorporation of Caladrius to effect the Reverse Stock Split and the Caladrius Name Change, in each case, upon consummation of the Merger, each of which requires the affirmative vote of holders of a majority of
            the outstanding shares of Caladrius Capital Stock on the Record Date. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCCM"><!--Anchor--></a>Conditions to the Completion of the
            Merger </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Each party&#8217;s obligation to complete the Merger is subject to the satisfaction or waiver
            by each of the parties, at or prior to the Closing, of various conditions, which include the following: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the registration statement on Form S-4, of which this proxy statement/prospectus/information statement is a part, must have been
                    declared effective by the SEC in accordance with the Securities Act and must not be subject to any stop order or proceeding, or any proceeding threatened by the SEC, seeking a stop order that has not been withdrawn; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">there must not have been issued, and remain in effect, any temporary restraining order, preliminary or permanent injunction or
                    other order preventing the consummation of the Merger or any of the other transactions contemplated by the Merger Agreement by any court of competent jurisdiction or other governmental entity of competent jurisdiction, and no law,
                    statute, rule, regulation, ruling or decree shall be in effect which has the effect of making the consummation of the Merger or any of the other transactions contemplated by the Merger Agreement illegal; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the holders of a majority of the outstanding shares of Cend Common Stock and Cend Preferred Stock, voting together as one class,
                    the holders of a majority of the outstanding shares of Cend Series A Preferred Stock, voting as a separate class, the holders of a majority of the outstanding shares of Cend Series B Preferred Stock, voting as a separate class, and
                    holders of a majority of the outstanding shares of Cend Series D Preferred Stock, voting as a separate class, must have adopted and approved the Merger, and the holders of a majority of the outstanding shares of Caladrius Capital Stock
                    must have approved the Merger Agreement and the transactions contemplated thereby, including the Merger and the issuance of Caladrius Common Stock in the Merger; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the existing shares of Caladrius Common Stock must have been continually listed on The Nasdaq Capital Market through the
                    Closing, and Caladrius must have caused the shares of Caladrius Common Stock to be issued in the Merger to be approved for listing on The Nasdaq Capital Market (subject to official notice of issuance) as of the Closing; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">there must not be any legal proceeding pending, or overtly threatened in writing, by an official governmental body
                    (i)&#160;challenging or seeking to restrain or prohibit the consummation of the Merger, (ii)&#160;relating to Caladrius and seeking to obtain from Caladrius, Cend or Merger Sub any damages or other relief that may be material to Caladrius or
                    Cend, (iii)&#160;seeking to prohibit or limit in any material and adverse respect a party&#8217;s ability to vote, transfer, receive dividends with respect to, or otherwise exercise ownership rights with respect to Caladrius Common Stock,
                    (iv)&#160;that would materially and adversely affect the right of Caladrius or Cend to own the assets or operate the business of Caladrius or Cend, or (v)&#160;seeking to compel Caladrius, Cend or any of Cend&#8217;s subsidiaries to dispose of or hold
                    separate any material assets as a result of the Merger. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">149<br />
        </div>

      </div>

    </div>

    <!--End Page 158-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 159-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, each party&#8217;s obligation to complete the Merger is further subject to
            the satisfaction or waiver by that party of the following additional conditions: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to (a) Cend, the representations and warranties regarding certain matters related to organization, organizational
                    documents, authority, vote required, financial advisors and disclosure in this this proxy statement/prospectus/information statement in the Merger Agreement must be true and correct on the date of the Merger Agreement and on the closing
                    date of the Merger with the same force and effect as if made on the date on which the Merger is to be completed or, if such representations and warranties address matters as of a particular date, then as of that particular date and (b)
                    Caladrius, the representations and warranties regarding certain matters related to organization, organizational documents, authority, vote required, no conflicts, financial advisors and disclosure in this this proxy
                    statement/prospectus/information statement in the Merger Agreement must be true and correct on the date of the Merger Agreement and on the closing date of the Merger with the same force and effect as if made on the date on which the
                    Merger is to be completed or, if such representations and warranties address matters as of a particular date, then as of that particular date; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the representations and warranties regarding (i)&#160;intellectual property matters of Cend and (ii)&#160;SEC filing and financial
                    statement matters of Caladrius in the Merger Agreement must be true and correct in all material respects on the date of the Merger Agreement and on the closing date of the Merger with the same force and effect as if made on the date on
                    which the Merger is to be completed or, if such representations and warranties address matters as of a particular date, then as of that particular date; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the representations and warranties regarding capitalization matters of the other party in the Merger Agreement must be true and
                    correct on the date of the Merger Agreement and on the closing date of the Merger with the same force and effect as if made on the date on which the Merger is to be completed or, if such representations and warranties address matters as
                    of a particular date, then as of that particular date, except for such inaccuracies which are de minimis, individually or in the aggregate; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the remaining representations and warranties of the other party in the Merger Agreement must be true and correct on the date of
                    the Merger Agreement and on the closing date of the Merger with the same force and effect as if made on the date on which the Merger is to be completed or, if such representations and warranties address matters as of a particular date,
                    then as of that particular date, except in each case, or in the aggregate, where the failure to be so true and correct would not reasonably be expected to have a Company Material Adverse Effect or Caladrius Material Adverse Effect (each
                    as defined below), as applicable (without giving effect to any references therein to any Company Material Adverse Effect or Caladrius Material Adverse Effect, as applicable, or other materiality qualifications); </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the other party to the Merger Agreement must have performed or complied with in all material respects all of such party&#8217;s
                    agreements and covenants required to be performed or complied with by it under the Merger Agreement at or prior to the Effective Time; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the other party must have delivered certain certificates and other documents required under the Merger Agreement for the
                    Closing;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the party must have received from the other party lock-up agreements executed by certain stockholders of such party and each
                    person who shall be elected or appointed as an executive officer or director of such party immediately following the Closing; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the other party must have obtained certain consents or authorizations required under the Merger Agreement for the Closing, which
                    must be in full force and effect at the Effective Time.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, the obligation of Caladrius and Merger Sub to complete the Merger is
            further subject to the satisfaction or waiver of the following conditions: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">there shall have been no effect, change, event, circumstance, or development that (considered together with all other effects,
                    changes, events, circumstances, or developments that have occurred prior to the applicable date of determination) has or would reasonably be expected to have a material adverse effect on the business, financial condition, assets,
                    liabilities or results of operations of Cend or its </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">150<br />
        </div>

      </div>

    </div>

    <!--End Page 159-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 160-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="bl">subsidiaries, taken as a whole (a &#8220;Company Material Adverse Effect&#8221;); <span style="font-style: italic;">provided</span> that effects, changes, events, circumstances or developments arising from the following shall not be taken into account for purposes of determining whether a Company Material Adverse Effect shall
            have occurred: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">the announcement or pendency of the Merger Agreement or the transactions contemplated thereby; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">the taking of any action, or the failure to take any action, by Cend that is required to comply
                      with the terms of the Merger Agreement or the taking of any action expressly permitted by a certain Cend disclosure schedule; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">continued losses from operations or decreases in cash balances of Cend or any of its subsidiaries
                      or on a consolidated basis among Cend and its subsidiaries; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any natural disaster or any act or threat of terrorism or war anywhere in the world, any armed
                      hostilities or terrorist activities anywhere in the world, any threat or escalation of armed hostilities or terrorist activities anywhere in the world or any governmental or other response or reaction to any of the foregoing; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any change in generally accepted accounting principles or any change in applicable laws, rules or
                      regulations or the interpretation thereof; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">general economic or political conditions or conditions generally affecting the industries in which
                      the Cend and its subsidiaries operate; or </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any epidemics, pandemics, disease outbreaks, or other public health emergencies or the escalation
                      or worsening thereof, including COVID-19 or Cend&#8217;s compliance with any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; social distancing, shut down, closure, sequester, safety or similar law, guidelines or recommendations promulgated
                      by any governmental body, the Centers for Disease Control and Prevention or the World Health Organization, in each case, in connection with, related to, or in response to COVID-19, including the CARES Act and Families First
                      Coronavirus Response Act; the conversion of Cend Preferred Stock (excluding any Cend Preferred Stock owned by Caladrius) into Cend Common Stock (the &#8220;Preferred Stock Conversion&#8221;) shall have occurred; and</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius shall have received any and all invoices in respect of Cend&#8217;s transaction costs indicating that, upon payment of any
                    applicable invoices, such party will have been paid in full.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, the obligation of Cend to complete the Merger is further subject to the
            satisfaction or waiver of the following conditions: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the officers and directors of Caladrius who are not to continue as officers of Caladrius following the consummation of the
                    Merger, will sign written resignations in forms reasonably satisfactory to Cend, dated as of the closing date and effective as of the Closing; the principal executive officer or the principal financial officer of Caladrius shall have
                    provided, with respect to any document filed with the&#160;SEC on or after the date of the Merger Agreement, any necessary certification required under Rule&#160;13a-14 under the Exchange Act; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">there shall have been no effect, change, event, circumstance, or development that (considered together with all other effects,
                    changes, circumstances, or developments that have occurred prior to the applicable date of determination) has or would reasonably be expected to have a material adverse effect on the business, financial condition, assets, liabilities or
                    results of operations of Caladrius and its subsidiaries, taken as a whole (a &#8220;Caladrius Material Adverse Effect&#8221;); <span style="font-style: italic;">provided</span>, that effects, changes, events, circumstances or developments
                    resulting from the following shall not be taken into account for purposes of determining whether a Caladrius Material Adverse Effect shall have occurred: </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any rejection or non-acceptance by a governmental body of a registration statement or filing by
                      Caladrius relating to intellectual property owned, licensed or controlled by Caladrius;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">the announcement or pendency of the Merger Agreement or the transactions contemplated thereby; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any change in the stock price or trading volume of Caladrius Common Stock; </span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">151<br />
        </div>

      </div>

    </div>

    <!--End Page 160-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 161-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">the taking of any action, or the failure to take any action, by Caladrius that is required to
                      comply with the terms of the Merger Agreement or the taking of any action expressly permitted by a certain Caladrius disclosure schedule; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any changes in or affecting research and development, clinical trials or other drug development
                      activities conducted by or on behalf of Caladrius or its subsidiaries; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">continued losses from operations or decreases in cash balances of Caladrius or any of its
                      subsidiaries or on a consolidated basis among Caladrius and its subsidiaries;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any natural disaster or any act or threat of terrorism or war anywhere in the world, any armed
                      hostilities or terrorist activities anywhere in the world, any threat or escalation of armed hostilities or terrorist activities anywhere in the world or any governmental or other response or reaction to any of the foregoing; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any change in generally accepted accounting principles or any change in applicable laws, rules or
                      regulations or the interpretation thereof;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">general economic or political conditions or conditions generally affecting the industries in which
                      Caladrius operates; or</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">any epidemics, pandemics, disease outbreaks, or other public health emergencies or the escalation
                      or worsening thereof, including COVID-19 or the Caladrius&#8217; compliance with any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; social distancing, shut down, closure, sequester, safety or similar law, guidelines or recommendations
                      promulgated by any governmental body, the Centers for Disease Control and Prevention or the World Health Organization, in each case, in connection with, related to, or in response to COVID-19, including the CARES Act and Families
                      First Coronavirus Response Act;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius must have a minimum net cash balance based on the closing date as follows:</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">if closing occurs in June of 2022, net cash shall be greater than or equal $70,465,000;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">if closing occurs in July of 2022, net cash shall be greater than or equal $68,697,000;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">if closing occurs in August of 2022, net cash shall be greater than or equal $66,976,000;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">if closing occurs in September of 2022, net cash shall be greater than or equal $64,872,000;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">if closing occurs in October of 2022, net cash shall be greater than or equal $63,134,000;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">if closing occurs in November of 2022, net cash shall be greater than or equal $61,400,000;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">if closing occurs in December of 2022, net cash shall be greater than or equal $59,709,000; and</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">if closing occurs in January of 2023, net cash shall be greater than or equal $57,642,000; and</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors shall have been constituted as set forth in the Merger Agreement.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tRW"><!--Anchor--></a>Representations and Warranties </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement contains customary representations and warranties of Caladrius,
            Merger Sub and Cend for a transaction of this type relating to, among other things: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">corporate organization and power, and similar corporate matters; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">subsidiaries; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">organizational documents; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">authority to enter into the Merger Agreement and the related agreements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">votes required for completion of the Merger and approval of the proposals that will come before the Annual Meeting and that will
                    be the subject of the written consent of the Cend Stockholders;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">except as otherwise specifically disclosed pursuant to in the Merger Agreement, the fact that the consummation of the Merger
                    would not contravene certain contracts or the organizational documents of the parties or require the consent of any third party;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">152<br />
        </div>

      </div>

    </div>

    <!--End Page 161-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 162-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">capitalization; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">financial statements and, with respect to Caladrius, documents filed with the SEC and the accuracy of information contained in
                    those documents; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">material changes or events; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">liabilities; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">title to assets; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">real property and leaseholds; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">intellectual property; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the validity of material contracts to which the parties or their subsidiaries are a party and any violation, default or breach
                    to such contracts; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulatory compliance, permits and restrictions; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">legal proceedings and orders; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax matters; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">employee and labor matters and benefit plans; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">environmental matters; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">insurance; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any brokerage or finder&#8217;s fee or other fee or commission in connection with the Merger; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the validity of information supplied for inclusion in this Registration Statement;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">transactions with affiliates; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to Caladrius, the valid issuance in the Merger of Caladrius Common Stock; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to Caladrius, the inapplicability of Section 203 of the DGCL.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The representations and warranties are, in many respects, qualified by materiality and
            knowledge, and will not survive the Merger, but their accuracy forms the basis of one of the conditions to the obligations of Caladrius, Merger Sub and Cend to complete the Merger. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tNS"><!--Anchor--></a>No Solicitation </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Each of Caladrius and Cend have agreed that, except as described below, Caladrius and
            Cend and any of their respective subsidiaries will not, nor will either party or any of its subsidiaries authorize any of the directors, officers, employees, agents, attorneys, accountants, investment bankers, advisors or representatives
            retained by it or any of its subsidiaries to, directly or indirectly: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">solicit, initiate or knowingly encourage, induce or facilitate the communication, making, submission or announcement of, any
                    Acquisition Proposal or Acquisition Inquiry; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">furnish any non-public information with respect to it to any person in connection with or in response to an Acquisition Proposal
                    or Acquisition Inquiry; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">engage in discussions or negotiations with any person with respect to any Acquisition Proposal or Acquisition Inquiry; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approve, endorse or recommend an Acquisition Proposal; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">execute or enter into any letter of intent or similar document or any contract contemplating or otherwise relating to an
                    Acquisition Transaction. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">An &#8220;Acquisition Inquiry&#8221; means an inquiry, indication of interest or request for
            information (other than an inquiry, indication of interest or request for information made or submitted by Cend, on the one hand, or Caladrius, on the other hand, to the other party) that could reasonably be expected to lead to an Acquisition
            Proposal; provided, however, that the term &#8220;Acquisition Inquiry&#8221; shall not include the Merger or the other </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">153<br />
        </div>

      </div>

    </div>

    <!--End Page 162-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 163-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">transactions contemplated by the Merger Agreement or any transactions related to any
            sale, lease, exchange, transfer, license, disposition or other monetization of the technology and intellectual property of Caladrius in existence on the date of the Merger Agreement (the &#8220;Legacy Caladrius Assets&#8221;; and any such sale, lease,
            exchange, transfer, license, disposition or other monetization, a &#8220;Legacy Caladrius Business Disposition&#8221;). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">An &#8220;Acquisition Proposal&#8221; means any offer or proposal, whether written or oral (other
            than an offer or proposal made or submitted by or on behalf of Cend or any of its affiliates, on the one hand, or by or on behalf of Caladrius or any of its affiliates, on the other hand, to the other party) contemplating or otherwise relating
            to any Acquisition Transaction; provided, however, that any Acquisition Proposal for the purchase of Legacy Caladrius Assets from a person that has previously negotiated with Caladrius, its subsidiaries and/or the representatives of it or its
            subsidiaries for the purchase of the Legacy Caladrius Assets shall not constitute an Acquisition Proposal for purposes of the Merger Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">An &#8220;Acquisition Transaction&#8221; means any transaction or series of related transactions
            involving: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any merger, consolidation, amalgamation, share exchange, business combination, issuance or acquisition of securities,
                    reorganization, recapitalization, tender offer, exchange offer or similar transaction: (i)&#160;in which Caladrius, Cend or Merger Sub is a constituent entity, (ii)&#160;in which any individual, entity, governmental entity, or &#8220;group,&#8221; as defined
                    under applicable securities laws, directly or indirectly acquires beneficial or record ownership of securities representing more than 20% of the outstanding securities of any class of voting securities of Caladrius, Cend or Merger Sub
                    or any of their respective subsidiaries or (iii)&#160;in which Caladrius, Cend or Merger Sub or any of their respective subsidiaries issues securities representing more than 20% of the outstanding securities of any class of voting securities
                    of such party or any of its subsidiaries; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any sale, lease, exchange, transfer, license, acquisition or disposition of any business or businesses or assets that constitute
                    or account for 20% or more of the consolidated book value or the fair market value of the assets of Caladrius, Cend or Merger Sub and their respective subsidiaries, as applicable, taken as a whole. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Notwithstanding the foregoing, before obtaining the applicable approvals of the
            Caladrius Stockholders or Cend Stockholders required to consummate the Merger, each party may furnish non-public information regarding such party and its subsidiaries to, and may enter into discussions or negotiations with, any third party in
            response to a bona fide written Acquisition Proposal, which such party&#8217;s board of directors determines in good faith, after consultation with such party&#8217;s outside financial advisors and outside legal counsel, constitutes or is reasonably likely
            to result in a Superior Offer (as defined below), if: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">neither such party nor any representative of such party has breached the non-solicitation provisions of the Merger Agreement
                    described above; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">such party&#8217;s board of directors concludes in good faith, based on the advice of outside legal counsel, that the failure to take
                    such action is reasonably likely to be inconsistent with the fiduciary duties of such board of directors under applicable legal requirements; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">such party gives the other party at least two business days&#8217; prior written notice of the identity of the third party and of that
                    party&#8217;s intention to furnish information to, or enter into discussions or negotiations with, such third party before furnishing any information or entering into discussions or negotiations with such third party; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">such party receives from the third party an executed confidentiality agreement containing provisions at least as favorable to
                    such party as those contained in the confidentiality agreement between Caladrius and Cend; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">at least two business days prior to the furnishing of any non-public information to a third party, such party furnishes the same
                    non-public information to the other party to the extent not previously furnished. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A &#8220;Superior Offer&#8221; means an unsolicited, bona fide written Acquisition Proposal (with
            all references to 20% in the definition of Acquisition Transaction being treated as references to greater than 90% for these purposes) that (a) was not obtained or made as a direct or indirect result of a breach, or violation, of the Merger
            Agreement, and (b) is on terms and conditions that the board of directors of the party receiving the offer determines in good </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">154<br />
        </div>

      </div>

    </div>

    <!--End Page 163-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 164-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">faith, based on such matters that it deems relevant, as well as any written offer by
            the other party to the Merger Agreement to amend the terms of the Merger Agreement, and following consultation with legal counsel and outside financial advisors, if any, are more favorable, from a financial point of view, to that party&#8217;s
            stockholders than the terms of the Merger Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">An Acquisition Proposal will not be considered a Superior Offer if the Acquisition
            Proposal is subject to a financing condition (and if any financing is required to consummate the transaction contemplated by such Acquisition Proposal, such financing must be fully committed). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement also provides that each party will promptly advise the other of
            the status and terms of, and keep the other party reasonably informed with respect to, any Acquisition Proposal or any inquiry, indication of interest or request for information that would reasonably be expected to lead to an Acquisition
            Proposal or any material change or proposed material change to that Acquisition Proposal or inquiry, indication of interest or request for information that would reasonably be expected to lead to an Acquisition Proposal. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tMOS"><!--Anchor--></a>Meetings of Stockholders </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius is obligated under the Merger Agreement to call, give notice of and hold a
            meeting of its stockholders for the purposes of considering the approval of the Merger Agreement and the transactions contemplated thereby, including the Merger and the issuance of shares of Caladrius Common Stock to Cend Stockholders in the
            Merger. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend is obligated under the Merger Agreement to obtain written consents of Cend
            Stockholders sufficient to adopt the Merger Agreement thereby approving the Merger and related transactions within two business days following the registration statement on Form S-4, of which this proxy statement/prospectus/information
            statement is a part, being declared effective by the SEC. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCCBP"><!--Anchor--></a>Covenants; Conduct of Business
            Pending the Merger </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has agreed that, except as permitted by the Merger Agreement, as required by
            law, in connection with a Legacy Caladrius Business Disposition, pursuant to the terms of the Joint Development Agreement or unless Cend shall have provided written consent, during the period commencing on the date of the Merger Agreement and
            continuing until the earlier to occur of the Effective Time and the termination of the Merger Agreement, Caladrius will conduct its business and operations in the ordinary course consistent with past practices and in compliance with all
            applicable laws, regulations and certain contracts, continue to pay outstanding accounts payable and other current liabilities when due and payable and will take other agreed-upon actions. Caladrius has also agreed that, subject to certain
            limited exceptions, without the consent of Cend, it will not, during the period commencing on the date of the Merger Agreement and continuing until the earlier to occur of the Effective Time and the termination of the Merger Agreement: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of capital stock; or
                    repurchase, redeem or otherwise reacquire any shares of capital stock or other securities (except for shares of Caladrius Common Stock from terminated employees, directors or consultants of Caladrius); </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">except in connection with the hiring of any new employees, sell, issue, grant, pledge or otherwise dispose of or encumber or
                    authorize any of the foregoing with respect to: any capital stock or other security (except for Caladrius Common Stock issued upon the valid exercise of outstanding Caladrius Options); any option, warrant or right to acquire any capital
                    stock or any other security; or any instrument convertible into or exchangeable for any capital stock or other security; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">except as required to give effect to anything in contemplation of the Closing, amend the certificate of incorporation, bylaws or
                    other charter or organizational documents of Caladrius, or effect or become a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or
                    similar transaction except as related to the proposed transactions under the Merger Agreement; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">form any subsidiary or acquire any equity interest or other interest in any other entity or enter into any joint venture with
                    any other entity; </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">155<br />
        </div>

      </div>

    </div>

    <!--End Page 164-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 165-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">lend money to any person; incur or guarantee any indebtedness for borrowed money, other than in the ordinary course of business;
                    guarantee any debt securities of others; make any capital expenditure or commitment in excess of $500,000; or forgive any loans to any persons, including Caladrius&#8217; employees, officers, directors or affiliates; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">other than in the ordinary course of business, adopt, establish or enter into any Caladrius employee benefit agreement, plan or
                    arrangement; cause or permit any Caladrius employee benefit agreement, plan or arrangement to be amended other than as required by law or in order to make amendments for purposes of Section 409A of the Internal Revenue Code; pay any
                    bonus or make any profit- sharing or similar payment to, or increase the amount of the wages, salary, commissions, fringe benefits or other compensation or remuneration payable to, any of its employees, directors or consultants; or
                    increase the severance or change of control benefits offered to any current or new employees, directors or consultants; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">enter into any material transaction other than in the ordinary course of business consistent with past practices; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">acquire any material asset or sell, lease or otherwise irrevocably dispose of any material portion of its assets or properties,
                    or grant any encumbrance with respect to such assets or properties, except in the ordinary course of business consistent with past practices; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">make, change or revoke any material tax election; file any material amendment to any tax return or adopt or change any material
                    accounting method in respect of taxes; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">take any action, other than as required by law or generally accepted accounting principles, to change accounting policies or
                    procedures; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">pay, discharge or satisfy any claims, liabilities or obligations, other than the payment, discharge or satisfaction in the
                    ordinary course consistent with past practice of liabilities reflected or reserved against in Caladrius&#8217; financial statements delivered to Cend or incurred in the ordinary course of business and consistent with past practice; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">except as permitted in the Merger Agreement, enter into, amend or terminate any of Caladrius&#8217; material contracts; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">materially change pricing or royalties or other payments set or charged by Caladrius to its customers or licensees or agree to
                    materially change pricing or royalties or other payments set or charged by persons who have licensed intellectual property of Caladrius; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">initiate or settle any legal proceeding or other claim or dispute involving or against Caladrius or any of its subsidiaries; or
                  </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">agree, resolve or commit to do any of the foregoing. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">During the period prior to the Closing, Caladrius shall have the right to distribute
            any Legacy Caladrius Assets Proceeds to the Caladrius Stockholders provided that any means and mechanism of distribution shall be reasonably acceptable to Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has agreed that, except as permitted by the Merger Agreement, pursuant to the
            terms of the Joint Development Agreement, as required by law, or unless Caladrius shall have provided written consent, during the period commencing on the date of the Merger Agreement and continuing until the earlier to occur of the Effective
            Time and the termination of the Merger Agreement, Cend will conduct its business and operations in the ordinary course consistent with past practices and in compliance with all applicable laws, regulations and certain contracts, and will take
            other agreed-upon actions. Cend has also agreed that, subject to certain limited exceptions, without the consent of Caladrius, it will not, during the period commencing on the date of the Merger Agreement and continuing until the earlier to
            occur of the Effective Time and the termination of the Merger Agreement: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">declare, accrue, set aside or pay any dividend or make any other distribution in respect of any shares of capital stock; or
                    repurchase, redeem or otherwise reacquire any shares of capital stock or other securities (except for shares of common stock from terminated employees, directors or consultants of Cend); </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">156<br />
        </div>

      </div>

    </div>

    <!--End Page 165-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 166-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">except as required to give effect to anything in contemplation of the Closing, amend the certificate of incorporation, bylaws or
                    other charter or organizational documents of Cend or its subsidiaries, or effect or become a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse
                    stock split or similar transaction except as related to the proposed transactions under the Merger Agreement; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">except in connection with the hiring of any new employees, sell, issue, grant, pledge or otherwise dispose of or encumber or
                    authorize any of the foregoing actions with respect to: any capital stock or other security (except for shares of Cend Common Stock issued upon the valid exercise of Cend Options); any option, warrant or right to acquire any capital
                    stock or any other security, other than option grants to employees and service providers in the ordinary course of business in accordance with past practices; or any instrument convertible into or exchangeable for any capital stock or
                    other security of Cend; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">form any subsidiary or acquire any equity interest or other interest in any other entity or enter into a joint venture with any
                    other entity;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">lend money to any person; incur or guarantee any indebtedness for borrowed money, other than in the ordinary course of business
                    in accordance with past practices; guarantee any debt securities of others; make any capital expenditure or commitment in excess of $500,000; or forgive any loans to any persons, including Cend&#8217;s or any of its subsidiaries&#8217; employees,
                    officers, directors or affiliates; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">other than in the ordinary course of business: adopt, establish or enter into any employee benefit agreement, plan or
                    arrangement; cause or permit any employee benefit agreement, plan or arrangement to be amended other than as required by law or in order to make amendments for purposes of Section 409A of the Code; pay any bonus or make any
                    profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, fringe benefits or other compensation or remuneration payable to, any of its directors, officers, employees or consultants; or increase the
                    severance or change of control benefits offered to any current or new employees, directors or consultants;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">enter into any material transaction outside the ordinary course of business in accordance with past practices; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">acquire any material asset or sell, lease or otherwise irrevocably dispose of any material portion of its assets or properties,
                    or grant any encumbrance with respect to such assets or properties, except in the ordinary course of business in accordance with past practices; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">sell, assign, transfer, license, sublicense or otherwise dispose of any material Cend intellectual property rights (other than
                    pursuant to non-exclusive licenses in the ordinary course of business in accordance with past practices); </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">make, change or revoke any material tax election; file any material amendment to any tax return or adopt or change any material
                    accounting method in respect of taxes; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">take any action, other than as required by law or U.S. GAAP, to change accounting policies or procedures; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">pay, discharge or satisfy any claims, liabilities or obligations (absolute, accrued, asserted or unasserted, contingent or
                    otherwise), other than the payment, discharge or satisfaction in the ordinary course of business and consistent with past practice of liabilities reflected or reserved against in Cend&#8217;s financial statements delivered to Caladrius, or
                    incurred in the ordinary course of business and consistent with past practice; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">enter into, amend or terminate any of Cend&#8217;s material contracts; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">materially change pricing or royalties or other payments set or charged by Cend or any of its subsidiaries to its customer or
                    licensees or agree to materially change pricing or royalties or other payments set or charged by persons who have licensed intellectual property to the Cend or any of its subsidiaries;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">initiate or settle any legal proceeding or other claim or dispute involving or against Cend or any of its subsidiaries; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">agree, resolve or commit to do any of the foregoing. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">157<br />
        </div>

      </div>

    </div>

    <!--End Page 166-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 167-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tOA"><!--Anchor--></a>Other Agreements </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Each of Caladrius and Cend has agreed to use its commercially reasonable efforts to
            cause to be taken all actions necessary to consummate the Merger and the other transactions contemplated by the Merger Agreement. In connection therewith, each party has agreed to: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">make all filings and other submissions (if any) and give all notices (if any) required to be made and given by such party in
                    connection with the Merger and the other transactions contemplated by the Merger Agreement; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">use commercially reasonable efforts to obtain each consent (if any) reasonably required to be obtained in connection with the
                    Merger and the other transactions contemplated by the Merger Agreement; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">use commercially reasonable efforts to lift any injunction prohibiting, or any other legal bar to, the Merger or the other
                    transactions contemplated by the Merger Agreement; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">use commercially reasonable efforts to satisfy the conditions precedent to the consummation of the transactions contemplated by
                    the Merger Agreement. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the Merger Agreement, Caladrius and Cend have further agreed that: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius will use its commercially reasonable efforts to (a) maintain the listing of the Caladrius Common Stock on The Nasdaq
                    Capital Market until the Closing and to obtain approval for listing of the combined organization on The Nasdaq Capital Market; (b) to the extent required by the rules and regulations of Nasdaq, (i)&#160;prepare and submit to Nasdaq a
                    notification form for the listing of the shares of Caladrius Common Stock to be issued in connection with the Merger and (ii)&#160;cause such shares to be approved for listing (subject to official notice of issuance); and (c) to the extent
                    required by Nasdaq Marketplace Rule 5110, file an initial listing application for the Caladrius Common Stock on The Nasdaq Capital Market and to cause such listing application to be conditionally approved prior to the Effective Time; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">for a period of six years after the Closing, Caladrius will indemnify each of the directors and officers of Caladrius and Cend
                    to the fullest extent permitted under the DGCL and will maintain directors&#8217; and officers&#8217; liability insurance for the directors and officers of Caladrius and Cend; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius shall maintain directors&#8217; and officers&#8217; liability insurance policies commencing at the Closing, on commercially
                    reasonable terms and conditions and with coverage limits customary for U.S. public companies similarly situated to Caladrius; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend shall take all action required to effect the Preferred Stock Conversion prior to the Closing; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius and Cend shall enter, or shall have entered, into a joint development agreement in substantially the form attached to
                    the Merger Agreement (the &#8220;Joint Development Agreement&#8221;).</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tTERM"><!--Anchor--></a>Termination </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement may be terminated at any time before the completion of the Merger,
            whether before or after the required stockholder approvals to complete the Merger have been obtained, as set forth below: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by mutual written consent of Caladrius and Cend; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by either Caladrius or Cend if the Merger shall not have been consummated by November&#160;11, 2022 (the &#8220;End Date&#8221;); <span style="font-style: italic;">provided</span>, <span style="font-style: italic;">however</span>, that this right to terminate the Merger Agreement will not be available to any party whose action or failure to act has been a principal
                    cause of the failure of the Merger to occur on or before the End Date and such action or failure to act constitutes a breach of the Merger Agreement, or in the event that the SEC has not declared effective the registration statement on
                    Form S-4, of which this proxy statement/prospectus/information statement is a part, by the date which is 60 days prior to the End Date, then either Cend or Caladrius shall be entitled, on one occasion, to extend the End Date for an
                    additional 60 days;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by either Caladrius or Cend if a court of competent jurisdiction or governmental entity has issued a final and nonappealable
                    order, decree or ruling or taken any other action that permanently restrains, enjoins or otherwise prohibits the Merger or any of the other transactions contemplated by the Merger Agreement; </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">158<br />
        </div>

      </div>

    </div>

    <!--End Page 167-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 168-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Caladrius if the written consent of Cend Stockholders necessary to adopt the Merger Agreement and approve the Merger and
                    related matters has not been obtained within two business days of the registration statement on Form S-4, of which this proxy statement/prospectus/information statement is a part, becoming effective; <span style="font-style: italic;">provided</span>
                    that this right to terminate the Merger Agreement will not be available to Caladrius once Cend obtains such stockholder approval; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Cend if (A) the Cend Board of Directors withdraws or modifies its recommendation that Cend Stockholders vote to adopt and
                    approve the Merger and related matters in a manner adverse to Caladrius and (B) the written consent of Cend Stockholders necessary to adopt the Merger Agreement and approve the Merger and related matters has not been obtained within two
                    business days of the registration statement on Form S-4, of which this proxy statement/prospectus/information statement is a part, becoming effective; <span style="font-style: italic;">provided</span> that this right to terminate the
                    Merger Agreement will not be available to Cend once Cend obtains such stockholder approval; <span style="font-style: italic;">provided, further,</span> that such right to terminate the Merger Agreement shall not be available to Cend
                    where the failure to obtain such stockholder approval shall have been caused by the action or failure to act of Cend and such action or failure to act constitutes a material breach by Cend of the Merger Agreement;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by either Caladrius or Cend if the Annual Meeting shall have been held and completed and Caladrius Stockholders shall have taken
                    a final vote and shall not have approved the Merger Agreement or any of the transactions contemplated thereby, including the Merger and the issuance of Caladrius Common Stock to Cend Stockholders in the Merger; <span style="font-style: italic;">provided</span>, that Caladrius may not terminate the Merger Agreement pursuant to this provision if the failure to obtain the approval of Caladrius Stockholders was caused by the action or failure to act of Caladrius and
                    such action or failure to act constitutes a material breach by Caladrius of the Merger Agreement; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Cend, at any time prior to the approval by Caladrius Stockholders of the proposals to be considered at the Annual Meeting, if
                    any of the following circumstances shall occur (each of the following, a &#8220;Caladrius Triggering Event&#8221;): </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">Caladrius fails to include in this proxy statement/prospectus/information statement the Caladrius
                      Board of Directors&#8217; recommendation that Caladrius Stockholders vote to approve the Merger and the issuance of Caladrius Common Stock to Cend Stockholders in connection with the Merger or withdraws or modifies its recommendation in a
                      manner adverse to Cend; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">the Caladrius Board of Directors approves, endorses or recommends any Acquisition Proposal; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">Caladrius enters into any letter of intent or similar document or any contract relating to any
                      Acquisition Proposal, other than a confidentiality agreement permitted pursuant to the Merger Agreement; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">Caladrius or any director, officer or agent of Caladrius willfully and intentionally breaches the
                      non-solicitation provisions or the provisions regarding the Annual Meeting set forth in the Merger Agreement; or </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">Caladrius fails to hold the Annual Meeting within 60 days after the of the registration statement
                      on Form S-4, of which this proxy statement/prospectus/information statement is a part, being declared effective by the SEC; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Caladrius, at any time prior to the adoption of the Merger Agreement by the Cend Stockholders, if any of the following
                    circumstances shall occur (each a &#8220;Cend Triggering Event&#8221;): </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">the Cend Board of Directors withdraws or modifies its recommendation in a manner adverse to
                      Caladrius or approves, endorses or recommends any Acquisition Proposal; </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">Cend enters into any letter of intent or similar document or any contract relating to any
                      Acquisition Proposal, other than a confidentiality agreement permitted pursuant to the Merger Agreement; or </span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">Cend or any director, officer or agent of Cend willfully and intentionally breaches the
                      non-solicitation provisions or the provisions regarding the Cend Stockholder written consent set forth in the Merger Agreement; </span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">159<br />
        </div>

      </div>

    </div>

    <!--End Page 168-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 169-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Caladrius or Cend if the other party has breached any of its representations, warranties, covenants or agreements contained
                    in the Merger Agreement or if any representation or warranty of the other party has become inaccurate, in either case such that the conditions to the Closing would not be satisfied as of time of such breach or inaccuracy, but if such
                    breach or inaccuracy is curable, then the Merger Agreement will not terminate pursuant to this provision as a result of a particular breach or inaccuracy until the earlier of the expiration of a 30-day period after delivery of written
                    notice of such breach or inaccuracy and the breaching party ceasing to exercise commercially reasonable efforts to cure such breach, if such breach has not been cured; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Caladrius, at any time prior to the approval by Caladrius Stockholders of the Merger Agreement and the transactions
                    contemplated by the Merger Agreement, including the issuance of shares of Caladrius Common Stock to Cend Stockholders in the Merger, if the Caladrius Board of Directors authorizes Caladrius to enter into any alternative agreement;
                    provided that Caladrius shall not enter into such alternative agreement unless (i)&#160;Cend shall have received written notice from Caladrius of its intention to enter into such alternative agreement at least four business days in advance,
                    with such notice describing the reasons for such intention as well as the material terms and conditions of such alternative agreement, including the identity of the counterparty and the then current draft of the alternative agreement,
                    (ii)&#160;Caladrius shall have complied in all material respects with the non-solicitation provisions or the provisions regarding the Caladrius Stockholder vote set forth in the Merger Agreement and (iii)&#160;the Caladrius Board of Directors
                    shall have determined in good faith, after consultation with its outside legal counsel, that he failure to enter into such alternative agreement would be inconsistent with its fiduciary duties under applicable law; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Caladrius if the Cend audited financial statements for the fiscal years ended December&#160;31, 2021 and December&#160;31, 2020 are not
                    delivered to Caladrius by August&#160;1, 2022; or</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Cend, at any time prior to the written consent of Cend Stockholders necessary to adopt the Merger Agreement and approve the
                    Merger and related matters and following compliance with all of the requirements set forth in the proviso hereto, upon the Cend Board of Directors authorizing Cend to enter into a definitive agreement that contemplates or otherwise
                    relates to an Acquisition Transaction that constitutes a Superior Offer (a &#8220;Permitted Alternative Agreement&#8221;); <span style="font-style: italic;">provided, however</span>, that the Company shall not enter into any Permitted Alternative
                    Agreement unless: (i)&#160;Caladrius shall have received written notice from Cend of Cend&#8217;s intention to enter into such Permitted Alternative Agreement at least four business days in advance, with such notice describing in reasonable detail
                    the reasons for such intention as well as the material terms and conditions of such Permitted Alternative Agreement, including the identity of the counterparty together with copies of the then-current draft of such Permitted Alternative
                    Agreement and any other related principal transaction documents, (ii)&#160;Cend shall have complied in all material respects with its applicable obligations under the Merger Agreement and (iii)&#160;the Cend Board of Directors shall have
                    determined in good faith, after consultation with its outside legal counsel, that the failure to enter into such Permitted Alternative Agreement would be inconsistent with its fiduciary duties under applicable law.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tTFE"><!--Anchor--></a>Termination Fee </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="h3">Fee payable by Caladrius </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius must pay Cend a termination fee of $1.0&#160;million if: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">(a)(i)&#160;the Merger Agreement is terminated by either Caladrius or Cend if the Annual Meeting shall have been held and completed
                    and the Caladrius Stockholders shall have not approved the Merger Agreement or the transactions contemplated by the Merger Agreement, including the issuance of shares of Caladrius Common Stock to Cend Stockholders in the Merger,
                    (ii)&#160;the Merger Agreement is terminated by Cend because Caladrius or Merger Sub has breached any of its representations, warranties, covenants or agreements contained in the Merger Agreement or if any representation or warranty of
                    Caladrius or Merger Sub has become inaccurate, in either case such that the conditions to the Closing would not be satisfied as of the time of such breach or inaccuracy, subject to a 30-day cure period or (iii)&#160;the Merger Agreement is
                    terminated by Cend if the Merger is not consummated by the End Date, (b) at any time after the date of Merger Agreement and prior to the Annual Meeting an </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">160<br />
        </div>

      </div>

    </div>

    <!--End Page 169-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 170-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="bl">Acquisition Proposal with respect to Caladrius was publicly announced, disclosed or
            otherwise communicated to the Caladrius Board of Directors, and (c) within 12 months after the date of such termination, Caladrius enters into a definitive agreement for or consummates an Acquisition Transaction; </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Caladrius, at any time prior to the Caladrius Stockholders&#8217; approval of the Merger
                    Agreement and the transactions contemplated by the Merger Agreement if the Caladrius Board of Directors authorizes Caladrius to enter into an alternative agreement; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Cend at any time prior to the approval of the Merger Agreement and the transactions
                    contemplated by the Merger Agreement by the Caladrius Stockholders upon the occurrence of a Caladrius Triggering Event. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius must reimburse Cend for expenses incurred by Cend in connection with the
            Merger Agreement and the transactions contemplated thereby, up to a maximum of $1.0&#160;million, if: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Cend if (a) the Annual Meeting shall have been held and completed and (b) the Caladrius
                    Stockholders shall have not approved the Merger Agreement and the transactions contemplated by the Merger Agreement, including the issuance of shares of Caladrius Common Stock to Cend Stockholders in the Merger; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Cend because Caladrius or Merger Sub has breached any of its representations, warranties,
                    covenants or agreements contained in the Merger Agreement or if any representation or warranty of Caladrius or Merger Sub has become inaccurate, in either case such that the conditions to the Closing would not be satisfied as of the
                    time of such breach or inaccuracy, subject to a 30-day cure period; or</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">in the event of a failure by Caladrius to consummate the transactions described in the Merger Agreement solely as a result of a
                    Caladrius Material Adverse Effect, as defined in the section entitled &#8220;<span style="font-style: italic;">The Merger Agreement&#8212;Conditions to the Completion of the Merger.</span>&#8221; </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Fee payable by Cend</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Cend must pay Caladrius a termination fee of $4.0&#160;million if: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Caladrius if (a)(i)&#160;the required approval of Cend Stockholders has not been obtained
                    within two business days of the registration statement on Form S-4, of which this proxy statement/prospectus/information statement is a part, being declared effective by the SEC, (ii)&#160;the Merger Agreement is terminated by Caladrius if
                    the Merger is not consummated by the End Date; or (iii)&#160;the Merger Agreement is terminated by Caladrius because Cend has breached any of its representations, warranties, covenants or agreements contained in the Merger Agreement or if
                    any representation or warranty of Cend has become inaccurate, in either case such that the conditions to the Closing would not be satisfied as of the time of such breach or inaccuracy, subject to a 30-day cure period, (b) at any time
                    after the date of the Merger Agreement and prior to obtaining the approval of the Cend Stockholders, an Acquisition Proposal with respect to Cend was publicly announced, disclosed or otherwise communicated to the Cend Board of Directors
                    and (c) within 12 months after the date of such termination, Cend enters into a definitive agreement for or consummates an Acquisition Transaction;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Caladrius at any time prior to the adoption of the Merger Agreement, and approval of the
                    Merger and the other transactions contemplated by the Merger Agreement, by the Cend Stockholders upon the occurrence of a Cend Triggering Event; or</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Cend upon the Cend Board of Directors authorizing Cend to enter into a Permitted
                    Alternative Agreement.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend must reimburse Caladrius for expenses incurred by Caladrius in connection with the
            Merger Agreement and the transactions contemplated thereby, up to a maximum of $1.0&#160;million, if: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Caladrius if the required approval of Cend Stockholders has not been obtained within two
                    business days of the registration statement on Form S-4, of which this proxy statement/prospectus/information statement is a part, being declared effective by the SEC; </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">161<br />
        </div>

      </div>

    </div>

    <!--End Page 170-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 171-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Merger Agreement is terminated by Caladrius because Cend has breached any of its representations, warranties, covenants or
                    agreements contained in the Merger Agreement or if any representation or warranty of Cend has become inaccurate, in either case such that the conditions to the Closing would not be satisfied as of the time of such breach or inaccuracy,
                    subject to a 30-day cure period; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">in the event of a failure by Cend to consummate the transactions described in the Merger Agreement solely as a result of the
                    occurrence of a Company Material Adverse Effect, as defined above in the section entitled &#8220;<span style="font-style: italic;">The Merger Agreement&#8212;Conditions to the Completion of the Merger.</span>&#8221; </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tAME"><!--Anchor--></a>Amendment</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement may be amended with the approval of the respective boards of
            directors of Caladrius, Cend and Merger Sub at any time, except that after the Merger Agreement has been adopted and approved by the Caladrius Stockholders or Cend Stockholders, no amendment which by law requires further approval by the
            Caladrius Stockholders or Cend Stockholders, as the case may be, shall be made without such further approval.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">162<br />
        </div>

      </div>

    </div>

    <!--End Page 171-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 172-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg16"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tARM"><!--Anchor--></a>AGREEMENTS RELATED TO THE MERGER</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tSUPP"><!--Anchor--></a>Support Agreements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In order to induce Caladrius to enter into the Merger Agreement, certain Cend
            Stockholders are parties to a support agreement with Caladrius pursuant to which, among other things, each stockholder has agreed, solely in his, her or its capacity as a Cend Stockholder, to vote all of his, her or its shares of Cend Capital
            Stock in favor of the adoption of the Merger Agreement, the approval of the transactions contemplated thereby, including the Merger and the approval of any other matter necessary to consummate the transactions contemplated by the Merger
            Agreement that are considered and voted upon by the Cend Stockholders and against any Acquisition Proposal. These Cend Stockholders have also granted Caladrius an irrevocable proxy to vote their respective shares of Cend Capital Stock in
            accordance with the support agreements. The Cend Stockholders may vote their shares of Cend Capital Stock on all other matters not referred to in such proxy. The parties to the support agreements with Caladrius include all directors and
            executive officers of Cend and certain major stockholders of Cend, including ER Trust 2/18/11, Innovation 2016 Kyoto Investment Limited Partnership, Leading Choice International Limited, Sanford Burnham Prebys Medical Discovery Institute,
            Kazuki Sugahara and Tambet Teesalu.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, the Cend Stockholders that are party to a support agreement with
            Caladrius owned an aggregate of 3,823,674 shares of Cend Common Stock, 371,396 shares of Cend Series A Preferred Stock and 951,637 shares of Cend Series B Preferred Stock, representing approximately 77.5% of the outstanding shares of Cend
            Capital Stock on an as converted to common stock basis (excluding shares held by Caladrius). These stockholders include executive officers and directors of Cend and certain stockholders owning a significant portion of the outstanding shares of
            Cend Capital Stock. Following the effectiveness of the registration statement of which this proxy statement/prospectus/information statement is a part and pursuant to the Merger Agreement, Cend Stockholders holding a sufficient number of shares
            of Cend Capital Stock to adopt the Merger Agreement and approve the Merger and related transactions will execute written consents providing for such adoption and approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; directors and executive officers are party to a support agreement with Cend
            pursuant to which, among other things, such individuals have agreed, solely in his or her capacity as a Caladrius Stockholder, to vote all of his or her shares of Caladrius Common Stock in favor of (i)&#160;the Merger Agreement and the transactions
            contemplated thereby, including the Merger and the issuance of Caladrius Common Stock to Cend Stockholders, (ii)&#160;an amendment to the certificate of incorporation of Caladrius to effect the Reverse Stock Split, (iii)&#160;an amendment to the
            certificate of incorporation of Caladrius to effect the Caladrius Name Change, (iv)&#160;any proposal to adjourn or postpone the meeting to a later date, if there are not sufficient votes for the approval of the other matters to be approved on date
            of the Annual Meeting, and (v)&#160;any other matter necessary to consummate the transactions contemplated by the Merger Agreement that are considered and voted upon by Caladrius Stockholders at the Annual Meeting and against any Acquisition
            Proposal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, the Caladrius Stockholders that are party to a support agreement
            with Cend beneficially owned an aggregate of 1,099,314 shares of Caladrius Common Stock, representing approximately 1.8% of the outstanding shares of Caladrius Common Stock. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under these support agreements, subject to certain exceptions, such stockholders have
            also agreed not to sell or transfer their shares of Caladrius Common Stock and securities convertible into shares of Caladrius Common Stock held by them until the earlier of the termination of the Merger Agreement and the completion of the
            Merger, subject to certain exceptions. To the extent that any such sale or transfer is permitted pursuant to the exceptions included in the support agreements, each person to which any shares of Caladrius Common Stock or securities convertible
            into shares of Caladrius Common Stock are so sold or transferred must agree in writing to be bound by the terms and provisions of the support agreement, subject to certain further exceptions with respect to certain Caladrius Stockholders. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tLOCK"><!--Anchor--></a>Lock-up Agreements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As a condition to the Closing, certain Caladrius Stockholders and Cend Stockholders
            have entered into lock-up agreements, pursuant to which such parties have agreed not to, except in limited circumstances, sell or transfer, or engage in swap or similar transactions with respect to, shares of Caladrius Common Stock, including,
            as applicable, shares received in the Merger and issuable upon exercise of certain options, in each case from the Closing until the date that is 120 days from the Closing. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">163<br />
        </div>

      </div>

    </div>

    <!--End Page 172-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 173-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_110-agreement_pg17"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, Caladrius Stockholders who have executed lock-up agreements
            beneficially owned in the aggregate approximately 1.8% of the outstanding shares of Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Stockholders who have executed lock-up agreements as of June&#160;13, 2022 owned in the
            aggregate approximately 77.5% of the outstanding shares of Cend Capital Stock on an as if converted into common stock basis (excluding shares held by Caladrius).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tSPA"><!--Anchor--></a>Stock Purchase Agreement</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Concurrently with the execution of the Merger Agreement and in order to provide Cend
            with capital for its development programs prior to the closing of the Merger, Caladrius and Cend entered into a Series D Preferred Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which Caladrius agreed to purchase from Cend
            1,135,628 shares of Series D Preferred Stock, $0.00001 par value per share (the &#8220;Series D Preferred Stock&#8221;), of Cend at a purchase price per share equal to $8.8057 per share (the &#8220;Series D Original Issue Price&#8221;), or approximately $10,000,000 in
            the aggregate. The Purchase Agreement contains customary representations, warranties and agreements by Caladrius and Cend and customary conditions to Closing. The Series D Preferred Stock ranks senior to Cend&#8217;s common stock and the other series
            of preferred stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of Cend. The Series&#160;D Preferred Stock has a liquidation preference equal to the Series D Original
            Issue Price plus an amount equal to any accrued and unpaid dividends to the date of payment and will participate with Cend&#8217;s common stockholders and other preferred stockholders thereafter on an as-converted basis, except in connection with the
            Merger. The Series D Preferred Stock shall vote with the shares of Caladrius Common Stock on an as-converted basis on any matters presented to the Cend Stockholders. Each share of Series D Preferred Stock is convertible, at the option of the
            holder thereof, into such number of shares of Cend Common Stock as is determined by dividing the Series&#160;D Original Issue Price by the conversion price in effect at the time of conversion, which conversion price shall be the Series D Original
            Issue Price as appropriately adjusted for stock splits, stock dividends, combinations, and subdivisions of Cend common stock, and as adjusted pursuant to a weighted-average antidilution adjustment. The Series D Preferred Stock will
            automatically convert into shares of Cend common stock upon the closing of a firm-commitment underwritten initial public offering implying a pre-equity offering value of at least $250&#160;million, resulting in at least $50&#160;million of gross proceeds
            to Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCOLLA"><!--Anchor--></a>Collaboration Agreement</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Concurrently with the execution of the Merger Agreement, Caladrius and Cend entered
            into a Collaboration Agreement (the &#8220;Collaboration Agreement&#8221;), pursuant to which Caladrius and Cend agreed to collaborate on certain developmental and clinical activities prior to the closing of the Merger. Under the Collaboration Agreement,
            Caladrius and Cend agreed to form a joint steering committee (the &#8220;Committee&#8221;) comprised of individuals from both entities. The Committee is required to meet regularly and be responsible for monitoring ongoing studies and making recommendations
            for development activity and trial planning. Cend has agreed to pay each member of the Committee from Caladrius an hourly consulting fee for such service.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">164<br />
        </div>

      </div>

    </div>

    <!--End Page 173-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 174-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCDO"><!--Anchor--></a>CALADRIUS DIRECTORS, OFFICERS AND CORPORATE
            GOVERNANCE</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tEOC"><!--Anchor--></a>Executive Officers of Caladrius</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth information regarding Caladrius&#8217; executive officers and
            directors as of June&#160;13, 2022: </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Age</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Position/Office Held <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">with Caladrius</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">65</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">President and Chief Executive Officer</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D.</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">48</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Executive Vice President R&amp;D and Chief Medical Officer</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.<span style="font-style: normal;"> Dr.&#160;Mazzo
              was appointed as Caladrius&#8217; President and Chief Executive Officer on March&#160;28, 2017. Dr.&#160;Mazzo was previously appointed as Caladrius&#8217; Chief Executive Officer and as a member of the Caladrius Board of Directors on January&#160;5, 2015. Dr.&#160;Mazzo
              brings to Caladrius over 38&#160;years of experience in the pharmaceutical industry. Prior to joining Caladrius, Dr.&#160;Mazzo served from August 2008 to October 2014 as Chief Executive Officer and as a member of the Board of Directors of Regado
              Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the development of novel antithrombotic drug systems for acute and sub-acute cardiovascular indications. Prior to his leading Regado, from March 2007 to April 2008,
              Dr.&#160;Mazzo was President, Chief Executive Officer and a director of &#198;terna Zentaris, Inc. (Nasdaq: AEZS), a publicly held international biopharmaceutical company. From 2003 until 2007 Dr.&#160;Mazzo served as President, Chief Executive Officer and
              director of Chugai Pharma USA, LLC, a biopharmaceutical company and U.S. subsidiary of Chugai Pharmaceutical Co., Ltd. of Japan and a member of the Roche Group. Dr.&#160;Mazzo has also held senior management and executive positions in research and
              development and was a director of the Essex Chimie European subsidiary at Schering-Plough Corporation, a publicly held pharmaceutical company that was subsequently acquired by Merck &amp; Co., Inc.; Hoechst Marion Roussel, Inc., the U.S.
              subsidiary of Hoechst AG, that was subsequently acquired by Sanofi, a multinational pharmaceuticals company; and Rhone-Poulenc Rorer, Inc., a subsidiary of Rhone-Poulenc SA, a French pharmaceuticals company, that was subsequently acquired by
              Hoechst AG. He previously served on the board of directors of publicly held EyePoint Pharmaceuticals, Inc. (formerly known as pSivida Corp.), a biopharmaceutical company, from October 2005 to June 2020, Seneca Biopharmaceuticals, Inc.
              (Nasdaq: SNCA), a therapeutics development company focused on CNS applications that merged with Palisade BIO, from April 2019 to April 2021 and Avanir Pharmaceuticals, Inc., from October 2005 through January 2015, a pharmaceutical company
              that was sold to Otsuka Holdings in 2015. He currently serves on the board of directors of VTI, Inc. (ASX: VTI), a developer and seller of therapeutic contact lenses, where he has served as Chairman of the board since February 2020 and Feldan
              Therapeutics, a private company developing technology for the intracellular delivery of therapeutic agents, where he has served on the board since January 2021.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D.<span style="font-style: normal;"> Dr.&#160;Buck
              joined Caladrius in September 2021 as Executive Vice President of R&amp;D and Chief Medical Officer (&#8220;CMO&#8221;) of the Company. Prior to joining Caladrius Dr.&#160;Buck worked at ICON plc from March 2020 to July 2021, where she served as its CMO and
              represented the company&#8217;s position on key scientific, ethical, and medical governance matters, provided guidance and oversight to the medical and scientific groups, and led the Drug Development Services group. Prior to that, Dr.&#160;Buck was
              Senior Vice President &amp; Chief of Clinical Development at Optum Insights (part of the United Healthcare Group) from August 2018 to March 2020, where she led the clinical operations and regulatory groups within the Digital Research Network
              (DRN) clinical trial business. From January 2014 to July 2018, Dr.&#160;Buck held a position at Quintiles/IQVIA as Vice President of Global Strategic Drug Development designing clinical development plans and protocols across all therapeutic areas
              for emerging biotech and large pharma. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Earlier in her career, Dr.&#160;Buck worked as a primary care physician and then later
            served as a medical officer in the FDA&#8217;s Office of New Drugs Division of Gastrointestinal and Hematology Drug Products where she was responsible for reviewing efficacy and safety data for new drug indications, as well as post-marketing safety
            data for over 40 drugs. Dr.&#160;Buck worked at AstraZeneca where she served as a Global Safety Physician and Global Study Physician. Her experience ranges over multiple therapeutic indications including cardiovascular/metabolic, rare diseases,
            gastrointestinal, neuroscience, oncology, immunology, and women&#8217;s health.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Buck is a board certified and licensed physician who received her medical degree
            from the Pennsylvania State University School of Medicine and completed her internship and residency in Internal Medicine at Abington Memorial Hospital before working in a private practice as a primary care physician.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">165<br />
        </div>

      </div>

    </div>

    <!--End Page 174-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 175-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tDOC"><!--Anchor--></a>Directors of Caladrius</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth information regarding Caladrius&#8217; directors as of
            June&#160;13, 2022: </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Age</div>
                </td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Position/Office Held <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">with Caladrius</div>
                </td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Director <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Since</div>
                </td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Director <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Term <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Expires</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D. </div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;" class="fpara">68</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.22pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2016</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2024</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D. </div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;" class="fpara">65</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.22pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2015</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2024</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Michael H. Davidson, M.D. </div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;" class="fpara">65</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.22pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2020</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;" class="fpara">62</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.22pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2018</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2023</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;" class="fpara">65</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.22pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2014</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven S. Myers</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;" class="fpara">75</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.22pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2006</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Peter G. Traber, M.D. </div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;" class="fpara">67</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.22pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2015</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2023</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Anne C. Whitaker</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;" class="fpara">55</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 14.91%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.22pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2020</div>
                </td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.7%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.36pt; text-align: left;" class="fpara">2023</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Mazzo&#8217;s biographical information is set forth above under the section entitled &#8220;<span style="font-style: italic;">Caladrius Directors, Officers and Corporate Governance&#8212;Executive Officers of Caladrius.</span>&#8221; We believe that Dr. Mazzo is qualified to serve on the Caladrius Board based on his experience
              within the pharmaceutical industry and his executive experience, specifically his experience as Chief Executive Officer at other companies in the biopharmaceutical industry, as well as his service on other boards of directors in the
              healthcare industry in addition to his scientific training and experience.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D.<span style="font-style: normal;"> Dr.&#160;Brown
              was appointed to the Caladrius Board of Directors in October 2016 and was elected Chairman by the Caladrius Board of Directors on February&#160;16, 2017. Dr.&#160;Brown is currently Chief Executive Officer of Memgen, Inc., a development-stage
              biotechnology company. In 2007, Dr.&#160;Brown co-founded HealthCare Royalty Partners (&#8220;HCR Partners&#8221;), a healthcare-focused private asset management firm investing in biopharmaceutical and medical products, and developing and deploying innovative
              risk-mitigated investment strategies to deliver non-correlated cash flow. Dr.&#160;Brown remains Vice Chairman of HCR Partners and a member of the firm&#8217;s SAB. Dr.&#160;Brown was educated as a transplantation immunologist and trained as a thoracic and
              vascular surgeon. He practiced thoracic and vascular surgery in a community setting where he also founded and led a health maintenance organization. He brings particular expertise in the scientific, technical, clinical and medical evaluation
              of products as well as in healthcare systems and payor/reimbursement dynamics. He has been involved in sourcing, performing due diligence on and closing more than $1&#160;billion of royalty financings.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Before co-founding HCR Partners, Dr.&#160;Brown was a partner at Paul Capital Partners where
            he co-managed that firm&#8217;s royalty investments as a member of the royalty management committee. Prior to beginning his principal investment career in 2003, Dr.&#160;Brown was co-head of investment banking and head of healthcare at Adams, Harkness
            &amp; Hill (now Canaccord Genuity) and a ranked biotechnology research analyst at Vector Securities International. Dr.&#160;Brown holds a B.A. from Yale, an M.D. from SUNY Upstate Medical Center and an M.B.A. from Harvard Business School. He
            currently serves on the boards of FAST Biomedical since January 2020, Memgen, Inc. since October 2018, Aquestive Therapeutics, Inc. since 2007, and Faron Pharmaceuticals, Oy since 2017. He previously served on the boards of Cambrex Corporation,
            Invuity, Inc. and Vanderbilt Clinical, S.a.r.l. We believe that Dr.&#160;Brown is qualified to serve on the Caladrius Board based on his medical, financial and management experience.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Michael H. Davidson, M.D.<span style="font-style: normal;">
              Dr.&#160;Davidson joined the Caladrius Board of Directors in July 2020. He is an industry leader and expert in preventative cardiology and lipidology and has served as the Chief Executive Officer and Member of the Board of New Amsterdam Pharma
              since August 2020. In addition, he has served on the Board of Directors for Tenax since March 2021 and the Board of Directors of Inositec since July 2021. Prior to that, he was the Founder and Chief Scientific Officer of Corvidia
              Therapeutics, which was sold in 2021 to Novo-Nordisk for $2.1&#160;billion. Dr.&#160;Davidson also serves as Clinical Professor and Director of the Lipid Clinic at the University of Chicago Pritzker School of Medicine. He previously served on the Board
              of Directors of Cerenis Therapeutic/Abionyx Therapeutics from January 2015 through September 2019.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition to his current roles, Dr.&#160;Davidson is a nationally recognized expert in
            lipidology and has been named one of &#8220;The Best Doctors in America&#8221; by Best Doctors Inc. for the past 11&#160;years. Dr.&#160;Davidson was the co-founding Chief Medical Officer of Omthera Pharmaceuticals in 2008, which was later acquired by Astra Zeneca
            Pharmaceutical in 2013 for $443&#160;million. His research and clinical development background encompass </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">166<br />
        </div>

      </div>

    </div>

    <!--End Page 175-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 176-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">both pharmaceutical and nutritional clinical trials, including extensive research on
            statins, novel lipid-lowering drugs, and omega-3 fatty acids. Dr.&#160;Davidson is board-certified in internal medicine, cardiology and clinical lipidology and served as President of the National Lipid Association from 2010 to 2011. He received his
            B.A. and M.S. from Northwestern University and an M.D. from The Ohio State University School of Medicine. We believe that Dr.&#160;Davidson is qualified to serve on the Caladrius Board of Directors based on his experience in healthcare, including as
            an industry leader and expert in preventative cardiology and lipidology.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers.<span style="font-style: normal;"> Ms.&#160;Flowers
              was appointed to the Caladrius Board of Directors in November 2018. She is the owner of EIR Advisory LLC, a life sciences advisory and strategic investment firm. From February 2014 through November 2017, Ms.&#160;Flowers was President and Chief
              Executive Officer of Ipsen North America, where she led the transformation of the company as it became the highest-growth subsidiary worldwide. Prior to joining Ipsen, she served as President of Eisai Pharmaceuticals, where she oversaw
              commercial operations, medical affairs and services, manufacturing, alliance management and other functions. She has also held general management roles, both domestically and internationally, at Amgen Inc. and Johnson &amp; Johnson.
              Ms.&#160;Flowers began her career as an oncology/critical care nurse.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Ms.&#160;Flowers currently serves on the board of Hikma Pharmaceuticals PLC, a
            multigenerational generics company and G1 Therapeutics Inc., a biotechnology clinical development company. She has held positions on numerous corporate and non-profit boards, including Nanoform Finland OYi, a nanoparticle manufacturing company,
            Kadmon Group, Inc., a clinical stage biopharmaceutical company, the Women&#8217;s Leadership Advisory Board for the John F. Kennedy School of Government at Harvard University and the board of directors for the Sarah Cannon Oncology Research
            Institute. She currently serves as a Wharton Business School Leadership Advisor. Ms.&#160;Flowers holds an M.B.A. from the Wharton School of the University of Pennsylvania and a B.S.N. from the University of Delaware. We believe that Ms.&#160;Flowers is
            qualified to serve on the Caladrius Board of Directors based on her pharmaceutical industry, management and scientific training and experience. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk.<span style="font-style: normal;"> Mr.&#160;Klosk joined
              the Caladrius Board of Directors in 2014. He is a senior executive with extensive management experience in the life sciences industry. He served as a Director at Cambrex Corporation (NYSE:CBM) from May 2008 through December 2019, until it was
              acquired by Permira and then as Director from December 2019 until June 2020. Cambrex is one of the leading providers of active pharmaceutical ingredients, advanced intermediates and finished dosage form products to the branded and generic
              pharmaceutical markets, where he served as President and Chief Executive Officer from May 2008 through June 2020. In that role he was responsible for all aspects of Cambrex&#8217;s global business with manufacturing and R&amp;D facilities in the
              United States, Sweden, Italy, Estonia and Germany. In addition, he has served on the Board of Directors of Recipharm, a leading pharmaceutical contract development &amp; manufacturing organization since March 2021 and Golden Arrow Merger
              Corp. since March 2021. In addition, since 2021 he has served on the board of directors of Formulated Solutions, a topicals contract development and manufacturing company (&#8220;CDMO&#8221;) where he is the chairman of the board; BioIVT, a leading
              supplier of biologics specimens for biotech research; BIOVECTRA, a leading small molecule and biologics CDMO; and NJ Bio, a leading antibody drug conjugate contract research organization.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Mr.&#160;Klosk held other executive positions at Cambrex Corporation, including President,
            Executive Vice President &amp; COO as well as President, Pharma Business Unit (2007-2008) where he had full P&amp;L and balance sheet responsibility for four operating units in North America and Europe. Prior to this he was Executive Vice
            President &amp; COO Cambrex Pharma &amp; Biopharmaceuticals Business Unit (2003-2007) where he was responsible for managing a highly profitable global business with six operating units in North America and Europe. Earlier in his career
            Mr.&#160;Klosk served as Vice President, Administration for The Genlyte Group, Inc., a publicly traded producer of lighting fixtures. Mr.&#160;Klosk earned a B.S. from Cornell University and a J.D. from New York Law School. We believe that Mr.&#160;Klosk is
            qualified to serve on the Caladrius Board of Directors based on his diversified management experience, particularly in the biopharmaceutical field.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Steven S. Myers<span style="font-style: normal;">. Mr.&#160;Myers joined
              the Caladrius Board of Directors in November 2006. He graduated from Stanford University with a B.S. in Mathematics. He is a four-time serial entrepreneur, an Ernst &amp; Young &#8220;Entrepreneur of the Year&#8221; for Software and Information Services,
              and a recipient of the California Governor&#8217;s Special Recognition Award.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Mr.&#160;Myers is the founder, President and Director of his private equity investment
            company, Dolphin Capital Holdings, Inc., which invests in companies with innovative business strategies. Portfolio investments have </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">167<br />
        </div>

      </div>

    </div>

    <!--End Page 176-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 177-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">included regenerative medicine, biotechnology, medical devices, applied materials
            development, alternative energy, distressed debt, and for-income real estate. He presently serves as a Director on the board of CEO International Inc., since November 2021. He also served as the Chairman of the LSI Business Development, Inc.
            board from January 2019 through August 2019. He previously served on the boards of Spikes Security, Inc., QuantumSphere, Inc., the Pacific Council of International Policy and the Bel Air Association. He has conducted business in a dozen
            countries in Europe and Asia. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">An Administration policy advisor on Cyber Security, he served in 2012 on the Department
            of Homeland Security Task Force on Cyber Security Resources and briefed then-DHS Secretary Napolitano on the Task Force recommendations. He was appointed to three terms on the U.S. State Department Advisory Committee on International Economic
            Policy, which advises the Secretary of State on foreign policy issues. At the Pacific Council on International Policy he serves on the Board of Directors and is Chairman of its National Security Member Committee.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Mr.&#160;Myers founded SM&amp;A, an Aerospace &amp; Defense Industry management consulting
            firm that grew over a 25&#160;year period to approximately $100&#160;million in annual revenue and over 800 employees, spearheading industry-changing innovations in competing for and managing U.S. Government contracts. During his tenure the company
            managed more than $360&#160;billion in major program competitions. After conducting a successful Nasdaq listed IPO in 1998 he served as Chairman and CEO of SM&amp;A for another ten years. The company was sold to private equity in 2008. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">An accomplished public speaker and author, Mr.&#160;Myers is a nationally recognized thought
            leader on business competitiveness and is a frequent guest lecturer on entrepreneurship at the USC Marshall School of Business. He is a two-time U.S. Air Force Veteran and a highly accomplished aviator. The Caladrius Board of Directors has
            concluded that Mr.&#160;Myers should continue serving as a Director based upon his technical background and diverse entrepreneurial and business expertise, including his having established and managed innovative enterprises (in the areas of proposal
            development for competitive procurements, aircraft leasing and private equity investment), together with his technical experience in the aerospace and defense sector.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Peter G. Traber, M.D.<span style="font-style: normal;"> Dr.&#160;Traber
              joined the Caladrius Board of Directors in January 2015. He has extensive experience in medicine, science and the pharmaceutical industry. Since August 2020 he has served as Chief Medical Officer at Selectra Biosciences. Prior to that, from
              July 2018 to July 2020, he served as Partner to Alacrita Consulting. From March 2011 until June 2018, he was President and Chief Executive Officer of Galectin Therapeutics, Inc. (Nasdaq: GALT), where he served since 2010 as Chief Medical
              Officer and starting in 2009 as a member of its Board of Directors. Galectin is a publicly traded biotechnology company that is developing carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer. Since 2008, he has
              been President Emeritus of Baylor College of Medicine, where he was Chief Executive Officer from 2003 to 2008. Dr.&#160;Traber also has extensive big pharma leadership experience, serving from 2000 to 2003 as Senior Vice President of clinical
              development and medical affairs and Chief Medical Officer of GlaxoSmithKline. He has also served as CEO of the University of Pennsylvania Health System, and as Chair of the Department of Internal Medicine and Chief of Gastroenterology for the
              University of Pennsylvania School of Medicine.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Traber has managed a molecular biology research laboratory and published more than
            100 research articles, reviews, and book chapters. He received his M.D. from Wayne State School of Medicine, a B.S. in chemical engineering from the University of Michigan, and a certificate in medical leadership from Wharton Business School.
            We believe that Dr.&#160;Traber is qualified to serve on the Caladrius Board of Directors based on his diverse experience in healthcare, including his expertise in clinical trial design and product development, and his management experience.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Anne C. Whitaker. <span style="font-style: normal;">Ms.&#160;Whitaker
              became a member of the Caladrius Board of Directors in November 2020. Ms.&#160;Whitaker is a seasoned healthcare executive and director with more than 30&#160;years of experience and a proven track record as an executive of building and leading
              high-performance teams. Ms.&#160;Whitaker currently serves as Managing Partner of Anne Whitaker Group, LLC, a board and private equity advisory firm, and is the current Chairperson of the Board of Aerami Therapeutics, a private life science
              company. Prior to taking the Chair role at Aerami, she served as the CEO from October 2018 to November 2020 and as a director from July 2018. She also serves as an independent director on the boards of three public companies including Faron
              Pharmaceuticals, a development stage pharma company; OraSure Technologies, a diagnostic company; and Mallinckrodt, a specialty pharmaceutical company. In addition to her board work, she is an active industry </span></div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">168<br />
        </div>

      </div>

    </div>

    <!--End Page 177-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 178-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">advisor to private equity and venture capital funds in the U.S. and Europe.
            Ms.&#160;Whitaker started her healthcare career with The Upjohn Company selling pharmaceuticals. She subsequently transitioned to GlaxoSmithKline PLC, where she spent 19&#160;years and rose in the commercial ranks from a sales representative to become a
            Senior Vice President, Business Unit Head for the Cardiovascular, Metabolic, and Urology franchises in 2009. She joined Sanofi SA in 2011 as the President of the North America Pharmaceutical Region. Anne served as the CEO and President of Synta
            Pharmaceuticals, Inc. in 2014 and 2015. She joined Bausch Health as an Executive Vice President and Company Group Chairman for the Branded Pharmaceuticals segment in mid-2015. From February 2017 until April 2018, she served as the CEO and
            President of Novoclem Therapeutics, Inc. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Ms.&#160;Whitaker holds a Bachelor of Science degree in chemistry from the University of
            North Alabama. We believe that Ms.&#160;Whitaker is qualified to serve on the Caladrius Board of Directors based on her experience in the life science industry, including her senior leadership roles with large pharmaceutical, biotech and specialty
            pharma companies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tBC"><!--Anchor--></a>Board Composition</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Director Independence</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The current Caladrius Board of Directors consists of Dr.&#160;Brown, Dr.&#160;Davidson,
            Ms.&#160;Flowers, Mr.&#160;Klosk, Dr.&#160;Mazzo, Mr.&#160;Myers, Dr.&#160;Traber and Ms.&#160;Whitaker. The Caladrius Board of Directors has reviewed the materiality of any relationship that each of our directors has with Caladrius, either directly or indirectly. Based
            upon this review, the Caladrius Board of Directors has determined that Dr.&#160;Brown, Dr.&#160;Davidson, Ms.&#160;Flowers, Mr.&#160;Klosk, Mr.&#160;Myers, Dr.&#160;Traber and Ms.&#160;Whitaker are &#8220;independent directors&#8221; applying the definition of independence under the listing
            standards of Nasdaq.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Classified Board of Directors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In accordance with Caladrius&#8217; amended and restated certificate of incorporation, the
            Caladrius Board of Directors is divided into three classes with staggered, three-year terms as set forth below. At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time
            of election and qualification until the third annual meeting following election. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Class&#160;I directors are Ms.&#160;Flowers, Dr.&#160;Traber and Ms.&#160;Whitaker, and their terms will expire at the 2023 annual meeting of
                    stockholders; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Class&#160;II directors are Dr.&#160;Brown and Dr.&#160;Mazzo, and their terms will expire at the 2024 annual meeting of stockholders; and
                  </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Class&#160;III directors are Dr.&#160;Davidson, Mr.&#160;Klosk and Mr.&#160;Myers, and their terms will expire at the Annual Meeting. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The authorized number of directors may be changed only by resolution of the Caladrius
            Board of Directors. Any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. The
            division of the Caladrius Board of Directors into three classes with staggered three-year terms may delay or prevent a change of management or a change in control of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tBLSR"><!--Anchor--></a>Board Leadership Structure and Role
            in Risk Oversight</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Brown serves as the Chairman of the Caladrius Board of Directors. When present, our
            Chairman presides over all Caladrius Board of Directors meetings. Dr.&#160;Brown coordinates with our President and Chief Executive Officer and Corporate Secretary to set the agenda for Caladrius Board of Directors meetings, chairs executive
            sessions of the independent directors, and performs any other duties assigned from time to time by the Caladrius Board of Directors. We believe that the separation of the Chairman and Chief Executive Officer roles at Caladrius enhances good
            corporate governance principles through reduction of conflicts of interest and greater board independence.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors oversees our risk management. This oversight is
            administered primarily through the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Caladrius Board of Directors&#8217; review and approval of our business plans and budget (prepared and presented to the Caladrius
                    Board of Directors by the President and Chief Executive Officer and other management), including the projected opportunities and challenges facing our business;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">169<br />
        </div>

      </div>

    </div>

    <!--End Page 178-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 179-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">At least quarterly review of our business developments, business plan implementation and financial results;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Our Audit Committee&#8217;s oversight of our internal control over cybersecurity and financial reporting and its discussions with
                    management and the independent accountants regarding the quality and adequacy of our internal controls and financial reporting; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Our Compensation Committee&#8217;s review and approval of our executive officer compensation, executive and general compensation
                    policies and its relationship to our business plans.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tBOARD"><!--Anchor--></a>Board Committees</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="h3">Audit Committee</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Audit Committee consists of four directors: Dr.&#160;Brown (Chairman), Ms.&#160;Flowers,
            Messrs. Klosk and Myers. Each member of the committee is independent applying the definition of independence under the listing standards of Nasdaq and SEC regulations. Dr.&#160;Brown, Ms.&#160;Flowers, Messrs. Klosk and Myers each qualify as an &#8220;audit
            committee financial expert&#8221; as defined by Item 407(d)(5)(ii)&#160;of Regulation S-K.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the terms of the Audit Committee charter, the Audit Committee is required
            to consist of at least three of our &#8220;independent&#8221; directors and shall serve at the pleasure of the Caladrius Board of Directors. An &#8220;independent&#8221; director is defined as an individual who (a) is not our officer or salaried employee or an
            affiliate, (b) does not have any relationship that, in the opinion of the Caladrius Board of Directors, would interfere with his or her exercise of independent judgment as an Audit Committee member, (c) meets the independence requirements of
            the SEC and Nasdaq or such other securities exchange or market on which our securities are traded and (d) except as permitted by the SEC and Nasdaq or such other securities exchange or market on which our securities are traded, does not accept
            any consulting, advisory or other compensatory fee from us. The Audit Committee&#8217;s charter requires the committee to oversee our accounting and financial reporting process, our system of internal controls regarding cybersecurity, finance,
            accounting, legal compliance and ethics, and the audits of our financial statements. A current copy of such charter is available to stockholders on our website, www.caladrius.com. The primary duties of the Audit Committee consist of, among
            other things:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">serving as an independent and objective party to monitor our financial reporting process, internal control system, cybersecurity
                    policy and disclosure control system;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewing and appraising the audit efforts of our independent accountants;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">assuming direct responsibility for the appointment, compensation, retention and oversight of the work of the outside auditors
                    and for the resolution of disputes between the outside auditors and our management regarding financial reporting issues;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">providing an open avenue of communication among the independent accountants, financial and senior management and the Caladrius
                    Board of Directors; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewing and approving all related party transactions.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h3">Compensation Committee</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our Compensation Committee consists of four directors: Mr.&#160;Klosk (Chairman), Dr.&#160;Brown,
            Mr.&#160;Myers and Ms.&#160;Whitaker. Each such member of the Compensation Committee is independent applying the definition of independence under the listing standards of Nasdaq. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Each member of our Compensation Committee must (i)&#160;be one of our independent directors
            satisfying the independence requirements of Nasdaq and other applicable regulatory requirements; (ii)&#160;qualify as an &#8220;outside director&#8221; under Section 162(m) of the Code and (iii)&#160;meet the requirements of a &#8220;non-employee director&#8221; for purposes of
            Section 16 of the Exchange Act. Except as permitted by Nasdaq, members of the Compensation Committee must not accept any consulting, advisory or the other compensatory fee from us or any of our subsidiaries. In determining whether a director is
            eligible to serve on the Compensation Committee, the Caladrius Board of Directors must consider whether the director is affiliated with us, one of our subsidiaries or an affiliate of one of our subsidiaries to determine whether such affiliation
            would impair the director&#8217;s judgment as a member of the Compensation Committee.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">170<br />
        </div>

      </div>

    </div>

    <!--End Page 179-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 180-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">The Compensation Committee oversees the determination of all matters relating to
            employee compensation and benefits and specifically determines and approves salaries, bonuses and equity-based compensation for our executive officers.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We have adopted a Compensation Committee charter which outlines the Compensation
            Committee&#8217;s primary duties which are to:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">evaluate the performance of the President and Chief Executive Officer considering, <span style="font-style: italic;">inter alia</span>,
                    achievement of committee-approved goals and objectives and determine and approve the President and Chief Executive Officer&#8217;s compensation based on this evaluation and such other factors as the Compensation Committee shall deem
                    appropriate;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">determine and approve all executive officer compensation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approve the aggregate amounts and methodology for determination of all salary, bonus, and long-term incentive awards for all
                    employees other than executive officers;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">review and recommend equity-based compensation plans to the full Caladrius Board of Directors and approve all grants and awards
                    thereunder;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">review and approve changes to our equity-based compensation plans other than those changes that require stockholder approval
                    under the plans, the requirements of Nasdaq or any exchange on which our securities may be listed and/or any applicable law;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">review and recommend to the full Caladrius Board of Directors changes to our equity-based compensation plans that require
                    stockholder approval under the plans, the requirements of Nasdaq or any exchange on which our securities may be listed and/or any applicable law;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">review and approve changes in our retirement, health, welfare and other benefit programs that result in a material change in
                    costs or the benefit levels provided;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">administer our equity-based compensation plans; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approve, as required by applicable law, the annual Compensation Committee report on executive compensation for inclusion in our
                    proxy statement.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Compensation Committee has the authority, in its sole discretion, to retain or
            obtain advice from compensation consultants, independent legal counsel and other advisers, and is directly responsible for the retention, termination, compensation and oversight of the work of any such consultant, counsel or other adviser. In
            selecting a consultant, counsel or other adviser, the Compensation Committee must, as required by Nasdaq rules, take into consideration all factors relevant to such person&#8217;s independence from management, including all factors that Nasdaq
            identifies in its listing standards.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Since March 2015, the Compensation Committee engaged the services of Radford/AON
            (&#8220;Radford&#8221;), a national executive compensation consulting firm, with expertise in the life science industry to review and provide recommendations concerning all of the components of Caladrius&#8217; executive and director compensation program.
            Radford performs services solely on behalf of the Compensation Committee and has no relationship with the Company or management except as may relate to performing such services. Radford assisted the Compensation Committee in defining the
            appropriate market of the Company&#8217;s peer companies for executive compensation and practices and in benchmarking our executive compensation program against the peer group for 2021 and in years past compensation actions. Radford also assisted the
            Compensation Committee in benchmarking our director compensation program and practices against those of our peers. The Compensation Committee has assessed the independence of Radford pursuant to SEC rules and the corporate governance rules of
            Nasdaq and concluded that no conflict of interest exists that would prevent Radford from independently representing the Compensation Committee.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A current copy of the Compensation Committee charter is available to stockholders on
            our website, www.caladrius.com. The Compensation Committee may form and delegate its authority to subcommittees as appropriate. Additionally, the President and Chief Executive Officer may make recommendations to the Compensation Committee
            relating to executive and director compensation, but consistent with Nasdaq rules, he may not be present during deliberations or voting regarding his own compensation.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">171<br />
        </div>

      </div>

    </div>

    <!--End Page 180-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 181-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Nominating and Corporate Governance Committee</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our Nominating and Governance Committee consists of three directors: Mr.&#160;Myers
            (Chairman), Dr.&#160;Davidson and Dr.&#160;Traber. The Nominating and Governance Committee is empowered by the Caladrius Board of Directors to recommend to the Caladrius Board of Directors qualified individuals to serve on the Caladrius Board of
            Directors and to identify the manner in which the Nominating and Governance Committee evaluates nominees recommended for the Caladrius Board of Directors. All members of the Nominating and Governance Committee have been determined to be
            &#8220;independent directors&#8221; pursuant to the definition contained in the rules of Nasdaq and SEC regulations. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors has adopted a Nominating and Governance Committee
            charter to govern the Nominating and Governance Committee, a current copy of which is available to stockholders on our website, www.caladrius.com.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Additional Board Committee:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors also maintains the following additional committee:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Science and Technology Committee<span style="font-style: normal; font-weight: normal;">: The Science and Technology Committee consists of Drs. Davidson (Chairman), Brown, Traber, Mazzo, Azab, Ms.&#160;Flowers, Mr.&#160;Klosk and Ms.&#160;Whitaker. This committee is authorized




                to review the science, clinical and regulatory strategy underlying Caladrius&#8217; research and development programs, as well as associated staffing and budgets. It also reviews the interactions of the research and development
                organization with healthcare providers and regulatory bodies. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Qualifications for Board Membership</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Nominating and Governance Committee Charter mandates that the Committee consider
            and recruit qualified candidates in consultation with the Company&#8217;s Chief Executive Officer and affords the Committee the flexibility to determine the desired qualifications, expertise and characteristics most suited to the needs of the
            Caladrius Board of Directors at any given time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Diversity Considerations in Director Nominations</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We do not have a formal diversity policy. Notwithstanding this, Caladrius is in
            compliance with current Nasdaq rules regarding board diversity. We believe the Caladrius Board of Directors represents a collection of individuals with a variety of complementary skills which, as a group, constitute the appropriate skills and
            experience to oversee Caladrius&#8217; business. Our directors come from diverse backgrounds, including medicine, private equity, and management of pharmaceutical and healthcare-related companies. In accordance with the mission set out in its
            charter, our Nominating and Governance Committee considers a wide variety of qualifications, attributes and other factors and recognizes that a diversity of viewpoints and practical experiences can enhance the effectiveness of the Caladrius
            Board of Directors. As part of its evaluation of each candidate, our Nominating and Governance Committee takes into account how that candidate&#8217;s background, experience, qualifications, attributes and skills may complement, supplement or
            duplicate those of other directors or prospective candidates.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">172<br />
        </div>

      </div>

    </div>

    <!--End Page 181-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 182-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Board Diversity Matrix, below, provides the diversity
            statistics for the Caladrius Board of Directors.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000;" class="fintab">


  <tr class="header">

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 98.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;" colspan="13">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Board Diversity Matrix for Caladrius As of July&#160;26, 2022</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 6.5pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

  </tr>

  <tr class="header">

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Total Number of Directors</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 40.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" colspan="10">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">8</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

  </tr>

  <tr class="header">

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Female</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Male</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Non-Binary</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Did Not <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Disclose <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Gender</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Part I: Gender Identity<br />
                  </div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Directors</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">2</span></div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">6</span></div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Part II: Demographic Background<br />
                  </div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">African American or Black</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Alaskan Native or Native American</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">1</span></div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Asian</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Hispanic or Latinx</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Native Hawaiian or Pacific Islander</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">White</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">1</span></div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">6</span></div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Two or More Races or Ethnicities</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.24%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.35%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.63pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">LGBTQ+</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 40.92%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" colspan="10">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 90.5pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 0.64%; font-size: 2pt; border-left: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 56.52%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.75pt; text-align: left;" class="fpara">Did Not Disclose Demographic Background</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 40.92%; text-align: center; vertical-align: bottom; white-space: nowrap; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;" colspan="10">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 90.5pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Nominating and Governance Committee Procedures</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors generally believes that we are well-served by our
            current directors. In the ordinary course, absent special circumstances or a material change in the criteria for board membership, the Caladrius Board of Directors will re-nominate incumbent directors who continue to be qualified for board
            service and are willing to continue as directors. If an incumbent director is not standing for re-election or is not re-nominated if a vacancy on the Caladrius Board of Directors occurs between annual stockholder meetings or if the Caladrius
            Board of Directors believes it is in our best interests to expand its size, the Caladrius Board of Directors may seek out potential candidates for Caladrius Board of Directors appointment who meet the criteria for selection as a nominee and
            have the specific qualities or skills being sought. Nominees for director must be discussed by the full Caladrius Board of Directors and approved for nomination by the affirmative vote of a majority of the Caladrius Board of Directors,
            including the affirmative vote of a majority of the independent directors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Nominating and Governance Committee assists the Caladrius Board of Directors by
            identifying qualified candidates for director and recommends to the Caladrius Board of Directors the director nominees for the annual meeting of stockholders. The Caladrius Board of Directors will conduct a process of making a preliminary
            assessment of each proposed nominee based upon the nominee&#8217;s resume and biographical information, an indication of the individual&#8217;s willingness to serve and other background information. This information is evaluated against specific needs at
            that time. Based upon a preliminary assessment of the candidate(s), those who appear best suited to meet our needs may be invited to participate in a series of interviews, which are used as a further means of evaluating potential candidates.
            Based on information learned during this process, the Caladrius Board of Directors will determine which nominee(s) to include in the slate of candidates that the Caladrius Board of Directors recommends for election at each annual meeting of our
            stockholders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h3">Procedures for Considering Nominations Made by
            Stockholders</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The procedures for stockholders submitting nominating recommendations described in our
            By-laws detail the procedures for nominations to be submitted by stockholders, other than candidates who have previously served on the Caladrius Board of Directors or who are recommended by the Caladrius Board of Directors. Our By-laws state
            that: &#8220;For any nomination or other business proposal to be properly brought before an Annual Meeting by a stockholder pursuant to clause (iii)&#160;of Article I, Section 1.10(A)(1) of these By-laws, the stockholder must (i)&#160;have given Timely Notice
            (as defined below) thereof in writing to the Secretary of the Corporation, (ii)&#160;have provided any updates or supplements to such notice at the times and in the forms required by these By-laws and, </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">173<br />
        </div>

      </div>

    </div>

    <!--End Page 182-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 183-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">(iii)&#160;together with the beneficial owner(s), if any, on whose behalf the nomination
            or other business proposal is made, have acted in accordance with the representations set forth in the Solicitation Statement (as defined below) required by these By-laws. To be timely, a stockholder&#8217;s written notice shall be received by the
            Secretary at the principal executive offices of the Corporation not later than the close of business on the one hundred and twentieth (120th) day nor earlier than the close of business on the one hundred fiftieth (150th) day prior to the
            one-year anniversary of the preceding year&#8217;s Annual Meeting date; provided that, in the event the Annual Meeting is first convened more than thirty (30) days before or more than sixty (60) days after the one-year anniversary of the preceding
            year&#8217;s Annual Meeting date, or if no Annual Meeting was held in the preceding year, notice by the stockholder to be timely must be received by the Secretary of the Corporation not later than the close of business on the later of the ninetieth
            (90th) day prior to the scheduled date of such Annual Meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first made (such notice within such time periods shall be referred to as &#8220;Timely
            Notice&#8221;).&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There will be no differences in the manner in which the Caladrius Board of Directors
            evaluates nominees recommended by stockholders and nominees recommended by the Caladrius Board of Directors or management, except that no specific process shall be mandated with respect to the nomination of any individuals who have previously
            served on the Caladrius Board of Directors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">Stockholder Communications</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors has established a procedure that enables stockholders
            to communicate in writing with members of the Caladrius Board of Directors. Any such communication should be addressed to our Corporate Secretary and should be sent to such individual c/o Caladrius Biosciences, Inc., 110 Allen Road, Second
            Floor, Basking Ridge, NJ 07920. Any such communication must state, in a conspicuous manner, that it is intended for distribution to the entire Caladrius Board of Directors. Under the procedures established by the Caladrius Board, upon our
            Secretary&#8217;s receipt of such a communication, a copy of such communication will be sent to each member of the Caladrius Board of Directors, identifying it as a communication received from a stockholder. Absent unusual circumstances, at the next
            regularly scheduled meeting of the Caladrius Board of Directors held more than two days after such communication has been distributed, the Caladrius Board of Directors will consider the substance of any such communication.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">Board and Committee Meeting Attendance</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">During the year ended December&#160;31, 2021, the Caladrius Board of Directors held four
            meetings, the Audit Committee held five meetings, the Compensation Committee held six meetings, the Nominating and Governance Committee held four meetings and the Science and Technology Committee held five meetings. The Caladrius Board of
            Directors took additional actions by written consent. Each director attended (or participated by telephone) in 100% of the total number of meetings of the Caladrius Board of Directors and committees on which he or she served, with the exception
            of one Audit meeting and one Nominating and Governance meeting at which one member was absent at each.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Director Attendance at Annual Stockholder Meetings</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We do not have a formal policy regarding attendance by directors at our annual meetings
            of stockholders but invite and encourage all directors to attend. We make every effort to schedule our annual meeting of stockholders at a time and date to permit attendance by directors, taking into account the directors&#8217; schedules and the
            timing requirements of applicable law. During the COVID-19 pandemic we implemented a virtual meeting format for the protection of our shareholders, directors and management. All incumbent board members attended Caladrius&#8217; virtual annual meeting
            in 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Delinquent Section 16(a) Reports</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Section 16(a) of the Exchange Act requires Caladrius&#8217; directors, certain officers of
            Caladrius, and persons who beneficially own more than 10% of a registered class of Caladrius&#8217; equity securities, to file initial reports of ownership and reports of changes in ownership with the SEC. These persons are required by the SEC to
            furnish Caladrius with copies of all Section 16(a) reports that they file.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Based solely on a review of Forms 3 and 4 and amendments thereto furnished to Caladrius
            during 2021, filed by our officers, directors, and any person whom we understand to own more than 10% of our common stock, all </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">174<br />
        </div>

      </div>

    </div>

    <!--End Page 183-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 184-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Section 16(a) filings were timely filed to our knowledge, with the exception of the
            filing on November&#160;8, 2021 of a Form 3 filed by Todd Girolamo, which should have been filed by June&#160;25, 2021. This Form 3 covered zero transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Code of Ethics</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We have adopted a code of ethics that applies to our directors, officers and employees,
            except to our Chief Executive Officer, principal financial officer, and any principal accounting officer, controller, or persons performing similar functions, who are subject to a separate code of ethics. Both codes of ethics are available on
            our website, www.caladrius.com.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tDIR"><!--Anchor--></a>Director Compensation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Directors who are employees of Caladrius or its subsidiaries do not receive additional
            cash compensation for serving as directors. Caladrius&#8217; non-employee directors are reimbursed for out-of-pocket travel expenses incurred in their capacity as Caladrius directors. Pursuant to the Plan, all directors (including independent
            directors) are eligible to receive equity awards.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth information on all compensation to Caladrius&#8217; directors
            (other than as reflected in the Summary Compensation Table) for the year ended December&#160;31, 2021.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Fees Earned or <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Paid in Cash</div>
                </td>

    <td style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Awards<sup>(1)</sup></div>
                </td>

    <td style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Awards<sup>(1)</sup></div>
                </td>

    <td style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Compensation</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D.<sup>(2)</sup></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">98,500</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">59,999</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.03pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.91pt; text-align: left;" class="fpara">$158,499</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Michael H. Davidson, M.D.<sup>(3)</sup></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">53,500</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">59,999</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.03pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.91pt; text-align: left;" class="fpara">$<span style="padding-left: 0.37pt;">113,499</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers<sup>(4)</sup></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">52,500</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">59,999</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.03pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.91pt; text-align: left;" class="fpara">$<span style="padding-left: 0.37pt;">112,499</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk<sup>(5)</sup></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">64,500</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">59,999</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.03pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.91pt; text-align: left;" class="fpara">$124,499</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven S. Myers<sup>(6)</sup></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">63,000</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">59,999</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.03pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.91pt; text-align: left;" class="fpara">$122,999</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Peter G. Traber, M.D.<sup>(7)</sup></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">49,000</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">59,999</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.03pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.91pt; text-align: left;" class="fpara">$108,999</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Anne Whitaker<sup>(8)</sup></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">50,500</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">59,999</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.03pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.91pt; text-align: left;" class="fpara">$<span style="padding-left: 0.37pt;">110,499</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total</div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$431,500</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$419,993</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.03pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.46%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.91pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$851,493</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Amounts shown under &#8220;Stock Awards&#8221;, &#8220;Restricted Stock Unit Awards&#8221; and &#8220;Option Awards&#8221; represent the aggregate grant date fair
                    value computed in accordance with FASB ASC Topic 718, in accordance with SEC rules. See Note 10 to the Notes to the Consolidated Financial Statements in our 2021 Form 10-K for a discussion of assumptions made in such valuations. All
                    stock awards, option awards and other shares discussed in this table were issued under Caladrius&#8217; Plan, with a per share price generally equal to the fair market value of a share of our common stock on the date of grant.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">On January&#160;11, 2021, Dr.&#160;Brown was granted 37,735 shares of restricted stock unit awards, none of which are vested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">On January&#160;11, 2021, Dr.&#160;Davidson was granted 37,735 shares of restricted stock unit awards, none of which are vested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">On January&#160;11, 2021, Ms.&#160;Flowers was granted 37,735 shares of restricted stock unit awards, none of which are vested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">On January&#160;11, 2021, Mr.&#160;Klosk was granted 37,735 shares of restricted stock unit awards, none of which are vested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">On January&#160;11, 2021, Mr.&#160;Myers was granted 37,735 shares of restricted stock unit awards, none of which are vested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">On January&#160;11, 2021, Dr.&#160;Traber was granted 37,735 shares of restricted stock unit awards, none of which are vested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">On January&#160;11, 2021, Ms.&#160;Whitaker was granted 37,735 shares of restricted stock unit awards, none of which are vested.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors&#8217; Compensation Plan (the &#8220;Directors&#8217; Compensation
            Plan&#8221;), which is only applicable to our non-employee directors, provides the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual cash retainer for each non-employee director of $40,000;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an additional annual cash compensation retainer of $30,000 for the non-executive chair;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual cash retainer for serving as chairperson of a committee as follows: Audit ($18,000); Compensation ($12,000);
                    Nominating and Governance ($9,000); Science and Technology ($9,000);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual cash retainer for serving as a member of a committee as follows: Audit ($8,000); Compensation ($6,000); Nominating and
                    Governance ($4,500); and Science and Technology ($4,500);</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">175<br />
        </div>

      </div>

    </div>

    <!--End Page 184-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 185-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_111-corporate_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">new non-employee directors receive an initial grant of restricted stock units with a value of 2x the annual grant with the
                    number of shares to be issued on the grant date calculated based on the grant date fair value with one-third vesting annually on each of the first, second and third anniversaries of the grant date; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual equity grant on the second Monday in January a grant of restricted stock units with a value of $60,000, vesting at one
                    year from the grant date.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The effective date for any annual equity grants to employees and non-employee directors
            is the second Monday in January, with the exercise price of options granted set at the closing price of our common stock on the date of grant.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCCI"><!--Anchor--></a>Compensation Committee Interlocks
            and Insider Participation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">During 2021, Mr.&#160;Klosk, Dr.&#160;Brown, Mr.&#160;Myers and Ms.&#160;Whitaker served as members of
            Caladrius&#8217; compensation committee. During 2021, none of the members of the compensation committee had at any time been one of Caladrius&#8217; officers or employees. None of Caladrius&#8217; executive officers currently serve, or in the past year has
            served, as a member of the board of directors or compensation committee of any entity that has one or more executive officers on the Caladrius Board of Directors or compensation committee.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">176<br />
        </div>

      </div>

    </div>

    <!--End Page 185-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 186-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_112-report_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tREPORT"><!--Anchor--></a>REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF
            DIRECTORS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The material in this report is not &#8220;soliciting material,&#8221; is not
            deemed &#8220;filed&#8221; with the SEC, and is not to be incorporated by reference into any filing of Caladrius under the Securities Act or the Exchange Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The primary purpose of the audit committee is to oversee Caladrius&#8217; financial reporting
            processes on behalf of the Caladrius Board of Directors. The audit committee&#8217;s functions are more fully described in its charter, which is available on the Caladrius website at https://ir.caladrius.com/corporate-governance/governance-overview.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In fulfilling its oversight responsibilities, the audit committee reviewed and
            discussed with management Caladrius&#8217; audited financial statements for the calendar year ended December&#160;31, 2021. The audit committee has discussed with Grant Thornton LLP (&#8220;GT&#8221;), Caladrius&#8217; independent registered public accounting firm, the
            matters required to be discussed by Auditing Standard No. 16, &#8220;Communications with Audit Committees,&#8221; issued by the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;). In addition, the audit committee has discussed with GT their independence,
            and received from GT the written disclosures and the letter required by Ethics and Independence Rule 3526 of the PCAOB. Finally, the audit committee discussed with GT, with and without management present, the scope and results of GT&#8217;s audit of
            the financial statements for the calendar year ended December&#160;31, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Based on these reviews and discussions, the audit committee recommended to the
            Caladrius Board of Directors that such audited financial statements be included in Caladrius&#8217; Annual Report on Form 10-K for the year ended December&#160;31, 2021 for filing with the SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Audit Committee<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="font-weight: normal;">Gregory B. Brown, M.D. </span><br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="font-weight: normal;">Cynthia L. Flowers </span><br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="font-weight: normal;">Steven M. Klosk </span><br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="font-weight: normal;">Steven S. Myers</span></div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">177<br />
        </div>

      </div>

    </div>

    <!--End Page 186-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 187-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCEC"><!--Anchor--></a>CALADRIUS EXECUTIVE COMPENSATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">The following is a discussion and analysis of compensation arrangements of Caladrius&#8217;
            named executive officers. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h2">Summary Compensation Table</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth the total compensation paid or accrued during the last
            two fiscal years with respect to (i)&#160;our President and Chief Executive Officer, (ii)&#160;our two other most highly compensated executive officers, who each earned more than $100,000 during the fiscal year ended December&#160;31, 2021, and were serving
            as executive officers as of such date.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name and <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Principal Position</div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year</div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Salary</div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Bonus</div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Awards<sup>(1)</sup></div>
                </td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Awards<sup>(1)</sup></div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">All Other <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Compensation</div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Compensation</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.,  <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President and Chief Executive Officer<br />
                  </div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2021</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$631,495</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$295,942</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$313,230<sup>(2)</sup></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 12.5pt;">64,298</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.41pt; text-align: left;" class="fpara">$30,250<sup>(3)</sup></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.16pt; text-align: left;" class="fpara">$1,335,216</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2020</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$613,102</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$329,576</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$235,783<sup>(4)</sup></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;">149,190</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.41pt; text-align: left;" class="fpara">$30,250<sup>(5)</sup></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.16pt; text-align: left;" class="fpara">$1,357,901</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D.,  <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Executive Vice President R&amp;D and Chief Medical Officer<sup>(10)</sup><br />
                  </div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2021</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$183,333</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$275,000</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$400,000</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$1,000,000</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.41pt; text-align: left;" class="fpara">$<span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.16pt; text-align: left;" class="fpara">$1,858,333</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2020</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 30pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.41pt; text-align: left;" class="fpara">$<span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.16pt; text-align: left;" class="fpara">$<span style="padding-left: 30pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Todd Girolamo,  <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Former Chief Legal Officer and Corporate Secretary<sup>(11)</sup><br />
                  </div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2021</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$359,801</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$130,427</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">84,270</span><sup>(6)</sup></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 12.5pt;">19,289</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.41pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">8,250</span><sup>(7)</sup></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.16pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;">602,037</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2020</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$333,373</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 0.37pt;">114,771</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$103,683<sup>(8)</sup></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 12.5pt;">95,120</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.41pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">8,250</span><sup>(9)</sup></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.16pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;">655,197</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Amounts shown under &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; represent the aggregate grant date fair value computed in accordance with
                    FASB ASC Topic 718, in accordance with SEC rules. See Note 10 to the Notes to the Consolidated Financial Statements in our 2021 Form 10-K, for a discussion of assumptions made in such valuations. All stock awards, option awards and
                    other shares discussed in this table were issued under the Plan, with a per share price generally equal to the fair market value of a share of our common stock on the date of grant.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes the grant of performance stock units valued at $124,020, which is also the maximum potential value at the time of the
                    grant. The performance criteria was met in 2021 for half of the performance stock units, and as a result, half of the performance stock units valued at $62,010 were canceled in 2021.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consisted of (i)&#160;a car allowance of $12,000, (ii) $8,250 of Company 401(k) match, and (iii)&#160;a life and disability insurance
                    allowance of $10,000.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes the grant of performance stock units valued at $84,903, which is also the maximum potential value at the time of the
                    grant. The performance criteria was not met in 2020, and as a result, the performance stock units were canceled in 2020.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consisted of (i)&#160;a car allowance of $12,000, (ii) $8,250 of Company 401(k) match, and (iii)&#160;a life and disability insurance
                    allowance of $10,000.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes the grant of performance stock units valued at $28,620, which is also the maximum potential value at the time of the
                    grant. The performance criteria was met in 2021 for half of the performance stock units, and as a result, half of the performance stock units valued at $14,310 were canceled in 2021.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consisted of $8,250 of Company 401(k) match.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes the grant of performance stock units valued at $41,363, which is also the maximum potential value at the time of the
                    grant. The performance criteria was not met in 2020, and as a result, the performance stock units were canceled in 2020.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consisted of $8,250 of Company 401(k) match.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Dr.&#160;Buck joined the Company in September 2021 and her salary represents an annual amount prorated for time in position in 2021.
                    The bonus was part of her recruitment package.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(11)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Mr.&#160;Girolamo resigned from the Company in March 2022.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;" class="h3">Caladrius Employment Agreements and Equity
            Grants</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h2">Employment Agreements and Other Arrangements with Executive Officers</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This section contains a description of the employment agreements and certain other
            arrangements that Caladrius has or had during the years ended December&#160;31, 2019 through March 2022, with the named executive officers listed in the Summary Compensation Table. All descriptions are qualified in their entirety by reference to
            such agreements. The descriptions to follow provide further information about the compensation that is shown in the Summary Compensation Table and the Grants of Plan Based Awards Table for the respective officers. They also give you information
            about payments that could be received by these officers under certain circumstances at such time as their employment with Caladrius ends, for example, certain severance arrangements.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">178<br />
        </div>

      </div>

    </div>

    <!--End Page 187-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 188-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">David J. Mazzo, Ph.D. - President and Chief
            Executive Officer</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In connection with his appointment as the Company&#8217;s Chief Executive Officer, Dr.&#160;Mazzo
            and the Company entered into an Amended and Restated Employment Agreement dated and effective as of March&#160;19, 2021, (the &#8220;Mazzo Agreement&#8221;). The Mazzo Agreement amends and restates the initial employment agreement entered into between the
            Company and Dr.&#160;Mazzo on January&#160;5, 2015, as amended on January&#160;16, 2015, July&#160;25, 2016, September&#160;18, 2017 and December&#160;6, 2018, setting forth the terms and conditions of Dr.&#160;Mazzo&#8217;s employment with the Company. Under the terms of the Mazzo
            Agreement, Dr.&#160;Mazzo received an annual base salary of $633,032 for 2021 (the &#8220;Mazzo Base Salary&#8221;) which subsequently adjustable based on the discretion of the Compensation Committee of the Caladrius Board of Directors. The Mazzo Agreement has
            an initial term expiring on December&#160;31, 2022, which shall be automatically extended for additional one-year periods, unless Dr.&#160;Mazzo is provided written notice by the Company no later than ninety (90) days prior to the expiration of the
            initial term. The Mazzo Agreement also provides Dr.&#160;Mazzo with the option to terminate his employment with the Company if: (i)&#160;the Company relocates Dr.&#160;Mazzo&#8217;s principal place of employment, without Dr.&#160;Mazzo&#8217;s consent, in a manner than
            lengthens his one-way commute distance by fifty (50) miles or more, and/or (ii)&#160;if Dr.&#160;Mazzo provides the Company with thirty (30) days&#8217; prior written notice.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Mazzo Agreement provides Dr.&#160;Mazzo with certain benefits, including but not limited
            to: (i)&#160;twenty-nine (29)&#160;days paid time off, (ii)&#160;severance payments and Consolidated Omnibus Budget Reconciliation Act (&#8220;COBRA&#8221;) medical and dental insurance for fifteen (15) months following a termination of his employment with the Company,
            and (iii)&#160;bonus payments equal to 125% of his target bonus (which is 55% of the Mazzo Base Salary), without proration, upon termination of his employment with the Company. The Mazzo Agreement is also governed by New Jersey law, to remain
            consistent with the Company&#8217;s principal place of business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Effective September&#160;18, 2017, the Caladrius Board of Directors approved an amendment to
            the Mazzo Agreement, which provides that upon the occurrence of the events in connection with a Change of Control&#160;(as&#160;described in the amendment), Dr.&#160;Mazzo shall instead receive (i)&#160;payment of his salary as then in effect through the
            eighteen-month anniversary of the termination date of the Mazzo Agreement and (ii)&#160;a lump sum payment equal to 1.5 times his target bonus as then in effect. The Amendment also provides for the continuation of Dr.&#160;Mazzo&#8217;s benefits for a period
            of eighteen months from the termination date, instead of the fifteen month period previously provided for in the Mazzo Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Kristen K. Buck, M.D. - Executive Vice President
            R&amp;D and Chief Medical Officer</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In connection with her appointment as Executive Vice President, R&amp;D and Chief
            Medical Officer, Dr.&#160;Buck and the Company entered into an Employment Agreement dated and effective as of July&#160;26, 2021 (the &#8220;Buck Agreement&#8221;), setting forth the terms and conditions of Dr.&#160;Buck&#8217;s employment with the Company. Under the terms of
            the Buck Agreement, Dr.&#160;Buck received an annual base salary of $550,000 for 2021 (&#8220;Base Salary&#8221;) which is subsequently adjustable based on the discretion of the Compensation Committee of the Caladrius Board of Directors. The Buck Agreement has
            an initial term expiring on September&#160;1, 2024, which shall be automatically extended for additional one-year periods unless Dr.&#160;Buck is provided written notice by the Company no later than ninety (90) days prior to the expiration of the initial
            term. In connection with her hire, Dr.&#160;Buck was granted options to purchase $1,000,000 of common stock and restricted stock awards with a value of $400,000, both of which vest in three equal annual installments starting on September&#160;1, 2021 in
            addition to annual bonus set at 50% of her Base Salary.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Buck Agreement provides Dr.&#160;Buck with certain benefits, including but not limited
            to: (i)&#160;twenty-nine&#160;(29)&#160;days paid time off, (ii)&#160;severance payments and COBRA medical and dental insurance for twelve (12)&#160;months following a termination of her employment with the Company without Cause or for Good Reason (each as defined in
            the Buck Agreement), and (iii)&#160;bonus payments equal to 100% of her target bonus (which is 50%&#160;of her Base Salary) prorated for the number of days employed in the calendar year upon termination of her employment with the Company and provide that
            the time period for the exercise of option equity awards shall be extended for a period equal to the shorter of one year following the termination date or the remaining term of the award. The Buck Agreement is also governed by New Jersey law,
            to remain consistent with the Company&#8217;s principal place of business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Buck Agreement provides that upon the occurrence of the events in connection with a
            Change of Control (as described in the agreement), Dr.&#160;Buck shall instead receive (i)&#160;payment of her salary as then in effect through the fifteenth-month anniversary of the termination date of the Buck Agreement and (ii)&#160;a lump sum payment
            equal to </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">179<br />
        </div>

      </div>

    </div>

    <!--End Page 188-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 189-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">125% of her target bonus as then in effect. The amendment also provides for the
            continuation of Dr.&#160;Buck&#8217;s benefits for a period of fifteen months from the termination date, the vesting of all outstanding unvested time-based equity awards and provide that the time period for the exercise of option equity awards shall be
            extended for a period equal to the shorter of one year following the termination date or the remaining term of the award.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Todd C. Girolamo, J.D., M.B.A. - Former Chief
            Legal Officer and Corporate Secretary</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Mr.&#160;Girolamo and the Company entered into a Change of Control Agreement (the &#8220;Girolamo
            Agreement&#8221;) dated and effective as of July&#160;25, 2016. The Girolamo Agreement provides that upon the occurrence of the events in connection with a Change of Control (as described in the agreement), Mr.&#160;Girolamo shall instead receive (i)&#160;payment
            of his salary as then in effect through the twelve-month anniversary of the termination date of the Girolamo Agreement and (ii)&#160;a lump sum payment equal to 100% of his target bonus as then in effect, and (iii)&#160;the continuation of his benefits
            for a period of twelve months from the termination date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Indemnification Agreements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We enter into indemnification agreements with each of our executive officers and each
            of our directors from time to time pursuant to which we have agreed to indemnify such party to the full extent permitted by law, subject to certain exceptions, if such party becomes subject to an action because such party is our director,
            officer, employee, agent or fiduciary.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h3">Acceleration of Vesting Under Equity
            Compensation Plans</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Generally, in the event of a Change in Control of Caladrius (as defined in the 2009
            Plan, the 2015 Plan and the Plan) and either (i)&#160;the failure of Caladrius&#8217; successor to assume a participant&#8217;s awards or (ii)&#160;such assumption of awards is followed by the participant&#8217;s termination without cause on or within the one-year period
            following the Change in Control, (a) all outstanding options and stock appreciation rights of each participant granted prior to the change in control shall be fully vested and immediately exercisable in their entirety, and (b) all unvested
            stock awards, restricted stock units, restricted stock, performance-based awards, and other awards shall become fully vested, including without limitation, the following: (i)&#160;the restrictions to which any shares of restricted stock granted
            prior to the change in control are subject shall lapse as if the applicable restriction period had ended upon such change in control, and (ii)&#160;the conditions required for vesting of any unvested performance-based awards shall be deemed to be
            satisfied upon such change in control.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h3">Termination or Change in Control Payments</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth aggregate estimated payment obligations to each of the
            named executive officers assuming a termination occurred on December&#160;31, 2021 under the circumstances specified below:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Benefit</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Before Change in <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Control Termination <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">w/o Cause or for Good <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Reason <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">($)</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">After Change in <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Control Termination <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">w/o Cause or for Good <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Reason <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">($)</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Voluntary <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Termination <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">($)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="4" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Severance</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara">1,226,500</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara">1,471,799</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Health Benefits</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">43,473</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">52,168</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Equity Award Acceleration</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 40pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 40pt;">104,160</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Total</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,269,973</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,628,127</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 5.25pt; padding-bottom: 3pt;" rowspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen Buck</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" rowspan="4" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Severance</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">825,000</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara">1,031,250</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Health Benefits</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">17,652</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">22,064</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Equity Award Acceleration</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 40pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 40pt;">175,875</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Total</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 3pt double #000000; min-width: 40pt;">842,652</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,229,189</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Todd Girolamo</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="4" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Severance</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 30pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">514,360</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Health Benefits</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 30pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">44,595</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Equity Award Acceleration</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 30pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">33,390</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 23.42%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Total</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.03%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 3pt double #000000; min-width: 40pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 17.02%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.84pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 3pt double #000000; min-width: 40pt;">592,345</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.05%; text-align: center; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.19pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">180<br />
        </div>

      </div>

    </div>

    <!--End Page 189-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 190-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth information on option awards outstanding at December&#160;31,
            2021 for Caladrius&#8217; named executive officers.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Securities <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Underlying <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Unexercised <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options (#) <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercisable</div>
                </td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Securities <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Underlying <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Unexercised <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options (#) <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Unexercisable</div>
                </td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Price**</div>
                </td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Expiration <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Date</div>
                </td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">shares or units of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">stock that have <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">not vested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(#)</div>
                </td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Market value of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">shares or units of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">stock that have <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">not vested <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">$(***)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="8">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="8" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.43pt;">40,000</span><sup>(1)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$35.00</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">1/5/2025</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.44pt;">35,000</span><sup>(2)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">6.30</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">1/25/2026</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.43pt;">50,919</span><sup>(3)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">4.77</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">9/29/2026</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.44pt;">50,000</span><sup>(4)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">3.54</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">1/9/2027</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.43pt;">50,000</span><sup>(5)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">3.79</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">1/8/2028</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.44pt;">53,250</span><sup>(6)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 4.81pt;">17,750</span><span style="padding-left: 0.2pt;"><sup>(6)</sup></span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">4.95</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">1/14/2029</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.43pt;">34,500</span><sup>(7)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">34,500</span><span style="padding-left: 0.2pt;"><sup>(7)</sup></span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">3.28</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">1/13/2030</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.44pt;">15,000</span><sup>(8)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 4.81pt;">45,000</span><span style="padding-left: 0.2pt;"><sup>(8)</sup></span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">1.59</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 0.37pt;">1/11/2031</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara">124,000</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara">$104,160</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen Buck</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara">375,511<sup>(9)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara">762,404<span style="padding-left: 0.2pt;"><sup>(9)</sup></span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">1.28</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">9/1/2031</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara">209,375</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara">$175,875</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="15">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Todd Girolamo</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="15" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 16.35pt;">750</span><sup>(10)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$52.00</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">1/4/2022</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.24pt;">1,251</span><sup>(11)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$62.00</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">1/2/2023</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.24pt;">2,500</span><sup>(12)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$77.70</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">1/2/2024</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.24pt;">2,500</span><sup>(13)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$62.10</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">8/1/2024</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.24pt;">2,752</span><sup>(14)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$38.70</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2/17/2025</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.24pt;">2,000</span><sup>(15)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$22.60</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">6/2/2025</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.24pt;">5,000</span><sup>(16)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">6.30</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">1/25/2026</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.43pt;">12,103</span><sup>(17)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">4.77</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">9/29/2026</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.44pt;">15,000</span><sup>(18)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">3.54</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">1/9/2027</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.43pt;">20,000</span><sup>(19)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 21.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">3.79</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">1/8/2028</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.44pt;">18,000</span><sup>(20)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 9.61pt;">6,000</span><span style="padding-left: 0.2pt;"><sup>(20)</sup></span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">4.95</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">1/14/2029</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 4.43pt;">14,500</span><sup>(21)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 4.8pt;">14,500</span><span style="padding-left: 0.2pt;"><sup>(21)</sup></span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">3.28</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">1/13/2030</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.24pt;">4,500</span><sup>(22)</sup></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"><span style="padding-left: 4.81pt;">13,500</span><span style="padding-left: 0.2pt;"><sup>(22)</sup></span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">1.59</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 0.37pt;">1/11/2031</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.43pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.27pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.14%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.11pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.33%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.64pt; text-align: left;" class="fpara"><span style="padding-left: 4.81pt;">39,750</span></div>
                </td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.45%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.23pt; text-align: left;" class="fpara">$<span style="padding-left: 4.8pt;">33,390</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">**<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">All option awards were made under and are governed by the terms of the Company&#8217;s 2003 Equity Participation Plan, the 2009 Plan,
                    the 2015 Plan or the Plan.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">***<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Calculated by multiplying the closing market price of Caladrius Common Stock on December&#160;31, 2021 by the number of shares of
                    restricted stock held by the applicable Named Executive Officer.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Mazzo pursuant to the terms of his employment agreement dated as of January&#160;5, 2015 and
                    amended on January&#160;16, 2015.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Mazzo by the Compensation Committee on January&#160;25, 2016.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Mazzo by the Compensation Committee on September&#160;29, 2016.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Mazzo by the Compensation Committee on January&#160;9, 2017.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Mazzo by the Compensation Committee on January&#160;8, 2018.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Mazzo by the Compensation Committee on January&#160;14, 2019.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Mazzo by the Compensation Committee on January&#160;13, 2020.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Mazzo by the Compensation Committee on January&#160;11, 2021.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Dr.&#160;Buck by the Compensation Committee on July&#160;27, 2021.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;4, 2012.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(11)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;2, 2013.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(12)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;2, 2014.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(13)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo effective on August&#160;1, 2014, all of which are vested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(14)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on February&#160;17, 2015.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">181<br />
        </div>

      </div>

    </div>

    <!--End Page 190-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 191-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 5.25pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(15)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on June&#160;2, 2015.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(16)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;25, 2016.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(17)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on September&#160;29, 2016.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(18)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;9, 2017.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(19)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;8, 2018.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(20)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;14, 2019.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(21)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;13, 2020.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(22)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of options granted to Mr.&#160;Girolamo by the Compensation Committee on January&#160;11, 2021.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2">Pension Benefits</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">We do not have any qualified or non-qualified defined benefit plans.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Non-qualified Deferred Compensation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">We do not have any non-qualified defined contribution plans or other deferred
            compensation plans.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Incentive Compensation Recoupment Policy</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On December&#160;5, 2017, the Company adopted an Incentive Compensation Recoupment Policy
            (the &#8220;Policy&#8221;) that applies to an employee of the Company who is serving as an &#8220;officer&#8221; within the meaning of Rule 16a-1(f) under the Exchange Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Compensation Committee of the Caladrius Board of Directors may seek recoupment of
            any payment deemed recoverable under the Policy (a &#8220;Recoverable Payment&#8221;), when in its judgment, after reviewing relevant facts and circumstances, it determines that: (a) an executive (i)&#160;engaged in serious misconduct, or (ii)&#160;failed to
            supervise a subordinate employee who engaged in serious misconduct which the executive knew, or was reckless in not knowing, was occurring, and (b) such misconduct resulted in a material violation of law or a written Company policy that caused
            significant financial or reputational harm to the Company. As used in this Policy, &#8220;serious misconduct&#8221; may be only found to have occurred where an executive or a supervised employee acted knowingly, intentionally, or recklessly in violating a
            law or written Company policy. For the avoidance of doubt, an executive&#8217;s business judgment made in good faith and in the reasonable belief that such judgments and related actions were in or not opposed to the best interests of the Company
            shall not subject the executive&#8217;s Incentive Compensation to recoupment.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">&#8220;Incentive Compensation&#8221; means (i)&#160;any equity or equity-based award granted on or after
            the effective date of the Policy, and (ii)&#160;any cash-based performance or incentive award (i.e., bonus or cash incentive plan payment, including any amounts deferred with respect thereto) made to an executive with respect to the Company&#8217;s 2019
            fiscal year or any subsequent fiscal year.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The determination by the Compensation Committee whether and the extent to which to seek
            recoupment may be influenced by a variety of factors, including, but not limited to, (i)&#160;the elements of the compensation received by the executive, (ii)&#160;retention, promotion, or succession planning considerations, (iii)&#160;pay equity factors,
            (iv)&#160;whether the underlying conduct was an isolated occurrence, (v)&#160;feasibility and cost of implementation, (vi)&#160;legal and compliance factors, (vii)&#160;whether other disciplinary actions have been taken against the executive, and (viii)&#160;the
            objective of administering the Policy in a way that does not discourage settlement of disputes when settlements are in the best long-term interests of the Company and its stockholders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Based on the facts and circumstances, the Compensation Committee may decide on the
            appropriate recoupment method, including whether to seek recoupment of Recoverable Payments already paid or otherwise seek recoupment (totally or partially) of Recoverable Payments that have not vested or have not been paid. However, the
            Compensation Committee may not seek recoupment of any Recoverable Payments (a) following a change in control (as defined in the executive&#8217;s employment agreement) or (b) that were awarded more than three years prior to the first event giving
            rise to the recoupment. This Policy shall operate prospectively from the effective date of the Policy and shall be construed so as not to violate any legally binding commitment of the Company arising prior to the effective date of the Policy.
            Recoupment determinations pursuant to this Policy shall only be made to the extent permitted by law, and this Policy shall be interpreted so as not to violate any law or regulation.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">182<br />
        </div>

      </div>

    </div>

    <!--End Page 191-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 192-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCEND"><!--Anchor--></a>CEND EXECUTIVE COMPENSATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s named executive officers, consisting of its principal executive officer and the
            next two highly compensated executive offers, for the fiscal year ended December&#160;31, 2021 were: </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 71.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Title </div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack, MBA</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President &amp; Chief Executive Officer</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Harri J&#228;rvel&#228;inen</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Chief Operating Officer</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Andy Dorr</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Chief Medical Officer</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h2">Summary Compensation Table </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth the total compensation paid or accrued during the last
            two fiscal years with respect to (i)&#160;our President and Chief Executive Officer, (ii)&#160;our two other most highly compensated executive officers, who each earned more than $100,000 during the fiscal year ended December&#160;31, 2021, and were serving
            as executive officers as of such date.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 33.33%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name and Principal Position</div>
                </td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year</div>
                </td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Salary</div>
                </td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Bonus<sup>(1)</sup></div>
                </td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Awards<sup>(2)</sup></div>
                </td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">All other <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Compensation</div>
                </td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 33.33%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Named Executive Officers and Directors</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack MBA <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><span style="font-style: italic;">President and Chief Executive Officer</span><br />
                  </div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2021</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$429,609<sup>(5)</sup></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">61,708</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.91pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$491,317</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2020</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$176,309</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$542,692</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.91pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$719,001</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Harri J&#228;rvel&#228;inen <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><span style="font-style: italic;">Chief Operating Officer</span><br />
                  </div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2021</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$336,818</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$162,958</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.91pt; text-align: left;" class="fpara">10,000<sup>(3)</sup></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$509,776</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2020</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$223,959<sup>(6)</sup></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">47,503</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.91pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">8,000</span><sup>(4)</sup></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$279,462</div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.33%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">F. Andrew Dorr <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><span style="font-style: italic;">Chief Medical Officer</span><br />
                  </div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2021</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$133,200</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$101,918</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 0.37pt;">235,118</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.27%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara">2020</div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.91pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: top; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Amounts reflect discretionary bonuses for all named executive officers. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The amounts in this column represent the aggregate grant-date fair value of stock option granted to each named executive officer,
                    computed in accordance with FASB ASC Topic 718. See Note 9 to the Notes to the Consolidated Financial Statements in our 2021 Form 10-K for a discussion of assumptions made in such valuations. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Reflects the amount contributed to Mr.&#160;Jarvelainen&#8217;s 401(k) retirement account. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Reflects the amount contributed to Mr. Jarvelainen&#8217;s 401(k) retirement account. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This amount includes (i) $91,827 paid to Mr.&#160;Slack for his services as a Director, as an independent contractor, from January&#160;1,
                    2021 to March&#160;28, 2021 and (ii) 337,782 after he was hired as Cend&#8217;s President and Chief Executive Officer. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This amount includes (i) $66,666 ($33,333 per month) paid pursuant to for services provided as an independent contractor on a
                    temporary basis prior to entering into the Cend USA Employment Agreement (as defined below), (ii) $125,333 paid pursuant to the Cend USA Employment Agreement, and (iii) $31,960 paid pursuant to the Cend Australia Employment Agreement
                    (as defined below). </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">183<br />
        </div>

      </div>

    </div>

    <!--End Page 192-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 193-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Outstanding equity awards as of December&#160;31,
            2021 </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth certain information about outstanding equity awards
            granted to Cend&#8217;s named executive officers that remain outstanding as of December&#160;31, 2021. </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 53.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="13">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option awards<sup>(1)</sup> </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Grant date</div>
                </td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">securities <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">underlying <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">unexrecised <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">options (#) <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">exercisable</div>
                </td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">securities <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">underlying <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">unexercised <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">options (#) <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">unexercisable</div>
                </td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">price ($)</div>
                </td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">expiration <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">date </div>
                </td>

  </tr>

  <tr>

    <td style="width: 43.59%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">F. Andrew Dorr</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/15/2021</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">44,000</span><sup>(2)</sup></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">27,500</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.9pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">3.82</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">12/15/2031</div>
                </td>

  </tr>

  <tr>

    <td style="width: 43.59%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack MBA</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/03/2019</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">20,000</span><sup>(3)</sup></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.9pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">2.25</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">12/03/2029</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/29/2020</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;" class="fpara">457,500<sup>(4)</sup></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;" class="fpara">285,938</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.9pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1.92</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">12/29/2030</div>
                </td>

  </tr>

  <tr>

    <td style="width: 43.59%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Harri J&#228;rvel&#228;inen</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" rowspan="4" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">10/20/2017</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;" class="fpara">189,604<sup>(5)</sup></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.9pt; text-align: left;" class="fpara">0.9993</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">10/20/2027</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">10/20/2017</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;" class="fpara">134,414<sup>(6)</sup></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.9pt; text-align: left;" class="fpara">0.9993</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">10/20/2027</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">04/08/2019</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;" class="fpara">250,000<sup>(7)</sup></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.9pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">2.25</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">04/08/2029</div>
                </td>

  </tr>

  <tr>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12/30/2020</div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">40,000</span><sup>(8)</sup></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">5,000</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.9pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1.92</span></div>
                </td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.21%; border-bottom: none; font-size: 2pt; padding-top: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">12/30/2030</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 10.75pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">All of the option awards listed in the table above were granted under the 2016 Plan the terms of which are described below under
                    &#8220;<span style="font-style: italic;">&#8212;Equity incentive plans</span>.&#8221; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Twelve and one-half percent (12.5%) of the shares underlying the Cend Options (the &#8220;Option Shares&#8221;) will be vested and
                    exercisable upon the last day of each three-month period following March&#160;11, 2021, such that 100% of the Option Shares will be vested and exercisable upon the second (2<sup>th</sup>) anniversary of the Vesting Commencement Date; <span style="font-style: italic;">provided, however</span>, that there has not been a Termination of Service (as defined in the Plan), as of each such date. In no event will the Option become exercisable for any additional Option Shares
                    after a Termination of Service. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Twenty-five percent (25%) of the Option Shares vested on the last day of each three-month period following the Vesting
                    Commencement Date which was October&#160;1, 2019 such that all of the Option Shares were vested on the one-year anniversary of the vesting commencement date. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Twenty-five percent (25%) of the Option Shares shall vest and become exercisable upon the one (1) year anniversary of the
                      Vesting Commencement Date which was June 4, 2020; and (iii) the remaining Option Shares will vest and become exercisable in a series of thirty-six&#160;(36) successive equal monthly installments, rounded downward to the nearest whole
                      share, measured from the first (1st) anniversary of the vesting commencement date, such that 100% of the Option Shares will be vested and exercisable upon the fourth (4th) anniversary of the Vesting Commencement Date; provided,
                      however, that there has not been a Termination of Service, as of each such date. In no event will the Option become exercisable for any additional Option Shares after a Termination of Service. However, in the event of an Involuntary
                      Termination (defined in the 2016 Plan, as amended) which results in Optionee&#8217;s Termination of Service, within twelve (12) months following a Change in Control (as defined in the 2016 Plan, as amended), the vesting of this Option, the
                      new option or other similar incentives replacing this Option, as applicable, shall accelerate in full automatically effective upon such Involuntary Termination.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Thirty-three percent (33%) of the Option Shares will be vested and exercisable upon the six (6) month, twelve (12) month, and
                    eighteen (18) month anniversaries of the Vesting Commencement Date which is July&#160;15, 2017, such that 100% of the Option Shares will be vested and exercisable upon the eighteenth (18th) month anniversary of the Vesting Commencement Date;
                    provided, however, that there has not been a Termination of Service (as defined in the Plan), as of each such date. In no event will the Option become exercisable for any additional Option Shares after a Termination of Service. In the
                    event of a Change in Control of the Company, the vesting of the Option shall accelerate, with respect to 100% of the Option Shares and such Option Shares shall immediately become fully exercisable, provided that there has not been a
                    Termination of Service as of the time of the consummation of such Change in Control.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Thirty-three percent (33%) of the Option Shares will be vested and exercisable upon the Company having a U.S. (or comparable
                    country) IND application granted; (iii)&#160;thirty-three percent (33%) of the Option Shares will be vested and exercisable upon the Company initiating a Phase I clinical trial; and (iv)&#160;thirty-three percent (33%) of the Option Shares became
                    vested and exercisable upon the Company completing a Phase I clinical trial; <span style="font-style: italic;">provided, however</span>, that there has not been a Termination of Service (as defined in the Plan), as of each such date.
                    In no event will the Option become exercisable for any additional Option Shares after a Termination of Service. In the event of a Change in Control of the Company, the vesting of the Option shall accelerate, with respect to 100% of the
                    Option Shares and such Option Shares shall immediately become fully exercisable, provided that there has not been a Termination of Service as of the time of the consummation of such Change in Control. As of the date of this proxy
                    statement/prospectus/information statement, all options have vested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Twelve and one-half percent (12.5%) of the Option Shares shall vest and become exercisable on the last day of each three-month
                    period following the Vesting Commencement Date which January&#160;16, 2019 such that all of the Option Shares shall be vested on the two (2) year anniversary of the Vesting Commencement Date; <span style="font-style: italic;">provided,
                      however</span>, that there has not been a Termination of Service (as defined in the 2016 Plan), as of each such date. In no event will the Option become exercisable for any additional Option Shares after a Termination of Service. In
                    the event of a Change in Control of the Company, the vesting of the Option shall accelerate with respect to 100% of the Option Shares and such Option Shares shall immediately become fully exercisable, provided there has not been a
                    Termination of Service as of the consummation of such Change in Control.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Twelve and one-half percent (12.5%) of the Option Shares will be vested and exercisable upon the last day of each three-month
                    period following the Vesting Commencement Date which was January&#160;17, 2020, such that 100% of the Option Shares will be vested and exercisable upon the second anniversary of the Vesting Commencement Date; <span style="font-style: italic;">provided, however</span>, that there has not been a Termination of Service (as defined in the Plan) as of each such date. In no event will the Option become exercisable for any additional Option Shares after a Termination of
                    Service.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">184<br />
        </div>

      </div>

    </div>

    <!--End Page 193-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 194-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">See &#8220;&#8212;Potential payments upon termination or change of control&#8221; for a description of
            vesting acceleration applicable to stock options held by Cend&#8217;s named executive officers. Cend may in the future, on an annual basis or otherwise, grant additional equity awards to Cend&#8217;s executive officers pursuant to its 2016 Plan, the terms
            of which are described below under &#8220;<span style="font-style: italic;">&#8212;Equity incentive plans</span>.&#8221; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Nonqualified deferred compensation </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">None of Cend&#8217;s named executive officers for the fiscal year ended December&#160;31, 2021
            participated in or have account balances in nonqualified defined contribution plans or other nonqualified deferred compensation plans maintained by Cend. The Cend Board of Directors may elect to provide Cend&#8217;s officers and other employees with
            nonqualified defined contribution or other nonqualified deferred compensation benefits in the future if it determines that doing so is in Cend&#8217;s best interests. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Pension Benefits</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Cend does not have any qualified or non-qualified defined benefit plans.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Employment arrangements </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Below is a description of Cend&#8217;s employment arrangements with each of Cend&#8217;s named
            executive officers for the fiscal year ended December&#160;31, 2021. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack, MBA.<span style="font-style: normal;"> Cend entered
              into an employment agreement with Mr.&#160;Slack on March&#160;29, 2021 (&#8220;Slack Employment Agreement&#8221;) setting forth the terms of his employment. Mr.&#160;Slack was entitled to annual base salary of $444,000 and is eligible to receive an annual performance
              bonus equivalent to 35% of his then current annual salary, provided he meets the annual bonus target performance expectations approved by the Cend Board of Directors, less applicable withholdings, with any such bonus to be determined at the
              sole discretion of the Cend Board of Directors. The term of the Slack Employment Agreement is 4&#160;years and continues until terminated by either party, and requires 60 days notice. It also provides for certain severance benefits, the terms of
              which are described below under &#8220;&#8212;</span>Potential payments upon termination or change of control<span style="font-style: normal;">.&#8221; </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Harri J&#228;rvel&#228;inen.<span style="font-style: normal;">
              Dr.&#160;Jarvelainen has entered into two different employment agreements. One employment agreement was entered into with DrugCendR Australia Pty Ltd., dated July&#160;18, 2020 (&#8220;Cend Australia Employment Agreement&#8221;), appointing Dr.&#160;Jarvelainen as
              President; his services commenced October&#160;1, 2020, contingent upon the happening of certain events as described therein. Dr.&#160;Jarvelainen was entitled to an annual salary of AUS$284,200, an allowance of AUS$650 per month for health insurance,
              superannuation contributions of nine percent (9%) of Dr.&#160;Jarvelainen&#8217;s salary, which were contributed by DrugCendR Australia Pty Ltd. into the superannuation fund, as nominated by Dr.&#160;Jarvelainen, and those additional benefits as provided by
              the National Employment Standards (&#8220;NSE&#8221;) and further described therein. The term of the Cend Australia Employment Agreement was one year, and was set to expire on October&#160;1, 2021, unless otherwise extended with a contract amendment or
              terminated. Subject to the requirements as provided by the NSE, termination may occur either by: (1) termination based on the specified grounds as described in the initial Cend Australia Employment Agreement whereby the employer shall provide
              three (3) months&#8217; notice or pay in lieu of notice; (2) termination in the event of serious misconduct without notice or pay; or (3) Dr.&#160;Jarvelainen providing his voluntary resignation with at least one months&#8217; notice. On January&#160;22, 2021 the
              Cend Australia Employment Agreement was amended to increase the rate to AUD$378,933 per year effective January&#160;1, 2021. On March&#160;3, 2021, the Cend Australia Employment Agreement was amended to increase the rate to AUD$473,667. On September&#160;8,
              2021, the Cend Australia Employment Agreement was amended to extend the term of Dr.&#160;Jarvelainen&#8217;s employment through December&#160;31, 2022 and increase the allowance for health insurance to AUS$251 per week (the &#8220;Third Australia Amendment&#8221;). All
              other terms of the Cend Australia Employment Agreement remain in place. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On October&#160;1, 2018, Dr.&#160;Jarvelainen entered into an Executive Employment Agreement with
            Cend (&#8220;Cend USA Employment Agreement&#8221;). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;1, 2021 Dr.&#160;Jarvelainen entered into the First Amendment to the Executive
            Employment Agreement in which Mr.&#160;Jarvelainen&#8217;s salary was increased to $333,333 per year, as to be reviewed and adjusted from time to time. All other terms of the initial USA Employment Agreement remain in place.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">F. Andrew Dorr, M.D<span style="font-style: normal;">. Cend entered
              into an initial consulting agreement with Mr.&#160;F. Andrew Dorr on March&#160;3, 2020 setting forth the terms of his consulting arrangement (&#8220;Initial Dorr Consulting Agreement&#8221;). Pursuant to </span></div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">185<br />
        </div>

      </div>

    </div>

    <!--End Page 194-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 195-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the Initial Dorr Consulting Agreement, Mr.&#160;Dorr was to serve as the Chief Medical
              Officer and was entitled to receive an hourly fee of $450.00 per hour, exclusive of travel time, payable monthly. Additionally, Mr.&#160;Dorr was entitled to receive reimbursement for certain expenses, including reasonable telephone expenses, long
              distance coach (or equivalent) travel within the continental US, including lodging, transportation, and meals, and business class for international travel, payable 30 days thereafter as provided by the Initial Dorr Consulting Agreement. The
              term of the Initial Dorr Consulting Agreement was indefinite, until terminated by either party, of which can occur by either party providing ten (10) days&#8217; notice following a breach of a material provision of the Initial Dorr Consulting
              Agreement, unless such breach is cured during such ten (10) day period. Alternatively, Cend may terminate for any reason, with or without cause, by providing fifteen (15) days&#8217; notice. If such termination is without cause, then Cend shall pay
              Mr.&#160;Dorr all unpaid and undisputed amounts due for the consulting services provided by the Initial Dorr Consulting Agreement. Furthermore, as of March&#160;11, 2021, the Initial Dorr Consulting Agreement was amended (&#8220;Dorr Amendment&#8221;) to extend
              the Initial Dorr Consulting Agreement through February&#160;22, 2022, unless further modified or extended. The Dorr Amendment further updated the scope of services to be provided by Mr.&#160;Dorr, and to updated the fees and expenses to be paid to
              Mr.&#160;Dorr. Particularly, pursuant to the Dorr Amendment, Mr.&#160;Dorr shall receive a monthly retainer of $14,000 per month, and may invoice Cend for excess hours at a rate of $450.00 per hour with travel time being payable at &#189; of the $450.00
              hourly rate. Mr.&#160;Dorr received options for 44,000 shares of common stock of Cend, 27,500 of such options have vested as of June 8, 2022, subject to non-cancellation or early termination of the Initial Dorr Consulting Agreement, as amended.
              All other terms of the Initial Dorr Consulting Agreement remain in place.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h3">Rule 10b5-1 Sales Plans </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The directors and executive officers of Cend may adopt written plans, known as Rule
            10b5-1 plans, in which they will contract with a broker to buy or sell shares of the combined organization's common stock on a periodic basis. Under a Rule 10b5-1 plan, a broker executes trades pursuant to parameters established by the director
            or executive officer when entering into the plan, without further direction from them. The director or executive officer may amend a Rule 10b5-1 plan in some circumstances and may terminate a plan at any time. Cend&#8217;s directors and executive
            officers also may buy or sell additional shares outside of a Rule 10b5-1 plan when they are not in possession of material nonpublic information subject to compliance with the terms of the combined organization's insider trading policy. Prior to
            120 days after the date of the Closing, the sale of any shares under such plan would be subject to the lock-up agreement that the director or executive officer has entered into as a condition to the Closing. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h3">Potential Payments Upon Termination or Change in
            Control </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Regardless of the manner in which a Cend named executive officer's service terminates,
            the named executive officer is entitled to receive amounts earned during his or her term of service, including salary. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack, MBA<span style="font-style: normal;">.
                Pursuant to his employment agreement dated March&#160;29, 2021, in the event Mr.&#160;Slack is terminated for good cause, he shall receive regular wages through the termination date. No other severance compensation is payable when he
                is terminated for good cause. In the event Mr.&#160;Slack is terminated for reasons other than good cause, after executing a release, Mr.&#160;Slack shall be entitled to (i)&#160;eight months compensation at his then-current annual salary
                rate, (ii)&#160;pro-rated annual bonus through termination date and (iii)&#160;Cend will continue to pay the premiums for Mr.&#160;Slack&#8217;s health insurance for eight months (or reimbursement for same) for COBRA
                coverage. Further, in the event Mr. Slack&#8217;s termination is an &#8220;Involuntary Termination&#8221; (as defined in the First Amendment to Stock Option Grant Notice dated July 1, 2022) and occurs within twelve months following a
                &#8220;Change in Control&#8221; (as defined in Cend's 2016 Plan) the vesting of options granted to Mr.&#160;Slack shall accelerate in full automatically effective upon such Involuntary Termination. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Equity Incentive Plans </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">2016 Equity Incentive Plan </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend Board of Directors and stockholders approved the Cend 2016 Equity Incentive
              Plan (the &#8220;Cend Plan&#8221;) on September&#160;14, 2016 and amendments to the Cend Plan were approved by the Cend Board of Directors and stockholders on October 18, 2017, March 3, 2018, August 31, 2019, August 18, 2020, December 30, 2020 and July&#160;1,
              2022. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">186<br />
        </div>

      </div>

    </div>

    <!--End Page 195-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 196-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Stock Awards.<span style="font-style: normal;"> The Cend Plan provides for the grant of (i)&#160;incentive stock options, (ii)&#160;nonstatutory stock options, (iii)&#160;stock bonuses, and (iv)&#160;rights to acquire restricted stock. Incentive stock options may be granted only to employees. Other
              awards may be granted to employees, including officers, and to non-employee directors and consultants. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.19pt;" class="fpara">Share Reserve.<span style="font-style: normal;"> The aggregate number of shares of Cend&#8217;s common stock that may be issued pursuant to awards under the Cend Plan is 3,217,700 shares. The maximum number of shares that may be issued upon the exercise of incentive stock options under
              the Cend Plan is 3,217,700 shares. If an award granted under the Cend Plan expires or otherwise terminates without being exercised in full, or if shares of stock still subject to restrictions are repurchased by Cend, the shares will become
              available for subsequent issuance under the Cend Plan. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Administration.<span style="font-style: normal;"> The Cend Board of Directors, or a duly authorized committee thereof, has the authority to administer the Cend Plan. Subject to the terms of the Cend Plan, the Cend Board of Directors or the authorized committee, referred to as the
              plan administrator, determines recipients, dates of grant, the numbers and types of stock awards to be granted and the terms and conditions of the stock awards, including the period of their exercisability and vesting schedule applicable to a
              stock award. Subject to the limitations set forth below, the plan administrator will also determine the exercise price, strike price or purchase price of awards granted and the types of consideration to be paid for the award. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Stock Options.<span style="font-style: normal;"> Incentive and nonstatutory stock options are evidenced by stock option agreements adopted by the plan administrator. The plan administrator determines the exercise price for a stock option, within the terms and conditions of the
              Cend Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of Cend&#8217;s common stock on the date of grant, however the Cend Board of Directors shall determine the exercise price of
              each nonstatutory stock option. Options granted under the Cend Plan vest at the rate specified by the plan administrator. Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined
              by the plan administrator and may include, without limitation, (1) cash, check, (2) shares acquired directly from Cend that have been held by the optionholder for at least six months and whose fair market value is equal to the aggregate
              exercise price of the shares to be purchased, (3) a cashless exercise program as established by Cend and (4) any combination of the foregoing. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Restricted Stock Purchase Awards.<span style="font-style: normal;"> Stock purchase rights represent the right to acquire Cend Common Stock. The plan administrator determines the number of award shares and the price to be paid. Cend has the right to repurchase the award shares upon
              the participant's termination of employment for the price paid by the participant. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Transferability.<span style="font-style: normal;"> Unless the plan administrator provides otherwise, awards generally are not transferable except by will, the laws of descent and distribution, or pursuant to a domestic relations order. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Changes to Capital Structure.<span style="font-style: normal;"> In the event that there is a specified type of change in Cend&#8217;s capital structure, such as a stock split or recapitalization, appropriate adjustments will be made to (1) the class and maximum number of shares
              reserved for issuance under the Cend Plan and (2) the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Corporate Transactions.<span style="font-style: normal;"> In the event of certain specified significant corporate transactions, awards will vest in full if not assumed or substituted. Under the Cend Plan, a significant corporate transaction is generally the consummation




                of (1) a sale or other disposition of all or substantially all of Cend&#8217;s consolidated assets, (2) a sale or other disposition of at least 50% of Cend&#8217;s outstanding securities, (3) a merger or consolidation immediately
              after which Cend&#8217;s stockholders cease to own more than 50% of the combined voting power of the surviving entity, or a merger with or into another corporation, or the Merger. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Amendment and Termination.<span style="font-style: normal;"> The Cend Board of Directors has the authority to amend, suspend, or terminate the Cend Plan, provided that such action does not materially impair the existing rights of any participant without such participant's
              written consent and provided further that certain types of amendments will require the approval of Cend&#8217;s stockholders. </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.2pt; margin-left: 0pt; text-align: left;" class="h2">401(k) Plan </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">Cend does not currently prove a 401(k) plan to it employees. In
            2020 Cend had adopted a 401(k) for a very limited purpose with limited eligibility. That plan is no longer active. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.7pt; margin-left: 0pt; text-align: left;" class="h2">Health and Welfare Benefits </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.2pt;" class="fpara">All of Cend&#8217;s full-time employees and certain of Cend&#8217;s part-time
            employees are eligible to participate in Cend&#8217;s employee benefit plans, including Cend&#8217;s medical, dental, life and disability insurance plans, in each case on the same basis as all of Cend&#8217;s other employees. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">187<br />
        </div>

      </div>

    </div>

    <!--End Page 196-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 197-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_113-executive_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCENDDC"><!--Anchor--></a>CEND DIRECTOR COMPENSATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h3">Director Compensation </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The following table sets forth information regarding compensation
              earned by or paid to Cend&#8217;s directors during the fiscal year ended December&#160;31, 2021.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Fees Earned or <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Paid in Cash</div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Awards</div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Option <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Awards</div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Other <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Compensation</div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Erkki Ruoslahti, MD, PhD<sup>(1)</sup></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.9pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">50,000</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.16pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">50,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack, MBA<sup>(2)</sup></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.9pt; text-align: left;" class="fpara">$491,317</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.16pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$491,317</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">James Xiao, EMBA<sup>(3)</sup></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.9pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.16pt; text-align: left;" class="fpara">$&#8212;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Heidi Henson, CPA, CFO<sup>(4)</sup></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.9pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.16pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mike Sailor, PhD<sup>(5)</sup></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.9pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.54pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.54%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.16pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As of December&#160;31, 2021, Dr.&#160;Ruoslahti held 308,727 vested shares of common stock that underlying stock options granted to
                    Dr.&#160;Ruoslahti. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As of December&#160;31, 2021, Mr.&#160;Slack held 477,500 shares of common stock that underlying stock options granted to Mr.&#160;Slack;
                      285,938&#160;of which are unvested.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As of December&#160;31, 2021, Mr.&#160;Xiao held 40,000 vested shares of common stock that underlying stock options granted to Mr.&#160;Xiao. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As of December&#160;31, 2021, Ms.&#160;Henson held 40,000 vested shares of common stock that underlying stock options granted to
                    Ms.&#160;Henson. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">As of December&#160;31, 2021, Dr.&#160;Sailor held 111,000 shares of common stock that underlying stock options granted to Dr.&#160;Sailor;
                      76,313 of which are unvested. Upon the Closing, all unvested shares will accelerate and vest in full.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h3">Nonqualified deferred compensation </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">None of Cend&#8217;s directors for the fiscal year ended December&#160;31, 2021 participated in or
            have account balances in nonqualified defined contribution plans or other nonqualified deferred compensation plans maintained by Cend. The Cend Board of Directors may elect to provide Cend&#8217;s directors, officers and other employees with
            nonqualified defined contribution or other nonqualified deferred compensation benefits in the future if it determines that doing so is in Cend&#8217;s best interests. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Pension Benefits</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">Cend does not have any qualified or non-qualified defined benefit plans.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">188<br />
        </div>

      </div>

    </div>

    <!--End Page 197-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 198-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_114-prop1_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tMBS"><!--Anchor--></a><a id="tPROP1"><!--Anchor--></a>MATTERS BEING
            SUBMITTED TO A VOTE OF CALADRIUS STOCKHOLDERS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">PROPOSAL NO. 1:<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195; <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">APPROVAL OF THE MERGER AND THE ISSUANCE OF COMMON STOCK IN THE MERGER</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Annual Meeting, Caladrius Stockholders will be asked to approve the Merger and
            the issuance of Caladrius Common Stock to Cend Stockholders pursuant to the Merger Agreement. Immediately following the Merger, it is expected that Cend Stockholders will own approximately 50% of the outstanding Caladrius Common Stock, and
            Caladrius Stockholders as of immediately prior to the Merger owning approximately 50% of the outstanding Caladrius Common Stock, subject to adjustment based on the Exchange Ratio as set forth in the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Changes in the amount of Caladrius&#8217; net cash balance and the amount of any transaction
            expenses of Cend in excess of $250,000 immediately prior to the Closing could result in relative ownership percentages that are different than those described above.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The terms of, reasons for and other aspects of the Merger Agreement, the Merger and the
            issuance of Caladrius Common Stock in the Merger are described in detail in the other sections in this proxy statement/prospectus/information statement. A copy of the Merger Agreement is attached to this proxy statement/prospectus/information
            statement as <span style="font-style: italic;">Annex&#160;A</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under Nasdaq Listing Rule 5635(a)(1), a company listed on Nasdaq is required to obtain
            stockholder approval prior to the issuance of common stock, among other things, in connection with the acquisition of another company&#8217;s stock, if the number of shares of common stock to be issued is in excess of 20% of the number of shares of
            common stock then outstanding. The potential issuance of the shares of Caladrius Common Stock in the Merger exceeds the 20% under the Nasdaq Listing Rules and is expected to represent approximately 50% of Caladrius Common Stock following the
            Merger. Accordingly, in order to ensure compliance with Nasdaq Listing Rule 5635(a)(1), Caladrius must obtain the approval of Caladrius Stockholders for the issuance of these shares of Caladrius Common Stock in the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under Nasdaq Listing Rule 5635(b), a company listed on Nasdaq is required to obtain
            stockholder approval prior to an issuance of stock that will result in a &#8220;change of control&#8221; of the listed company. Accordingly, in order to ensure compliance with Nasdaq Listing Rule 5635(b), Caladrius must obtain the approval of Caladrius
            Stockholders of the change of control as defined under the Nasdaq Listing Rules resulting from the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Required Vote</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The affirmative vote of the holders of a majority of the shares of Caladrius Common
            Stock having voting power present in person or represented by proxy at the Annual Meeting is required to approve Proposal No. 1.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;" class="fpara">THE CALADRIUS BOARD OF DIRECTORS RECOMMENDS THAT THE CALADRIUS STOCKHOLDERS VOTE
            &#8220;FOR&#8221; PROPOSAL NO. 1 TO APPROVE THE MERGER AND THE ISSUANCE OF CALADRIUS COMMON STOCK PURSUANT TO THE MERGER AGREEMENT.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">189<br />
        </div>

      </div>

    </div>

    <!--End Page 198-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 199-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_115-prop2_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPROP2"><!--Anchor--></a>PROPOSAL NO. 2:<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195; <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">APPROVAL OF AN AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
            CALADRIUS EFFECTING THE REVERSE STOCK SPLIT</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2">General</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Annual Meeting, Caladrius Stockholders will be asked to approve an amendment to
            the amended and restated certificate of incorporation of Caladrius effecting the Reverse Stock Split. Upon the effectiveness of the amended and restated certificate of incorporation of Caladrius effecting the Reverse Stock Split (the &#8220;Split
            Effective Time&#8221;), the issued shares of Caladrius Common Stock immediately prior to the Split Effective Time will be reclassified into a smaller number of shares such that a Caladrius Stockholder will own one new share of Caladrius Common Stock
            for every five to fifteen shares (or any number in-between and as determined by Caladrius and Cend) of issued Caladrius Common Stock held by that stockholder immediately prior to the Split Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The approval of the Reverse Stock Split (Proposal No. 2) is required in order to avoid
            a potential delisting of Caladrius Common Stock from The Nasdaq Capital Market. However, the approval of the Reverse Stock Split (Proposal No. 2) is not a condition to closing the Merger and is also not conditioned upon the consummation of the
            Merger, and as such the Reverse Stock Split may be implemented by the Caladrius Board of Directors even if the Merger does not take place.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Proposal No. 2 is approved, the Reverse Stock Split would become effective in
            connection with the Closing. The Caladrius Board of Directors may affect only one reverse stock split in connection with this Proposal No. 2. The Caladrius Board of Director&#8217;s decision will be based on a number of factors, including market
            conditions, existing and expected trading prices for Caladrius Common Stock and the listing requirements of Nasdaq.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The form of the amendment to the amended and restated certificate of incorporation of
            Caladrius to effect the Reverse Stock Split, as more fully described below, will affect the Reverse Stock Split but will not change the number of authorized shares of Caladrius Common Stock or preferred stock, or the par value of Caladrius
            Common Stock or Caladrius preferred stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h2">Purpose</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors approved the proposal to amend the amended and
            restated certificate of incorporation of Caladrius effecting the Reverse Stock Split for the following reasons: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors believes effecting the Reverse Stock Split may be an effective means of avoiding a delisting of
                    Caladrius Common Stock from The Nasdaq Capital Market in the future; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Caladrius Board of Directors believes a higher stock price may help generate investor interest in Caladrius and help
                    Caladrius attract and retain employees. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Reverse Stock Split successfully increases the per share price of Caladrius
            Common Stock, the Caladrius Board of Directors believes this increase may increase trading volume in Caladrius Common Stock and facilitate future financings by Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h2">Requirements for Listing on The Nasdaq Capital Market</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Common Stock is quoted on The Nasdaq Capital Market under the symbol &#8220;CLBS.&#8221;
            The Nasdaq Capital Market imposes, among other requirements, a minimum $1.00 per share bid price requirement pursuant to the Minimum Bid Price Requirement. The closing bid price for our common stock must remain at or above $1.00 per share to
            comply with the Minimum Bid Price Requirement for continued listing. Since July&#160;12, 2021, the closing bid price for our common stock has been below $1.00 per share. On February&#160;18, 2022, we received a deficiency letter from the Listing
            Qualifications Department of Nasdaq notifying us that, for the preceding 30 consecutive trading days, the closing bid price for shares of our common stock was below $1.00 per share and, accordingly, we no longer satisfied the Minimum Bid Price
            Requirement. Because we require Nasdaq approval to list the combined company following the Merger, the Reverse Stock Split may be necessary in order to consummate the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">One of the effects of the Reverse Stock Split will be to effectively increase the
            proportion of authorized shares which are unissued relative to those which are issued. This could result in Caladrius&#8217; management being able to issue more shares without further stockholder approval. For example, before the Reverse Stock Split,
            Caladrius&#8217; authorized but </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">190<br />
        </div>

      </div>

    </div>

    <!--End Page 199-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 200-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_115-prop2_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">unissued shares immediately prior to the Closing would be approximately 500,000,000,
            compared to 60,518,478 shares issued and outstanding as of June&#160;13, 2022. If Caladrius effects the Reverse Stock Split using a 1:15 ratio, its authorized but unissued shares immediately prior to the Closing would be approximately 33,333,333
            compared to shares issued and outstanding of approximately 4,034,565. Caladrius currently has no plans to issue shares, other than in connection with the Merger, and to satisfy obligations under Caladrius Options from time to time as Caladrius
            Options are exercised. The Reverse Stock Split will not affect the number of authorized shares of Caladrius Common Stock, which will continue to be authorized pursuant to the certificate of incorporation of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Potential Increased Investor Interest</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On June&#160;14, 2022, Caladrius Common Stock closed at $0.50 per share. An investment in
            Caladrius Common Stock may not appeal to brokerage firms that are reluctant to recommend lower priced securities to their clients. Investors may also be dissuaded from purchasing lower priced stocks because the brokerage commissions, as a
            percentage of the total transaction, tend to be higher for such stocks. Moreover, the analysts at many brokerage firms do not monitor the trading activity or otherwise provide coverage of lower priced stocks. Also, the Caladrius Board of
            Directors believes that most investment funds are reluctant to invest in lower priced stocks.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There are risks associated with the Reverse Stock Split, including that the Reverse
            Stock Split may not result in an increase in the per share price of Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius cannot predict whether the Reverse Stock Split will increase the market price
            for the Caladrius Common Stock. The history of similar stock split combinations for companies in like circumstances is varied. There is no assurance that: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the market price per share of Caladrius Common Stock after the Reverse Stock Split will rise in proportion to the reduction in
                    the number of shares of Caladrius Common Stock outstanding before the Reverse Stock Split; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Reverse Stock Split will result in a per share price that will attract brokers and investors who do not trade in lower
                    priced stocks; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Reverse Stock Split will result in a per share price that will increase the ability of Caladrius to attract and retain
                    employees; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the market price per share will either exceed or remain in excess of the Minimum Bid Price Requirement as required by The Nasdaq
                    Capital Market for continued listing, or that Caladrius will otherwise meet the requirements of The Nasdaq Capital Market for inclusion for trading on The Nasdaq Capital Market. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The market price of Caladrius Common Stock will also be based on the performance of
            Caladrius and other factors, some of which are unrelated to the number of shares outstanding. If the Reverse Stock Split is effected and the market price of Caladrius Common Stock declines, the percentage decline as an absolute number and as a
            percentage of the overall market capitalization of Caladrius may be greater than would occur in the absence of a reverse stock split. Furthermore, the liquidity of Caladrius Common Stock could be adversely affected by the reduced number of
            shares that would be outstanding after the Reverse Stock Split.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Principal Effects of the Reverse Stock Split</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The amendment to the amended and restated certificate of incorporation of Caladrius
            effecting the Reverse Stock Split is set forth in <span style="font-style: italic;">Annex&#160;D</span> to this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Reverse Stock Split will be effected simultaneously for all outstanding shares of
            Caladrius Common Stock. The Reverse Stock Split will affect all of the Caladrius Stockholders uniformly and will not affect any Caladrius Stockholder&#8217;s percentage ownership interests in Caladrius, except to the extent that the Reverse Stock
            Split results in any of the Caladrius Stockholders owning a fractional share. Caladrius Common Stock issued pursuant to the Reverse Stock Split will remain fully paid and nonassessable. The Reverse Stock Split does not affect the total
            proportionate ownership of Caladrius following the Merger. The Reverse Stock Split will not affect Caladrius continuing to be subject to the periodic reporting requirements of the Exchange Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Procedure for Effecting the Reverse Stock Split and Exchange of Stock
            Certificates</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the Caladrius Stockholders approve the amendment to the amended and restated
            certificate of incorporation of Caladrius effecting the Reverse Stock Split, and if the Caladrius Board of Directors still believes that the Reverse </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">191<br />
        </div>

      </div>

    </div>

    <!--End Page 200-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 201-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_115-prop2_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Split is in the best interests of Caladrius and the Caladrius Stockholders,
            Caladrius will file the amendment to the amended and restated certificate of incorporation with the Secretary of State of the State of Delaware at such time as the Caladrius Board of Directors has determined to be the appropriate Split
            Effective Time. The Caladrius Board of Directors may delay effecting the Reverse Stock Split without resoliciting stockholder approval. Beginning at the Split Effective Time, each certificate representing pre-split shares will be deemed for all
            corporate purposes to evidence ownership of post-split shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As soon as practicable after the Split Effective Time, Caladrius Stockholders will be
            notified that the Reverse Stock Split has been effected. Caladrius expects that the Caladrius transfer agent will act as exchange agent for purposes of implementing the exchange of stock certificates. Holders of pre-split shares will be asked
            to surrender to the exchange agent certificates representing pre-split shares in exchange for certificates representing post-split shares in accordance with the procedures to be set forth in a letter of transmittal to be sent by Caladrius. In
            the event that Proposal No. 3 is approved, the certificates reflecting the post-split shares will also reflect the change of Caladrius&#8217; corporate name to &#8220;Lisata Therapeutics, Inc.&#8221; No new certificates will be issued to a stockholder until such
            stockholder has surrendered such stockholder&#8217;s outstanding certificate(s) together with the properly completed and executed letter of transmittal to the exchange agent. Any pre-split shares submitted for transfer, whether pursuant to a sale or
            other disposition, or otherwise, will automatically be exchanged for post-split shares. <span style="font-weight: bold;">Caladrius Stockholders should not destroy any stock certificate(s) and should not submit any certificate(s) unless and
              until requested to do so.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;" class="h2">Fractional Shares</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">No fractional shares will be issued in connection with the Reverse Stock Split.
            Caladrius Stockholders of record who otherwise would be entitled to receive fractional shares because they hold a number of pre-split shares not evenly divisible by the number of pre-split shares for which each post-split share is to be
            reclassified, will be entitled, upon surrender to the exchange agent of certificates representing such shares, to a cash payment in lieu thereof at a price equal to the fraction to which the stockholder would otherwise be entitled multiplied by
            the closing price of the Caladrius Common Stock on The Nasdaq Capital Market on the date immediately preceding the Split Effective Time. The ownership of a fractional interest will not give the holder thereof any voting, dividend, or other
            rights except to receive payment therefor as described herein.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">By approving the amended and restated certificate of incorporation of Caladrius
            effecting the Reverse Stock Split, Caladrius Stockholders will be approving the combination of a range of five to fifteen shares (or any number in between) of Caladrius Common Stock into one share of Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Stockholders should be aware that, under the escheat laws of the various
            jurisdictions where Caladrius Stockholders reside, where Caladrius is domiciled, and where the funds will be deposited, sums due for fractional interests that are not timely claimed after the effective date of the split may be required to be
            paid to the designated agent for each such jurisdiction, unless correspondence has been received by Caladrius or the exchange agent concerning ownership of such funds within the time permitted in such jurisdiction. Thereafter, Caladrius
            Stockholders otherwise entitled to receive such funds will have to seek to obtain them directly from the state to which they were paid.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;" class="h2">Potential Anti-Takeover Effect</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Although the increased proportion of unissued authorized shares to issued shares could,
            under certain circumstances, have an anti-takeover effect, for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of the Caladrius Board of Directors or contemplating
            a tender offer or other transaction for the combination of Caladrius with another company, the Reverse Stock Split proposal is not being proposed in response to any effort of which Caladrius is aware to accumulate shares of Caladrius Common
            Stock or obtain control of Caladrius, other than in connection with the Merger, nor is it part of a plan by management to recommend a series of similar amendments to the Caladrius Board of Directors and Caladrius Stockholders. Other than the
            proposals being submitted to the Caladrius Stockholders for their consideration at the Annual Meeting, the Caladrius Board of Directors does not currently contemplate recommending the adoption of any other actions that could be construed to
            affect the ability of third parties to take over or effect a change of control of Caladrius. For more information, please see the section entitled &#8220;<span style="font-style: italic;">Risk Factors&#8212;Risks Related to Caladrius Common Stock,</span>&#8221;
            and &#8220;<span style="font-style: italic;">Description of Caladrius Capital Stock&#8212;Anti-Takeover Effects of Provisions of Certain Provisions of Delaware Law and Our Certificate of Incorporation and Bylaws.</span>&#8221;</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">192<br />
        </div>

      </div>

    </div>

    <!--End Page 201-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 202-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_115-prop2_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Material U.S. Federal Income Tax Consequences of the Reverse Stock
            Split</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following discussion is a summary of the material U.S. federal income tax
            consequences of the Reverse Stock Split to U.S. holders (as defined below) of Caladrius Common Stock, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and
            gift tax laws, and any applicable state, local or non-U.S. tax laws are not discussed. This discussion is based on the Code, U.S. Treasury Regulations promulgated thereunder (the &#8220;Treasury Regulations&#8221;), judicial decisions, and published
            rulings and administrative pronouncements of the IRS, in each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied
            retroactively in a manner that could adversely affect a holder of Caladrius Common Stock. Caladrius has not sought and will not seek an opinion of counsel or any rulings from the IRS regarding the matters discussed below. There can be no
            assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the Reverse Stock Split.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This discussion is limited to holders who hold their Caladrius Common Stock as a
            &#8220;capital asset&#8221; within the meaning of Section 1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to the particular circumstances of a Caladrius
            Stockholder, including the impact of the alternative minimum tax or the Medicare contribution tax on net investment income. In addition, it does not address consequences relevant to holders of Caladrius Common Stock that are subject to special
            rules, including, without limitation: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons who are not U.S. holders (as defined below); </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">U.S. holders (as defined below) whose functional currency is not the U.S. dollar; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons holding Caladrius Common Stock as part of a hedge, straddle or other risk reduction strategy or as part of a conversion
                    transaction or other integrated investment; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">banks, insurance companies and other financial institutions; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">real estate investment trusts or regulated investment companies; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">brokers, dealers or traders in securities; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">S corporations, partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and
                    investors therein); </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-exempt organizations or governmental organizations; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons deemed to sell Caladrius Common Stock under the constructive sale provisions of the Code; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">persons who hold or receive Caladrius Common Stock pursuant to the exercise of any employee stock options or otherwise as
                    compensation; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-qualified retirement plans. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For purposes of this discussion, a &#8220;U.S. holder&#8221; is a beneficial owner of Caladrius
            Common Stock that, for U.S. federal income tax purposes, is or is treated as: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an individual who is a citizen or resident of the United States; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a corporation created or organized under the laws of the United States, any state thereof or the District of Columbia; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a trust that (1) is subject to the primary supervision of a U.S. court and all substantial decisions of which are subject to the
                    control of one or more &#8220;United States persons&#8221; (within the meaning of Section 7701(a)(30) of the Code) or (2) has a valid election in effect to be treated as a United States person for U.S. federal income tax purposes. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">193<br />
        </div>

      </div>

    </div>

    <!--End Page 202-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 203-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_115-prop2_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">If an entity treated as a partnership for U.S. federal income tax purposes holds
            Caladrius Common Stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly, partnerships holding
            Caladrius Common Stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, the following discussion does not address the tax consequences of the
            Reverse Stock Split under state, local and foreign tax laws. Furthermore, the following discussion does not address any tax consequences of transactions effectuated before, after or at the same time as the Reverse Stock Split, whether or not
            they are in connection with the Reverse Stock Split.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">HOLDERS OF CALADRIUS COMMON STOCK SHOULD CONSULT THEIR TAX ADVISORS
            WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT ARISING UNDER OTHER U.S. FEDERAL TAX LAWS (INCLUDING ESTATE AND GIFT TAX LAWS), UNDER
            THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Tax Consequences of the Reverse Stock Split</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Reverse Stock Split should constitute a &#8220;recapitalization&#8221; for U.S. federal income
            tax purposes. As a result, a U.S. holder of Caladrius Common Stock generally should not recognize gain or loss upon the Reverse Stock Split, except with respect to cash received in lieu of a fractional share of Caladrius Common Stock, as
            discussed below. A U.S. holder&#8217;s aggregate tax basis in the shares of Caladrius Common Stock received pursuant to the Reverse Stock Split should equal the aggregate tax basis of the shares of the Caladrius Common Stock surrendered (excluding
            any portion of such basis that is allocated to any fractional share of Caladrius Common Stock), and such U.S. holder&#8217;s holding period in the shares of Caladrius Common Stock received should include the holding period in the shares of Caladrius
            Common Stock surrendered. Treasury Regulations provide detailed rules for allocating the tax basis and holding period of the shares of Caladrius Common Stock surrendered to the shares of Caladrius Common Stock received in a recapitalization
            pursuant to the Reverse Stock Split. U.S. holders of shares of Caladrius Common Stock acquired on different dates and at different prices should consult their tax advisors regarding the allocation of the tax basis and holding period of such
            shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Cash in Lieu of Fractional Shares</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A U.S. holder of Caladrius Common Stock that receives cash in lieu of a fractional
            share of Caladrius Common Stock pursuant to the Reverse Stock Split should recognize capital gain or loss in an amount equal to the difference between the amount of cash received and the U.S. holder&#8217;s tax basis in the shares of Caladrius Common
            Stock surrendered that is allocated to such fractional share of Caladrius Common Stock. Such capital gain or loss should be long-term capital gain or loss if the U.S. holder&#8217;s holding period for Caladrius Common Stock surrendered exceeded one
            year at the Split Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Information Reporting and Backup Withholding</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Payments of cash made in lieu of a fractional share of Caladrius Common Stock may,
            under certain circumstances, be subject to information reporting and backup withholding. To avoid backup withholding, each holder of Caladrius Common Stock that does not otherwise establish an exemption should furnish its taxpayer
            identification number and comply with the applicable certification procedures.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Backup withholding is not an additional tax. Any amounts withheld will be allowed as a
            credit against the holder&#8217;s U.S. federal income tax liability and may entitle such holder to a refund, provided the required information is timely furnished to the IRS. Holders of Caladrius Common Stock should consult their tax advisors
            regarding their qualification for an exemption from backup withholding and the procedures for obtaining such an exemption.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">194<br />
        </div>

      </div>

    </div>

    <!--End Page 203-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 204-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_115-prop2_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Required Vote</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The affirmative vote of holders of a majority of the outstanding shares of Caladrius
            Common Stock having voting power outstanding on the Record Date for the Annual Meeting is required to approve the amendment to the amended and restated certificate of incorporation of Caladrius effecting the Reverse Stock Split, at a ratio
            mutually agreed to by Caladrius and Cend in the range of one new share for every five to fifteen shares outstanding (or any number in between).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;" class="fpara">THE CALADRIUS BOARD OF DIRECTORS RECOMMENDS THAT CALADRIUS STOCKHOLDERS VOTE &#8220;FOR&#8221;
            PROPOSAL NO. 2 TO APPROVE AN AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CALADRIUS EFFECTING THE REVERSE STOCK SPLIT.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">195<br />
        </div>

      </div>

    </div>

    <!--End Page 204-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 205-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_116-prop3_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPROP3"><!--Anchor--></a>PROPOSAL NO. 3:<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195; <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">APPROVAL OF AN AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF
            CALADRIUS EFFECTING THE CALADRIUS NAME CHANGE</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Annual Meeting, Caladrius Stockholders will be asked to approve an amendment to
            the amended and restated certificate of incorporation of Caladrius to effect the Caladrius Name Change. Caladrius&#8217; management believes that the current name will no longer accurately reflect the business of Caladrius and the mission of
            Caladrius subsequent to the consummation of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Required Vote</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The affirmative vote of holders of a majority of the shares of Caladrius Common Stock
            having voting power outstanding on the Record Date for the Annual Meeting is required to approve the amendment to the amended and restated certificate of incorporation to effect the Caladrius Name Change.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;" class="fpara">THE CALADRIUS BOARD OF DIRECTORS RECOMMENDS THAT CALADRIUS STOCKHOLDERS VOTE &#8220;FOR&#8221;
            PROPOSAL NO. 3 TO APPROVE AN AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF CALADRIUS EFFECTING THE CALADRIUS NAME CHANGE.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">196<br />
        </div>

      </div>

    </div>

    <!--End Page 205-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 206-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_117-prop4_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPROP4"><!--Anchor--></a>PROPOSAL NO. 4:<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195; <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">ELECTION OF DIRECTORS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Annual Meeting, Caladrius Stockholders will vote on the election of three
            Class&#160;III directors to serve for a three-year term until Caladrius&#8217; 2025 annual meeting of stockholders or until their successors are elected and qualified, or until his earlier death, resignation or removal. The Caladrius Board of Directors
            has unanimously nominated Michael H. Davidson, M.D., Steven M. Klosk and Steven S. Myers upon the recommendation of Caladrius&#8217; nominating and governance committee, for reelection to the Caladrius Board of Directors as Class&#160;III directors. The
            nominees have agreed to stand for election. If the nominees for Class&#160;III are elected at the Annual Meeting, then each nominee will serve for a three-year term expiring at the 2025 annual meeting of stockholders, or until his successor is
            elected and qualified, or until his earlier death, resignation or removal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Stockholders should understand, however, that if the Merger is completed, the
            effect of the approval of Proposal No. 4 will be limited since the composition of the Caladrius Board of Directors will be changed upon completion of the Merger in accordance with the Merger Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Required Vote</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; directors are elected by a plurality of the votes cast. If a choice is
            specified on the proxy card by a stockholder, the shares will be voted as specified. If a choice is not specified on the proxy card, and authority to do so is not withheld, the shares will be voted &#8220;FOR&#8221; the election of the three nominees for
            Class&#160;III above. If any of the nominees becomes unavailable for election as a result of an unexpected occurrence, shares that would have been voted for the nominee will instead be voted for the election of a substitute nominee proposed by
            Caladrius&#8217; management or the Caladrius Board of Directors. Each person nominated for election has agreed to serve if elected. Caladrius&#8217; management has no reason to believe that any nominee will be unable to serve.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;" class="fpara">THE CALADRIUS BOARD OF DIRECTORS RECOMMENDS A VOTE &#8220;FOR&#8221; THE ELECTION OF EACH THE
            CLASS III NOMINEES FOR DIRECTOR PURSUANT TO THIS PROPOSAL NO. 4.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">197<br />
        </div>

      </div>

    </div>

    <!--End Page 206-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 207-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_118-prop5_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPROP5"><!--Anchor--></a>PROPOSAL NO. 5:<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195; <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h2">Re-Appointment of Grant Thornton LLP</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Grant Thornton LLP currently serves as our independent registered public accounting
            firm and has audited our financial statements for the year ended December&#160;31, 2021. Grant Thornton LLP was initially appointed as our independent registered public accounting firm in 2011.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Grant Thornton LLP has again been appointed by the Audit Committee of the Caladrius
            Board of Directors (the &#8220;Audit Committee&#8221;) to serve as our independent registered public accounting firm for our fiscal year ending December&#160;31, 2022. The Caladrius Board of Directors is submitting this appointment to our stockholders for
            ratification at the Annual Meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h2">Representatives of Grant Thornton LLP at Annual Meeting</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Representatives of Grant Thornton LLP are expected to be present at the Annual Meeting
            to have an opportunity to make a statement, if they desire to do so and to be available to respond to appropriate questions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h2">Accounting Fees and Other Accounting Matters</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Grant Thornton LLP was engaged to serve as Caladrius&#8217; independent registered public
            accounting firm in 2021 and 2020 and accordingly, audited Caladrius&#8217; financial statements for the fiscal years ended December&#160;31, 2021 and 2020. The following table sets forth a summary of the fees billed or expected to be billed to us by Grant
            Thornton LLP for professional services rendered for the fiscal years ended December&#160;31, 2021 and 2020.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Fee Category</div>
                </td>

    <td style="width: 1.02%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Fiscal 2021 Fees</div>
                </td>

    <td style="width: 1.02%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Fiscal 2020 Fees</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Audit Fees<sup>(1)</sup></div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara">$420,000</div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara">$401,000</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Audit-Related Fees<sup>(2)</sup></div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Tax Fees<sup>(3)</sup></div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara">$<span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">All Other Fees<sup>(4)</sup></div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 37.5pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 37.5pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Fees</div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$420,000</span></div>
                </td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.02%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.46pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$401,000</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Audit Fees consist of aggregate fees billed or expected to be billed for professional services rendered for the audit of
                    Caladrius&#8217; annual consolidated financial statements included in Caladrius&#8217; Annual Reports on Form 10-K and review of the interim consolidated financial statements included in Quarterly Reports on Form 10-Q or services that are normally
                    provided by the independent registered public accounting firm in connection with statutory and regulatory filings or engagements for the fiscal years ended December&#160;31, 2021 and 2020, respectively.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Audit-Related Fees consist of aggregate fees billed for assurance and related services that are reasonably related to the
                    performance of the audit or review of Caladrius&#8217; consolidated financial statements and are not reported under &#8220;Audit Fees.&#8221;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Tax Fees consist of aggregate fees billed or expected to be billed for professional services rendered for tax compliance, tax
                    advice and tax planning. These fees related to preparation of Caladrius&#8217; federal and state income tax returns and other tax compliance activities.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">All Other Fees consist of aggregate fees billed for products and services provided by Grant Thornton (as applicable), other than
                    those disclosed above.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Audit Committee is responsible for the appointment, compensation and oversight of
            the work of the independent registered public accounting firm and approves in advance any services to be performed by the independent registered public accounting firm, whether audit-related or not. The Audit Committee reviews each proposed
            engagement to determine whether the provision of services is compatible with maintaining the independence of the independent registered public accounting firm. All of the fees shown above were pre-approved by the Audit Committee.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h2">Required Vote; Recommendation of the Caladrius Board of Directors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Approval of the Proposal No. 5 requires the affirmative vote of a majority of the stock
            present at the virtual meeting or represented by proxy entitled to vote and voting on the Auditor Ratification Proposal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;" class="fpara">THE CALADRIUS BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE
            RE-APPOINTMENT OF GRANT THORNTON LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">198<br />
        </div>

      </div>

    </div>

    <!--End Page 207-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 208-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_119-prop6_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPROP6"><!--Anchor--></a>PROPOSAL NO. 6: <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">THE NON-BINDING, ADVISORY VOTE ON EXECUTIVE COMPENSATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2">Background of the Proposal</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Dodd-Frank Act and Section 14A of the Exchange Act, the Caladrius
            Stockholders are entitled to vote to approve, on an advisory (non-binding) basis, the compensation of its Chief Executive Officer and its other named executive officers as disclosed in this proxy statement/prospectus/information statement in
            accordance with the SEC rules.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Executive Compensation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius believes that its executive compensation programs, which are reviewed and
            approved by the Compensation Committee and reviewed by Radford, its compensation consultants, are designed to retain and incentivize the talented executives whose efforts are key to our long-term success. <span style="font-weight: bold;">Caladrius




              Stockholders are encouraged to review carefully the &#8220;</span><span style="font-style: italic; font-weight: bold;">Caladrius Executive Compensation</span><span style="font-weight: bold;">&#8221; section of this proxy statement/prospectus/information
              statement for additional details about Caladrius&#8217; executive compensation, including information about the fiscal year 2021 compensation of our named executive officers.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius is asking the Caladrius Stockholders to indicate their support for our Named
            Executive Officer compensation as described in this proxy statement/prospectus/information statement. This proposal, commonly known as a &#8220;say-on-pay&#8221; proposal, gives the Caladrius Stockholders the opportunity to express their views on the named
            executive officers&#8217; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of the named executive officersnamed executive officers as described in this proxy
            statement/prospectus/information statement. Accordingly, Caladrius is asking the Caladrius Stockholders to cast a non-binding advisory vote &#8220;<span style="font-weight: bold;">FOR</span>&#8221; the following resolution at the Annual Meeting:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">&#8220;RESOLVED, that the compensation of Caladrius&#8217; named executive officers, as disclosed
            in Caladrius&#8217; Proxy Statement for the 2022 Annual Meeting of Stockholders pursuant to Item 402 of Regulation S-K, is hereby APPROVED.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Required Vote; Recommendation of the Caladrius Board of Directors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Approval of this proposal requires the affirmative vote of a majority of the stock
            present at the virtual meeting or represented by proxy entitled to vote and voting on the proposal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The say-on-pay vote is advisory, and therefore not binding on Caladrius, the
            Compensation Committee or the Caladrius Board of Directors. Nevertheless, the Caladrius Board of Directors and our Compensation Committee value the opinions of our stockholders, whether expressed through this vote or otherwise, and,
            accordingly, the Caladrius Board of Directors and Compensation Committee intend to consider the results of this vote in making determinations in the future regarding executive compensation arrangements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;" class="fpara">THE CALADRIUS BOARD OF DIRECTORS RECOMMENDS THAT THE CALADRIUS STOCKHOLDERS VOTE
            &#8220;FOR&#8221; PROPOSAL NO. 6 TO APPROVE THE EXECUTIVE COMPENSATION ON A NON-BINDING ADVISORY VOTE BASIS.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">199<br />
        </div>

      </div>

    </div>

    <!--End Page 208-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 209-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_120-prop7_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPROP7"><!--Anchor--></a>PROPOSAL NO. 7: <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">THE AMENDMENT TO THE 2018 EQUITY INCENTIVE COMPENSATION PLAN</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2">Background of the Proposal</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors has unanimously approved an amendment (subject to
            stockholder approval at the Annual Meeting) of the Caladrius 2018 Equity Incentive Compensation Plan (the &#8220;Plan&#8221;) that increases the number of shares that may be issued under the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Annual Meeting, you are being asked to approve the amendment to the Plan that
            increases the number of shares that may be issued under the Plan by 5,000,000 shares from 8,500,000 shares to 13,500,000 shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following is a summary of the Plan, as amended. This summary is qualified in its
            entirety by reference to the full text of the Plan, as amended, which is attached to <span style="font-style: italic;">Annex&#160;F</span> to this proxy statement/prospectus/information statement and is incorporated herein by reference.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Plan was approved by the Caladrius Board of Directors and our stockholders in 2018.
            By its terms, the Plan may be amended by the Caladrius Board of Directors, provided that any amendment that the Caladrius Board of Directors determines requires stockholder approval is subject to receiving such stockholder approval. Approval by
            the Caladrius Stockholders is required by the listing rules of Nasdaq. In addition, stockholder approval is required in order to ensure favorable federal income tax treatment for grants of incentive stock options under Section 422 of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of June&#160;13, 2022, a total of 3,504,420 shares of our common stock remain available
            for issuance under the Plan; options to purchase a total of 2,623,288 shares of common stock are outstanding; and restricted stock units for the issuance of a maximum of 1,453,795 shares of our common stock were outstanding. As of June&#160;13,
            2022, a total of 2,023,095 shares of our common stock have been issued upon the exercise of options and vesting of other equity awards granted under the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Reasons for Amendment of the Plan</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In concert with Radford, the independent consultant to the Company, the Caladrius Board
            of Directors and our management believe that the effective use of stock-based long-term incentive compensation is vital to our ability to achieve strong performance in the future. The Plan is intended to maintain and enhance the key policies
            and practices adopted by our management and the Caladrius Board of Directors to align employee and stockholder interests and to link compensation to Company performance. In addition, our future success depends, in large part, upon our ability
            to maintain a competitive position in attracting, retaining and motivating key personnel. We believe that the increase in the number of shares available for issuance under our Plan is essential to permit our management to continue to provide
            long-term, equity-based incentives to present and future key employees, consultants and directors. The Caladrius Board of Directors believes that the number of shares currently remaining available for issuance pursuant to future awards under
            the Plan (3,504,420 shares as of June&#160;13, 2022) is not sufficient for future granting needs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following is a brief summary of the Plan, as amended. This summary is qualified in
            its entirety by reference to the text of the Plan, a copy of which is attached as <span style="font-style: italic;">Annex&#160;F</span> hereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Summary of Material Features of the Plan</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Plan Administration<span style="font-weight: normal;">. In
              accordance with the terms of the Plan, the Plan shall be administered by a committee appointed by the Caladrius Board of Directors, which committee shall consist of not less than two members of the Caladrius Board of Directors and shall be
              comprised solely of members of the Caladrius Board of Directors who qualify as non-employee directors. The Caladrius Board of Directors shall have the power to add or remove members of the committee. The Plan administrator has the authority,
              in its discretion, to determine, among other matters, (i)&#160;the fair market value of shares in connection with awards, (ii)&#160;the recipients to whom awards may be granted, (iii)&#160;the number of shares of the Company&#8217;s common stock to be covered by
              each award granted under the Plan, (iv)&#160;the forms of agreements for use under the Plan and (v)&#160;all other terms and conditions of awards in accordance with the Plan.</span></div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">200<br />
        </div>

      </div>

    </div>

    <!--End Page 209-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 210-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_120-prop7_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Eligibility<span style="font-weight: normal;">. The Plan allows
              us, under the direction of the Plan administrator, to make grants of stock options, restricted stock, restricted stock units, deferred share units, unrestricted shares and stock appreciation rights to the Company&#8217;s employees, consultants and
              directors. As of June&#160;13, 2022, there were approximately 26 individuals eligible to participate in the Plan.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Corporate Governance Aspects of the Plan<span style="font-weight: normal;">. The Plan includes several provisions that we believe promote best practices by reinforcing alignment with stockholders&#8217; interests. These provisions include, but are not limited to, the following:</span></div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">No Discounted Options or Stock Appreciation Rights</span>: Stock options and stock
                    appreciation rights may not be granted with exercise prices lower than the fair market value of the underlying shares on the grant date except to replace equity awards due to a corporate transaction.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">No Repricing without Stockholder Approval</span>: Other than in connection with certain
                    changes in the Company&#8217;s capitalization or changes in control, without the prior approval of stockholders, (i)&#160;the exercise price of stock options and stock appreciation rights may not be reduced, (ii)&#160;no option or stock appreciation
                    right may be cancelled in exchange for cash, other awards, or options or stock appreciation rights with an exercise price that is less than the exercise price of the original option or stock appreciation right and (iii)&#160;the Company may
                    not repurchase an option or stock appreciation right for value if the fair market value of the shares underlying such option or stock appreciation right is lower than its exercise price per share.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">No Dividends</span>: Dividends on stock awards may accrue but are not payable until such time
                    as any applicable vesting period or achievement of performance conditions has been met.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">No Transferability</span>: Equity awards other than unrestricted shares generally may not be
                    transferred, except by will or the laws of descent and distribution, unless approved by the Plan administrator.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Limits on Director Grants:</span> The number of shares that may be granted to any non-employee
                    director in any calendar year is limited to an aggregate grant date fair value of $60,000, except for grants made pursuant to an election by a non-employee director to receive a grant of equity in lieu of cash for any cash fees to be
                    received for service on the Caladrius Board of Directors or any committee thereof or in connection with a non-employee director initially joining the Caladrius Board of Directors.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Shares Available for Issuance<span style="font-weight: normal;">.
              The Plan provides for the issuance of up to 8,500,000 shares of our common stock plus a number of additional shares to be issued if awards outstanding under our Amended and Restated 2009 Equity Compensation Plan (the &#8220;2009 Plan&#8221;) and/or 2015
              Equity Compensation Plan (the &#8220;2015 Plan&#8221;) are cancelled, expire or net share settled. As of June&#160;13, 2022, 3,504,420 shares were available for future awards under the Plan. If our stockholders approve this proposal, an additional 5,000,000
              shares would be available for future awards under the Plan. Generally, shares of common stock reserved for awards under the Plan that lapse or are canceled (other than by exercise) will be added back to the share reserve available for future
              awards.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Options<span style="font-weight: normal;">. Stock options
              granted under the Plan may either be incentive stock options, which are intended to satisfy the requirements of Section 422 of the Code, or non-statutory stock options, which are not intended to meet those requirements. Incentive stock
              options may be granted to employees of the Company and its affiliates. Non-statutory options may be granted to employees, directors and consultants of the Company and its affiliates. The exercise price of a stock option may not be less than
              100% of the fair market value of our common stock on the date of grant and the term of the option may not be longer than ten years. If an incentive stock option is granted to an individual who owns more than 10% of the combined voting power
              of all classes of our capital stock, the exercise price may not be less than 110% of the fair market value of our common stock on the date of grant and the term of the option may not be longer than five years.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Award agreements for stock options include rules for exercise of the stock options
            after termination of service. Options may not be exercised unless they are vested, and no option may be exercised after the end of the term set forth in the award agreement. Generally, stock options will be exercisable, to the extent vested at
            the time of termination of service, for 90 days after termination of service for any reason other than death or total and permanent disability, and for one year after termination of service on account of death or total and permanent disability,
            but will not be exercisable if the termination of service was due to cause.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">201<br />
        </div>

      </div>

    </div>

    <!--End Page 210-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 211-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_120-prop7_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Awards<span style="font-weight: normal;">. Stock awards
              under the Plan may be granted to any participant under the Plan, pursuant to the terms of a stock award agreement evidencing such grant. The Plan administrator shall establish a vesting period and may prescribe certain additional
              restrictions, including the satisfaction of corporate or individual performance objectives, on such stock awards. Generally, holders of stock award shares shall have the right to vote such shares, and cash dividends may accrue on stock
              awards, though they may be paid only to the extent that the applicable restricted period has lapsed or the corporate or individual performance objectives have been achieved. Unless otherwise provided by the stock award agreement or determined
              by the Plan administrator in its sole discretion, any unvested stock award shares shall be forfeited if the grantee&#8217;s employment or service with the Company terminates for any reason prior to the expiration or termination of the applicable
              vesting period and/or the achievement of such other vesting conditions applicable to the award.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Restricted Stock Units<span style="font-weight: normal;">.
              Restricted stock units are awards denominated in units evidencing the right to receive shares, which may vest over such period of time and/or upon satisfaction of such performance criteria or objectives as is determined by the Plan
              administrator at the time of grant and set forth in a stock award agreement, without payment of any amounts by the grantee except to the extent required by law. Prior to delivery of shares with respect to an award of restricted stock units,
              the grantee shall have no rights as a shareholder of the Company. Unless otherwise provided by the stock award agreement or determined by the Plan administrator in its sole discretion, restricted stock units shall be forfeited if the
              grantee&#8217;s employment or service with the Company terminates for any reason prior to the expiration or termination of the applicable vesting period and/or the achievement of such other vesting conditions applicable to the restricted stock
              units.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Unrestricted Shares<span style="font-weight: normal;">. The Plan
              administrator may cause the Company to grant unrestricted shares at such time or times, in such amounts and for such reasons as the Plan administrator, in its sole discretion, shall determine. No payment shall be required for unrestricted
              shares.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Appreciation Rights<span style="font-weight: normal;">. Stock
              appreciation rights may be granted by the Plan administrator either alone, in addition to, or in tandem with other awards under the Plan. Each stock appreciation right shall relate to such number of shares as shall be determined by the Plan
              administrator and shall be exercisable for shares only.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Changes in Capitalization<span style="font-weight: normal;">. In
              connection with any increase or decrease in the number of issued shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of our common stock, or any other increase or decrease in the number of
              issued shares without receipt of consideration by us, subject to any required action by our shareholders, the number of shares covered by each outstanding award, and the number of shares which have been authorized for issuance under the Plan
              but as to which no awards have yet been granted or which have been returned to the Plan upon cancellation or expiration, as well as the price per share covered by each such outstanding option or stock appreciation right and the share
              limitations set forth in the Plan, shall be proportionately and equitably adjusted.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Corporate Transactions<span style="font-weight: normal;">. In the
              event of a change in control, and either (i)&#160;the failure of the Company&#8217;s successor to assume a participant&#8217;s awards or (ii)&#160;an assumption of such awards followed by a participant&#8217;s termination without cause within the one-year period
              following such change in control, then, except as otherwise provided by the Plan administrator in a participant&#8217;s award agreement, the participant shall be entitled to the following benefits: (i)&#160;all outstanding options and stock appreciation
              rights granted prior to the change in control shall be fully vested and immediately exercisable in their entirety upon such change in control (or upon later termination of the participant&#8217;s employment without cause, if applicable), and
              (ii)&#160;all unvested stock awards, performance-based awards, and other awards shall become fully vested.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Amendment and Termination<span style="font-weight: normal;">. The
              Plan may be amended, altered, suspended or terminated by the Caladrius Board of Directors at any time. No amendment, alteration, suspension or termination of the Plan shall materially impair the rights of any participant unless mutually
              agreed otherwise between the participant and the Plan administrator, which agreement must be in writing and signed by the participant and the Company.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">Duration of Plan<span style="font-weight: normal;">. The Plan will
              expire by its terms on April&#160;23, 2028.</span></div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">202<br />
        </div>

      </div>

    </div>

    <!--End Page 211-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 212-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_120-prop7_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Federal Income Tax Considerations</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The material federal income tax consequences of the issuance and exercise of stock
            options and other awards under the Plan, based on the current provisions of the Code and regulations, are as follows. Changes to these laws could alter the tax consequences described below. This summary assumes that all awards granted under the
            Plan are exempt from or comply with, the rules under Section 409A of the Code related to nonqualified deferred compensation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">Incentive Stock Options: <span style="font-weight: normal;">Incentive




              stock options are intended to qualify for treatment under Section 422 of the Code. An incentive stock option does not result in taxable income to the optionee or deduction to us at the time it is granted or exercised, provided that no
              disposition is made by the optionee of the shares acquired pursuant to the option within two years after the date of grant of the option nor within one year after the date of issuance of shares to the optionee (referred to as the &#8220;ISO holding
              period&#8221;). However, the difference between the fair market value of the shares on the date of exercise and the option price will be an item of tax preference includible in &#8220;alternative minimum taxable income&#8221; of the optionee. Upon disposition
              of the shares after the expiration of the ISO holding period, the optionee will generally recognize long term capital gain or loss based on the difference between the disposition proceeds and the option price paid for the shares. If the
              shares are disposed of prior to the expiration of the ISO holding period, the optionee generally will recognize taxable compensation, and we will have a corresponding deduction, in the year of the disposition, equal to the excess of the fair
              market value of the shares on the date of exercise of the option over the option price. Any additional gain realized on the disposition will normally constitute capital gain. If the amount realized upon such a disqualifying disposition is
              less than fair market value of the shares on the date of exercise, the amount of compensation income will be limited to the excess of the amount realized over the optionee&#8217;s adjusted basis in the shares.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">Non-Statutory Options: <span style="font-weight: normal;">Options
              otherwise qualifying as incentive stock options, to the extent the aggregate fair market value of shares with respect to which such options are first exercisable by an individual in any calendar year exceeds $100,000, and options designated
              as non-statutory options will be treated as options that are not incentive stock options.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">A non-statutory option ordinarily will not result in income to the optionee or
            deduction to us at the time of grant. The optionee will recognize compensation income at the time of exercise of such non-statutory option in an amount equal to the excess of the then value of the shares over the option price per share. Such
            compensation income of optionees may be subject to withholding taxes, and a deduction may then be allowable to us in an amount equal to the optionee&#8217;s compensation income.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">An optionee&#8217;s initial basis in shares so acquired will be the amount paid on exercise
            of the non-statutory option plus the amount of any corresponding compensation income. Any gain or loss as a result of a subsequent disposition of the shares so acquired will be capital gain or loss.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">Stock Grants: <span style="font-weight: normal;">With respect to
              stock grants under our Plan that result in the issuance of shares that are either not restricted as to transferability or not subject to a substantial risk of forfeiture, the grantee must generally recognize ordinary income equal to the fair
              market value of shares received. Thus, deferral of the time of issuance will generally result in the deferral of the time the grantee will be liable for income taxes with respect to such issuance. We generally will be entitled to a deduction
              in an amount equal to the ordinary income recognized by the grantee.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: left;" class="fpara">With respect to stock grants involving the issuance of shares that are restricted as
            to transferability and subject to a substantial risk of forfeiture, the grantee must generally recognize ordinary income equal to the fair market value of the shares received at the first time the shares become transferable or are not subject
            to a substantial risk of forfeiture, whichever occurs earlier. A grantee may elect to be taxed at the time of receipt of shares rather than upon lapse of restrictions on transferability or substantial risk of forfeiture, but if the grantee
            subsequently forfeits such shares, the grantee would not be entitled to any tax deduction, including as a capital loss, for the value of the shares on which he previously paid tax. The grantee must file such election with the Internal Revenue
            Service within 30 days of the receipt of the shares. We generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the grantee.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">203<br />
        </div>

      </div>

    </div>

    <!--End Page 212-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 213-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_120-prop7_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="fpara">Stock Units: <span style="font-weight: normal;">The grantee
              recognizes no income until the issuance of the shares. At that time, the grantee must generally recognize ordinary income equal to the fair market value of the shares received. We generally will be entitled to a deduction in an amount equal
              to the ordinary income recognized by the grantee.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Plan Benefits</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Since the adoption of the Plan through June&#160;13, 2022, we have granted the following
            stock options (and restricted stock units/performance units/etc.) under the Plan to the individuals and groups listed below. In all cases, the securities underlying such equity awards were shares of our common stock.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name and Position</div>
                </td>

    <td style="width: 1.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">shares subject to <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">equity awards</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Named Executive Officers:<br />
                  </div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D. President and Chief Executive Officer*</div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.02pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">839,300</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Todd Girolamo, Former General Counsel and Corporate Secretary*</div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.02pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">298,000</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">All Current Executive Officers as a group</div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.02pt; text-align: left;" class="fpara">2,423,715</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director Nominees:<br />
                  </div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Michael H. Davidson, M.D., Director</div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.02pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">154,228</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk, Director</div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.02pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">133,578</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven S. Myers, Director</div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.02pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">133,578</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">All current directors who are not executive officers as a group</div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.02pt; text-align: left;" class="fpara">1,017,022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">All employees who are not executive officers as a group</div>
                </td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.49%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.02pt; text-align: left;" class="fpara">1,252,906</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Dr. Mazzo and Mr.&#160;Girolamo have received greater than 5 percent of the total awards granted to date under the Plan.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Other than the annual grant of restricted stock units, or any initial grant of
            restricted stock units to our non-employee directors, the amounts of future grants under the Plan are not determinable and will be granted at the sole discretion of the Caladrius Board of Directors or committee or other delegated persons. We
            cannot determine at this time either the persons who will receive such awards under the Plan or the amount or types of any such awards.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">On June&#160;14, 2022, the closing market price per share of our common stock was $0.50,
            as reported by Nasdaq.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The affirmative vote of a majority of the shares cast affirmatively or negatively at
            the Annual Meeting is required for the adoption of the amendment to our Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;" class="fpara">THE CALADRIUS BOARD OF DIRECTORS RECOMMENDS THAT THE CALADRIUS STOCKHOLDERS VOTE
            &#8220;FOR&#8221; PROPOSAL NO. 7 TO APPROVE PROPOSED THE AMENDMENT TO THE 2018 EQUITY INCENTIVE COMPENSATION PLAN<span style="font-weight: normal;">.</span></div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">204<br />
        </div>

      </div>

    </div>

    <!--End Page 213-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 214-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_121-prop8_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPROP8"><!--Anchor--></a>PROPOSAL NO. 8:<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195; <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">APPROVAL OF POSSIBLE ADJOURNMENT OF THE ANNUAL MEETING</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Caladrius fails to receive a sufficient number of votes to approve Proposal No. 1 or
            2, Caladrius may propose to adjourn the Annual Meeting, for a period of not more than 30 days, for the purpose of soliciting additional proxies to approve Proposal No. 1 or 2. Caladrius currently does not intend to propose adjournment at the
            Annual Meeting if there are sufficient votes to approve Proposal No. 1 or 2. The affirmative vote of the holders of a majority of the shares of Caladrius Common Stock having voting power present in person or represented by proxy at the Annual
            Meeting is required to approve the adjournment of the Annual Meeting for the purpose of soliciting additional proxies to approve Proposal No. 1 or 2.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; text-align: center;" class="fpara">THE CALADRIUS BOARD OF DIRECTORS RECOMMENDS THAT THE CALADRIUS STOCKHOLDERS VOTE
            &#8220;FOR&#8221; PROPOSAL NO. 8 TO ADJOURN THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF PROPOSAL NO. 1 OR 2.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">&#8195; <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">THE APPROVAL OF <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">PROPOSAL NO. 1 IS REQUIRED TO CONSUMMATE THE MERGER.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">205<br />
        </div>

      </div>

    </div>

    <!--End Page 214-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 215-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_121-prop8_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tEPT"><!--Anchor--></a>EQUITY PLAN TABLE</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tECPI"><!--Anchor--></a>Equity Compensation Plan
            Information</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table provides information as of December&#160;31, 2021 regarding shares of
            our common stock that may be issued under our existing equity compensation plans, including our 2018 Equity Incentive Compensation Plan (the &#8220;Plan&#8221;), our 2015 Equity Compensation Plan (the &#8220;2015 Plan&#8221;), our 2009 Stock Option and Incentive Plan
            (the &#8220;2009 Plan&#8221;), and our amended 2017 Employee Stock Purchase Plan (the &#8220;Amended 2017 ESPP&#8221;).</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="7">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Equity Compensation Plan Information</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 13.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">securities <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">to be issued upon <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">exercise of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">outstanding <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">options<sup>(1)</sup></div>
                </td>

    <td style="width: 0.67%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 14.53%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">exercise price of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">outstanding options <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">and rights</div>
                </td>

    <td style="width: 0.67%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 14.59%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">securities <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">remaining available <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">for <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">future issuance <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">under equity <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">compensation plan <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(excluding <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">securities <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">referenced in <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">column (a))</div>
                </td>

  </tr>

  <tr>

    <td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Equity compensation plans approved by security holders<sup>(2)</sup></div>
                </td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.44pt; text-align: left;" class="fpara">2,131,849</div>
                </td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 14.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.75pt; text-align: left;" class="fpara">$5.64</div>
                </td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 14.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.14pt; text-align: left;" class="fpara">5,886,238<sup>(3)</sup></div>
                </td>

  </tr>

  <tr>

    <td style="width: 53.85%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Equity compensation plans not approved by security holders</div>
                </td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.44pt; text-align: left;" class="fpara"><span style="padding-left: 35pt;">0</span></div>
                </td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 14.53%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.75pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.67%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 14.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.14pt; text-align: left;" class="fpara"><span style="padding-left: 35pt;">0</span></div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes stock options only; does not include purchase rights accruing under the Amended 2017 ESPP Plan because the purchase
                    price (and therefore the number of shares to be purchased) will not be determined until the end of the purchase period.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of the Plan, the 2015 Plan, the 2009 Plan, and the Amended 2017 ESPP.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes shares available for future issuance under the Plan and the Amended 2017 ESPP.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">206<br />
        </div>

      </div>

    </div>

    <!--End Page 215-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 216-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCBUS"><!--Anchor--></a>CALADRIUS BUSINESS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Overview</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Caladrius&#8221; or the &#8220;Company&#8221;) is a
            clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. We are developing what are intended to be first-in-class therapeutics based on the characteristics of naturally occurring CD34+
            cells and their ability to stimulate the growth of new microvasculature. Our technology is intended to leverage these cells to enable the body&#8217;s natural repair mechanisms using formulations unique to each medical indication.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our leadership team has decades of collective biopharmaceutical development experience.
            Our goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. Our current product candidates include:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA&#174; (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow-on Phase 2b study
                    (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA&#174; (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the treatment of
                    critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients with chronic kidney
                    disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Corporate Information</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We incorporated in 1980 as a Delaware corporation and our principal executive offices
            are located at 110 Allen Road, Second Floor, Basking Ridge, NJ 07920. Our telephone number is (908) 842-0100 and the corporate website address is <span style="font-style: italic;">www.caladrius.com</span>. Our website address in this proxy
            statement/prospectus/information statement is included only as an inactive textual reference and is not intended to be an active link to our website. The information on the website is not incorporated by reference into this proxy
            statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on
            Form 8-K and all amendments to those reports, as well as other documents filed with the SEC, are available free of charge through the Investors section of the website as soon as reasonably practicable after such material is electronically filed
            with or furnished to the SEC. The public can obtain documents that are filed with the SEC at <span style="font-style: italic;">www.sec.gov</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This proxy statement/prospectus/information statement includes the following trademarks
            owned by us: Caladrius&#174;, XOWNA&#174; and HONEDRA&#174;. These trademarks are the property of Caladrius. This proxy statement/prospectus/information statement also includes other trademarks, service marks and trade names owned by us or other companies.
            All trademarks, service marks and traded names included herein are the property of their respective owners.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Ischemic Repair (CD34 Cell Technology)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The CD34+ cell was discovered as a result of the deliberate search for a cell capable
            of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels
            after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our proprietary cell technology using autologous (a patient&#8217;s own naturally occurring)
            CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is restricted or reduced. Through the
            administration of CD34+ cells, we seek to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. We believe that a number of conditions caused by underlying ischemic injury can be
            improved through our CD34+ cell technology including, but not limited to, Buerger&#8217;s disease, CLI, CMD, and DKD.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">207<br />
        </div>

      </div>

    </div>

    <!--End Page 216-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 217-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">XOWNA&#174; for Treatment of Coronary Microvascular
            Dysfunction</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In 2017, with the assistance of a $1.9&#160;million grant from the National Institutes of
            Health (Award Number R44HL135889), we initiated our program for XOWNA&#174; for the treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the
            ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a
            statistically significant improvement in angina frequency, coronary flow reserve, Canadian Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study
            was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr. Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, we commenced enrollment in our Phase 2b FREEDOM Trial of XOWNA&#174;, a
            double-blind, randomized and placebo-controlled clinical trial designed to further evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease.
            The FREEDOM Trial, was originally designed to enroll 105 patients randomized 4:3 active:placebo and was expected to complete enrollment in approximately 12 months. The primary objectives of the FREEDOM Trial were to corroborate the results of
            ESCaPE-CMD trial, to get a better estimation of the magnitude of treatment effect of XOWNA&#174; on clinical endpoints likely to be required by the FDA in a pivotal trial and to assess the impact of XOWNA&#174; on a patient population more broadly
            representative of the intended treatment population. Enrollment in the FREEDOM Trial initiated as planned and the first patient was treated in January 2021. Unfortunately, shortly thereafter, the impact of the COVID-19 pandemic in the U.S. has
            contributed to a general slowing of enrollment that continues to this day. The Company intends to conduct an interim analysis of the data from not less than the first 20 patients enrolled using the 6-month follow-up data to evaluate the
            efficacy and safety of XOWNA&#174; in subjects with CMD and corroborate the ESCaPE-CMD study results. The following is a list of major challenges to the FREEDOM Trial execution:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Accessibility of subjects to investigational sites which had restricted access to the treatment of COVID-19 patients and/or only
                    patients with grave illness;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Availability of staff at the clinical sites due to reassignment to COVID-19 treatment areas and/or to the resignation of
                    personnel; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Unexpected discontinuation by the manufacturer of the catheter originally specified for the diagnosis of CMD as part of the
                    inclusion criteria;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Subjects testing positive for COVID-19 prior to treatment;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Competition for available apheresis resources; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">6.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Supply chain (i.e., out-of-stock) issues associated with some of the catheters cleared by FDA for administration of XOWNA&#174;;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">7.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Discontinuation by the manufacturer of catheters cleared by FDA for administration of XOWNA&#174;;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">8.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Supply chain (i.e., out-of-stock) issues associated with Omnipaque, a commonly used contrast agent in catheter laboratories; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">9.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Financial pressures associated with dramatically increased costs of personnel, materials in general and with the cost of capital
                    in particular.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition to the above, in the coming months we would be required to commit a
            significant amount of capital not originally budgeted for this program to an extension of our contract manufacturing organization arrangements, another unanticipated consequence of the pandemic-related delays in enrollment. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To date, despite multiple protocol amendments to address the aforementioned challenges,
            along with an increased number of sites in the study, the FREEDOM Trial has enrolled approximately one third of the targeted 105 patients. At this rate and given the continued uncertainty of the direct and indirect impact of the COVID-19
            pandemic on enrollment, an additional more than four years would likely be required to complete enrollment and reach the primary endpoint at 6-months follow-up for all subjects. We evaluated the value and viability of continuing the FREEDOM
            Trial as originally designed and determined that the trial has served its purpose and that further enrollment would not provide clinical data particularly useful for future regulatory and/or commercial use. Consequently, we have decided to
            discontinue enrollment activities in the FREEDOM Trial and will conduct </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">208<br />
        </div>

      </div>

    </div>

    <!--End Page 217-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 218-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">an analysis of the data from not fewer than the first 20 patients with 6-month
            follow up (the same number as was evaluated in the ESCaPE-CMD trial) to achieve one of the objectives of the study, i.e., evaluation of the efficacy and safety of XOWNA&#174; in subjects with CMD in a controlled trial with the aim of corroboration
            of the ESCaPE-CMD study results. Additionally, these data will provide an estimation of the XOWNA&#174; effect size on the clinical endpoints likely to be required by the FDA in a future pivotal study. The next steps of development of XOWNA&#174; will be
            determined based on the results of this interim analysis, appropriate discussions with the FDA, if warranted, a review of costs and timeline and the interest of any of possible collaborators. Per good clinical practice, we will continue to
            assess and follow all treated subjects according to protocol through completion of follow-up. The interim analysis is expected to be completed in August 2022 and the following potential outcomes are projected based on the results of the
            analysis of the FREEDOM Trial data: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The data corroborate the ESCaPE-CMD data</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">a.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">We will meet with the FDA to discuss the path to registration for the product and then determine whether future clinical
                    development can be solely supported by us or if a partner or licensee will be required for continued development and if such a partner is available</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The data do not corroborate ESCaPE-CMD results</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">a.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">We will likely terminate the development of XOWNA&#174; for CMD </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The final decision on the future development of XOWNA&#174; is expected by end of 2022. As
            with all development activities, there can be no assurance of a positive outcome.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">HONEDRA&#174; for Treatment of Critical Limb Ischemia</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our randomized, open-label, registration-eligible study of HONEDRA&#174; in Japan for the
            treatment of CLI and Buerger&#8217;s disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA&#174; study&#8217;s enrollment, however, has been significantly curtailed by the COVID-19 pandemic&#8217;s impact in Japan, including the
            States of Emergency in Japan that have persisted for much of the past 18 months. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19 delays, coupled with the unpredictability of the
            timing of site enrollment re-initiation, we suspended further enrollment and are focusing our efforts on consummating a partnership for the product in Japan. Such a partnership may become the basis for the completion of development and
            registration of HONEDRA&#174; in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or exploration of submitting the existing data to Japan&#8217;s
            Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) under Japan&#8217;s regenerative medicine regulations, which allow for conditional approval of innovative regenerative medicine products. Despite receipt from FDA in March 2021 of orphan designation
            in the United States for CLBS12 as a potential treatment for Buerger&#8217;s disease, based on a response from the FDA in October 2021 regarding a development plan for U.S. registration, we have decided not to pursue U.S. development in Buerger&#8217;s
            disease at this time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">CLBS201 for Treatment of Diabetic Kidney Disease</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Progressive kidney failure is associated with attrition of the microcirculation of the
            kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, we have elected to move forward with a
            Phase&#160;1, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol, as approved by an IRB, is expected to include six subjects in total with the first two subjects
            sequentially dosed and followed for a two-week safety observation period. Clearance by an independent Data Safety Monitoring Board (&#8220;DSMB&#8221;) overseeing the study will then permit the treatment of the next four patients, with all patients being
            followed for safety and therapeutic effect. A read-out of data will occur after the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201 will be our ability to demonstrate a therapeutic effect that
            will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Additional Out-licensing Opportunities and
            Pipeline Diversification</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our broad intellectual property portfolio of cell therapy assets includes notable
            programs available for out-licensing in order to continue their clinical development. Our current long-term strategy focuses on advancing our therapies through development with the ultimate objective of obtaining market authorizations and
            entering </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">209<br />
        </div>

      </div>

    </div>

    <!--End Page 218-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 219-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">commercialization, either alone or with partners, to provide treatment options to
            patients suffering from life-threatening medical conditions. We believe that we are well-positioned to realize potentially meaningful value increases within our own proprietary pipeline if we are successful in advancing our product candidates
            to their next significant development milestones.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, we further desire to diversify our pipeline of development product
            candidates and are exploring a range of strategic transactions in furtherance of that goal. We have taken, and intend to continue to take, active steps to identify assets and/or companies for acquisition and/or partnership that would complement
            our current development programs and de-risk our overall development portfolio. Such assets potentially could target indications beyond cardiovascular disease as well as product categories outside of cell therapy. The range of possible
            transactions includes an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute the shares of our existing stockholders.
            There can be no assurance that this exploration of strategic alternatives will result in us entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">COVID-19 Considerations</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which causes COVID-19,
            was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world&#8217;s economies began to experience pronounced effects. Despite the FDA approval of multiple
            COVID-19 vaccines, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, we implemented a universal work
            from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. Our clinical study of HONEDRA&#174; in Japan has experienced significant delays in enrollment due to the States of
            Emergency in effect in Japan for most of 2020 and re-implemented from January&#160;7, 2021 through March&#160;21, 2021 covering Tokyo and other regions in response to an increased number of COVID-19 infections. Due to reported increases in COVID-19 cases
            and a low rate of vaccination in Japan, States of Emergency were renewed on April&#160;25, 2021 through May&#160;11, 2021 and then re-implemented in Tokyo from July&#160;12, 2021 through September&#160;30, 2021. With our expectation that COVID-19 in Japan would
            continue to impact negatively enrollment of patients in the HONEDRA&#174; clinical trial, we have elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory authorities regarding the submission of
            patient data already accrued. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, our Phase 2b trial of XOWNA&#174; in the United States has also experienced
            delays in enrolling patients as a result of COVID-19. As described above, the impact of the COVID-19 pandemic in the U.S. has contributed to a general slowing of enrollment for the FREEDOM Trial that continues to this day. The impact of
            COVID-19 on the trial included: limited accessibility of subjects to investigational sites which had restricted access to the treatment of COVID-19 patients and/or only patients with grave illness; limited availability of staff at the clinical
            sites due to reassignment to COVID-19 treatment areas and/or to the resignation of personnel; subjects testing positive for COVID-19 prior to treatment; and supply chain issues relating to catheters and other materials used for the trial.
            Consequently, the Company has decided to discontinue enrollment activities in the FREEDOM Trial and will conduct an analysis of the data from not fewer than the first 20 patients with 6-month follow up (the same number as was evaluated in the
            ESCaPE-CMD trial) to achieve one of the objectives of the study, i.e., evaluation of the efficacy and safety of XOWNA&#174; in subjects with CMD in a controlled trial with the aim of corroboration of the ESCaPE-CMD study results. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h2">THE FIELD OF CELL THERAPY</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Regenerative medicine is defined as the process of replacing or regenerating human
            cells, tissues or organs to restore normal function. Among the categories of therapeutic technology platforms within this field are cell therapy, gene therapy, tissue engineering, tools, device diagnostics and aesthetic medicine. All living
            complex organisms start as a single cell that replicates and then individual groups of cells differentiate (mature into complex cell types), thereby yielding the diversity of organs and organ systems in an adult organism. Cell therapy is a
            process that uses cells to prevent, treat or cure disease, or to regenerate damaged or aged tissue. Since the 1970s, bone marrow, blood and umbilical cord-derived stem cells have been used to restore bone marrow, as well as blood and immune
            system cells damaged by the chemotherapy and radiation historically used to treat many cancers. Notably, this approach holds certain curative potential for patients with otherwise fatal conditions.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">210<br />
        </div>

      </div>

    </div>

    <!--End Page 219-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 220-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">There are two general classes of cell therapies: autologous and allogeneic. When
            cells are collected from a person (donor) and transplanted or used to develop a treatment solely for that same person (recipient or patient) with or without modification, the treatment paradigm is known as &#8220;autologous&#8221; cell therapy. For
            long-term repair of cardiovascular tissues, evidence indicates that the repair cells must remain in the target tissue for a period of time. Since autologous cells are not destroyed by the immune system, autologous cell therapy can be expected
            to result in long-term residence of the administered cells. When the donor and the recipient are not the same individual, however, the procedures are referred to as &#8220;allogeneic&#8221; cell therapy.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Various cell therapies are in clinical development for an array of human diseases,
            including autoimmune, oncologic, cardiovascular, neurologic and orthopedic diseases, among other indications. While no assurances can be given regarding future medical developments, we believe that the field of cell therapy holds the promise to
            better the human experience and minimize or ameliorate the pain and suffering from many common and often life-threatening diseases. The FDA has been investing significant resources into policies and organizational changes to advance the cell
            and gene therapy fields in recent years through what the agency has labeled its &#8220;comprehensive regenerative medicine policy framework,&#8221; as first announced in late 2017 and incrementally developed since that time through various agency actions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2">TECHNOLOGY OUT-LICENSING OPPORTUNITIES</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Ischemic Repair (CD34+ Cell Technology)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our CD34+ Cell Technology is an autologous cell platform technology with potential
            application to a broad array of ischemic conditions and we will seek to out-license the technology in geographies and/or indications in which we do not intend to pursue development ourselves.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h5"><span style="text-decoration: underline;">Intellectual Property Platform</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Our developed and owned ischemic repair patent portfolio comprises the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">a.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Nine U.S. patents, three European Union (&#8220;EU&#8221;) patents (each filed in 5 individual countries) and ten other patents in Japan,
                    Canada, Russia and Hong Kong;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">b.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Claims cover, <span style="font-style: italic;">inter alia</span>, a pharmaceutical composition that contains a therapeutic
                    concentration of non-expanded CD34+ stem cells that move in response to SDF-1 or VEGF, together with a stabilizing amount of serum, that can be delivered to repair an injury caused by vascular insufficiency;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">c.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Issued and pending claims can be applied to a broad range of conditions caused by underlying ischemia, including acute
                    myocardial infarction, chronic myocardial ischemia post-acute myocardial infarction, chronic heart failure, critical limb ischemia, and ischemic brain injury and DKD;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">d.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">One pending patent application in the United States; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">e.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">One pending patent application outside the United States.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h5"><span style="text-decoration: underline;">Market Opportunity for CLI</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In Japan, there are approximately 300,000 patients with CLI, of whom approximately
            51,000 are not candidates for revascularization, together with an addressable population of approximately 560,000 patients in the EU and 300,000 in the United States.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The field of cardiovascular cell therapy development is competitive. There are a number
            of companies that are developing cell-based therapies for cardiovascular diseases. These companies are utilizing a number of different therapeutic approaches in their development efforts. There are both autologous and allogeneic based
            competitive therapies that derive cells principally from four sources: fat, peripheral blood, cord blood, and bone marrow. HONEDRA&#174; is an autologous therapy that derives its cells from the peripheral blood of the patient via apheresis.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h5"><span style="text-decoration: underline;">Market Opportunity for CMD</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the United States there is an addressable population of approximately 400,000 to
            1,600,000 patients with CMD, while the addressable population is roughly 1,200,000 to 4,800,000 in the EU and between 43,000 and 166,000 in Japan.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">211<br />
        </div>

      </div>

    </div>

    <!--End Page 220-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 221-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h5"><span style="text-decoration: underline;">Market Opportunity for DKD</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the United States, stage 3 and 4 DKD patients represent an addressable population of
            approximately 7,000,000 and there is an estimated addressable population of 12,000,000 patients in the EU.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">SEASONALITY</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">We do not believe that our operations are seasonal in nature.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">GOVERNMENT REGULATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The healthcare industry is one of the most highly regulated industries in the United
            States and abroad. Various governmental regulatory authorities, as well as private accreditation organizations, oversee and monitor the activities of individuals and businesses engaged in the development, manufacture and delivery of health care
            products and services. The following is a general description of certain current laws and regulations that are relevant to our business:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Premarket Review and Approval of Pharmaceutical
            and Biological Products in the United States</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left; line-height: 11.5pt;" class="fpara">In the United States, pharmaceutical and biological products,
            including cellular therapies, are subject to extensive pre- and post-market regulation by the FDA. The FD&amp;C Act and other federal and state statutes and regulations, govern, among other things, the research, development, testing,
            manufacture, storage, recordkeeping, approval, labeling, promotion and marketing, distribution, post-approval monitoring and reporting, sampling, and import and export of pharmaceutical products, including biological products, intended for
            therapeutic uses. Biological products are approved for marketing under provisions of the Public Health Service Act (&#8220;PHS Act&#8221;). However, biological products that also meet the definition of &#8220;drugs&#8221; under the FD&amp;C Act are also subject to
            regulation under FD&amp;C Act provisions and to applicable provisions from two sets of FDA&#8217;s implementing regulations, those for biological products and those for drugs. Another distinction between pharmaceuticals and cellular therapies is that
            the PHS Act requires the submission of a BLA, rather than a New Drug Application (&#8220;NDA&#8221;), for market authorization of a cellular therapy candidate like ours. Generally, the application process and requirements for product approval under BLA is
            similar to those for an NDA, and the review process for biological products is associated with similar approval risks and application costs as for chemical entity drug products.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Failure to comply with applicable U.S. requirements may subject a company to a variety
            of administrative or judicial sanctions, such as the FDA refusal to approve pending NDAs or BLAs, withdrawal of an approval, issuance of warning letters and other types of enforcement letters, product recalls, product seizures, total or partial
            suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement of profits, or civil or criminal investigations and penalties brought by the FDA and the Department of Justice or other
            governmental entities. Under certain circumstances, individual members of company management may also be subject to civil or criminal penalties related to company violations of applicable legal requirements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">An applicant seeking approval to market and distribute a new pharmaceutical or
            biological product in the United States typically must undertake the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">completion of preclinical laboratory tests, animal studies and formulation studies in compliance with the FDA&#8217;s good laboratory
                    practice or GLP regulations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">submission to the FDA of an IND, which includes the detailed clinical protocol, which must take effect before human clinical
                    trials can commence;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approval of the clinical trial protocol and the sponsor&#8217;s safeguards for human subjects by one or more IRBs depending on the
                    numbers of clinical sites and other features of the study design, before each clinical trial may be initiated;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">performance of adequate and well-controlled human clinical trials in accordance with good clinical practices, or &#8220;GCPs,&#8221; to
                    establish the safety and efficacy of the proposed drug or biological product for each proposed indication for which FDA approval is sought;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">satisfactory completion of FDA audits of clinical trial sites to assure compliance with GCPs and the integrity of the clinical
                    data;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">preparation and submission to the FDA of an NDA or BLA, as appropriate;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">review of the product by an FDA advisory committee, where appropriate or if applicable, as determined by the FDA at its
                    discretion;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">212<br />
        </div>

      </div>

    </div>

    <!--End Page 221-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 222-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">satisfactory completion of one or more FDA inspections of the manufacturing facility or facilities at which the product, or
                    components thereof, are produced to assess compliance with the regulations establishing cGMP/cGTP (if applicable), and to assure that the facilities, methods and controls used for the manufacture, processing and packing of the drug or
                    biological product are adequate to preserve the product&#8217;s identity, strength, quality and purity; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">payment of applicable user fees and securing FDA approval of the NDA or BLA.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Satisfaction of FDA pre-market approval requirements typically takes many years and the
            actual time required may vary substantially based upon the type, complexity and novelty of the product or disease. Moreover, submission of an IND may not result in FDA authorization to initiate a clinical trial if the FDA raises concerns or
            questions about the design of the clinical trial or the preclinical or manufacturing information supporting it, including concerns that human research subjects will be exposed to unreasonable health risks. A separate submission to an existing
            IND must also be made for each successive clinical trial conducted during product development. After a trial is initiated, the FDA may order the temporary or permanent discontinuation of a clinical trial at any time, or impose other sanctions,
            if it believes that the clinical trial is not being conducted in accordance with FDA requirements, or presents an unacceptable risk to the clinical trial patients.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Clinical trials involve the administration of the investigational new drug to healthy
            volunteers or patients under the supervision of a qualified investigator. Clinical trials must be conducted in compliance with federal regulations and GCPs, which are meant to protect the rights and health of patients and to define the roles of
            clinical trial sponsors, administrators, and monitors. In addition, sponsors of most clinical trials involving FDA regulated products, including drugs and biologics, are required to register and disclose certain clinical trial information on a
            public registry and results database managed by the National Institutes of Health called ClinicalTrials.gov. Registration information that must be submitted includes information related to the product, patient population, phase of
            investigation, study sites and investigators, and other aspects of the clinical trial. Sponsors are also obligated to disclose the results of their clinical trials after completion. Competitors may use this publicly available information to
            gain knowledge regarding the progress of development programs. Failure to comply with applicable clinical trial registration or results reporting obligations can result in civil monetary penalties or the withholding of grant funds from a
            federally funded grantee.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Clinical trials to support NDAs or BLAs for marketing approval are typically conducted
            in three sequential phases, but the phases may overlap or may be combined. Under certain circumstances, a fourth post-approval phase may be required.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Phase 1</span>: Trials in this phase are initially conducted in a limited population of
                    healthy volunteers to test the product candidate for safety, dose tolerance, absorption, metabolism, distribution and excretion in healthy humans or, on occasion, in patients, such as cancer patients, when the drug or biologic is too
                    toxic to be ethically given to healthy individuals.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Phase 2</span>: These clinical trials are generally conducted in a limited patient population
                    to determine the presence and approximate magnitude of therapeutic effect of the product for specific targeted indications and to identify appropriate therapeutic dose and dose frequency as well as any corresponding additional possible
                    adverse effects and safety risks. Multiple Phase 2 clinical trials may be conducted by the sponsor to obtain information prior to beginning larger and more expensive Phase&#160;3 clinical trials.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Phase 3</span>: These are commonly referred to as pivotal or registration studies. When Phase
                    2 evaluations demonstrate that a dose range of the product is effective and has an acceptable safety profile, Phase 3 clinical trials are typically undertaken in a larger patient population to further evaluate dosage, to provide
                    substantial evidence of clinical efficacy and to further test for safety in an expanded and diverse patient population at multiple and geographically-dispersed clinical trial sites. In most cases, the FDA requires two adequate and
                    well-controlled Phase 3 clinical trials to demonstrate the efficacy of the drug or biologic as a requirement for marketing authorization.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Phase 4</span>: In some cases, the FDA may condition approval of an NDA or BLA for a product
                    candidate on the sponsor&#8217;s agreement to conduct additional clinical trials after NDA or BLA approval. In other cases, a sponsor may voluntarily carry out additional trials post approval to gain more information about the drug or
                    biologic.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">213<br />
        </div>

      </div>

    </div>

    <!--End Page 222-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 223-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Submission of an NDA or BLA to the FDA</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Assuming successful completion of the required clinical testing, the results of the
            preclinical studies and clinical trials, together with detailed information relating to the product&#8217;s chemistry, manufacture, controls and proposed labeling, among other things, are submitted to the FDA as part of an NDA or BLA seeking approval
            to market the drug product for one or more indications. FDA approval of the NDA or BLA is required before marketing of the product may begin in the United States. The cost of preparing and submitting an NDA or BLA is substantial. Under federal
            law, most NDA or BLA submissions are additionally subject to a substantial application user fee. The current fee for fiscal year 2022 is $3,117,218 (some small businesses may qualify for a waiver under certain circumstances) and an annual
            program fee, currently $369,413, must also be paid for each approved prescription drug or biological product. These fees are typically adjusted annually.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA has 60 days from its receipt of an NDA or BLA to determine whether the
            application will be accepted for filing based on the Agency&#8217;s threshold determination that the application is sufficiently complete to permit substantive review. Once the submission is accepted for filing, the FDA begins an in-depth review. If
            the application is not sufficiently complete, the FDA may issue a Refusal to File, or RTF, letter, although the FDA may permit an applicant to correct certain easily correctable deficiencies in the NDA/BLA before filing without taking an
            official RTF action. Under certain NDA and BLA review performance goals to which the FDA has agreed, most applications for standard review of drug or biological products are reviewed within ten to twelve months, and most applications for
            priority review drugs or biologics are reviewed within six to eight months. If a sponsor submits a major amendment to a filed NDA or BLA at any time during the review cycle, the FDA may extend these reviews by three months although only one
            such extension is permitted during a review cycle. Priority review can be applied to drugs or biologics that, in the FDA&#8217;s determination, offer major advances in treatment or provide a treatment for a disease or condition for which no adequate
            therapy exists. For biologics, priority review is further limited to products intended to treat a serious or life-threatening disease relative to currently approved products. Priority review requests must be submitted in conjunction with the
            original NDA/BLA for which the sponsor is seeking the designation, and the FDA decision will be made in conjunction with its official action to file the application and begin the substantive review process.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Before approving an NDA or BLA, the FDA will typically inspect one or more clinical
            trial sites to ensure compliance with GCPs. Additionally, the FDA will inspect the facility or the facilities at which the drug is manufactured. These pre-approval inspections cover all facilities associated with an NDA or BLA submission,
            including drug component manufacturing (such as active pharmaceutical ingredients), finished drug product manufacturing, and control testing laboratories. The FDA will not approve the product unless it determines that the manufacturing
            processes and facilities are in compliance with applicable cGMP and cGTP requirements and are adequate to assure consistent production of the drug or biological product within required specifications and the NDA or BLA contains data that
            provide substantial evidence that the drug or biologic is safe and effective for the proposed indication.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA may refer applications for novel drug or biological products, or drug or
            biological products that present difficult questions of safety or efficacy, to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation, and a recommendation as to whether the application
            should be approved. The FDA is not bound by the recommendation of an advisory committee, but the FDA will carefully consider them.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">After the FDA fully evaluates the NDA or BLA and the relevant manufacturing facilities,
            the FDA will issue either an approval/licensure letter or a complete response letter (&#8220;CRL&#8221;). A CRL generally outlines the deficiencies in the submission and may require substantial additional testing or information in order for the FDA to
            reconsider the application. If and when those deficiencies have been addressed to the FDA&#8217;s satisfaction in a resubmitted NDA or BLA, the FDA will issue an approval letter. The FDA has committed to reviewing such resubmissions within two or six
            months, depending on the type of information being provided to address the deficiencies in the CRL. Even with the submission of this additional information, however, the FDA ultimately may decide that the application does not satisfy the
            regulatory criteria for approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If the FDA approves a drug or biological product for marketing in the United States, it
            may limit the approved indications for use for the product; require that contraindications, warnings or precautions be included in the product labeling; require that post-approval studies, including Phase 4 clinical trials, be conducted to
            further assess the drug&#8217;s safety after approval; require testing and surveillance programs to monitor the product after commercialization; or impose other conditions, including distribution restrictions or other risk management </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">214<br />
        </div>

      </div>

    </div>

    <!--End Page 223-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 224-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">mechanisms, such as a REMS, which can materially affect the potential market and
            profitability of the product. The FDA also may prevent or limit further marketing of a product based on the results of post-market studies or surveillance programs. After approval, many types of changes to the approved product, such as adding
            new indications or patient populations, making certain types of manufacturing changes or seeking to make additional labeling claims, are subject to further testing requirements and FDA review and approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">One potential condition of approval is that the FDA may require an applicant to develop
            a REMS to ensure that the benefits of the drug outweigh its risks. To determine whether a REMS is needed, the FDA will consider the size of the population likely to use the product, seriousness of the disease, expected benefit of the product,
            expected duration of treatment, seriousness of known or potential adverse events, and whether the product is a new molecular entity. REMS requirements are tailored to the specific risk/benefit profile of a drug and can include requirements such
            as medication guides for patients, detailed communication plans for health care professionals, and elements to assure safe use, or &#8220;ETASU.&#8221; ETASU may include, but are not limited to, special training or certification for prescribing or
            dispensing, dispensing only under certain circumstances, special monitoring, restricted distribution, and the use of patient registries. The FDA may require a REMS as a condition of approval or may add such a requirement at any point
            post-approval if it becomes aware of a serious risk associated with use of the product. The requirement for a REMS and the specific components that are involved can materially affect the potential market and profitability of a product. If the
            FDA concludes a REMS plan is needed, the sponsor of the NDA or BLA must submit a proposed REMS. The FDA will not approve an NDA without a REMS, if required.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h3">Expedited Review Programs (Fast Track,
            Breakthrough, RMAT) and Accelerated Approval Pathways</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA is authorized to facilitate the development and expedite the review of certain
            drugs or biologics that are intended for the treatment of a serious or life-threatening disease or condition for which there is no effective treatment and which demonstrate the potential to address unmet medical needs for the condition. Under
            the Fast Track Program, the sponsor of an IND for a drug candidate may request that the FDA designate the drug candidate for a specific indication as a Fast Track drug concurrent with, or after, the submission of the IND for the drug candidate.
            The FDA must determine if the drug candidate qualifies for Fast Track designation within 60&#160;days of receipt of the sponsor&#8217;s request. In addition to other benefits such as the ability to engage in more frequent interactions with the FDA, the
            FDA may initiate review of sections of a Fast Track drug&#8217;s NDA or BLA before the application is complete. This &#8220;rolling review&#8221; is available if the applicant provides, and the FDA approves, a schedule for the submission of the remaining
            information and the applicant pays applicable user fees. The FDA&#8217;s time period goal for reviewing an application, however, does not begin until the last section of the NDA/BLA is submitted. Additionally, the Fast Track designation may be
            withdrawn by the FDA if the FDA believes that the designation is no longer supported by data emerging in the clinical trial process.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Separately, under the FDA&#8217;s accelerated approval regulations, the FDA may approve a
            drug for a serious or life-threatening illness that provides meaningful therapeutic benefit to patients beyond existing treatments based upon a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint
            that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity or prevalence of
            the condition and the availability or lack of alternative treatments.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In clinical trials, a surrogate endpoint is a measurement of laboratory or clinical
            signs of a disease or condition that substitutes for a direct measurement of how a patient feels, functions or survives. Surrogate endpoints can often be measured more easily or more rapidly than clinical endpoints. A drug candidate approved on
            this basis is subject to rigorous post-marketing compliance requirements, including the completion of Phase 4 or post-approval clinical trials to confirm the effect on the clinical endpoint. Failure to conduct required post-approval studies, or
            confirm a clinical benefit during post-marketing studies, will allow the FDA to withdraw approval of the drug such that accelerated approval is also referred to as U.S. &#8220;conditional&#8221; approval. Products granted accelerated approval also are
            subject to additional requirements for the pre-dissemination review by the FDA of proposed promotional materials both during the NDA review process and for 120 days after marketing approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition to the above, the FDA may designate an investigational product as a
            Breakthrough Therapy or as a Regenerative Medicine Advanced Therapy (&#8220;RMAT&#8221;), depending on the type of investigational product and its ability to meet applicable eligibility criteria. Breakthrough Therapy designation is a process designed to
            expedite </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">215<br />
        </div>

      </div>

    </div>

    <!--End Page 224-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 225-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the development and review of drugs that are intended to treat a serious condition
            and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on a clinically significant endpoint(s). The RMAT designation requires similar eligibility criteria to be met, but it is
            available only to cell therapies, tissue therapies, and other products that meet the statutory definition of a &#8220;regenerative medicine therapy.&#8221; Specifically, a biological product is eligible for RMAT designation if: (a) the product candidate is
            a regenerative medicine therapy, which is defined in the FD&amp;C Act as a cell therapy, therapeutic tissue engineering product, human cell and tissue product, or any combination product using such therapies or products, except for those
            regulated solely under the PHS Act (that is, excluding those biological products that are not also regulated as &#8220;drugs&#8221; under the FD&amp;C Act); (b) the product candidate is intended to treat, modify, reverse, or cure a serious or
            life-threatening disease or condition; and (c) preliminary clinical evidence indicates that the product candidate has the potential to address unmet medical needs for such disease or condition. Both Breakthrough Therapy and RMAT designations
            are intended to help accelerate product development by allowing more frequent interactions with the FDA and receiving intensive FDA guidance on efficient drug development.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">Pediatric Information</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Pediatric Research Equity Act (&#8220;PREA&#8221;), NDAs or BLAs or supplements to NDAs
            or BLAs must contain data that are adequate to assess the safety and effectiveness of the drug or biologic for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric
            subpopulation for which the drug is safe and effective. Sponsors must also submit pediatric trial plans prior to the assessment data, and those plans must contain an outline of the proposed pediatric trial or trials the applicant plans to
            conduct, including trial objectives and design, any deferral or waiver requests and other information required by regulation. The applicant, the FDA, and the FDA&#8217;s internal review committee must then review the information submitted, consult
            with each other, and agree upon a final plan. The FDA or the applicant may request an amendment to the plan at any time. The FDA may grant full or partial waivers or deferrals for submission of data. Unless otherwise required by regulation, the
            pediatric data requirements do not apply to products with orphan designation, although the FDA has recently taken steps to limit what it considers abuse of this statutory exemption in PREA by announcing that it does not intend to grant any
            additional orphan drug designations for rare pediatric subpopulations of what is otherwise a common disease.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Best Pharmaceuticals for Children Act (&#8220;BPCA&#8221;) provides approved NDA and BLA
            holders a six-month extension of any exclusivity that attaches to the end of all existing marketing exclusivities and patents for the drug or biologic. Conditions for exclusivity include the FDA&#8217;s determination that information relating to the
            use of a new drug or biologic in the pediatric population may produce health benefits in that population, the FDA making a written request for pediatric studies, and the applicant agreeing to perform, and reporting on, the requested studies
            within the statutory timeframe. The data do not need to show the product to be effective in the pediatric population studied; rather, if the clinical trial is deemed to fairly respond to the FDA&#8217;s request, the additional protection is granted.
            If reports of requested pediatric studies are submitted to and accepted by the FDA within the statutory time limits, whatever statutory or regulatory periods of exclusivity or patent protection cover the product are extended by six months.
            Applications under the BPCA are treated as priority applications, with all of the benefits that designation confers.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">Orphan Drugs</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Orphan Drug Act, the FDA may designate a candidate as an orphan drug if it is
            intended to treat a rare disease or condition (generally meaning that it affects fewer than 200,000 individuals in the United States). Orphan drug designation must be requested by an applicant before submitting an NDA or BLA for the relevant
            drug candidate. If the FDA grants orphan drug designation, the FDA will publicly disclose the generic identity of the drug candidate and its potential orphan use. Orphan drug designation does not convey any advantage in, or shorten the duration
            of, the regulatory review and approval process.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If a product with orphan status receives the first FDA approval for the disease or
            condition for which it has such designation, the product generally will receive orphan drug exclusivity. Orphan drug exclusivity means that the FDA may not approve any other applications for the same product for the same indication for seven
            years, except in certain limited circumstances comprising methods by which a second sponsor can demonstrate clinical superiority of its drug in comparison to the first approved orphan drug. Regardless of the orphan drug designation, a
            competitor may receive FDA approval for a different product (i.e., a different therapeutic agent from the orphan drug) for the same indication for which the orphan product has exclusivity and may obtain </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">216<br />
        </div>

      </div>

    </div>

    <!--End Page 225-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 226-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">approval for the same product (i.e., the same therapeutic agent as the orphan drug)
            but for a different indication. If a designated orphan drug ultimately receives marketing approval for an indication broader than what was described in its orphan drug designation request, it may not be entitled to exclusivity under the Orphan
            Drug Act. Among the other benefits of orphan drug designation, the sponsor receives a waiver of the NDA or BLA application user fee and is eligible for tax credits for certain research (although the amount of this potential tax credit was
            decreased from 50% to 25% of qualified clinical testing expenses with the 2017 overhaul of the U.S. Tax Code, effective in 2018).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Post-Approval Requirements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Drugs and biological products manufactured, marketed or distributed pursuant to FDA
            approval decisions are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion, and
            reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to FDA review and approval before they can be implemented. There also
            are continuing, annual program fee requirements for any marketed, approved prescription products, as well as new application fees for supplemental applications.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, drug manufacturers and other entities involved in the manufacture of
            approved drugs are required to register their facilities with the FDA and state agencies and are subject to periodic unannounced inspections by the FDA for compliance with cGMP/cGTP requirements. Prescription drug distribution facilities are
            also subject to state licensure, including inspections, by the relevant local regulatory authority. Changes to the manufacturing process, specifications or container closure system for an approved drug or biologic are strictly regulated and
            often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP or cGTP and impose reporting and documentation requirements upon the sponsor and others involved in
            the product&#8217;s manufacturing process. We rely, and expect to continue to rely, on third parties for the production of clinical and commercial quantities of our products in accordance with cGMP regulations. These manufacturers must comply with
            cGMP regulations that require, among other things, quality control and quality assurance, the maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Accordingly, manufacturers must
            continue to expend time, money and effort in the area of production and quality control to maintain cGMP/cGTP compliance and ensure ongoing compliance with other statutory requirements the FD&amp;C Act, such as the requirements for making
            manufacturing changes to an approved NDA or BLA.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Even after a new drug or biologic approval is granted, the FDA may withdraw that
            approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. If a previously unknown problem, including adverse events of unanticipated severity or frequency, or
            with manufacturing processes, is discovered or the manufacturer fails to comply with regulatory requirements, the FDA may require revisions to the approved labeling to add new safety information; may impose additional post-market studies or
            clinical trials to assess new safety risks; or may impose distribution or other restrictions under a REMS program. Other potential consequences of regulatory non-compliance include, among other things:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product
                    recalls;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fines, warning letters or holds on post-approval clinical trials;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">refusal of the FDA to approve pending NDAs/BLAs or supplements to approved NDAs/BLAs, or suspension or revocation of product
                    license approvals;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">product seizure or detention, or refusal to permit the import or export of products;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">injunctions or the imposition of civil or criminal penalties;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">consent degrees, corporate integrity agreements, debarment, or exclusion from federal health care programs; or</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">mandated modification of promotional materials and labeling and the issuance of corrective information.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA strictly regulates marketing, labeling, advertising and promotion of
            prescription drug and biological products that are placed on the market. Drugs may be promoted only for the approved indications and in </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">217<br />
        </div>

      </div>

    </div>

    <!--End Page 226-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 227-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">accordance with the provisions of the approved label. The FDA and other agencies
            actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant penalties. In addition, the distribution of prescription
            pharmaceutical products is subject to a variety of federal and state laws, the most recent of which is still in the process of being phased into the U.S. supply chain and regulatory framework.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, the distribution of prescription pharmaceutical products is subject to the
            Prescription Drug Marketing Act, or PDMA, which regulates the distribution of drugs and drug samples at the federal level and sets minimum standards for the registration and regulation of drug distributors by the states. Both the PDMA and state
            laws limit the distribution of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution. Most recently, the Drug Supply Chain Security Act, or DSCSA, was enacted with the aim of building an
            electronic system to identify and trace certain prescription drugs distributed in the United States, including most biological products. The DSCSA mandates phased-in and resource-intensive obligations for pharmaceutical manufacturers, wholesale
            distributors, and dispensers over a 10-year period that is expected to culminate in November 2023. From time to time, new legislation and regulations may be implemented that could significantly change the statutory provisions governing the
            approval, manufacturing and marketing of products regulated by the FDA. It is impossible to predict whether further legislative or regulatory changes will be enacted, or FDA regulations, guidance or interpretations changed or what the impact of
            such changes, if any, may be.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Other Health Care Regulations</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If our product candidates are approved in the United States, we will have to comply
            with various U.S. federal and state laws, rules and regulations pertaining to health care fraud and abuse, including anti-kickback laws and physician self-referral laws, rules and regulations. Violations of the fraud and abuse laws are
            punishable by criminal and civil sanctions, including, in some instances, exclusion from participation in federal and state health care programs, including Medicare and Medicaid. Other federal and state laws and regulations that could directly
            or indirectly affect our ability to operate the business and/or financial performance include:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">state and local licensure, applicable to the processing and storage of human cells and tissues;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">laws and regulations administered by the United States Department of Health and Human Services, including the Office for Human
                    Research Protections and the Office of Inspector General;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">state laws and regulations governing human subject research;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">federal and state coverage and reimbursement laws and regulations, including laws and regulations administered by the Centers
                    for Medicare &amp; Medicaid Services and state Medicaid agencies;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the federal Medicare and Medicaid Anti-Kickback Law and similar state laws and regulations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act and similar state laws and
                    regulations;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the federal physician self-referral prohibition commonly known as the Stark Law, and state equivalents of the Stark Law;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the federal transparency requirements under the Physician Payments Sunshine Act that require manufacturers of FDA-approved
                    drugs, devices, biologics and medical supplies covered by Medicare or Medicaid to report, on an annual basis, to the Department of Health and Human Services information related to payments and other transfers of value physicians,
                    teaching hospitals, and certain advanced non-physician health care practitioners and physician ownership and investment interests;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Occupational Safety and Health Administration requirements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">state and local laws and regulations dealing with the handling and disposal of medical waste; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the Intermediate Sanctions rules of the IRS providing for potential financial sanctions with respect to &#8220;Excess Benefit
                    Transactions&#8221; with tax-exempt organizations.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Some state laws require pharmaceutical companies to comply with the pharmaceutical
            industry&#8217;s voluntary compliance guidelines, or the relevant compliance guidance promulgated by the federal government, in addition to requiring drug manufacturers to report information related to payments to physicians and other health care </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">218<br />
        </div>

      </div>

    </div>

    <!--End Page 227-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 228-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">providers or marketing expenditures to the extent that those laws impose
            requirements that are more stringent than the Physician Payments Sunshine Act. State and foreign laws also govern the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and
            often are not preempted by HIPAA, thus complicating compliance efforts.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Japan&#8217;s Pharmaceutical and Medical Device
            Authority Regulation of Regenerative Medicine</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Prior to 2014, there was no specific regulatory oversight of regenerative medicine
            products in Japan. However, in November 2013, the Japanese authorities revised the Pharmaceutical Affairs Law and renamed it the Pharmaceuticals, Medical Devices, and Other Therapeutic Products Act (the &#8220;PMD Act&#8221;). The new legislation became
            effective on November&#160;25, 2014 and provides for a timely introduction of innovative regenerative medicine products. The new legislation formalizes a legal basis for development of regenerative medicine therapies. The new legislation defines
            regenerative medicine products as processed human cells that are intended to be used for either (1) the reconstructive repair, or formation of structures or functions of the human body; (2)&#160;the treatment or prevention of human diseases; or (3)
            gene therapy.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The legislation allows the PMDA/Ministry of Health, Labour and Welfare (&#8220;MHLW&#8221;) to
            award conditional approval to a regenerative medicine therapy if there is evidence of adequate safety and results which predict likely efficacy. The evidence for efficacy may be based on surrogate endpoints and may come from an exploratory
            study. This conditional approval is time-limited, and there must be an agreement with PMDA/MHLW as to follow-up collection of information which confirms efficacy and safety, similar to a post-marketing commitment in the United States.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the PMD Act, products under consideration may also be given a SAKIGAKE
            designation (similar to an FDA &#8220;Breakthrough&#8221; or &#8220;RMAT&#8221; designation in certain respects) with a priority six month review period. Additionally, there is a commitment that the PMDA will facilitate research and development by giving scientific
            and regulatory advice to sponsors from the early stage of development.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">According to the new legislation, the sponsor prepares a marketing authorization
            application which is submitted for review to the PMDA. The PMDA reviews the application and prepares a review report and recommendation which is submitted to the MHLW. The MHLW reviews the recommendation and makes a decision regarding approval
            of the product. This procedure is followed for both a conditional approval and subsequently for a full approval after the post-marketing commitments have been fulfilled.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">219<br />
        </div>

      </div>

    </div>

    <!--End Page 228-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 229-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCEBUS"><!--Anchor--></a>CEND BUSINESS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h2">Overview </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Therapeutics, Inc. (formerly DrugCendR, Inc.) is a Delaware corporation, formed in
            October 2015 (&#8220;Cend&#8221; or &#8220;the Company&#8221;) and based in San Diego, California. Cend is focused on a tumor microenvironment (&#8220;TME&#8221;)-modifying approach to enable more effective treatment for a range of solid tumor cancers. Cend is advancing a
            pipeline of product and partnering opportunities based on the CendR Platform&#8482; to potentially improve outcomes for patients with a range of solid tumor cancers that are currently poorly treated, representing high unmet medical needs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2">Cend Approach</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Many solid tumor cancers, including pancreatic ductal adenocarcinoma (&#8220;PDAC&#8221;), gastric
            cancers and many other solid tumor cancers are surrounded by dense fibrotic tissue, or stroma. This limits the efficacy of current chemotherapies for these cancers. Emerging immunotherapy treatments, including checkpoint inhibitors, adoptive
            cell therapies such as chimeric antigen receptor T (&#8220;CAR-T&#8221;) cells, as well as nucleic acid-based therapies, such as short interfering RNA (&#8220;siRNA&#8221;), antisense, and messenger RNAs (&#8220;mRNAs&#8221;) face particular challenges in penetrating solid
            tumors. Many tumors also exhibit an immunosuppressive tumor immuno-microenvironment, which suppresses patients&#8217; immune systems&#8217; ability to fight their cancer and can limit effectiveness of immunotherapies. These factors negatively impact the
            ability of many therapeutic agents and immunotherapies to effectively treat these cancers. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To address the tumor stroma&#8217;s role as a primary impediment to effective treatment,
            Cend&#8217;s approach activates a natural transport system that normally brings nutrients into a tissue under emergency situations such as an injury. Cancers highjack this system to promote their own growth. Cend&#8217;s lead investigational drug, CEND-1
            (an internalizing R-G-D or iRGD peptide) activates this transport system in a tumor-specific manner (Sugahara, <span style="font-style: italic;">Science</span>, 2010). This results in tumors taking up systemically administered anticancer drugs
            as if they were nutrients. As a result, more drug accumulates in the tumor than would accumulate without CEND-1, while normal tissues are not affected. Moreover, the drugs penetrate tumor cells further away from blood vessels with CEND-1 than
            without. The overall result is enhanced anticancer activity without an increase in side effects. Anticancer drugs can be coupled or conjugated to CEND-1 or other CendR peptides in Cend&#8217;s portfolio, but can be also simply given together with
            CEND-1. Cend believes that the co-administration option is an advantage because it is not necessary to create a new chemical entity with its attendant regulatory hurdles, providing a potentially faster-to-clinic and potentially faster-to-market
            product opportunity for a range of solid tumor cancers and for co-administration with a range of therapies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Clinical progress with other approaches to address delivery to highly fibrotic tumors,
            such as PEGylated hyaluronidase and hedgehog inhibitors, has been limited by toxicity and side effects. CEND-1 has demonstrated favorable safety/tolerability and activity in clinical trials to enhance delivery of standard-of-care chemotherapy
            for PDAC. Cend and its collaborators have also amassed non-clinical data demonstrating enhanced delivery of a range of emerging anticancer therapies, including immunotherapies, and RNA-based therapeutics. CEND-1&#8217;s cancer-targeted delivery may
            enable such emerging treatment modalities to potentially more effectively treat a range of solid tumor cancers.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Patients in Cend&#8217;s PDAC Phase 1b clinical trial received CEND-1 plus standard
            gemcitabine/nab-paclitaxel (Abraxane) therapy. CEND-1 was well tolerated and the combination generated a promising response rate as well as encouraging progression-free and overall survival results. Preliminary clinical results were presented
            at the European Society for Molecular Oncology meeting in 2020 and provided clinical validation of safety/tolerability and clinical utility. Full results from that study have been accepted for publication in a major medical journal in the third
            quarter of 2022. Cend and its collaborators have initiated a randomized Phase 2 trial in first-line (&#8220;1L&#8221;), metastatic PDAC (&#8220;mPDAC&#8221;) with CEND-1/gemcitabine/nab-paclitaxel versus placebo/gemcitabine/nab-paclitaxel. Enrollment has begun and the
            first patients have initiated treatment in the Phase 2b trial.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Over 20 scientific papers from laboratories all over the world provide non-clinical
            validation for Cend&#8217;s technology and suggest that CEND-1 can enhance antitumor activity of a variety of therapeutics in a variety of solid tumor types. The drugs that have been targeted to tumors in preclinical tumor models include siRNA,
            antisense, microRNAs, immunostimulatory oligonucleotides, chemotherapeutics, kinase inhibitors, antibodies, </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">220<br />
        </div>

      </div>

    </div>

    <!--End Page 229-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 230-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">nanoparticle drugs, cytokines and even adoptive cell immunotherapies, indicating the
            potential broad applicability of CEND&#8217;s technology. Cend believes that the CendR Platform&#8482; holds potential to improve the efficacy of a broad range of cancer therapies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">RNA-based therapies, including antisense, siRNA, microRNA and mRNA have faced
            particular delivery issues for solid tumor cancer applications. These drugs also encounter issues in non-specific binding to serum proteins as well as degradation by nucleases. Once taken up by cells, they may also become sequestered in
            endosomes that, in some cases, may keep them from reaching their targeted intracellular compartments in adequate concentrations. Cend&#8217;s Tumor-Penetrating Nanocomplex, or TPN technology platform utilized the same tumor-targeted tissue
            penetrating capabilities that CEND-1 has demonstrated in the clinic to enable effective delivery of nucleic acid-based drugs into solid tumors. In TPNs, these targeting moieties are combined with other elements to form nanocomplexes that
            self-assemble with RNA-based drugs to encapsulate them to protect from undesired serum protein binding and/or degradation. The TPN platform includes endosome-release moieties that can be employed for applications where release from such
            endosomes will enhance activity in other cellular compartments. TPN technology has been shown to enhance tumor-targeted delivery of constructs such as siRNA to the G12D mutant of K-Ras, which drives approximately 90% of PDAC, as well as other
            RNA-based drugs targeted to high interest anticancer tumor targets. With alternative CendR targeting moieties, it has also been used by Cend and its collaborators to deliver RNA-based drugs to immunomodulatory genes selectively targeting
            certain immune cells. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In 2021, Cend entered a license and collaboration agreement with a major pharmaceutical
            company in China, Qilu Pharmaceutical Co., Ltd., in which Qilu gained rights to CEND-1 for development and commercialization in Greater China. Under terms of the agreement, Cend received $10&#160;million in up-front license fees and is eligible to
            receive development and commercial milestone payments up to $100&#160;million and $125&#160;million, respectively, tiered royalties on net sales in the Qilu territory ranging from 10% to 15%, and tiered sublicensing revenues ranging from 12% to 35%. The
            parties also have an active collaboration in which Qilu provides funding for development and regulatory activities within China.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 30.77%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Product</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Indication</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Status</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Rights</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CEND-1/gemcitabine/nab-paclitaxel</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Pancreatic cancer (1L&#160;mPDAC)</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Phase 2b</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cend / Qilu (China)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CEND-1/FOLFIRINOX</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Pancreatic cancer (Locally&#160;advanced/potentially resectable PDAC)</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Phase 1b/2</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cend / Qilu (China)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CEND-1/FOLFIRINOX/ panitumumab (non-Ras mutated pts)</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Colorectal and appendiceal cancers</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Phase 1b/2</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cend / Qilu (China)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CEND1/gemcitabine/nab-paclitaxel +/- anti-PD(L)1</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Pancreatic cancer (1L&#160;mPDAC)</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Phase 1b/2 expected to commence in fourth quarter of 2022</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cend / Qilu (China)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CEND-1/SoC</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Solid tumor basket study</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Phase 1b/2 expected to commence in first half of 2023</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cend / Qilu (China)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">TPN</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Solid tumor cancer(s)</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Planning development</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 17.95%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cend</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To fully exploit the CendR Platform&#8482;, Cend anticipates that it will enter into
            additional partnerships that may include significant upfront licensing fee, milestone and royalty revenues as well as research and development funding for Cend. In some circumstances, Cend may elect to enter joint venture or other strategic
            relationships with partners who possess complementary assets or capabilities. This approach enables Cend stakeholders to participate in broad application of Cend&#8217;s technology in a capital-efficient business model.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">About CEND-1</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">CEND-1 is an investigational drug that modifies the TME. It is targeted to tumor
            vasculature by its affinity for <span style="font-style: italic;">alpha</span>-v integrins that are selectively expressed in tumor, but not healthy tissue vasculature. CEND-1 is a cyclic internalizing RGD (&#8220;iRGD&#8221;) peptide that, once bound to
            these integrins, is cleaved by proteases expressed in </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">221<br />
        </div>

      </div>

    </div>

    <!--End Page 230-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 231-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg16"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">tumors to release a peptide fragment, called a CendR fragment, which binds to a
            second receptor, called neuropilin-1, to activate a novel uptake pathway that allows anticancer drugs to more selectively penetrate solid tumors. The ability of CEND-1and iRGD peptides to modify the TME to enhance delivery and efficacy of
            co-administered drugs has been demonstrated in models of a range of solid tumors. Results from Cend, collaborators and research groups around the world have been the subject of over 200 scientific publications.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 17.5pt; margin-left: 0pt; text-align: left;" class="h4">Clinical development </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h5">CEND-1 Phase 1b Data</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend conducted its Phase 1b clinical trial on 29 evaluable first-line metastatic
            pancreatic ductal adenocarcinoma patients. The safety profile of CEND-1 combination regimen was similar to standard of care (&#8220;SoC&#8221;) alone. CEND-1 was shown to be well-tolerated with no-dose limiting toxicities. Favorable pharmacokinetic profile
            with median circulating half-life of ~2 hours. An Objective Response Rate (&#8220;ORR&#8221;) of fifty nine percent was observed, including a rare complete response, which compares favorably to the twenty three percent ORR observed in the &#8220;MPACT&#8221; clinical
            trial that served as the basis for approval of nab-paclitaxel for use in combination with gemcitabine for the treatment of first line, metastatic pancreatic ductal adenocarcinoma. The Disease Control Rate (partial and complete responses plus
            stable disease) of over seventy nine percent was observed, which compares favorably to forty eight percent observed in the MPACT trial. Reduction in the level of circulating tumor biomarker CA19-1 was observed in ninety six percent of patients
            versus sixty one percent in the MPACT trial. Median progression-free survival of nearly ten months was observed and compares favorably to less than six months in the MPACT trial. Median overall survival of over thirteen months was observed and
            compares favorably to less than nine months in the MPACT trial.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2">Sales and Marketing </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Target Market and Customers.<span style="font-style: normal;"> </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s initial target market for its drug delivery technology is expected to be the
            pancreatic cancer market, initially the enhancement of gemcitabine and nab-paclitaxel combination chemotherapy with potential to expand for combination with other chemotherapy regimens as well as targeted therapies and immunotherapies. In terms
            of patient population, the potential market for CEND-1 includes 62,210 new pancreatic cancer patients per year in the U.S., as reported by the American Cancer Society, and 496,000 new cases per year and 466,000 deaths per year due to pancreatic
            cancer worldwide, as reported by the International Agency for Research on Cancer. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h4">Production and Marketing Plan. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">CEND-1 is manufactured via relationships with CDMO partners, who Cend believes possess
            sufficient scale and experience to cost-effectively address projected commercial demand. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend plans to commercialize via standard distribution relationships by itself or via
            partnerships to bring its products to cancer patients around the world. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2">Research and Development </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend believes that there are many opportunities to leverage its expertise to develop
            new treatments for significant unmet medical needs. Cend will also continue to seek research and development synergies across all its programs and indications. Cend&#8217;s research and development accrued expenses were $65,000 and $174,000 in the
            years ended December&#160;31, 2020 and 2021, respectively. Cend&#8217;s research and development expenses were $1,291 and $3,200 in the three months ended March&#160;31, 2020 and 2021, respectively. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2">Competition </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The commercialization of new drugs is competitive, and Cend may face worldwide
            competition from major pharmaceutical companies, specialty pharmaceutical companies, biotechnology companies and ultimately generic companies. Cend&#8217;s competitors may develop or market therapies that are more effective, safer or less costly than
            any that Cend is commercializing, or may obtain regulatory or reimbursement approval for their therapies more rapidly than Cend may obtain approval for those of Cend&#8217;s. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">222<br />
        </div>

      </div>

    </div>

    <!--End Page 231-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 232-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg17"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Strategies that specifically aim at dealing with the stromal barrier in tumors by
            reducing the synthesis (inhibition of Notch signaling; (e.g. Olive et al., 2009; Provenzano et al., 2012)) and by increasing the degradation of the stroma (hyaluronidase treatment; Halozyme PEGPH20) would most directly compete with CEND-1, but
            have failed in the clinic. Cend&#8217;s technology is based on a different principle: CEND-1 targets its effects to tumor via affinity for integrins that are selectively expressed on tumor vasculature and initiates an active transport pathway that
            converts the stromal barrier into a drug conduit without destroying the surrounding tissue. It can also be used without the need to couple the drug to the targeting agent. Although effective in mouse cancer models, Notch inhibitors appear to
            have failed in human trials. Cend believes that these matrix remodeling methods lack the targeting aspect provided by CEND-1. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Tumor-targeted variations of cell-penetrating peptides, such as TAT, are a potential
            competing technology that does involve tumor targeting<sup>2</sup>. However, as the cell-penetrating peptide lacks tumor specificity, Cend believes that these compounds are likely to be less specific for tumors than iRGD/CEND-1. Also, their
            cell internalization pathway is different from the CendR pathway used by iRGD<sup>3</sup>, and they have not been shown to possess the ability of the tumor-penetrating peptides to promote drug penetration without covalent coupling.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h2">Intellectual Property </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of December&#160;31, 2021, Cend had eight issued U.S. patents, seven U.S. patent
            applications pending, no U.S. trademark registrations and one trademark applications pending in the United States and other countries. Cend also licenses certain technologies from third parties on an exclusive basis in order to make, use and/or
            sell certain products in the United States and some foreign jurisdictions. Cend&#8217;s material issued U.S. patents generally expire between 2029 and 2030. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s success will significantly depend upon its ability to obtain and maintain patent
            and other intellectual property and proprietary protection for Cend&#8217;s drug candidates in the U.S. and internationally. In addition to trademarks and patents, Cend relies upon unpatented trade secrets, know-how, and continuing technological
            innovation to develop and maintain Cend&#8217;s competitive position. Cend protects its proprietary information, in part, using confidentiality agreements with its commercial partners, collaborators, employees and consultants and invention assignment
            agreements with its employees. Cend also has confidentiality agreements or invention assignment agreements with its commercial partners and selected consultants. Despite these measures, any of Cend&#8217;s intellectual property and proprietary rights
            could be challenged, invalidated, circumvented, infringed or misappropriated, or such intellectual property and proprietary rights may not be sufficient to permit Cend to take advantage of current market trends or otherwise to provide
            competitive advantages. In addition, such confidentiality agreements and invention assignment agreements can be breached and Cend may not have adequate remedies for any such breach. For more information, please see &#8220;<span style="font-style: italic;">Risk Factors&#8212;Risks Related to Cend&#8217;s Intellectual Property</span>.&#8221; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h2">License Agreements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">SBP Exclusive License Agreement. </span>On December&#160;1, 2015, Cend (then DrugCendR LLC)
            entered into an Exclusive License Agreement (the &#8220;SBP License Agreement&#8221;) with the Sanford Burnham Prebys Medical Discovery Institute (&#8220;SBP&#8221;), a California not-for-profit, public benefit corporation based in San Diego, California. Pursuant to
            the SBP License Agreement, SBP licensed to Cend the exclusive right to use certain patents to further Cend&#8217;s research and development efforts. As partial consideration, Cend paid a license fee, and is obligated to pay SBP a royalty on
            sub-license revenues as well as royalty on net sales of identified products as well as development-based milestone payments (as defined therein).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">Qilu Exclusive License Agreement</span>. On February&#160;11, 2021 (&#8220;Effective Date&#8221;), Cend
            and Qilu entered into an Exclusive License and Collaboration Agreement (&#8220;Qilu Agreement&#8221;) wherein Cend agreed to license to Qilu, certain patents and other rights relating to CEND-1 exclusively in the territory of the Greater Area of China
            (including China, Macau, Hong Kong and Taiwan, each a Region (collectively, the &#8220;Territory&#8221;)). Under the terms of the agreement, Cend received $10&#160;million in up-front license fees and is eligible to receive developmental and commercial
            milestone payments up to $100&#160;million and $125&#160;million, respectively, tiered royalties on net sales in the Qilu territory ranging from 10% to 15%, and tiered sublicensing revenues ranging from 12% to 35%.</div>

        </div>

        <div style="width: 468pt; margin-left: 0pt;" class="block-footnote">
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-top: 3pt; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt;" class="rule-partial"> </div>

          </div>

        </div>

        <div style="width: 468pt; margin-left: 0pt;" class="block-footnote">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 10pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;"><span style="position: relative; top: -3.25pt;">2</span><br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 8pt;">Myrdal et al., 2008; Savariar et al., 2013; Liu et al., 2014</span></div>
                </td>

  </tr>


</table>
        </div>

        <div style="width: 468pt; margin-left: 0pt;" class="block-footnote">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 10pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;"><span style="position: relative; top: -3.25pt;">3</span><br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 8pt;">Pang et al., 2014; 2015</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">223<br />
        </div>

      </div>

    </div>

    <!--End Page 232-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 233-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg18"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">UC Exclusive Patent License Agreement.</span> On March&#160;9, 2021, Cend entered into an
            Exclusive License Agreement (the &#8220;UC License Agreement&#8221;) with the Regents of the University of California (&#8220;UC&#8221;). Pursuant to the UC License Agreement, UC licensed to Cend the exclusive right to use certain patents to further Cend&#8217;s research
            and development efforts. As partial consideration, Cend paid a license fee, and is obligated to pay UC a royalty on sub-license revenues as well as royalty on net sales of products as well as development-based milestone payments (as defined
            therein).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">MIT Exclusive Patent License Agreement.</span> On October&#160;4, 2021, Cend entered into an
            Exclusive License Agreement (the &#8220;MIT License Agreement&#8221;) with the Massachusetts Institute of Technology (&#8220;MIT&#8221;). Pursuant to the MIT License Agreement, MIT licensed to Cend the exclusive right to use certain patents to further Cend&#8217;s research
            and development efforts. As partial consideration, Cend paid a license fee, and is obligated to pay MIT a royalty on sub-license revenues as well as royalty on net sales of products as well as development-based milestone payments (as defined
            therein).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">SBP Exclusive Patent License Agreement 2.</span> On October&#160;19, 2021, Cend entered into
            an Exclusive License Agreement (the SBP License Agreement 2) with the Sanford Burnham Prebys Medical Discovery Institute (&#8220;SBP&#8221;), a California not-for-profit, public benefit corporation based in San Diego, California. Pursuant to the SBP
            License Agreement 2, SBP licensed to Cend the exclusive right to use certain patents to further Cend&#8217;s research and development efforts. As partial consideration, Cend paid a license fee, and is obligated to pay UC a royalty on sub-license
            revenues as well as royalty on net sales of products as well as development-based milestone payments (as defined therein).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Manufacturing </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend relies on CDMOs to produce its drug candidates in accordance with cGMP,
            regulations for use in Cend&#8217;s preclinical and clinical trials. The manufacture of pharmaceuticals is subject to extensive cGMP regulations, which impose various procedural and documentation requirements and govern all areas of record keeping,
            production processes and controls, personnel and quality control. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To meet Cend&#8217;s projected needs for clinical supplies to support its activities through
            regulatory approval and commercial manufacturing, the CDMOs with whom Cend currently works currently possess the scale of production to support development and commercialization of CEND-1. Cend believes that there are multiple potential sources
            for its contract manufacturing. Cend retains the option to engage alternate suppliers in the event that its current CDMOs fail to scale production or are not cost competitive. Cend&#8217;s relationships with CDMOs are managed by personnel with
            extensive experience in pharmaceutical development and manufacturing. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If Cend is unable to obtain sufficient quantities of drug candidates or receive raw
            materials in a timely manner, Cend could be required to delay its ongoing clinical trials and seek alternative manufacturers, which would be costly and time-consuming. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Government Regulation and Approval </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">United States-FDA process </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the United States, the FDA regulates drugs. The FD&amp;C Act and other federal and
            state statutes and regulations, govern, among other things, the research, development, testing, manufacture, storage, recordkeeping, approval, labeling, promotion and marketing, distribution, post-approval monitoring and reporting, sampling,
            and import and export of drugs. To obtain regulatory approvals in the United States and in foreign countries, and subsequently comply with applicable statutes and regulations, Cend will need to spend substantial time and financial resources. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h3">Approval process </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA must approve any new drug or a drug with certain changes to a previously
            approved drug before a manufacturer can market it in the United States. If a company does not comply with applicable United States requirements it may be subject to a variety of administrative or judicial sanctions, such as FDA refusal to
            approve pending applications, warning or untitled letters, clinical holds, drug recalls, drug seizures, total or partial suspension of production or distribution, injunctions, fines, civil penalties, and criminal prosecution.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">224<br />
        </div>

      </div>

    </div>

    <!--End Page 233-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 234-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg19"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">The steps Cend must complete before it can market a drug include:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">completion of preclinical laboratory tests, animal studies, and formulation studies, all performed in accordance with the FDA's
                    good laboratory practice, or Good Laboratory Practice (&#8220;GLP&#8221;), regulations; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">submission to the FDA of an Investigational New Drug (&#8220;IND&#8221;) application for human clinical testing, which must become effective
                    before human clinical studies start. The sponsor must update the IND annually; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approval of the study by an independent IRB or ethics committee representing each clinical site before each clinical study
                    begins; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">performance of adequate and well-controlled human clinical studies to establish the safety and efficacy of the drug for each
                    indication to the FDA's satisfaction; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">submission to the FDA of a New Drug Application (&#8220;NDA&#8221;); </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">potential review of the drug application by an FDA advisory committee, where appropriate and if applicable; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">satisfactory completion of an FDA inspection of the manufacturing facility or facilities to assess compliance with cGMP or
                    regulations; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">FDA review and approval of the NDA. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">It generally takes companies many years to satisfy the FDA approval requirements, but
            this varies substantially based upon the type, complexity, and novelty of the drug or disease. Preclinical tests include laboratory evaluation of a drug's chemistry, formulation, and toxicity, as well as animal trials to assess the
            characteristics and potential safety and efficacy of the drug. The conduct of the preclinical tests must comply with federal regulations and requirements, including GLP. The company submits the results of the preclinical testing to the FDA as
            part of an IND along with other information, including information about the product drug's chemistry, manufacturing and controls, and a proposed clinical study protocol. Long term preclinical tests, such as animal tests of reproductive
            toxicity and carcinogenicity, may continue after submitting the initial IND. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA requires a 30-day waiting period after the submission of each IND before the
            company can begin clinical testing in humans. The FDA may, within the 30-day time period, raise concerns or questions relating to one or more proposed clinical studies and place the study on a clinical hold. In such a case, the company and the
            FDA must resolve any outstanding concerns before the company begins the clinical study. Accordingly, the submission of an IND may or may not be sufficient for the FDA to permit the sponsor to start a clinical study. The company must also make a
            separate submission to an existing IND for each successive clinical study conducted during drug development. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Clinical studies </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Clinical studies involve administering the investigational new drug to healthy
            volunteers or patients under the supervision of a qualified investigator. The company must conduct clinical studies:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">in compliance with federal regulations; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">in compliance with good clinical practice, or GCP, an international standard meant to protect the rights and health of patients
                    and to define the roles of clinical study sponsors, administrators, and monitors; as well as </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">under protocols detailing the objectives of the trial, the safety monitoring parameters, and the effectiveness criteria. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The sponsoring company must submit each protocol involving testing on United States
            patients and subsequent protocol amendments to the FDA as part of the IND. The FDA may order the temporary, or permanent, discontinuation of a clinical study at any time, or impose other sanctions, if it believes that the sponsor is not
            conducting the clinical study in accordance with FDA requirements or presents an unacceptable risk to the </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">225<br />
        </div>

      </div>

    </div>

    <!--End Page 234-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 235-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg20"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">clinical study patients. The sponsor must also submit the study protocol and
            informed consent information for patients in clinical studies to an institutional review board for approval. An IRB may halt the clinical study, either temporarily or permanently, for failure to comply with the IRB's requirements, or may impose
            other conditions. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Companies generally divide the clinical investigation of a drug into three or four
            phases. While companies usually conduct these phases sequentially, they are sometimes overlapped or combined. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Phase 1.</span> The company evaluates the drug in healthy human subjects or patients with the
                    target disease or condition. These studies typically evaluate the safety, dosage tolerance, metabolism and pharmacologic actions of the investigational new drug in humans, the side effects associated with increasing doses, and if
                    possible, gain early evidence on effectiveness. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Phase 2.</span> The company administers the drug to a limited patient population to evaluate
                    dosage tolerance and optimal dosage, identify possible adverse side effects and safety risks, and preliminarily evaluate efficacy. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Phase 3.</span> The company administers the drug to an expanded patient population, generally
                    at geographically dispersed clinical study sites, to generate enough data to statistically evaluate dosage, clinical effectiveness and safety, to establish the overall benefit-risk relationship of the investigational drug, and to
                    provide an adequate basis for product approval. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><span style="font-style: italic;">Phase 4.</span> In some cases, the FDA may condition approval of an NDA for a drug on the
                    company's agreement to conduct additional clinical studies after approval. In other cases, a sponsor may voluntarily conduct additional clinical studies after approval to gain more information about the drug. Cend typically refers to
                    such post-approval studies as Phase 4 clinical studies. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A pivotal study is a clinical study that adequately meets regulatory agency
            requirements to evaluate a drug's efficacy and safety to justify the approval of the drug. Generally, pivotal studies are Phase 3 studies, but the FDA may accept results from Phase 2 studies if the study design provides a well-controlled and
            reliable assessment of clinical benefit, particularly in situations in which there is an unmet medical need and the results are sufficiently robust. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA, the IRB, or the clinical study sponsor may suspend or terminate a clinical
            study at any time on various grounds, including a finding that the research subjects are being exposed to an unacceptable health risk. Additionally, an independent group of qualified experts organized by the clinical study sponsor, known as a
            data safety monitoring board or committee, may oversee some clinical studies. This group provides authorization for whether or not a study may move forward at designated checkpoints based on access to certain data from the study. Cend may also
            suspend or terminate a clinical study based on evolving business objectives and the competitive climate. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">CEND-1 is currently in Phase 2b and that is expected to continue until 1H&#8217;2024. In
            parallel with that study, Cend and its partners are advancing additional clinical studies to explore additional solid tumor cancer applications and additional combination therapies including CEND-1. The Company and partners may also initiate
            registrational (Phase 3 or other) clinical trials to serve as a basis for filing for regulatory approvals in the U.S. and other geographies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Submission of an NDA </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">After Cend completes the required clinical testing, Cend can prepare and submit an NDA
            to the FDA, who must approve the NDA before Cend can start marketing the drug in the United States. An NDA must include all relevant data available from pertinent preclinical and clinical studies, including negative or ambiguous results as well
            as positive findings, together with detailed information relating to the drug's chemistry, manufacturing, controls, and proposed labeling, among other things. Data can come from company-sponsored clinical studies on a drug, or from a number of
            alternative sources, including studies initiated by investigators. To support marketing authorization, the data Cend submit must be sufficient in quality and quantity to establish the safety and effectiveness of the investigational drug to the
            FDA's satisfaction. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">226<br />
        </div>

      </div>

    </div>

    <!--End Page 235-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 236-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg21"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">The cost of preparing and submitting an NDA is substantial. The submission of most
            NDAs is additionally subject to a substantial application user fee, and the manufacturer and/or sponsor under an approved new drug application are also subject to annual program user fees. The FDA typically increases these fees annually. Orphan
            drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical study costs, tax advantages, and user-fee waivers. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA has 60 days from its receipt of an NDA to determine whether it will accept the
            application for filing based on the agency's threshold determination that the application is sufficiently complete to permit substantive review. Once the FDA accepts the filing, the FDA begins an in-depth review. The FDA has agreed to certain
            performance goals in the review of NDAs. Under the Prescription Drug User Fee Act, the FDA has a goal of responding to standard review NDAs within ten months after the 60-day filing review period, but this timeframe is often extended. The FDA
            reviews most applications for standard review drugs within ten to 12 months and most applications for priority review drugs within six to eight months. Priority review can be applied to drugs that the FDA determines offer major advances in
            treatment, or provide a treatment where no adequate therapy exists. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA may also refer applications for novel drugs that present difficult questions of
            safety or efficacy, to an advisory committee. This is typically a panel that includes clinicians and other experts that will review, evaluate, and recommend whether the FDA should approve the application. The FDA is not bound by the
            recommendation of an advisory committee, but it generally follows such recommendations. Before approving an NDA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP, and will inspect the facility or the
            facilities at which the drug is manufactured. The FDA will not approve the drug unless compliance with cGMP is satisfactory and the NDA contains data that provide evidence that the drug is safe and effective in the indication studied. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">The FDA's decision on an NDA </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">After the FDA evaluates the NDA and the manufacturing facilities, it issues either an
            approval letter or a complete response letter. A complete response letter indicates that the FDA has completed its review of the application, and the agency has determined that it will not approve the application in its present form. A complete
            response letter generally outlines the deficiencies in the submission and may require substantial additional clinical data and/or other significant, expensive, and time-consuming requirements related to clinical studies, preclinical studies
            and/or manufacturing. The FDA has committed to reviewing resubmissions of the NDA addressing such deficiencies in two or six months, depending on the type of information included. Even if Cend submits such data the FDA may ultimately decide
            that the NDA does not satisfy the criteria for approval. Also, the government may establish additional requirements, including those resulting from new legislation, or the FDA's policies may change, which could delay or prevent regulatory
            approval of Cend&#8217;s drugs under development. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">An approval letter authorizes commercial marketing of the drug with specific
            prescribing information for specific indications. As a condition of NDA approval, the FDA may require a REMS to help ensure that the benefits of the drug outweigh the potential risks. REMS can include medication guides, communication plans for
            healthcare professionals, special training or certification for prescribing or dispensing, dispensing only under certain circumstances, special monitoring, and the use of patient registries. The requirement for REMS can materially affect the
            potential market and profitability of the drug. Moreover, the FDA may condition approval on substantial post-approval testing and surveillance to monitor the drug's safety or efficacy. Once granted, the FDA may withdraw drug approvals if the
            company fails to comply with regulatory standards or identifies problems following initial marketing. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Changes to some of the conditions established in an approved application, including
            changes in indications, labeling, or manufacturing processes or facilities, require submission and FDA approval of a new NDA or NDA supplement before Cend can implement the change. An NDA supplement for a new indication typically requires
            clinical data similar to that in the original application, and the FDA uses the same procedures and actions in reviewing NDA supplements as it does in reviewing new NDAs. As with new NDAs, the FDA often significantly extends the review process
            with requests for additional information or clarification. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Post-approval requirements </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA regulates drugs that are manufactured or distributed pursuant to FDA approvals
            and has specific requirements pertaining to recordkeeping, periodic reporting, drug sampling and distribution, advertising and </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">227<br />
        </div>

      </div>

    </div>

    <!--End Page 236-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 237-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg22"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">promotion and reporting of adverse experiences with the drug. After approval, the
            FDA must provide review and approval for most changes to the approved drug, such as adding new indications or other labeling claims. There also are continuing, annual user fee requirements for any marketed drugs and the establishments who
            manufacture its drugs, as well as new application fees for supplemental applications with clinical data. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In some cases, the FDA may condition approval of an NDA for a drug on the sponsor's
            agreement to conduct additional clinical studies after approval. In other cases, a sponsor may voluntarily conduct additional clinical studies after approval to gain more information about the drug. Such post-approval studies are typically
            referred to as Phase 4 clinical studies. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Drug manufacturers are subject to periodic unannounced inspections by the FDA and state
            agencies for compliance with cGMP requirements. There are strict regulations regarding changes to the manufacturing process, and, depending on the significance of the change, it may require prior FDA approval before Cend can implement it. FDA
            regulations also require investigation and correction of any deviations from cGMP and impose reporting and documentation requirements upon Cend and any third-party manufacturers that Cend may decide to use. Accordingly, manufacturers must
            continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA may withdraw approval if a company does not comply with regulatory requirements
            and maintain standards or if problems occur after the drug reaches the market. If a company or the FDA discovers previously unknown problems with a drug, including adverse events of unanticipated severity or frequency, issues with manufacturing
            processes, or the company's failure to comply with regulatory requirements, the FDA may revise the approved labeling to add new safety information; impose post-marketing studies or other clinical studies to assess new safety risks; or impose
            distribution or other restrictions under a REMS program. Other potential consequences may include:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">restrictions on the marketing or manufacturing of the drug, complete withdrawal of the drug from the market or drug recalls; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fines, warning letters or holds on post-approval clinical studies; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA refusing to approve pending NDAs or supplements to approved NDAs, or suspending or revoking of drug license approvals; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">drug seizure or detention, or refusal to permit the import or export of drugs; or </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">injunctions or the imposition of civil or criminal penalties. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA strictly regulates marketing, labeling, advertising, and promotion of drugs
            that are placed on the market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion
            of off-label uses. Cend could be subject to significant liability if it violated these laws and regulations. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Orphan drug designation </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">CEND-1 has been granted both Orphan Drug and Fast Track Designations by the FDA for the
            treatment of pancreatic cancer. The Company plans to file for similar designations for additional indications and in additional geographies. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The FDA may grant orphan drug designation to drugs intended to treat a rare disease or
            condition that affects fewer than 200,000 individuals in the United States, or if it affects more than 200,000 individuals in the United States, there is no reasonable expectation that the cost of developing and making the drug for this type of
            disease or condition will be recovered from sales in the United States. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Orphan drug designation entitles a party to financial incentives such as opportunities
            for grant funding towards clinical study costs, tax advantages, and user-fee waivers. In addition, if a drug receives FDA approval for the indication for which it has orphan designation, the drug may be entitled to orphan drug exclusivity,
            which means the FDA may not approve any other application to market the same drug for the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority over the drug with orphan
            exclusivity. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">228<br />
        </div>

      </div>

    </div>

    <!--End Page 237-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 238-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg23"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Pediatric information </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Pediatric Research Equity Act, or PREA, NDAs or supplements to NDAs must
            contain data to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the drug is safe and
            effective. The FDA may grant full or partial waivers, or deferrals, for submission of data. Unless otherwise required by regulation, PREA does not apply to any drug for an indication for which the FDA has granted an orphan designation. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Healthcare reform </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In the United States and foreign jurisdictions, the legislative landscape continues to
            evolve. There have been a number of legislative and regulatory changes to the healthcare system that could affect its future results of operations. In particular, there have been and continue to be a number of initiatives at the United States
            federal and state levels that seek to reform the way in which healthcare is funded and reduce healthcare costs. In March 2010, the PPACA was enacted, which includes measures that have significantly changed health care financing by both
            governmental and private insurers. The provisions of PPACA of importance to the pharmaceutical and biotechnology industry are, among others, the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an annual, nondeductible fee on any entity that manufactures or imports certain branded prescription drugs agents, apportioned
                    among these entities according to their market share in certain government healthcare programs; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an increase in the rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13% of the average
                    manufacturer price for branded and generic drugs, respectively; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50% (and 70% starting January&#160;1,
                    2019) point-of-sale discounts to negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer's outpatient drugs to be covered under Medicare Part D; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">extension of manufacturers' Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid
                    managed care organizations, unless the drug is subject to discounts under the 340B drug discount program; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to
                    additional individuals and by adding new mandatory eligibility categories for certain individuals with income at or below 133% of the Federal Poverty Level, thereby potentially increasing manufacturers' Medicaid rebate liability; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expansion of the entities eligible for discounts under the Public Health Service pharmaceutical pricing program; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">expansion of healthcare fraud and abuse laws, including the Federal False Claims Act and the federal Anti-Kickback Statue, new
                    government investigative powers and enhanced penalties for noncompliance; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">new requirements under the federal Physician Payments Sunshine Act for drug manufacturers to report information related to
                    payments and other transfers of value made to physicians and teaching hospitals as well as ownership or investment interests held by physicians and their immediate family members; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">new requirement to annually report certain drug samples that manufacturers and distributors provide to licensed practitioners,
                    or to pharmacies of hospitals or other healthcare entities. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Some of the provisions of the PPACA have yet to be implemented, and there have been
            judicial and Congressional challenges to certain aspects of the PPACA, as efforts to repeal or replace certain aspects of the PPACA. Since January 2017, President Trump signed two Executive Orders and other directives designed to delay the
            implementation of certain provisions of the PPACA or otherwise circumvent some of the requirements for health insurance mandated by the PPACA. Concurrently, Congress has considered legislation that would repeal or repeal and replace all or part
            of the PPACA. While Congress has not passed comprehensive repeal legislation, two bills affecting the implementation of certain taxes under the PPACA have been signed into law. The Tax Cuts and Jobs Act of 2017 includes a provision repealing,
            effective January&#160;1, 2019, the tax-based </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">229<br />
        </div>

      </div>

    </div>

    <!--End Page 238-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 239-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_122-bus_pg24"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">shared responsibility payment imposed by the PPACA on certain individuals who fail
            to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#8220;individual mandate&#8221;. Additionally, on January&#160;22, 2018, President Trump signed a continuing resolution on appropriations for fiscal year 2018
            that delayed the implementation of certain PPACA-mandated fees, including the so-called &#8220;Cadillac&#8221; tax on certain high cost employer-sponsored insurance plans, the annual fee imposed on certain health insurance providers based on market share,
            and the medical device excise tax on non-exempt medical devices. Further, the Bipartisan Budget Act of 2018, among other things, amends the PPACA, effective January&#160;1, 2019, to increase from 50&#160;percent to 70 percent the point-of-sale discount
            that is owed by pharmaceutical manufacturers who participate in Medicare Part D and to close the coverage gap in most Medicare drug plans, commonly referred to as the &#8220;donut hole&#8221;. More recently, in July 2018, CMS published a final rule
            permitting further collections and payments to and from certain PPACA qualified health plans and health insurance issuers under the PPACA risk adjustment program in response to the outcome of federal district court litigation regarding the
            method CMS uses to determine this risk adjustment. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, other health reform measures have been proposed and adopted in the United
            States since PPACA was enacted. For example, as a result of the Budget Control Act of 2011, as amended, providers are subject to Medicare payment reductions of 2% per fiscal year through 2027 unless additional Congressional action is taken.
            Further, the American Taxpayer Relief Act of 2012 reduced Medicare payments to several providers and increased the statute of limitations period for the government to recover overpayments from providers from three to five years. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Employees </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">As of March&#160;31, 2022, Cend had three employees, all of whom were full-time employees.
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Facilities </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s corporate headquarters are located in San Diego, California. Cend plans to add
            facilities in the future as it continues to build its research, development, commercial, and support teams. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tLP"><!--Anchor--></a>Legal Proceedings </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">From time to time, Cend may be involved in various claims and legal proceedings
            relating to claims arising out of its operations, in the normal course of business. Cend is currently a party to one pending legal proceeding.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;28, 2022, Lingmed, LTD, a limited liability corporation with its principal
            place of business in Shanghai,&#160;China (&#8220;Lingmed&#8221;), filed a complaint in the Superior Court of California, San Diego against Cend, Harri&#160;J&#228;rvel&#228;inen (Cend&#8217;s Chief Operating Officer) and various unnamed defendants alleging breach of contract,
            fraud and declaratory relief. Pursuant to a May 2020 contract between Lingmed and Cend (the &#8220;Lingmed Agreement&#8221;), between May 2020 and August 2020, Lingmed acted as Cend&#8217;s exclusive agent in China for the purpose of identifying potential
            partners and assisting in negotiating deals, including licensing arrangements and research collaborations for the development of CEND-1 in China. Lingmed alleges that it established the first contact between Cend and Qilu and that pursuant to
            the Lingmed Agreement, this should have triggered payments to Lingmed when Cend entered into the Qilu Agreement. Lingmed is seeking interest, costs, punitive damages and other relief the court deems proper. Cend management believes this suit is
            without merit and intends to vigorously defend against the action. Additionally, Cend has filed a cross-complaint seeking declaratory relief that it owes no further payments to Lingmed based on discussions Cend had with Qilu prior to entering
            into the Lingmed Agreement and thus Lingmed did not establish the first contact between the companies. Regardless of outcome, litigation can have an adverse impact on Cend because of defense and settlement costs, diversion of management
            resources and other factors.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">230<br />
        </div>

      </div>

    </div>

    <!--End Page 239-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 240-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCMDAF"><!--Anchor--></a>CALADRIUS MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">References in this section to &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; or &#8220;Caladrius&#8221;
            generally refer to Caladrius and its subsidiaries. The following discussion and analysis of financial condition and results of operations should be read together with the section entitled &#8220;Summary Historical and Unaudited Pro Forma Condensed
            Combined Financial Data&#8212;Selected Historical Financial Data of Caladrius&#8221; and the financial statements of Caladrius and accompanying notes, each appearing elsewhere in this proxy statement/prospectus/information statement. This discussion of the
            Caladrius financial condition and results of operations contains certain statements that are not strictly historical and are &#8220;forward-looking&#8221; statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve a
            high degree of risk and uncertainty. Actual results may differ materially from those projected in the forward-looking statements due to other risks and uncertainties that exist in Caladrius&#8217; operations, development efforts and business
            environment, including those set forth in the section entitled &#8220;Risk Factors&#8212;Risks Related to Caladrius&#8221; in this proxy statement/prospectus/information statement, the other risks and uncertainties described in the section entitled &#8220;Risk
            Factors&#8221; in this proxy statement/prospectus/information statement and the other risks and uncertainties described elsewhere in this proxy statement/prospectus/information statement. All forward-looking statements included in this proxy
            statement/prospectus/information statement are based on information available to Caladrius as of the date hereof, and Caladrius assumes no obligation to update any such forward-looking statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results
            of Operations contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set
            forth under &#8220;<span style="font-style: italic;">Forward-Looking Statements</span>&#8221; herein and under &#8220;<span style="font-style: italic;">Risk Factors</span>&#8221; in our 2021 Form 10-K. The following discussion should be read in conjunction with our
            consolidated financial statements and related notes thereto included elsewhere in this proxy statement/prospectus/information statement and in our 2021 Form 10-K and subsequent filings with the SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Overview</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We are a clinical-stage biopharmaceutical company dedicated to the development and
            commercialization of cellular therapies designed to reverse disease and/or promote the regeneration of damaged tissue. We are developing first-in-class therapeutics based on the characteristics of naturally occurring CD34+ cells and their
            ability to stimulate the growth of new microvasculature. Our technology leverages these cells to enable the body&#8217;s natural repair mechanisms using formulations unique to each medical indication.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our leadership team has decades of collective biopharmaceutical product development
            experience in a variety of therapeutic categories. Our goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. Our current product candidates include:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA&#174; (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow on Phase 2b study
                    (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA&#174; (CLBS12), recipient of SAKIGAKE designation and eligible for early conditional approval in Japan for the treatment of
                    critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan. CLBS12 was the recipient of orphan drug designation in March 2021 from the FDA for Buerger&#8217;s
                    disease; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, the subject of a study designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients
                    with chronic kidney disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, we also desire to diversify our pipeline of development product candidates
            and are exploring a range of strategic transactions in furtherance of that goal. We have taken, and intend to continue to take, active steps to identify diligence-suitable assets and/or companies that would complement and de-risk our current
            development programs. Such assets could potentially include indications beyond cardiovascular as well as product categories outside of cell therapy and transactions could include an acquisition, merger, business combination, in-license or </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">231<br />
        </div>

      </div>

    </div>

    <!--End Page 240-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 241-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">other strategic transaction, any of which could result in the issuance of securities
            that could significantly dilute the shares of our existing stockholders. There can be no assurance that this exploration of strategic alternatives will result in us entering into or completing any transaction or that such transaction, if
            completed, will add to shareholder value.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Cend Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;26, 2022, we, Merger Sub, and Cend entered into the Merger Agreement, pursuant
            to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Cend, with Cend continuing as our wholly owned subsidiary and the surviving
            corporation of the merger. The Merger is intended to qualify for federal income tax purposes as a tax-free reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986, as amended.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Subject to the terms and conditions of the Merger Agreement, at the closing of the
            Merger, (a) each outstanding share of Cend common stock and Cend preferred stock will be converted into the right to receive a number of shares of our common stock (&#8220;Caladrius Common Stock&#8221;) equal to an exchange ratio calculated pursuant to the
            terms of the Merger Agreement; and (b) each outstanding Cend stock option that has not previously been exercised prior to the closing of the Merger will be assumed by us.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the exchange ratio formula, as of immediately after the Merger, the former Cend
            stockholders are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock and our stockholders as of immediately prior to the Merger are expected to own approximately 50% of the outstanding shares of Caladrius
            Common Stock. The actual allocation will be subject to adjustment based on our net cash balance at the time of closing and the amount of any transaction expenses of Cend in excess of $250,000 at the time of Closing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Consummation of the Merger is subject to certain closing conditions, including, among
            other things, approval by the stockholders of Caladrius and Cend, and Caladrius&#8217; satisfaction of a minimum net cash threshold at closing, expected to be approximately $69.9&#160;million assuming a closing at the end of the third quarter of 2022, and
            as described further in the Merger Agreement. In accordance with the terms of the Merger Agreement, (i)&#160;certain executive officers, directors and stockholders of Cend (solely in their respective capacities as Cend stockholders) holding
            approximately 77.5% of the outstanding Cend Capital Stock (excluding shares held by Caladrius) have entered into support agreements with Caladrius to vote all of their shares of Cend Capital Stock in favor of adoption of the Merger Agreement
            (the &#8220;Cend Support Agreements&#8221;) and (ii)&#160;certain executive officers and directors of Caladrius (solely in their respective capacities as Caladrius Stockholders) holding approximately 1.8% of the outstanding Caladrius Common Stock have entered
            into support agreements with Cend to vote all of their shares of Caladrius Common Stock in favor of approval of the Merger Agreement (the &#8220;Caladrius Support Agreements,&#8221; together with the Cend Support Agreements, the &#8220;Support Agreements&#8221;). The
            Support Agreements include covenants with respect to the voting of such shares in favor of approving the transactions contemplated by the Merger Agreement and against any competing Acquisition Proposals and place certain restrictions on the
            transfer of the shares of Caladrius and Cend held by the respective signatories thereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Concurrently with the execution of the Merger Agreement, certain officers and directors
            of Caladrius holding approximately 1.8% of the outstanding Caladrius Common Stock and certain officers, directors and stockholders of Cend holding approximately 77.5% of the Cend Capital Stock have entered into lock-up agreements (the &#8220;Lock-Up
            Agreements&#8221;) pursuant to which they accepted certain restrictions on transfers of shares of Caladrius Common Stock for the 120-day period following the closing of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement contains certain termination rights for both us and Cend, and
            further provides that, upon termination of the Merger Agreement under specified circumstances, we may be required to pay Cend a termination fee of $1.0&#160;million, Cend may be required to pay us a termination fee of $4.0&#160;million, or in some
            circumstances reimburse the other party&#8217;s expenses up to a maximum of $1.0&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">At the Effective Time of the Merger, the board of directors of the combined company is
            expected to consist of nine members, four of whom will be designated by us, four of whom will be designated by Cend and one member who will be mutually agreed between us and Cend.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">232<br />
        </div>

      </div>

    </div>

    <!--End Page 241-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 242-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Cend Investment and Collaboration Agreement</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In order to provide Cend with capital for its development programs prior to the closing
            of the Merger, we and Cend entered into a Series D Preferred Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which we agreed to purchase from Cend 1,135,628 shares of Series D Preferred Stock, $0.00001 par value per share (the
            &#8220;Series D Preferred Stock&#8221;), of Cend at a purchase price per share equal to $8.8057 per share (the &#8220;Series D Original Issue Price&#8221;), or approximately $10&#160;million in the aggregate. The Purchase Agreement contains customary representations,
            warranties and agreements by us and Cend and customary conditions to closing. The Series D Preferred Stock ranks senior to Cend&#8217;s common stock and the other series of preferred stock with respect to rights on the distribution of assets on any
            voluntary or involuntary liquidation, dissolution or winding up of Cend. The Series D Preferred Stock has a liquidation preference equal to the Series D Original Issue Price plus an amount equal to any accrued and unpaid dividends to the date
            of payment and will participate with Cend&#8217;s common stockholders and other preferred stockholders thereafter on an as-converted basis, except in connection with the Merger. The Series D Preferred Stock shall vote with the common stock on an
            as-converted basis on any matters presented to the stockholders of Cend. Each share of Series D Preferred Stock is convertible, at the option of the holder thereof, into such number of shares of Cend common stock as is determined by dividing
            the Series D Original Issue Price by the conversion price in effect at the time of conversion, which conversion price shall be the Series D Original Issue Price as appropriately adjusted for stock splits, stock dividends, combinations, and
            subdivisions of Cend common stock, and as adjusted pursuant to a weighted-average antidilution adjustment. The Series D Preferred Stock will automatically convert into shares of Cend common stock upon the closing of a firm-commitment
            underwritten initial public offering implying a pre-equity offering value of at least $250&#160;million, resulting in at least $50&#160;million of gross proceeds to Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In connection with the Purchase Agreement, we and Cend entered into a Collaboration
            Agreement (the &#8220;Collaboration Agreement&#8221;), pursuant to which we agreed to collaborate with Cend on certain developmental and clinical activities prior to the closing of the Merger. Under the Collaboration Agreement, we and Cend agreed to form a
            joint steering committee (the &#8220;Committee&#8221;) comprised of individuals from both entities. The Committee is required to meet regularly and be responsible for monitoring ongoing studies and making recommendations for development activity and trial
            planning. Cend has agreed to pay each member of the Committee from Caladrius an hourly consulting fee for such service.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h3">Ischemic Repair (CD34 Cell Technology)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The CD34+ cell was discovered as a result of the deliberate search for a cell capable
            of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building new blood vessels
            after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same capability.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our proprietary cell technology using autologous (a patient&#8217;s own naturally occurring)
            CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is restricted or reduced. Through the
            administration of CD34+ cells, we seek to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. We believe that a number of conditions caused by underlying ischemic injury can be
            improved through our CD34+ cell technology including, but not limited to, Buerger&#8217;s disease, CLI, CMD, and DKD.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h3">XOWNA&#174; for Treatment of Coronary Microvascular
            Dysfunction</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In 2017, with the assistance of a $1.9&#160;million grant from the National Institutes of
            Health (Award Number R44HL135889), we initiated our program for XOWNA&#174; for the treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the
            ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a
            statistically significant improvement in angina frequency, coronary flow reserve, Canadian Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study
            was presented at the SCAI 2020 Scientific Sessions Virtual </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">233<br />
        </div>

      </div>

    </div>

    <!--End Page 242-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 243-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Conference on May&#160;14, 2020 by Dr. Timothy Henry, FACC, of the Christ Hospital in
            Cincinnati, Ohio. In December 2020, we commenced enrollment in our Phase 2b FREEDOM Trial of XOWNA&#174;, a double-blind, randomized and placebo-controlled clinical trial designed to further evaluate the efficacy and safety of intracoronary artery
            delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in January 2021, the impact of the COVID-19 pandemic contributed to
            a general slowing of enrollment, including supply chain disruptions affecting the availability of qualified catheters used in the diagnosis of CMD and/or administration of XOWNA&#174;. Protocol amendments to the initial FREEDOM Trial protocol, as
            agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of subject enrollment.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">HONEDRA&#174; for Treatment of Critical Limb Ischemia</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our randomized, open-label, registration-eligible study of HONEDRA&#174; in Japan for the
            treatment of CLI and Buerger&#8217;s disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA&#174; study&#8217;s enrollment, however, has been significantly curtailed by the COVID-19 pandemic&#8217;s impact in Japan, including the
            States of Emergency in Japan that have persisted for much of 2020 and 2021. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19 delays, coupled with the unpredictability of the timing of
            site enrollment re-initiation, we suspended further enrollment and are focusing our efforts on consummating a partnership for the product in Japan. Such a partnership may become the basis for the completion of development and registration of
            HONEDRA&#174; in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or exploration of submitting the existing data to Japan&#8217;s Pharmaceuticals and
            Medical Devices Agency (&#8220;PMDA&#8221;) under Japan&#8217;s regenerative medicine regulations, which allow for conditional approval of innovative regenerative medicine products. Despite receipt from FDA in March 2021 of orphan designation in the United
            States for CLBS12 as a potential treatment for Buerger&#8217;s disease, based on a response from the FDA in October 2021 regarding a development plan for U.S. registration, we have decided not to pursue U.S. development in Buerger&#8217;s disease at this
            time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h3">CLBS201 for Treatment of Diabetic Kidney Disease</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Progressive kidney failure is associated with attrition of the microcirculation of the
            kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, we have elected to move forward with a
            Phase&#160;1b, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol is expected to include six subjects in total with the first two subjects sequentially dosed and followed
            for a two-week safety observation period. Clearance by an independent Data Safety Monitoring Board (&#8220;DSMB&#8221;) overseeing the study will then permit the treatment of the next four patients, with all patients being followed for safety and
            therapeutic effect. A read-out of data will occur after the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201 will be our ability to demonstrate a therapeutic effect that will make it competitive
            in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate. As announced recently, the Company has treated the first patient in the CLBS201 proof-of-concept study and targets
            treatment completion for all six subjects during the third quarter of 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Additional Out-licensing Opportunities and
            Pipeline Diversification</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our broad intellectual property portfolio of cell therapy assets includes notable
            programs available for out-licensing in order to continue their clinical development. Our current long-term strategy focuses on advancing our therapies through development with the ultimate objective of obtaining market authorizations and
            entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. We believe that we are well-positioned to realize potentially meaningful value increases
            within our own proprietary pipeline if we are successful in advancing our product candidates to their next significant development milestones.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, we further desire to diversify our pipeline of development product
            candidates and are exploring a range of strategic transactions in furtherance of that goal. We have taken, and intend to continue to take, active steps to identify assets and/or companies for acquisition and/or partnership that would enhance
            and de-risk our current development portfolio. Such assets could target indications beyond cardiovascular disease as well as </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">234<br />
        </div>

      </div>

    </div>

    <!--End Page 243-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 244-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">product categories outside of cell therapy. The range of possible transactions
            includes an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute the shares of our existing stockholders. There can be no
            assurance that this exploration of strategic alternatives will result in us entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h3">Impact of the COVID-19 Pandemic</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The COVID-19 pandemic continues to present substantial public health and economic
            challenges around the world, and to date has led to the implementation of various responses, including government-imposed quarantines, stay-at-home orders, travel restrictions, mandated business closures and other public health safety measures.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We continue to closely monitor the impact of the COVID-19 pandemic on all aspects of
            our business, including how it has and will continue to impact our operations and the operations of our suppliers, vendors and business partners, and may take further precautionary and preemptive actions as may be required by federal, state or
            local authorities. In addition, we have taken steps to minimize the current environment&#8217;s impact on our business and strategy, including devising contingency plans and securing additional resources from third party service providers. For the
            safety of our employees and families, we implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. Our clinical study of HONEDRA&#174; in Japan has
            experienced significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 and 2021 covering Tokyo and other regions in response to an increased number of COVID-19 infections. With our expectation that
            COVID-19 in Japan would continue to impact negatively enrollment of patients in the HONEDRA&#174; clinical trial, we elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory authorities regarding the
            submission of patient data already accrued. In addition, our Phase 2b trial of XOWNA&#174; in the United States has also experienced delays in enrolling patients as a result of COVID-19.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Beyond its impact on our development pipeline described above, the extent to which
            COVID-19 ultimately impacts our business, results of operations and financial condition will depend on future developments, which remain highly uncertain and cannot be predicted with confidence, such as the duration of the outbreak, the
            emergence of new variants, new information that may emerge concerning the severity of COVID-19 or the effectiveness of actions taken to contain COVID-19 or treat its impact, including vaccination campaigns, among others. If we or any of the
            third parties with whom we engage, however, were to experience any additional shutdowns or other prolonged business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially or
            negatively affected, which could have a material adverse impact on our business, financial condition and results of operations. It is possible that our clinical development timelines could continue to be negatively affected by COVID-19, which
            could materially and adversely affect our business, financial condition and results of operations. See &#8220;Risk Factors&#8221; in our 2021 Form 10-K for additional discussion of the potential adverse impact of the COVID-19 pandemic on our business,
            financial condition and results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h2">Results of Operations</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Three Months Ended March&#160;31, 2022 Compared to Three
            Months Ended March&#160;31, 2021</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table summarizes our results of operations for the three months ended
            March&#160;31, 2022 and March&#160;31, 2021:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 25.77%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

    <td style="width: 1.53%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 1.53%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.53%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3.75pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Change</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Expenses:<br />
                  </div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">3,278</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">5,076</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$(1,798)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">3,342</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">3,010</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">332</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total operating expenses</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">6,620</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">8,086</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,466)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Loss from operations</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(6,620</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(8,086</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">1,466</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total other (expense) income</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">(85)</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">23</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">(108)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Benefit from income taxes</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(2,479</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">2,479</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;" class="fpara">$(4,226)</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara">$(8,063)</div>
                </td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.53%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">3,837</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">235<br />
        </div>

      </div>

    </div>

    <!--End Page 244-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 245-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Overall, net losses were $4.2&#160;million for the three months ended March&#160;31, 2022,
            compared to $8.1&#160;million for the three months ended March&#160;31, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Operating Expenses</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For the three months ended March&#160;31, 2022, operating expenses totaled $6.6&#160;million
            compared to $8.1&#160;million for the three months ended March&#160;31, 2021, representing a decrease of 18%. Operating expenses comprised the following: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Research and development expenses were approximately $3.3&#160;million for the three months ended March&#160;31, 2022, compared to
                    $5.1&#160;million for the three months ended March&#160;31, 2021, representing a decrease of $1.8&#160;million or 35%. This decrease was primarily due to a decrease in expenses associated with manufacturing startup costs and process development
                    expenses for our XOWNA&#174; Phase 2b study (the FREEDOM Trial). Research and development in both periods focused on the advancement of our ischemic repair platform and related to:</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">expenses associated with our XOWNA&#174; Phase 2b study (the FREEDOM Trial) which commenced in the
                      fourth quarter of 2020 with the first patient in the study treated in January 2021;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">ongoing registration-eligible study expenses for HONEDRA&#174; in critical limb ischemia in Japan which
                      focused on patient enrollment completion. The study&#8217;s enrollment has been significantly curtailed by the COVID-19 pandemic&#8217;s impact in Japan, including the States of Emergency that have persisted there for most of 2020 and 2021. Due
                      to the significant and continued operational and financial burden incurred as a result of these COVID-19 delays, coupled with the complete unpredictability of the timing of site enrollment re-initiation, we will focus our efforts on
                      consummating a partnership with a Japanese company in order to complete the study enrollment as well as to explore the possibility of submitting the existing data to PMDA under the SAKIGAKE designation;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">expenses associated with the preparation of our filing of an IND and study start-up expenses for
                      the clinical study of CLBS201 for treatment of diabetic kidney disease. A Phase 1b, open-label, proof-of-concept trial which commenced in the first quarter of 2022 with the first patient in the study treated in April 2022. The trial
                      is expected to include six subjects in total with enrollment completion targeted during the third quarter of 2022.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">General and administrative expenses were approximately $3.3&#160;million for the three months ended March&#160;31, 2022, compared to
                    $3.0&#160;million for the three months ended March&#160;31, 2021, representing an increase of 11%. This increase was primarily due to an increase in fees associated with the review of potential strategic transactions. Our general and
                    administrative expenses focus on general corporate-related activities.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Historically, to minimize our use of cash, we have used a variety of equity and
            equity-linked instruments to compensate employees, consultants and other service providers. The use of these instruments has resulted in charges to the results of operations, which have been significant in the past.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Other Income (Expense)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Total other income (expense) is comprised of investment income on cash, cash
            equivalents and marketable securities and a loss on sale of $0.1&#160;million related to the sale of our New Jersey net operating losses (&#8220;NJ NOLs&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Income Tax Benefit</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In February 2022, we received final approval from the New Jersey Economic Development
            Authority (&#8220;NJEDA&#8221;) under the Technology Business Tax Certificate Transfer Program (&#8220;Program&#8221;) to sell a percentage of our NJ NOLs, which were subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of
            $2.3&#160;million. The $2.5&#160;million of our NJ NOL tax benefits have been recorded as a benefit from income taxes and the loss on sale of $0.1&#160;million recorded in other income (expense).</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">236<br />
        </div>

      </div>

    </div>

    <!--End Page 245-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 246-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Year Ended December&#160;31, 2021 Compared to Year
            Ended December&#160;31, 2020</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">The following table summarizes our results of operations for the years ended
            December&#160;31, 2021 and 2020:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 22.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Change</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Expenses:<br />
                  </div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">17,680</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">9,253</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">8,427</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 8.7pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">11,370</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">9,892</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">1,478</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total operating expenses</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">29,050</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">19,145</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">9,905</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Loss from operations</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(29,050</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(19,145</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(9,905</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total other income (expense)</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">76</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">132</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(56)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Benefit from income taxes</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(1,508</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,872</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(9,364</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara">$(27,466)</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.22pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">(8,141)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$(19,325)</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Overall, net losses were $27.5&#160;million and $8.1&#160;million for the years ended
            December&#160;31, 2021 and 2020, respectively.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Operating Expenses</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For the year ended December&#160;31, 2021, operating expenses totaled $29.1&#160;million compared
            to $19.1&#160;million for the year ended December&#160;31, 2020, representing an increase of $9.9&#160;million or 52%. Operating expenses comprise the following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Research and development expenses were approximately $17.7&#160;million for the year ended December&#160;31, 2021 compared to $9.3&#160;million
                    for the year ended December&#160;31, 2020, representing an increase of approximately $8.4&#160;million, or 91%. This increase was primarily due to an increase in expenses associated with the enrollment of our XOWNA&#174; Phase 2b study (the FREEDOM
                    Trial). Research and development in both periods focused on the advancement of our ischemic repair platform and related to:</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">expenses associated with our XOWNA&#174; Phase 2b study (the FREEDOM Trial) which commenced in the
                      fourth quarter of 2020 with the first patient in the study treated in January 2021;</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">ongoing registration-eligible study expenses for HONEDRA&#174; in CLI in Japan which focused on patient
                      enrollment completion. The study&#8217;s enrollment has been significantly curtailed by the COVID-19 pandemic&#8217;s impact in Japan, including the States of Emergency that have persisted there for over 18 months. Due to the significant and
                      continued operational and financial burden incurred as a result of these COVID-19 delays, coupled with the complete unpredictability of the timing of site enrollment re-initiation, we have suspended enrollment efforts and will focus
                      on consummating a partnership with a Japanese company in order to complete the study enrollment as well as to explore the possibility of submitting the existing data to PMDA under the SAKIGAKE designation; and</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 40pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt; text-align: left;"><span style="font-size: 10pt;">expenses associated with the preparation for filing an IND for the clinical study of CLBS201 for
                      treatment of DKD. A Phase 1, open-label, proof-of-concept trial has been initiated recently and is expected to include six subjects in total.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">General and administrative expenses were approximately $11.4&#160;million for the year ended December&#160;31, 2021, compared to
                    $9.9&#160;million for the year ended December&#160;31, 2020, representing an increase of approximately $1.5&#160;million, or 15%. This increase was primarily due to an increase in directors and officers insurance premiums and strategic consulting
                    expenses. Our general and administrative expenses focus on general corporate-related activities.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Historically, to minimize our use of cash, we have used a variety of equity and
            equity-linked instruments as compensation to employees, consultants, directors and other service providers. The use of these instruments has resulted in charges to the results of operations, which has been significant in the past.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">237<br />
        </div>

      </div>

    </div>

    <!--End Page 246-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 247-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Other Income (Expense)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Total other income (expense) is comprised primarily of investment income on cash, cash
            equivalents and marketable securities and a loss on sale of $0.1&#160;million related to the sale of our New Jersey net operating losses (&#8220;NJ NOLs&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Income Tax Benefit</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In April 2020, we received approval from the New Jersey Economic Development Authority
            (&#8220;NJEDA&#8221;) to participate in the Technology Business Tax Certificate Transfer Program (the &#8220;Program&#8221;), whereby we qualified to sell a percentage of its New Jersey net operating losses (&#8220;NJ NOLs&#8221;). We subsequently sold a portion of our NJ NOLs to
            a qualifying and approved buyer pursuant to the Program for net proceeds of $10.9&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In April 2021, we received final approval from the NJEDA under the Program to sell a
            portion of our NJ NOLs, which subsequently were sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $1.4&#160;million. The $1.5&#160;million of our NJ NOL tax benefits have been recorded as a benefit from income taxes and
            the loss on sale of $0.1&#160;million recorded in other income (expense).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Analysis of Liquidity and Capital Resources</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of March&#160;31, 2022, we had cash, cash equivalents and marketable securities of
            approximately $88.5&#160;million, working capital of approximately $87.9&#160;million, and stockholders&#8217; equity of approximately $88.5&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">During the three months ended March&#160;31, 2022, we met our immediate cash requirements
            through existing cash balances. Additionally, we used equity and equity-linked instruments to pay for services and compensation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash used in or provided by, operating, investing and financing activities were as
            follows (in thousands): </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 25.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 1.37%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.89%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash used in operating activities</div>
                </td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.92pt; text-align: left;" class="fpara">$(5,642)</div>
                </td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.92pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">(7,975)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash used in investing activities</div>
                </td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.92pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(6,090)</span></div>
                </td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.92pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(65,090)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash (used in) provided by financing activities</div>
                </td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.92pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">(168)</span></div>
                </td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.89%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.92pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">85,297</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash provided by or used in operating, investing and financing activities were as
            follows (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 23.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 2.53%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash used in operating activities</div>
                </td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;" class="fpara">$(22,245)</div>
                </td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.05pt; text-align: left;" class="fpara">$<span style="padding-left: 1.67pt;">(8,823)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash used in investing activities</div>
                </td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(54,896)</span></div>
                </td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.05pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(7,277)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash provided by financing activities</div>
                </td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">85,276</span></div>
                </td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.53%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.05pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">18,580</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h4"><span style="text-decoration: underline;">Operating Activities</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in operating activities during the three months ended March&#160;31, 2022 was
            $5.6&#160;million, which is comprised of (i)&#160;our net loss of $4.2&#160;million, adjusted for non-cash expenses totaling $1.3&#160;million (which includes adjustments for equity-based compensation, depreciation and amortization, and amortization/accretion of
            marketable securities), and (ii)&#160;changes in operating assets and liabilities using approximately $2.7&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in operating activities during the three months ended March&#160;31, 2021 was
            $8.0&#160;million, which is comprised of (i)&#160;our net loss of $8.1&#160;million, adjusted for non-cash expenses totaling $0.9&#160;million (which includes adjustments for equity-based compensation, depreciation and amortization, and amortization/accretion of
            marketable securities), and (ii)&#160;changes in operating assets and liabilities using approximately $0.8&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in operating activities during the year ended December&#160;31, 2021 totaled
            approximately $22.2&#160;million, comprising (i)&#160;our net loss of $27.5&#160;million, as adjusted for non-cash income and expenses totaling $4.6&#160;million (which includes adjustments for equity-based compensation, depreciation and amortization, and
            amortization/accretion of marketable securities), and (ii)&#160;changes in operating assets and liabilities of approximately $0.6&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in operating activities during the year ended December&#160;31, 2020 totaled
            approximately $8.8&#160;million, which is the sum of (i)&#160;our net loss of $8.1&#160;million, as adjusted for non-cash income and expenses </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">238<br />
        </div>

      </div>

    </div>

    <!--End Page 247-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 248-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">totaling $1.6&#160;million (which includes adjustments for equity-based compensation,
            depreciation and amortization, and amortization/accretion of marketable securities), and (ii)&#160;changes in operating assets and liabilities of approximately $2.3&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h4"><span style="text-decoration: underline;">Investing Activities</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in investing activities during the three months ended March&#160;31, 2022
            totaled $6.1&#160;million and was primarily due to net purchases of marketable securities (net of sales of marketable securities).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in investing activities during the three months ended March&#160;31, 2021
            totaled $65.1&#160;million and was primarily due to net purchases of marketable securities (net of sales of marketable securities).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in investing activities during the year ended December&#160;31, 2021 totaled
            approximately $54.9&#160;million and was primarily due to net purchases of marketable securities (net of sales of marketable securities).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in investing activities during the year ended December&#160;31, 2020 totaled
            approximately $7.3&#160;million and was primarily due to net purchases of marketable securities (net of sales of marketable securities).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h4"><span style="text-decoration: underline;">Financing Activities</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash used in financing activities during the three months ended March&#160;31, 2022
            totaled $0.2&#160;million, consisted of tax withholding-related payments on net share settlement equity awards to employees.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash provided by financing activities during the three months ended March&#160;31, 2021
            totaled $85.3&#160;million, primarily consisted of (i)&#160;net proceeds of $23.1&#160;million through the issuance of common shares and warrants in our January 2021 private placement, (ii)&#160;net proceeds of $1.8&#160;million in connection with warrant exercises,
            (iii)&#160;net proceeds of $60.6&#160;million through the issuance of common shares and warrants in both of our February 2021 registered direct offerings, which was partially offset by tax withholding-related payments on net share settlement equity
            awards to employees.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash provided by financing activities during the year ended December&#160;31, 2021,
            primarily consisted of (i)&#160;net proceeds of $23.1&#160;million through the issuance of common shares and warrants in our January 2021 private placement, (ii)&#160;net proceeds of $1.8&#160;million in connection with warrant exercises, (iii)&#160;net proceeds of
            $60.6&#160;million through the issuance of common shares and warrants in both of our February 2021 registered direct offerings which was partially offset by tax withholding-related payments on net share settlement equity awards to employees.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our cash provided by financing activities during the year ended December&#160;31, 2020
            primarily consisted of (i)&#160;net proceeds of $4.5&#160;million through the issuance of common shares and warrants in our April 2020 registered direct offering, (ii)&#160;net proceeds of $3.8&#160;million through the issuance of common shares and warrants in our
            May 2020 registered direct offering, and (iii)&#160;net proceeds of $1.9&#160;million through the issuance of common shares and warrants in our July 2020 private placement offering, and (iv)&#160;net proceeds of $8.4&#160;million through the issuance of common
            shares under our common stock sales agreement with HCW, which was partially offset by tax withholding-related payments on net share settlement equity awards to employees.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h2">Liquidity and Capital Requirements Outlook</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To meet our short and long-term liquidity needs, we expect to use existing cash
            balances and a variety of other means. Other sources of liquidity could include additional potential issuances of debt or equity securities in public or private financings, partnerships and/or collaborations and/or sale of assets. Our history
            of operating losses and liquidity challenges may make it difficult for us to raise capital on acceptable terms or at all. The demand for the equity and debt of biopharmaceutical companies like ours is dependent upon many factors, including the
            general state of the financial markets. During times of extreme market volatility, capital may not be available on favorable terms, if at all. Our inability to obtain such additional capital could materially and adversely affect our business
            operations. We will also continue to seek, as appropriate, grants for scientific and clinical studies from various governmental agencies and foundations, and other sources of non-dilutive funding. We believe that our cash on hand will enable us
            to fund operating expenses for at least the next 12 months following the issuance of our financial statements, absent any impact from the Merger, if consummated. Our </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">239<br />
        </div>

      </div>

    </div>

    <!--End Page 248-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 249-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">future capital requirements are difficult to forecast and will depend on many
            factors, including our ability to consummate the Merger; if the Merger is not completed, the timing and nature of any other strategic transactions that we undertake; and our ability to establish and maintain collaboration partnerships,
            in-license/out-license or other similar arrangements and the financial terms of such agreements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In order to provide Cend with capital for its development programs prior to the closing
            of the Merger, pursuant to the Purchase Agreement, we purchased 1,135,628 shares of Series D Preferred Stock of Cend for an aggregate purchase price of approximately $10.0&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On June&#160;4, 2021, we entered into an At The Market Offering Agreement (the &#8220;ATM
            Agreement&#8221;) with H.C. Wainwright &amp; Co., LLC (&#8220;HCW&#8221;), as sales agent, in connection with an &#8220;at the market offering&#8221; under which we from time to time may offer and sell shares of our common stock, having an aggregate offering price of up to
            $50.0&#160;million. On February&#160;18, 2022, we received a deficiency notice from Nasdaq informing us that we are not in compliance with the Minimum Bid Price Requirement. As such, we will not be able to sell shares under the ATM Agreement until we
            regain compliance, if ever. As of March&#160;31, 2022, we had not issued any shares under the ATM Agreement. HCW is only obligated to make sales when we are in compliance with all Nasdaq listing standards.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In December 2021, we received preliminary approval from the NJEDA to participate in the
            NJ Technology Business Tax Certificate Transfer Program (the &#8220;Program&#8221;). The Program permits qualified companies to sell a percentage of their NJ NOLs to unrelated profitable corporations. On February&#160;22, 2022, we received final approval from
            NJEDA to sell $2.5&#160;million of our NJ NOL tax benefits, which were subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.3&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">While we continue to seek capital through a number of means, there can be no assurance
            that additional financing will be available on acceptable terms, if at all, and our negotiating position in capital generating efforts may worsen as existing resources are used. Additional equity financing may be dilutive to our stockholders;
            debt financing, if available, may involve significant cash payment obligations and covenants that restrict our ability to operate as a business; our stock price may not reach levels necessary to induce option or warrant exercises; and asset
            sales may not be possible on terms we consider acceptable. If we are unable to access capital necessary to meet our long-term liquidity needs, we may have to delay the expansion of our business or raise funds on terms that we currently consider
            unfavorable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Seasonality</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">We do not believe that our operations are seasonal in nature.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Off-Balance Sheet Arrangements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">We do not have any off-balance sheet arrangements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Critical Accounting Policies and Estimates</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There have been no material changes in our critical accounting policies and estimates
            during the three months ended March&#160;31, 2022, compared to those reported in our 2021 Form 10-K.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">240<br />
        </div>

      </div>

    </div>

    <!--End Page 249-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 250-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCENDOP"><!--Anchor--></a>CEND MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following discussion and analysis of financial condition and
            results of operations should be read together with Cend&#8217;s financial statements, accompanying notes and other financial information appearing elsewhere in this proxy statement/prospectus/information statement. This Management&#8217;s Discussion and
            Analysis contains forward-looking statements that involve risks and uncertainties. Cend&#8217;s actual results may differ materially from those anticipated or projected in these forward-looking statements as a result of certain factors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Additional information on factors relating to such statements is
            included in this proxy statement under the headings &#8220;Cautionary Information Regarding Forward-Looking Statements&#8221; on page&#160;<a href="#tFLS">105</a>. Additional information on certain risk factors applicable to Cend&#8217;s business, financial condition
            and results of operations is included in this proxy statement under the heading &#8220;Risk Factors&#8212;Risks Related to Cend&#8221; beginning on page&#160;<a href="#tRRTC">58</a>. Operating results are not necessarily indicative of results that may occur in future
            periods. All forward-looking statements included in this proxy statement are based on information available to Cend as of the date hereof, and Cend assumes no obligation to update any such forward-looking statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h2">Overview</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Therapeutics, Inc. (formerly DrugCendR, Inc.) is a Delaware corporation, formed in
            October 2015 (&#8220;Cend&#8221; or &#8220;the Company&#8221;) and based in San Diego, California. Cend is focused on a tumor microenvironment (&#8220;TME&#8221;)-modifying approach to potentially enable more effective treatment for a range of solid tumor cancers. Cend is
            advancing a pipeline of product and partnering opportunities based on the CendR Platform&#8482; to potentially improve outcomes for patients with a range of solid tumor cancers that are currently poorly treated, representing high unmet medical needs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Many solid tumor cancers, including pancreatic ductal adenocarcinoma (&#8220;PDAC&#8221;), gastric
            cancers and many other solid tumor cancers are surrounded by dense fibrotic tissue, or stroma. This limits the efficacy of current chemotherapies for these cancers. Emerging immunotherapy treatments, including checkpoint inhibitors, adoptive
            cell therapies such as chimeric antigen receptor T (&#8220;CAR-T&#8221;) cells, as well as nucleic acid-based therapies, such as short interfering RNA (&#8220;siRNA&#8221;), antisense, and messenger RNAs (&#8220;mRNAs&#8221;) face particular challenges in penetrating solid
            tumors. Many tumors also exhibit an immunosuppressive tumor immuno-microenvironment, which suppresses patients&#8217; immune systems&#8217; ability to fight their cancer and can limit effectiveness of immunotherapies. These factors negatively impact the
            ability of many therapeutic agents and immunotherapies to effectively treat these cancers. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To address the tumor stroma&#8217;s role as a primary impediment to effective treatment,
            Cend&#8217;s approach activates a natural transport system that normally brings nutrients into a tissue under emergency situations such as an injury. Cancers highjack this system to promote their own growth. Cend&#8217;s lead investigational drug, CEND-1
            (an internalizing R-G-D or iRGD peptide) activates this transport system in a tumor-specific manner. This results in tumors taking up systemically administered anticancer drugs as if they were nutrients. As a result, more drug accumulates in
            the tumor than would accumulate without CEND-1, while normal tissues are not affected. Moreover, the drugs penetrate tumor cells further away from blood vessels with CEND-1 than without. The overall result is enhanced anticancer activity
            without an increase in side effects. Anticancer drugs can be coupled or conjugated to CEND-1 or other CendR peptides in Cend&#8217;s portfolio, but can be also simply given together with CEND-1. Cend believes that the co-administration option is an
            advantage because it is not necessary to create a new chemical entity with its attendant regulatory hurdles, providing a potentially faster-to-clinic and potentially faster-to-market product opportunity for a range of solid tumor cancers and
            for co-administration with a range of therapies. CEND-1 has also been shown to selectively deplete certain immunosuppressive cell types in tumors wherein the TME is dominated by such immunosuppressive cells, hampering the patients&#8217; immune
            systems&#8217; and immunotherapies&#8217; abilities to fight disease. Cend plans to explore its potential for combination therapy with immunotherapies. As part of the CendR Platform&#8482;, Cend is also conducting preclinical research on a tumor-penetrating
            nanocomplex (&#8220;TPN&#8221;) technology that may enable nucleic acid-based drugs, such as antisense, siRNA or mRNA, to more effectively treat solid tumor cancers, which Cend believes may bring earlier stage product and partnership opportunities. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Since Cend&#8217;s formation in October 2015, it has devoted substantially all of its
            resources to conducting research and development activities, including drug discovery, preclinical studies and clinical trials, including developing CEND-1, building and maintaining its intellectual property portfolio, developing third-party
            manufacturing </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">241<br />
        </div>

      </div>

    </div>

    <!--End Page 250-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 251-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">capabilities, business planning, raising capital and providing general and
            administrative support for such operations. Cend has experienced net losses and negative cash flows from operating activities since its inception, aside from the year ended December&#160;31, 2021, as a result of a one-time license payment and a
            milestone payment from the Exclusive License and Collaboration Agreement with Qilu Pharmaceutical Co., Ltd. (&#8220;Qilu&#8221;), which rendered net income in 2021. As of March&#160;31, 2022, the Company had cash of $4.7&#160;million and an accumulated deficit of
            $11.6&#160;million. Management expects that expenses and operating losses will increase as Cend conducts ongoing preclinical studies and planned clinical trials, continues research and development activities, utilizes third parties to manufacture
            drug product and related raw materials, hires additional personnel, and protects its intellectual property. Cend does not have any products approved for sale, and it has not generated any revenue from commercial product sales.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of May&#160;20, 2022, the issuance date of Cend&#8217;s consolidated financial statements for
            the year ended December&#160;31, 2021, Cend expects that its cash balance, as well as the proceeds received from the Purchase Agreement would enable it to fund its operating expense and capital requirements into the first quarter of 2023. The future
            viability of Cend is largely dependent on its ability to generate cash from operating activities and to raise additional capital to finance its operations. Cend&#8217;s failure to raise capital as needed would have a negative impact on its financial
            condition and its ability to continue to pursue its business strategies. Accordingly, if the Merger described below does not occur, there is substantial doubt about Cend&#8217;s ability to continue as a going concern as Cend does not believe that its
            cash will be sufficient to fund operations for at least twelve months from the date of issuance of these financial statements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2">Recent Developments</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;" class="h3">The Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April&#160;26, 2022, Cend entered into the Merger Agreement with Caladrius and Merger
            Sub. Pursuant to the Merger Agreement, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Cend, with Cend continuing as a wholly owned
            subsidiary of Caladrius and the surviving corporation of the Merger. The Merger Agreement and the Merger were approved by the members of the Cend Board of Directors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Subject to the terms and conditions of the Merger Agreement, at the closing of the
            Merger, (a) each outstanding share of Cend common stock and Cend preferred stock will be converted into the right to receive a number of shares of Caladrius Common Stock at the Exchange Ratio described below; and (b) each outstanding Cend stock
            option that has not previously been exercised prior to the closing of the Merger will be assumed by Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the Exchange Ratio formula in the Merger Agreement, as of immediately after the
            Merger, Cend&#8217;s former stockholders are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock and stockholders of Caladrius as of immediately prior to the Merger are expected to own approximately 50% of the
            outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on Caladrius&#8217; net cash balance at the time of closing and the amount of any transaction expenses of Cend in excess of $250,000 at the time
            of closing. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Concurrently with the execution of the Merger Agreement and in order to provide the
            Company with capital for its development programs prior to the closing of the Merger, Caladrius and the Company entered into a Purchase Agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which Caladrius agreed to purchase from Cend
            1,135,628&#160;shares of Series D Preferred Stock, $0.00001 par value per share (the &#8220;Series D Preferred Stock&#8221;), of Cend at a purchase price per share equal to $8.8057 per share (the &#8220;Series D Original Issue Price&#8221;), or approximately $10.0&#160;million
            in the aggregate. The Series D Preferred Stock ranks senior to the Company&#8217;s common stock and the other series of preferred stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or
            winding up of the Company. The Series D Preferred Stock has a liquidation preference equal to the Series D Original Issue Price plus an amount equal to any accrued and unpaid dividends to the date of payment and will participate with the
            Company&#8217;s common stockholders and other preferred stockholders thereafter on an as-converted basis, except in connection with the Merger. The Series D Preferred Stock votes with the common stock on an as-converted basis on any matters presented
            to the stockholders of Cend. Each share of Series D Preferred Stock is convertible, at the option of the holder thereof, into such number of shares of Cend common stock as is determined by dividing the Series D Original Issue Price by the
            conversion price in effect at the time of conversion, which conversion price is initially the Series D Original Issue Price, as appropriately adjusted for stock splits, stock dividends, combinations, and subdivisions of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">242<br />
        </div>

      </div>

    </div>

    <!--End Page 251-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 252-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Cend common stock, and as adjusted pursuant to a weighted-average antidilution
            adjustment. The Series D Preferred Stock will automatically convert into shares of Cend common stock upon the closing of a firm-commitment underwritten initial public offering implying a pre-equity offering value of at least $250.0&#160;million,
            resulting in at least $50.0&#160;million of gross proceeds to Cend. The closing of the Merger is subject to certain conditions, including, among other things, approval by the stockholders of Caladrius and Cend, and Caladrius&#8217; satisfaction of a
            minimum net cash threshold at closing of $69.9&#160;million assuming a closing at the end of the third quarter of 2022, and as described further in the Merger Agreement. In accordance with the terms of the Merger Agreement, (i)&#160;certain executive
            officers, directors and stockholders of the Company (solely in their respective capacities as Cend stockholders) holding approximately 77.5% of the outstanding Cend Capital Stock (excluding shares held by Caladrius) have entered into support
            agreements with Caladrius to vote all of their shares of Cend Capital Stock in favor of adoption of the Merger Agreement (the &#8220;Cend Support Agreements&#8221;) and (ii)&#160;certain executive officers and directors of Caladrius (solely in their respective
            capacities as Caladrius Stockholders) holding approximately 1.8% of the outstanding Caladrius Common Stock have entered into support agreements with Cend to vote all of their shares of Caladrius Common Stock in favor of approval of the Merger
            Agreement (the &#8220;Caladrius Support Agreements,&#8221; together with the Cend Support Agreements, the &#8220;Support Agreements&#8221;). The Support Agreements include covenants with respect to the voting of such shares in favor of approving the transactions
            contemplated by the Merger Agreement and against any competing acquisition proposals and place certain restrictions on the transfer of the shares of Caladrius and Cend held by the respective signatories thereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement contains certain termination rights for both Caladrius and the
            Cend, and further provides that, upon termination of the Merger Agreement under specified circumstances, Caladrius may be required to pay Cend a termination fee of $1.0&#160;million, and Cend may be required to pay Caladrius a termination fee of
            $4.0&#160;million, or in some circumstances reimburse the other party&#8217;s expenses up to a maximum of $1.0&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 20pt; text-align: left;" class="h3">Business Impact of the COVID-19 Pandemic</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The global coronavirus disease 2019, or COVID-19, pandemic continues to evolve, and
            Cend will continue to monitor the COVID-19 situation. The extent of the impact of the COVID-19 pandemic on Cend&#8217;s business, operations and clinical timelines and plans remains uncertain, and will depend on certain developments, including the
            duration and spread of the outbreak and its impact on CROs, third-party manufacturers, and other third parties with whom Cend does business, as well as its impact on regulatory authorities and key scientific and management personnel. The
            ultimate impact of the COVID-19 pandemic or a similar health epidemic is highly uncertain and subject to change. To the extent possible, Cend is conducting business as usual, with only advisable modifications to employee travel. Cend will
            continue to actively monitor the situation related to COVID-19 and may take further actions that alter its operations, including those that may be required by federal, state or local authorities, or that are determined to be in the best
            interests of Cend employees and other third parties with whom Cend does business with. At this point, the extent to which the COVID-19 pandemic may affect Cend&#8217;s business, operations and clinical timelines and plans, including the resulting
            impact on Cend&#8217;s expenditures and capital needs, remains uncertain and is subject to change.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2">Components of Results of Operations</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;" class="h3">Revenue</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In February 2021, Cend entered into an Exclusive License and Collaboration Agreement
            (the &#8220;Qilu Agreement&#8221;) in which Cend granted an exclusive license to Qilu for the development and commercialization of CEND-1 in the Territory. Under the terms of the agreement, Qilu is solely responsible for the development of CEND-1 in its
            Territory. In consideration for the license, Qilu made a one-time, non-refundable, non-creditable upfront payment of $10&#160;million to Cend. Cend is also eligible to receive developmental and commercial milestone payments up to $100&#160;million and
            $125&#160;million, respectively, tiered royalties on net sales ranging from 10% to 15%, and tiered sublicensing revenues ranging from 12% to 35%.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the terms of the Qilu Agreement, Qilu was also required to file an
            Investigational New Drug Application (&#8220;IND&#8221;) and receive approval by the National Medical Products Administration in the People&#8217;s Republic of China in the Territory within 12 months of the effective date of the arrangement, which would result
            in a $5&#160;million milestone payment. Qilu was also required to dose its first patient in a Phase I clinical trial in the Territory within six months of the acceptance of the IND, subject to certain extensions, or Cend would have had </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">243<br />
        </div>

      </div>

    </div>

    <!--End Page 252-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 253-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the option to terminate the Qilu Agreement. In August of 2021, Qilu achieved the
            regulatory milestone, and Cend received the $5&#160;million milestone payment. Qilu also dosed its first patient within the six-month period.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Company may also earn an additional $1&#160;million upon completing process optimization
            and scale up activities and delivering three validation batches of CEND-1 in full commercial scale by Qilu or its subcontractor (the &#8220;Technology Transfer&#8221;). After completing the Technology Transfer, Qilu will be responsible for manufacturing
            CEND-1 for use in subsequent clinical trials. In the event the Company and its contract manufacturers fail to complete the process optimization and scale up activities, Qilu would have the right to manufacture CEND-1 using its independent
            manufacturing process and would have no obligation to pay the Technology Transfer milestone payment. Prior to the completion of the Technology Transfer, the Company has agreed to supply CEND-1 to Qilu at cost.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Unless earlier terminated, the Qilu Agreement will continue in effect until the
            expiration of all Qilu payment obligations. Either party may terminate the Qilu Agreement if an undisputed material breach by the other party is not cured within a defined period of time, or upon notice for insolvency-related events of the
            other party that are not discharged within a defined time period. Qilu may terminate the Qilu Agreement in its entirety, at any time with at least sixty days written notice. All rights and obligations of Qilu with respect to such licensed
            patents and patent applications would terminate at such time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the framework of ASC Topic 606, &#8220;Revenue from Contracts with Customers&#8221; (&#8220;ASC
            606&#8221;), Cend identified two performance obligations, which was the delivery of the license, and a material right related to the supply of CEND-1 prior to the completion of the Technology Transfer. At the onset of the Qilu Agreement, the
            Technology Transfer was only an option of Qilu and Cend further determined the fee for the Technology Transfer approximated the standalone selling price and therefore the option would not represent a material right and accordingly, did not
            represent a performance obligation at the onset of the arrangement. Cend recognized $9.7&#160;million in revenue upon delivery of the license to Qilu in February 2021. Cend initially deferred $0.3&#160;million in revenue for the material right, which
            will subsequently be recognized as revenue as the clinical supply is delivered. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In August 2021, Cend received $5.0&#160;million from Qilu upon achievement of the first
            development milestone. In December 2021 and in March of 2022, Cend provided Qilu with clinical supply material and recognized revenue of $51,000 and $178,000, respectively. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of March&#160;31, 2022, the Technology Transfer had not been completed and no payment had
            been made by Qilu. Additionally, all remaining future development and sales milestones (variable consideration) were fully constrained and will only be recognized upon achievement of the milestones.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;" class="h3">Operating Expenses</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 20pt; text-align: left;" class="h4">Research and Development Expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development expenses, which consist primarily of costs associated with
            Cend&#8217;s research and development efforts, are expensed as incurred. Research and development expenses consist primarily of:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">employee related costs, including salaries, benefits and stock-based compensation expense for employees engaged in scientific
                    research and development functions;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">third-party contract costs relating to research, formulation, manufacturing, nonclinical studies and clinical trial activities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">external costs of outside consultants who assist with technology development, regulatory affairs and clinical development; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">payments made under Cend&#8217;s third-party licensing agreements.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Costs for certain activities, such as manufacturing, nonclinical studies and clinical
            trials are generally recognized based on the evaluation of the progress of completion of specific tasks using information and data provided by Cend&#8217;s vendors and collaborators. Research and development expenses are presented net of
            reimbursement received related to refundable research and development tax credits from the Australian government. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development activities are central to Cend&#8217;s business. Cend expects to
            increase its investment in research and development in order to advance its lead product candidate through clinical trials, and to advance additional product candidates derived from the CendR Platform&#8482;. As a result, Cend expects that its
            research and </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">244<br />
        </div>

      </div>

    </div>

    <!--End Page 253-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 254-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">development expenses will increase substantially in the foreseeable future as it
            continues to invest in research and development activities and pursues clinical development of its lead product candidate. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The process of commercialization and conducting the necessary preclinical and clinical
            research to obtain regulatory approval is costly and time-consuming. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the
            increased size and duration of later-stage clinical trials. Accordingly, to the extent that Cend&#8217;s lead product candidate continues to advance into clinical trials, including larger and later-stage clinical trials, Cend&#8217;s expenses will increase
            substantially and may become more variable. Cend may never succeed in achieving marketing approval for any of Cend&#8217;s product candidates. Cend anticipates it will make determinations as to which other programs, if any, to pursue and how much
            funding to direct to each program on an ongoing basis in response to the development and regulatory success of its lead product candidate, and ongoing assessments as to of the lead candidate&#8217;s commercial potential. Successful development of any
            future product candidates is highly uncertain and may not result in approved products. At this time, Cend cannot reasonably estimate or know the nature, timing and estimated costs of the efforts that will be necessary to complete the
            development of its lead product candidates or additional product candidates it may pursue. Cend is also unable to predict when, if ever, material net cash inflows will commence from sales of its product candidates. The duration, costs and
            timing of clinical trials and further product development will depend on a variety of factors, including:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the scope, rate of progress and expense of clinical trials and other research and development activities;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">clinical trial results;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">uncertainties in clinical trial enrollment rate or design;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">significant and changing government regulation;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing and receipt of any regulatory approvals;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the FDA&#8217;s or other regulatory authority&#8217;s influence on clinical trial design;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">establishing commercial manufacturing arrangements with third-party manufacturers;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">commercializing Cend&#8217;s product candidates, if and when approved, whether alone or in collaboration with others;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining and maintaining patent and trade secret protection and regulatory exclusivity for Cend&#8217;s product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">continued applicable safety profiles of the products following approval; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">retention of key research and development personnel.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A change in the outcome of any of these variables with respect to the development of a
            product candidate could significantly change the costs, timing and viability associated with the development of that product candidate. For example, if the FDA, or another regulatory authority were to require Cend to conduct clinical trials
            beyond those that Cend currently anticipates will be required for the completion of clinical development of a product candidate, or if Cend experiences significant delays in enrollment in any of its clinical trials, Cend could be required to
            expend significant additional financial resources and time on the completion of clinical development.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;" class="h4">In-process research and development expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In-process research and development expenses include rights acquired as part of asset
            acquisitions or in-licenses to develop and commercialize product candidates. Upfront payments that relate to the acquisition of a new drug compound, as well as pre-commercial milestone payments, are immediately expensed as in-process research
            and development in the period in which they are incurred, provided that the new drug compound did not also include processes or activities that would constitute a &#8220;business&#8221; as defined under U.S.GAAP, the drug has not achieved regulatory
            approval for marketing and, absent obtaining such approval, has no established alternative future use.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In-process research and development expenses consist primarily of 1,345,699 shares of
            Cend&#8217;s Series C convertible preferred stock issued to Impilo Therapeutics, Inc. (&#8220;Impilo&#8221;), the University of California San </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">245<br />
        </div>

      </div>

    </div>

    <!--End Page 254-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 255-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg16"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Diego (&#8220;UCSD&#8221;) and Sanford Burnham Prebys (&#8220;SBP&#8221;) in connection with the development
            stage assets acquired from Impilo and licenses obtained from SBP and UCSD. In-process research and development expenses also consist of 81,000 shares of Cend common stock issued pursuant to a license with the Massachusetts Institute of
            Technology (&#8220;MIT&#8221;). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 20pt; text-align: left;" class="h4">General and Administrative Expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative expenses consist primarily of salaries and related benefits,
            including stock-based compensation, related to Cend&#8217;s executive, finance, and other corporate functions. Other general and administrative expenses include professional fees for legal, auditing, tax and business consulting services, insurance
            costs, intellectual property and patent costs, facility costs and travel costs. Cend expects that general and administrative expenses will increase in the future as Cend expands its operating activities. Additionally, if Cend completes the
            Merger, the combined company will incur significant additional expenses associated with being a public company, that Cend did not incur as a privately-held company, including costs (i)&#160;to comply with the rules and regulations of the SEC and
            those of the Nasdaq, (ii)&#160;for legal, accounting and other expenses, (iii)&#160;for additional insurance, (iv)&#160;for investor relations activities and (v)&#160;for other administrative and professional services.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 20pt; text-align: left;" class="h4">Other Income (Expense).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense) consists of the interest income earned on cash held by Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 20pt; text-align: left;" class="h4">Income Taxes.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Since its formation in 2015, Cend has not recorded any U.S. federal or state income tax
            expense, aside from U.S. federal income tax expense of $0.2&#160;million recorded during the year ended December&#160;31, 2021, as a result of a one-time license payment and a milestone payment from Qilu. As of December&#160;31, 2021, the Company had state
            and foreign net operating losses, or NOL, carryforwards of approximately $4.3&#160;million and $1.3&#160;million, respectively. The state NOLs will begin to expire in 2036 unless previously utilized. The foreign NOLs will carryforward indefinitely. As of
            December&#160;31, 2021, the Company had state research credit carryforwards of approximately $48,000 that will carryforward indefinitely.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h2">Results of Operations</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;" class="h3">Comparison of the three months ended March&#160;31,
            2021 and 2022</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">The following table summarizes Cend&#8217;s results of operations for the periods indicated
            (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 25.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Increase <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(Decrease)</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net revenues</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">9,736</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara">$<span style="padding-left: 10.83pt;">178</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara">$ (9,558)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating expenses:<br />
                  </div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">3,200</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">1,291</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,909)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Acquired in process research &amp; development</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">520</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">(520)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">237</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">316</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">79 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total operating expenses</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">3,957</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">1,607</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(2,350</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating income (loss)</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">5,779</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,429)</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(7,208)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) before taxes</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">5,779</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara">$ (1,429)</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara">$(7,208)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Income tax expense</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">192</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(192</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consolidated net income (loss)</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">5,587</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$
                      (1,429</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$ (7,016</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Income allocable to participating securities</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(2,166</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">2,166 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.16pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">3,421</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.18pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$
                      (1,429</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$ (4,850</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">246<br />
        </div>

      </div>

    </div>

    <!--End Page 255-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 256-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg17"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="h4">Revenue.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Revenue from the delivery of clinical supply material is recognized in the period the
            clinical supply material is delivered. License revenue is recognized from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is able to use and benefit from the license. No
            clinical supply material was delivered to Qilu during the three months ended March&#160;31, 2021. During the three months ended March&#160;31, 2021, Cend recognized $9.7&#160;million in revenue associated with the upfront license fee paid by Qilu. During the
            three months ended March&#160;31, 2022, Cend delivered clinical supply material to Qilu totaling $0.2&#160;million. Clinical supply revenue amounts can vary from period to period depending on the needs of Cend&#8217;s license partner. Future revenue associated
            with development and commercial milestone payments are uncertain and will only be recognized upon notification of achievement from Qilu. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;" class="h4">Research and development expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development expenses were $3.2&#160;million for the three months ended
            March&#160;31, 2021 and $1.3&#160;million for the three months ended March&#160;31, 2022, a decrease of $1.9&#160;million. The decrease was primarily driven by a $2.5&#160;million decrease in sublicense fees as no related revenue was recognized in the three months
            ended March&#160;31, 2022, offset by $0.6&#160;million of net increases in research and development expenses with consultants, clinical research organizations, and employee related costs. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;" class="h4">In-process research and development expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In-process research and development expenses were $0.5&#160;million for the three months
            ended March&#160;31, 2021 and related to 66,545 shares of Series C convertible preferred stock issued in connection with a technology license with UCSD.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;" class="h4">General and administrative expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative expenses were $0.2&#160;million for the three months ended
            March&#160;31, 2021 and $0.3&#160;million for the three months ended March&#160;31, 2022, an increase of $0.1&#160;million. The change was primarily driven by increased legal, insurance, employee related and stock-based compensation expenses, partially offset by a
            decrease in consulting and travel expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;" class="h4">Income tax expense.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Income tax expense for the three months ended March&#160;31, 2021 was $0.2&#160;million and was
            primarily driven by the revenue and resulting income associated with the upfront license fee paid by Qilu. There was no income tax expense for the three months ended March&#160;31, 2022.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">247<br />
        </div>

      </div>

    </div>

    <!--End Page 256-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 257-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg18"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="h3">Comparison of the years ended December&#160;31, 2020
            and 2021</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">The following table summarizes Cend&#8217;s results of operations for the periods indicated:
            (in thousands)</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 22.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Increase <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(Decrease)</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 2.12%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net revenues</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara">$ 14,787</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">$14,787 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating expenses:<br />
                  </div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">1,555</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">8,148</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">6,593 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Acquired in process research &amp; development</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">6,572</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1,584</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(4,988)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">598</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">1,150</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">552 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total operating expenses</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">8,725</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">10,882</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">2,157 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating income (loss)</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(8,725)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">3,905</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">12,630 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense)<br />
                  </div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Interest income</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">5</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">4</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 24.17pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(1</span><span style="min-width: 32.5pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total other income (expense), net</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">5</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">4</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 24.17pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(1</span><span style="min-width: 32.5pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) before taxes</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara">$(8,720)</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">3,909</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">$ 12,629 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Income tax expense</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">170</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">170 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consolidated net income (loss)</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(8,720</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">3,739</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$12,459
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Income allocable to participating securities</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(1,466</span><span style="min-width: 32.5pt;">)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(1,466</span><span style="min-width: 32.5pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders</div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(8,720</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">2,273</span></div>
                </td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.12%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$ 10,993</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h4">Revenues.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There was no revenue recognized for the year ended December&#160;31, 2020 compared to
            revenues of $14.8&#160;million for the year ended December&#160;31, 2021. License revenue for the year ended December&#160;31, 2021, was $9.7&#160;million, development milestone revenue was $5.0&#160;million, and revenue related to the delivery of clinical supply
            material was $51,000.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;" class="h4">Research and development expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development expenses were $1.6&#160;million for the year ended December&#160;31,
            2020 and $8.1&#160;million for the year ended December&#160;31, 2021, an increase of $6.5&#160;million. The increase was primarily due to $3.8&#160;million of sublicense fees incurred as a result of the license and development milestone revenue recognized in
            connection with the Qilu Agreement. The increase was all due to a $2.4&#160;million increase in research and development expenses incurred with clinical research organizations, third parties to manufacture drug product and related raw materials, and
            an increase in employee and consulting related costs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;" class="h4">General and administrative expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative expenses were $0.6&#160;million for the year ended December&#160;31,
            2020 and $1.2&#160;million for the year ended December&#160;31, 2021, an increase of $0.6&#160;million. The change was primarily driven by increased consulting, legal, travel, recruitment, employee related costs and stock-based compensation expense.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;" class="h4">Income tax expense.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There was no Income tax expense recorded for the year ended December&#160;31, 2020 and was
            $0.2&#160;million for the year ended December&#160;31, 2021. The income tax expense during the year ended December&#160;31, 2021, was primarily driven by the revenue and resulting income associated with the upfront license fee paid by Qilu.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Liquidity and Capital Resources</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;" class="h3">Overview</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has no products approved for commercial sale and has not generated any revenue
            from commercial product sales. Cend has incurred operating losses in each year since inception, aside from the year ended December&#160;31, </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">248<br />
        </div>

      </div>

    </div>

    <!--End Page 257-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 258-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg19"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">2021, as a result of a one-time license payment and a milestone payment from Qilu.
            As a result, Cend will need substantial additional financing to support its continuing operations. Until such time that Cend can generate significant revenue from product sales, if ever, Cend expects to finance its operations through a
            combination of public or private equity offerings, debt financings, or other sources, which may include collaborations with third parties. Arrangements with collaborators or others may require Cend to relinquish rights to certain of its
            technologies or product candidates. The amount and timing of Cend&#8217;s future funding requirements will depend on many factors, including the pace and results of its development efforts. In addition, Cend may never successfully complete
            development of any of its product candidates, obtain adequate patent protection for its technology, obtain necessary regulatory approval for its product candidates or achieve commercial viability for any approved product candidates. Adequate
            additional financing may not be available to Cend on acceptable terms, or at all. Cend&#8217;s failure to raise capital as and when needed would have a negative impact on its financial condition and ability to pursue its business strategy. Cend will
            need to generate significant revenue to achieve profitability and may never do so.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend had an accumulated deficit of $10.2&#160;million as of December&#160;31, 2021, and
            $11.6&#160;million as of March&#160;31, 2022. Cend&#8217;s net loss was $1.4&#160;million for the three months ended March&#160;31, 2022. Cend&#8217;s losses have resulted principally from costs incurred in connection with research and development activities and general and
            administrative costs associated with its operations. Cend does not expect to generate meaningful revenue from product sales for the foreseeable future, and Cend expects to continue to incur significant expenses and operating losses for the
            foreseeable future due to the cost of research and development, including identifying and designing product candidates and conducting preclinical studies and clinical trials, and the regulatory approval process for its product candidates. Cend
            expects its expenses, and the potential for losses, to increase substantially as it conducts clinical trials of its lead product candidate. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 20pt; text-align: left;" class="h3">Sources of Liquidity</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has historically funded its operations primarily through the sale of its common
            stock, Series A preferred stock, Series B preferred stock, and proceeds from collaborators. From its inception in October 2015 through March&#160;31, 2022, Cend has received aggregate gross proceeds of $5.8&#160;million from the sale of its common stock
            and convertible preferred stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of December&#160;31, 2021, and March&#160;31, 2022, Cend had cash and cash totaling
            $6.3&#160;million and $4.7&#160;million, respectively.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table summarizes Cend&#8217;s sources and uses of cash for each of the periods
            presented below (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 24.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.05%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.59%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash (used in) provided by:<br />
                  </div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Operating activities</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara">$9,332</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara">$(1,597)</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara">$(818)</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara">$5,689 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Investing activities</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(12)</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Financing activities</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Effect of exchange rate changes on cash</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">25</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(15</span><span style="min-width: 23.33pt;">)</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara"><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">(85</span><span style="min-width: 27.5pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net increase (decrease) in cash</div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$9,333</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 30.83pt;">$(1,572</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.59%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 23.33pt;">$(845</span><span style="min-width: 23.33pt;">)</span></div>
                </td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.99%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.43pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$5,604</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;" class="h3">Cash Flows</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 20pt; text-align: left;" class="h3">Net cash provided by (used) in operating
            activities</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s net cash provided by or used in operating activities primarily results from
            Cend&#8217;s net income or loss adjusted for non-cash expenses and changes in working capital components. The cash flows from operating activities will continue to be affected by spending to advance and support Cend&#8217;s product candidate and other
            operating and general administrative activities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For the three months ended March&#160;31, 2021, operating activities provided cash of
            $9.3&#160;million, primarily as the result of net income of $5.6&#160;million, an increase in working capital liabilities of $3.1&#160;million, primarily driven by </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">249<br />
        </div>

      </div>

    </div>

    <!--End Page 258-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 259-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg20"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the increase in accrued expenses for the accrual of the sublicense fees due to SBP
            on the Qilu Agreement, and $0.6&#160;million in non-cash expenses related to stock-based compensation of $0.1&#160;million and in-process research and development expenses for the issuance of Series C preferred stock in connection with a technology
            license with UCSD of $0.5&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For the three months ended March&#160;31, 2022, operating activities used cash of
            $1.6&#160;million, primarily as the result of a net loss of $1.4&#160;million, in addition to an increase in working capital of $0.3&#160;million, offset by $0.1&#160;million in non-cash expenses related to stock-based compensation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For the year ended December&#160;31, 2020, operating activities used cash of $0.8&#160;million,
            primarily as the result of a net loss of $8.7&#160;million, offset by an increase in working capital liabilities of $0.7&#160;million, primarily driven by an increase in the Australian income tax benefit receivable, and offset by $7.2&#160;million in non-cash
            expenses related to stock-based compensation of $0.6&#160;million and in-process research and development expenses for the issuance of Series C preferred stock in connection with the asset acquisition of Impilo of $6.6&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For the year ended December&#160;31, 2021, operating activities provided cash of
            $5.7&#160;million, primarily as the result of net income of $3.7&#160;million an increase in working capital liabilities of $0.2&#160;million, and $1.8&#160;million in non-cash expenses related to stock-based compensation of $0.4&#160;million and in-process research
            and development expenses for the issuance of Series C preferred stock in connection with a technology license with UCSD and SBP of $1.1&#160;million and common stock in connection with a technology license with and MIT of $0.3&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;" class="h3">Net cash used in investing activities</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">There were no cash flows from investing activities during the three months ended
            March&#160;31, 2021 or 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">During the year ended December&#160;31, 2020, investing activities used $12,000 of cash
            relating to acquired in-process research and development assets. There were no cash flows from investing activities during the year ended December&#160;31, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Net cash (used in) provided by financing
            activities</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">There were no cash flows from financing activities during the three months ended
            March&#160;31, 2021 or 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">There were no cash flows from financing activities during the years ended December&#160;31,
            2020 or 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Future Capital Requirements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has not generated any revenue from commercial product sales. Cend does not know
            when, or if, it will generate any revenue from commercial product sales. Cend does not expect to generate any revenue from commercial product sales unless and until Cend obtains regulatory approval for and commercializes any of its product
            candidates. At the same time, Cend expects its expenses to increase in connection with its ongoing development and third-party manufacturing activities, particularly as Cend continues the research, development, manufacture and clinical trials
            of, and seeks regulatory approval for its lead product candidate. As of May&#160;20, 2022, the issuance date of Cend&#8217;s consolidated financial statements for the year ended December&#160;31, 2021, Cend expects that its cash balance, as well as the
            proceeds received from the April&#160;26, 2022 Purchase Agreement, would enable it to fund its operating expense and capital requirements into the first quarter of 2023. The future viability of Cend is largely dependent on its ability to generate
            cash from operating activities and to raise additional capital to finance its operations. Accordingly, if the Merger does not occur, there is substantial doubt about Cend&#8217;s ability to continue as a going concern as Cend does not believe that
            its cash will be sufficient to fund operations for at least twelve months from the date of issuance of these financial statements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Assuming the Merger is consummated, the combined company expects that its existing cash
            will be sufficient to fund its operating expenses and capital expenditure requirements for at least the next 12 months from the date of this filing. Upon the closing of the Merger, the combined company expects to incur additional costs
            associated with operating as an SEC registrant. In addition, the combined company anticipates that it will need substantial additional funding in connection with its continuing operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s future capital requirements will depend on many factors, including the
            following:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the initiation, type, number, scope, results, costs and timing of, Cend&#8217;s ongoing and planned preclinical studies and clinical
                    trials of its existing product candidate or clinical trials of other potential product candidates it may choose to pursue in the future, including feedback received from regulatory authorities;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">250<br />
        </div>

      </div>

    </div>

    <!--End Page 259-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 260-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg21"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs and timing of manufacturing for current or future product candidates, including commercial scale manufacturing if any
                    product candidate is approved;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs, timing and outcome of regulatory review of current or future product candidates;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs of obtaining, maintaining and enforcing Cend&#8217;s patents and other intellectual property rights;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s efforts to enhance operational systems and hire additional, including enhanced internal controls over financial
                    reporting;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs associated with hiring additional personnel and consultants as Cend&#8217;s business grows, including additional executive
                    officers and clinical development personnel;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing and amount of the milestone or other payments Cend must make to current and future licensors;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the costs and timing of establishing or securing sales and marketing capabilities if current or future product candidates are
                    approved;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Cend&#8217;s ability to achieve sufficient market acceptance, coverage and adequate reimbursement from third-party payors and adequate
                    market share and revenue for any approved products;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">patients&#8217; willingness to pay out-of-pocket for any approved products in the absence of coverage and/or adequate reimbursement
                    from third-party payors;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">costs associated with any products or technologies that Cend may in-license or acquire; and</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">delays or issues with any of the above, including the risk that each of which may be exacerbated by the ongoing COVID-19
                    pandemic.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Identifying potential product candidates and conducting preclinical studies and
            clinical trials is a time-consuming, expensive, and uncertain process that takes many years to complete, and Cend may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition,
            Cend&#8217;s product candidates, if approved, may not achieve commercial success. Cend&#8217;s commercial revenues, if any, will be derived from sales of product candidates that Cend expects to be commercially available no sooner than 2025, if at all.
            Accordingly, Cend will need to continue to rely on additional financing to achieve its business objectives. Adequate additional financing may not be available to Cend on acceptable terms, or at all.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Until such time, if ever, as Cend can generate substantial product revenue, Cend
            expects to finance its cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances, licensing arrangements and other marketing and distribution arrangements. To the extent that Cend raises
            additional capital through the sale of equity or convertible debt securities, the ownership interest of its stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the
            rights of its other stockholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting Cend&#8217;s ability to take specific actions, such as incurring additional debt, making capital expenditures or
            declaring dividends and may require the issuance of warrants, which could potentially dilute stockholders&#8217; ownership interest. If Cend raises additional funds through collaborations, strategic alliances or licensing arrangements with third
            parties, Cend may have to relinquish valuable rights to its technologies, future revenue streams, research programs or grant licenses on terms that may not be favorable to Cend. Cend&#8217;s ability to raise additional funds will depend on financial,
            economic and other factors, many of which are beyond its control. If Cend is unable to raise additional funds through equity or debt financings when needed, Cend may be required to delay, limit, reduce or terminate its product development or
            future commercialization efforts or grant rights to develop and market its product candidates that it would otherwise prefer to develop and market itself. Because of the numerous risks and uncertainties associated with the development and
            commercialization of Cend&#8217;s product candidates, Cend is unable to estimate the amounts of increased capital outlays and operating expenditures associated with Cend&#8217;s current and anticipated preclinical studies and clinical trials.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">251<br />
        </div>

      </div>

    </div>

    <!--End Page 260-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 261-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_123-mda_pg22"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Contractual Obligations and Commitments</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has contracts with various organizations to conduct research and development
            activities, including clinical trial organizations to manage clinical trial activities and manufacturing companies to manufacture the drug product used in the clinical trials. The scope of the services under these research and development
            contracts can be modified and the contracts cancelled by Cend upon written notice. In the event of a cancellation, Cend would be liable for the cost and expenses incurred to date as well as any close out costs of the service arrangement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Critical Accounting Policies and Significant Judgments and Estimates</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The preparation of financial statements in conformity with U.S. GAAP requires Cend to
            make estimates and judgments that affect the reported amounts of assets, liabilities and expenses. On an ongoing basis, Cend evaluates these estimates and judgments. Cend bases its estimates on historical experience and on various assumptions
            that Cend believes to be reasonable under the circumstances. These estimates and assumptions form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent
            from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s significant accounting policies are described in more detail in Note 2 to the
            consolidated financial statements appearing elsewhere in this proxy statement and are important to understanding and evaluating Cend&#8217;s reported financial results. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Off-Balance Sheet Arrangements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">During the periods presented Cend did not have and Cend does not currently have, any
            off-balance sheet arrangements, as defined under SEC rules, such as relationships with unconsolidated entities or financial partnerships, which are often referred to as structured finance or special purpose entities, established for the purpose
            of facilitating financing transactions that are not required to be reflected on its consolidated balance sheets.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">252<br />
        </div>

      </div>

    </div>

    <!--End Page 261-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 262-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_124-management_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tMFTM"><!--Anchor--></a>MANAGEMENT FOLLOWING THE MERGER</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tEOAD"><!--Anchor--></a>Executive Officers and Directors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Executive Officers and Directors of the Combined
            Organization Following the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors is currently composed of eight directors. Pursuant
              to the Merger Agreement, all of the current directors of Caladrius, other than four designees selected by Caladrius to remain on the Caladrius Board of Directors, shall resign from the Caladrius Board of Directors at or prior to the Effective
              Time. The four directors designated by Caladrius will then elect, effective as of the Effective Time, four designees selected by Cend and one director mutually designated by Caladrius and Cend, each to serve as members of the Caladrius Board
              of Directors in staggered classes to be agreed upon by Caladrius and Cend prior to the Effective Time. Collectively, the reconstituted Caladrius Board of Directors is expected to satisfy the requisite independence requirements for the
              Caladrius Board of Directors, as well as the sophistication and independence requirements for the required committees pursuant to Nasdaq listing requirements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following the consummation of the Merger, the management team of Caladrius is
              expected to be composed of the management team of Caladrius in addition to David Slack of Cend. The following table lists the names and ages as of July&#160;26, 2022 and positions of the individuals who are expected to serve as executive officers
              and directors of Caladrius upon completion of the Merger: </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Age</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Position(s)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Executive Officers<br />
                  </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D. </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">65</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Chief Executive Officer and Class II Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">59</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">President and Chief Business Officer and Class I Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D. </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">48</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Executive Vice President R&amp;D and Chief Medical Officer</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Non-Employee Directors<br />
                  </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D. </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">69</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Class II Director; Chairman of Board of Directors</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">65</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Class III Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">62</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Class I Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Heidi Henson</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">56</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Class II Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Erkki Ruoslahti, M.D., Ph.D. </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">82</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Class I Director</div>
                </td>

  </tr>

  <tr>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mohammad Azab, MD, MBA</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.85%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;" class="fpara">66</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 50.93%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">Class III Director</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Executive Officers</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h4">David J. Mazzo, Ph.D.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D. was appointed as Caladrius&#8217; President and Chief Executive Officer
            on March&#160;28, 2017. Dr.&#160;Mazzo was previously appointed as Caladrius&#8217; Chief Executive Officer and as a member of the Caladrius Board of Directors on January&#160;5, 2015. Dr.&#160;Mazzo brings to Caladrius over 38&#160;years of experience in the pharmaceutical
            industry. Prior to joining Caladrius, Dr.&#160;Mazzo served from August 2008 to October 2014 as Chief Executive Officer and as a member of the Board of Directors of Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the
            development of novel antithrombotic drug systems for acute and sub-acute cardiovascular indications. Prior to his leading Regado, from March 2007 to April 2008, Dr.&#160;Mazzo was President, Chief Executive Officer and a director of &#198;terna Zentaris,
            Inc. (Nasdaq: AEZS), a publicly held international biopharmaceutical company. From 2003 until 2007 Dr.&#160;Mazzo served as President, Chief Executive Officer and director of Chugai Pharma USA, LLC, a biopharmaceutical company and U.S. subsidiary of
            Chugai Pharmaceutical Co., Ltd. of Japan and a member of the Roche Group. Dr.&#160;Mazzo has also held senior management and executive positions in research and development and was a director of the Essex Chimie European subsidiary at
            Schering-Plough Corporation, a publicly held pharmaceutical company that was subsequently acquired by Merck &amp; Co., Inc.; Hoechst Marion Roussel, Inc., the U.S. subsidiary of Hoechst AG, that was subsequently acquired by Sanofi, a
            multinational pharmaceuticals company; and Rhone-Poulenc Rorer, Inc., a subsidiary of Rhone-Poulenc SA, a French pharmaceuticals company, that was subsequently acquired by Hoechst AG. He previously served on the board of directors of publicly
            held EyePoint Pharmaceuticals, Inc. (formerly known as pSivida Corp.), a biopharmaceutical company, from October 2005 to June 2020, Seneca Biopharmaceuticals, Inc. (Nasdaq: SNCA), a therapeutics development company focused on CNS applications
            that merged with Palisade BIO, from April 2019 to April 2021 and Avanir Pharmaceuticals, Inc., from October </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">253<br />
        </div>

      </div>

    </div>

    <!--End Page 262-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 263-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_124-management_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">2005 through January 2015, a pharmaceutical company that was sold to Otsuka Holdings
            in 2015. He currently serves on the board of directors of VTI, Inc. (ASX: VTI), a developer and seller of therapeutic contact lenses, where he has served as Chairman of the board since February 2020 and Feldan Therapeutics, a private company
            developing technology for the intracellular delivery of therapeutic agents, where he has served on the board since January 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Mazzo earned a B.A. in the Honors Program (Interdisciplinary Humanities) and a B.S.
            in Chemistry from Villanova University. In addition, Dr.&#160;Mazzo received his M.S. in chemistry and his Ph.D. degree in Analytical Chemistry from the University of Massachusetts, Amherst. He was also a research fellow at the Ecole Polytechnique
            Federale de Lausanne, Switzerland. Based on Dr.&#160;Mazzo&#8217;s experience within the pharmaceutical industry and his executive experience, specifically his experience as Chief Executive Officer at other companies in the biopharmaceutical industry, as
            well as his service on other boards of directors in the healthcare industry in addition to his scientific training and experience, we believe that Dr.&#160;Mazzo is qualified to serve on the Caladrius Board of Directors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h4">David Slack </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Mr.&#160;Slack has served as a Director of Cend since December&#160;3, 2019 and as its President
            and Chief Executive Officer since March&#160;29, 2021. He is responsible for overseeing all Research and Development and operational activities, as well as overseeing fundraising, business development and M&amp;A activity. Mr.&#160;Slack also acts as the
            Chairman of Cend&#8217;s wholly owned subsidiary, DrugCendR Australia. He also currently serves as an Industry Advisor for non-profit pancreatic cancer patient advocacy organization, Trovanow, where he advises the organization with respect to
            prospective industry partnership and philanthropic fund raising. From March 2020 to March 2021, Mr.&#160;Slack was a Consultant for Cend. From January 2004 to March 2021, Mr.&#160;Slack served as a Principal of DS Lifescience Consulting. Also, from
            August 2016 to July 2020 he was the Chief Business Officer of Viracta Therapeutics, a publicly traded company, listed on Nasdaq. From 2000 to 2004, Mr.&#160;Slack served as Vice President of Business Development for Ionis Pharmaceuticals, Inc. a
            publicly traded company, listed on Nasdaq. From 1998-2000, Mr.&#160;Slack served as Director of Technology Alliances and Licensing at Rhone-Poulenc Rorer Pharmaceuticals and Aventis Pharmaceuticals, a publicly listed pharmaceutical company He
            received his Bachelor of Arts in Psychology and his Bachelor of Science in Molecular Biology from California State University Sacramento. Mr.&#160;Slack received his Masters of Business Administration in Business and Strategic Marketing from
            Monterey Institute of International Studies (now Middlebury Institute of International Studies).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h4">Kristen K. Buck, M.D.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Kristen K. Buck joined Caladrius in September 2021 as Executive Vice President of
            R&amp;D and Chief Medical Officer (&#8220;CMO&#8221;) of the Company. Prior to joining Caladrius Dr.&#160;Buck worked at ICON plc from March 2020 to July 2021, where she served as its CMO and represented the company&#8217;s position on key scientific, ethical, and
            medical governance matters, provided guidance and oversight to the medical and scientific groups, and led the Drug Development Services group. Prior to that, Dr.&#160;Buck was Senior Vice President &amp; Chief of Clinical Development at Optum
            Insights (part of the United Healthcare Group) from August 2018 to March 2020, where she led the clinical operations and regulatory groups within the Digital Research Network (DRN) clinical trial business. From January 2014 to July 2018,
            Dr.&#160;Buck held a position at Quintiles/IQVIA as Vice President of Global Strategic Drug Development designing clinical development plans and protocols across all therapeutic areas for emerging biotech and large pharma.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Earlier in her career, Dr.&#160;Buck worked as a primary care physician and then later
            served as a medical officer in the FDA&#8217;s Office of New Drugs Division of Gastrointestinal and Hematology Drug Products where she was responsible for reviewing efficacy and safety data for new drug indications, as well as post-marketing safety
            data for over 40 drugs. Dr.&#160;Buck worked at AstraZeneca where she served as a Global Safety Physician and Global Study Physician. Her experience ranges over multiple therapeutic indications including cardiovascular/metabolic, rare diseases,
            gastrointestinal, neuroscience, oncology, immunology, and women&#8217;s health.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Buck is a board certified and licensed physician who received her medical degree
            from the Pennsylvania State University School of Medicine and completed her internship and residency in Internal Medicine at Abington Memorial Hospital before working in a private practice as a primary care physician.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">254<br />
        </div>

      </div>

    </div>

    <!--End Page 263-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 264-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_124-management_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Non-Employee Directors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h4">Gregory B. Brown, M.D.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D. was appointed to the Caladrius Board of Directors in October
            2016 and was elected Chairman by the Caladrius Board of Directors on February&#160;16, 2017. Dr.&#160;Brown is currently Chief Executive Officer of Memgen, Inc., a development-stage biotechnology company. In 2007, Dr.&#160;Brown co-founded HealthCare Royalty
            Partners (&#8220;HCR Partners&#8221;), a healthcare-focused private asset management firm investing in biopharmaceutical and medical products, and developing and deploying innovative risk-mitigated investment strategies to deliver non-correlated cash flow.
            Dr.&#160;Brown remains Vice Chairman of HCR Partners and a member of the firm&#8217;s SAB. Dr.&#160;Brown was educated as a transplantation immunologist and trained as a thoracic and vascular surgeon. He practiced thoracic and vascular surgery in a community
            setting where he also founded and led a health maintenance organization. He brings particular expertise in the scientific, technical, clinical and medical evaluation of products as well as in healthcare systems and payor/reimbursement dynamics.
            He has been involved in sourcing, performing due diligence on and closing more than $1&#160;billion of royalty financings.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Before co-founding HCR Partners, Dr.&#160;Brown was a partner at Paul Capital Partners where
            he co-managed that firm&#8217;s royalty investments as a member of the royalty management committee. Prior to beginning his principal investment career in 2003, Dr.&#160;Brown was co-head of investment banking and head of healthcare at Adams, Harkness
            &amp; Hill (now Canaccord Genuity) and a ranked biotechnology research analyst at Vector Securities International. Dr.&#160;Brown holds a B.A. from Yale, an M.D. from SUNY Upstate Medical Center and an M.B.A. from Harvard Business School. He
            currently serves on the boards of FAST Biomedical since January 2020, Memgen, Inc. since October 2018, Aquestive Therapeutics, Inc. since 2007, and Faron Pharmaceuticals, Oy since 2017. He previously served on the boards of Cambrex Corporation,
            Invuity, Inc. and Vanderbilt Clinical, S.a.r.l. We believe that Dr.&#160;Brown is qualified to serve on the Caladrius Board of Directors based on his medical, financial and management experience.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15.5pt; margin-left: 0pt; text-align: left;" class="h4">Steven M. Klosk</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk joined the Caladrius Board of Directors in 2014. He is a senior
            executive with extensive management experience in the life sciences industry. He served as a Director at Cambrex Corporation (NYSE:CBM) from May 2008 through December 2019, until it was acquired by Permira and then as Director from December
            2019 until June 2020. Cambrex is one of the leading providers of active pharmaceutical ingredients, advanced intermediates and finished dosage form products to the branded and generic pharmaceutical markets, where he served as President and
            Chief Executive Officer from May 2008 through June 2020. In that role he was responsible for all aspects of Cambrex&#8217;s global business with manufacturing and R&amp;D facilities in the United States, Sweden, Italy, Estonia and Germany. In
            addition, he has served on the Board of Directors of Recipharm, a leading pharmaceutical contract development &amp; manufacturing organization since March 2021 and Golden Arrow Merger Corp. since March 2021. In addition, since 2021 he has
            served on the board of directors of Formulated Solutions, a topicalsCDMO where he is the chairman of the board; BioIVT, a leading supplier of biologics specimens for biotech research; BIOVECTRA, a leading small molecule and biologics CDMO; and
            NJ Bio, a leading antibody drug conjugate contract research organization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Mr.&#160;Klosk held other executive positions at Cambrex Corporation, including President,
            Executive Vice President &amp; COO as well as President, Pharma Business Unit (2007-2008) where he had full P&amp;L and balance sheet responsibility for four operating units in North America and Europe. Prior to this he was Executive Vice
            President &amp; COO Cambrex Pharma &amp; Biopharmaceuticals Business Unit (2003-2007) where he was responsible for managing a highly profitable global business with six operating units in North America and Europe. Earlier in his career
            Mr.&#160;Klosk served as Vice President, Administration for The Genlyte Group, Inc., a publicly traded producer of lighting fixtures. Mr.&#160;Klosk earned a B.S. from Cornell University and a J.D. from New York Law School. We believe that Mr.&#160;Klosk is
            qualified to serve on the Caladrius Board of Directors based on his diversified management experience, particularly in the biopharmaceutical field.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15.5pt; margin-left: 0pt; text-align: left;" class="h4">Cynthia L. Flowers </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Ms.&#160;Flowers was appointed to the Caladrius Board of Directors in November 2018. She is
            the owner of EIR Advisory LLC, a life sciences advisory and strategic investment firm. From February 2014 through November 2017, Ms.&#160;Flowers was President and Chief Executive Officer of Ipsen North America, where she led the transformation of
            the company as it became the highest-growth subsidiary worldwide. Prior to joining Ipsen, she </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">255<br />
        </div>

      </div>

    </div>

    <!--End Page 264-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 265-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_124-management_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">served as President of Eisai Pharmaceuticals, where she oversaw commercial
            operations, medical affairs and services, manufacturing, alliance management and other functions. She has also held general management roles, both domestically and internationally, at Amgen Inc. and Johnson &amp; Johnson. Ms.&#160;Flowers began her
            career as an oncology/critical care nurse.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Ms.&#160;Flowers currently serves on the board of Hikma Pharmaceuticals PLC, a
            multigenerational generics company and G1 Therapeutics Inc., a biotechnology clinical development company. She has held positions on numerous corporate and non-profit boards, including Nanoform Finland OYi, a nanoparticle manufacturing company,
            Kadmon Group, Inc., a clinical stage biopharmaceutical company, the Women&#8217;s Leadership Advisory Board for the John F. Kennedy School of Government at Harvard University and the board of directors for the Sarah Cannon Oncology Research
            Institute. She currently serves as a Wharton Business School Leadership Advisor. Ms.&#160;Flowers holds an M.B.A. from the Wharton School of the University of Pennsylvania and a B.S.N. from the University of Delaware. We believe that Ms.&#160;Flowers is
            qualified to serve on the Caladrius Board of Directors based on her pharmaceutical industry, management and scientific training and experience.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h4">Heidi Henson </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Ms.&#160;Henson has served as Cend Director since 2019. Since 2021, she has served as the
            Chief Financial Officers of Pardes Biosciences, Inc., a publicly traded company listed on Nasdaq under the symbol &#8220;PRDS&#8221;, where she is responsible for building out the company&#8217;s infrastructure and implementing processes and procedures relating
            to being a public company. She also concurrently serves on the board of directors of PepGen, Inc. (Nasdaq: PEPG). From 2012-2012 she served on the board as Chief Financial Officer of the San Diego Children&#8217;s Choir, and from 2010 to 2013 she
            served as the board as Treasurer of the San Diego Children&#8217;s Choir Parent Association. From 2020 to 2021 she was a consultant for Pardes. From 2019-2020 Ms.&#160;Henson served as the Chief Financial Officer of Imbria Pharmaceuticals, Inc. and from
            2018 to 2019 she was the Chief Financial Officer and Chief Compliance Officers of Respivant Sciences, Inc. where she was responsible for the implementation and monitoring the compliance program. From 2014 to 2018, she served as the Chief
            Financial Officers of Kura Oncology, Inc, a publicly traded company listed on Nasdaq under the symbol &#8220;KURA&#8221;, where she led the private placement, reverse merger, and up-listing of the company to Nasdaq. From 2012 to 2018, she was the Chief
            Financial Officer for Wellspring Biosciences, LLC and its parent company Araxes Pharma, LLC. From 2007 to 2012, Ms.&#160;Henson was the Vice President of Finance for Intellikine, Inc. From 2005 to 2011, she worked as a consultant for various
            pharmaceutical industry clients, and she would assist with SEC reporting, implementation of financial processes and controls and implementation of SOX 404 compliance plans and documentation. From 2004 to 2005, she was the Controller for La
            Jolla Pharmaceutical Company, listed on Nasdaq under &#8220;LJPC&#8221;. Prior to 2005 she was a Director, Finance at Anadys Pharmaceutical, Inc. (Nasdaq: ANDS), held several positions at Fair Isaac &amp; Co, Inc (Nasdaq: FICO), and was a financial analyst
            at Alaris Medical Systems, Inc. and senior auditor from PricewaterhouseCoopers, LLP. Ms.&#160;Henson received her Bachelors of Accountancy from the University of San Diego and is a member of the Association of Bioscience Financial Officers.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h4">Erkki Ruoslahti, M.D., Ph.D. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Dr.&#160;Ruoslahti has served as a Cend Director since 2015 and as Founder, President and
            Chief Executive Officer from 2015 to 2020. In 2020, Dr.&#160;Ruoslahti became a Consultant for Cend. He has over 30&#160;years of experience in biotech that includes founding Impilo Therapeutics, Inc. where he served as a Director until about September
            2020 when it was acquired by Cend. Most significantly, from January 1976 to September 2020 Dr.&#160;Ruoslahti has served as Researcher, Scientific Director, President, Chief Executive Officer of Sanford Burnham Prebys Medical Discovery Institute
            where he took the once fledgling 50-person research organization to a world-renowned research institution. When he stepped down as Chief Executive Officer, the institute had 500 employees and was ranked number on among all research
            organizations in world in the number of citations its publications received in the cell/molecular biology literature. The core technology from Cend originates from his laboratory. Currently, Dr.&#160;Ruoslahti has an informal emeritus relationship
            with the institute. From 2005 to 2008 he served as a Director for Advances Technologies, Inc, a publicly traded company listed on Nasdaq. From 2000 to 2002, he co-founded was a Director of Targeted Molecules, Inc. and from 1993 to 1996 he
            served as a Director of Canji and from 1987 to 1995, he co-founded and served as a director of Telios Pharmaceuticals, Inc. a publicly traded company on Nasdaq. Mr.&#160;Ruoslahti received his M.D., and Ph.D. from the University of Helsinki,
            Helsinki Finland. From 1968 to 1970 he was a Postdoctoral fellow at CalTech. Dr.&#160;Ruoslahti is a member of the U.S. National Academy of Sciences.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">256<br />
        </div>

      </div>

    </div>

    <!--End Page 265-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 266-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_124-management_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h4">Mohammad Azab, MD, MBA </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Mohammad Azab, M.D., MSc, MBA, will be a member of the Caladrius Board of Directors
              following the consummation of the Merger. Dr. Azab is a leader in clinical and regulatory development of biopharmaceutical drugs with particular expertise in oncology drug development. In July 2009, Dr. Azab joined Astex Pharmaceuticals, Inc.
              (&#8220;Astex&#8221;), a pharmaceutical company focused on the discovery and development of drugs in oncology and other areas, as its Chief Medical Officer. Dr. Azab served as President and Chief Medical Officer of Astex from January 2014 to November
              2020, and has been serving as the chair of its board of directors from November 2020 to May 1, 2022. Since January 2021, Dr. Azab has served on the board of directors of DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed
              to transforming the treatment of acute organ injury and chronic liver diseases. Additionally, Dr. Azab has served on the board of directors of Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a biopharmaceutical company delivering innovative
              medicines to patients with neurological disorders, since January 2003. Previously, Dr. Azab served as President and Chief Executive Officer of Intradigm Corporation, a developer of siRNA cancer therapeutics. Prior to this, Dr. Azab served as
              Executive Vice President of Research and Development and Chief Medical Officer of QLT Inc. and in several leadership positions at AstraZeneca plc in the United Kingdom and Sanofi in France. Dr. Azab holds an MBA from the Richard Ivey School
              of Business, University of Western Ontario, and an MB ChB from Cairo University. He received post-graduate training and degrees in oncology research from the University of Paris-Sud and in biostatistics from the University of Pierre et Marie
              Curie in Paris, France.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCOMP"><!--Anchor--></a>Composition of the Board of Directors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors is currently comprised of eight directors divided into
            three staggered classes, each class serving three-year terms. The staggered structure of the Caladrius Board of Directors will remain in place following completion of the Merger. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">The director classes for the Caladrius Board of Directors are currently as follows: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Class&#160;I directors: Cynthia L. Flowers, Peter G. Traber, M.D. and Anne C. Whitaker; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Class&#160;II directors: Gregory B. Brown, M.D. and David J. Mazzo, Ph.D.; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Class&#160;III directors: Michael H. Davidson, M.D., Steven M. Klosk and Steven S. Myers.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the Merger Agreement, each of the directors and officers of Caladrius
              who will not continue as directors or officers of Caladrius or the combined organization following the consummation of the Merger shall resign immediately prior to the Effective Time. Pursuant to the terms of the Merger Agreement, four of the
              directors on the Caladrius Board of Directors will be designated by Cend and four of such directors will be designated by Caladrius. Effective as of the Effective Time, it is anticipated that Dr.&#160;Mazzo, Dr.&#160;Brown, Mr.&#160;Klosk and Ms.&#160;Flowers
              will remain on the Caladrius Board of Directors. Then, Dr.&#160;Mazzo, Dr.&#160;Brown, Mr.&#160;Klosk and Ms.&#160;Flowers will elect Mr.&#160;Slack, Ms.&#160;Henson, Dr.&#160;Ruoslahti and Mohammad Azab, MD, MBA to the Caladrius Board of Directors. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">It is anticipated that these directors will be appointed to the three staggered
            director classes of the combined organization&#8217;s board of directors as follows: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Class&#160;I directors (expiring in 2023): David Slack, Cynthia L. Flowers and Erkki Ruoslahti, M.D., Ph.D.; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Class&#160;II directors (expiring in 2024): David J. Mazzo, Ph.D., Gregory B. Brown and Heidi Henson; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Class&#160;III directors (expiring in 2025): Steven M. Klosk and Mohammad Azab, MD, MBA. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The division of the Caladrius Board of Directors into three classes with staggered
            three-year terms may delay or prevent a change of management or a change of control of Caladrius, or, following the completion of the Merger, the combined organization.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">There are no family relationships among any of Caladrius&#8217; current directors and
            executive officers, and there are no family relationships among any of the combined organization&#8217;s proposed directors and executive officers.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCOMMI"><!--Anchor--></a>Committees of the Board of Directors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors currently has, and after completion of the Merger the
            Caladrius Board of Directors will continue to have, an Audit Committee, a Compensation Committee, a Nominating and Corporate Governance Committee and a Science and Technology Committee.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">257<br />
        </div>

      </div>

    </div>

    <!--End Page 266-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 267-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_124-management_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Audit Committee</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The purpose of the audit committee is to oversee Caladrius&#8217; accounting and financial
            reporting processes and audits of its financial statements. Although management has primary responsibility for the system of internal controls and the financial reporting process, the responsibilities of the audit committee include: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">appointing the independent registered public accounting firm; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">evaluating the independent registered public accounting firm&#8217;s qualifications, independence and performance; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">determining the engagement of the independent registered public accounting firm; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewing and approving the scope of the annual audit and the audit fee; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">discussing with management and the independent registered public accounting firm the results of the annual audit and the review
                    of quarterly financial statements; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">approving the retention of the independent registered public accounting firm to perform any proposed permissible non-audit
                    services; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">monitoring the rotation of partners of the independent registered public accounting firm on the engagement team as required by
                    law; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">responsibility for reviewing the financial statements and management&#8217;s discussion and analysis of financial condition and
                    results of operations to be included in annual and quarterly reports to be filed with the SEC; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewing critical accounting policies and estimates; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">annually reviewing the audit committee charter and the committee&#8217;s performance. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The audit committee of the combined organization is expected to retain these duties and
            responsibilities following completion of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following completion of the Merger, the members of the Audit Committee are expected to
            be Heidi Henson, Cynthia Flowers and Steven Klosk. Heidi Henson is expected to serve as the chairman of the committee and its financial expert under the rules of the SEC. To qualify as independent to serve on the combined organization&#8217;s audit
            committee, the listing standards of The Nasdaq Capital Market and the applicable rules of the SEC require that a director not accept any consulting, advisory or other compensatory fee from the combined organization, other than for service as a
            director, or be an affiliated person of the combined organization. Caladrius and Cend believe that, following completion of the Merger, the composition of the audit committee will comply with the applicable requirements of the rules and
            regulations of Nasdaq and the SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Compensation Committee</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The compensation committee reviews and recommends policies relating to compensation and
            benefits of Caladrius&#8217; officers and employees. The compensation committee reviews and recommends corporate goals and objectives relevant to the compensation of Caladrius&#8217; chief executive officer and other executive officers, evaluates the
            performance of these officers in light of those goals and objectives and recommends to the Caladrius Board of Directors the compensation of these officers based on such evaluations. The compensation committee also recommends to the Caladrius
            Board of Directors the issuance of stock options and other awards under Caladrius&#8217; stock plans. The compensation committee will review and evaluate, at least annually, the performance of the compensation committee and its members, including
            compliance by the compensation committee with its charter.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Under the compensation committee&#8217;s charter, it has the authority, in its sole
            discretion, to retain (or obtain the advice of) any compensation consultant, legal counsel or other adviser to assist it in the performance of its duties. The compensation committee also has the direct responsibility for the appointment,
            compensation and oversight of the work of any advisers retained or engaged by the compensation committee. Under its charter, the compensation committee also has the authority to delegate its authority and responsibilities to members of the
            committee or a subcommittee. Finally, the compensation committee has the sole authority to approve the fees and the other terms and conditions of the engagement of any such advisor. Caladrius must provide for appropriate funding, as determined
            by the compensation committee, for the payment of reasonable compensation to any such adviser retained by the compensation committee.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">258<br />
        </div>

      </div>

    </div>

    <!--End Page 267-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 268-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_124-management_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">The compensation committee of the combined organization is expected to retain these
            duties and responsibilities following completion of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following the consummation of the Merger, the members of the compensation committee are
            expected to be Steven Klosk, who is expected to serve as chairman, Gregory Brown and Heidi Henson. To qualify as independent to serve on the combined organization&#8217;s compensation committee, the listing standards of The Nasdaq Capital Market
            require a director not to accept any consulting, advisory, or other compensatory fee from the combined organization, other than for service on the combined organization&#8217;s board of directors, and that the combined organization&#8217;s board of
            directors consider whether a director is affiliated with the combined organization and, if so, whether such affiliation would impair the director&#8217;s judgment as a member of the combined organization&#8217;s compensation committee. Caladrius and Cend
            believe that, after the completion of the Merger, the composition of the compensation committee will meet the requirements for independence under, and the functioning of such compensation committee will comply with any applicable requirements
            of the rules and regulations of The Nasdaq Capital Market and the SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h3">Nominating and Corporate Governance Committee</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The nominating and corporate governance committee is responsible for making
            recommendations to the Caladrius Board of Directors regarding candidates for directorships and the size and composition of the Caladrius Board of Directors. In addition, the nominating and corporate governance committee is responsible for
            overseeing Caladrius&#8217; corporate governance policies and reporting and making recommendations to the Caladrius Board of Directors concerning governance matters.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In evaluating the suitability of individual candidates (both new candidates and current
            members), the Nominating and Corporate Governance Committee and the Caladrius Board of Directors may take into account many factors, including the following: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">personal and professional integrity; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ethics and values; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">experience in corporate management, such as serving as an officer or former officer of a publicly held company; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">experience in the industries in which Caladrius competes; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">experience as a board member or executive officer of another publicly held company; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">diversity of expertise and experience in substantive matters pertaining to Caladrius&#8217; business relative to other board members;
                  </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">conflicts of interest; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">practical and mature business judgment. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The nominating and governance committee of the combined organization is expected to
            retain these responsibilities following completion of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following the closing of the Merger, the members of the nominating and governance
            committee are expected to be Gregory Brown, who is expected to serve as chairman, Erkki Ruoslahti and &#8195;&#8195;&#8195;. Caladrius and Cend believe that, after the completion of the Merger, the composition of the nominating and governance committee will meet
            the requirements for independence under, and the functioning of such nominating and governance committee will comply with any applicable requirements of the rules and regulations of The Nasdaq Capital Market.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h3">Additional Board Committee:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="h3">Science and Technology Committee </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Following the consummation of the Merger, the members of the Science and Technology
              Committee are expected to be Erkki Ruoslahti, who is expected to serve as chairman, David J. Mazzo, Ph.D., David Slack, Gregory Brown and Mohammad&#160;Azab, MD,&#160;MBA . This committee is authorized to review the science, clinical and regulatory
              strategy underlying Caladrius&#8217; research and development programs, as well as associated staffing and budgets. It also reviews the interactions of the research and development organization with healthcare providers and regulatory bodies. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">259<br />
        </div>

      </div>

    </div>

    <!--End Page 268-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 269-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_125-transactions_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPARTY"><!--Anchor--></a>RELATED PARTY TRANSACTIONS OF DIRECTORS AND
            EXECUTIVE OFFICERS OF THE COMBINED ORGANIZATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Described below are any transactions occurring since January&#160;1, 2022 as to Caladrius,
            any transactions occurring since January&#160;1, 2022 as to Cend, and any currently proposed transactions as to Caladrius and Cend, to which either Caladrius or Cend was a party and in which: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the amounts involved exceeded or will exceed $120,000; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a director, executive officer, holder of more than 5% of the outstanding capital stock of Caladrius or Cend, or any member of
                    such person&#8217;s immediate family, had or will have a direct or indirect material interest. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition to the transactions described below, please see the compensation agreements
            and other arrangements described under the sections entitled &#8220;<span style="font-style: italic;">Caladrius Directors, Officers and Corporate Governance&#8212;Director Compensation,</span>&#8221; &#8220;<span style="font-style: italic;">Caladrius Executive
              Compensation,</span>&#8221; &#8220;<span style="font-style: italic;">Cend Executive Compensation</span>&#8221; and &#8220;<span style="font-style: italic;">Cend Director Compensation</span>&#8221; in this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCALA"><!--Anchor--></a>Caladrius Transactions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Indemnification Agreements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has entered into indemnification agreements with each of its directors and
            executive officers. These agreements, among other things, require Caladrius to indemnify each director and executive officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys&#8217; fees,
            judgments, penalties fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action or proceeding by or in right of Caladrius, arising out of the person&#8217;s services as a director or
            executive officer.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Change of Control, Severance Benefits Agreements
            and Compensation Arrangements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">See the sections entitled &#8220;<span style="font-style: italic;">Caladrius Directors,
              Officers and Corporate Governance&#8212;Director Compensation</span>&#8221; and &#8220;<span style="font-style: italic;">Caladrius Executive Compensation</span>&#8221; in this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Policies and Procedures for Related Party
            Transactions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors has adopted a written related person transaction
            policy setting forth the policies and procedures for the review and approval or ratification of related person transactions. This policy covers, with certain exceptions set forth in Item 404 of Regulation S-K under the Securities Act, any
            transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which Caladrius was or is to be a participant, where the amount involved exceeds $120,000 and a related person had or will have a
            direct or indirect material interest, including, without limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and
            employment by Caladrius of a related person. In reviewing and approving any such transactions, Caladrius&#8217; audit committee is tasked to consider all relevant facts and circumstances, including, but not limited to, whether the transaction is on
            terms comparable to those that could be obtained in an arm&#8217;s length transaction with an unrelated third party and the extent of the related person&#8217;s interest in the transaction.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tTRANS"><!--Anchor--></a>Cend Transactions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Indemnification Agreements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Cend has entered into indemnification agreements with each of its directors and
            executive officers. These agreements, among other things, require Cend to indemnify each director and executive officer to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys&#8217; fees, judgments,
            penalties fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action or proceeding by or in right of Cend, arising out of the person&#8217;s services as a director or executive
            officer.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Change of Control, Severance Benefits Agreements
            and Compensation Arrangements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">See the sections entitled &#8220;<span style="font-style: italic;">Cend Executive
              Compensation</span>&#8221; and &#8220;<span style="font-style: italic;">Cend Director Compensation</span>&#8221; in this proxy statement/prospectus/information statement.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">260<br />
        </div>

      </div>

    </div>

    <!--End Page 269-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 270-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_125-transactions_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Policies and Procedures for Related Party
            Transactions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Cend Board of Directors has adopted a written related person transaction policy
            setting forth the policies and procedures for the review and approval or ratification of related person transactions. This policy covers, with certain exceptions set forth in Item 404 of Regulation S-K under the Securities Act, any transaction,
            arrangement or relationship, or any series of similar transactions, arrangements or relationships in which Cend was or is to be a participant, where the amount involved exceeds $120,000 and a related person had or will have a direct or indirect
            material interest, including, without limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and employment by Cend of a
            related person. In reviewing and approving any such transactions, Cend&#8217;s audit committee is tasked to consider all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those that
            could be obtained in an arm&#8217;s length transaction with an unrelated third party and the extent of the related person&#8217;s interest in the transaction.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Amendment to Cend&#8217;s 2016 Plan and Grants</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On July 1, 2022 the Cend Board of Directors adopted Amendment No. 6 to Cend
              Therapeutics, Inc. 2016 Incentive Plan (&#8220;2016 Plan&#8221;) to include the Merger in the definition of a &#8220;Change in Control&#8221; under section 2(d)(iii). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Additionally, on July 1, 2022, the Cend Board of Directors adopted the First
              Amendment to Stock Option Grant Notice for David Slack to replace, in its entirely, Section 3 &#8220;Vesting Schedule&#8221; to provide that in the event of an Involuntary Termination which results in Optionee&#8217;s Termination of Service, within twelve (12)
              months following a Change in Control (as defined in the Plan), the vesting of his Option, the new option or other similar incentives replacing this Option, as applicable, shall accelerate in full automatically effective upon such Involuntary
              Termination.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">An &#8220;Involuntary Termination&#8221; shall mean Optionee&#8217;s Termination of Service by reason
              of (i) Optionee&#8217;s involuntary dismissal or discharge by Cend, or by the acquiring or successor entity (or parent or any subsidiary thereof employing the Optionee) for reasons other than Cause (as defined in the Option Agreement); or
              (ii)&#160;Optionee&#8217;s voluntary resignation following (x) a change in Optionee&#8217;s position with Cend, the acquiring or successor entity (or parent or any subsidiary thereof) which materially reduces Optionee&#8217;s duties and responsibilities (provided
              that a change in title alone shall not be sufficient to constitute such a change), (y) a reduction in Optionee&#8217;s level of cash compensation (including base salary and target bonus under any performance based bonus or incentive programs), or a
              reduction of more than twenty percent (20%) in the value of fringe benefits provided, or (z) a relocation of Optionee&#8217;s principal place of employment by more than thirty (30) miles; provided, however, any resignation by Optionee due to the
              foregoing shall only be deemed an Involuntary Termination if (I) Optionee gives Cend written notice of the intent to terminate within sixty (60) days of the occurrence of the condition Optionee believes constitute an Involuntary Termination,
              (II) Cend fails to remedy such condition within thirty (30) days of such written notice (the &#8220;Cure Period&#8221;), and (III) Optionee actually resigns within sixty (60) days after the expiration of the Cure Period.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Further on June 9, 2022, Cend&#8217;s Board of Directors granted the following options to
              purchase shares of Cend common Stock: (i) 5,000 to Tambet Teesalu, fully vested, at an exercise price of $4.01 for 10 years, (ii) 20,000 to Heidi Henson, fully vested at an exercise price of $4.01 for 10 years and (iii) 5,000 to Kazuki
              Sugahara, fully vested at an exercise price of $4.01 for 10 years.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">261<br />
        </div>

      </div>

    </div>

    <!--End Page 270-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 271-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPRO"><!--Anchor--></a>UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
            STATEMENTS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April 26, 2022, Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;), CS Cedar Merger Sub,
            Inc., a Delaware corporation and wholly owned subsidiary of Caladrius (&#8220;Merger Sub&#8221;), and Cend Therapeutics, Inc. (&#8220;Cend&#8221; or the &#8220;Company&#8221;), a privately-held, clinical-stage biotechnology company, entered into an Agreement and Plan of Merger
            and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Cend, with Cend continuing
            as a wholly owned subsidiary of Caladrius (the &#8220;Merger&#8221;). Following closing, the combined company will be renamed Lisata Therapeutics, Inc. (&#8220;Lisata&#8221;) and is expected to trade on the Nasdaq under the ticker symbol &#8220;LSTA.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Subject to the terms and conditions of the Merger Agreement, at the closing of the
            Merger, (a) each outstanding share of Cend common stock and Cend preferred stock (except shares of Cend Series D Preferred Stock held by Caladrius) will be converted into the right to receive a number of shares of Caladrius common stock
            (&#8220;Caladrius Common Stock&#8221;) equal to the exchange ratio described below; and (b) each outstanding Cend stock option that has not previously been exercised prior to the closing of the Merger will be assumed by Caladrius. Under the exchange ratio
            formula in the Merger Agreement, as of immediately after the Merger, Cend&#8217;s former stockholders are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock and stockholders of Caladrius as of immediately prior to
            the Merger are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on Caladrius&#8217; net cash balance at the time of closing and the amount of any
            transaction expenses of Cend in excess of $0.3 million at the time of closing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Concurrently with the execution of the Merger Agreement and in order to provide Cend
            with capital for its development programs prior to the closing of the Merger, Caladrius agreed to purchase from Cend shares of Series D Preferred Stock (the &#8220;Cend Series D Preferred Stock&#8221;), of Cend at a purchase price of $10.0 million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If deemed necessary by the parties, Caladrius shall submit to Caladrius&#8217; stockholders
            an amendment to Caladrius&#8217; certificate of incorporation to authorize the Caladrius board to effect a reverse stock split of all outstanding shares of Caladrius common stock at a reverse stock split ratio mutually agreed to by Cend and Caladrius
            (the &#8220;Caladrius Reverse Stock Split&#8221;), and shall take such other actions as shall be reasonably necessary to effectuate the Caladrius Reverse Stock Split.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement contains certain termination rights for both Caladrius and Cend,
            and further provides that, upon termination of the Merger Agreement, under specified circumstances, Caladrius may be required to pay Cend a termination fee of $1.0 million, Cend may be required to pay Caladrius a termination fee of $4.0
            million, or in some circumstances reimburse the other party&#8217;s expenses up to a maximum of $1.0 million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h4">Unaudited Pro Forma Condensed Combined Financial Statements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following unaudited pro forma condensed combined financial statements have been
            prepared to illustrate the estimated effects of the Merger. The accompanying unaudited pro forma condensed combined balance sheet as of March 31, 2022 combines the historical consolidated balance sheets of Caladrius and Cend, giving effect to
            the Merger as if it had been completed on March 31, 2022. The unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2022 and for the year ended December 31, 2021 combine the historical consolidated
            statements of operations of Caladrius and Cend, giving effect to the Merger as if it had been completed on January 1, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma condensed combined financial statements has been prepared in
            accordance with Regulation S-X Article 11, Pro Forma Financial Information, as amended by the final rule, Amendments to Financial Disclosures about Acquired and Disposed Businesses, as adopted by the SEC in May 2020 (&#8220;Article 11&#8221;). The
            unaudited pro forma condensed combined financial information is provided for illustrative purposes only, does not necessarily reflect what the actual consolidated results of operations would have been had the acquisition occurred on the dates
            assumed and may not be useful in predicting the future consolidated results of operations or financial position. Cend&#8217;s results of operations and actual financial position may differ significantly from the pro forma amounts reflected herein due
            to a variety of factors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius is acquiring Cend and the Merger is expected to be accounted for using the
            asset acquisition method under accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). Caladrius is considered to be the accounting acquirer based on the terms of the Merger Agreement and certain factors </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">262<br />
        </div>

      </div>

    </div>

    <!--End Page 271-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 272-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">including: (i) Caladrius is issuing equity of approximately 60.5 million common
            shares to shareholders of Cend; (ii) although both entities will contribute to the new management team of Lisata, the Caladrius team will have more individuals on the management team and will hold the President and CEO roles; (iii) Caladrius
            paid a premium to acquire Cend&#8217;s assets; and (iv) Caladrius is significantly larger than Cend regarding total assets, operations, and research and development activities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger is expected to be accounted for as an asset acquisition as substantially all
            of the fair value is concentrated in intangible assets, primarily, In-Process Research and Development (&#8220;IPR&amp;D&#8221;). Cend&#8217;s assets (except for cash) and liabilities will be measured and recognized as an allocation of the transaction price
            based on their relative fair values as of the transaction date with any value associated with IPR&amp;D with no alternative future use being expensed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma condensed combined financial information is based on the
            assumptions and adjustments that are described in the accompanying notes. Accordingly, the pro forma adjustments are preliminary, subject to further revision as additional information becomes available and additional analyses are performed and
            have been made solely for the purpose of providing unaudited pro forma condensed combined financial information. Differences between these preliminary estimates and the final accounting, expected to be completed after the closing of the Merger,
            will occur and these differences could have a material impact on the accompanying unaudited pro forma condensed combined financial information and the combined company&#8217;s future results of operations and financial position. In addition,
            differences between the preliminary and final amounts will likely occur as a result of the amount of cash used for Cend&#8217;s operations, changes in the fair value of Caladrius' common stock, and other changes in Cend&#8217;s assets and liabilities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma condensed combined financial information does not give effect
            to the potential impact of current financial conditions, regulatory matters, operating efficiencies or other savings or expenses that may be associated with the integration of the two companies. The unaudited pro forma condensed combined
            financial information is preliminary and has been prepared for illustrative purposes only and is not necessarily indicative of the financial position or results of operations in future periods or the results that actually would have been
            realized had Caladrius and Cend been a combined company during the specified periods. The actual results reported in periods following the Merger may differ significantly from those reflected in the unaudited pro forma condensed combined
            financial information presented herein for a number of reasons, including, but not limited to, differences in the assumptions used to prepare this pro forma financial information.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma condensed combined financial statements, including the notes
            thereto, should be read in conjunction with the separate historical financial statements of Caladrius and Cend, and their respective accompanying notes included elsewhere in this registration statement. Caladrius&#8217; condensed consolidated
            statement of operations and comprehensive loss for the three month period ended March 31, 2022 is derived from Caladrius&#8217; Form 10-Q for the three month period ended March 31, 2022 and Caladrius&#8217; Form 10-K for the year ended December 31, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Accounting rules require evaluation of certain assumptions, estimates, or determination
            of financial statement classifications. The accounting policies of Cend may materially vary from those of Caladrius. During preparation of the unaudited pro forma condensed combined financial information, management has performed a preliminary
            analysis and is not aware of any material differences, and accordingly, this unaudited pro forma condensed combined financial information assumes no material differences in accounting policies. Following the acquisition, management will conduct
            a final review of Cend&#8217;s accounting policies in order to determine if differences in accounting policies require adjustment or reclassification of Cend&#8217;s results of operations or reclassification of assets or liabilities to conform to
            Caladrius&#8217; accounting policies and classifications. As a result of this review, management may identify differences that, when conformed, could have a material impact on these unaudited pro forma condensed combined financial statements.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">263<br />
        </div>

      </div>

    </div>

    <!--End Page 272-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 273-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">Unaudited Pro Forma Condensed Combined Balance Sheet <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">As of March 31, 2022 <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(in thousands, except per share data)</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Historical <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Caladrius </div>
                </td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Historical <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend </div>
                </td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Transaction <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accounting <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Adjustments </div>
                </td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Notes </div>
                </td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.75pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Pro <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Forma <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Combined </div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">ASSETS<br />
                  </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Cash and cash equivalents </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">12,747 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 7.96pt;">4,716 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara">$<span style="padding-left: 20.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">G </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">17,463 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Marketable securities </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">75,772 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">75,772 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Tax benefit receivable </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.46pt;">867 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">867 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Prepaid expenses and other current assets </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">2,181 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">849 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">3,030 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total current assets </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">90,700 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">6,432 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">97,132 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Property and equipment, net </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">55 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">55 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Investment in Cend </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">G </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other assets </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">708 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">708 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Intangible assets </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">2,299 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">L </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">2,299 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total assets </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;">91,463 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.46pt;">$</span><span style="padding-left: 7.96pt; border-bottom: 3pt double #000000; min-width: 35.46pt;">6,432 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">2,299 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 4.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;">100,194 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 4.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 100%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" colspan="16">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">LIABILITIES, REDEEMABLE CONVERTIBLE
                    PREFERRED STOCK, AND STOCKHOLDERS' EQUITY (DEFICIT)<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Liabilities<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accounts payable </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 20.83pt;">697 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 15.46pt;">635 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara">$<span style="padding-left: 20.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 13.33pt;">1,332 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accrued liabilities </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">2,104 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.46pt;">413 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">5,955 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">C,D </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">8,472 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other current liabilities </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">52 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">52 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total current liabilities </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">2,801 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">1,100 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">5,955 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;">9,856 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other long-term liabilities </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">421 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">216 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">637 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total liabilities </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">3,222 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">1,316 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">5,955 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">10,493 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 100%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" colspan="16">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">COMMITMENTS AND CONTINGENCIES<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Redeemable convertible preferred stock<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Series A redeemable convertible preferred stock </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">1,100 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(1,100) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">A </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Series B redeemable convertible preferred stock </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">3,941 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(3,941) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">A </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stockholders' equity (deficit)<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Series C convertible preferred stock </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">A </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Series D convertible preferred stock </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">A,G </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Preferred stock, $0.01 par value </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Common stock, $0.001 par value </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">61 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">61 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">B </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">122 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Additional paid-in capital </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">546,580 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">11,750 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">27,728 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">A,B,K </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">586,058 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Treasury stock </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(708) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(708) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accumulated deficit </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(457,242) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(11,636) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(26,443) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">A,B,C,D,J,<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">K,L </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(495,321) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accumulated other comprehensive loss </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(196</span><span style="min-width: 40.83pt;">) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">(39</span><span style="min-width: 35.46pt;">) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">39 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">A </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(196</span><span style="min-width: 40.83pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total stockholders' equity (deficit) </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">88,495 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">75 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,385 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 2.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">89,955 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Non-controlling interests </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(254</span><span style="min-width: 40.83pt;">) </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 2.5pt; padding-bottom: 3.75pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.5pt; padding-bottom: 3.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(254</span><span style="min-width: 40.83pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total stockholders' equity (deficit) </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">88,241 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">75 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">1,385 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">89,701 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 48.72%; text-align: left; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;" class="fpara">Total liabilities, redeemable convertible preferred stock,
                    and stockholders' equity (deficit) </div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;">91,463 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.46pt;">$</span><span style="padding-left: 7.96pt; border-bottom: 3pt double #000000; min-width: 35.46pt;">6,432 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.86pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">2,299 </span></div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.79%; text-align: center; vertical-align: bottom; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.72%; border-bottom: none; font-size: 2pt; padding-top: 3.75pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.72%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.75pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;">100,194</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to unaudited pro forma condensed combined financial information<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">264<br />
        </div>

      </div>

    </div>

    <!--End Page 273-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 274-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">Unaudited Pro Forma Condensed Combined Financial Statements of Operations <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">For the Three Months Ended March 31, 2022 <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(in thousands, except per share data)</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Historical <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Caladrius </div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Historical <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend </div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Transaction <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accounting <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Adjustments </div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Notes </div>
                </td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Pro Forma <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Combined </div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net revenues </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">178 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">178 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Expenses:<br />
                  </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Research and development </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">3,278 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">1,291 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 15pt;">4,569 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">General and administrative </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">3,342 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">316 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">42 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">L </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 15pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">3,700 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Operating expenses </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">6,620 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">1,607 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">42 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 15pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">8,269 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Operating loss </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(6,620) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,429) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt;">(42) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 11.67pt;">(8,091) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense): <br />
                  </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Investment income, net </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">63 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">63 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other expense, net </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(148</span><span style="min-width: 32.5pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">(148</span><span style="min-width: 37.5pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total other expense </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt;">(85) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 24.17pt;">(85) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss before benefit from income taxes </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(6,705) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,429) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt;">(42) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 11.67pt;">(8,176) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Benefit from income taxes </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(2,479</span><span style="min-width: 32.5pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 11.67pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;">(2,479</span><span style="min-width: 37.5pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 1.67pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(4,226</span><span style="min-width: 32.5pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$
                      (1,429</span><span style="min-width: 30.83pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(42</span><span style="min-width: 32.5pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 6.67pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">(5,697</span><span style="min-width: 37.5pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss per share attributable to common shareholders:<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 6.67pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(0.07</span><span style="min-width: 32.5pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">(0.33</span><span style="min-width: 30.83pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 6.67pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(0.05</span><span style="min-width: 32.5pt;">)</span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 6.67pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(0.07</span><span style="min-width: 32.5pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 25.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;"> </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 11.67pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(0.33</span><span style="min-width: 32.5pt;">) </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 11.67pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">(0.05</span><span style="min-width: 37.5pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding:<br />
                  </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">60,560 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">4,280 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">56,241 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">I </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">121,081 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">60,560 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.47pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">4,280 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">56,241 </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.08%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">I </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.28pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">121,081</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to unaudited pro forma condensed combined financial information<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">265<br />
        </div>

      </div>

    </div>

    <!--End Page 274-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 275-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">Unaudited Pro Forma Condensed Combined Statements of Operations <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">For the Year Ended December 31, 2021 <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(in thousands, except per share data)</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Historical <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Caladrius </div>
                </td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Historical <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Cend </div>
                </td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Transaction <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accounting <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Adjustments </div>
                </td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Notes </div>
                </td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Pro Forma <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Combined </div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net revenues </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 20.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara">$ 14,787 </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara">$<span style="padding-left: 20.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara">$<span style="padding-left: 4.63pt;">14,787 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Expenses:<br />
                  </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Research and development </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">17,680 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">8,148 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt;">25,828 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">In-process research and development </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">1,584 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">35,012 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">H </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt;">36,596 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">General and administrative </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.7pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">11,370 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">1,150 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">6,317 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">C,D,L </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;">18,837 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Operating expenses </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">29,050 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">10,882 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">41,329 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;">81,261 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Operating income (loss) </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(29,050) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">3,905 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(41,329) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(66,474) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense): </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Investment income, net </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">151 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt;">151 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other expense, net </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(75) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 23.8pt;">(75) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Interest income </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">4 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 32.13pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;">4 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Total other income </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">76 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">4 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 27.13pt;">80 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Net income (loss) before expense (benefit) from income
                    taxes </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(28,974) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">3,909 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(41,329) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(66,394) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Income tax expense (benefit) </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(1,508</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">170 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 11.3pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;">(1,338</span><span style="min-width: 37.13pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$ (27,466</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">3,739 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$
                      (41,329</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$</span><span style="padding-left: 1.3pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">(65,056</span><span style="min-width: 37.13pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Income allocable to participating securities </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 1.67pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(1,466</span><span style="min-width: 32.5pt;">) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$</span><span style="padding-left: 22.13pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$ (27,466</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">2,273 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$
                      (41,329</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$</span><span style="padding-left: 1.3pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">(65,056</span><span style="min-width: 37.13pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Net income (loss) per share
                    attributable to common shareholders:<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">(0.50</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">0.54 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$</span><span style="padding-left: 11.3pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">(0.56</span><span style="min-width: 37.13pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">(0.50</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">0.48 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$</span><span style="padding-left: 11.3pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">(0.56</span><span style="min-width: 37.13pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding:<br />
                  </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">55,313</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">4,211 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">55,719 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">I </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">115,243 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">55,313 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">5,076 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.85pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">54,854 </span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.58%; text-align: center; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">I </div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.46pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.13pt;">115,243</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to unaudited pro forma condensed combined financial information<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">266<br />
        </div>

      </div>

    </div>

    <!--End Page 275-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 276-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Note 1 - Description of the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">On April 26, 2022, Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;), CS Cedar Merger Sub,
            Inc., a Delaware corporation and wholly owned subsidiary of Caladrius (&#8220;Merger Sub&#8221;), and Cend Therapeutics, Inc. (&#8220;Cend&#8221; or the &#8220;Company&#8221;), a privately-held, clinical-stage biotechnology company, entered into an Agreement and Plan of Merger
            and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into Cend, with Cend continuing
            as a wholly owned subsidiary of Caladrius (the &#8220;Merger&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Subject to the terms and conditions of the Merger Agreement, at the closing of the
            Merger, (a) each outstanding share of Cend common stock and Cend preferred stock (except shares of Cend Series D Preferred Stock held by Caladrius) will be converted into the right to receive an estimated 60,521,480 shares of Caladrius common
            stock (&#8220;Caladrius Common Stock&#8221;), based on an estimated exchange ratio of 8.5627; and (b) each outstanding Cend stock option that has not previously been exercised prior to the closing of the Merger will be assumed by Caladrius and converted
            into options to purchase shares of Caladrius Common Stock based on the estimated exchange ratio of 8.5627. Under the exchange ratio formula in the Merger Agreement, as of immediately after the Merger, Cend&#8217;s former stockholders are expected to
            own approximately 50% of the outstanding shares of Caladrius Common Stock and stockholders of Caladrius as of immediately prior to the Merger are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock. The actual
            allocation will be subject to adjustment based on Caladrius&#8217; net cash balance at the time of closing and the amount of any transaction expenses of Cend in excess of $0.3 million at the time of closing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If deemed necessary by the parties, Caladrius shall submit to Caladrius&#8217; stockholders
            an amendment to Caladrius&#8217; certificate of incorporation to authorize the Caladrius board to effect a reverse stock split of all outstanding shares of Caladrius common stock at a reverse stock split ratio mutually agreed to by Cend and Caladrius
            (the &#8220;Caladrius Reverse Stock Split&#8221;), and shall take such other actions as shall be reasonably necessary to effectuate the Caladrius Reverse Stock Split.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Consummation of the Merger is subject to certain closing conditions, including, among
            other things, approval by the stockholders of Caladrius and Cend, and Caladrius&#8217;s satisfaction of a minimum net cash threshold at closing, expected to be approximately $64.9 million assuming a closing at the end of the third quarter of 2022,
            and as described further in the Merger Agreement. In accordance with the terms of the Merger Agreement, (i) certain executive officers, directors and stockholders of Cend (solely in their respective capacities as Cend stockholders) holding
            approximately 77.5% of the outstanding Cend capital stock have entered into support agreements with Caladrius to vote all of their shares of Cend capital stock in favor of adoption of the Merger Agreement (the &#8220;Cend Support Agreements&#8221;) and
            (ii) certain executive officers and directors of Caladrius (solely in their respective capacities as Caladrius stockholders) holding approximately 1.8% of the outstanding Caladrius common stock have entered into support agreements with Cend to
            vote all of their shares of Caladrius common stock in favor of approval of the Merger Agreement (the &#8220;Caladrius Support Agreements,&#8221; together with the Cend Support Agreements, the &#8220;Support Agreements&#8221;). The Support Agreements include covenants
            with respect to the voting of such shares in favor of approving the transactions contemplated by the Merger Agreement and against any competing acquisition proposals and place certain restrictions on the transfer of the shares of Caladrius and
            Cend held by the respective signatories thereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger Agreement contains certain termination rights for both Caladrius and Cend,
            and further provides that, upon termination of the Merger Agreement under specified circumstances, Caladrius may be required to pay Cend a termination fee of $1.0 million, Cend may be required to pay Caladrius a termination fee of $4.0 million,
            or in some circumstances reimburse the other party&#8217;s expenses up to a maximum of $1.0 million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Concurrently with the execution of the Merger Agreement and in order to provide Cend
            with capital for its development programs prior to the closing of the Merger, Caladrius agreed to purchase from Cend shares of Series D Preferred Stock (the &#8220;Cend Series D Preferred Stock&#8221;), of Cend at a purchase price of $10.0 million. In
            addition, Caladrius and Cend entered into a Collaboration Agreement (the &#8220;Collaboration Agreement&#8221;), pursuant to which Caladrius and Cend agreed to collaborate on certain developmental and clinical activities prior to the closing of the Merger.
            Under the Collaboration Agreement, Caladrius and Cend will form a joint steering committee (the &#8220;Committee&#8221;) comprised of individuals from both entities.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">267<br />
        </div>

      </div>

    </div>

    <!--End Page 276-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 277-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Note 2 - Basis of Pro Forma Presentation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma condensed combined financial information of the combined
            company is presented to illustrate the proposed effects of the Merger. The unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X, as amended by Securities and Exchange
            Commission (&#8220;SEC&#8221;) Final Rule Release No. 33-10786 &#8220;Amendments to Financial Disclosures about Acquired and Disposed Businesses.&#8221; Release No. 33-10786 replaced the existing pro forma adjustment criteria with simplified requirements to depict the
            accounting for the transaction (&#8220;Transaction Accounting Adjustments&#8221;) and present the reasonably estimable synergies and other transaction effects that have occurred or are reasonably expected to occur (&#8220;Management&#8217;s Adjustments&#8221;). The combined
            company has elected not to present Management&#8217;s Adjustments and will only be presenting Transaction Accounting Adjustments in the unaudited pro forma condensed combined financial information. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Merger is accounted for by using the cost accumulation and allocation model of
            accounting in accordance with the asset acquisition accounting guidance set forth in Accounting Standards Codification (ASC) 805, Business Combinations (&#8220;ASC 805&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma condensed combined statements of operations for the three month
            period ended March 31, 2022 and for the year ended December 31, 2021, give effect to the Merger as if it had been consummated on January 1, 2021. The unaudited pro forma condensed combined balance sheet as of March 31, 2022 gives effect to the
            Merger as if it had been consummated on March 31, 2022. Based on Caladrius&#8217; preliminary review of Cend&#8217;s summary of significant accounting policies and preliminary discussions between management teams of Caladrius and Cend, the nature and
            amount of any adjustments to the historical financial statements of Cend to conform its accounting policies to those of Caladrius are not expected to be material. Upon completion of the Merger, further review of Cend&#8217;s accounting policies may
            result in additional revisions to Cend&#8217;s accounting policies and classifications to conform to those of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">To determine the accounting for this Merger under GAAP, a company must assess whether
            an integrated set of assets and activities should be accounted for as an acquisition of a business or an asset acquisition. The initial screen test is met as substantially all of Cend&#8217;s fair value is concentrated in intangible assets,
            primarily, In-Process Research &amp; Development (&#8220;IPR&amp;D&#8221;). As such, the acquisition is expected to be treated as an asset acquisition. Cend&#8217;s assets (except for cash) and liabilities will be measured and recognized as an allocation of the
            transaction price based on their relative fair values as of the transaction date with any value associated with IPR&amp;D with no alternative future use being expensed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Asset acquisitions are to be accounted for by allocating costs, including transaction
            costs, of the acquisition to the acquired assets based on their relative fair value basis. For the purpose of measuring the estimated fair value of the assets acquired and liabilities assumed, Caladrius estimated the fair values as the price
            that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The fair value measurements utilize estimates based on key assumptions of the Merger,
            including historical and current market data. The unaudited pro forma adjustments included herein are preliminary and will be adjusted as additional information becomes available and as additional analyses are performed. The final purchase
            price allocation will be determined subsequent to the Merger, and the final amounts of the assets acquired, and liabilities assumed may differ materially from the values recorded in the pro forma financial information.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pro forma transaction accounting adjustments are included only to the extent they are
            adjustments that reflect the accounting for the Merger in accordance with GAAP.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius and Cend expect to incur significant costs associated with integrating the
            operations of Caladrius and Cend after the Merger is completed. The unaudited pro forma condensed combined financial information does not reflect the costs of any integration activities or benefits that may result from realization of future
            cost savings from operating efficiencies expected to result from the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius and Cend expect to incur significant costs associated with integrating the
            operations of Caladrius and Cend after the Merger is completed. The unaudited pro forma condensed combined financial information does not reflect the costs of any integration activities or benefits that may result from realization of future
            cost savings from operating efficiencies expected to result from the Merger.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">268<br />
        </div>

      </div>

    </div>

    <!--End Page 277-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 278-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">Note 3 &#8212; Preliminary Purchase Price</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The accompanying unaudited pro forma condensed combined financial statements reflect an
            estimated preliminary purchase price of approximately $42.6 million (the &#8220;Consideration&#8221;) comprised of equity consideration of approximately $27.8 million, the carrying value of Caladrius&#8217; existing cost method investment in Cend&#8217;s Series D
            Preferred Stock of approximately $10.0 million, the incremental fair value of Cend&#8217;s fully vested stock options of approximately $1.8 million, and estimated transaction costs of approximately $3.0 million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Consideration payable by Caladrius takes into account the value of Caladrius&#8217;
            interests in Cend&#8217;s Series D Preferred Stock. Prior to the closing of the Merger, Caladrius will account for its existing interest in Cend using the cost method, and the carrying value was approximately $10.0 million as of April 26, 2022. The
            Company accounted for the asset acquisition of the interest of Cend as a step acquisition, which required a cost accumulation approach of the Company&#8217;s existing ownership interest in Cend which will be valued at its carryover basis of $10.0
            million and included in the estimated purchase price.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The table below represents the total estimated preliminary purchase price (dollars in
            thousands, except per share data):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Estimated number of common shares of the combined company
                    to be owned by Cend stockholders <sup>(1)</sup></div>
                </td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">60,521,480 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Multiplied by the fair value per share of Caladrius common stock on May&#160;18,
                    2022 <sup>(2)</sup></div>
                </td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 50pt;">$</span><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 50pt;">0.46 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total</div>
                </td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 50pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 50pt;">27,840 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Carrying value of Caladrius' existing cost method investment in Cend <sup>(3)</sup></div>
                </td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">10,000 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Incremental fair value of Cend's fully vested stock options <sup>(4)</sup></div>
                </td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">1,796 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius estimated transaction costs <sup>(5)</sup></div>
                </td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 50pt;">3,000 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total estimated purchase price</div>
                </td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 50pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 50pt;">42,636</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">For purposes of this unaudited pro forma combined financial information, 60,521,480 represents the historical 7,068,037 shares
                    of Cend common stock and preferred stock outstanding on April&#160;26, 2022, adjusted for the exchange ratio.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The equity portion of the estimated purchase price was based on the closing price of Caladrius as reported on the Nasdaq Capital
                    Market on May 18, 2022. The final purchase price arising from the actual transaction costs, as well as the number of shares of Caladrius Common Stock and the fair market value of Caladrius Common Stock outstanding immediately prior to
                    the closing of the Merger could result in a total purchase price different from that assumed in this unaudited pro forma condensed combined financial information, and that difference may be material. Therefore, the estimated
                    Consideration expected to be transferred reflected in this unaudited pro forma condensed combined financial information does not purport to represent what the actual Consideration transferred will be when the Merger is completed. The
                    actual purchase price will fluctuate until the closing date of the Merger, and the final valuation of the purchase consideration could differ significantly from the current estimate.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Using cost accumulation accounting, the carrying value of Caladrius&#8217; cost method investment in Cend&#8217;s Series D Preferred Stock
                    is included in the total estimated purchase price as of March&#160;31, 2022. Caladrius will evaluate the cost method investment for impairment indicators each reporting period and through the closing of the Merger.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Represents the incremental fair value of the Cend replacement options of $1.7 million related to the fully vested replacement
                    options subject to service-based vesting conditions and less than $0.1 million related to replacement options subject to performance-based vesting conditions achieved prior to the Closing Date assumed by Caladrius upon the consummation
                    of the Merger as described in Note 4 &#8212; Shares of Caladrius Common Stock Issued to Cend&#8217;s Stockholders upon closing of the Merger. In accordance with, and analogous to ASC 805, as no post-Merger services are required for the fully vested
                    replacement awards, and Cend&#8217;s employees had rendered all of the required service for the Cend awards as of the date of the Merger, the incremental fair value is included in the estimated purchase price.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">269<br />
        </div>

      </div>

    </div>

    <!--End Page 278-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 279-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="fpara">The amount attributable to post-Merger service is approximately $0.5 million for
            replacement options subject to servicebased vesting conditions and less than $0.1 million for replacement options subject to performance-based vesting conditions. Caladrius will recognize the stock-based compensation expense for the replacement
            options subject to service-based vesting conditions as additional compensation cost on a straight-line basis over the remaining vesting period of the original awards, and will recognize the stock-based compensation related to the achievement of
            the performance-based vesting conditions in the period during which it becomes probable the conditions will be met.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-align: left;" class="fpara">The difference between the total value of the replacement awards of approximately $6.6
            million, and the fair value of the original Cend awards of approximately $4.3 million, is approximately $2.4 million.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Caladrius transaction costs are estimated to be approximately $3.0 million. The transaction costs have been reflected as an
                    increase in the purchase price. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In accordance with GAAP, the fair value of equity securities comprising the
            Consideration will be measured on the closing date of the Merger at the then-current market price per share of Caladrius common stock. Given that the estimate purchase price is variable depending upon the price of Caladrius common stock,
            management performed a sensitivity analysis over the change in purchase consideration based on +/- 10% volatility in Caladrius&#8217; stock price, which is reasonably possible during the period between the date of this joint proxy
            statement/prospectus/information statement and then expected effective time of the Merger. An increase or decrease in the price of Caladrius common stock by 10% would increase or decrease the Consideration, excluding transaction costs, by
            approximately $3.0 million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">For purposes of this pro forma analysis, the above estimated purchase price has been
            allocated based the relative fair value of the preliminary estimate of the fair value of assets and liabilities to be acquired (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March 31, 2022 <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Pro forma </div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Preliminary Purchase Price Allocation:<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash and cash equivalents </div>
                </td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">4,716 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net working capital (excluding cash) </div>
                </td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">616 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other liabilities </div>
                </td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 14.17pt;">(216) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Acquired in-process research and development </div>
                </td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">35,012 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">License </div>
                </td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">2,508 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net assets acquired</div>
                </td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$ 42,636</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The guidance in ASC 805 requires an initial screen test to determine if substantially
            all of the fair value of the gross assets acquired is concentrated in a single asset or group of similar assets. If that screen is met, the set is not a business. The initial screen test was met as Caladrius determined that substantially all of
            the fair value was concentrated in the acquired IPR&amp;D. The fair value of the IPR&amp;D was determined to be approximately $55.4 million before the purchase price was allocated among the assets and liabilities acquired, as shown above.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">IPR&amp;D represents the research and development assets of Cend which were in-process,
            but not yet completed, and which Caladrius has the opportunity to advance. Current accounting standards require that the fair value of IPR&amp;D projects acquired in an asset acquisition with no alternative future use be allocated a portion of
            the consideration transferred and charged to expense at the acquisition date. The actual purchase price allocated to IPR&amp;D will fluctuate until the closing date of the Merger, and the final valuation of the IPR&amp;D consideration could
            differ significantly from the current estimate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">License represents the Exclusive License and Collaboration Agreement (the &#8220;Qilu
            Agreement&#8221;) in which Cend granted an exclusive license to Qilu for the development and commercialization of CEND-1 in the Territory (defined as the Greater Area of China including China, Macau, Hong Kong, and Taiwan). Under the terms of the
            agreement, Qilu is solely responsible for the development of CEND-1 in its Territory. In consideration for the license, Qilu made a one-time, non-refundable, non-creditable upfront payment of $10.0 million to Cend. Cend is also eligible to
            receive developmental and commercial milestone payments up to $100.0 million and $125.0 </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">270<br />
        </div>

      </div>

    </div>

    <!--End Page 279-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 280-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">million, respectively, tiered royalties on net sales ranging from 10% to 15%, and
            tiered sublicensing revenues ranging from 12% to 35%. To date, Cend has recognized approximately $15.0 million in revenue under the Qilu Agreement resulting from the upfront license fee, a development milestone, as well as through the sale of
            clinical supply materials.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h2">Note 4 &#8212; Shares of Caladrius Common Stock Issued to Cend&#8217;s
            Stockholders upon Closing of the Merger</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the Merger Agreement, at the Effective Time, Caladrius expects to issue
            60,521,480 shares of Common Stock to the holders of all of the Cend capital stock in exchange for all of the shares of Cend capital stock (including the shares of common stock issuable upon the conversion of all shares of preferred stock,
            except Series D Preferred Stock), immediately prior to the Effective Time, determined as follows:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares </div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend:<br />
                  </div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Cend Series A Preferred Stock outstanding </div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">371,396 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Cend Series B Preferred Stock outstanding </div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">1,071,237 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Cend Series C Preferred Stock outstanding </div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">1,345,699 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Cend shares of common stock outstanding </div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,279,705 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Cend outstanding shares pre-close </div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">7,068,037 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exchange ratio </div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">8.5627 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Cend merger common shares </div>
                </td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.17%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">60,521,480</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, in accordance with the Merger Agreement, Caladrius assumed all of the
            issued and outstanding options to acquire Cend common stock, pursuant to the Cend 2016 Equity Incentive Plan (the &#8220;Cend Plan&#8221;), with such stock options representing the right to purchase a number of shares of Caladrius Common Stock equal to
            8.5627 multiplied by the number of shares of Cend&#8217;s common stock previously represented by such stock options immediately prior to the closing of the Merger, with a proportional adjustment to the exercise price of such options.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Basic loss per share represents the net loss per share calculated using the historical
            weighted average shares outstanding, and the issuance of additional shares in connection with the Merger, assuming the shares were outstanding at the beginning of the periods presented. Diluted loss per common share is the same as basic loss
            per common share for all periods presented because the effects of potentially dilutive items were anti-dilutive. The following common share equivalent securities have been excluded from the calculation of weighted-average common shares
            outstanding because the effect is anti-dilutive for the periods presented:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March 31, 2022 </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Anti-dilutive common share equivalents:<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">(in thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stock options of Caladrius </div>
                </td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.39pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">7,883 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stock options of Cend </div>
                </td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.39pt; text-align: left;" class="fpara">19,438 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Warrants to purchase Caladrius common stock </div>
                </td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.39pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">21,357 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total anti-dilutive common share equivalents<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.6%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 13.39pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">48,678</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The information below reflects historical per share information for Caladrius and Cend
            and unaudited pro forma per share information of the combined company as if Caladrius and Cend had been combined as of or for the periods presented. The net loss per share information reflects the Merger as if the transaction had occurred on
            January&#160;1, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h2">Note 5 &#8212; Pro Forma Adjustments</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Adjustments included in the column under the heading &#8220;Transaction Accounting
            Adjustments&#8221; are primarily based on information contained within the analysis will be performed after the completion of the merger to confirm these estimates or make adjustments in the final purchase price allocation, as necessary.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Given Caladrius&#8217; history of net losses and valuation allowance, management assumed a
            statutory tax rate of 0%. Therefore, the pro forma adjustments to the condensed combined statements of operations and comprehensive loss resulted in no additional income tax adjustment to the pro forma financials.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">271<br />
        </div>

      </div>

    </div>

    <!--End Page 280-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 281-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">The unaudited pro forma adjustments reflected in the unaudited pro forma condensed
            combined financial statements as as follows:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To eliminate Cend&#8217;s pre-merger redeemable convertible preferred stock,
                      convertible preferred stock, common stock, paid-in capital, accumulated deficit, and accumulated other comprehensive loss balances.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 396.28pt; margin-left: 48pt;" class="fintab">


  <tr class="header">

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March 31, 2022 </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">(in thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's Series A redeemable convertible preferred stock </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara">$<span style="padding-left: 4.63pt;">(1,100) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's Series B redeemable convertible preferred stock </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt;">(3,941) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's Series C convertible preferred stock </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's Series D preferred stock </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's common stock </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's additional paid-in capital </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(11,750) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's historical accumulated deficit </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">11,636 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's accumulated other comprehensive loss </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">39 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Elimination of Cend's accumulated deficit for other pro
                    forma adjustments impacting accumulated deficit, such as transaction costs (C) </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">3,097 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total adjustments to Cend's historical equity<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.46pt;">$</span><span style="padding-left: 4.63pt; border-bottom: 3pt double #000000; min-width: 35.46pt;">(2,019</span><span style="min-width: 35.46pt;">)</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">B.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To reflect the asset acquisition Consideration, including the
                      capitalization of the fair value of the estimated number of shares of the combined company to be owned by Cend&#8217;s stockholders and Caladrius&#8217; transaction costs as well as the adjustment to accumulated deficit for the acquired
                      in-process research and development:</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 396.28pt; margin-left: 48pt;" class="fintab">


  <tr class="header">

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March 31, 2022 </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">(in thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Capitalization of the fair value of the estimated number
                    of shares of the combined company to be owned by Cend's stockholders </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">27,840 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Carrying value of Caladrius' existing cost method investment in Cend </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">10,000 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius' estimated transaction costs as part of asset acquisition (D) </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">3,000 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Incremental fair value of Cend's fully vested replacement options (Note 3) </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,796 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Impact of expensed IPR&amp;D acquired (H) and accumulated
                    amortization of the acquired license (L) </div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(35,079</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total adjustment to reflect asset acquisition purchase price<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 13.7%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">7,557</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">C.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To record Cend&#8217;s estimated transaction costs of approximately $3.1
                      million, for legal and advisory fees, and transactional fees in addition to $0.1 million included in accrued liabilities as of March 31, 2022.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">D.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To record Caladrius&#8217; estimated transaction costs of approximately $2.9
                      million, for legal and advisory fees and transactional fees, in addition to $0.1 million included in accrued liabilities as of March 31, 2022.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">E.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To record Cend&#8217;s estimated transaction costs of approximately $3.2
                      million, for legal and advisory fees, and transactional fees for the year ended December 31, 2021.</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">F.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To record Caladrius&#8217; estimated transaction costs of $3.0 million, for
                      legal and advisory fees and transactional fees for the year ended December 31, 2021. Estimated transaction costs directly related to the Merger of $3.0 million will be included in the estimated purchase price (see Note 3).</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">G.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To record Caladrius&#8217; cost method investment in Cend&#8217;s Series D Preferred
                      Stock as of March 31, 2022 of approximately $10.0 million and the elimination of Caladrius&#8217; cost method investment in Cend at the Effective Time of the Merger, as well as the cancellation of the shares of Series D Preferred Stock that
                      were issued to Caladrius. Per the Merger Agreement, the Series D Preferred Stock will not be converted to shares of common stock of Cend at the time of the Merger, rather the Series D Preferred Stock will be cancelled and no
                      consideration exchanged.</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">272<br />
        </div>

      </div>

    </div>

    <!--End Page 281-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 282-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_126-unaudited_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">H.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">To record the impact of expensing the acquired IPR&amp;D upon consummation
                      of the asset acquisition (Note 3).</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">I.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Calculation of weighted-average shares outstanding:</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 420.1pt; margin-left: 48pt;" class="fintab">


  <tr class="header">

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March 31, 2022 </div>
                </td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 15.67%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December 31, 2021 </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 30.02%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(in thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Historical Cend weighted-average shares of common stock
                    outstanding </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">4,280 </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.67%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.93pt; text-align: left;" class="fpara"><span style="padding-left: 9.82pt;">4,211 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Impact of Cend's convertible preferred stock assuming conversion </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">2,788 </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 15.67%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.93pt; text-align: left;" class="fpara"><span style="padding-left: 9.45pt; border-bottom: 1pt solid #000000; min-width: 31.95pt;">2,788 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">7,068 </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.67%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.93pt; text-align: left;" class="fpara"><span style="padding-left: 9.45pt; border-bottom: 1pt solid #000000; min-width: 31.95pt;">6,999 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Application of exchange ratio of historical Cend
                    weighted-average shares outstanding </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">8.5627 </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 15.67%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.93pt; text-align: left;" class="fpara"><span style="padding-left: 4.45pt;">8.5627 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Adjusted Cend weighted-average shares outstanding </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">60,521 </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.67%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.93pt; text-align: left;" class="fpara"><span style="padding-left: 4.45pt;">59,930 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Historical Caladrius weighted-average shares outstanding </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">60,560 </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 15.67%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.93pt; text-align: left;" class="fpara"><span style="padding-left: 4.45pt; border-bottom: 1pt solid #000000; min-width: 31.95pt;">55,313 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 68.56%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total weighted average shares outstanding<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">121,081 </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 15.67%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 16.93pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 31.95pt;">115,243</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-align: left;" class="fpara">As Caladrius had a net loss on a pro forma combined basis, stock options to purchase
            common stock have been excluded from the calculation of diluted net loss per share because all such securities are anti-dilutive for all periods presented. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; margin-left: 20pt; text-align: left;" class="fpara">J.<span style="font-weight: normal;"> To record the following
              adjustments to accumulated deficit:</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 420.28pt; margin-left: 48pt;" class="fintab">


  <tr class="header">

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March 31, 2022 </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">(in thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's accumulated deficit </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">14,733 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Impact of Cend's estimated transaction costs as part of asset acquisition (C) </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">(3,097) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Impact of expensed IPR&amp;D acquired (H), Caladrius'
                    estimated transaction costs as part of asset acquisition (D), and accumulated amortization of the acquired license (L) </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(38,079</span><span style="min-width: 35.83pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total adjustment to accumulated deficit<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.22pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$ (26,443</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.5pt; margin-left: 20pt; text-align: left;" class="fpara">K.<span style="font-weight: normal;"> To record the following
              adjustments to additional paid-in capital:</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 420.28pt; margin-left: 48pt;" class="fintab">


  <tr class="header">

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March 31, 2022 </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">(in thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elimination of Cend's additional paid-in capital and par value </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara">$ (11,750) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">To reflect Cend's remaining stock post-Merger </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 7.96pt;">37,459 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">To reflect the reclassification of additional paid-in
                    capital to par for the shares expected to be outstanding </div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">2,019 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 85.66%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total adjustment to additional paid-in capital<span style="font-weight: normal;"> </span></div>
                </td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.71%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 9.41pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.46pt;">$</span><span style="padding-left: 2.96pt; border-bottom: 3pt double #000000; min-width: 35.46pt;">27,728</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">L.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><span style="font-weight: normal;">Represents the acquired Qilu Agreement in which Cend granted an exclusive
                      license to Qilu for the development and commercialization of CEND-1 in the amount of approximately $2.5 million, net of accumulated amortization of approximately $0.3 million. The license is a definite lived intangible asset with an
                      estimated remaining useful life of fifteen years. The amortization expense of approximately $0.2 million and approximately $41.8 thousand has been included in the pro forma statements of operations for the year ended December 31, 2021
                      and three months ended March 31, 2022, respectively.</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">273<br />
        </div>

      </div>

    </div>

    <!--End Page 282-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 283-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_127-description_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tSTOCK"><!--Anchor--></a>DESCRIPTION OF CALADRIUS CAPITAL
            STOCK</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following description of Caladrius&#8217; capital stock is not complete and may not
            contain all the information you should consider before investing in Caladrius&#8217; capital stock. This description is summarized from, and qualified in its entirety by reference to, Caladrius&#8217; amended and restated certificate of incorporation and
            amended and restated bylaws, which have been publicly filed with the SEC. See &#8220;<span style="font-style: italic;">Where You Can Find More Information</span>.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2">Authorized Capital Stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our authorized capital stock consists of 500,000,000 shares of common stock, par value
            $0.001 per share and 20,000,000 shares of preferred stock, par value $0.01 per share.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2">Common Stock </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The holders of our common stock are entitled to one vote per share in the election of
            directors and on all other matters on which stockholders are entitled or permitted to vote. The holders of our common stock are not entitled to cumulative voting rights. Therefore, holders of a majority of the shares voting for the election of
            directors can elect all of the directors. Subject to the terms of any outstanding series of preferred stock, the holders of our common stock are entitled to dividends in the amounts and at times as may be declared by the Caladrius Board of
            Directors out of funds legally available. Upon liquidation or dissolution, holders of our common stock are entitled to share ratably in all net assets available for distribution to stockholders after payment of any liquidation preferences to
            holders of our preferred stock. The holders of our common stock have no redemption, conversion or preemptive rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of March&#160;31, 2022, we had 60,533,064 shares of common stock issued and outstanding,
            exclusive of existing convertible preferred stock, options and warrants.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2">Preferred Stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Board of Directors has the authority to issue up to 20,000,000 shares of
            preferred stock with such designations, rights, and preferences as may be determined from time to time by the Caladrius Board of Directors. Accordingly, the Caladrius Board of Directors is empowered, without stockholder approval, to issue
            preferred stock with dividend, liquidation, conversion, voting, or other rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock could have the effect of
            restricting dividends on our common stock, diluting the voting power of our common stock, impairing the liquidation rights of our common stock, or delaying or preventing a change in control of our company, all without further action by our
            stockholders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of March&#160;31, 2022, there were 10,000 shares of our Series B Convertible Redeemable
            Preferred Stock, $0.01&#160;par value per share (&#8220;Caladrius Series B Preferred Stock&#8221;), issued and outstanding.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Series B Preferred Stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Caladrius Series B Preferred Stock ranks pari passu with our common stock with
            respect to the payment of dividends and to the distribution of assets upon liquidation, dissolution or winding up.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">So long as any shares of the Caladrius Series B Preferred Stock are outstanding, no
            dividend shall be declared or paid or set aside for payment or other distribution declared or made upon our common stock or upon any other stock ranking junior to, or on a parity with, the Caladrius Series B Preferred Stock as to dividends or
            upon liquidation, dissolution or winding up, unless, in the case of our preferred stock, the same dividend is declared, paid or set aside for payment on all outstanding shares of the Caladrius Series B Preferred Stock or in the case of our
            common stock, ten times such dividend per share is declared, paid or set aside for payment on each outstanding share of the Caladrius Series B Preferred Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Except as otherwise provided by law, each share of the Caladrius Series B Preferred
            Stock has the same voting rights as ten shares of our common stock and the holders of the Caladrius Series B Preferred Stock and the common stock shall vote together as one class on all matters.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The holder of any share of Caladrius Series B Preferred Stock has the right, at such
            holder&#8217;s option, to convert such share into one one-hundredth of a fully paid and non-assessable share of our common stock, subject to adjustment.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">274<br />
        </div>

      </div>

    </div>

    <!--End Page 283-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 284-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_127-description_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">In the event of any voluntary or involuntary dissolution, liquidation or winding up
            of our Company, after any distribution of assets is made to the holders of any other class or series of stock that ranks prior to the Caladrius Series B Preferred Stock in respect of distributions upon the liquidation of the Company, the holder
            of each share of Caladrius Series B Preferred Stock then outstanding shall be entitled to be paid out of our assets available for distribution to our stockholders, an amount on a pari passu basis equal to ten times the amount per share
            distributed to the holders of our common stock. After payment of the full amount of the distribution to which they are entitled, the holders of shares of the Caladrius Series B Preferred Stock will not be entitled to any further participation
            in any distribution of assets by the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Shares of Caladrius Series B Preferred Stock issued and reacquired by us shall have the
            status of authorized and unissued shares of preferred stock, undesignated as to series, subject to later issuance.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Holders of shares of Caladrius Series B Preferred Stock are not entitled to any
            preemptive or subscription rights in respect of any securities of the corporation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h2">Options and Restricted Stock Units</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of March&#160;31, 2022, we had outstanding options to purchase an aggregate of 2,639,609
            shares of our common stock with exercise prices ranging from $0.76 to $77.70 per share, with an approximate weighted average exercise price of $4.51 per share. The shares of our common stock underlying all such options are registered with the
            SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">As of March&#160;31, 2022, we had 1,460,295 restricted stock units outstanding.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h2">Warrants</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of March&#160;31, 2022, we had outstanding warrants to purchase an aggregate of
            21,356,600 shares of our common stock with an approximate weighted average exercise price of $2.84. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Anti-Takeover Effects of Certain Provisions of Delaware Law and Our
            Certificate of Incorporation and Bylaws</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our Amended and Restated Certificate of Incorporation and bylaws contain some
            provisions that could make our acquisition by means of a tender or exchange offer, a proxy contest or otherwise more difficult. These provisions are summarized below.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Special Meetings<span style="font-style: normal;">. Our bylaws
              provide that special meetings of our stockholders may, unless otherwise prescribed by law, be called by our Chairman of the Caladrius Board of Directors (if any), the Caladrius Board of Directors or our Chief Executive Officer and shall be
              held at such place, on such date and at such time as shall be fixed by the Caladrius Board of Directors or the person calling the meeting. Business transacted at any special meeting shall be limited to matters relating to the purpose or
              purposes stated in the notice of the meeting.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Undesignated Preferred Stock<span style="font-style: normal;">. The
              ability to authorize undesignated preferred stock makes it possible for the Caladrius Board of Directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to acquire us. The
              ability to issue preferred stock may have the effect of deferring hostile takeovers or delaying changes in control or management of our company.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Delaware Anti-Takeover Statute<span style="font-style: normal;">.
              We are subject to the provisions of Section 203 of the Delaware General Corporation Law regulating corporate takeovers. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a business combination with an
              interested stockholder for a period of three years following the date the person became an interested stockholder unless:</span></div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the
                    transaction which resulted in the stockholder becoming an interested stockholder;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the stockholder owned at
                    least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the number of shares outstanding (1)&#160;shares owned by persons who are directors and also officers
                    and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; and</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">275<br />
        </div>

      </div>

    </div>

    <!--End Page 284-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 285-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_127-description_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">on or subsequent to the date of the transaction, the business combination is approved by the board and authorized at an annual
                    or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder.</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Generally, a business combination includes a merger, asset or stock sale, or other
            transaction resulting in a financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder
            status, owned 15% or more of a corporation&#8217;s outstanding voting securities. We expect the existence of this provision to have an anti-takeover effect with respect to transactions the Caladrius Board of Directors does not approve in advance. We
            also anticipate that Section 203 may discourage attempted acquisitions that might result in a premium over the market price for the shares of our common stock held by stockholders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The provisions of Delaware law, our Amended and Restated Certificate of Incorporation
            and our bylaws could have the effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored
            hostile takeover attempts. These provisions may also have the effect of preventing changes in our management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to
            be in their best interests.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">276<br />
        </div>

      </div>

    </div>

    <!--End Page 285-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 286-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCRHCF"><!--Anchor--></a>COMPARISON OF RIGHTS OF HOLDERS OF CALADRIUS STOCK
            AND CEND STOCK</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Both Caladrius and Cend are incorporated under the laws of the State of Delaware and,
            accordingly, the rights of the stockholders of each are currently, and will continue to be, governed by the DGCL. If the Merger is completed, Cend Stockholders will become Caladrius Stockholders, and their rights will be governed by the DGCL,
            the amended and restated by-laws of Caladrius and, assuming Proposal Nos. 2 and 3 are approved by Caladrius Stockholders at the Annual Meeting, the amended and restated certificate of incorporation of Caladrius, as amended by the amendments
            thereto attached to this proxy statement/prospectus/information statement as <span style="font-style: italic;">Annex&#160;D </span>and <span style="font-style: italic;">Annex&#160;E</span>, respectively.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The table below summarizes the material differences between the current rights of Cend
            Stockholders under Cend&#8217;s amended and restated certificate of incorporation and by-laws and the rights of Caladrius Stockholders, post-Merger, under Caladrius&#8217; amended and restated certificate of incorporation and by-laws, each as amended, as
            applicable, and as in effect immediately following the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">While Caladrius and Cend believe that the summary tables cover the material differences
            between the rights of their respective stockholders prior to the Merger and the rights of Caladrius Stockholders following the Merger, these summary tables may not contain all of the information that is important to you. These summaries are not
            intended to be a complete discussion of the respective rights of Caladrius Stockholders and Cend Stockholders and are qualified in their entirety by reference to the DGCL and the various documents of Caladrius and Cend that are referred to in
            the summaries. You should carefully read this entire proxy statement/prospectus/information statement and the other documents referred to in this proxy statement/prospectus/information statement for a more complete understanding of the
            differences between being a Caladrius Stockholder and a Cend Stockholder before the Merger and being a Caladrius Stockholder after the Merger. Caladrius has filed copies of its current amended and restated certificate of incorporation and
            by-laws with the SEC and will send copies of the documents referred to in this proxy statement/prospectus/information statement to you upon your request. Cend will also send copies of its documents referred to in this proxy
            statement/prospectus/information statement to you upon your request. See the section entitled <span style="font-style: italic;">&#8220;Where You Can Find More Information&#8221;</span> in this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tPOSTM"><!--Anchor--></a>Current Cend Rights Versus Caladrius
            Rights Post-Merger </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 61.54%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Elections; Voting; Procedural Matters</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Authorized Capital Stock</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation of Cend authorizes the
                    issuance of up to (i) 11,500,000 shares of common stock, par value $0.00001 per share, (ii) 4,350,000 shares of preferred stock, par value $0.00001 per share, of which (A) 371,396 shares have been designated as &#8220;Series&#160;A Preferred
                    Stock&#8221; (B) 1,071,240 shares have been designated as &#8220;Series&#160;B Preferred Stock&#8221; (C)&#160;1,345,700 shares have been designated as &#8220;Series&#160;C Preferred Stock&#8221; and (D)&#160;1,135,650 shares have been designated as &#8220;Series&#160;D Preferred Stock&#8221;. Series&#160;A
                    Preferred Stock, Series&#160;B Preferred Stock, Series&#160;C Preferred Stock and Series&#160;D Preferred Stock is referred to collectively as &#8220;Cend Preferred Stock.&#8221;<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">It is expected that holders of Cend Preferred Stock will be converting into
                    common stock immediately prior to the Merger.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation of Caladrius authorizes
                    the issuance of up to 500,000,000 shares of common stock, par value $0.001 per share, and 20,000,000 shares of preferred stock, par value $0.01 per share. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">277<br />
        </div>

      </div>

    </div>

    <!--End Page 286-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 287-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Number of Directors</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The by-laws of Cend currently provide that the authorized number of directors
                    shall be fixed by the Cend Board of Directors from time to time. Directors need not be stockholders, unless so required by the Cend amended and restated certificate of incorporation.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated by-laws of Caladrius currently provide that the number
                    of directors that shall constitute the whole Caladrius Board of Directors shall be determined by resolution of the Caladrius Board of Directors, but in no event shall be less than three. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stockholder Nominations and Proposals</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s by-laws provide that nominations for persons for election to the Cend
                    Board of Directors or proposals of Cend may be made (i)&#160;pursuant to the corporation&#8217;s notice of meeting of stockholders; (ii)&#160;by or at the direction of the Cend Board of Directors; or (iii)&#160;by any stockholder of the corporation who was
                    a stockholder of record at the time of giving of notice. At an annual meeting of the stockholders, for nominations or other business to be properly brought before an annual meeting, by a stockholder, (i)&#160;the stockholder must have given
                    timely notice thereof in writing to the Secretary of the corporation, (ii)&#160;such other business must be a proper matter for stockholder action under the DGCL, (iii)&#160;if the stockholder, or the beneficial owner on whose behalf any such
                    proposal or nomination is made, has provided the corporation with a solicitation notice, must, in the case of a proposal, have delivered a proxy statement and form of proxy to holders of at least the percentage of the corporation&#8217;s
                    voting shares required under applicable law to carry any such proposal, or, in the case of a nomination or nominations, have delivered a proxy statement and form of proxy to holders of a percentage of the corporation&#8217;s voting shares
                    reasonably believed by such stockholder or beneficial owner to be sufficient to elect the nominee or nominees proposed to be nominated by such stockholder, and must, in either case, have included in such materials the solicitation
                    notice, and (iv)&#160;if no solicitation notice relating thereto has been timely provided, the proposing such business or nomination must not have solicited a number of proxies sufficient to have required the delivery of such a solicitation
                    notice.<br />
                  </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amendments to the amended and restated by-laws of Caladrius provide that
                    nominations of any person for election to the Caladrius Board of Directors at an annual meeting or at a special meeting (but only if the election of directors is a matter specified in the notice of meeting given by or at the discretion
                    of the person calling such special meeting) may be made at such meeting only (a) by or at the direction of the Caladrius Board of Directors, including by any committee or persons authorized to do so by the Caladrius Board of Directors,
                    or (b) by a stockholder present in person (A) who was a beneficial owner of shares of Caladrius both at the time of giving the notice of such meeting and at the time of the meeting, (B) is entitled to vote at the meeting and (C) has
                    complied with the notice and nomination provisions of the amendments to the amended and restated by-laws of Caladrius.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amendments to the amended and restated by-laws of Caladrius provide that
                    nominations of any person for election to the Caladrius Board of Directors at an annual meeting, or at a special meeting held in lieu of an annual meeting of Caladrius Stockholders, may be made provided that the nominations are
                    (i)&#160;specified in the notice of the annual meeting given by or at the direction of the Caladrius Board of Directors, in accordance to the amendments to the amended and restated by-laws of Caladrius, (ii)&#160;given timely notice in accordance
                    with the amendments to the amended and restated by-laws of Caladrius and (iii)&#160;brought by any stockholder of Caladrius who is a stockholder of record at the time of giving of notice as provided for in the amendments to the amended and
                    restated by-laws. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">278<br />
        </div>

      </div>

    </div>

    <!--End Page 287-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 288-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation provide that the
                      holders of the Series&#160;B Preferred Stock shall be entitled to elect one director and the holders of Series&#160;C Preferred Stock shall be entitled to elect one director.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Classified Board of Directors</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The by-laws of Cend do not provide for the division of the Cend Board of
                      Directors into staggered classes.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated by-laws of Caladrius provide for the division of
                      the Caladrius Board of Directors into staggered classes. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Removal of Directors</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the by-laws of Cend, a Director may be removed from office at
                      any time (i)&#160;with cause by the affirmative vote of the holders of a majority of the voting power of all then-outstanding shares of capital stock, (ii)&#160;without cause by the affirmative vote of the holders of a majority of the voting
                      power of the then outstanding shares of capital stock entitled to elect such director.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Under the amended and restated by-laws of Caladrius, a Director may be
                      removed from office at any time (i)&#160;without cause, by the affirmative vote of at least 75&#160;percent of the voting power of all outstanding shares of voting stock of Caladrius with the power to vote at an election of directors or
                      (ii)&#160;with cause, by the holders of at least a majority of all outstanding shares of voting stock of Caladrius with the power to vote at an election of the directors. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Special Meeting of the Stockholders</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The by-laws of Cend provide that a special meeting may be called by the
                      Chairman of the Board, the Cend Board of Directors, the Chief Executive Officer or by the holders of shares entitled to cast not less than 50% of the votes at the meeting.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated by-laws of Caladrius provide that a special meeting
                      may be called by the Chairman of the Board (if any), the Caladrius Board of Directors or the Chief Executive Officer. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cumulative Voting</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and certificate of incorporation states that unless required by
                      law, there shall be no cumulative voting.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The DGCL provides that stockholders are not entitled to the right to
                      cumulate votes in the election of directors unless a corporation's certificate of incorporation provides otherwise. The amended and restated certificate of incorporation of Caladrius does not provide for cumulative voting </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Vacancies</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The by-laws and amended and restated certificate of incorporation of Cend
                      provide that subject to the rights of holders of any series of Preferred Stock, any vacancies on the Cend Board of Directors shall, unless filled by the Cend stockholders, be filled by the affirmative vote of a majority the majority
                      of the directors then in office, or by a sole remaining director.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated by-laws of Caladrius provide that any vacancy or
                      newly created directorships on the Caladrius Board of Directors will, unless and until filled by the Caladrius Stockholders, be filled by vote of a majority of the directors then in office, although less than a quorum, or by a sole
                      remaining Director. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">279<br />
        </div>

      </div>

    </div>

    <!--End Page 288-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 289-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Voting Stock</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">According to the amended and restated certificate of incorporation the holders
                    of Cend common stock are entitled to one vote for each share of common stock held at all meeting of stockholders. Each holder of Preferred Stock may cast the number of votes equal to the number of whole shares of common stock into which
                    the shares of Preferred Stock are convertible as of the record date. Holders of Preferred Stock shall vote together with the holders of common stock as a single class on an as-converted basis.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The by-laws state that the Cend Board of Directors may fix, in advance, a
                    records date, which records date shall not precede the date upon which resolution the record date is adopted and which shall not be more than 60 days nor less than 10 days before the date of such meeting. If no record date is fixed by
                    the Cend Board of Directors, the record date shall be at the close of business on the day next preceding the day on which notice is given, or if notice is waived, at the close of business on the day next preceding the day on which the
                    meeting is held.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Under the amended and restated certificate of incorporation and the amended and
                    restated by-laws of Caladrius, the holders of Caladrius Common Stock are entitled to one vote for each share of stock held by them and holders of Caladrius Series&#160;B Convertible Redeemable Preferred Stock are entitled to ten votes for
                    each share of Caladrius Series&#160;B Convertible Redeemable Preferred Stock into which such share of Caladrius Series&#160;B Convertible Redeemable Preferred Stock is convertible. The amended and restated by-laws of Caladrius further state that
                    in order for Caladrius to determine which Caladrius Stockholders are entitled to vote, the Caladrius Board of Directors may fix, in advance, a record date, which record date shall not precede the date on which the resolution fixing the
                    record date is adopted and which shall not be more than 60 nor less than 10&#160;days before the date of such meeting, nor more than 60 days prior to any other such action. If the Caladrius Board of Directors do not so fix a record date, the
                    record date for determining stockholders entitled to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given, or, if notice is waived, at the close of business on
                    the day next preceding the day on which the meeting is held. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stockholders Agreement</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The holders of Cend&#8217;s Series&#160;A Preferred Stock and Series&#160;B Preferred Stock
                    entered into a Voting Agreement with Cend, in March 2019 (&#8220;Voting Agreement&#8221;). On April&#160;26, 2022, the parties to the Voting Agreement entered into Amendment No. 1 to Voting Agreement (&#8220;Amended Voting Agreement&#8221;) wherein Caladrius as the
                    sole holder of Series&#160;D Preferred Stock became a party to and subject to the terms of the Voting Agreement, among other things. Pursuant to the Voting Agreement and Amended Voting Agreement, for as long as at least 50% of the initially
                    issued shares of Series&#160;B Preferred Stock remain outstanding, the</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius does not have a stockholders agreement or any such similar agreement
                    with any of its stockholders in place. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">280<br />
        </div>

      </div>

    </div>

    <!--End Page 289-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 290-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">holders of at least a majority of the Series&#160;B Preferred Stock shall be
                    entitled to elect one member of the Cend Board of Directors. No director elected as a result of this provision can be removed unless removal s approved by the holders of at least 50% of the shares of stock entitled to vote.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Drag Along</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The Voting Agreement contains a Drag-Along provision that provides that in the
                    event that (i)&#160;the holders of at least 70% of the shares of common stock issued or issuable upon conversion of the Cend Preferred Stock, (ii)&#160;the Cend Board of Directors, (iii)&#160;the holders of 70% of the then outstanding common stock
                    held by Key Holders (defined therein) who are then providing services to Cend as officers, employees, or consultant, and (iv)&#160;the holder of 50% or more of the outstanding shares of Series&#160;B Preferred Stock approve the sale by Cend, in
                    writing, and certain other conditions are met, then (a) in the event of a Stock Sale, the same proportion of shares of capital stock by Cend beneficially owned by stockholder parties to the Voting Agreement will be sold on the same
                    terms and conditions as sold by certain other stockholders, (b)&#160;parties to the Voting Agreement must vote in favor of such sale and refrain from exercising dissenters rights or rights of appraisals, challenging the sale, or alleging
                    breach of fiduciary duty in relation to the sale.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">No party to the Voting Agreement or the Amended Voting Agreement shall be a
                    party to any Stock Sale unless all holders are allowed to participate and the consideration received under such transaction is allocated amongst the parties in accordance with Cend&#8217;s Certificate of Incorporation.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius does not have any drag along terms in place. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stockholder Action by Written Consent</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The by-laws and the certificate of incorporation state that any action required
                    by statute to be taken at any annual or special meeting of the stockholders, or any action which may be taken at any annual or special meeting of the stockholders may be</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amendments to the amended and restated by-laws of Caladrius specify that
                    any action permitted to be taken at an annual or special meeting may be taken without a meeting if a consent or consents in writing are (i)&#160;signed in compliance with the amended and </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">281<br />
        </div>

      </div>

    </div>

    <!--End Page 290-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 291-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">taken without a meeting, without prior notice and without a vote, if a consent
                    in writing, or by electronic transmission setting forth the action so taken, shall be signed by the holders of outstanding stock not having less than the minimum number of votes that would be necessary to authorize such action at a
                    meeting at which all shares entitled to vote were present and voted.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">restated by-laws by not less than the minimum number of outstanding shares
                    necessary to authorize or take such action at a meeting at which all shares are entitled to vote thereon were present and voted and (ii)&#160;delivered Caladrius in compliance with the provisions of the amendments to the amended and restated
                    by-laws. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Notice of Stockholder Meeting</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The by-laws provide that written notice of each meeting of the stockholders
                    including all information provided for in the by-laws of Cend, must be given not less than 10 days nor more than 60 days before the meeting to each Cend stockholder entitled to vote at such meeting.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Under the amended and restated by-laws of Caladrius, written notice of each
                    meeting of the stockholders, including all information provided for in the by-laws of Caladrius, must be given no less than 10&#160;nor more than 60 days before the date of the meeting to each Caladrius Stockholder entitled to vote at such
                    meeting. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Conversion Rights and Protective Provisions</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation of Cend provides that
                    each holders of Cend Preferred Stock shall have the right to convert such shares into shares of Cend common stock, at any time in accordance with the amended and restated certificate of incorporation. However, upon either (a) the
                    closing of a public offering resulting in at least $50&#160;million in gross proceeds to Cend or (b) the written vote or consent of the Series&#160;A Preferred Stock, Series&#160;B Preferred Stock and Series&#160;D Preferred Stock, such Preferred Stock
                    shall be mandatorily converted into Cend Common Stock.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">According to the amended and restated certification of incorporation, at any
                    time when at least 50% of the initially issued Series&#160;A Preferred Stock remains outstanding, Cend shall not without the written consent or affirmative vote of the holders of Series&#160;A Preferred Stock (a)&#160;effect any sale of substantially
                    all of the assets, merger, consolidation or other reorganization of Cend where Cend&#8217;s shareholders retain less than 50% voting power (b) liquidate, dissolve or wind-up the business and affairs of Cend (c)&#160;acquire shares of capital stock
                    of any other corporation, joint venture or partnership (d) enter into any transaction</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation of Caladrius does not
                    provide that holders of Caladrius&#8217; capital stock shall have preemptive or other protective rights, however, provides that each holder of Caladrius Series&#160;B Convertible Redeemable Preferred Stock shall have the right to convert such
                    shares into shares of Caladrius Common Stock at any time in accordance with the amended and restated certificate of incorporation. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">282<br />
        </div>

      </div>

    </div>

    <!--End Page 291-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 292-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">that might result in the change of ownership of any intellectual property of
                    Cend or enter into any exclusive license of any Cend intellectual property or (e)&#160;approve the annual business plan or other action which may lead to result in change of the business of Cend.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the amended and restated certificate of incorporation, Cend shall
                    not without the written consent or affirmative vote of the holders of Series&#160;B Preferred Stock (a)&#160;effect any sale of substantially all of the assets, merger, consolidation or other reorganization of Cend where Cend&#8217;s shareholders
                    retain less than 50% voting power (b)&#160;liquidate, dissolve or wind-up the business and affairs of Cend, (c)&#160;acquires shares of capital stock of any other corporation, joint venture or partnership (d)&#160;enter into any transaction that might
                    result in the change of ownership of any intellectual property of Cend or enter into any exclusive license of any Cend intellectual property (e)&#160;approve the annual business plan or other action which may lead to result in change of the
                    business of Cend or (f)&#160;increase the authorized number of shares of any class or series of stock of Cend, or issue shares or other securities convertible into or exercisable into Cend Capital Stock with a financing transaction.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation provides that Cend shall
                    not without the written consent or affirmative vote of the holders of Series&#160;C Preferred Stock (a) alter the rights, powers or privileges in a way that adversely affects the Series&#160;C Preferred Stock (b) increase the number of authorized
                    shares of any class or series of any capital stock of Cend, other than in connection with a permitted financing.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation provides that Cend shall
                    not, without the written consent of the holders of Series&#160;D Preferred Stock, (a) effect any sale of substantially all the assets of Cend wherein Cend&#8217;s shareholders retain less than 50% voting power (except for the</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">283<br />
        </div>

      </div>

    </div>

    <!--End Page 292-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 293-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Merger Agreement), (b) liquidate, dissolve or wind-up the business
                    and affairs of Cend, (c) acquire shares of capital stock of any other corporation, joint venture or partnership (d) approve the annual business plan or other action which may lead to result in change of the business of Cend or (e)
                    increase the authorized number of shares of any class or series of capital stock of Cend or issue shares in connection with a financing transaction in which the shares have an original issue prove equal to or greater than the original
                    issue price of the Series&#160;D Preferred Stock., (f) purchase or redeem or pay or declare any dividend, make distribution other than authorized redemptions on Preferred Stock or repurchases from former officers, directors or other
                    consultants, or (g) enter into any transaction outside the ordinary course of business with an executive officer, director, or holder of more than 10% of Cend&#8217;s outstanding common stock and Preferred Stock, other than transactions that
                    are negotiated on an arms-length bases, are approved by a majority of disinterested members of the Cend Board of Directors, involving compensation for services as an employee or independent director or with the holder of the Series&#160;D
                    Preferred Stock.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Right of First Refusal</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the by-laws no stockholder shall transfer any shares of Cend stock
                    unless the stockholder provides notice to Cend. For 30 days following receipt of that notice, Cend shall have the option to purchase the share specified in the notice, upon the terms outlined, however, with the consent of the
                    stockholder, Cend shall have the option to purchase a lesser portion of the shares specified in the notice at the price and terms set forth. Cend shall provide notice to stockholder of its intent to acquire all or a portion of the
                    shares. In the event Cend does not elect to acquire the shares, stockholder may within 60 days following the expiration of or waiver of the right of first refusal, transfer the shares as specified in the stockholder&#8217;s notice. All shares
                    transferred shall continue to be subject to the provisions of the by-laws. Transfers</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius does not have a right of first refusal in place. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">284<br />
        </div>

      </div>

    </div>

    <!--End Page 293-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 294-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <a id="tIOOA"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">made (i)&#160;to a stockholder&#8217;s immediate family by will or intestacy, (ii)&#160;bona
                    fide pledge or mortgage of shares with a lending institution (iii)&#160;to Cend or any other stockholder of Cend, (iv)&#160;an officer or director of Cend, (v)&#160;pursuant to a merger, consolidation, reclassification, reorganization, or sale of all
                    of the assets of the stockholder, (vi)&#160;transfer to a stockholder&#8217;s own shareholders, (vii)&#160;transfer to a stockholders&#8217; limited partners are exempt from this Right of First Refusal.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Right of Co-Sale</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend does not have a right of co-sale in place.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius does not have a right of co-sale in place.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 100%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;" colspan="7">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Indemnification of Officers
                    and Directors and Advancement of Expenses; Limitation on Personal Liability<span style="font-weight: normal;"> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Indemnification</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation of Cend provides that the
                    corporation is authorized to provide indemnification of directors, officers and agents of Cend through by-laws provisions, agreements with such agents and other persons, vote of stockholders or disinterested directors or otherwise, in
                    excess of the indemnification and advancement otherwise permitted by Delaware General Corporation Law. Cend&#8217;s by-laws provide that Cend shall indemnify its directors and executive officers to the fullest extent not prohibited by the
                    DGCL or any other applicable law; <span style="font-style: italic;">provided, however, </span>that Cend may modify the extent of indemnification by individual contracts with its directors and executive officers; and, <span style="font-style: italic;">provided, further, </span>that Cend shall not be required to indemnify any director or executive officer in connection with any proceeding (or part thereof) initiated by such person unless (i)&#160;such
                    indemnification is expressly required to be made by-law, (ii)&#160;the proceeding was authorized by the Cend Board of Directors of the corporation, (iii)&#160;such indemnification is provided by the corporation, in its sole discretion, pursuant
                    to the powers vested in Cend under the DGCL or any other applicable law.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation of Caladrius provides
                    that Caladrius shall have the power to indemnify any director, officer, employee or agent of Caladrius who was or is a party or is threated to be made a party to any threatened, pending or completed action, suit or proceeding, whether
                    civil, criminal, administrative or investigative by reason of the fact that he or she is or was, or was serving at the request of Caladrius in good faith and in a manner reasonably believed to be in or not opposed to the best interests
                    of Caladrius. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Advancement of Expenses</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certification of incorporation state that to the
                    fullest extent permitted by law, Cend is authorized to</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation states that Caladrius
                    shall pay the expenses incurred by a director, </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">285<br />
        </div>

      </div>

    </div>

    <!--End Page 294-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 295-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <a id="tATCO"><!--Anchor--></a>
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">advance expenses relating to indemnification of directors, offices and agents
                    of Cend.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend&#8217;s by-laws states that Cend shall pay the advance and reimburse the
                    expenses incurred by a director, officer, employee or agent of Cend against expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding if
                    he or she acted in good faith and in a manner reasonably believed to be or not opposed to the best interests of Cend, and, with respect to any criminal action or proceedings, had no reasonable cause to believe his or her conduct was
                    unlawful.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">officer, employee or agent of Caladrius against expenses, judgments, fines and
                    amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding if he or she acted in good faith and in a manner reasonably believed to be or not opposed to the best interests
                    of Caladrius, and, with respect to any criminal action or proceedings, had no reasonable cause to believe his or her conduct was unlawful. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Declaration and Payment of Dividends</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation provides that Cend shall
                    declare all dividends pro rata on the common stock and Preferred Stock on a <span style="font-style: italic;">pari passu</span> basis according to the number of shares of common stock held by such holders. For this purpose, each holder
                    of shares of Preferred Stock will be treated as holding the greatest whole number of shares of Common Stock then issuable upon conversion of all shares of Preferred Stock.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated certificate of incorporation provides that the
                    Caladrius Board of Directors, subject to the rights of the holders of Series&#160;B Convertible Redeemable Preferred Stock, may declare and pay dividends upon the shares of Caladrius Common Stock. Caladrius shall not declare any dividends
                    paid or set aside for payment or other distribution so long as any shares of the Caladrius Series&#160;B Convertible Redeemable Preferred Stock are outstanding, unless upon liquidation, dissolution or winding up, the same dividend is
                    declared, paid or set aside for payment on all outstanding shares of the Series&#160;B Convertible Redeemable Preferred Stock or in the case of Caladrius Common Stock, ten times such dividend per share is declared, paid or set aside for
                    payment on each outstanding share of the Caladrius Series&#160;B Preferred Stock. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 100%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;" colspan="7">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Amendments to Certificate
                    of Incorporation or By-Laws<span style="font-weight: normal;"> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 2pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 2pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">General Provisions</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The by-laws of Cend provide that the Cend Board of Directors is expressly
                    empowered to adopt, amend or repeal the by-laws or any provision of the by-laws, provided however that in addition to any vote of the holders of any class or series of stock the corporation required by law or pursuant to the amended and
                    restated certificate of incorporation, such action by the stockholders shall require the affirmative vote of the holders of at least a</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 2pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 2pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated by-laws of Caladrius state that notwithstanding any
                    other provisions of the amended and restated certificate of incorporation, the amended and restated by-laws or any provision of law which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the
                    holders of a particular class or series of the voting stock required by law or by the amended and restated by-laws of </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">286<br />
        </div>

      </div>

    </div>

    <!--End Page 295-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 296-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_128-comparison_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 23.08%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Provision</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend (Pre-Merger)</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 3.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 3.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius (Post-Merger)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 23.08%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">majority of the voting power of the then- outstanding shares of capital stock
                    of the corporation entitled to vote generally in the election of the directors, voting together, as a single class.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Notwithstanding any other provisions of the amended and restated certificate of
                    incorporation, the amended and restated certificate of incorporation can be amended by in accordance with Sections&#160;242 and 245 of the DGCL when approved by the requisite number Cend shares in accordance with Section&#160;228 of the DGCL.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 35.9%; text-align: left; vertical-align: top; padding-top: 3.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius, the affirmative vote of the holders of at least 75 percent of the
                    votes which all the stockholders would be entitled to cast at any annual election of directors or class of directors shall be required to alter, amend or repeal Article II of the amended and restated by-laws.<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195;<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The amended and restated by-laws of Caladrius further state that the Caladrius
                    Board of Directors may alter, amend or repeal the amended and restated by-laws of Caladrius, except as otherwise stated in the amended and restated by-laws, by a vote of a majority of the directors present at any regular or special
                    meeting with a quorum. The stockholders may alter, amend or repeal the amended and restated by-laws of Caladrius, except as otherwise stated in the amended and restated by-laws, by a vote of the holders of at least 75 percent of the
                    voting power of then outstanding shares of capital stock.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">287<br />
        </div>

      </div>

    </div>

    <!--End Page 296-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 297-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPSOC"><!--Anchor--></a>PRINCIPAL STOCKHOLDERS OF CALADRIUS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Except where specifically noted, the following information and all
            other information contained in this proxy statement/prospectus/information statement do not give effect to the proposed Reverse Stock Split described in Proposal No. 2.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth information relating to the beneficial ownership of
            Caladrius Common Stock as of June&#160;13, 2022: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by each person, or group of affiliated persons, known by Caladrius to beneficially own more than 5% of the outstanding shares of
                    Caladrius Common Stock; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each of Caladrius&#8217; directors and nominees for director; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each of Caladrius&#8217; named executive officers; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all directors, nominees and executive officers as a group. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Beneficial ownership is determined in accordance with SEC rules and regulations, and
            generally includes voting power or investment power with respect to securities held. Unless otherwise indicated and subject to applicable community property laws, we believe that each of the Caladrius Stockholders named in the table below has
            sole voting and investment power with respect to the shares shown as beneficially owned. Securities that may be beneficially acquired within 60 days after June&#160;13, 2022 are deemed to be beneficially owned by the person holding such securities
            for the purpose of computing the ownership of such person, but are not treated as outstanding for the purpose of computing the ownership of any other person.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The percentage of shares beneficially owned is computed on the basis of 60,518,478
            shares of Caladrius Common Stock outstanding as of June&#160;13, 2022. Shares of Caladrius Common Stock that a person has the right to acquire within 60 days of June&#160;13, 2022 are deemed outstanding for purposes of computing the percentage ownership
            of the person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership of all directors and executive officers as a group. Unless
            otherwise indicated below, the address for each beneficial owner listed is c/o Caladrius Biosciences, Inc., at 110 Allen Road, 2<sup>nd</sup> Floor, Basking Ridge, New Jersey 07920. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The tables below list the number and percentage of shares beneficially owned based on
            60,518,478 shares of Caladrius Common Stock outstanding as of June&#160;13, 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">Directors and Named Executive Officers</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name of Beneficial Owner</div>
                </td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total Shares of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Common Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Beneficially Owned (#)</div>
                </td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Percentage</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D., President and Chief Executive Officer</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 3.47pt;">1,059,734</span><sup>(1)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara">1.7%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Kristen K. Buck, MD., Executive Vice President R&amp;D
                      and Chief Medical Officer</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 10.97pt;">702,839</span><sup>(2)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara">1.2%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Todd Girolamo, Former Chief Legal Officer and Corporate Secretary</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 10.97pt;">229,930</span><sup>(3)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D., Chairman of the Board</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 15.97pt;">90,510</span><sup>(4)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Michael Davidson, M.D., Director</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 11.34pt;">110,281</span><sup>(5)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers, Director</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 15.97pt;">80,417</span><sup>(6)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven Klosk, Director</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 15.97pt;">93,330</span><sup>(7)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven S. Myers, Director</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 10.97pt;">163,531</span><sup>(8)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Peter G. Traber, M.D., Director</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 15.97pt;">92,060</span><sup>(9)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Anne C. Whitaker, Director</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara"><span style="padding-left: 12.22pt;">64,225</span><sup>(10)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">All directors and executive officers as a group</div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.68pt; text-align: left;" class="fpara">2,686,857<sup>(11)</sup></div>
                </td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.1%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.56pt; text-align: left;" class="fpara">4.3%</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.25pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Indicates beneficial ownership of less than 1% of the total outstanding shares of Caladrius Common Stock. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes options to purchase up to 428,669 shares of our common stock which are exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes options to purchase up to 383,636 shares of our common stock which are exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes options to purchase up to 188,103 shares of our common stock which are exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 79,460 fully vested restricted stock units and options to purchase up to 6,900 shares of our common stock which are
                    exercisable within 60 days.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">288<br />
        </div>

      </div>

    </div>

    <!--End Page 297-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 298-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 5.25pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 54,756 fully vested restricted stock units which are exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 80,417 fully vested restricted stock units which are exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 79,460 fully vested restricted stock units and options to purchase up to 7,370 shares of our common stock which are
                    exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 79,460 fully vested restricted stock units and options to purchase up to 5,500 shares of our common stock which are
                    exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 79,460 fully vested restricted stock units and options to purchase up to 8,300 shares of our common stock which are
                    exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 64,225 fully vested restricted stock units which are exercisable within 60 days.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(11)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 517,238 fully vested restricted stock units and options to purchase up to 1,028,478 shares of our common stock which are
                    exercisable within 60 days.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">289<br />
        </div>

      </div>

    </div>

    <!--End Page 298-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 299-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPSCEND"><!--Anchor--></a>PRINCIPAL STOCKHOLDERS OF CEND</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table sets forth information relating to the beneficial ownership of Cend
            Common Stock and each series of Preferred Stock as of June&#160;13, 2022: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by each person, or group of affiliated persons, known by Cend to beneficially own more than 5% of the outstanding shares of Cend
                    Common Stock; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each of Cend&#8217;s directors and nominees for director; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each of Cend&#8217;s named executive officers; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all directors, nominees and executive officers as a group. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Beneficial ownership is determined in accordance with SEC rules and regulations, and
            generally includes voting power or investment power with respect to securities held. Unless otherwise indicated and subject to applicable community property laws, Cend believes that each of the Cend stockholders named in the table below has
            sole voting and investment power with respect to the shares shown as beneficially owned. Securities that may be beneficially acquired within 60 days after June&#160;13, 2022 are deemed to be beneficially owned by the person holding such securities
            for the purpose of computing the ownership of such person, but are not treated as outstanding for the purpose of computing the ownership of any other person.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The percentage of shares beneficially owned is computed on the basis of 7,068,037
            shares of Cend Common Stock outstanding as of June&#160;13, 2022. Shares of Cend Common Stock that a person has the right to acquire within 60 days of June&#160;13, 2022 are deemed outstanding for purposes of computing the percentage ownership of the
            person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership of all directors and executive officers as a group. Unless
            otherwise indicated below, the address for each beneficial owner listed is c/o Cend Therapeutics, Inc., 12544 High Bluff Drive, Suite 400, San Diego, California 92130. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The tables below list the number and percentage of shares beneficially owned based on
            8,203,665 shares of Cend common stock outstanding as of June&#160;8, 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h2">Directors, Named Executive Officers and Greater than 5% Stockholders</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name of Beneficial Owner</div>
                </td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total Shares of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Common Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Beneficially Owned (#)</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Percentage</div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Erkki Ruoslahti, MD, PhD, Scientific Founder and Chairman</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara">2,502,789<sup>(1)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara">29.40 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack, MBA, President and Chief Executive Officer, Director</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">477,500</span><sup>(2)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">5.50</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Hari Jarvelainen, PhD, DVM, Chief Operating Officer</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">614,018</span><sup>(3)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">6.96</span> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">F. Andrew Dorr, MD, Chief Medical Officer</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">44,000</span><sup>(4)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">0.33</span> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">James Xiao, EMBA, Director</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">833,066</span><sup>(5)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 0.37pt;">10.11</span> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Heidi Henson, CPA, CFO, Director</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">40,000</span><sup>(6)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">0.49</span> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mike Sailor, PhD, Director</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">452,980</span><sup>(7)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">4.76</span> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Sanford Burnham Prebys Medical Discovery Institute</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">715,707</span><sup>(8)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">8.72</span> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kazuki Sugahara </div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">524,790</span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">6.36</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Tambet Teesalu</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">514,790</span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">6.25</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Innovation 2016 Kyoto Investment Limited Partnership</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">815,400</span><sup>(9)</sup></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 2.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">9.94</span> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 2.25pt; padding-bottom: 3.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc.</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3.5pt;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">1,135,628</span><span style="min-width: 40pt;"><sup>(1</sup><sup>0</sup><sup>)</sup></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3.5pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 2.25pt; padding-bottom: 3.5pt;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 2.25pt; padding-bottom: 3.5pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">13.84 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 70.09%; text-align: left; vertical-align: bottom; padding-top: 3.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">All directors and executive officers as a group</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 16.9%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.54pt; text-align: left;" class="fpara">4,964,353 </div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3.5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.04%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3.5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.56pt; text-align: left;" class="fpara">57.55</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes (i)&#160;an option to purchase 308,727 shares of common stock held by Erkki Ruoslahti (ii) 1,808,263 shares of common
                    stock held by ER Trust 2/18/11 (ii) 54,691 shares of Series B Preferred Stock held by ER Trust 2/18/11 and (iii) 331,108 shares of Series C Preferred Stock held by ER Trust 2/18/11. Erkki Ruoslahti is the Trustee of ER Trust 2/18/11. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes an option to purchase 477,500 shares of common stock. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes an option to purchase 614,018 shares of common stock. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes an option to purchase 44,000 shares of common stock. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes an option to purchase 40,000 shares of common stock held by Jun Xiao, as an individual, and (i) 340,124 shares of
                    common, (ii) 371,396 shares of Series A Preferred Stock and (iii) 81,546 shares of Series B Preferred Stock all held by Leading Choice International Limited. James Xiao is the Managing Director of Leading Choice International Limited. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes an option to purchase 40,000 shares of common stock. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">290<br />
        </div>

      </div>

    </div>

    <!--End Page 299-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 300-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 5.25pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes an option to purchase 111,000 shares of common stock held by Michael Sailor as an individual and (i) 10,872 shares
                    of Series B Preferred Stock, and (ii) 331,108 shares of Series C Preferred Stock held by Sailor Cheung Trust 10 March 2000. Michael Sailor is the Trustee. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The business address for the Sanford Burnham Prebys Medical Discovery Institute is 10901 North Torrey Pines Road, La Jolla, CA
                    92037. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes 815,400 shares of Series B Preferred Stock. Nobuhiro Yagi is the Managing Director of Innovation 2016 Kyoto
                    Investment Limited Partnership. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">This includes 1,135,628 shares of Series D Preferred Stock. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">291<br />
        </div>

      </div>

    </div>

    <!--End Page 300-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 301-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tPRINC"><!--Anchor--></a>PRINCIPAL STOCKHOLDERS OF THE COMBINED
            ORGANIZATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Except where specifically noted, the following information and all
            other information contained in this proxy statement/prospectus/information statement do not give effect to the proposed Reverse Stock Split described in Caladrius Proposal No. 2.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table and the related notes present certain information with respect to
            the beneficial ownership of Caladrius Common Stock upon consummation of the Merger, assuming the Closing occurs on September&#160;30, 2022, by: </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each person, or group of affiliated persons, expected by Caladrius or Cend to become the beneficial owner of more than 5% of the
                    outstanding shares of Caladrius Common Stock upon consummation of the Merger; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each of the combined organization&#8217;s directors and nominees for director; </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">each of the combined organization&#8217;s named executive officers; and </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">all directors, nominees and executive officers of the combined organization as a group. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The number of shares of Caladrius Common Stock beneficially owned by each entity,
            person, director, nominee or executive officer is determined in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership
            includes any shares over which the individual has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire within 60 days of September&#160;30, 2022 through the exercise of stock options or
            other rights. Except as otherwise indicated, and subject to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of capital stock held by that person.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The following table assumes that Caladrius will have 60,518,478 shares of Caladrius
            Common Stock outstanding as of immediately prior to the Effective Time, and that Cend will have 7,068,037 shares of Cend Capital Stock outstanding as of immediately prior to the Effective Time. Based on the assumed capitalization of Caladrius
            and Cend immediately prior to the Effective Time as set forth above, and further assuming that Caladrius&#8217; net cash immediately prior to the Effective Time is $70.0&#160;million, the Exchange Ratio will be approximately 8.5623 and at the Effective
            Time each share of Cend Capital Stock will be converted into the right to receive an aggregate of approximately 8.5623 shares of Caladrius Common Stock. Neither the assumed capitalization nor the assumed Exchange Ratio set forth above give
            effect to the Reverse Stock Split. Shares of Caladrius Common Stock that may be acquired by an individual or group within 60 days of September&#160;30, 2022, pursuant to the exercise of options or warrants, are deemed to be outstanding for the
            purpose of computing the percentage ownership of such individual or group, but are not deemed to be outstanding for the purpose of computing the percentage ownership of Caladrius Common Stock of any other person shown in the table. Unless
            otherwise indicated below, the address for each beneficial owner listed is c/o Caladrius Biosciences, Inc., at 110 Allen Road, 2nd Floor, Basking Ridge, New Jersey 07920. </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 23.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Beneficial Ownership</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name and Address of Beneficial Owner</div>
                </td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Beneficially <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Owned</div>
                </td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Percentage of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Beneficial <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Ownership</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">5% and Greater Stockholders<br />
                  </div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Innovation 2016 Kyoto Investment Limited Partnership</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">6,981,699</span></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">5.8% </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Sanford Burnham Prebys Medical Discovery Institute</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">6,128,098</span></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">5.1% </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Named Executive Officers and Directors<br />
                  </div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D. </div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">1,059,734</span><sup>(1)</sup></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">* </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">4,088,498</span><sup>(2)</sup></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">3.3%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Kristen K. Buck, M.D. </div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">702,839</span><sup>(3)</sup></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Heidi Henson</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">342,49</span>2<sup>(4)</sup></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Erkki Ruoslahti</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">21,429,630<sup>(5)</sup></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara">17.3% </div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D. </div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">90,510</span><sup>(6)</sup></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">*</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">292<br />
        </div>

      </div>

    </div>

    <!--End Page 301-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 302-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 23.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Beneficial Ownership</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name and Address of Beneficial Owner</div>
                </td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Number of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Beneficially <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Owned</div>
                </td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Percentage of <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Beneficial <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Ownership</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">93,330</span><sup>(7)</sup></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">80,417</span><sup>(8)</sup></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">*</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mohammad Azab, MD, MBA </div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 35pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">All directors and executive officers as a group (9 persons)</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: justify;" class="fpara">27,887,450</div>
                </td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.14%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.72pt; text-align: left;" class="fpara">21.6%</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 16pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Indicates beneficial ownership of less than 1% of the total outstanding shares of Caladrius Common Stock. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes options to purchase up to 428,669 shares of our common stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes options to purchase up to 4,088,498 shares of our common stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes options to purchase up to 383,636 shares of our common stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes options to purchase up to 342,492 shares of our common stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes options to purchase up to 2,643,413 shares of our common stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 79,460 fully vested restricted stock units and options to purchase up to 6,900 shares of our common stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 79,460 fully vested restricted stock units and options to purchase up to 7,370 shares of our common stock.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes 80,417 fully vested restricted stock units.</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">293<br />
        </div>

      </div>

    </div>

    <!--End Page 302-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 303-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tLEGAL"><!--Anchor--></a>LEGAL MATTERS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. will pass upon the validity of the
            Caladrius Common Stock offered by this proxy statement/prospectus/information statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;" class="h1"><a id="tEXPER"><!--Anchor--></a>EXPERTS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The audited consolidated financial statements of Caladrius Biosciences, Inc. included
            in this proxy statement/prospectus and elsewhere in the registration statement have been so included in reliance upon the report of Grant Thornton LLP, independent registered public accountants, upon the authority of said firm as experts in
            accounting and auditing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The financial statements of Cend Therapeutics, Inc. as of December&#160;31, 2021 and 2020,
            and for each of the two years in the period ended December&#160;31, 2021, included in this proxy statement/prospectus have been so included in reliance on the report of Withum Smith+Brown, PC, independent registered public accounting firm, given on
            the authority of said firm as experts in auditing and accounting. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;" class="h1"><a id="tWHERE"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius files annual, quarterly and current reports, proxy statements and other
            information with the SEC. You may read and copy any reports, statements or other information that Caladrius files at the SEC public reference room in at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for
            further information on the public reference rooms. Caladrius SEC filings are also available to the public from commercial document retrieval services and on the website maintained by the SEC at http://www.sec.gov. Reports, proxy statements and
            other information concerning Caladrius also may be inspected at the offices of the National Association of Securities Dealers, Inc., Listing Section, 1735 K Street, Washington, D.C. 20006.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">As of the date of this proxy statement/prospectus/information statement, Caladrius has
            filed a registration statement on Form S-4 to register with the SEC the Caladrius Common Stock that Caladrius will issue to Cend Stockholders in the Merger. This proxy statement/prospectus/information statement is a part of that registration
            statement and constitutes a prospectus of Caladrius, as well as a proxy statement of Caladrius for the Annual Meeting and an information statement for the purpose of Cend for its written consent.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has supplied all information contained in this proxy
            statement/prospectus/information statement relating to Caladrius, and Cend has supplied all information contained in this proxy statement/prospectus/information statement relating to Cend.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If you would like to request documents from Caladrius or Cend, please send a request in
            writing or by telephone to either Caladrius or Cend at the following addresses: </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 48.72%; text-align: center; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Caladrius Biosciences, Inc. <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">110 Allen Road, 2<sup>nd</sup> Floor <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Basking Ridge, New Jersey 07920 <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Telephone: (908) 842-0100 <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Attn: President and Chief Financial Officer</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 48.72%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Cend Therapeutics, Inc. <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">12544 High Bluff Drive, Suite 400 <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">San Diego, California <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Telephone: (858) 795-5123 <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">E-mail: info@cendrx.com <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Attn: President and Chief Executive Officer</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If you are a Caladrius Stockholder and would like additional copies, without charge, of
            this proxy statement/prospectus or if you have questions about the Merger, including the procedures for voting your shares, you should contact Caladrius&#8217; proxy solicitor, Alliance Advisors, at the following address and telephone number:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;" class="fpara">Alliance Advisors, LLC<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">200 Broadacres Drive, 3rd Floor<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Bloomfield, NJ 07003<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Call: 973-873-7700 <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Fax: 973-338-1430</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">294<br />
        </div>

      </div>

    </div>

    <!--End Page 303-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 304-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tTRADEN"><!--Anchor--></a>TRADEMARK NOTICE</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#174;, XOWNA&#174; and HONEDRA&#174; are registered trademarks of Caladrius in the United
            States and other jurisdictions. CendR Platform&#8482; is an unregistered trademark of Cend. Other third-party logos and product/trade names are registered trademarks or trade names of their respective companies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; text-align: center;" class="h1"><a id="tOMS"><!--Anchor--></a>OTHER MATTERS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tSHP"><!--Anchor--></a>Stockholder Proposals</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If you wish to submit a stockholder proposal pursuant to Rule 14a-8 under the
              Exchange Act for inclusion in our proxy statement for our 2023 annual meeting of stockholders, you must submit the proposal to our Secretary at Caladrius&#8217; principal executive offices located at 110 Allen Road, 2nd Floor, Basking Ridge, New
              Jersey 07920 no later than April&#160;4, 2023, in accordance with Rule 14a-8 under the Exchange Act. Any such proposal must meet the requirements set forth in the rules and regulations of the SEC in order to be eligible for inclusion in the proxy
              statement for the 2023 annual meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">In addition, if you desire to bring business or nominate an individual for election
              or re-election as a director outside of Rule 14a-8 under the Exchange Act before our 2023 annual meeting, you must comply with our bylaws, which currently require that you have provided written notice of such business or nominee to our
              Secretary at Caladrius&#8217; principal executive offices located at 110 Allen Road, 2nd Floor, Basking Ridge, New Jersey 07920 no earlier than 5:00 pm, May&#160;16, 2023 and no later 5:00 pm, June&#160;15, 2023, and otherwise comply with the advance notice
              and other provisions set forth in our bylaws, which contain additional requirements regarding advance notice of stockholder proposals and director nominations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tCOMM"><!--Anchor--></a>Stockholder Communications with the
            Caladrius Board of Directors</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Stockholders may communicate with the Caladrius Board of Directors, or an
            individual director, by sending written correspondence to Caladrius&#8217; Corporate Secretary at Caladrius Biosciences, Inc., 110 Allen Road, 2<sup>nd</sup> Floor, Basking Ridge, New Jersey 07920. The Corporate Secretary will review such
            correspondence and forward it to the Caladrius Board of Directors, or an individual director, as appropriate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tHOUSE"><!--Anchor--></a>Householding of Proxy Materials</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The SEC has adopted rules known as &#8220;householding&#8221; that permit companies and
            intermediaries (such as brokers) to deliver one set of proxy materials to multiple stockholders residing at the same address. This process enables Caladrius to reduce Caladrius&#8217; printing and distribution costs, and reduce Caladrius&#8217;
            environmental impact. Householding is available to both Caladrius registered stockholders and beneficial owners of Caladrius shares held in street name.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h3">Registered Stockholders</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If you are a Caladrius registered stockholder and have consented to householding, then
            Caladrius will deliver or mail one set of its proxy materials, as applicable, for all registered stockholders residing at the same address. Your consent will continue unless you revoke it, which you may do at any time by providing notice to
            Caladrius&#8217; Corporate Secretary by telephone at (908) 842-0100 or by mail at 110 Allen Road, 2<sup>nd</sup> Floor, Basking Ridge, New Jersey 07920.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">If you are a registered stockholder who has not consented to householding, then
            Caladrius will continue to deliver or mail copies of Caladrius&#8217; proxy materials, as applicable, to each registered stockholder residing at the same address. You may elect to participate in householding and receive only one set of proxy
            materials for all registered stockholders residing at the same address by providing notice to Caladrius as described above.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h3">Street Name Holders</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Stockholders who hold their shares through a brokerage may elect to
            participate in householding, or revoke their consent to participate in householding, by contacting their respective brokers.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h2"><a id="tAREPORT"><!--Anchor--></a>Annual Reports</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">This proxy statement is accompanied by Caladrius&#8217; 2021 Annual Report on Form 10-K (the
            &#8220;2021 Annual Report&#8221;), excluding exhibits. Exhibits to the 2021 Annual Report are available upon payment of a reasonable </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">295<br />
        </div>

      </div>

    </div>

    <!--End Page 304-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 305-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_129-principal_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">fee, which is limited to Caladrius&#8217; expenses in furnishing the requested exhibit.
            All requests should be directed to Caladrius&#8217; Corporate Secretary at Caladrius Biosciences, Inc., 110 Allen Road, 2<sup>nd</sup> Floor, Basking Ridge, New Jersey 07920.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">WHETHER OR NOT YOU PLAN TO PARTICIPATE IN THE LIVE WEBCAST ANNUAL
            MEETING, PLEASE VOTE YOUR SHARES THROUGH THE INTERNET, BY TELEPHONE OR, IF YOU RECEIVED A PROXY CARD, BY SIGNING AND RETURNING THE ENCLOSED PROXY CARD AS SOON AS POSSIBLE TO MAKE SURE THAT YOUR SHARES OF CALADRIUS STOCK ARE REPRESENTED AT THE
            ANNUAL MEETING. THANK YOU FOR YOUR ATTENTION IN THIS MATTER. YOUR PROMPT RESPONSE WILL GREATLY FACILITATE ARRANGEMENTS FOR THE ANNUAL MEETING.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has filed the 2021 Annual Report and this proxy
            statement/prospectus/information statement with the SEC and each is also available in the &#8220;Financials &amp; Filings&#8221; section on Caladrius&#8217; investor relations website at https://ir.caladrius.com and at the SEC&#8217;s website at www.sec.gov. In
            addition, upon written request to Caladrius&#8217; Corporate Secretary at Caladrius Biosciences, Inc., 110 Allen Road, 2<sup>nd</sup> Floor, Basking Ridge, New Jersey 07920, Caladrius will mail a paper copy of the 2021 Annual Report, including the
            financial statements and the financial statement schedules, to you free of charge.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">296<br />
        </div>

      </div>

    </div>

    <!--End Page 305-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 306-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_200-fintoc_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tINDEX1"><!--Anchor--></a>INDEX TO FINANCIAL STATEMENTS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="text-transform: uppercase;">Caladrius Biosciences, Inc. and Subsidiaries</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Financial Statements:<br />
                  </div>
                </td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tREPORT1">Report of Independent Registered Public Accounting Firm
                      (PCAOB ID Number 248)</a></div>
                </td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tREPORT1">FS-2</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#bs-fs3">Consolidated Balance Sheets at December&#160;31, 2021 and 2020</a></div>
                </td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter"><a href="#bs-fs3">&#8203;</a></td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter"><a href="#bs-fs3">&#8203;</a></td>

    <td style="width: 4.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#bs-fs3">FS-3</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCSO">Consolidated Statements of Operations - Years Ended
                      December&#160;31, 2021 and 2020</a></div>
                </td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCSO">FS-4</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCSCL">Consolidated Statements of Comprehensive Loss - Years Ended
                      December&#160;31, 2021 and 2020</a></div>
                </td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCSCL">FS-5</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCSE">Consolidated Statements of Equity - Years Ended December&#160;31,
                      2021 and 2020</a></div>
                </td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCSE">FS-6</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCSCF">Consolidated Statements of Cash Flows - Years Ended
                      December&#160;31, 2021 and 2020</a></div>
                </td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCSCF">FS-7</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tNTC1">Notes to Consolidated Financial Statements</a></div>
                </td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.77%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tNTC1">FS-8</a></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Financial Statements:<br />
                  </div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED1">Consolidated Balance Sheets at March&#160;31, 2022
                      (unaudited) and December&#160;31, 2021</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED1">FS-23</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED2">Consolidated Statements of Operations for the three
                      months ended March&#160;31, 2022 and <br />
                    </a></div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED2">2021 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED2">FS-24</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED3">Consolidated Statements of
                      Comprehensive Loss for the three months ended March&#160;31, 2022 and 2021 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED3">FS-25</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED4">Consolidated Statements of Equity for the three
                      months ended March&#160;31, 2022 and <br />
                    </a></div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED4">2021 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED4">FS-26</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED5">Consolidated Statements of Cash Flows for the three
                      months ended March&#160;31, 2022 and <br />
                    </a></div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED5">2021 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED5">FS-27</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tNOTE2">Notes to Unaudited Consolidated Financial Statements</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tNOTE2">FS-28</a></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;" class="h1"><a id="tNOTE1"><!--Anchor--></a>CEND THERAPEUTICS, INC.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Audited Financial Statements:<br />
                  </div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tREPORT2">Report of Independent Registered Public Accounting Firm</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tREPORT2">FS-39</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Consolidated Financial Statements as of and for the Year Ended December&#160;31,
                    2020 and 2021:<br />
                  </div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED6">Consolidated Balance Sheets</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED6">FS-40</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED7">Consolidated Statements of Operations</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED7">FS-41 </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED8">Consolidated Statements of Comprehensive Income
                      (Loss)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED8">FS-42 </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED9">Consolidated Statements of Convertible Preferred
                      Stock and Stockholders&#8217; Equity (Deficit)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED9">FS-43</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED10">Consolidated Statements of Cash Flows</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCONSOLIDATED10">FS-44</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara"><a href="#tNOTE3">Notes to Consolidated Financial Statements</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tNOTE3">FS-45</a></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;" class="h1"><a id="tINDEX2"><!--Anchor--></a>CEND THERAPEUTICS, INC. <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCB4">Condensed Consolidated Balance Sheets as of December 31, 2021
                      and March 31, 2022 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCB4">FS-64 </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tCCS4">Condensed Consolidated Statements of
                      Operations for the Three Months Ended March 31, 2021 and 2022 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCS4">FS-65 </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tCCSI4">Condensed Consolidated Statements of
                      Comprehensive Income (Loss) for the Three Months Ended March 31, 2021 and 2022 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCSI4">FS-66 </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tCCCP4">Condensed Consolidated Statements of
                      Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) for the Three Months Ended March 31, 2021 and 2022 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCCP4">FS-67</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tCCSCF4">Condensed Consolidated Statements of
                      Cash Flows for the Three Months Ended March 31, 2021 and 2022 (unaudited)</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tCCSCF4">FS-68 </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 92.31%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tNOTE4">Notes to Unaudited Condensed Consolidated Financial
                      Statements</a></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.22%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tNOTE4">FS-69</a></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-1<br />
        </div>

      </div>

    </div>

    <!--End Page 306-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 307-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_201-fintab01_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tREPORT1"><!--Anchor--></a><span style="text-decoration: underline;">REPORT OF INDEPENDENT REGISTERED PUBLIC
              ACCOUNTING FIRM</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">Board of Directors and Stockholders of Caladrius Biosciences, Inc.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Opinion on the financial statements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We have audited the accompanying consolidated balance sheets of Caladrius Biosciences,
            Inc. (a Delaware corporation) and subsidiaries (the &#8220;Company&#8221;) as of December&#160;31, 2021 and 2020, the related consolidated statements of operations, comprehensive loss, equity, and cash flows for each of the two years in the period ended
            December&#160;31, 2021, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2021
            and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December&#160;31, 2021, in conformity with accounting principles generally accepted in the United States of America.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Basis for opinion</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">These financial statements are the responsibility of the Company&#8217;s management. Our
            responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be
            independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">We conducted our audits in accordance with the standards of the PCAOB. Those standards
            require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to
            perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the
            effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Our audits included performing procedures to assess the risks of material misstatement
            of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
            Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis
            for our opinion.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">Critical audit matters</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Critical audit matters are matters arising from the current period audit of the
            financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging,
            subjective, or complex judgments. We determined that there are no critical audit matters.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">/s/ GRANT THORNTON LLP</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">We have served as the Company&#8217;s auditor since 2011.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">New York, New York<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">March&#160;22, 2022</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-2<br />
        </div>

      </div>

    </div>

    <!--End Page 307-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 308-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_201-fintab01_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><br />
      </p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><!--Anchor--> </div>

        </div>

      </div>

    </div>

    <div><br /></div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a id="tCBS"><!--Anchor--></a></div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">
            <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
<div>
            CALADRIU<a id="bs-fs3"><!--Anchor--></a>S BIOSCIENCES, INC. AND SUBSIDIARIES<br /></div>

          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED BALANCE SHEETS<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><span style="font-weight: normal;">(In thousands, except share data)</span></div>

          <table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">ASSETS<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current Assets<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;">$&#160;&#160; <ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_4f706008f38d42959f3a25816f2cc4fe" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,647</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;">$&#160;&#160; <ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_6378aac9e58f4fea95e25dd057172a8d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,512</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:MarketableSecurities" id="Fact_e3655d3ae41748f58d389f81a77fb1ae" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:MarketableSecurities" id="Fact_683953c60e604540b28da57081dea267" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,061</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid and other current assets</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_eb7b2e3784214f05b76b6111e65e73c0" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,212</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_d5bc1d43587f45c5b1ef4145a0566e55" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">758</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current assets</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_d6d8d76dc08247b496911bfc8f97e9ce" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96,182</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_a144fbad57804481a4221185804aaa36" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,331</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_707d1fda3f1c4a608d6bdea5dd4f2d36" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_fa17bd27a2f04b989da8ebc8c0170ce9" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other assets</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_98273a1d047b4a9a8d56dcaddea2a39b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">764</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_25e379a136d24676a004bb6e7bfe5169" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">614</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total assets</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$&#160;&#160; <ix:nonFraction name="us-gaap:Assets" id="Fact_3fb5a146fd154ba2a1c0650c472bb324" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">97,008</ix:nonFraction> </span> </div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; border-bottom: 3pt double rgb(0, 0, 0); min-width: 40.83pt;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 8.33pt; border-bottom: 3pt double rgb(0, 0, 0); min-width: 40.83pt;"><span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_ab0568f2465b48359beeded821b4e24d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">36,002</ix:nonFraction></span></span></span> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">LIABILITIES, NON-CONTROLLING INTERESTS AND EQUITY<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Liabilities<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 13.33pt;"><span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_1640881b842e480ba3a072b6f2029ab1" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,934</ix:nonFraction></span></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 13.33pt;"><span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_6ef9e9b08be041c7a5ecd8fb12f4f31c" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,020</ix:nonFraction></span></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued liabilities</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_5ed45443ed0e46ddbe8811138498eff3" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,589</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_f9ec3ba46b8f41409b6f06688721cd4b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,486</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current liabilities</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_3d3736e6b29f4edcbb3cb791b8e129ef" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,523</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_da3fb9521a34406f9b64deeb9b1e1374" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,506</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other long-term liabilities</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_23362d668b574881b7d85cd923fa4f09" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">485</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_c26325949fa44f3a84661818092fb27b" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">254</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_7db2082ad1cd43e0b533473318e45221" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,008</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_0e373271491b4106b874a7cc4f2353be" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,760</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Commitments and Contingencies<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_bc88fa29a7ec4335a446b74a37c6ad33" contextRef="c20211231" unitRef="U001" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_f94401450b7545d1adac90a25bf513f5" contextRef="c20201231" unitRef="U001" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholders' Equity<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Preferred stock; authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_6d53c4b9bb6b4298989039f32e41af54" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_af982deb5f3c4feab633b46acc86213e" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction></span> shares Series B convertible redeemable preferred stock liquidation value, <span style="text-indent: 0pt;"><ix:nonFraction name="clbs:PreferredStockLiquidationPreferenceShare" id="Fact_7592194032a04eb3a35e47fa09b28789" contextRef="c20211231" unitRef="U002" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="clbs:PreferredStockLiquidationPreferenceShare" id="Fact_fa8d1a7fdecc49a59ea71521fcd429a6" contextRef="c20201231" unitRef="U002" decimals="INF" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction></span> share of common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_16d68f7576c747528355ea1d379a7112" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_8d1388b139ca44dfb6d6d290d01637e8" contextRef="c20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction></span> par value;
                    <span style="text-indent: 0pt;"><ix:nonFraction name="clbs:PreferredStockSharesDesignated" id="Fact_375e5aad2e87477099601b0602cb27e9" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="clbs:PreferredStockSharesDesignated" id="Fact_1fb7c1d33df34e4583cdec13f62e9fe9" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">825,000</ix:nonFraction></ix:nonFraction></span> shares designated; issued and outstanding, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_084b3dd56ca74f6c80711979cdae2f1d" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_532b4b451fb646ea9b7ea414fbbe8920" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_e919c4a7164d4088873f18dc238481a8" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_ebe439019aef4b23a4847d7936613490" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">10,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span> shares at December&#160;31, 2021 and December&#160;31, 2020, respectively</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_edc8b55ab509407780034d85b80fb46b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_903c2a46a2c34f63b6ba618c7b21d3bd" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_d880fb6637d04cb1be0f769c987e7a3b" contextRef="c20211231" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_389c6a22fc1b4024b38dc8198339ec9f" contextRef="c20201231" unitRef="U003" decimals="3" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction></span> par value, authorized <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_fd90a8b140a6404680d368679a9d807f" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_7ab39bc2ef4b4623a21635097659e3ab" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">500,000,000</ix:nonFraction></ix:nonFraction></span>
                    shares; issued <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_9a1d58e9963e474a9e71ecb911b28b5f" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">59,800,792</ix:nonFraction></span> and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_9678c9f8fbfe4118a3b2eda52a5e0b32" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">19,389,413</ix:nonFraction></span>
                    shares, at December&#160;31, 2021 and December&#160;31, 2020, respectively; and outstanding, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_e11a9d842b49451aba7b1e36932fe2c0" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">59,789,712</ix:nonFraction></span> and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_8ba042e48fb54d30885de180554068f2" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">19,378,333</ix:nonFraction></span> shares, at December&#160;31, 2021 and December&#160;31, 2020, respectively</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_dfacaf548a3d477fb6352817a4ff2583" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_d4d452d3ccb847a6a080bd65b3bf130a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additional paid-in capital</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_83652405c70a4878a84d0b5ceb88303b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">545,988</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_a279eb5da21f449c9ca2c9d16c9633ed" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">458,748</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Treasury stock, at cost; <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_4f4f0c29bd934259af3bded25b69240f" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_c199f4f2659443589d5dcf6b1dfef9c3" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">11,080</ix:nonFraction></ix:nonFraction></span> shares at December&#160;31, 2021 and December&#160;31, 2020 respectively</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_74ef592640f2497f8e167f529aacf63a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">708</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_3537ddd33e16469fb85bc3f1b68ba439" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">708</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accumulated deficit</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_ebf72b39945e45a58ac184f82bdddea9" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">453,016</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_f1674e69496b4e8885eaf7ba6bcc8b49" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">425,550</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accumulated other comprehensive loss</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" id="Fact_7781b99bfeef447da87264b2336d82b5" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">70</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" id="Fact_e7e731cc56b844a18f0cf1b0492657be" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total Caladrius Biosciences, Inc. stockholders' equity</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_e2048f15debe46ac9163edd69a19bb36" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">92,254</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_db4fcc1e5ede4db49701e983f83dd3f8" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,496</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-controlling interests</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_fcf386360cc741a581c325589014403c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_49e2837febff4cd68e245cf46ef2bd1f" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total equity</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_bed677ed1b4a4a269ff073a1c07d35f0" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">92,000</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_0ec0862a02a14f51a4cec34ba252bb4d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,242</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities, non-controlling interests and equity</div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$&#160;&#160; <ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_2ac4c6c46ce7469a8f458d58bfad643c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">97,008</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.37%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$&#160;&#160; <ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_7adb937a3a124489bb8e3d41df48ca10" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">36,002</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-3<br />
        </div>

      </div>

    </div>

    <!--End Page 3-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 4-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_201-fintab01_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCSO"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED STATEMENTS OF OPERATIONS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands, except per share data)</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 21.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Expenses:<br />
                  </div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_730faa7e6b3f43408d243b8c791b4132" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,680</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_f2a01141bc2047ecbc0ada85ad877d48" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,253</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 8.7pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_a5e36dc3271c44d6869f04e8485d501f" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11,370</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_cd1828acfff64bcfafc171c6cee6b785" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9,892</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Operating expenses</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_103d07189e574bf8a528e6327fbdafa4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">29,050</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_1c15296560574b2abd997f5ddcba0ef8" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19,145</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Operating loss</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_a3edfaeb80f648a7a3063f217081ccf0" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">29,050</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_6f9c869ee53a4c08a23f3a350d972ce3" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">19,145</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense):<br />
                  </div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Investment income, net</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" id="Fact_94543b28727e4ead8444a28ad9b0bc43" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">151</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" id="Fact_68ca4e57cb894ffd921da26f612116c5" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other expense, net</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_64bc85c642e54e13892df11752bad7ae" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">75</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_8dc1eb0e36674ad49994890145cedad0" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total other income</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_631d87ba9b0f4c8fa99bd852d73fb505" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">76</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_39d4c910b9f54dfcad84a94c5a69edee" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">132</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss before benefit from income taxes and noncontrolling interests</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_cea1751ec8264e0fab4159ef1c541039" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">28,974</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_10e6afd265074312a2c66913dbd2a2d6" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">19,013</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Benefit from income taxes</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_4b4162348e694020928d9d72bb20f378" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,508</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_4bdfd548e6a04061b57185daf84e3ee9" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,872</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara">$(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_d2b382715bc04cf78438b8531f4a331d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,466</ix:nonFraction>)</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_1ef46c6f074f4233a024b03ed5d073b6" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,141</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Less - net income attributable to noncontrolling interests</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" id="Fact_7c9980801d484652aa56a7a8965e2bd2" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" id="Fact_dfd5ec91616641bdba866d4a20e98631" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss attributable to Caladrius Biosciences, Inc. common shareholders</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_225353637d1c462f978bca02951b5f77" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,466</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_14a0e7dfdfb84fe79cd2912b6ae8f49d" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,150</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic and diluted loss per share:<br />
                  </div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc. common shareholders</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara">$<span style="padding-left: 10pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_49097c908e0b408c934cfc7e9483ca44" contextRef="c20210101to20211231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_5c6129726dec4068a1a7f8df694589e4" contextRef="c20210101to20211231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.50</ix:nonFraction></ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara">$<span style="padding-left: 10pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_bd0ee92921ed4b74863d83403df1989f" contextRef="c20200101to20201231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_b8b890886bf144b0b5dd2576084e96f7" contextRef="c20200101to20201231" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.53</ix:nonFraction></ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding:<br />
                  </div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic and diluted shares</div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_9c14e7c4c6834fefbb34231147b27533" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_4f2bbd568d8d49939ee3e141b458fe30" contextRef="c20210101to20211231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">55,313</ix:nonFraction></ix:nonFraction></span></div>
                </td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_5e22c4d818c646438c3ceea17c04d483" contextRef="c20200101to20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_2b8a4c373e8044fa88ba0c3a4bf823f6" contextRef="c20200101to20201231" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">15,440</ix:nonFraction></ix:nonFraction></span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-4<br />
        </div>

      </div>

    </div>

    <!--End Page 4-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 5-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_201-fintab01_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a id="tCSCL"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><span style="font-weight: normal;">(In thousands)</span></div>

          <table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 21.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;">$(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_d22fc70c05564d3ab4deb7d3c7dea574" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,466</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;">$(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_9c6e3f7ed45b42d3abd751ee15de1326" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,141</ix:nonFraction>)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other comprehensive loss:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Available for sale securities - net unrealized loss</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" id="Fact_0074a9e7da334317ae2e9b14af6b6550" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">57</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" id="Fact_6a3c6a4118084fa4a75b352ec6586a4c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">15</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total other comprehensive loss</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" id="Fact_562579d47dd64d9a801c5a8072959d28" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">57</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="padding-left: 17.5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" id="Fact_9367449a5e41435681ac373cc0da0e4e" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">15</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Comprehensive loss</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" id="Fact_49ee771c1b444a1a8115d077af97aa3b" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,523</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" id="Fact_40265068c9e149e29254719db7821059" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,156</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Comprehensive income attributable to noncontrolling interests</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" id="Fact_623e6308b6fe4c778412cc79b6e94bc6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;"><ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" id="Fact_6d24eb6dc80a44ba9fa2f96db60c69d6" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Comprehensive loss attributable to Caladrius Biosciences,
                    Inc. common stockholders</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" id="Fact_877b093471984c3d8bb262ef4e3f397e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,523</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.48pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" id="Fact_91ae8e4d37ee4741a31162df6689fe72" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,165</ix:nonFraction>)</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-5<br />
        </div>

      </div>

    </div>

    <!--End Page 5-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 6-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 528pt;"><a id="ny20004343x1_s4_201-fintab01_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 30pt;"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 528pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 30pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCSE"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED STATEMENTS OF EQUITY<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands)</span></div>

        </div>

        <div style="width: 528pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 528pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Series B <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Convertible <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Preferred Stock</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.34%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Common Stock</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Additional <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Paid-in <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Capital</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accumulated <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Other <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Comprehensive <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Income (Loss)</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accumulated <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Deficit</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Treasury <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Caladrius <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Biosciences, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Inc. <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stockholders' <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Equity</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Non- <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Controlling <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Interest in <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Subsidiary</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Equity</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Balance at December&#160;31, 2019</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_0c7b759d82704a499c273446c199041e" contextRef="c20191231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_b76bd8c3167443c0a3fef4b35f4f5be3" contextRef="c20191231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_583c6553a96043c2bb252e2e7381dab5" contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10,529</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_afe7866be25c41328ccb7902bcb84afc" contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">11</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 0.37pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_6ca80407112a40e79e977d0f834b7eff" contextRef="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">438,911</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_338963560d724e8187a66a70ab6cf90b" contextRef="c20191231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_ad138ddc9aa4490497473bea2f3bce31" contextRef="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">417,400</ix:nonFraction>)</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_367ea42980f4498fb63c4ce96656c6ff" contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">708</ix:nonFraction>)</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_64bd9c91ebed481aa822e9158878dc4c" contextRef="c20191231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,816</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_1e85a7a521824bf6b3c14951b3bfd6bc" contextRef="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">263</ix:nonFraction>)</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_03ad501f382047b48cab6fedd16999cc" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,553</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 15pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_531653fcc05845278c0ce40a4c0bea11" contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,150</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_a9b62c8a608540b0abeb55a5cb604644" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,150</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 18.33pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_686ccf36a7b142b0be25471a76a98c45" contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">9</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_a796cc30b38c438991d07dc52da3de97" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,141</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Unrealized loss on marketable securities</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_53d056c9721047d0ab3755d406fa81ce" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">15</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_637c104d7b4046c78b73a0a38f47aebd" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">15</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_90035d8c91ef45c4ad2e26e4fff7322c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">15</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Share-based compensation</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_876940d4bd7d4c4ebbdd5f3a134edc2e" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" id="Fact_f2e882059d254bf49a29c42d77c76318" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">53</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 15.37pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_eb7904cefa704d9e9102e39652d1b9ad" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,117</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 13.7pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_cb5204845652402a9d115a1a153578a3" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,117</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.7pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_4a4fca8a325e47b7bca70d79a2b20efc" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,117</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Net proceeds from issuance of common stock and warrants</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="Fact_a39d50320e524251851329a19c744ebb" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">8,807</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 15pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_3ded4b6a4599410c8cef86fa5aa87822" contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_09540c5bb61b43478415cfb1395572fe" contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,720</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_52744e2ec4024edfa0fb4721fcf7f0de" contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,728</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_94507d8dc29c4d3e9a5aeddb90f17d2c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,728</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Balance at December&#160;31, 2020</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_7049e91b284448fd9573fde55ab66f36" contextRef="c20201231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_e9b39c0971aa45c9b4ca89d4010d532d" contextRef="c20201231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_ad3897fb537b4bd9a16c54cb23538ab7" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">19,389</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a915f1ef9b2c4fc3bc082f4ba67f95e2" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_1c94de6bb36a416b9063ee7d6a7cd40f" contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">458,748</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_70fe314411eb4682a64e233c078d93c7" contextRef="c20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction>)</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_bedbd1510fea4c808fda91640f15aaac" contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">425,550</ix:nonFraction>)</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_020265c442914faa8ea689662bff9f4d" contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">708</ix:nonFraction>)</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_b57ada58dc824f24ba0121e12c699b86" contextRef="c20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,496</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_43c142ac6266466885664619558c9491" contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_614a83f7fdea4a739d80e5d25eb02be7" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,242</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_9fa0bbdae9e347ccb158544503dc70ef" contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,466</ix:nonFraction>) </span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_fa310e0c51584f7c9551dfc5f716f136" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,466</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_2598fa8f236a427dbfffe1633d57f747" contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_c9bd8f45c672423bad760052cfd519ea" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,466</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Unrealized loss on marketable securities</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_798afd7a6dea4242a5507ff8e3784db5" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">57</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_cb8c118dfddc410d8526169795341135" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">57</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_cdc527d2278645a498bb462da4630691" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">57</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Share-based compensation</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_1082b8af81da449bb507e2b298edf145" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" id="Fact_3eb6f8f76b0c44f582fea0e8251ac767" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">517</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 15pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_ac92670e90f64c169a33b79dff2886d7" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,757</ix:nonFraction> </span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_12c071a2cd874faabaef3a6dcefd9f32" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,757</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_b1edbc11d234455da20d728b0c6133ac" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,757</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Net proceeds from issuance of common stock and warrants</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara">&#8212;</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="Fact_063180016d024d9faf268ca6a5664217" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">39,888</ix:nonFraction></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_6555ae291a084d1e9345c2313c2edd44" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">41</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_80bf964946184af0b5ddd0eb58cdc7ed" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,459</ix:nonFraction> </span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_0f3bf2e8fd924732941c6ed400d80d30" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,500</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_26ff2b72514043949857ab4e63cc1eb9" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,500</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Proceeds from option exercises</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_d40434ee5b264fda830c533bfd53563a" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_a878b9ce8fc54a978a1ebb68bddbab8e" contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_34fb4b523ac841aa886a97a53e557325" contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_6b64f2b4e0db4e20996412873177a705" contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_97516d87cde14951b57fa8e281ddf98c" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Balance at December&#160;31, 2021</div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_5edbd4050fe346fe9f9a1a99179de06d" contextRef="c20211231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.49pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_122bfbf6faef487093ccf00a494c85fb" contextRef="c20211231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_45429c52e2bb42299d4415c37fe07a89" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">59,801</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_95b3c390bd6040108c9d1cea976acc3a" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 37.5pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_6bc13017326f4c9fa237097c8eedd080" contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">545,988</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 18.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_2895e3c3735a4daa9b4c0d490d79db0d" contextRef="c20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">70</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.25pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40.83pt;">$ (<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a75e3deadd0441ae8d3f68b65e3a56f2" contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">453,016</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 23.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_786f23a6d57c47b0be7734a3d296ed5d" contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">708</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.64pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_c918c6c1f3284dfe87f61a56d8d6a5dd" contextRef="c20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">92,254</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.04pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 23.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_46c0d6d77639459ba33b5d395d57c1ef" contextRef="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_bbbe99c3621545b9a85bcb09283017ff" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">92,000</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 30pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 30pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-6<br />
        </div>

      </div>

    </div>

    <!--End Page 6-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 7-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_201-fintab01_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a id="tCSCF"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED STATEMENTS OF CASH FLOWS<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><span style="font-weight: normal;">(In thousands)</span></div>

          <table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 21.85%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from operating activities:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;">$<span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_bf03ebf94b9f4727b31baec9a405b35e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">27,466</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;">$<span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_20c6e284064c4e0f8199385a58f04129" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,141</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Adjustments to reconcile net loss to net cash used in operating activities:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Equity-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 18.33pt;"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" id="Fact_d4a53a5cff8441acb5d3910920954b1a" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,005</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" id="Fact_242207e22694449db81e695d94117499" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,265</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Depreciation and amortization</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" id="Fact_0c576bc2c77a4319bf54d0c2518128c6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">55</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" id="Fact_153aacbbca73492291cda31cecb8fbff" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">63</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Amortization/accretion on marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 18.33pt;"><ix:nonFraction name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" id="Fact_789a8138e4444ef8bf5dfe922b6a74e8" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,514</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" id="Fact_4bcfdd08dde14ba98a95e62e03789ed4" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">307</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Changes in operating assets and liabilities:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-align: left;">Prepaid and other current assets</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_3012079badca4f80b30fa16b4d6181cc" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">453</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_d3c543bdc0a24d0a853905706c53394b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">56</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-align: left;">Other assets</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_93eb6a33392341429a557fa7a89e54b2" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">150</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_896ebf9e347e4796b63c124405a3a327" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">466</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-align: left;">Accounts payable, accrued liabilities and other liabilities</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" id="Fact_c47c62e50f2940838ef6f49dea6795e6" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,250</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" id="Fact_e078b771973e45d883e99519e3a565a6" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,839</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash used in operating activities</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_7a2545d8217c4c5498f2e010c8f5512c" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">22,245</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_e2b03c50319d464e9d65fbbef2a95fd7" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,823</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from investing activities:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Purchase of marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireMarketableSecurities" id="Fact_315c1814b88e41cea718fdbf41f5db12" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">179,775</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireMarketableSecurities" id="Fact_9835bf08c2e04281b225159d1c39879d" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34,799</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales of marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" id="Fact_29a661688e4747f7932f45418d0acae8" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">124,939</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" id="Fact_86cb338ef5a94cc389f9839a740815bf" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">27,542</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Purchases of property and equipment</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_559bb51d54cb4becabb0e0b8443b9c95" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" id="Fact_90da396232a74d18acaee3910e261f79" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash used in investing activities</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_bf3b613563d844fcb73f41b0cbc82af1" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">54,896</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_bff14723fe4540c7a7bc15951b323439" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">7,277</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from financing activities:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from exercise of options</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_80cba98b0ead4813b72d8a0c9ab70e4b" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_b3c3565fbfb5422892f77da1bc9c13c8" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Tax withholding payments on net share settlement equity awards</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_67c57a1fb3994d0eae09d61ac7616aca" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">248</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 17.5pt;">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_69ef8d25198a43cb9dab2b3cd1fac980" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">148</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net proceeds from issuance of capital stock</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_401be99e6e9a4cb1b3270dcedb69b34f" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,500</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_2b3a54317fcf47d696208828814c72cb" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,728</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash provided by financing activities</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_9de717464f6545e096a0a486505179a4" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,276</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_5764c4c42b494d5980ae420c24c4ea23" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,580</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net increase in cash and cash equivalents</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 18.33pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_247506825b084cd885e11b852be4f300" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,135</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_37b4e94358064de3ae5e12eba01a0432" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,480</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents at beginning of year</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_fa7f30af90a14de4b511e9fabb9268b2" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,512</ix:nonFraction><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_f15e36ab2cb4460eaba449576af17781" contextRef="c20191231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,032</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents at end of year</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_b48b47c4cc7445aaa7ccb63de4e67621" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,647</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_83a854bf9276448d8a86bb7e733c740f" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,512</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Supplemental Disclosure of Cash Flow Information:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash paid during the period for:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;">$<span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_9931cc7c059e4002b85bb5745973f798" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;">$<span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:InterestPaidNet" id="Fact_b5c819360e1d4be58dd427cb806a8214" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Taxes</div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" id="Fact_ef712ddf72bf4ddb82bf0211337ec7ae" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.98pt; text-align: left;"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" id="Fact_1945a96c1fdd42988bfd4c8f9e9a7e65" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-7<br />
        </div>

      </div>

    </div>

    <!--End Page 7-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 8-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a id="tNTC1"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>


          <ix:nonNumeric name="clbs:BusinessTextBlock" id="Text_5985e66aba6949ca8a068d74294d0c4a" contextRef="c20210101to20211231" escape="true" continuedAt="Text_34e9ab21028848548a3ab896f5f440b11">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 1 &#8211; The Business</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b11" continuedAt="Text_34e9ab21028848548a3ab896f5f440b12">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">OVERVIEW</span></div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b12" continuedAt="Text_34e9ab21028848548a3ab896f5f440b13">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Caladrius&#8221; or the
            &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The Company is developing what are intended to be first-in-class therapeutics based on the characteristics of
            naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its technology is intended to leverage these cells to enable the body's natural repair mechanisms using formulations unique to each medical
            indication.</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b13" continuedAt="Text_34e9ab21028848548a3ab896f5f440b14">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's leadership team has decades of collective
            biopharmaceutical development experience. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The Company's current product candidates include:</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b14" continuedAt="Text_34e9ab21028848548a3ab896f5f440b15">
<table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA<sup>&#174;</sup> (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow-on Phase
                    2b study (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b15" continuedAt="Text_34e9ab21028848548a3ab896f5f440b16">
<table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA<sup>&#174;</sup> (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the
                    treatment of critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan. HONEDRA&#174; was the recipient of orphan drug designation in March 2021 from the U.S. Food
                    and Drug Administration (&#8220;FDA&#8221;) for Buerger's disease; and</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b16" continuedAt="Text_34e9ab21028848548a3ab896f5f440b17">
<table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients with chronic kidney
                    disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b17" continuedAt="Text_34e9ab21028848548a3ab896f5f440b18">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Ischemic Repair (CD34 Cell Technology)</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b18" continuedAt="Text_34e9ab21028848548a3ab896f5f440b19">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The CD34+ cell was discovered as a result of the deliberate search
            for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building
            new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same
            capability.</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b19" continuedAt="Text_34e9ab21028848548a3ab896f5f440b110">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's proprietary cell technology using autologous (a
            patient&#8217;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is
            restricted or reduced. Through the administration of CD34+ cells, Caladrius seeks to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. The Company believes that a number of
            conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology including, but not limited to, Buerger's disease, CLI, CMD, and DKD.</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b110" continuedAt="Text_34e9ab21028848548a3ab896f5f440b111">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">XOWNA<sup>&#174;</sup> for Treatment of Coronary
            Microvascular Dysfunction</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b111" continuedAt="Text_34e9ab21028848548a3ab896f5f440b112">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In 2017, with the assistance of a $<ix:nonFraction name="us-gaap:GrantsReceivable" id="Fact_c07d90e653b940b3ba1e2d50080b964d" contextRef="c20171231_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_CLBS16TreatmentOfCMDMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction> million grant from the National Institutes of Health (Award Number&#160;R44HL135889), the Company initiated its program for XOWNA<sup>&#174;</sup> for the
            treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled
            patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian
            Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr.
            Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, the Company commenced enrollment in its Phase 2b FREEDOM Trial of XOWNA&#174;, a </div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-8<br />
        </div>

      </div>

    </div>

    <!--End Page 8-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 9-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b112" continuedAt="Text_34e9ab21028848548a3ab896f5f440b113">
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">double-blind, randomized and placebo-controlled clinical trial designed to further
            evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in January
            2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment. Protocol amendments to the initial FREEDOM Trial protocol, as agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of
            subject enrollment.</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b113" continuedAt="Text_34e9ab21028848548a3ab896f5f440b114">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">HONEDRA<sup>&#174;</sup> for Treatment of Critical
            Limb Ischemia</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b114" continuedAt="Text_34e9ab21028848548a3ab896f5f440b115">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's randomized, open-label, registration-eligible study of
            HONEDRA<sup>&#174;</sup> in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA<sup>&#174;</sup> study's enrollment, however, has been significantly curtailed by the
            COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of the past 18 months. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19
            delays, coupled with the unpredictability of the timing of site enrollment re-initiation, Caladrius suspended further enrollment and is focusing its efforts on consummating a partnership for the product in Japan. Such a partnership may become
            the basis for the completion of development and registration of HONEDRA<sup>&#174;</sup> in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or
            exploration of the possibility of submitting the existing data to Japan's Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) under Japan's regenerative medicine regulations, which allow for conditional approval of innovative regenerative
            medicine products. Despite receipt from FDA in March 2021 of orphan designation in the U.S. for CLBS12 as a potential treatment for Buerger's disease, based on a response from the FDA in October 2021 regarding a development plan for U.S.
            registration the Company decided not to pursue United States development in Buerger's disease at this time.</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b115" continuedAt="Text_34e9ab21028848548a3ab896f5f440b116">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">CLBS201 for Treatment of Diabetic Kidney Disease</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b116" continuedAt="Text_34e9ab21028848548a3ab896f5f440b117">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Progressive kidney failure is associated with attrition of the
            microcirculation of the kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, the Company
            has elected to move forward with a Phase 1, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol, as approved by an Institutional Review Board (the &#8220;IRB&#8221;), is expected
            to include six subjects in total with the first two subjects sequentially dosed and followed for a two-week safety observation period. Clearance by the independent Data Safety Monitoring Board (&#8220;DSMB&#8221;) overseeing the study will then permit the
            treatment of the next four patients, with all patients being followed for safety and therapeutic effect. A read-out of data will occur after at the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201
            will be its ability to demonstrate a therapeutic effect that will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate.</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b117" continuedAt="Text_34e9ab21028848548a3ab896f5f440b118">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Additional Out-licensing Opportunities and
            Pipeline Diversification</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b118" continuedAt="Text_34e9ab21028848548a3ab896f5f440b119">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's broad intellectual property portfolio of cell therapy
            assets includes notable programs available for out-licensing in order to continue their clinical development. The Company's current long-term strategy focuses on advancing its therapies through development with the ultimate objective of
            obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to
            realize potentially meaningful value increases within its own proprietary pipeline if it is successful in advancing its product candidates to their next significant development milestones.</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b119" continuedAt="Text_34e9ab21028848548a3ab896f5f440b120">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the Company further desires to diversify its pipeline of
            development products candidates and is exploring a range of strategic transactions in furtherance of that goal. The Company has taken, and intends to continue to take, active steps to identify assets and/or companies for acquisition and/or
            partnership that would complement its current development programs and de-risk its overall development portfolio. Such assets potentially could target indications beyond cardiovascular disease as well as product categories outside of cell
            therapy. The range of possible transactions includes an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute </div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-9<br />
        </div>

      </div>

    </div>

    <!--End Page 9-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 10-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b120" continuedAt="Text_34e9ab21028848548a3ab896f5f440b121">
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">the shares of its existing stockholders. There can be no assurance that this
            exploration of strategic alternatives will result in Caladrius entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b121" continuedAt="Text_34e9ab21028848548a3ab896f5f440b122">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Coronavirus Considerations</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b122" continuedAt="Text_34e9ab21028848548a3ab896f5f440b123">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which
            causes COVID-19, was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects. Despite the FDA approval
            of multiple COVID-19 vaccines in late 2020, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, the
            Company implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. The Company's clinical study of HONEDRA<sup>&#174;</sup> in Japan has experienced
            significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 and re-implemented from January&#160;7, 2021 through March&#160;21, 2021 covering Tokyo and other regions in response to an increased number of COVID-19
            infections. Due to reported increases in COVID-19 cases and a low rate of vaccination in Japan, States of Emergency were renewed on April&#160;25, 2021 through May&#160;11, 2021 and then re-implemented in Tokyo from July&#160;12, 2021 through September&#160;30,
            2021. With the Company's expectation that</div>
</ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b123" continuedAt="Text_34e9ab21028848548a3ab896f5f440b124">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">COVID-19 in Japan would continue to impact negatively enrollment of
            patients in the HONEDRA<sup>&#174;</sup> clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory authorities regarding the submission of patient data already accrued. Caladrius'
            phase 2b trial of XOWNA<sup>&#174;</sup> in the U.S. has also experienced delays in enrolling patients as a result of COVID-19.</div>
</ix:continuation>

          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b124" continuedAt="Text_34e9ab21028848548a3ab896f5f440b125"><ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Text_6c65e5604e594013b182c526fa6246a5" contextRef="c20210101to20211231" escape="true" continuedAt="Text_50fea0af7fb54f8aafd7a309af6d448f1">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b125" continuedAt="Text_34e9ab21028848548a3ab896f5f440b126"><ix:continuation id="Text_50fea0af7fb54f8aafd7a309af6d448f1">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying consolidated financial statements have been prepared
            in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b126" continuedAt="Text_34e9ab21028848548a3ab896f5f440b127"><ix:nonNumeric name="us-gaap:UseOfEstimates" id="Text_e633129383ff47cba9687b59dd0f55af" contextRef="c20210101to20211231" escape="true" continuedAt="Text_6a172429b3794f6992cd66e7de01d3141">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b127" continuedAt="Text_34e9ab21028848548a3ab896f5f440b128"><ix:continuation id="Text_6a172429b3794f6992cd66e7de01d3141">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments
            about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimate and assumptions in determining stock-based awards values. Accordingly, actual results could differ from
            those estimates and assumptions.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b128" continuedAt="Text_34e9ab21028848548a3ab896f5f440b129"><ix:nonNumeric name="us-gaap:ConsolidationPolicyTextBlock" id="Text_4f1d7b3a412f407abc76f7b042d960c8" contextRef="c20210101to20211231" escape="true" continuedAt="Text_b8f55b591cb7489abef9b6fd488e8b8d1">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_34e9ab21028848548a3ab896f5f440b129"><ix:continuation id="Text_b8f55b591cb7489abef9b6fd488e8b8d1">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
</ix:continuation></ix:continuation>
            </div>

        <div class="block-main" style="width: 468pt; margin-left: 0pt;"> <br />
        </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" id="Text_74b32556132f4e5c8c40f5c02fedf852" contextRef="c20210101to20211231" escape="true" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b61">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 2 &#8211; Summary of Significant Accounting Policies</span></div>
</ix:nonNumeric>

          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b61" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b62"><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="Text_827707f29d164046bf9342bdde1907dd" contextRef="c20210101to20211231" escape="true" continuedAt="Text_f3d5f596b366477393ed8e614c4e42831">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Cash and Cash Equivalents</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b62" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b63"><ix:continuation id="Text_f3d5f596b366477393ed8e614c4e42831">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Cash and cash equivalents include short-term, highly liquid,
            investments with maturities of ninety days or less when purchased.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b63" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b64"><ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" id="Text_126ac2df768748838e6b3bb17a12cdc1" contextRef="c20210101to20211231" escape="true" continuedAt="Text_5b424ce648324ecda0be1a9996df152d1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Concentration of Risks</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b64" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b65"><ix:continuation id="Text_5b424ce648324ecda0be1a9996df152d1" continuedAt="Text_5b424ce648324ecda0be1a9996df152d2">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of </div>
</ix:continuation></ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-10<br />
        </div>

      </div>

    </div>

    <!--End Page 10-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 11-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_202-finnotes01_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b65" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b66"><ix:continuation id="Text_5b424ce648324ecda0be1a9996df152d2">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">credit risk from these financial instruments. The goals of the Company's investment
            policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b66" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b67"><ix:nonNumeric name="us-gaap:MarketableSecuritiesPolicy" id="Text_63837709f05346b99fa20eff3cbfefef" contextRef="c20210101to20211231" escape="true" continuedAt="Text_7316cce3bfdc47d9b2a1497dc39a096a1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Marketable Securities</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b67" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b68"><ix:continuation id="Text_7316cce3bfdc47d9b2a1497dc39a096a1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company determines the appropriate classification of its
            marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash
            equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity.
            Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of
            securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the
            impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and
            whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and
            this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b68" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b69"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="Text_4de7f5965bee4c51b551e85c88c8b791" contextRef="c20210101to20211231" escape="true" continuedAt="Text_50fa47379671462b9329963a666028ad1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Property and Equipment</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b69" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b610"><ix:continuation id="Text_50fa47379671462b9329963a666028ad1" continuedAt="Text_50fa47379671462b9329963a666028ad2">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The cost of property and equipment is depreciated over the estimated
            useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="Text_f71b903b428f43a08c9b19af21e40bbc" contextRef="c20210101to20211231" escape="true" continuedAt="Text_85ac608400874cb081e4179935de59bc1"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The estimated useful
            lives of property and equipment are as follows:</span></ix:nonNumeric></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_85ac608400874cb081e4179935de59bc1" continuedAt="Text_85ac608400874cb081e4179935de59bc2"><ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b610" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b611"><ix:continuation id="Text_50fa47379671462b9329963a666028ad2">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Furniture and fixtures</div>
                </td>

    <td style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_0ff85d8d023d419bbc4e61f704d188b8" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" format="ixt-sec:duryear">10</ix:nonNumeric>
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Computer equipment</div>
                </td>

    <td style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_68960595f3b84957be069a5f964a1e15" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" format="ixt-sec:duryear">3</ix:nonNumeric>
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Software</div>
                </td>

    <td style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="Fact_845970771e18468b8c58fddbf87e73e6" contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt-sec:duryear">3</ix:nonNumeric>
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Leasehold improvements</div>
                </td>

    <td style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">Life of lease</div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation></ix:continuation>


          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b611" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b612"><ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentImpairment" id="Text_32d9c6b10a3c49d4b54b40c0c9c0b470" contextRef="c20210101to20211231" escape="true" continuedAt="Text_e4a50ff18f244db8957346f384da741f1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Long-lived Assets</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b612" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b613"><ix:continuation id="Text_e4a50ff18f244db8957346f384da741f1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Long-lived assets consist of property and equipment. The assets are
            amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the
            asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result
            from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair
            value of the assets.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b613" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b614"><ix:nonNumeric name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="Text_318a78ee4c2e42b8aee525a0ee5c470d" contextRef="c20210101to20211231" escape="true" continuedAt="Text_6194f1c665e84bf8afd85c3f980bf0d91">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Share-Based Compensation </div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b614" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b615"><ix:continuation id="Text_6194f1c665e84bf8afd85c3f980bf0d91">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be
            forfeited. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant.</div>
</ix:continuation></ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-11<br />
        </div>

      </div>

    </div>

    <!--End Page 11-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 12-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_202-finnotes01_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b615" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b616"><ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" id="Text_229949e280c14aba98bf907574ba6736" contextRef="c20210101to20211231" escape="true" continuedAt="Text_b85a52cde1394eb298e585f51798cad41">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Loss Per Share</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b616" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b617"><ix:continuation id="Text_b85a52cde1394eb298e585f51798cad41">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Basic loss per share is based on the weighted effect of all common
            shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to
            common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding.
            Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b617" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b618"><ix:nonNumeric name="clbs:TreasuryStockPolicyPolicyTextBlock" id="Text_1f28623617d745e28008a273615b8b4f" contextRef="c20210101to20211231" escape="true" continuedAt="Text_f0b65b3707d648fca9c5fc99eebc7f7b1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Treasury Stock</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b618" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b619"><ix:continuation id="Text_f0b65b3707d648fca9c5fc99eebc7f7b1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Treasury stock purchases are accounted for under the cost method
            whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b619" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b620"><ix:nonNumeric name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="Text_3a733640beae417da568782acdc215f0" contextRef="c20210101to20211231" escape="true" continuedAt="Text_cb3d87e9d6b24c1db22c9a6fef4d0a641">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Research and Development Costs </div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b620" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b621"><ix:continuation id="Text_cb3d87e9d6b24c1db22c9a6fef4d0a641" continuedAt="Text_cb3d87e9d6b24c1db22c9a6fef4d0a642">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Research and development (&#8220;R&amp;D&#8221;) expenses include salaries,
            benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the
            costs associated with research and development activities when incurred.</div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b621" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b622"><ix:continuation id="Text_cb3d87e9d6b24c1db22c9a6fef4d0a642">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">To further drive the Company&#8217;s cell therapy initiatives, the Company
            will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#8217;s research and development programs. The Company accounts for such grants as a deduction to the
            related expense in research and development operating expenses when earned.</div>
</ix:continuation></ix:continuation>


          <ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b622" continuedAt="Text_ebb0d8c5317d4261b21d36fb6c8e47b623"><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="Text_79edd43165384ef0806f28ffed73354a" contextRef="c20210101to20211231" escape="true" continuedAt="Text_cb31d68a78094b138e40f592bbb61dff1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">New Accounting Pronouncements</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_cb31d68a78094b138e40f592bbb61dff1"><ix:continuation id="Text_ebb0d8c5317d4261b21d36fb6c8e47b623">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In October 2019, the FASB issued ASU 2019-12, which affects general
            principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and
            interim periods within those fiscal years, beginning after December&#160;15, 2020. The Company believes that the adoption of this new accounting guidance has not had a material impact on its financial statements and footnote disclosures. </div>
</ix:continuation></ix:continuation>

        </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:nonNumeric name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="Text_5d4fd5c63958430b94f34dacee0c9be1" contextRef="c20210101to20211231" escape="true" continuedAt="Text_646a3eb4ea474003a315869854e9ea301">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 3 &#8211; Available-for-Sale-Securities</span></div>
</ix:nonNumeric>

          <ix:continuation id="Text_646a3eb4ea474003a315869854e9ea301" continuedAt="Text_646a3eb4ea474003a315869854e9ea302"><ix:nonNumeric name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="Text_bce55a7d69734b0a921be48c0cdf5d1c" contextRef="c20210101to20211231" escape="true" continuedAt="Text_5a6ee3e4202143c0b2da732d2733930c1">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or debt marketable securities in the Company's Consolidated Balance Sheets (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_646a3eb4ea474003a315869854e9ea302" continuedAt="Text_646a3eb4ea474003a315869854e9ea303"><ix:continuation id="Text_5a6ee3e4202143c0b2da732d2733930c1">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_4f6a006f37454e2f87b726182ab053c2" contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">53,135</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_a013835e16a24ee7b18b286c3f43b626" contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_8cb167fc3ea8466cae4e25619ae8ad9f" contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">65</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_e9dde7478dae4b87b2600e6c7d794879" contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">53,070</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_456ff69a43c54083bf3863ed4c6b22ce" contextRef="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,406</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_f838abf3f4384fd38d1148ab5b3d1f5e" contextRef="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 5pt;">(<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_cd4a0efd57974e14b47a6fdbee1bdd9d" contextRef="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7</ix:nonFraction></span>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$<span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_b6c3e3f4057a466286e31fccff2aaf72" contextRef="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,399</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_e7cdb35e9ef041599e6beb949a5a8b75" contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,124</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_ae9be37dd04b4adab6696c3fa854976a" contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_eab6b32ae877479c8d284a91060df678" contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_364b2ebe8d2a419f89795e2b67d880aa" contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,124</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_6dbede363ee745cb9ee9ddb57c5bb8e0" contextRef="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,591</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_322205b05da14f109864a9fa58b3a873" contextRef="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_e9877634089e4a90924f1431c3db4b5c" contextRef="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_05d842e6624f4166a9b606de55b37b11" contextRef="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7,591</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_e9db045922854f7a8d5d9a7ba3a6993a" contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,263</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_93b4ee110f3e491999e8e7a9eae11138" contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_6d3e955ea652446d910f3915907d87be" contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_839ae07e39824f32be6f7159feec21e4" contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,258</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_c46c0d7372b145cb9e0a4fca3912cd0e" contextRef="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,753</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_e4cd0db5a8304ed6a4a98ecf3543cdbc" contextRef="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_946db39cee594db190b657c31e628fa9" contextRef="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_a8f1baa0d57746acb8568d6d86090782" contextRef="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">14,747</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_cee7c256b5ff4ac4bd45af4321910772" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,522</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_31627a9c41ac4102bc5313a42b772796" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_235f44ca7718427c8e07d41d9c25d31b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_728be5e175024741876a5f0f9d27e6c6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,452</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_6a37753ac68348499bfe416d638f2e53" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,750</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_b8808b68675c4fd1be637cb0ad6dfe44" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_45c8ddd8c3204f51964a023404c83609" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">13</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_9f991d96ce6646b2a11879a2f43fdb93" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,737</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>


          <ix:continuation id="Text_646a3eb4ea474003a315869854e9ea303" continuedAt="Text_646a3eb4ea474003a315869854e9ea304"><ix:nonNumeric name="us-gaap:MarketableSecuritiesTextBlock" id="Text_6fe93092e0dc4c69a973fbaaa52e0e92" contextRef="c20210101to20211231" escape="true" continuedAt="Text_57f1e1ea751c433ab650252f2e4fea581">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are generally
            based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale debt securities on the Company's Consolidated Balance Sheets (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_646a3eb4ea474003a315869854e9ea304" continuedAt="Text_646a3eb4ea474003a315869854e9ea305"><ix:continuation id="Text_57f1e1ea751c433ab650252f2e4fea581">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_726b5c2b40014e67a078058b0b762424" contextRef="c20211231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,129</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_09448f97990c4340b2f65a165ad82281" contextRef="c20201231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,676</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_e677502ff0b94f7db6d25276efc4c769" contextRef="c20211231_BalanceSheetLocationAxis_MarketableSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_34dab8df743b42599400dba14741a2ea" contextRef="c20201231_BalanceSheetLocationAxis_MarketableSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,061</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_ac6d86f796b740eb842d3c82de536313" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,452</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_15a02c15eabd4427af4965a2e7b636da" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,737</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-12<br />
        </div>

      </div>

    </div>

    <!--End Page 12-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 13-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_646a3eb4ea474003a315869854e9ea305" continuedAt="Text_646a3eb4ea474003a315869854e9ea306"><ix:nonNumeric name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="Text_e752d9d60f254d4aab37fa5c31e58e77" contextRef="c20210101to20211231" escape="true" continuedAt="Text_6a89ae199486446380e088c436fc5afa1">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the Company's portfolio of
            available-for-sale securities by contractual maturity (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_646a3eb4ea474003a315869854e9ea306"><ix:continuation id="Text_6a89ae199486446380e088c436fc5afa1">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" id="Fact_456602eda8094cbba26bced12d37485c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,522</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" id="Fact_3d339753562d4b1da7d5eb5994a682aa" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,452</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" id="Fact_e5cfe8d682ed431495e8390018db47b6" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,750</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" id="Fact_1d3bb9ebb6164f018bbfc12a59d27c73" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,737</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" id="Fact_6ef41cdc8da5496990d6e2009c1a3830" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" id="Fact_f9b65bd75dbb4a63befad5be9c0c43c6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" id="Fact_3c86a4942b8942cca3302133cd8929b7" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" id="Fact_5aee6a1c48f944679fcb354165ac7ca4" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_ddf5fc3c587446ae88edcf7d75e3a424" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,522</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_9d2bf1c68bbc4f7199893a18c152c04f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,452</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_d67d8eeb3a71471bbfe2a397713c60f8" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,750</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_f73f17ee3681431ca33d0eb7192ff33d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">30,737</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="Text_75249614e9124de690b3161233efff92" contextRef="c20210101to20211231" escape="true" continuedAt="Text_c664afba8c26487fb3f86678a0d1ca201">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 4 &#8211; Property and Equipment</span></div>
</ix:nonNumeric>

          <ix:continuation id="Text_85ac608400874cb081e4179935de59bc2" continuedAt="Text_85ac608400874cb081e4179935de59bc3"><ix:continuation id="Text_c664afba8c26487fb3f86678a0d1ca201" continuedAt="Text_c664afba8c26487fb3f86678a0d1ca202">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Property and equipment consisted of the following (in thousands):</div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_85ac608400874cb081e4179935de59bc3"><ix:continuation id="Text_c664afba8c26487fb3f86678a0d1ca202" continuedAt="Text_c664afba8c26487fb3f86678a0d1ca203">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Furniture and fixtures</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_e1b11e6f0c53445b8a0e6113b9148414" contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_bc92b7343d6f47e79291807e7161ee57" contextRef="c20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Computer equipment</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_9894d70910d04b9788c6ad0925acbeb6" contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">314</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_3d4d25b263934113bf68bf9fcfe1ac51" contextRef="c20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">254</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Leasehold improvements</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_94dd6e1c15384bee8985c181882fdf65" contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">90</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_3b2c5fb9547a42d09a6188c2c3985c7d" contextRef="c20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">90</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Property and equipment, gross</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_c2100f16fd0f40f792d7e158a892f3b7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">430</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" id="Fact_fc68981667e8408e8ae2620817164a5d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">370</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Accumulated depreciation</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_58067a54839b40959f7c90bcb1168334" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">368</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" id="Fact_e7fb274a65d540159cd79b99dba04298" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">313</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Property and equipment, net</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_5b80a3fa7f794365a54363691f5efeb2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_c433e68b926446d797bbb39fae5bb7c4" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">57</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_c664afba8c26487fb3f86678a0d1ca203">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s results included depreciation expense of approximately
            $<ix:nonFraction name="us-gaap:Depreciation" id="Fact_6f7eefc1ebb6479ba427a5e608700adc" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:Depreciation" id="Fact_267c7e3809864e678f9fe8a3c3ff1216" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction>
            million for the years ended December&#160;31, 2021 and 2020, respectively.</div>
</ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_723cb341442c46e78a690abce25cfcfd" contextRef="c20210101to20211231" escape="true" continuedAt="Text_7e1a5fc855844467a604d0ea40b88c3d1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 5 &#8211; Loss Per Share</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_7e1a5fc855844467a604d0ea40b88c3d1" continuedAt="Text_7e1a5fc855844467a604d0ea40b88c3d2">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">For the years ended December&#160;31, 2021 and 2020, the Company incurred
            net losses and therefore no common stock equivalents were utilized in the calculation of loss per share as they are anti-dilutive in the periods presented. <ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="Text_c8821af336b240808865388e49e0c2ab" contextRef="c20210101to20211231" escape="true" continuedAt="Text_bfeea082e2d74a3db57fb517fc06c3e21"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At December&#160;31, 2021 and 2020, the Company excluded the
            following potentially dilutive securities (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
          <ix:continuation id="Text_bfeea082e2d74a3db57fb517fc06c3e21"><ix:continuation id="Text_7e1a5fc855844467a604d0ea40b88c3d2">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 13.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Options</div>
                </td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_53247c0acc2246788447ce1f207c2175" contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,132</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_fa4b68d6316d409187911305766024b7" contextRef="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">964</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Warrants</div>
                </td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_bd9f8e086282423ba5e98d4385e76249" contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21,357</ix:nonFraction></div>
                </td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_ebf91115c32a425182441c9892dd5b44" contextRef="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,638</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Restricted Stock Units</div>
                </td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_b462dace2b64448f9743fdf354d8c1a4" contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">604</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_0334ac8068074577bc1435dfe00f953c" contextRef="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">340</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" id="Text_420d16aedfe84c4d853738a5eb588d1a" contextRef="c20210101to20211231" escape="true" continuedAt="Text_2d7d85bb947a4a3bbd34bedb609442251">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 6 &#8211; Fair Value Measurements</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_2d7d85bb947a4a3bbd34bedb609442251" continuedAt="Text_2d7d85bb947a4a3bbd34bedb609442252">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Fair value of financial assets and liabilities that are being
            measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price).
            The Company is required to classify fair value measurements in one of the following categories:</div>
</ix:continuation>
          <ix:continuation id="Text_2d7d85bb947a4a3bbd34bedb609442252" continuedAt="Text_2d7d85bb947a4a3bbd34bedb609442253">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 1 inputs are defined as quoted prices (unadjusted) in active
            markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</div>
</ix:continuation>
          <ix:continuation id="Text_2d7d85bb947a4a3bbd34bedb609442253" continuedAt="Text_2d7d85bb947a4a3bbd34bedb609442254">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 2 inputs are defined as inputs other than quoted prices
            included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</div>
</ix:continuation>
          <ix:continuation id="Text_2d7d85bb947a4a3bbd34bedb609442254" continuedAt="Text_2d7d85bb947a4a3bbd34bedb609442255">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 3 inputs are defined as unobservable inputs for the assets or
            liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
            requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-13<br />
        </div>

      </div>

    </div>

    <!--End Page 13-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 14-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_2d7d85bb947a4a3bbd34bedb609442255" continuedAt="Text_2d7d85bb947a4a3bbd34bedb609442256"><ix:nonNumeric name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="Text_6149aa0fca2f4b61a4bf3aceeab81215" contextRef="c20210101to20211231" escape="true" continuedAt="Text_e09e6dd8e7084467b699a87002fc99771">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's financial assets and liabilities that were accounted
            for at fair value on a recurring basis as of December&#160;31, 2021 and December&#160;31, 2020 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_2d7d85bb947a4a3bbd34bedb609442256" continuedAt="Text_2d7d85bb947a4a3bbd34bedb609442257"><ix:continuation id="Text_e09e6dd8e7084467b699a87002fc99771">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_7c74b49d67b14a18846867761c363bb6" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_e2787236eb884ee3877f30bb6821d2d8" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_ba7f5584341743cc95490ade7e76dd9c" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_920b038e5a8e4f30b24d3c8063c6f4d9" contextRef="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_bc43c2c990184e21a020bf5658199108" contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_b3441a7073ed44d7b6bd1552d5defa2f" contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,061</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_63570e6bab2b41b393eae0b78fe966b4" contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_d0dba4f25d654470b98ca7ba85ec28af" contextRef="c20201231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,061</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_5ce05cd546f74cc3a7430f07c8e3588d" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_e0ba9f4c22474911a9f23e8590a7faa3" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_76550c631f394de4b625791a002ca58c" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_2a43a90c108d48f89aa1b01f66c9d73a" contextRef="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_3479db8585644a3c821f051d1ff3b705" contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_1406e2c746ef4d909cc7e9b2f6941f14" contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,061</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_8b3df2273c81480998e76400d1da0b8d" contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_4e357f72eec94d2ea5da9a9332f11b52" contextRef="c20201231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,061</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_2d7d85bb947a4a3bbd34bedb609442257">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The carrying values of cash, cash equivalents, accounts payable and
            accrued expenses approximate fair value at December&#160;31, 2021 and December&#160;31, 2020, due to the short maturity nature of these items.</div>
</ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_c359572323ac433c9e47c072a7299a6e" contextRef="c20210101to20211231" escape="true" continuedAt="Text_9793acf628574ef09bb4a3acffd4ebca1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 7 &#8211; Accrued Liabilities</span></div>
</ix:nonNumeric>

          <ix:continuation id="Text_9793acf628574ef09bb4a3acffd4ebca1" continuedAt="Text_9793acf628574ef09bb4a3acffd4ebca2"><ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_f406e2bc20ad4d7cab0e783bd7d2f3c0" contextRef="c20210101to20211231" escape="true" continuedAt="Text_2d34653cce9846f7980905d334fc4a9f1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Accrued liabilities were as follow (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_9793acf628574ef09bb4a3acffd4ebca2"><ix:continuation id="Text_2d34653cce9846f7980905d334fc4a9f1">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 13.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Salaries, employee benefits and related taxes</div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" id="Fact_888d94298e7146f1957da1c5827f646c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,034</ix:nonFraction></div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" id="Fact_ce6edc46432f460ba5fa708433eb357d" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,716</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating lease liabilities - current</div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_0e76dfb74fa242a5bd8da8b28c11fecc" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">229</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_b92b07fc06904e7e9403f12610f58464" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">370</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other</div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_f1c0213ec134467ab906c450a1dad975" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">326</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_656176357d8b4b5d852d86ec92d11105" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">400</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" id="Fact_040f6a657bce4a69bb9daa2344d97e08" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,589</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" id="Fact_5ffee8d9a4c94ca2b139b38dd2f699df" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,486</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_0b621830e7394dddaa3c6667885f9486" contextRef="c20210101to20211231" escape="true" continuedAt="Text_8760ccec80064e0d86dffd63c64395d91">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 8 &#8211; Operating Leases</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_8760ccec80064e0d86dffd63c64395d91" continuedAt="Text_8760ccec80064e0d86dffd63c64395d92">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company adopted ASU No. 2016-02, Leases (Topic 842) on January&#160;1,
            2019 and recognized leases with duration greater than 12 months on the balance sheet using the modified retrospective approach. The Company has operating leases for <ix:nonFraction name="clbs:NumberOfOfficesUnderOperatingLeases" id="Fact_f6a380f3a060413d81efb9c92718f7b5" contextRef="c20211231" unitRef="U004" decimals="0" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> offices with terms that expire in 2023 and 2025, respectively. The Company estimates its incremental borrowing rate at lease commencement to determine the present value of lease
            payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic
            842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases includes options for the Company to extend the lease term and/or sub-lease
            space in whole or in part.</div>
</ix:continuation>

          <ix:continuation id="Text_8760ccec80064e0d86dffd63c64395d92" continuedAt="Text_8760ccec80064e0d86dffd63c64395d93"><ix:nonNumeric name="clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" id="Text_5f8538b0aa4a4baaa0a1984e1c7ab6c6" contextRef="c20210101to20211231" escape="true" continuedAt="Text_186eca3d633545c58d783378f0ac98991">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_8760ccec80064e0d86dffd63c64395d93" continuedAt="Text_8760ccec80064e0d86dffd63c64395d94"><ix:continuation id="Text_186eca3d633545c58d783378f0ac98991">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Right-of Use Assets:<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="-sec-ix-hidden:Fact_6c255ea4f7c24c48b604a925c0f5819f"><span style="-sec-ix-hidden:Fact_02a6f0c3111348a5b2e0df82b435956e">Other assets</span></span><br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_5df9a28676794aff96ae4e657138eeae" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">724</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_b0614e88506b43edb9f39c7b60b63269" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">574</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Right-of-Use Asset</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_dd73741a45e44d18828d31bb7e09673e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">724</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_86aff1f5f68d4c80b69310a131b9afde" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">574</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Lease Liabilities:<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="-sec-ix-hidden:Fact_d2023c19465a459a9ecb0fec411ae9c3"><span style="-sec-ix-hidden:Fact_f6a138b4447e4c69840c11bceb8fe65d">Accrued liabilities</span></span><br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_51cd0e33d9c04689ab189e48dbea2085" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">229</ix:nonFraction></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_1456fdc201464fbfaea48f821d9fce66" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">370</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="-sec-ix-hidden:Fact_b65fe760104b4546b3abaa579a18c88c"><span style="-sec-ix-hidden:Fact_3980d08cb35e4c0087f62256aa859a67">Other long-term liabilities</span></span><br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_0ccc6158c0914d07902bc3e2987930d7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">485</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_9dc9788c5d3d41c7bceba397df4eaedb" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">254</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Operating Lease Liabilities</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_ddda62b1fd5a4ca2b6ba46a50909de85" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">714</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_69cc25e6f76141468db8f84783716627" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">624</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-14<br />
        </div>

      </div>

    </div>

    <!--End Page 14-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 15-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_202-finnotes01_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_8760ccec80064e0d86dffd63c64395d94" continuedAt="Text_8760ccec80064e0d86dffd63c64395d95">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2021, the weighted average remaining lease term
            for our operating leases was <ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_0fcb3ba4efe4406196bf2e965c92155a" contextRef="c20211231" format="ixt-sec:duryear">2.50</ix:nonNumeric> years, and the weighted average discount rate for our operating leases was <ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_a9cd80ee680c402c869fc4bfa782a741" contextRef="c20211231" unitRef="U005" decimals="5" scale="-2" format="ixt:numdotdecimal">9.625</ix:nonFraction>%. <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_f1c4e57e90d44ff4a0bab570608d2cd6" contextRef="c20210101to20211231" escape="true" continuedAt="Text_82c3cdba164f4dabb463e7ae72bdffb41"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of December&#160;31, 2021 were as follows (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
          <ix:continuation id="Text_82c3cdba164f4dabb463e7ae72bdffb41"><ix:continuation id="Text_8760ccec80064e0d86dffd63c64395d95">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Years ended</div>
                </td>

    <td style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Operating <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2022</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 3.33pt;"><span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_e5dbbea9ea2b47209bf645a66a665673" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">286</ix:nonFraction></span></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2023</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_54dce5ad4ae14a27a34579bd33a92b3c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">217</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2024</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_28f50b875fa0474bbddfedf21c05ec87" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">190</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2025</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" id="Fact_b81bd856f6db45e7b1f324065ecdae81" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">143</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total lease payments</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_00c58c2e419e485cbf712926c6841409" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">836</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Less: Amounts representing interest</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_f1bf7cb268c447cc8c9a8990ca6c3dad" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">122</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Present value of lease liabilities</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_93ace6af18e44f1d9268b653c7b2dcd9" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">714</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_bb4adc1ff8a144bdb166370f51f46e58" contextRef="c20210101to20211231" escape="true" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069821">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 9 &#8211; Stockholders' Equity</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069821" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069822">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Equity Plans</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069822" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069823">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company has used long-term incentive plans for the purpose of
            granting equity awards to employees of the Company, including officers, and nonemployees, including consultants and nonemployee members of the Company's board of directors (collectively, the &#8220;Participants&#8221;). The Participants may receive awards
            as determined by a committee of independent members of the Company's board of directors or, to the extent authorized by such committee with respect to certain Participants, a duly authorized employee (collectively, the &#8220;Committee&#8221;). The
            incentive plan currently used by the Company is the 2018 Equity Incentive Compensation Plan (the &#8220;2018 Plan&#8221;), as adopted by the stockholders of the Company in June 2018, and subsequently increased by the stockholders of the Company in June
            2021 with <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_c759c721ee1a45d68b8bc0e8a110e6c0" contextRef="c20210630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">6,000,000</ix:nonFraction> shares authorized for issuance thereunder and in June of 2020 with <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_23464e3a0e2143c586d80b037d108676" contextRef="c20200630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,500,000</ix:nonFraction> shares authorized for issuance thereunder, plus any shares awarded under the 2015 Equity Compensation Plan (the &#8220;2015 Plan&#8221;) or the Amended and Restated 2009
            Equity Compensation Plan (the &#8220;2009 Plan&#8221;) that are not issued due to their subsequent forfeiture, cancellation, or other settlement thereof. Concurrent with the adoption of the 2018 Plan, no future awards will occur under the 2015&#160;Plan or the
            2009 Plan. The awards that may be made under the 2018 Plan include: (a) incentive stock options and nonqualified stock options, (b) shares of restricted stock, (c) restricted stock units, and (d) other kinds of equity-based compensation awards.
            All stock options under the 2015 Plan and 2009 Plan were granted and the 2018 Plan are granted at the fair market value of the common stock at the grant date. Stock options vest either on the date of grant, ratably over a period determined at
            time of grant, or upon the accomplishment of specified business milestones, and generally expire&#160;<ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_a823c34997084d4f96fd461efc8a856a" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheOneMember" format="ixt-sec:duryear">2</ix:nonNumeric>, <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_ba47942c4b8b4453ba1c95bbdb1449a9" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember" format="ixt-sec:duryear">3</ix:nonNumeric>, or <ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="Fact_9f7619d354ff49f2bbece96a2c86b136" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheThreeMember" format="ixt-sec:duryear">10</ix:nonNumeric> years from the grant date
            depending on the status of the recipient as a nonemployee, employee or director of the Company. As of December&#160;31, 2021, there were <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_916ccc7e7ac8432d91a1b597a2b741c9" contextRef="c20211231_PlanNameAxis_EquityIncentiveCompensationPlan2018Member" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">5,585,661</ix:nonFraction>
            shares available for future grants under the 2018 Plan. No additional awards may be made under the 2015 Plan or the 2009 Plan.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069823" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069824">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company adopted an employee stock purchase plan effective
            January&#160;1, 2013 and authorized <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_c93184c18e654253b3eb21328b9e5e89" contextRef="c20130101_PlanNameAxis_EmployeeStockPurchasePlan2012Member" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">50,000</ix:nonFraction> shares under the plan (the &#8220;2012 ESPP&#8221;). The plan has&#160;<ix:nonFraction name="clbs:NumberofOfferingPeriodsEmployeeStockPurchasePlan" id="Fact_ebc9a86f63244666ab7561cf22e8712f" contextRef="c20211231_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U006" decimals="0" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> <ix:nonNumeric name="clbs:OfferingPeriodsEmployeeStockPurchasePlanTerm" id="Fact_bc88eea52bba4afe8e57ce2ac2d7fa7b" contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember" format="ixt-sec:durwordsen">six-month</ix:nonNumeric> offering periods per year under which eligible
            employees may contribute up to <ix:nonFraction name="clbs:EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" id="Fact_1bce556ff3ec4e16be7dd91bd19449c2" contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">15</ix:nonFraction>% of their compensation toward the purchase of the Company's common stock per offering period (with
            a $<ix:nonFraction name="clbs:EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" id="Fact_cf5108515df34b47b2b5030167076995" contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">25,000</ix:nonFraction> cap per calendar year). The employee's purchase price is equal to (i) <ix:nonFraction name="clbs:EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" id="Fact_844e364645b04413bcd41ada8116b8e2" contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">85</ix:nonFraction>% of the closing price of a share of the Company's common stock on the enrollment date of such offering period or (ii) <ix:nonFraction name="clbs:EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" id="Fact_55dc02cb978547dca5bf7dbafc381f47" contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">85</ix:nonFraction>% of the closing price of a share of the Company's common stock on the Exercise Date of such Offering Period, whichever is lower. In May 2017, the Company's stockholders
            approved an amendment and restatement to the 2012 ESPP (the &#8220;2017 ESPP&#8221;) in order to effect an increase of authorized shares from <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_1d4eca76d4444c00a995cdef7811d989" contextRef="c20130101_PlanNameAxis_EmployeeStockPurchasePlan2012Member" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">50,000</ix:nonFraction>
            to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_07925e4729d44d0c919e796665faac04" contextRef="c20170531_PlanNameAxis_EmployeeStockPurchasePlan2017Member" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">100,000</ix:nonFraction>. In June 2018, the Company's stockholders approved an amendment to the 2017 ESPP (the &#8220;Amended 2017 ESPP&#8221;) in order to
            effect an increase of authorized shares from <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_68b774efe9ae439f9ff6c6b02517358c" contextRef="c20170531_PlanNameAxis_EmployeeStockPurchasePlan2017Member" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">100,000</ix:nonFraction> to <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" id="Fact_6845fb42314142898a73992413743e27" contextRef="c20200630_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">500,000</ix:nonFraction>. During the year ended December&#160;31, 2021, <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" id="Fact_0fcc18f3b17140828e128bb1f214de34" contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">47,132</ix:nonFraction> shares were
            issued under the Amended 2017 ESPP. At December&#160;31, 2021, the Company had <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" id="Fact_dba8399dc2e446caabd136e446a8963a" contextRef="c20211231_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">300,577</ix:nonFraction> shares of the Company's common stock available for
            future grant in connection with this plan.</div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-15<br />
        </div>

      </div>

    </div>

    <!--End Page 15-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 16-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069824" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069825">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Equity Issuances</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069825" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069826">
<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Purchase Agreement</span></div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069826" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069827">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In March 2019, the Company and Lincoln Park Capital Fund, LLC
            (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company&#8217;s
            common stock having an aggregate value of up to $<ix:nonFraction name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" id="Fact_66a7f3d0ac88431db3afbfaa5c1e9554" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">26.0</ix:nonFraction> million, subject to certain limitations and conditions set forth in the
            Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional <ix:nonFraction name="clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration" id="Fact_8ab9a5fc006c4eb4b9d03b0856bfca58" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">181,510</ix:nonFraction>
            shares of common stock as commitment shares.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069827" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069828">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the Purchase Agreement, upon commencement Lincoln Park
            purchased <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" id="Fact_e7da65c020ee4761850ebe8d00c47abc" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">250,000</ix:nonFraction> shares of common stock, at a price of $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" id="Fact_2a72a9576fdc48359710a3e5be9169a1" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">4.00</ix:nonFraction> per share for a total gross purchase price of $<ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" id="Fact_6ecb6ab329cc465f96f08ca274197f74" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">1,000,000</ix:nonFraction> (the &#8220;Initial
            Purchase&#8221;) upon commencement. Thereafter, as often as every business day from and after one business day following the date of the Initial Purchase and over the <ix:nonNumeric name="clbs:TermOfAgreement" id="Fact_e042a7577a1f403882b7216ae9091b11" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" format="ixt-sec:durmonth">36</ix:nonNumeric>-month term of the Purchase Agreement, the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to
            <ix:nonFraction name="clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" id="Fact_a8f945086f174f438fd3fc32c11fcf49" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">100,000</ix:nonFraction> shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln
            Park&#8217;s obligation under any single such purchase will not exceed $<ix:nonFraction name="clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" id="Fact_e7642eb5d1fa400a88de05fc64f1de55" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U001" decimals="0" scale="0" format="ixt:numdotdecimal">2,500,000</ix:nonFraction>, unless the Company and Lincoln Park mutually agree to
            increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;). If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such
            Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of
            (i) <ix:nonFraction name="clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" id="Fact_0fd6b3b305c54e73bde553be87eefbab" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">300</ix:nonFraction>% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) <ix:nonFraction name="clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" id="Fact_9e97bb44e83d4f98a4eca743a4452b27" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>% of the total number of shares of the Company&#8217;s common stock traded during a specified period on the applicable purchase date as set forth in the
            Purchase Agreement (each, an &#8220;Accelerated Purchase&#8221;). Under certain circumstances and in accordance with the Purchase Agreement, the Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069828" continuedAt="Text_5d2f2c66316d48a2bd7b2276141069829">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company controls the timing and amount of any sales of its common
            stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the
            floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than <ix:nonFraction name="clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" id="Fact_3554504aee5b43198ca2307f912e66eb" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">9.99</ix:nonFraction>% of its common stock.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b2276141069829" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698210">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Purchase Agreement does not limit the Company&#8217;s ability to raise
            capital from other sources at the Company&#8217;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating
            conversion rate or variable priced equity-like securities) during the <ix:nonNumeric name="clbs:TermOfAgreement" id="Fact_697a4c6fcc29443fa2c7fafda651baea" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" format="ixt-sec:durmonth">36</ix:nonNumeric> months after the date of the Purchase Agreement. The
            Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698210" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698211">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, the Company had not made any sales of common
            stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase. In addition, the Company may not direct Lincoln Park to make Accelerated Purchases under the Purchase Agreement if the stock is below the specified floor price
            of $<ix:nonFraction name="clbs:PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" id="Fact_63586193418244568da72357fdc61282" contextRef="c20211231_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.00</ix:nonFraction>.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698211" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698212">
<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Common Stock Sales Agreement</span></div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698212" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698213">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2018, the Company entered into a common stock sales
            agreement with H.C. Wainwright &amp; Co., LLC (&#8220;HCW&#8221;) as sales agent, which was subsequently amended in August 2018 (the &#8220;Sales Agreement&#8221;), in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and
            sell shares of its common stock, having an aggregate offering price of not more than $<ix:nonFraction name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" id="Fact_e6a696402f4d4201b0875ec9126a018d" contextRef="c20180831_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">25.0</ix:nonFraction> million.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698213" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698214">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company provided HCW with customary indemnification rights, and
            HCW was entitled to a commission at a fixed commission rate equal to <ix:nonFraction name="clbs:SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" id="Fact_3b9038d0c5ab4263adfd56a4c45fd092" contextRef="c20180801to20180831_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember" unitRef="U005" decimals="INF" scale="-2" format="ixt:numdotdecimal">3.0</ix:nonFraction>% of the gross proceeds per share sold.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698214" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698215">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On February&#160;12, 2021, the Company suspended the use of the
            at-the-market transactions facility and terminated the continuous offering pursuant to the Sales Agreement.</div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-16<br />
        </div>

      </div>

    </div>

    <!--End Page 16-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 17-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698215" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698216">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of the termination of the Sales Agreement on February&#160;12, 2021,
            the Company had sold an aggregate <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="Fact_a9bba5b722994263bf2b52b2a2912f84" contextRef="c20180201to20210212_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">3,784,912</ix:nonFraction> shares of its common stock pursuant to the Sales Agreement for net proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_b57d8fa888994a5383dcf0da2edfd8bf" contextRef="c20180201to20210212_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">9.5</ix:nonFraction> million since inception. For the year ended December&#160;31, 2021, the Company had <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="Fact_1a9e8ef56db44374a677acf8e1f682b8" contextRef="c20210101to20211231_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>t issued any shares under the Sales Agreement.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698216" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698217">
<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">At The Market Offering Agreement</span></div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698217" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698218">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June&#160;4, 2021, the Company entered into an At The Market Offering
            Agreement (the &#8220;ATM Agreement&#8221;) with HCW, as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $<ix:nonFraction name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" id="Fact_bde3ee5ecea94965baf3d97124ff66a6" contextRef="c20210604_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">50.0</ix:nonFraction> million. During the twelve months ended December&#160;31, 2021, the Company had <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="Fact_4537ae8bcc984db39c97e0f6421c2f61" contextRef="c20210101to20211231_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>t issued any shares under the ATM Agreement. Having received a listing deficiency notice from Nasdaq on February&#160;18, 2022 after the Company&#8217;s shares traded below $1.00 for 30
            consecutive trading days, the Company will not be permitted to sell additional shares under the ATM Agreement until it re-establishes timely compliance. Compliance may be reestablished by various mechanisms, including stock price appreciation
            at or above $1.00 for a requisite period of time and reverse stock split.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698218" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698219">
<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Registered Direct Offerings</span></div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698219" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698220">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2021, the Company entered into a Securities Purchase
            Agreement (the &#8220;Institutional Purchase Agreement&#8221;) with certain institutional investors (the &#8220;Institutional Purchasers&#8221;). Pursuant to the terms of the Institutional Purchase Agreement, the Company sold to the Institutional Purchasers in a
            registered direct offering an aggregate of <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" id="Fact_f385172f2f454219b33cc44a1977c140" contextRef="c20210201to20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">24,906,134</ix:nonFraction> shares of its common stock and warrants to purchase an aggregate of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_321e6a5c12114e80a946d3cfa23ef6c5" contextRef="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">12,453,067</ix:nonFraction> shares of its common stock at a combined purchase price equal to $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" id="Fact_1d83aa645cfe4fe58ea6b689cccc29fd" contextRef="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.45</ix:nonFraction> per share and associated warrant. Each warrant features an exercise price equal to $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_c3ec86402acb4e128aa867d3c03f213b" contextRef="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.90</ix:nonFraction>
            per share, is exercisable immediately upon issuance and will expire <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_ccfb91448a71459ba2d4b5a6d3cf4b9e" contextRef="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric> from the issuance date. Additionally, in a concurrent
            non-brokered registered direct offering, the Company entered into a Securities Purchase Agreement (the &#8220;Additional Purchase Agreement&#8221;) with certain accredited investors (the &#8220;Additional Purchasers&#8221;). Pursuant to the terms of the Additional
            Purchase Agreement, the Company sold to the Additional Purchasers an aggregate of <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" id="Fact_bc3ae37710b24150902c51cf20b2d019" contextRef="c20210201to20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,632,652</ix:nonFraction> shares of its common stock and warrants
            to purchase an aggregate of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_67eb5fd9e23a479f89427131471b699c" contextRef="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">816,326</ix:nonFraction> shares of its common stock at a combined purchase price equal to $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" id="Fact_cf361ad7aa554c948ed209be91ddc873" contextRef="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.45</ix:nonFraction> per share and associated warrant. Each warrant features an exercise price equal to $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_c775eb2435d44c2783312eeac89deb03" contextRef="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.90</ix:nonFraction> per share, is exercisable immediately upon issuance and will expire <ix:nonNumeric name="us-gaap:WarrantsAndRightsOutstandingTerm" id="Fact_10a45e4044584cf2868d0d0de058f041" contextRef="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember" format="ixt-sec:durwordsen">five years</ix:nonNumeric>
            from the issuance date. In connection with the registered direct offerings, the Company received gross proceeds of approximately $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_4123f26b1a3548e6a3a9ef0c8a4af353" contextRef="c20210201to20210228" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">65.0</ix:nonFraction>
            million.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698220" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698221">
<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Private Placement</span></div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698221" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698222">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January 2021, the Company entered into a securities purchase
            agreement (the &#8220;January Private Placement&#8221;) with certain investors (the &#8220;January Purchasers&#8221;). Pursuant to the terms of the January Private Placement, the Company agreed to sell to the January Purchasers an aggregate of <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" id="Fact_7055f20014cc471f9de48349828f65b6" contextRef="c20210101to20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">12,500,000</ix:nonFraction> shares of its common stock at a purchase price equal to $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" id="Fact_2bb20140396c4ca2aee2a526057a6629" contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.00</ix:nonFraction> per share, along with warrants to purchase an aggregate of <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" id="Fact_505c077889c24a81a63c3f770083b9e5" contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">6,250,000</ix:nonFraction>
            shares of its common stock. In connection with the January Private Placement, the Company received gross proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_91da2f3a0ff64f75945e95318cda8c2a" contextRef="c20210101to20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">25.0</ix:nonFraction> million.
            Each warrant is exercisable for <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" id="Fact_3aee704d8d3549a2b7f73203607b62fb" contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">one</ix:nonFraction> share of common stock and features an exercise price equal to $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" id="Fact_f735d335cb45445bb36530947488731f" contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.90</ix:nonFraction> per share. The warrants are exercisable immediately upon issuance and will expire <span style="-sec-ix-hidden:Fact_b33f9ae5fcb543bd9c7f792ce5439476">five and one-half years</span> from the issuance date.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698222" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698223">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Warrant Exercises</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698223" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698224">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January 2021, the Company issued <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" id="Fact_cb40ce79b3264e2baa488f261bfe12fe" contextRef="c20210101to20210131" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">801,148</ix:nonFraction> shares of common stock for net proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromWarrantExercises" id="Fact_d960e8030d9549cca5cccfee3023da14" contextRef="c20210101to20210131" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.8</ix:nonFraction>
            million in connection with warrant exercises associated with the April&#160;23, 2020 securities purchase agreement and the May&#160;25, 2020 securities purchase agreement.</div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-17<br />
        </div>

      </div>

    </div>

    <!--End Page 17-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 18-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698224" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698225">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Stock Options and Warrants</div>
</ix:continuation>

          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698225" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698226"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="Text_60bd97bd4dd94834ba342e2043ec665a" contextRef="c20210101to20211231" escape="true" continuedAt="Text_8d74af62b0c04989b4f2b519423758c71">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the year ended December&#160;31, 2021:</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698226" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698227"><ix:continuation id="Text_8d74af62b0c04989b4f2b519423758c71" continuedAt="Text_8d74af62b0c04989b4f2b519423758c72">
<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698227" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698228"><ix:continuation id="Text_8d74af62b0c04989b4f2b519423758c72">
<table cellspacing="0" cellpadding="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2020</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_c95c49e85a074f7fb62c3ce92eef26c8" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">963,700</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_8c1d67bf688848349fc930367a3170d2" contextRef="c20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">14.64</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_65ca0397ffbf4956bc0c2633d5a77ba8" contextRef="c20200101to20201231" format="ixt-sec:duryear">5.86</ix:nonNumeric></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_ca1bcd1904e449e38666d36917b8ac13" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="clbs:CommonStockWarrantsShares" id="Fact_f6f189ee2782442097c8a911f6546a15" contextRef="c20201231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,638,355</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsOutstanding" id="Fact_06c40717fe604b47ab1b5d8b87289d0b" contextRef="c20201231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.18</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><ix:nonNumeric name="clbs:WeightedAverageRemainingContractualTermwarrantoutstanding" id="Fact_f69e7dba954748e5bde828143a5bf5ea" contextRef="c20200101to20201231" format="ixt-sec:duryear">4.98</ix:nonNumeric></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$<ix:nonFraction name="clbs:AggregateIntrinsicValueWarrantsOutstanding" id="Fact_6fdd0797c21543ffbb778b5664d59d45" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the Year:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" id="Fact_c0ab60d384bb40b2b130cc02f8ef65ab" contextRef="c20210101to20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,314,790</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" id="Fact_2f75ba876fa94fbf8da906ccbfdabad1" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.32</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><ix:nonFraction name="clbs:WarrantsGranted" id="Fact_a04135c9803848fba608df2cc06a9f9e" contextRef="c20210101to20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">19,519,393</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsGranted" id="Fact_c944ea82f45a4d26b2008f6245941d2f" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.90</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_6a190d8ad60242d68845f0769b6f4e7d" contextRef="c20210101to20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">7,250</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" id="Fact_1d29bfc0247943c6889deb100f4a552a" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">3.28</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="padding-left: 6.67pt;">(<ix:nonFraction name="clbs:AggregateIntrinsicValueOptionExercised" id="Fact_eb811c3a3f2945d59cea000dbf9cc5aa" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(<ix:nonFraction name="clbs:WarrantsExercised" id="Fact_a68eeb75a6b846d6890291193b7c7456" contextRef="c20210101to20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">801,148</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsExercised" id="Fact_5deebe117fd64767a72035ee735e31a1" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.19</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" id="Fact_fc7ed8e5778b4a3d8d1703f8cbb94c77" contextRef="c20210101to20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">29,842</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="Fact_ecede4bcec77467d9192db227bb26756" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.18</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;"><ix:nonFraction name="clbs:WarrantsCanceled" id="Fact_49354ddd68124ac68d1a8b8997e0b895" contextRef="c20210101to20211231" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<span style="padding-left: 7.5pt;"><ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsCanceled" id="Fact_0878c5a3a920418e80f643708d00fd27" contextRef="c20210101to20211231" unitRef="U003" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 4.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" id="Fact_65bffdc772604e5298b93954f1c4a08b" contextRef="c20210101to20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">109,549</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" id="Fact_4a8b298c85bb4d9fbfeb9f7c050066de" contextRef="c20210101to20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">34.12</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;"><ix:nonFraction name="clbs:WarrantsExpired" id="Fact_59fd299600b848f389c98db878b42ef8" contextRef="c20210101to20211231" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$</span><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;"><ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsExpired" id="Fact_9c34828fa73d4df9a11be655267d66c8" contextRef="c20210101to20211231" unitRef="U003" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_698d0f4e5a0e4a9f8a193ffaabfcaa3a" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,131,849</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_243e291de021455c9bf4fbbce94b0c94" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">5.64</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_b4d4c38991654b37998b9da5c54a4f96" contextRef="c20210101to20211231" format="ixt-sec:duryear">7.97</ix:nonNumeric></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_4df992263e264ff39a0d5cd2166b7aac" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;"><ix:nonFraction name="clbs:CommonStockWarrantsShares" id="Fact_a96e3f771f654e21a74cc4c534b0d84a" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">21,356,600</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsOutstanding" id="Fact_b7aa650b35c24870b78338674fb3432d" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.84</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;"><ix:nonNumeric name="clbs:WeightedAverageRemainingContractualTermwarrantoutstanding" id="Fact_138e888156a5406da6111898e707e120" contextRef="c20210101to20211231" format="ixt-sec:duryear">4.37</ix:nonNumeric></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="clbs:AggregateIntrinsicValueWarrantsOutstanding" id="Fact_ddebfe0bbfc24d8eb8c4896634fc372c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at December&#160;31, 2021 or expected to vest in the
                    future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" id="Fact_f666aca26c324190b06087e8e360f967" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,120,643</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" id="Fact_955aea8673fb4c0ca5f2aa22dcca5db5" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">5.66</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="Fact_716e65638da34e7cb70506afb7bba0fd" contextRef="c20210101to20211231" format="ixt-sec:duryear">7.96</ix:nonNumeric></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" id="Fact_74cde875d1244b50827eb2a8894717c7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="clbs:Sharesvestedandexpectedtovest" id="Fact_b17c6a8f163b480eae67f50a2ae39b2c" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">21,356,600</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" id="Fact_0cf7d4cee38d424c88eba8c0324f3da1" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.84</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" id="Fact_9694fb91d338444c9721bbd7084658bc" contextRef="c20210101to20211231" format="ixt-sec:duryear">4.37</ix:nonNumeric></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest" id="Fact_6a6207285909497d90f30ef83cd65e5a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Exercisable at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" id="Fact_cbcdd0acffb24d83b16f8c1107b41412" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,122,783</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" id="Fact_0df883a8d2394f7fb52dac927ffe668d" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">9.26</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="Fact_df8698535139450095374bf459b8078f" contextRef="c20210101to20211231" format="ixt-sec:duryear">6.70</ix:nonNumeric></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" id="Fact_a99e84727afd4cecbaa2a8e21a28c8ee" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="clbs:WarrantsVested" id="Fact_beaa0d293b5a407cb6ca981a449c6090" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">21,356,600</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsExercisable" id="Fact_a36dac770f534990993d44031476b736" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.84</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="clbs:WeightedAverageRemainingContractualTermwarrantsvested" id="Fact_f01c165cba8c480cbd4ae3aa5bfa16a7" contextRef="c20210101to20211231" format="ixt-sec:duryear">4.37</ix:nonNumeric></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="clbs:AggregateIntrinsicValueWarrantsvested" id="Fact_33d9b69a445a4c96ade5802394669aec" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698228" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698229">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Restricted Stock</div>
</ix:continuation>

          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698229" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698230"><ix:nonNumeric name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="Text_98b6d60a9c2f40a1bb1230e3776be2e3" contextRef="c20210101to20211231" escape="true" continuedAt="Text_4a6008222227466f97b83283853b932f1">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock for services as follows ($ in thousands, except share data):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698230" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698231"><ix:continuation id="Text_4a6008222227466f97b83283853b932f1">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_eaa4d9e46e964ffbb51e140de682ecf3" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">612,950</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_60f0a6afc38c4eea902a29dd1d6d8c0f" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">156,184</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_aeb9bb45dfc8457f80089a522d17f48c" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-2" scale="3" format="ixt:numdotdecimal">877.7</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_5070987804ea44a6893bb8f5c5343add" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-2" scale="3" format="ixt:numdotdecimal">512.3</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698231" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698232">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock issued
            for services in the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_f3e202588b0d461f9fe02b24e3d8a743" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.43</ix:nonFraction> and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_7b607d44f6e348a9b487a48fe1017eb1" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">3.28</ix:nonFraction> per share, respectively. The fair value of the restricted stock was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms of restricted stock
            issuances are generally between <span style="-sec-ix-hidden:Fact_71e638d2f8944c3b8762be6c9f077488">one</span> to <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_54d125464c7348188d8dffd623964bf1" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric>.</div>
</ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698232" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698233">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
</ix:continuation>

          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698233" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698234"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="Text_2b435b8ebfd44098b15928c6f17fc81c" contextRef="c20210101to20211231" escape="true" continuedAt="Text_79407514262b4d26b2274c0f11c0664d1">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock units for services as follows ($ in thousands, except share data):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698234" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698235"><ix:continuation id="Text_79407514262b4d26b2274c0f11c0664d1" continuedAt="Text_79407514262b4d26b2274c0f11c0664d2">
<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698235" continuedAt="Text_5d2f2c66316d48a2bd7b22761410698236"><ix:continuation id="Text_79407514262b4d26b2274c0f11c0664d2">
<table cellspacing="0" cellpadding="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Units Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_12cb7ab0c8ff45a2bf962857c85c7b49" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">458,245</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_ebf90454c84c46b5a13d38cc5edad594" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">325,853</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Units Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_cd58779a54e6422ab97edfbf1f376011" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-2" scale="3" format="ixt:numdotdecimal">728.6</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_8e3e43f9b9ec4bf1b39fef85b80b7d29" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-2" scale="3" format="ixt:numdotdecimal">863.0</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_5d2f2c66316d48a2bd7b22761410698236">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock units
            issued for services in the years ended December&#160;31, 2021 and 2020 was $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_ca8d47fcb59f4be79f23249edf5ec899" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.59</ix:nonFraction> and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_9404cd5e872c448e9e28e411f9a8aab0" contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.65</ix:nonFraction> per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms
            of restricted stock unit issuances are generally <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_d9de68b84e1a4f9abfde569b6b39e6ec" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">one year</ix:nonNumeric>, or upon the achievement of performance-based milestones.</div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-18<br />
        </div>

      </div>

    </div>

    <!--End Page 18-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 19-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_202-finnotes01_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Text_4aa7b79d118741bbbd43513722b76b97" contextRef="c20210101to20211231" escape="true" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 10 &#8211; Share-Based Compensation</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af1" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af2">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="h3">Share-based Compensation</div>
</ix:continuation>
          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af2" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af3">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company utilizes share-based compensation in the form of stock
            options, restricted stock, and restricted stock units. <ix:nonNumeric name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="Text_fa997cf0755d458d82281d530d0eb974" contextRef="c20210101to20211231" escape="true" continuedAt="Text_9c66ee2cb9174f80a30b7de3541cf4c41"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the years ended December&#160;31, 2021 and 2020 ($ in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
          <ix:continuation id="Text_9c66ee2cb9174f80a30b7de3541cf4c41" continuedAt="Text_9c66ee2cb9174f80a30b7de3541cf4c42"><ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af3" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af4">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_9c66ee2cb9174f80a30b7de3541cf4c42" continuedAt="Text_9c66ee2cb9174f80a30b7de3541cf4c43"><ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af4" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af5">
<table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_1837aad33c424822b36190f23f0d81c8" contextRef="c20210101to20211231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">760</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_168db0dddb24414eafd2ba50696e4dee" contextRef="c20200101to20201231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">179</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_7c1d6e6f554f4280b51dd0aed3b2f354" contextRef="c20210101to20211231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,245</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_0b766f7a8a6943c6a1aaaf75850e06b9" contextRef="c20200101to20201231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,086</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total share-based compensation expense</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_89f0daaf9fa740e0a670e0a4931a4d7e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,005</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_52739c813e67496cbca430675d5e3103" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,265</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_9c66ee2cb9174f80a30b7de3541cf4c43" continuedAt="Text_9c66ee2cb9174f80a30b7de3541cf4c44"><ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af5" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af6">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Total compensation cost related to unvested awards not yet recognized
            and the weighted-average periods over which the awards are expected to be recognized at December&#160;31, 2021 were as follows ($ in thousands):</div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_9c66ee2cb9174f80a30b7de3541cf4c44" continuedAt="Text_9c66ee2cb9174f80a30b7de3541cf4c45"><ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af6" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af7">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_9c66ee2cb9174f80a30b7de3541cf4c45"><ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af7" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af8">
<table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Restricted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Units</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Restricted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Unrecognized compensation cost</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;" class="fpara">$<span style="padding-left: 2.5pt;"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" id="Fact_0c74cd9c02dd4f328f6ce7ef4cd49fb2" contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">757</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 2.5pt;"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" id="Fact_1092abbdda424ac5bd7ae1156c097da1" contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">149</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 2.5pt;"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" id="Fact_691b0b364c6c41d480e6ac220fc29ec7" contextRef="c20211231_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">546</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_0565468c292f44f6aa812253543f9810" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">1.64</ix:nonNumeric></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_df6d52c88cd54740913c20ae1c4337c3" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember" format="ixt-sec:duryear">1.57</ix:nonNumeric> </span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_38790f596c3a48f9ac2e6699586431ec" contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember" format="ixt-sec:duryear">1.70</ix:nonNumeric></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af8" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af9"><ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="Text_1b3fcad8f78b4965a0fb931565ad9130" contextRef="c20210101to20211231" escape="true" continuedAt="Text_73826af162f848af8d8412fe3c2a17941">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the years ended December&#160;31, 2021 and 2020 were as follows ($ in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af9" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af10"><ix:continuation id="Text_73826af162f848af8d8412fe3c2a17941" continuedAt="Text_73826af162f848af8d8412fe3c2a17942">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af10" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af11"><ix:continuation id="Text_73826af162f848af8d8412fe3c2a17942">
<table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total fair value of shares vested</div>
                </td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 2.5pt;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" id="Fact_4599da3b18c84ec6bbd43decc61587c0" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">757</ix:nonFraction></span></div>
                </td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 2.13pt;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" id="Fact_0a5e6a923ac5464cab7d5c51768afe9d" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">536</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average estimated fair value of shares granted</div>
                </td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_60912d6289a84b9e8e265eabf5cd30ee" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.91</ix:nonFraction></span></div>
                </td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_2a294da650c44c31bff41ddf4f942866" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.11</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af11" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af12">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h3">Valuation Assumptions</div>
</ix:continuation>
          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af12" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af13">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The fair value of stock options at the date of grant was estimated
            using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and
            exercise of options for all employees.</div>
</ix:continuation>

          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af13" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af14"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Text_1e8e93c2b2e84f9c8facfb3fd3dbcd50" contextRef="c20210101to20211231" escape="true" continuedAt="Text_88d4c51928fa45aeb2fb085c049d299c1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The range of assumptions made in calculating the fair values of
            stock options was as follow:</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af14" continuedAt="Text_a7e7dd9c3d3b4233abad4bb25daea7af15"><ix:continuation id="Text_88d4c51928fa45aeb2fb085c049d299c1" continuedAt="Text_88d4c51928fa45aeb2fb085c049d299c2">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_a7e7dd9c3d3b4233abad4bb25daea7af15"><ix:continuation id="Text_88d4c51928fa45aeb2fb085c049d299c2">
<table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Expected term - minimum (in years)</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_cbf3add653bf43c79b878a7bca78d954" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember" format="ixt-sec:duryear">6</ix:nonNumeric></span></div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_29114b76d3444fb0aea1a5f7b4ed47dd" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember" format="ixt-sec:duryear">6</ix:nonNumeric></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Expected term - maximum (in years)</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_a84ee38e6534461493437567a7df1c9f" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember" format="ixt-sec:duryear">6</ix:nonNumeric></span></div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="Fact_412161404f1947899496da68ee558cfd" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember" format="ixt-sec:duryear">6</ix:nonNumeric></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Expected volatility - minimum</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" id="Fact_0f0d5582236640ad910b0d52e45ab5e9" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">79</ix:nonFraction>%</span></div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" id="Fact_8874663df04044f3af68897a0fc264eb" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Expected volatility - maximum</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" id="Fact_c1c1978ac37945ea978bb902e70def7b" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">84</ix:nonFraction>%</span></div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" id="Fact_b4ec743db684449998f3881945dac292" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">79</ix:nonFraction>%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted Average volatility</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" id="Fact_8280381ecdd644d6b17d0adac09ee879" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">81</ix:nonFraction>%</span></div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" id="Fact_a2e41cbe01084be4b78a5100929558a8" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">75</ix:nonFraction>%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Expected dividend yield</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_915a0ec5ceb049e99876f94e41803ac8" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" id="Fact_faa62ed5ecd0401aae1c9d23af6c2d21" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Risk-free interest rate - minimum</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" id="Fact_49ad1b684bea411197d16283874f1599" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">0.63</ix:nonFraction>%</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" id="Fact_c7f857e6f9a64b698f656bde9b6a2c66" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">0.40</ix:nonFraction>%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Risk-free interest rate - maximum</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" id="Fact_d9236ab85fd345f88b1b3c011229193e" contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">1.16</ix:nonFraction>%</div>
                </td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" id="Fact_cf162e9dc3d941eab545c5abed779ea3" contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">1.71</ix:nonFraction>%</div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-19<br />
        </div>

      </div>

    </div>

    <!--End Page 19-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 20-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_202-finnotes01_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="Text_cc2807baa95649d39447418d6b5fb83b" contextRef="c20210101to20211231" escape="true" continuedAt="Text_e0430ebb1ae648fea65d5d424907abd11">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 11 &#8211; Research Funding</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_e0430ebb1ae648fea65d5d424907abd11" continuedAt="Text_e0430ebb1ae648fea65d5d424907abd12">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="h3">California Institute of Regenerative Medicine
            Grant Award</div>
</ix:continuation>
          <ix:continuation id="Text_e0430ebb1ae648fea65d5d424907abd12" continuedAt="Text_e0430ebb1ae648fea65d5d424907abd13">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In February 2017, the California Institute for Regenerative Medicine
            (&#8220;CIRM&#8221;) awarded the Company funds of up to $<ix:nonFraction name="us-gaap:GrantsReceivable" id="Fact_dea1076357e6459a8a9378ba010c81da" contextRef="c20170228" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">12.2</ix:nonFraction> million to support The Sanford Project: T-Rex Study, a prospective, randomized,
            placebo-controlled, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of CLBS03 as a treatment for recent-onset type 1 diabetes. The funding is based upon the achievement of certain milestones related to the proportion of
            subjects enrolled in California, as well as manufacturing and development costs incurred in California. Based on the actual number of subjects enrolled in California, the total amount of funding was revised to $<ix:nonFraction name="clbs:FundingAmountAwarded" id="Fact_5b83c13637974f6bbdd2e35b14c77ac3" contextRef="c20170228" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.6</ix:nonFraction> million, of which $<ix:nonFraction name="clbs:FundingOfGrantAwardCashReceived" id="Fact_17b4e63edd02475ba0fde2fa81775d1b" contextRef="c20170501to20200930" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">8.2</ix:nonFraction> million
            has been received through the grant project period completion.</div>
</ix:continuation>
          <ix:continuation id="Text_e0430ebb1ae648fea65d5d424907abd13">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company received $<ix:nonFraction name="clbs:FundingOfGrantAwardCashReceived" id="Fact_de924e3ef605480abd6c1128dd3feb5d" contextRef="c20170501to20170531" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">5.7</ix:nonFraction> million in initial funding in May 2017, a $<ix:nonFraction name="clbs:MilestonePaymentOnGrantAwardCashReceived" id="Fact_80e139b124d04353a4b9350fc892a626" contextRef="c20171201to20171231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction> million
            milestone payment in December 2017, a $<ix:nonFraction name="clbs:ProgressPaymentOnGrantAwardCashReceived" id="Fact_bd939843ef1d4e9da1cda6d4d604c78e" contextRef="c20180301to20180331" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.3</ix:nonFraction> million progress payment in March 2018, and a $<ix:nonFraction name="us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" id="Fact_e150742d18094f53a76a14278b0ad5c6" contextRef="c20190501to20190531" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.2</ix:nonFraction> million progress payment in May&#160;2019, of which the total was amortized over the estimated award period through July 2020 as a reduction to the related research and
            development expenses, with the final true up payment of $<ix:nonFraction name="us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" id="Fact_038a0ce93d824ba88bd544f5e42b1995" contextRef="c20200901to20200930" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">46</ix:nonFraction> thousand received in September 2020 and recorded as a reduction to the
            related research and development expenses. During the year ended December&#160;31, 2021 and December&#160;31, 2020 the Company amortized and recognized $<ix:nonFraction name="clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" id="Fact_07ff10a33f7b4e67954f28b462ddca81" contextRef="c20210101to20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0</ix:nonFraction>.0







            million and $<ix:nonFraction name="clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" id="Fact_64daed7437b74c4386d326e8a0449e14" contextRef="c20200101to20201231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.6</ix:nonFraction> million in credits, respectively, to research and development related to CIRM funds received.</div>
</ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="Text_5cad08bc886b4ccd857affebec7e757e" contextRef="c20210101to20211231" escape="true" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 12 &#8211; Income Taxes</span></div>
</ix:nonNumeric>

          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d1" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d2"><ix:nonNumeric name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="Text_763d9d5c90ad4bcd8b9349cbb0cbe23c" contextRef="c20210101to20211231" escape="true" continuedAt="Text_427f0e508df64e69a9ddb49f3f90eae41">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The provision (benefit) for income taxes is based on loss from
            operations before provision for income taxes and noncontrolling interests as follows ($ in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d2" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d3"><ix:continuation id="Text_427f0e508df64e69a9ddb49f3f90eae41" continuedAt="Text_427f0e508df64e69a9ddb49f3f90eae42">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d3" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d4"><ix:continuation id="Text_427f0e508df64e69a9ddb49f3f90eae42">
<table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Pre-tax book income</div>
                </td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">United States</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" id="Fact_7ec859f1f49140e9bed0d556473da11b" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">28,974</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" id="Fact_c5f7ea68c6984af69124e92b021a8290" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">19,013</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_4061714876fc429d8e90160953c6f0e9" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">28,974</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_326af574c6134271b3975a73b09832da" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">19,013</ix:nonFraction>)</span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>


          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d4" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d5"><ix:nonNumeric name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="Text_bc58dfcf8de142af92ae460a9419a088" contextRef="c20210101to20211231" escape="true" continuedAt="Text_099c22f032114bbfae6215cc6ea7469c1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The provision (benefit) from income taxes was as follows ($ in
            thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d5" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d6"><ix:continuation id="Text_099c22f032114bbfae6215cc6ea7469c1" continuedAt="Text_099c22f032114bbfae6215cc6ea7469c2">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d6" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d7"><ix:continuation id="Text_099c22f032114bbfae6215cc6ea7469c2">
<table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Current<br />
                  </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">U.S. Federal</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_6a964e02a3a346eabb8a99070e6e94b2" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara">$<span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" id="Fact_3df7902d001f4e188ec62c0c0b606e7f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">State and local</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_1784700f45154042b3f8e54489eb25ab" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" id="Fact_9eb5959ed295462fa0a3c16eb0a8b187" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 15.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_3b4c8066d8a34a12b18c84b974f44f10" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:CurrentIncomeTaxExpenseBenefit" id="Fact_3a49a75b59da4215ab9255e787c73d0c" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Deferred<br />
                  </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">U.S. Federal</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_ad3e60c75dd947ed83a22c4d04d3c592" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara">$<span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" id="Fact_078bbb2a7c2840488b2912cb072823be" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">State and local</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_c6bea8bd712544d2856fb081d979d733" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,508</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" id="Fact_d852cd6c031140cd8002b0ffe4ce3eaa" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,872</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_cd45b460699c4123ab38ab0e67f7515e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,508</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" id="Fact_6dda46dae47643efbd06d3180b11936d" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,872</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total<br />
                  </div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">U.S. Federal</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;"><ix:nonFraction name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" id="Fact_a93d7562020d46f5b5c9c0f8de7f0d25" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara">$<span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations" id="Fact_5ddb512cf7c24528b59a41858db211cd" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">State and local</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(<ix:nonFraction name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" id="Fact_7a97e5a84b424edbab8659c79fdeb870" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,508</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" id="Fact_40edc4b1bbb64d1183572ba9d60f8f6b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,872</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_977d8fdcc2424f2c9a4d5edaaec21d68" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,508</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_43867bc2583a44738cfec050381e8b7f" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,872</ix:nonFraction>)</span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d7" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d8">
<div><br />
          </div>
</ix:continuation>
        </div>

         </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-20<br />
        </div>

      </div>

    </div>

    <!--End Page 20-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 21-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_202-finnotes01_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d8" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d9"><ix:nonNumeric name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="Text_7a19108814244ae79134378c663f6b51" contextRef="c20210101to20211231" escape="true" continuedAt="Text_30741a1952de49c9b7aba5de62e90acd1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The provision (benefit) for income taxes is determined by applying
            the U.S. Federal statutory rate of <ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" id="Fact_4c5e79801ceb4e0bb9d9719121723553" contextRef="c20210101to20211231" unitRef="U005" decimals="INF" scale="-2" format="ixt:numdotdecimal">21</ix:nonFraction>% to income before income taxes, and the components are set forth below ($ in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d9" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d10"><ix:continuation id="Text_30741a1952de49c9b7aba5de62e90acd1" continuedAt="Text_30741a1952de49c9b7aba5de62e90acd2">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d10" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d11"><ix:continuation id="Text_30741a1952de49c9b7aba5de62e90acd2">
<table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">U.S. Federal benefit at statutory rate</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" id="Fact_b4264b71f88f4548a7b237174a308dc1" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6,085</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" id="Fact_695894dd606e4bf68c5fd62b306c7cd8" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">3,993</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Permanent non deductible expenses for U.S. taxes</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" id="Fact_1554a8751f1543d5b07d69eb8a0db17d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">320</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" id="Fact_cfcbf5bdbeaa4d8a955b089bcfa1b7a6" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Change in state deferred</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="clbs:EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" id="Fact_7abfcba57916404eb9a17451db3f5221" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">622</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;"><ix:nonFraction name="clbs:EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" id="Fact_bfe8a46784a340a0b52a10b9ebe47892" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,122</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Return to actual</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" id="Fact_086cd7285ded40f7b6276046e23dbe1d" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,277</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" id="Fact_94c59636aa4046bda0f511084f70173e" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other true ups</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" id="Fact_563f6465139f4ef1bc02fab42236a746" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,407</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationOtherAdjustments" id="Fact_e3db77eeb42143a0aa7d4ea301537b1a" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">387</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Section 382 NOL Limitation</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="clbs:EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" id="Fact_241d3560132b440d8139bac3a61736ff" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">35,438</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="clbs:EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" id="Fact_006d6565417e4495a18b2086c1ead76b" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Sale of New Jersey State NOLs</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(<ix:nonFraction name="clbs:EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" id="Fact_ee2cc2eb2c074e7d890ff5b28dc1c30e" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,508</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="clbs:EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" id="Fact_6ff86479e4ca47df95cb4e080ed0c428" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,872</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Valuation allowance for deferred tax assets</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="Fact_18195f66ee9f43ad804ebfd5ecc9d6a9" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">33,979</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" id="Fact_bb95f1133a6f44be944e9e64c73c8ffc" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,521</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Tax provision (benefit)</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_3fca542e11da4eb3a6a47e34cef7e763" contextRef="c20210101to20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,508</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_d271067274664b8bad370e5140f46eff" contextRef="c20200101to20201231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">10,872</ix:nonFraction>)</span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d11" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d12"><ix:nonNumeric name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="Text_cdcc5a120a1545baa09ad8dac351cb7e" contextRef="c20210101to20211231" escape="true" continuedAt="Text_c319d2d13e4549c2bb921abbd10fb0071">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Deferred income taxes at December&#160;31, 2021 and 2020 consist of the
            following ($ in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d12" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d13"><ix:continuation id="Text_c319d2d13e4549c2bb921abbd10fb0071" continuedAt="Text_c319d2d13e4549c2bb921abbd10fb0072">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> <br /></div>
</ix:continuation></ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d13" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d14"><ix:continuation id="Text_c319d2d13e4549c2bb921abbd10fb0072">
<table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 19.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Deferred Tax Assets:<br />
                  </div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Accumulated net operating losses (tax effected)</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" id="Fact_81a4e28922d64ca2a6699029ca6878ea" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">36,281</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" id="Fact_780b755b514e4fb4921d7b5e98fa6eed" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">68,286</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Right of use liability</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="clbs:DeferredTaxAssetsRightOfUseLiability" id="Fact_02f68960c941414bb560fbfb40f75ca9" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">201</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="clbs:DeferredTaxAssetsRightOfUseLiability" id="Fact_3b8e153831ca4eb985bb33105a62b55a" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">176</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Share-based compensation</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" id="Fact_7abb3519a588484bb10705186949e6a4" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,086</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" id="Fact_2871b734bf1a4333aaf8eaa674663bd3" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,025</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Intangibles</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" id="Fact_38a5a5ee0bfa4fbb942446c3ad278bca" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">97</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" id="Fact_35569933e40e4be2ab79bc7b14a8d40e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">131</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Accumulated depreciation</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="clbs:DeferredTaxAssetsAccumulatedDepreciation" id="Fact_e127febe803344a4b6286155b02892f3" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="clbs:DeferredTaxAssetsAccumulatedDepreciation" id="Fact_5fec75f0c7bc498b8cb425f0baa10acc" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Accrued payroll</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" id="Fact_e4ae5bcfde9d41558f85dff393266b0a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">176</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" id="Fact_db005b280d46481b9dc6a3d20a4ed192" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">167</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" id="Fact_94a8046c787c42deaf6f91cfb13f9119" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">526</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOther" id="Fact_722d26ecdf1144a5853597ae7ffcfcb3" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">526</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Deferred tax assets</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_3491b0fce14e438f990404c837c7cf85" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,393</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsGross" id="Fact_04f345defc114c47be1038e9b4688cec" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">74,330</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Deferred Tax Liabilities:<br />
                  </div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Right of use asset</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" id="Fact_02746c7a4acb4480b6c880b7ea251404" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">204</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" id="Fact_1cb73e245e2f4ac4977a019c5b0f1125" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">161</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Deferred tax liabilities</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_4752f069dfc442cb8f5a754e21dfd00a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">204</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:DeferredIncomeTaxLiabilities" id="Fact_083a661fdd0e486b901563b308b3f5cf" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">161</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="clbs:NetDeferredTaxAssetsAndLiabilitiesGross" id="Fact_ca162b26b960421696fb9d230ce7eec1" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,189</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="clbs:NetDeferredTaxAssetsAndLiabilitiesGross" id="Fact_27fa6afe69bc4f37b62815c3bbc4a0f4" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">74,169</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Valuation allowance</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" id="Fact_e505a6c875174a9c8439bf775315eddc" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">40,189</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" id="Fact_56df7cc09efe4b8f99929fe6d0eab6c3" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">74,169</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net deferred tax asset</div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" id="Fact_37af15d050184f85a0051063fd07a773" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:DeferredTaxAssetsLiabilitiesNet" id="Fact_bba483577a23445987d530959fb545e8" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d14" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d15">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In assessing the realizability of deferred tax assets, including the
            net operating loss carryforwards (NOLs), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets. Based on its assessment,
            the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</div>
</ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d15" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d16">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2021, and 2020, the Company had approximately $<ix:nonFraction name="clbs:OperatingLossCarryforwardsBeforeWriteDown" id="Fact_78669cb620e14f3096217f1549768fd4" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">281</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_bff9fcff02c04a59ab7b79c272da07de" contextRef="c20201231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">264</ix:nonFraction> million,
            respectively, of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on
            January&#160;25, 2021. As a result, $<ix:nonFraction name="clbs:OperatingLossCarryforwardsSetToExpireWrittenDown" id="Fact_8a74aa290a464a4e8a056fecd5d71c3c" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">169</ix:nonFraction> million of the $<ix:nonFraction name="clbs:OperatingLossCarryforwardsBeforeWriteDown" id="Fact_af7b5970411e41fc988ca7c6f6fc8819" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">281</ix:nonFraction> million of Federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_155ba48613ab4761bf176826ac21fd9d" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">112</ix:nonFraction> million of remaining Federal NOL. The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact
            to the balance sheet or income statement. Losses incurred before the ownership change on January&#160;25, 2021 will be subject to an annual limitation of $173k under Internal Revenue Code Section 382, while losses incurred after January&#160;25, 2021
            will not be subject to limitations. The Company may be able to utilize additional NOLs of approximately $<ix:nonFraction name="clbs:OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" id="Fact_e45ff6d65cf04983a8f0ea22163a596d" contextRef="c20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction> million per year for the
            first five years after this ownership change as a result of the application of the Net Unrealized Built-in Gain rules.</div>
</ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-21<br />
        </div>

      </div>

    </div>

    <!--End Page 21-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 22-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_202-finnotes01_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d16" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d17">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2021 and 2020, the Company had State NOLs
            available in New Jersey of $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_fdd6531d6ba444659bf7ded9618d1a11" contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">97</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_ee794425524d40c2aa649fc73be70859" contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">99</ix:nonFraction> million, respectively, California of $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_7eda14f514a94ff692420188c8b0b3f1" contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">70</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_a11a795210f14b1c9a0bc0db9410d337" contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">70</ix:nonFraction> million, respectively, and New York City of $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_001bc190b26b490d978933e7ecf2210f" contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction>
            million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_b6ac782837dd437eaabbd861774e9cc7" contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction> million, respectively, to offset future taxable income expiring from 2031 through 2041. In accordance with Section
            382 of the Internal Revenue code, the usage of the Company&#8217;s state NOLs would be limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period
            when those temporary differences become deductible.</div>
</ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d17" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d18">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company applies the FASB&#8217;s provisions for uncertain tax
            positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest
            benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant taxing authority. The Company recognizes interest and penalties associated with certain tax positions as a component of income tax
            expense.</div>
</ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d18" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d19">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2021, management does not believe the Company has
            any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in
            future periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</div>
</ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d19" continuedAt="Text_4aa6b56ce9db45f29e7b05699759f24d20">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">For years prior to 2018 the federal statute of limitations is closed
            for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from date of filing.</div>
</ix:continuation>
          <ix:continuation id="Text_4aa6b56ce9db45f29e7b05699759f24d20">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In February 2021, the Company received preliminary approval from the
            New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) to participate in the Technology Business Tax Certificate Transfer Program (the &#8220;Program&#8221;). The Program permits qualified companies to sell a percentage of their New Jersey net operating
            losses (&#8220;NJ NOLs&#8221;) to unrelated profitable corporations. On April&#160;12, 2021, the Company received final approval from NJEDA to sell a portion of our NJ NOLs, which were subsequently sold to a qualifying and approved buyer pursuant to the Program
            for net proceeds of $<ix:nonFraction name="clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" id="Fact_2b01f0528f7f484ca0fcb3c4ac5f9722" contextRef="c20210412to20210412" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.4</ix:nonFraction> million. The $<ix:nonFraction name="clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" id="Fact_c3f189976e7941dcb77203dfb7d55140" contextRef="c20210412to20210412" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.5</ix:nonFraction>
            million of our NJ NOL related tax benefits (&#8220;NJ NOL Tax Benefits&#8221;) have been recorded as a benefit from income taxes and the loss on sale of $<ix:nonFraction name="clbs:LossOnSaleOfNetOperatingLosses" id="Fact_ff274cc2689a4fc38ff23ce9a649bbbe" contextRef="c20210412to20210412" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction>
            million recorded in other income (expense) in the consolidated financial statements.</div>
</ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Text_60158982f36c491b976269b60b6cee13" contextRef="c20210101to20211231" escape="true" continuedAt="Text_8732eeb445c04164b0fdb6aa29cc1ffa1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 13 &#8211; Contingencies</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_8732eeb445c04164b0fdb6aa29cc1ffa1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">From time to time, the Company is subject to legal proceedings and
            claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a
            material adverse effect on the Company's financial condition or operating results.</div>
</ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-22<br />
        </div>

      </div>

    </div>

    <!--End Page 22-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 23-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_203-fintab02_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a id="tCONSOLIDATED1"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND
            SUBSIDIARIES<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED BALANCE SHEETS<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><span style="font-weight: normal;">(In thousands, except share data)</span></div>

          <table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.04%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Unaudited)</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">ASSETS<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;">$<span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_a92d52bd48704b04aa1637757d94381b" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,747</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;">$<span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" id="Fact_3d402322e3624bb6973668b3e7c3f23d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,647</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:MarketableSecurities" id="Fact_caa05e7c13db4479803a6e4d67ac7989" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">75,772</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:MarketableSecurities" id="Fact_62aaab255aa54287874bfa8e327ae528" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid and other current assets</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_5674f0942a2845a98f4066f58d10a786" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,181</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" id="Fact_dcfa7d18ba6149d4982a9c568f0b12d9" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,212</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current assets</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_eb072c7bb64d4a0cbb7807bc5b60cc85" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">90,700</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:AssetsCurrent" id="Fact_20d38c87ff584747898d90d526d6d0bf" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96,182</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_c67213a5e30440e58258d8c264edc966" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">55</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" id="Fact_ef7a589bb2bd4efc824c5cf5f163b08b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other assets</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_f5176358617249e5aa37a21a45758c32" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">708</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:OtherAssetsNoncurrent" id="Fact_5127676b958b4992b2e4e4119b7d5e33" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">764</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total assets</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_fcc6abd236b4468a815c3722c76a9188" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,463</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:Assets" id="Fact_f5f43ceb828446f5bda8a8ccbdda94f7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">97,008</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">LIABILITIES AND STOCKHOLDERS' EQUITY<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Liabilities<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;">$<span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_9e7d3162c32243f2862c66f265ae648e" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">697</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;">$<span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" id="Fact_1720291a54c545b8a4af8dace99b84b6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,934</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued liabilities</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_a3bd31d38e06457f92e42643ed559237" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,104</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_e010b426aaaf4aeb9c914c909a6b0131" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,589</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current liabilities</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 18.33pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_a91467346cd445e893051527e9b3c562" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,801</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt;"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" id="Fact_52343e7ebaf34d0da041cdbdb8bd9859" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">4,523</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other long-term liabilities</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_7d58ba0379bc46f5a8ef5890a19cc9c4" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">421</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:OtherLiabilitiesNoncurrent" id="Fact_d92b1cabd7174c308d1468fb241b9465" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">485</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_359017941698447a9f9d86c9703820f9" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,222</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:Liabilities" id="Fact_c1694bde392a47cd9d016224298b525f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,008</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Commitments and Contingencies<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_a13d6e059a784c64b8f9f984cbd1840b" contextRef="c20220331" unitRef="U001" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><ix:nonFraction name="us-gaap:CommitmentsAndContingencies" id="Fact_12c9182086fe42ebb55f6fd7e5311a32" contextRef="c20211231" unitRef="U001" xsi:nil="true" format="ixt:nocontent"></ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholders' Equity<br />
                  </div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Preferred stock, authorized, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_f1f3d89be3b044f59893f8ee1ecbb94e" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" id="Fact_08e7148452f24f5bace1b22b4f4f46a2" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction></span> shares Series B convertible redeemable preferred stock liquidation value, <span style="text-indent: 0pt;"><ix:nonFraction name="clbs:PreferredStockLiquidationPreferenceShare" id="Fact_cca1a9d66bc54d3fbd16472776a3e712" contextRef="c20220331" unitRef="U002" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="clbs:PreferredStockLiquidationPreferenceShare" id="Fact_11f41bf00ae04ce798baa222d05a5cfe" contextRef="c20211231" unitRef="U002" decimals="INF" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction></span> share of common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_ac3ffe5a2fe64263be8537a9353d7a98" contextRef="c20220331" unitRef="U003" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_590e9a1a04f449cdb5641fc4c88c2edf" contextRef="c20211231" unitRef="U003" decimals="INF" scale="0" format="ixt:numdotdecimal">0.01</ix:nonFraction></ix:nonFraction></span> par value;
                    <span style="text-indent: 0pt;"><ix:nonFraction name="clbs:PreferredStockSharesDesignated" id="Fact_627301d9e5fc47e08f5098b8a4af5b4e" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="clbs:PreferredStockSharesDesignated" id="Fact_351092cb632044feb9b3763672fe9c25" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">825,000</ix:nonFraction></ix:nonFraction></span> shares designated; issued and outstanding, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_ee423311a0bd47f9b8af3a81a77825a8" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_c81e6ff511c54eeea7c451e13c07dc34" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" id="Fact_98421872e02f4c8ab08e339fcbc1b058" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" id="Fact_3c81c3eed605441fb12b284206951db0" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">10,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span> shares at March&#160;31, 2022 and December&#160;31, 2021, respectively</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_592691232de8430e84ad2ad17c456369" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:PreferredStockValue" id="Fact_5456918e483840d5bc7e75e027b8e7b9" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Common stock, $<span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_8bf1f54ef57f42fd9b1e7cce47958d3c" contextRef="c20220331" unitRef="U003" decimals="INF" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="Fact_637cabc1ffcc48e38534b2868efe4312" contextRef="c20211231" unitRef="U003" decimals="INF" scale="0" format="ixt:numdotdecimal">0.001</ix:nonFraction></ix:nonFraction></span> par value, authorized <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_37b9132e1baf4ce3919b998e74227151" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="Fact_1de40aeac3ed43ac8f6531b4ecb8d213" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">500,000,000</ix:nonFraction></ix:nonFraction></span>
                    shares; issued <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_4e979b4882a84ab08282a2ce5841db3a" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">60,544,144</ix:nonFraction></span> and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="Fact_c51ee9bcb0484559b7c4ab05b2bb41be" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">59,800,792</ix:nonFraction></span>
                    shares at March&#160;31, 2022 and December&#160;31, 2021, respectively; and outstanding, <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_c495d895e8754e6694244ba3e2e4a261" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">60,533,064</ix:nonFraction></span> and <span style="text-indent: 0pt;"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="Fact_95a098b9e85046549cc5c74262cd98de" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">59,789,712</ix:nonFraction></span> shares at March&#160;31, 2022 and December&#160;31, 2021, respectively</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_b35eefa7876a4830a041fea01c1df0f5" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">61</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:CommonStockValue" id="Fact_2baa38aa9a9e4cd3b47427569db55d5a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additional paid-in capital</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_df4216e31e684522b7a4e40e2eae4bf0" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">546,580</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" id="Fact_1b9af99ef0454249b13caf24c01162fa" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">545,988</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Treasury stock, at cost; <ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_bf16dcde815d421cad5f64795ed91fb4" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:TreasuryStockShares" id="Fact_97aade5c8adc400b94fa29b274410206" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">11,080</ix:nonFraction></ix:nonFraction> shares at March&#160;31, 2022 and December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_792d4eec6e5149e98f6a51b84189e45e" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">708</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 22.5pt;">(<ix:nonFraction name="us-gaap:TreasuryStockValue" id="Fact_e990598ccc4845399d77805c8d19c8fc" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">708</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accumulated deficit</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_f6d1cbdf56b042e2afebe010d3fec426" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">457,242</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" id="Fact_bff8a12244b04fe98649293806cbd87c" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">453,016</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accumulated other comprehensive loss</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" id="Fact_9f946afd07ed4530ad71b539fb5b0ddf" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">196</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" id="Fact_50371cbbfd5f4ed0a82505f23eaf8760" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">70</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total Caladrius Biosciences, Inc. stockholders' equity</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_19113624a9204365939d4e67c3afff50" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">88,495</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:StockholdersEquity" id="Fact_486791862f9c486199e2371711736b8d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">92,254</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-controlling interests</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_8b44aa4fa0bb41fb99cf4ea7f5baf0da" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">(<ix:nonFraction name="us-gaap:MinorityInterest" id="Fact_04738d5b81194e968778289866620982" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total stockholders' equity</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_f143af27082d4f709de49ae6df322740" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">88,241</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_88b1b7151d5d4453ac68644739d1222a" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">92,000</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities, non-controlling interests and stockholders' equity</div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_ea85f5d3d06d40c8aee11fca1288571a" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,463</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.04%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 40.83pt;"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" id="Fact_6e62f249e56b4132be01e1c11b672014" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">97,008</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
          <div class="footer" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; text-align: center;"></div>

        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-23<br />
        </div>

      </div>

    </div>

    <!--End Page 23-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 24-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_203-fintab02_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCONSOLIDATED2"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND
            SUBSIDIARIES<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED STATEMENTS OF OPERATIONS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(Unaudited)<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands, except per share data)</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 24.18%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Expenses:<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_9b685af5a06c4f128959126e0e94c102" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,278</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara">$<span style="padding-left: 4.63pt;"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" id="Fact_125b07ce1a2041c9aa7e67bcd9cad671" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5,076</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_3b6d31755b404d72b01539af191e7e47" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,342</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" id="Fact_f4b5fc5efd1c422fb869bf25bebdb918" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">3,010</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total operating expenses</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_0114ed89967346d5a39fa7002cacea5b" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,620</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 9.63pt;"><ix:nonFraction name="us-gaap:OperatingExpenses" id="Fact_f0d638d79ddf46ad9588267a0d61ff37" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">8,086</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Operating loss</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_47c04285c05b47dfbbb242290daa139a" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6,620</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" id="Fact_815d5d1199dc43d990b7f0a89ec582c9" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,086</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income (expense):<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Investment income, net</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" id="Fact_ba5c65993a95455fbfe79bc4a7b068b4" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">63</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt;"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" id="Fact_c2a518ef34724eb1913f3e976b366cba" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other expense, net</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_91005a0ffea74ac2b02f0a6a0a5c6ee0" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">148</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" id="Fact_e0d67d2a4af74303b4ece42ab179befa" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total other (expense) income</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_5f81a3cdc644451fac2ccf5da10c93af" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">85</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" id="Fact_3b815887d31b4b3d973f169aa2912f40" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">23</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Net loss before benefit from income taxes and noncontrolling interests</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_950608eb2e154e38ba5d93ddfc23cb97" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6,705</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 6.3pt;">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" id="Fact_9f0b0150c19e4e6594cf8ed708558690" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,063</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Benefit from income taxes</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_c6aa10d9f2fd4443b5dde3e093e06380" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">2,479</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt; border-bottom: 1pt solid #000000; min-width: 32.13pt;"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" id="Fact_abc1a881da434d338232055547d8c072" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net loss attributable to Caladrius Biosciences, Inc. common stockholders</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$</span><span style="padding-left: 1.67pt; border-bottom: 3pt double #000000; min-width: 32.5pt;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_4fbabd2386cf4124adb6dbb4e9466834" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,226</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.13pt;">$</span><span style="padding-left: 1.3pt; border-bottom: 3pt double #000000; min-width: 32.13pt;">(<ix:nonFraction name="us-gaap:NetIncomeLoss" id="Fact_59330b4df26a4017aeb8591fbc6be9f9" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,063</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic and diluted loss per share<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc. common stockholders</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara">$<span style="padding-left: 6.67pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_c7e36c6b2f994763a9a61a632dd02cf7" contextRef="c20220101to20220331" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_54524011d116485ba8e65ea3108917b0" contextRef="c20220101to20220331" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.07</ix:nonFraction></ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara">$<span style="padding-left: 6.3pt;">(<ix:nonFraction name="us-gaap:EarningsPerShareDiluted" id="Fact_0a95f1b407514c828036ba36950da11b" contextRef="c20210101to20210331" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" id="Fact_4d4dc74e08f94391b70d3f5e14317b1c" contextRef="c20210101to20210331" unitRef="U003" decimals="2" sign="-" scale="0" format="ixt:numdotdecimal">0.19</ix:nonFraction></ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic and diluted shares</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_a46b4a4f1e6f475db7fd7a2ac6c41806" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_75357b9b25a54e3c968dc4f871dc466a" contextRef="c20220101to20220331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">60,560</ix:nonFraction></ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.32%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.43pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="Fact_f8793a4126e24c7d9e6bb45127339f25" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="Fact_559e5c5bc9564c2e82d50d7a0a25a3bb" contextRef="c20210101to20210331" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">42,117</ix:nonFraction></ix:nonFraction></span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-24<br />
        </div>

      </div>

    </div>

    <!--End Page 24-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 25-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_203-fintab02_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a id="tCONSOLIDATED3"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND
            SUBSIDIARIES<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Unaudited)<span style="font-weight: normal;"> </span><br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><span style="font-weight: normal;">(In thousands)</span></div>

          <table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 24.18%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;">$(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_dbf63bf573804684847a5373ea643271" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,226</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;">$(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_6221a60e941c463696726b9624606d6d" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,063</ix:nonFraction>)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other comprehensive loss:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Available for sale securities - net unrealized loss</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" id="Fact_cb8bcbff2e7b477081974576a60b1acd" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">126</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" id="Fact_de0556c03f83471f871e9c65609087a8" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total other comprehensive loss</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" id="Fact_b9a1f49763214e84b73fc45163888028" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">126</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" id="Fact_e71f1124610b493c9892aa8ad8da721c" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Comprehensive loss attributable to Caladrius Biosciences,
                    Inc. common stockholders</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" id="Fact_bb3b6bf362e64ccd93fb24b07c8caf61" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,352</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.17pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(<ix:nonFraction name="us-gaap:ComprehensiveIncomeNetOfTax" id="Fact_4f2678b9b9b244fe9b2d9ba7f7c6bffb" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,122</ix:nonFraction>)</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-25<br />
        </div>

      </div>

    </div>

    <!--End Page 25-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 26-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 528pt;"><a id="ny20004343x1_s4_203-fintab02_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 30pt;"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 528pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 30pt;">
          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a id="tCONSOLIDATED4"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND
            SUBSIDIARIES<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED STATEMENTS OF EQUITY<br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Unaudited)<span style="font-weight: normal;"> </span><br />
          </div>

          <div class="h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><span style="font-weight: normal;">(In thousands)</span></div>

        </div>

        <div class="block-main" style="width: 528pt; margin-left: 0pt;">
          <table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 528pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 10.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Series B <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Convertible <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div>
                </td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 11.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div>
                </td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 7.1%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Paid-in <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Capital</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 10.07%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Other <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Comprehensive <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Loss</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 8.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 5.84%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Treasury <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 8.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Caladrius <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Biosciences, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Inc. <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholders' <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 7.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Non- <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Controlling <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Interest in <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Subsidiary</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.42%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 6.16%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div>
                </td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div>
                </td>

    <td class="gutter" style="width: 0.42%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Balance at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_4fca8c6a083c4c5bbaf30aac8ebbd7a8" contextRef="c20211231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_f8c0d81f24604bd5955e16b72b300168" contextRef="c20211231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_edbb46860152428fb9e1fb0c4d1fb1ab" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">59,801</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_60ff33ea767d487897cda60d97a115df" contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_453da17cd12741e9b49026698fec3915" contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">545,988</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.93pt; text-align: left;">$<span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_07366bf41d024655a21bc27f669c7eef" contextRef="c20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">70</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_d96b852c54004b37853b9e6109c8e2bf" contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">453,016</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7f0a373a2e534e6baf5d1f462567f7b2" contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">708</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.31pt; text-align: left;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_31e8e4aa7c4d484bbf32a38c48f8f907" contextRef="c20211231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">92,254</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_e78904a2f981483abe61a946e67d6c18" contextRef="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.16%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_d8b66a4664954e339957b274eb0918e4" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">92,000</ix:nonFraction> </div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;">&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.93pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="padding-left: 15pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_aad8d2994d8447778bba8285e0b55659" contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,226</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.31pt; text-align: left;"><span style="padding-left: 6.67pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_89e116e17a694cb3a22a51ff9e21ab2c" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,226</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_156fc1e9e78c4f8cbc40ea88a24c56ad" contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.16%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 6.67pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_bc518076ed18422d87da46a38b6f508a" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,226</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Unrealized loss on marketable securities</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;">&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.93pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_30fee710efff45e98425f30738610066" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">126</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.31pt; text-align: left;"><span style="padding-left: 14.17pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_087f97d74e0e4144b1e7c4bb0a86c764" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">126</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.16%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_906c83200a1949a29715ff98c496128f" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">126</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Share-based compensation</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" id="Fact_962886faa136415fa96caee40bbd903d" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">743</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 15pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_5096b951c7114538bd605fa4a712389e" contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_01dfdbcd0a5947a0b33139f32dfa8453" contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">592</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.93pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.31pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_116d8d8c8d684d0bbb6eec566752e75c" contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">593</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.16%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_5a8c661be1604f7a95058fb4dbf0aeee" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">593</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Balance at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_df5fa457dd054d4eb63acdaf8d70f884" contextRef="c20220331_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_80da5e5b440d448d931084f8e7d7c4f9" contextRef="c20220331_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_5b906777829a4a6db3751d4de2f23152" contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">60,544</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_63b9f6abd3a943f29adb2cc055923b5f" contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">61</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_367c5f5fdb454ab5a60ebd5702c18dbf" contextRef="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">546,580</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.93pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_fc9c20211e844cc199dda169ffabd081" contextRef="c20220331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">196</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_d5fefa1b927e41d096b49ae9a8ee9fc9" contextRef="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">457,242</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a7b17e8a8f094d12ada0201b5c5e39bc" contextRef="c20220331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">708</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.31pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_a525dd75038e48e0a279eb9ef17aaf04" contextRef="c20220331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">88,495</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7bd51255ba0042b8b1a8c8a29af10b81" contextRef="c20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.42%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.16%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_c411646724c64a29b2ee08d2ba8b78e1" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">88,241</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 528pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 10.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Series B <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Convertible <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div>
                </td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 11.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div>
                </td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 7.1%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Paid-in <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Capital</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 10.07%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Other <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Comprehensive <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Income (Loss)</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 8.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 5.84%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Treasury <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 8.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Caladrius <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Biosciences, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Inc. <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholders' <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 7.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Non- <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Controlling <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Interest in <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Subsidiary</div>
                </td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" rowspan="2" style="width: 0.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td rowspan="2" style="width: 7.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div>
                </td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div>
                </td>

    <td class="gutter" style="width: 0.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Balance at December&#160;31, 2020</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_62e2e76477b548c2a2aeaa1805ad0209" contextRef="c20201231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_221c0660730e4282b08d4802c525a162" contextRef="c20201231_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_bdc76b3ef4bf4fa0adc332fe3a2efa42" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">19,389</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_f67f35610f274410840578d9b9c42103" contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">19</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7132d791043c4728a24397dd44048e0b" contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">458,748</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_e5d5af1f1ee74c5fb8101d34a8590af2" contextRef="c20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">13</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_735a9322fedd46e2a67eafd53e464800" contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">425,550</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_2740fe7ac6424533990bf1838f8fac5d" contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">708</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;">$<span style="padding-left: 4.63pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_3110238813174cc8bd4bf2420c565236" contextRef="c20201231_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,496</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_6a9b5126c74c4ce4841dae6fb7aaeff5" contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<span style="padding-left: 4.63pt;"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_db0d0ea7b2a14c0ab3ed53953ce3e897" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">32,242</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;">&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="padding-left: 15pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_05e0b43219e84e8b82ce802ac3ce5354" contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,063</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;"><span style="padding-left: 11.3pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_afc64f6c996e4b6fbc7a8223db50370b" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,063</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_949d310b74a048c18cf1a3eaf89cdc4d" contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 11.3pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_25df5b8e00404d7fa3548bf755e6f324" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,063</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Unrealized loss on marketable securities</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;">&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 27.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_8b563b7ba2e749dca5812a5290c22315" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;"><span style="padding-left: 23.8pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_170b83938a934d329266750f024a6946" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 23.8pt;">(<ix:nonFraction name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" id="Fact_156d824ea67648e68602e357dfdd0ae1" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">59</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Share-based compensation</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;">&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 12.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" id="Fact_0f43fdfb3bcc4714a98c4fd50577175f" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">273</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 22.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_383d229903c345a28abfd1379ae4e3bc" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">413</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;"><span style="padding-left: 22.13pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_a0baa62d4d3849e69b8f8875c5bfa680" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">413</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 22.13pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" id="Fact_598c7bf67b0044fb9095c94fce774b6d" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">413</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net proceeds from issuances of common stock and warrants</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;">&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="Fact_37f44177c4cb42ad816314a563dd433a" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">39,841</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_c7634357dadf451a9114ccfa0cdeda40" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">41</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_a93dd26e42834c4f84471f3999ab2fcb" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,416</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="padding-left: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;"><span style="padding-left: 9.63pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_51b8ecbad20c40aeac5b8bbdbf1dfd92" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,457</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 9.63pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" id="Fact_0ac1080dd5fc4f84bfaaeb88f9caaf2b" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,457</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Proceeds from option exercises</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 10pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_5e227d81707b4d79b3e6fb1bd51b0498" contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">7</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_8c6e4972611b47638ee0ca4850458fb8" contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; min-width: 40.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;"><span style="padding-left: 27.13pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_945ac806b309421f991fc8c50dff0d32" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 27.13pt; border-bottom: 1pt solid #000000; min-width: 37.13pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" id="Fact_bb5aa00cb557455d81cc80e10e2b2441" contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.48%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Balance at March&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.35%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.48pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 10pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_ad8e26f4d5254d52aaf17be9cccbb89b" contextRef="c20210331_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">10</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_b5f7ffab83904a6085cddd9bdcd9f93e" contextRef="c20210331_StatementEquityComponentsAxis_PreferredStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.21%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:SharesOutstanding" id="Fact_f86915ebe1184d92b03b17d7ea799c17" contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">59,510</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.3%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.5pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7b3fe1d752fd482b8f04d0dbd611ef2c" contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">60</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.1%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_7667e7737b3a48e2853830e285a8d00a" contextRef="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">544,601</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.07%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_28d1840c7f2c4cee926f9b5a4db80dfa" contextRef="c20210331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">72</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.24pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40.83pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_2fc7ad3d99b04ac1b81fdf07bbdf8c7b" contextRef="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">433,613</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.75pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_371e8961d4f24d2f9cab2af4e9d2c571" contextRef="c20210331_StatementEquityComponentsAxis_TreasuryStockMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">708</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.98pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_e2b36fdc4a814c2b8024302539633643" contextRef="c20210331_StatementEquityComponentsAxis_ParentMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">110,268</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.46%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_6129063f347949058cc95b23a8406283" contextRef="c20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">254</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.13pt;">$<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" id="Fact_66b9eeacb10d4d04bdccb0fb5ee0bb7b" contextRef="c20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">110,014</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-26<br />
        </div>

      </div>

    </div>

    <!--End Page 26-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 27-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_203-fintab02_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCONSOLIDATED5"><!--Anchor--></a>CALADRIUS BIOSCIENCES, INC. AND
            SUBSIDIARIES<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED STATEMENTS OF CASH FLOWS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(Unaudited)<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands)</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 24.18%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash flows from operating activities:<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Net loss</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_97e8c893f3eb43a3b5b536eb1de0dc48" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">4,226</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:ProfitLoss" id="Fact_69bc0581a99b4feb919ba5aeb65dabc1" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">8,063</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Adjustments to reconcile net loss to net cash used in operating activities:<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Share-based compensation</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" id="Fact_58088fd0c0144aff9bd00fad15b02b89" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">760</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" id="Fact_f4a91605ba624b3a9d9ff6d19fffecbc" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">597</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Depreciation and amortization</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" id="Fact_11329796d06a40b59d23fc2669de65a8" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">7</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" id="Fact_4cda5d0b4f6e484e9a209d6c3fd55a17" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Accretion on marketable securities</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" id="Fact_ac83cd10d58a4dcf9d21ab7df397a17e" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">515</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;"><ix:nonFraction name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" id="Fact_501c1f79fdcd48fb9182c65d001d7756" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">323</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Changes in operating assets and liabilities:<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-align: left;" class="fpara">Prepaid and other current assets</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_12122b856a5f4e138197fded20b5c6ad" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">969</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" id="Fact_2cc93ad31edb42ceb6291d176fe6a523" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,763</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-align: left;" class="fpara">Other assets</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_27261a5e052d4504883c1efc15e2e7c5" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">57</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" id="Fact_c348a29f9dc24e2d8148acfd84c7e732" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">81</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-align: left;" class="fpara">Accounts payable, accrued liabilities and other liabilities</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" id="Fact_367aab4a8acf459a8d1c0150e0a8a920" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">1,786</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" id="Fact_50a22af69b23464c8763e9d0caa98282" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">834</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Net cash used in operating activities</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_70b999bc52a54d2b9f6e4c15741e3583" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">5,642</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" id="Fact_e94abe667af44c28b7c675fcefc20dfb" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">7,975</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash flows from investing activities:<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Purchase of marketable securities</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireMarketableSecurities" id="Fact_01dce1bf32994c94a182b6cce000cc6f" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">26,546</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 5.37pt;">(<ix:nonFraction name="us-gaap:PaymentsToAcquireMarketableSecurities" id="Fact_d4fbc033bf8444d199c66d8937cfb621" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">75,911</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Sale of marketable securities</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" id="Fact_0caa7e9fa80742fcb0eaa1fca23b3657" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,456</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" id="Fact_d14a037e5f5d4b5292cc108c6b3d0aba" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,821</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Net cash used in investing activities</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_e54f8938bf484a51b37c5b1ed6e5b112" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">6,090</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" id="Fact_f9f83f8f859b4497998af6efd8e75156" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">65,090</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash flows from financing activities:<br />
                  </div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Proceeds from exercise of options</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_3730080c9a6641c7ac8f0e00cd7b12ff" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromStockOptionsExercised" id="Fact_e4e8776b483e495995929f13c8c20593" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Tax withholding payments on net share settlement equity awards</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_06f2dadb7d214fccac15bb5a6e7dcea8" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">168</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">(<ix:nonFraction name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" id="Fact_90bd0208290c43da8ad63b559a2e1d19" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">184</ix:nonFraction>)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Net proceeds from issuance of common stock</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_0594d02ef580476d9efa8a2b3457df2d" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" id="Fact_c300ca71225945eb82595ff4489e481e" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,457</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Net cash (used in) provided by financing activities</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_0cda345ce1a6480cb70e05710ed61e56" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">168</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" id="Fact_1592af5b4c83459f82f333e842d86e99" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">85,297</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net (decrease) increase in cash and cash equivalents</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 5.37pt;">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_0539e4c3f5164bc59ad54f1d613e6030" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" sign="-" format="ixt:numdotdecimal">11,900</ix:nonFraction>)</span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" id="Fact_9834e35d561841aa9ad5eddf1247a967" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,232</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash and cash equivalents at beginning of period</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_53250825a03e484abe3ef14ea0bdb4bd" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">24,647</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_8b19c82674f241829de1a18da455780e" contextRef="c20201231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">16,512</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 74.36%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash and cash equivalents at end of period</div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_fd9fa18961544a62b31ee51830047d8d" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">12,747</ix:nonFraction></span></div>
                </td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.67pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" id="Fact_bc00d206d9a847bfaa7e8d0564fbe57d" contextRef="c20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">28,744</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-27<br />
        </div>

      </div>

    </div>

    <!--End Page 27-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 28-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_204-finnotes02_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">CALADRIUS BIOSCIENCES, INC. AND SUBSIDIARIES<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><a id="tNOTE2"><!--Anchor--></a>NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS</div>


          <ix:nonNumeric name="clbs:BusinessTextBlock" id="Text_f536e5430175482aa5c7508e577127ca" contextRef="c20220101to20220331" escape="true" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93631">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 1 &#8211; The Business</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93631" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93632">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h2">Overview</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93632" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93633">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Caladrius&#8221; or the
            &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The Company is developing what are intended to be first-in-class therapeutics based on the characteristics of
            naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its technology is intended to leverage these cells to enable the body's natural repair mechanisms using formulations unique to each medical
            indication.</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93633" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93634">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company's leadership team has decades of collective
            biopharmaceutical product development experience in a variety of therapeutic categories. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The
            Company&#8217;s current product candidates include:</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93634" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93635">
<table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA<sup>&#174;</sup> (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow on Phase
                    2b study (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93635" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93636">
<table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA<sup>&#174;</sup> (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the
                    treatment of critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan. HONEDRA&#174; was the recipient of orphan drug designation in March 2021 from the U.S. Food
                    and Drug Administration (&#8220;FDA&#8221;) for Buerger's disease; and</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93636" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93637">
<table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, the subject of a study designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients
                    with chronic kidney disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93637" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93638">
<table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">On April&#160;26, 2022, the Company and Cend Therapeutics, Inc., a Delaware corporation (&#8220;Cend&#8221;), entered into an Agreement and Plan
                    of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, a wholly-owned subsidiary of Caladrius will
                    merge with and into Cend, with Cend surviving as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;), subject to the terms of the Merger Agreement and stockholder approval of the transaction. Under the exchange ratio formula, as of
                    immediately after the Merger, the former Cend stockholders are expected to own approximately <ix:nonFraction name="clbs:MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" id="Fact_29e40cd7cd1546eebf44cd4060a33333" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="INF" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% of the outstanding shares
                    of Caladrius Common Stock and the Company&#8217;s stockholders as of immediately prior to the Merger are expected to own approximately <ix:nonFraction name="clbs:MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" id="Fact_5bd885b4388741a3baf10ef2494a7e0e" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="INF" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>%
                    of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on our net cash balance at the time of closing and the amount of any transaction expenses of Cend in excess of $<ix:nonFraction name="clbs:MergerAgreementTransactionExpensesThresholdForRatioAllocation" id="Fact_a4776233846a48d5be5845a46d874496" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">250</ix:nonFraction> thousand at the time of closing. See Note 12 below for more information regarding the Merger and related transactions.</div>
                </td>

  </tr>


</table>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93638" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b93639">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;" class="h3">Ischemic Repair (CD34 Cell Technology)</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b93639" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936310">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The CD34+ cell was discovered as a result of the deliberate search
            for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building
            new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same
            capability.</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936310" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936311">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company's proprietary cell technology using autologous (a
            patient&#8217;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is
            restricted or reduced. Through the administration of CD34+ cells, Caladrius seeks to promote the development and formation </div>
</ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-28<br />
        </div>

      </div>

    </div>

    <!--End Page 28-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 29-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_204-finnotes02_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936311" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936312">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">of new microvasculature and thereby increase blood flow to the impacted area. The
            Company believes that a number of conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology including but not limited to Buerger's disease, CLI, CMD, and DKD.</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936312" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936313">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h3">XOWNA<sup>&#174;</sup> for Treatment of Coronary
            Microvascular Dysfunction</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936313" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936314">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In 2017, with the assistance of a $<ix:nonFraction name="us-gaap:GrantsReceivable" id="Fact_d035a67a0afe474581a168a8c2e6c434" contextRef="c20171231_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_CLBS16TreatmentOfCMDMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.9</ix:nonFraction> million grant from the National Institutes of Health (Award Number&#160;R44HL135889), the Company initiated its program for XOWNA<sup>&#174;</sup> for the
            treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled
            patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian
            Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr.
            Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, the Company commenced enrollment in its Phase 2b FREEDOM Trial of XOWNA<sup>&#174;</sup>, a double-blind, randomized and placebo-controlled clinical trial designed to
            further evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in
            January 2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment, including supply chain disruptions affecting the availability of qualified catheters used in the diagnosis of CMD and/or administration of XOWNA<sup>&#174;</sup>.
            Protocol amendments to the initial FREEDOM Trial protocol, as agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of subject enrollment.</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936314" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936315">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h3">HONEDRA<sup>&#174;</sup> for Treatment of Critical
            Limb Ischemia</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936315" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936316">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company's randomized, open-label, registration-eligible study of
            HONEDRA<sup>&#174;</sup> in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA<sup>&#174;</sup> study's enrollment, however, has been significantly curtailed by the
            COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of 2020 and 2021. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19 delays,
            coupled with the unpredictability of the timing of site enrollment re-initiation, Caladrius suspended further enrollment and is focusing its efforts on consummating a partnership for the product in Japan. Such a partnership may become the basis
            for the completion of development and registration of HONEDRA<sup>&#174;</sup> in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or exploration
            of the possibility of submitting the existing data to Japan's Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) under Japan's regenerative medicine regulations, which allow for conditional approval of innovative regenerative medicine
            products. Despite receipt from FDA in March 2021 of orphan designation in the U.S. for CLBS12 as a potential treatment for Buerger's disease, based on a response from the FDA in October 2021 regarding a development plan for U.S. registration
            the Company decided not to pursue United States development in Buerger's disease at this time.</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936316" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936317">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">CLBS201 for Treatment of Diabetic Kidney Disease</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936317" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936318">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Progressive kidney failure is associated with attrition of the
            microcirculation of the kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, the Company
            has elected to move forward with a Phase 1b, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol is expected to include six subjects in total with the first two
            subjects sequentially dosed and followed for a two-week safety observation period. Clearance by the independent Data Safety Monitoring Board (&#8220;DSMB&#8221;) overseeing the study will then permit the treatment of the next four patients, with all
            patients being followed for safety and therapeutic effect. A read-out of data will occur after at the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201 will be its ability to demonstrate a
            therapeutic effect that will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate. As announced recently, the Company has treated the first patient in the
            CLBS201 proof-of-concept study and targets treatment completion for all six subjects during the third quarter of 2022.</div>
</ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-29<br />
        </div>

      </div>

    </div>

    <!--End Page 29-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 30-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_204-finnotes02_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936318" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936319">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Additional Out-licensing Opportunities and
            Pipeline Diversification</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936319" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936320">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company's broad intellectual property portfolio of cell therapy
            assets includes notable programs available for out-licensing in order to continue their clinical development. The Company's current long-term strategy focuses on advancing its therapies through development with the ultimate objective of
            obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to
            realize potentially meaningful value increases within its own proprietary pipeline if it is successful in advancing its product candidates to their next significant development milestones.</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936320" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936321">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In addition, the Company further desires to diversify its pipeline of
            development products candidates and is exploring a range of strategic transactions in furtherance of that goal. The Company has taken, and intends to continue to take, active steps to identify assets and/or companies for acquisition and/or
            partnership that would enhance and de-risk its current development portfolio. Such assets could target indications beyond cardiovascular disease as well as product categories outside of cell therapy. The range of possible transactions includes
            an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute the shares of its existing stockholders. There can be no assurance
            that this exploration of strategic alternatives will result in Caladrius entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936321" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936322">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Coronavirus Considerations</div>
</ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936322" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936323">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which
            causes COVID-19, was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects. Despite the FDA approval
            of multiple COVID-19 vaccines in late 2020, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, the
            Company implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. The Company's clinical study of HONEDRA<sup>&#174;</sup> in Japan has experienced
            significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 2021 covering Tokyo and other regions in response to an increased number of COVID-19 infections. With the Company's expectation that COVID-19 in
            Japan would continue to impact negatively clinical site operations and enrollment of patients in the HONEDRA<sup>&#174;</sup> clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory
            authorities regarding the submission of patient data already accrued. Caladrius' phase 2b trial of XOWNA<sup>&#174;</sup> in the U.S. has also experienced delays in enrolling patients as a result of COVID-19.</div>
</ix:continuation>

          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936323" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936324"><ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="Text_9b1454c72db84da6948e2f14b2b9de6d" contextRef="c20220101to20220331" escape="true" continuedAt="Text_e1ca2d5fbe004e5b8c165395c87366c41">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Basis of Presentation</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936324" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936325"><ix:continuation id="Text_e1ca2d5fbe004e5b8c165395c87366c41">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The accompanying unaudited Consolidated Financial Statements have
            been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim
            financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated
            Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of March&#160;31, 2022, and the results of its
            operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2021
            and 2020 included in our 2021 Form 10-K. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936325" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936326"><ix:nonNumeric name="us-gaap:UseOfEstimates" id="Text_113c5b9d46d0474c960f453df67d3358" contextRef="c20220101to20220331" escape="true" continuedAt="Text_5d8e20efe03546a7ac8462593da85d921">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Use of Estimates</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936326" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936327"><ix:continuation id="Text_5d8e20efe03546a7ac8462593da85d921" continuedAt="Text_5d8e20efe03546a7ac8462593da85d922">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other </div>
</ix:continuation></ix:continuation>
            </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-30<br />
        </div>

      </div>

    </div>

    <!--End Page 30-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 31-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_204-finnotes02_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">

          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936327" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936328"><ix:continuation id="Text_5d8e20efe03546a7ac8462593da85d922">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">assumptions believed to be reasonable under the circumstances, the results of which
            form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly,
            actual results could differ from those estimates and assumptions.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936328" continuedAt="Text_cfc2ad1a38194bb5ba3c8eab660b936329"><ix:nonNumeric name="us-gaap:ConsolidationPolicyTextBlock" id="Text_042ed7f892014923857aa12d2e315838" contextRef="c20220101to20220331" escape="true" continuedAt="Text_a845cc68e86944b1ab1a250808fbad5e1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Principles of Consolidation</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_cfc2ad1a38194bb5ba3c8eab660b936329"><ix:continuation id="Text_a845cc68e86944b1ab1a250808fbad5e1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
</ix:continuation></ix:continuation>
            </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" id="Text_79b1a489344141aa928e3d11e80d1478" contextRef="c20220101to20220331" escape="true" continuedAt="Text_f4ec1e43840943efa44d1f4d175544301">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 2 &#8211; Summary of Significant Accounting Policies</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_f4ec1e43840943efa44d1f4d175544301" continuedAt="Text_f4ec1e43840943efa44d1f4d175544302">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In addition to the policies below, the Company's significant
            accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included in its 2021 Form 10-K. There were no changes to these policies during the three months ended March&#160;31, 2022.</div>
</ix:continuation>

          <ix:continuation id="Text_f4ec1e43840943efa44d1f4d175544302" continuedAt="Text_f4ec1e43840943efa44d1f4d175544303"><ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" id="Text_261863b3249940f2a8dc47ef23a35339" contextRef="c20220101to20220331" escape="true" continuedAt="Text_e969929ac12141ab90acaf177cb84fc41">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Concentration of Risks</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_f4ec1e43840943efa44d1f4d175544303" continuedAt="Text_f4ec1e43840943efa44d1f4d175544304"><ix:continuation id="Text_e969929ac12141ab90acaf177cb84fc41">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of
            priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_f4ec1e43840943efa44d1f4d175544304" continuedAt="Text_f4ec1e43840943efa44d1f4d175544305"><ix:nonNumeric name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="Text_3577991e36d24c7e85bae11716375b73" contextRef="c20220101to20220331" escape="true" continuedAt="Text_2a1be3692cd2454b9e9ef7fa9415b54b1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Share-Based Compensation </div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_f4ec1e43840943efa44d1f4d175544305"><ix:continuation id="Text_2a1be3692cd2454b9e9ef7fa9415b54b1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the
            date of grant.</div>
</ix:continuation></ix:continuation>
            </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:nonNumeric name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="Text_ae17541791d84f628a2c5c9cfdb0faa2" contextRef="c20220101to20220331" escape="true" continuedAt="Text_15b91ee4de7747cfaf49d446add3515e1">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 3 &#8211; Available-for-Sale-Securities</span></div>
</ix:nonNumeric>

          <ix:continuation id="Text_15b91ee4de7747cfaf49d446add3515e1" continuedAt="Text_15b91ee4de7747cfaf49d446add3515e2"><ix:nonNumeric name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="Text_e444fe8640ff47e287f03d9ce7334ac5" contextRef="c20220101to20220331" escape="true" continuedAt="Text_0f0715c882fa4d468d55074d157978ea1">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_15b91ee4de7747cfaf49d446add3515e2" continuedAt="Text_15b91ee4de7747cfaf49d446add3515e3"><ix:continuation id="Text_0f0715c882fa4d468d55074d157978ea1">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_c3765e2699f145d68f348ee45b54f01b" contextRef="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62,770</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_7c3a18d4bcaf44d3aa4663b71ef43acb" contextRef="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;">$(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_0ab4767477494e3782991bbb23d519e3" contextRef="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">162</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_2771acfefb954fbf8bff71b71c5e7014" contextRef="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">62,608</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_867724428db443109cafc7ff05994c85" contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">53,135</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_5b14d845c8844b42bd63ea547007d098" contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_e7901d67c6864751bc96ce8935eefafa" contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">65</ix:nonFraction>)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_05ccdef4f2a443bb90d128844075522e" contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">53,070</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_fe254bace3d646e182a60b5fa796937e" contextRef="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,578</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_8d21eed6719445978782550fb4d741f5" contextRef="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 13.33pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_502c8e6b976246b0bf1060aabd335db3" contextRef="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_9a0be722fe864ce0a7d274c65117e6c2" contextRef="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">6,578</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_8ef07fd6ef3c4c8b937520c20a631dff" contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,124</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_7a76c00dc0d14332858e9d6779d69d48" contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_c2ee3d08249f4243a88b11be29d94d18" contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_183e46dbf91c486f98867a76d0c9d341" contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">18,124</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_a9e1d0da7d9c4b3eaf852ae748ca2107" contextRef="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,267</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_203b9516d58340c88dbf075b1b641103" contextRef="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_5598ff80b800403cad38566d09b05e96" contextRef="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">34</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_d224a76050d4410390d01685b11addd4" contextRef="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">17,233</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_46b6e5027aa74a398c941f095a6dd430" contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,263</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_58d9172128d949f8b7e690bd9e7512a3" contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_8aaad14adba74dc3bf2fc7e7ed5163d1" contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">5</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_e3218be46e4d4da5b6bed14906887d6f" contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">20,258</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_f479d5a58cac432f86c7bb7b4d54c231" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,615</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_ccda01b5f52d4828acab7b5068ac9a6f" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_8224419e040740358f3570df73ae1794" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">196</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_eac66ed9ab044263a95ffc7d2d43b14d" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,419</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_afe66022c30e4679b05daceb19f9c2e7" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_9c1dbd1ea7cd40cca58bddbb57d7fc32" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,522</ix:nonFraction></ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" id="Fact_90ab9311abfb497b8506367f86a764a3" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" id="Fact_757c6943e3584a0885cb7f7ca9c791e6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_6289a4d567ad479094b02ef9433c2596" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,452</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
            </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-31<br />
        </div>

      </div>

    </div>

    <!--End Page 31-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 32-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_204-finnotes02_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_15b91ee4de7747cfaf49d446add3515e3" continuedAt="Text_15b91ee4de7747cfaf49d446add3515e4"><ix:nonNumeric name="us-gaap:MarketableSecuritiesTextBlock" id="Text_2b250b4f98284e28b16cb08d8e767bd3" contextRef="c20220101to20220331" escape="true" continuedAt="Text_94b0bc01013f45e882487b1ad5d620ab1">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are
            generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_15b91ee4de7747cfaf49d446add3515e4" continuedAt="Text_15b91ee4de7747cfaf49d446add3515e5"><ix:continuation id="Text_94b0bc01013f45e882487b1ad5d620ab1">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash equivalents</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;">$<ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" id="Fact_eb157e1c0109422680e40fb53168482e" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">10,647</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$<ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" id="Fact_607a7586232942709403bd0060db3e80" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">21,129</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:MarketableSecurities" id="Fact_90db233daaa3430c9d302fdb059a8494" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">75,772</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:MarketableSecurities" id="Fact_190f90aaae8e4de5b8552a412456944d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" id="Fact_afb55fccd5d24f308eee90661db83601" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,419</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:CashCashEquivalentsAndShortTermInvestments" id="Fact_ee5a540da1cc4aecb47d9e48f0797ab6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_bc49e621160c47a085811484660ba348" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">91,452</ix:nonFraction></ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_15b91ee4de7747cfaf49d446add3515e5" continuedAt="Text_15b91ee4de7747cfaf49d446add3515e6"><ix:nonNumeric name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="Text_81b01e6dca0148e09ce0a3e389ef8550" contextRef="c20220101to20220331" escape="true" continuedAt="Text_df0f75ee8be84d86b5c9f632cd7f36521">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes our portfolio of available-for-sale
            securities by contractual maturity (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_15b91ee4de7747cfaf49d446add3515e6"><ix:continuation id="Text_df0f75ee8be84d86b5c9f632cd7f36521">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 19.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" id="Fact_f807c8584d3949a9bbfcc4c552125d39" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,615</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" id="Fact_37a27cfa675e4dfb84c70aec8770894a" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,419</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"><ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" id="Fact_5c8aaf1b11974bfdbef0d75d435c3a45" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="Fact_1cd51ec43ffc4caa833b7a5e18ab0c48" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,615</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" id="Fact_579d0619e9da49fb972f5f8b2400ac94" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">86,419</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
            </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:EarningsPerShareTextBlock" id="Text_73fcadad799946fcb79287451d2040b4" contextRef="c20220101to20220331" escape="true" continuedAt="Text_28779e532b6b4af397ac9fff5ec838fa1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 4 &#8211; Income (Loss) Per Share</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_28779e532b6b4af397ac9fff5ec838fa1" continuedAt="Text_28779e532b6b4af397ac9fff5ec838fa2">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">For the three months ended March&#160;31, 2022 and 2021, the Company
            incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive. <ix:nonNumeric name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="Text_84522f7600ff4a12985a405deb2ceaa9" contextRef="c20220101to20220331" escape="true" continuedAt="Text_8080f0af2f3742c4a9a696ca220d3b671"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At March&#160;31, 2022 and 2021, the Company excluded
            the following potentially dilutive securities (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
          <ix:continuation id="Text_8080f0af2f3742c4a9a696ca220d3b671"><ix:continuation id="Text_28779e532b6b4af397ac9fff5ec838fa2">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 17.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Options</div>
                </td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_3d47e9ca0b654a94a6a2b9411697df47" contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">2,640</ix:nonFraction></span></div>
                </td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_d3f33c8eebae41c6b6e0759a03063348" contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,022</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Warrants</div>
                </td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_e3bf1ad559a84a8f8301b7559c4bae62" contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21,357</ix:nonFraction></div>
                </td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_81b8b8eeb5e742e19f611be2b821d6ad" contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">21,357</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Restricted Stock Units</div>
                </td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_4e53a59a95cd441f89cc785686074cbf" contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">1,460</ix:nonFraction></span></div>
                </td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" id="Fact_9f9144234ca34c6ea5c8ef0c19d364ac" contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="-3" scale="3" format="ixt:numdotdecimal">798</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:FairValueDisclosuresTextBlock" id="Text_fa393a9faca0421a80825f4709604ef7" contextRef="c20220101to20220331" escape="true" continuedAt="Text_a477f4d7dac246b6a64f0a771daa30001">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 5 &#8211; Fair Value Measurements</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_a477f4d7dac246b6a64f0a771daa30001" continuedAt="Text_a477f4d7dac246b6a64f0a771daa30002">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The fair value of financial assets and liabilities that are being
            measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price).
            The Company is required to classify fair value measurements in one of the following categories:</div>
</ix:continuation>
          <ix:continuation id="Text_a477f4d7dac246b6a64f0a771daa30002" continuedAt="Text_a477f4d7dac246b6a64f0a771daa30003">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Level 1 inputs are defined as quoted prices (unadjusted) in active
            markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</div>
</ix:continuation>
          <ix:continuation id="Text_a477f4d7dac246b6a64f0a771daa30003" continuedAt="Text_a477f4d7dac246b6a64f0a771daa30004">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Level 2 inputs are defined as inputs other than quoted prices
            included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</div>
</ix:continuation>
          <ix:continuation id="Text_a477f4d7dac246b6a64f0a771daa30004" continuedAt="Text_a477f4d7dac246b6a64f0a771daa30005">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Level 3 inputs are defined as unobservable inputs for the assets or
            liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
            requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</div>
</ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-32<br />
        </div>

      </div>

    </div>

    <!--End Page 32-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 33-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_204-finnotes02_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_a477f4d7dac246b6a64f0a771daa30005" continuedAt="Text_a477f4d7dac246b6a64f0a771daa30006"><ix:nonNumeric name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="Text_477bfde4a3e346319330ab5958b28da5" contextRef="c20220101to20220331" escape="true" continuedAt="Text_2d6b51caa18947d0939e9c31cb495b0d1">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The following table sets forth by level within the fair value
            hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands).</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_a477f4d7dac246b6a64f0a771daa30006"><ix:continuation id="Text_2d6b51caa18947d0939e9c31cb495b0d1">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="10">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31, 2022</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="10">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Level 1</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Level 2</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Level 3</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Level 1</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Level 2</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Level 3</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Assets: </div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Marketable securities - available for sale</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_7fef356f76e44b2cb05214e36e294d20" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_1f110618655a4c95948ea1a6c2dc95a6" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">75,772</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_c5e14725eb5f47a3b6dc657eefea30b1" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_0a41061d314e47d18c7d492d434bcb75" contextRef="c20220331_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">75,772</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_a5c2ce99581e4907942f099a40bc6ac6" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_cc1e7d890eac4987a7acd0565a47f861" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_4c1a76c387e94cdb8d20ec7e605aaca8" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:InvestmentsFairValueDisclosure" id="Fact_b3642c409cb24506883ffa0d803e257b" contextRef="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_cba70a5b460643669cf2490ae3a085a6" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_408ee1a0d1d243d7af4000e35c8df7e5" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">75,772</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_f6a84740db724463b1319e779600a2aa" contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_4ff83c26030740f8805f70ad7b3eaaeb" contextRef="c20220331_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">75,772</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_c7b0dcb1da6449e9b3db66474cc0b983" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_8a1bc202fd0b4828b3afd2fe9ea71ef4" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_3fb9698efc744e02ade5f39475d70922" contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$<ix:nonFraction name="us-gaap:AssetsFairValueDisclosure" id="Fact_032ded14f5034f509828766ce91c1972" contextRef="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">70,323</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
            </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="Text_1515bf9949424cae92e6357367cc464d" contextRef="c20220101to20220331" escape="true" continuedAt="Text_e3f0744ee6cf41db8e3e404f0c8fdb141">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 6 &#8211; Accrued Liabilities</span></div>
</ix:nonNumeric>

          <ix:continuation id="Text_e3f0744ee6cf41db8e3e404f0c8fdb141" continuedAt="Text_e3f0744ee6cf41db8e3e404f0c8fdb142"><ix:nonNumeric name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="Text_0cd42b77435a482fb3bf62e6149e7b04" contextRef="c20220101to20220331" escape="true" continuedAt="Text_f1bbba7c0de14748a3a532a414d39e121">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Accrued liabilities as of March&#160;31, 2022 and December&#160;31, 2021 were
            as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_e3f0744ee6cf41db8e3e404f0c8fdb142"><ix:continuation id="Text_f1bbba7c0de14748a3a532a414d39e121">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Salaries, employee benefits and related taxes</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_246d2973f4314ad886e85af7144e135b" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,005</ix:nonFraction></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:EmployeeRelatedLiabilitiesCurrent" id="Fact_d30706a42f274cf4bd0df7e39d9e1869" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,034</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating lease liabilities &#8212; current</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_da0777e1b5ac4f828ba7d6248d5e01fd" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">205</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_f7bd34395b4f4094a5d5df17ea4330c2" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">229</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_2a3dd0067cd14d9da5e15c86f0177800" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">894</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesCurrent" id="Fact_aaa07bb834294567b332457a631b05e6" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">326</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_ecbaad73bad949ec803ff162188d1dc5" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,104</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$<ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" id="Fact_86383e3aa23e441ca2e8efc9bcb466bc" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">2,589</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:LesseeOperatingLeasesTextBlock" id="Text_7db16f5660114739a0035bfb1409223a" contextRef="c20220101to20220331" escape="true" continuedAt="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be1">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 7 &#8211; Operating Leases</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be1" continuedAt="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be2">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has operating leases for <ix:nonFraction name="clbs:NumberOfOfficesUnderOperatingLeases" id="Fact_2f7f1cd0aa374dad983882bfb95f8cd8" contextRef="c20220331" unitRef="U004" decimals="0" scale="0" format="ixt-sec:numwordsen">two</ix:nonFraction> offices with terms that expire in 2023 and 2025, respectively. The Company estimates its incremental borrowing rate at lease commencement to
            determine the present value of lease payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or
            reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases includes options for the Company to
            extend the lease term and/or sub-lease space in whole or in part.</div>
</ix:continuation>

          <ix:continuation id="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be2" continuedAt="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be3"><ix:nonNumeric name="clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" id="Text_3fc91bb115d54959b0b02d44cc7f7d61" contextRef="c20220101to20220331" escape="true" continuedAt="Text_5ee665e9341c44f0ad93bd2cbd0624021">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be3" continuedAt="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be4"><ix:continuation id="Text_5ee665e9341c44f0ad93bd2cbd0624021">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Right-of Use Assets:<br />
                  </div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="-sec-ix-hidden:Fact_ce1d736a988a4564aff92c00256cdd92"><span style="-sec-ix-hidden:Fact_2bb6a876105046b48a849d6ac8adfc37">Other assets</span></span><br />
                  </div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_818d5b3b6f26488a843fff1def7368cf" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">667</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_59b00c5bf16c4fdab820a35ed46cc91d" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">724</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Right-of-Use Asset</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_e216ba22b15a47338b8f3adb9511f271" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">667</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" id="Fact_26b8b9387c0b4a08b38e4e10d4375ba3" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">724</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating Lease Liabilities:<br />
                  </div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="-sec-ix-hidden:Fact_394d33db98754a5dbaa2063579daa0be"><span style="-sec-ix-hidden:Fact_01cbbf57a5d5461f83158b26769ed161">Accrued liabilities</span></span><br />
                  </div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_b1b75d4169f54e89ae11b4f25d22c1d5" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">205</ix:nonFraction></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" id="Fact_06c6ba22d72643e786778d9fb4ce4c4e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">229</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="-sec-ix-hidden:Fact_646cbb0a67a54f629dc6c425eb143706"><span style="-sec-ix-hidden:Fact_52d14b2a09d54c84bb4a3b7e7f351e66">Other long-term liabilities</span></span> </div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_8d47b144c74d46b992950e148e051a02" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">421</ix:nonFraction> </span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" id="Fact_e32f9a73b5544b6d97e95c1daabad5ea" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">485</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total Operating Lease Liabilities</div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_67b921052da44ea88340a47ede6e6835" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">626</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_25af6510705b4b7787aa13f9b9193d5b" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">714</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-33<br />
        </div>

      </div>

    </div>

    <!--End Page 33-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 34-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_204-finnotes02_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:continuation id="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be4" continuedAt="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be5">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of March&#160;31, 2022, the weighted average remaining lease term
            for our operating leases was <ix:nonNumeric name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="Fact_a1dbc465cd3e4a698838f2e35b0bb755" contextRef="c20220331" format="ixt-sec:duryear">2.3</ix:nonNumeric> years, and the weighted average discount rate for our operating leases was <ix:nonFraction name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" id="Fact_0af2f1879cde4a3a9b8112f3f4a1b487" contextRef="c20220331" unitRef="U005" decimals="5" scale="-2" format="ixt:numdotdecimal">9.625</ix:nonFraction>%. <ix:nonNumeric name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="Text_11e72fc091a64eec91ef223e13590ddf" contextRef="c20220101to20220331" escape="true" continuedAt="Text_928bc12a21574b18bb8bd0124277fd3a1"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of March&#160;31, 2022 were as follows (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
          <ix:continuation id="Text_928bc12a21574b18bb8bd0124277fd3a1"><ix:continuation id="Text_df6dfaa6bf9a4b1ebad96b3e3f4c01be5">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Years ended</div>
                </td>

    <td style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Operating <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2022</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" id="Fact_92d5d9ec1b1e40bab7ea0883d5f9e4ad" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">181</ix:nonFraction><br />
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2023</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" id="Fact_81436dc3f99f4013aeb6fc6cf9212543" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">217</ix:nonFraction><br />
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2024</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" id="Fact_8c8f71465ea94238af0e83405f1aa5b0" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">190</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2025</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" id="Fact_89686fa86c6d4404bf89e5bd41bde1b0" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">143</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total lease payments</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" id="Fact_db178d4728a6486bbdac643638a28289" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">731</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Less: Amounts representing interest</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(<ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" id="Fact_9fa49193f1314039be228ad6dfe3962a" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">105</ix:nonFraction>) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Present value of lease liabilities</div>
                </td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" id="Fact_8c7ffa3cb8f34d4cb0f6c2e9b35bce1b" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">626</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="Text_839f7f30e02840f799a4754270238b87" contextRef="c20220101to20220331" escape="true" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf1">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 8 &#8211; Stockholders' Equity</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf1" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf2">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Equity Issuances</div>
</ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf2" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf3">
<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Purchase Agreement</span></div>
</ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf3" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf4">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In March 2019, the Company and Lincoln Park Capital Fund, LLC
            (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company&#8217;s
            common stock having an aggregate value of up to $<ix:nonFraction name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" id="Fact_1ae19c090a3843e18a20963cbb917b31" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">26.0</ix:nonFraction> million, subject to certain limitations and conditions set forth in the
            Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional <ix:nonFraction name="clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration" id="Fact_7277d241456c461fa868ce688fb95c14" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">181,510</ix:nonFraction>
            shares of common stock as commitment shares.</div>
</ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf4" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf5">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the Purchase Agreement, Lincoln Park purchased <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" id="Fact_c04787dccaa945ce877513f95af6dc7b" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">250,000</ix:nonFraction> shares of common stock, at a price of $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" id="Fact_0b8f2b03cb804e79b8795a1403dac888" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">4.00</ix:nonFraction>
            per share, for a total gross purchase price of $<ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" id="Fact_f781cf82ff6a4d6fac5a8194a2036227" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million (the &#8220;Initial Purchase&#8221;) upon commencement. Thereafter, as often as every
            business day from and after one business day following the date of the Initial Purchase and over the <ix:nonNumeric name="clbs:TermOfAgreement" id="Fact_18b0cd57f26b44fea64238a9fe4bf3ab" contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" format="ixt-sec:durmonth">36</ix:nonNumeric>-month term of the Purchase
            Agreement the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to <ix:nonFraction name="clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" id="Fact_fee15084e7724ec6b61156c466d53b9c" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">100,000</ix:nonFraction> shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln Park&#8217;s obligation under any single such purchase will not exceed $<ix:nonFraction name="clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" id="Fact_debc6322b3a7430db2c5b02670bfbf66" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction> million, unless the Company and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;).
            If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase
            Agreement, the Company may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of (i) <ix:nonFraction name="clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" id="Fact_8ad80778fad341928dadcbc893335629" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">300</ix:nonFraction>% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) <ix:nonFraction name="clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" id="Fact_1f798a75cd1248b59bd5494b038c28e9" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U005" decimals="2" scale="-2" format="ixt:numdotdecimal">30</ix:nonFraction>% of
            the total number of shares of the Company&#8217;s common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement. Under certain circumstances and in accordance with the Purchase Agreement, the
            Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.</div>
</ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf5" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf6">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company controls the timing and amount of any sales of its common
            stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the
            floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than <ix:nonFraction name="clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" id="Fact_86b49d648dcc4c4eb798954989184bd1" contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember" unitRef="U005" decimals="4" scale="-2" format="ixt:numdotdecimal">9.99</ix:nonFraction>% of its common stock.</div>
</ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf6" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf7">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Purchase Agreement does not limit the Company&#8217;s ability to raise
            capital from other sources at the Company&#8217;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating
            conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.</div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-34<br />
        </div>

      </div>

    </div>

    <!--End Page 34-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 35-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_204-finnotes02_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf7" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf8">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of March&#160;31, 2022, the Company had not made any sales of common
            stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase. The agreement expired on April&#160;1, 2022.</div>
</ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf8" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf9">
<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">At The Market Offering Agreement</span></div>
</ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf9" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf10">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June&#160;4, 2021, the Company entered into an At The Market Offering
            Agreement (the &#8220;ATM Agreement&#8221;) with HCW, as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $<ix:nonFraction name="clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" id="Fact_24da1ea978c44e7f8fe82ce7f768f621" contextRef="c20210604_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">50.0</ix:nonFraction> million. During the three months ended March&#160;31, 2022 and since inception the Company had <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="Fact_9111a1959363481084910ab2278cfd04" contextRef="c20220101to20220331_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember" unitRef="U002" decimals="INF" scale="0" format="ixt-sec:numwordsen">no</ix:nonFraction>t issued any shares under the ATM Agreement. Having received a listing deficiency notice from Nasdaq on February&#160;18, 2022 after the Company&#8217;s shares traded below $1.00
            for 30 consecutive trading days, the Company will not be permitted to sell additional shares under the ATM Agreement until it re-establishes timely compliance. Compliance may be reestablished by various mechanisms, including stock price
            appreciation at or above $1.00 for a requisite period of time and reverse stock split.</div>
</ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf10" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf11">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Stock Options and Warrants</div>
</ix:continuation>

          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf11" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf12"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="Text_63e51c18b35346ad942fee5577867554" contextRef="c20220101to20220331" escape="true" continuedAt="Text_bca5abf743e94b81b4a70147ca966a071">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the three months ended March&#160;31, 2022:</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf12" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf13"><ix:continuation id="Text_bca5abf743e94b81b4a70147ca966a071">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_0a8aac52d9cd4a5cad0ffff69145ddf6" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,131,849</ix:nonFraction><br />
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_1737eb09bbd04772adaf334bac1d0d98" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">5.64</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_d3ceb3b08a9f43928712fedc09c78f6a" contextRef="c20210101to20211231" format="ixt-sec:duryear">7.97</ix:nonNumeric><br />
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_844fe32673da45efa7e31c4bf0fc327f" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><ix:nonFraction name="clbs:CommonStockWarrantsShares" id="Fact_7e82ae12b0f144bba0084546451c8f94" contextRef="c20211231" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">21,356,600</ix:nonFraction><br />
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsOutstanding" id="Fact_f8bc7989a5324f5f9520950539dff6f4" contextRef="c20211231" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.84</ix:nonFraction></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><ix:nonNumeric name="clbs:WeightedAverageRemainingContractualTermwarrantoutstanding" id="Fact_c8254038903c4304a98d74fd4bab2590" contextRef="c20210101to20211231" format="ixt-sec:duryear">4.37</ix:nonNumeric><br />
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$<ix:nonFraction name="clbs:AggregateIntrinsicValueWarrantsOutstanding" id="Fact_f05d9de2d4db457f8130aa29f0798a8e" contextRef="c20211231" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the period:<br />
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" id="Fact_98c4797539ce462c8e542b9da65438e0" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">540,600</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" id="Fact_ce30f0b05eb840d9b4d4b2176cfb6210" contextRef="c20220101to20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.91</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;"><ix:nonFraction name="clbs:WarrantsGranted" id="Fact_2ff39fb74e9849c59d51f2aff606b5c3" contextRef="c20220101to20220331" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;"><ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsGranted" id="Fact_3290c15580e141ff82fd77732977ddaf" contextRef="c20220101to20220331" unitRef="U003" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 30pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" id="Fact_69b1e376659e402da005140dee327ffb" contextRef="c20220101to20220331" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 17.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" id="Fact_170300b359f4424da49a40b4210f8438" contextRef="c20220101to20220331" unitRef="U003" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;"><ix:nonFraction name="clbs:WarrantsExercised" id="Fact_5a08277a4d464eb695578ddbba765ddf" contextRef="c20220101to20220331" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;"><ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsExercised" id="Fact_cf7f53bfb2274af88a509ffe34151539" contextRef="c20220101to20220331" unitRef="U003" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" id="Fact_6123a40f5e7c4a4499d0c0b14e0b1098" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">9,565</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" id="Fact_947b75f56f6d4c4dae2487cd22837780" contextRef="c20220101to20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.90</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;"><ix:nonFraction name="clbs:WarrantsCanceled" id="Fact_0da77c89ee4c4ba5859119fe6808875f" contextRef="c20220101to20220331" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;"><ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsCanceled" id="Fact_4fcbb1208f8e45658575e343db91ab80" contextRef="c20220101to20220331" unitRef="U003" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" id="Fact_2d5eab29ce0646369302427fb1b8a007" contextRef="c20220101to20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">23,275</ix:nonFraction>)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" id="Fact_b92d7fd7f87e4f0f81d7c32ebdf86beb" contextRef="c20220101to20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">26.00</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;"><ix:nonFraction name="clbs:WarrantsExpired" id="Fact_2934e48abc00426880cfabda6d2cb660" contextRef="c20220101to20220331" unitRef="U002" decimals="INF" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;"><ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsExpired" id="Fact_62d10134ae6b479380f2678fe2067206" contextRef="c20220101to20220331" unitRef="U003" decimals="0" scale="0" format="ixt:zerodash">&#8212;</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" id="Fact_7955b42fc9a549c68bd2b84ccd2e9068" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,639,609</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" id="Fact_26d1923d9fb34844bcb89f7474f302be" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">4.51</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="Fact_f9b34464d46a4c2d9b011ec3fbc9d82c" contextRef="c20220101to20220331" format="ixt-sec:duryear">7.83</ix:nonNumeric><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" id="Fact_e2f8cc48b72b47928b6d5d442a7bdb33" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="clbs:CommonStockWarrantsShares" id="Fact_f2b2e0bd329943ada6e86032fce8a6d0" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">21,356,600</ix:nonFraction><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsOutstanding" id="Fact_c77329a79f1c46c582a4a038a37b816f" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.84</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="clbs:WeightedAverageRemainingContractualTermwarrantoutstanding" id="Fact_040892a4b6c24f9aa884d11a899007f1" contextRef="c20220101to20220331" format="ixt-sec:duryear">4.13</ix:nonNumeric><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="clbs:AggregateIntrinsicValueWarrantsOutstanding" id="Fact_7bdc1e6671f942e5bc96120fb0124ad6" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at March&#160;31, 2022 or expected to vest in the future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" id="Fact_8b4f9499752649eebb70106e36b2da1b" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">2,594,630</ix:nonFraction><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" id="Fact_e1ef9c4ad34d432cb9f8501b421927e8" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">4.57</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="Fact_852846ced2de4c338e7eba54f2cd8c2a" contextRef="c20220101to20220331" format="ixt-sec:duryear">7.80</ix:nonNumeric><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" id="Fact_80c70f5a3abd48b8b78826fb9afcf4cf" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="clbs:Sharesvestedandexpectedtovest" id="Fact_8043ad793d9d49c3a3f6850888acad7b" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">21,356,600</ix:nonFraction><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" id="Fact_5a83379237f74bf1979165ce930727cd" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.84</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" id="Fact_d4cbe693e6f643d4aff3a97e6cf94128" contextRef="c20220101to20220331" format="ixt-sec:duryear">4.13</ix:nonNumeric><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest" id="Fact_af24645ca3ec44d48cbff436e58cb2f3" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" id="Fact_fb65b45cae144244b744d8698ac54f63" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,408,083</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" id="Fact_dd51bcffa1dc4385ad9b704234459d9c" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">7.36</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="clbs:OptionsVestedweightedAverageRemainingContractualTerm" id="Fact_f13013846887486f9308a317d0936499" contextRef="c20220101to20220331" format="ixt-sec:duryear">6.41</ix:nonNumeric><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" id="Fact_111ddb9096804dcaa9249eca4940b978" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="clbs:WarrantsVested" id="Fact_8edb830485f44e8e8c7f9b75b29c8ca8" contextRef="c20220331" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">21,356,600</ix:nonFraction><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$<ix:nonFraction name="clbs:WeightedAverageExercisePriceWarrantsExercisable" id="Fact_fd9ca6c17edc4b0db4868c4f54982564" contextRef="c20220331" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">2.84</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"><ix:nonNumeric name="clbs:WeightedAverageRemainingContractualTermwarrantsvested" id="Fact_723bdc1fe26c4541a851f6c7b4435dcf" contextRef="c20220101to20220331" format="ixt-sec:duryear">4.13</ix:nonNumeric><br />
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$<ix:nonFraction name="clbs:AggregateIntrinsicValueWarrantsvested" id="Fact_f2a084ec6dd8482fb1758049a3a64b3f" contextRef="c20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:zerodash">&#8212;</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf13" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf14">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Restricted Stock</div>
</ix:continuation>

          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf14" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf15"><ix:nonNumeric name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="Text_81c564b83d7e4d9ebd72f19fa4d4f32d" contextRef="c20220101to20220331" escape="true" continuedAt="Text_fb83334f5c874878829648ba71e85b301">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock for services as follows ($ in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf15" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf16"><ix:continuation id="Text_fb83334f5c874878829648ba71e85b301">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_9bce703c58ef42288008446472dff63b" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,061,175</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_a0bc2cff2168465aa03a2c846a293a12" contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">300,450</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 25pt; border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_657acf36c64242dabb5fd7f2f1eac707" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">973</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_99186fdbb105486a9f2be695e7e26190" contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">478</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf16" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf17">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The vesting terms of restricted stock issuances are generally
            between <span style="-sec-ix-hidden:Fact_09a53c4a1103459dacf922bb1b50b09c">one</span> to <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_34b525dd845144f49e2b68100041c53b" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMember" format="ixt-sec:durwordsen">four years</ix:nonNumeric>.</div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-35<br />
        </div>

      </div>

    </div>

    <!--End Page 35-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 36-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_204-finnotes02_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf17" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf18">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
</ix:continuation>

          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf18" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf19"><ix:nonNumeric name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="Text_6bee3e0c5b2f43b882dab054f4aade40" contextRef="c20220101to20220331" escape="true" continuedAt="Text_aa409b815aec467dbb0894b807ea5aa51">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock units for services as follows ($ in thousands, except share data):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf19" continuedAt="Text_7fc1485291f74f3dba4d548b0d71b3bf20"><ix:continuation id="Text_aa409b815aec467dbb0894b807ea5aa51">
<table cellspacing="0" cellpadding="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br />
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock units issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_1a388ff54cf14f0cb9deef6e14272f6e" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,379,860</ix:nonFraction> </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" id="Fact_11662cd3110041d6969e762ec367fcb1" contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">458,245</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock units issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_d4d392900b8d47c5a95f6fe7eed26f76" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,265</ix:nonFraction></span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" id="Fact_02a3864b25de46198b6ee2387f8d8163" contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">729</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_7fc1485291f74f3dba4d548b0d71b3bf20">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock issued
            for services in the three months ended March&#160;31, 2022 and 2021 was $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_46e20d1b99a447c79251bd50555546e0" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.92</ix:nonFraction> and $<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_ac649c9a8f9f45e683ccf673c4f724f1" contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.59</ix:nonFraction> per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms
            of restricted stock unit issuances are generally <ix:nonNumeric name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="Fact_ed1516c9e5b642a494787c97eb066cef" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" format="ixt-sec:durwordsen">one year</ix:nonNumeric>, or upon the achievement of performance-based milestones.</div>
</ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="Text_ab0376df24f742d8a04fa7a05b63eb55" contextRef="c20220101to20220331" escape="true" continuedAt="Text_45029e885bb549a09781dda8e87995f61">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 9 &#8211; Share-Based Compensation</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_45029e885bb549a09781dda8e87995f61" continuedAt="Text_45029e885bb549a09781dda8e87995f62">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Share-Based Compensation</div>
</ix:continuation>
          <ix:continuation id="Text_45029e885bb549a09781dda8e87995f62" continuedAt="Text_45029e885bb549a09781dda8e87995f63">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">We utilize share-based compensation in the form of stock options,
            restricted stock, and restricted stock units. <ix:nonNumeric name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="Text_79ade1563cca413a9ab4787ce57c40e3" contextRef="c20220101to20220331" escape="true" continuedAt="Text_6c435c475f7f43c0a157c995bbac0e2c1"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></ix:nonNumeric></div>
</ix:continuation>
          <ix:continuation id="Text_6c435c475f7f43c0a157c995bbac0e2c1"><ix:continuation id="Text_45029e885bb549a09781dda8e87995f63" continuedAt="Text_45029e885bb549a09781dda8e87995f64">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_15bcd3db5f4040c3b70c461bad7de12f" contextRef="c20220101to20220331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">218</ix:nonFraction></div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_e8750fc045fd451bada12cc07c9d8bdc" contextRef="c20210101to20210331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">96</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_d0052139ab5e4808befdbcc53d1007e9" contextRef="c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">542</ix:nonFraction> </span></div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_1585980d235741069b9ebc2cfb914943" contextRef="c20210101to20210331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">501</ix:nonFraction> </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total share-based compensation expense</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_a3c1aa9813cf4992950a2ec6984d80d6" contextRef="c20220101to20220331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">760</ix:nonFraction></span></div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$<ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" id="Fact_055f765629414fcb9642d9ad718f28b2" contextRef="c20210101to20210331" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">597</ix:nonFraction></span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_45029e885bb549a09781dda8e87995f64" continuedAt="Text_45029e885bb549a09781dda8e87995f65"><ix:nonNumeric name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="Text_2e4a8af45f004fef8e310b4089cf5302" contextRef="c20220101to20220331" escape="true" continuedAt="Text_5dfc04e930df4e32baacb26365fa68b11">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Total compensation cost related to non-vested awards not yet
            recognized and the weighted-average periods over which the awards were expected to be recognized at March&#160;31, 2022 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_45029e885bb549a09781dda8e87995f65" continuedAt="Text_45029e885bb549a09781dda8e87995f66"><ix:continuation id="Text_5dfc04e930df4e32baacb26365fa68b11">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Restricted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Units</div>
                </td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Restricted <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Unrecognized compensation cost</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;" class="fpara">$<span style="padding-left: 2.5pt;"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" id="Fact_b03cf2392fda40cb870169f7da1c6a98" contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">814</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara">$<span style="padding-left: 2.5pt;"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" id="Fact_88536e6a29e3440d8d946695f96ddb7e" contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">444</ix:nonFraction></span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" id="Fact_62a14e3fe70c47e9af96af0c9004093e" contextRef="c20220331_AwardTypeAxis_RestrictedStockMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">1,004</ix:nonFraction></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_85cec763f2af4d2abdd341fcea9794ee" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" format="ixt-sec:duryear">1.77</ix:nonNumeric> </span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;"><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_5d4df826e8f74bada52c47c545ef583d" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember" format="ixt-sec:duryear">0.96</ix:nonNumeric> </span></div>
                </td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;"><ix:nonNumeric name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="Fact_633da930efee40b38ab6bf4ef6ce952d" contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember" format="ixt-sec:duryear">2.25</ix:nonNumeric> </span></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>


          <ix:continuation id="Text_45029e885bb549a09781dda8e87995f66" continuedAt="Text_45029e885bb549a09781dda8e87995f67"><ix:nonNumeric name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="Text_9fff4a6384fe4abfa30cd50b72d1eea8" contextRef="c20220101to20220331" escape="true" continuedAt="Text_a652a2c14c9d4bc0a2b3745664e045831">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the three months ended March&#160;31, 2022 and 2021 were as follows (in thousands):</div>
</ix:nonNumeric></ix:continuation>
          <ix:continuation id="Text_45029e885bb549a09781dda8e87995f67" continuedAt="Text_45029e885bb549a09781dda8e87995f68"><ix:continuation id="Text_a652a2c14c9d4bc0a2b3745664e045831">
<table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total fair value of shares vested</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;" class="fpara">$<span style="padding-left: 2.5pt;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" id="Fact_5e7d5a685523469c80706cf3bab1e990" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">377</ix:nonFraction></span></div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;" class="fpara">$<span style="padding-left: 2.5pt;"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" id="Fact_34fed4c3970b45ee8967ab12ba2657fa" contextRef="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">397</ix:nonFraction></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average estimated fair value of shares granted</div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_e193c9c7f5fc46c4851e1a8169a028f1" contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">0.62</ix:nonFraction></div>
                </td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;" class="fpara">$<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" id="Fact_7f6c53ebb6534bf5b3070101005eb4e4" contextRef="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember" unitRef="U003" decimals="2" scale="0" format="ixt:numdotdecimal">1.08</ix:nonFraction></div>
                </td>

  </tr>


</table>
</ix:continuation></ix:continuation>

          <ix:continuation id="Text_45029e885bb549a09781dda8e87995f68" continuedAt="Text_45029e885bb549a09781dda8e87995f69">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h3">Valuation Assumptions</div>
</ix:continuation>
          <ix:continuation id="Text_45029e885bb549a09781dda8e87995f69">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The fair value of stock options and warrants at the date of grant was
            estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant
            and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.</div>
</ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-36<br />
        </div>

      </div>

    </div>

    <!--End Page 36-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 37-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_204-finnotes02_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:nonNumeric name="us-gaap:IncomeTaxDisclosureTextBlock" id="Text_694bbc021b284f538d33d56f20ed2867" contextRef="c20220101to20220331" escape="true" continuedAt="Text_84a272d9b9fe483c8e0ea88cb46a64be1">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 10 &#8211; Income Taxes</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_84a272d9b9fe483c8e0ea88cb46a64be1" continuedAt="Text_84a272d9b9fe483c8e0ea88cb46a64be2">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In assessing the realizability of deferred tax assets, including the
            net operating loss carryforwards (&#8220;NOLs&#8221;), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets. Based on its assessment,
            the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</div>
</ix:continuation>
          <ix:continuation id="Text_84a272d9b9fe483c8e0ea88cb46a64be2" continuedAt="Text_84a272d9b9fe483c8e0ea88cb46a64be3">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021 and 2020, the Company had approximately $<ix:nonFraction name="clbs:OperatingLossCarryforwardsBeforeWriteDown" id="Fact_f261d540aa6844c081ebb28872c29cdc" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">281</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_505043f6d54c4de48aec3592c9a76ecf" contextRef="c20201231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">264</ix:nonFraction> million,
            respectively of federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on
            January&#160;25, 2021. As a result, $<ix:nonFraction name="clbs:OperatingLossCarryforwardsSetToExpireWrittenDown" id="Fact_fc5d2ac218264a28b32fcf4879144622" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">169</ix:nonFraction> million of the $<ix:nonFraction name="clbs:OperatingLossCarryforwardsBeforeWriteDown" id="Fact_24991f632b864d3086681ceb709f95c5" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">281</ix:nonFraction> million of federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_6b01f9675067465dadf40b7b966c38af" contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">112</ix:nonFraction> million of remaining federal NOL. The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact
            to the balance sheet or income statement. Losses incurred before the ownership change on January&#160;25, 2021 will be subject to an annual limitation of $173k under Internal Revenue Code Section 382, while losses incurred after January&#160;25, 2021
            will not be subject to limitations. The Company may be able to utilize additional NOLs of approximately $<ix:nonFraction name="clbs:OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" id="Fact_566942ed8e944079901239f5bbc362f4" contextRef="c20211231" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.1</ix:nonFraction> million per year for the
            first five years after this ownership change as a result of the application of the Net Unrealized Built-in Gain rules.</div>
</ix:continuation>
          <ix:continuation id="Text_84a272d9b9fe483c8e0ea88cb46a64be3" continuedAt="Text_84a272d9b9fe483c8e0ea88cb46a64be4">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021 and 2020 the Company had State NOLs available
            in New Jersey of $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_1cfe6d0fd4e74b80af58ff74bc45c0b3" contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">97</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_dba60e7032b2418eb3b806336095f851" contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">99</ix:nonFraction>
            million, respectively, California of $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_32691a24dd0546c1a32106f3e9a96567" contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">70</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_d9fdac5678814f24885e5d872d329edc" contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">70</ix:nonFraction> million, respectively, and New York City of $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_18d681268a824cfeb89254cea888f438" contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction> million and $<ix:nonFraction name="us-gaap:OperatingLossCarryforwards" id="Fact_1392558620ec48a497c837fcca825f2c" contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">13</ix:nonFraction> million, respectively, to offset future taxable income expiring from 2031 through 2041. In accordance with Section 382 of the Internal Revenue
            code, the usage of the Company&#8217;s NOLs would be limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences
            become deductible.</div>
</ix:continuation>
          <ix:continuation id="Text_84a272d9b9fe483c8e0ea88cb46a64be4" continuedAt="Text_84a272d9b9fe483c8e0ea88cb46a64be5">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company applies the FASB&#8217;s provisions for uncertain tax
            positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest
            benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with uncertain tax positions as a component of income tax
            expense.</div>
</ix:continuation>
          <ix:continuation id="Text_84a272d9b9fe483c8e0ea88cb46a64be5" continuedAt="Text_84a272d9b9fe483c8e0ea88cb46a64be6">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of March&#160;31, 2022, management does not believe the Company has any
            material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in future
            periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</div>
</ix:continuation>
          <ix:continuation id="Text_84a272d9b9fe483c8e0ea88cb46a64be6" continuedAt="Text_84a272d9b9fe483c8e0ea88cb46a64be7">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For years prior to 2018, the federal statute of limitations is closed
            for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from date of filing.</div>
</ix:continuation>
          <ix:continuation id="Text_84a272d9b9fe483c8e0ea88cb46a64be7">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2021, the Company received preliminary approval from the
            New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) to participate in the Technology Business Tax Certificate Transfer Program (the &#8220;Program&#8221;). The Program permits qualified companies to sell a percentage of their New Jersey net operating
            losses (&#8220;NJ NOLs&#8221;) to unrelated profitable corporations. On February&#160;22, 2022, the Company received final approval from NJEDA to sell $<ix:nonFraction name="clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" id="Fact_e31e8d594b7840af845611ca2fcaf3cf" contextRef="c20220222to20220222" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction>
            million of its NJ NOLs related tax benefits (&#8220;NJ NOL Tax Benefits&#8221;), which was subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $<ix:nonFraction name="clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" id="Fact_e2b69f06156c47eebdbfe94be9216add" contextRef="c20220222to20220222" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.3</ix:nonFraction> million. The gross proceeds of $<ix:nonFraction name="clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" id="Fact_92bda2c6a2a142428b64da0bbb7c558e" contextRef="c20220222to20220222" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">2.5</ix:nonFraction> million have been
            recorded as a benefit from income taxes and the loss on sale of NJ NOLs of $<ix:nonFraction name="clbs:LossOnSaleOfNetOperatingLosses" id="Fact_d100ed3ce9054192a6a3696e953642ee" contextRef="c20220222to20220222" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">0.1</ix:nonFraction> million recorded in other income (expense) in the
            consolidated financial statements.</div>
</ix:continuation>
           </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;">
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;">
          <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="Text_a32c022d28264fe5a2bf6eeb998b0154" contextRef="c20220101to20220331" escape="true" continuedAt="Text_76b6afc7c09947ffa4ab03ce84a94ce41">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 11 &#8211; Contingencies</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_76b6afc7c09947ffa4ab03ce84a94ce41" continuedAt="Text_76b6afc7c09947ffa4ab03ce84a94ce42">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Contingencies</div>
</ix:continuation>
          <ix:continuation id="Text_76b6afc7c09947ffa4ab03ce84a94ce42">
<div style="display:none;"><br /></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, the Company is subject to legal proceedings and
            claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a
            material adverse effect on the Company's financial condition or operating results.</div>
</ix:continuation>
           </div>

      </div>

      <div class="block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;">
        <div class="unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">FS-37<br />
        </div>

      </div>

    </div>

    <!--End Page 37-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 38-->
    <div class="page" style="text-align: left; margin: auto; position: relative; width: 468pt;"><a id="ny20004343x1_s4_204-finnotes02_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div class="block-main" style="width: 468pt; margin-left: 0pt;"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page">
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" id="Text_25ef6d05863f49f08ec6c7fbe5b9df61" contextRef="c20220101to20220331" escape="true" continuedAt="Text_30bd33c59b80429f8f77d613d1a0fbd21">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">Note 12 &#8211; Subsequent Event</span></div>
</ix:nonNumeric>
          <ix:continuation id="Text_30bd33c59b80429f8f77d613d1a0fbd21" continuedAt="Text_30bd33c59b80429f8f77d613d1a0fbd22">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Cend Merger Agreement</div>
</ix:continuation>
          <ix:continuation id="Text_30bd33c59b80429f8f77d613d1a0fbd22" continuedAt="Text_30bd33c59b80429f8f77d613d1a0fbd23">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">On April&#160;26, 2022, the Company and Cend Therapeutics, Inc., a
            Delaware corporation (&#8220;Cend&#8221;), entered into an Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger
            Agreement, a wholly-owned subsidiary of Caladrius will merge with and into Cend, with Cend surviving as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;), subject to the terms of the Merger Agreement and stockholder approval of the
            transaction. Under the exchange ratio formula, as of immediately after the Merger, the former Cend stockholders are expected to own approximately <ix:nonFraction name="clbs:MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" id="Fact_caa53e6f893e4299a293cb1e66e15b50" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="INF" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>%
            of the outstanding shares of Caladrius Common Stock and the Company&#8217;s stockholders as of immediately prior to the Merger are expected to own approximately <ix:nonFraction name="clbs:MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" id="Fact_d94dbeb384e448cdb97e729182278da3" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U005" decimals="INF" scale="-2" format="ixt:numdotdecimal">50</ix:nonFraction>% of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on the Company&#8217;s net cash balance at the time of closing and the amount
            of any transaction expenses of Cend in excess of $<ix:nonFraction name="clbs:MergerAgreementTransactionExpensesThresholdForRatioAllocation" id="Fact_a047edb98c8649b9bb863ba51659d3ab" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-3" scale="3" format="ixt:numdotdecimal">250</ix:nonFraction> thousand at the time of closing.</div>
</ix:continuation>
          <ix:continuation id="Text_30bd33c59b80429f8f77d613d1a0fbd23" continuedAt="Text_30bd33c59b80429f8f77d613d1a0fbd24">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Consummation of the Merger is subject to certain closing conditions,
            including, among other things, approval by the stockholders of the Company and Cend, and the Company&#8217;s satisfaction of a minimum net cash threshold at closing, expected to be approximately $<ix:nonFraction name="clbs:MergerAgreementMinimumNetCashThreshold" id="Fact_3371433814c74c9dbb530476b1893855" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">64.9</ix:nonFraction> million assuming a closing at the end of the third quarter of 2022, and as described further in the Merger Agreement. The Merger Agreement contains certain termination rights for
            both the Company and Cend, and further provides that, upon termination of the Merger Agreement under specified circumstances, the Company may be required to pay Cend a termination fee of $<ix:nonFraction name="clbs:MergerAgreementPotentialTerminationFeePayable" id="Fact_06bef34ba02847b9b6fdb019add49d28" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million, Cend may be required to pay the Company a termination fee of $<ix:nonFraction name="clbs:MergerAgreementPotentialTerminationFeeReceivable" id="Fact_10e0745448704815b5171f948c490a96" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">4.0</ix:nonFraction>
            million, or in some circumstances reimburse the other party&#8217;s expenses up to a maximum of $<ix:nonFraction name="clbs:MergerAgreementPotentialExpenseReimbursement" id="Fact_07fb86e5d1bb49d8a7744f7f88652e50" contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember" unitRef="U001" decimals="-5" scale="6" format="ixt:numdotdecimal">1.0</ix:nonFraction> million.</div>
</ix:continuation>
          <ix:continuation id="Text_30bd33c59b80429f8f77d613d1a0fbd24" continuedAt="Text_30bd33c59b80429f8f77d613d1a0fbd25">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">At the effective time of the Merger, the Company&#8217;s Board of Directors
            is expected to consist of nine members, four of whom will be designated by the Company, four of whom will be designated by Cend and one member who will be mutually agreed between the Company and Cend.</div>
</ix:continuation>
          <ix:continuation id="Text_30bd33c59b80429f8f77d613d1a0fbd25" continuedAt="Text_30bd33c59b80429f8f77d613d1a0fbd26">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Stock Purchase Agreement</div>
</ix:continuation>
          <ix:continuation id="Text_30bd33c59b80429f8f77d613d1a0fbd26" continuedAt="Text_30bd33c59b80429f8f77d613d1a0fbd27">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In order to provide Cend with capital for its development programs
            prior to the closing of the Merger, the Company and Cend entered into a Series D Preferred Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which the Company agreed to purchase from Cend <ix:nonFraction name="clbs:PurchaseOfPreferredStockShares" id="Fact_1c6c7e25cd454e65a6727d4e3a014f63" contextRef="c20220426to20220426_StatementClassOfStockAxis_SeriesDPreferredStockCendMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember" unitRef="U002" decimals="0" scale="0" format="ixt:numdotdecimal">1,135,628</ix:nonFraction> shares of Series D Preferred Stock, $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" id="Fact_f2892699525d4342b715825837569840" contextRef="c20220426_StatementClassOfStockAxis_SeriesDPreferredStockCendMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember" unitRef="U003" decimals="INF" scale="0" format="ixt:numdotdecimal">0.00001</ix:nonFraction> par
            value per share (the &#8220;Series D Preferred Stock&#8221;), of Cend at a purchase price per share equal to $<ix:nonFraction name="clbs:PurchaseOfPreferredStockPricePerShare" id="Fact_70167f542b834833a0fbe91796664811" contextRef="c20220426to20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember" unitRef="U003" decimals="4" scale="0" format="ixt:numdotdecimal">8.8057</ix:nonFraction> per share (the &#8220;Series D
            Original Issue Price&#8221;), or approximately $<ix:nonFraction name="clbs:PurchaseOfPreferredStockAggregatePrice" id="Fact_8a4cdda0c0724c4baa4d3d59c3e1c414" contextRef="c20220426to20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">10</ix:nonFraction> million in the aggregate. The Series D Preferred Stock ranks senior to Cend&#8217;s common
            stock and the other series of preferred stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of Cend. The Series D Preferred Stock has a liquidation preference equal
            to the Series D Original Issue Price plus an amount equal to any accrued and unpaid dividends to the date of payment and will participate with Cend&#8217;s common stockholders and other preferred stockholders thereafter on an as-converted basis. The
            Series D Preferred Stock shall vote with the common stock on an as-converted basis on any matters presented to the stockholders of Cend. Each share of Series D Preferred Stock is convertible, at the option of the holder thereof, into such
            number of shares of Cend common stock as is determined by dividing the Original Issue Price by the conversion price in effect at the time of conversion, which conversion price shall be the Original Issue Price as appropriately adjusted for
            stock splits, stock dividends, combinations, and subdivisions of Cend common stock, and as adjusted pursuant to a weighted-average antidilution adjustment. The Series D Preferred Stock will automatically convert into shares of Cend common stock
            upon the closing of a firm-commitment underwritten initial public offering implying a pre-equity offering value of at least $<ix:nonFraction name="clbs:PreEquityOfferingValueAfterConversion" id="Fact_f122d2010a824616a925f6dd2ddceb25" contextRef="c20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">250</ix:nonFraction>
            million, resulting in at least $<ix:nonFraction name="clbs:GrossProceedsOnTransaction" id="Fact_7524974db38d44a791b2efeecf4ba897" contextRef="c20220426to20220426_LegalEntityAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember" unitRef="U001" decimals="-6" scale="6" format="ixt:numdotdecimal">50</ix:nonFraction> million of gross proceeds to Cend.</div>
</ix:continuation>
          <ix:continuation id="Text_30bd33c59b80429f8f77d613d1a0fbd27" continuedAt="Text_30bd33c59b80429f8f77d613d1a0fbd28">
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Collaboration Agreement</div>
</ix:continuation>
          <ix:continuation id="Text_30bd33c59b80429f8f77d613d1a0fbd28">
<div style="display:none;"><br /></div>
<div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In connection with such Purchase Agreement, Cend entered into a
            Collaboration Agreement (the &#8220;Collaboration Agreement&#8221;), pursuant to which the Company agreed to collaborate with Cend on certain developmental and clinical activities prior to the closing of the Merger. Under the Collaboration Agreement, the
            Company and Cend will form a joint steering committee (the &#8220;Committee&#8221;) comprised of individuals from both entities. The Committee will meet regularly and be responsible for monitoring ongoing studies and making recommendations for development
            activity and trial planning. Cend has agreed to pay each member of the Committee from the Company an hourly consulting fee for such service.</div>
</ix:continuation>
           </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-38<br />
        </div>

      </div>

    </div>

    <!--End Page 38-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 39-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x1_s4_205-fintab03_pg1"><!--Anchor--></a>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main"> </div>

      </div>

    </div>

  </div>


  <div style="color: #000000;">
    <!--Begin Page 1-->
    <div style="text-align: left; margin: auto; position: relative; width: 540pt;" class="page"><!--Anchor--> </div>

    <div><br /></div>

    <!--Begin Page 344-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_205-fintab03_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tREPORT2"><!--Anchor--></a>Report of Independent
            Registered Public Accounting Firm</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="fpara">To the Stockholders and Board of Directors<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cend Therapeutics, Inc.:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h4">Opinion on the Financial Statements </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">We have audited the accompanying consolidated balance sheets of Cend
            Therapeutics, Inc. and Subsidiary (collectively, the &#8220;Company&#8221;) as of December&#160;31, 2020 and 2021, the related consolidated statements of operations, comprehensive income (loss), convertible preferred stock and stockholders&#8217; equity (deficit),
            and cash flows for each of the two years in the period ended December&#160;31, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly,
            in all material respects, the financial position of the Company as of December&#160;31, 2020 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December&#160;31, 2021, in conformity with
            accounting principles generally accepted in the United States of America.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h4">The Company&#8217;s Ability to Continue as a Going Concern</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The accompanying consolidated financial statements have been prepared
            assuming that the Company will continue as a going concern. As discussed in Note 1, management expects operating losses and negative cash flows for at least twelve months from the date of issuance. In addition, the Company has an accumulated
            deficit at December&#160;31, 2021. All of these matters raise substantial doubt about the Company&#8217;s ability to continue as a going concern. Management&#8217;s plans in regard to these matters are also described in Note 1. The consolidated financial
            statements do not include any adjustments that might result from the outcome of this uncertainty.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h4">Basis for Opinion</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">These consolidated financial statements are the responsibility of the
            Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United
            States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">We conducted our audits in accordance with the standards of the PCAOB
            and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free
            of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an
            understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Our audits included performing procedures to assess the risks of
            material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the
            consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We
            believe that our audits provide a reasonable basis for our opinion.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">We have served as the Company's auditor since 2022.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">/s/ Withum Smith+Brown, PC<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195; <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">San Francisco, California<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">May 20, 2022<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">PCAOB ID Number 100</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-39<br />
        </div>

      </div>

    </div>

    <!--End Page 344-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 345-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_205-fintab03_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCONSOLIDATED6"><!--Anchor--></a>CEND THERAPEUTICS, INC. <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED BALANCE SHEETS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands, except share and par value amounts)</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 16.63%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 0.66%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Assets<br />
                  </div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Current assets:<br />
                  </div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Cash</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">684</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">6,288 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Tax incentive receivable</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">844</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">509 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other current assets (including related party amounts of $0 and $14,
                    respectively)</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">1</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">690 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total current assets</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">1,529</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">7,487 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total assets</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">1,529</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">7,487 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Liabilities, convertible preferred stock, and stockholders'
                    equity (deficit)<br />
                  </div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Current liabilities:<br />
                  </div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accounts payable (including related party amounts of $26 and $0, respectively)</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">226</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">259 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accrued expenses (including related party amounts of $12 and $27,
                    respectively)</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">227</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">535 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other current liabilities</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">24</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">66 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total current liabilities</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">477</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">860 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other long-term liabilities</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">216 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total liabilities</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">477</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">1,076 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Commitments and contingencies (Note 7)<br />
                  </div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Redeemable convertible preferred stock:<br />
                  </div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Series A redeemable convertible preferred stock, $0.00001
                    par value; 371,396 shares authorized as of December&#160;31, 2020 and 2021; 371,396 shares issued and outstanding as of December&#160;31, 2020 and 2021; $1.1&#160;million liquidation preference as of December&#160;31, 2020 and 2021</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,100</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,100 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Series B redeemable convertible preferred stock, $0.00001
                    par value; 1,250,304 shares authorized as of December&#160;31, 2020 and 2021; 1,071,237 shares issued and outstanding as of December&#160;31, 2020 and 2021; $3.9&#160;million liquidation preference as of December&#160;31, 2020 and 2021</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">3,941</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">3,941 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stockholders' equity (deficit):<br />
                  </div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Series C convertible preferred stock, $0.00001 par value;
                    1,478,807 shares authorized as of December&#160;31, 2020 and 2021; 1,212,609 and 1,345,699 shares issued and outstanding as of December&#160;31, 2020 and 2021, respectively; $6.6&#160;million and $7.3&#160;million liquidation preference as of December&#160;31,
                    2020 and 2021, respectively</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Common stock, $0.00001 par value; 10,000,000 and
                    10,500,000 shares authorized as of December&#160;31, 2020 and 2021, respectively; 4,168,705 and 4,279,705 shares issued and outstanding as of December&#160;31, 2020 and 2021, respectively</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Additional paid-in capital</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">9,917</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 8.7pt;">11,656 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accumulated other comprehensive income (loss)</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">40</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(79)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accumulated deficit</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(13,946</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,207</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total stockholders' equity (deficit)</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(3,989</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">1,370 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total liabilities, convertible preferred stock, and stockholders' equity
                    (deficit)</div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">1,529</span></div>
                </td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">7,487</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-40<br />
        </div>

      </div>

    </div>

    <!--End Page 345-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 346-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_205-fintab03_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCONSOLIDATED7"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED STATEMENTS OF OPERATIONS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands, except share and par amounts)</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 23.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 2.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net revenues</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 30pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 12.5pt;">14,787</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating expenses:<br />
                  </div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Research and development (including related party amounts
                    of $26 and $3,869, respectively)</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">1,555</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">8,148 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">In-process research and development (including related
                    party amounts of $1,614 and $373, respectively)</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">6,572</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">1,584 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 45pt;">598</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">1,150 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total operating expenses</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">8,725</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">10,882</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating income (loss)</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt;">(8,725)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">3,905</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income<br />
                  </div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Interest income</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 40pt; border-bottom: 1pt solid #000000; min-width: 45pt;">5</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 40pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total other income</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 40pt; border-bottom: 1pt solid #000000; min-width: 45pt;">5</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 40pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Income (loss) before income taxes</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt;">(8,720)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">3,909</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Income tax expense</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 45pt;">170 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss)</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(8,720</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">3,739</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Income allocable to participating securities</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(1,466</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(8,720</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">2,273</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) per share attributable to common shareholders:<br />
                  </div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 19.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(2.09</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">0.54 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 19.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(2.09</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">0.48 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted-average common shares outstanding:</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">4,168,705</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5.37pt; border-bottom: 3pt double #000000; min-width: 45pt;">4,211,256 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">4,168,705</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">5,075,832</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-41<br />
        </div>

      </div>

    </div>

    <!--End Page 346-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 347-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_205-fintab03_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCONSOLIDATED8"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands)</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss)</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara">$(8,720)</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara">$3,739 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cumulative translation adjustment arising during the year</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">91</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 9.54pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">(119</span><span style="min-width: 27.5pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Comprehensive income (loss)</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(8,629</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$3,620</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-42<br />
        </div>

      </div>

    </div>

    <!--End Page 347-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 348-->
    <div style="text-align: left; margin: auto; position: relative; width: 528pt;" class="page"><a id="ny20004343x2_s4a_205-fintab03_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 30pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCONSOLIDATED9"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">AND STOCKHOLDERS&#8217; EQUITY (DEFICIT)<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands, except share amounts)</span></div>

        </div>

        <div style="width: 528pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 528pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Series A <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Redeemable <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Convertible <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Preferred Stock</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Series B <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Redeemable <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Convertible <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Preferred Stock</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Series C <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Convertible <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Preferred Stock</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.7%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Common <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Additional <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Paid-in <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Capital</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accumulated <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Other <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Comprehensive <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Income (Loss)</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accumulated <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Deficit</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stockholders' <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Equity <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(Deficit)</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6.8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.57%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;" class="fpara">Balance as of December&#160;31, 2019</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">371,396</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">1,100</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,071,237</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">3,941</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">4,168,705</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 7.7pt;">2,741</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 7.7pt;">(51)</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 8pt;">(5,226)</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">(2,536) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Issuance of Series C convertible preferred stock</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,212,609</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 7.7pt;">6,560</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 20.66pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 6.66pt;">6,560 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Stock-based compensation expense</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 13.7pt;">616</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 20.66pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 12.66pt;">616 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Net loss</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 17.7pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 8pt;">(8,720)</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">(8,720)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Foreign currency translation adjustment</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt; border-bottom: 1pt solid #000000; min-width: 26pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt; border-bottom: 1pt solid #000000; min-width: 22pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt; border-bottom: 1pt solid #000000; min-width: 22pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 17.7pt; border-bottom: 1pt solid #000000; min-width: 25.7pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt; border-bottom: 1pt solid #000000; min-width: 18.37pt;">91</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 20.66pt; border-bottom: 1pt solid #000000; min-width: 28.66pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 16.66pt; border-bottom: 1pt solid #000000; min-width: 24.66pt;">91 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;" class="fpara">Balance as of December&#160;31, 2020</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 26pt;">371,396</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22pt;">$1,100</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32pt;">1,071,237</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22pt;">$3,941</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32pt;">1,212,609</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 12pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32pt;">4,168,705</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 12pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 25.7pt;">$</span><span style="padding-left: 3.7pt; border-bottom: 3pt double #000000; min-width: 25.7pt;">9,917</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 18.37pt;">$</span><span style="padding-left: 6.37pt; border-bottom: 3pt double #000000; min-width: 18.37pt;">40</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 28.66pt;">$(13,946</span><span style="min-width: 28.66pt;">)</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.66pt;">$(3,989</span><span style="min-width: 24.66pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Issuance of common stock</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">81,000</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 13.7pt;">309</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 20.66pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 12.66pt;">309 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Issuance of Series C convertible preferred stock</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 6pt;">133,090</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 7.7pt;">1,040</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 20.66pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 6.66pt;">1,040 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Stock-based compensation expense</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 13.7pt;">390</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 20.66pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 12.66pt;">390 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Exercise of stock options</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">30,000</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 17.7pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 20.66pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 16.66pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Net income</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 17.7pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 10.37pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 10.66pt;">3,739</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 6.66pt;">3,739 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Foreign currency translation adjustment</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 18pt; border-bottom: 1pt solid #000000; min-width: 26pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt; border-bottom: 1pt solid #000000; min-width: 22pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="padding-left: 14pt; border-bottom: 1pt solid #000000; min-width: 22pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 24pt; border-bottom: 1pt solid #000000; min-width: 32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 12pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="padding-left: 17.7pt; border-bottom: 1pt solid #000000; min-width: 25.7pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="padding-left: 4pt; border-bottom: 1pt solid #000000; min-width: 18.37pt;">(119</span><span style="min-width: 18.37pt;">)</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="padding-left: 20.66pt; border-bottom: 1pt solid #000000; min-width: 28.66pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="padding-left: 10.3pt; border-bottom: 1pt solid #000000; min-width: 24.66pt;">(119</span><span style="min-width: 24.66pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;" class="fpara">Balance at December&#160;31, 2021</div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.92%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 26pt;">371,396</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22pt;">$1,100</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32pt;">1,071,237</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22pt;">$3,941</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32pt;">1,345,699</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 12pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.06%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32pt;">4,279,705</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 12pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.86%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 2.63pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 25.7pt;">$11,656</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 13.41pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 18.37pt;">$</span><span style="padding-left: 3.7pt; border-bottom: 3pt double #000000; min-width: 18.37pt;">(79</span><span style="min-width: 18.37pt;">)</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.29%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.92pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 28.66pt;">$(10,207</span><span style="min-width: 28.66pt;">)</span></div>
                </td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.57%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.67pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.66pt;">$</span><span style="padding-left: 2.66pt; border-bottom: 3pt double #000000; min-width: 24.66pt;">1,370</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 30pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 30pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-43<br />
        </div>

      </div>

    </div>

    <!--End Page 348-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 349-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_205-fintab03_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCONSOLIDATED10"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONSOLIDATED STATEMENTS OF CASH FLOWS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1"><span style="font-weight: normal;">(In thousands)</span></div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash flows from operating activities:<br />
                  </div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss)</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara">$(8,720)</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara">$3,739</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Adjustments to reconcile net income (loss) to cash
                    provided by (used in) operating activities:<br />
                  </div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Stock-based compensation</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">616</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">390</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">In-process research and development expenses</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">6,572</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">1,350</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Changes in operating assets and liabilities:</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Tax benefit receivable</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">370</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">286</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Other current assets</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 9.17pt;">(689)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Other current liabilities</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">24</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">43</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Other long-term liabilities</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">216</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Accounts payable</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">216</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">44</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Accrued expenses</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">104</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">310</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash provided by (used in) operating activities</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">(818)</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">5,689</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash flows from investing activities:<br />
                  </div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Acquired in-process research and development</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(12</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash used in investing activities</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">(12)</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Effect of exchange rate changes on cash</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(15</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">(85</span><span style="min-width: 27.5pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net increase (decrease) in cash</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">(845)</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">5,604</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash at beginning of year</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">1,529</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">684</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash at end of year</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 10.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">684</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$6,288</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Supplemental noncash financing activities<br />
                  </div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Issuance of Series C convertible preferred stock in
                    connection with in-process research and development</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara">$<span style="padding-left: 3.33pt;">6,560</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara">$1,040</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Issuance of Common stock in connection with in-process research and development</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.39%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.56pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.68%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.55pt; text-align: left;" class="fpara">$<span style="padding-left: 7.5pt;">309</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-44<br />
        </div>

      </div>

    </div>

    <!--End Page 349-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 350-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tNOTE3"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">1.&#8195;Organization and Description of Business</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Cend Therapeutics, Inc. (the &#8220;Company&#8221; or &#8220;Cend&#8221;), headquartered in
            San Diego, California, is a biopharmaceutical company dedicated to developing next generation cancer therapies that are designed to overcome the barriers of drug delivery to solid tumors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company was initially formed as DrugCendR, LLC. (&#8220;DrugCendR&#8221;), on
            October&#160;22, 2015, and subsequently changed from an LLC to a corporation, and changed its name to Cend Therapeutics. On February&#160;28, 2018, DrugCendR established a wholly-owned Australian subsidiary, DrugCendR Australia Pty Ltd. (&#8220;DrugCendR
            AUS&#8221;), in order to conduct clinical activities in Australia for its development candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Liquidity and Going Concern</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has a limited operating history and the sales and income
            potential of the Company&#8217;s business and market are unproven. The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the
            satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may
            result from the outcome of this uncertainty.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Management is required to perform a two-step analysis over its
            ability to continue as a going concern. Management must first evaluate whether there are conditions and events that raise substantial doubt about the Company&#8217;s ability to continue as a going concern (step 1). If management concludes that
            substantial doubt is raised, management is also required to consider whether its plans alleviate that doubt (step 2).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has experienced net losses and negative cash flows from
            operating activities since its inception, aside from the year ended December&#160;31, 2021, as a result of a one-time license payment and a milestone payment from the Exclusive License and Collaboration Agreement with Qilu Pharmaceutical Co., Ltd.
            (&#8220;Qilu&#8221;), which rendered net income in 2021 (Note 6). The Company has an accumulated deficit of $10.2&#160;million as of December&#160;31, 2021. In 2021, the Company generated $5.7&#160;million of cash from operations. As of December&#160;31, 2021, the Company had
            cash of $6.3&#160;million. Management expects operating losses and negative cash flows to continue for at least the next year as the Company continues to incur costs related to ongoing clinical development of its drug candidates. Management has
            prepared cash flow forecasts which indicate that based on the Company&#8217;s expected operating losses and negative cash flows, there is substantial doubt about the Company&#8217;s ability to continue as a going concern within twelve months after the date
            that the consolidated financial statements for the year ended December&#160;31, 2021 are issued. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Management&#8217;s ability to continue as a going concern is dependent upon
            its ability to receive additional funds. Management intends to raise additional capital through equity offerings, debt financings or strategic arrangements with third parties. Additionally, the Company may receive further milestone payments
            from the Exclusive License and Collaboration Agreement with Qilu. However, the Company may not be able to secure additional financing in a timely manner or on favorable terms, if at all, and may not receive any milestone payments. Without
            additional funds, the Company may be forced to delay, scale back or eliminate some research and development activities, or other operations and potentially delay product development in an effort to provide sufficient funds to continue
            operations. If any of these events occur, the Company&#8217;s ability to develop and commercialize its product candidates would be adversely affected.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">2.&#8195;Summary of Significant Accounting Policies</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Basis of Presentation and Consolidation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The accompanying consolidated financial statements have been prepared
            in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;). The consolidated financial statements include the accounts of Cend (a U.S. Corporation) and its wholly owned subsidiary DrugCendR (an Australian
            corporation). All intercompany accounts and transactions have been eliminated in consolidation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Use of Estimates</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The preparation of consolidated financial statements in conformity
            with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-45<br />
        </div>

      </div>

    </div>

    <!--End Page 350-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 351-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">accompanying notes. Management bases its estimates and judgments on historical
            experience, knowledge of current conditions, and beliefs of what could occur in the future, given the available information. On an ongoing basis, management evaluates such estimates and assumptions for continued reasonableness. In particular,
            management makes estimates with respect to accruals for research and development activities, for the fair value of common stock and stock-based compensation expense. Appropriate adjustments, if any, to the estimates used are made prospectively
            based upon such periodic evaluation. Actual results could differ materially from those estimates and assumptions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h3">Segment Reporting</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Operating segments are identified as components of an enterprise
            about which separate discrete financial information is available for evaluation by the chief operating decision-maker (the &#8220;CODM&#8221;). The Company&#8217;s CODM is its chief executive officer who reviews financial information together with certain
            operating metrics principally to make decisions about how to allocate resources and to measure the Company&#8217;s performance. The Company has determined that it operates as a single operating segment. The Company&#8217;s CODM evaluates financial
            information on a consolidated basis. As the Company operates as one operating segment, all required segment financial information is presented in the consolidated financial statements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h3">Foreign Currency Remeasurement</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s reporting currency is the U.S. Dollar. The functional
            currency of DrugCendR is the Australian Dollar. The assets and liabilities of DrugCendR are translated into U.S. Dollars at the exchange rates in effect at each balance sheet date, and the results of operations are translated using the average
            exchange rates prevailing throughout the reporting period. Adjustments resulting from translating foreign functional currency financial statements into U.S. Dollars are included in the foreign currency translation adjustment, a component of
            accumulated other comprehensive income (loss) in stockholders' equity (deficit).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Concentration of Credit Risk</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Financial instruments, which potentially subject the Company to
            concentrations of credit risk, consist primarily of cash. The Company&#8217;s cash is held by one financial institution in the U.S. and one financial institution in Australia, which the Company believes to be financially sound, and accordingly,
            minimal credit risk exists with respect to the financial institutions. At times, the Company&#8217;s deposits held in the U.S. may exceed the Federal Depository Insurance Corporation insured limits. The Company has not experienced any credit losses
            in such accounts and does not believe it is exposed to any significant credit risk on these funds.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Fair Value Measurements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The accounting guidance defines fair value, establishes a consistent
            framework for measuring fair value, and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing the amount that would
            be received to sell and asset or paid to transfer a liability in an orderly transaction between marketplace participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants
            would use in pricing an asset or liability. The carrying amounts of cash, other current assets, accounts payable, accrued expenses and other liabilities are reasonable estimates of their fair value because of the short maturity of these items.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Cash</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Cash represents funds in the Company&#8217;s operating bank accounts. The
            Company has no cash equivalents.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h3">Commitment and Contingencies</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company recognizes a liability with regard to loss contingencies
            when it believes it is probable a liability has been incurred, and the amount can be reasonably estimated. If some amount within a range of loss appears at the time to be a better estimate than any other amount within the range, the Company
            accrues that amount. When no amount within the range is a better estimate than any other amount the Company accrues the minimum amount in the range. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-46<br />
        </div>

      </div>

    </div>

    <!--End Page 351-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 352-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Redeemable Convertible Preferred Stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company records redeemable convertible preferred stock at fair
            value on the dates of issuance, net of issuance costs. Upon the occurrence of certain events that are outside the Company&#8217;s control, including an optional redemption (Note 8), holders of the redeemable convertible preferred stock can cause
            redemption for cash. Therefore, redeemable convertible preferred stock is classified outside of stockholders&#8217; equity (deficit) on the consolidated balance sheets as events triggering the liquidation are not solely within the Company&#8217;s control.
            No accretion has been recorded as the shares are already recorded at the estimated redemption amounts. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Convertible Preferred Stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company records convertible preferred stock at fair value on the
            dates of issuance, net of issuance costs. As the convertible preferred stock is not redeemable, and the shareholders cannot cause the Company to redeem the convertible preferred stock, the convertible preferred stock is classified within
            stockholders&#8217; equity (deficit) on the consolidated balance sheets.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Revenue Recognition</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company evaluates license and collaboration arrangements to
            determine whether units of account within the arrangement exhibit the characteristics of a vendor and customer relationship. For arrangements and units of account where a customer relationship exists, the Company applies the revenue recognition
            guidance. The Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine
            revenue recognition for contracts with customers the Company performs the following five steps: (i)&#160;identify the contract(s) with a customer; (ii)&#160;identify the performance obligations in the contract; (iii)&#160;determine the transaction price;
            (iv)&#160;allocate the transaction price to the performance obligations in the contract; and (v)&#160;recognize revenue when (or as) the Company satisfies the performance obligations. At contract inception, the Company assesses the goods or services
            promised within each contract and assesses whether each promised good or service is distinct and determines those that are performance obligations. The Company then recognizes as revenue the amount of the transaction price that is allocated to
            the respective performance obligation when (or as) the performance obligation is satisfied. Taxes imposed by governmental authorities on the Company's revenue, such as sales taxes and withholding taxes, are excluded from net revenue.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">If a license to the Company&#8217;s intellectual property is determined to
            be distinct from the other performance obligations identified in the arrangement, the Company recognizes revenues from non-refundable, upfront fees allocated to the license when the license is transferred to the licensee and the licensee is
            able to use and benefit from the license. If licenses are bundled with other performance obligations, the Company would utilize judgment to assess the nature of the combined performance obligation to determine whether the combined performance
            obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">All of the Company&#8217;s revenue to date is with one customer, and
            substantially all relates to license revenue. Given this, there is no disaggregation of revenue required.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h4">Milestones</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">At the inception of each arrangement that includes milestone payments
            (variable consideration), the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. If it is probable that a
            significant revenue reversal would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the Company or the Company&#8217;s collaboration partner&#8217;s control, such as regulatory
            approvals, are generally not considered probable of being achieved until those approvals are received. The transaction price is then allocated to each performance obligation on a relative stand-alone selling price basis, for which the Company
            recognizes revenue as or when the performance obligations under the contract are satisfied. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of such milestones and any related constraint,
            and if necessary, adjusts the Company&#8217;s estimate of the overall transaction price. Any such adjustments are allocated on a cumulative catch-up basis to satisfied and partially satisfied performance obligations, with the consideration allocated
            to an ongoing performance obligation being recognized over the period of performance.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-47<br />
        </div>

      </div>

    </div>

    <!--End Page 352-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 353-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h4">Royalties</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">For arrangements that include sales-based royalties, including
            milestone payments based on the level of sales, and for which the license is deemed to be the predominant item to which the royalties relate, the Company recognizes revenue at the later of (i)&#160;when the related sales occur, or (ii)&#160;when the
            performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). To date, the Company has not recognized any royalty revenue from any collaborative arrangement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Research and Development</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Research and development costs are expensed as incurred. Research and
            development costs consist of salaries, benefits, and other personnel related costs, including stock-based compensation, process development costs, fees paid to other entities to conduct certain research and development activities on the
            Company&#8217;s behalf, including contract manufacturing organizations and contract research organizations. Non-refundable advance payments for goods or services that will be used or rendered for future research and development activities are
            deferred and capitalized as prepaid expenses until the related goods are delivered or services are performed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company records accrued liabilities for estimated costs of
            research and development activities conducted by third-party service providers. The Company accrues for these costs based on factors such as estimates of the work completed and in accordance with agreements established with its third-party
            service providers under the service agreements. The Company makes significant judgments and estimates in determining the accrued liabilities balance in each reporting period. As actual costs become known, the Company adjusts its accrued
            liabilities. For the years ended December&#160;31, 2020 and 2021, the Company has not experienced any material differences between accrued and actual costs incurred.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Australian Research and Development Tax Incentive
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company is eligible under the Australian Research and Development
            Tax Incentive Program (the &#8220;Tax Incentive&#8221;) to obtain a cash refund from the Australian Taxation Office for eligible research and development expenditures. The Tax Incentive is recognized as a reduction to research and development expense when
            there is reasonable assurance that the Tax Incentive will be received, the relevant expenditure has been incurred, and the amount can be reliably measured. The Tax Incentive is denominated in Australian dollars and, therefore, the related
            receivable is remeasured into U.S. Dollars as of each reporting date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">In-process Research and Development Expense</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has acquired rights as part of asset acquisitions or
            in-licenses to develop and commercialize product candidates. Upfront payments that relate to the acquisition of a new drug compound, as well as pre-commercial milestone payments, are immediately expensed as in-process research and development
            in the period in which they are incurred, provided that the new drug compound did not also include processes or activities that would constitute a &#8220;business&#8221; as defined under U.S. GAAP, the drug has not achieved regulatory approval for
            marketing and, absent obtaining such approval, has no established alternative future use. The Company accounts for contingent consideration payable upon achievement of certain regulatory, development or sales milestones in such asset
            acquisitions when the underlying contingency is resolved.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Common Stock Valuation </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Due to the absence of an active market for the Company&#8217;s common
            stock, the Company utilized methodologies, approaches, and assumptions consistent with the American Institute of Certified Public Accountants&#8217; Audit and Accounting Practice Guide: Valuation of Privately-Held Company Equity Securities Issued as
            Compensation to estimate the fair value of its common stock. In determining the exercise prices for options granted, the Company has considered the fair value of the common stock as of the grant date. The fair value of the common stock has been
            determined based upon a variety of factors, including valuations of the Company&#8217;s common stock performed with the assistance of independent third-party valuation specialists; the Company&#8217;s stage of development and business strategy, including
            the status of research and development efforts of its product candidates, and the material risks related to its business and industry; the Company&#8217;s business conditions and projections; the Company&#8217;s results of operations and financial
            position, including its levels of available capital resources; the valuation of publicly traded companies in the life sciences and biotechnology sectors, as well as recently completed mergers and acquisitions of peer companies; the lack of
            marketability of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-48<br />
        </div>

      </div>

    </div>

    <!--End Page 353-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 354-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">the Company&#8217;s common stock as a private company; the prices of the Company&#8217;s
            convertible preferred stock sold to investors in arm&#8217;s length transactions and the rights, preferences and privileges of its convertible preferred stock relative to those of its common stock; the likelihood of achieving a liquidity event for
            the holders of the Company&#8217;s common stock, such as an initial public offering or a sale of the Company given prevailing market conditions; trends and developments in its industry; the hiring of key personnel and the experience of management;
            and external market conditions affecting the life sciences and biotechnology industry sectors. Significant changes to the key assumptions underlying the factors used could result in different fair values of common stock at each valuation date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h3">Stock-Based Compensation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company recognizes stock-based compensation expense for employee,
            officer, director and non-employee stock options and restricted stock awards on a straight-line basis over the requisite service period. The Company accounts for forfeitures as they occur.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company classifies stock-based compensation expense in its
            consolidated statements of operations and comprehensive income (loss) in the same manner in which the award recipient&#8217;s cash compensation costs are classified.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The fair value of each stock option award is estimated on the date of
            grant using the Black-Scholes option pricing model. As there is no public market for its common stock the Company determined the volatility for awards granted based on an analysis of reported data for a group of guideline companies that issued
            options with substantially similar terms. The expected volatility has been determined using a weighted-average of the historical volatility measures of this group of guideline companies. The Company expects to continue to do so until such time
            as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#8217;s stock options has been determined utilizing the &#8220;simplified&#8221; method for awards that qualify as &#8220;plain-vanilla&#8221;
            options. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. The Company has not paid, and
            does not anticipate paying, cash dividends on its common stock; therefore, the expected dividend yield is assumed to be zero.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h3">Income Taxes</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Income taxes are accounted for using the asset and liability method.
            Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts or existing assets and liabilities and their respective tax bases. Deferred tax
            assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of
            a change in tax rates is recognized in income in the period of enactment. The Company records a valuation allowance to reduce deferred tax assets to an amount for which realization is more likely than not.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company recognizes the tax benefit from an uncertain tax position
            if it is more likely than not that the tax position will be sustained upon examination by the tax authorities, based on the merits of the position. The Company&#8217;s policy is to recognize interest and penalties related to the underpayment of
            income taxes as a component of income tax expense or benefit. To date, there have been no interest or penalties charged in relation to the unrecognized tax benefits.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h3">Comprehensive Income (Loss)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Comprehensive income (loss) is composed of two components &#8212; net
            income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to gains and losses that under U.S.&#160;GAAP are recorded as an element of stockholders&#8217; equity but are excluded from net income (loss). The Company&#8217;s
            other comprehensive income (loss) consists of foreign currency translation adjustments. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;" class="h3">Net Income (Loss) Per Share</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company computes net income (loss) per share in accordance with
            the Financial Accounting Standards Board (FASB) guidance for Earnings Per Share, which established standards regarding the computation of earnings per share by companies that have issued securities other than common stock that contractually
            entitle </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-49<br />
        </div>

      </div>

    </div>

    <!--End Page 354-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 355-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">the holder to participate in earnings and dividends. The guidance requires earnings
            available to common shareholders for the period, after deduction of preferred stock preferences, to be allocated between the common and preferred shareholders based on their respective rights to receive dividends. The Company is not required to
            present basic and diluted net income (loss) per share for securities other than common stock; therefore, the net income (loss) per share amounts only pertain to the Company&#8217;s common stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Basic net income (loss) per share is calculated by dividing income
            (loss) allocable to common shareholders (net income after reduction for any required returns to preferred stock shareholders prior to paying dividends to the common shareholders, assuming current income for the period had been distributed) by
            the weighted-average number of common shares outstanding, during the period.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has used the two-class method to calculate diluted net
            income (loss) per share for the years ended December&#160;31, 2020 and 2021. Diluted net income per share for the year ended December&#160;31, 2021, also reflects the assumed conversion of options outstanding during the period using the treasury stock
            method, to the extent dilutive. For purposes of calculating the net loss per share for the year ended December&#160;31, 2020, stock options were not included as their effect would be antidilutive.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The following table sets forth the computation of basic and diluted
            net income (loss) per share:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 23.72%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 2.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic Net Income (Loss) per share<br />
                  </div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss)</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 14.17pt;">(8,720)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 17.5pt;">3,739 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Less: income allocated to participating securities</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(1,466</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(8,720</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">2,273 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding - basic</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,168,705</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5.37pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,211,256 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) per share - basic</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 19.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(2.09</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">0.54 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Diluted Net Income (Loss) per share<br />
                  </div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss)</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 14.17pt;">(8,720)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">$<span style="padding-left: 17.5pt;">3,739 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Less: income allocated to participating securities</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(1,303</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(8,720</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">2,436 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding - basic</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,168,705</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5.37pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,211,256 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average effect of dilutive stock options</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 35pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">864,576 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding - diluted</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,168,705</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">5,075,832 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) per share - diluted</div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 19.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(2.09</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">0.48</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Potentially dilutive securities as of December&#160;31, 2020 and 2021 are
            as follows (in common stock equivalent shares):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 22.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">As of December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 2.78%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Series A redeemable convertible preferred stock</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">371,396</span></div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">371,396 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Series B redeemable convertible preferred stock</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,071,237</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,071,237 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Series C convertible preferred stock</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,212,609</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,345,699 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Options</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">2,141,079</span></div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">2,270,079 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total</div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">4,796,321</span></div>
                </td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.78%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 0.37pt; border-bottom: 3pt double #000000; min-width: 40pt;">5,058,411</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-50<br />
        </div>

      </div>

    </div>

    <!--End Page 355-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 356-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">3.&#8195;Accrued Expenses</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Accrued expenses consist of the following (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 13.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 2.29%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development</div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">65</span></div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara">$174 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Employee related</div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">120</span></div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">177 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Taxes</div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">&#8212;</span></div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">148 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other</div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 20pt;">42</span></div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 20pt;">36 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$227</span></div>
                </td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.29%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.29pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$535</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;" class="h2">4.&#8195;Asset Acquisition </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In September 2020, the Company entered into an Asset Purchase
            Agreement (the &#8220;Impilo Agreement&#8221;) with Impilo Therapeutics, Inc. (&#8220;Impilo&#8221;). In accordance with the Impilo Agreement, the Company purchased all the intellectual property rights, know-how and product data of Impilo, as well as certain assumed
            contracts. The acquired assets expand the Company&#8217;s drug delivery capabilities for targeted tissue penetrating delivery of nucleic acid-based medicines for the treatment of solid tumor cancers. The Company&#8217;s founding shareholder was a
            significant shareholder in Impilo prior to the acquisition. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In connection with the Impilo Agreement, the Company issued 1,212,609
            shares of a newly created class of Series C convertible preferred stock, with a value of $5.41 per share, for a total value of $6.6&#160;million. The Company recorded the purchase price as in-process research and development expense. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Impilo Agreement and assumed contracts also allowed for the
            Company to pursue four license options that were under negotiation by the former shareholders of Impilo at the time of acquisition. If executed by the Company, additional shares (&#8220;License Shares&#8221;) were to be issued to the original Impilo
            shareholders. In addition, the Company also assumed the right to pursue a license with the Massachusetts Institute of Technology (&#8220;MIT&#8221;). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In March 2021 and October 2021, two of the four license options,
            University of California San Diego (&#8220;UCSD&#8221;) and Sanford Burnham Prebys (&#8220;SBP&#8221;), respectively, were executed, and additional License Shares of 66,545 each (Series C shares) were issued to the original Impilo shareholders. The License Shares were
            valued at $7.82 per share, based on a third-party valuation, for a total value of $1.0&#160;million, which was recorded as in-process research and development expense.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In October 2021, the Company executed a license with MIT, and 81,000
            shares of common stock were issued to MIT at $3.82 per share, based on a third-party valuation, for a total value of $0.3&#160;million, which was recorded as in-process research and development expense.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s founding shareholder held shares in Impilo prior to
            occurrence of the Impilo Agreement. A total of 331,108 shares of Series C convertible preferred stock were issued to the Company&#8217;s founding shareholder in connection with the Impilo acquisition, of which 298,361 were issued in 2020 and 32,747
            were issued in 2021. The shares transferred had the same terms as other investors and the amounts recorded as in-process research and development expenses for the years ended December&#160;31, 2020 and 2021, totaled $1.6&#160;million and $0.3&#160;million,
            respectively.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h2">5.&#8195;License Agreements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Sanford Burnham Prebys</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In December 2015, the Company entered into a license agreement with
            Sanford Burnham Prebys under which the Company was granted an exclusive, worldwide, royalty-bearing license to certain patent rights and know-how controlled by SBP related to the development of CEND-1. At the time the license agreement was
            entered into, the Company&#8217;s founding shareholder was an executive at SBP. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the
            license, the Company made an initial upfront payment in the form of common stock, issuing 540,000 shares in September 2016, at $0.00001 per share (the &#8220;License Fee&#8221;). In addition, the Company was required to reimburse SBP for past expenses
            totaling $0.6&#160;million, of which $0.2&#160;million was paid and the </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-51<br />
        </div>

      </div>

    </div>

    <!--End Page 356-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 357-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">remainder was settled with the issuance of 175,707 shares of common stock. The
            Company is required to pay an annual license maintenance fee of $5,000, increasing to $10,000 on year four of the agreement, and increasing to $20,000 on year seven of the agreement. The Company could also be required to make milestone payments
            to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential milestone payments are approximately $10.6&#160;million. The Company has also agreed to pay SBP royalties of 4% of net sales of products sold by the
            Company, or through a sublicense, subject to certain reductions. Additionally, the Company agreed to pay SBP 25% of any sublicensing income. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">During each of the years ended December&#160;31, 2020 and 2021, the
            Company paid $10,000 in license maintenance fees, which were recorded to research and development expense. The Company paid $3.8&#160;million in sublicense fees, related to the Qilu upfront payment and milestone payment received, during the year
            ended December&#160;31, 2021, which were expensed to research and development expense (Note 6). SBP owns 715,707 shares of the Company&#8217;s common stock and is a related party. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In October 2021, the Company entered into a license agreement with
            SBP under which the Company was granted an exclusive, royalty-bearing license to certain patent rights and know-how controlled by SBP. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and
            otherwise exploit the patent rights. As consideration for the license, the Company made an initial upfront payment of $50,000, which was recorded to in-process research and development expense. In addition, the Company was required to reimburse
            SBP for past expenses totaling $67,000, $50,000 of which was paid, and all of which was recorded to in-process research and development expense during the year ended December&#160;31, 2021. In addition, the Company is required to pay an annual
            license maintenance fee of $20,000, increasing to $30,000 on year four of the agreement. Further, the Company could be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate
            potential milestone payments are approximately $23.2&#160;million. The Company has also agreed to pay SBP royalties of 4% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company
            agreed to pay SBP varying sublicense fees, ranging from 10% to 25%, dependent on when the related milestones are reached. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The agreements will expire upon the later of (i)&#160;the final
            abandonment of all pending patent applications within the licensed patents or (ii)&#160;the expiration of the last to expire patent within the licensed patents. The agreements may be terminated in their entirety by the Company at any time by giving
            SBP sixty days&#8217; prior written notice. The agreements may be terminated in their entirety by SBP if the Company, at any time, defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written
            notice. The agreements may be terminated in their entirety by SBP or the Company in (i)&#160;the event of an uncured material breach by the other party, or (ii)&#160;in the event the other party (a) files for, or is involuntarily petitioned with,
            bankruptcy (other than dissolution or winding up for the purposes of reconstruction or amalgamation), (b) makes an assignment of all or substantially all of its assets for the benefit of creditors, or (c)&#160;has a receiver or trustee is appointed
            and is unable to secure a dismissal, stay or other suspension of such proceedings within thirty days. Upon termination of the agreements for any reason, all rights and obligations of the Company with respect to the patents and patent
            applications shall terminate and revert to SBP.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h3">University of California at San Diego</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In March 2021, the Company entered into a license agreement with the
            University of California at San Diego under which the Company was granted an exclusive, royalty-bearing license to certain patent rights related to the development of nano particles to modulate immune response. The agreement provides the
            Company with the rights to grant and authorize sublicenses to use, sell and otherwise exploit the patent rights. As consideration for the license, the Company made an initial upfront payment of $10,000, which was recorded to in-process research
            and development expense. In addition, the Company was required to reimburse UCSD for past expenses totaling $18,000, all of which were paid and recorded to in-process research and development expense during the year ended December&#160;31, 2021. In
            addition, the Company is required to pay an annual license maintenance fee of $5,000. Further, the Company could be required to make milestone payments to UCSD upon completion of certain regulatory and commercial milestones. The aggregate
            potential milestone payments are approximately $1.2&#160;million. The Company has also agreed to pay UCSD royalties of 1.5% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the
            Company agreed to pay UCSD varying sublicense fees, ranging from 10% to 20%, dependent on when the related milestones are reached. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-52<br />
        </div>

      </div>

    </div>

    <!--End Page 357-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 358-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The agreement will expire upon the expiration of the longest-lived
            patent rights. The agreement may be terminated in its entirety by the Company at any time by giving UCSD ninety days&#8217; prior written notice. The agreement may be terminated in its entirety by UCSD if the Company, at any time, (i)&#160;fails to
            perform or violates any term of the agreement and fails to cure the default within sixty days. Upon termination of the agreement for any reason, UCSD may terminate a sublicensee but will allow the Company to assign any sublicenses to UCSD
            provided a) that the sublicensee is in good standing upon termination of the agreement with the Company; and b) the sublicensee is not currently involved in litigation as an adverse party to UCSD.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h3">Massachusetts Institute of Technology</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In October 2021, the Company entered into a license agreement with
            the Massachusetts Institute of Technology under which the Company was granted an exclusive, royalty-bearing license to certain patent rights related to the development of tissue specific delivery of interfering RNA. The agreement provides the
            Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, the Company made an initial upfront payment of $15,000, which was recorded to in-process
            research and development expense. In addition, the Company was required to reimburse MIT for past expenses totaling $75,000, $37,000 of which was paid, and all of which was recorded to in-process research and development expense during the year
            ended December&#160;31, 2021. In addition, the Company is required to pay an annual license maintenance fee of $20,000, increasing to $25,000 for year two and three of the agreement, increasing to $50,000 on year four of the agreement and thereafter
            until the first commercial sale, and increasing to $150,000 each year of the agreement after the first sale. Further, the Company could be required to make milestone payments to MIT upon completion of certain regulatory and commercial
            milestones. The aggregate potential milestone payments are approximately $5.0&#160;million. The Company has also agreed to pay MIT royalties of 2% of net sales of products sold by the Company or through a sublicense, subject to certain reductions.
            Additionally, the Company agreed to pay MIT varying sublicense fees, ranging from 3% to 20%, dependent on when the related milestones are reached. Lastly, the Company could be required to pay MIT a change in control fee of $0.3&#160;million if the
            control of the Company or the agreement is assigned to a third-party. As of December&#160;31, 2021, the Company concluded the change in control event was not probable and therefore no obligation was recorded.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The agreement will expire upon the expiration or abandonment of all
            valid claims. The agreement may be terminated in its entirety by the Company at any time by giving MIT six months prior written notice. The agreement may be terminated in its entirety by MIT if the Company, at any time, (i)&#160;defaults in the
            payment of any sum when due and fails to make such payment within thirty days after receipt of written notice, or (ii)&#160;in the event the Company commits a material breach of its obligations under the agreement (aside from item (i)) and fails to
            cure that breach within sixty days after receipt of written notice. Upon termination of the agreement for any reason, the rights and licenses granted to the Company shall terminate and revert to MIT. Upon termination of the agreement for any
            reason, MIT may terminate a sublicensee but will allow the Company to assign any sublicenses to MIT provided that the sublicensee is in good standing upon termination of the agreement with the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h2">6.&#8195;Research Collaboration and License Agreement</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Exclusive License and Collaboration Agreement</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In February 2021, the Company entered into an Exclusive License and
            Collaboration Agreement (the &#8220;Qilu Agreement&#8221;) in which the Company granted an exclusive license to Qilu for the development and commercialization of CEND-1 in the Territory (defined as the Greater Area of China including China, Macau, Hong
            Kong, and Taiwan). Under the terms of the agreement, Qilu is solely responsible for the development of CEND-1 in its Territory. In consideration for the license, Qilu made a one-time, non-refundable, non-creditable upfront payment of
            $10&#160;million to the Company. The Company is also eligible to receive developmental and commercial milestone payments up to $100&#160;million and $125&#160;million, respectively, tiered royalties on net sales ranging from 10% to 15%, and tiered
            sublicensing revenues ranging from 12% to 35%.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Under the terms of the Qilu Agreement, Qilu was also required to file
            an Investigational New Drug Application (&#8220;IND&#8221;) and receive approval by the National Medical Products Administration (&#8220;NMPA&#8221;) in the People&#8217;s Republic of China in the Territory within 12 months of the effective date of the arrangement, which
            would result in a $5&#160;million milestone payment. Qilu was also required to dose its first patient in a Phase I </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-53<br />
        </div>

      </div>

    </div>

    <!--End Page 358-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 359-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">clinical trial in the Territory within six months of the acceptance of the IND,
            subject to certain extensions, or the Company would have had the option to terminate the Qilu Agreement. In August of 2021, Qilu achieved the regulatory milestone, and the Company received the $5&#160;million milestone payment. Qilu also dosed its
            first patient within the six-month period.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company may also earn an additional $1&#160;million upon completing
            process optimization and scale up activities and delivering three validation batches of CEND-1in full commercial scale by Qilu or its subcontractor (the &#8220;Technology Transfer&#8221;). After completing the Technology Transfer, Qilu will be responsible
            for manufacturing CEND-1 for use in subsequent clinical trials. In the event the Company and its contract manufacturers fail to complete the process optimization and scale up activities, Qilu would have the right to manufacture CEND-1 using its
            independent manufacturing process and would have no obligation to pay the Technology Transfer milestone payment. Prior to the completion of the Technology Transfer, the Company has agreed to supply CEND-1 to Qilu at cost.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Unless terminated early, the Qilu Agreement will continue in effect
            until the expiration of all Qilu payment obligations. Either party may terminate the Qilu Agreement if an undisputed material breach by the other party is not cured within a defined period of time, or upon notice for insolvency-related events
            of the other party that are not discharged within a defined time period. Qilu may terminate the Qilu Agreement in its entirety, at any time with at least sixty days written notice. All right and obligations of Qilu with respect to such licensed
            patents and patent applications would terminate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Under the framework of ASC Topic 606, &#8220;Revenue from Contracts with
            Customers&#8221; (&#8220;ASC 606&#8221;), the Company identified two performance obligations, which was the delivery of the license, and a material right related to the supply of CEND-1 prior to the completion of the Technology Transfer. At the onset of the Qilu
            Agreement, the Technology Transfer was only an option of Qilu, and the Company further determined the fee for the Technology Transfer approximated the standalone selling price and therefore the option would not represent a material right and
            accordingly, did not represent a performance obligation at the onset of the arrangement. The Company recognized $9.7&#160;million in revenue upon delivery of the license to Qilu in February 2021. The Company initially deferred $0.3&#160;million in
            revenue for the material right, which will subsequently be recognized as revenue as the clinical supply is delivered. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In August 2021, the Company received $5.0&#160;million from Qilu upon
            achievement of the first development milestone. In December 2021, the Company provided Qilu with clinical supply material and recognized $51,000 in revenue. As of December&#160;31, 2021, the Company has $0.3&#160;million recorded as deferred revenue, of
            which $66,000 is included in other current liabilities and $0.2&#160;million is included in other long-term liabilities. There was no deferred revenue as of December&#160;31, 2020. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2021, the Technology Transfer had not been
            completed and no payment had been made by Qilu. Additionally, all remaining future development and sales milestones (variable consideration) were fully constrained and will only be recognized upon achievement of the milestones.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h2">7.&#8195;Commitments and Contingencies</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Legal proceedings</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In May 2021, the Company received a written threat of litigation on
            behalf of a Chinese entity called Lingmed Limited (&#8220;Lingmed&#8221;) claiming Lingmed was entitled to a success fee based on the Company&#8217;s Collaboration and License Agreement with Qilu Pharmaceuticals. The Company responded by denying that Lingmed is
            entitled to a success fee under the terms of their agreement. In May 2022, the Company was served with a complaint filed by Lingmed in the San Diego County Superior Court, alleging claims for breach of contract, fraud and declaratory relief.
            The Company&#8217;s response to the complaint is due on or before June&#160;5, 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In addition, the Company may be involved in litigation or claims
            arising out of its operations in the normal course of business. Other than the Lingmed matter, there are currently no such other matters, and any such other matters that would, in the opinion of management, be expected to be immaterial with
            respect to the Company&#8217;s consolidated financial position, liquidity, or results of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">8.&#8195;Stockholders&#8217; Equity (Deficit)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Under the Restated Certificate of Incorporation dated April&#160;27, 2021,
            the Company has a total of 13,600,507&#160;shares of capital stock authorized for issuance, consisting of 10,500,000 shares of common stock, par </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-54<br />
        </div>

      </div>

    </div>

    <!--End Page 359-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 360-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">value of $0.00001 per share, and 3,100,507 shares of preferred stock, par value
            $0.00001 per share. Shares of authorized preferred stock are designated as 371,396 shares of Series A redeemable convertible preferred stock, 1,250,304 shares of Series B redeemable convertible preferred stock, and 1,478,807 shares of Series C
            convertible preferred stock. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Preferred Stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Redeemable convertible preferred stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In March 2018, the Company executed the Series A Stock Purchase
            Agreement and issued 371,396 shares of Series A redeemable convertible preferred stock at $2.96 per share for proceeds of $1.1&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In September 2019, the Company executed the Series B Stock Purchase
            Agreement and issued 1,071,237&#160;shares of Series B redeemable convertible preferred stock at $3.68 per share for proceeds of $3.9&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Convertible preferred stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In connection with the Impilo Asset Purchase Agreement (Note 4), the
            Company issued a total of 1,345,699&#160;shares of Series C convertible preferred stock. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s preferred stock has the following characteristics
            applicable to all classes, unless otherwise specified:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Dividends</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Each holder of preferred stock is entitled to receive dividends when
            and if declared by the board of directors, pro rata and on a pari passu basis according to the number of shares of common stock then issuable upon conversion of all shares of preferred stock held by such holders. Dividends are noncumulative,
            and no cash dividends have been declared to date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Conversion</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Each share of preferred stock is convertible without payment of
            additional consideration at the option of the holder any time after the issuance date into shares of common stock determined by dividing the original issuance price by the conversion price. The conversion price of the preferred stock is
            initially equal to the original issuance price and is subject to certain adjustments. The preferred stock is subject to a mandatory conversion in the event (i)&#160;that there is a closing of the sale of shares of common stock to the public at a
            pre-equity valuation of at least $100&#160;million, resulting in at least $15&#160;million in gross proceeds to the Company, in an underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended,
            and in connection with such offering the common stock is listed for trading on the Nasdaq Stock Market&#8217;s National Market, the New York Stock Exchange or another exchange or marketplace approved by the board of directors or (ii)&#160;upon the vote or
            written consent for such conversion from the Requisite Holders (defined as holders of at least a majority of the outstanding shares of preferred stock, voting as a single class on an as-converted basis). As of December&#160;31, 2020 and 2021, all
            series of preferred stock are convertible into shares of common stock on a one-to-one basis.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h3">Liquidation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Holders of the Series B preferred stock are entitled to receive
            liquidation preferences at the Series B original issue price, plus all accrued and declared but unpaid dividends. After full payment of the liquidation preference to the holders of the Series B preferred stock, the holders of the Series A
            preferred stock are entitled to receive liquidation preferences at the Series A original issue price, plus all accrued and declared but unpaid dividends. After full payment of the liquidation preference to the holders of the Series B preferred
            stock and Series A preferred stock, the holders of the Series C preferred stock are entitled to receive liquidation preferences at the Series C original issue price, plus all accrued and declared but unpaid dividends.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The remaining assets, if any, will be distributed ratably to the
            holders of the Series B preferred stock, Series&#160;A preferred stock and common stock, pro rata, based on the number of shares held by each such holder, treating for this purpose all such securities as if they had been converted to common stock
            immediately prior to such liquidation. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-55<br />
        </div>

      </div>

    </div>

    <!--End Page 360-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 361-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h3">Voting rights</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The holder of each share of preferred stock is entitled to one vote
            for each share of common stock into which it would convert and to vote as one class with the common stockholders on all matters.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Redemption rights and classification</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The holders of Series A and Series B redeemable convertible preferred
            stock have redemption rights. At any time on or after the sixth anniversary of the March&#160;6, 2018 Restated Certificate of Incorporation, the Requisite Holders may provide written notice requesting redemption of all shares of redeemable
            convertible preferred stock at a price equal to the original issue price, plus all declared but unpaid dividends. Subject to the Company&#8217;s election for an initial nine-month deferral, the redemption shall be paid in three annual installments
            commencing not more than sixty days after the written notice. As a result, the Company has classified the redeemable convertible preferred stock outside of stockholders&#8217; equity (deficit) on the consolidated balance sheets as the stock is
            contingently redeemable. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The holders of Series C preferred stock do not have any redemption
            rights. Additionally, as the majority of the Company&#8217;s voting shares are held by common stock shareholders, the preferred shareholders cannot use their vote to force a liquidation. Therefore, the Company has classified the convertible Series C
            preferred stock within stockholders&#8217; equity (deficit) on the consolidated balance sheets.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h3">Common stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2020 and 2021, the Company had 10,000,000 and
            10,500,000 shares, respectively, of its common stock authorized. As of December&#160;31, 2020 and 2021, the Company had 4,168,705 and 4,279,705&#160;shares, respectively, of its common stock issued and outstanding. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Each share of common stock has the right to one vote. The holders of
            common stock are also entitled to receive dividends when and if declared by the board of directors. No cash dividends have been declared by the board of directors during the years ended December&#160;31, 2020 and 2021. In the event of a liquidation,
            dissolution or winding-up, the holders of common stock are entitled to share ratably in the net assets remaining after payment of liabilities and the liquidation value of the preferred stock then outstanding. The common stock has no preemptive
            rights, conversion rights or redemption rights. All shares of common stock have equal distribution, liquidation and voting rights, and have no preferences or exchange rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has reserved the following shares of common stock for
            issuance, on an as-converted basis, as follows:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.09%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.5%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Redeemable convertible preferred stock</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,442,633</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,442,633 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Convertible preferred stock</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,212,609</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,345,699 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stock options issued and outstanding</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2,141,079</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2,270,079 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Authorized for future stock awards or option grants</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">1,041,621</span></div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 40pt;">882,621 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total</div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">5,837,942</span></div>
                </td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.5%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">5,941,032</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h2">9.&#8195;Stock-Based Compensation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">2016 Equity Incentive Plan</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In September 2016, the Company adopted the 2016 Equity Incentive Plan
            (the &#8220;Plan&#8221;), which provides for the grant of incentive stock options, non-statutory stock options, stock bonuses, and rights to acquire restricted stock to employees, directors, and consultants of the Company. As of December&#160;31, 2020 and 2021,
            the number of shares reserved under the Plan was 3,217,700. As of December&#160;31, 2020 and 2021, the number of shares issued and outstanding under the Plan was 2,141,079 and 2,270,079, respectively. As of December&#160;31, 2020 and 2021, the number of
            shares available for grant under the Plan was 1,041,621 and 882,621, respectively. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Options granted under the Plan are exercisable at various dates as
            determined upon grant and will expire no more than ten years from their date of grant, or in the case of grants to a 10% shareholder, five years from the date of grant. The exercise price of each option shall be determined by the Board of
            Directors based on the </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-56<br />
        </div>

      </div>

    </div>

    <!--End Page 361-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 362-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">estimated fair value of the Company&#8217;s stock on the date of the option grant. In the
            case of incentive stock options, the exercise price shall not be less than 100% of the fair market value of the Company&#8217;s common stock at the time the option is granted, unless the option is granted pursuant to an assumption of or substitution
            for another option. For holders of more than 10% of the Company&#8217;s total combined voting power of all classes of stock, incentive stock options may not be granted at less than 110% of the fair market value of the Company&#8217;s stock at the date of
            grant.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Stock Option Activity</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">A summary of the Company&#8217;s stock option activity under the Plan is as
            follows (in thousands, except share and per share amounts and years):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Outstanding</div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted- <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Price</div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted- <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Remaining <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Contractual <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Term</div>
                </td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Aggregate <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Intrinsic <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Balance at December&#160;31, 2020</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,141,079</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$1.82</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">8.81</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 7.5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">473 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Options granted</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">159,000</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">3.82</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Options exercised</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="padding-left: 9.17pt;">(30,000)</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">0.01</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Options cancelled and forfeited</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 40pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 17.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Balance at December&#160;31, 2021</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,270,079</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$1.98</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">8.00</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$4,174 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 58.98%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Vested and exercisable at December&#160;31, 2021</div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,548,579</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$1.83</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.53</span></div>
                </td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.01%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$3,086</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">For the years ended December&#160;31, 2020 and 2021, the total fair value
            of options that vested during each year was $0.5&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">There were no options exercised during the year ended December&#160;31,
            2020. There was one option exercised during the year ended December&#160;31, 2021, with an aggregate intrinsic value of $0.1&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The weighted-average grant date fair value of employee and
            non-employee option grants during the years ended December&#160;31, 2020 and 2021 was $1.19 per share and $2.32 per share, respectively. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Stock-Based Compensation Expense</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company recognized stock-based compensation expense of
            $0.6&#160;million and $0.4&#160;million for the years ended December&#160;31, 2020 and 2021. The assumptions used in the Black-Scholes option pricing model to determine the fair value of the stock option grants were as follows:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.33%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Risk-free interest rate</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.33%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">0.4% - 1.6%</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">1.3%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Expected volatility</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.33%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">75% - 76%</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">72%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Expected term (in years)</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.33%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">5.3</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">5.3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Expected dividend yield</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.33%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">0%</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.74%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">0%</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In determining the fair value of the stock options granted, the
            Company uses the Black-Scholes option-pricing model and assumptions discussed below. Each of these inputs is subjective and generally requires significant judgment.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Risk-free interest rate<span style="font-style: normal;"> &#8211; The risk-free rate assumption is based on the U.S. Treasury instruments, the terms of which were consistent with the expected term of the Company&#8217;s stock options.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Expected volatility<span style="font-style: normal;"> &#8211; Due to the Company&#8217;s limited operating history and lack of company-specific historical or implied volatility as a private company, the expected volatility assumption was determined by examining the historical volatilities of a
              group of industry peers whose share prices are publicly available.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Expected term<span style="font-style: normal;"> &#8211;
              The expected term of stock options represents the weighted-average period the stock options are expected to be outstanding. The Company uses the simplified method for estimating the expected </span></div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-57<br />
        </div>

      </div>

    </div>

    <!--End Page 362-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 363-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">term as provided by the Securities and Exchange Commission. The simplified method
            calculates the expected term as the average of the time-to-vesting and the contractual life of the options.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Expected dividend yield<span style="font-style: normal;"> &#8211; The expected dividend assumption is based on the Company&#8217;s history and expectation of dividend payouts. The Company has not paid and does not intend to pay dividends.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Forfeitures <span style="font-style: normal;">&#8211;
              The Company reduces stock-based compensation expense for actual forfeitures during the period.</span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2021, the unrecognized compensation cost related
            to outstanding employee options was $0.4&#160;million and is expected to be recognized as expense over approximately 3.5&#160;years. Unrecognized compensation cost related to outstanding nonemployee options was $0.5&#160;million as of December&#160;31, 2021 and is
            expected to be recognized as expense over approximately 2.1&#160;years.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">10.&#8195;Australia Research and Development Tax Incentive</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s Australian subsidiary, which conducts core research and
            development activities, is eligible to receive a 43.5% refundable tax incentive for qualified research and development activities. For the year ended December&#160;31, 2021, $0.5&#160;million was recorded as a reduction of research and development
            expenses in the consolidated statements of operations, as the Company determined that it met the eligibility criteria and the amounts claimed are expected by received shortly after the related tax returns are filed. For the year ended
            December&#160;31, 2020, $0.3&#160;million was recorded as a reduction of research and development expenses in the consolidated statements of operations, as the Company determined that it met the eligibility criteria and subsequently collected the tax
            incentives after filing the related tax returns.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h2">11.&#8195;Related Party Transactions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;" class="h3">Consulting Arrangements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Company has an advisory consulting agreement with the founding shareholder, who is
            also a member on the Board of Directors. During the years ended December&#160;31, 2020 and 2021, the Company incurred and paid $0 and $45,000, respectively, which was recorded to research and development expense. As of December&#160;31, 2020 and 2021,
            the Company has a prepayment of $0 and $5,000, respectively, relating to the agreement included within other current assets on the consolidated balance sheets.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Other Transactions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As discussed in Note 4, the Company entered into an asset purchase
            agreement with Impilo, which included several additional license agreements, all of which were paid for with the newly created class of Series C preferred stock, and one of the investors was the Company&#8217;s founding shareholder. During the years
            ended December&#160;31, 2020 and 2021, the Company recorded $1.6&#160;million and $0.3&#160;million, respectively, related to this agreement, which was recorded to in-process research and development expense. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As discussed in Note 5, the Company has license agreements with SBP,
            who owns 715,707 shares of the Company&#8217;s common stock. During the years ended December&#160;31, 2020 and 2021, the Company incurred $26,000 and $3.8&#160;million, respectively, related to the license agreements, which was recorded to research and
            development expense. During the years ended December&#160;31, 2020 and 2021, the Company incurred $0 and $0.1&#160;million, respectively, related to the license agreements, which was recorded to in-process research and development expense. As of
            December&#160;31, 2020 and 2021, $26,000 and $0, respectively, of these expenses, respectively, is included in accounts payable within the consolidated balance sheets, and $12,000 and $27,000, respectively, of these expenses, respectively, is
            included in accrued expenses within the consolidated balance sheets. As of December&#160;31, 2020 and 2021, the Company has a prepayment of $0 and $9,000, respectively, relating to the agreements included within other current assets on the
            consolidated balance sheets.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-58<br />
        </div>

      </div>

    </div>

    <!--End Page 363-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 364-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">12.&#8195;Income Taxes</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s income (loss) before provision (benefit) for income
            taxes for the years ended December&#160;31, 2020 and 2021, respectively, were generated in the following jurisdictions (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Domestic</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.53pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(8,180)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.53pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">5,447 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Foreign</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.53pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(540</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.53pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(1,538</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Worldwide Income</div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.53pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(8,720</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.53pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">3,909</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">A reconciliation of income tax expense (benefit) for the years ended
            December&#160;31, 2020 and 2021 is as follows (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Current:<br />
                  </div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Federal</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">170</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">State</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Foreign</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,684</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total current income tax expense</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,854</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Deferred:<br />
                  </div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Federal</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">State</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Foreign</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total deferred income tax expense</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total income tax expense</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.77pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$1,854</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">During 2021, $1.7&#160;million of foreign income tax was withheld related
            to the Qilu Agreement and the related delivery of the exclusive license and achievement of the first development milestone (Note 6). This foreign income tax expense has been presented as an offset to the revenue on the consolidated statements
            of operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">A reconciliation of the federal statutory income tax rate to the
            Company&#8217;s effective income tax rate for the years ended December&#160;31, 2020 and 2021, is as follows (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 19.96%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Statutory federal income tax rate</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,831)</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">821</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">State income taxes</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">1</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Acquired R&amp;D</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">1,380</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">218</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Foreign rate differential including withholding tax</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">48</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">1,795</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Foreign tax credits</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,330)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research credits</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">(94)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">76</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">34</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Change in valuation allowance</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">326</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">410</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total income tax expense</div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 15.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.56%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.42%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.29pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">1,854</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-59<br />
        </div>

      </div>

    </div>

    <!--End Page 364-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 365-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg16"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Significant components of the Company&#8217;s deferred income taxes for
            the years ended December&#160;31, 2020 and 2021, respectively, is as follows (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Deferred tax assets:<br />
                  </div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Intangibles</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">815</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Net operating loss carryforwards</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">840</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">383</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Stock-based compensation</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">102</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">150</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">18</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">16</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total gross deferred tax assets</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">960</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">1,364 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Valuation allowance</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(960</span><span style="min-width: 23.33pt;">)</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(1,364</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net deferred tax assets</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.23%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.84%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.6pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 15.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Deferred income tax assets and liabilities are recorded for
            differences between the financial statement and tax basis of the assets and liabilities that will result in taxable or deductible amounts in the future based on enacted laws and rates applicable to the periods in which the differences are
            expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has evaluated the available evidence supporting the realization of its gross
            deferred tax assets, including the amount and timing of future taxable income, and has determined it is more likely than not that the assets will not be realized. Due to uncertainties surrounding the realizability of the deferred tax assets,
            the Company maintains a full valuation allowance against its deferred tax assets as of December&#160;31, 2021 and 2020. During the year ended December&#160;31, 2021, the valuation allowance increased by $0.4&#160;million.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">At December&#160;31, 2021, the Company had state and foreign net operating
            losses, or NOL, carryforwards of approximately $4.3&#160;million and $1.3&#160;million, respectively. The state NOLs will begin to expire in 2036 unless previously utilized. The foreign NOLs will carryforward indefinitely.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">At December&#160;31, 2021, the Company had state research credit
            carryforwards of approximately $48,000 that will carryforward indefinitely.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Utilization of the Company&#8217;s NOL and R&amp;D credit carryforwards may
            be subject to substantial annual limitations in the event a cumulative ownership change has occurred, or that could occur in the future, as required by Section 382 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). In general, an
            &#8220;ownership change,&#8221; as defined by Section 382 of the Code, results from a transaction, or series of transactions over a three-year period, resulting in an ownership change of more than 50% of the outstanding common stock of a company by certain
            stockholders or public groups. Such an ownership change may limit the amount of NOL and R&amp;D credit carryforwards that can be utilized annually to offset future taxable income and tax, respectively. If ownership changes occur in the future,
            the amount of remaining tax attribute carryforwards available to offset taxable income and income tax expense in future years may be restricted or eliminated. If eliminated, the related asset would be removed from deferred tax assets with a
            corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by future ownership changes, if any, will not impact the Company&#8217;s effective tax rate. The Company recognizes a tax benefit
            from an uncertain tax position when it is more likely than not that the position will be sustained upon examination by tax authorities. The Company does not expect that there will be a significant change in the unrecognized tax benefits over
            the next twelve months. Further, due to the existence of the valuation allowance, future changes in the Company&#8217;s unrecognized tax benefits will not impact the effective tax rate.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-60<br />
        </div>

      </div>

    </div>

    <!--End Page 365-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 366-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg17"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The following table summarizes the changes to the Company&#8217;s gross
            unrecognized tax benefits for the years ended December&#160;31, 2020 and 2021, respectively (in thousands):</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2020</div>
                </td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Balance at beginning of year</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">237</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">310</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Increases (decreases) related to prior year tax positions</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Increases related to current year tax positions</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">73</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">34</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Decreases due to settlements</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Expiration of the statute of limitations for the assessment of taxes</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 20pt;">&#8212;</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 20pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Balance at end of year</div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$310</span></div>
                </td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.14pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$344</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2020 and 2021, the Company had unrecognized tax
            benefits of $0.3&#160;million and $0.3&#160;million, respectively, which if recognized currently, should not impact the effective tax rate due to the Company maintaining a full valuation allowance. The Company does not expect that there will be a
            significant change in the unrecognized tax benefit over the next twelve months. The Company&#8217;s policy is to recognize interest and penalties related to income tax matters as income tax expense. The Company had no accrual for interest or
            penalties on the Company&#8217;s balance sheets as of December&#160;31, 2020 or 2021, and has not recognized interest and/or penalties in the statement of operations and comprehensive loss for the years ended December&#160;31, 2020 and 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company is subject to taxation in the United States, California,
            and Australia. As of December&#160;31, 2021, the Company&#8217;s tax years are subject to examination by the tax authorities from 2018 and forward for Federal tax purposes and 2017 and forward for California and Australia tax purposes. However, to the
            extent allowed by law, the tax authorities may have the right to examine the period from inception forward where NOLs and credits were generated and carried forward and make adjustments to the amount of the NOL and credit carryforward amounts.
            The Company is not currently under examination by any federal, state, or foreign tax authority.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">On March&#160;27, 2020, the Coronavirus Aid, Relief, and Economic Security
            Act (&#8220;CARES&#8221; Act) was enacted in response to the COVID-19 pandemic. The CARES Act, among other things, permits net operating loss carryforwards generated in taxable years beginning after December&#160;31, 2017, to offset 100% of taxable income for
            taxable years beginning before January&#160;1, 2021, and 80% of taxable income in taxable years beginning after December&#160;31, 2020. In addition, the CARES Act allows net operating losses incurred in taxable years beginning after December&#160;31, 2017,
            and before January&#160;1, 2021, to be carried back to each of the five preceding taxable years to generate a refund of previously paid income taxes. The CARES Act also temporarily increased the business interest expense limitation from 30% of
            adjusted taxable income (&#8220;ATI&#8221;) to 50% of ATI for tax years 2019 and 2020, and allowed taxpayers to elect to use their 2019 ATI to compute their 2020 limitation. The legislation also included a technical correction related to qualified
            improvement property. The impact of the CARES Act was not material to the Company&#8217;s financial statements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">On June&#160;29, 2020, the state of California enacted Assembly Bill No.
            85 (&#8220;AB 85&#8221;) suspending California net operating loss utilization and imposing a cap on the amount of business incentive tax credits companies can utilize, effective for tax years 2020 and 2021. There was no material impact from the provisions
            of AB 85 on the Company's financial statements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In December 2019, the FASB issued ASU No. 2019-12 Income Taxes (Topic
            740) Simplifying the Accounting for Income Taxes. The Board issued this Update as part of its Simplification Initiative to improve areas of GAAP and reduce cost and complexity while maintaining usefulness. The ASU removes certain exceptions for
            recognizing deferred taxes for investments, performing intra-period allocation and calculating income taxes in interim periods. The ASU also adds guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax
            goodwill and allocating taxes to members of a consolidated group. ASU&#160;2019-12 is effective for annual periods, including interim periods within those annual periods, beginning after December&#160;15, 2021. The Company early adopted this standard as
            of January&#160;1, 2021. The adoption did not have a significant impact on the Company&#8217;s financial results.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-61<br />
        </div>

      </div>

    </div>

    <!--End Page 366-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 367-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg18"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="h2">13.&#8195;Subsequent Events </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company evaluated subsequent events for recognition and
            measurement purposes through May&#160;20, 2022, the date the consolidated financial statements were issued.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Merger Agreement </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">On April&#160;26, 2022, the Company entered into an agreement and plan of
            merger (&#8220;Merger Agreement&#8221;) with Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;), a Delaware corporation and CS Cedar Merger Sub, Inc., a wholly-owned subsidiary of Caladrius (&#8220;Merger Sub&#8221;). Pursuant to the Merger Agreement, among other matters, and
            subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into the Company, with the Company continuing as a wholly owned subsidiary of Caladrius and the surviving corporation of
            the merger (the &#8220;Merger&#8221;). The Merger is intended to qualify for federal income tax purposes as a tax-free reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986, as amended. The Merger Agreement and the
            Merger were approved by the members of the board of directors of the Company (the &#8220;Board&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Subject to the terms and conditions of the Merger Agreement, at the
            closing of the Merger, (a) each outstanding share of Company common stock will be converted into the right to receive a number of shares of Caladrius common stock (&#8220;Caladrius Common Stock&#8221;) equal to the exchange ratio described below; and
            (b)&#160;each outstanding Company stock option that has not previously been exercised prior to the closing of the Merger will be assumed by Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Under the exchange ratio formula in the Merger Agreement, as of
            immediately after the Merger, the Company&#8217;s former stockholders are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock and stockholders of Caladrius as of immediately prior to the Merger are expected to own
            approximately 50% of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on Caladrius&#8217; net cash balance at the time of closing and the amount of any transaction expenses of the Company in
            excess of $0.3&#160;million at the time of closing. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Concurrently with the execution of the Merger Agreement and in order
            to provide the Company with capital for its development programs prior to the closing of the Merger, Caladrius and the Company entered into a Series D Preferred Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which Caladrius
            agreed to purchase from the Company 1,135,628 shares of Series D Preferred Stock, $0.00001 par value per share (the &#8220;Series D Preferred Stock&#8221;), of Cend at a purchase price per share equal to $8.8057 per share (the &#8220;Series D Original Issue
            Price&#8221;), or approximately $10.0&#160;million in the aggregate. The Series D Preferred Stock ranks senior to the Company&#8217;s common stock and the other series of preferred stock with respect to rights on the distribution of assets on any voluntary or
            involuntary liquidation, dissolution or winding up of the Company. The Series D Preferred Stock has a liquidation preference equal to the Series D Original Issue Price plus an amount equal to any accrued and unpaid dividends to the date of
            payment and will participate with the Company&#8217;s common stockholders and other preferred stockholders thereafter on an as-converted basis. The Series D Preferred Stock shall vote with the common stock on an as-converted basis on any matters
            presented to the stockholders of the Company. Each share of Series D Preferred Stock is convertible, at the option of the holder thereof, into such number of shares of Company common stock as is determined by dividing the Original Issue Price
            by the conversion price in effect at the time of conversion, which conversion price shall be the Original Issue Price as appropriately adjusted for stock splits, stock dividends, combinations, and subdivisions of Company common stock, and as
            adjusted pursuant to a weighted-average antidilution adjustment. The Series D Preferred Stock will automatically convert into shares of Company common stock upon the closing of a firm-commitment underwritten initial public offering implying a
            pre-equity offering value of at least $250.0&#160;million, resulting in at least $50.0&#160;million of gross proceeds to the Company. The closing of the Merger is subject to certain conditions, including, among other things, approval by the stockholders
            of Caladrius and the Company, and Caladrius&#8217; satisfaction of a minimum net cash threshold at closing of $64.9&#160;million assuming a closing at the end of the third quarter of 2022, and as described further in the Merger Agreement. In accordance
            with the terms of the Merger Agreement, (i)&#160;certain executive officers, directors and stockholders of the Company (solely in their respective capacities as Company stockholders) holding approximately 77.5% of the outstanding Company capital
            stock have entered into support agreements with Caladrius to vote all of their shares of Company capital stock in favor of adoption of the Merger Agreement (the &#8220;Cend Support Agreements&#8221;) and (ii)&#160;certain executive officers and directors of
            Caladrius (solely in their respective capacities as Caladrius stockholders) holding approximately 1.8% of the outstanding Caladrius common stock have entered </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-62<br />
        </div>

      </div>

    </div>

    <!--End Page 367-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 368-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_206-finnotes03_pg19"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">into support agreements with the Company to vote all of their shares of Caladrius
            common stock in favor of approval of the Merger Agreement (the &#8220;Caladrius Support Agreements,&#8221; together with the Cend Support Agreements, the &#8220;Support Agreements&#8221;). The Support Agreements include covenants with respect to the voting of such
            shares in favor of approving the transactions contemplated by the Merger Agreement and against any competing acquisition proposals and place certain restrictions on the transfer of the shares of Caladrius and Cend held by the respective
            signatories thereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Merger Agreement contains certain termination rights for both
            Caladrius and the Company, and further provides that, upon termination of the Merger Agreement under specified circumstances, Caladrius may be required to pay the Company a termination fee of $1.0&#160;million, and the Company may be required to pay
            Caladrius a termination fee of $4.0&#160;million, or in some circumstances reimburse the other party&#8217;s expenses up to a maximum of $1.0&#160;million.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-63<br />
        </div>

      </div>

    </div>

    <!--End Page 368-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 369-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_207-fintab04_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCCB4"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONDENSED CONSOLIDATED BALANCE SHEETS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(IN THOUSANDS, EXCEPT SHARE AND PAR VALUE AMOUNTS)</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara"></div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31,</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Assets<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Current assets:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Cash</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara">$<span style="padding-left: 8.33pt;">6,288</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara">$<span style="padding-left: 7.96pt;">4,716</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Tax incentive receivable</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">509</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 20.46pt;">867</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Other current assets (including related party amounts of
                    $14 and $12, respectively)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">690</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 20.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">849 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total current assets</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">7,487</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">6,432 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total assets</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">7,487</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 5pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 5pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.46pt;">$</span><span style="padding-left: 7.96pt; border-bottom: 3pt double #000000; min-width: 35.46pt;">6,432 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Liabilities, convertible preferred stock, and stockholders'
                    equity (deficit)<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Current liabilities:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accounts payable</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">259</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara">$<span style="padding-left: 15.46pt;">635</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Accrued expenses (including related party amounts of $27
                    and $30, respectively)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">535</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 20.46pt;">413</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other current liabilities</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">66</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">52 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total current liabilities</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">860</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">1,100</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Other long-term liabilities</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">216</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 20.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">216 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total liabilities</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">1,076</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">1,316</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Commitments and contingencies (Note 7)<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Redeemable convertible preferred stock:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Series A redeemable convertible preferred stock, $0.00001
                    par value; 371,396 shares authorized as of December&#160;31, 2021 and March&#160;31, 2022; 371,396 shares issued and outstanding as of December&#160;31, 2021 and March&#160;31, 2022; $1.1&#160;million liquidation preference as of December&#160;31, 2021 and March&#160;31,
                    2022</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">1,100</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">1,100</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Series B redeemable convertible preferred stock, $0.00001
                    par value; 1,250,304 shares authorized as of December&#160;31, 2021 and March&#160;31, 2022; 1,071,237 shares issued and outstanding as of December&#160;31, 2021 and March&#160;31, 2022; $3.9&#160;million liquidation preference as of December&#160;31, 2021 and
                    March&#160;31, 2022</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt;">3,941</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 12.96pt;">3,941</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stockholders' equity:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Series C convertible preferred stock, $0.00001 par value;
                    1,478,807 shares authorized as of December&#160;31, 2021 and March&#160;31, 2022; 1,345,699 shares issued and outstanding as of December&#160;31, 2021 and March&#160;31, 2022; $7.3&#160;million liquidation preference as of December&#160;31, 2021 and March&#160;31, 2022</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Common stock, $0.00001 par value; 10,500,000 shares
                    authorized as of December&#160;31, 2021 and March&#160;31, 2022; 4,279,705 shares issued and outstanding as of December&#160;31, 2021 and March&#160;31, 2022</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Additional paid-in capital</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 8.7pt;">11,656</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt;">11,750</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accumulated other comprehensive loss</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">(79)</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 2.75pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 22.13pt;">(39)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Accumulated deficit</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,207</span><span style="min-width: 35.83pt;">)</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 2.75pt; padding-bottom: 4pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 2.75pt; padding-bottom: 4pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">(11,636</span><span style="min-width: 35.46pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total stockholders' equity</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">1,370</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 4pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="padding-left: 25.46pt; border-bottom: 1pt solid #000000; min-width: 35.46pt;">75 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total liabilities, convertible preferred stock, and stockholders' equity</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.09pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">7,487</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.27pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 35.46pt;">$</span><span style="padding-left: 7.96pt; border-bottom: 3pt double #000000; min-width: 35.46pt;">6,432</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to the condensed consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-64<br />
        </div>

      </div>

    </div>

    <!--End Page 369-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 370-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_207-fintab04_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCCS4"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(IN THOUSANDS, EXCEPT SHARE AND PAR VALUE AMOUNTS)</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 26.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net revenues</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara">$<span style="padding-left: 17.5pt;">9,736</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara">$<span style="padding-left: 25pt;">178</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating expenses:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Research and development (including related party amounts
                    of $2,522 and $27, respectively)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">3,200</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">1,291</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">In-process research and development (including related
                    party amounts of $128 and $0, respectively)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 30pt;">520</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 35pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">General and administrative</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 45pt;">237</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 45pt;">316 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total operating expenses</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">3,957</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">1,607 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Operating income (loss)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">5,779</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(1,429</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other income:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Interest income</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total other income</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Income (loss) before income taxes</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">5,779</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt;">(1,429)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Income tax expense</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 45pt;">192</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">5,587</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(1,429</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Income allocable to participating securities</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(2,166</span><span style="min-width: 45pt;">)</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">3,421</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(1,429</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) per share attributable to common shareholders:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">0.82</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 19.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(0.33</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">0.73</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 19.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(0.33</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted-average common shares outstanding:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Basic</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">4,194,705</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">4,279,705 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Diluted</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">5,038,088</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">4,279,705</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to the condensed consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-65<br />
        </div>

      </div>

    </div>

    <!--End Page 370-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 371-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_207-fintab04_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCCSI4"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(IN THOUSANDS)</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 26.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.25pt; text-align: left;" class="fpara">$5,587</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara">$(1,429)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cumulative translation adjustment arising during the period</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.25pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">(8</span><span style="min-width: 27.5pt;">)</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">40 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Comprehensive income (loss)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.25pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$5,579</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,389</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to the condensed consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-66<br />
        </div>

      </div>

    </div>

    <!--End Page 371-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 372-->
    <div style="text-align: left; margin: auto; position: relative; width: 528pt;" class="page"><a id="ny20004343x2_s4a_207-fintab04_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 528pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCCCP4"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">STOCKHOLDERS&#8217; EQUITY (DEFICIT)<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(IN THOUSANDS, EXCEPT SHARE AMOUNTS)</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 528pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Series A<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Redeemable <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Convertible <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Preferred Stock</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Series B<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Redeemable <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Convertible <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Preferred Stock</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Series C<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Convertible <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Preferred Stock</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Common <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stock</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Additional <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Paid-in<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Capital</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accumulated<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Other <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Comprehensive<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Income <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(Loss)</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Accumulated<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Deficit</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Total<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Stockholders'<br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Equity <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">(Deficit)</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares </div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares </div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Shares</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Amount</div>
                </td>

    <td style="width: 0.39%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;" class="fpara">Balance as of December&#160;31, 2020</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.69pt;">371,396</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20.89pt;">$1,100</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">1,071,237</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20.89pt;">$3,941</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">1,212,609</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 11.4pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">4,168,705</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 11.4pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.69pt;">$</span><span style="padding-left: 3.8pt; border-bottom: 3pt double #000000; min-width: 24.69pt;">9,917</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 13.92pt;">$</span><span style="padding-left: 2.53pt; border-bottom: 3pt double #000000; min-width: 13.92pt;">40</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.22pt;">$(13,946</span><span style="min-width: 27.22pt;">)</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.42pt;">$(3,989</span><span style="min-width: 23.42pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Issuance of Series C convertible preferred stock</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 9.49pt;">66,545</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">520</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 6.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 19.62pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 12.02pt;">520</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Stock-based compensation expense</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 13.57pt;">117</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 6.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 19.62pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 12.3pt;">117</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Exercise of stock options</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 9.49pt;">30,000</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 6.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 19.62pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 15.82pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Net income</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 6.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 10.13pt;">5,587 </span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 6.33pt;">5,587</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Foreign currency translation adjustment</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt; border-bottom: 1pt solid #000000; min-width: 24.69pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt; border-bottom: 1pt solid #000000; min-width: 20.89pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt; border-bottom: 1pt solid #000000; min-width: 30.38pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt; border-bottom: 1pt solid #000000; min-width: 20.89pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt; border-bottom: 1pt solid #000000; min-width: 30.38pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt; border-bottom: 1pt solid #000000; min-width: 11.4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt; border-bottom: 1pt solid #000000; min-width: 30.38pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt; border-bottom: 1pt solid #000000; min-width: 11.4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt; border-bottom: 1pt solid #000000; min-width: 24.69pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 7.6pt; border-bottom: 1pt solid #000000; min-width: 13.92pt;">(8</span><span style="min-width: 13.92pt;">)</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 19.62pt; border-bottom: 1pt solid #000000; min-width: 27.22pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt; border-bottom: 1pt solid #000000; min-width: 23.42pt;">(8</span><span style="min-width: 23.42pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;" class="fpara">Balance at March&#160;31, 2021</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.69pt;">371,396</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20.89pt;">$1,100</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">1,071,237</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20.89pt;">$3,941</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">1,279,154</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 11.4pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">4,198,705</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 11.4pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.69pt;">$10,554</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 13.92pt;">$</span><span style="padding-left: 2.53pt; border-bottom: 3pt double #000000; min-width: 13.92pt;">32</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.22pt;">$</span><span style="padding-left: 3.8pt; border-bottom: 3pt double #000000; min-width: 27.22pt;">(8,359</span><span style="min-width: 27.22pt;">)</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.42pt;">$</span><span style="padding-left: 2.53pt; border-bottom: 3pt double #000000; min-width: 23.42pt;">2,227</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 6.32pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 19.62pt;">&#8195;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 15.82pt;">&#8195; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;" class="fpara">Balance at December&#160;31, 2021</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.69pt;">371,396</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20.89pt;">$1,100</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">1,071,237</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20.89pt;">$3,941</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">1,345,699</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 11.4pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">4,279,705</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 11.4pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.69pt;">$</span><span style="padding-left: 0.28pt; border-bottom: 3pt double #000000; min-width: 24.69pt;">11,656</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 13.92pt;">$(79</span><span style="min-width: 13.92pt;">)</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.22pt;">$(10,207</span><span style="min-width: 27.22pt;">)</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.42pt;">$</span><span style="padding-left: 2.53pt; border-bottom: 3pt double #000000; min-width: 23.42pt;">1,370</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Stock-based compensation expense</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">94</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 6.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 19.62pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 15.82pt;">94</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Net loss</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 6.32pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 7.6pt;">(1,429)</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt;">(1,429)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;" class="fpara">Foreign currency translation adjustment</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt; border-bottom: 1pt solid #000000; min-width: 24.69pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt; border-bottom: 1pt solid #000000; min-width: 20.89pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt; border-bottom: 1pt solid #000000; min-width: 30.38pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="padding-left: 13.29pt; border-bottom: 1pt solid #000000; min-width: 20.89pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt; border-bottom: 1pt solid #000000; min-width: 30.38pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt; border-bottom: 1pt solid #000000; min-width: 11.4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="padding-left: 22.78pt; border-bottom: 1pt solid #000000; min-width: 30.38pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="padding-left: 3.8pt; border-bottom: 1pt solid #000000; min-width: 11.4pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="padding-left: 17.09pt; border-bottom: 1pt solid #000000; min-width: 24.69pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="padding-left: 6.33pt; border-bottom: 1pt solid #000000; min-width: 13.92pt;">40</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="padding-left: 19.62pt; border-bottom: 1pt solid #000000; min-width: 27.22pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="padding-left: 15.82pt; border-bottom: 1pt solid #000000; min-width: 23.42pt;">40</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 15.91%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;" class="fpara">Balance at March&#160;31, 2022</div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 4.67%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.69pt;">371,396</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20.89pt;">$1,100</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">1,071,237</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 2.85pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20.89pt;">$3,941</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; border-right: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.75%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">1,345,699</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.59pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 11.4pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.38pt;">4,279,705</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.04%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.61pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 11.4pt;">$&#8212;</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 6.56%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 24.69pt;">$</span><span style="padding-left: 0.28pt; border-bottom: 3pt double #000000; min-width: 24.69pt;">11,750</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.57%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 18.29pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 13.92pt;">$(39</span><span style="min-width: 13.92pt;">)</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.15%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 7.92pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.22pt;">$</span><span style="padding-left: 0.28pt; border-bottom: 3pt double #000000; min-width: 27.22pt;">(11,636</span><span style="min-width: 27.22pt;">)</span></div>
                </td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.39%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.6pt; margin-top: 0pt; margin-left: 10.66pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 23.42pt;">$</span><span style="padding-left: 12.02pt; border-bottom: 3pt double #000000; min-width: 23.42pt;">75</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 30pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to the condensed consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 30pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-67<br />
        </div>

      </div>

    </div>

    <!--End Page 372-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 373-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_207-fintab04_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tCCSCF4"><!--Anchor--></a>CEND THERAPEUTICS, INC.<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">(IN THOUSANDS)</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 26.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash flows from operating activities:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss)</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara">$<span style="padding-left: 5pt;">5,587</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara">$(1,429)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Adjustments to reconcile net income (loss) to cash
                    provided by (used in) operating activities:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Stock-based compensation</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 17.87pt;">117</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">94</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">In-process research and development expenses</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">520</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Changes in operating assets and liabilities:<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Tax benefit receivable</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt;">(39)</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">(342)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Other current assets</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 22.5pt;">&#8212;</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">(156)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Other current liabilities</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 24.17pt;">(8)</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">(14)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Other long-term liabilities</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">284</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Accounts payable</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt;">477</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 15.83pt;">371</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;" class="fpara">Accrued expenses</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">2,394</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(121</span><span style="min-width: 30.83pt;">)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net cash provided by (used in) operating activities</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">9,332</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,597)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Effect of exchange rate changes on cash</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">1</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">25</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net increase (decrease) in cash</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">9,333</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">(1,572)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash at beginning of period</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">684</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">6,288 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cash at end of period</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$10,017</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">4,716 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Supplemental noncash financing activities<br />
                  </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.79%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara">Issuance of Series C convertible preferred stock in
                    connection with in-process research and development</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.75pt; text-align: left;" class="fpara">$<span style="padding-left: 12.5pt;">520</span></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 12.82%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.59pt; text-align: left;" class="fpara">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;" class="unknown">See accompanying notes to the condensed consolidated financial statements.<br />
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-68<br />
        </div>

      </div>

    </div>

    <!--End Page 373-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 374-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tNOTE4"><!--Anchor--></a>CEND THERAPEUTICS, INC. <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">1.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Organization and Description of Business</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Cend Therapeutics, Inc. (the &#8220;Company&#8221; or &#8220;Cend&#8221;), headquartered in
            San Diego, California, is a biopharmaceutical company dedicated to developing next generation cancer therapies that are designed to overcome the barriers of drug delivery to solid tumors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company was initially formed as DrugCendR, LLC. (&#8220;DrugCendR&#8221;), on
            October&#160;22, 2015, and subsequently changed from an LLC to a corporation, and changed its name to Cend Therapeutics. On February&#160;28, 2018, DrugCendR established a wholly-owned Australian subsidiary, DrugCendR Australia Pty Ltd. (&#8220;DrugCendR
            AUS&#8221;), in order to conduct clinical activities in Australia for its development candidates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;" class="h3">Liquidity and Going Concern</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has a limited operating history and the sales and income
            potential of the Company&#8217;s business and market are unproven. The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and
            the satisfaction of liabilities in the normal course of business, and do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or amounts and classification of liabilities that may
            result from the outcome of this uncertainty.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Management is required to perform a two-step analysis over its
            ability to continue as a going concern. Management must first evaluate whether there are conditions and events that raise substantial doubt about the Company&#8217;s ability to continue as a going concern (step 1). If management concludes that
            substantial doubt is raised, management is also required to consider whether its plans alleviate that doubt (step 2).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has experienced net losses and negative cash flows from
            operating activities since its inception, aside from the year ended December&#160;31, 2021, as a result of a one-time license payment and a milestone payment from the Exclusive License and Collaboration Agreement with Qilu Pharmaceutical Co., Ltd.
            (&#8220;Qilu&#8221;), which rendered net income in 2021 (Note 6). The Company has an accumulated deficit of $11.6&#160;million as of March&#160;31, 2022. For the three months ended March&#160;31, 2022, the Company used $1.6&#160;million of cash in operations. As of March&#160;31,
            2022, the Company had cash of $4.7&#160;million. Management expects operating losses and negative cash flows to continue for at least the next year as the Company continues to incur costs related to ongoing clinical development of its drug
            candidates. Management has prepared cash flow forecasts which indicate that based on the Company&#8217;s expected operating losses and negative cash flows, there is substantial doubt about the Company&#8217;s ability to continue as a going concern within
            twelve months after the date that the condensed consolidated financial statements for the three months ended March&#160;31, 2022, are issued. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Management&#8217;s ability to continue as a going concern is dependent upon
            its ability to receive additional funds. Management intends to raise additional capital through equity offerings, debt financings or strategic arrangements with third parties. Additionally, the Company may receive further milestone payments
            from the Exclusive License and Collaboration Agreement with Qilu. However, the Company may not be able to secure additional financing in a timely manner or on favorable terms, if at all, and may not receive any milestone payments. Without
            additional funds, the Company may be forced to delay, scale back or eliminate some research and development activities, or other operations and potentially delay product development in an effort to provide sufficient funds to continue
            operations. If any of these events occur, the Company&#8217;s ability to develop and commercialize its product candidates would be adversely affected.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">2.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Summary of Significant Accounting Policies</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Basis of Presentation and Consolidation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The accompanying unaudited condensed consolidated financial
            statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;). The unaudited condensed consolidated financial statements include the accounts of Cend (a U.S. Corporation) and its
            wholly owned subsidiary DrugCendR (an Australian corporation). All intercompany accounts and transactions have been eliminated in consolidation.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-69<br />
        </div>

      </div>

    </div>

    <!--End Page 374-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 375-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In the opinion of the Company, the accompanying unaudited
            condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the interim periods presented. These unaudited interim condensed consolidated financial
            statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes for the year ended December&#160;31, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s significant accounting policies are disclosed in the
            audited consolidated financial statements for the years ended December&#160;31, 2020 and 2021, included elsewhere in this registration statement. Since the date of those consolidated financial statements, there have been no changes to its
            significant accounting policies. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Net Income (Loss) Per Share</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company computes net income (loss) per share in accordance with
            the FASB guidance for Earnings Per Share, which established standards regarding the computation of earnings per share by companies that have issued securities other than common stock that contractually entitle the holder to participate in
            earnings and dividends. The guidance requires earnings available to common shareholders for the period, after deduction of preferred stock preferences, to be allocated between the common and preferred shareholders based on their respective
            rights to receive dividends. The Company is not required to present basic and diluted net income (loss) per share for securities other than common stock; therefore, the net income (loss) per share amounts only pertain to the Company&#8217;s common
            stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Basic net income (loss) per share is calculated by dividing income
            (loss) allocable to common shareholders (net income after reduction for any required returns to preferred stock shareholders prior to paying dividends to the common shareholders, assuming current income for the period had been distributed) by
            the weighted-average number of common shares outstanding, during the period.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has used the two-class method to calculate diluted net
            income (loss) per share for the three months ended March&#160;31, 2021 and 2022. Diluted net income per share for the three months ended March&#160;31, 2021, also reflects the assumed conversion of options outstanding during the period using the treasury
            stock method, to the extent dilutive. For purposes of calculating the net loss per share for the three months ended March&#160;31, 2022, stock options were not included as their effect would be antidilutive.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The following table sets forth the computation of basic and diluted
            net income (loss) per share:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 28.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31, </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021 </div>
                </td>

    <td style="width: 2.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basic Net Income (Loss) per share<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara">$<span style="padding-left: 17.5pt;">5,587 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara">$<span style="padding-left: 14.17pt;">(1,429) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Less: income allocated to participating securities </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(2,166</span><span style="min-width: 45pt;">) </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">3,421 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(1,429</span><span style="min-width: 45pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding - basic </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,194,705 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,279,705 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) per share - basic </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">0.82 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 19.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(0.33</span><span style="min-width: 45pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Diluted Net Income (Loss) per share<span style="font-weight: normal;"> </span><br />
                  </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara">$<span style="padding-left: 17.5pt;">5,587 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara">$<span style="padding-left: 14.17pt;">(1,429) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Less: income allocated to participating securities </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(1,928</span><span style="min-width: 45pt;">) </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) attributable to common shareholders </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">3,659 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">$</span><span style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; min-width: 45pt;">(1,429</span><span style="min-width: 45pt;">) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding - basic </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,194,705 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,279,705 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average effect of dilutive stock options </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">843,383 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Weighted average common shares outstanding - diluted </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">5,038,088 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 45pt;">4,279,705 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Net income (loss) per share - diluted </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 22.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">0.73 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.08pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 19.17pt; border-bottom: 3pt double #000000; min-width: 45pt;">(0.33</span><span style="min-width: 45pt;">)</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.5pt; margin-left: 0pt; text-align: justify;" class="fpara"> </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-70<br />
        </div>

      </div>

    </div>

    <!--End Page 375-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 376-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Potentially dilutive securities as of March&#160;31, 2021 and 2022 are
            as follows (in common stock equivalent shares): </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 28.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Three Months Ended March&#160;31, </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021 </div>
                </td>

    <td style="width: 2.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Series A redeemable convertible preferred stock </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">371,396 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">371,396 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Series B redeemable convertible preferred stock </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara">1,071,237 </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara">1,071,237 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Series C convertible preferred stock </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara">1,279,154 </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara">1,345,699 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stock Options </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara"><span style="padding-left: 0.74pt; border-bottom: 1pt solid #000000; min-width: 40pt;">2,111,079 </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">2,270,079 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Total </div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">4,832,866
                    </span></div>
                </td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 11.36%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.58pt; text-align: left;" class="fpara"><span style="padding-left: 0.37pt; border-bottom: 3pt double #000000; min-width: 40pt;">5,058,411</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">3.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Accrued Expenses</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Accrued expenses consist of the following (in thousands):</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, </div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31, </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021 </div>
                </td>

    <td style="width: 3.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Research and development </div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara">$ 174 </div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara">$ 340 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Employee related </div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">177 </span></div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">57 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Taxes </div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="padding-left: 5pt;">148 </span></div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara"><span style="padding-left: 10pt;">&#8212; </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Other </div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 20pt;">36 </span></div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 20pt;">16 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8195;<br />
                  </div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$ 535 </span></div>
                </td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$ 413</span></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">4.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Asset Acquisition </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In September 2020, the Company entered into an Asset Purchase
            Agreement (the &#8220;Impilo Agreement&#8221;) with Impilo Therapeutics, Inc. (&#8220;Impilo&#8221;). In accordance with the Impilo Agreement, the Company purchased all the intellectual property rights, know-how and product data of Impilo, as well as certain assumed
            contracts. The acquired assets expand the Company&#8217;s drug delivery capabilities for targeted tissue penetrating delivery of nucleic acid-based medicines for the treatment of solid tumor cancers. The Company&#8217;s founding shareholder was a
            significant shareholder in Impilo prior to the acquisition. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In connection with the Impilo Agreement, the Company issued 1,212,609
            shares of a newly created class of Series C convertible preferred stock, with a value of $5.41 per share, for a total value of $6.6&#160;million. The Company recorded the purchase price as in-process research and development expense during the year
            ended December&#160;31, 2020. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Impilo Agreement and assumed contracts also allowed for the
            Company to pursue four license options that were under negotiation by the former shareholders of Impilo at the time of acquisition. If executed by the Company, additional shares (&#8220;License Shares&#8221;) were to be issued to the original Impilo
            shareholders. In addition, the Company also assumed the right to pursue a license with the Massachusetts Institute of Technology (&#8220;MIT&#8221;). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In March 2021 and October 2021, two of the four license options,
            University of California San Diego (&#8220;UCSD&#8221;) and Sanford Burnham Prebys (&#8220;SBP&#8221;), respectively, were executed, and additional License Shares of 66,545 each (Series C shares) were issued to the original Impilo shareholders. The License Shares were
            valued at $7.82 per share, based on a third-party valuation, for a total value of $1.0&#160;million, of which $0.5&#160;million was recorded as in-process research and development expense during the three months ended March&#160;31, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In October 2021, the Company executed a license with MIT, and 81,000
            shares of common stock were issued to MIT at $3.82 per share, based on a third-party valuation, for a total value of $0.3&#160;million</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s founding shareholder held shares in Impilo prior to
            occurrence of the Impilo Agreement. A total of 331,108 shares of Series C convertible preferred stock were issued to the Company&#8217;s founding shareholder in connection with the Impilo acquisition, of which 298,361 were issued in 2020 and 32,747
            were issued in 2021. The shares transferred had the same terms as other investors and the amounts recorded as in-process research and development expenses for the three months ended March&#160;31, 2021 and 2022, totaled $0.1&#160;million and $0,
            respectively.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-71<br />
        </div>

      </div>

    </div>

    <!--End Page 376-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 377-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">5.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">License Agreements</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Sanford Burnham Prebys</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In December 2015, the Company entered into a license agreement with
            Sanford Burnham Prebys under which the Company was granted an exclusive, worldwide, royalty-bearing license to certain patent rights and know-how controlled by SBP related to the development of CEND-1. At the time the license agreement was
            entered into, the Company&#8217;s founding shareholder was an executive at SBP. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the
            license, the Company made an initial upfront payment in the form of common stock, issuing 540,000 shares in September 2016, at $0.00001 per share (the &#8220;License Fee&#8221;). In addition, the Company was required to reimburse SBP for past expenses
            totaling $0.6&#160;million, of which $0.2&#160;million was paid and the remainder was settled with the issuance of 175,707 shares of common stock. The Company is required to pay an annual license maintenance fee of $5,000, increasing to $10,000 on year
            four of the agreement, and increasing to $20,000 on year seven of the agreement. The Company could also be required to make milestone payments to SBP upon completion of certain regulatory and commercial milestones. The aggregate potential
            milestone payments are approximately $10.6&#160;million. The Company has also agreed to pay SBP royalties of 4% of net sales of products sold by the Company, or through a sublicense, subject to certain reductions. Additionally, the Company agreed to
            pay SBP 25% of any sublicensing income. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">During the three months ended March&#160;31, 2021 and 2022, the Company
            amortized $0 and $2,500 of license maintenance fees and accrued for $2.5&#160;million and $0 in sublicense fees related to the Qilu upfront payment (Note 6), which were recorded to research and development expense. SBP owns 715,707 shares of the
            Company&#8217;s common stock as of December&#160;31, 2021 and March&#160;31, 2022, and is a related party. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In October 2021, the Company entered into a license agreement with
            SBP under which the Company was granted an exclusive, royalty-bearing license to certain patent rights and know-how controlled by SBP. The agreement provides the Company with the rights to grant and authorize sublicenses to use, sell, and
            otherwise exploit the patent rights. As consideration for the license, the Company made an initial upfront payment of $50,000, which was paid and recorded to in-process research and development expense in November 2021. In addition, the Company
            is required to pay an annual license maintenance fee of $20,000, increasing to $30,000 on year four of the agreement. Further, the Company could be required to make milestone payments to SBP upon completion of certain regulatory and commercial
            milestones. The aggregate potential milestone payments are approximately $23.2&#160;million. The Company has also agreed to pay SBP royalties of 4% of net sales of products sold by the Company or through a sublicense, subject to certain reductions.
            Additionally, the Company agreed to pay SBP varying sublicense fees, ranging from 10% to 25%, dependent on when the related milestones are reached. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The agreements will expire upon the later of (i)&#160;the final
            abandonment of all pending patent applications within the licensed patents or (ii)&#160;the expiration of the last to expire patent within the licensed patents. The agreements may be terminated in their entirety by the Company at any time by giving
            SBP sixty days&#8217; prior written notice. The agreements may be terminated in their entirety by SBP if the Company, at any time, defaults in the payment of any sum when due and fails to make such payment within thirty days after receipt of written
            notice. The agreements may be terminated in their entirety by SBP or the Company in (i)&#160;the event of an uncured material breach by the other party, or (ii)&#160;in the event the other party (a) files for, or is involuntarily petitioned with,
            bankruptcy (other than dissolution or winding up for the purposes of reconstruction or amalgamation), (b) makes an assignment of all or substantially all of its assets for the benefit of creditors, or (c)&#160;has a receiver or trustee is appointed
            and is unable to secure a dismissal, stay or other suspension of such proceedings within thirty days. Upon termination of the agreements for any reason, all rights and obligations of the Company with respect to the patents and patent
            applications shall terminate and revert to SBP.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;" class="h3">University of California at San Diego</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In March 2021, the Company entered into a license agreement with the
            University of California at San Diego under which the Company was granted an exclusive, royalty-bearing license to certain patent rights related to the development of nano particles to modulate immune response. The agreement provides the
            Company with the rights to grant and authorize sublicenses to use, sell and otherwise exploit the patent rights. As consideration for the license, the Company made an initial upfront payment of $10,000, which was accrued for and recorded to
            in-process research and development expense as of March&#160;31, 2021. In addition, the Company was required to </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-72<br />
        </div>

      </div>

    </div>

    <!--End Page 377-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 378-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">reimburse UCSD for past expenses totaling $18,000. In addition, the Company is
            required to pay an annual license maintenance fee of $5,000 beginning in March 2022, which was paid in February 2022. Further, the Company could be required to make milestone payments to UCSD upon completion of certain regulatory and commercial
            milestones. The aggregate potential milestone payments are approximately $1.2&#160;million. The Company has also agreed to pay UCSD royalties of 1.5% of net sales of products sold by the Company or through a sublicense, subject to certain
            reductions. Additionally, the Company agreed to pay UCSD varying sublicense fees, ranging from 10% to 20%, dependent on when the related milestones are reached. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The agreement will expire upon the expiration of the longest-lived
            patent rights. The agreement may be terminated in its entirety by the Company at any time by giving UCSD ninety days&#8217; prior written notice. The agreement may be terminated in its entirety by UCSD if the Company, at any time, (i)&#160;fails to
            perform or violates any term of the agreement and fails to cure the default within sixty days. Upon termination of the agreement for any reason, UCSD may terminate a sublicensee but will allow the Company to assign any sublicenses to UCSD
            provided a) that the sublicensee is in good standing upon termination of the agreement with the Company; and b) the sublicensee is not currently involved in litigation as an adverse party to UCSD.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;" class="h3">Massachusetts Institute of Technology</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In October 2021, the Company entered into a license agreement with
            the Massachusetts Institute of Technology under which the Company was granted an exclusive, royalty-bearing license to certain patent rights related to the development of tissue specific delivery of interfering RNA. The agreement provides the
            Company with the rights to grant and authorize sublicenses to use, sell, and otherwise exploit the patent rights. As consideration for the license, the Company made an initial upfront payment of $15,000, which was paid and recorded to
            in-process research and development expense in December 2021. In addition, the Company is required to pay an annual license maintenance fee of $20,000, increasing to $25,000 for year two and three of the agreement, increasing to $50,000 on year
            four of the agreement and thereafter until the first commercial sale, and increasing to $150,000 each year of the agreement after the first sale. The Company paid the $20,000 annual license maintenance fee during the three months ended
            March&#160;31, 2022, and amortized $5,000 to research and development expense. Further, the Company could be required to make milestone payments to MIT upon completion of certain regulatory and commercial milestones. The aggregate potential
            milestone payments are approximately $5.0&#160;million. The Company has also agreed to pay MIT royalties of 2% of net sales of products sold by the Company or through a sublicense, subject to certain reductions. Additionally, the Company agreed to
            pay MIT varying sublicense fees, ranging from 3% to 20%, dependent on when the related milestones are reached. Lastly, the Company could be required to pay MIT a change in control fee of $0.3&#160;million if the control of the Company or the
            agreement is assigned to a third-party. As of March&#160;31, 2022, the Company concluded the change in control event was not probable and therefore no obligation was recorded.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The agreement will expire upon the expiration or abandonment of all
            valid claims. The agreement may be terminated in its entirety by the Company at any time by giving MIT six months prior written notice. The agreement may be terminated in its entirety by MIT if the Company, at any time, (i)&#160;defaults in the
            payment of any sum when due and fails to make such payment within thirty days after receipt of written notice, or (ii)&#160;in the event the Company commits a material breach of its obligations under the agreement (aside from item (i)) and fails to
            cure that breach within sixty days after receipt of written notice. Upon termination of the agreement for any reason, the rights and licenses granted to the Company shall terminate and revert to MIT. Upon termination of the agreement for any
            reason, MIT may terminate a sublicensee but will allow the Company to assign any sublicenses to MIT provided that the sublicensee is in good standing upon termination of the agreement with the Company.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">6.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Research Collaboration and License Agreement</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Exclusive License and Collaboration Agreement</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In February 2021, the Company entered into an Exclusive License and
            Collaboration Agreement (the &#8220;Qilu Agreement&#8221;) in which the Company granted an exclusive license to Qilu for the development and commercialization of CEND-1 in the Territory (defined as the Greater Area of China including China, Macau, Hong
            Kong, and Taiwan). Under the terms of the agreement, Qilu is solely responsible for the development of CEND-1 in its Territory. In consideration for the license, Qilu made a one-time, non-refundable, non-creditable upfront payment of
            $10&#160;million to the Company. The Company is also eligible to receive developmental and </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-73<br />
        </div>

      </div>

    </div>

    <!--End Page 378-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 379-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">commercial milestone payments up to $100&#160;million and $125&#160;million, respectively,
            tiered royalties on net sales ranging from 10% to 15%, and tiered sublicensing revenues ranging from 12% to 35%.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Under the terms of the Qilu Agreement, Qilu was also required to file
            an Investigational New Drug Application (&#8220;IND&#8221;) and receive approval by the National Medical Products Administration (&#8220;NMPA&#8221;) in the People&#8217;s Republic of China in the Territory within 12 months of the effective date of the arrangement, which
            would result in a $5&#160;million milestone payment. Qilu was also required to dose its first patient in a Phase I clinical trial in the Territory within six months of the acceptance of the IND, subject to certain extensions, or the Company would
            have had the option to terminate the Qilu Agreement. In August of 2021, Qilu achieved the regulatory milestone, and the Company received the $5&#160;million milestone payment. Qilu also dosed its first patient within the six-month period.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company may also earn an additional $1&#160;million upon completing
            process optimization and scale up activities and delivering three validation batches of CEND-1in full commercial scale by Qilu or its subcontractor (the &#8220;Technology Transfer&#8221;). After completing the Technology Transfer, Qilu will be responsible
            for manufacturing CEND-1 for use in subsequent clinical trials. In the event the Company and its contract manufacturers fail to complete the process optimization and scale up activities, Qilu would have the right to manufacture CEND-1 using its
            independent manufacturing process and would have no obligation to pay the Technology Transfer milestone payment. Prior to the completion of the Technology Transfer, the Company has agreed to supply CEND-1 to Qilu at its cost.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Unless terminated early, the Qilu Agreement will continue in effect
            until the expiration of all Qilu payment obligations. Either party may terminate the Qilu Agreement if an undisputed material breach by the other party is not cured within a defined period of time, or upon notice for insolvency-related events
            of the other party that are not discharged within a defined time period. Qilu may terminate the Qilu Agreement in its entirety, at any time with at least sixty days written notice. All right and obligations of Qilu with respect to such licensed
            patents and patent applications would terminate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Under the framework of ASC Topic 606, &#8220;Revenue from Contracts with
            Customers&#8221; (&#8220;ASC 606&#8221;), the Company identified two performance obligations, which was the delivery of the license, and a material right related to the supply of CEND-1 prior to the completion of the Technology Transfer. At the onset of the Qilu
            Agreement, the Technology Transfer was only an option of Qilu, and the Company further determined the fee for the Technology Transfer approximated the standalone selling price and therefore the option would not represent a material right and
            accordingly, did not represent a performance obligation at the onset of the arrangement. The Company recognized $9.7&#160;million in revenue upon delivery of the license to Qilu in February 2021. The Company initially deferred $0.3&#160;million in
            revenue for the material right, which will subsequently be recognized as revenue as the clinical supply is delivered. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In August 2021, the Company received $5.0&#160;million from Qilu upon
            achievement of the first development milestone. In March 2022, the Company provided Qilu with clinical supply material and recognized $0.2&#160;million in revenue. As of March&#160;31, 2022, the Company had $0.2&#160;million recorded as deferred revenue, of
            which $52,000 was included in other current liabilities and $0.2&#160;million was included in other long-term liabilities. As of December&#160;31, 2021, the Company had $0.3&#160;million recorded as deferred revenue, of which $66,000 was included in other
            current liabilities and $0.2&#160;million was included in other long-term liabilities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of March&#160;31, 2022, the Technology Transfer had not been completed
            and no payment had been made by Qilu. Additionally, all remaining future development and sales milestones (variable consideration) were fully constrained and will only be recognized upon achievement of the milestones.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">7.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Commitments and Contingencies</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Legal proceedings</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In May 2021, the Company received a written threat of litigation on
            behalf of a Chinese entity called Lingmed Limited (&#8220;Lingmed&#8221;) claiming Lingmed was entitled to a success fee based on the Company&#8217;s Collaboration and License Agreement with Qilu Pharmaceuticals. The Company responded by denying that Lingmed is
            entitled to a success fee under the terms of their agreement. In May 2022, the Company was served with a complaint filed by Lingmed in the San Diego County Superior Court, alleging claims for breach of contract, fraud and declaratory relief.
            The Company&#8217;s response to the complaint was filed on June&#160;6, 2022.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-74<br />
        </div>

      </div>

    </div>

    <!--End Page 379-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 380-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In addition, the Company may be involved in litigation or claims
            arising out of its operations in the normal course of business. Other than the Lingmed matter, there are currently no such other matters, and any such other matters that would, in the opinion of management, be expected to be immaterial with
            respect to the Company&#8217;s consolidated financial position, liquidity, or results of operations.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">8.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Stockholders&#8217; Equity (Deficit)</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Under the Restated Certificate of Incorporation dated April&#160;27, 2021,
            the Company has a total of 13,600,507&#160;shares of capital stock authorized for issuance, consisting of 10,500,000 shares of common stock, par value of $0.00001 per share, and 3,100,507 shares of preferred stock, par value $0.00001 per share.
            Shares of authorized preferred stock are designated as 371,396 shares of Series A redeemable convertible preferred stock, 1,250,304 shares of Series B redeemable convertible preferred stock, and 1,478,807 shares of Series C convertible
            preferred stock. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;" class="h3">Preferred Stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;" class="h3">Redeemable convertible preferred stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In March 2018, the Company executed the Series A Stock Purchase
            Agreement and issued 371,396 shares of Series A redeemable convertible preferred stock at $2.96 per share for proceeds of $1.1&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In September 2019, the Company executed the Series B Stock Purchase
            Agreement and issued 1,071,237&#160;shares of Series B redeemable convertible preferred stock at $3.68 per share for proceeds of $3.9&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Convertible preferred stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In connection with the Impilo Asset Purchase Agreement (Note 4), the
            Company issued a total of 1,345,699&#160;shares of Series C convertible preferred stock. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s preferred stock has the following characteristics
            applicable to all classes, unless otherwise specified:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Dividends</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Each holder of preferred stock is entitled to receive dividends when
            and if declared by the board of directors, pro rata and on a pari passu basis according to the number of shares of common stock then issuable upon conversion of all shares of preferred stock held by such holders. Dividends are noncumulative,
            and no cash dividends have been declared to date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Conversion</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Each share of preferred stock is convertible without payment of
            additional consideration at the option of the holder any time after the issuance date into shares of common stock determined by dividing the original issuance price by the conversion price. The conversion price of the preferred stock is
            initially equal to the original issuance price and is subject to certain adjustments. The preferred stock is subject to a mandatory conversion in the event (i)&#160;that there is a closing of the sale of shares of common stock to the public at a
            pre-equity valuation of at least $100&#160;million, resulting in at least $15&#160;million in gross proceeds to the Company, in an underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended,
            and in connection with such offering the common stock is listed for trading on the Nasdaq Stock Market&#8217;s National Market, the New York Stock Exchange or another exchange or marketplace approved by the board of directors or (ii)&#160;upon the vote or
            written consent for such conversion from the Requisite Holders (defined as holders of at least a majority of the outstanding shares of preferred stock, voting as a single class on an as-converted basis). As of March&#160;31, 2022, all series of
            preferred stock are convertible into shares of common stock on a one-to-one basis.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;" class="h3">Liquidation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Holders of the Series B preferred stock are entitled to receive
            liquidation preferences at the Series B original issue price, plus all accrued and declared but unpaid dividends. After full payment of the liquidation preference to the holders of the Series B preferred stock, the holders of the Series A
            preferred stock are entitled to receive </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-75<br />
        </div>

      </div>

    </div>

    <!--End Page 380-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 381-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">liquidation preferences at the Series A original issue price, plus all accrued and
            declared but unpaid dividends. After full payment of the liquidation preference to the holders of the Series B preferred stock and Series A preferred stock, the holders of the Series C preferred stock are entitled to receive liquidation
            preferences at the Series C original issue price, plus all accrued and declared but unpaid dividends.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The remaining assets, if any, will be distributed ratably to the
            holders of the Series B preferred stock, Series A preferred stock and common stock, pro rata, based on the number of shares held by each such holder, treating for this purpose all such securities as if they had been converted to common stock
            immediately prior to such liquidation. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Voting rights</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The holder of each share of preferred stock is entitled to one vote
            for each share of common stock into which it would convert and to vote as one class with the common stockholders on all matters.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;" class="h3">Redemption rights and classification</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The holders of Series A and Series B redeemable convertible preferred
            stock have redemption rights. At any time on or after the sixth anniversary of the March&#160;6, 2018 Restated Certificate of Incorporation, the Requisite Holders may provide written notice requesting redemption of all shares of redeemable
            convertible preferred stock at a price equal to the original issue price, plus all declared but unpaid dividends. Subject to the Company&#8217;s election for an initial nine-month deferral, the redemption shall be paid in three annual installments
            commencing not more than sixty days after the written notice. As a result, the Company has classified the redeemable convertible preferred stock outside of stockholders&#8217; equity (deficit) on the condensed consolidated balance sheets as the stock
            is contingently redeemable. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The holders of Series C preferred stock do not have any redemption
            rights. Additionally, as the majority of the Company&#8217;s voting shares are held by common stock shareholders, the preferred shareholders cannot use their vote to force a liquidation. Therefore, the Company has classified the convertible Series C
            preferred stock within stockholders&#8217; equity (deficit) on the condensed consolidated balance sheets.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;" class="h3">Common stock</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of December&#160;31, 2021 and March&#160;31, 2022, the Company had
            10,500,000 shares of its common stock authorized. As of December&#160;31, 2021 and March&#160;31, 2022, the Company had 4,279,705 shares of its common stock issued and outstanding. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Each share of common stock has the right to one vote. The holders of
            common stock are also entitled to receive dividends when and if declared by the board of directors. No cash dividends have been declared by the board of directors during the three months ended March&#160;31, 2021 and 2022. In the event of a
            liquidation, dissolution or winding-up, the holders of common stock are entitled to share ratably in the net assets remaining after payment of liabilities and the liquidation value of the preferred stock then outstanding. The common stock has
            no preemptive rights, conversion rights or redemption rights. All shares of common stock have equal distribution, liquidation and voting rights, and have no preferences or exchange rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has reserved the following shares of common stock for
            issuance, on an as-converted basis, as follows:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">December&#160;31, </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">March&#160;31, </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2021 </div>
                </td>

    <td style="width: 3.68%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">2022 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Redeemable convertible preferred stock </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.58pt; text-align: left;" class="fpara">1,442,633 </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,442,633 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Convertible preferred stock </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.58pt; text-align: left;" class="fpara">1,345,699 </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">1,345,699 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Stock options issued and outstanding </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.58pt; text-align: left;" class="fpara">2,270,079 </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2,270,079 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Authorized for future stock awards or option grants </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.58pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 40pt;">882,621 </span></div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 40pt;">882,621 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 66.67%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Total </div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.58pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">5,941,032
                    </span></div>
                </td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 3.68%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">5,941,032</span></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-76<br />
        </div>

      </div>

    </div>

    <!--End Page 381-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 382-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">9.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Stock-Based Compensation</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">2016 Equity Incentive Plan</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In September 2016, the Company adopted the 2016 Equity Incentive Plan
            (the &#8220;Plan&#8221;), which provides for the grant of incentive stock options, non-statutory stock options, stock bonuses, and rights to acquire restricted stock to employees, directors, and consultants of the Company. As of March&#160;31, 2022, the number
            of shares reserved under the Plan was 3,217,700 and the number of shares issued and outstanding under the Plan was 2,270,079, respectively. As of March&#160;31, 2022, the number of shares available for grant under the Plan was 882,621. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Options granted under the Plan are exercisable at various dates as
            determined upon grant and will expire no more than ten years from their date of grant, or in the case of grants to a 10% shareholder, five years from the date of grant. The exercise price of each option shall be determined by the Board of
            Directors based on the estimated fair value of the Company&#8217;s stock on the date of the option grant. In the case of incentive stock options, the exercise price shall not be less than 100% of the fair market value of the Company&#8217;s common stock at
            the time the option is granted, unless the option is granted pursuant to an assumption of or substitution for another option. For holders of more than 10% of the Company&#8217;s total combined voting power of all classes of stock, incentive stock
            options may not be granted at less than 110% of the fair market value of the Company&#8217;s stock at the date of grant.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Stock Option Activity</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">A summary of the Company&#8217;s stock option activity under the Plan is as
            follows (in thousands, except share and per share amounts and years):</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"> </div>

          <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Options <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Outstanding </div>
                </td>

    <td style="width: 1.98%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted- <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Exercise <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Price </div>
                </td>

    <td style="width: 1.98%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Weighted- <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Average <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Remaining <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Contractual <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Term </div>
                </td>

    <td style="width: 1.98%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Aggregate <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Intrinsic <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Value </div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Balance at December&#160;31, 2021 </div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,270,079
                    </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$ 1.98 </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">8.00 </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$ 4,174
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Options granted </div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="padding-left: 30pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Options exercised </div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="padding-left: 30pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;" class="fpara">Options cancelled and forfeited </div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="padding-left: 30pt; border-bottom: 1pt solid #000000; min-width: 40pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 17.5pt;">&#8212; </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara"></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Balance at March&#160;31, 2022 </div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,270,079
                    </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$ 1.98 </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.75 </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;" class="fpara"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$ 4,174
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Vested and exercisable at March&#160;31, 2022 </div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 9.12%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.33pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">1,613,860 </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$ 1.85 </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">7.35 </span></div>
                </td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 1.98%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 7.47%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;" class="fpara"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$ 3,184</span></div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">For the three months ended March&#160;31, 2021 and 2022, the total fair
            value of options that vested during the year was $0.1&#160;million. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">There was one option exercised during the three months ended
            March&#160;31, 2021, with an aggregate intrinsic value of $0.1&#160;million. There were no options exercised during the three months ended March&#160;31, 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;" class="h3">Stock-Based Compensation Expense</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company recognized stock-based compensation expense of
            $0.1&#160;million for the three months ended March&#160;31, 2021 and 2022. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As of March&#160;31, 2022, the unrecognized compensation cost related to
            outstanding employee options was $0.4&#160;million and is expected to be recognized as expense over approximately 3.6&#160;years. Unrecognized compensation cost related to outstanding nonemployee options was $0.5&#160;million as of March&#160;31, 2022 and is
            expected to be recognized as expense over approximately 1.9&#160;years.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">10.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Australia Research and Development Tax Incentive </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s Australian subsidiary, which conducts core research and
            development activities, is eligible to receive a 43.5% refundable tax incentive for qualified research and development activities. For the three months ended March&#160;31, 2022, $0.3&#160;million was recorded as a reduction of research and development
            expenses </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-77<br />
        </div>

      </div>

    </div>

    <!--End Page 382-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 383-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">in the condensed consolidated statements of operations, as the Company determined
            that it met the eligibility criteria and the amounts claimed are expected by received shortly after the related tax returns are filed. For the three months ended March&#160;31, 2021, $0.1&#160;million was recorded as a reduction of research and
            development expenses in the condensed consolidated statements of operations, as the Company determined that it met the eligibility criteria and subsequently collected the tax incentives after filing the related tax returns.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">11.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Related Party Transactions</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="h3">Consulting Arrangements</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company has an advisory consulting agreement with the founding
            shareholder, who is also a member on the Board of Directors. During the three months ended March&#160;31, 2021 and 2022, the Company incurred and paid $0 and $15,000, respectively, which was recoded to research and development expense. As of
            December&#160;31, 2021 and March&#160;31, 2022, the Company had a $5,000 prepayment relating to the agreement included within other current assets on the condensed consolidated balance sheets.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Other Transactions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As discussed in Note 4, the Company entered into an asset purchase
            agreement with Impilo, which included several additional license agreements, all of which were paid for with the newly created class of Series C preferred stock, and one of the investors was the Company&#8217;s founding shareholder. During the three
            months ended March&#160;31, 2021 and 2022, the Company recorded $0.1&#160;million and $0, respectively, related to this agreement, which was recorded to in-process research and development expense. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">As discussed in Note 5, the Company has license agreements with SBP,
            who owns 715,707 shares of the Company&#8217;s common stock. During the three months ended March&#160;31, 2021 and 2022, the Company incurred $2.5&#160;million and $12,000, respectively, related to the license agreements, which was recorded to research and
            development expense. As of December&#160;31, 2021 and March&#160;31, 2022, $27,000 and $30,000, respectively, of these expenses is included in accrued expenses within the condensed consolidated balance sheets. As of December&#160;31, 2021 and March&#160;31, 2022,
            the Company had a $9,000 and $7,000, respectively, prepayment relating to the agreements included within other current assets on the condensed consolidated balance sheets.</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">12.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Income Taxes</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company uses an estimated annual effective tax rate, which is
            based on expected annual income and statutory tax rates in the jurisdictions in which the Company operates, to determine its quarterly provision for income taxes. Certain significant or unusual items are separately recognized in the quarter in
            which they occur and can be a source of variability in the effective tax rates from quarter to quarter.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company&#8217;s effective tax rates for the three months ended
            March&#160;31, 2021, and March&#160;31, 2022, were 3.39% and 0%, respectively. The effective tax rate for the three months ended March&#160;31, 2021 differs from the U.S. federal statutory tax rate primarily due to foreign tax credits and research credits
            offset by nondeductible acquired R&amp;D and the change in the full valuation allowance. The effective tax rate for the three months ended March&#160;31, 2022 differs from the U.S. federal statutory tax rate primarily due to a full valuation
            allowance related to the Company&#8217;s deferred tax assets.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">During 2021, $1.7&#160;million of foreign income tax was withheld related
            to the Qilu Agreement and the related delivery of the exclusive license and achievement of the first development milestone (Note 6). This foreign income tax expense has been presented as an offset to the revenue on the condensed consolidated
            statements of operations. As the withholding tax on the foreign revenue is considered an unusual and non-recurring item, it is not included in the above-mentioned effective tax rate for the period ended March&#160;31, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The mandatory &#167;174 capitalization rules went into effect on
            January&#160;1, 2022, and were considered as part of the Company&#8217;s estimated annual effective tax rate. The new rules are not expected to have a material impact on the Company for the year ending December&#160;31, 2022.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company is subject to taxation in the United States, California,
            and Australia. As of March&#160;31, 2022, the Company&#8217;s tax years are subject to examination by the tax authorities from 2018 and forward for Federal tax purposes and 2017 and forward for California and Australia tax purposes. However, to the extent
            allowed by law, the tax authorities may have the right to examine the period from inception forward where NOLs and credits were generated and carried forward and make adjustments to the amount of the NOL and credit carryforward amounts. The
            Company is not currently under examination by any federal, state, or foreign tax authority.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-78<br />
        </div>

      </div>

    </div>

    <!--End Page 383-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 384-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6.75pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">13.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Subsequent Events </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Company evaluated subsequent events for recognition and
            measurement purposes through June&#160;15, 2022, the date the financial statements were issued.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;" class="h3">Merger Agreement </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">On April&#160;26, 2022, the Company entered into an agreement and plan of
            merger (&#8220;Merger Agreement&#8221;) with Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;), a Delaware corporation and CS Cedar Merger Sub, Inc., a wholly-owned subsidiary of Caladrius (&#8220;Merger Sub&#8221;). Pursuant to the Merger Agreement, among other matters, and
            subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into the Company, with the Company continuing as a wholly owned subsidiary of Caladrius and the surviving corporation of
            the merger (the &#8220;Merger&#8221;). The Merger is intended to qualify for federal income tax purposes as a tax-free reorganization under the provisions of Section 368(a) of the Internal Revenue Code of 1986, as amended. The Merger Agreement and the
            Merger were approved by the members of the board of directors of the Company (the &#8220;Board&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Subject to the terms and conditions of the Merger Agreement, at the
            closing of the Merger, (a) each outstanding share of Company common stock will be converted into the right to receive a number of shares of Caladrius common stock (&#8220;Caladrius Common Stock&#8221;) equal to the exchange ratio described below; and (b)
            each outstanding Company stock option that has not previously been exercised prior to the closing of the Merger will be assumed by Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Under the exchange ratio formula in the Merger Agreement, as of
            immediately after the Merger, the Company&#8217;s former stockholders are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock and stockholders of Caladrius as of immediately prior to the Merger are expected to own
            approximately 50% of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on Caladrius&#8217; net cash balance at the time of closing and the amount of any transaction expenses of the Company in
            excess of $0.3&#160;million at the time of closing. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Concurrently with the execution of the Merger Agreement and in order
            to provide the Company with capital for its development programs prior to the closing of the Merger, Caladrius and the Company entered into a Series D Preferred Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which Caladrius
            agreed to purchase from the Company 1,135,628 shares of Series D Preferred Stock, $0.00001 par value per share (the &#8220;Series D Preferred Stock&#8221;), of Cend at a purchase price per share equal to $8.8057 per share (the &#8220;Series D Original Issue
            Price&#8221;), or approximately $10.0&#160;million in the aggregate. The Series D Preferred Stock ranks senior to the Company&#8217;s common stock and the other series of preferred stock with respect to rights on the distribution of assets on any voluntary or
            involuntary liquidation, dissolution or winding up of the Company. The Series D Preferred Stock has a liquidation preference equal to the Series D Original Issue Price plus an amount equal to any accrued and unpaid dividends to the date of
            payment and will participate with the Company&#8217;s common stockholders and other preferred stockholders thereafter on an as-converted basis. The Series D Preferred Stock shall vote with the common stock on an as-converted basis on any matters
            presented to the stockholders of the Company. Each share of Series D Preferred Stock is convertible, at the option of the holder thereof, into such number of shares of Company common stock as is determined by dividing the Original Issue Price
            by the conversion price in effect at the time of conversion, which conversion price shall be the Original Issue Price as appropriately adjusted for stock splits, stock dividends, combinations, and subdivisions of Company common stock, and as
            adjusted pursuant to a weighted-average antidilution adjustment. The Series D Preferred Stock will automatically convert into shares of Company common stock upon the closing of a firm-commitment underwritten initial public offering implying a
            pre-equity offering value of at least $250.0&#160;million, resulting in at least $50.0&#160;million of gross proceeds to the Company. The closing of the Merger is subject to certain conditions, including, among other things, approval by the stockholders
            of Caladrius and the Company, and Caladrius&#8217; satisfaction of a minimum net cash threshold at closing of $64.9&#160;million assuming a closing at the end of the third quarter of 2022, and as described further in the Merger Agreement. In accordance
            with the terms of the Merger Agreement, (i)&#160;certain executive officers, directors and stockholders of the Company (solely in their respective capacities as Company stockholders) holding approximately 77.5% of the outstanding Company capital
            stock have entered into support agreements with Caladrius to vote all of their shares of Company capital stock in favor of adoption of the Merger Agreement (the &#8220;Cend Support Agreements&#8221;) and (ii)&#160;certain executive officers and directors of
            Caladrius (solely in their respective capacities as Caladrius stockholders) holding approximately 1.8% of the outstanding Caladrius common stock have entered </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-79<br />
        </div>

      </div>

    </div>

    <!--End Page 384-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 385-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_208-finnotes04_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">into support agreements with the Company to vote all of their shares of Caladrius
            common stock in favor of approval of the Merger Agreement (the &#8220;Caladrius Support Agreements,&#8221; together with the Cend Support Agreements, the &#8220;Support Agreements&#8221;). The Support Agreements include covenants with respect to the voting of such
            shares in favor of approving the transactions contemplated by the Merger Agreement and against any competing acquisition proposals and place certain restrictions on the transfer of the shares of Caladrius and Cend held by the respective
            signatories thereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Merger Agreement contains certain termination rights for both
            Caladrius and the Company, and further provides that, upon termination of the Merger Agreement under specified circumstances, Caladrius may be required to pay the Company a termination fee of $1.0&#160;million, and the Company may be required to pay
            Caladrius a termination fee of $4.0&#160;million, or in some circumstances reimburse the other party&#8217;s expenses up to a maximum of $1.0&#160;million.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">FS-80<br />
        </div>

      </div>

    </div>

    <!--End Page 385-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 386-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;" class="h1"><!--Anchor-->Annex&#160;A<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: right;" class="h1"><span style="font-weight: normal;">&#8195;</span><br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: right;" class="h1"><span style="font-weight: normal;">Execution Version </span></div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 187.5pt; text-align: center;" class="h1">AGREEMENT AND PLAN OF MERGER<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="h1">AND REORGANIZATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; text-align: center;" class="fpara">among:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; text-align: center;" class="h1">CALADRIUS BIOSCIENCES, INC.,<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="h1">a Delaware corporation;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 19.5pt; text-align: center;" class="h1">CS CEDAR MERGER SUB, INC.,<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="h1">a Delaware corporation;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; text-align: center;" class="fpara">and</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; text-align: center;" class="h1">CEND THERAPEUTICS, INC.,<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="h1">a Delaware corporation</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; text-align: center;" class="fpara">Dated as of April&#160;26, 2022</div>

          <div>
            <div style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 15.25pt;" class="rule-partial"> </div>

          </div>

        </div>

      </div>

    </div>

    <!--End Page 386-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 387-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">TABLE OF CONTENTS </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Page</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS1">Section 1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS1">Description of Transactions</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS1"><span style="padding-left: 5pt;">A-</span>2</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS11">1.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS11">The Merger</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS11"><span style="padding-left: 5pt;">A-</span>2</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS12">1.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS12">Effects of the Merger</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS12"><span style="padding-left: 5pt;">A-</span>2</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS13">1.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS13">Closing; Effective Time</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS13"><span style="padding-left: 5pt;">A-</span>2</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS14">1.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS14">Certificate of Incorporation and Bylaws; Director and
                      Officers</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS14"><span style="padding-left: 5pt;">A-</span>2</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS15">1.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS15">Conversion of Shares</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS15"><span style="padding-left: 5pt;">A-</span>3</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS16">1.6</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS16">Closing of the Company&#8217;s Transfer Books</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS16"><span style="padding-left: 5pt;">A-</span>4</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS17">1.7</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS17">Surrender Of Certificates</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS17"><span style="padding-left: 5pt;">A-</span>4</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS18">1.8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS18">Appraisal Rights</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS18"><span style="padding-left: 5pt;">A-</span>5</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS19">1.9</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS19">Further Action</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS19"><span style="padding-left: 5pt;">A-</span>5</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS110">1.10</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS110">Tax Consequences</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS110"><span style="padding-left: 5pt;">A-</span>5</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS2">Section 2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS2">Representations and Warranties of the Company</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS2"><span style="padding-left: 5pt;">A-</span>6</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS21">2.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS21">Due Organization; Subsidiaries; Etc</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS21"><span style="padding-left: 5pt;">A-</span>6</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS22">2.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS22">Organizational Documents</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS22"><span style="padding-left: 5pt;">A-</span>6</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS23">2.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS23">Authority; Binding Nature of Agreement</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS23"><span style="padding-left: 5pt;">A-</span>6</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS24">2.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS24">Vote Required</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS24"><span style="padding-left: 5pt;">A-</span>6</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS25">2.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS25">Non-Contravention; Consents</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS25"><span style="padding-left: 5pt;">A-</span>7</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS26">2.6</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS26">Capitalization, Etc</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS26"><span style="padding-left: 5pt;">A-</span>7</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS27">2.7</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS27">Financial Statements</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS27"><span style="padding-left: 5pt;">A-</span>9</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS28">2.8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS28">Absence of Changes</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS28"><span style="padding-left: 5pt;">A-</span>9</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS29">2.9</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS29">Absence of Undisclosed Liabilities</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS29"><span style="padding-left: 5pt;">A-</span>9</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS210">2.10</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS210">Title to Assets</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS210">A-10</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS211">2.11</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS211">Real Property; Leasehold</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS211">A-10</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS212">2.12</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS212">Intellectual Property</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS212">A-10</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS213">2.13</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS213">Agreements, Contracts and Commitments</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS213">A-12</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS214">2.14</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS214">Compliance; Permits; Restrictions</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS214">A-14</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS215">2.15</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS215">Legal Proceedings; Orders</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS215">A-15</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS216">2.16</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS216">Tax Matters</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS216">A-15</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS217">2.17</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS217">Employee and Labor Matters; Benefit Plans</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS217">A-17</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS218">2.18</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS218">Environmental Matters</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS218">A-20</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS219">2.19</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS219">Insurance</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS219">A-20</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS220">2.20</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS220">No Financial Advisors</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS220">A-20</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS221">2.21</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS221">Disclosure</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS221">A-20</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS222">2.22</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS222">Transactions with Affiliates</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS222">A-20</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS223">2.23</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS223">No Other Representations or Warranties</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS223">A-21</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS3">Section 3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS3">Representations and Warranties of Caladrius and Merger Sub</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS3">A-21</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS31">3.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS31">Due Organization; Subsidiaries; Etc</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS31">A-21</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS32">3.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS32">Organizational Documents</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS32">A-21</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS33">3.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS33">Authority; Binding Nature of Agreement</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS33">A-21</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS34">3.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS34">Vote Required</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS34">A-22</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS35">3.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS35">Non-Contravention; Consents</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS35">A-22</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS36">3.6</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS36">Capitalization, Etc</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS36">A-23</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS37">3.7</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS37">SEC Fillings; Financial Statements</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS37">A-24</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS38">3.8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS38">Absence of Changes</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS38">A-25</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS39">3.9</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS39">Absence of Undisclosed Liabilities</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS39">A-25</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS310">3.10</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS310">Title to Assets</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS310">A-26</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS311">3.11</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS311">Real Property; Leasehold</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS311">A-26</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS312">3.12</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS312">Intellectual Property</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS312">A-26</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS313">3.13</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS313">Agreements, Contracts and Commitments</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS313">A-28</a></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-i<br />
        </div>

      </div>

    </div>

    <!--End Page 387-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 388-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Page</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS314">3.14</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS314">Compliance; Permits; Restrictions</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS314">A-28</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS315">3.15</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS315">Legal Proceedings; Orders</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS315">A-30</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS316">3.16</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS316">Tax Matters</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS316">A-30</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS317">3.17</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS317">Employee and Labor Matters; Benefit Plans</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS317">A-31</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS318">3.18</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS318">Environmental Matters</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS318">A-34</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS319">3.19</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS319">Insurance</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS319">A-34</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS320">3.20</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS320">Transactions with Affiliates</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS320">A-34</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS321">3.21</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS321">No Financial Advisors</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS321">A-35</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS322">3.22</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS322">Valid Issuance</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS322">A-35</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS323">3.23</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS323">Inapplicability of Anti-takeover Statutes</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS323">A-35</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS324">3.24</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS324">Disclosure</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS324">A-35</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS325">3.25</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS325">No Other Representations or Warranties</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS325">A-35</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS4">Section 4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS4">Certain Covenants of the Parties</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS4">A-35</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS41">4.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS41">Operation of Caladrius&#8217; Business</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS41">A-35</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS42">4.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS42">Operation of the Company&#8217;s Business</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS42">A-37</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS43">4.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS43">Access and Investigation</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS43">A-38</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS44">4.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS44">No Solicitation</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS44">A-38</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS45">4.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS45">Notification of Certain Matters</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS45">A-39</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS5">Section 5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS5">Additional Agreements of the Parties</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS5">A-40</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS51">5.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS51">Registration Statement; Proxy Statement</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS51">A-40</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS52">5.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS52">Company Stockholder Written Consent</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS52">A-40</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS53">5.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS53">Caladrius Stockholders&#8217; Meeting</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS53">A-42</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS54">5.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS54">Regulatory Approvals</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS54">A-44</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS55">5.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS55">Company Options</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS55">A-44</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS56">5.6</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS56">Caladrius Awards</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS56">A-45</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS57">5.7</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS57">Employee Benefits</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS57">A-45</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS58">5.8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS58">Indemnification of Officers and Directors</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS58">A-45</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS59">5.9</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS59">Additional Agreements</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS59">A-46</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS510">5.10</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS510">Disclosure</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS510">A-46</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS511">5.11</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS511">Listing</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS511">A-46</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS512">5.12</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS512">Tax Matters</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS512">A-46</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS513">5.13</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS513">Legends</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS513">A-47</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS514">5.14</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS514">Directors and Officers</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS514">A-47</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS515">5.15</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS515">Section 16 Matters</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS515">A-47</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS516">5.16</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS516">Cooperation</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS516">A-47</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS517">5.17</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS517">Allocation Certificate; Transaction Costs</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS517">A-47</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS518">5.18</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS518">Company Financial Statements</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS518">A-47</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS519">5.19</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS519">Caladrius Reverse Stock Split</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS519">A-47</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS520">5.20</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS520">Preferred Stock</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS520">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS521">5.21</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS521">Joint Development Agreement</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS521">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS6">Section 6</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS6">Conditions Precedent to Obligations of Each Party</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS6">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS61">6.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS61">Effectiveness of Registration Statement</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS61">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS62">6.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS62">No Restraints</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS62">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS63">6.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS63">Stockholder Approval</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS63">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS64">6.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS64">Listing</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS64">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS65">6.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;" class="fpara"><a href="#tANXAS65">No Governmental Proceedings Relating
                      to Contemplated Transactions or Right to Operate Business</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS65">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS7">Section 7</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS7">Additional Conditions Precedent to Obligations of Caladrius
                      and Merger Sub</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS7">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS71">7.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS71">Accuracy of Representations</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS71">A-48</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS72">7.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS72">Performance of Convenants</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS72">A-49</a></div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-ii<br />
        </div>

      </div>

    </div>

    <!--End Page 388-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 389-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Page</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS73">7.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS73">Closing Certificate</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS73">A-49</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS74">7.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS74">Preferred Stock Conversion</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS74">A-49</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS75">7.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS75">FIRPTA Certificate</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS75">A-49</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS76">7.6</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS76">No Company Material Adverse Effect</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS76">A-49</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS77">7.7</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS77">Other Deliveries</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS77">A-49</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS78">7.8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS78">Company Lock-Up Agreements</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS78">A-49</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS79">7.9</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS79">Consents</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS79">A-49</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS710">7.10</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS710">Company Invoices</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS710">A-50</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS8">Section 8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS8">Additional Conditions Precedent to Obligation of the Company</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS8">A-50</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS81">8.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS81">Accuracy of Representations</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS81">A-50</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS82">8.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS82">Performance of Covenants</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS82">A-50</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS83">8.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS83">Documents</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS83">A-50</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS84">8.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS84">Sarbanes-Oxley Certifications</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS84">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS85">8.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS85">FIRPTA Certificate</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS85">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS86">8.6</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS86">No Caladrius Material Adverse Effect</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS86">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS87">8.7</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS87">Board of Directors</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS87">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS88">8.8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS88">Other Deliveries</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS88">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS89">8.9</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS89">Caladrius Lock-Up Agreements</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS89">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS810">8.10</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS810">Net Cash</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS810">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS811">8.11</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS811">Consents</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS811">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS9">Section 9</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS9">Termination</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS9">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS91">9.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS91">Termination</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS91">A-51</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS92">9.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS92">Effect of Termination</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS92">A-53</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS93">9.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS93">Expenses</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS93">A-53</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS10">Section 10</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS10">Miscellaneous Provisions</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS10">A-55</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS101">10.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS101">Non-Survival of Representations, Warranties and Covenants</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS101">A-55</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS102">10.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS102">Amendment</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS102">A-55</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS103">10.3</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS103">Waiver</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS103">A-55</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS104">10.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS104">Entire Agreement; Counterparts; Exchanges by Facsimile</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS104">A-56</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS105">10.5</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS105">Applicable Law; Jurisdiction</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS105">A-56</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS106">10.6</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS106">Attorneys&#8217; Fees</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS106">A-56</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS107">10.7</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS107">Assignability</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS107">A-56</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS108">10.8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS108">Notices</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS108">A-56</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS109">10.9</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS109">Cooperation</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS109">A-57</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS1010">10.10</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS1010">Severability</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS1010">A-57</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS1011">10.11</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS1011">Other Remedies; Specific Performance</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS1011">A-57</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS1012">10.12</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS1012">No Third Party Beneficiaries</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS1012">A-58</a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: right; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;" class="fpara"><a href="#tANXAS1013">10.13</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 82.05%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><a href="#tANXAS1013">Construction</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: center; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;" class="fpara"><a href="#tANXAS1013">A-58</a></div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">Exhibits</span>:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 87.18%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit A</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Definitions</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit B</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Caladrius Stockholder Support Agreement</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit C</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Company Stockholder Support Agreement</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit D</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Lock-Up Agreement</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit E</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Joint Development Agreement</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-iii<br />
        </div>

      </div>

    </div>

    <!--End Page 389-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 390-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><!--Anchor-->AGREEMENT AND PLAN OF MERGER AND REORGANIZATION</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION is made and
            entered into as of April&#160;26, 2022, by and among CALADRIUS BIOSCIENCES, INC., a Delaware corporation (&#8220;Caladrius&#8221;), CS CEDAR MERGER SUB, INC., a Delaware corporation and wholly owned subsidiary of Caladrius (&#8220;Merger Sub&#8221;), and CEND THERAPEUTICS,
            INC., a Delaware corporation (the &#8220;Company&#8221;). Certain capitalized terms used in this Agreement are defined in Exhibit A.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;" class="h1">RECITALS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">A.&#8195;Caladrius and the Company intend to effect a merger of Merger Sub
            with and into the Company (the &#8220;Merger&#8221;) in accordance with this Agreement and the DGCL. Upon consummation of the Merger, Merger Sub will cease to exist and the Company will become a wholly owned subsidiary of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">B.&#8195;The Parties intend that the Merger qualify as a &#8220;reorganization&#8221;
            within the meaning of Section 368(a) of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">C.&#8195;The Caladrius Board has (i)&#160;determined that the Contemplated
            Transactions are fair to, advisable and in the best interests of Caladrius and its stockholders, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares of Caladrius Common Stock
            to the stockholders of the Company pursuant to the terms of this Agreement and (iii)&#160;determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of Caladrius vote to adopt and approve
            this Agreement and thereby approve the Contemplated Transactions, including the issuance of shares of Caladrius Common Stock to the stockholders of the Company pursuant to the terms of this Agreement and, if deemed necessary by the Parties, an
            amendment to Caladrius&#8217; certificate of incorporation to effect the Caladrius Reverse Stock Split.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">D.&#8195;The Merger Sub Board has (i)&#160;determined that the Contemplated
            Transactions are fair to, advisable and in the best interests of, Merger Sub and its sole stockholder, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined to recommend, upon the terms and
            subject to the conditions set forth in this Agreement, that the stockholder of Merger Sub vote to adopt this Agreement and thereby approve the Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">E.&#8195;The Company Board has (i)&#160;determined that the Contemplated
            Transactions are fair to, advisable and in the best interests of the Company and its stockholders, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined to recommend, upon the terms and
            subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to adopt and approve this Agreement and thereby approve the Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">F.&#8195;Concurrently with the execution and delivery of this Agreement and
            as a condition and inducement to the Company&#8217;s willingness to enter into this Agreement, the officers and directors of Caladrius listed on Section A of the Caladrius Disclosure Schedule (solely in their capacity as stockholders of Caladrius)
            are executing support agreements in favor of the Company in substantially the form attached hereto as Exhibit B (the &#8220;Caladrius Stockholder Support Agreement&#8221;), pursuant to which such Persons have, subject to the terms and conditions set forth
            therein, agreed to vote all of their shares of capital stock of Caladrius in favor of the approval of this Agreement and thereby approve the Contemplated Transactions and against any competing proposals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">G.&#8195;Concurrently with the execution and delivery of this Agreement and
            as a condition and inducement to Caladrius&#8217; willingness to enter into this Agreement, the officers, directors and 5% or greater stockholders (together with their Affiliates) of the Company listed on Section A of the Company Disclosure Schedule
            (solely in their capacity as stockholders of the Company) are executing support agreements in favor of Caladrius in substantially the form attached hereto as Exhibit C (the &#8220;Company Stockholder Support Agreement&#8221;), pursuant to which such
            Persons have, subject to the terms and conditions set forth therein, agreed to vote all of their shares of Company Capital Stock in favor of the adoption of this Agreement and thereby approve the Contemplated Transactions and against any
            competing proposals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">H.&#8195;Concurrently with the execution and delivery of this Agreement and
            as a condition and inducement to Caladrius&#8217; willingness to enter into this Agreement, the officers, directors and stockholders of the Company listed on Section A of the Company Disclosure Schedule are executing lock-up agreements in
            substantially the form attached hereto as Exhibit D (collectively, the &#8220;Company Lock-Up Agreements&#8221;).</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-1<br />
        </div>

      </div>

    </div>

    <!--End Page 390-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 391-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">I.&#8195;Concurrently with the execution and delivery of this Agreement
            and as a condition and inducement to the Company&#8217;s willingness to enter into this Agreement, the officers and directors of Caladrius listed on Section&#160;A of the Caladrius Disclosure Schedule are executing lock-up agreements in substantially the
            form attached hereto as Exhibit&#160;D (collectively, the &#8220;Caladrius Lock-Up Agreements&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">J.&#8195;It is expected that within two (2) Business Days after the
            Registration Statement is declared effective under the Securities Act, the holders of shares of Company Capital Stock sufficient to adopt and approve this Agreement and the Merger as required under the DGCL and the Company&#8217;s certificate of
            incorporation and bylaws will execute and deliver an action by written consent adopting this Agreement in order to obtain the Required Company Stockholder Vote (each, a &#8220;Company Stockholder Written Consent&#8221; and collectively, the &#8220;Company
            Stockholder Written Consents&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; text-align: center;" class="h1">AGREEMENT</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Parties, intending to be legally bound, agree as follows:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tANXAS1"><!--Anchor--></a>Section 1&#8195;Description of Transaction</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS11"><!--Anchor--></a>1.1&#8195;The Merger. Upon the terms
            and subject to the conditions set forth in this Agreement, at the Effective Time, Merger Sub shall be merged with and into the Company, and the separate existence of Merger Sub shall cease. The Company will continue as the surviving corporation
            in the Merger (the &#8220;Surviving Corporation&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS12"><!--Anchor--></a>1.2&#8195;Effects of the Merger. The
            Merger shall have the effects set forth in this Agreement and in the applicable provisions of the DGCL. As a result of the Merger, the Company will become a wholly owned subsidiary of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS13"><!--Anchor--></a>1.3&#8195;Closing; Effective Time.
            Unless this Agreement is earlier terminated pursuant to the provisions of <span style="text-decoration: underline;">Section&#160;9.1</span>, and subject to the satisfaction or waiver of the conditions set forth in <span style="text-decoration: underline;">Sections 6</span>, <span style="text-decoration: underline;">7</span> and <span style="text-decoration: underline;">8</span>, the consummation of the Merger
            (the &#8220;Closing&#8221;) shall take place at the offices of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., 666 Third Avenue, New York, New York 10017, as promptly as practicable (but in no event later than the second Business Day following the
            satisfaction or waiver of the last to be satisfied or waived of the conditions set forth in <span style="text-decoration: underline;">Sections 6</span>, <span style="text-decoration: underline;">7</span> and <span style="text-decoration: underline;">8</span>, other than those conditions that by their nature are to be satisfied at the Closing, but subject to the
            satisfaction or waiver of each of such conditions), or at such other time, date and place as Caladrius and the Company may mutually agree in writing. The date on which the Closing actually takes place is referred to as the &#8220;Closing Date.&#8221; At
            the Closing, the Parties shall cause the Merger to be consummated by executing and filing with the Secretary of State of the State of Delaware a certificate of merger with respect to the Merger, satisfying the applicable requirements of the
            DGCL and in a form reasonably acceptable to Caladrius and the Company (the &#8220;Certificate of Merger&#8221;). The Merger shall become effective at the time of the filing of such Certificate of Merger with the Secretary of State of the State of Delaware
            or at such later time as may be specified in such Certificate of Merger with the consent of Caladrius and the Company (the time as of which the Merger becomes effective being referred to as the &#8220;Effective Time&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS14"><!--Anchor--></a>1.4&#8195;Certificate of Incorporation
            and Bylaws; Directors and Officers. At the Effective Time:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;the certificate of incorporation of the Surviving Corporation
            shall be amended and restated in its entirety to read identically to the certificate of incorporation of Merger Sub as in effect immediately prior to the Effective Time, until thereafter amended as provided by the DGCL and such certificate of
            incorporation;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;the certificate of incorporation of Caladrius shall be identical
            to the certificate of incorporation of Caladrius immediately prior to the Effective Time, until thereafter amended as provided by the DGCL and such certificate of incorporation; provided, however, that at the Effective Time, Caladrius shall
            file an amendment to its certificate of incorporation to (i)&#160;change the name of Caladrius to &#8220;Lisata Therapeutics&#8221;, (ii)&#160;effect the Caladrius Reverse Stock Split (to the extent applicable and necessary) and (iii)&#160;make such other changes as are
            mutually agreeable to Caladrius and the Company;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;the bylaws of the Surviving Corporation shall be identical to
            the bylaws of Merger Sub as in effect immediately prior to the Effective Time, until thereafter amended as provided by the DGCL and such bylaws; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;the directors and officers of Caladrius, each to hold office in
            accordance with the certificate of incorporation and bylaws of Caladrius, shall be as set forth in <span style="text-decoration: underline;">Section 5.14</span>; and</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-2<br />
        </div>

      </div>

    </div>

    <!--End Page 391-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 392-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;the directors and officers of the Surviving Corporation, each
            to hold office in accordance with the certificate of incorporation and bylaws of the Surviving Corporation, shall be the directors and officers of Caladrius as set forth in <span style="text-decoration: underline;">Section 5.14</span>, after giving effect to the provisions of <span style="text-decoration: underline;">Section




              5.14</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS15"><!--Anchor--></a>1.5&#8195;Conversion of Shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;At the Effective Time, by virtue of the Merger and without any
            further action on the part of Caladrius, Merger Sub, the Company or any stockholder of the Company or Caladrius:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;any shares of Company Capital Stock held as treasury stock or
            held or owned by the Company or Merger Sub, any Subsidiary of the Company or Caladrius or any Affiliate of Caladrius immediately prior to the Effective Time shall be canceled and retired and shall cease to exist, and no consideration shall be
            delivered in exchange therefor; and </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;subject to <span style="text-decoration: underline;">Section 1.5(c)</span>, each share of Company
            Capital Stock outstanding immediately prior to the Effective Time (excluding shares to be canceled pursuant to <span style="text-decoration: underline;">Section 1.5(a)(i)</span> and excluding Dissenting Shares) shall be converted solely into the right to receive a number of shares of
            Caladrius Common Stock equal to the Exchange Ratio (the &#8220;Merger Consideration&#8221;). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;If any shares of Company Capital Stock outstanding immediately
            prior to the Effective Time are unvested or are subject to a repurchase option or a risk of forfeiture under any applicable restricted stock purchase agreement or other similar agreement with the Company, then the shares of Caladrius Common
            Stock issued in exchange for such shares of Company Capital Stock will to the same extent be unvested and subject to the same repurchase option or risk of forfeiture, and such shares of Caladrius Common Stock shall accordingly be marked with
            appropriate legends. The Company shall take all actions that may be necessary to ensure that, from and after the Effective Time, Caladrius is entitled to exercise any such repurchase option or other right set forth in any such restricted stock
            purchase agreement or other agreement. For the avoidance of doubt, shares of Company Capital Stock issuable upon exercise of unvested Company Options are not deemed outstanding for purposes of this <span style="text-decoration: underline;">Section 1.5(b)</span>. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;No fractional shares of Caladrius Common Stock shall be issued
            in connection with the Merger, and no certificates or scrip for any such fractional shares shall be issued. Any holder of Company Capital Stock who would otherwise be entitled to receive a fraction of a share of Caladrius Common Stock (after
            aggregating all fractional shares of Caladrius Common Stock issuable to such holder) shall, in lieu of such fraction of a share and upon surrender by such holder of a letter of transmittal in accordance with <span style="text-decoration: underline;">Section&#160;1.8</span> and any
            accompanying documents as required therein, be paid in cash the dollar amount (rounded to the nearest whole cent), without interest, determined by multiplying such fraction by the closing price of a share of Caladrius Common Stock on the Nasdaq
            Capital Market (or such other Nasdaq market on which the Caladrius Common Stock then trades) on the date the Merger becomes effective.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;All Company Options outstanding immediately prior to the
            Effective Time under the Company Plan shall be treated in accordance with <span style="text-decoration: underline;">Section 5.5</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Each share of common stock, $0.0001 par value per share, of
            Merger Sub issued and outstanding immediately prior to the Effective Time shall be converted into and exchanged for one validly issued, fully paid and nonassessable share of common stock, $0.0001 par value per share, of the Surviving
            Corporation. Each stock certificate of Merger Sub evidencing ownership of any such shares shall, as of the Effective Time, evidence ownership of such shares of common stock of the Surviving Corporation. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;lf, between the date of this Agreement and the Effective Time,
            the outstanding shares of Company Capital Stock or Caladrius Common Stock shall have been changed into, or exchanged for, a different number of shares or a different class, by reason of any stock dividend, subdivision, reclassification,
            recapitalization, split (including the Caladrius Reverse Stock Split to the extent such split has not previously been taken into account in calculating the Exchange Ratio), combination or exchange of shares or other like change, the Exchange
            Ratio shall, to the extent necessary, be equitably adjusted to reflect such change to the extent necessary to provide the holders of Company Capital Stock, Company Options and Caladrius Common Stock with the same economic effect as contemplated
            by this Agreement prior to such stock dividend, subdivision, reclassification, recapitalization, split, combination or exchange of shares or other like </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-3<br />
        </div>

      </div>

    </div>

    <!--End Page 392-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 393-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">change; provided, however, that nothing herein will be construed to permit the
            Company or Caladrius to take any action with respect to Company Capital Stock or Caladrius Common Stock, respectively, that is prohibited or not expressly permitted by the terms of this Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS16"><!--Anchor--></a>1.6&#8195;Closing of the Company&#8217;s
            Transfer Books. At the Effective Time: (a) all shares of Company Capital Stock outstanding immediately prior to the Effective Time shall be treated in accordance with <span style="text-decoration: underline;">Section 1.5(a)</span>, and all holders of certificates representing shares
            of Company Capital Stock that were outstanding immediately prior to the Effective Time shall cease to have any rights as stockholders of the Company; and (b) the stock transfer books of the Company shall be closed with respect to all shares of
            Company Capital Stock outstanding immediately prior to the Effective Time. No further transfer of any such shares of Company Capital Stock shall be made on such stock transfer books after the Effective Time. If, after the Effective Time, a
            valid certificate previously representing any shares of Company Capital Stock outstanding immediately prior to the Effective Time (a &#8220;Company Stock Certificate&#8221;) is presented to the Exchange Agent or to the Surviving Corporation, such Company
            Stock Certificate shall be canceled and shall be exchanged as provided in <span style="text-decoration: underline;">Sections 1.5</span> and <span style="text-decoration: underline;">1.7</span>. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS17"><!--Anchor--></a>1.7&#8195;Surrender of Certificates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;On or prior to the Closing Date, Caladrius and the Company shall
            agree upon and select a reputable bank, transfer agent or trust company to act as exchange agent in the Merger (the &#8220;Exchange Agent&#8221;). At the Effective Time, Caladrius shall deposit with the Exchange Agent: (i)&#160;evidence of book-entry shares
            representing the Caladrius Common Stock issuable pursuant to <span style="text-decoration: underline;">Section 1.5(a)</span> and (ii)&#160;cash sufficient to make payments in lieu of fractional shares in accordance with <span style="text-decoration: underline;">Section 1.5(c)</span>. The Caladrius Common Stock and cash amounts so
            deposited with the Exchange Agent, together with any dividends or distributions received by the Exchange Agent with respect to such shares, are referred to collectively as the &#8220;Exchange Fund.&#8221; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Promptly after the Effective Time, the Parties shall cause the
            Exchange Agent to mail to the Persons who were record holders of shares of Company Capital Stock that were converted into the right to receive the Merger Consideration: (i)&#160;a letter of transmittal in customary form and containing such
            provisions as Caladrius may reasonably specify (including a provision confirming that delivery of any Company Stock Certificates shall be effected, and risk of loss and title to any Company Stock Certificates shall pass, only upon delivery of
            such Company Stock Certificates to the Exchange Agent); and (ii)&#160;instructions for effecting the surrender of any Company Stock Certificates, or uncertificated shares of Company Common Stock, in exchange for book-entry shares of Caladrius Common
            Stock. Upon surrender of a Company Stock Certificate or other reasonable evidence of the ownership of uncertificated Company Common Stock to the Exchange Agent for exchange, together with a duly executed letter of transmittal and such other
            documents as may be reasonably required by the Exchange Agent or Caladrius: (A) the holder of such Company Common Stock shall be entitled to receive in exchange therefor book- entry shares representing the Merger Consideration (in a number of
            whole shares of Caladrius Common Stock) that such holder has the right to receive pursuant to the provisions of <span style="text-decoration: underline;">Section 1.5(a)</span> (and cash in lieu of any fractional share of Caladrius Common Stock pursuant to the provisions of <span style="text-decoration: underline;">Section&#160;1.5(c))</span>;
            and (B) any Company Stock Certificate so surrendered shall be canceled. Until surrendered as contemplated by this <span style="text-decoration: underline;">Section 1.7(b)</span>, each Company Stock Certificate shall be deemed, from and after the Effective Time, to represent only the
            right to receive book-entry shares of Caladrius Common Stock representing the Merger Consideration (and cash in lieu of any fractional share of Caladrius Common Stock). If any Company Stock Certificate shall have been lost, stolen or destroyed,
            Caladrius may, in its discretion and as a condition precedent to the delivery of any shares of Caladrius Common Stock, require the owner of such lost, stolen or destroyed Company Stock Certificate to provide an applicable affidavit with respect
            to such Company Stock Certificate and post a bond indemnifying Caladrius against any claim suffered by Caladrius related to the lost, stolen or destroyed Company Stock Certificate or any Caladrius Common Stock issued in exchange therefor as
            Caladrius may reasonably request. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;No dividends or other distributions declared or made with
            respect to Caladrius Common Stock with a record date after the Effective Time shall be paid to the holder of any unsurrendered Company Stock Certificate with respect to the shares of Caladrius Common Stock that such holder has the right to
            receive in </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-4<br />
        </div>

      </div>

    </div>

    <!--End Page 393-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 394-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">the Merger until such holder surrenders such Company Stock Certificate or provides
            an affidavit of loss or destruction in lieu thereof in accordance with this <span style="text-decoration: underline;">Section 1.7</span> (at which time such holder shall be entitled, subject to the effect of applicable abandoned property, escheat or similar laws, to receive all such
            dividends and distributions, without interest). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Any portion of the Exchange Fund that remains undistributed to
            holders of Company Common Stock as of the date that is 180 days after the Closing Date shall be delivered to Caladrius upon demand, and any holders of Company Stock Certificates who have not theretofore surrendered their Company Stock
            Certificates in accordance with this <span style="text-decoration: underline;">Section 1.7</span> shall thereafter look only to Caladrius for satisfaction of their claims for Caladrius Common Stock, cash in lieu of fractional shares of Caladrius Common Stock and any dividends or
            distributions with respect to shares of Caladrius Common Stock. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Each of the Exchange Agent, Caladrius and the Surviving
            Corporation shall be entitled to deduct and withhold from any consideration deliverable pursuant to this Agreement to any holder of any Company Common Stock such amounts as are required to be deducted or withheld from such consideration under
            the Code or under any other applicable Law. To the extent such amounts are so deducted or withheld, and remitted to the appropriate taxing authority, such amounts shall be treated for all purposes under this Agreement as having been paid to the
            Person to whom such amounts would otherwise have been paid. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;No party to this Agreement shall be liable to any holder of any
            Company Common Stock or to any other Person with respect to any shares of Caladrius Common Stock (or dividends or distributions with respect thereto) or for any cash amounts delivered to any public official pursuant to any applicable abandoned
            property law, escheat law or similar Law. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS18"><!--Anchor--></a>1.8&#8195;Appraisal Rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Notwithstanding any provision of this Agreement to the contrary,
            shares of Company Capital Stock that are outstanding immediately prior to the Effective Time and which are held by stockholders who have exercised and perfected appraisal rights for such shares of Company Capital Stock in accordance with the
            DGCL (collectively, the &#8220;Dissenting Shares&#8221;) shall not be converted into or represent the right to receive the Merger Consideration described in <span style="text-decoration: underline;">Section 1.5</span> attributable to such Dissenting Shares. Such stockholders shall be entitled to
            receive payment of the appraised value of such shares of Company Capital Stock held by them in accordance with the DGCL, unless and until such stockholders fail to perfect or effectively withdraw or otherwise lose their appraisal rights under
            the DGCL. All Dissenting Shares held by stockholders who shall have failed to perfect or who effectively shall have withdrawn or lost their right to appraisal of such shares of Company Capital Stock under the DGCL shall thereupon be deemed to
            be converted into and to have become exchangeable for, as of the Effective Time, the right to receive the Merger Consideration attributable to such Dissenting Shares upon their surrender in the manner provided in <span style="text-decoration: underline;">Section 1.5</span>. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;The Company shall give Caladrius prompt written notice of any
            demands by dissenting stockholders received by the Company, withdrawals of such demands and any other instruments served on the Company and any material correspondence received by the Company in connection with such demands. The Company shall
            not, without Caladrius&#8217; prior written consent, make any payment with respect to, or settle or offer to settle, any such demands, or agree to do any of the foregoing. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS19"><!--Anchor--></a>1.9&#8195;Further Action. If, at any
            time after the Effective Time, any further action is determined by the Surviving Corporation to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right, title and possession of
            and to all rights and property of the Company, then the officers and directors of the Surviving Corporation shall be fully authorized, and shall use their and its commercially reasonable efforts (in the name of the Company, in the name of
            Merger Sub, in the name of the Surviving Corporation or otherwise) to take such action. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS110"><!--Anchor--></a>1.10&#8195;Tax Consequences. For
            United States federal income tax purposes, the Merger is intended to constitute a reorganization within the meaning of Section 368(a) of the Code. The Parties adopt this Agreement as a &#8220;plan of reorganization&#8221; within the meaning of Section
            1.368-2(g) of the Treasury Regulations. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-5<br />
        </div>

      </div>

    </div>

    <!--End Page 394-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 395-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tANXAS2"><!--Anchor--></a>Section 2&#8195;Representations and Warranties of the
            Company</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Subject to Section 10.13(h), except as set forth in the written
            disclosure schedule delivered by the Company to Caladrius (the &#8220;Company Disclosure Schedule&#8221;), the Company represents and warrants to Caladrius and Merger Sub as follows: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS21"><!--Anchor--></a>2.1&#8195;Due Organization;
            Subsidiaries; Etc.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Each of the Company and its Subsidiaries is a corporation or
            other legal entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization and has all necessary power and authority: (i)&#160;to conduct its business in
            the manner in which its business is currently being conducted; (ii)&#160;to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used; and (iii)&#160;to perform its obligations
            under all Contracts by which it is bound. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Each of the Company and its Subsidiaries is duly licensed and
            qualified to do business, and is in good standing (to the extent applicable in such jurisdiction), under the laws of all jurisdictions where the nature of its business requires such licensing or qualification other than in jurisdictions where
            the failure to be so qualified individually or in the aggregate would not be reasonably expected to have a Company Material Adverse Effect. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;The Company has no Subsidiaries, except for the Entities
            identified in Section 2.1(c) of the Company Disclosure Schedule; and neither the Company nor any of the Entities identified in Section 2.1(c) of the Company Disclosure Schedule owns any capital stock of, or any equity, ownership or profit
            sharing interest of any nature in, or controls directly or indirectly, any other Entity other than the Entities identified in Section&#160;2.1(c) of the Company Disclosure Schedule. Neither the Company nor any of its Subsidiaries is and or has
            otherwise been, directly or indirectly, a party to, member of or participant in any partnership, joint venture or similar business entity. Neither the Company nor any of its Subsidiaries has agreed or is obligated to make, or is bound by any
            Contract under which it may become obligated to make, any future investment in or capital contribution to any other Entity. Neither the Company nor any of its Subsidiaries has, at any time, been a general partner of, or has otherwise been
            liable for any of the debts or other obligations of, any general partnership, limited partnership or other Entity. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS22"><!--Anchor--></a>2.2&#8195;Organizational Documents. The
            Company has made available to Caladrius accurate and complete copies of the Organizational Documents of the Company and each of its Subsidiaries. Neither the Company nor any of its Subsidiaries is in breach or violation of its Organizational
            Documents in any material respect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS23"><!--Anchor--></a>2.3&#8195;Authority; Binding Nature of
            Agreement. The Company and each of its Subsidiaries have all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Company Board has
            (i)&#160;determined that the Contemplated Transactions are fair to, advisable and in the best interests of the Company and its stockholders, (ii)&#160;approved and declared advisable this Agreement and the Contemplated Transactions and (iii)&#160;determined
            to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of the Company vote to adopt this Agreement and thereby approve the Contemplated Transactions. This Agreement has been duly executed
            and delivered by the Company and, assuming the due authorization, execution and delivery by Caladrius and Merger Sub, constitutes the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its
            terms, subject to the Enforceability Exceptions. Prior to the execution of the Company Stockholder Support Agreements, the Company Board approved the Company Stockholder Support Agreements and the transactions contemplated thereby. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS24"><!--Anchor--></a>2.4&#8195;Vote Required. The
            affirmative vote of (i)&#160;the holders of a majority of the shares of Company Common Stock and Company Preferred Stock voting together as a single class, (ii)&#160;the holders of a majority of the Company&#8217;s Series A Preferred Stock, voting as a
            separate class, and (iii)&#160;the holders of a majority of the Company&#8217;s Series B Preferred Stock, voting as a separate class, each outstanding on the record date for the Company Stockholder Written Consent and entitled to vote thereon (the
            &#8220;Required Company Stockholder Vote&#8221;), is the only vote of the holders of any class or series of Company Capital Stock necessary to adopt and approve this Agreement and approve the Contemplated Transactions.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-6<br />
        </div>

      </div>

    </div>

    <!--End Page 395-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 396-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS25"><!--Anchor--></a>2.5&#8195;Non-Contravention;
            Consents. Subject to obtaining the Required Company Stockholder Vote and the filing of the Certificate of Merger required by the DGCL, neither (x)&#160;the execution, delivery or performance of this Agreement by the Company, nor (y) the consummation
            of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time): </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;contravene, conflict with or result in a violation of any of the
            provisions of the Company&#8217;s Organizational Documents; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;contravene, conflict with or result in a material violation of,
            or give any Governmental Body or other Person the right to challenge the Contemplated Transactions or to exercise any remedy or obtain any relief under, any Law or any order, writ, injunction, judgment or decree to which the Company or its
            Subsidiaries, or any of the assets owned or used by the Company or its Subsidiaries, is subject;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;contravene, conflict with or result in a material violation of
            any of the terms or requirements of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by the Company or its Subsidiaries; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;contravene, conflict with or result in a violation or breach of,
            or result in a default under, any provision of any Company Material Contract, or give any Person the right to: (i)&#160;declare a default or exercise any remedy under any Company Material Contract; (ii)&#160;any material payment, rebate, chargeback,
            penalty or change in delivery schedule under any Company Material Contract; (iii)&#160;accelerate the maturity or performance of any Company Material Contract; or (iv)&#160;cancel, terminate or modify any term of any Company Material Contract, except in
            the case of any non-material breach, default, penalty or modification; or </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;result in the imposition or creation of any Encumbrance upon or
            with respect to any asset owned or used by the Company or its Subsidiaries (except for Permitted Encumbrances).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Except for (i)&#160;any Consent set forth on Section 2.5 of the Company
            Disclosure Schedule under any Company Contract, (ii) the Required Company Stockholder Vote, (iii)&#160;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DGCL and (iv)&#160;such consents, waivers,
            approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable federal and state securities laws, neither the Company nor any of its Subsidiaries was, is, or will be required to make any filing
            with or give any notice to, or to obtain any Consent from, any Person in connection with (x)&#160;the execution, delivery or performance of this Agreement, or (y) the consummation of the Contemplated Transactions. The Company Board has taken and
            will take all actions necessary to ensure that the restrictions applicable to business combinations contained in Section&#160;203 of the DGCL are, and will be, inapplicable to the execution, delivery and performance of this Agreement and the Company
            Stockholder Support Agreements and to the consummation of the Contemplated Transactions. To the Company&#8217;s Knowledge, no other state takeover statute or similar Law applies or purports to apply to the Merger, this Agreement, the Company
            Stockholder Support Agreements or any of the Contemplated Transactions. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS26"><!--Anchor--></a>2.6&#8195;Capitalization, Etc.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;The authorized Company Capital Stock as of the date of this
            Agreement consists of (i)&#160;11,500,000&#160;shares of Company Common Stock, par value $0.00001 per share, of which 4,279,705 shares are issued and outstanding as of the date of this Agreement, (ii) 4,350,000 shares of preferred stock, par value
            $0.00001 per share, of which (A) 371,396 shares have been designated as &#8220;Series A Preferred Stock&#8221; and of which 371,396 shares are issued and outstanding as of the date of this Agreement (the &#8220;Series A Preferred Stock&#8221;), (B) 1,071,240 shares
            have been designated as &#8220;Series B Preferred Stock&#8221; and of which 1,071,237&#160;shares are issued and outstanding as of the date of this Agreement (the &#8220;Series B Preferred Stock&#8221;), (C)&#160;1,345,700 shares have been designated as &#8220;Series C Preferred
            Stock&#8221; and of which 1,345,700 shares are issued and outstanding as of the date of this Agreement (the &#8220;Series C Preferred Stock)&#8221; and (D)&#160;1,135,650&#160;shares have been designated as &#8220;Series D Preferred Stock&#8221; and of which no shares are issued and
            outstanding as of the date of this Agreement (the &#8220;Series D Preferred Stock,&#8221; and, collectively with the Series&#160;A Preferred Stock, the Series B Preferred Stock, and the Series C Preferred Stock, the &#8220;Company Preferred Stock&#8221;). The Company does
            not hold any shares of its capital stock in its treasury. Except as contemplated herein, there is no Company Contract relating to the voting or registration of, or restricting </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-7<br />
        </div>

      </div>

    </div>

    <!--End Page 396-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 397-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">any Person from purchasing, selling, pledging or otherwise disposing of (or granting
            any option or similar right with respect to), any shares of Company Common Stock or Company Preferred Stock. An aggregate of 2,788,333 shares of Company Common Stock are issuable upon conversion of the Company Preferred Stock. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;All of the outstanding shares of Company Common Stock and
            Company Preferred Stock have been duly authorized and validly issued, and are fully paid and nonassessable and are free of any Encumbrances, other than those imposed by relevant securities laws. None of the outstanding shares of Company Common
            Stock or Company Preferred Stock is entitled or subject to any preemptive right, right of participation, right of maintenance or any similar right. None of the outstanding shares of Company Common Stock or Company Preferred Stock is subject to
            any right of first refusal in favor of the Company. The Company is not under any obligation, nor is it bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Company
            Common Stock or other securities. Section 2.6(b) of the Company Disclosure Schedule accurately and completely lists all repurchase rights held by the Company with respect to shares of Company Common Stock (including shares issued pursuant to
            the exercise of stock options) and specifies which of those repurchase rights are currently exercisable. Each share of Company Preferred Stock is convertible into one share of Company Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Except for the Company&#8217;s 2016 Equity Incentive Plan, as amended
            (the &#8220;Company Plan&#8221;), the Company does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person. As of the date of this Agreement, the Company has reserved
            3,217,700 shares of Company Common Stock for issuance under the Company Plan, of which 65,000 shares have been issued and are currently outstanding, 2,270,079 shares have been reserved for issuance upon exercise of Company Options granted under
            the Company Plan, and 882,621 shares of Company Common Stock remain available for future issuance pursuant to the Company Plan. Section 2.6(c) of the Company Disclosure Schedule sets forth the following information with respect to each Company
            Option outstanding as of the date of this Agreement: (i)&#160;the name of the optionee; (ii)&#160;the number of shares of Company Common Stock subject to such Company Option at the time of grant; (iii)&#160;the number of shares of Company Common Stock subject
            to such Company Option as of the date of this Agreement; (iv)&#160;the exercise price of such Company Option; (v)&#160;the date on which such Company Option was granted; (vi)&#160;the applicable vesting schedule, including the number of vested and unvested
            shares as of the date of this Agreement; (vii)&#160;the date on which such Company Option expires; and (viii)&#160;whether such Company Option is an &#8220;incentive stock option&#8221; (as defined in the Code) or a non-qualified stock option. The Company has made
            available to Caladrius an accurate and complete copy of the Company Plan and forms of all stock option agreements approved for use thereunder. No vesting of Company Options will accelerate in connection with the closing of the Contemplated
            Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Except for the outstanding Company Options set forth on Section
            2.6(c) of the Company Disclosure Schedule and except as set forth on Section 2.6(d) of the Company Disclosure Schedule, there is no: (i)&#160;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire
            any shares of the capital stock or other securities of the Company or any of its Subsidiaries; (ii)&#160;outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or
            other securities of the Company or any of its Subsidiaries; (iii)&#160;stockholder rights plan (or similar plan commonly referred to as a &#8220;poison pill&#8221;) or Contract under which the Company or any of its Subsidiaries is or may become obligated to
            sell or otherwise issue any shares of its capital stock or any other securities; or (iv)&#160;condition or circumstance that is reasonably likely to give rise to or provide a basis for the assertion of a claim by any Person to the effect that such
            Person is entitled to acquire or receive any shares of capital stock or other securities of the Company or any of its Subsidiaries. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar
            rights with respect to the Company or any of its Subsidiaries.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;All outstanding shares of Company Common Stock, Company
            Preferred Stock, Company Options and other securities of the Company have been issued and granted in material compliance with (i)&#160;all applicable securities laws and other applicable Law, and (ii)&#160;all requirements set forth in applicable
            Contracts.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-8<br />
        </div>

      </div>

    </div>

    <!--End Page 397-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 398-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS27"><!--Anchor--></a>2.7&#8195;Financial Statements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Section 2.7(a) of the Company Disclosure Schedule includes true
            and complete copies of the Company&#8217;s unaudited consolidated financial statements which comprise the consolidated balance sheets as of December&#160;31, 2021 and 2020, and the related consolidated statements of operations, equity, and cash flows for
            the years ended December&#160;31, 2021 and 2020, and the related notes to the consolidated financial statements (collectively, the &#8220;Company Financials&#8221;). The Company Financials (A) were prepared in accordance with United States generally accepted
            accounting principles (&#8220;GAAP&#8221;) (except as may be indicated in the footnotes to such Company Financials and that unaudited financial statements may not have notes thereto and other presentation items that may be required by GAAP and are subject
            to normal and recurring year-end adjustments) and (B) fairly present, in all material respects, the financial position and operating results of the Company and its consolidated Subsidiaries as of the dates and for the periods indicated therein
            (except as may be indicated in the footnotes to such Company Financials and that unaudited financial statements may not have notes thereto and other presentation items that may be required by GAAP and are subject to normal and recurring
            year-end adjustments).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Each of the Company and its Subsidiaries maintains a system of
            internal accounting controls designed to provide reasonable assurance that: (i)&#160;transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii)&#160;transactions are recorded as necessary to permit preparation of
            the financial statements of the Company and its Subsidiaries in conformity with GAAP and to maintain accountability of the Company&#8217;s and its Subsidiaries&#8217; assets; (iii) access to the Company&#8217;s and its Subsidiaries&#8217; assets is permitted only in
            accordance with management&#8217;s general or specific authorization; and (iv)&#160;the recorded accountability for the Company&#8217;s and its Subsidiaries&#8217; assets is compared with the existing assets at regular intervals and appropriate action is taken with
            respect to any differences. The Company and each of its Subsidiaries maintains internal control over financial reporting that provides reasonable assurance regarding the reliability of financial reporting and the preparation of financial
            statements for external purposes in accordance with GAAP.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Section 2.7(c) of the Company Disclosure Schedule lists, and the
            Company has delivered to Caladrius accurate and complete copies of the documentation creating or governing, all securitization transactions and &#8220;off-balance sheet arrangements&#8221; (as defined in Item 303(c) of Regulation S-K under the Exchange
            Act) effected by the Company or any of its Subsidiaries since January&#160;1, 2019.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Since January&#160;1, 2019, there have been no formal internal
            investigations regarding financial reporting or accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer or general counsel of the Company, the Company
            Board or any committee thereof. As of the date of this Agreement, neither the Company nor its independent auditors have identified any significant deficiency or material weakness in the design or operation of the system of internal accounting
            controls utilized by the Company and its Subsidiaries. Since January&#160;1, 2019, neither the Company nor its independent auditors have identified (i)&#160;any fraud, whether or not material, that involves the Company, any of its Subsidiaries, the
            Company&#8217;s management or other employees who have a role in the preparation of financial statements or the internal accounting controls utilized by the Company and its Subsidiaries or (ii)&#160;any claim or allegation regarding any of the foregoing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS28"><!--Anchor--></a>2.8&#8195;Absence of Changes. Between
            December&#160;31, 2021 and the date of this Agreement, the Company has conducted its business only in the Ordinary Course of Business (except for the execution and performance of this Agreement and the discussions, negotiations and transactions
            related thereto) and there has not been any (a) Company Material Adverse Effect or (b) action, event or occurrence that would have required consent of Caladrius pursuant to <span style="text-decoration: underline;">Section 4.2(b) </span>of this Agreement had such action, event or
            occurrence taken place after the execution and delivery of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS29"><!--Anchor--></a>2.9&#8195;Absence of Undisclosed
            Liabilities. As of the date hereof, neither the Company nor any of its Subsidiaries has any liability, indebtedness, obligation, expense, claim, deficiency, guaranty or endorsement of any kind, whether accrued, absolute, contingent, matured,
            unmatured or other (whether or not required to be reflected in the financial statements in accordance with GAAP) (each a &#8220;Liability&#8221;), individually or in the aggregate, except for: (a) Liabilities identified as such in the &#8220;liabilities&#8221; column
            of the Company Unaudited Balance Sheet; (b) normal and recurring current Liabilities that have been incurred by the Company or its Subsidiaries since the date of the Company Unaudited Balance Sheet in the Ordinary Course of Business and </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-9<br />
        </div>

      </div>

    </div>

    <!--End Page 398-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 399-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">which are not in excess of $100,000 in the aggregate; (c) Liabilities for performance
            of obligations of the Company or any of its Subsidiaries under Company Contracts; (d) Liabilities incurred inconnection with the Contemplated Transactions; and (e) any Liabilities listed in Section 2.9 of the Company Disclosure Schedule.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS210"><!--Anchor--></a>2.10&#8195;Title to Assets. Each of
            the Company and its Subsidiaries owns, and has good andvalid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or assets and equipment used or held for use in its business or
            operations or purported to be owned by it, including: (a) all assets reflected on the Company Unaudited Balance Sheet; and (b) all other assets reflected in the books and records of the Company or any of its Subsidiaries as being owned by the
            Company or such Subsidiary. All of such assets are owned or, in the case of leased assets, leased by the Company or any of its Subsidiaries free and clear of any Encumbrances, other than Permitted Encumbrances.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS211"><!--Anchor--></a>2.11&#8195;Real Property; Leasehold.
            Neither the Company nor any of its Subsidiaries ownsor has ever owned any real property. The Company has made available to Caladrius (a) an accurate and complete list of all real properties with respect to which the Company directly or
            indirectly holds a valid leasehold interest as well as any other real estate that is in the possession of or leased by the Company or any of its Subsidiaries, and (b) copies of all leases under which any such real property is possessed (the
            &#8220;Company Real Estate Leases&#8221;), each of which is in full force and effect, with no existing material default thereunder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS212"><!--Anchor--></a>2.12&#8195;Intellectual Property.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;To the Company&#8217;s Knowledge, the Company, directly or through any
            of itsSubsidiaries, owns, or has the right to use, as currently being used by the Company, all CompanyIP Rights, and with respect to Company IP Rights that are owned by the Company, has the rightto bring actions for the infringement of such
            Company IP Rights, in each case except for any failure to own or have the right to use or bring actions that would not reasonably be expected to have a Company Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Section 2.12(b) of the Company Disclosure Schedule is an
            accurate, true and complete listing of all Company Registered IP.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Section 2.12(c) of the Company Disclosure Schedule accurately
            identifies (i)&#160;all Company IP Rights licensed to the Company or any of its Subsidiaries (other than (A) any non-customized software that (1) is so licensed solely in executable or object code form pursuant to a non-exclusive, internal use
            software license and other Intellectual Property associated with such software and (2) is not incorporated into, or material to the development, manufacturing, or distribution of, any of the Company&#8217;s or any of its Subsidiaries&#8217; products or
            services, (B) any Intellectual Property licensed ancillary to the purchase or use of equipment, reagents or other materials, and (C) any confidential information provided under confidentiality agreements), (ii)&#160;the corresponding Company
            Contract pursuant to which such Company IP Rights are licensed to the Company or any of its Subsidiaries and (iii)&#160;whether the license or licenses granted to the Company or any of its Subsidiaries are exclusive or non-exclusive.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Section 2.12(d) of the Company Disclosure Schedule accurately
            identifies each Company Contract pursuant to which any Person has been granted any license under, or otherwise has received or acquired any right (whether or not currently exercisable) or interest in, any Company IP Rights (other than (i)&#160;any
            confidential information provided under confidentiality agreements, (ii)&#160;any non-disclosure or other template agreements entered into in the Ordinary Course of Business, and (iii)&#160;any Company IP Rights non-exclusively licensed to suppliers
            orservice providers for the sole purpose of enabling such supplier or service providers to provide services for the Company&#8217;s benefit).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Neither the Company nor any of its Subsidiaries is bound by, and
            no Company IP Rights are subject to, any Contract containing any covenant or other provision that in any way limits or restricts the ability of the Company or any of its Subsidiaries to use, exploit, assert, or enforce any Company IP Rights
            anywhere in the world, in each case, in a manner that would materially limit the business of the Company as currently conducted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;The Company or one of its Subsidiaries exclusively owns all
            right, title, and interest to and in Company IP Rights (other than (i)&#160;Company IP Rights exclusively and non-exclusively licensed to the Company or one of its Subsidiaries, as identified in Section 2.12(c) of the Company Disclosure Schedule,
            (ii)&#160;any non-customized software that (A) is licensed to the Company or any of its Subsidiaries solely in executable or object code form pursuant to a non-exclusive, internal use software license and other Intellectual Property </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-10<br />
        </div>

      </div>

    </div>

    <!--End Page 399-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 400-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">associated with such software and (B)&#160;is not incorporated into, or material to the
            development, manufacturing, or distribution of, any of the Company&#8217;s or any of its Subsidiaries&#8217; products or services and (iii)&#160;any Intellectual Property licensed ancillary to the purchase or use of equipment, reagents or other materials), in
            each case, free and clear of any Encumbrances (other than Permitted Encumbrances). Without limiting the generality of the foregoing:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;All documents and instruments necessary to register or apply for
            or renew registration of Company Registered IP have been validly executed, delivered, and filed in a timely manner with the appropriate Governmental Body except for any such failure, individually or collectively, that would not reasonably be
            expected to have a Company Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;Each Person who is or was an employee or contractor of the
            Company or any of its Subsidiaries and who is or was involved in the creation or development of any Company IP Rights purported to be owned by the Company has signed a valid, enforceable agreement containing an assignment of such Intellectual
            Property to the Company or such Subsidiary and confidentiality provisions protecting trade secrets and confidential information of the Company and its Subsidiaries; provided, that any such agreement with a third party contractor for research,
            development or manufacturing services on behalf of the Company may provide that such third party contractor reserves its rights in improvements to such third party contractor&#8217;s Intellectual Property or generally applicable research, development
            or manufacturing technology, in either case that is not specific to any product or service of the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iii)&#8195;To the Knowledge of the Company, no current or former
            stockholder, officer, director, or employee of the Company or any of its Subsidiaries has any claim, right (whether or not currently exercisable), or interest to or in any Company IP Rights purported to be owned by the Company. To the Knowledge
            of the Company, no employee of the Company or any of its Subsidiaries is (a) bound by or otherwise subject to any Contract restricting him or her from performing his or her duties for the Company or such Subsidiary or (b) in breach of any
            Contract with any current or former employer or other Person concerning Company IP Rights purported to be owned by the Company or confidentiality provisions protecting trade secrets and confidential information comprising Company IP Rights
            purported to be owned by the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iv)&#8195;No funding, facilities, or personnel of any Governmental Body
            were used, directly or indirectly, to develop or create, in whole or in part, any Company IP Rights in which the Company or any of its Subsidiaries has an ownership interest.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(v)&#8195;The Company and each of its Subsidiaries has taken reasonable
            steps to maintain the confidentiality of and otherwise protect and enforce its rights in all proprietary information that the Company or such Subsidiary holds, or purports to hold, as a trade secret.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vi)&#8195;Neither the Company nor any of its Subsidiaries has assigned or
            otherwise transferred ownership of, or agreed to assign or otherwise transfer ownership of, any Company IP Rights to any other Person.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vii)&#8195;To the Knowledge of the Company, the Company IP Rights
            constitute all Intellectual Property necessary for the Company and its Subsidiaries to conduct its business as currently conducted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;The Company has delivered or made available to Caladrius a
            complete and accurate copy of all Company IP Rights Agreements. With respect to each of the Company IP Rights Agreements: (i)&#160;each such agreement is valid and binding on the Company or its Subsidiaries, as applicable, and in full force and
            effect; (ii)&#160;the Company has not received any written notice of termination or cancellation under such agreement, or received any written notice of breach or default under such agreement, which breach has not been cured or waived; and (iil)
            neither the Company nor its Subsidiaries, and to the Knowledge of the Company, no other party to any such agreement, is in breach or default thereof in any material respect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;The manufacture, marketing, license, sale or intended use of any
            product or technology currently licensed or sold or under development by the Company or any of its Subsidiaries does not violate any license or agreement between the Company or its Subsidiaries and any third party, and, to the Knowledge of the
            Company, does not infringe or misappropriate any Intellectual Property right of any other party, which </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-11<br />
        </div>

      </div>

    </div>

    <!--End Page 400-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 401-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg16"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">infringement or misappropriation would reasonably be expected to have a Company
            Material Adverse Effect. To the Knowledge of the Company, no third party is infringing upon, or violating any license or agreement with the Company or its Subsidiaries relating to any Company IP Rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;There is no current or pending Legal Proceeding (including, but
            not limited to, opposition, interference or other proceeding in any patent or other government office) contesting the validity, ownership or right to use, sell, license or dispose of any Company IP Rights, nor has the Company or any of its
            Subsidiaries received any written notice asserting that any Company IP Rights or the proposed use, sale, license or disposition thereof conflicts with or infringes or misappropriates or will conflict with or infringe or misappropriate the
            rights of any other Person.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(j)&#8195;Each item of Company IP Rights that is Company Registered IP is
            and at all times has been filed and maintained in compliance with all applicable Law and all filings, payments, and other actions required to be made or taken to maintain such item of Company Registered IP in full force and effect have been
            made by the applicable deadline, except for any failure to perform any of the foregoing, individually or collectively, that would not reasonably be expected to have a Company Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(k)&#8195;To the Knowledge of the Company, no trademark (whether
            registered or unregistered) or trade name owned, used, or applied for by the Company or any of its Subsidiaries conflicts or interferes with any trademark (whether registered or unregistered) or trade name owned, used, or applied for by any
            other Person. None of the goodwill associated with or inherent in any trademark (whether registered or unregistered) in which the Company or any of its Subsidiaries has or purports to have an ownership interest has been impaired as determined
            by the Company or any of its Subsidiaries in accordance with GAAP.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(l)&#8195;Except as set forth in Sections 2.12(c) or 2.12(d) of the
            Company Disclosure Schedule (i)&#160;neither the Company nor any of its Subsidiaries is bound by any Contract to indemnify, defend, hold harmless, or reimburse any other Person with respect to any Intellectual Property infringement,
            misappropriation, or similar claim, and (ii)&#160;neither the Company nor any of its Subsidiaries has ever assumed, or agreed to discharge or otherwise take responsibility for, any existing or potential liability of another Person for infringement,
            misappropriation, or violationof any Intellectual Property right, which assumption, agreement or responsibility remains in force as of the date of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(m)&#8195;Neither the Company nor any of its Subsidiaries is party to any
            Contract that, as a result of such execution, delivery and performance of this Agreement, will cause the grant of any license or other right to any Company IP Rights or impair the right of the Company or the Surviving Corporation and its
            Subsidiaries to use, sell or license or enforce any Company IP Rights or portion thereof, except for the occurrence of any such grant or impairment that would not individually or in the aggregate, reasonably be expected to result in a Company
            Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS213"><!--Anchor--></a>2.13&#8195;Agreements, Contracts and
            Commitments.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Section 2.13(a) of the Company Disclosure Schedule lists the
            following Company Contracts in effect as of the date of this Agreement (each, a &#8220;Company Material Contract&#8221; and collectively, the &#8220;Company Material Contracts&#8221;):</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;each Company Contract relating to any material bonus, deferred
            compensation, severance, incentive compensation, pension, profit-sharing or retirement plans, or any other employee benefit plans or arrangements;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;each Company Contract requiring payments by the Company after
            the date of this Agreement in excess of $150,000 pursuant to its express terms relating to the employment of, or the performance of employment-related services by, any Person, including any employee, consultant or independent contractor, or
            entity providing employment related, consulting or independent contractor services, not terminable by the Company or its Subsidiaries on 90 calendar days&#8217; or less notice without liability, except to the extent general principles of wrongful
            termination law may limit the Company&#8217;s, its Subsidiaries&#8217; or such successor&#8217;s ability to terminate employees at will;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iii)&#8195;each Company Contract relating to any agreement or plan,
            including any stock option plan, stock appreciation right plan or stock purchase plan, any of the benefits of which will be increased, or </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-12<br />
        </div>

      </div>

    </div>

    <!--End Page 401-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 402-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg17"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="para">the vesting of benefits of which will be accelerated, by the occurrence of any of
            the Contemplated Transactions (either alone or in conjunction with any other event, such as termination of employment), or the value of any of the benefits of which will be calculated on the basis of any of the Contemplated Transactions;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iv)&#8195;except as otherwise may be set forth in the Contracts listed on
            Section 2.12(c) or Section 2.12(d) of the Company Disclosure Schedule, each Company Contract relating to any agreement of indemnification or guaranty not entered into in the Ordinary Course of Business;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(v)&#8195;each Company Contract containing (A) any covenant limiting the
            freedom of the Company, its Subsidiaries or the Surviving Corporation to engage in any line of business or compete with any Person, (B) any most-favored pricing arrangement, (C) any exclusivity provision, or (D) any non-solicitation provision;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vi)&#8195;each Company Contract relating to capital expenditures and
            requiring payments after the date of this Agreement in excess of $25,000 pursuant to its express terms and not cancelable without penalty;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vii)&#8195;each Company Contract relating to the disposition or
            acquisition of material assets or any ownership interest in any Entity;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(viii)&#8195;each Company Contract relating to any mortgages, indentures,
            loans, notes or credit agreements, security agreements or other agreements or instruments relating to the borrowing of money or extension of credit in excess of $10,000 or creating any material Encumbrances with respect to any assets of the
            Company or any of its Subsidiaries or any loans or debt obligations with officers or directors of the Company;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ix)&#8195;each Company Contract requiring payment by or to the Company
            after the date of this Agreement in excess of $100,000 pursuant to its express terms relating to: (A) any distribution agreement (identifying any that contain exclusivity provisions); (B) any agreement involving provision of services or
            products with respect to any pre-clinical or clinical development activities of the Company; (C) any dealer, distributor, joint marketing, alliance, joint venture, cooperation, development or other agreement currently in force under which the
            Company has continuing obligations to develop or market any product, technology or service, or any agreement pursuant to which the Company has continuing obligations to develop any Intellectual Property that will not be owned, in whole or in
            part, by the Company; or (D) any Contract to license any third party to manufacture or produce any product, service or technology of the Company or any Contract to sell, distribute or commercialize any products or service of the Company, in
            each case, except for Company Contracts entered into in the Ordinary Course of Business;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(x)&#8195;each Company Contract with any Person, including any financial
            advisor, broker, finder, investment banker or other Person, providing advisory services to the Company in connection with the Contemplated Transactions;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xi)&#8195;each Company Real Estate Lease; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xii)&#8195;any other Company Contract that is not terminable at will
            (with no penalty or payment) by the Company or its Subsidiaries, as applicable, and which involves payment or receipt by the Company or its Subsidiaries after the date of this Agreement under any such agreement, contract or commitment of more
            than $100,000 in the aggregate, or obligations after the date of this Agreement in excess of $100,000 in the aggregate.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;The Company has delivered or made available to Caladrius
            accurate and complete copies of all Company Material Contracts, including all amendments thereto. There are no Company Material Contracts that are not in written form. Neither the Company nor any of its Subsidiaries has, nor to the Company&#8217;s
            Knowledge, as of the date of this Agreement has any other party to a Company Material Contract, breached, violated or defaulted under, or received notice that it breached, violated or defaulted under, any of the terms or conditions of any
            Company Material Contract in such manner as would permit any other party to cancel or terminate any such Company Material Contract, or would permit any other party to seek damages which would reasonably be expected to have a Company Material
            Adverse Effect. As to the Company and its </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-13<br />
        </div>

      </div>

    </div>

    <!--End Page 402-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 403-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg18"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">Subsidiaries, as of the date of this Agreement, each Company Material Contract is
            valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. No Person is renegotiating, or has a right pursuant to the terms of any Company Material Contract to change, any material amount paid or payable
            to the Company under any Company Material Contract or any other material term or provision of any Company Material Contract.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS214"><!--Anchor--></a>2.14&#8195;Compliance; Permits;
            Restrictions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;The Company and each of its Subsidiaries are, and since
            January&#160;1, 2019 have been, in compliance in all material respects with all applicable Laws. No investigation, claim, suit, proceeding, audit or other action by any Governmental Body is pending or, to the Knowledge of the Company, threatened
            against the Company or any of its Subsidiaries. There is no agreement, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries which (i)&#160;has or would reasonably be expected to have the effect of prohibiting or
            materially impairing any business practice of the Company or any of its Subsidiaries, any acquisition of material property by the Company or any of its Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as
            currently conducted, (ii)&#160;is reasonably likely to have an adverse effect on the Company&#8217;s ability to comply with or perform any covenant or obligation under this Agreement, or (iii) is reasonably likely to have the effect of preventing,
            delaying, making illegal or otherwise interfering with the Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;The Company and its Subsidiaries hold all required Governmental
            Authorizations which are material to the operation of the business of the Company and its Subsidiaries as currently conducted (the &#8220;Company Permits&#8221;). Section 2.14(b) of the Company Disclosure Schedule identifies each Company Permit. Each of
            the Company and its Subsidiaries is in material compliance with the terms of the Company Permits. No Legal Proceeding is pending or, to the Knowledge of the Company, threatened, which seeks to revoke, limit, suspend, or materially modify any
            Company Permit. The rights and benefits of each Company Permit will be available to the Surviving Corporation or its Subsidiaries, as applicable, immediately after the Effective Time on terms substantially identical to those enjoyed by the
            Company and its Subsidiaries as of the date of this Agreement and immediately prior to the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;There are no proceedings pending or, to the Knowledge of the
            Company, threatened with respect to an alleged material violation by the Company or any of its Subsidiaries of the Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;), Food and Drug Administration (&#8220;FDA&#8221;) regulations adopted thereunder, the
            Controlled Substance Act or any other similar Laws or regulations promulgated or enforced by the FDA, the European Medicines Agency, the Therapeutic Goods Administration or other comparable Governmental Body responsible for regulation of the
            development, clinical testing, manufacturing, sale, marketing, distribution and importation or exportation of drug products (&#8220;Drug Regulatory Agency&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;The Company and each of its Subsidiaries holds all required
            Governmental Authorizations issuable by any Drug Regulatory Agency necessary for the conduct of the business of the Company or such Subsidiary as currently conducted, and the development, clinical testing, manufacturing, marketing, distribution
            and importation or exportation, as currently conducted, of any of its products or product candidates (the &#8220;Company Product Candidates&#8221;) (collectively, the &#8220;Company Regulatory Permits&#8221;) and no such Company Regulatory Permit has been (i)&#160;revoked,
            withdrawn, suspended, cancelled or terminated or (ii)&#160;modified in any adverse manner, other than immaterial adverse modifications. The Company and each of its Subsidiaries are in compliance in all material respects with the Company Regulatory
            Permits and have not received any written notice or other written communication from any Drug Regulatory Agency regarding (A) any material violation of or failure to comply materially with any term or requirement of any Company Regulatory
            Permit or (B) any revocation, withdrawal, suspension, cancellation, termination or material modification of any Company Regulatory Permit. The Company has made available to Caladrius all information requested by Caladrius in the Company&#8217;s or
            its Subsidiaries&#8217; possession or control relating to the Company Product Candidates and the development, clinical testing, manufacturing, importation and exportation of the Company Product Candidates, including complete copies of the following
            (to the extent there are any): (x)&#160;adverse event reports; clinical study reports and material study data; inspection reports, notices of adverse findings, warning letters, filings and letters and other written correspondence to and from any
            Drug Regulatory Agency; and meeting minutes with any Drug Regulatory Agency; and (y) similar reports, material study data, notices, letters, filings, correspondence and meeting minutes with any other Governmental Body.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-14<br />
        </div>

      </div>

    </div>

    <!--End Page 403-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 404-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg19"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;All clinical, pre-clinical and other studies and tests
            conducted by or, to the Knowledge of the Company, on behalf of or sponsored by the Company or its Subsidiaries, or in which the Company or its Subsidiaries or their respective current products or product candidates, including the Company
            Product Candidates, have participated, were and, if still pending, are being conducted in all material respects in accordance with standard medical and scientific research procedures and ethics and in compliance in all material respects with
            the applicable regulations of the Drug Regulatory Agencies and other applicable Law, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58 and 312. Since January&#160;1, 2019, neither the Company nor any of its Subsidiaries has received any
            notices, correspondence, or other communications from any Drug Regulatory Agency requiring, or to the Knowledge of the Company threatening to initiate, the termination or suspension of any clinical trials conducted by or on behalf of, or
            sponsored by, the Company or any of its Subsidiaries or in which the Company or any of its Subsidiaries or their respective current products or product candidates, including the Company Product Candidates, have participated.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Neither the Company nor any of its Subsidiaries is the subject
            of any pending or, to the Knowledge of the Company, threatened investigation in respect of its business or products by the FDA, pursuant to its &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy set forth
            in 56 Fed. Reg. 46191 (September&#160;10, 1991) and any amendments thereto, or any other Drug Regulatory Agency pursuant to any similar Laws or regulations promulgated or enforced thereby. To the Knowledge of the Company, neither the Company nor any
            of its Subsidiaries has committed any acts, made any statement, or failed to make any statement, in each case in respect of its business or products that would violate the FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal
            Gratuities&#8221; Final Policy, and any amendments thereto, or any other Laws or regulations promulgated or enforced by any other Drug Regulatory Agency. None of the Company, any of its Subsidiaries or any of their respective officers, employees or
            agents has been convicted of any crime or engaged in any conduct that could result in a debarment or exclusion (i)&#160;under 21 U.S.C. Section&#160;335a or (ii)&#160;any similar applicable Law. To the Knowledge of the Company, no debarment or exclusionary
            claims, actions, proceedings or investigations in respect of their business or products are pending or threatened against the Company, any of its Subsidiaries or any of their respective officers, employees or agents.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS215"><!--Anchor--></a>2.15&#8195;Legal Proceedings;
            Orders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Except as set forth in Section 2.15(a) of the Company Disclosure
            Schedule, there is no pending Legal Proceeding and, to the Knowledge of the Company, no Person has threatened in writing to commence any Legal Proceeding: (i)&#160;that involves the Company or any of its Subsidiaries, any Company Associate (in his
            or her capacity as such) or any of the material assets owned or used by the Company or its Subsidiaries; or (ii)&#160;that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the
            Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;There is no order, writ, injunction, judgment or decree to which
            the Company or any of its Subsidiaries, or any of the material assets owned or used by the Company or any of its Subsidiaries, is subject. To the Knowledge of the Company, no officer or other Key Employee of the Company or any of its
            Subsidiaries is subject to any order, writ, injunction, judgment or decree that prohibits such officer or employee from engaging in or continuing any conduct, activity or practice relating to the business of the Company or any of its
            Subsidiaries or to any material assets owned or used by the Company or any of its Subsidiaries.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS216"><!--Anchor--></a>2.16&#8195;Tax Matters.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;The Company and each of its Subsidiaries have timely filed or
            caused to be filed all federal, state and local Tax Returns and other material Tax Returns that they were required to file under applicable Law. All such Tax Returns, following any subsequent amendments, were correct and complete in all
            material respects and have been prepared in material compliance with all applicable Law. Subject to exceptions as would not be material, no written claim has ever been made by an authority in a jurisdiction where the Company or any of its
            Subsidiaries does not file Tax Returns that it is subject to taxation by that jurisdiction.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-15<br />
        </div>

      </div>

    </div>

    <!--End Page 404-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 405-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg20"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;To the Knowledge of the Company, all material Taxes due and
            owing by the Company or any of its Subsidiaries on or before the date hereof (whether or not shown on any Tax Return) have been paid. Since the date of the Company Unaudited Balance Sheet, neither the Company nor any of its Subsidiaries has
            incurred any material Liability for Taxes outside the Ordinary Course of Business or otherwise inconsistent with past custom and practice.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;The Company and each of its Subsidiaries have withheld and paid
            all Taxes required to have been withheld and paid in connection with any amounts paid or owing to any employee, independent contractor, creditor, stockholder, or other third party.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;There are no Encumbrances for material Taxes (other than Taxes
            not yet due and payable) upon any of the assets of the Company or any of its Subsidiaries.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;No deficiencies for material Taxes with respect to the Company
            or any of its Subsidiaries have been claimed, proposed or assessed by any Governmental Body in writing. There are no pending (or based on written notice, threatened) material audits, assessments or other actions for or relating to any Tax
            Return or any liability in respect of Taxes of the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries (or any of their predecessors) has waived any statute of limitations in respect of material Taxes or agreed
            to any extension of time with respect to a material Tax assessment or deficiency. Neither the Company nor any of its Subsidiaries has received in writing from any Tax authority any notice of proposed adjustment relating to any Tax Return filed
            by the Company or any of its Subsidiaries. Neither the Company nor any of its Subsidiaries is a party to or bound by any closing or other agreement or ruling with any Governmental Entity with respect to Taxes.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Neither the Company nor any of its Subsidiaries has been a
            United States real property holding corporation within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii)&#160;of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;Neither the Company nor any of its Subsidiaries is a party to
            any material Tax allocation, Tax sharing or similar agreement (including indemnity arrangements), other than commercial contracts entered into in the Ordinary Course of Business with vendors, customers and landlords. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;Neither the Company nor any of its Subsidiaries has ever been a
            member of an affiliated group filing a consolidated U.S. federal income Tax Return (other than a group the common parent of which is the Company). Neither the Company nor any of its Subsidiaries has any material Liability for the Taxes of any
            Person (other than the Company and any of its Subsidiaries) under Treasury Regulations Section 1.1502-6 (or any similar provision of state, local, or foreign law) or as a transferee or successor. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;Neither the Company nor any of its Subsidiaries will be required
            to include any income or gain or exclude any deduction or loss from taxable income for any Tax period or portion thereof ending after the Closing as a result of (A) any adjustment under Section 481 of the Code (or any corresponding provision of
            state, local or non-U.S. Tax Law) by reason of a change in a method of accounting, or use of an improper method of accounting, or otherwise, for a taxable period that ends on or prior to the Closing Date; (B) any &#8220;closing agreement&#8221; within the
            meaning of Section 7121 of the Code (or any similar provision of applicable state, local or non-U.S. Law) entered into prior to the Closing; (C) any intercompany transaction or excess loss account described in the Treasury Regulations
            promulgated pursuant to Section 1502 of the Code (or any corresponding or similar provision of state, local or non-U.S. Law) with respect to a transaction occurring prior to the Closing; (D) any installment sale or open transaction disposition
            made prior to the Closing; or (E) any deferred revenue or prepaid amount received on or prior to the Closing Date. Neither the Company nor any Subsidiary has made an election under Section 965(h) or Section 108(i)&#160;of the Code (or any
            corresponding or similar provision of state, local or non-U.S. Law).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(j)&#8195;Neither the Company nor any of its Subsidiaries has (A)
            deferred, extended or delayed the payment of the employer&#8217;s share of any &#8220;applicable employment taxes&#8221; under Section 2302 of the CARES Act, (B) failed to properly comply with and duly account for all credits received under Sections 7001 through
            7005 of the Families First Coronavirus Response Act (Public Law 116-127) and Section 2301 of the CARES Act, (C)&#160;deferred any payroll tax obligations (including those imposed by Section 3101(a) and 3201 of the Code) (for example, by failure to
            timely withhold, deposit or remit such amounts in accordance with </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-16<br />
        </div>

      </div>

    </div>

    <!--End Page 405-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 406-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg21"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">the applicable provisions of the Code and the Treasury Regulations promulgated
            thereunder) pursuant to or in connection with the Payroll Tax Executive Order, or (D) sought, or intends to seek, a covered loan under Section 7(a)(36) of the Small Business Act (15 U.S.C. 636(a)), as added by Section 1102 of the CARES Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(k)&#8195;Neither the Company nor any of its Subsidiaries has, or has ever
            had, a permanent establishment (as defined in any applicable Tax treaty or convention), an office or fixed place of business, or otherwise is or has been subject to Tax, in any country other than the country in which it is organized.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(l)&#8195;Each of the Company and its Subsidiaries is currently in
            compliance with the requirements for all Tax holidays and similar Tax benefits and have been in compliance since such holiday or benefit was originally claimed. To the Knowledge of the Company, no such Tax holiday or similar Tax benefit will
            terminate by reason of the transactions contemplated by this Agreement, or will be subject to recapture or clawback.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(m)&#8195;Neither the Company nor any of its Subsidiaries has distributed
            stock of another Person, or has had its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 of the Code or Section 361 of the Code in the last two years.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(n)&#8195;Neither the Company nor any of its Subsidiaries has entered into
            any transaction identified as a &#8220;reportable transaction&#8221; for purposes of Treasury Regulations Section 1.6011-4(b).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS217"><!--Anchor--></a>2.17&#8195;Employee and Labor
            Matters; Benefit Plans.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;The employment of each of the Company&#8217;s and any of its
            Subsidiaries&#8217; employees is terminable by the Company or the applicable Subsidiary at will (or otherwise in accordance with general principles of wrongful termination law). The Company has made available to Caladrius accurate and complete copies
            of all employee manuals and handbooks, disclosure materials, policy statements and other materials relating to the employment of Company Associates to the extent currently effective and material.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Neither the Company nor any of its Subsidiaries is a party to,
            bound by, or has a duty to bargain under, any collective bargaining agreement or other Contract with a labor organization representing any of its employees, and there are no labor organizations representing or, to the Knowledge of the Company,
            purporting to represent or seeking to represent any employees of the Company or its Subsidiaries.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Section 2.17(c) of the Company Disclosure Schedule lists all
            written and describes all non-written employee benefit plans (as defined in Section 3(3) of ERISA) and all bonus, equity-based, incentive, deferred compensation, retirement or supplemental retirement, profit sharing, severance, golden
            parachute, vacation, cafeteria, dependent care, medical care, employee assistance program, education or tuition assistance programs and other similar material fringe or employee benefit plans, programs or arrangements, including any employment
            or executive compensation or severance agreements, written or otherwise, which are currently in effect relating to any present or former employee or director of the Company or any of its Subsidiaries (or any trade or business (whether or not
            incorporated) which is a Company Affiliate) or which is maintained by, administered or contributed to by, or required to be contributed to by, the Company, any of its Subsidiaries or any Company Affiliate, or under which the Company or any of
            its Subsidiaries or any Company Affiliate has any current liability or may incur liability after the date hereof (each, a &#8220;Company Employee Plan&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;With respect to Company Options granted pursuant to the Company
            Plan, (i)&#160;each Company Option intended to qualify as an &#8220;incentive stock option&#8221; under Section 422 of the Code so qualified at the time of its grant, (ii)&#160;each grant of a Company Option was duly authorized no later than the date on which the
            grant of such Company Option was by its terms to be effective (the &#8220;Grant Date&#8221;) by all necessary corporate action, including, as applicable, approval by the Company Board (or a duly constituted and authorized committee thereof) and any
            required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii)&#160;each Company Option grant was made in
            accordance with the terms of the Company Plan and all other applicable Law and regulatory rules or requirements and (iv)&#160;the per share exercise price of each Company Option was not less than the fair market value of a share of Company Common
            Stock on the applicable Grant Date.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-17<br />
        </div>

      </div>

    </div>

    <!--End Page 406-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 407-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg22"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Each Company Employee Plan that is intended to be qualified
            under Section 401(a) of the Code has received a favorable determination or opinion letter with respect to such qualified status from the IRS. To the Knowledge of the Company, nothing has occurred that would reasonably be expected to adversely
            affect the qualified status of any such Company Employee Plan or the exempt status of any related trust.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Each Company Employee Plan has been maintained in compliance, in
            all material respects, with its terms and, both as to form and operation, with all applicable Law, including the Code and ERISA. No action or claims (other than routine claims for benefits made in the ordinary course of Company Employee Plan
            administration) are pending, or to the Knowledge of the Company, threatened, or imminent against or with respect to the Company Employee Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;Neither the Company nor any of its Subsidiaries has engaged in
            any transaction in violation of Sections 404 or 406 of ERISA or any &#8220;prohibited transaction,&#8221; as defined in Section 4975(c)(1) of the Code, for which no exemption exists under Section 408 of ERISA or Section 4975(c)(2) or (d) of the Code, or
            has otherwise violated the provisions of Part 4 of Title I, Subtitle B of ERISA. Neither the Company nor any of its Subsidiaries has knowingly participated in a violation of Part 4 of Title I, Subtitle B of ERISA by any plan fiduciary of any
            Company Employee Plan subject to ERISA and neither the Company nor any of its Subsidiaries has been assessed any civil penalty under Section 502(I) of ERISA.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;No Company Employee Plan is subject to Title IV or Section 302
            of ERISA or Section 412 of the Code, and neither the Company nor any of its ERISA Affiliates has ever maintained, contributed to or partially or completely withdrawn from, or incurred any obligation or liability with respect to, any such plan.
            No Company Employee Plan is a Multiemployer Plan, and neither the Company nor any of its ERISA Affiliates has ever contributed to or had an obligation to contribute, or incurred any liability in respect of a contribution, to any Multiemployer
            Plan. No Company Employee Plan is a Multiple Employer Plan. No Company Employee Plan is a Multiple Employer Welfare Arrangement. Neither the Company nor any of its ERISA Affiliates sponsors or maintains any self-funded welfare employee benefit
            plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;No Company Employee Plan provides for medical or death benefits
            beyond termination of service or retirement, other than (i)&#160;pursuant to COBRA or an analogous state law requirement or (ii)&#160;death or retirement benefits under a Company Employee Plan qualified under Section 401(a) of the Code. No Company Plan
            is subject to any Law of a foreign jurisdiction outside of the United States.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(j)&#8195;Neither the Company nor any of its Subsidiaries is a party to
            any Contract that has resulted or would reasonably be expected to result, separately or in the aggregate, in the payment of (i)&#160;any &#8220;excess parachute payment&#8221; within the meaning of Section 280G of the Code or (ii)&#160;any amount the deduction for
            which would be disallowed under Section 162(m) of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(k)&#8195;To the Knowledge of the Company, no Company Options or other
            equity-based awards issued or granted by the Company are subject to the requirements of Code Section 409A. To the Knowledge of the Company, each &#8220;nonqualified deferred compensation plan&#8221; (as such term is defined under Section 409A(d)(1) of the
            Code and the guidance thereunder) (each, a &#8220;409A Plan&#8221;) under which the Company makes, is obligated to make or promises to make, payments, complies in all material respects, in both form and operation, with the requirements of Code Section 409A
            and the guidance thereunder. No payment currently to be made under any 409A Plan is or, to the Knowledge of the Company, will be subject to the penalties of Code Section 409A(a)(1).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(l)&#8195;The Company and each of its Subsidiaries is in material
            compliance with all of its bonus, commission and other compensation plans and has paid any and all amounts required to be paid under such plans, including any and all bonuses and commissions (or pro rata portion thereof) that may have accrued
            or been earned through the calendar quarter preceding the Effective Time, and is not liable for any material payments, taxes or penalties for failure to comply with any of the terms or conditions of such plans or the laws governing such plans.
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(m)&#8195;The Company and each of its Subsidiaries is in material
            compliance with all applicable foreign, federal, state and local laws, rules and regulations respecting employment, employment practices, terms and conditions of employment, worker classification, tax withholding, prohibited discrimination,
            equal employment, fair employment practices, meal and rest periods, immigration status, employee safety and health, wages (including overtime wages), compensation, and hours of work, and in each case, with respect </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-18<br />
        </div>

      </div>

    </div>

    <!--End Page 407-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 408-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg23"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">to the employees of the Company and its Subsidiaries: (i)&#160;has withheld and reported
            all material amounts required by law or by agreement to be withheld and reported with respect to wages, salaries and other payments to employees, (ii)&#160;is not liable for any arrears of wages, severance pay or any Taxes or any penalty for failure
            to comply with any of the foregoing, and (iii)&#160;is not liable for any material payment to any trust or other fund governed by or maintained by or on behalf of any governmental authority, with respect to unemployment compensation benefits, social
            security or other benefits or obligations for employees (other than routine payments to be made in the Ordinary Course of Business). To the Knowledge of the Company, there are no pending or threatened or reasonably anticipated claims or actions
            against the Company, any of its Subsidiaries, any Company trustee or any trustee of any Subsidiary under any workers&#8217; compensation policy or long-term disability policy. Neither the Company nor any Subsidiary thereof is a party to a
            conciliation agreement, consent decree or other agreement or order with any federal, state, or local agency or governmental authority with respect to employment practices.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(n)&#8195;Section 2.17(n) of the Company Disclosure Schedule lists all
            contractual liabilities of the Company or any of its Subsidiaries to any employee that result from the termination by the Company or any of its Subsidiaries of such employee&#8217;s employment or provision of services, a change of control of the
            Company, or a combination thereof. Neither the Company nor any of its Subsidiaries has any material liability with respect to any misclassification of: (a) any Person as an independent contractor rather than as an employee, (b) any employee
            leased from another employer, or (c) any employee currently or formerly classified as exempt from overtime wages. Neither the Company nor any Subsidiary has taken any action which would constitute a &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; within the
            meaning of the WARN Act or similar state or local law, issued any notification of a plant closing or mass layoff required by the WARN Act or similar state or local law, or incurred any liability or obligation under WARN or any similar state or
            local law that remains unsatisfied. No terminations of employees of the Company or any of its Subsidiaries prior to the Closing would trigger any notice or other obligations under the WARN Act or similar state or local law. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(o)&#8195;With respect to each Company Employee Plan, the Company has made
            available to Caladrius a true and complete copy of, to the extent applicable, (i)&#160;such Company Employee Plan, (ii)&#160;the three most recent annual reports (Form 5500) as filed with the IRS, (iii)&#160;each currently effective trust agreement related to
            such Company Employee Plan, (iv)&#160;the most recent summary plan description for each Company Employee Plan for which such description is required, along with all summaries of material modifications, amendments, resolutions and all other material
            plan documentation related thereto in the possession of the Company, (v)&#160;the most recent IRS determination or opinion letter or analogous ruling under foreign law issued with respect to any Company Employee Plan, and (vi)&#160;any filings under any
            amnesty, voluntary compliance, self-correction, or similar program sponsored by any Governmental Body.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(p)&#8195;There has never been, nor has there been any threat of, any
            strike, slowdown, work stoppage, lockout, job action, union, organizing activity, question concerning representation or any similar activity or dispute, affecting the Company or any of its Subsidiaries. No event has occurred, and no condition
            or circumstance exists, that might directly or indirectly be likely to give rise to or provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, job action, union organizing activity, question concerning
            representation or any similar activity or dispute.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(q)&#8195;Neither the Company nor any of its Subsidiaries is, nor has the
            Company or any of its Subsidiaries been, engaged in any unfair labor practice within the meaning of the National Labor Relations Act. There is no Legal Proceeding, claim, labor dispute or grievance pending or, to the Knowledge of the Company,
            threatened or reasonably anticipated relating to any employment contract, privacy right, labor dispute, wages and hours, leave of absence, plant closing notification, workers&#8217; compensation policy, long-term disability policy, harassment,
            retaliation, immigration, employment statute or regulation, safety or discrimination matter involving any Company Associate, including charges of unfair labor practices or discrimination complaints. There are no actions, suits, claims or
            administrative matters pending or, to the Knowledge of the Company, threatened or reasonably anticipated against the Company or any of its Subsidiaries relating to any employee, employment agreement or Company Employee Plan (other than routine
            claims for benefits). </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-19<br />
        </div>

      </div>

    </div>

    <!--End Page 408-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 409-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg24"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(r)&#8195;There is no contract, agreement, plan or arrangement to which
            the Company or any Company Affiliate is a party or by which it is bound to compensate any of its employees for excise taxes paid pursuant to Section&#160;4999 of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS218"><!--Anchor--></a>2.18&#8195;Environmental Matters.
            Since January&#160;1, 2019, the Company and each of its Subsidiaries has complied with all applicable Environmental Laws, which compliance includes the possession by the Company of all permits and other Governmental Authorizations required under
            applicable Environmental Laws and compliance with the terms and conditions thereof, except for any failure to be in compliance that, individually or in the aggregate, would not result in a Company Material Adverse Effect. Neither the Company
            nor any of its Subsidiaries has received since January&#160;1, 2019, any written notice or other communication (in writing or otherwise), whether from a Governmental Body, citizens group, employee or otherwise, that alleges that the Company or any
            of its Subsidiaries is not in compliance with any Environmental Law, and, to the Knowledge of the Company, there are no circumstances that may prevent or interfere with the Company&#8217;s or any of its Subsidiaries&#8217; compliance with any Environmental
            Law in the future, except where such failure to comply would not reasonably be expected to have a Company Material Adverse Effect. To the Knowledge of the Company: (i)&#160;no current or prior owner of any property leased or controlled by the
            Company or any of its Subsidiaries has received since January&#160;1, 2019, any written notice or other communication relating to property owned or leased at any time by the Company or any of its Subsidiaries, whether from a Governmental Body,
            citizens group, employee or otherwise, that alleges that such current or prior owner or the Company or any of its Subsidiaries is not in compliance with or violated any Environmental Law relating to such property and (ii)&#160;neither the Company
            nor any of its Subsidiaries has any material liability under any Environmental Law. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS219"><!--Anchor--></a>2.19&#8195;Insurance. The Company has
            made available to Caladrius accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of the Company and each of its
            Subsidiaries. Each of such insurance policies is in full force and effect and the Company and each of its Subsidiaries are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from
            insurance carriers, since January&#160;1, 2019, neither the Company nor any of its Subsidiaries has received any notice or other communication regarding any actual or possible: (i)&#160;cancellation or invalidation of any insurance policy; or
            (ii)&#160;refusal or denial of any coverage, reservation of rights or rejection of any material claim under any insurance policy. The Company and each of its Subsidiaries have provided timely written notice to the appropriate insurance carrier(s) of
            each Legal Proceeding pending against the Company or any of its Subsidiaries for which the Company or such Subsidiary has insurance coverage, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any
            such Legal Proceeding, or informed the Company or any of its Subsidiaries of its intent to do so. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS220"><!--Anchor--></a>2.20&#8195;No Financial Advisors.
            Except as set forth on Section 2.20 of the Company Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee, finder&#8217;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection
            with the Contemplated Transactions based upon arrangements made by or on behalf of the Company or any of its Subsidiaries. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS221"><!--Anchor--></a>2.21&#8195;Disclosure. The information
            supplied by the Company and each of its Subsidiaries for inclusion in the Proxy Statement (including any of the Company Financials) will not, as of the date of the Proxy Statement or as of the date such information is prepared or presented,
            (i)&#160;contain any statement that is inaccurate or misleading with respect to any material facts, or (ii)&#160;omit to state any material fact necessary in order to make such information, in light of the circumstances under which such information will
            be provided, not false or misleading. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS222"><!--Anchor--></a>2.22&#8195;Transactions with
            Affiliates. Section 2.22 of the Company Disclosure Schedule describes any material transactions or relationships, since January&#160;1, 2019, between, on one hand, the Company or any of its Subsidiaries and, on the other hand, any (a) executive
            officer or director of the Company or any of its Subsidiaries or any of such executive officer&#8217;s or director&#8217;s immediate family members, (b) owner of more than five percent (5%) of the voting power of the outstanding Company Capital Stock or
            (c) to the Knowledge of the Company, any &#8220;related person&#8221; (within the meaning of Item 404 of Regulation S-K under the Securities Act) of any such officer, director or owner (other than the Company or its Subsidiaries) in the case of each of
            (a), (b) or (c) that is of the type that would be required to be disclosed under Item 404 of Regulation S-K under the Securities Act. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-20<br />
        </div>

      </div>

    </div>

    <!--End Page 409-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 410-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg25"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS223"><!--Anchor--></a>2.23.&#8195;No Other
            Representations or Warranties. The Company hereby acknowledges and agrees that, except for the representations and warranties contained in this Agreement, neither Caladrius nor any other person on behalf of Caladrius makes any express or
            implied representation or warranty with respect to Caladrius or with respect to any other information provided to the Company, any of its Subsidiaries or stockholders or any of their respective Affiliates in connection with the transactions
            contemplated hereby, and (subject to the express representations and warranties of Caladrius set forth in <span style="text-decoration: underline;">Section 3</span> (in each case as qualified and limited by the Caladrius Disclosure Schedule)) none of the Company, its Subsidiaries or
            any of their respective Representatives or stockholders, has relied on any such information (including the accuracy or completeness thereof). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara"><a id="tANXAS3"><!--Anchor--></a>Section 3&#8195;Representations and Warranties of
            Caladrius and Merger Sub</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Subject to<span style="text-decoration: underline;"> Section 10.13(h)</span>, except (i)&#160;as set forth in the
            written disclosure schedule delivered by Caladrius to the Company (the &#8220;Caladrius Disclosure Schedule&#8221;) or (ii)&#160;as disclosed in the Caladrius SEC Documents filed with the SEC prior to the date hereof and publicly available on the SEC&#8217;s
            Electronic Data Gathering Analysis and Retrieval system (but (A) without giving effect to any amendment thereof filed with, or furnished to, the SEC on or after the date hereof and (B) excluding any disclosures contained under the heading &#8220;Risk
            Factors&#8221; and any disclosure of risks included in any &#8220;forward-looking statements&#8221; disclaimer or in any other section to the extent they are forward-looking statements or cautionary, predictive or forward-looking in nature), Caladrius and Merger
            Sub represent and warrant to the Company as follows: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS31"><!--Anchor--></a>3.1&#8195;Due Organization;
            Subsidiaries; Etc.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Each of Caladrius and Merger Sub is a corporation duly
            incorporated, validly existing and in good standing under the laws of the State of Delaware and has all necessary corporate power and authority: (i)&#160;to conduct its business in the manner in which its business is currently being conducted;
            (ii)&#160;to own or lease and use its property and assets in the manner in which its property and assets are currently owned or leased and used; and (iii)&#160;to perform its obligations under all Contracts by which it is bound. Since the date of its
            incorporation, Merger Sub has not engaged in any activities other than in connection with or as contemplated by this Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Caladrius is licensed and qualified to do business, and is in
            good standing (to the extent applicable in such jurisdiction), under the laws of all jurisdictions where the nature of its business requires such licensing or qualification other than in jurisdictions where the failure to be so qualified
            individually or in the aggregate would not be reasonably expected to have a Caladrius Material Adverse Effect. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Caladrius does not own any capital stock of, or any equity
            ownership or profit sharing interest of any nature in, or control directly or indirectly, any other Entity other than the capital stock of its Subsidiaries, each of which and Caladrius&#8217; ownership therein are set forth on Section 3.1(c) of the
            Caladrius Disclosure Schedule. Caladrius is not and has not otherwise been, directly or indirectly, a party to, member of or participant in any partnership, joint venture or similar business entity. Caladrius has not agreed and is not obligated
            to make, nor is Caladrius bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any other Entity. Caladrius has not, at any time, been a general partner of, and has not otherwise
            been liable for any of the debts or other obligations of, any general partnership, limited partnership or other Entity. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;No Caladrius Subsidiary has any material operations, assets or
            liabilities.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS32"><!--Anchor--></a>3.2.&#8195;Organizational Documents.
            Caladrius has made available to the Company accurate and complete copies of Caladrius&#8217; Organizational Documents. Caladrius is not in breach or violation of its Organizational Documents in any material respect. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS33"><!--Anchor--></a>3.3.&#8195;Authority; Binding Nature of
            Agreement. Each of Caladrius and Merger Sub has all necessary corporate power and authority to enter into and to perform its obligations under this Agreement and to consummate the Contemplated Transactions. The Caladrius Board (at meetings duly
            called and held) <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">has: (a)&#160;determined that the Contemplated Transactions are fair to, advisable and in the
            best interests of Caladrius and its stockholders; (b)&#160;approved and declared advisable this Agreement and the Contemplated Transactions, including the issuance of shares of Caladrius Common Stock to the stockholders of the Company pursuant to
            the terms of this Agreement; and (c) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholders of Caladrius vote to approve this Agreement and the Contemplated Transactions,
            including the issuance of shares of Caladrius Common Stock to the stockholders of the Company </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-21<br />
        </div>

      </div>

    </div>

    <!--End Page 410-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 411-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg26"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">pursuant to the terms of this Agreement. The Merger Sub Board (by unanimous written
            consent) has: (x)&#160;determined that the Contemplated Transactions are fair to, advisable, and in the best interests of Merger Sub and its sole stockholder; (y) deemed advisable and approved this Agreement and the Contemplated Transactions; and
            (z) determined to recommend, upon the terms and subject to the conditions set forth in this Agreement, that the stockholder of Merger Sub vote to adopt this Agreement and thereby approve the Contemplated Transactions. This Agreement has been
            duly executed and delivered by Caladrius and Merger Sub and, assuming the due authorization, execution and delivery by the Company, constitutes the legal, valid and binding obligation of Caladrius and Merger Sub, enforceable against each of
            Caladrius and Merger Sub in accordance with its terms, subject to the Enforceability Exceptions. Prior to the execution of the Caladrius Stockholder Support Agreements, the Caladrius Board approved the Caladrius Stockhalder Support Agreements
            and the transactions contemplated thereby. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS34"><!--Anchor--></a>3.4&#8195;Vote Required. The
            affirmative vote of the holders of a majority of the shares of Caladrius Capital Stock entitled to vote thereon (the &#8220;Required Caladrius Stockholder Vote&#8221;) is the only vote of the holders of any class or series of Caladrius&#8217; capital stock
            necessary to approve the Caladrius Stockholder Matters. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS35"><!--Anchor--></a>3.5&#8195;Non-Contravention; Consents.
            Subject to obtaining the Required Caladrius Stockholder Vote and the filing of the Certificate of Merger required by the DGCL, neither (x)&#160;the execution, delivery or performance of this Agreement by Caladrius or Merger Sub, nor (y) the
            consummation of the Contemplated Transactions, will directly or indirectly (with or without notice or lapse of time): </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;contravene, conflict with or result in a violation of any of the
            provisions of the Organizational Documents of Caladrius or Merger Sub;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;contravene, conflict with or result in a material violation of,
            or give any Governmental Body or other Person the right to challenge the Contemplated Transactions or to exercise any remedy or obtain any relief under, any Law or any order, writ, injunction, judgment or decree to which Caladrius or any of the
            assets owned or used by Caladrius, is subject; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;contravene, conflict with or result in a material violation of
            any of the terms or requirements of, or give any Governmental Body the right to revoke, withdraw, suspend, cancel, terminate or modify, any Governmental Authorization that is held by Caladrius or that otherwise relates to the business of
            Caladrius, or any of the assets owned, leased or used by Caladrius; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;contravene, conflict with or result in a violation or breach of,
            or result ina default under, any provision of any Caladrius Material Contract, or give any Person the right to: (i)&#160;declare a default or exercise any remedy under any Caladrius Material Contract; (ii)&#160;any material payment, rebate, chargeback,
            penalty or change in delivery schedule under any such Caladrius Material Contract; (iii)&#160;accelerate the maturity or performance of any Caladrius Material Contract; or (iv)&#160;cancel, terminate or modify any term of any Caladrius Material Contract,
            except in the case of any non-material breach, default, penalty or modification; or </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;result in the imposition or creation of any Encumbrance upon or
            with respect to any asset owned or used by Caladrius (except for Permitted Encumbrances).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Except for (i)&#160;the Required Caladrius Stockholder Vote, (ii)&#160;the filing of the
            Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the DGCL and (iii)&#160;such consents, waivers, approvals, orders, authorizations, registrations, declarations and filings as may be required under applicable
            federal and state securities laws, Caladrius was not, is not, and will not be required to make any filing with or give any notice to, or to obtain any Consent from, any Person in connection with (x)&#160;the execution, delivery or performance of
            this Agreement, or (y) the consummation of the Contemplated Transactions. The Caladrius Board and the Merger Sub Board have taken and will take all actions necessary to ensure that the restrictions applicable to business combinations contained
            in Section 203 of the DGCL are, and will be, inapplicable to the execution, delivery and performance of this Agreement and the Caladrius Stockholder Support Agreements and to the consummation of the Contemplated Transactions. No other state
            takeover statute or similar Law applies or purports to apply to the Merger, this Agreement, the Caladrius Stockholder Support Agreements or any of the Contemplated Transactions.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-22<br />
        </div>

      </div>

    </div>

    <!--End Page 411-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 412-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg27"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS36"><!--Anchor--></a>3.6&#8195;Capitalization, Etc.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;The authorized capital stock of Caladrius consists of (i)
            500,000,000 shares of Caladrius Common Stock, par value $0.001 per share, of which 60,544,144 shares are issued and 60,533,064 are outstanding as of March&#160;31, 2022 (the &#8220;Capitalization Date&#8221;) and (ii) 20,000,000 shares of Preferred Stock, par
            value $0.01&#160;per&#160;share, of which 10,000 shares are issued and are outstanding as of the Capitalization Date. Caladrius holds 11,080 shares of its capital stock in its treasury.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;All of the outstanding shares of Caladrius Capital Stock have
            been duly authorized and validly issued, and are fully paid and nonassessable and are free of any Encumbrances, other than those imposed by relevant securities laws. None of the outstanding shares of Caladrius Capital Stock is entitled or
            subject to any preemptive right, right of participation, right of maintenance or any similar right. None of the outstanding shares of Caladrius Capital Stock is subject to any right of first refusal in favor of Caladrius. Except as contemplated
            herein, there is no Caladrius Contract relating to the voting or registration of, or restricting any Person from purchasing, selling, pledging or otherwise disposing of (or granting any option or similar right with respect to), any shares of
            Caladrius Capital Stock. Caladrius is not under any obligation, nor is Caladrius bound by any Contract pursuant to which it may become obligated, to repurchase, redeem or otherwise acquire any outstanding shares of Caladrius Capital Stock or
            other securities. Section 3.6(b) of the Caladrius Disclosure Schedule accurately and completely describes all repurchase rights held by Caladrius with respect to shares of Caladrius Capital Stock (including shares issued pursuant to the
            exercise of stock options) and specifies which of those repurchase rights are currently exercisable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Except for the Caladrius Biosciences, Inc. amended 2018 Equity
            Incentive Compensation Plan, as amended, the Caladrius Biosciences, Inc. 2015 Equity Compensation Plan and the Caladrius Biosciences, Inc. 2009 Stock Option and Incentive Plan (collectively, the &#8220;Caladrius Stock Plans&#8221;) and the Caladrius
            Biosciences, Inc. amended 2017 Employee Stock Purchase Plan (the &#8220;Caladrius ESPP&#8221;), Caladrius does not have any stock option plan or any other plan, program, agreement or arrangement providing for any equity-based compensation for any Person.
            As of the date of this Agreement, Caladrius has reserved 9,892,300 shares of Caladrius Common Stock for issuance under the Caladrius Stock Plans, of which 2,670,792 shares have been issued and 1,949,166 are currently outstanding, 2,633,378
            shares have been reserved for issuance upon exercise of Caladrius Options granted under the Caladrius Stock Plans, 1,455,395 shares have been reserved for issuance upon exercise of outstanding Caladrius RSUs and 3,493,600 shares remain
            available for future issuance pursuant to the Caladrius Stock Plans. As of the date of this Agreement, Caladrius has reserved 300,577 shares of Caladrius Common Stock for future issuance pursuant to the Caladrius ESPP. Section 3.6(c) of the
            Caladrius Disclosure Schedule sets forth the following information with respect to each Caladrius Award outstanding as of the date of this Agreement: (i)&#160;the name of the recipient; (ii)&#160;the number of shares of Caladrius Common Stock subject to
            such Caladrius Award at the time of grant; (iii)&#160;the number of shares of Caladrius Common Stock subject to such Caladrius Award as of the date of this Agreement; (iv)&#160;the exercise price of each Caladrius Option; (v)&#160;the date on which such
            Caladrius Award was granted; (vi)&#160;the applicable vesting schedule, including the number of vested and unvested shares as of the date of this Agreement; (vii)&#160;the date on which such Caladrius Award expires; and (viii)&#160;whether such Caladrius
            Option is an &#8220;incentive stock option&#8221; (as defined in the Code) or a non-qualified stock option. Caladrius has made available to the Company accurate and complete copies of equity incentive plans pursuant to which Caladrius has equity-based
            awards, the forms of all award agreements evidencing such equity-based awards and evidence of board and stockholder approval of the Caladrius Stock Plans and any amendments thereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Except for the outstanding Caladrius Awards or as set forth on
            Section 3.6(d) of the Caladrius Disclosure Schedule, there is no: (i)&#160;outstanding subscription, option, call, warrant or right (whether or not currently exercisable) to acquire any shares of the capital stock or other securities of Caladrius;
            (ii)&#160;outstanding security, instrument or obligation that is or may become convertible into or exchangeable for any shares of the capital stock or other securities of Caladrius; (iii)&#160;stockholder rights plan (or similar plan commonly referred to
            as a &#8220;poison pill&#8221;) or Contract under which Caladrius is or may become obligated to sell or otherwise issue any shares of its capital stock or any other securities; or (iv)&#160;condition or circumstance that is reasonably likely to give rise to or
            provide a basis for the assertion of a claim by any </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-23<br />
        </div>

      </div>

    </div>

    <!--End Page 412-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 413-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg28"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">Person to the effect that such Person is entitled to acquire or receive any shares
            of capital stock or other securities of Caladrius. There are no outstanding or authorized stock appreciation, phantom stock, profit participation or other similar rights with respect to Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;All outstanding shares of Caladrius Common Stock, Caladrius
            Awards and other securities of Caladrius have been issued and granted in material compliance with (i)&#160;all applicable securities laws and other applicable Law, and (ii)&#160;all requirements set forth in applicable Contracts.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS37"><!--Anchor--></a>3.7.&#8195;SEC Filings; Financial
            Statements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Caladrius has delivered to the Company accurate and complete
            copies of all registration statements, proxy statements, Certifications and other statements, reports, schedules, forms and other documents filed by Caladrius with the SEC since January&#160;1, 2019 (the &#8220;Caladrius SEC Documents&#8221;), other than such
            documents that can be obtained on the SEC&#8217;s website at <span style="text-decoration: underline;">www.sec.gov</span>. Except as set forth on Section 3.7(a) of the Caladrius Disclosure Schedule, all material statements, reports, schedules, forms and other documents required to have been
            filed by Caladrius or its officers with the SEC have been so filed on a timely basis. As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of such filing), each
            of the Caladrius SEC Documents complied in all material respects with the applicable requirements of the Securities Act or the Exchange Act (as the case may be) and as of the time they were filed, none of the Caladrius SEC Documents contained
            any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. The
            certifications and statements required by (i)&#160;Rule 13a-14 under the Exchange Act and (ii) 18 U.S.C. &#167;1350 (Section 906 of the Sarbanes-Oxley Act) relating to the Caladrius SEC Documents (collectively, the &#8220;Certifications&#8221;) are accurate and
            complete and comply as to form and content with all applicable Laws. As used in this <span style="text-decoration: underline;">Section 3.7</span>, the term &#8220;file&#8221; and variations thereof shall be broadly construed to include any manner in which a document or information is furnished,
            supplied or otherwise made available to the SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;The financial statements (including any related notes) contained
            or incorporated by reference in the Caladrius SEC Documents (the &#8220;Caladrius Financials&#8221;): (i)&#160;complied as to form in all material respects with the published rules and regulations of the SEC applicable thereto; (ii)&#160;were prepared in accordance
            with GAAP (except as may be indicated in the notes to such financial statements or, in the case of unaudited financial statements, as permitted by Form 10-Q of the SEC, and except that the unaudited financial statements may not contain
            footnotes and are subject to normal and recurring year-end adjustments that are not reasonably expected to be material in amount) applied on a consistent basis unless otherwise noted therein throughout the periods indicated; and (iii)&#160;fairly
            present, in all material respects, the financial position of Caladrius as of the respective dates thereof and the results of operations and cash flows of Caladrius for the periods covered thereby. Other than as expressly disclosed in the
            Caladrius SEC Documents filed prior to the date hereof, there has been no material change in Caladrius&#8217; accounting methods or principles that would be required to be disclosed in Caladrius&#8217; financial statements in accordance with GAAP. The
            books of account and other financial records of Caladrius and each of its Subsidiaries are true and complete in all material respects.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Caladrius&#8217; auditor has at all times since the date of enactment
            of the Sarbanes-Oxley Act been: (i)&#160;a registered public accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act); (ii)&#160;to the Knowledge of Caladrius, &#8220;independent&#8221; with respect to Caladrius within the meaning of Regulation S-X
            under the Exchange Act; and (iii)&#160;to the Knowledge of Caladrius, in compliance with subsections (g) through (l) of Section 10A of the Exchange Act and the rules and regulations promulgated by the SEC and the Public Company Accounting Oversight
            Board thereunder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Caladrius has not received any comment letter from the SEC or
            the staff thereof or any correspondence from Nasdaq or the staff thereof relating to the delisting or maintenance of listing of the Caladrius Common Stock on the Nasdaq Capital Market. Caladrius has not disclosed any unresolved comments in the
            Caladrius SEC Documents.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-24<br />
        </div>

      </div>

    </div>

    <!--End Page 413-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 414-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg29"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Since January&#160;1, 2019, there have been no formal internal
            investigations regarding financial reporting or accounting policies and practices discussed with, reviewed by or initiated at the direction of the chief executive officer, chief financial officer, or general counsel of Caladrius, the Caladrius
            Board or any committee thereof, other than ordinary course audits or reviews of accounting policies and practices or internal controls required by the Sarbanes-Oxley Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Caladrius is in compliance in all material respects with the
            applicable provisions of the Sarbanes-Oxley Act and the applicable listing and governance rules and regulations of the Nasdaq Capital Market.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;Caladrius maintains a system of internal control over financial
            reporting (as defined in Rules&#160;13a-15(f) and 15d-15(f) of the Exchange Act) that is sufficient to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
            accordance with GAAP, including policies and procedures sufficient to provide reasonable assurance (i)&#160;that Caladrius maintains records that in reasonable detail accurately and fairly reflect Caladrius&#8217; transactions and dispositions of assets,
            (ii)&#160;that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (iii) that receipts and expenditures are made only in accordance with authorizations of management and the Caladrius Board,
            and (iv)&#160;regarding prevention or timely detection of the unauthorized acquisition, use or disposition of Caladrius&#8217; assets that could have a material effect on Caladrius&#8217; financial statements. Caladrius has evaluated the effectiveness of
            Caladrius&#8217; internal control over financial reporting and, to the extent required by applicable Law, presented in any applicable Caladrius SEC Document that is a report on Form 10-K or Form 10-Q (or any amendment thereto) its conclusions about
            the effectiveness of the internal control over financial reporting as of the end of the period covered by such report or amendment based on such evaluation. Caladrius has disclosed to Caladrius&#8217; auditors and the Audit Committee of the Caladrius
            Board (and made available to the Company a summary of the significant aspects of such disclosure) (A) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are
            reasonably likely to adversely affect Caladrius&#8217; ability to record, process, summarize and report financial information and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in
            Caladrius&#8217; or its Subsidiaries&#8217; internal control over financial reporting. Except as disclosed in the Caladrius SEC Documents filed prior to the date hereof, Caladrius has not identified any material weaknesses in the design or operation of
            Caladrius&#8217; internal control over financial reporting. Since January&#160;1, 2019, there have been no material changes in Caladrius&#8217; internal control over financial reporting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;Caladrius&#8217; &#8220;disclosure controls and procedures&#8221; (as defined in
            Rules 13a-15(e) and 15d-15(e) of the Exchange Act) are reasonably designed to ensure that all information (both financial and non-financial) required to be disclosed by Caladrius in the reports that it files or submits under the Exchange Act is
            recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such information is accumulated and communicated to Caladrius&#8217; management as appropriate to allow timely decisions
            regarding required disclosure and to make the Certifications.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;Since January&#160;1, 2021, Caladrius has not entered into or
            effected any securitization transactions or any &#8220;off-balance sheet arrangements&#8221; of the type required to be disclosed pursuant to Item 303 of Regulation S-K under the Exchange Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS38"><!--Anchor--></a>3.8&#8195;Absence of Changes. Except as
            set forth on Section 3.8 of the Caladrius Disclosure Schedule, between December&#160;31, 2021, and the date of this Agreement, Caladrius has conducted its business only in the Ordinary Course of Business (except for the execution and performance of
            this Agreement and the discussions, negotiations and transactions related thereto) and there has not been any (a) Caladrius Material Adverse Effect or (b) action, event or occurrence that would have required consent of the Company pursuant to <span style="text-decoration: underline;">Section




              4.1(b)</span> of this Agreement had such action, event or occurrence taken place after the execution and delivery of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS39"><!--Anchor--></a>3.9&#8195;Absence of Undisclosed
            Liabilities. As of the date hereof, Caladrius does not have any Liability, individually or in the aggregate, except for: (a) Liabilities identified as such in the &#8220;liabilities&#8221; column of the Caladrius Audited Balance Sheet; (b) normal and
            recurring current Liabilities that have been incurred by </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-25<br />
        </div>

      </div>

    </div>

    <!--End Page 414-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 415-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg30"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">Caladrius since the date of the Caladrius Audited Balance Sheet in the Ordinary
            Course of Business and which are not in excess of $100,000, in the aggregate; (c) Liabilities for performance of obligations of Caladrius under Caladrius Contracts; and (d) Liabilities incurred in connection with the Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS310"><!--Anchor--></a>3.10&#8195;Title to Assets. Caladrius
            owns, and has good and valid title to, or, in the case of leased properties and assets, valid leasehold interests in, all tangible properties or assets and equipment used or held for use in its business or operations or purported to be owned by
            it, including: (a) all assets reflected on the Caladrius Audited Balance Sheet; and (b) all other assets reflected in the books and records of Caladrius as being owned by Caladrius. All of such assets are owned or, in the case of leased assets,
            leased by Caladrius free and clear of any Encumbrances, other than Permitted Encumbrances.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS311"><!--Anchor--></a>3.11&#8195;Real Property; Leasehold.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Caladrius does not own and has never owned any real property.
            Caladrius has made available to the Company (a) an accurate and complete list of all real properties with respect to which Caladrius directly or indirectly holds a valid leasehold interest as well as any other real estate that is in the
            possession of or leased by Caladrius (the &#8220;Caladrius Leased Real Property&#8221;), and (b) copies of all leases under which any such real property is possessed (the &#8220;Caladrius Real Estate Leases&#8221;), each of which is in full force and effect, with no
            existing material default thereunder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Caladrius has not received any written notice from any
            Governmental Body of a violation of any governmental requirements (including Environmental Laws) with respect to any of the Caladrius Leased Real Property and, to Caladrius&#8217; Knowledge, the Caladrius Leased Real Property is not in violation of
            any material governmental requirements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS312"><!--Anchor--></a>3.12&#8195;Intellectual Property.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;To the Knowledge of Caladrius, Caladrius owns, or has the right
            to use, as currently being used by Caladrius, all Caladrius IP Rights, and with respect to Caladrius IP Rights that are owned by Caladrius, has the right to bring actions for the infringement of such Caladrius IP Rights, in each case except for
            any failure to own or have the right to use or bring actions that would not reasonably be expected to have a Caladrius Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Section 3.12(b) of the Caladrius Disclosure Schedule is an
            accurate, true and complete listing of all Caladrius Registered IP.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Section 3.12(c) of the Caladrius Disclosure Schedule accurately
            identifies (i)&#160;all Caladrius Contracts pursuant to which Caladrius IP Rights are licensed to Caladrius (other than (A) any non-customized software that (1) is so licensed solely in executable or object code form pursuant to a non-exclusive,
            internal use software license and other Intellectual Property associated with such software and (2) is not incorporated into, or material to the development, manufacturing, or distribution of, any of Caladrius products or services, (B) any
            Intellectual Property licensed ancillary to the purchase or use of equipment, reagents or other materials and (C) any confidential information provided under confidentiality agreements), and (ii)&#160;whether the license or licenses granted to
            Caladrius are exclusive or non-exclusive.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Section 3.12(d) of the Caladrius Disclosure Schedule accurately
            identifies each Caladrius Contract pursuant to which any Person has been granted any license under, or otherwise has received or acquired any right (whether or not currently exercisable) or interest in, any Caladrius IP Rights (other than
            (i)&#160;any confidential information provided under confidentiality agreements; (ii)&#160;any non-disclosure or other template agreements entered into in the Ordinary Course of Business; and (iii)&#160;any Caladrius IP Rights non-exclusively licensed to
            suppliers or service providers for the sole purpose of enabling such supplier or service providers to provide services for Caladrius&#8217; benefit). Caladrius is not bound by, and no Caladrius IP Rights are subject to, any Contract containing any
            covenant or other provision that in any way limits or restricts the ability of Caladrius to use, exploit, assert or enforce any Caladrius IP Rights anywhere in the world, in each case as would materially limit the business of Caladrius as
            currently conducted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Caladrius exclusively owns all right, title, and interest to and
            in Caladrius IP Rights (other than (i)&#160;Caladrius IP Rights exclusively and non-exclusively licensed Caladrius, as identified in Section 3.12(c) of the Caladrius Disclosure Schedule), (ii)&#160;any non-customized software that (A) is licensed to
            Caladrius solely in executable or object code form pursuant to a non-exclusive, internal use software license and other </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-26<br />
        </div>

      </div>

    </div>

    <!--End Page 415-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 416-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg31"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">Intellectual Property associated with such software and (B) is not incorporated
            into, or material to the development, manufacturing, or distribution of, any of Caladrius&#8217; products or services and (iii)&#160;any Intellectual Property licensed ancillary to the purchase or use of equipment, reagents or other materials), in each
            case, free and clear of any Encumbrances (other than Permitted Encumbrances). Without limiting the generality of the foregoing:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;All documents and instruments necessary to register or apply for
            or renew registration of all Caladrius Registered IP has been validly executed, delivered and filed in a timely manner with the appropriate Governmental Body except for any such failure, individually or collectively, that would not reasonably
            be expected to have a Caladrius Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;Each Person who is or was an employee or contractor of
            Caladrius and who is or was involved in the creation or development of any Caladrius IP Rights purported to be owned by Caladrius has signed a valid, enforceable written agreement containing an assignment of such Intellectual Property to
            Caladrius and confidentiality provisions protecting trade secrets and confidential information of Caladrius; provided, that any such agreement with a third party contractor for research, development or manufacturing services on behalf of
            Caladrius may provide that such third party contractor reserves its rights in improvements to such third party contractor&#8217;s Intellectual Property or generally applicable research, development or manufacturing technology, in either case that is
            not specific to any product or service of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iii)&#8195;To the Knowledge of Caladrius, no current or former
            stockholder, officer, director, employee or contractor of Caladrius has any claim, right (whether or not currently exercisable), or interest to or in any Caladrius IP Rights purported to be owned by Caladrius. To the Knowledge of Caladrius, no
            employee or contractor of Caladrius is (a) bound by or otherwise subject to any Contract restricting him or her from performing his or her duties for Caladrius or (b) in breach of any Contract with any current or former employer or other Person
            concerning Caladrius IP Rights purported to be owned by Caladrius or confidentiality provisions protecting trade secrets and confidential information comprising Caladrius IP Rights purported to be owned by Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iv)&#8195;No funding, facilities or personnel of any Governmental Body
            were used, directly or indirectly, to develop or create, in whole or in part, any Caladrius IP Rights in which Caladrius has an ownership interest.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(v)&#8195;Caladrius has taken reasonable steps to maintain the
            confidentiality of and otherwise protect and enforce its rights in all proprietary information that Caladrius holds, or purports to hold, as a trade secret.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vi)&#8195;Caladrius has not assigned or otherwise transferred ownership
            of, or agreed to assign or otherwise transfer ownership of, any Caladrius Registered IP to any other Person.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vii)&#8195;To the Knowledge of Caladrius, the Caladrius IP Rights
            constitute all Intellectual Property necessary for Caladrius to conduct its business as currently conducted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Caladrius has delivered, or made available to the Company, a
            complete and accurate copy of all material Caladrius IP Rights Agreements. Caladrius is not a party to any Contract that, as a result of such execution, delivery and performance of this Agreement, will cause the grant of any license or other
            right to any Caladrius IP Rights or impair the right of Caladrius or the Surviving Corporation and its Subsidiaries to use, sell or license or enforce any Caladrius IP Rights or portion thereof, except for the occurrence of any such grant or
            impairment that would not individually or in the aggregate, reasonably be expected to result in a Caladrius Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;With respect to each of the Caladrius IP Rights Agreements:
            (i)&#160;each such agreement is valid and binding on Caladrius and in full force and effect; (ii)&#160;Caladrius has not received any notice of termination or cancellation under such agreement, or received any written notice of breach or default under
            such agreement, which breach has not been cured or waived; and (iii)&#160;neither Caladrius, and to the Knowledge of Caladrius, nor any other party to any such agreement, is in breach or default thereof in any material respect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;The manufacture, marketing, license, sale or intended use of any
            product or technology currently licensed or sold or under development by Caladrius, (i)&#160;to the Knowledge of Caladrius, does not infringe or </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-27<br />
        </div>

      </div>

    </div>

    <!--End Page 416-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 417-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg32"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">misappropriate any valid Intellectual Property right of any other party, which
            infringement or misappropriation would reasonably be expected to have a Caladrius Material Adverse Effect and (ii)&#160;does not violate or constitute a breach of any license or agreement between Caladrius and any third party. To the Knowledge of
            Caladrius, no third party is infringing upon any Caladrius IP Rights, or violating any license or agreement with Caladrius relating to any Caladrius IP Rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;To the Knowledge of Caladrius, there is no current or pending
            Legal Proceeding (including, but not limited to, opposition, interference or other proceeding in any patent or other government office) contesting the validity, ownership or right to use, sell, license or dispose of any Caladrius IP Rights.
            Caladrius has not received any written notice asserting that any Caladrius IP Rights or the proposed use, sale, license or disposition thereof conflicts with or infringes or misappropriates or will conflict with or infringe or misappropriate
            the rights of any other party.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(j)&#8195;Each item of Caladrius IP Rights that is Caladrius Registered IP
            is and at all times has been filed and maintained in compliance with all applicable Law and all filings, payments and other actions required to be made or taken to maintain such item of Caladrius Registered IP in full force and effect have been
            made by the applicable deadline, except for any failure to perform any of the foregoing, individually or collectively, that would not reasonably be expected to have a Caladrius Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(k)&#8195;To the Knowledge of Caladrius, no trademark (whether registered
            or unregistered) or trade name owned, used, or applied for by Caladrius conflicts or interferes with any trademark (whether registered or unregistered) or trade name owned, used, or applied for by any other Person. None of the goodwill
            associated with or inherent in any trademark (whether registered or unregistered) in which Caladrius has or purports to have an ownership interest has been impaired as determined by Caladrius in accordance with GAAP.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(I)&#8195;Except as may be set forth in the Contracts listed on Section
            3.12(c) or 3.12(d) of the Caladrius Disclosure Schedule (i)&#160;Caladrius is not bound by any Contract to indemnify, defend, hold harmless, or reimburse any other Person with respect to any Intellectual Property infringement, misappropriation, or
            similar claim, and (ii)&#160;Caladrius has never assumed, or agreed to discharge or otherwise take responsibility for, any existing or potential liability of another Person for infringement, misappropriation, or violation of any Intellectual
            Property right, which assumption, agreement or responsibility remains in force as of the date of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS313"><!--Anchor--></a>3.13&#8195;Agreements, Contracts and
            Commitments.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Caladrius&#8217; material contracts (the &#8220;Caladrius Material
            Contracts&#8221;) are the material contracts as defined in Item 601(b)(10) of Regulation S-K as promulgated under the Securities Act and as filed with the exhibit list to Caladrius&#8217; Annual Report on Form 10-K for the year ended December&#160;31, 2021.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Caladrius has delivered or made available to the Company
            accurate and complete copies of all Caladrius Material Contracts, including all amendments thereto. Caladrius has not nor, to Caladrius&#8217; Knowledge as of the date of this Agreement, has any other party to a Caladrius Material Contract, breached,
            violated or defaulted under, or received notice that it breached, violated or defaulted under, any of the terms or conditions of any Caladrius Material Contract in such manner as would permit any other party to cancel or terminate any such
            Caladrius Material Contract, or would permit any other party to seek damages which would reasonably be expected to have a Caladrius Material Adverse Effect. As to Caladrius, as of the date of this Agreement, each Caladrius Material Contract is
            valid, binding, enforceable and in full force and effect, subject to the Enforceability Exceptions. No Person is renegotiating, or has a right pursuant to the terms of any Caladrius Material Contract to change, any material amount paid or
            payable to Caladrius under any Caladrius Material Contract or any other material term or provision of any Caladrius Material Contract.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS314"><!--Anchor--></a>3.14&#8195;Compliance; Permits;
            Restrictions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Caladrius is, and since January&#160;1, 2019, has been, in compliance
            in all material respects with all applicable Laws. No investigation, claim, suit, proceeding, audit or other action by any Governmental Body is pending or, to the Knowledge of Caladrius, threatened against Caladrius. There is no agreement,
            judgment, injunction, order or decree binding upon Caladrius which (i)&#160;has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of Caladrius, any acquisition of material property by
            Caladrius or the conduct of business by Caladrius as currently conducted, (ii)&#160;is </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-28<br />
        </div>

      </div>

    </div>

    <!--End Page 417-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 418-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg33"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">reasonably likely to have an adverse effect on Caladrius&#8217; ability to comply with or
            perform any covenant or obligation under this Agreement, or (iii)&#160;is reasonably likely to have the effect of preventing, delaying, making illegal or otherwise interfering with the Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Each of Caladrius and Merger Sub holds all required Governmental
            Authorizations that are material to the operation of the business of Caladrius and Merger Sub as currently conducted (collectively, the &#8220;Caladrius Permits&#8221;). Section 3.14(b) of the Caladrius Disclosure Schedule identifies each Caladrius Permit.
            Each of Caladrius and Merger Sub is in material compliance with the terms of the Caladrius Permits. No Legal Proceeding is pending or, to the Knowledge of Caladrius, threatened, which seeks to revoke, limit, suspend, or materially modify any
            Caladrius Permit. The rights and benefits of each Caladrius Permit will be available to Caladrius and Surviving Corporation immediately after the Effective Time on terms substantially identical to those enjoyed by Caladrius and Merger Sub as of
            the date of this Agreement and immediately prior to the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;There are no proceedings pending or, to the Knowledge of
            Caladrius, threatened with respect to an alleged material violation by Caladrius of the FDCA, FDA regulations adopted thereunder, the Controlled Substance Act or any other similar Law promulgated by a Drug Regulatory Agency.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Each of Caladrius and Merger Sub holds all required Governmental
            Authorizations issuable by any Drug Regulatory Agency necessary for the conduct of the business of Caladrius and Merger Sub as currently conducted, and, as applicable, the development, clinical testing, manufacturing, marketing, distribution
            and importation or exportation, as currently conducted, of any of its products or product candidates (the &#8220;Caladrius Product Candidates&#8221;) (the &#8220;Caladrius Regulatory Permits&#8221;) and no such Caladrius Regulatory Permit has been (i)&#160;revoked,
            withdrawn, suspended, cancelled or terminated or (ii)&#160;modified in any adverse manner other than immaterial adverse modifications. Caladrius is in compliance in all material respects with the Caladrius Regulatory Permits and neither Caladrius
            nor Merger Sub has received any written notice or other written communication from any Drug Regulatory Agency regarding (A) any material violation of or failure to comply materially with any term or requirement of any Caladrius Regulatory
            Permit or (B) any revocation, withdrawal, suspension, cancellation, termination or material modification of any Caladrius Regulatory Permit. Caladrius has made available to the Company all information requested by the Company in Caladrius&#8217;
            possession or control relating to the Caladrius Product Candidates and the development, clinical testing, manufacturing, importation and exportation of the Caladrius Product Candidates, including complete copies of the following (to&#160;the extent
            there are any): (x)&#160;adverse event reports; clinical study reports and material study data; inspection reports, notices of adverse findings, warning letters, filings and letters and other written correspondence to and from any Drug Regulatory
            Agency; and meeting minutes with any Drug Regulatory Agency; and (y) similar reports, material study data, notices, letters, filings, correspondence and meeting minutes with any other Governmental Body.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;All clinical, pre-clinical and other studies and tests conducted
            by or, to the Knowledge of Caladrius, on behalf of, or sponsored by, Caladrius or in which Caladrius or its respective products or product candidates, including the Caladrius Product Candidates, have participated were and, if still pending, are
            being conducted in all material respects in accordance with standard medical and scientific research procedures and ethics and in compliance in all material respects with the applicable regulations of the Drug Regulatory Agencies and other
            applicable Law, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58 and 312. Since January&#160;1, 2019, neither Caladrius nor Merger Sub has received any notices, correspondence, or other communications from any Drug Regulatory Agency
            requiring or, to the Knowledge of Caladrius, threatening to initiate, the termination or suspension of any clinical trials conducted by or on behalf of, or sponsored by, Caladrius or in which Caladrius or its current products or product
            candidates, including the Caladrius Product Candidates, have participated.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Caladrius is not the subject of any pending or, to the Knowledge
            of Caladrius, threatened investigation in respect of its business or products by the FDA pursuant to its &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#8221; Final Policy set forth in 56 Fed. Reg. 46191 (September&#160;10,
            1991) and any amendments thereto, or any other Drug Regulatory Agency pursuant to any similar Laws or regulations promulgated or enforced thereby. To the Knowledge of Caladrius, Caladrius has not committed any acts, made any statement, or
            failed to make any statement, in each case in respect of its business or products that would violate FDA&#8217;s &#8220;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-29<br />
        </div>

      </div>

    </div>

    <!--End Page 418-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 419-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg34"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">Gratuities&#8221; Final Policy, and any amendments thereto, or any other Drug Regulatory
            Agency pursuant to any similar Laws or regulations promulgated or enforced thereby. None of Caladrius, Merger Sub, or any of their respective officers, employees or agents has been convicted of any crime or engaged in any conduct that could
            result in a debarment or exclusion (i)&#160;under 21 U.S.C. Section 335a or (ii)&#160;any similar applicable Law. To the Knowledge of Caladrius, no debarment or exclusionary claims, actions, proceedings or investigations in respect of their business or
            products are pending or threatened against Caladrius or any of its officers, employees or agents.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS315"><!--Anchor--></a>3.15&#8195;Legal Proceedings;
            Orders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Except as set forth in Section 3.15 of the Caladrius Disclosure
            Schedule, there is no pending Legal Proceeding and, to the Knowledge of Caladrius, no Person has threatened in writing to commence any Legal Proceeding: (i)&#160;that involves Caladrius or any Caladrius Associate (in his or her capacity as such) or
            any of the material assets owned or used by Caladrius; or (ii)&#160;that challenges, or that may have the effect of preventing, delaying, making illegal or otherwise interfering with, the Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;There is no order, writ, injunction, judgment or decree to which
            Caladrius, or any of the material assets owned or used by Caladrius is subject. To the Knowledge of Caladrius, no officer or other Key Employee of Caladrius is subject to any order, writ, injunction, judgment or decree that prohibits such
            officer or employee from engaging in or continuing any conduct, activity or practice relating to the business of Caladrius or to any material assets owned or used by Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS316"><!--Anchor--></a>3.16&#8195;Tax Matters.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Each of Caladrius and Merger Sub has timely filed all federal,
            state and local Tax Returns and other material Tax Returns that they were required to file under applicable Law. All such Tax Returns, following any subsequent amendments, were correct and complete in all material respects and have been
            prepared in material compliance with all applicable Law. Subject to exceptions as would not be material, no written claim has ever been made by an authority in a jurisdiction where Caladrius does not file Tax Returns that it is subject to
            taxation by that jurisdiction.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;To the Knowledge of Caladrius, all material Taxes due and owing
            by Caladrius on or before the date hereof (whether or not shown on any Tax Return) have been paid. Since the date of the Caladrius Audited Balance Sheet, Caladrius has not incurred any material Liability for Taxes outside the Ordinary Course of
            Business or otherwise inconsistent with past custom and practice.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Each of Caladrius and Merger Sub has withheld and paid all
            material Taxes required to have been withheld and paid in connection with any amounts paid or owing to any employee, independent contractor, creditor, stockholder, or other third party.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;There are no Encumbrances for material Taxes (other than Taxes
            not yet due and payable) upon any of the assets of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;No deficiencies for material Taxes with respect to Caladrius
            have been claimed, proposed or assessed by any Governmental Body in writing. There are no pending (or, based on written notice, threatened) material audits, assessments or other actions for or relating to any Tax Return or any liability in
            respect of Taxes of Caladrius. Caladrius has not (nor has Merger Sub or any of their respective predecessors) waived any statute of limitations in respect of material Taxes or agreed to any extension of time with respect to a material Tax
            assessment or deficiency. Caladrius has not received in writing from any Tax authority any notice of proposed adjustment relating to any Tax Return filed by Caladrius. Caladrius is not a party to or bound by any closing or other agreement or
            ruling with any Governmental Entity with respect to Taxes.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Caladrius has never been a United States real property holding
            corporation within the meaning of Section 897(c)(2) of the Code during the applicable period specified in Section 897(c)(1)(A)(ii)&#160;of the Code, </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;Caladrius is a not party to any material Tax allocation, Tax
            sharing or similar agreement (including indemnity arrangements), other than commercial contracts entered into in the Ordinary Course of Business with vendors, customers and landlords.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-30<br />
        </div>

      </div>

    </div>

    <!--End Page 419-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 420-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg35"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;Caladrius has never been a member of an affiliated group
            filing a consolidated U.S. federal income Tax Return (other than a group the common parent of which is Caladrius). Caladrius does not have any material Liability for the Taxes of any Person (other than Caladrius and Merger Sub) under Treasury
            Regulations Section&#160;1.1502-6 (or any similar provision of state, local, or foreign law) or as a transferee or successor.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;Caladrius will not be required to include any income or gain or
            exclude any deduction or loss from taxable income for any Tax period or portion thereof ending after the Closing as a result of (A) any adjustment under Section 481 of the Code (or any corresponding provision of state, local or non-U.S. Tax
            Law) by reason of a change in a method of accounting, or use of an improper method of accounting, or otherwise, for a taxable period that ends on or prior to the Closing Date; (B) any &#8220;closing agreement&#8221; within the meaning of Section&#160;7121 of
            the Code(or any similar provision of applicable state, local or non-U.S. Law) entered into prior to the Closing; (C) any intercompany transaction or excess loss account described in the Treasury Regulations promulgated pursuant to Section 1502
            of the Code (or any corresponding or similar provision of state, local or non-U.S. Law) with respect to a transaction occurring prior to the Closing; (D) any installment sale or open transaction disposition made prior to the Closing; or (E) any
            deferred revenue or prepaid amount received on or prior to the Closing Date. Caladrius has not made an election under Section 965(h) or Section 108(i)&#160;of the Code (or any corresponding or similar provision of state, local or non-U.S. Law).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(j)&#8195;Caladrius has not (A) deferred, extended or delayed the payment
            of the employer&#8217;s share of any &#8220;applicable employment taxes&#8221; under Section 2302 of the CARES Act, (B) failed to properly comply with and duly account for all credits received under Sections 7001 through 7005 of the Families First Coronavirus
            Response Act (Public Law 116-127) and Section 2301 of the CARES Act, (C) deferred any payroll tax obligations (including those imposed by Section 3101(a) and 3201 of the Code) (for example, by failure to timely withhold, deposit or remit such
            amounts in accordance with the applicable provisions of the Code and the Treasury Regulations promulgated thereunder) pursuant to or in connection with the Payroll Tax Executive Order, or (D) sought, or intends to seek, a covered loan under
            Section 7(a)(36) of the Small Business Act (15&#160;U.S.C. 636(a)), as added by Section 1102 of the CARES Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(k)&#8195;Caladrius has not, nor has ever had, a permanent establishment
            (as defined in any applicable Tax treaty or convention), an office or fixed place of business, or otherwise is or has been subject to Tax, in any country other than the country in which it is organized.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(l)&#8195;Caladrius is currently in compliance with the requirements for
            all Tax holidays and similar Tax benefits and have been in compliance since such holiday or benefit was originally claimed. To the Knowledge of Caladrius, no such Tax holiday or similar Tax benefit will terminate by reason of the transactions
            contemplated by this Agreement, or will be subject to recapture or clawback.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(m)&#8195;Caladrius has not distributed stock of another Person, or had
            its stock distributed by another Person, in a transaction that was purported or intended to be governed in whole or in part by Section 355 of the Code or Section 361 of the Code in the last two years.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(n)&#8195;Caladrius has not entered into any transaction identified as a
            &#8220;reportable transaction&#8221; for purposes of Treasury Regulations Section 1.6011-4(b).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS317"><!--Anchor--></a>3.17&#8195;Employee and Labor
            Matters; Benefit Plans.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;The employment of each of Caladrius&#8217; and any of its
            Subsidiaries&#8217;employees is terminable by Caladrius or the applicable Subsidiary at will (or otherwise in accordance with general principles of wrongful termination law). Caladrius has made available to the Company accurate and complete copies of
            all employee manuals and handbooks, disclosure materials, policy statements and other materials relating to the employment of Caladrius Associates to the extent currently effective and material.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Neither Caladrius nor any of its Subsidiaries is a party to,
            bound by, or has a duty to bargain under, any collective bargaining agreement or other Contract with a labor organization representing any of its employees, and there are no labor organizations representing or, to the Knowledge of Caladrius,
            purporting to represent or seeking to represent any employees of Caladrius or its Subsidiaries.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-31<br />
        </div>

      </div>

    </div>

    <!--End Page 420-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 421-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg36"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Section 3.17(c) of the Caladrius Disclosure Schedule lists
            all written and describes all non-written employee benefit plans (as defined in Section 3(3) of ERISA) and all bonus, equity-based, incentive, deferred compensation, retirement or supplemental retirement, profit sharing, severance, golden
            parachute, vacation, cafeteria, dependent care, medical care, employee assistance program, education or tuition assistance programs and other similar material fringe or employee benefit plans, programs or arrangements, including any employment
            or executive compensation or severance agreements, written or otherwise, which are currently in effect relating to any present or former employee or director of Caladrius or any of its Subsidiaries (or any trade or business (whether or not
            incorporated) which is a Caladrius Affiliate) or which is maintained by, administered or contributed to by, or required to be contributed to by, Caladrius, any of its Subsidiaries or any Caladrius Affiliate, or under which Caladrius or any of
            its Subsidiaries or any Caladrius Affiliate has any current liability or may incur liability after the date hereof (each, a &#8220;Caladrius Employee Plan&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;With respect to each Caladrius Employee Plan, Caladrius has made
            available to the Company a true and complete copy of, to the extent applicable, (i)&#160;such Caladrius Employee Plan, (ii)&#160;the three most recent annual report (Form 5500) as filed with the IRS, (iii)&#160;each currently effective trust agreement related
            to such Caladrius Employee Plan, (iv)&#160;the most recent summary plan description for each Caladrius Employee Plan for which such description is required, along with all summaries of material modifications, amendments, resolutions and all other
            material plan documentation related thereto in the possession of Caladrius, (v)&#160;the most recent IRS determination or opinion letter or analogous ruling under foreign law issued with respect to any Caladrius Employee Plan, and (vi)&#160;any filings
            under any amnesty, voluntary compliance, self-correction, or similar program sponsored by any Governmental Body.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Each Caladrius Employee Plan that is intended to be qualified
            under Section 401(a) of the Code has received a favorable determination or opinion letter with respect to such qualified status from the IRS. To the Knowledge of Caladrius, nothing has occurred that would reasonably be expected to adversely
            affect the qualified status of any such Caladrius Employee Plan or the exempt status of any related trust.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Each Caladrius Employee Plan has been maintained in compliance,
            in all material respects, with its terms and, both as to form and operation, with all applicable Law, including the Code and ERISA. No action or claims (other than routine claims for benefits made in the ordinary course of Caladrius Employee
            Plan administration) are pending, or to the Knowledge of Caladrius, threatened, or imminent against or with respect to the Caladrius Employee Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;Neither Caladrius nor any of its Subsidiaries has engaged in any
            transaction in violation of Sections&#160;404 or 406 of ERISA or any &#8220;prohibited transaction,&#8221; as defined in Section 4975(c)(1) of the Code, for which no exemption exists under Section 408 of ERISA or Section 4975(c)(2) or (d) of the Code, or has
            otherwise violated the provisions of Part 4 of Title I, Subtitle B of ERISA. Neither Caladrius nor any of its Subsidiaries has knowingly participated in a violation of Part 4 of Title I, Subtitle B of ERISA by any plan fiduciary of any
            Caladrius Employee Plan subject to ERISA and neither Caladrius nor any of its Subsidiaries has been assessed any civil penalty under Section 502(I) of ERISA.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;No Caladrius Employee Plan is subject to Title IV or Section 302
            of ERISA or Section 412 of the Code, and neither Caladrius nor any of its ERISA Affiliates has ever maintained, contributed to or partially or completely withdrawn from, or incurred any obligation or liability with respect to, any such plan. No
            Caladrius Employee Plan is a Multiemployer Plan, and neither Caladrius nor any of its ERISA Affiliates has ever contributed to or had an obligation to contribute, or incurred any liability in respect of a contribution, to any Multiemployer
            Plan. No Caladrius Employee Plan is a Multiple Employer Plan. No Caladrius Employee Plan is a Multiple Employer Welfare Arrangement. Neither Caladrius nor any of its ERISA Affiliates sponsors or maintains any self-funded welfare employee
            benefit plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;Except as set forth in Section 3.17(i)&#160;of the Caladrius
            Disclosure Schedule, no Caladrius Employee Plan provides for medical or death benefits beyond termination of service or retirement, other than (i)&#160;pursuant to COBRA or an analogous state law requirement or (ii)&#160;death or retirement benefits
            under a Caladrius Employee Plan qualified under Section 401(a) of the Code. No Caladrius Employee Plan is subject to any Law of a foreign jurisdiction outside of the United States.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(j)&#8195;With respect to Caladrius Awards granted pursuant to the
            Caladrius Stock Plans, (i)&#160;each Caladrius Option intended to qualify as an &#8220;incentive stock option&#8221; under Section 422 of the Code so qualified at the </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-32<br />
        </div>

      </div>

    </div>

    <!--End Page 421-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 422-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg37"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">time of its grant, (ii)&#160;each grant of a Caladrius Award was duly authorized no later
            than the Grant Date by all necessary corporate action, including, as applicable, approval by the Caladrius Board (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or
            written consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, (iii)&#160;each Caladrius Award grant was made in accordance with the terms of the Caladrius Stock Plans and all other
            applicable Law and regulatory rules or requirements and (iv)&#160;the per share exercise price of each Caladrius Option was not less than the fair market value of a share of Caladrius Common Stock on the applicable Grant Date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(k)&#8195;To the Knowledge of Caladrius, no Caladrius Awards or other
            equity-based awards issued or granted by Caladrius are subject to the requirements of Code Section 409A. To the Knowledge of Caladrius, each 409A Plan under which Caladrius makes, is obligated to make or promises to make, payments complies in
            all material respects, in both form and operation, with the requirements of Code Section 409A and the guidance thereunder. No payment currently to be made under any 409A Plan is or, to the Knowledge of Caladrius, will be subject to the
            penaltiesof Code Section 409A(a)(1).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(l)&#8195;Caladrius and each of its Subsidiaries is in material compliance
            with all of its bonus, commission and other compensation plans and has paid any and all amounts required to be paid under such plans, including any and all bonuses and commissions (or pro rata portion thereof) that may have accrued or been
            earned through the calendar quarter preceding the Effective Time, and is not liable for any material payments, taxes or penalties for failure to comply with any of the terms or conditions of such plans or the laws governing such plans.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(m)&#8195;Caladrius and each of its Subsidiaries is in material compliance
            with all applicable foreign, federal, state and local laws, rules and regulations respecting employment, employment practices, terms and conditions of employment, worker classification, tax withholding, prohibited discrimination, equal
            employment, fair employment practices, meal and rest periods, immigration status, employee safety and health, wages (including overtime wages),compensation, and hours of work, and in each case, with respect to the employees of Caladrius and its
            Subsidiaries: (i)&#160;has withheld and reported all material amounts required by law or by agreement to be withheld and reported with respect to wages, salaries and other payments to employees, (ii)&#160;is not liable for any arrears of wages, severance
            pay or any Taxes or any penalty for failure to comply with any of the foregoing, and (iii)&#160;is not liable for any material payment to any trust or other fund governed by or maintained by or on behalf of any governmental authority, with respect
            to unemployment compensation benefits, social security or other benefits or obligations for employees (other than routine payments to be made in the Ordinary Course of Business). To the Knowledge of Caladrius, there are no pending or threatened
            or reasonably anticipated claims or actions against Caladrius, any of its Subsidiaries, any Caladrius trustee or any trustee of any Subsidiary under any workers&#8217; compensation policy or long-term disability policy. Neither Caladrius nor any
            Subsidiary thereof is a party to a conciliation agreement, consent decree or other agreement or order with any federal, state, or local agency or governmental authority with respect to employment practices.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(n)&#8195;Section 3.17(n) of the Caladrius Disclosure Schedule lists all
            contractual liabilities of Caladrius or any of its Subsidiaries to any employee that result from the termination by Caladrius or any of its Subsidiaries of such employee&#8217;s employment or provision of services, a change of control of Caladrius,
            or a combination thereof. Neither Caladrius nor any of its Subsidiaries has any material liability with respect to any misclassification of: (a) any Person as an independent contractor rather than as an employee, (b) any employee leased from
            another employer, or (c) any employee currently or formerly classified as exempt from overtime wages. Neither Caladrius nor any of its Subsidiaries has taken any action which would constitute a &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; within the
            meaning of the WARN Act or similar state or local law, issued any notification of a plant closing or mass layoff required by the WARN Act or similar state or local law, or incurred any liability or obligation under WARN or any similar state or
            local law that remains unsatisfied. No terminations of employees of Caladrius or any of its Subsidiaries prior to the Closing would trigger any notice or other obligations under the WARN Act or similar state or local law.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(o)&#8195;There has never been, nor has there been any threat of, any
            strike, slowdown, work stoppage, lockout, job action, union, organizing activity, question concerning representation or any similar activity or dispute, affecting Caladrius or any of its Subsidiaries. No event has occurred, and no condition or
          </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-33<br />
        </div>

      </div>

    </div>

    <!--End Page 422-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 423-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg38"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">circumstance exists, that might directly or indirectly be likely to give rise to or
            provide a basis for the commencement of any such strike, slowdown, work stoppage, lockout, job action, union organizing activity, question concerning representation or any similar activity or dispute.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(p)&#8195;Neither Caladrius nor any of its Subsidiaries is, nor has
            Caladrius or any of its Subsidiaries been, engaged in any unfair labor practice within the meaning of the National Labor Relations Act. There is no Legal Proceeding, claim, labor dispute or grievance pending or, to the Knowledge of Caladrius,
            threatened or reasonably anticipated relating to any employment contract, privacy right, labor dispute, wages and hours, leave of absence, plant closing notification, workers&#8217; compensation policy, long-term disability policy, harassment,
            retaliation, immigration, employment statute or regulation, safety or discrimination matter involving any Caladrius Associate, including charges of unfair labor practices or discrimination complaints. There are no actions, suits, claims or
            administrative matters pending or, to the Knowledge of Caladrius, threatened or reasonably anticipated against Caladrius or any of its Subsidiaries relating to any employee, employment agreement or Caladrius Employee Plan (other than routine
            claims for benefits).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(q)&#8195;There is no contract, agreement, plan or arrangement to which
            Caladrius or any Caladrius Affiliate is a party or by which it is bound to compensate any of its employees for excise taxes paid pursuant to Section&#160;4999 of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(r)&#8195;Caladrius is not a party to any Contract that has resulted or
            would reasonably be expected to result, separately or in the aggregate, in the payment of (i)&#160;any &#8220;excess parachute payment&#8221; within the meaning of Section 280G of the Code or (ii)&#160;any amount the deduction for which would be disallowed under
            Section 162(m) of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS318"><!--Anchor--></a>3.18&#8195;Environmental Matters.
            Since January&#160;1, 2019, Caladrius has complied with all applicable Environmental Laws, which compliance includes the possession by Caladrius of all permits and other Governmental Authorizations required under applicable Environmental Laws and
            compliance with the terms and conditions thereof, except for any failure to be in compliance that, individually or in the aggregate, would not result in a Caladrius Material Adverse Effect. Caladrius has not received since January&#160;1, 2019, any
            written notice or other communication (in writing or otherwise), whether from a Governmental Body, citizens group, employee or otherwise, that alleges that Caladrius is not in compliance with any Environmental Law, and, to theKnowledge of
            Caladrius, there are no circumstances that may prevent or interfere with Caladrius&#8217;compliance with any Environmental Law in the future, except where such failure to comply would not reasonably be expected to have a Caladrius Material Adverse
            Effect. To the Knowledge of Caladrius: (i)&#160;no current or prior owner of any property leased or controlled by Caladrius has received since January&#160;1, 2019, any written notice or other communication relating to property owned or leased at any
            time by Caladrius, whether from a Governmental Body, citizens group, employee or otherwise, that alleges that such current or prior owner or Caladrius is not in compliance with or violated any Environmental Law relating to such property and
            (ii)&#160;Caladrius has no material liability under any Environmental Law.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS319"><!--Anchor--></a>3.19&#8195;Insurance. Caladrius has
            made available to the Company accurate and complete copies of all material insurance policies and all material self-insurance programs and arrangements relating to the business, assets, liabilities and operations of Caladrius and Merger Sub.
            Each of such insurance policies is in full force and effect and Caladrius and Merger Sub are in compliance in all material respects with the terms thereof. Other than customary end of policy notifications from insurance carriers, since
            January&#160;1, 2019, Caladrius has not received any notice or other communication regarding any actual or possible: (i)&#160;cancellation or invalidation of any insurance policy; or (ii)&#160;refusal or denial of any coverage, reservation of rights or
            rejection of any material claim under any insurance policy. Each of Caladrius and Merger Sub has provided timely written notice to the appropriate insurance carrier(s) of each Legal Proceeding pending against Caladrius for which Caladrius has
            insurance coverage, and no such carrier has issued a denial of coverage or a reservation of rights with respect to any such Legal Proceeding, or informed Caladrius of itsintent to do so.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS320"><!--Anchor--></a>3.20&#8195;Transactions with
            Affiliates. Except as set forth in the Caladrius SEC Documents filed prior to the date of this Agreement, since the date of Caladrius&#8217; last proxy statement filed in 2021 with the SEC, no event has occurred that would be required to be reported
            by Caladrius pursuant to Item 404 of Regulation S-K promulgated by the SEC. Section 3.20 of the Caladrius Disclosure Schedule identifies each Person who is (or who may be deemed to be) an Affiliate of Caladrius as of the date of this Agreement.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-34<br />
        </div>

      </div>

    </div>

    <!--End Page 423-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 424-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg39"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS321"><!--Anchor--></a>3.21&#8195;No Financial Advisors.
            Except as set forth on Section 3.21 of the Caladrius Disclosure Schedule, no broker, finder or investment banker is entitled to any brokerage fee,finder&#8217;s fee, opinion fee, success fee, transaction fee or other fee or commission in connection
            with the Contemplated Transactions based upon arrangements made by or on behalf of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS322"><!--Anchor--></a>3.22&#8195;Valid Issuance. The
            Caladrius Common Stock to be issued in the Merger will, when issued in accordance with the provisions of this Agreement, be validly issued, fully paid and nonassessable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS323"><!--Anchor--></a>3.23&#8195;Inapplicability of
            Anti-takeover Statutes. The Boards of Directors of Caladrius and Merger Sub have taken and will take all actions necessary to ensure that the restrictions applicable to business combinations contained in Section 203 of the DGCL are, and will
            be, inapplicable to the execution, delivery and performance of this Agreement and the Caladrius Stockholder Support Agreements and to the consummation of the Merger and the other Contemplated Transactions. No other state takeover statute or
            similar Law applies or purports to apply to the Merger, this Agreement, the Caladrius Stockholder Support Agreements or any of the other Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS324"><!--Anchor--></a>3.24&#8195;Disclosure. The information
            supplied by Caladrius for inclusion or incorporation by reference in the Proxy Statement (including any of the Caladrius Financials) will not, as of the date of the Proxy Statement or as of the date such information is prepared or presented,
            (i)&#160;contain any statement that is inaccurate or misleading with respect to any material facts, or (ii)&#160;omit to state any material fact necessary in order to make such information, in light of the circumstances under which such information will
            be provided, not false or misleading. The Proxy Statement will comply in all material respects as to form with the requirements of the Exchange Act and the rules and regulations thereunder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS325"><!--Anchor--></a>3.25&#8195;No Other Representations or
            Warranties. Caladrius hereby acknowledges and agrees that, except for the representations and warranties contained in this Agreement, neither the Company nor any of its Subsidiaries nor any other person on behalf of the Company or its
            Subsidiaries makes any express or implied representation or warranty with respect to the Company or its Subsidiaries or with respect to any other information provided to Caladrius, Merger Sub orstockholders or any of their respective Affiliates
            in connection with the transactions contemplated hereby, and (subject to the express representations and warranties of the Company set forth in <span style="text-decoration: underline;">Section 2</span> (in each case as qualified and limited by the Company Disclosure Schedule)) none
            of Caladrius, Merger Sub or any of their respective Representatives or stockholders, has relied on any such information (including the accuracy or completeness thereof).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS4"><!--Anchor--></a>Section 4&#8195;Certain Covenants of
            the Parties</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS41"><!--Anchor--></a>4.1&#8195;Operation of Caladrius&#8217;
            Business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Except as set forth on Section 4.1(a) of the Caladrius
            Disclosure Schedule, as expressly contemplated or permitted by this Agreement, as required by applicable Law, in connection with a Legacy Caladrius Business Disposition, pursuant to the terms of the Joint Development Agreement or unless the
            Company shall otherwise consent in writing (which consent shall not be unreasonably withheld, delayed or conditioned), during the period commencing on the date of this Agreement and continuing until the earlier to occur of the termination of
            this Agreement pursuant to <span style="text-decoration: underline;">Section 9</span> and the Effective Time (the &#8220;Pre-Closing Period&#8221;): Caladrius shall (i)&#160;conduct its business and operations in the Ordinary Course of Business; (ii)&#160;continue to pay outstanding accounts payable and
            other current Liabilities (including payroll) when due and payable; and (iii)&#160;conduct its business and operations in compliance with all applicable Law andthe requirements of all Contracts that constitute Caladrius Material Contracts.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Except (i)&#160;as expressly contemplated or permitted by this
            Agreement, (ii)&#160;as set forth in Section&#160;4.1(b) of the Caladrius Disclosure Schedule, (iii)&#160;as required by applicable Law or (iv)&#160;with the prior written consent of the Company (which consent shall not be unreasonably withheld, delayed or
            conditioned), at all times during the Pre-Closing Period, Caladrius shall not:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;declare, accrue, set aside or pay any dividend or make any other
            distribution in respect of any shares of its capital stock or repurchase, redeem or otherwise reacquire any shares of its capital stock or other securities (except for shares of Caladrius Common Stock from terminated employees, directors or
            consultants of Caladrius);</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-35<br />
        </div>

      </div>

    </div>

    <!--End Page 424-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 425-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg40"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;except in connection with the hiring of any new employees,
            sell, issue, grant, pledge or otherwise dispose of or encumber or authorize the issuance of: (A) any capital stock or other security (except for Caladrius Common Stock issued upon the valid exercise of outstanding Caladrius Options); (B) any
            option, warrant or right to acquire any capital stock or any other security; or (C) any instrument convertible into or exchangeable for any capital stock or other security;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iii)&#8195;except as required to give effect to anything in contemplation
            of the Closing, amend any of its Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock split or similar
            transaction except, for the avoidance of doubt, the Contemplated Transactions;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iv)&#8195;form any Subsidiary or acquire any equity interest or other
            interest in any other Entity or enter into a joint venture with any other Entity;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(v)&#8195;(A) lend money to any Person, (B) incur or guarantee any
            indebtedness for borrowed money, other than in the Ordinary Course of Business, (C) guarantee any debt securities of others, (D) make any capital expenditure or commitment in excess of $500,000 or (E) forgive any loans to any Persons, including
            Caladrius&#8217; employees, officers, directors or Affiliates;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vi)&#8195;&#160;other than in the Ordinary Course of Business: (A) adopt,
            establish or enter into any Caladrius Employee Plan; (B) cause or permit any Caladrius Employee Plan to be amended other than as required by law or in order to make amendments for the purposes of Section 409A of the Code; (C)&#160;pay any bonus or
            make any profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, fringe benefits or other compensation or remuneration payable to, any of its employees, directors or consultants; or (D) increase the
            severance or change of control benefits offered to any current or new employees, directors or consultants;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vii)&#8195;enter into any material transaction outside the Ordinary
            Course of Business;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(viii)&#8195;acquire any material asset or sell, lease or otherwise
            irrevocably dispose of any material portion of its assets or properties, or grant any Encumbrance with respect to such assets or properties, except in the Ordinary Course of Business;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ix)&#8195;make, change or revoke any material Tax election; file any
            material amendment to any Tax Return or adopt or change any accounting method in respect of Taxes;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(x)&#8195;take any action, other than as required by Law or GAAP, to
            change accounting policies or procedures;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xi)&#8195;pay, discharge or satisfy any claims, liabilities or
            obligations (absolute, accrued, asserted or unasserted, contingent or otherwise), other than the payment, discharge or satisfaction in the Ordinary Course of Business and consistent with past practice of liabilities reflected or reserved
            against in the Caladrius Financials, or incurred in the Ordinary Course of Business and consistent with past practice;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xii)&#8195;except as set forth in Section 4.1(b)(xii)&#160;of the Caladrius
            Disclosure Schedule, enter into, amend or terminate any Caladrius Material Contract;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xiii)&#8195;(A) materially change pricing or royalties or other payments
            set or charged by Caladrius to its customers or licensees or (B) agree to materially change pricing or royalties or other payments set or charged by persons who have licensed Intellectual Property to Caladrius;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xiv)&#8195;initiate or settle any Legal Proceeding or other claim or
            dispute involving or against Caladrius or any Subsidiary of Caladrius; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xv)&#8195;agree, resolve or commit to do any of the foregoing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Nothing contained in this Agreement shall give the Company, directly
            or indirectly, the right to control or direct the operations of Caladrius prior to the Effective Time. Prior to the Effective Time, Caladrius shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral
            control and supervision over its business operations.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-36<br />
        </div>

      </div>

    </div>

    <!--End Page 425-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 426-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg41"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;During the Pre-Closing Period, Caladrius shall have the right
            to distribute the Legacy Caladrius Assets Proceeds to the Caladrius stockholders provided that any means and mechanism of distribution shall be reasonably acceptable to the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS42"><!--Anchor--></a>4.2&#8195;Operation of the Company&#8217;s
            Business.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Except as set forth on Section 4.2(a) of the Company Disclosure
            Schedule, as expressly contemplated or permitted by this Agreement, pursuant to the terms of the Joint Development Agreement, as required by applicable Law or unless Caladrius shall otherwise consent in writing (which consent shall not be
            unreasonably withheld, delayed or conditioned), during the Pre-Closing Period: each of the Company and its Subsidiaries shall conduct its business and operations in the Ordinary Course of Business and in compliance with all applicable Law and
            the requirements of all Contracts that constitute Company Material Contracts.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Except (i)&#160;as expressly contemplated or permitted by this
            Agreement, (ii)&#160;as set forth in Section&#160;4.2(b) of the Company Disclosure Schedule, (iii)&#160;as required by applicable Law, or (iv)&#160;with the prior written consent of Caladrius (which consent shall not be unreasonably withheld, delayed or
            conditioned), at all times during the Pre-Closing Period, the Company shall not, nor shall it cause or permit any of its Subsidiaries to, do any of the following:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;declare, accrue, set aside or pay any dividend or make any other
            distribution in respect of any shares of capital stock; or repurchase, redeem or otherwise reacquire any shares of Company Capital Stock or other securities (except for shares of Company Common Stock from terminated employees, directors or
            consultants of the Company);</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;except as required to give effect to anything in contemplation
            of the Closing, amend any of its or its Subsidiaries&#8217; Organizational Documents, or effect or be a party to any merger, consolidation, share exchange, business combination, recapitalization, reclassification of shares, stock split, reverse stock
            split or similar transaction except, for the avoidance of doubt, the Contemplated Transactions;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iii)&#8195;except in connection with the hiring of any new employees,
            sell, issue, grant, pledge or otherwise dispose of or encumber or authorize any of the foregoing actions with respect to: (A) any capital stock or other security of the Company or any of its Subsidiaries (except for shares of outstanding
            Company Common Stock issued upon the valid exercise of Company Options); (B) any option, warrant or right to acquire any capital stock or any other security; or (C) any instrument convertible into or exchangeable for any capital stock or other
            security of the Company or any of its Subsidiaries;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(iv)&#8195;form any Subsidiary or acquire any equity interest or other
            interest in any other Entity or enter into a joint venture with any other Entity;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(v)&#8195;(A) lend money to any Person, (B) incur or guarantee any
            indebtedness for borrowed money, other than in the Ordinary Course of Business, (C) guarantee any debt securities of others, (D) make any capital expenditure or commitment in excess of $500,000 or (E) forgive any loans to any Persons, including
            the Company&#8217;s or any of its Subsidiaries&#8217; employees, officers, directors or Affiliates;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vi)&#8195;other than in the Ordinary Course of Business: (A) adopt,
            establish or enter into any Company Employee Plan; (B) cause or permit any Company Employee Plan to be amended other than as required by law or in order to make amendments for the purposes of Section 409A of the Code; (C)&#160;pay any bonus or make
            any profit-sharing or similar payment to, or increase the amount of the wages, salary, commissions, fringe benefits or other compensation or remuneration payable to, any of its directors, officers, employees or consultants; or (D) increase the
            severance or change of control benefits offered to any current or new employees, directors or consultants;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(vii)&#8195;enter into any material transaction outside the Ordinary
            Course of Business;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(viii)&#8195;acquire any material asset or sell, lease or otherwise
            irrevocably dispose of any material portion of its assets or properties, or grant any Encumbrance with respect to such assets or properties, except in the Ordinary Course of Business;</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-37<br />
        </div>

      </div>

    </div>

    <!--End Page 426-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 427-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg42"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ix)&#8195;sell, assign, transfer, license, sublicense or otherwise
            dispose of any material Company IP Rights (other than pursuant to non-exclusive licenses in the Ordinary Course of Business);</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(x)&#8195;make, change or revoke any material Tax election; file any
            material amendment to any Tax Return or adopt or change any accounting method in respect of Taxes;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xi)&#8195;take any action, other than as required by Law or GAAP, to
            change accounting policies or procedures;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xii)&#8195;pay, discharge or satisfy any claims, liabilities or
            obligations (absolute, accrued, asserted or unasserted, contingent or otherwise), other than the payment, discharge or satisfaction in the Ordinary Course of Business and consistent with past practice of liabilities reflected or reserved
            against in the Company Financials, or incurred in the Ordinary Course of Business and consistent with past practice;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xiii)&#8195;enter into, amend or terminate any Company Material
            Contract;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xiv)&#8195;(A) materially change pricing or royalties or other payments
            set or charged by the Company or any of its Subsidiaries to its customers or licensees or (B) agree to materially change pricing or royalties or other payments set or charged by persons who have licensed Intellectual Property to the Company or
            any of its Subsidiaries:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xv)&#8195;initiate or settle any Legal Proceeding or other claim or
            dispute involving or against the Company or any Subsidiary of the Company; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(xvi)&#8195;agree, resolve or commit to do any of the foregoing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Nothing contained in this Agreement shall give Caladrius, directly or
            indirectly, the right to control or direct the operations of the Company prior to the Effective Time. Prior to the Effective Time, the Company shall exercise, consistent with the terms and conditions of this Agreement, complete unilateral
            control and supervision over its business operations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS43"><!--Anchor--></a>4.3.&#8195;Access and Investigation.
            Subject to the terms of the Confidentiality Agreement, which the Parties agree will continue in full force following the date of this Agreement, during the Pre-Closing Period, upon reasonable notice, Caladrius, on the one hand, and the Company,
            on the other hand, shall and shall use commercially reasonable efforts to cause such Party&#8217;s Representatives to: (a) provide the other Party and such other Party&#8217;s Representatives with reasonable access during normal business hours to such
            Party&#8217;s Representatives, personnel and assets and to all existing books, records, Tax Returns, work papers and other documents and information relating to such Party and its Subsidiaries; (b) provide the other Party and such other Party&#8217;s
            Representatives with such copies of the existing books, records, Tax Returns, work papers, product data, and other documents and information relating to such Party and its Subsidiaries, and with such additional financial, operating and other
            data and information regarding such Party and its Subsidiaries as the other Party may reasonably request; and (c) permit the other Party&#8217;s officers and other employees to meet, upon reasonable notice and during normal business hours, with the
            chief financial officer and other officers and managers of such Party responsible for such Party&#8217;s financial statements and the internal controls of such Party to discuss such matters as the other Party may reasonably deem necessary. Any
            investigation conducted by either Caladrius or the Company pursuant to this <span style="text-decoration: underline;">Section 4.3</span> shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the other Party.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Notwithstanding the foregoing, any Party may restrict the foregoing
            access to the extent that any Law applicable to such Party requires such Party to restrict or prohibit access to any such properties or information.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS44"><!--Anchor--></a>4.4&#8195;No Solicitation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Each of Caladrius and the Company agrees that, during the
            Pre-Closing Period, neither it nor any of its Subsidiaries shall, nor shall it or any of its Subsidiaries authorize any of its Representatives to, directly or indirectly: (i)&#160;solicit, initiate or knowingly encourage, induce or facilitate the
            communication, making, submission or announcement of any Acquisition Proposal or Acquisition Inquiry or take any action that could reasonably be expected to lead to an Acquisition Proposal or Acquisition Inquiry; (ii)&#160;furnish any non-public
            information regarding such Party to any Person in connection with or in response to an Acquisition Proposal or Acquisition Inquiry; (iii)&#160;engage in discussions or negotiations with any Person with respect to any Acquisition Proposal or
            Acquisition Inquiry; (iv)&#160;approve, endorse or recommend any </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-38<br />
        </div>

      </div>

    </div>

    <!--End Page 427-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 428-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg43"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">Acquisition Proposal (subject to <span style="text-decoration: underline;">Section 5.2</span> and <span style="text-decoration: underline;">Section 5.3</span>); or
            (v)&#160;execute or enter into any letter of intent or similar document or any Contract contemplating or otherwise relating to any Acquisition Transaction; provided, however, that, notwithstanding anything contained in this <span style="text-decoration: underline;">Section 4.4</span> and
            subject to compliance with this <span style="text-decoration: underline;">Section 4.4</span>, prior to the approval of this Agreement by a Party&#8217;s stockholders (i.e., the Required Company Stockholder Vote, in the case of the Company and its Subsidiaries, or the Required Caladrius
            Stockholder Vote in the case of Caladrius), such Party may furnish non-public information regarding such Party and its Subsidiaries to, and enter into discussions or negotiations with, any Person in response to a bona fide written Acquisition
            Proposal by such Person which such Party&#8217;s board of directors determines in good faith, after consultation with such Party&#8217;s financial advisors and outside legal counsel, constitutes, or is reasonably likely to result in, a Superior Offer (and
            is not withdrawn) if: (A) neither such Party nor any Representative of such Party shall have breached this <span style="text-decoration: underline;">Section 4.4</span> in any material respect, (B) the board of directors of such Party concludes in good faith based on the advice of
            outside legal counsel, that the failure to take such action is reasonably likely to be inconsistent with the fiduciary duties of the board of directors of such Party under applicable Law; (c) at least two (2) Business Days prior to initially
            furnishing any such nonpublic information to, or entering into discussions with, such Person, such Party gives the other Party written notice of the identity of such Person and of such Party&#8217;s intention to furnish nonpublic information to, or
            enter into discussions with, such Person; (D) such Party receives from such Person an executed confidentiality agreement containing provisions (including nondisclosure provisions, use restrictions, non-solicitation provisions, no hire and
            &#8220;standstill&#8221; provisions) at least as favorable to such Party as those contained in the Confidentiality Agreement; and (E) at least two (2) Business Days prior to furnishing any such nonpublic information to such Person, such Party furnishes
            such nonpublic information to the other Party (to the extent such information has not been previously furnished by such Party to the other Party). Without limiting the generality of the foregoing, each Party acknowledges and agrees that, in the
            event any Representative of such Party takes any action that, if taken by such Party, would constitute a breach of this <span style="text-decoration: underline;">Section 4.4</span> by such Party, the taking of such action by such Representative shall be deemed to constitute a breach
            of this <span style="text-decoration: underline;">Section 4.4</span> by such Party for purposes of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;If any Party or any Representative of such Party receives an
            Acquisition Proposal or Acquisition Inquiry at any time during the Pre-Closing Period, then such Party shall promptly (and in no event later than one Business Day after such Party becomes aware of such Acquisition Proposal or Acquisition
            Inquiry) advise the other Party orally and in writing of such Acquisition Proposal or Acquisition Inquiry (including the identity of the Person making or submitting such Acquisition Proposal or Acquisition Inquiry, and the terms thereof). Such
            Party shall keep the other Party reasonably informed with respect to the status and terms of any such Acquisition Proposal or Acquisition Inquiry and any material modification or material proposed modification thereto.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Each Party shall immediately cease and cause to be terminated
            any existing discussions, negotiations and communications with any Person that relate to any Acquisition Proposal or Acquisition Inquiry as of the date of this Agreement and request the destruction or return of any nonpublic information
            provided to such Person.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS45"><!--Anchor--></a>4.5&#8195;Notification of Certain
            Matters. During the Pre-Closing Period, each of the Company, on the one hand, and Caladrius, on the other hand, shall promptly notify the other (and, if in writing, furnish copies of) if any of the following occurs: (a) any notice or other
            communication is received from any Person alleging that the Consent of such Person is or may be required in connection with any of the Contemplated Transactions; (b) any Legal Proceeding against or involving or otherwise affecting such Party or
            its Subsidiaries is commenced, or, to the Knowledge of such Party, threatened against such Party or, to the Knowledge of such Party, any director, officer or Key Employee of such Party; (c) such Party becomes aware of any inaccuracy in any
            representation or warranty made by such Party in this Agreement; or (d) the failure of such Party to comply with any covenant or obligation of such Party; in each case that could reasonably be expected to make the timely satisfaction of any of
            the conditions set forth in <span style="text-decoration: underline;">Sections 6</span>, <span style="text-decoration: underline;">7</span> and <span style="text-decoration: underline;">8</span>, as applicable, impossible or materially less likely. No notification given to a Party pursuant to this <span style="text-decoration: underline;">Section 4.5</span> shall change, limit or otherwise affect any of
            the representations, warranties, covenants or obligations of the Party providing such notification or any of such Party&#8217;s Subsidiaries contained in this Agreement or the Company Disclosure Schedule or the Caladrius Disclosure Schedule, as
            appropriate, for purposes of <span style="text-decoration: underline;">Section 8.2</span> or <span style="text-decoration: underline;">Section 7.1</span>, as appropriate.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-39<br />
        </div>

      </div>

    </div>

    <!--End Page 428-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 429-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg44"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS5"><!--Anchor--></a>Section 5 Additional Agreements
            of the Parties</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS51"><!--Anchor--></a>5.1&#8195;Registration Statement;
            Proxy Statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;As promptly as practicable after the date of this Agreement, the
            Parties shall prepare, and Caladrius shall cause to be filed with the SEC, the Registration Statement, in which the Proxy Statement will be included as a prospectus. Caladrius covenants and agrees that the Proxy Statement (and the letter to
            stockholders, notice of meeting and form of proxy included therewith) will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made
            therein, in light of the circumstances under which they were made, not misleading. The Company covenants and agrees that the information supplied by the Company or its Subsidiaries to Caladrius for inclusion in the Proxy Statement (including
            the Company Financials) will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make such information not misleading. Notwithstanding the foregoing,
            Caladrius makes no covenant, representation or warranty with respect to statements made in the Proxy Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith), if any, based on information provided by
            the Company or its Subsidiaries or any of their Representatives for inclusion therein. Each of the Parties shall use commercially reasonable efforts to cause the Registration Statement and the Proxy Statement to comply with the applicable rules
            and regulations promulgated by the SEC, to respond promptly to any comments of the SEC or its staff and to have the Registration Statement declared effective under the Securities Act as promptly as practicable after it is filed with the SEC.
            Each of the Parties shall use commercially reasonable efforts to cause the Proxy Statement to be mailed to Caladrius&#8217; stockholders as promptly as practicable after the Registration Statement is declared effective under the Securities Act. Each
            Party shall promptly furnish to the other Party all information concerning such Party and such Party&#8217;s Affiliates and such Party&#8217;s stockholders that may be required or reasonably requested in connection with any action contemplated by this <span style="text-decoration: underline;">Section
              5.1</span>. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">lf Caladrius, Merger Sub or the Company become aware of any event or
            information that, pursuant to the Securities Act or the Exchange Act, should be disclosed in an amendment or supplement to the Registration Statement or Proxy Statement, as the case may be, then such Party, as the case may be, shall promptly
            inform the other Parties thereof and shall cooperate with such other Parties in filing such amendment or supplement with the SEC and, if appropriate, in mailing such amendment or supplement to the Caladrius stockholders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Prior to the Effective Time, Caladrius shall use commercially
            reasonable efforts to obtain all regulatory, corporate and other approvals needed to ensure that the Caladrius Common Stock to be issued in the Merger (to the extent required) shall be registered or qualified or exempt from registration or
            qualification under the securities law of every jurisdiction of the United States in which any registered holder of Company Capital Stock has an address of record on the applicable record date for determining the holders of Company Capital
            Stock entitled to notice of and to vote pursuant to the Company Stockholder Written Consent; provided, however, that Caladrius shall not be required: (i)&#160;to qualify to do business as a foreign corporation in any jurisdiction in which it is not
            now qualified; or (ii)&#160;to file a general consent to service of process in any jurisdiction.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;The Company shall reasonably cooperate with Caladrius and
            provide, and require its Representatives to provide, Caladrius and its Representatives, with all true, correct and complete information regarding the Company or its Subsidiaries that is required by law to be included in the Registration
            Statement or reasonably requested by Caladrius to be included in the Registration Statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS52"><!--Anchor--></a>5.2&#8195;Company Stockholder Written
            Consent.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Promptly after the Registration Statement shall have been
            declared effective under the Securities Act, and in any event no later than two (2) Business Days thereafter, the Company shall obtain the approval by written consent from Company stockholders sufficient for the Required Company Stockholder
            Vote in lieu of a meeting pursuant to Section 228 of the DGCL, for purposes of (i)&#160;adopting and approving this Agreement and the Contemplated Transactions, (ii)&#160;acknowledging that the approval given thereby is irrevocable and that such
            stockholder is aware of its rights to demand appraisal for its shares pursuant to Section 262 of the DGCL, a copy of which will be attached thereto, and that such stockholder has received and read a copy of Section 262 of the DGCL, and
            (iii)&#160;acknowledging that by its approval of the Merger it </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-40<br />
        </div>

      </div>

    </div>

    <!--End Page 429-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 430-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg45"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">is not entitled to appraisal rights with respect to its shares in connection with
            the Merger and thereby waives any rights to receive payment of the fair value of its capital stock under the DGCL (collectively, the &#8220;Company Stockholder Matters&#8221;). Under no circumstances shall the Company assert that any other approval or
            consent is necessary by its stockholders to approve this Agreement and the Contemplated Transactions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Reasonably promptly following receipt of the Required Company
            Stockholder Vote, the Company shall prepare and mail a notice (the &#8220;Stockholder Notice&#8221;) to every stockholder of the Company that did not execute the Company Stockholder Written Consent. The Stockholder Notice shall (i)&#160;be a statement to the
            effect that the Company Board determined that the Merger is advisable in accordance with Section 251(b) of the DGCL and in the best interests of the stockholders of the Company and approved and adopted this Agreement, the Merger and the other
            Contemplated Transactions, (ii) provide the stockholders of the Company to whom it is sent with notice of the actions taken in the Company Stockholder Written Consent, including the adoption and approval of this Agreement, the Merger and the
            other Contemplated Transactions in accordance with Section&#160;228(e) of the DGCL and the certificate of incorporation and bylaws of the Company and (iii)&#160;include a description of the appraisal rights of the Company&#8217;s stockholders available under
            the DGCL, along with such other information as is required thereunder and pursuant to applicable Law. All materials (including any amendments thereto) submitted to the stockholders of the Company in accordance with this <span style="text-decoration: underline;">Section 5.2(b)</span>
            shall be subject to Caladrius&#8217; advance review and reasonable approval.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;The Company agrees that, subject to <span style="text-decoration: underline;">Section 5.2(d)</span>:
            (i)&#160;the Company Board shall recommend that the Company&#8217;s stockholders vote to adopt and approve this Agreement and the Contemplated Transactions and shall use commercially reasonable efforts to solicit such approval within the time set forth in
            <span style="text-decoration: underline;">Section&#160;5.2(a)</span> (the recommendation of the Company Board that the Company&#8217;s stockholders vote to adopt and approve this Agreement being referred to as the &#8220;Company Board Recommendation&#8221;); and (ii)&#160;the Company Board Recommendation shall
            not be withdrawn or modified (and the Company Board shall not publicly propose to withdraw or modify the Company Board Recommendation) in a manner adverse to Caladrius, and no resolution by the Company Board or any committee thereof to withdraw
            or modify the Company Board Recommendation in a manner adverse to Caladrius or to adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any Acquisition Proposal shall be adopted or proposed (the actions set forth in
            the foregoing clause&#160;(ii), collectively, a &#8220;Company Board Adverse Recommendation Change&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Notwithstanding anything to the contrary contained in <span style="text-decoration: underline;">Section

              5.2(c)</span>, and subject to compliance with <span style="text-decoration: underline;">Section 4.4</span> and this <span style="text-decoration: underline;">Section 5.2</span>, if at any time prior to approval of this Agreement and the contemplated Transactions by the Required Company Stockholder Vote, (i)&#160;the Company
            receives a bona fide written Superior Offer or (ii)&#160;as a result of a material development or change in circumstances (other than any such event, development or change to the extent related to (A) any Acquisition Proposal, Acquisition Inquiry or
            the consequences thereof or (B) the fact, in and of itself, that the Company meets or exceeds internal budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations) that affects the business,
            assets or operations of the Company that occurs or arises after the date of this Agreement (a &#8220;Company Intervening Event&#8221;), the Company Board may make a Company Board Adverse Recommendation Change if, but only if:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;in the case of a Superior Offer, (1) the Company Board
            determines in good faith, based on the advice of its outside legal counsel, that the failure to make a Company Board Adverse Recommendation Change would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law,
            (2)&#160;the Company has, and has caused its financial advisors and outside legal counsel to, at least four Business Days in advance of the Company Board Adverse Recommendation Change (the &#8220;Company Notice Period&#8221;), negotiate with Caladrius in good
            faith to make such adjustments to the terms and conditions of this Agreement so that such Acquisition Proposal ceases to constitute a Superior Offer, and (3) if after Caladrius shall have delivered to the Company a written offer to alter the
            terms or conditions of this Agreement during the Notice Period, the Company Board shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the Company Board
            Recommendation would result in a breach of its fiduciary duties under applicable Law (after taking into account such alterations of the terms and conditions of this Agreement); provided that (x)&#160;the Company shall be required to provide
            Caladrius </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-41<br />
        </div>

      </div>

    </div>

    <!--End Page 430-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 431-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg46"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="para">with written notice confirming that the Company Board has determined to change its
            recommendation during the Company Notice Period, which notice shall include a description in reasonable detail of the reasons for such Company Board Adverse Recommendation Change, and written copies of any relevant proposed transaction
            agreements with any party making a potential Superior Offer; (y) during any Company Notice Period, Caladrius shall be entitled to deliver to the Company one or more counterproposals to such Acquisition Proposal and the Company will, and cause
            its Representatives to, negotiate with Caladrius in good faith (to the extent Caladrius desires to negotiate) to make such adjustments in the terms and conditions of this Agreement so that the applicable Acquisition Proposal ceases to
            constitute a Superior Offer; and (z) in the event of any material amendment to any Superior Offer (including any revision in price or percentage of the combined company that the Company&#8217;s stockholders would receive as a result of such potential
            Superior Offer), the Company shall be required to provide Caladrius with notice of such material amendment and the Company Notice Period shall be extended, if applicable, to ensure that at least two (2) Business Days remain in the Notice Period
            following such notification during which the parties shall comply again with the requirements of this <span style="text-decoration: underline;">Section 5.2(d)</span> and the Company Board shall not make a Company Board Adverse Recommendation Change prior to the end of such Company
            Notice Period as so extended (it being understood that there may be multiple extensions); or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;in the case of a Company Intervening Event, the Company
            promptly notifies Caladrius, in writing, within the Company Notice Period before making a Company Board Adverse Recommendation Change, which notice shall state expressly the material facts and circumstances related to the applicable Company
            Intervening Event and that the Company Board intends to make a Company Board Adverse Recommendation Change. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;The Company&#8217;s obligation to solicit the consent of its
            stockholders to sign the Company Stockholder Written Consent in accordance with <span style="text-decoration: underline;">Section 5.2(a)</span> shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission of any Superior Offer or other
            Acquisition Proposal, or by any withholding, amendment, withdrawal or modification by the Company Board of the Company Board Recommendation (or public proposal to withhold, amend, withdraw or modify the Company Board Recommendation) in a manner
            adverse to Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS53"><!--Anchor--></a>5.3&#8195;Caladrius Stockholders&#8217;
            Meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Caladrius shall take all action necessary under applicable Law
            to call, give notice of and hold a meeting of the holders of Caladrius Common Stock to consider and vote to approve this Agreement and the Contemplated Transactions, including the issuance of the shares of Caladrius Common Stock to the
            stockholders of the Company pursuant to the terms of this Agreement and, if deemed necessary by the Parties, an amendment to Caladrius&#8217; certificate of incorporation to effect the Caladrius Reverse Stock Split (collectively, the &#8220;Caladrius
            Stockholder Matters&#8221; and such meeting, the &#8220;Caladrius Stockholders&#8217; Meeting&#8221;). The Caladrius Stockholders&#8217; Meeting shall be held as promptly as practicable after the Registration Statement is declared effective under the Securities Act.
            Caladrius shall take reasonable measures to ensure that all proxies solicited in connection with the Caladrius Stockholders&#8217; Meeting are solicited in compliance with all applicable Law.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Caladrius agrees that, subject to <span style="text-decoration: underline;">Section 5.3(c)</span>:
            (i)&#160;the Caladrius Board shall recommend that the holders of Caladrius Common Stock vote to approve the Caladrius Stockholder Matters and shall use commercially reasonable efforts to solicit such approval within the timeframe set forth in <span style="text-decoration: underline;">Section

              5.3(a)</span> above, (ii)&#160;the Proxy Statement shall include a statement to the effect that the Caladrius Board recommends that Caladrius&#8217; stockholders vote to approve the Caladrius Stockholder Matters (the recommendation of the Caladrius Board
            being referred to as the &#8220;Caladrius Board Recommendation&#8221;); and (iii)&#160;the Caladrius Board Recommendation shall not be withheld, amended, withdrawn or modified (and the Caladrius Board shall not publicly propose to withhold, amend, withdraw or
            modify the Caladrius Board Recommendation) in a manner adverse to the Company, and no resolution by the Caladrius Board or any committee thereof to withdraw or modify the Caladrius Board Recommendation in a manner adverse to the Company or to
            adopt, approve or recommend (or publicly propose to adopt, approve or recommend) any Acquisition Proposal shall be adopted or proposed (the actions set forth in the foregoing clause (iil), collectively, a &#8220;Caladrius Board Adverse Recommendation
            Change&#8221;).</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-42<br />
        </div>

      </div>

    </div>

    <!--End Page 431-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 432-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg47"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Notwithstanding anything to the contrary contained in<span style="text-decoration: underline;">
              Section 5.3(b)</span>, and subject to compliance with <span style="text-decoration: underline;">Section 4.4</span> and <span style="text-decoration: underline;">Section 5.3</span>, if at any time prior to approval of the Caladrius Stockholder Matters by the Required Caladrius Stockholder Vote, (i)&#160;Caladrius receives a bona
            fide written Superior Offer or (ii)&#160;as a result of a material development or change in circumstances (other than any such event, development or change to the extent related to (A) any Acquisition Proposal, Acquisition Inquiry or the
            consequences thereof or (B) the fact, in and of itself, that Caladrius meets or exceeds internal budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations) that affects the business, assets or
            operations of Caladrius that occurs or arises after the date of this Agreement (a &#8220;Caladrius Intervening Event&#8221;), the Caladrius Board may make a Caladrius Board Adverse Recommendation Change if, but only if:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;in the case of a Superior Offer, (1) the Caladrius Board
            determines in good faith, based on the advice of its outside legal counsel, that the failure to make a Caladrius Board Adverse Recommendation Change would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law,
            (2)&#160;Caladrius has, and has caused its financial advisors and outside legal counsel to, at least four Business Days in advance of the Caladrius Board Adverse Recommendation Change (the &#8220;Caladrius Notice Period&#8221;), negotiate with the Company in
            good faith to make such adjustments to the terms and conditions of this Agreement so that such Acquisition Proposal ceases to constitute a Superior Offer, and (3) if after the Company shall have delivered to Caladrius a written offer to alter
            the terms or conditions of this Agreement during the Caladrius Notice Period, the Caladrius Board shall have determined in good faith, based on the advice of its outside legal counsel, that the failure to withhold, amend, withdraw or modify the
            Caladrius Board Recommendation would result in a breach of its fiduciary duties under applicable Law (after taking into account such alterations of the terms and conditions of this Agreement); provided that (x)&#160;Caladrius shall be required to
            provide the Company with written notice confirming that the Caladrius Board has determined to change its recommendation during the Caladrius Notice Period, which notice shall include a description in reasonable detail of the reasons for such
            Caladrius Board Adverse Recommendation Change, and written copies of any relevant proposed transaction agreements with any party making a potential Superior Offer; (y) during any Caladrius Notice Period, the Company shall be entitled to deliver
            to Caladrius one or more counterproposals to such Acquisition Proposal and Caladrius will, and cause its Representatives to, negotiate with the Company in good faith (to the extent the Company desires to negotiate) to make such adjustments in
            the terms and conditions of this Agreement so that the applicable Acquisition Proposal ceases to constitute a Superior Offer; and (z) in the event of any material amendment to any Superior Offer (including any revision in price or percentage of
            the combined company that Caladrius&#8217; stockholders would receive as a result of such potential Superior Offer), Caladrius shall be required to provide the Company with notice of such material amendment and the Caladrius Notice Period shall be
            extended, if applicable, to ensure that at least two (2) Business Days remain in the Caladrius Notice Period following such notification during which the parties shall comply again with the requirements of this <span style="text-decoration: underline;">Section 5.3(c)</span> and the
            Caladrius Board shall not make a Caladrius Board Adverse Recommendation Change prior to the end of such Caladrius Notice Period as so extended (it being understood that there may be multiple extensions); or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;in the case of a Caladrius Intervening Event, Caladrius
            promptly notifies the Company, in writing, within the Caladrius Notice Period before making a Caladrius Board Adverse Recommendation Change, which notice shall state expressly the material facts and circumstances related to the applicable
            Caladrius Intervening Event and that the Caladrius Board intends to make a Caladrius Board Adverse Recommendation Change.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;Caladrius&#8217; obligation to call, give notice of or hold the
            Caladrius Stockholders&#8217; Meeting in accordance with <span style="text-decoration: underline;">Section 5.3(a)</span> shall not be limited or otherwise affected by the commencement, disclosure, announcement or submission of any Superior Offer or other Acquisition Proposal, or by any
            withdrawal or modification of the Caladrius Board Recommendation (or public proposal to withhold, amend, withdraw or modify the Caladrius Board Recommendation) in a manner adverse to the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Nothing contained in this Agreement shall prohibit Caladrius or
            the Caladrius Board from complying with Rules 14d-9 and 14e-2(a) promulgated under the Exchange Act; provided however, that any disclosure made by Caladrius or the Caladrius Board pursuant to Rules 14d-9 and 14e-2(a) shall be limited </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-43<br />
        </div>

      </div>

    </div>

    <!--End Page 432-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 433-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg48"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">to a statement that Caladrius is unable to take a position with respect to the
            bidder&#8217;s tender offer unless the Caladrius Board determines in good faith, after consultation with its outside legal counsel, that such statement would result in a breach of its fiduciary duties under applicable Law. Caladrius shall not
            withdraw or modify in a manner adverse to the Company the Caladrius Board Recommendation unless specifically permitted pursuant to the terms of <span style="text-decoration: underline;">Section 5.3(c)</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS54"><!--Anchor--></a>5.4&#8195;Regulatory Approvals. Each
            Party shall use commercially reasonable efforts to file or otherwise submit, as soon as practicable after the date of this Agreement, all applications, notices, reports and other documents reasonably required to be filed by such Party with or
            otherwise submitted by such Party to any Governmental Body with respect to the Contemplated Transactions, and to submit promptly any additional information requested by any such Governmental Body.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS55"><!--Anchor--></a>5.5&#8195;Company Options.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Subject to <span style="text-decoration: underline;">Section 5.5(c)</span>, at the Effective Time, each
            Company Option that is outstanding and unexercised immediately prior to the Effective Time under the Company Plan, whether or not vested, shall be converted into and become an option to purchase Caladrius Common Stock, and Caladrius shall
            assume the Company Plan and each such Company Option in accordance with the terms (as in effect as of the date of this Agreement) of the Company Plan and the terms of the stock option agreement by which such Company Option is evidenced. Any
            Company Options not issued under the Company Plan shall be cancelled immediately prior to the Effective Time. All rights with respect to Company Common Stock under Company Options assumed by Caladrius shall thereupon be converted into rights
            with respect to Caladrius Common Stock. Accordingly, from and after the Effective Time: (i)&#160;each Company Option assumed by Caladrius may be exercised solely for shares of Caladrius Common Stock; (ii)&#160;the number of shares of Caladrius Common
            Stock subject to each Company Option assumed by Caladrius shall be determined by multiplying (A) the number of shares of Company Common Stock that were subject to such Company Option, as in effect immediately prior to the Effective Time, by (B)
            the Exchange Ratio, and rounding the resulting number down to the nearest whole number of shares of Caladrius Common Stock; (iii)&#160;the per share exercise price for the Caladrius Common Stock issuable upon exercise of each Company Option assumed
            by Caladrius shall be determined by dividing (A) the per share exercise price of Company Common Stock subject to such Company Option, as in effect immediately prior to the Effective Time, by (B) the Exchange Ratio and rounding the resulting
            exercise price up to the nearest whole cent; and (iv)&#160;any restriction on the exercise of any Company Option assumed by Caladrius shall continue in full force and effect and the term, exercisability, vesting schedule and other provisions of such
            Company Option shall otherwise remain unchanged; provided, however, that: (A) to the extent provided under the terms of a Company Option, such Company Option assumed by Caladrius in accordance with this <span style="text-decoration: underline;">Section 5.5(a)</span> shall, in
            accordance with its terms, be subject to further adjustment as appropriate to reflect any stock split, division or subdivision of shares, stock dividend, reverse stock split, consolidation of shares, reclassification, recapitalization or other
            similar transaction with respect to Caladrius Common Stock subsequent to the Effective Time; and (B) the Caladrius Board or a committee thereof shall succeed to the authority and responsibility of the Company Board or any committee thereof with
            respect to each Company Option assumed by Caladrius. Notwithstanding anything to the contrary in this <span style="text-decoration: underline;">Section 5.5(a)</span>, the conversion of each Company Option (regardless of whether such option qualifies as an &#8220;incentive stock option&#8221;
            within the meaning of Section 422 of the Code) into an option to purchase shares of Caladrius Common Stock shall be made in a manner consistent with Treasury Regulation Section 1.424-1, such that the conversion of a Company Option shall not
            constitute a &#8220;modification&#8221; of such Company Option for purposes of Section 409A or Section 424 of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Caladrius shall file with the SEC, promptly after the Effective
            Time, a registration statement on Form&#160;S-8 relating to the shares of Caladrius Common Stock issuable with respect to Company Options assumed by Caladrius in accordance with <span style="text-decoration: underline;">Section 5.5(a)</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;Prior to the Effective Time, the Company shall take all actions
            that may be necessary (under the Company Plan or otherwise) to effectuate the provisions of this <span style="text-decoration: underline;">Section 5.5</span> and to ensure that, from and after the Effective Time, holders of Company Options have no rights with respect thereto other
            than those specifically provided in this <span style="text-decoration: underline;">Section 5.5</span>.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-44<br />
        </div>

      </div>

    </div>

    <!--End Page 433-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 434-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg49"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS56"><!--Anchor--></a>5.6&#8195;Caladrius Awards. At the
            Effective Time, each Caladrius Award that is outstanding and unexercised immediately prior to the Effective Time, whether or not vested, shall survive the Closing and remain outstanding in accordance with its terms.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS57"><!--Anchor--></a>5.7.&#8195;Employee Benefits. Caladrius
            and the Company shall cause Caladrius to comply with the terms of any employment, severance, retention, change of control, or similar agreement specified on Section 3.17(c) of the Caladrius Disclosure Schedule or Section 2.1(c) of the Company
            Disclosure Schedule, as applicable, subject to the provisions of such agreements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS58"><!--Anchor--></a>5.8&#8195;Indemnification of Officers
            and Directors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;From the Effective Time through the sixth anniversary of the
            date on which the Effective Time occurs, each of Caladrius and the Surviving Corporation shall indemnify and hold harmless each person who is now, or has been at any time prior to the date hereof, or who becomes prior to the Effective Time, a
            director or officer of Caladrius or the Company, respectively (the &#8220;D&amp;O Indemnified Parties&#8221;), against all claims, losses, liabilities, damages, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and
            disbursements (collectively, &#8220;Costs&#8221;), incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or pertaining to the fact that the D&amp;O
            Indemnified Party is or was a director or officer of Caladrius or of the Company, whether asserted or claimed prior to, at or after the Effective Time, in each case, to the fullest extent permitted under the DGCL for directors or officers of
            Delaware corporations. Each D&amp;O Indemnified Party will be entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation from each of Caladrius and the Surviving Corporation, jointly
            and severally, upon receipt by Caladrius or the Surviving Corporation from the D&amp;O Indemnified Party of a request therefor; provided that any such person to whom expenses are advanced provides an undertaking to Caladrius, to the extent then
            required by the DGCL, to repay such advances if it is ultimately determined that such person is not entitled to indemnification.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;The provisions of the certificate of incorporation and bylaws of
            Caladrius and the Company with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of the same that are presently set forth in the certificate of incorporation and bylaws of Caladrius
            or the Company shall not be amended, modified or repealed for a period of six years from the Effective Time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the Effective Time, were officers or
            directors of Caladrius or the Company, unless such modification is required by applicable Law. The certificate of incorporation and bylaws of the Surviving Corporation shall contain, and Caladrius shall cause the certificate of incorporation
            and bylaws of the Surviving Corporation to so contain, provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers as those presently set forth in the
            certificate of incorporation and bylaws of Caladrius and the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;From and after the Effective Time, (i)&#160;the Surviving Corporation
            shall fulfill and honor in all respects the obligations of the Company to its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under the Company&#8217;s Organizational Documents and
            pursuant to any indemnification agreements between the Company and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time and (ii)&#160;Caladrius shall fulfill and honor in all
            respects the obligations of Caladrius to its D&amp;O Indemnified Parties as of immediately prior to the Closing pursuant to any indemnification provisions under Caladrius&#8217; Organizational Documents and pursuant to any indemnification agreements
            between Caladrius and such D&amp;O Indemnified Parties, with respect to claims arising out of matters occurring at or prior to the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;From and after the Effective Time, Caladrius shall maintain
            directors&#8217; and officers&#8217; liability insurance policies, with an effective date as of the Closing Date, on commercially available terms and conditions and with coverage limits customary for U.S. public companies similarly situated to Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;From and after the Effective Time, Caladrius shall pay all
            expenses, including reasonable attorneys&#8217; fees, that are incurred by the persons referred to in this <span style="text-decoration: underline;">Section 5.8</span> in connection with their enforcement of the rights provided to such persons in this <span style="text-decoration: underline;">Section 5.8</span>.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-45<br />
        </div>

      </div>

    </div>

    <!--End Page 434-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 435-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg50"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;The provisions of this <span style="text-decoration: underline;">Section 5.8</span> are intended to be
            in addition to the rights otherwise available to the current and former officers and directors of Caladrius and the Company by law, charter, statute, bylaw or agreement, and shall operate for the benefit of, and shall be enforceable by, each of
            the D&amp;O Indemnified Parties, their heirs and their representatives.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;In the event Caladrius or the Surviving Corporation or any of
            their respective successors or assigns (i)&#160;consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger, or (ii)&#160;transfers all or substantially all of its
            properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of Caladrius or the Surviving Corporation, as the case may be, shall succeed to the obligations set forth in
            this <span style="text-decoration: underline;">Section 5.8. </span>Caladrius shall cause the Surviving Corporation to perform all of the obligations of the Surviving Corporation under this <span style="text-decoration: underline;">Section 5.8</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS59"><!--Anchor--></a>5.9&#8195;Additional Agreements. The
            Parties shall use commercially reasonable efforts to cause to be taken all actions necessary to consummate the Contemplated Transactions. Without limiting the generality of the foregoing, each Party to this Agreement: (a) shall make all filings
            and other submissions (if any) and give all notices (if any) required to be made and given by such Party in connection with the Contemplated Transactions; (b) shall use commercially reasonable efforts to obtain each Consent (if any) reasonably
            required to be obtained (pursuant to any applicable Law or Contract, or otherwise) by such Party in connection with the Contemplated Transactions or for such Contract to remain in full force and effect; (c) shall use commercially reasonable
            efforts to lift any injunction prohibiting, or any other legal bar to, the Contemplated Transactions; and (d) shall use commercially reasonable efforts to satisfy the conditions precedent to the consummation of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS510"><!--Anchor--></a>5.10&#8195;Disclosure. Without
            limiting any Party&#8217;s obligations under the Confidentiality Agreement, no Party shall, and no Party shall permit any of its Subsidiaries or any Representative of such Party to, issue any press release or make any disclosure (to any customers or
            employees of such Party, to the public or otherwise) regarding the Contemplated Transactions unless: (a) the other Party shall have approved such press release or disclosure in writing, such approval not to be unreasonably conditioned, withheld
            or delayed; or (b) such Party shall have determined in good faith, upon the advice of outside legal counsel, that such disclosure is required by applicable Law and, to the extent practicable, before such press release or disclosure is issued or
            made, such Party advises the other Party of, and consults with the other Party regarding, the text of such press release or disclosure; provided, however, that each of the Company and Caladrius may make any public statement in response to
            specific questions by the press, analysts, investors or those attending industry conferences or financial analyst conference calls, so long as any such statements are consistent with previous press releases, public disclosures or public
            statements made by the Company or Caladrius in compliance with this <span style="text-decoration: underline;">Section 5.10</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS511"><!--Anchor--></a>5.11&#8195;Listing. Caladrius shall
            use its commercially reasonable efforts: (a) to maintain its existing listing on the Nasdaq Capital Market until the Closing Date and to obtain approval of the listing of the combined company on the Nasdaq Capital Market; (b) without derogating
            from the generality of the requirements of clause (a) and to the extent required by the rules and regulations of Nasdaq, to (i)&#160;prepare and submit to Nasdaq a notification form for the listing of the shares of Caladrius Common Stock to be
            issued in connection with the Contemplated Transactions and (ii)&#160;to cause such shares to be approved for listing (subject to official notice of issuance); and (c) to the extent required by Nasdaq Marketplace Rule 5110, to file an initial
            listing application for the Caladrius Common Stock on Nasdaq (the &#8220;Nasdag Listing Application&#8221;) and to cause such Nasdaq Listing Application to be conditionally approved prior to the Effective Time. The Company will cooperate with Caladrius as
            reasonably requested by Caladrius with respect to the Nasdaq Listing Application and promptly furnish to Caladrius all information concerning the Company and its stockholders that may be required or reasonably requested in connection with any
            action contemplated by this <span style="text-decoration: underline;">Section&#160;5.11</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS512"><!--Anchor--></a>5.12&#8195;Tax Matters. The Parties
            shall use their respective commercially reasonable efforts to cause the Merger to qualify, and will not take any action or cause any action to be taken which action would reasonably be expected to prevent the Merger from qualifying, as a
            reorganization within the meaning of Section 368(a) of the Code. Specifically, Caladrius shall use its commercially reasonable efforts to operate the Surviving Corporation so as to meet the &#8220;continuity of business enterprise&#8221; requirement. The
            Parties shall not file any U.S. federal, state or local Tax Return in a manner that is inconsistent with the treatment of the Merger as a reorganization within the meaning of Section 368(a) of the Code for U.S. federal, state and other relevant
            Tax purposes, unless otherwise required by applicable Law.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-46<br />
        </div>

      </div>

    </div>

    <!--End Page 435-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 436-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg51"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS513"><!--Anchor--></a>5.13&#8195;Legends. Caladrius shall
            be entitled to place appropriate legends on the book entries and/or certificates evidencing any shares of Caladrius Common Stock to be received in the Merger by equityholders of the Company who may be considered &#8220;affiliates&#8221; of Caladrius for
            purposes of Rules 144 and 145 under the Securities Act reflecting the restrictions set forth in Rules 144 and 145 and to issue appropriate stop transfer instructions to the transfer agent for Caladrius Common Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS514"><!--Anchor--></a>5.14&#8195;Directors and Officers. The
            Parties shall take all actions necessary cause the board of directors of Caladrius, immediately after the Effective Time, to consist of up to nine (9) directors, of which four (4) directors shall be designated by Caladrius, four (4) directors
            shall be designated by the Company and one (1) director who shall be mutually determined by Caladrius and the Company. The parties hereby agree that David Mazzo shall be appointed as Chief Executive Officer of Caladrius and David Slack shall be
            appointed as President and Chief Business Officer of Caladrius, each case, following the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS515"><!--Anchor--></a>5.15&#8195;Section 16 Matters. Prior
            to the Effective Time, Caladrius shall take all such steps as may be required to cause any acquisitions of Caladrius Common Stock and any options to purchase Caladrius Common Stock in connection with the Contemplated Transactions, by each
            individual who is reasonably expected to become subject to the reporting requirements of Section 16(a) of the Exchange Act with respect to Caladrius, to be exempt under Rule&#160;16b-3 promulgated under the Exchange Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS516"><!--Anchor--></a>5.16&#8195;Cooperation. Each Party
            shall cooperate reasonably with the other Party and shall provide the other Party with such assistance as may be reasonably requested for the purpose of facilitating the performance by each Party of its respective obligations under this
            Agreement and to enable the combined entity to continue to meet its obligations following the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS517"><!--Anchor--></a>5.17&#8195;Allocation Certificate;
            Transaction Costs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;The Company will prepare and deliver to Caladrius at least two
            Business Days prior to the Closing Date a certificate signed by the Chief Executive Officer or Chief Financial Officer of the Company in a form reasonably acceptable to Caladrius setting forth (as of immediately prior to the Effective Time) (a)
            each holder of Company Capital Stock or Company Options, (b) such holder&#8217;s name and address; (c) the number and type of Company Capital Stock held and/or underlying the Company Options as of the Closing Date for each such holder; and (d) the
            number of shares of Caladrius Common Stock to be issued to such holder, or to underlie any Caladrius Option to be issued to such holder, pursuant to this Agreement in respect of the Company Capital Stock or Company Options held by such holder
            as of immediately prior to the Effective Time (the &#8220;Allocation Certificate&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;At least five (5) Business Days prior to the Closing Date, the
            Company shall, to the extent applicable, deliver to Caladrius an accurate and complete copy of all Company Invoices with respect to all related Transaction Costs estimated to be due and payable by the Company as of the Closing Date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS518"><!--Anchor--></a>5.18&#8195;Company Financial
            Statements. As promptly as reasonably practicable following the date of this Agreement (and in any event within thirty (30) days following the date of this Agreement with respect to the Company Audited Financial Statements), the Company will
            cause its independent auditors to furnish (i)&#160;audited financial statements for the fiscal year ended December&#160;31, 2021 and 2020, for inclusion in the Proxy Statement and the Registration Statement (the &#8220;Company Audited Financial Statements&#8221;)
            and (ii)&#160;unaudited interim financial statements for each interim period completed prior to Closing that would be required to be included in the Registration Statement or any periodic report due prior to the Closing if the Company were subject
            to the periodic reporting requirements under the Securities Act or the Exchange Act (the &#8220;Company Interim Financial Statements&#8221;). Each of the Company Audited Financial Statements and the Company Interim Financial Statements will be suitable for
            inclusion in the Proxy Statement and the Registration Statement and prepared in accordance with GAAP as applied on a consistent basis during the periods involved (except in each case as described in the notes thereto) and on that basis will
            present fairly, in all material respects, the financial position and the results of operations, changes in stockholders&#8217; equity, and cash flows of the Company as of the dates of and for the periods referred to in the Company Audited Financial
            Statements or the Company Interim Financial Statements, as the case may be.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS519"><!--Anchor--></a>5.19&#8195;Caladrius Reverse Stock
            Split. If deemed necessary by the Parties, Caladrius shall submit to Caladrius&#8217; stockholders at the Caladrius Stockholders&#8217; Meeting an amendment to Caladrius&#8217; certificate of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-47<br />
        </div>

      </div>

    </div>

    <!--End Page 436-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 437-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg52"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">incorporation to authorize the Caladrius Board to effect a reverse stock split of all
            outstanding shares of Caladrius Common Stock at a reverse stock split ratio mutually agreed to by the Company and Caladrius (the &#8220;Caladrius Reverse Stock Split&#8221;), and shall take such other actions as shall be reasonably necessary to effectuate
            the Caladrius Reverse Stock Split.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS520"><!--Anchor--></a>5.20&#8195;Preferred Stock. The
            Company shall take all action required to effect the conversion of the Company Preferred Stock (other than any Company Preferred Stock owned by Caladrius) into Company Common Stock pursuant to the Company Stockholder Written Consent prior to
            the Closing Date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS521"><!--Anchor--></a>5.21&#8195;Joint Development
            Agreement. As an inducement for Caladrius and the Company to enter into this Agreement and effect the Merger, Caladrius and the Company shall enter, or shall have entered, into a Joint Development Agreement in substantially the form attached
            hereto as <span style="text-decoration: underline;">Exhibit E</span> (the &#8220;Joint Development Agreement&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS6"><!--Anchor--></a>Section 6&#8195;Conditions Precedent
            to Obligations of Each Party</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The obligations of each Party to effect the Merger and otherwise
            consummate the Contemplated Transactions to be consummated at the Closing are subject to the satisfaction or, to the extent permitted by applicable law, the written waiver by each of the Parties, at or prior to the Closing, of each of the
            following conditions:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS61"><!--Anchor--></a>6.1&#8195;Effectiveness of Registration
            Statement. The Registration Statement shall have become effective in accordance with the provisions of the Securities Act, and shall not be subject to any stop order or proceeding (or threatened proceeding by the SEC) seeking a stop order with
            respect to the Registration Statement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS62"><!--Anchor--></a>6.2&#8195;No Restraints. No temporary
            restraining order, preliminary or permanent injunction or other order preventing the consummation of the Contemplated Transactions shall have been issued by any court of competent jurisdiction or other Governmental Body of competent
            jurisdiction and remain in effect and there shall not be any Law which has the effect of making the consummation of the Contemplated Transactions illegal.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS63"><!--Anchor--></a>6.3&#8195;Stockholder Approval. (a)
            Caladrius shall have obtained the Required Caladrius Stockholder Vote and (b)&#160;the Company shall have obtained the Required Company Stockholder Vote.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS64"><!--Anchor--></a>6.4&#8195;Listing. The existing shares
            of Caladrius Common Stock shall have been continually listed on the Nasdaq Capital Market as of and from the date of this Agreement through the Closing Date, the approval of the listing of the additional shares of Caladrius Common Stock on the
            Nasdaq Capital Market shall have been obtained and the shares of Caladrius Common Stock to be issued in the Merger pursuant to this Agreement shall have been approved for listing (subject to official notice of issuance) on the Nasdaq Capital
            Market or such other Nasdaq market on which shares of Caladrius Common Stock are then listed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS65"><!--Anchor--></a>6.5&#8195;No Governmental Proceedings
            Relating to Contemplated Transactions or Right to Operate Business. There shall not be any Legal Proceeding pending, or overtly threatened in writing by an official of a Governmental Body in which such Governmental Body indicates that it
            intends to conduct any Legal Proceeding: (a) challenging or seeking to restrain or prohibit the consummation of the Merger; (b) relating to the Merger and seeking to obtain from Caladrius, Merger Sub or the Company any damages or other relief
            that may be material to Caladrius or the Company; (c) seeking to prohibit or limit in any material and adverse respect a Party&#8217;s ability to vote, transfer, receive dividends with respect to or otherwise exercise ownership rights with respect to
            the stock of Caladrius; (d) that would materially and adversely affect the right or ability of Caladrius or the Company to own the assets or operate the business of Caladrius or the Company; or (e) seeking to compel Caladrius, the Company or
            any Subsidiary of the Company to dispose of or hold separate any material assets as a result of the Merger.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS7"><!--Anchor--></a>Section 7&#8195;Additional Conditions
            Precedent to Obligations of Caladrius and Merger Sub</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The obligations of Caladrius and Merger Sub to effect the Merger and
            otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by Caladrius, at or prior to the Closing, of each of the following conditions:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS71"><!--Anchor--></a>7.1&#8195;Accuracy of Representations.
            Each of the Company Fundamental Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as of
            such date (except to the extent such representations </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-48<br />
        </div>

      </div>

    </div>

    <!--End Page 437-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 438-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg53"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">and warranties are specifically made as of a particular date, in which case such
            representations and warranties shall be true and correct as of such date). The Company IP Representations shall have been true and correct in all material respects as of the date of this Agreement and shall be true and correct in all material
            respects on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations
            and warranties shall be true and correct as of such date). The Company Capitalization Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct on and as of the Closing Date
            with the same force and effect as if made on and as of such date, except, in each case, (x)&#160;for such inaccuracies which are de minimis, individually or in the aggregate or (y) for those representations and warranties which address matters only
            as of a particular date (which representations and warranties shall have been true and correct, subject to the qualifications as set forth in the preceding clause (x), as of such particular date). The representations and warranties of the
            Company contained in this Agreement (other than the Company Fundamental Representations, the Company Capitalization Representations and the Company IP Representations) shall have been true and correct as of the date of this Agreement and shall
            be true and correct on and as of the Closing Date with the same force and effect as if made on the Closing Date except (a) in each case, or in the aggregate, where the failure to be so true and correct would not reasonably be expected to have a
            Company Material Adverse Effect (without giving effect to any references therein to any Company Material Adverse Effect or other materiality qualifications), or (b) for those representations and warranties which address matters only as of a
            particular date (which representations shall have been true and correct, subject to the qualifications as set forth in the preceding clause (a), as of such particular date) (it being understood that, for purposes of determining the accuracy of
            such representations and warranties, any update of or modification to the Company Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS72"><!--Anchor--></a>7.2&#8195;Performance of Covenants. The
            Company shall have performed or complied with in all material respects all agreements and covenants required to be performed or complied with by it under this Agreement at or prior to the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS73"><!--Anchor--></a>7.3&#8195;Closing Certificate.
            Caladrius shall have received a certificate executed by the Chief Executive Officer or Chief Financial Officer of the Company certifying (a) that the conditions set forth in <span style="text-decoration: underline;">Sections 7.1</span>, <span style="text-decoration: underline;">7.2</span>, and <span style="text-decoration: underline;">7.6</span> have been duly
            satisfied and (b) that the information set forth in the Allocation Certificate delivered by the Company in accordance with <span style="text-decoration: underline;">Section 5.17</span> is true and accurate in all respects as of the Closing Date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS74"><!--Anchor--></a>7.4&#8195;Preferred Stock Conversion.
            The Company Preferred Stock, excluding any Company Preferred Stock owned by Caladrius, shall have been converted into Company Common Stock (the &#8220;Preferred Stock Conversion&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS75"><!--Anchor--></a>7.5&#8195;FIRPTA Certificate. Caladrius
            shall have received from the Company a properly executed statement, in accordance with Treasury Regulation Sections 1.897-2(h) and 1.1445-2(c)(3) certifying that the Company is not and has not been a &#8220;United States real property holding
            corporation&#8221; (as defined in Section 897(c)(2) of the Code) during the applicable period specified in Section 897(c)(1)(A)(ii)&#160;of the Code, together with the required notice to the IRS in accordance with the requirements of Treasury Regulation
            Section 1.897-2(h) and in form and substance reasonably acceptable to Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS76"><!--Anchor--></a>7.6&#8195;No Company Material Adverse
            Effect. Since the date of this Agreement, there shall not have occurred any Company Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS77"><!--Anchor--></a>7.7&#8195;Other Deliveries. Caladrius
            shall have received: (a) certificates of good standing of the Company in its jurisdiction of organization and the various foreign jurisdictions in which it is qualified, (b) certified charter documents, and (c) certificates as to the incumbency
            of officers and the adoption of authorizing resolutions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS78"><!--Anchor--></a>7.8&#8195;Company Lock-Up Agreements.
            The Company Lock-Up Agreements will continue to be in full force and effect as of immediately following the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS79"><!--Anchor--></a>7.9&#8195;Consents.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;All of the consents set forth on Schedule 7.9(a) shall have been
            obtained and shall be in full force and effect.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-49<br />
        </div>

      </div>

    </div>

    <!--End Page 438-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 439-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg54"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Any Company Permit or other consent required to be obtained
            by the Company under any applicable antitrust or competition Law or regulation or other Law shall have been obtained and shall remain in full force and effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS710"><!--Anchor--></a>7.10&#8195;Company Invoices. Caladrius
            shall have received written acknowledgements pursuant to which the Company&#8217;s outside legal counsel and any financial advisor, accountant or other Person who performed services for or on behalf of the Company, or who is otherwise entitled to any
            compensation from the Company that in each case is owed Transaction Costs from the Company: (i)&#160;the total amount of Transaction Costs that are payable to such Person; and (ii)&#160;that, upon receipt of the amount referred to in clause &#8220;(i)&#8221; above,
            such party will have been paid in full and is not (and will not be) owed any other Transaction Costs (collectively, the &#8220;Company Invoices&#8221;).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS8"><!--Anchor--></a>Section 8&#8195;Additional Conditions
            Precedent to Obligation of the Company</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The obligations of the Company to effect the Merger and otherwise
            consummate the transactions to be consummated at the Closing are subject to the satisfaction or the written wavier by the Company, at or prior to the Closing, of each of the following conditions:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS81"><!--Anchor--></a>8.1&#8195;Accuracy of Representations.
            Each of the Caladrius Fundamental Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as
            of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct as of such date). The Caladrius SEC Matters
            Representations shall have been true and correct in all material respects as of the date of this Agreement and shall be true and correct in all material respects on and as of the Closing Date with the same force and effect as if made on and as
            of such date (except to the extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct as of such date). The Caladrius Capitalization
            Representations shall have been true and correct as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case, (x)&#160;for such
            inaccuracies which are de minimis, individually or in the aggregate or (y) for those representations and warranties which address matters only as of a particular date (which representations and warranties shall have been true and correct,
            subject to the qualifications as set forth in the preceding clause (x), as of such particular date). The representations and warranties of Caladrius and Merger Sub contained in this Agreement (other than the Caladrius Fundamental
            Representations, the Caladrius SEC Matters Representations and the Caladrius Capitalization Representations) shall have been true and correct as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the
            same force and effect as if made on the Closing Date except (a) in each case, or in the aggregate, where the failure to be true and correct would not reasonably be expected to have a Caladrius Material Adverse Effect (without giving effect to
            any references therein to any Caladrius Material Adverse Effect or other materiality qualifications), or (b) for those representations and warranties which address matters only as of a particular date (which representations shall have been true
            and correct, subject to the qualifications as set forth in the preceding clause (a), as of such particular date) (it being understood that, for purposes of determining the accuracy of such representations and warranties, any update of or
            modification to the Caladrius Disclosure Schedule made or purported to have been made after the date of this Agreement shall be disregarded).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS82"><!--Anchor--></a>8.2&#8195;Performance of Covenants.
            Caladrius and Merger Sub shall have performed or complied with in all material respects all of their respective agreements and covenants required to be performed or complied with by each of them, as applicable, under this Agreement at or prior
            to the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS83"><!--Anchor--></a>8.3&#8195;Documents. The Company shall
            have received the following documents, each of which shall be in full force and effect:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;a certificate executed by the Chief Executive Officer or Chief
            Financial Officer of Caladrius confirming that the conditions set forth in <span style="text-decoration: underline;">Sections 8.1</span>, <span style="text-decoration: underline;">8.2</span>, <span style="text-decoration: underline;">8.6</span> and <span style="text-decoration: underline;">8.10</span> have been duly satisfied; and</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;written resignations in form reasonably satisfactory to the
            Company, dated as of the Closing Date and effective as of the Closing, executed by the officers and directors of Caladrius who are not to continue as officers or directors of Caladrius pursuant to <span style="text-decoration: underline;">Section 5.14</span> hereof.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-50<br />
        </div>

      </div>

    </div>

    <!--End Page 439-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 440-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg55"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS84"><!--Anchor--></a>8.4&#8195;Sarbanes-Oxley
            Certifications. Neither the principal executive officer nor the principal financial officer of Caladrius shall have failed to provide, with respect to any Caladrius SEC Document filed (or required to be filed) with the SEC on or after the date
            of this Agreement, any necessary certification in the form required under Rule&#160;13a-14 under the Exchange Act and 18 U.S.C. &#167;1350.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS85"><!--Anchor--></a>8.5&#8195;FIRPTA Certificate. The
            Company shall have received from Caladrius a properly executed statement, in accordance with Treasury Regulation Sections 1.897-2(h) and 1.1445- 2(c)(3) certifying that Caladrius is not and has not been a &#8220;United States real property holding
            corporation&#8221; (as defined in Section 897(c)(2) of the Code) during the applicable period specified in Section 897(c)(1)(A)(ii)&#160;of the Code, together with the required notice to the IRS in accordance with the requirements of Treasury Regulation
            Section 1.897-2(h) and in form and substance reasonably acceptable to the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS86"><!--Anchor--></a>8.6&#8195;No Caladrius Material Adverse
            Effect. Since the date of this Agreement, there shall not have occurred any Caladrius Material Adverse Effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS87"><!--Anchor--></a>8.7&#8195;Board of Directors. Caladrius
            shall have caused the Caladrius Board to be constituted as set forth in <span style="text-decoration: underline;">Section 5.14</span> of this Agreement effective as of the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS88"><!--Anchor--></a>8.8&#8195;Other Deliveries. The Company
            shall have received: (a) certificates of good standing of Caladrius in its jurisdiction of organization and the various foreign jurisdictions in which it is qualified, (b) certified charter documents, and (c) certificates as to the incumbency
            of officers and the adoption of authorizing resolutions.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS89"><!--Anchor--></a>8.9&#8195;Caladrius Lock-Up Agreements.
            The Caladrius Lock-Up Agreements will continue to be in full force and effect as of immediately following the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS810"><!--Anchor--></a>8.10&#8195;Net Cash. Net Cash shall be
            greater than or equal to the applicable amount as set forth on Schedule&#160;8.10.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS811"><!--Anchor--></a>8.11&#8195;Consents.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;All of the consents set forth on Schedule 8.11(a) shall have
            been obtained and shall be in full force and effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;Any Caladrius Permit or other consent required to be obtained by
            Caladrius under any applicable antitrust or competition Law or regulation or other Law shall have been obtained and shall remain in full force and effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS9"><!--Anchor--></a>Section 9&#8195;Termination</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS91"><!--Anchor--></a>9.1&#8195;Termination. This Agreement
            may be terminated prior to the Effective Time (whether before or after adoption of this Agreement by the Company&#8217;s stockholders and whether before or after approval of the Caladrius Stockholder Matters by Caladrius&#8217; stockholders, unless
            otherwise specified below):</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;by mutual written consent of Caladrius and the Company;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;by either Caladrius or the Company if the Contemplated
            Transactions shall not have been consummated by November&#160;11, 2022 (subject to possible extension as provided in this <span style="text-decoration: underline;">Section 9.1(b)</span>, the &#8220;End Date&#8221;); provided, however, that the right to terminate this Agreement under this <span style="text-decoration: underline;">Section
              9.1(b)</span> shall not be available to the Company, on the one hand, or to Caladrius or Merger Sub, on the other hand, if such Party&#8217;s action or failure to act has been a principal cause of the failure of the Contemplated Transactions to occur
            on or before the End Date and such action or failure to act constitutes a breach of this Agreement, or in the event that the SEC has not declared effective under the Securities Act the Registration Statement by the date which is 60 days prior
            to the End Date, then either the Company or Caladrius shall be entitled, on one occasion, to extend the End Date for an additional 60 days;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;by either Caladrius or the Company tf a court of competent
            jurisdiction or other Governmental Body shall have issued a final and nonappealable order, decree or ruling, or shall have taken any other action, having the effect of permanently restraining, enjoining or otherwise prohibiting the Contemplated
            Transactions;</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-51<br />
        </div>

      </div>

    </div>

    <!--End Page 440-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 441-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg56"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;(i)&#160;by Caladrius if the Required Company Stockholder Vote
            shall not have been obtained within two (2) Business Days of the Registration Statement becoming effective in accordance with the provisions of the Securities Act; provided, however, that once the Required Company Stockholder Vote has been
            obtained, Caladrius may not terminate this Agreement pursuant to this <span style="text-decoration: underline;">Section 9.1(d)(i)</span>; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: left;" class="para">(ii)&#8195;&#160;by the Company if (A) the Company Board has effected a Company
            Change of Recommendation and (B) the Company Stockholder Approval shall not have been obtained within two (2)&#160;Business Days of the Registration Statement becoming effective in accordance with the provisions of the Securities Act; provided,
            however, that once the Required Company Stockholder Vote has been obtained, the Company may not terminate this Agreement pursuant to this <span style="text-decoration: underline;">Section 9.1(d)(ii)</span>; and provided, further, that the right to terminate this Agreement under this <span style="text-decoration: underline;">Section




              9.1(d)(ii)</span> shall not be available to the Company where the failure to obtain the Required Company Stockholder Vote shall have been caused by the action or failure to act of the Company and such action or failure to act constitutes a
            material breach by the Company of this Agreement;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;by either Caladrius or the Company if (i)&#160;the Caladrius
            Stockholders&#8217; Meeting (including any adjournments and postponements thereof) shall have been held and completed and Caladrius&#8217; stockholders shall have taken a final vote on the Caladrius Stockholder Matters and (ii)&#160;the Caladrius Stockholder
            Matters shall not have been approved at the Caladrius Stockholders&#8217; Meeting (or at any adjournment or postponement thereof) by the Required Caladrius Stockholder Vote; provided, however, that the right to terminate this Agreement under this <span style="text-decoration: underline;">Section




              9.1(e)</span> shall not be available to Caladrius where the failure to obtain the Required Caladrius Stockholder Vote shall have been caused by the action or failure to act of Caladrius and such action or failure to act constitutes a material
            breach by Caladrius of this Agreement;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;by the Company (at any time prior to the approval of the
            Caladrius Stockholder Matters by the Required Caladrius Stockholder Vote) if a Caladrius Triggering Event shall have occurred;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;by Caladrius (at any time prior to the adoption of this
            Agreement and the approval of the Contemplated Transactions by the Required Company Stockholder Vote) if a Company Triggering Event shall have occurred;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;by the Company, upon a breach of any representation, warranty,
            covenant or agreement set forth in this Agreement by Caladrius or Merger Sub, or if any representation or warranty of Caladrius or Merger Sub shall have become inaccurate, in either case, such that the conditions set forth in <span style="text-decoration: underline;">Section 8.1</span>
            or <span style="text-decoration: underline;">Section&#160;8.2</span> would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; provided that the Company is not then in material breach of any representation,
            warranty, covenant or agreement under this Agreement; provided, further, that if such inaccuracy in Caladrius&#8217; or Merger Sub&#8217;s representations and warranties or breach by Caladrius or Merger Sub is curable by Caladrius or Merger Sub, then this
            Agreement shall not terminate pursuant to this <span style="text-decoration: underline;">Section&#160;9.1(h)</span> as a result of such particular breach or inaccuracy until the earlier of (i)&#160;the expiration of a 30-day period commencing upon delivery of written notice from the Company to
            Caladrius or Merger Sub of such breach or inaccuracy and its intention to terminate pursuant to this <span style="text-decoration: underline;">Section 9.1(h)</span> and (ii)&#160;Caladrius or Merger Sub (as applicable) ceasing to exercise commercially reasonable efforts to cure such breach
            following delivery of written notice from the Company to Caladrius or Merger Sub of such breach or inaccuracy and its intention to terminate pursuant to this <span style="text-decoration: underline;">Section 9.1(h)</span> (it being understood that this Agreement shall not terminate
            pursuant to this <span style="text-decoration: underline;">Section 9.1(h)</span> as a result of such particular breach or inaccuracy if such breach by Caladrius or Merger Sub is cured prior to such termination becoming effective);</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;by Caladrius, upon a breach of any representation, warranty,
            covenant or agreement set forth in this Agreement by the Company, or if any representation or warranty of the Company shall have become inaccurate, in either case, such that the conditions set forth in <span style="text-decoration: underline;">Section 7.1</span> or <span style="text-decoration: underline;">Section 7.2</span>
            would not be satisfied as of the time of such breach or as of the time such representation or warranty shall have become inaccurate; provided that Caladrius is not then in material breach of any representation, warranty, covenant or agreement
            under this Agreement; provided, further, that if such inaccuracy in the Company&#8217;s representations and warranties or breach by the Company is curable by the Company then this Agreement shall not terminate pursuant to this <span style="text-decoration: underline;">Section&#160;9.1(i)</span>
            as a result of such particular breach or inaccuracy until the earlier of (i)&#160;the expiration of a 30-day period commencing upon delivery of written notice from Caladrius </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-52<br />
        </div>

      </div>

    </div>

    <!--End Page 441-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 442-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg57"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">to the Company of such breach or inaccuracy and its intention to terminate pursuant
            to this <span style="text-decoration: underline;">Section&#160;9.1(i)</span> and (ii)&#160;the Company ceasing to exercise commercially reasonable efforts to cure such breach following delivery of written notice from Caladrius to the Company of such breach or inaccuracy and its intention to
            terminate pursuant to this <span style="text-decoration: underline;">Section 9.1(i)</span> (it being understood that this Agreement shall not terminate pursuant to this <span style="text-decoration: underline;">Section 9.1(i)</span> as a result of such particular breach or inaccuracy if such breach by the Company is cured
            prior to such termination becoming effective);</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(j)&#8195;by Caladrius, at any time prior to the approval of the Caladrius
            Stockholder Matters by the Required Caladrius Stockholder Vote and following compliance with all of the requirements set forth in the proviso to this <span style="text-decoration: underline;">Section 9.1(j)</span>, upon the Caladrius Board authorizing Caladrius to enter into a
            Permitted Alternative Agreement; provided, however, that Caladrius shall not enter into any Permitted Alternative Agreement unless: (i)&#160;the Company shall have received written notice from Caladrius of Caladrius&#8217; intention to enter into such
            Permitted Alternative Agreement at least four Business Days in advance, with such notice describing in reasonable detail the reasons for such intention as well as the material terms and conditions of such Permitted Alternative Agreement,
            including the identity of the counterparty together with copies of the then current draft of such Permitted Alternative Agreement and any other related principal transaction documents, (ii)&#160;Caladrius shall have complied in all material respects
            with its obligations under <span style="text-decoration: underline;">Section 4.4</span> and <span style="text-decoration: underline;">Section 5.3</span> and (iii)&#160;the Caladrius Board shall have determined in good faith, after consultation with its outside legal counsel, that the failure to enter into such Permitted
            Alternative Agreement would be inconsistent with its fiduciary duties under applicable Law;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(k)&#8195;by Caladrius if the Company Audited Financial Statements are not
            delivered to Caladrius by August&#160;1, 2022; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(l)&#8195;by the Company, at any time prior to the approval of the Company
            Stockholder Matters by the Required Company Stockholder Vote and following compliance with all of the requirements set forth in the proviso to this <span style="text-decoration: underline;">Section 9.1(l)</span>, upon the Company Board authorizing the Company to enter into a Permitted
            Alternative Agreement; provided, however, that the Company shall not enter into any Permitted Alternative Agreement unless: (i)&#160;Caladrius shall have received written notice from the Company of the Company&#8217;s intention to enter into such
            Permitted Alternative Agreement at least four Business Days in advance, with such notice describing in reasonable detail the reasons for such intention as well as the material terms and conditions of such Permitted Alternative Agreement,
            including the identity of the counterparty together with copies of the then current draft of such Permitted Alternative Agreement and any other related principal transaction documents, (ii)&#160;the Company shall have complied in all material
            respects with its obligations under <span style="text-decoration: underline;">Section 4.4</span> and <span style="text-decoration: underline;">Section 5.2</span> and (iii)&#160;the Company Board shall have determined in good faith, after consultation with its outside legal counsel, that the failure to enter into such Permitted
            Alternative Agreement would be inconsistent with its fiduciary duties under applicable Law.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Party desiring to terminate this Agreement pursuant to this <span style="text-decoration: underline;">Section 9.1</span>
            (other than pursuant to <span style="text-decoration: underline;">Section&#160;9.1(a))</span> shall give a notice of such termination to the other Party specifying the provisions hereof pursuant to which such termination is made and the basis therefor described in reasonable detail.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS92"><!--Anchor--></a>9.2&#8195;Effect of Termination. In the
            event of the termination of this Agreement as provided in <span style="text-decoration: underline;">Section 9.1</span>, this Agreement shall be of no further force or effect; provided, however, that (a) this <span style="text-decoration: underline;">Section 9.2</span>, <span style="text-decoration: underline;">Section 9.3</span>, and <span style="text-decoration: underline;">Section&#160;10</span> shall
            survive the termination of this Agreement and shall remain in full force and effect, and (b) the termination of this Agreement and the provisions of <span style="text-decoration: underline;">Section 9.3</span> shall not relieve any Party of any liability for fraud or for any willful
            and material breach of any representation, warranty, covenant, obligation or other provision contained in this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS93"><!--Anchor--></a>9.3&#8195;Expenses.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;Except as set forth in this <span style="text-decoration: underline;">Section 9.3</span>, all fees and
            expenses incurred in connection with this Agreement and the Contemplated Transactions shall be paid by the Party incurring such expenses, whether or not the Merger is consummated.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;If (i)(A) this Agreement is terminated by Caladrius or the
            Company pursuant to Section 9.1(e), or (B)&#160;this Agreement is terminated by the Company pursuant to <span style="text-decoration: underline;">Section 9.1(b)</span> or <span style="text-decoration: underline;">Section 9.1(h)</span>, (ii)&#160;at any time after the date of this Agreement and prior to the Caladrius Stockholders&#8217;
            Meeting, an Acquisition Proposal with respect to Caladrius shall have been publicly announced, disclosed or otherwise </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-53<br />
        </div>

      </div>

    </div>

    <!--End Page 442-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 443-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg58"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;" class="para">communicated to the Caladrius Board (and shall not have been withdrawn) and
            (iii)&#160;within 12 months after the date of such termination, Caladrius enters into a definitive agreement with respect to a Subsequent Transaction or consummates a Subsequent Transaction, then Caladrius shall pay to the Company, upon such entry
            into a definitive agreement and/or consummation of a Subsequent Transaction, a nonrefundable fee in an amount equal to $1,000,000 (the &#8220;Company Termination Fee&#8221;), plus any amount payable to the Company pursuant to <span style="text-decoration: underline;">Section 9.3(i)</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;If (i)(A) this Agreement is terminated by Caladrius or the
            Company pursuant to <span style="text-decoration: underline;">Section 9.1(d)(i) </span><span style="text-decoration: underline;">or (ii), as applicable</span>, or (B) this Agreement is terminated by Caladrius pursuant to <span style="text-decoration: underline;">Section 9.1(b)</span> or <span style="text-decoration: underline;">Section&#160;9.1(i)</span>, (ii)&#160;at any time after the date of this Agreement and
            prior to the receipt of the Required Company Stockholder Vote, an Acquisition Proposal with respect to the Company shall have been publicly announced, disclosed or otherwise communicated to the Company Board (and shall not have been withdrawn)
            and (iii)&#160;within 12 months after the date of such termination, the Company enters into a definitive agreement with respect to a Subsequent Transaction or consummates a Subsequent Transaction, then the Company shall pay to Caladrius, upon such
            entry into a definitive agreement and/or consummation of a Subsequent Transaction, a nonrefundable fee in an amount equal to $4,000,000 (the &#8220;Caladrius Termination Fee&#8221;), plus any amount payable to Caladrius pursuant to <span style="text-decoration: underline;">Section 9.3(i)</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;If (i)&#160;this Agreement is terminated by Caladrius pursuant to <span style="text-decoration: underline;">Section




              9.1(g)</span> or (ii)&#160;this Agreement is terminated by the Company pursuant to <span style="text-decoration: underline;">Section 9.1(l)</span>, then the Company shall pay to Caladrius, concurrent with such termination, the Caladrius Termination Fee, in addition to any amount payable to
            Caladrius pursuant to <span style="text-decoration: underline;">Section 9.3(i)</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;If (i)&#160;this Agreement is terminated by Caladrius pursuant to <span style="text-decoration: underline;">Section




              9.1(j)</span> or (ii)&#160;this Agreement is terminated by the Company pursuant to <span style="text-decoration: underline;">Section 9.1(f)</span>, then Caladrius shall pay to the Company, concurrent with such termination, the Company Termination Fee, in addition to any amount payable to
            the Company pursuant to <span style="text-decoration: underline;">Section 9.3(i)</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;(i)&#160;If this Agreement is terminated by the Company pursuant to <span style="text-decoration: underline;">Section




              9.1(e)</span> or <span style="text-decoration: underline;">9.1(h)</span> or (ii)&#160;in the event of the failure of the Company to consummate the transactions to be contemplated at the Closing solely as a result of a Caladrius Material Adverse Effect as set forth in <span style="text-decoration: underline;">Section 8.5</span>
            (provided, that at such time all of the other conditions precedent to Caladrius&#8217; obligation to close set forth in <span style="text-decoration: underline;">Section 6</span> and <span style="text-decoration: underline;">Section&#160;7</span> have been satisfied by the Company, are capable of being satisfied by the Company or have
            been waived by Caladrius), then Caladrius shall reimburse the Company for all reasonable out-of-pocket fees and expenses incurred by the Company in connection with this Agreement and the Contemplated Transactions (such expenses, collectively,
            the &#8220;Third Party Expenses&#8221;), up to a maximum of $1,000,000, by wire transfer of same-day funds within ten Business Days following the date on which the Company submits to Caladrius true and correct copies of reasonable documentation supporting
            such Third Party Expenses; provided, however, that such Third Party Expenses shall not include any amounts for financial advisors to the Company except for reasonably documented out-of-pocket expenses otherwise reimbursable by the Company to
            such financial advisors pursuant to the terms of the Company&#8217;s engagement letter or similar arrangement with such financial advisors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;(i) If this Agreement is terminated (A) by Caladrius or the
            Company pursuant to <span style="text-decoration: underline;">Section 9.1(d)(i)</span> or <span style="text-decoration: underline;">(ii)</span>, as applicable, or (B) by Caladrius pursuant to <span style="text-decoration: underline;">Section 9.1(i)</span> or (ii)&#160;in the event of the failure of Caladrius to consummate the transactions to be consummated at the
            Closing solely as a result of a Company Material Adverse Effect as set forth in <span style="text-decoration: underline;">Section 7.6</span>, (provided, that at such time all of the other conditions precedent to the Company&#8217;s obligation to close set forth in <span style="text-decoration: underline;">Section 6</span> and <span style="text-decoration: underline;">Section
              8</span> have been satisfied by Caladrius, are capable of being satisfied by Caladrius or have been waived by the Company), the Company shall reimburse Caladrius for all Third Party Expenses incurred by Caladrius up to a maximum of $1,000,000,
            by wire transfer of same-day funds within ten Business Days following the date on which Caladrius submits to the Company true and correct copies of reasonable documentation supporting such Third Party Expenses; provided, however, that such
            Third Party Expenses shall not include any amounts for financial advisors to Caladrius except for reasonably documented out-of-pocket expenses otherwise reimbursable by Caladrius to such financial advisors pursuant to the terms of Caladrius&#8217;
            engagement letter or similar arrangement with such financial advisors.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-54<br />
        </div>

      </div>

    </div>

    <!--End Page 443-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 444-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg59"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;If either Party fails to pay when due any amount payable by
            it under this <span style="text-decoration: underline;">Section 9.3</span>, then (i)&#160;such Party shall reimburse the other Party for reasonable costs and expenses (including reasonable fees and disbursements of counsel) incurred in connection with the collection of such overdue amount
            and the enforcement by the other Party of its rights under this <span style="text-decoration: underline;">Section 9.3</span>, and (ii)&#160;such Party shall pay to the other Party interest on such overdue amount (for the period commencing as of the date such overdue amount was originally
            required to be paid and ending on the date such overdue amount is actually paid to the other Party in full) at a rate per annum equal to the &#8220;prime rate&#8221; (as announced by Bank of America or any successor thereto) in effect on the date such
            overdue amount was originally required to be paid plus three percent.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;The Parties agree that, subject to <span style="text-decoration: underline;">Section 9.2</span>, the
            payment of the fees and expenses set forth in this <span style="text-decoration: underline;">Section 9.3</span> shall be the sole and exclusive remedy of each Party following a termination of this Agreement under the circumstances described in this <span style="text-decoration: underline;">Section 9.3</span>, it being
            understood that in no event shall either Caladrius or the Company be required to pay the individual fees or damages payable pursuant to this <span style="text-decoration: underline;">Section 9.3</span> on more than one occasion. Subject to <span style="text-decoration: underline;">Section 9.2</span>, following the payment of
            the fees and expenses set forth in this <span style="text-decoration: underline;">Section&#160;9.3</span> by a Party, (i)&#160;such party shall have no further liability to the other Party in connection with or arising out of this Agreement or the termination thereof, any breach of this
            Agreement by the other Party giving rise to such termination, or the failure of the Contemplated Transactions to be consummated, (ii)&#160;no other Party or their respective Affiliates shall be entitled to bring or maintain any other claim, action
            or proceeding against such Party or seek to obtain any recovery, judgment or damages of any kind against such Party (or any partner, member, stockholder, director, officer, employee, Subsidiary, Affiliate, agent or other representative of such
            Party) in connection with or arising out of this Agreement or the termination thereof, any breach by such Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated and (iii) all other Parties and
            their respective Affiliates shall be precluded from any other remedy against such Party and its Affiliates, at law or in equity or otherwise, in connection with or arising out of this Agreement or the termination thereof, any breach by such
            Party giving rise to such termination or the failure of the Contemplated Transactions to be consummated. Each of the Parties acknowledges that (x)&#160;the agreements contained in this <span style="text-decoration: underline;">Section 9.3</span> are an integral part of the Contemplated
            Transactions, (y) without these agreements, the Parties would not enter into this Agreement and (z) any amount payable pursuant to this <span style="text-decoration: underline;">Section 9.3</span> is not a penalty, but rather is liquidated damages in a reasonable amount that will
            compensate the Parties in the circumstances in which such amount is payable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS10"><!--Anchor--></a>Section 10&#8195;Miscellaneous
            Provisions</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS101"><!--Anchor--></a>10.1&#8195;Non-Survival of
            Representations, Warranties and Covenants. The representations and warranties of the Company, Caladrius and Merger Sub contained in this Agreement or any certificate or instrument delivered pursuant to this Agreement shall terminate at the
            Effective Time, and only the covenants that by their terms survive the Effective Time and this <span style="text-decoration: underline;">Section 10</span> shall survive the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS102"><!--Anchor--></a>10.2&#8195;Amendment. This Agreement
            may be amended with the approval of the respective Boards of Directors of the Company, Merger Sub and Caladrius at any time (whether before or after the adoption and approval of this Agreement by the Company&#8217;s stockholders or before or after
            obtaining the Required Caladrius Stockholder Vote); provided, however, that after any such approval of this Agreement by a Party&#8217;s stockholders, no amendment shall be made which by law requires further approval of such stockholders without the
            further approval of such tockholders. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Company, Merger Sub and Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS103"><!--Anchor--></a>10.3&#8195;Waiver.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;No failure on the part of any Party to exercise any power,
            right, privilege or remedy under this Agreement, and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy; and no single
            or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-55<br />
        </div>

      </div>

    </div>

    <!--End Page 444-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 445-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg60"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;No Party shall be deemed to have waived any claim arising out
            of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such
            Party and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS104"><!--Anchor--></a>10.4&#8195;Entire Agreement;
            Counterparts; Exchanges by Facsimile. This Agreement and the other agreements referred to in this Agreement constitute the entire agreement and supersede all prior agreements and understandings, both written and oral, among or between any of
            the Parties with respect to the subject matter hereof and thereof; provided, however, that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect in accordance with its terms. This Agreement may be
            executed in several counterparts, each of which shall be deemed an original and all of which shall constitute one and the same instrument. The exchange of a fully executed Agreement (in counterparts or otherwise) by all Parties by facsimile or
            electronic transmission in .PDF format shall be sufficient to bind the Parties to the terms and conditions of this Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS105"><!--Anchor--></a>10.5&#8195;Applicable Law;
            Jurisdiction. This Agreement shall be governed by, and construed in accordance with, the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of laws. In any action or
            proceeding between any of the Parties arising out of or relating to this Agreement or any of the Contemplated Transactions, each of the Parties: (a) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of
            the Court of Chancery of the State of Delaware or, to the extent such court does not have subject matter jurisdiction, the Superior Court of the State of Delaware or the United States District Court for the District of Delaware; (b) agrees that
            all claims in respect of such action or proceeding shall be heard and determined exclusively in accordance with clause (a) of this <span style="text-decoration: underline;">Section 10.5</span>; (c) waives any objection to laying venue in any such action or proceeding in such courts;
            (d)&#160;waives any objection that such courts are an inconvenient forum or do not have jurisdiction over any Party; (e) agrees that service of process upon such Party in any such action or proceeding shall be effective if notice is given in
            accordance with <span style="text-decoration: underline;">Section 10.8</span> of this Agreement; and (f) irrevocably waives the right to trial by jury.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS106"><!--Anchor--></a>10.6&#8195;Attorneys&#8217; Fees. In any
            action at law or suit in equity to enforce this Agreement or the rights of any of the Parties, the prevailing Party in such action or suit (as determined by a court of competent jurisdiction) shall be entitled to recover its reasonable
            out-of-pocket attorneys&#8217; fees and all other reasonable costs and expenses incurred in such action or suit.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS107"><!--Anchor--></a>10.7&#8195;Assignability. This
            Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective successors and assigns; provided, however, that neither this Agreement nor any of a Party&#8217;s rights or obligations
            hereunder may be assigned or delegated by such Party without the prior written consent of the other Party, and any attempted assignment or delegation of this Agreement or any of such rights or obligations by such Party without the other Party&#8217;s
            prior written consent shall be void and of no effect.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS108"><!--Anchor--></a>10.8&#8195;Notices. All notices and
            other communications hereunder shall be in writing and shall be deemed to have been duly delivered and received hereunder (a) one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable international
            overnight courier service, (b) upon delivery in the case of delivery by hand, or (c) on the date delivered in the place of delivery if sent by email or facsimile (with a written or electronic confirmation of delivery) prior to 6:00 p.m. New
            York City time, otherwise on the next succeeding Business Day, in each case to the intended recipient as set forth below:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 94.87%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">if to Caladrius or Merger Sub:</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">110 Allen Road, 2<sup>nd</sup> Floor </div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basking Ridge, New Jersey 07920</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Attention: David J. Mazzo, Ph.D., President and CEO</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Email: dmazzo@caladrius.com</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-56<br />
        </div>

      </div>

    </div>

    <!--End Page 445-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 446-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg61"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 94.87%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">with a copy to (which shall not constitute notice):</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">666 Third Avenue</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">New York, New York 10017</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Attention: Joel Papernik, Esq.; Daniel Bagliebter, Esq.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Email: JIPapernik@mintz.com; DABagliebter@mintz.com</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 94.87%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">if to the Company:</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CEND Therapeutics, Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12544 High Bluff Drive, Suite 400</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">San Diego, California 92130</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Attention: David Slack, President and CEO</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Email: dslack@cendrx.com</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 94.87%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">with a copy to (which shall not constitute notice):</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Procopio, Cory, Hargreaves &amp; Savitch LLP </div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">12544 High Bluff Drive, Suite 400</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">San Diego, California 92130</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Attention: Paul Johnson, Esq.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 2.56%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 2.56%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 89.74%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Email: paul.johnson@procopio.com</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS109"><!--Anchor--></a>10.9&#8195;Cooperation. Each Party
            agrees to cooperate fully with the other Party and to execute and deliver such further documents, certificates, agreements and instruments and to take such other actions as may be reasonably requested by the other Party to evidence or reflect
            the Contemplated Transactions and to carry out the intent and purposes of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS1010"><!--Anchor--></a>10.10&#8195;Severability. Any term or
            provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the
            offending term or provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that any term or provision of this Agreement is invalid or unenforceable, the Parties agree that
            the court making such determination shall have the power to limit such term or provision, to delete specific words or phrases or to replace such term or provision with a term or provision that is valid and enforceable and that comes closest to
            expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power granted to it in the prior sentence, the Parties
            agree to replace such invalid or unenforceable term or provision with a valid and enforceable term or provision that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term or
            provision.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS1011"><!--Anchor--></a>10.11&#8195;Other Remedies; Specific
            Performance. Except as otherwise provided herein, any and all remedies herein expressly conferred upon a Party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Party, and the
            exercise by a Party of any one remedy will not preclude the exercise of any other remedy. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with
            their specific terms or were otherwise breached. It is accordingly agreed that the Parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in
            any court of the United States or any state having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity, and each of the Parties waives any bond, surety or other security that might be required
            of any other Party with respect thereto.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-57<br />
        </div>

      </div>

    </div>

    <!--End Page 446-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 447-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg62"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS1012"><!--Anchor--></a>10.12&#8195;No Third Party
            Beneficiaries. Nothing in this Agreement, express or implied, is intended to or shall confer upon any Person (other than the Parties and the D&amp;O Indemnified Parties to the extent of their respective rights pursuant to <span style="text-decoration: underline;">Section 5.8</span>)
            any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para"><a id="tANXAS1013"><!--Anchor--></a>10.13&#8195;Construction.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;For purposes of this Agreement, whenever the context requires:
            the singular number shall include the plural, and vice versa; the masculine gender shall include the feminine and neuter genders; the feminine gender shall include the masculine and neuter genders; and the neuter gender shall include masculine
            and feminine genders.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;The Parties agree that any rule of construction to the effect
            that ambiguities are to be resolved against the drafting Party shall not be applied in the construction or interpretation of this Agreement.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(c)&#8195;As used in this Agreement, the words &#8220;include&#8221; and &#8220;including,&#8221;
            and variations thereof, shall not be deemed to be terms of limitation, but rather shall be deemed to be followed by the words &#8220;without limitation.&#8221;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(d)&#8195;The use of the word &#8220;or&#8221; shall not be exclusive.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(e)&#8195;Except as otherwise indicated, all references in this Agreement
            to &#8220;Sections,&#8221; &#8220;Exhibits&#8221; and &#8220;Schedules&#8221; are intended to refer to Sections of this Agreement and Exhibits and Schedules to this Agreement, respectively.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(f)&#8195;Any reference to legislation or to any provision of any
            legislation shall include any modification, amendment, re-enactment thereof, any legislative provision substituted therefore and all rules, regulations, and statutory instruments issued or related to such legislations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(g)&#8195;The bold-faced headings contained in this Agreement are for
            convenience of reference only, shall not be deemed to be a part of this Agreement and shall not be referred to in connection with the construction or interpretation of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(h)&#8195;The Parties agree that the Company Disclosure Schedule or
            Caladrius Disclosure Schedule shall be arranged in sections and subsections corresponding to the numbered and lettered sections and subsections contained in <span style="text-decoration: underline;">Section 2</span> or <span style="text-decoration: underline;">Section 3</span>, respectively. The disclosures in any section or
            subsection of the Company Disclosure Schedule or the Caladrius Disclosure Schedule shall qualify other sections and subsections in <span style="text-decoration: underline;">Section&#160;2</span> or <span style="text-decoration: underline;">Section 3</span>, respectively, to the extent it is readily apparent from a reading of the
            disclosure that such disclosure is applicable to such other sections and subsections.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(i)&#8195;&#8220;delivered&#8221; or &#8220;made available&#8221; shall mean, with respect to any
            documentation, that prior to 11:59&#160;p.m. (New York City time) on the date that is two calendar days prior to the date of this Agreement, a copy of such material has been posted to and made available by a Party to the other Party and its
            Representatives in the electronic data room maintained by such disclosing Party.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;" class="fpara">(Remainder of page intentionally left blank)</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-58<br />
        </div>

      </div>

    </div>

    <!--End Page 447-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 448-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg63"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">IN WITNESS WHEREOF, the Parties have caused this Agreement to be
            executed as of the date first above written.</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 52.56%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CALADRIUS BIOSCIENCES, INC.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">By: </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">/s/ David Mazzo, Ph.D.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name: </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Mazzo, Ph.D.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Title: </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President and Chief Executive Officer</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 52.56%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CS CEDAR MERGER SUB, INC.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">By: </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">/s/ David Mazzo, Ph.D.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name: </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Mazzo, Ph.D.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Title: </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 52.56%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CEND THERAPEUTICS, INC.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">By:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">/s/ David Slack</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name: </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David Slack</div>
                </td>

  </tr>

  <tr>

    <td style="width: 44.87%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Title: </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 44.87%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President &amp; Chief Executive Officer</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 385.5pt; text-align: center;" class="h1">[SIGNATURE PAGE TO AGREEMENT AND PLAN OF MERGER AND REORGANIZATION]</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-59<br />
        </div>

      </div>

    </div>

    <!--End Page 448-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 449-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg64"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; text-align: center;" class="h1">EXHIBIT A<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="h1">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="h1">CERTAIN DEFINITIONS</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">a)&#8195;For purposes of the Agreement (including this Exhibit A):</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Acquisition Inquiry&#8221; shall mean, with respect to a Party, an
            inquiry, indication of interest or request for information (other than an inquiry, indication of interest or request for information made or submitted by the Company, on the one hand, or Caladrius, on the other hand, to the other Party) that
            could reasonably be expected to lead to an Acquisition Proposal; provided, however, that the term &#8220;Acquisition Inquiry&#8221; shall not include the Merger or the other transactions contemplated by this Agreement or any transactions related to a
            Legacy Caladrius Business Disposition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Acquisition Proposal&#8221; shall mean, with respect to a Party, any offer
            or proposal, whether written or oral (other than an offer or proposal made or submitted by or on behalf of the Company or any of its Affiliates, on the one hand, or by or on behalf of Caladrius or any of its Affiliates, on the other hand, to
            the other Party) contemplating or otherwise relating to any Acquisition Transaction with such Party; provided, however, that any Acquisition Proposal for the purchase of Legacy Caladrius Assets from a Person that has previously negotiated with
            Caladrius, its Subsidiaries and/or the Representatives of it or its Subsidiaries for the purchase of the Legacy Caladrius Assets shall not constitute an Acquisition Proposal for purposes of this Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Acquisition Transaction&#8221; shall mean any transaction or series of
            related transactions involving:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(a)&#8195;any merger, consolidation, amalgamation, share exchange,
            business combination, issuance of securities, acquisition of securities, reorganization, recapitalization, tender offer, exchange offer or other similar transaction: (i)&#160;in which a Party is a constituent entity; (ii)&#160;in which a Person or
            &#8220;group&#8221; (as defined in the Exchange Act and the rules promulgated thereunder) of Persons directly or indirectly acquires beneficial or record ownership of securities representing more than 20% of the outstanding securities of any class of
            voting securities of a Party or any of its Subsidiaries; or (iii)&#160;in which a Party or any of its Subsidiaries issues securities representing more than 20% of the outstanding securities of any class of voting securities of such Party or any of
            its Subsidiaries; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">(b)&#8195;any sale, lease, exchange, transfer, license, acquisition or
            disposition of any business or businesses or assets that constitute or account for 20% or more of the consolidated book value or the fair market value of the assets of a Party and its Subsidiaries, taken as a whole.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Affiliate&#8221; shall have the meaning given to such term in Rule 145
            under the Securities Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Agreement&#8221; shall mean the Agreement and Plan of Merger and
            Reorganization to which this Exhibit A is attached, as it may be amended from time to time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Allocation Certificate&#8221; shall have the meaning set forth in <span style="text-decoration: underline;">Section




              5.20</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Business Day&#8221; shall mean any day other than a day on which banks in
            the State of New York are authorized or obligated to be closed.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Affiliate&#8221; shall mean any Person that is (or at any
            relevant time was) under common control with Caladrius within the meaning of Sections 414(b), (c), (m) and (o) of the Code, and the regulations issued thereunder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Associate&#8221; shall mean any current or former employee,
            independent contractor, officer or director of Caladrius or any of its Subsidiaries.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Audited Balance Sheet&#8221; shall mean the audited balance
            sheet of Caladrius as of December&#160;31, 2021, included in Caladrius&#8217; Report on Form 10-K for the fiscal year ended December&#160;31, 2021, as filed with the SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Awards&#8221; means, collectively, the Caladrius Options,
            Caladrius RSUs and Caladrius Restricted Stock Awards.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Board&#8221; shall mean the board of directors of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Capital Stock&#8221; shall mean the Caladrius Common Stock and
            the Caladrius Preferred Stock.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-60<br />
        </div>

      </div>

    </div>

    <!--End Page 449-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 450-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg65"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Capitalization Representations&#8221; shall mean the
            representations and warranties of Caladrius and Merger Sub set forth in <span style="text-decoration: underline;">Sections 3.6(a)</span>, <span style="text-decoration: underline;">3.6(d)</span> and <span style="text-decoration: underline;">3.22</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Common Stock&#8221; shall mean the Common Stock, $0.001 par
            value per share, of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Contract&#8221; shall mean any Contract: (a) to which Caladrius
            is a party; (b) by which Caladrius or any Caladrius IP Rights or any other asset of Caladrius is or may become bound or under which Caladrius has, or may become subject to, any obligation; or (c) under which Caladrius has or may acquire any
            right or interest.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Fundamental Representations&#8221; shall mean the
            representations and warranties of Caladrius and Merger Sub set forth in <span style="text-decoration: underline;">Sections 3.1</span>, <span style="text-decoration: underline;">3.2</span>, <span style="text-decoration: underline;">3.3</span>, <span style="text-decoration: underline;">3.4</span>, <span style="text-decoration: underline;">3.5(a)</span>, <span style="text-decoration: underline;">3.21</span> and <span style="text-decoration: underline;">3.24</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius IP Rights&#8221; shall mean all Intellectual Property owned,
            licensed or controlled by Caladrius that is necessary for the operation of the business of Caladrius as presently conducted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius IP Rights Agreement&#8221; shall mean any instrument or
            agreement governing, related or pertaining to any Caladrius IP Rights.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Material Adverse Effect&#8221; shall mean any Effect that,
            considered together with all other Effects that have occurred prior to the date of determination of the occurrence of the Caladrius Material Adverse Effect, has or would reasonably be expected to have a material adverse effect on the business,
            financial condition, assets, liabilities or results of operations of Caladrius; provided, however, that Effects arising or resulting from the following shall not be taken into account in determining whether there has been a Caladrius Material
            Adverse Effect: (a) any rejection or non-acceptance by a Governmental Body of a registration statement or filing by Caladrius relating to the Caladrius IP Rights; (b) the announcement of the Agreement or the pendency of the Contemplated
            Transactions; (c) any change in the stock price or trading volume of Caladrius Common Stock (it being understood, however, that any Effect causing or contributing to any change in stock price or trading volume of Caladrius Common Stock may be
            taken into account in determining whether a Caladrius Material Adverse Effect has occurred, unless such Effects are otherwise excepted from this definition); (d) the taking of any action, or the failure to take any action, by Caladrius that is
            required to comply with the terms of the Agreement or the taking of any action expressly permitted by <span style="text-decoration: underline;">Section&#160;4.1(b)</span> of the Caladrius Disclosure Schedule; (e) any changes in or affecting research and development, clinical trials or
            other drug development activities conducted by or on behalf of Caladrius or its Subsidiaries; (f) continued losses from operations or decreases in cash balances of Caladrius or any of its Subsidiaries or on a consolidated basis among Caladrius
            and its Subsidiaries; (g) any natural disaster or any act or threat of terrorism or war anywhere in the world, any armed hostilities or terrorist activities anywhere in the world, any threat or escalation or armed hostilities or terrorist
            activities anywhere in the world or any governmental or other response or reaction to any of the foregoing; (h) any change in GAAP or applicable Law or the interpretation thereof; (i)&#160;general economic or political conditions or conditions
            generally affecting the industries in which Caladrius operates; or (j) any epidemics, pandemics, disease outbreaks, or other public health emergencies or the escalation or worsening thereof, including COVID-19 or the Caladrius&#8217; compliance with
            any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; social distancing, shut down, closure, sequester, safety or similar Law, guidelines or recommendations promulgated by any Governmental Body, the Centers for Disease Control and Prevention or
            the World Health Organization, in each case, in connection with, related to, or in response to COVID-19, including the CARES Act and Families First Coronavirus Response Act; except, in each case with respect to clauses (g), (h),(i)&#160;and (j), to
            the extent disproportionately affecting Caladrius relative to other similarly situated companies in the industries in which Caladrius operates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Options&#8221; shall mean options or other rights to purchase
            shares of Caladrius Common Stock issued by Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Preferred Stock&#8221; shall mean the Series B convertible
            redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value, of Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Registered IP&#8221; shall mean all Caladrius IP Rights that are
            registered, filed or issued under the authority of, with or by any Governmental Body, including all patents, registered copyrights and registered trademarks and all applications for any of the foregoing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Reverse Stock Split&#8221; shall have the meaning set forth in <span style="text-decoration: underline;">Section




              5.19</span>.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-61<br />
        </div>

      </div>

    </div>

    <!--End Page 450-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 451-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg66"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Restricted Stock Awards&#8221; means awards of shares of
            Caladrius Common Stock subject to forfeiture and certain vesting criteria.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius RSUs&#8221; means a restricted stock unit covering shares of
            Caladrius Common Stock issued or granted by Caladrius, which for the avoidance of doubt, shall include performance stock units covering shares of Caladrius Common Stock issued or granted by Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius SEC Matters Representations&#8221; shall mean the
            representations and warranties of Caladrius and Merger Sub set forth in <span style="text-decoration: underline;">Sections 3.7</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Stockholder Support Agreements&#8221; shall have the meaning
            set forth in the recitals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Caladrius Triggering Event&#8221; shall be deemed to have occurred if: (a)
            Caladrius shall have failed to include in the Proxy Statement the Caladrius Board Recommendation or shall have made a Caladrius Board Adverse Recommendation Change; (b) the Caladrius Board or any committee thereof shall have approved, endorsed
            or recommended any Acquisition Proposal; (c) Caladrius shall have entered into any letter of intent or similar document or any Contract relating to any Acquisition Proposal (other than a confidentiality agreement permitted pursuant to <span style="text-decoration: underline;">Section

              4.4</span>); (d) Caladrius or any director or officer of Caladrius shall have willfully and intentionally breached the provisions set forth in <span style="text-decoration: underline;">Section 4.4</span> or <span style="text-decoration: underline;">Section 5.3</span> of the Agreement; or (e) Caladrius shall have failed to
            hold the Caladrius Stockholders&#8217; Meeting within 60 days after the Registration Statement is declared effective under the Securities Act. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Cash Determination Time&#8221; means the close of business on the last
            Business Day prior to the anticipated date for Closing. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;COBRA&#8221; means the Consolidated Omnibus Budget Reconciliation Act of
            1985, as set forth in Section&#160;4980B of the Code and Part 6 of Title I of ERISA.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Code&#8221; shall mean the Internal Revenue Code of 1986, as amended.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Affiliate&#8221; shall mean any Person that is (or at any relevant
            time was) under common control with the Company within the meaning of Sections 414(b), (c), (m) and (o) of the Code, and the regulations issued thereunder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Associate&#8221; shall mean any current or former employee,
            independent contractor, officer or director of the Company or any of its Subsidiaries.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Board&#8221; shall mean the board of directors of the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Capital Stock&#8221; shall mean the Company Common Stock and the
            Company Preferred Stock.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Capitalization Representations&#8221; shall mean the
            representations and warranties of the Company set forth in <span style="text-decoration: underline;">Sections 2.6(a)</span> and <span style="text-decoration: underline;">(d)</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Common Stock&#8221; shall mean the Common Stock, $0.00001 par
            value per share, of the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Contract&#8221; shall mean any Contract: (a) to which the Company
            or any of its Subsidiaries is a Party; (b) by which the Company or any of its Subsidiaries or any Company IP Rights or any other asset of the Company or its Subsidiaries is or may become bound or under which the Company or any of its
            Subsidiaries has, or may become subject to, any obligation; or (c) under which the Company or any of its Subsidiaries has or may acquire any right or interest. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Fundamental Representations&#8221; shall mean the representations
            and warranties of the Company set forth in <span style="text-decoration: underline;">Sections 2.1</span>, <span style="text-decoration: underline;">2.2</span>, <span style="text-decoration: underline;">2.3</span>, <span style="text-decoration: underline;">2.4</span>, <span style="text-decoration: underline;">2.20</span> and <span style="text-decoration: underline;">2.21</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company IP Representations&#8221; shall mean the representations and
            warranties of the Company set forth in <span style="text-decoration: underline;">Section 2.12</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company IP Rights&#8221; shall mean all Intellectual Property owned,
            licensed, or controlled by the Company or its Subsidiaries that is necessary for or used in the operation of the business of the Company and its Subsidiaries as presently conducted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company IP Rights Agreement&#8221; shall mean any instrument or agreement
            governing, related to or pertaining to any Company IP Rights.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-62<br />
        </div>

      </div>

    </div>

    <!--End Page 451-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 452-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg67"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Material Adverse Effect&#8221; shall mean any Effect that,
            considered together with all other Effects that have occurred prior to the date of determination of the occurrence of a Company Material Adverse Effect, has or would reasonably be expected to have a material adverse effect on the business,
            financial condition, assets, liabilities or results of operations of the Company or its Subsidiaries, taken as a whole; provided, however, that Effects arising or resulting from the following shall not be taken into account in determining
            whether there has been a Company Material Adverse Effect: (a) the announcement of the Agreement or the pendency of the Contemplated Transactions; (b) the taking of any action, or the failure to take any action, by the Company that is required
            to comply with the terms of the Agreement or the taking of any action expressly permitted by Section 4.2(a) of the Company Disclosure Schedule; (c) continued losses from operations or decreases in cash balances of the Company or any of its
            Subsidiaries or on a consolidated basis among the Company and its Subsidiaries; (d) any natural disaster or any act or threat of terrorism or war anywhere in the world, any armed hostilities or terrorist activities anywhere in the world, any
            threat or escalation or armed hostilities or terrorist activities anywhere in the world or any governmental or other response or reaction to any of the foregoing; (e) any change in GAAP or applicable Law or the interpretation thereof; (f)
            general economic or political conditions or conditions generally affecting the industries in which the Company and its Subsidiaries operate; or (g) any epidemics, pandemics, disease outbreaks, or other public health emergencies or the
            escalation or worsening thereof, including COVID-19 or the Company&#8217;s compliance with any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221; social distancing, shut down, closure, sequester, safety or similar Law, guidelines or recommendations
            promulgated by any Governmental Body, the Centers for Disease Control and Prevention or the World Health Organization, in each case, in connection with, related to, or in response to COVID-19, including the CARES Act and Families First
            Coronavirus Response Act; except in each case with respect to clauses (e), (f) and (g), to the extent disproportionately affecting the Company and its Subsidiaries, taken as a whole, relative to other similarly situated companies in the
            industries in which the Company and its Subsidiaries operate. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Options&#8221; shall mean options or other rights to purchase
            shares of Company Capital Stock issued by the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Registered IP&#8221; shall mean all Company IP Rights that are
            owned by the Company that are registered, filed or issued under the authority of, with or by any Governmental Body, including all patents, registered copyrights and registered trademarks and all applications for any of the foregoing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Stockholder Support Agreements&#8221; shall have the meaning set
            forth in the recitals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Stockholder Written Consent&#8221; shall have the meaning set
            forth in the recitals.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Stockholders&#8221; shall mean the holders of the capital stock of
            the Company immediately prior to the Effective Time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Triggering Event&#8221; shall be deemed to have occurred if: (a)
            the Company Board or any committee thereof shall have made a Company Board Adverse Recommendation Change or approved, endorsed or recommended any Acquisition Proposal; (b) the Company shall have entered into any letter of intent or similar
            document or any Contract relating to any Acquisition Proposal (other than a confidentiality agreement permitted pursuant to <span style="text-decoration: underline;">Section 4.4</span>); or (c) the Company or any director or officer of the Company shall have willfully and
            intentionally breached the provisions set forth in <span style="text-decoration: underline;">Section 4.4</span> or <span style="text-decoration: underline;">Section 5.2</span> of the Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Company Unaudited Balance Sheet&#8221; shall mean the unaudited
            consolidated balance sheet of the Company and its consolidated Subsidiaries as of December&#160;31, 2021 provided to Caladrius prior to the date of the Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Confidentiality Agreement&#8221; shall mean the Confidentiality Agreement
            dated November&#160;16, 2021, between the Company and Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Consent&#8221; shall mean any approval, consent, ratification, permission,
            waiver or authorization (including any Governmental Authorization).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Contemplated Transactions&#8221; shall mean the Merger and the other
            transactions contemplated by the Agreement.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-63<br />
        </div>

      </div>

    </div>

    <!--End Page 452-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 453-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg68"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Contract&#8221; shall mean, with respect to any Person, any written
            agreement, contract, subcontract, lease (whether for real or personal property), mortgage, license, or other legally binding commitment or undertaking of any nature to which such Person is a party or by which such Person or any of its assets
            are bound or affected under applicable Law. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;DGCL&#8221; shall mean the General Corporation Law of the State of
            Delaware.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Effect&#8221; shall mean any effect, change, event, circumstance, or
            development.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Encumbrance&#8221; shall mean any lien, pledge, hypothecation, charge,
            mortgage, security interest, lease, license, option, easement, reservation, servitude, adverse title, claim, infringement, interference, option, right of first refusal, preemptive right, community property interest or restriction or encumbrance
            of any nature (including any restriction on the voting of any security, any restriction on the transfer of any security or other asset, any restriction on the receipt of any income derived from any asset, any restriction on the use of any asset
            and any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Enforceability Exceptions&#8221; means the (a) laws of general application
            relating to bankruptcy, insolvency and the relief of debtors; and (b) rules of law governing specific performance, injunctive relief and other equitable remedies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Entity&#8221; shall mean any corporation (including any non-profit
            corporation), partnership (including any general partnership, limited partnership or limited liability partnership), joint venture, estate, trust, company (including any company limited by shares, limited liability company or joint stock
            company), firm, society or other enterprise, association, organization or entity, and each of its successors.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Environmental Law&#8221; means any federal, state, local or foreign Law
            relating to pollution or protection of human health or the environment (including ambient air, surface water, ground water, land surface or subsurface strata), including any law or regulation relating to emissions, discharges, releases or
            threatened releases of Hazardous Materials, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;ERISA&#8221; shall mean the Employee Retirement Income Security Act of
            1974.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;ERISA Affiliate&#8221; means any entity (whether or not incorporated)
            treated as a single employer with the Company or Caladrius, as applicable, for purposes of Section 414 of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Exchange Act&#8221; shall mean the Securities Exchange Act of 1934.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Exchange Ratio&#8221; means, subject to <span style="text-decoration: underline;">Section 1.5(f)</span>, the
            following ratio (rounded to four decimal places): the quotient obtained by dividing (a) the Company Merger Shares by (b) the Company Outstanding Shares, in which:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Caladrius Allocation Percentage&#8221; means 1.00 minus the Company Allocation Percentage; provided, however, that the Caladrius
                    Allocation Percentage is subject to adjustment pursuant to Schedule A. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Caladrius Outstanding Shares&#8221; means, subject to <span style="text-decoration: underline;">Section 1.5(f)</span>, the total number of shares of Caladrius Common Stock
                    issued and outstanding immediately prior to the Effective Time. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Company Merger Shares&#8221; means the product determined by multiplying (i)&#160;the Post-Closing Caladrius Shares by (ii)&#160;the Company
                    Allocation Percentage. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Company Outstanding Shares&#8221; means the total number of shares of Company Capital Stock issued and outstanding immediately prior
                    to the Effective Time after the effectiveness of the Preferred Stock Conversion. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Company Allocation Percentage&#8221; means 0.5; provided, however, that to the extent that the Company Transaction Costs is greater
                    than two hundred fifty thousand dollars ($250,000), then 0.5 shall be reduced by 0.000056 for each ten thousand dollars ($10,000) (rounded down to the next nearest ten thousand dollar ($10,000) increment) that the Company Transaction
                    Costs as so determined is greater than two hundred fifty thousand dollars ($250,000). </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Post-Closing Caladrius Shares&#8221; mean the quotient determined by dividing (i)&#160;the Caladrius Outstanding Shares by (ii)&#160;the
                    Caladrius Allocation Percentage. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-64<br />
        </div>

      </div>

    </div>

    <!--End Page 453-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 454-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg69"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Governmental Authorization&#8221; shall mean any: (a) permit, license,
            certificate, franchise, permission, variance, exception, order, clearance, registration, qualification or authorization issued, granted, given or otherwise made available by or under the authority of any Governmental Body or pursuant to any
            Law; or (b)&#160;right under any Contract with any Governmental Body. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Governmental Body&#8221; shall mean any: (a) nation, state, commonwealth,
            province, territory, county, municipality, district or other jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; (c) governmental or quasi-governmental authority of any nature (including any
            governmental division, department, agency, commission, bureau, instrumentality, official, ministry, fund, foundation, center, organization, unit, body or Entity and any court or other tribunal, and for the avoidance of doubt, any taxing
            authority); or (d) self- regulatory organization (including the Nasdaq Stock Market). </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Hazardous Materials&#8221; shall mean any pollutant, chemical, substance
            and any toxic, infectious, carcinogenic, reactive, corrosive, ignitable or flammable chemical, or chemical compound, or hazardous substance, material or waste, whether solid, liquid or gas, that is subject to regulation, control or remediation
            under any Environmental Law, including without limitation, crude oil or any fraction thereof, and petroleum products or by-products.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Intellectual Property&#8221; shall mean (a) United States, foreign and
            international patents, patent applications, including provisional applications, statutory invention registrations, invention disclosures and inventions, (b)&#160;trademarks, service marks, trade names, domain names, URLs, trade dress, logos and
            other source identifiers, including registrations and applications for registration thereof, (c) copyrights, including registrations and applications for registration thereof, and (d) software, formulae, customer lists, trade secrets, know-how,
            confidential information and other proprietary rights and intellectual property, whether patentable or not.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;IRS&#8221; shall mean the United States Internal Revenue Service.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Key Employee&#8221; shall mean, with respect to the Company or Caladrius,
            an executive officer of such Party or any employee of such Party that reports directly to the board of directors of such Party or to the Chief Executive Officer or Chief Operating Officer of such Party.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Knowledge&#8221; means, with respect to an individual, that such
            individual is actually aware of the relevant fact or such individual would reasonably be expected to know such fact in the ordinary course of the performance of such individual&#8217;s employment responsibilities. Any Person that is an Entity shall
            have Knowledge if any executive officer or director of such Person as of the date such knowledge is imputed has Knowledge of such fact or other matter. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Law&#8221; shall mean any federal, state, national, foreign, material
            local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect
            by or under the authority of any Governmental Body (including under the authority of the Nasdaq Stock Market or the Financial Industry Regulatory Authority).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Legacy Caladrius Business Disposition&#8221; means any sale, lease,
            exchange, transfer, license, disposition or other monetization of the technology and intellectual property of the Legacy Caladrius Assets. For the avoidance of doubt, the Legacy Caladrius Assets do not include any shares of capital stock of
            Caladrius. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Legacy Caladrius Assets&#8221; means the technology and intellectual
            property of Caladrius in existence on the date of this Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Legacy Caladrius Assets Proceeds&#8221; means the proceeds received by
            Caladrius in connection with the Legacy Caladrius Business Disposition prior to the Closing.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Legal Proceeding&#8221; shall mean any action, suit, litigation,
            arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), hearing, inquiry, audit, examination or investigation commenced, brought, conducted or heard by or before, or otherwise involving,
            any court or other Governmental Body or any arbitrator or arbitration panel. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Merger Sub Board&#8221; shall mean the board of directors of Merger Sub.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-65<br />
        </div>

      </div>

    </div>

    <!--End Page 454-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 455-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg70"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Multiemployer Plan&#8221; shall mean (a) a &#8220;multiemployer plan,&#8221; as
            defined in Section 3(37) or 4001(a)(3) of ERISA, or (b) a plan which if maintained or administered in or otherwise subject to the laws of the United States would be described in paragraph (a).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Multiple Employer Plan&#8221; shall mean (a) a &#8220;multiple employer plan&#8221;
            within the meaning of Section 413(c) of the Code, or (b) a plan which if maintained or administered in or otherwise subject to the laws of the United States would be described in paragraph (a).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Multiple Employer Welfare Arrangement&#8221; shall mean (a) a &#8220;multiple
            employer welfare arrangement&#8221; within the meaning of Section 3(40) of ERISA, or (b) a plan which if maintained or administered in or otherwise subject to the laws of the United States would be described in paragraph (a) of this definition.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Net Cash&#8221; shall mean (a) the sum of (without duplication) in each
            case as of the Cash Determination Time, (i)&#160;Caladrius&#8217; cash and cash equivalents, marketable securities, prepaid and other current assets, accounts receivable, interest and other receivables, determined in a manner consistent with the manner in
            which such items were historically determined and in accordance with GAAP and Caladrius&#8217; audited financial statements, including the Legacy Caladrius Assets Proceeds to the extent not distributed to the Caladrius Stockholders immediately prior
            to the Merger, (ii)&#160;expenses paid, or liabilities incurred, prior to Closing, that are approved and guaranteed in writing (without conditions) to be paid to Caladrius pursuant to any directors&#8217; and officers&#8217; insurance policy, and (iii)&#160;amounts
            invested in the Series D Preferred Stock of the Company, minus (b) the sum of (without duplication) in each case as of the Cash Determination Time, (i)&#160;Caladrius&#8217; accounts payable and accrued liabilities (other than accrued liabilities which
            are Caladrius Transaction Costs), in each case determined in a manner consistent with the manner in which such items were historically determined and in accordance with GAAP and Caladrius&#8217; audited financial statements, (ii)&#160;any unpaid Caladrius
            Transaction Costs, and (iii)&#160;any declared but unpaid Caladrius cash dividends. Notwithstanding the foregoing, in no case shall Net Cash be reduced for any costs or expenses, including attorney&#8217;s fees or settlement costs, incurred in connection
            with any Dissenting Shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Ordinary Course of Business&#8221; shall mean, in the case of each of the
            Company and Caladrius, such actions taken in the ordinary course of its normal operations and consistent with its past practices (which, in the case of Caladrius, shall include the potential wind down of its activities related to the Legacy
            Caladrius Assets).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Organizational Documents&#8221; means, with respect to any Person (other
            than an individual), (a) the certificate or articles of association or incorporation or organization or limited partnership or limited liability company, and any joint venture, limited liability company, operating or partnership agreement and
            other similar documents adopted or filed in connection with the creation, formation or organization of such Person and (b) all bylaws, regulations and similar documents or agreements relating to the organization or governance of such Person, in
            each case, as amended or supplemented.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Party&#8221; or &#8220;Parties&#8221; shall mean the Company, Merger Sub and
            Caladrius.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Permitted Alternative Agreement&#8221; means a definitive agreement that
            contemplates or otherwise relates to an Acquisition Transaction that constitutes a Superior Offer.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Permitted Encumbrance&#8221; shall mean: (a) any liens for current Taxes
            not yet due and payable or for Taxes that are being contested in good faith and for which adequate reserves have been made on the Company Unaudited Interim Balance Sheet or the Caladrius Audited Balance Sheet, as applicable; (b) minor liens
            that have arisen in the Ordinary Course of Business and that do not (in any case or in the aggregate) materially detract from the value of the assets subject thereto or materially impair the operations of the Company or any of its Subsidiaries
            or Caladrius, as applicable; (c) statutory liens to secure obligations to landlords, lessors or renters under leases or rental agreements; (d) deposits or pledges made in connection with, or to secure payment of, workers&#8217; compensation,
            unemployment insurance or similar programs mandated by Law; and (e) statutory liens in favor of carriers, warehousemen, mechanics and materialmen, to secure claims for labor, materials or supplies.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Person&#8221; shall mean any individual, Entity or Governmental Body.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Pro Rata Share&#8221; shall mean, with respect to each Company
            Stockholder, the percentage set forth opposite the name of such Company Stockholder on the Allocation Certificate. For the avoidance of doubt, the Pro Rata Share of all Company Stockholders in the aggregate will equal 100%. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-66<br />
        </div>

      </div>

    </div>

    <!--End Page 455-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 456-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg71"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Proxy Statement&#8221; shall mean the proxy statement to be sent to
            Caladrius&#8217; stockholders in connection with the Caladrius Stockholders&#8217; Meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Registration Statement&#8221; shall mean the registration statement on
            Form S-4 (or any other applicable form under the Securities Act to register Caladrius Common Stock) to be filed with the SEC by Caladrius registering the public offering and sale of Caladrius Common Stock to some or all holders of Company
            Capital Stock in the Merger, including all shares of Caladrius Common Stock to be issued in exchange for all shares of Company Capital Stock in the Merger, as said registration statement may be amended prior to the time it is declared effective
            by the SEC.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Representatives&#8221; shall mean directors, officers, employees, agents,
            attorneys, accountants, investment bankers, advisors and representatives.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Sarbanes-Oxley Act&#8221; shall mean the Sarbanes-Oxley Act of 2002.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;SEC&#8221; shall mean the United States Securities and Exchange
            Commission.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Securities Act&#8221; shall mean the Securities Act of 1933.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Straddle Period&#8221; shall mean a taxable period that begins on or
            before and ends after the Closing Date. For all purposes of this Agreement, in the case of Taxes based upon income, sales, proceeds, profits, receipts, wages, compensation or similar items, the Taxes attributable to the portion of any Straddle
            Period ending on the Closing Date shall be determined on the basis of a closing of the books as of the close of business on the Closing Date, except that exemptions, allowances or deductions that are calculated on an annual basis (including
            depreciation and amortization deductions), other than with respect to property placed in service after the Closing, shall be allocated on a daily basis, and the amount of any other Taxes attributable to such Straddle Period shall equal the
            amount of such Tax for the entire taxable period multiplied by a fraction, the numerator of which is the number of days in the taxable period up to and including the Closing Date, and the denominator of which is the total number of days in the
            taxable period.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">An entity shall be deemed to be a &#8220;Subsidiary&#8221; of a Person if such
            Person directly or indirectly owns or purports to own, beneficially or of record, (a) an amount of voting securities or other interests in such entity that is sufficient to enable such Person to elect at least a majority of the members of such
            entity&#8217;s board of directors or other governing body, or (b) at least 50% of the outstanding equity, voting, beneficial or financial interests in such Entity.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Subsequent Transaction&#8221; shall mean any Acquisition Transaction (with
            all references to 20% in the definition of Acquisition Transaction being treated as references to 50% for these purposes).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Superior Offer&#8221; shall mean an unsolicited bona fide written
            Acquisition Proposal (with all references to 20% in the definition of Acquisition Transaction being treated as references to 90% for these purposes) <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">that: (a)&#160;was not obtained or made as a direct or indirect result of a breach of (or in
            violation of) the Agreement; and (b) is on terms and conditions that the Caladrius Board or the Company Board, as applicable, determines in good faith, based on such matters that it deems relevant (including the likelihood of consummation
            thereof and the financing terms thereof), as well as any written offer by the other Party to the Agreement to amend the terms of the Agreement, and following consultation with its outside legal counsel and financial advisors, if any, are more
            favorable, from a financial point of view, to Caladrius&#8217; stockholders or the Company&#8217;s stockholders, as applicable, than the terms of the Contemplated Transactions and is not subject to any financing condition (and if financing is required,
            such financing is then fully committed to the third party).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Tax&#8221; shall mean any federal, state, local, foreign or other tax,
            assessment and other charges and duties in the nature of a tax, including (a) any income tax, franchise tax, capital gains tax, gross receipts tax, value-added tax, surtax, estimated tax, unemployment tax, escheat, unclaimed property, national
            health insurance tax, excise tax, ad valorem tax, transfer tax, stamp tax, sales tax, use tax, property tax, business tax, withholding tax, payroll tax, customs duty, alternative or add-on minimum or other tax of any kind whatsoever, and
            including any fine, penalty, addition to tax or interest imposed by a Governmental Body with respect thereto, (b) any liability for the payment of any amounts of the type described in clause (a) as a result of being or having been a member of
            an affiliated, consolidated, combined, unitary or similar group for any period, and (c) any liability for the payment </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-67<br />
        </div>

      </div>

    </div>

    <!--End Page 456-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 457-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg72"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">of any amounts of the type described in clauses (a) or (b) as a result of any
            obligation to indemnify any other Person or as a result of any obligation under any agreement or arrangement with any other Person with respect to such amounts and including any liability for taxes of as a successor or transferee, by operation
            of Law or otherwise.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Tax Return&#8221; shall mean any return (including any information
            return), report, statement, declaration, estimate, schedule, notice, notification, form, election, certificate or other document or information, and any amendment or supplement to any of the foregoing, filed with or submitted to, or required to
            be filed with or submitted to, any Governmental Body in connection with the determination, assessment, collection or payment of any Tax or in connection with the administration, implementation or enforcement of or compliance with any Law
            relating to any Tax.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Transaction Costs&#8221; means the aggregate amount of costs and expenses
            of a Person or any of its Subsidiaries incurred in connection with the negotiation, preparation and execution of this Agreement and the consummation of the Merger and the other Contemplated Transactions, including (a) any brokerage fees and
            commissions, finders&#8217; fees or financial advisory fees, any fees and expenses of counsel or accountants payable by such Person or any of its Subsidiaries and any transaction bonuses or similar items in connection with the Contemplated
            Transactions, (b) any bonus, severance, change-in-control payments or similar payment obligations (including payments with &#8220;single-trigger&#8221; provisions triggered at and as of the consummation of the Contemplated Transactions) that become due or
            payable to any director, officer, employee or consultant of such Person in connection with the consummation of the Contemplated Transactions, (c) any payments to third parties under any Contract to which such Person or its Subsidiaries are a
            party triggered by the consummation of the Contemplated Transactions, or any payment or consideration arising under or in relation to obtaining any consents, waivers or approvals of any third party under any Contract to which such Person or its
            Subsidiaries are a party required to be obtained in connection with the consummation of the Contemplated Transactions in order for any such Contract to remain in full force and effect following the Closing or resulting from agreed- upon
            modification or early termination of any such Contract, in each case with respect to the foregoing matters (a)-(c), to the extent unpaid. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">&#8220;Treasury Regulations&#8221; shall mean the United States Treasury
            regulations promulgated under the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-indent: 20pt; text-align: left;" class="para">b)&#8195;Each of the following terms is defined in the Section set forth
            opposite such term:</div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Term </div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="para">Section</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">409A Plan </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.17(k)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Capitalization Date </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.6(a) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Certificate of Merger </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Certification </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.7(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Closing </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">Preamble</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Board Recommendation</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.3(b)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Disclosure Schedule </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Employee Plan </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.17(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Intervening Event </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.3(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Leased Real Property </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.11.(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Material Contract </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.13</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Notice Period </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.3(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Permits </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.14(b)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Product Candidates </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.14(d)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Regulatory Permits </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.14(d)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Real Estate Leases </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.11</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius SEC Documents </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.7(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Stock Plans </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.6(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Caladrius Stockholders&#8217; Meeting </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.3(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Closing Date </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.3</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">Preamble</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-68<br />
        </div>

      </div>

    </div>

    <!--End Page 457-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 458-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_300-annexa_pg73"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Term </div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="para">Section</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Board Adverse Recommendation Change </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.2(d)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Board Recommendation </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.2(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Disclosure Schedule </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">Section 2</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Employee Plan </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.17(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Financials </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.7(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Material Contract </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.13</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Plan </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.6(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Permits </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.14(b)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Preferred Stock </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.6(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Product Candidates </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.14(d)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Real Estate Leases </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.11</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Regulatory Permits </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.14(d)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Company Stock Certificate </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.7</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Costs </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.8(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">D&amp;O Indemnified Party </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.8(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Dissenting Shares </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.9(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Drug Regulatory Agency </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.14(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Effective Time </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.3 </div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">End Date </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">9.1(b)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Exchange Agent </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.8(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Exchange Fund </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.8(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">FDA </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.14(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">FDCA </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.14(c)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">GAAP </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.7(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Investor Agreements </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.16</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Joint Development Agreement </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.21</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Liability </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.9</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Merger </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">Recitals</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Merger Sub </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">Preamble</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Notice Period </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">5.3(c)(i)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Pre-Closing Period </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">4.1(a)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Preferred Stock Conversion </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">7.4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Required Company Stockholder Vote </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">2.4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Required Caladrius Stockholder Vote </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">3.4</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Surviving Corporation </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">1.1</div>
                </td>

  </tr>

  <tr>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="para">Third Party Expenses </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 47.44%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="para">9.3(b)</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">A-69<br />
        </div>

      </div>

    </div>

    <!--End Page 458-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 459-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_301-annexb_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;" class="h1"><a id="tANNEXB"><!--Anchor--></a>Annex B</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;" class="fpara">April&#160;25, 2022 <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Board of Directors <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc. <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">110 Allen Road, 2nd Floor <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Basking Ridge, NJ 07920 </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">Members of the Board of Directors: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">We understand that Caladrius Biosciences, Inc. (&#8220;Caladrius&#8221;) intends
            to enter into an Agreement and Plan of Merger and Reorganization (the &#8220;Agreement&#8221;) by and between Caladrius, CS Cedar Merger Sub, Inc., (&#8220;Merger Sub&#8221;), Cend Therapeutics (&#8220;Cend&#8221;). Pursuant to the Agreement, Merger Sub will merge with and into
            Cend, and Cend will become a wholly owned subsidiary of Caladrius (the &#8220;Transaction&#8221;). At the Effective Date of the Transaction, (i)&#160;those 1,135,650 shares of Cend Series D Preferred Stock, $.00001 par value per share, to be issued to Caladrius
            for an aggregate purchase price of $10.0&#160;million pursuant to a Collaboration Agreement to be entered into by Caladrius and Cend concurrently with their entry into the Merger Agreement shall be cancelled and (ii)&#160;each other then-outstanding
            share of Cend capital stock shall be converted into the right to receive a number of shares of Caladrius Common Stock equal to the quotient of (x)&#160;the number of shares of Caladrius Common Stock issued and outstanding immediately prior to the
            effective time of the Transaction (the &#8220;Effective Time&#8221;) <span style="font-style: italic;">divided by </span>(y) the total number of shares of Cend capital stock issued and outstanding immediately prior to the Effective Time, subject to
            certain adjustments, limitations and procedures set forth in the Agreement (collectively, the &#8220;Consideration&#8221;). The terms and conditions of the Transaction are set forth in more detail in the Merger Agreement, and the summary of the Transaction
            set forth above is qualified in its entirety by the terms of the Merger Agreement. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Caladrius Board of Directors has requested our opinion as to the
            fairness to Caladrius, from a financial point of view, of the Consideration to be paid in the aggregate in the Transaction. Back Bay Life Science Advisors, LLC is an investment banking and strategic advisory boutique engaged in life
            sciences-focused strategic, corporate financial and mergers and acquisition advisory services, offering securities-related services through a wholly owned broker-dealer subsidiary. We have been engaged by Caladrius to act as financial advisor
            to Caladrius with respect to the Transaction and in connection with this Opinion. We have received advisory fees in conjunction with our services to-date and will receive an opinion fee from Caladrius in conjunction with the rendering of this
            Opinion. No fees payable to us are contingent upon the closing of the Transaction. Caladrius has also agreed to reimburse us for expenses, and indemnify us against liabilities that may arise from our engagement. In the ordinary course of our
            business, we may, in the future, provide additional advisory services to Caladrius, receiving customary fees therefor, or hold positions for our own accounts in securities of Caladrius. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In connection with our Opinion, we have among other things:
            (i)&#160;reviewed the draft Merger Agreement, dated April&#160;24, 2022, and other Transaction-related documentation, including the Collaboration Agreement, dated April&#160;25, 2022, and the Series D Stock Purchase Agreement, dated April&#160;25, 2022;
            (ii)&#160;reviewed certain publicly available historic financials, operating data, and other business information regarding Caladrius; (iii)&#160;reviewed financial and operating information with respect to the business, operations and prospects of
            Caladrius furnished to us by Caladrius, including financial projections of Caladrius prepared by management of Caladrius (the &#8220;Caladrius Projections&#8221;) (iii)&#160;reviewed financials, operating data, capitalization, pro formas, other internal
            documents, trading information of Caladrius stock, and other business information regarding Cend, prepared by and furnished to us by the management of Cend, including financial projections of Cend prepared by management of Cend (the &#8220;Cend
            Projections&#8221;); (iv)&#160;held discussions with members of senior management of Caladrius and Cend, regarding past and current operations, financial condition and prospects; (v)&#160;reviewed certain financial and stock market data of Caladrius and other
            selected publicly held companies we deemed to be comparable to Caladrius and Cend; (vi)&#160;reviewed the financial terms, to the extent publicly available, of certain announced acquisitions and corporate transactions we deemed to be comparable to
            the Transaction; (viii)&#160;performed a discounted cash flow analysis of Cend on a stand-alone basis; and (ix)&#160;taken into account such other quantitative analyses and other matters we deemed relevant and necessary, including an assessment of
            general economic, market and monetary conditions. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In conducting our review and analysis and in arriving at our Opinion,
            we have, with your consent, assumed and relied, without independent investigation, upon the accuracy and completeness of all financial and other information provided to us or publicly available. We have not undertaken any responsibility for
            independently </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">B-1<br />
        </div>

      </div>

    </div>

    <!--End Page 459-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 460-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_301-annexb_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">verifying, and did not independently verify the accuracy, completeness, or
            reasonableness of any such information and have further relied upon the assurances of the management of Caladrius that they are not aware of any facts or circumstances that would make such information inaccurate or misleading. We have not made
            or obtained any independent evaluations, valuations or appraisals of the assets or liabilities (contingent or otherwise) of Caladrius or Cend, nor have we been furnished with such materials. We have made no independent investigation of any
            legal, accounting or tax matters relating to Caladrius, Cend, or the Transaction, and have assumed the correctness and adequacy of all legal, accounting and tax advice given. With respect to the Caladrius Projections, upon your advice, we have
            assumed that such projections have been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of Caladrius as to the future financial performance of Caladrius and that Caladrius will
            perform substantially in accordance with such projections and have relied on the Caladrius Projections in arriving at our opinion. With respect to the Cend Projections, upon your advice and at your direction, we have assumed that such
            projections have been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of Cend as to the future financial performance of Cend and that Cend will perform substantially in accordance
            with such projections and have relied on the Cend Projections in arriving at our opinion. We are assuming in our analysis that Caladrius will be deemed to be the acquiring party for accounting purposes. For purposes of rendering our Opinion, we
            have assumed in all respects material to our analysis, that the Consideration was determined through arm&#8217;s-length negotiations between the appropriate parties, that the representations and warranties of each party contained in the Agreement are
            true and correct, that each party will perform all of the covenants and agreements required to be performed by it under the Agreement without material alteration or waiver thereof, that all estimated financial forecasts will be realized, that
            all governmental, regulatory, shareholder or other consents and approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the expected benefits of the Transaction or in any way meaningful to our
            analysis, and that all conditions to the consummation of the proposed Transaction will be satisfied without material alteration. We have also assumed, with your consent, that the final form of the Agreement will be substantially the same as the
            last draft reviewed by us. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In addition, we have assumed, with your consent, that the historical
            financial statements of Caladrius reviewed by us have been prepared and fairly presented in accordance with U.S. generally accepted accounting principles (GAAP) consistently applied. We understand that the Cend historical financial statements
            reviewed by us have not been prepared in accordance with U.S. GAAP. We have assumed, with your consent, that the Cend historical financial statements reviewed by us are materially complete and fairly present the financial condition and results
            of operations of Cend as of and for the dates and periods indicated therein. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">We have further assumed, with your consent, that as of the date
            hereof, there has been no material adverse change in Caladrius&#8217;s or Cend&#8217;s assets, financial condition, results of operations, business, or prospects since the date of the last financial statements made available to us which change has not been
            disclosed to us prior to the date hereof. We do not express any opinion as to (i)&#160;the value of any other arrangement entered into in connection with the proposed Transaction, or (ii)&#160;any tax or other consequences that might result from the
            proposed Transaction. We are not expressing any opinion as to the impact of the Transaction on the solvency or viability of the combined company. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Our opinion does not address the relative merits of the Transaction
            as compared to alternative transactions or strategies that might be available to Caladrius, nor does it address the underlying business decision of Caladrius or the Board to pursue, structure, approve, recommend or proceed with the Transaction.
            We do not express any view on, and this opinion does not address, any other term or aspect of the Agreement or the transactions contemplated thereby or any term or aspect of any other agreement or instrument contemplated by the Agreement or
            entered into or amended in connection therewith. Furthermore, no opinion, counsel or interpretation is intended in matters that require legal, regulatory, accounting, insurance, tax or other similar professional advice. It is assumed that such
            opinions, counsel or interpretations have been or will be obtained from the appropriate professional sources. Furthermore, we have relied, with your consent, on the advice of the outside counsel and independent accountants of Caladrius, and on
            the assumptions of the management of Caladrius, as to all legal, regulatory, accounting, insurance and tax matters with respect to Caladrius, Cend, and the Transaction. In addition, we express no opinion on, and our opinion does not in any
            manner address, the fairness of the amount or the nature of any compensation to be paid to any officers, directors or employees of any parties to the Transaction, or any class of such persons, relative to the consideration paid in the
            Transaction or otherwise. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">B-2<br />
        </div>

      </div>

    </div>

    <!--End Page 460-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 461-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_301-annexb_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In preparing our opinion, we performed a variety of valuation
            analyses, including those described above. The summary of our analyses is not a complete description of the analyses underlying our opinion. The preparation of a fairness opinion is a complex process involving various quantitative and
            qualitative judgments and determinations with respect to the financial, comparative and other analytic methods employed and the adaptation and application of those methods to the unique facts and circumstances presented. As a consequence,
            neither our opinion nor the analyses underlying our opinion are readily susceptible to partial analysis or summary description. We arrived at our opinion based on the results of all analyses undertaken by us and assessed as a whole and did not
            draw, in isolation, conclusions from or with regard to any individual analysis, analytic method or factor. Accordingly, we believe that our analyses must be considered as a whole and that selecting portions of our analyses, analytic methods and
            factors, without considering all analyses and factors or the narrative description of the analyses, could create a misleading or incomplete view of the processes underlying its analyses and opinion. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">It is understood that our opinion is for the sole benefit and use of
            the Board of Directors of Caladrius in its consideration of the aggregate Consideration to be paid in the Transaction, and it is explicitly agreed between Caladrius and Back Bay that the Opinion should not be construed as a recommendation or
            investment advice to any holders of Caladrius securities with respect to how such securityholders should vote or otherwise act with respect to the Transaction. This opinion is approved by an authorized internal committee of Back Bay and is
            necessarily based upon information made available to it and market, economic and other conditions as they exist on, and can be evaluated as of the date hereof. We express no opinion as to the prices at which shares of Caladrius Common Stock
            would trade following the announcement or consummation of the Transaction. With the exception of a Bringdown Opinion as defined in the Addendum to our advisory services agreement with Caladrius we have and undertake no obligation to update,
            revise, reaffirm or withdraw its opinion, or otherwise comment on or consider events occurring hereafter. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Based upon and subject to the foregoing, it is our opinion that the
            Consideration to be paid in the Transaction pursuant to the Agreement is fair to Caladrius, from a financial point of view. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">Sincerely, </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 19.75pt; margin-left: 0pt; text-align: left;" class="fpara"><img src="sig_backbay.jpg" style="height: 29px; width: 297px;" alt="graphic" /><br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">&#8201;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;" class="fpara">BACK BAY LIFE SCIENCE ADVISORS, LLC</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">B-3<br />
        </div>

      </div>

    </div>

    <!--End Page 461-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 462-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_302-annexc_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;" class="h1"><a id="tANNEXC"><!--Anchor--></a>Annex C </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; text-align: center;" class="h1">SECTION 262 OF THE GENERAL CORPORATION LAW OF THE STATE OF DELAWARE </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;" class="h2"><span style="text-decoration: underline;">&#167;</span><span style="text-decoration: underline;"> 262. Appraisal rights.</span> </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(a) Any stockholder of a corporation of this State who holds shares of stock on the
            date of the making of a demand pursuant to subsection (d) of this section with respect to such shares, who continuously holds such shares through the effective date of the merger or consolidation, who has otherwise complied with subsection (d)
            of this section and who has neither voted in favor of the merger or consolidation nor consented thereto in writing pursuant to &#167; 228 of this title shall be entitled to an appraisal by the Court of Chancery of the fair value of the stockholder&#8217;s
            shares of stock under the circumstances described in subsections (b) and (c) of this section. As used in this section, the word &#8220;stockholder&#8221; means a holder of record of stock in a corporation; the words &#8220;stock&#8221; and &#8220;share&#8221; mean and include
            what is ordinarily meant by those words; and the words &#8220;depository receipt&#8221; mean a receipt or other instrument issued by a depository representing an interest in 1 or more shares, or fractions thereof, solely of stock of a corporation, which
            stock is deposited with the depository. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(b) Appraisal rights shall be available for the shares of any class or series of stock
            of a constituent corporation in a merger or consolidation to be effected pursuant to &#167; 251 (other than a merger effected pursuant to &#167; 251(g) of this title and, subject to paragraph (b)(3) of this section, &#167; 251(h) of this title), &#167; 252, &#167; 254,
            &#167; 255, &#167; 256, &#167; 257, &#167; 258, &#167; 263 or &#167; 264 of this title: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(1) Provided, however, that, except as expressly provided in &#167; 363(b) of this title, no
            appraisal rights under this section shall be available for the shares of any class or series of stock, which stock, or depository receipts in respect thereof, at the record date fixed to determine the stockholders entitled to receive notice of
            the meeting of stockholders to act upon the agreement of merger or consolidation, were either: (i)&#160;listed on a national securities exchange or (ii)&#160;held of record by more than 2,000 holders; and further provided that no appraisal rights shall
            be available for any shares of stock of the constituent corporation surviving a merger if the merger did not require for its approval the vote of the stockholders of the surviving corporation as provided in &#167; 251(f) of this title. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(2) Notwithstanding paragraph (b)(1) of this section, appraisal rights under this
            section shall be available for the shares of any class or series of stock of a constituent corporation if the holders thereof are required by the terms of an agreement of merger or consolidation pursuant to &#167;&#167; 251, 252, 254, 255, 256, 257, 258,
            263 and 264 of this title to accept for such stock anything except: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">a. Shares of stock of the corporation surviving or resulting from such merger or
            consolidation, or depository receipts in respect thereof; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">b. Shares of stock of any other corporation, or depository receipts in respect thereof,
            which shares of stock (or depository receipts in respect thereof) or depository receipts at the effective date of the merger or consolidation will be either listed on a national securities exchange or held of record by more than 2,000 holders;
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">c. Cash in lieu of fractional shares or fractional depository receipts described in the
            foregoing paragraphs (b)(2)a. and b. of this section; or </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">d. Any combination of the shares of stock, depository receipts and cash in lieu of
            fractional shares or fractional depository receipts described in the foregoing paragraphs (b)(2)a., b. and c. of this section. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(3) In the event all of the stock of a subsidiary Delaware corporation party to a
            merger effected under &#167; 251(h), &#167; 253 or &#167; 267 of this title is not owned by the parent immediately prior to the merger, appraisal rights shall be available for the shares of the subsidiary Delaware corporation. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(4) In the event of an amendment to a corporation&#8217;s certificate of incorporation
            contemplated by &#167; 363(a) of this title, appraisal rights shall be available as contemplated by &#167; 363(b) of this title, and the procedures of this section, including those set forth in subsections (d) and (e) of this section, shall apply as
            nearly as practicable, with the word &#8220;amendment&#8221; substituted for the words &#8220;merger or consolidation,&#8221; and the word &#8220;corporation&#8221; substituted for the words &#8220;constituent corporation&#8221; and/or &#8220;surviving or resulting corporation.&#8221; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(c) Any corporation may provide in its certificate of incorporation that appraisal
            rights under this section shall be available for the shares of any class or series of its stock as a result of an amendment to its certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation
            or the sale of all </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">C-1<br />
        </div>

      </div>

    </div>

    <!--End Page 462-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 463-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_302-annexc_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">or substantially all of the assets of the corporation. If the certificate of
            incorporation contains such a provision, the provisions of this section, including those set forth in subsections (d), (e), and (g) of this section, shall apply as nearly as is practicable. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;" class="fpara">(d) Appraisal rights shall be perfected as follows: </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(1) If a proposed merger or consolidation for which appraisal rights are provided under
            this section is to be submitted for approval at a meeting of stockholders, the corporation, not less than 20 days prior to the meeting, shall notify each of its stockholders who was such on the record date for notice of such meeting (or such
            members who received notice in accordance with &#167; 255(c) of this title) with respect to shares for which appraisal rights are available pursuant to subsection (b) or (c) of this section that appraisal rights are available for any or all of the
            shares of the constituent corporations, and shall include in such notice a copy of this section and, if 1 of the constituent corporations is a nonstock corporation, a copy of &#167; 114 of this title. Each stockholder electing to demand the
            appraisal of such stockholder&#8217;s shares shall deliver to the corporation, before the taking of the vote on the merger or consolidation, a written demand for appraisal of such stockholder&#8217;s shares. Such demand will be sufficient if it reasonably
            informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such stockholder&#8217;s shares. A proxy or vote against the merger or consolidation shall not constitute such a demand. A
            stockholder electing to take such action must do so by a separate written demand as herein provided. Within 10 days after the effective date of such merger or consolidation, the surviving or resulting corporation shall notify each stockholder
            of each constituent corporation who has complied with this subsection and has not voted in favor of or consented to the merger or consolidation of the date that the merger or consolidation has become effective; or </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(2) If the merger or consolidation was approved pursuant to &#167; 228, &#167; 251(h), &#167; 253, or
            &#167; 267 of this title, then either a constituent corporation before the effective date of the merger or consolidation or the surviving or resulting corporation within 10 days thereafter shall notify each of the holders of any class or series of
            stock of such constituent corporation who are entitled to appraisal rights of the approval of the merger or consolidation and that appraisal rights are available for any or all shares of such class or series of stock of such constituent
            corporation, and shall include in such notice a copy of this section and, if 1 of the constituent corporations is a nonstock corporation, a copy of &#167; 114 of this title. Such notice may, and, if given on or after the effective date of the merger
            or consolidation, shall, also notify such stockholders of the effective date of the merger or consolidation. Any stockholder entitled to appraisal rights may, within 20 days after the date of mailing of such notice or, in the case of a merger
            approved pursuant to &#167; 251(h) of this title, within the later of the consummation of the offer contemplated by &#167; 251(h) of this title and 20 days after the date of mailing of such notice, demand in writing from the surviving or resulting
            corporation the appraisal of such holder&#8217;s shares. Such demand will be sufficient if it reasonably informs the corporation of the identity of the stockholder and that the stockholder intends thereby to demand the appraisal of such holder&#8217;s
            shares. If such notice did not notify stockholders of the effective date of the merger or consolidation, either (i)&#160;each such constituent corporation shall send a second notice before the effective date of the merger or consolidation notifying
            each of the holders of any class or series of stock of such constituent corporation that are entitled to appraisal rights of the effective date of the merger or consolidation or (ii)&#160;the surviving or resulting corporation shall send such a
            second notice to all such holders on or within 10 days after such effective date; provided, however, that if such second notice is sent more than 20 days following the sending of the first notice or, in the case of a merger approved pursuant to
            &#167; 251(h) of this title, later than the later of the consummation of the offer contemplated by &#167; 251(h) of this title and 20 days following the sending of the first notice, such second notice need only be sent to each stockholder who is entitled
            to appraisal rights and who has demanded appraisal of such holder&#8217;s shares in accordance with this subsection. An affidavit of the secretary or assistant secretary or of the transfer agent of the corporation that is required to give either
            notice that such notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein. For purposes of determining the stockholders entitled to receive either notice, each constituent corporation may fix, in
            advance, a record date that shall be not more than 10 days prior to the date the notice is given, provided, that if the notice is given on or after the effective date of the merger or consolidation, the record date shall be such effective date.
            If no record date is fixed and the notice is given prior to the effective date, the record date shall be the close of business on the day next preceding the day on which the notice is given. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(e) Within 120 days after the effective date of the merger or consolidation, the
            surviving or resulting corporation or any stockholder who has complied with subsections (a) and (d) of this section hereof and who is otherwise </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">C-2<br />
        </div>

      </div>

    </div>

    <!--End Page 463-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 464-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_302-annexc_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">entitled to appraisal rights, may commence an appraisal proceeding by filing a
            petition in the Court of Chancery demanding a determination of the value of the stock of all such stockholders. Notwithstanding the foregoing, at any time within 60 days after the effective date of the merger or consolidation, any stockholder
            who has not commenced an appraisal proceeding or joined that proceeding as a named party shall have the right to withdraw such stockholder&#8217;s demand for appraisal and to accept the terms offered upon the merger or consolidation. Within 120 days
            after the effective date of the merger or consolidation, any stockholder who has complied with the requirements of subsections (a) and (d) of this section hereof, upon written request, shall be entitled to receive from the corporation surviving
            the merger or resulting from the consolidation a statement setting forth the aggregate number of shares not voted in favor of the merger or consolidation and with respect to which demands for appraisal have been received and the aggregate
            number of holders of such shares. Such written statement shall be mailed to the stockholder within 10 days after such stockholder&#8217;s written request for such a statement is received by the surviving or resulting corporation or within 10 days
            after expiration of the period for delivery of demands for appraisal under subsection (d) of this section hereof, whichever is later. Notwithstanding subsection (a) of this section, a person who is the beneficial owner of shares of such stock
            held either in a voting trust or by a nominee on behalf of such person may, in such person&#8217;s own name, file a petition or request from the corporation the statement described in this subsection. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(f) Upon the filing of any such petition by a stockholder, service of a copy thereof
            shall be made upon the surviving or resulting corporation, which shall within 20 days after such service file in the office of the Register in Chancery in which the petition was filed a duly verified list containing the names and addresses of
            all stockholders who have demanded payment for their shares and with whom agreements as to the value of their shares have not been reached by the surviving or resulting corporation. If the petition shall be filed by the surviving or resulting
            corporation, the petition shall be accompanied by such a duly verified list. The Register in Chancery, if so ordered by the Court, shall give notice of the time and place fixed for the hearing of such petition by registered or certified mail to
            the surviving or resulting corporation and to the stockholders shown on the list at the addresses therein stated. Such notice shall also be given by 1 or more publications at least 1 week before the day of the hearing, in a newspaper of general
            circulation published in the City of Wilmington, Delaware or such publication as the Court deems advisable. The forms of the notices by mail and by publication shall be approved by the Court, and the costs thereof shall be borne by the
            surviving or resulting corporation. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(g) At the hearing on such petition, the Court shall determine the stockholders who
            have complied with this section and who have become entitled to appraisal rights. The Court may require the stockholders who have demanded an appraisal for their shares and who hold stock represented by certificates to submit their certificates
            of stock to the Register in Chancery for notation thereon of the pendency of the appraisal proceedings; and if any stockholder fails to comply with such direction, the Court may dismiss the proceedings as to such stockholder. If immediately
            before the merger or consolidation the shares of the class or series of stock of the constituent corporation as to which appraisal rights are available were listed on a national securities exchange, the Court shall dismiss the proceedings as to
            all holders of such shares who are otherwise entitled to appraisal rights unless (1) the total number of shares entitled to appraisal exceeds 1% of the outstanding shares of the class or series eligible for appraisal, (2) the value of the
            consideration provided in the merger or consolidation for such total number of shares exceeds $1&#160;million, or (3) the merger was approved pursuant to &#167; 253 or &#167; 267 of this title. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(h) After the Court determines the stockholders entitled to an appraisal, the appraisal
            proceeding shall be conducted in accordance with the rules of the Court of Chancery, including any rules specifically governing appraisal proceedings. Through such proceeding the Court shall determine the fair value of the shares exclusive of
            any element of value arising from the accomplishment or expectation of the merger or consolidation, together with interest, if any, to be paid upon the amount determined to be the fair value. In determining such fair value, the Court shall take
            into account all relevant factors. Unless the Court in its discretion determines otherwise for good cause shown, and except as provided in this subsection, interest from the effective date of the merger through the date of payment of the
            judgment shall be compounded quarterly and shall accrue at 5% over the Federal Reserve discount rate (including any surcharge) as established from time to time during the period between the effective date of the merger and the date of payment
            of the judgment. At any time before the entry of judgment in the proceedings, the surviving corporation may pay to each stockholder entitled to appraisal an amount in cash, in which case interest shall accrue thereafter as provided herein only
            upon the sum of (1) the difference, if any, between the amount so paid and the fair value of the shares as determined by the Court, and (2) interest theretofore accrued, unless paid at that time. Upon application by the surviving or resulting </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">C-3<br />
        </div>

      </div>

    </div>

    <!--End Page 464-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 465-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_302-annexc_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">corporation or by any stockholder entitled to participate in the appraisal
            proceeding, the Court may, in its discretion, proceed to trial upon the appraisal prior to the final determination of the stockholders entitled to an appraisal. Any stockholder whose name appears on the list filed by the surviving or resulting
            corporation pursuant to subsection (f) of this section and who has submitted such stockholder&#8217;s certificates of stock to the Register in Chancery, if such is required, may participate fully in all proceedings until it is finally determined that
            such stockholder is not entitled to appraisal rights under this section. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(i)&#160;The Court shall direct the payment of the fair value of the shares, together with
            interest, if any, by the surviving or resulting corporation to the stockholders entitled thereto. Payment shall be so made to each such stockholder, in the case of holders of uncertificated stock forthwith, and the case of holders of shares
            represented by certificates upon the surrender to the corporation of the certificates representing such stock. The Court&#8217;s decree may be enforced as other decrees in the Court of Chancery may be enforced, whether such surviving or resulting
            corporation be a corporation of this State or of any state. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(j) The costs of the proceeding may be determined by the Court and taxed upon the
            parties as the Court deems equitable in the circumstances. Upon application of a stockholder, the Court may order all or a portion of the expenses incurred by any stockholder in connection with the appraisal proceeding, including, without
            limitation, reasonable attorney&#8217;s fees and the fees and expenses of experts, to be charged pro rata against the value of all the shares entitled to an appraisal. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(k) From and after the effective date of the merger or consolidation, no stockholder
            who has demanded appraisal rights as provided in subsection (d) of this section shall be entitled to vote such stock for any purpose or to receive payment of dividends or other distributions on the stock (except dividends or other distributions
            payable to stockholders of record at a date which is prior to the effective date of the merger or consolidation); provided, however, that if no petition for an appraisal shall be filed within the time provided in subsection (e) of this section,
            or if such stockholder shall deliver to the surviving or resulting corporation a written withdrawal of such stockholder&#8217;s demand for an appraisal and an acceptance of the merger or consolidation, either within 60 days after the effective date
            of the merger or consolidation as provided in subsection (e) of this section or thereafter with the written approval of the corporation, then the right of such stockholder to an appraisal shall cease. Notwithstanding the foregoing, no appraisal
            proceeding in the Court of Chancery shall be dismissed as to any stockholder without the approval of the Court, and such approval may be conditioned upon such terms as the Court deems just; provided, however that this provision shall not affect
            the right of any stockholder who has not commenced an appraisal proceeding or joined that proceeding as a named party to withdraw such stockholder&#8217;s demand for appraisal and to accept the terms offered upon the merger or consolidation within 60
            days after the effective date of the merger or consolidation, as set forth in subsection (e) of this section. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">(l) The shares of the surviving or resulting corporation to which the shares of such
            objecting stockholders would have been converted had they assented to the merger or consolidation shall have the status of authorized and unissued shares of the surviving or resulting corporation. </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">C-4<br />
        </div>

      </div>

    </div>

    <!--End Page 465-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 466-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_303-annexd_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;" class="h1"><a id="tANNEXD"><!--Anchor--></a>Annex D</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; text-align: center;" class="h1">CERTIFICATE OF AMENDMENT <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">TO THE <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">AMENDED AND RESTATED <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CERTIFICATE OF INCORPORATION <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">OF <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CALADRIUS BIOSCIENCES, INC. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc. (the &#8220;<span style="font-style: italic; font-weight: bold;">Corporation</span>&#8221;),




            a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, as amended (the &#8220;<span style="font-style: italic; font-weight: bold;">DGCL</span>&#8221;), hereby certifies as follows:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The name of the Corporation is Caladrius Biosciences, Inc., and the original certificate of incorporation of the Corporation was
                    filed with the Secretary of State of the State of Delaware on September&#160;18, 1980. A Certificate of Amendment to the Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on September&#160;28, 1995. A
                    Certificate of Amendment to the Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July&#160;24, 2003. An Amended and Restated Certificate of Incorporation was filed with the Secretary of State of
                    the State of Delaware on August&#160;29, 2006. An Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on October&#160;3, 2013 (the &#8220;<span style="font-style: italic; font-weight: bold;">Prior




                      Certificate</span>&#8221;). A Certificate of Amendment to the Prior Certificate was filed with the Secretary of State of the State of Delaware on May&#160;29, 2015. A Certificate of Amendment to the Prior Certificate was filed with the Secretary
                    of State of the State of Delaware on July&#160;26, 2016. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">B.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">This Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the &#8220;<span style="font-style: italic; font-weight: bold;">Certificate of Amendment</span>&#8221;) amends the Prior Certificate, and has been duly adopted by the Corporation&#8217;s Board of Directors and stockholders in accordance with the provisions of Sections 141, 211 and 242 of
                    the DGCL. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">C.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Article FOURTH of the Prior Certificate is hereby amended to add the following Section D: </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">&#8220;D. Immediately upon the filing of this Certificate of Amendment of Amended and
            Restated Certificate of Incorporation with the Secretary of State of the State of Delaware every [_____]<sup>1</sup> shares of Common Stock outstanding immediately prior to such filing shall be automatically reclassified into of one share of
            Common Stock. The aforementioned reclassification shall be referred to collectively as the &#8220;<span style="font-style: italic; font-weight: bold;">Reverse Split</span>.&#8221; </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The Reverse Split shall occur without any further action on the part of the Corporation
            or stockholders of the Corporation and whether or not certificates representing such stockholders&#8217; shares prior to the Reverse Split are surrendered for cancellation. No fractional interest in a share of Common Stock shall be deliverable upon
            the Reverse Split. All shares of Common Stock (including fractions thereof) issuable upon the Reverse Split held by a holder prior to the Reverse Split shall be aggregated for purposes of determining whether the Reverse Split would result in
            the issuance of any fractional share. Any fractional share resulting from such aggregation upon the Reverse Split shall be rounded down to the nearest whole number. Each holder who would otherwise be entitled to a fraction of a share of Common
            Stock upon the Reverse Split (after aggregating all fractions of a share to which such stockholder would otherwise be entitled) shall, in lieu thereof, be entitled to receive a cash payment in an amount equal to the fraction to which the
            stockholder would otherwise be entitled multiplied by the closing price of the Corporation&#8217;s Common Stock as reported on The Nasdaq Capital Market on the trading day immediately preceding the filing of this Certificate of Amendment of Amended
            and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware. The Corporation shall not be obliged to issue certificates evidencing the shares of Common Stock outstanding as a result of the Reverse Split unless
            and until the certificates evidencing the shares held by a holder prior to the Reverse Split are either delivered to the Corporation or its transfer agent, or the holder notifies the Corporation or its transfer agent that such certificates have
            been lost, stolen or destroyed and executes an agreement satisfactory to the Corporation to indemnify the Corporation from any loss incurred by it in connection with such certificates.&#8221;</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">D.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Certificate of Amendment so adopted reads in full as set forth above and is hereby incorporated by reference. All other
                    provisions of the Prior Certificate remain in full force and effect. </div>
                </td>

  </tr>


</table>
        </div>

        <div style="width: 468pt; margin-left: 0pt;" class="block-footnote">
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-top: 3pt; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt;" class="rule-partial"> </div>

          </div>

        </div>

        <div style="width: 468pt; margin-left: 0pt;" class="block-footnote">
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">1<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">To be a number between five and fifteen (inclusive)</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">D-1<br />
        </div>

      </div>

    </div>

    <!--End Page 466-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 467-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_303-annexd_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">IN WITNESS WHEREOF, Caladrius Biosciences, Inc. has caused this Certificate of
            Amendment to be signed by David J. Mazzo, Ph.D., a duly authorized officer of the Corporation, on &#8195;&#8195;&#8195;&#8195;&#8195;, 2022. </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CALADRIUS BIOSCIENCES, INC.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">By:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Title:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President and Chief Executive Officer</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">D-2<br />
        </div>

      </div>

    </div>

    <!--End Page 467-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 468-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_304-annexe_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;" class="h1"><a id="tANNEXE"><!--Anchor--></a>Annex E</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; text-align: center;" class="h1">CERTIFICATE OF AMENDMENT <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">TO THE <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">AMENDED AND RESTATED <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CERTIFICATE OF INCORPORATION <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">OF <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">CALADRIUS BIOSCIENCES, INC. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius Biosciences, Inc. (the &#8220;<span style="font-style: italic; font-weight: bold;">Corporation</span>&#8221;),




            a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, as amended (the &#8220;<span style="font-style: italic; font-weight: bold;">DGCL</span>&#8221;), hereby certifies as follows:</div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The name of the Corporation is Caladrius Biosciences, Inc., and the original certificate of incorporation of the Corporation was
                    filed with the Secretary of State of the State of Delaware on September&#160;18, 1980. A Certificate of Amendment to the Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on September&#160;28, 1995. A
                    Certificate of Amendment to the Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July&#160;24, 2003. An Amended and Restated Certificate of Incorporation was filed with the Secretary of State of
                    the State of Delaware on August&#160;29, 2006. An Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on October&#160;3, 2013 (the &#8220;<span style="font-style: italic; font-weight: bold;">Prior




                      Certificate</span>&#8221;). A Certificate of Amendment to the Prior Certificate was filed with the Secretary of State of the State of Delaware on May&#160;29, 2015. A Certificate of Amendment to the Prior Certificate was filed with the Secretary
                    of State of the State of Delaware on July&#160;26, 2016.</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">B.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">This Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the &#8220;<span style="font-style: italic; font-weight: bold;">Certificate of Amendment</span>&#8221;) amends the Prior Certificate, and has been duly adopted by the Corporation&#8217;s Board of Directors and stockholders in accordance with the provisions of Sections 141, 211 and 242 of
                    the DGCL. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">C.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Article FIRST of the Prior Certificate is hereby amended and restated to read as follows: </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">&#8220;FIRST: The name of the corporation is Lisata Therapeutics, Inc. (hereinafter sometimes
            referred to as the &#8220;Corporation&#8221;).&#8221; </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">D.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Certificate of Amendment so adopted reads in full as set forth above and is hereby incorporated by reference. All other
                    provisions of the Prior Certificate remain in full force and effect. </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">IN WITNESS WHEREOF, Caladrius Biosciences, Inc. has caused this Certificate of
            Amendment to be signed by David J. Mazzo, Ph.D., a duly authorized officer of the Corporation, on &#8195;&#8195;&#8195;&#8195;&#8195;, 2022. </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 51.28%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;" colspan="4">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CALADRIUS BIOSCIENCES, INC.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">By:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Name:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 46.15%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 5.13%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Title:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 43.59%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President and Chief Executive Officer</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">E-1<br />
        </div>

      </div>

    </div>

    <!--End Page 468-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 469-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tANNEXF"><!--Anchor--></a>ANNEX F<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="h1">&#8195;<br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; text-align: center;" class="h1">CALADRIUS BIOSCIENCES, INC. 2018 EQUITY INCENTIVE COMPENSATION PLAN, <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">AS AMENDED</div>

          <div>
            <div style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 14.25pt;" class="rule-partial"> </div>

          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; text-align: center;" class="fpara">Effective as of ___, 2022</div>

          <div>
            <div style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 15.25pt;" class="rule-partial"> </div>

          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">1.&#8195;<span style="font-weight: bold;">Purposes of the Plan</span>. The
            purposes of this Caladrius Biosciences, Inc. 2018 Equity Incentive Compensation Plan (the &#8220;<span style="text-decoration: underline;">Plan</span>&#8221;) are: to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentives to
            Employees, Directors and Consultants, and to promote the success of the Company and any Parent or Subsidiary. Options granted under the Plan may be Incentive Stock Options or Nonstatutory Stock Options, as determined by the Administrator at the
            time of grant. Restricted Stock, Restricted Stock Units, Deferred Share Units, Unrestricted Shares and Stock Appreciation Rights may also be granted under the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">2.&#8195;<span style="font-weight: bold;">Definitions</span>. As used
            herein, the following definitions shall apply:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Administrator</span>&#8221; means a Committee which has been delegated
            the responsibility of administering the Plan in accordance with Section 4 of the Plan or, if there is no such Committee, the Board.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Applicable Laws</span>&#8221; means the requirements relating to the
            administration of equity compensation plans under the applicable corporate and securities laws of any of the states in the United States, U.S. federal securities laws, the Code, any stock exchange or quotation system on which the Common Stock
            is listed or quoted and the applicable laws of any foreign country or jurisdiction where Awards are, or will be, granted under the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Award</span>&#8221; means the grant of an Option, Restricted Stock,
            Restricted Stock Units, Deferred Share Units, a Stock Appreciation Right and/or the grant of Unrestricted Shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Board</span>&#8221; means the Board of Directors of the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Cause</span>&#8221;, with respect to any Service Provider, means
            (unless otherwise determined by the Administrator) such Service Provider&#8217;s (i)&#160;conviction of, or plea of nolo contendere to, a felony or crime involving moral turpitude; (ii)&#160;fraud on or misappropriation of any funds or property of the Company;
            (iii)&#160;personal dishonesty, willful misconduct, willful violation of any law, rule or regulation (other than minor traffic violations or similar offenses) or breach of fiduciary duty which involves personal profit; (iv)&#160;willful misconduct in
            connection with the Service Provider&#8217;s duties; (v)&#160;chronic use of alcohol, drugs or other similar substances which affects the Service Provider&#8217;s work performance; or (vi)&#160;material breach of any provision of any employment, non-disclosure,
            non-competition, non-solicitation or other similar agreement executed by the Service Provider for the benefit of the Company, all as reasonably determined by the Administrator, which determination will be conclusive. Notwithstanding the
            foregoing, if a Service Provider and the Company (or any of its Subsidiaries or affiliates) have entered into an employment agreement, consulting agreement, advisory agreement or other similar agreement that specifically defines &#8220;cause,&#8221; then
            with respect to such Service Provider, &#8220;Cause&#8221; shall have the meaning defined in that employment agreement, consulting agreement, advisory agreement or other agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Code</span>&#8221; means the Internal Revenue Code of 1986, as amended.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Committee</span>&#8221; means a committee of Directors appointed by the
            Board in accordance with Section 4 of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Common Stock</span>&#8221; means the common stock, par value $.001 per share, of the
            Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Company</span>&#8221; means Caladrius Biosciences, Inc., a Delaware corporation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Consultant</span>&#8221; means any person, including an advisor,
            engaged by the Company or a Parent or Subsidiary to render services to such entity, other than an Employee or a Director.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Deferred </span><span style="text-decoration: underline;">Share Unit</span>&#8221; (or &#8220;<span style="text-decoration: underline;">DSU</span>&#8221;) has the meaning set forth in
            Section 12 of the Plan.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-1<br />
        </div>

      </div>

    </div>

    <!--End Page 469-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 470-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Director</span>&#8221; means a member of the Board.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Disability</span>&#8221; means total and permanent disability as defined in Section
            22(e)(3) of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Employee</span>&#8221; means any person, including officers and
            Directors, serving as an employee of the Company or any Parent or Subsidiary. An individual shall not cease to be an Employee in the case of (i)&#160;any leave of absence approved by the Company or (ii)&#160;transfers between locations of the Company or
            between the Company, its Parent, any Subsidiary or any successor. For purposes of an Option initially granted as an Incentive Stock Option, if a leave of absence of more than three months precludes such Option from being treated as an Incentive
            Stock Option under the Code, such Option thereafter shall be treated as a Nonstatutory Stock Option for purposes of this Plan. Neither service as a Director nor payment of a director&#8217;s fee by the Company shall be sufficient to constitute
            &#8220;employment&#8221; by the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Exchange Act</span>&#8221; means the Securities Exchange Act of 1934, as amended.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Fair Market Value</span>&#8221; means, as of any date, the value of Common Stock
            determined as follows:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 57.5pt; text-align: left;" class="fpara">(i) if the Common Stock is listed on any established stock
            exchange or a national market system, including without limitation the NYSE Amex, Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, or any successor to any of them, the Fair Market Value of a Share of Common Stock
            shall be the closing sales price of a Share of Common Stock as quoted on such exchange or system for such date (or the most recent trading day preceding such date if there were no trades on such date), as reported in <span style="text-decoration: underline;">The Wall </span><span style="text-decoration: underline;">Street
              Journal</span> or such other source as the Administrator deems reliable, including without limitation, Yahoo! Finance;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 57.5pt; text-align: left;" class="fpara">(ii) if the Common Stock is regularly quoted by a recognized
            securities dealer but is not listed in the manner contemplated by clause (i)&#160;above, the Fair Market Value of a Share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock for such date (or the most
            recent trading day preceding such date if there were no trades on such date), as reported in <span style="text-decoration: underline;">The Wall Street Journal</span> or such other source as the Administrator deems reliable, including without limitation Yahoo! Finance; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 57.5pt; text-align: left;" class="fpara">(iii) if neither clause (i)&#160;above nor clause (ii)&#160;above applies,
            the Fair Market Value shall be determined in good faith by the Administrator based on the reasonable application of a reasonable valuation method.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Grant Agreement</span>&#8221; means an agreement between the Company
            and a Participant evidencing the terms and conditions of an individual Option or Stock Appreciation Right grant. Each Grant Agreement shall be subject to the terms and conditions of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Incentive </span><span style="text-decoration: underline;">Stock Option</span>&#8221; means an Option intended
            to qualify as an incentive stock option within the meaning of Section 422 of the Code and the regulations promulgated thereunder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Nonstatutory Stock Option</span>&#8221; means an Option not intended to qualify as an
            Incentive Stock Option.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Notice of </span><span style="text-decoration: underline;">Grant</span>&#8221; means a written or electronic
            notice evidencing certain terms and conditions of an individual Option grant, Stock Award grant or grant of Unrestricted Shares or Stock Appreciation Rights. The Notice of Grant applicable to Awards shall be part of the Grant Agreement or Stock
            Award Agreement, as applicable.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Option</span>&#8221; means a stock option granted pursuant to the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Optioned Stock</span>&#8221; means the Common Stock subject to an Option.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Optionee</span>&#8221; means the holder of an outstanding Option granted under the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Parent</span>&#8221; means a &#8220;parent corporation&#8221; of the Company (or,
            for purposes of Section 16(b) of the Plan, a successor to the Company), whether now or hereafter existing, as defined in Section 424(e) of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Participant</span>&#8221; shall mean any Service Provider who holds an
            Option, Restricted Stock, a Restricted Stock Units, Deferred Share Units, Unrestricted Shares or a Stock Appreciation Right granted or issued pursuant to the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Restricted Stock</span>&#8221; means an Award of Shares pursuant to Section 11 of the
            Plan.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-2<br />
        </div>

      </div>

    </div>

    <!--End Page 470-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 471-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Restricted </span><span style="text-decoration: underline;">Stock Unit</span>&#8221; means an Award of Shares pursuant to
            Section 12 of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Rule </span><span style="text-decoration: underline;">16b-3</span>&#8221; means Rule 16b-3 of the Exchange Act
            or any successor to such Rule 16b-3, as such rule is in effect when discretion is being exercised with respect to the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Section 16(b)</span>&#8221; means Section 16(b) of the Exchange Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Service Provider</span>&#8221; means an Employee, Director or Consultant.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Share</span>&#8221; means a share of the Common Stock, as adjusted in accordance with
            Section 16 of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Stock </span><span style="text-decoration: underline;">Appreciation Right</span>&#8221; means a right awarded pursuant to
            Section 14 of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Stock Award</span>&#8221; means an Award of Restricted Stock pursuant
            to Section 11 of the Plan, an Award of Restricted Stock Units (including Deferred Share Units) pursuant to Section 12 of the Plan and an Award of Unrestricted Shares pursuant to Section 13 of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Stock Award Agreement</span>&#8221; means an agreement, approved by the
            Administrator, providing the terms and conditions of a Stock Award.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Stock Award Shares</span>&#8221; means Shares subject to a Stock Award.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Stock Awardee</span>&#8221; means the holder of an outstanding Stock Award granted
            under the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara"><span style="text-decoration: underline;">&#8220;Subsidiary</span>&#8221; means a &#8220;subsidiary corporation&#8221; of the
            Company (or, for purposes of Section 16(b) of the Plan, a successor to the Company), whether now or hereafter existing, as defined in Section 424(f) of the Code.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">&#8220;<span style="text-decoration: underline;">Unrestricted Shares</span>&#8221; means a grant of Shares made on an
            unrestricted basis pursuant to Section 13 of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">3.&#8195;<span style="font-weight: bold;">Stock Subject to the Plan</span>.
            Subject to adjustment pursuant to the provisions of Section 16(a) of the Plan, the maximum aggregate number of Shares that may be issued under the Plan is 13,500,000 Shares, all of which may be issued in respect of Incentive Stock Options. In
            addition there shall be added to the reserve any Shares that are subject to awards under the Company&#8217;s Amended and Restated 2009 Equity Compensation Plan and 2015 Equity Compensation Plan, as amended, and not thereafter issued under such plan
            due to a forfeiture, cancellation, or other settlement thereof up to a maximum of 406,904 shares, all of which may be issued in respect of Incentive Stock Options.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The maximum number of Shares subject to Options and Stock
            Appreciation Rights which may be issued to any Participant under the Plan during the term of the Plan is fifty percent (50%) of the number of Shares determined from time to time pursuant to the first sentence of this Section. If an Option or
            Stock Appreciation Right expires or becomes unexercisable without having been exercised in full or is canceled or terminated, or if any Shares of Restricted Stock or Shares underlying any other type of Stock Award are forfeited or reacquired by
            the Company or results in any Shares not being issued even if used to satisfy the exercise price or a tax withholding obligation, the Shares that were subject thereto shall be added back to the Shares available for issuance under the Plan. The
            Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Notwithstanding anything to the contrary herein, the maximum number
            of Shares that may be subject to Awards granted to any non-Employee Director in any calendar year under the Plan shall not exceed an aggregate grant date fair value of $60,000, except that the foregoing limitation shall not apply to awards made
            (i)&#160;pursuant to an election by a non-Employee Director to receive the Award in lieu of cash for all or a portion of cash fees to be received for service on the Board or any Committee thereof or (ii)&#160;in connection with a non-Employee Director
            initially joining the Board.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">4.&#8195;<span style="font-weight: bold;">Administration of the Plan</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) <span style="font-style: italic;">Appointment</span>. The
            Plan shall be administered by a Committee to be appointed by the Board, which Committee shall consist of not less than two members of the Board and shall be comprised solely of members of the Board who qualify as both non-employee directors as
            defined in Rule 16b-3(b)(3) of the Exchange Act. The Board shall have the power to add or remove members of the Committee, from time to time, and to fill </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-3<br />
        </div>

      </div>

    </div>

    <!--End Page 471-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 472-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">vacancies thereon arising; by resignation, death, removal, or otherwise. Meetings
            shall be held at such times and places as shall be determined by the Committee. A majority of the members of the Committee shall constitute a quorum for the transaction of business, and the vote of a majority of those members present at any
            meeting shall decide any question brought before that meeting.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 37.5pt; text-align: left;" class="fpara">(b) <span style="font-style: italic;">Powers of the Administrator</span>. The
            Administrator shall have the authority, in its discretion:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 52.5pt; text-align: left;" class="fpara">(i) to determine the Fair Market Value of Shares;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 52.5pt; text-align: left;" class="fpara">(ii) to select the Service Providers to whom Awards may be granted hereunder;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(iii) to determine the number of shares of Common Stock to be
            covered by each Award granted hereunder;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(iv) to approve forms of agreement for use under the Plan,
            including but not limited to Grant Agreements and Stock Award Agreements;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(v) to determine the terms and conditions, not inconsistent with
            the terms of the Plan or of any Award granted hereunder. Such terms and conditions include, but are not limited to, the exercise price, the time or times when Options and Stock Appreciation Rights may be exercised (which may be based on
            performance criteria), any vesting, acceleration or waiver of forfeiture provisions, and any restriction or limitation regarding any Option, Stock Appreciation Right or Stock Award, or the Shares of Common Stock relating thereto, based in each
            case on such factors as the Administrator, in its sole discretion, shall determine;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(vi) to construe and interpret the terms of the Plan, Awards
            granted pursuant to the Plan and agreements entered into pursuant to the Plan;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(vii) to prescribe, amend and rescind rules and regulations
            relating to the Plan, including rules and regulations relating to sub-plans established for the purpose of qualifying for preferred tax treatment under foreign tax laws. Without limiting the foregoing, the Administrator is specifically
            authorized to adopt rules and procedures regarding the conversion of local currency, taxes, withholding procedures, escrow accounts, sub-plans, and handling of stock certificates, making of book entries, and/or settlement of Awards in cash in
            lieu of Shares, in all of the foregoing instances in ways that may vary with the customs and requirements of Applicable Laws and other considerations of particular countries or jurisdictions thereof;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(viii) to modify or amend each Award (subject to Section 19(c) of
            the Plan) in any manner that would be allowed for a new Award under the Plan, including the discretionary authority to accelerate the vesting of any Stock Award, to extend, subject to the terms of the Plan, the post-termination exercisability
            period of Options or Stock Appreciation Rights longer than is otherwise provided for in a Grant Agreement, and to accelerate the time at which any outstanding Option or Stock Appreciation Right may be exercised; provided however that, except as
            approved by the Company&#8217;s stockholders, for any period during which the Company is subject to the reporting requirements of the Exchange Act, the Administrator may not cancel an outstanding Option or SAR whose exercise price is greater than
            Fair Market Value at the time of cancellation for the purpose of reissuing the Option or SAR to the Participant at a lower exercise price, granting a replacement award of a different type, or otherwise allowing for a &#8220;repricing&#8221; within the
            meaning of either the federal securities laws applicable to proxy statement disclosures or other applicable governance standards;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(ix) to allow grantees to satisfy withholding tax obligations by
            having the Company withhold from the Shares to be issued upon exercise of an Option or Stock Appreciation Right, upon vesting of a Stock Award or upon the grant of Unrestricted Shares that number of Shares having a Fair Market Value equal to
            the amount required to be withheld. The Fair Market Value of the Shares to be withheld shall be determined on the date that the amount of tax to be withheld is to be determined. All determinations to have Shares withheld for this purpose shall
            be made by the Administrator in its discretion;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(x) to reduce the exercise price of any Option or Stock
            Appreciation Right, provided such reduction receives shareholder approval in accordance with Applicable Law;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(xi) to authorize any person to execute on behalf of the Company
            any agreement entered into pursuant to the Plan and any instrument required to effect the grant of an Award previously granted by the Administrator;</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-4<br />
        </div>

      </div>

    </div>

    <!--End Page 472-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 473-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg5"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(xii) to correct any defect, omission or inconsistency in this
            Plan or any Grant or Stock Award Agreement, in the manner and to the extent deemed necessary or expedient to make this Plan or an Award fully effective;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 52.5pt; text-align: left;" class="fpara">(xiii) to settle all controversies regarding this Plan and Awards granted hereunder;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(xiv) to the extent consistent with the purposes of this Plan and
            without amending this Plan, to cancel or waive the Company&#8217;s rights with respect to any Awards, to adjust or to modify Grant and/or Stock Award Agreements for changes in Applicable Laws, and to recognize differences in foreign law, tax policies
            or customs;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(xv) to require, as a condition precedent to the grant, vesting,
            exercise, settlement and/or issuance of Shares pursuant to any Award, that a Participant agree to execute a general release of claims (in any form that the Administrator may require, in its sole and absolute discretion, which form may include
            any other provisions, e.g., confidentiality and restrictions on competition, that are found in general claims release agreements that the Company utilizes or expects to utilize);</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(xvi) in the event that the Company establishes, for itself or
            through using the services of a third party, an automated system for the documentation, granting, settlement, or exercise of Awards, such as a system using an internet website or interactive voice response, to implement paperless documentation,
            granting, settlement, or exercise of Awards by Participants, to permit or to unilaterally require the future use of such an automated system (for all Awards, whenever granted); and</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 52.5pt; text-align: left;" class="fpara">(xvii) to make all other determinations deemed necessary or advisable for
            administering the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) <span style="font-style: italic;">Action by Administrator</span>.
            Unless otherwise established by the Board or in any charter of the Committee or the Administrator, or by the terms of this Plan, a majority of the members of the Administrator shall constitute a quorum and the acts of a majority of the members
            present at any meeting at which a quorum is present, and acts approved in writing by all members of the Administrator in lieu of a meeting, shall be deemed the acts of the Administrator. Each member of the Administrator is entitled to, in good
            faith, rely or act upon any report or other information furnished to that member by an officer or other Employee of the Company or any of its Subsidiaries affiliates, the Company&#8217;s independent certified public accountants or independent
            registered public accounting firm, or any executive compensation Consultant or other professional retained by the Administrator or the Company to assist in the administration of this Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;" class="h4">Effect</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(d) <span style="font-style: italic;">of Administrator&#8217;s Decision</span>.
            The Administrator&#8217;s decisions, determinations findings of fact, and interpretations shall be final and binding on all holders of Awards. The validity of any such decisions, determinations, findings of fact, or interpretations shall not be given
            de novo review if challenged in court, by arbitration or in any other forum, and shall be upheld unless clearly and convincingly shown to have been made in bad faith or materially affected by fraud. None of the Board, the Committee or the
            Administrator, nor any member or delegate thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and each of the foregoing shall be entitled in all cases to
            indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including without limitation reasonable attorneys&#8217; fees) arising or resulting therefrom to the fullest extent permitted by law and/or under any
            directors&#8217; and officers&#8217; liability insurance coverage which may be in effect from time to time.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(e) <span style="font-style: italic;">Delegation of Grant
              Authority</span>. Notwithstanding any other provision in the Plan, the Board may, to the full extent allowable under Applicable Laws, authorize the Company&#8217;s Chief Executive Officer or another executive officer of the Company or a committee
            of such officers (&#8220;<span style="text-decoration: underline;">Authorized Officers</span>&#8221;) to grant Awards under the Plan; <span style="text-decoration: underline;">provided</span>, <span style="text-decoration: underline;">however</span>, that in no event shall the Authorized Officers be permitted to grant Awards to (i)&#160;any Director, (ii)&#160;any person who is
            identified by the Company as an executive officer of the Company or who is subject to the restrictions imposed under Section 16 of the Exchange Act, (iii)&#160;any person who is not an employee of the Company or any Subsidiary, or (iv)&#160;such other
            person or persons as may be designated from time to time by the Board. If such authority is provided by the Board, the Board shall establish and adopt written guidelines setting forth the maximum number of shares for which the Authorized
            Officers may grant Awards to any individual during a specified period of time and such other terms and conditions as the Board deems appropriate for such grants. Such guidelines may be amended by the Board prospectively at any time. Subject to
            the foregoing, the Authorized Officers shall have the same authority as the Administrator under this Section 4 with respect to the grant of Awards under the Plan.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-5<br />
        </div>

      </div>

    </div>

    <!--End Page 473-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 474-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg6"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(f) <span style="font-style: italic;">Claims Limitations
              Period</span>. Any Participant who believes he or she is being denied any benefit or right under this Plan or under any Award may file a written claim with the Administrator. Any claim must be delivered to the Administrator (care of the
            Company&#8217;s President and Chief Financial Officer) within forty-five (45) days of the specific event giving rise to the claim. Untimely claims will not be processed and shall be deemed denied. The Administrator, or its designee, will notify the
            Participant of its decision in writing as soon as administratively practicable. Claims not responded to by the Administrator in writing within one hundred and twenty (120) days of the date the written claim is delivered to the Administrator
            shall be deemed denied. No lawsuit relating to this Plan or any Award(s) may be filed before a written claim is filed with the Administrator and is denied or deemed denied, and any lawsuit must be filed within one year of such denial or deemed
            denial or be forever barred.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(g) <span style="font-style: italic;">Expenses</span>. The
            expenses of administering this Plan (including the settlement of Awards) shall be borne by the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">5.&#8195;<span style="font-weight: bold;">Eligibility</span>. Nonstatutory
            Stock Options, Stock Awards and Stock Appreciation Rights may be granted to Service Providers. Incentive Stock Options may be granted only to Employees. Notwithstanding anything contained herein to the contrary, an Award may be granted to a
            person who is not then a Service Provider; provided, however, that the grant of such Award shall be conditioned upon such person becoming a Service Provider at or prior to the time of the execution of the agreement evidencing such Award.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">6.&#8195;<span style="font-weight: bold;">Limitations</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) Each Option shall be designated in the Grant Agreement as
            either an Incentive Stock Option or a Nonstatutory Stock Option. However, notwithstanding such designation, if a single Employee becomes eligible in any given year to exercise Incentive Stock Options for Shares having a Fair Market Value in
            excess of $100,000, those Options representing the excess shall be treated as Nonstatutory Stock Options. In the previous sentence, &#8220;Incentive Stock Options&#8221; include Incentive Stock Options granted under any plan of the Company or any Parent or
            any Subsidiary. For the purpose of deciding which Options apply to Shares that &#8220;exceed&#8221; the $100,000 limit, Incentive Stock Options shall be taken into account in the same order as granted. The Fair Market Value of the Shares shall be
            determined as of the time the Option with respect to such Shares is granted.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) Neither the Plan nor any Award nor any agreement entered into
            pursuant to the Plan shall confer upon a Participant any right with respect to continuing the Participant&#8217;s relationship as a Service Provider with the Company, nor shall they interfere in any way with the Participant&#8217;s right or the Company&#8217;s
            right to terminate such relationship at any time, with or without cause.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">7.&#8195;<span style="font-weight: bold;">Term of the Plan</span>. The Plan
            shall continue in effect until April&#160;23, 2028 unless terminated earlier under Section 19 of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">8.&#8195;<span style="font-weight: bold;">Term of Options</span>. Unless
            otherwise provided in the applicable Grant Agreement, the term of each Option granted to anyone other than a Consultant shall be ten (10) years from the date of grant and the term of each Option granted to any Consultant shall be three (3)
            years from the date of grant. In the case of an Incentive Stock Option, the term shall be ten (10) years from the date of grant or such shorter term as may be provided in the applicable Grant Agreement. However, in the case of an Incentive
            Stock Option granted to an Optionee who, at the time the Incentive Stock Option is granted, owns, directly or indirectly, stock representing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company
            or any Parent or Subsidiary, the term of the Incentive Stock Option shall be five (5) years from the date of grant or such shorter term as may be provided in the applicable Grant Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">9.&#8195;<span style="font-weight: bold;">Option Exercise Price;
              Exercisability</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) <span style="font-style: italic;">Exercise Price</span>. The
            per share exercise price for the Shares to be issued pursuant to exercise of an Option shall be determined by the Administrator, subject to the following:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 52.5pt; text-align: left;" class="fpara">(i) In the case of an Incentive Stock Option</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 65pt; text-align: left;" class="fpara">(1) granted to an Employee who, at the time the Incentive Stock
            Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price shall be no less than 110% of the Fair Market Value per
            Share on the date of grant, or</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-6<br />
        </div>

      </div>

    </div>

    <!--End Page 474-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 475-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg7"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 65pt; text-align: left;" class="fpara">(2) granted to any Employee other than an Employee described in
            paragraph (A) immediately above, the per Share exercise price shall be no less than 100% of the Fair Market Value per Share on the date of grant.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(ii) In the case of a Nonstatutory Stock Option, the per Share
            exercise price shall be no less than 100% of the Fair Market Value per Share on the date of grant, as determined by the Administrator in good faith.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) <span style="font-style: italic;">Exercise Period and
              Conditions</span>. At the time that an Option is granted, the Administrator shall fix the period within which the Option may be exercised and shall determine any conditions that must be satisfied before the Option may be exercised.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) <span style="font-style: italic;">Prohibition on Repricing</span>.
            Except as otherwise provided in Section 16, but notwithstanding any other provision of the Plan, without the prior approval of the shareholders of the Company: (i)&#160;the exercise price of an Option or Stock Appreciation Right may not be reduced,
            directly or indirectly, (ii)&#160;no Option or Stock Appreciation Right may be cancelled in exchange for cash, other Awards, or Options or Stock Appreciation Rights with an exercise price that is less than the exercise price of the original Option
            or Stock Appreciation Right, or otherwise, and (iii)&#160;the Company may not repurchase an Option or Stock Appreciation Right for value (in cash, substitutions, cash buyouts, or otherwise) from a Participant if the current Fair Market Value of the
            Shares underlying the Option or Stock Appreciation Right is lower than its exercise price per Share.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">10.&#8199;<span style="font-weight: bold;">Exercise of Options;
              Consideration</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) <span style="font-style: italic;">Procedure for Exercise;
              Rights as a Shareholder</span>. Any Option granted hereunder shall be exercisable according to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Grant Agreement. Unless
            the Administrator provides otherwise, vesting of Options granted hereunder shall be tolled during any unpaid leave of absence. An Option may not be exercised for a fraction of a Share. An Option shall be deemed exercised when the Company
            receives: (i) written or electronic notice of exercise (in accordance with the Grant Agreement) from the person entitled to exercise the Option, and (ii)&#160;full payment for the Shares with respect to which the Option is exercised. Full payment
            may consist of any consideration and method of payment authorized by the Administrator and permitted by the Grant Agreement and Section 10(f) of the Plan. Shares issued upon exercise of an Option shall be issued in the name of the Optionee.
            Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a shareholder shall exist with
            respect to the Optioned Stock, notwithstanding the exercise of the Option. The Company shall issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend or other right for which
            the record date is prior to the date the Shares are issued, except as provided in Section 16 of the Plan. Exercising an Option in any manner shall decrease the number of Shares thereafter available, both for purposes of the Plan and for sale
            under the Option, by the number of Shares as to which the Option is exercised.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) <span style="font-style: italic;">Termination of Relationship
              as a Service Provider</span>. Unless otherwise specified in the Grant Agreement or provided by the Administrator, if an Optionee ceases to be a Service Provider, other than as a result of (x)&#160;the Optionee&#8217;s death or Disability, or (y)
            termination of such Optionee&#8217;s employment or relationship with the Company with Cause, the Optionee may exercise his or her Option for up to ninety (90) days following the date on which the Optionee ceases to be a Service Provider to the extent
            that the Option is vested on the date of termination (but in no event later than the expiration of the term of such Option as set forth in the Grant Agreement). If, on the date that the Optionee ceases to be a Service Provider, the Optionee is
            not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall revert to the Plan. If, after the date that the Optionee ceases to be a Service Provider the Optionee does not exercise his or her Option
            in full within the time set forth herein or the Grant Agreement, as applicable, the unexercised portion of the Option shall terminate, and the Shares covered by such unexercised portion of the Option shall revert to the Plan. Notwithstanding
            the foregoing, if there is a blackout period under the Company&#8217;s insider trading policy or Applicable Law (or an Administrator-imposed blackout period) that prohibits the buying or selling of Shares during any part of the ten-day period before
            the expiration of any Option based on the termination of a Participant&#8217;s employment for any reason other than Cause, the period for exercising the Option shall be extended until the earlier of ten days beyond when such blackout period ends and
            the expiration date of its original term as set forth in the applicable Grant Agreement. An Optionee who changes his or her status as a Service Provider (e.g., from being an Employee to being a Consultant) shall not be deemed to have ceased
            being a Service </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-7<br />
        </div>

      </div>

    </div>

    <!--End Page 475-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 476-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg8"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Provider for purposes of this Section 10(b), nor shall a transfer of employment
            among the Company and any Subsidiary be considered a termination of employment; however, if an Optionee holding Incentive Stock Options ceases being an Employee but continues as a Service Provider, such Incentive Stock Options shall be deemed
            to be Nonstatutory Stock Options three months after the date of such cessation.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) <span style="font-style: italic;">Disability of an Optionee</span>.
            Unless otherwise specified in the Grant Agreement, if an Optionee ceases to be a Service Provider as a result of the Optionee&#8217;s Disability, the Optionee may exercise his or her Option, to the extent the Option is vested on the date that the
            Optionee ceases to be a Service Provider, up until the one-year anniversary of the date on which the Optionee ceases to be a Service Provider (but in no event later than the expiration of the term of such Option as set forth in the Grant
            Agreement). If, on the date that the Optionee ceases to be a Service Provider, the Optionee is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall revert to the Plan. If, after the Optionee
            ceases to be a Service Provider, the Optionee does not exercise his or her Option in full within the time set forth herein or the Grant Agreement, as applicable, the unexercised portion of the Option shall terminate, and the Shares covered by
            such unexercised portion of the Option shall revert to the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(d) <span style="font-style: italic;">Death of an Optionee</span>.
            Unless otherwise specified in the Grant Agreement, if an Optionee dies while a Service Provider, the Option may be exercised, to the extent that the Option is vested on the date of death, by the Optionee&#8217;s estate or by a person who acquires the
            right to exercise the Option by bequest or inheritance up until the one-year anniversary of the Optionee&#8217;s death (but in no event later than the expiration of the term of such Option as set forth in the Notice of Grant). If, at the time of
            death, the Optionee is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option shall revert to the Plan. If the Option is not so exercised in full within the time set forth herein or the Grant
            Agreement, as applicable, the unexercised portion of the Option shall terminate, and the Shares covered by the unexercised portion of such Option shall revert to the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(e) <span style="font-style: italic;">Termination for Cause or
              Voluntary Termination</span>. If a Service Provider&#8217;s relationship with the Company is terminated for Cause (or the Service Provider resigns or is terminated at a time when the Company had Cause for such termination), then, unless otherwise
            provided in such Service Provider&#8217;s Grant Agreement or by the Administrator, such Service Provider shall have no right to exercise any of such Service Provider&#8217;s Options at any time on or after the effective date of such termination.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(f) <span style="font-style: italic;">Form of Consideration</span>.
            The Administrator shall determine the acceptable form of consideration for exercising an Option, including the method of payment. In the case of an Incentive Stock Option, the Administrator shall determine the acceptable form of consideration
            at the time of grant. Such consideration may consist entirely of:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 52.5pt; text-align: left;" class="fpara">(i) cash;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 52.5pt; text-align: left;" class="fpara">(ii) check;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(iii) other Shares which (A) in the case of Shares acquired upon
            exercise of an option at a time when the Company is subject to Section 16(b) of the Exchange Act, have been owned by the Optionee for more than six months on the date of surrender, and (B) have a Fair Market Value on the date of surrender equal
            to the aggregate exercise price of the Shares as to which said Option shall be exercised;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(iv) consideration received by the Company under a cashless
            exercise program implemented by the Company in connection with the Plan;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(v) a reduction in the number of Shares otherwise issuable by a
            number of Shares having a Fair Market Value equal to the exercise price of the Option being exercised;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 52.5pt; text-align: left;" class="fpara">(vi) any combination of the foregoing methods of payment; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(vii) such other consideration and method of payment for the
            issuance of Shares to the extent permitted by Applicable Laws.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-8<br />
        </div>

      </div>

    </div>

    <!--End Page 476-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 477-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg9"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Notwithstanding any other provision of this Plan to the contrary,
            no Participant who is a Director or an &#8220;executive officer&#8221; of the Company within the meaning of Section 13(k) of the Exchange Act shall be permitted to make payment with respect to any Awards granted under this Plan, or continue any extension
            of credit with respect to such payment with a loan from the Company or a loan arranged by the Company in violation of Section 13(k) of the Exchange Act.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(g) <span style="font-style: italic;">Non-Exempt Employees</span>.
            If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any Shares until at least six (6) months following
            the Grant Date of the Option or Stock Appreciation Right (although the Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i)&#160;if such non-exempt Employee dies or becomes Disabled, or
            (ii)&#160;upon a Change in Control in which such Option or Stock Appreciation Right is not assumed, continued or substituted, the vested portion of any Options and SARs may be exercised earlier than six months following the Grant Date. The foregoing
            provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or Stock Appreciation Right will be exempt from his or her regular rate of pay. To the extent permitted
            and/or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under any other Award will be exempt from the
            employee&#8217;s regular rate of pay, the provisions of this Section will apply to all Awards and are hereby incorporated by reference into such applicable Award Agreements.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">11.&#8195;<span style="font-weight: bold;">Stock Awards</span>. The
            Administrator may, in its sole discretion, grant (or sell at par value or such higher purchase price as it determines) Shares to any Service Provider subject to such terms and conditions as the Administrator sets forth in a Stock Award
            Agreement evidencing such grant. Stock Awards may be granted or sold in respect of past services or other valid consideration or in lieu of any cash compensation otherwise payable to such individual. The grant of Stock Awards under this Section
            11 shall be subject to the following provisions:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) At the time a Stock Award under this Section 11 is made, the
            Administrator shall establish a vesting period (the &#8220;<span style="text-decoration: underline;">Restricted Period</span>&#8221;) applicable to the Stock Award Shares subject to such Stock Award. The Administrator may, in its sole discretion, at the time a grant is made, prescribe restrictions
            in addition to the expiration of the Restricted Period, including the satisfaction of corporate or individual performance objectives. None of the Stock Award Shares may be sold, transferred, assigned, pledged or otherwise encumbered or disposed
            of during the Restricted Period applicable to such Stock Award Shares or prior to the satisfaction of any other restrictions prescribed by the Administrator with respect to such Stock Award Shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) The Company shall issue, in the name of each Service Provider
            to whom Stock Award Shares have been granted, stock certificates representing the total number of Stock Award Shares granted to such person, as soon as reasonably practicable after the grant. The Company, at the direction of the Administrator,
            shall hold such certificates, properly endorsed for transfer, for the Stock Awardee&#8217;s benefit until such time as the Stock Award Shares are forfeited to the Company, or the restrictions lapse.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) Unless otherwise provided by the Administrator, holders of
            Stock Award Shares shall have the right to vote such Shares and cash dividends may accrue with respect to such Shares but shall not be paid prior to the time, and may be paid only to the extent that the Restricted Period applicable to the Stock
            Award Shares subject to such Stock Award have lapsed or the corporate or individual performance objectives have been achieved. All distributions, if any, received by a Stock Awardee with respect to Stock Award Shares as a result of any stock
            split, stock distribution, combination of shares, or other similar transaction shall be subject to the restrictions of this Section 11.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(d) Unless otherwise provided by the Stock Award Agreement or
            determined by the Administrator in its sole discretion, any unvested Stock Award Shares granted to a Service Provider pursuant to the Plan shall be forfeited if the Stock Awardee&#8217;s employment or service with the Company or its Subsidiaries
            terminates for any reason prior to the expiration or termination of the applicable vesting period and/or the achievement of such other vesting conditions applicable to the Award.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-9<br />
        </div>

      </div>

    </div>

    <!--End Page 477-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 478-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg10"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(e) Upon the expiration or termination of the Restricted Period
            and the satisfaction of any other conditions prescribed by the Administrator, the restrictions applicable to the Stock Award Shares shall lapse and, at the Stock Awardee&#8217;s request, a stock certificate for the number of Stock Award Shares with
            respect to which the restrictions have lapsed shall be delivered, free of all such restrictions, to the Stock Awardee or his beneficiary or estate, as the case may be.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">12.&#8195;<span style="font-weight: bold;">Restricted Stock Units</span>.
            The Administrator may, in its sole discretion, grant Restricted Stock Units to a Service Provider subject to such terms and conditions as the Administrator sets forth in a Stock Award Agreement evidencing such grant. &#8220;Restricted Stock Units&#8221;
            are Awards denominated in units evidencing the right to receive Shares, which may vest over such period of time and/or upon satisfaction of such performance criteria or objectives as is determined by the Administrator at the time of grant and
            set forth in the applicable Stock Award Agreement, without payment of any amounts by the Stock Awardee thereof (except to the extent required by law). Prior to delivery of Shares with respect to an award of Restricted Stock Units, the Stock
            Awardee shall have no rights as a shareholder of the Company.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Upon satisfaction and/or achievement of the applicable vesting
            requirements relating to an Award of Restricted Stock Units, the Stock Awardee shall be entitled to receive a number of Shares that are equal to the number of Restricted Stock Units that became vested. To the extent, if any, set forth in the
            applicable Stock Award Agreement, cash dividend equivalents may be accumulated and paid at the end of, the applicable vesting period or achievement of the performance conditions only to the extent that the Stock Awardee receives the Shares
            issuable pursuant to the Restricted Stock Units.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Unless otherwise provided by the Stock Award Agreement or determined
            by the Administrator in its sole discretion, any Restricted Stock Units granted to a Service Provider pursuant to the Plan shall be forfeited if the Stock Awardee&#8217;s employment or service with the Company or its Subsidiaries terminates for any
            reason prior to the expiration or termination of the applicable vesting period and/or the achievement of such other vesting conditions applicable to the Restricted Stock Units.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">Notwithstanding the foregoing provisions for the settlement of
            Restricted Stock Units at the time of vesting, the Administrator may pursuant to Stock Award Agreements permit Stock Awardees who are Directors or members of a select group of management or &#8220;highly compensated employees&#8221; (within the meaning of
            ERISA) to irrevocably elect, on a form provided by and acceptable to the Administrator (the &#8220;<span style="text-decoration: underline;">Election</span><span style="text-decoration: underline;"> </span><span style="text-decoration: underline;">Form</span>&#8221;), to forego the receipt of cash or other compensation (including the Shares deliverable pursuant to any Restricted
            Stock Unit Award) and in lieu thereof to have the Company credit to an internal Plan account a number of Deferred Share Units having a Fair Market Value equal to the Shares and other compensation deferred. These credits will be made at the end
            of each calendar year (or other period determined by the Administrator) during which compensation is deferred. A Participant&#8217;s Election Form will in no event be effective with respect to any compensation that the Participant earns before the
            date on which the Election Form takes effect. For any Participant who is subject to U.S. income taxation, the Administrator shall only authorize deferral elections under this Section pursuant to written procedures, and using written Election
            Forms, that satisfy the requirements of Code Section 409A. In all cases, DSUs shall be subject to the following terms and conditions:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) <span style="font-style: italic;">Vesting</span>. Unless a
            Stock Award Agreement expressly provides otherwise, each Participant shall be 100% vested at all times in any Shares subject to DSUs.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) <span style="font-style: italic;">Issuances of Shares</span>.
            Unless a Stock Award Agreement expressly provides otherwise, the Company shall settle a Participant&#8217;s DSUs by delivering one Share for each DSU, in five substantially equal annual installments that are issued before the last day of each of the
            five calendar years that end after the date on which the Participant&#8217;s Continuous Service ends for any reason, subject to:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(i) the Participant&#8217;s right to elect a different form of
            distribution, only on a form provided by and acceptable to the Administrator, that permits the Participant to select any combination of a lump sum and annual installments that are triggered by, and completed within ten years following, the last
            day of the Participant&#8217;s Continuous Service; and</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(ii) the Company&#8217;s acceptance of the Participant&#8217;s distribution
            election form executed at the time the Participant elects to defer the receipt of cash or other compensation pursuant to this Section ; provided that the Participant may change a distribution election through any subsequent election that (A)
            the Participant delivers to </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-10<br />
        </div>

      </div>

    </div>

    <!--End Page 478-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 479-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg11"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">the Company at least one year before the date on which distributions are otherwise
            scheduled to commence pursuant to the Participant&#8217;s initial distribution election, and (B) defers the commencement of distributions by at least five years from the originally scheduled distribution commencement date. Fractional shares shall not
            be issued, and instead shall be paid out in cash.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) <span style="font-style: italic;">Termination of Service</span>.
            For purposes of this Section, a Participant&#8217;s employment shall be considered to have terminated only when the Participant incurs a &#8220;separation from service&#8221; within the meaning of Treasury Regulations Section 1.409A-1(h). A Participant shall be
            considered to have experienced a Separation from Service when the facts and circumstances indicate that either (i)&#160;no further services will be performed for the Company or any of its Subsidiaries or affiliates after a certain date, or (ii) the
            level of bona fide services the Participant will perform after such date (whether as an Employee, Director or Consultant) are reasonably expected to permanently decrease to no more than 50% of the average level of bona fide services performed
            by such Participant (whether as an Employee, Director or Consultant) over the immediately preceding 36-month period (or full period of services to the Company and its Subsidiaries and affiliates if the Participant has been providing such
            services for less than 36 months).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">13.&#8195;<span style="font-weight: bold;">Unrestricted Shares</span>. The
            Administrator may grant Unrestricted Shares in accordance with the following provisions:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) The Administrator may cause the Company to grant Unrestricted
            Shares to Service Providers at such time or times, in such amounts and for such reasons as the Administrator, in its sole discretion, shall determine. No payment shall be required for Unrestricted Shares.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) The Company shall issue, in the name of each Service Provider
            to whom Unrestricted Shares have been granted, stock certificates representing the total number of Unrestricted Shares granted to such individual, and shall deliver such certificates to such Service Provider as soon as reasonably practicable
            after the date of grant or on such later date as the Administrator shall determine at the time of grant.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">14.&#8195;<span style="font-weight: bold;">Stock Appreciation Rights</span>.
            A Stock Appreciation Right may be granted by the Administrator either alone, in addition to, or in tandem with other Awards granted under the Plan. Each Stock Appreciation Right granted under the Plan shall be subject to the following terms and
            conditions:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) Each Stock Appreciation Right shall relate to such number of
            Shares as shall be determined by the Administrator.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) The date of grant of a Stock Appreciation Right shall be the
            date specified by the Administrator, provided that that date shall not be before the date on which the Stock Appreciation Right is actually granted and shall not be prior to the date on which the recipient commences providing services as a
            Service Provider. The term of each Stock Appreciation Right shall be determined by the Administrator, but shall not exceed ten years from the date of grant. Each Stock Appreciation Right shall become exercisable at such time or times and in
            such amount or amounts during its term as shall be determined by the Administrator. Unless otherwise specified by the Administrator, once a Stock Appreciation Right becomes exercisable, whether in full or in part, it shall remain so exercisable
            until its expiration, forfeiture, termination or cancellation. Notwithstanding the foregoing, if there is a blackout period under the Company&#8217;s insider trading policy or Applicable Law (or an Administrator-imposed blackout period) that
            prohibits the buying or selling of Shares during any part of the ten-day period before the expiration of any Stock Appreciation Right based on the termination of a Participant&#8217;s employment without Cause, the period for exercising the Stock
            Appreciation Right shall be extended until the earlier of ten days beyond when such blackout period ends and the expiration date of its original term as set forth in the applicable Grant Agreement.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) A Stock Appreciation Right may be exercised, in whole or in
            part, by giving written notice to the Administrator. As soon as practicable after receipt of the written notice, the Company shall deliver to the person exercising the Stock Appreciation Right stock certificates for the Shares to which that
            person is entitled under Section 14(d) hereof, subject however to prior satisfaction of applicable withholding requirements in accordance with any method consistent with those set forth in Section 10(f) above.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(d) A Stock Appreciation Right shall be exercisable for Shares
            only. The number of Shares issuable upon the exercise of the Stock Appreciation Right shall be determined by dividing:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(i) the number of Shares for which the Stock Appreciation Right is
            exercised multiplied by the amount of the appreciation per Share (for this purpose, the &#8220;appreciation per Share&#8221; shall be the amount by </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-11<br />
        </div>

      </div>

    </div>

    <!--End Page 479-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 480-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg12"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">which the Fair Market Value of a Share on the exercise date exceeds (x)&#160;in the case
            of a Stock Appreciation Right granted in tandem with an Option, the exercise price or (y) in the case of a Stock Appreciation Right granted alone without reference to an Option, the Fair Market Value of a Share on the Award Date of the Stock
            Appreciation Right); by</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="para">(ii) the Fair Market Value of a Share on the exercise date.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">15.&#8195;<span style="font-weight: bold;">Non-Transferability</span>.
            Awards other than Unrestricted Shares shall not be transferable by the Participant other than (i)&#160;by will or by the laws of descent and distribution, or (ii) as approved by the Administrator in its discretion and set forth in the applicable
            Agreement provided that no Award may be transferred by a Participant for value. Notwithstanding the foregoing, an ISO transferred except in compliance with clause (i)&#160;above shall no longer qualify as an ISO. If the Administrator makes an Option
            or Stock Appreciation Right transferable, such Option or Stock Appreciation Right shall contain such additional terms and conditions as the Administrator deems appropriate. Notwithstanding the foregoing, the Administrator, in its sole
            discretion, may provide in the Grant Agreement regarding a given Option that the Optionee may transfer, without consideration for the transfer, his or her Nonstatutory Stock Options to members of his or her immediate family, to trusts for the
            benefit of such family members, or to partnerships in which such family members are the only partners, provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of this Plan and the
            applicable Option.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">16.&#8195;<span style="font-weight: bold;">Adjustments Upon Changes in
              Capitalization; Change in Control Provisions</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) <span style="font-style: italic;">Changes in Capitalization</span>.
            Subject to any required action by the shareholders of the Company, the number of Shares covered by each outstanding Award, and the number of Shares which have been authorized for issuance under the Plan but as to which no Awards have yet been
            granted or which have been returned to the Plan upon cancellation or expiration of any Awards, as well as the price per Share covered by each such outstanding Option or Stock Appreciation Right and the share limitations set forth in Section 3,
            shall be proportionately and equitably adjusted for any increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other
            increase or decrease in the number of issued Shares effected without receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall not be deemed to have been &#8220;effected without
            receipt of consideration.&#8221; Such adjustment shall be made by the Administrator, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of shares of stock of any
            class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an Award hereunder. Except as expressly provided
            herein, the issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, for cash or property, or for labor or services either upon direct sale or upon the exercise of rights or warrants
            to subscribe therefor, or upon conversion of shares or obligations of the Company convertible into sub-shares or other securities, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number of Shares then
            subject to Awards (or the price of Shares then subject to outstanding Options and Stock Appreciation Rights).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="para">(i) <span style="font-style: italic;">Change in Control
              Provisions</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(ii) <span style="font-style: italic;">Benefits</span>. In the
            event of a Change in Control of the Company (as defined below) and either (i)&#160;the failure of the Company&#8217;s successor to assume a Participant&#8217;s Awards or (ii) such assumption of Awards followed by the Participant&#8217;s termination without Cause on
            or within the one-year period following the Change in Control, then, except as otherwise provided by the Administrator in a Participant&#8217;s Grant or Stock Award Agreement, the Participant shall be entitled to the following benefits:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) All outstanding Options and Stock Appreciation Rights of such
            Participant, if any, granted prior to the Change in Control shall be fully vested and immediately exercisable in their entirety upon such Change in Control (or upon later termination of the Participant&#8217;s employment without Cause, if
            applicable).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) All unvested Stock Awards, performance-based Awards, and other
            Awards shall become fully vested, including without limitation, the following: (i)&#160;the restrictions to which any Stock Award granted prior to the Change in Control are subject shall lapse as if the applicable Restriction Period had ended upon
            such Change in Control (or upon later termination of the Participant&#8217;s employment without Cause, if applicable), and the conditions required for vesting of any unvested performance-based Awards shall be deemed to be satisfied, at </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-12<br />
        </div>

      </div>

    </div>

    <!--End Page 480-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 481-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg13"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">their maximum performance level, upon such Change in Control (or upon later
            termination of the Participant&#8217;s employment without Cause, if applicable).</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 52.5pt; text-align: left;" class="fpara">(iii) <span style="font-style: italic;">Change in Control</span>. A &#8220;Change in
            Control&#8221; shall mean the occurrence of any of the following:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) any person (as defined in Section 3(a)(9) of the Exchange Act
            and as used in Sections 13(d) and 14(d) thereof), excluding the Company, any subsidiary of the Company and any employee benefit plan sponsored or maintained by the Company or any subsidiary of the Company (including any trustee of any such plan
            acting in his capacity as trustee), becoming the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under the Exchange Act) of securities of the Company representing thirty percent (30%) of the total combined voting power of the Company&#8217;s then
            outstanding securities;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) the merger, consolidation or other business combination of the
            Company (a &#8220;<span style="text-decoration: underline;">Transaction</span>&#8221;), other than (A) a Transaction involving only the Company and one or more of its subsidiaries, or (B) a Transaction immediately following which the shareholders of the Company immediately prior to the Transaction
            continue to have a majority of the voting power in the resulting entity and no person (other than those covered by the exceptions in (1) above) becomes the beneficial owner of securities of the resulting entity representing more than
            twenty-five percent (25%) of the voting power in the resulting entity;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) during any period of two (2) consecutive years beginning on or
            after the date of the approval of this Plan by the shareholders (the &#8220;<span style="text-decoration: underline;">Effective Date</span>&#8221;), the persons who were members of the Board immediately before the beginning of such period (the &#8220;<span style="text-decoration: underline;">Incumbent Directors</span>&#8221;) ceasing (for any reason
            other than death) to constitute at least a majority of the Board or the board of directors of any successor to the Company, provided that, any director who was not a director as of the Effective Date shall be deemed to be an Incumbent Director
            if such director was elected to the board of directors by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually or by prior operation of the
            foregoing unless such election, recommendation or approval occurs as a result of an actual or threatened election contest (as such terms are used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act or any successor provision) or
            other actual or threatened solicitation of proxies or contests by or on behalf of a person other than a member of the Board; or</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(d) the approval by the shareholders of the Company of any plan of
            complete liquidation of the Company or an agreement for the sale of all or substantially all of the Company&#8217;s assets other than the sale of all or substantially all of the assets of the Company to a person or persons who beneficially own,
            directly or indirectly, at least fifty percent (50%) or more of the combined voting power of the outstanding voting securities of the Company at the time of such sale.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">17.&#8195;<span style="font-weight: bold;">Substitute Options</span>. In
            the event that the Company, directly or indirectly, acquires another entity, the Board may authorize the issuance of stock options (&#8220;<span style="text-decoration: underline;">Substitute </span><span style="text-decoration: underline;">Options</span>&#8221;) to the individuals performing services for the acquired entity in
            substitution of stock options previously granted to those individuals in connection with their performance of services for such entity upon such terms and conditions as the Board shall determine, taking into account the conditions of Code
            Section 424(a), as from time to time amended or superseded, in the case of a Substitute Option that is intended to be an Incentive Stock Option. Shares of capital stock underlying Substitute Stock Options shall not constitute Shares issued
            pursuant to the Plan for any purpose.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">18.&#8195;<span style="font-weight: bold;">Date of Grant</span>. The date
            of grant of an Award shall be, for all purposes, the date on which the Administrator makes the determination granting such Award, or such other later date as is determined by the Administrator. Notice of the determination shall be provided to
            each Participant within a reasonable time after the date of such grant.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">19.&#8195;<span style="font-weight: bold;">Amendment and Termination of the
              Plan</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) <span style="font-style: italic;">Amendment and Termination</span>.
            The Board may at any time amend, alter, suspend or terminate the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) <span style="font-style: italic;">Shareholder Approval</span>.
            The Company shall obtain shareholder approval of any Plan amendment to the extent necessary to comply with Applicable Laws.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) <span style="font-style: italic;">Effect of Amendment or
              Termination</span>. No amendment, alteration, suspension or termination of the Plan shall materially impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be
            in writing and signed by the Participant and the </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-13<br />
        </div>

      </div>

    </div>

    <!--End Page 481-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 482-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg14"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Company. Termination of the Plan shall not affect the Administrator&#8217;s ability to
            exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">20.&#8195;<span style="font-weight: bold;">Conditions Upon Issuance of
              Shares</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) <span style="font-style: italic;">Legal Compliance</span>.
            Shares shall not be issued in connection with the grant or vesting of any Stock Award or Unrestricted Share or the exercise of any Option or Stock Appreciation Right unless such grant or the exercise of such Option or Stock Appreciation Right
            and the issuance and delivery of such Shares shall comply with Applicable Laws and shall be further subject to the approval of counsel for the Company with respect to such compliance.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) <span style="font-style: italic;">Investment Representations</span>.
            As a condition to the grant of any Stock Award or the exercise of any Option or Stock Appreciation Right, the Company may require the person receiving such Award or exercising such Option or Stock Appreciation Right to represent and warrant at
            the time of any such exercise or grant that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(c) <span style="font-style: italic;">Additional Conditions</span>.
            The Administrator shall have the authority to condition the grant of any Award in such other manner that the Administrator determines to be appropriate, provided that such condition is not inconsistent with the terms of the Plan.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(d) <span style="font-style: italic;">Trading Policy Restrictions</span>.
            Option and or Stock Appreciation Right exercises and Shares issued in connection with any Stock Awards under the Plan shall be subject to the terms and conditions of any insider trading policy established by the Company or the Administrator.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">21.&#8195;<span style="font-weight: bold;">Inability to Obtain Authority</span>.
            The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company&#8217;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company
            of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">22.&#8195;<span style="font-weight: bold;">Withholding; Notice of Sale</span>.
            The Company shall be entitled to withhold from any amounts payable to an Employee or other Service Provider any amounts which the Company determines, in its discretion, are required to be withheld under any Applicable Law as a result of any
            action taken by a holder of an Award. Furthermore, prior to the delivery of any Shares in connection with any Award, the Company shall be entitled to require as a condition of delivery that the Participant shall pay or make adequate provision
            acceptable to the Company for the satisfaction of the statutory minimum prescribed amount of federal and state income tax and other withholding obligations of the Company, including, if permitted by the Administrator, by having the Company
            withhold from the number of Shares otherwise deliverable in connection with the Award, a number of Shares having a Fair Market Value equal to an amount sufficient to satisfy such tax withholding obligations.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">23.&#8195;<span style="font-weight: bold;">Recoupment of Awards</span>.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(a) Unless otherwise specifically provided in a Grant or Stock
            Award Agreement, and to the extent permitted by Applicable Law, the Administrator may, in its sole and absolute discretion, without obtaining the approval or consent of the Company&#8217;s shareholders or of any Participant, require that any
            Participant forfeit or reimburse the Company for all or any portion of any previously-settled Awards granted under this Plan (&#8220;<span style="text-decoration: underline;">Reimbursement</span>&#8221;), if and to the extent:</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(i)&#160;the granting, vesting or payment of such Award was predicated
            upon the achievement of certain financial results that were subsequently the subject of a material financial restatement;</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(ii)&#160;in the Administrator&#8217;s view the Participant either benefited
            from a calculation that later proves to be materially inaccurate, or engaged in fraud or misconduct that caused or partially caused the need for a material financial restatement by the Company or any of its Subsidiaries and affiliates; and</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 52.5pt; text-align: left;" class="fpara">(iii)&#160;a lower granting, vesting, or payment of such Award would
            have occurred based upon the conduct described in subsection (ii)&#160;above.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">In each instance, the Administrator may, to the extent practicable
            and allowable or required under Applicable Law, require forfeiture or Reimbursement of any such Award granted to a Participant; provided that the Company will not seek forfeiture or Reimbursement of any such Awards that were paid or vested more
            than three years prior to the first date of the applicable restatement period.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-14<br />
        </div>

      </div>

    </div>

    <!--End Page 482-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 483-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg15"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 37.5pt; text-align: left;" class="fpara">(b) Notwithstanding any other provision of this Plan, all
            Awards will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any securities exchange, trading market or automated quotation system on which the Company&#8217;s
            securities are listed, quoted or traded or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, including but not limited to Section 10D of the Exchange Act, or any other Applicable Law. In
            addition, the Administrator, in its sole and absolute discretion, may impose such other clawback, recovery or recoupment provisions in a Grant or Stock Award Agreement as the Administrator determines is necessary, advisable or appropriate,
            including but not limited to a reacquisition right in respect of previously acquired Shares or other cash or property upon the occurrence of a termination for Cause and/or violation of any post-employment covenants, including but not limited to
            ones relating to noncompetition, nonsolicitation, and trade secrets. No recovery of compensation under such a clawback policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term)
            under any agreement with the Company or any of its Subsidiaries or affiliates.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">24.&#8195;<span style="font-weight: bold;">Data Privacy</span>. As a
            condition of receipt of any Award, each Participant explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of personal data as described in this Section by and among, as applicable, the Company
            and its Subsidiaries and affiliates for the exclusive purpose of implementing, administering and managing this Plan and Awards and the Participant&#8217;s participation in this Plan. In furtherance of such implementation, administration, and
            management, the Company and its Subsidiaries and affiliates may hold certain personal information about a Participant, including, but not limited to, the Participant&#8217;s name, home address, telephone number, date of birth, social insurance or
            security number or other identification number, salary, nationality, job title(s), information regarding any securities of the Company or any of its Subsidiaries or affiliates, and details of all Awards (the &#8220;<span style="text-decoration: underline;">Personal Data</span>&#8221;). In addition
            to transferring the Personal Data amongst themselves as necessary for the purpose of implementation, administration and management of this Plan and Awards and the Participant&#8217;s participation in this Plan, the Company and its Subsidiaries and
            affiliates may each transfer the Personal Data to any third parties assisting the Company in the implementation, administration and management of this Plan and Awards and the Participant&#8217;s participation in this Plan. Recipients of the Personal
            Data may be located in the Participant&#8217;s country or elsewhere, and the Participant&#8217;s country and any given recipient&#8217;s country may have different data privacy laws and protections. By accepting an Award, each Participant authorizes such
            recipients to receive, possess, use, retain and transfer the Personal Data, in electronic or other form, for the purposes of assisting the Company in the implementation, administration and management of this Plan and Awards and the
            Participant&#8217;s participation in this Plan, including any requisite transfer of such Personal Data as may be required to a broker or other third party with whom the Company or the Participant may elect to deposit any shares of capital stock of
            the Company. The Personal Data related to a Participant will be held only as long as is necessary to implement, administer and manage this Plan and Awards and the Participant&#8217;s participation in this Plan. A Participant may, at any time, view
            the Personal Data held by the Company with respect to such Participant, request additional information about the storage and processing of the Personal Data with respect to such Participant, recommend any necessary corrections to the Personal
            Data with respect to the Participant, or refuse or withdraw the consents herein in writing, in any case without cost, by contacting the Participant&#8217;s local human resources representative. The Company may cancel the Participant&#8217;s eligibility to
            participate in this Plan, and in the Administrator&#8217;s sole and absolute discretion, the Participant may forfeit any outstanding Awards if the Participant refuses or withdraws the consents described herein. For more information on the
            consequences of refusal to consent or withdrawal of consent, Participants may contact their local human resources representative.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">25.&#8195;<span style="font-weight: bold;">Relationship to other Benefits</span>.
            No Award, Share issuance, or other payment pursuant to this Plan shall be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company or
            any of its Subsidiaries except to the extent otherwise expressly provided in writing in such other plan or an agreement thereunder.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">26.&#8195;<span style="font-weight: bold;">Section 409A.</span> If a
            Participant is a &#8220;specified employee&#8221; as defined in Section 409A of the Code (and as applied according to procedures of the Company) as of his or her &#8220;separation from service&#8221; within the meaning of Treasury Regulations Section 1.409A-1(h) to
            the extent any payment under this Plan or pursuant to the grant of Restricted Stock Units or DSUs constitutes deferred compensation (after taking into account any applicable exemptions from Section 409A of the Code), and to the extent required
            by Section 409A of the Code, no payments due under this Plan or pursuant to such Award may be made until the earlier of: (i)&#160;the first day of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-15<br />
        </div>

      </div>

    </div>

    <!--End Page 483-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 484-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_305-annexf_pg16"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="para">the seventh month following the Participant&#8217;s separation from service, or (ii)&#160;the
            Participant&#8217;s date of death; provided, however, that any payments delayed during this six-month period shall be paid in the aggregate in a lump sum, without interest, on the first day of the seventh month following the Participant&#8217;s separation
            from service.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">The Administrator shall administer the Plan with a view toward
            ensuring that all Restricted Stock Units and DSUs issued under the Plan that are subject to Section 409A of the Code comply with the requirements thereof and that Options and Stock Appreciation Rights under the Plan be exempt from the
            requirements of Section 409A of the Code, but neither the Administrator nor any member of the Board, nor the Company nor any other person acting hereunder on behalf of the Company, the Administrator or the Board shall be liable to a Participant
            by reason of the acceleration of any income, or the imposition of any additional tax or penalty, with respect to an Award, whether by reason of a failure to satisfy the requirements of Section 409A of the Code or otherwise.</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;" class="para">27.&#8195;<span style="font-weight: bold;">Governing Law</span>. This Plan
            shall be governed by the laws of the State of Delaware, without regard to conflict of law principles.</div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">F-16<br />
        </div>

      </div>

    </div>

    <!--End Page 484-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 485-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_400-part2_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">PART II</div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; text-align: center;" class="h1">INFORMATION NOT REQUIRED IN PROXY <br />
          </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="h1">STATEMENT/PROSPECTUS/INFORMATION STATEMENT </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 50pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 20.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Indemnification of Directors and Officers </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Subsection (a) of Section 145 of the General Corporation Law of the State of Delaware
            (&#8220;DGCL&#8221;), empowers a corporation to indemnify any person who was or is a party or who is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative
            (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director,
            officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the
            person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
            action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Subsection (b) of Section 145 empowers a corporation to indemnify any person who was or
            is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person acted in any of the capacities
            set forth above, against expenses (including attorneys&#8217; fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person
            reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the
            corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the
            case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Section 145 further provides that to the extent a director or officer of a corporation
            has been successful on the merits or otherwise in the defense of any action, suit or proceeding referred to in subsections (a) and (b) of Section 145, or in defense of any claim, issue or matter therein, such person shall be indemnified against
            expenses (including attorneys&#8217; fees) actually and reasonably incurred by such person in connection therewith; that indemnification provided for by Section 145 shall not be deemed exclusive of any other rights to which the indemnified party may
            be entitled; and the indemnification provided for by Section 145 shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of
            such person&#8217;s heirs, executors and administrators. Section 145 also empowers the corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was
            serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in
            any such capacity, or arising out of his status as such, whether or not the corporation would have the power to indemnify such person against such liabilities under Section 145. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Section 102(b)(7) of the DGCL provides that a corporation&#8217;s certificate of
            incorporation may contain a provision eliminating or limiting the personal liability of a director to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, provided that such provision shall not
            eliminate or limit the liability of a director (i)&#160;for any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders, (ii)&#160;for acts or omissions not in good faith or which involve intentional misconduct or a knowing
            violation of law, (iii)&#160;under Section 174 of the DGCL or (iv)&#160;for any transaction from which the director derived an improper personal benefit. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius&#8217; amended and restated certificate of incorporation provides that Caladrius,
            to the fullest extent permitted by law, shall indemnify and advance expenses to any person made or threatened to be made a party to an action, suit or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact
            that he or she, or his or her testator or intestate, is or was a director or officer of Caladrius or any predecessor of </div>

        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">II-1<br />
        </div>

      </div>

    </div>

    <!--End Page 485-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 486-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_400-part2_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius, or serves or served at any other enterprise as a director or officer at
            the request of Caladrius or any predecessor to Caladrius. Caladrius&#8217; amended and restated bylaws provide that Caladrius shall indemnify and hold harmless, to the fullest extent permitted by the DGCL as it presently exists or may hereafter be
            amended, any director or officer of Caladrius who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal administrative or investigative, by reason of the fact that
            he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the corporation or is or was serving at the request of Caladrius as a director, officer, employee or agent of another corporation or of a
            partnership, joint venture, trust, enterprise or nonprofit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys&#8217; fees) reasonably incurred by such person. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius entered into indemnification agreements with each of its directors and
            executive officers, in addition to the indemnification provided for in its amended and restated certificate of incorporation and bylaws, and intends to enter into indemnification agreements with any new directors and executive officers in the
            future. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Caladrius has purchased and intends to maintain insurance on behalf of any person who
            is or was a director or officer of Caladrius against any loss arising from any claim asserted against him or her and incurred by him or her in any such capacity, subject to certain inclusions. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the terms of the Merger Agreement, from the Effective Time through the
            sixth anniversary of the date on which the Effective Time occurs, Caladrius must indemnify and hold harmless each person who is now, or has been at any time prior to the date thereof, or who becomes prior to the Effective Time, a director or
            officer of Caladrius or Cend, respectively, against all claims, losses, liabilities, damages, judgments, fines and reasonable fees, costs and expenses, including attorneys&#8217; fees and disbursements, incurred in connection with any claim, action,
            suit, proceeding or investigation to the fullest extent permitted under the DGCL. Each such person will also be entitled to advancement of expenses incurred in the defense of any such claim, action, suit, proceeding or investigation, provided
            that such person provides an undertaking required by the DGCL, to repay such advances if it is ultimately determined that such person is not entitled to indemnification. From and after the Effective Time, Caladrius must maintain directors&#8217; and
            officers&#8217; liability insurance policies, with an effective date as of the closing date of the Merger, on commercially available terms and conditions and with coverage limits customary for U.S. public companies similarly situated to Caladrius. In
            addition, Caladrius shall purchase, prior to the Effective Time, a six-year prepaid &#8220;tail policy&#8221; for the non-cancellable extension of the directors&#8217; and officers&#8217; liability coverage of Caladrius&#8217; existing directors&#8217; and officers&#8217; insurance
            policies with terms, conditions, retentions and limits of liability that are no less favorable than the current directors&#8217; and officers&#8217; liability insurance policies maintained by Caladrius. </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Further, pursuant to the terms of the Merger Agreement, the provisions of the amended
            and restated certificate of incorporation and bylaws of Caladrius with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of Caladrius shall not be amended, modified or repealed for
            a period of six years from the Effective Time in a manner that would adversely affect the rights thereunder of individuals who, at or prior to the Effective Time, were officers and directors of Caladrius, unless such modification is required by
            applicable law. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 50pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 21.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Exhibits and Financial Statement Schedules </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Exhibit Index </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">A list of exhibits filed with this registration statement on Form S-4 is set forth on
            the Exhibit Index and is incorporated herein by reference. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Financial Statements </div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">The financial statements filed with this registration statement on Form S-4 is set
            forth on the Financial Statement Index and is incorporated herein by reference. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 12pt; margin-left: 0pt;">


  <tr>

    <td style="width: 50pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 22.<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Undertakings </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The undersigned registrant hereby undertakes as follows: </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">That prior to any public reoffering of the securities registered hereunder through use of a proxy
                    statement/prospectus/information statement which is a part of this registration statement, by any person </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">II-2<br />
        </div>

      </div>

    </div>

    <!--End Page 486-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 487-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_400-part2_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: left;" class="fpara">or party who is deemed to be an underwriter within the meaning of Rule 145(c), the
            issuer undertakes that such reoffering proxy statement/prospectus/information statement will contain the information called for by the applicable registration form with respect to reofferings by persons who may be deemed underwriters, in
            addition to the information called for by the other items of the applicable form. </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">That every proxy statement/prospectus/information statement (i)&#160;that is filed pursuant to paragraph (a)(1) immediately
                    preceding, or (ii)&#160;that purports to meet the requirements of Section 10(a)(3) of the Securities Act and is used in connection with an offering of securities subject to Rule 415, will be filed as a part of an amendment to the
                    registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration
                    statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To respond to requests for information that is incorporated by reference into this proxy statement/prospectus/information
                    statement pursuant to Item 4, 10(b), 11, or 13 of this Form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information
                    contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(4)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired
                    involved therein, that was not the subject of and included in the registration statement when it became effective. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 6pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and
                    controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act
                    and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the
                    registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its
                    counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
                    by the final adjudication of such issue. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">II-3<br />
        </div>

      </div>

    </div>

    <!--End Page 487-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 488-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_401-exhibits_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1">EXHIBIT INDEX </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit Number</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Description of Document</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">2.1</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Agreement and Plan of Merger and Reorganization, dated April&#160;26, 2022, among
                      Caladrius Biosciences, Inc., CS Cedar Merger Sub, Inc., and Cend Therapeutics, Inc. (included as <span style="font-style: italic;">Annex&#160;A</span> to the proxy statement/prospectus/information statement forming a part of
                      this Registration Statement).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001722000031/exhibit22-supportagreeme.htm">2.2*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Support Agreement, by and between Caladrius Biosciences, Inc., and
                      certain securityholders of Cend Therapeutics Inc. (filed as Exhibit 2.2 to Caladrius&#8217; Current Report on Form&#160;8-K, filed with the SEC on April&#160;27, 2022).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001722000031/exhibit23-supportagreeme.htm">2.3*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Support Agreement, by and between Cend Therapeutics Inc., and
                      certain securityholders of Caladrius Biosciences, Inc. (filed as Exhibit 2.3 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on April&#160;27, 2022).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001722000031/exhibit24-lockxupagreeme.htm">2.4*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Lock-Up Agreement, by and between Caladrius Biosciences, Inc. and
                      certain securityholders of Caladrius Biosciences, Inc. and Cend Therapeutics Inc. (filed as Exhibit 2.4 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on April&#160;27, 2022).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001716000143/exhibit31arcertofincorpeff.htm">3.1*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Amended and Restated Certificate of Incorporation of Caladrius Biosciences,
                      Inc., as amended, effective July&#160;27, 2016 (filed as Exhibit 3.1 to Caladrius&#8217; Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2016, filed with the SEC on August&#160;9, 2016).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001716000143/exhibit32arbylawseff072720.htm">3.2*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Amended and Restated By-Laws of the Caladrius Biosciences, Inc. as amended,
                      effective as of July&#160;27, 2016 (filed as Exhibit 3.2 to Caladrius&#8217; Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2016, filed with the SEC on August&#160;9, 2016).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001717000082/exhibit31092017.htm">3.3*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Amendments to Amended and Restated Bylaws of Caladrius Biosciences, Inc.,
                      effective as of September&#160;18, 2017 (filed as Exhibit 3.1 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on September&#160;21, 2017).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000115752307009113/a5489369ex4_1.htm">4.1*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Common Stock certificate of Caladrius Biosciences, Inc.
                      (incorporated by reference from the Registration Statement on Form S-3 filed by Caladrius with the Securities and Exchange Commission on September&#160;11, 2007).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex5-1.htm">5.1*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. regarding the
                      validity of the securities.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001722000031/exhibit101-stockpurchase.htm">10.1*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Series D Preferred Stock Purchase Agreement, dated April&#160;26, 2022, among
                      Caladrius Biosciences, Inc. and Cend Therapeutics Inc. (filed as Exhibit 10.1 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on April&#160;27, 2022).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001722000031/exhibit102-collaboration.htm">10.2*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Collaboration Agreement, dated April&#160;26, 2022, between Caladrius
                      Biosciences, Inc. and Cend Therapeutics Inc. (filed as Exhibit 10.2 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on April&#160;27, 2022).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001718000021/exhibit101directorcompensa.htm">10.3*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director Compensation Policy (filed as Exhibit 10.1 to Caladrius&#8217; Annual
                      Report on Form 10-K for the year ended December&#160;31, 2018, filed with the SEC on March&#160;22, 2018 and amended on April&#160;2, 2018).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001715000050/def14a-2015.htm">10.4*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2015 Equity Compensation Plan (filed as Annex&#160;A to Caladrius&#8217; Definitive
                      Proxy Statement filed on Schedule 14A, filed with the SEC on June&#160;8, 2015).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">II-4<br />
        </div>

      </div>

    </div>

    <!--End Page 488-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 489-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_401-exhibits_pg2"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit Number</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Description of Document</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001717000060/clbs-ex1012017employeestoc.htm">10.5+*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">2017 Employee Stock Purchase Plan (filed as Exhibit 10.1 to Caladrius&#8217;
                      Quarterly Report on Form&#160;10-Q filed with the SEC on August&#160;10, 2017).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001715000013/exh1045.htm">10.6*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Indemnification Agreement for executive officers (filed as Exhibit
                      10.44 to Caladrius&#8217; Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2014 as filed with the SEC&#160;on March&#160;2, 2015).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001715000002/exhibit102dm.htm">10.7(A)#*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Employment Agreement, dated as of January&#160;5, 2015 and effective on
                      January&#160;5, 2015, by and between Caladrius and David J. Mazzo, Ph.D. (filed as Exhibit 10.2 to Caladrius&#8217; Current Report on Form 8-K filed on January&#160;5, 2015).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001715000008/exh102dm.htm">10.7(B)#*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Amendment, dated as of January&#160;16, 2015, to Employment Agreement, dated as
                      of January&#160;5, 2015 and effective on January&#160;5, 2015, by and between Caladrius and David J. Mazzo, Ph.D. (filed as Exhibit 10.2 to Caladrius&#8217; Current Report on Form 8-K filed on January&#160;16, 2015).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001716000143/exhibit101djmamendment.htm">10.7(C)#*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Amendment to Employment Agreement, dated as of July&#160;25, 2016, by and between
                      Caladrius and David J. Mazzo, Ph.D. (filed as Exhibit 10.1 to Caladrius&#8217; Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2016, filed with the SEC on August&#160;9, 2016).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001717000082/exhibit101amendedemploymen.htm">10.7(D)#*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Amendment to Employment Agreement with David J. Mazzo, Ph.D., effective
                      September&#160;18, 2017 (filed as Exhibit 10.1 to Caladrius&#8217; Current Report on Form 8-K filed with the SEC on September&#160;21, 2017).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114420418063631/tv508609_ex10-1.htm">10.7(E)#*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Amendment to Employment Agreement with David J. Mazzo, Ph.D., dated
                      December&#160;6, 2018 (filed as Exhibit 10.1 to Caladrius&#8217; Current Report on Form 8-K filed with the SEC on December&#160;7, 2018).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001722000025/ex1019buckemploymentcont.htm">10.8*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Employment Agreement, dated as of July&#160;26, 2021 and effective on
                      September&#160;1, 2021, by and between the Company and Kristen K. Buck, M.D. (filed as Exhibit&#160;10.19 to Caladrius' Annual Report on Form&#160;10-K filed with the SEC on April&#160;21, 2022).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001720000022/ex101.htm">10.9*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Purchase Agreement, dated April&#160;23, 2020, by and between Caladrius
                      Biosciences, Inc. and each purchaser identified on the signature pages thereto (filed as Exhibit 10.1 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on April&#160;24, 2020).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001720000039/ex102.htm">10.10*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Placement Agent Agreement, dated November&#160;5, 2019, as subsequently amended
                      on each of March&#160;11, 2020, April&#160;23, 2020 and May&#160;25, 2020, by and between Caladrius Biosciences, Inc. and H.C. Wainwright &amp; Co., LLC (filed as Exhibit 10.2 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on May&#160;26,
                      2020).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001720000039/ex101.htm">10.11*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Purchase Agreement, dated May&#160;25, 2020, by and between Caladrius
                      Biosciences, Inc. and each purchaser identified on the signature pages thereto (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on May&#160;26, 2020).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001720000060/pipe20200710ex101.htm">10.12*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Purchase Agreement, dated July&#160;10, 2020, by and between Caladrius
                      Biosciences, Inc. and each purchaser identified on the signature pages thereto (filed as Exhibit 10.1 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on July&#160;10, 2020).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001720000060/pipe20200710ex102.htm">10.13*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Registration Rights Agreement, dated July&#160;10, 2020, by and between
                      Caladrius Biosciences, Inc. and each purchaser identified on the signature pages thereto (filed as Exhibit 10.2 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on July&#160;10, 2020).</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">II-5<br />
        </div>

      </div>

    </div>

    <!--End Page 489-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 490-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_401-exhibits_pg3"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit Number</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Description of Document</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001721000006/a20210121ex101formofsecpur.htm">10.14*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Purchase Agreement, dated January&#160;21, 2021, by and between Caladrius
                      Biosciences, Inc. and certain Investors, as defined therein (filed as Exhibit 10.1 to Caladrius&#8217; Current Report on Form&#160;8-K, filed with the SEC on January&#160;25, 2021).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001721000006/a20210121ex102formofregrts.htm">10.15*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Registration Rights Agreement, dated January&#160;21, 2021, by and
                      between Caladrius Biosciences, Inc. and each purchaser identified on the signature pages thereto (filed as Exhibit 10.2 to Caladrius&#8217; Current Report on Form 8-K, filed with the SEC on January&#160;25, 2021).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001721000032/exhibit10120210212.htm">10.16*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Institutional Securities Purchase Agreement, by and between
                      Caladrius Biosciences, Inc. and each purchaser identified on the signature pages thereto (incorporated by reference to Exhibit 10.1 to Caladrius&#8217; Form 8-K filed on February&#160;16, 2021).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000032001721000032/exhibit10220210212.htm">10.17*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Institutional Additional Securities Purchase Agreement, by and
                      between Caladrius Biosciences, Inc. and each purchaser identified on the signature pages thereto (incorporated by reference to Exhibit 10.2 to Caladrius&#8217; Form 8-K filed on February&#160;16, 2021). </div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex10-18.htm">10.18*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exclusive License Agreement, dated December&#160;1, 2015, by and between Cend
                      Therapeutics, Inc. (f/k/a DrugCendR, LLC) and Sanford Burnham Prebys Medical Discovery Institute. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex10-19.htm">10.19*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">First Amendment to Exclusive License Agreement, dated December&#160;1, 2015, by
                      and between Cend Therapeutics, Inc. (f/k/a DrugCendR, LLC) and Sanford Burnham Prebys Medical Discovery Institute. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex10-20.htm">10.20*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Second Amendment to Exclusive License Agreement, dated December&#160;1, 2015, by
                      and between Cend Therapeutics, Inc. (f/k/a DrugCendR, LLC) and Sanford Burnham Prebys Medical Discovery Institute. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex10-21.htm">10.21*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Third Amendment to Exclusive License Agreement, dated December&#160;1, 2015, by
                      and between Cend Therapeutics, Inc. (f/k/a DrugCendR, LLC) and Sanford Burnham Prebys Medical Discovery Institute. </div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex10-22.htm">10.22*</a> </div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Employment Agreement, dated March 29, 2021, by and between Cend
                      Therapeutics, Inc. and David Slack.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="ny20004343x2_ex23-1.htm">23.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consent of Grant Thornton, LLP, Independent Registered Public Accounting
                      Firm to Caladrius Biosciences, Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="ny20004343x2_ex23-2.htm">23.2</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consent of Withum Smith+Brown, PC Independent Registered Public Accounting
                      Firm to Cend Therapeutics Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex5-1.htm">23.3*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in
                      Exhibit 5.1 hereto).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_s4.htm#tSIG">24.1*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Power of attorney (included on the signature page to this Registration
                      Statement).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="ny20004343x2_ex99-1.htm">99.1</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Form of Proxy Card for the Caladrius Biosciences, Inc. Annual Meeting of
                      Stockholders.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_s4.htm#tANNEXB">99.2*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Opinion of Back Bay Life Science Advisors LLC, financial advisor to
                      Caladrius Biosciences, Inc. (included as <span style="font-style: italic;">Annex&#160;B</span> to the proxy statement/prospectus/information statement forming a part of this Registration Statement).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">II-6<br />
        </div>

      </div>

    </div>

    <!--End Page 490-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 491-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_401-exhibits_pg4"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="fintab">


  <tr class="header">

    <td style="width: 10.26%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Exhibit Number</div>
                </td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Description of Document</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex99-3.htm">99.3*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consent of Back Bay Life Science Advisors LLC, financial advisor to
                      Caladrius Biosciences, Inc.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="#tANNEXD">99.4</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Proposed Amended and Restated Certificate of Incorporation of Caladrius
                      Biosciences, Inc. (included as <span style="font-style: italic;">Annex&#160;D</span> to the proxy statement/prospectus/information statement forming a part of this Registration Statement).</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex99-5.htm">99.5*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consent of David Slack to be named as director.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex99-6.htm">99.6*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consent of Heidi Henson to be named as director.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex99-7.htm">99.7*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consent of Erkki Ruoslahti, M.D., Ph.D. to be named as director.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="ny20004343x2_ex99-8.htm">99.8</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Consent of Mohammad Azab, MD, MBA to be named as director.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">101</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">The following materials from the Registrant&#8217;s Annual Report on Form 10-K for
                      the year ended December&#160;31, 2021 and the Registrant&#8217;s Quarterly Report on Form 10-Q for the quarter ending March&#160;31, 2022, formatted in Extensible Business Reporting Language (XBRL) includes: (i)&#160;Consolidated Balance Sheets at
                      March&#160;31, 2022 and December&#160;31, 2021, (ii)&#160;Consolidated Statements of Operations for the Three Months Ended March&#160;31, 2022 and 2021, (iii)&#160;Consolidated Statements of Comprehensive Loss for the Three Months Ended March&#160;31, 2022 and
                      2021, (iv)&#160;Consolidated Statements of Equity for the Three Months Ended March&#160;31, 2022 and 2021, (v)&#160;Consolidated Statements of Cash Flows for the Three Months Ended March&#160;31, 2022 and 2021 and (vi)&#160;Notes to Unaudited Consolidated
                      Financial Statements.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 10.26%; text-align: center; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara"><a href="https://www.sec.gov/Archives/edgar/data/320017/000114036122023089/ny20004343x1_ex107.htm">107*</a></div>
                </td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 0.64%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;" class="gutter">&#8203;</td>

    <td style="width: 88.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Filing Fee Table.</div>
                </td>

  </tr>


</table>
          <div>
            <div style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 16pt;" class="rule-partial"> </div>

          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Previously filed. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">#<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Indicates a management contract or compensatory plan, contract or arrangement. </div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" border="0" style="margin-top: 3pt; margin-left: 0pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#8224;<br />
                  </div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Confidential treatment has been requested or granted as to certain portions, which portions have been omitted and filed
                    separately with the Securities and Exchange Commission. </div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">II-7<br />
        </div>

      </div>

    </div>

    <!--End Page 491-->
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <!--Begin Page 492-->
    <div style="text-align: left; margin: auto; position: relative; width: 468pt;" class="page"><a id="ny20004343x2_s4a_402-sig_pg1"><!--Anchor--></a>
      <p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p>
      <div class="page-content">
        <div style="width: 468pt; margin-left: 0pt;" class="block-main">
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;" class="h1"><a id="tSIG"><!--Anchor--></a>SIGNATURES </div>

          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the requirements of the Securities Act, the registrant has duly caused
              this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the city of Basking Ridge (Bernards Township), State of New Jersey, on the 26th day of July, 2022. </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">CALADRIUS BIOSCIENCES, INC.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">/s/ David J. Mazzo, Ph.D.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 41.03%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">President and Chief Executive Officer</div>
                </td>

  </tr>


</table>
          <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: left;" class="fpara">Pursuant to the requirements of the Securities Act, this registration statement has
              been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. </div>

          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr class="header">

    <td style="width: 28.21%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Signature</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Title</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;" class="fpara">Date</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">/s/ David J. Mazzo, Ph.D. </div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;" rowspan="2">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director, and President and Chief Executive Officer (Principal Executive
                      Officer, Principal Financial Officer and Principal Accounting Officer) </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" rowspan="2" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July&#160;26, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J.Mazzo, Ph.D. </div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">* </div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Chairman of the Board of Directors</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July&#160;26, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Gregory B. Brown, M.D.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">* </div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July&#160;26, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Michael H. Davidson</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">* </div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July&#160;26, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Cynthia L. Flowers</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">* </div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July&#160;26, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven M. Klosk</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">* </div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July&#160;26, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Steven S. Myers</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">* </div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July&#160;26, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Peter G. Traber, M.D.</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">* </div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Director</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;" class="fpara">July&#160;26, 2022</div>
                </td>

  </tr>

  <tr>

    <td style="width: 28.21%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Anne C. Whitaker</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 46.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 20.51%; text-align: center; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
          <table cellspacing="0" cellpadding="0" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;" class="txttab">


  <tr>

    <td style="width: 5.13%; text-align: left; vertical-align: top; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">*By:</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">/s/ David J. Mazzo, Ph.D.</div>
                </td>

    <td style="width: 1.28%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;" class="gutter">&#8203;</td>

    <td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 5.13%; text-align: left; vertical-align: top; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">David J. Mazzo, Ph.D. <br />
                  </div>
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;" class="fpara">Attorney-in-Fact</div>
                </td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 1.28%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;" class="gutter">&#8203;</td>

    <td style="width: 64.1%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;" class="fpara">&#160;</div>
                </td>

  </tr>


</table>
        </div>

      </div>

      <div style="width: 468pt; margin-top: 12pt; margin-left: 0pt;" class="block-frill">
        <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;" class="unknown">II-8<br />
        </div>

      </div>

    </div>

    <!--End Page 492-->
  </div>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ny20004343x2_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">


  <div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif;">
      <hr style="height: 4px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 23.1</font><br>
      </div>
      <div><br>
      </div>
      CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div>&#160;</div>
    <div>We have issued our report dated<font style="font-family: 'Times New Roman',Times,serif; color: rgb(255, 0, 0);">&#160;</font>March 22, 2022, with respect
      to the consolidated financial statements of Caladrius Biosciences, Inc. contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our
      name as it appears under the caption &#8220;Experts.&#8221;</div>
    <div>&#160;<font style="font-family: 'Times New Roman',Times,serif;"><br>
      </font>/s/ GRANT THORNTON LLP</div>
    <div>&#160;</div>
    <div>New York, New York</div>
    <div>July 26, 2022</div>
    <div> <br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
    <div> <br>
      </div>
    <div>&#160;</div>
    <div><br>
    </div>
    <div>&#160;</div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ny20004343x2_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div>
      <div style="text-align: center; font-weight: bold;">
        <hr style="height: 4px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
        <div style="text-align: right;">Exhibit 23.2<br>
        </div>
        <div><br>
        </div>
        CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    </div>
    <div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">We hereby consent to the use in this Prospectus constituting a part of this Registration Statement on Form S-4, Amendment No. 1, of our
        report dated May 20, 2022 relating to the consolidated financial statements of Cend Therapeutics, Inc., which is contained in that Prospectus. We also consent to the reference to us under the caption &#8220;Experts&#8221; in the Prospectus.</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">/s/ WithumSmith+Brown, PC</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">San Francisco, California</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">July 26, 2022</div>
      <div style="text-align: justify; color: #000000;"> <br>
      </div>
      <div style="text-align: justify; color: #000000;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
      <div style="text-align: justify; color: #000000;">&#160;</div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ny20004343x2_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div style="text-align: right;">Exhibit 99.1<br>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center;"> <img src="ny20004343x2_ex99-1img01.jpg"></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center;"> <img src="ny20004343x2_ex99-1img02.jpg"></div>
    <div><br>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.8
<SEQUENCE>5
<FILENAME>ny20004343x2_ex99-8.htm
<DESCRIPTION>EXHIBIT 99.8
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 22.7.2.5062
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">


  <div>
    <div style="text-align: right; font-family: 'Times New Roman',Times,serif; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> Exhibit 99.8<br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;">CONSENT OF MOHAMMAD AZAB</div>
    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif;">Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, the undersigned hereby consents to be named in
      the Registration Statement on Form&#160;S-4&#160;of Caladrius Biosciences, Inc., a Delaware corporation (the &#8220;Company&#8221;), and any amendments or supplements thereto, including the prospectus contained therein, as an individual who has agreed to serve as a
      director of the Company upon completion of the merger, to all references to the undersigned in connection therewith, and to the filing or attachment of this consent as an exhibit to such Registration Statement and any amendment or supplement thereto.</div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman',Times,serif;"> <br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif;">Dated: July 26, 2022</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z8e3de182ad494064bba80101a65c106c" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ Mohammad Azab, M.D.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>&#160;Mohammad Azab, M.D.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>


</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>clbs-20220726.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<xs:schema targetNamespace="http://caladrius.com/20220726" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:clbs="http://caladrius.com/20220726" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="clbs-20220726_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="clbs-20220726_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="clbs-20220726_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="clbs-20220726_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://caladrius.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsFy" id="ConsolidatedBalanceSheetsFy">
        <link:definition>010000 - Statement - Consolidated Balance Sheets (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical" id="ConsolidatedBalanceSheetsFyParenthetical">
        <!--Parent Role: Consolidated Balance Sheets (FY)-->
        <link:definition>010100 - Statement - Consolidated Balance Sheets (FY) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy" id="ConsolidatedStatementsOfOperationsFy">
        <link:definition>020000 - Statement - Consolidated Statements of Operations (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy" id="ConsolidatedStatementsOfComprehensiveLossFy">
        <link:definition>030000 - Statement - Consolidated Statements of Comprehensive Loss (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedStatementsOfEquityFy" id="ConsolidatedStatementsOfEquityFy">
        <link:definition>040000 - Statement - Consolidated Statements of Equity (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy" id="ConsolidatedStatementsOfCashFlowsFy">
        <link:definition>050000 - Statement - Consolidated Statements of Cash Flows (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1" id="ConsolidatedBalanceSheetsQ1">
        <link:definition>060000 - Statement - Consolidated Balance Sheets (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals" id="ConsolidatedBalanceSheetsQ1Parentheticals">
        <!--Parent Role: Consolidated Balance Sheets (Q1)-->
        <link:definition>060100 - Statement - Consolidated Balance Sheets (Q1) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1" id="ConsolidatedStatementsOfOperationsQ1">
        <link:definition>070000 - Statement - Consolidated Statements of Operations (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1" id="ConsolidatedStatementsOfComprehensiveLossQ1">
        <link:definition>080000 - Statement - Consolidated Statements of Comprehensive Loss (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1" id="ConsolidatedStatementsOfEquityQ1">
        <link:definition>090000 - Statement - Consolidated Statements of Equity (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1" id="ConsolidatedStatementsOfCashFlowsQ1">
        <link:definition>100000 - Statement - Consolidated Statements of Cash Flows (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/BusinessFy" id="BusinessFy">
        <link:definition>110100 - Disclosure - The Business (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy" id="SummaryOfSignificantAccountingPoliciesFy">
        <link:definition>110200 - Disclosure - Summary of Significant Accounting Policies (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesFy" id="AvailableforsalesecuritiesFy">
        <link:definition>110300 - Disclosure - Available-for-Sale-Securities (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/PropertyAndEquipmentFy" id="PropertyAndEquipmentFy">
        <link:definition>110400 - Disclosure - Property and Equipment (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/LossPerShareFy" id="LossPerShareFy">
        <link:definition>110500 - Disclosure - Loss Per Share (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/FairValueMeasurementsFy" id="FairValueMeasurementsFy">
        <link:definition>110600 - Disclosure - Fair Value Measurements (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AccruedLiabilitiesFy" id="AccruedLiabilitiesFy">
        <link:definition>110700 - Disclosure - Accrued Liabilities (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesFy" id="OperatingLeasesFy">
        <link:definition>110800 - Disclosure - Operating Leases (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityFy" id="StockholdersEquityFy">
        <link:definition>110900 - Disclosure - Stockholders' Equity (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationFy" id="SharebasedCompensationFy">
        <link:definition>111000 - Disclosure - Share-Based Compensation (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ResearchFundingFy" id="ResearchFundingFy">
        <link:definition>111100 - Disclosure - Research Funding (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesFy" id="IncomeTaxesFy">
        <link:definition>111200 - Disclosure - Income Taxes (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ContingenciesFy" id="ContingenciesFy">
        <link:definition>111300 - Disclosure - Contingencies (FY)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/BusinessQ1" id="BusinessQ1">
        <link:definition>111400 - Disclosure - The Business (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1" id="SummaryOfSignificantAccountingPoliciesQ1">
        <link:definition>111500 - Disclosure - Summary of Significant Accounting Policies (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesQ1" id="AvailableforsalesecuritiesQ1">
        <link:definition>111600 - Disclosure - Available-for-Sale-Securities (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeLossPerShareQ1" id="IncomeLossPerShareQ1">
        <link:definition>111700 - Disclosure - Income (Loss) Per Share (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/FairValueMeasurementsQ1" id="FairValueMeasurementsQ1">
        <link:definition>111800 - Disclosure - Fair Value Measurements (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1" id="AccruedLiabilitiesQ1">
        <link:definition>111900 - Disclosure - Accrued Liabilities (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesQ1" id="OperatingLeasesQ1">
        <link:definition>112000 - Disclosure - Operating Leases (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityQ1" id="StockholdersEquityQ1">
        <link:definition>112100 - Disclosure - Stockholders' Equity (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationQ1" id="SharebasedCompensationQ1">
        <link:definition>112200 - Disclosure - Share-Based Compensation (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesQ1" id="IncomeTaxesQ1">
        <link:definition>112300 - Disclosure - Income Taxes (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ContingenciesQ1" id="ContingenciesQ1">
        <link:definition>112400 - Disclosure - Contingencies (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SubsequentEventsQ1" id="SubsequentEventsQ1">
        <link:definition>112500 - Disclosure - Subsequent Events (Q1)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies" id="SummaryOfSignificantAccountingPoliciesFyPolicies">
        <!--Parent Role: Summary of Significant Accounting Policies (FY)-->
        <link:definition>120200 - Disclosure - Summary of Significant Accounting Policies (FY) (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" id="SummaryOfSignificantAccountingPoliciesQ1Policies">
        <!--Parent Role: Summary of Significant Accounting Policies (Q1)-->
        <link:definition>121500 - Disclosure - Summary of Significant Accounting Policies (Q1) (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables" id="SummaryOfSignificantAccountingPoliciesFyTables">
        <!--Parent Role: Summary of Significant Accounting Policies (FY)-->
        <link:definition>130200 - Disclosure - Summary of Significant Accounting Policies (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesFyTables" id="AvailableforsalesecuritiesFyTables">
        <!--Parent Role: Available-for-Sale-Securities (FY)-->
        <link:definition>130300 - Disclosure - Available-for-Sale-Securities (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/PropertyAndEquipmentFyTables" id="PropertyAndEquipmentFyTables">
        <!--Parent Role: Property and Equipment (FY)-->
        <link:definition>130400 - Disclosure - Property and Equipment (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/LossPerShareFyTables" id="LossPerShareFyTables">
        <!--Parent Role: Loss Per Share (FY)-->
        <link:definition>130500 - Disclosure - Loss Per Share (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/FairValueMeasurementsFyTables" id="FairValueMeasurementsFyTables">
        <!--Parent Role: Fair Value Measurements (FY)-->
        <link:definition>130600 - Disclosure - Fair Value Measurements (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AccruedLiabilitiesFyTables" id="AccruedLiabilitiesFyTables">
        <!--Parent Role: Accrued Liabilities (FY)-->
        <link:definition>130700 - Disclosure - Accrued Liabilities (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesFyTables" id="OperatingLeasesFyTables">
        <!--Parent Role: Operating Leases (FY)-->
        <link:definition>130800 - Disclosure - Operating Leases (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityFyTables" id="StockholdersEquityFyTables">
        <!--Parent Role: Stockholders' Equity (FY)-->
        <link:definition>130900 - Disclosure - Stockholders' Equity (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationFyTables" id="SharebasedCompensationFyTables">
        <!--Parent Role: Share-Based Compensation (FY)-->
        <link:definition>131000 - Disclosure - Share-Based Compensation (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesFyTables" id="IncomeTaxesFyTables">
        <!--Parent Role: Income Taxes (FY)-->
        <link:definition>131200 - Disclosure - Income Taxes (FY) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables" id="AvailableforsalesecuritiesQ1Tables">
        <!--Parent Role: Available-for-Sale-Securities (Q1)-->
        <link:definition>131600 - Disclosure - Available-for-Sale-Securities (Q1) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeLossPerShareQ1Tables" id="IncomeLossPerShareQ1Tables">
        <!--Parent Role: Income (Loss) Per Share (Q1)-->
        <link:definition>131700 - Disclosure - Income (Loss) Per Share (Q1) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/FairValueMeasurementsQ1Tables" id="FairValueMeasurementsQ1Tables">
        <!--Parent Role: Fair Value Measurements (Q1)-->
        <link:definition>131800 - Disclosure - Fair Value Measurements (Q1) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1Tables" id="AccruedLiabilitiesQ1Tables">
        <!--Parent Role: Accrued Liabilities (Q1)-->
        <link:definition>131900 - Disclosure - Accrued Liabilities (Q1) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesQ1Tables" id="OperatingLeasesQ1Tables">
        <!--Parent Role: Operating Leases (Q1)-->
        <link:definition>132000 - Disclosure - Operating Leases (Q1) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityQ1Tables" id="StockholdersEquityQ1Tables">
        <!--Parent Role: Stockholders' Equity (Q1)-->
        <link:definition>132100 - Disclosure - Stockholders' Equity (Q1) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationQ1Tables" id="SharebasedCompensationQ1Tables">
        <!--Parent Role: Share-Based Compensation (Q1)-->
        <link:definition>132200 - Disclosure - Share-Based Compensation (Q1) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/BusinessFyDetails" id="BusinessFyDetails">
        <!--Parent Role: The Business (FY)-->
        <link:definition>140100 - Disclosure - The Business (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" id="SummaryOfSignificantAccountingPoliciesFyDetails">
        <!--Parent Role: Summary of Significant Accounting Policies (FY)-->
        <link:definition>140200 - Disclosure - Summary of Significant Accounting Policies (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails" id="AvailableforsalesecuritiesSummaryFyDetails">
        <!--Parent Role: Available-for-Sale-Securities (FY)-->
        <link:definition>140300 - Disclosure - Available-for-Sale-Securities - Summary (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails" id="AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails">
        <!--Parent Role: Available-for-Sale-Securities (FY)-->
        <link:definition>140302 - Disclosure - Available-for-Sale-Securities - Classification on Consolidated Balance Sheets (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails" id="AvailableforsalesecuritiesContractualMaturitiesFyDetails">
        <!--Parent Role: Available-for-Sale-Securities (FY)-->
        <link:definition>140304 - Disclosure - Available-for-Sale-Securities - Contractual Maturities (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails" id="PropertyAndEquipmentSummaryFyDetails">
        <!--Parent Role: Property and Equipment (FY)-->
        <link:definition>140400 - Disclosure - Property and Equipment - Summary (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/PropertyAndEquipmentNarrativeFyDetails" id="PropertyAndEquipmentNarrativeFyDetails">
        <!--Parent Role: Property and Equipment (FY)-->
        <link:definition>140402 - Disclosure - Property and Equipment - Narrative (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/LossPerShareFyDetails" id="LossPerShareFyDetails">
        <!--Parent Role: Loss Per Share (FY)-->
        <link:definition>140500 - Disclosure - Loss Per Share (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/FairValueMeasurementsFyDetails" id="FairValueMeasurementsFyDetails">
        <!--Parent Role: Fair Value Measurements (FY)-->
        <link:definition>140600 - Disclosure - Fair Value Measurements (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AccruedLiabilitiesFyDetails" id="AccruedLiabilitiesFyDetails">
        <!--Parent Role: Accrued Liabilities (FY)-->
        <link:definition>140700 - Disclosure - Accrued Liabilities (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesNarrativeFyDetails" id="OperatingLeasesNarrativeFyDetails">
        <!--Parent Role: Operating Leases (FY)-->
        <link:definition>140800 - Disclosure - Operating Leases - Narrative (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails" id="OperatingLeasesBalanceSheetPresentationFyDetails">
        <!--Parent Role: Operating Leases (FY)-->
        <link:definition>140802 - Disclosure - Operating Leases - Balance Sheet Presentation (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails" id="OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails">
        <!--Parent Role: Operating Leases (FY)-->
        <link:definition>140804 - Disclosure - Operating Leases - Future Minimum Lease Payments Under Lease Agreements (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" id="OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01">
        <!--Parent Role: Operating Leases - Future Minimum Lease Payments Under Lease Agreements (FY) (Details)-->
        <link:definition>140806 - Disclosure - Operating Leases - Future Minimum Lease Payments Under Lease Agreements (FY) (Details) CALC 01</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails" id="StockholdersEquityEquityPlanFyDetails">
        <!--Parent Role: Stockholders' Equity (FY)-->
        <link:definition>140900 - Disclosure - Stockholders' Equity - Equity Plan (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails" id="StockholdersEquityEquityIssuancesFyDetails">
        <!--Parent Role: Stockholders' Equity (FY)-->
        <link:definition>140902 - Disclosure - Stockholders' Equity - Equity Issuances (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails" id="StockholdersEquityStockOptionsAndWarrantsFyDetails">
        <!--Parent Role: Stockholders' Equity (FY)-->
        <link:definition>140904 - Disclosure - Stockholders' Equity - Stock Options and Warrants (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails" id="StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails">
        <!--Parent Role: Stockholders' Equity (FY)-->
        <link:definition>140906 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails" id="SharebasedCompensationSharebasedCompensationExpenseFyDetails">
        <!--Parent Role: Share-Based Compensation (FY)-->
        <link:definition>141000 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails" id="SharebasedCompensationCompensationCostNotYetRecognizedFyDetails">
        <!--Parent Role: Share-Based Compensation (FY)-->
        <link:definition>141002 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails" id="SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails">
        <!--Parent Role: Share-Based Compensation (FY)-->
        <link:definition>141004 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails" id="SharebasedCompensationValuationAssumptionsFyDetails">
        <!--Parent Role: Share-Based Compensation (FY)-->
        <link:definition>141006 - Disclosure - Share-Based Compensation - Valuation Assumptions (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/ResearchFundingFyDetails" id="ResearchFundingFyDetails">
        <!--Parent Role: Research Funding (FY)-->
        <link:definition>141100 - Disclosure - Research Funding (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails" id="IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails">
        <!--Parent Role: Income Taxes (FY)-->
        <link:definition>141200 - Disclosure - Income Taxes - Loss from Operations Before Provision for Income Taxes (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails" id="IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails">
        <!--Parent Role: Income Taxes (FY)-->
        <link:definition>141202 - Disclosure - Income Taxes - Components of Benefit from Income Taxes (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails" id="IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails">
        <!--Parent Role: Income Taxes (FY)-->
        <link:definition>141204 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails" id="IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails">
        <!--Parent Role: Income Taxes (FY)-->
        <link:definition>141206 - Disclosure - Income Taxes - Components of Deferred Income Taxes (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesNarrativeFyDetails" id="IncomeTaxesNarrativeFyDetails">
        <!--Parent Role: Income Taxes (FY)-->
        <link:definition>141208 - Disclosure - Income Taxes - Narrative (FY) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/BusinessQ1Details" id="BusinessQ1Details">
        <!--Parent Role: The Business (Q1)-->
        <link:definition>141400 - Disclosure - The Business (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details" id="AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details">
        <!--Parent Role: Available-for-Sale-Securities (Q1)-->
        <link:definition>141600 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details" id="AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details">
        <!--Parent Role: Available-for-Sale-Securities (Q1)-->
        <link:definition>141602 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details" id="AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details">
        <!--Parent Role: Available-for-Sale-Securities (Q1)-->
        <link:definition>141604 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeLossPerShareQ1Details" id="IncomeLossPerShareQ1Details">
        <!--Parent Role: Income (Loss) Per Share (Q1)-->
        <link:definition>141700 - Disclosure - Income (Loss) Per Share (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/FairValueMeasurementsQ1Details" id="FairValueMeasurementsQ1Details">
        <!--Parent Role: Fair Value Measurements (Q1)-->
        <link:definition>141800 - Disclosure - Fair Value Measurements (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1Details" id="AccruedLiabilitiesQ1Details">
        <!--Parent Role: Accrued Liabilities (Q1)-->
        <link:definition>141900 - Disclosure - Accrued Liabilities (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesNarrativeQ1Details" id="OperatingLeasesNarrativeQ1Details">
        <!--Parent Role: Operating Leases (Q1)-->
        <link:definition>142000 - Disclosure - Operating Leases - Narrative (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details" id="OperatingLeasesBalanceSheetPresentationQ1Details">
        <!--Parent Role: Operating Leases (Q1)-->
        <link:definition>142002 - Disclosure - Operating Leases - Balance Sheet Presentation (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details" id="OperatingLeasesFutureMinimumLeasePaymentsQ1Details">
        <!--Parent Role: Operating Leases (Q1)-->
        <link:definition>142004 - Disclosure - Operating Leases - Future Minimum Lease Payments (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" id="OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01">
        <!--Parent Role: Operating Leases - Future Minimum Lease Payments (Q1) (Details)-->
        <link:definition>142006 - Disclosure - Operating Leases - Future Minimum Lease Payments (Q1) (Details) CALC 01</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details" id="StockholdersEquityEquityIssuancesQ1Details">
        <!--Parent Role: Stockholders' Equity (Q1)-->
        <link:definition>142100 - Disclosure - Stockholders' Equity - Equity Issuances (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details" id="StockholdersEquityStockOptionsAndWarrantsQ1Details">
        <!--Parent Role: Stockholders' Equity (Q1)-->
        <link:definition>142102 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details" id="StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details">
        <!--Parent Role: Stockholders' Equity (Q1)-->
        <link:definition>142104 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details" id="SharebasedCompensationSharebasedCompensationExpenseQ1Details">
        <!--Parent Role: Share-Based Compensation (Q1)-->
        <link:definition>142200 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details" id="SharebasedCompensationCompensationCostNotYetRecognizedQ1Details">
        <!--Parent Role: Share-Based Compensation (Q1)-->
        <link:definition>142202 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details" id="SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details">
        <!--Parent Role: Share-Based Compensation (Q1)-->
        <link:definition>142204 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/IncomeTaxesQ1Details" id="IncomeTaxesQ1Details">
        <!--Parent Role: Income Taxes (Q1)-->
        <link:definition>142300 - Disclosure - Income Taxes (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://caladrius.com/role/SubsequentEventsQ1Details" id="SubsequentEventsQ1Details">
        <!--Parent Role: Subsequent Events (Q1)-->
        <link:definition>142500 - Disclosure - Subsequent Events (Q1) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <xs:element name="PreferredStockSharesDesignated" id="clbs_PreferredStockSharesDesignated" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PreferredStockLiquidationPreferenceShare" id="clbs_PreferredStockLiquidationPreferenceShare" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="January2021PurchaseAgreementMember" id="clbs_January2021PurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="AdditionalPurchaseAgreementMember" id="clbs_AdditionalPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="H.C.WainwrightSalesAmendedAgreementMember" id="clbs_H.C.WainwrightSalesAmendedAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="LincolnParkAgreementMember" id="clbs_LincolnParkAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="InstitutionalPurchaseAgreementMember" id="clbs_InstitutionalPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TermOfAgreement" id="clbs_TermOfAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="StockIssuedDuringPeriodSharesIssuedAsConsideration" id="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" id="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" id="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" id="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" id="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" id="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" id="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AtTheMarketOfferingAgreementMember" id="clbs_AtTheMarketOfferingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" id="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="FundingOfGrantAwardCashReceived" id="clbs_FundingOfGrantAwardCashReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="MilestonePaymentOnGrantAwardCashReceived" id="clbs_MilestonePaymentOnGrantAwardCashReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="FundingAmountAwarded" id="clbs_FundingAmountAwarded" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="ProgressPaymentOnGrantAwardCashReceived" id="clbs_ProgressPaymentOnGrantAwardCashReceived" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" id="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmployeeStockPurchasePlan2012Member" id="clbs_EmployeeStockPurchasePlan2012Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmployeeStockPurchasePlan2017AmendedMember" id="clbs_EmployeeStockPurchasePlan2017AmendedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmployeeStockPurchasePlan2017Member" id="clbs_EmployeeStockPurchasePlan2017Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmployeeStockPurchasePlanMember" id="clbs_EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EquityIncentiveCompensationPlan2018Member" id="clbs_EquityIncentiveCompensationPlan2018Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" id="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="NumberofOfferingPeriodsEmployeeStockPurchasePlan" id="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" id="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" id="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" id="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="OfferingPeriodsEmployeeStockPurchasePlanTerm" id="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" id="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="NumberOfOfficesUnderOperatingLeases" id="clbs_NumberOfOfficesUnderOperatingLeases" type="xbrli:integerItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="OperatingLeaseRightOfUseAssetAbstract" id="clbs_OperatingLeaseRightOfUseAssetAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="BusinessTextBlock" id="clbs_BusinessTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="LossOnSaleOfNetOperatingLosses" id="clbs_LossOnSaleOfNetOperatingLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="OperatingLossCarryforwardsBeforeWriteDown" id="clbs_OperatingLossCarryforwardsBeforeWriteDown" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="OperatingLossCarryforwardsSetToExpireWrittenDown" id="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" id="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="NetDeferredTaxAssetsAndLiabilitiesGross" id="clbs_NetDeferredTaxAssetsAndLiabilitiesGross" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxAssetsAccumulatedDepreciation" id="clbs_DeferredTaxAssetsAccumulatedDepreciation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="DeferredTaxAssetsRightOfUseLiability" id="clbs_DeferredTaxAssetsRightOfUseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" id="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" id="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" id="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" id="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="WarrantsWeightedAverageExercisePriceRollForward" id="clbs_WarrantsWeightedAverageExercisePriceRollForward" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WeightedAverageExercisePriceWarrantsOutstanding" id="clbs_WeightedAverageExercisePriceWarrantsOutstanding" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="WeightedAverageExercisePriceWarrantsCanceled" id="clbs_WeightedAverageExercisePriceWarrantsCanceled" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WeightedAverageExercisePriceWarrantsGranted" id="clbs_WeightedAverageExercisePriceWarrantsGranted" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WeightedAverageExercisePriceWarrantsExercised" id="clbs_WeightedAverageExercisePriceWarrantsExercised" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="Sharesvestedandexpectedtovest" id="clbs_Sharesvestedandexpectedtovest" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AggregateIntrinsicValueOptionExercised" id="clbs_AggregateIntrinsicValueOptionExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="WeightedAverageExercisePriceWarrantsExpired" id="clbs_WeightedAverageExercisePriceWarrantsExpired" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantsOtherDisclosuresAbstract" id="clbs_WarrantsOtherDisclosuresAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="WeightedAverageRemainingContractualTermwarrantsvested" id="clbs_WeightedAverageRemainingContractualTermwarrantsvested" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantsVested" id="clbs_WarrantsVested" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" id="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" id="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WeightedAverageRemainingContractualTermwarrantoutstanding" id="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="AggregateIntrinsicValueWarrantsOutstanding" id="clbs_AggregateIntrinsicValueWarrantsOutstanding" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AggregateIntrinsicValueWarrantsvested" id="clbs_AggregateIntrinsicValueWarrantsvested" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="CommonStockWarrantsShares" id="clbs_CommonStockWarrantsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="WarrantsCanceled" id="clbs_WarrantsCanceled" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantsGranted" id="clbs_WarrantsGranted" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantsExercised" id="clbs_WarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WarrantsExpired" id="clbs_WarrantsExpired" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="WeightedAverageExercisePriceWarrantsExercisable" id="clbs_WeightedAverageExercisePriceWarrantsExercisable" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" id="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="OptionsVestedweightedAverageRemainingContractualTerm" id="clbs_OptionsVestedweightedAverageRemainingContractualTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="CendSeriesDPreferredStockPurchaseAgreementMember" id="clbs_CendSeriesDPreferredStockPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="MergerAgreementTransactionExpensesThresholdForRatioAllocation" id="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="PurchaseOfPreferredStockShares" id="clbs_PurchaseOfPreferredStockShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="GrossProceedsOnTransaction" id="clbs_GrossProceedsOnTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" />
  <xs:element name="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" id="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="PurchaseOfPreferredStockAggregatePrice" id="clbs_PurchaseOfPreferredStockAggregatePrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" />
  <xs:element name="MergerAgreementPotentialTerminationFeePayable" id="clbs_MergerAgreementPotentialTerminationFeePayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="PreEquityOfferingValueAfterConversion" id="clbs_PreEquityOfferingValueAfterConversion" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" />
  <xs:element name="MergerAgreementPotentialExpenseReimbursement" id="clbs_MergerAgreementPotentialExpenseReimbursement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="AgreementAndPlanOfMergerAndReorganizationMember" id="clbs_AgreementAndPlanOfMergerAndReorganizationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="PurchaseOfPreferredStockPricePerShare" id="clbs_PurchaseOfPreferredStockPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MergerAgreementMinimumNetCashThreshold" id="clbs_MergerAgreementMinimumNetCashThreshold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" id="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" />
  <xs:element name="MergerAgreementPotentialTerminationFeeReceivable" id="clbs_MergerAgreementPotentialTerminationFeeReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" />
  <xs:element name="CendTherapeuticsIncMember" id="clbs_CendTherapeuticsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="SeriesDPreferredStockCendMember" id="clbs_SeriesDPreferredStockCendMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="CLBS16TreatmentOfCMDMember" id="clbs_CLBS16TreatmentOfCMDMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
  <xs:element name="TreasuryStockPolicyPolicyTextBlock" id="clbs_TreasuryStockPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" abstract="false" xbrli:periodType="duration" />
  <xs:element name="MarketableSecuritiesMember" id="clbs_MarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" nillable="true" abstract="true" xbrli:periodType="duration" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>clbs-20220726_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesBalanceSheetPresentationFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentSummaryFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesContractualMaturitiesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesSummaryFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfComprehensiveLossQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfOperationsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfCashFlowsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfComprehensiveLossFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfOperationsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsFy" />
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="CommitmentsAndContingencies" xlink:title="calculation: LiabilitiesAndStockholdersEquity to CommitmentsAndContingencies" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: Liabilities to OtherLiabilitiesNoncurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccruedLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to AccruedLiabilitiesCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableCurrent" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Liabilities" xlink:to="LiabilitiesCurrent" xlink:title="calculation: Liabilities to LiabilitiesCurrent" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="Liabilities" xlink:title="calculation: LiabilitiesAndStockholdersEquity to Liabilities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="MinorityInterest" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to MinorityInterest" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquity to RetainedEarningsAccumulatedDeficit" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="TreasuryStockValue" xlink:title="calculation: StockholdersEquity to TreasuryStockValue" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="PreferredStockValue" xlink:title="calculation: StockholdersEquity to PreferredStockValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="calculation: StockholdersEquity to AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquity to AdditionalPaidInCapital" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquity" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquity to CommonStockValue" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="StockholdersEquity" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to StockholdersEquity" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to PrepaidExpenseAndOtherAssetsCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="MarketableSecurities" xlink:title="MarketableSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="MarketableSecurities" xlink:title="calculation: AssetsCurrent to MarketableSecurities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="calculation: AssetsCurrent to CashAndCashEquivalentsAtCarryingValue" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: Assets to OtherAssetsNoncurrent" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="ResearchAndDevelopmentExpense" xlink:title="calculation: OperatingExpenses to ResearchAndDevelopmentExpense" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingExpenses" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="calculation: OperatingExpenses to SellingGeneralAndAdministrativeExpense" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="OperatingExpenses" xlink:title="calculation: OperatingIncomeLoss to OperatingExpenses" order="1.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to OperatingIncomeLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="calculation: NonoperatingIncomeExpense to OtherNonoperatingIncomeExpense" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="InvestmentIncomeNet" xlink:title="InvestmentIncomeNet" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NonoperatingIncomeExpense" xlink:to="InvestmentIncomeNet" xlink:title="calculation: NonoperatingIncomeExpense to InvestmentIncomeNet" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="NonoperatingIncomeExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to NonoperatingIncomeExpense" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: ProfitLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: ProfitLoss to IncomeTaxExpenseBenefit" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="ProfitLoss" xlink:title="calculation: NetIncomeLoss to ProfitLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:label="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:title="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:title="calculation: NetIncomeLoss to IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" order="2.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:title="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:title="calculation: ComprehensiveIncomeNetOfTax to ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:title="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OtherComprehensiveIncomeLossNetOfTax" xlink:to="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="calculation: OtherComprehensiveIncomeLossNetOfTax to OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="OtherComprehensiveIncomeLossNetOfTax" xlink:title="calculation: ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest to OtherComprehensiveIncomeLossNetOfTax" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="ProfitLoss" xlink:title="calculation: ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest to ProfitLoss" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:title="calculation: ComprehensiveIncomeNetOfTax to ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProfitLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProfitLoss" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="4.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="DepreciationAndAmortization" xlink:title="DepreciationAndAmortization" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DepreciationAndAmortization" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DepreciationAndAmortization" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingAssets" order="6.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" order="7.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="5.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IssuanceOfStockAndWarrantsForServicesOrClaims" order="2.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInOperatingActivities" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfCommonStock" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromStockOptionsExercised" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInFinancingActivities" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="PaymentsToAcquireMarketableSecurities" xlink:title="PaymentsToAcquireMarketableSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireMarketableSecurities" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireMarketableSecurities" order="1.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquirePropertyPlantAndEquipment" order="3.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to NetCashProvidedByUsedInInvestingActivities" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="calculation: NetIncomeLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetIncomeLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: NetIncomeLoss to IncomeTaxExpenseBenefit" order="2.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="OtherComprehensiveIncomeLossNetOfTax" xlink:title="calculation: ComprehensiveIncomeNetOfTax to OtherComprehensiveIncomeLossNetOfTax" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="ProfitLoss" xlink:title="calculation: ComprehensiveIncomeNetOfTax to ProfitLoss" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="calculation: AvailableForSaleDebtSecuritiesAmortizedCostBasis to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="calculation: AvailableForSaleDebtSecuritiesAmortizedCostBasis to AvailableForSaleSecuritiesDebtSecurities" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="calculation: AvailableForSaleDebtSecuritiesAmortizedCostBasis to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:title="calculation: AvailableForSaleDebtSecuritiesAmortizedCostBasis to AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="calculation: AvailableForSaleDebtSecuritiesAmortizedCostBasis to AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="calculation: AvailableForSaleSecuritiesDebtSecurities to AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:title="calculation: AvailableForSaleSecuritiesDebtSecurities to AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="calculation: PropertyPlantAndEquipmentNet to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" weight="-1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="calculation: PropertyPlantAndEquipmentNet to PropertyPlantAndEquipmentGross" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="InvestmentsFairValueDisclosure" xlink:title="InvestmentsFairValueDisclosure" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsFairValueDisclosure" xlink:to="InvestmentsFairValueDisclosure" xlink:title="calculation: AssetsFairValueDisclosure to InvestmentsFairValueDisclosure" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="AccruedLiabilitiesCurrentAndNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: AccruedLiabilitiesCurrentAndNoncurrent to OperatingLeaseLiabilityCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:label="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:title="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:title="calculation: AccruedLiabilitiesCurrentAndNoncurrent to EmployeeRelatedLiabilitiesCurrentAndNoncurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrentAndNoncurrent to OtherAccruedLiabilitiesCurrent" order="3.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingLeaseLiability" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: OperatingLeaseLiability to OperatingLeaseLiabilityCurrent" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingLeaseLiability" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="calculation: OperatingLeaseLiability to OperatingLeaseLiabilityNoncurrent" order="2.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredFederalIncomeTaxExpenseBenefit" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="calculation: DeferredIncomeTaxExpenseBenefit to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="calculation: IncomeTaxExpenseBenefit to StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="calculation: IncomeTaxExpenseBenefit to FederalIncomeTaxExpenseBenefitContinuingOperations" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentStateAndLocalTaxExpenseBenefit" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="calculation: CurrentIncomeTaxExpenseBenefit to CurrentFederalTaxExpenseBenefit" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:label="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:title="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:title="calculation: IncomeTaxExpenseBenefit to EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="IncomeTaxReconciliationOtherAdjustments" xlink:title="IncomeTaxReconciliationOtherAdjustments" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationOtherAdjustments" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationOtherAdjustments" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:label="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:title="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:title="calculation: IncomeTaxExpenseBenefit to EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="8.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationNondeductibleExpense" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationNondeductibleExpense" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:title="IncomeTaxReconciliationPriorYearIncomeTaxes" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationPriorYearIncomeTaxes" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="calculation: IncomeTaxExpenseBenefit to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:label="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:title="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeTaxExpenseBenefit" xlink:to="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:title="calculation: IncomeTaxExpenseBenefit to EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" order="7.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="DeferredTaxAssetsLiabilitiesNet" xlink:title="DeferredTaxAssetsLiabilitiesNet" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NetDeferredTaxAssetsAndLiabilitiesGross" xlink:label="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:title="NetDeferredTaxAssetsAndLiabilitiesGross" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_DeferredTaxAssetsAccumulatedDepreciation" xlink:label="DeferredTaxAssetsAccumulatedDepreciation" xlink:title="DeferredTaxAssetsAccumulatedDepreciation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsAccumulatedDepreciation" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsAccumulatedDepreciation" order="5.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" order="6.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsOperatingLossCarryforwards" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:title="DeferredTaxAssetsGoodwillAndIntangibleAssets" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsGoodwillAndIntangibleAssets" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_DeferredTaxAssetsRightOfUseLiability" xlink:label="DeferredTaxAssetsRightOfUseLiability" xlink:title="DeferredTaxAssetsRightOfUseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsRightOfUseLiability" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsRightOfUseLiability" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="DeferredTaxAssetsOther" xlink:title="DeferredTaxAssetsOther" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsGross" xlink:to="DeferredTaxAssetsOther" xlink:title="calculation: DeferredTaxAssetsGross to DeferredTaxAssetsOther" order="7.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:to="DeferredTaxAssetsGross" xlink:title="calculation: NetDeferredTaxAssetsAndLiabilitiesGross to DeferredTaxAssetsGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="DeferredTaxLiabilitiesLeasingArrangements" xlink:title="DeferredTaxLiabilitiesLeasingArrangements" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="DeferredTaxLiabilitiesLeasingArrangements" xlink:title="calculation: DeferredIncomeTaxLiabilities to DeferredTaxLiabilitiesLeasingArrangements" order="1.0" weight="1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="calculation: NetDeferredTaxAssetsAndLiabilitiesGross to DeferredIncomeTaxLiabilities" order="2.0" weight="-1.0" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsLiabilitiesNet" xlink:to="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:title="calculation: DeferredTaxAssetsLiabilitiesNet to NetDeferredTaxAssetsAndLiabilitiesGross" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="DeferredTaxAssetsLiabilitiesNet" xlink:to="DeferredTaxAssetsValuationAllowance" xlink:title="calculation: DeferredTaxAssetsLiabilitiesNet to DeferredTaxAssetsValuationAllowance" order="2.0" weight="-1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="CashCashEquivalentsAndShortTermInvestments" xlink:title="CashCashEquivalentsAndShortTermInvestments" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="MarketableSecurities" xlink:title="MarketableSecurities" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsAndShortTermInvestments" xlink:to="MarketableSecurities" xlink:title="calculation: CashCashEquivalentsAndShortTermInvestments to MarketableSecurities" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="CashEquivalentsAtCarryingValue" xlink:title="CashEquivalentsAtCarryingValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashCashEquivalentsAndShortTermInvestments" xlink:to="CashEquivalentsAtCarryingValue" xlink:title="calculation: CashCashEquivalentsAndShortTermInvestments to CashEquivalentsAtCarryingValue" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:title="calculation: AvailableForSaleSecuritiesDebtSecurities to AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:title="calculation: AvailableForSaleSecuritiesDebtSecurities to AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" order="1.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:title="calculation: AvailableForSaleDebtSecuritiesAmortizedCostBasis to AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:title="calculation: AvailableForSaleDebtSecuritiesAmortizedCostBasis to AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to OperatingLeaseLiabilityCurrent" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to OtherAccruedLiabilitiesCurrent" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AccruedLiabilitiesCurrent" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="calculation: AccruedLiabilitiesCurrent to EmployeeRelatedLiabilitiesCurrent" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="OperatingLeaseLiability" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to OperatingLeaseLiability" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="1.0" weight="1.0" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="4.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="3.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="2.0" weight="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="calculation: LesseeOperatingLeaseLiabilityPaymentsDue to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="1.0" weight="1.0" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>clbs-20220726_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm" />
  <link:roleRef roleURI="http://caladrius.com/role/SubsequentEventsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#SubsequentEventsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationCompensationCostNotYetRecognizedQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationSharebasedCompensationExpenseQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityStockOptionsAndWarrantsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityEquityIssuancesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesBalanceSheetPresentationQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesNarrativeQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesNarrativeQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeLossPerShareQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeLossPerShareQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/BusinessQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#BusinessQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesNarrativeFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesNarrativeFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/ResearchFundingFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#ResearchFundingFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationValuationAssumptionsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationCompensationCostNotYetRecognizedFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationSharebasedCompensationExpenseFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityStockOptionsAndWarrantsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityEquityIssuancesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityEquityPlanFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesBalanceSheetPresentationFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesNarrativeFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesNarrativeFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/LossPerShareFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#LossPerShareFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentNarrativeFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentNarrativeFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentSummaryFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesContractualMaturitiesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesSummaryFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/BusinessFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#BusinessFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeLossPerShareQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeLossPerShareQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/LossPerShareFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#LossPerShareFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesQ1Policies" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesFyPolicies" />
  <link:roleRef roleURI="http://caladrius.com/role/SubsequentEventsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#SubsequentEventsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ContingenciesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ContingenciesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeLossPerShareQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeLossPerShareQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/BusinessQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#BusinessQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ContingenciesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ContingenciesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ResearchFundingFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ResearchFundingFy" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationFy" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityFy" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/LossPerShareFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#LossPerShareFy" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentFy" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/BusinessFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#BusinessFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfCashFlowsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfEquityQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfComprehensiveLossQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfOperationsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsQ1Parentheticals" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfCashFlowsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfEquityFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfEquityFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfComprehensiveLossFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfOperationsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsFyParenthetical" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="clbs-20220726.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/DocumentAndEntityInformation" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfEquityFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="definition: StatementLineItems to ProfitLoss" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="definition: StatementLineItems to OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesShareBasedCompensation" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueShareBasedCompensation" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesNewIssues" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueNewIssues" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesStockOptionsExercised" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueStockOptionsExercised" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="ParentMember" xlink:title="definition: EquityComponentDomain to ParentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="NoncontrollingInterestMember" xlink:title="definition: EquityComponentDomain to NoncontrollingInterestMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="PreferredStockMember" xlink:title="definition: ParentMember to PreferredStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="CommonStockMember" xlink:title="definition: ParentMember to CommonStockMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: ParentMember to AdditionalPaidInCapitalMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="AccumulatedOtherComprehensiveIncomeMember" xlink:title="definition: ParentMember to AccumulatedOtherComprehensiveIncomeMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="RetainedEarningsMember" xlink:title="definition: ParentMember to RetainedEarningsMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="TreasuryStockMember" xlink:title="definition: ParentMember to TreasuryStockMember" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="definition: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="SharesOutstanding" xlink:title="definition: StatementLineItems to SharesOutstanding" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="definition: StatementLineItems to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="ProfitLoss" xlink:title="definition: StatementLineItems to ProfitLoss" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="definition: StatementLineItems to OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesShareBasedCompensation" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueShareBasedCompensation" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesNewIssues" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueNewIssues" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodSharesStockOptionsExercised" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="StatementLineItems" xlink:to="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="definition: StatementLineItems to StockIssuedDuringPeriodValueStockOptionsExercised" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="StatementLineItems" xlink:to="StatementTable" xlink:title="definition: StatementLineItems to StatementTable" order="12.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="definition: StatementTable to StatementEquityComponentsAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain_2" xlink:title="EquityComponentDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain_2" xlink:title="definition: StatementEquityComponentsAxis to EquityComponentDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="ParentMember" xlink:title="definition: EquityComponentDomain to ParentMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EquityComponentDomain" xlink:to="NoncontrollingInterestMember" xlink:title="definition: EquityComponentDomain to NoncontrollingInterestMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="PreferredStockMember" xlink:title="definition: ParentMember to PreferredStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="CommonStockMember" xlink:title="definition: ParentMember to CommonStockMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="AdditionalPaidInCapitalMember" xlink:title="definition: ParentMember to AdditionalPaidInCapitalMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="AccumulatedOtherComprehensiveIncomeMember" xlink:title="definition: ParentMember to AccumulatedOtherComprehensiveIncomeMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="RetainedEarningsMember" xlink:title="definition: ParentMember to RetainedEarningsMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ParentMember" xlink:to="TreasuryStockMember" xlink:title="definition: ParentMember to TreasuryStockMember" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/BusinessFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/LossPerShareFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ResearchFundingFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ContingenciesFy" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/BusinessQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeLossPerShareQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ContingenciesQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SubsequentEventsQ1" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/LossPerShareFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesFyTables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeLossPerShareQ1Tables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsQ1Tables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesQ1Tables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesQ1Tables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityQ1Tables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationQ1Tables" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/BusinessFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="GrantsReceivable" xlink:title="definition: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to GrantsReceivable" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="definition: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" order="2.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="definition: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProjectMember" xlink:label="ProjectMember" xlink:title="ProjectMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="ProjectMember" xlink:title="definition: CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis to ProjectMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProjectMember" xlink:label="ProjectMember_2" xlink:title="ProjectMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="ProjectMember_2" xlink:title="definition: CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis to ProjectMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CLBS16TreatmentOfCMDMember" xlink:label="CLBS16TreatmentOfCMDMember" xlink:title="CLBS16TreatmentOfCMDMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProjectMember" xlink:to="CLBS16TreatmentOfCMDMember" xlink:title="definition: ProjectMember to CLBS16TreatmentOfCMDMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ScheduleOfPropertyPlantAndEquipmentTable" order="2.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="SoftwareAndSoftwareDevelopmentCostsMember" xlink:title="SoftwareAndSoftwareDevelopmentCostsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="SoftwareAndSoftwareDevelopmentCostsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to SoftwareAndSoftwareDevelopmentCostsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleSecuritiesDebtSecurities" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="DebtSecuritiesAvailableForSaleTable" xlink:title="DebtSecuritiesAvailableForSaleTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="DebtSecuritiesAvailableForSaleTable" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to DebtSecuritiesAvailableForSaleTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="FinancialInstrumentAxis" xlink:title="FinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="FinancialInstrumentAxis" xlink:title="definition: DebtSecuritiesAvailableForSaleTable to FinancialInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FinancialInstrumentAxis" xlink:to="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="definition: FinancialInstrumentAxis to TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" xlink:title="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FinancialInstrumentAxis" xlink:to="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" xlink:title="definition: FinancialInstrumentAxis to TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="CorporateDebtSecuritiesMember" xlink:title="definition: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to CorporateDebtSecuritiesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="MoneyMarketFundsMember" xlink:title="MoneyMarketFundsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="MoneyMarketFundsMember" xlink:title="definition: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to MoneyMarketFundsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:label="USStatesAndPoliticalSubdivisionsMember" xlink:title="USStatesAndPoliticalSubdivisionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="USStatesAndPoliticalSubdivisionsMember" xlink:title="definition: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to USStatesAndPoliticalSubdivisionsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleSecuritiesDebtSecurities" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="DebtSecuritiesAvailableForSaleTable" xlink:title="DebtSecuritiesAvailableForSaleTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="DebtSecuritiesAvailableForSaleTable" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to DebtSecuritiesAvailableForSaleTable" order="2.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="BalanceSheetLocationAxis" xlink:title="BalanceSheetLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="BalanceSheetLocationAxis" xlink:title="definition: DebtSecuritiesAvailableForSaleTable to BalanceSheetLocationAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain" xlink:title="BalanceSheetLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BalanceSheetLocationAxis" xlink:to="BalanceSheetLocationDomain" xlink:title="definition: BalanceSheetLocationAxis to BalanceSheetLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain_2" xlink:title="BalanceSheetLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BalanceSheetLocationAxis" xlink:to="BalanceSheetLocationDomain_2" xlink:title="definition: BalanceSheetLocationAxis to BalanceSheetLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="CashAndCashEquivalentsMember" xlink:title="CashAndCashEquivalentsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BalanceSheetLocationDomain" xlink:to="CashAndCashEquivalentsMember" xlink:title="definition: BalanceSheetLocationDomain to CashAndCashEquivalentsMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MarketableSecuritiesMember" xlink:label="MarketableSecuritiesMember" xlink:title="MarketableSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BalanceSheetLocationDomain" xlink:to="MarketableSecuritiesMember" xlink:title="definition: BalanceSheetLocationDomain to MarketableSecuritiesMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGross" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="definition: PropertyPlantAndEquipmentLineItems to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="definition: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNet" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="definition: PropertyPlantAndEquipmentLineItems to ScheduleOfPropertyPlantAndEquipmentTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="definition: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain_2" xlink:title="definition: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="definition: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentNarrativeFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/LossPerShareFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="2.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain_2" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain_2" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to WarrantMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="AssetsFairValueDisclosureAbstract" xlink:title="AssetsFairValueDisclosureAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="AssetsFairValueDisclosureAbstract" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to AssetsFairValueDisclosureAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="InvestmentsFairValueDisclosure" xlink:title="InvestmentsFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="InvestmentsFairValueDisclosure" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to InvestmentsFairValueDisclosure" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="AssetsFairValueDisclosure" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to AssetsFairValueDisclosure" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="4.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByMeasurementFrequencyAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByMeasurementFrequencyAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="FairValueMeasurementFrequencyDomain" xlink:title="definition: FairValueByMeasurementFrequencyAxis to FairValueMeasurementFrequencyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain_2" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="FairValueMeasurementFrequencyDomain_2" xlink:title="definition: FairValueByMeasurementFrequencyAxis to FairValueMeasurementFrequencyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="FairValueMeasurementsRecurringMember" xlink:title="FairValueMeasurementsRecurringMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementFrequencyDomain" xlink:to="FairValueMeasurementsRecurringMember" xlink:title="definition: FairValueMeasurementFrequencyDomain to FairValueMeasurementsRecurringMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesNarrativeFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:label="NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:title="NumberofOfferingPeriodsEmployeeStockPurchasePlan" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberofOfferingPeriodsEmployeeStockPurchasePlan" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:label="OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:title="OfferingPeriodsEmployeeStockPurchasePlanTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to OfferingPeriodsEmployeeStockPurchasePlanTerm" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:label="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:title="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:label="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:title="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:label="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:title="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:label="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:title="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="11.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="definition: PlanNameAxis to PlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain_2" xlink:title="PlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain_2" xlink:title="definition: PlanNameAxis to PlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EquityIncentiveCompensationPlan2018Member" xlink:label="EquityIncentiveCompensationPlan2018Member" xlink:title="EquityIncentiveCompensationPlan2018Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="EquityIncentiveCompensationPlan2018Member" xlink:title="definition: PlanNameDomain to EquityIncentiveCompensationPlan2018Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMember" xlink:label="EmployeeStockPurchasePlanMember" xlink:title="EmployeeStockPurchasePlanMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlanMember" xlink:title="definition: PlanNameDomain to EmployeeStockPurchasePlanMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2012Member" xlink:label="EmployeeStockPurchasePlan2012Member" xlink:title="EmployeeStockPurchasePlan2012Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlan2012Member" xlink:title="definition: PlanNameDomain to EmployeeStockPurchasePlan2012Member" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2017Member" xlink:label="EmployeeStockPurchasePlan2017Member" xlink:title="EmployeeStockPurchasePlan2017Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlan2017Member" xlink:title="definition: PlanNameDomain to EmployeeStockPurchasePlan2017Member" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2017AmendedMember" xlink:label="EmployeeStockPurchasePlan2017AmendedMember" xlink:title="EmployeeStockPurchasePlan2017AmendedMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlan2017AmendedMember" xlink:title="definition: PlanNameDomain to EmployeeStockPurchasePlan2017AmendedMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="VestingAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to VestingAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="definition: VestingAxis to VestingDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain_2" xlink:title="VestingDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="VestingAxis" xlink:to="VestingDomain_2" xlink:title="definition: VestingAxis to VestingDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheOneMember" xlink:title="definition: VestingDomain to ShareBasedCompensationAwardTrancheOneMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="ShareBasedCompensationAwardTrancheTwoMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="definition: VestingDomain to ShareBasedCompensationAwardTrancheTwoMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="ShareBasedCompensationAwardTrancheThreeMember" xlink:title="ShareBasedCompensationAwardTrancheThreeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheThreeMember" xlink:title="definition: VestingDomain to ShareBasedCompensationAwardTrancheThreeMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:label="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="definition: ClassOfStockLineItems to SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:label="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="StockIssuedDuringPeriodSharesIssuedAsConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesIssuedAsConsideration" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="definition: ClassOfStockLineItems to SaleOfStockNumberOfSharesIssuedInTransaction" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="SaleOfStockPricePerShare" xlink:title="SaleOfStockPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockPricePerShare" xlink:title="definition: ClassOfStockLineItems to SaleOfStockPricePerShare" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="SaleOfStockConsiderationReceivedOnTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="definition: ClassOfStockLineItems to SaleOfStockConsiderationReceivedOnTransaction" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_TermOfAgreement" xlink:label="TermOfAgreement" xlink:title="TermOfAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="TermOfAgreement" xlink:title="definition: ClassOfStockLineItems to TermOfAgreement" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:label="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="definition: ClassOfStockLineItems to SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:label="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="definition: ClassOfStockLineItems to SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="definition: ClassOfStockLineItems to SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="definition: ClassOfStockLineItems to SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:label="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="definition: ClassOfStockLineItems to RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:label="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="definition: ClassOfStockLineItems to PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:label="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:title="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:title="definition: ClassOfStockLineItems to SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesNewIssues" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="definition: ClassOfStockLineItems to ProceedsFromIssuanceOfCommonStock" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="definition: ClassOfStockLineItems to WarrantsAndRightsOutstandingTerm" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="definition: ClassOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="StockIssuedDuringPeriodSharesOther" xlink:title="StockIssuedDuringPeriodSharesOther" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesOther" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesOther" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="ProceedsFromWarrantExercises" xlink:title="definition: ClassOfStockLineItems to ProceedsFromWarrantExercises" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfStockLineItems" xlink:to="ScheduleOfStockByClassTable" xlink:title="definition: ClassOfStockLineItems to ScheduleOfStockByClassTable" order="22.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="SubsidiarySaleOfStockAxis" xlink:title="SubsidiarySaleOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="SubsidiarySaleOfStockAxis" xlink:title="definition: ScheduleOfStockByClassTable to SubsidiarySaleOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain" xlink:title="definition: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain_2" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain_2" xlink:title="definition: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LincolnParkAgreementMember" xlink:label="LincolnParkAgreementMember" xlink:title="LincolnParkAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="LincolnParkAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to LincolnParkAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:label="H.C.WainwrightSalesAmendedAgreementMember" xlink:title="H.C.WainwrightSalesAmendedAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="H.C.WainwrightSalesAmendedAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to H.C.WainwrightSalesAmendedAgreementMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AtTheMarketOfferingAgreementMember" xlink:label="AtTheMarketOfferingAgreementMember" xlink:title="AtTheMarketOfferingAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="AtTheMarketOfferingAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to AtTheMarketOfferingAgreementMember" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_InstitutionalPurchaseAgreementMember" xlink:label="InstitutionalPurchaseAgreementMember" xlink:title="InstitutionalPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="InstitutionalPurchaseAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to InstitutionalPurchaseAgreementMember" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AdditionalPurchaseAgreementMember" xlink:label="AdditionalPurchaseAgreementMember" xlink:title="AdditionalPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="AdditionalPurchaseAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to AdditionalPurchaseAgreementMember" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_January2021PurchaseAgreementMember" xlink:label="January2021PurchaseAgreementMember" xlink:title="January2021PurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="January2021PurchaseAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to January2021PurchaseAgreementMember" order="6.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:label="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:title="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to RestrictedStockAndRestrictedStockUnitsIssuedAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="6.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to AllocatedShareBasedCompensationExpense" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="definition: EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="2.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="IncomeStatementLocationAxis" xlink:title="definition: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to IncomeStatementLocationAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain_2" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain_2" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/ResearchFundingFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesNarrativeFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="definition: OperatingLossCarryforwardsLineItems to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:label="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="OperatingLossCarryforwardsBeforeWriteDown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsBeforeWriteDown" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwards" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwards" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:label="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="OperatingLossCarryforwardsSetToExpireWrittenDown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsSetToExpireWrittenDown" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:label="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="definition: OperatingLossCarryforwardsLineItems to ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="definition: OperatingLossCarryforwardsLineItems to ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LossOnSaleOfNetOperatingLosses" xlink:label="LossOnSaleOfNetOperatingLosses" xlink:title="LossOnSaleOfNetOperatingLosses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="LossOnSaleOfNetOperatingLosses" xlink:title="definition: OperatingLossCarryforwardsLineItems to LossOnSaleOfNetOperatingLosses" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsTable" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsTable" order="9.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="definition: OperatingLossCarryforwardsTable to IncomeTaxAuthorityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain_2" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain_2" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="DomesticCountryMember" xlink:title="definition: IncomeTaxAuthorityDomain to DomesticCountryMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="definition: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="IncomeTaxAuthorityNameAxis" xlink:title="IncomeTaxAuthorityNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityNameAxis" xlink:title="definition: OperatingLossCarryforwardsTable to IncomeTaxAuthorityNameAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="IncomeTaxAuthorityNameDomain" xlink:title="IncomeTaxAuthorityNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeTaxAuthorityNameAxis" xlink:to="IncomeTaxAuthorityNameDomain" xlink:title="definition: IncomeTaxAuthorityNameAxis to IncomeTaxAuthorityNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="IncomeTaxAuthorityNameDomain_2" xlink:title="IncomeTaxAuthorityNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityNameAxis" xlink:to="IncomeTaxAuthorityNameDomain_2" xlink:title="definition: IncomeTaxAuthorityNameAxis to IncomeTaxAuthorityNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="NewJerseyDivisionOfTaxationMember" xlink:title="NewJerseyDivisionOfTaxationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="NewJerseyDivisionOfTaxationMember" xlink:title="definition: IncomeTaxAuthorityNameDomain to NewJerseyDivisionOfTaxationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="CaliforniaFranchiseTaxBoardMember" xlink:title="CaliforniaFranchiseTaxBoardMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="CaliforniaFranchiseTaxBoardMember" xlink:title="definition: IncomeTaxAuthorityNameDomain to CaliforniaFranchiseTaxBoardMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:label="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="NewYorkStateDivisionOfTaxationAndFinanceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="definition: IncomeTaxAuthorityNameDomain to NewYorkStateDivisionOfTaxationAndFinanceMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/BusinessQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="GrantsReceivable" xlink:title="definition: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to GrantsReceivable" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="definition: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="definition: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:label="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="MergerAgreementTransactionExpensesThresholdForRatioAllocation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="definition: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to MergerAgreementTransactionExpensesThresholdForRatioAllocation" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="definition: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="definition: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProjectMember" xlink:label="ProjectMember" xlink:title="ProjectMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="ProjectMember" xlink:title="definition: CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis to ProjectMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProjectMember" xlink:label="ProjectMember_2" xlink:title="ProjectMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="ProjectMember_2" xlink:title="definition: CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis to ProjectMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CLBS16TreatmentOfCMDMember" xlink:label="CLBS16TreatmentOfCMDMember" xlink:title="CLBS16TreatmentOfCMDMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ProjectMember" xlink:to="CLBS16TreatmentOfCMDMember" xlink:title="definition: ProjectMember to CLBS16TreatmentOfCMDMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to SubsequentEventTypeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to BusinessAcquisitionAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AgreementAndPlanOfMergerAndReorganizationMember" xlink:label="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="AgreementAndPlanOfMergerAndReorganizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AgreementAndPlanOfMergerAndReorganizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="CounterpartyNameAxis" xlink:title="definition: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to CounterpartyNameAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CounterpartyNameAxis" xlink:to="RepurchaseAgreementCounterpartyNameDomain" xlink:title="definition: CounterpartyNameAxis to RepurchaseAgreementCounterpartyNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain_2" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CounterpartyNameAxis" xlink:to="RepurchaseAgreementCounterpartyNameDomain_2" xlink:title="definition: CounterpartyNameAxis to RepurchaseAgreementCounterpartyNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CendTherapeuticsIncMember" xlink:label="CendTherapeuticsIncMember" xlink:title="CendTherapeuticsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RepurchaseAgreementCounterpartyNameDomain" xlink:to="CendTherapeuticsIncMember" xlink:title="definition: RepurchaseAgreementCounterpartyNameDomain to CendTherapeuticsIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleSecuritiesDebtSecurities" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesLineItems to ScheduleOfAvailableForSaleSecuritiesTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="FinancialInstrumentAxis" xlink:title="FinancialInstrumentAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="FinancialInstrumentAxis" xlink:title="definition: ScheduleOfAvailableForSaleSecuritiesTable to FinancialInstrumentAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FinancialInstrumentAxis" xlink:to="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="definition: FinancialInstrumentAxis to TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" xlink:title="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FinancialInstrumentAxis" xlink:to="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" xlink:title="definition: FinancialInstrumentAxis to TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="CorporateDebtSecuritiesMember" xlink:title="definition: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to CorporateDebtSecuritiesMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="MoneyMarketFundsMember" xlink:title="MoneyMarketFundsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="MoneyMarketFundsMember" xlink:title="definition: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to MoneyMarketFundsMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:label="USStatesAndPoliticalSubdivisionsMember" xlink:title="USStatesAndPoliticalSubdivisionsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="USStatesAndPoliticalSubdivisionsMember" xlink:title="definition: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to USStatesAndPoliticalSubdivisionsMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeLossPerShareQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="2.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="definition: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain_2" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain_2" xlink:title="definition: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to WarrantMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="InvestmentsFairValueDisclosure" xlink:title="InvestmentsFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="InvestmentsFairValueDisclosure" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to InvestmentsFairValueDisclosure" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="AssetsFairValueDisclosure" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to AssetsFairValueDisclosure" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="definition: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain_2" xlink:title="definition: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="definition: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="FairValueByMeasurementFrequencyAxis" xlink:title="definition: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to FairValueByMeasurementFrequencyAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="FairValueMeasurementFrequencyDomain" xlink:title="definition: FairValueByMeasurementFrequencyAxis to FairValueMeasurementFrequencyDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain_2" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="FairValueMeasurementFrequencyDomain_2" xlink:title="definition: FairValueByMeasurementFrequencyAxis to FairValueMeasurementFrequencyDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="FairValueMeasurementsRecurringMember" xlink:title="FairValueMeasurementsRecurringMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="FairValueMeasurementFrequencyDomain" xlink:to="FairValueMeasurementsRecurringMember" xlink:title="definition: FairValueMeasurementFrequencyDomain to FairValueMeasurementsRecurringMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesQ1Details" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesNarrativeQ1Details" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:label="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="definition: ClassOfStockLineItems to SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:label="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="StockIssuedDuringPeriodSharesIssuedAsConsideration" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesIssuedAsConsideration" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="definition: ClassOfStockLineItems to SaleOfStockNumberOfSharesIssuedInTransaction" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="SaleOfStockPricePerShare" xlink:title="SaleOfStockPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockPricePerShare" xlink:title="definition: ClassOfStockLineItems to SaleOfStockPricePerShare" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="SaleOfStockConsiderationReceivedOnTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="definition: ClassOfStockLineItems to SaleOfStockConsiderationReceivedOnTransaction" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_TermOfAgreement" xlink:label="TermOfAgreement" xlink:title="TermOfAgreement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="TermOfAgreement" xlink:title="definition: ClassOfStockLineItems to TermOfAgreement" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:label="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="definition: ClassOfStockLineItems to SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:label="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="definition: ClassOfStockLineItems to SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="definition: ClassOfStockLineItems to SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="definition: ClassOfStockLineItems to SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:label="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="definition: ClassOfStockLineItems to RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:label="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="definition: ClassOfStockLineItems to PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="definition: ClassOfStockLineItems to StockIssuedDuringPeriodSharesNewIssues" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ClassOfStockLineItems" xlink:to="ScheduleOfStockByClassTable" xlink:title="definition: ClassOfStockLineItems to ScheduleOfStockByClassTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="SubsidiarySaleOfStockAxis" xlink:title="SubsidiarySaleOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfStockByClassTable" xlink:to="SubsidiarySaleOfStockAxis" xlink:title="definition: ScheduleOfStockByClassTable to SubsidiarySaleOfStockAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain" xlink:title="definition: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain_2" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain_2" xlink:title="definition: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LincolnParkAgreementMember" xlink:label="LincolnParkAgreementMember" xlink:title="LincolnParkAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="LincolnParkAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to LincolnParkAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AtTheMarketOfferingAgreementMember" xlink:label="AtTheMarketOfferingAgreementMember" xlink:title="AtTheMarketOfferingAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="AtTheMarketOfferingAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to AtTheMarketOfferingAgreementMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details" />
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="5.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="definition: RangeAxis to RangeMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember_2" xlink:title="RangeMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="RangeAxis" xlink:to="RangeMember_2" xlink:title="definition: RangeAxis to RangeMember_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="definition: RangeMember to MinimumMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="definition: RangeMember to MaximumMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="2.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain_2" xlink:title="IncomeStatementLocationDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain_2" xlink:title="definition: IncomeStatementLocationAxis to IncomeStatementLocationDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="definition: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="2.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="definition: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="3.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="definition: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" xlink:title="definition: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="definition: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:label="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="OperatingLossCarryforwardsBeforeWriteDown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsBeforeWriteDown" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwards" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwards" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:label="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="OperatingLossCarryforwardsSetToExpireWrittenDown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsSetToExpireWrittenDown" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:label="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="definition: OperatingLossCarryforwardsLineItems to ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="definition: OperatingLossCarryforwardsLineItems to ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LossOnSaleOfNetOperatingLosses" xlink:label="LossOnSaleOfNetOperatingLosses" xlink:title="LossOnSaleOfNetOperatingLosses" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="LossOnSaleOfNetOperatingLosses" xlink:title="definition: OperatingLossCarryforwardsLineItems to LossOnSaleOfNetOperatingLosses" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsTable" xlink:title="definition: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsTable" order="8.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="definition: OperatingLossCarryforwardsTable to IncomeTaxAuthorityAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain_2" xlink:title="IncomeTaxAuthorityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain_2" xlink:title="definition: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="DomesticCountryMember" xlink:title="definition: IncomeTaxAuthorityDomain to DomesticCountryMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="definition: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="IncomeTaxAuthorityNameAxis" xlink:title="IncomeTaxAuthorityNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityNameAxis" xlink:title="definition: OperatingLossCarryforwardsTable to IncomeTaxAuthorityNameAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="IncomeTaxAuthorityNameDomain" xlink:title="IncomeTaxAuthorityNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="IncomeTaxAuthorityNameAxis" xlink:to="IncomeTaxAuthorityNameDomain" xlink:title="definition: IncomeTaxAuthorityNameAxis to IncomeTaxAuthorityNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="IncomeTaxAuthorityNameDomain_2" xlink:title="IncomeTaxAuthorityNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="IncomeTaxAuthorityNameAxis" xlink:to="IncomeTaxAuthorityNameDomain_2" xlink:title="definition: IncomeTaxAuthorityNameAxis to IncomeTaxAuthorityNameDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="NewJerseyDivisionOfTaxationMember" xlink:title="NewJerseyDivisionOfTaxationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="NewJerseyDivisionOfTaxationMember" xlink:title="definition: IncomeTaxAuthorityNameDomain to NewJerseyDivisionOfTaxationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="CaliforniaFranchiseTaxBoardMember" xlink:title="CaliforniaFranchiseTaxBoardMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="CaliforniaFranchiseTaxBoardMember" xlink:title="definition: IncomeTaxAuthorityNameDomain to CaliforniaFranchiseTaxBoardMember" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:label="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="NewYorkStateDivisionOfTaxationAndFinanceMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="definition: IncomeTaxAuthorityNameDomain to NewYorkStateDivisionOfTaxationAndFinanceMember" order="3.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://caladrius.com/role/SubsequentEventsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="definition: SubsequentEventLineItems to MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="definition: SubsequentEventLineItems to MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:label="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="MergerAgreementTransactionExpensesThresholdForRatioAllocation" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="definition: SubsequentEventLineItems to MergerAgreementTransactionExpensesThresholdForRatioAllocation" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementMinimumNetCashThreshold" xlink:label="MergerAgreementMinimumNetCashThreshold" xlink:title="MergerAgreementMinimumNetCashThreshold" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementMinimumNetCashThreshold" xlink:title="definition: SubsequentEventLineItems to MergerAgreementMinimumNetCashThreshold" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialTerminationFeePayable" xlink:label="MergerAgreementPotentialTerminationFeePayable" xlink:title="MergerAgreementPotentialTerminationFeePayable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementPotentialTerminationFeePayable" xlink:title="definition: SubsequentEventLineItems to MergerAgreementPotentialTerminationFeePayable" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialTerminationFeeReceivable" xlink:label="MergerAgreementPotentialTerminationFeeReceivable" xlink:title="MergerAgreementPotentialTerminationFeeReceivable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementPotentialTerminationFeeReceivable" xlink:title="definition: SubsequentEventLineItems to MergerAgreementPotentialTerminationFeeReceivable" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialExpenseReimbursement" xlink:label="MergerAgreementPotentialExpenseReimbursement" xlink:title="MergerAgreementPotentialExpenseReimbursement" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementPotentialExpenseReimbursement" xlink:title="definition: SubsequentEventLineItems to MergerAgreementPotentialExpenseReimbursement" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockShares" xlink:label="PurchaseOfPreferredStockShares" xlink:title="PurchaseOfPreferredStockShares" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="PurchaseOfPreferredStockShares" xlink:title="definition: SubsequentEventLineItems to PurchaseOfPreferredStockShares" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="definition: SubsequentEventLineItems to PreferredStockParOrStatedValuePerShare" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockPricePerShare" xlink:label="PurchaseOfPreferredStockPricePerShare" xlink:title="PurchaseOfPreferredStockPricePerShare" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="PurchaseOfPreferredStockPricePerShare" xlink:title="definition: SubsequentEventLineItems to PurchaseOfPreferredStockPricePerShare" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockAggregatePrice" xlink:label="PurchaseOfPreferredStockAggregatePrice" xlink:title="PurchaseOfPreferredStockAggregatePrice" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="PurchaseOfPreferredStockAggregatePrice" xlink:title="definition: SubsequentEventLineItems to PurchaseOfPreferredStockAggregatePrice" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreEquityOfferingValueAfterConversion" xlink:label="PreEquityOfferingValueAfterConversion" xlink:title="PreEquityOfferingValueAfterConversion" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="PreEquityOfferingValueAfterConversion" xlink:title="definition: SubsequentEventLineItems to PreEquityOfferingValueAfterConversion" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_GrossProceedsOnTransaction" xlink:label="GrossProceedsOnTransaction" xlink:title="GrossProceedsOnTransaction" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventLineItems" xlink:to="GrossProceedsOnTransaction" xlink:title="definition: SubsequentEventLineItems to GrossProceedsOnTransaction" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="SubsequentEventLineItems" xlink:to="SubsequentEventTable" xlink:title="definition: SubsequentEventLineItems to SubsequentEventTable" order="14.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="definition: SubsequentEventTable to SubsequentEventTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain_2" xlink:title="SubsequentEventTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain_2" xlink:title="definition: SubsequentEventTypeAxis to SubsequentEventTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="definition: SubsequentEventTypeDomain to SubsequentEventMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="SubsidiarySaleOfStockAxis" xlink:title="SubsidiarySaleOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="SubsidiarySaleOfStockAxis" xlink:title="definition: SubsequentEventTable to SubsidiarySaleOfStockAxis" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain" xlink:title="definition: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain_2" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain_2" xlink:title="definition: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CendSeriesDPreferredStockPurchaseAgreementMember" xlink:label="CendSeriesDPreferredStockPurchaseAgreementMember" xlink:title="CendSeriesDPreferredStockPurchaseAgreementMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="CendSeriesDPreferredStockPurchaseAgreementMember" xlink:title="definition: SaleOfStockNameOfTransactionDomain to CendSeriesDPreferredStockPurchaseAgreementMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="LegalEntityAxis" xlink:title="definition: SubsequentEventTable to LegalEntityAxis" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="definition: LegalEntityAxis to EntityDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="EntityDomain_2" xlink:title="EntityDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="LegalEntityAxis" xlink:to="EntityDomain_2" xlink:title="definition: LegalEntityAxis to EntityDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CendTherapeuticsIncMember" xlink:label="CendTherapeuticsIncMember" xlink:title="CendTherapeuticsIncMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityDomain" xlink:to="CendTherapeuticsIncMember" xlink:title="definition: EntityDomain to CendTherapeuticsIncMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="StatementClassOfStockAxis" xlink:title="definition: SubsequentEventTable to StatementClassOfStockAxis" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain_2" xlink:title="ClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain_2" xlink:title="definition: StatementClassOfStockAxis to ClassOfStockDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SeriesDPreferredStockCendMember" xlink:label="SeriesDPreferredStockCendMember" xlink:title="SeriesDPreferredStockCendMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ClassOfStockDomain" xlink:to="SeriesDPreferredStockCendMember" xlink:title="definition: ClassOfStockDomain to SeriesDPreferredStockCendMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="BusinessAcquisitionAxis" xlink:title="definition: SubsequentEventTable to BusinessAcquisitionAxis" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain_2" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain_2" xlink:title="definition: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AgreementAndPlanOfMergerAndReorganizationMember" xlink:label="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="AgreementAndPlanOfMergerAndReorganizationMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="definition: BusinessAcquisitionAcquireeDomain to AgreementAndPlanOfMergerAndReorganizationMember" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="SubsequentEventTable" xlink:to="CounterpartyNameAxis" xlink:title="definition: SubsequentEventTable to CounterpartyNameAxis" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="CounterpartyNameAxis" xlink:to="RepurchaseAgreementCounterpartyNameDomain" xlink:title="definition: CounterpartyNameAxis to RepurchaseAgreementCounterpartyNameDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain_2" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="CounterpartyNameAxis" xlink:to="RepurchaseAgreementCounterpartyNameDomain_2" xlink:title="definition: CounterpartyNameAxis to RepurchaseAgreementCounterpartyNameDomain_2" order="2.0" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="RepurchaseAgreementCounterpartyNameDomain" xlink:to="CendTherapeuticsIncMember" xlink:title="definition: RepurchaseAgreementCounterpartyNameDomain to CendTherapeuticsIncMember" order="1.0" />
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="definition: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="definition: AssetsAbstract to OtherAssetsNoncurrent" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>clbs-20220726_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AwardTypeAxis_lbl1" xml:lang="en-US" id="us-gaap_AwardTypeAxis_lbl1">Award Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl1" xlink:title="label: AwardTypeAxis to us-gaap_AwardTypeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" id="us-gaap_AccountingPoliciesAbstract_lbl">Accounting Policies [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:title="label: AccountingPoliciesAbstract to us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl">Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" xlink:title="label: AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock to us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccountsPayableCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccountsPayableCurrent_lbl1">Accounts Payable, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl1" xlink:title="label: AccountsPayableCurrent to us-gaap_AccountsPayableCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xml:lang="en-US" id="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl">Accretion on marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:title="label: AccretionAmortizationOfDiscountsAndPremiumsInvestments to us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl1" xml:lang="en-US" id="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl1">Amortization/accretion on marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl1" xlink:title="label: AccretionAmortizationOfDiscountsAndPremiumsInvestments to us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl2" xml:lang="en-US" id="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl2">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl2" xlink:title="label: AccretionAmortizationOfDiscountsAndPremiumsInvestments to us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl1">Total accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrent_lbl2" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrent_lbl2">Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl2" xlink:title="label: AccruedLiabilitiesCurrent to us-gaap_AccruedLiabilitiesCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl">Accrued Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl" xlink:title="label: AccruedLiabilitiesCurrentAndNoncurrentAbstract to us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="AccruedLiabilitiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl">Accrued liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:title="label: AccruedLiabilitiesCurrentAndNoncurrent to us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl1">Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl1" xlink:title="label: AccruedLiabilitiesCurrentAndNoncurrent to us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" id="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl">Accumulated other comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossNetOfTax to us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl1">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl1" xlink:title="label: AccumulatedOtherComprehensiveIncomeLossNetOfTax to us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" id="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl">Accumulated Other Comprehensive Loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:title="label: AccumulatedOtherComprehensiveIncomeMember to us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl1">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl1" xlink:title="label: AccumulatedOtherComprehensiveIncomeMember to us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl2" xml:lang="en-US" id="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl2">AOCI Attributable to Parent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl2" xlink:title="label: AccumulatedOtherComprehensiveIncomeMember to us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl">Accumulated depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" xlink:title="label: AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment to us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapital_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapital_lbl1">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl1" xlink:title="label: AdditionalPaidInCapital to us-gaap_AdditionalPaidInCapital_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl">Additional Paid in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl1" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl1">Additional Paid-in Capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl1" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdditionalPaidInCapitalMember_lbl2" xml:lang="en-US" id="us-gaap_AdditionalPaidInCapitalMember_lbl2">Additional Paid-in Capital [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl2" xlink:title="label: AdditionalPaidInCapitalMember to us-gaap_AdditionalPaidInCapitalMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl">Share-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl1">Total share-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl1" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xml:lang="en-US" id="us-gaap_AllocatedShareBasedCompensationExpense_lbl2">Share-based Payment Arrangement, Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl2" xlink:title="label: AllocatedShareBasedCompensationExpense to us-gaap_AllocatedShareBasedCompensationExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl1" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl1">Antidilutive Securities [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl1" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl1" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl1">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl1" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl">Anti-dilutive securities excluded from computation of loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1">Antidilutive securities excluded from computation of earnings per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl2" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl2">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl2" xlink:title="label: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount to us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesNameDomain_lbl">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:title="label: AntidilutiveSecuritiesNameDomain to us-gaap_AntidilutiveSecuritiesNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AntidilutiveSecuritiesNameDomain_lbl1" xml:lang="en-US" id="us-gaap_AntidilutiveSecuritiesNameDomain_lbl1">Antidilutive Securities, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl1" xlink:title="label: AntidilutiveSecuritiesNameDomain to us-gaap_AntidilutiveSecuritiesNameDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="AssetsFairValueDisclosureAbstract" xlink:title="AssetsFairValueDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsFairValueDisclosureAbstract_lbl">Assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xlink:title="label: AssetsFairValueDisclosureAbstract to us-gaap_AssetsFairValueDisclosureAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsFairValueDisclosureAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsFairValueDisclosureAbstract_lbl1">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl1" xlink:title="label: AssetsFairValueDisclosureAbstract to us-gaap_AssetsFairValueDisclosureAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Assets_lbl" xml:lang="en-US" id="us-gaap_Assets_lbl">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl" xlink:title="label: Assets to us-gaap_Assets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Assets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Assets_lbl1" xml:lang="en-US" id="us-gaap_Assets_lbl1">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Assets" xlink:to="us-gaap_Assets_lbl1" xlink:title="label: Assets to us-gaap_Assets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl">ASSETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsAbstract_lbl1">Assets [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1" xlink:title="label: AssetsAbstract to us-gaap_AssetsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US" id="us-gaap_AssetsFairValueDisclosure_lbl">Assets, fair value disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:title="label: AssetsFairValueDisclosure to us-gaap_AssetsFairValueDisclosure_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsFairValueDisclosure_lbl1" xml:lang="en-US" id="us-gaap_AssetsFairValueDisclosure_lbl1">Assets, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl1" xlink:title="label: AssetsFairValueDisclosure to us-gaap_AssetsFairValueDisclosure_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrent_lbl1">Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl1" xlink:title="label: AssetsCurrent to us-gaap_AssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl">Current Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AssetsCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_AssetsCurrentAbstract_lbl1">Assets, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl1" xlink:title="label: AssetsCurrentAbstract to us-gaap_AssetsCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl">Greater than one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl1">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl">Gross Unrealized Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:title="label: AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax to us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl1">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl1" xlink:title="label: AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax to us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl">Gross Unrealized Gains</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:title="label: AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax to us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl1">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl1" xlink:title="label: AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax to us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl">Less than one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl1">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl">Less than one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl1">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl">Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:title="label: AvailableForSaleDebtSecuritiesAmortizedCostBasis to us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl1">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl1" xlink:title="label: AvailableForSaleDebtSecuritiesAmortizedCostBasis to us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl">Greater than one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl1">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl">Greater than one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl1">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl">Greater than one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl1">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="AvailableForSaleSecuritiesAbstract" xlink:title="AvailableForSaleSecuritiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesAbstract_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesAbstract_lbl">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesAbstract_lbl" xlink:title="label: AvailableForSaleSecuritiesAbstract to us-gaap_AvailableForSaleSecuritiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl">Total estimated fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtSecurities to us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl1">Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtSecurities to us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl2" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl2">Available-for-sale debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl2" xlink:title="label: AvailableForSaleSecuritiesDebtSecurities to us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl3" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl3">Debt Securities, Available-for-sale</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl3" xlink:title="label: AvailableForSaleSecuritiesDebtSecurities to us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl">Less than one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl1">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl">Less than one year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl1">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl">Estimated Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl1">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl">Amortized Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl1" xml:lang="en-US" id="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl1">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl1" xlink:title="label: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain" xlink:title="BalanceSheetLocationDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BalanceSheetLocationDomain_lbl" xml:lang="en-US" id="us-gaap_BalanceSheetLocationDomain_lbl">Balance Sheet Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl" xlink:title="label: BalanceSheetLocationDomain to us-gaap_BalanceSheetLocationDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BalanceSheetLocationDomain_lbl1" xml:lang="en-US" id="us-gaap_BalanceSheetLocationDomain_lbl1">Balance Sheet Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl1" xlink:title="label: BalanceSheetLocationDomain to us-gaap_BalanceSheetLocationDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="BalanceSheetLocationAxis" xlink:title="BalanceSheetLocationAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US" id="us-gaap_BalanceSheetLocationAxis_lbl">Balance Sheet Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xlink:title="label: BalanceSheetLocationAxis to us-gaap_BalanceSheetLocationAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BalanceSheetLocationAxis_lbl1" xml:lang="en-US" id="us-gaap_BalanceSheetLocationAxis_lbl1">Balance Sheet Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl1" xlink:title="label: BalanceSheetLocationAxis to us-gaap_BalanceSheetLocationAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl">Basis of Presentation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" xlink:title="label: BasisOfAccountingPolicyPolicyTextBlock to us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAxis_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAxis_lbl1">Business Acquisition [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl1" xlink:title="label: BusinessAcquisitionAxis to us-gaap_BusinessAcquisitionAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_BusinessAcquisitionAcquireeDomain_lbl1" xml:lang="en-US" id="us-gaap_BusinessAcquisitionAcquireeDomain_lbl1">Business Acquisition, Acquiree [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl1" xlink:title="label: BusinessAcquisitionAcquireeDomain to us-gaap_BusinessAcquisitionAcquireeDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="CaliforniaFranchiseTaxBoardMember" xlink:title="CaliforniaFranchiseTaxBoardMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xml:lang="en-US" id="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl">California</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CaliforniaFranchiseTaxBoardMember" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" xlink:title="label: CaliforniaFranchiseTaxBoardMember to us-gaap_CaliforniaFranchiseTaxBoardMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl1" xml:lang="en-US" id="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl1">California Franchise Tax Board [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CaliforniaFranchiseTaxBoardMember" xlink:to="us-gaap_CaliforniaFranchiseTaxBoardMember_lbl1" xlink:title="label: CaliforniaFranchiseTaxBoardMember to us-gaap_CaliforniaFranchiseTaxBoardMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl" xml:lang="en-US" id="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl">Project [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl" xlink:title="label: CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis to us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl1" xml:lang="en-US" id="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl1">Project [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl1" xlink:title="label: CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis to us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:label="CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:title="CashCashEquivalentsAndMarketableSecuritiesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl">Available-for-Sale-Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" xlink:title="label: CashCashEquivalentsAndMarketableSecuritiesTextBlock to us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl1">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl1" xlink:title="label: CashCashEquivalentsAndMarketableSecuritiesTextBlock to us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl">Cash and cash equivalents at beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1">Cash and cash equivalents at end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xml:lang="en-US" id="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" xlink:title="label: CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents to us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl">Cash and Cash Equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" xlink:title="label: CashAndCashEquivalentsPolicyTextBlock to us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="CashAndCashEquivalentsMember" xlink:title="CashAndCashEquivalentsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsMember_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsMember_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl" xlink:title="label: CashAndCashEquivalentsMember to us-gaap_CashAndCashEquivalentsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsMember_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsMember_lbl1">Cash and Cash Equivalents [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsMember" xlink:to="us-gaap_CashAndCashEquivalentsMember_lbl1" xlink:title="label: CashAndCashEquivalentsMember to us-gaap_CashAndCashEquivalentsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US" id="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="CashEquivalentsAtCarryingValue" xlink:title="CashEquivalentsAtCarryingValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" id="us-gaap_CashEquivalentsAtCarryingValue_lbl">Cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:title="label: CashEquivalentsAtCarryingValue to us-gaap_CashEquivalentsAtCarryingValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US" id="us-gaap_CashEquivalentsAtCarryingValue_lbl1">Cash Equivalents, at Carrying Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl1" xlink:title="label: CashEquivalentsAtCarryingValue to us-gaap_CashEquivalentsAtCarryingValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="CashCashEquivalentsAndShortTermInvestments" xlink:title="CashCashEquivalentsAndShortTermInvestments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xml:lang="en-US" id="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:title="label: CashCashEquivalentsAndShortTermInvestments to us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl1" xml:lang="en-US" id="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl1">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl1" xlink:title="label: CashCashEquivalentsAndShortTermInvestments to us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl">Number of shares called by warrants issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfStockLineItems_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockLineItems_lbl">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" xlink:title="label: ClassOfStockLineItems to us-gaap_ClassOfStockLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockLineItems_lbl1" xml:lang="en-US" id="us-gaap_ClassOfStockLineItems_lbl1">Class of Stock [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl1" xlink:title="label: ClassOfStockLineItems to us-gaap_ClassOfStockLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfStockDomain_lbl1" xml:lang="en-US" id="us-gaap_ClassOfStockDomain_lbl1">Class of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl1" xlink:title="label: ClassOfStockDomain to us-gaap_ClassOfStockDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl">Warrant exercise price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" xlink:title="label: ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 to us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl">Number of shares per each warrant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xml:lang="en-US" id="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" xlink:title="label: ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight to us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureAbstract to us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl">Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommitmentsAndContingencies_lbl1" xml:lang="en-US" id="us-gaap_CommitmentsAndContingencies_lbl1">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl1" xlink:title="label: CommitmentsAndContingencies to us-gaap_CommitmentsAndContingencies_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:title="label: CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract to us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1">Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1" xlink:title="label: CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract to us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonStockMember_lbl" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl">Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockMember_lbl1" xml:lang="en-US" id="us-gaap_CommonStockMember_lbl1">Common Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1" xlink:title="label: CommonStockMember to us-gaap_CommonStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl">Common stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl1">Common stock, shares, issued (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl1" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesIssued_lbl2" xml:lang="en-US" id="us-gaap_CommonStockSharesIssued_lbl2">Common Stock, Shares, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl2" xlink:title="label: CommonStockSharesIssued to us-gaap_CommonStockSharesIssued_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl">Common stock, par value (in usd per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl1">Common stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockParOrStatedValuePerShare_lbl2" xml:lang="en-US" id="us-gaap_CommonStockParOrStatedValuePerShare_lbl2">Common Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl2" xlink:title="label: CommonStockParOrStatedValuePerShare to us-gaap_CommonStockParOrStatedValuePerShare_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockValue_lbl" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl">Common stock, $0.001 par value, authorized 500,000,000 shares; issued 60,544,144 and 59,800,792 shares at March 31, 2022 and December 31, 2021, respectively; and outstanding, 60,533,064 and 59,789,712 shares at March 31, 2022 and December 31, 2021, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonStockValue_lbl1" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl1">Common stock, $0.001 par value, authorized 500,000,000 shares; issued 59,800,792 and 19,389,413 shares, at December 31, 2021 and December 31, 2020, respectively; and outstanding, 59,789,712 and 19,378,333 shares, at December 31, 2021 and December 31, 2020, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl1" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockValue_lbl2" xml:lang="en-US" id="us-gaap_CommonStockValue_lbl2">Common Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl2" xlink:title="label: CommonStockValue to us-gaap_CommonStockValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl">Common stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl1">Common stock, shares authorized (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl1" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesAuthorized_lbl2" xml:lang="en-US" id="us-gaap_CommonStockSharesAuthorized_lbl2">Common Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl2" xlink:title="label: CommonStockSharesAuthorized to us-gaap_CommonStockSharesAuthorized_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl">Common stock, shares, outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl1">Common stock, shares, outstanding (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl1" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CommonStockSharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_CommonStockSharesOutstanding_lbl2">Common Stock, Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl2" xlink:title="label: CommonStockSharesOutstanding to us-gaap_CommonStockSharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" xlink:title="label: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl1">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl1" xlink:title="label: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:title="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" xlink:title="label: ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest to us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl1">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl1" xlink:title="label: ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest to us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:title="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl">Comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:title="label: ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest to us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl1">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:title="label: ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest to us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" id="us-gaap_ComprehensiveIncomeNetOfTax_lbl">Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:title="label: ComprehensiveIncomeNetOfTax to us-gaap_ComprehensiveIncomeNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComprehensiveIncomeNetOfTax_lbl1" xml:lang="en-US" id="us-gaap_ComprehensiveIncomeNetOfTax_lbl1">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl1" xlink:title="label: ComprehensiveIncomeNetOfTax to us-gaap_ComprehensiveIncomeNetOfTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US" id="us-gaap_ComputerEquipmentMember_lbl">Computer equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:title="label: ComputerEquipmentMember to us-gaap_ComputerEquipmentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ComputerEquipmentMember_lbl1" xml:lang="en-US" id="us-gaap_ComputerEquipmentMember_lbl1">Computer Equipment [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl1" xlink:title="label: ComputerEquipmentMember to us-gaap_ComputerEquipmentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US" id="us-gaap_ConcentrationRiskCreditRisk_lbl">Concentration of Risks</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:title="label: ConcentrationRiskCreditRisk to us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConcentrationRiskCreditRisk_lbl1" xml:lang="en-US" id="us-gaap_ConcentrationRiskCreditRisk_lbl1">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl1" xlink:title="label: ConcentrationRiskCreditRisk to us-gaap_ConcentrationRiskCreditRisk_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="ConsolidationPolicyTextBlock" xlink:title="ConsolidationPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_ConsolidationPolicyTextBlock_lbl">Principles of Consolidation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:title="label: ConsolidationPolicyTextBlock to us-gaap_ConsolidationPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ConsolidationPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ConsolidationPolicyTextBlock_lbl1">Consolidation, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl1" xlink:title="label: ConsolidationPolicyTextBlock to us-gaap_ConsolidationPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CorporateDebtSecuritiesMember_lbl" xml:lang="en-US" id="us-gaap_CorporateDebtSecuritiesMember_lbl">Corporate debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:title="label: CorporateDebtSecuritiesMember to us-gaap_CorporateDebtSecuritiesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CorporateDebtSecuritiesMember_lbl1" xml:lang="en-US" id="us-gaap_CorporateDebtSecuritiesMember_lbl1">Corporate Debt Securities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl1" xlink:title="label: CorporateDebtSecuritiesMember to us-gaap_CorporateDebtSecuritiesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl">State and local</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:title="label: CurrentStateAndLocalTaxExpenseBenefit to us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1">Current State and Local Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" xlink:title="label: CurrentStateAndLocalTaxExpenseBenefit to us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl">U.S. Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1">Current Federal Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" xlink:title="label: CurrentFederalTaxExpenseBenefit to us-gaap_CurrentFederalTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl">Total current income tax provision (benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1">Current Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefit to us-gaap_CurrentIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="DebtSecuritiesAvailableForSaleTable" xlink:title="DebtSecuritiesAvailableForSaleTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xml:lang="en-US" id="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl">Debt Securities, Available-for-sale [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:title="label: DebtSecuritiesAvailableForSaleTable to us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl1" xml:lang="en-US" id="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl1">Debt Securities, Available-for-sale [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl1" xlink:title="label: DebtSecuritiesAvailableForSaleTable to us-gaap_DebtSecuritiesAvailableForSaleTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:title="DeferredTaxAssetsGoodwillAndIntangibleAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl">Intangibles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:title="label: DeferredTaxAssetsGoodwillAndIntangibleAssets to us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl1">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl1" xlink:title="label: DeferredTaxAssetsGoodwillAndIntangibleAssets to us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl">Deferred tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxLiabilities_lbl1">Deferred Tax Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl1" xlink:title="label: DeferredIncomeTaxLiabilities to us-gaap_DeferredIncomeTaxLiabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl">Deferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl">U.S. Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredFederalIncomeTaxExpenseBenefit to us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl">Total deferred income tax provision (benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1">Deferred Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredIncomeTaxExpenseBenefit to us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl">State and local</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" xlink:title="label: DeferredStateAndLocalIncomeTaxExpenseBenefit to us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl">Accumulated net operating losses (tax effected)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwards to us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl1">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl1" xlink:title="label: DeferredTaxAssetsOperatingLossCarryforwards to us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="DeferredTaxAssetsLiabilitiesNet" xlink:title="DeferredTaxAssetsLiabilitiesNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl">Net deferred tax asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:title="label: DeferredTaxAssetsLiabilitiesNet to us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl1">Deferred Tax Assets, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl1" xlink:title="label: DeferredTaxAssetsLiabilitiesNet to us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl">Deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsGross_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGross_lbl1">Deferred Tax Assets, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl1" xlink:title="label: DeferredTaxAssetsGross to us-gaap_DeferredTaxAssetsGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="DeferredTaxAssetsGrossAbstract" xlink:title="DeferredTaxAssetsGrossAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGrossAbstract_lbl">Deferred Tax Assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xlink:title="label: DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsGrossAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsGrossAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsGrossAbstract_lbl1">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl1" xlink:title="label: DeferredTaxAssetsGrossAbstract to us-gaap_DeferredTaxAssetsGrossAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl">Share-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl1">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="DeferredTaxAssetsOther" xlink:title="DeferredTaxAssetsOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsOther_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl" xlink:title="label: DeferredTaxAssetsOther to us-gaap_DeferredTaxAssetsOther_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsOther_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsOther_lbl1">Deferred Tax Assets, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl1" xlink:title="label: DeferredTaxAssetsOther to us-gaap_DeferredTaxAssetsOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl">Accrued payroll</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl1">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl1" xlink:title="label: DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation to us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="DeferredTaxLiabilitiesAbstract" xlink:title="DeferredTaxLiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesAbstract_lbl">Deferred Tax Liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xlink:title="label: DeferredTaxLiabilitiesAbstract to us-gaap_DeferredTaxLiabilitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesAbstract_lbl1">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl1" xlink:title="label: DeferredTaxLiabilitiesAbstract to us-gaap_DeferredTaxLiabilitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsValuationAllowance_lbl">Valuation allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:title="label: DeferredTaxAssetsValuationAllowance to us-gaap_DeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" xlink:title="label: DeferredTaxAssetsValuationAllowance to us-gaap_DeferredTaxAssetsValuationAllowance_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="DeferredTaxLiabilitiesLeasingArrangements" xlink:title="DeferredTaxLiabilitiesLeasingArrangements" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl">Right of use asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" xlink:title="label: DeferredTaxLiabilitiesLeasingArrangements to us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl1" xml:lang="en-US" id="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl1">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxLiabilitiesLeasingArrangements" xlink:to="us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl1" xlink:title="label: DeferredTaxLiabilitiesLeasingArrangements to us-gaap_DeferredTaxLiabilitiesLeasingArrangements_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_Depreciation_lbl" xml:lang="en-US" id="us-gaap_Depreciation_lbl">Depreciation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:title="label: Depreciation to us-gaap_Depreciation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Depreciation_lbl1" xml:lang="en-US" id="us-gaap_Depreciation_lbl1">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Depreciation" xlink:to="us-gaap_Depreciation_lbl1" xlink:title="label: Depreciation to us-gaap_Depreciation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="DepreciationAndAmortization" xlink:title="DepreciationAndAmortization" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US" id="us-gaap_DepreciationAndAmortization_lbl">Depreciation and amortization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:title="label: DepreciationAndAmortization to us-gaap_DepreciationAndAmortization_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DepreciationAndAmortization_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DepreciationAndAmortization_lbl1" xml:lang="en-US" id="us-gaap_DepreciationAndAmortization_lbl1">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl1" xlink:title="label: DepreciationAndAmortization to us-gaap_DepreciationAndAmortization_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl">Share-based Payment Arrangement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl">Share-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1">Share-based Payment Arrangement [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:title="DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xml:lang="en-US" id="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl">Schedule of Total Compensation Cost Related to Nonvested Awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" xlink:title="label: DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock to us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl1" xml:lang="en-US" id="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl1">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl1" xlink:title="label: DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock to us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US" id="us-gaap_DomesticCountryMember_lbl">Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:title="label: DomesticCountryMember to us-gaap_DomesticCountryMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_DomesticCountryMember_lbl1" xml:lang="en-US" id="us-gaap_DomesticCountryMember_lbl1">Domestic Tax Authority [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl1" xlink:title="label: DomesticCountryMember to us-gaap_DomesticCountryMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl">Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl1">Income (Loss) Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl1" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareTextBlock_lbl2" xml:lang="en-US" id="us-gaap_EarningsPerShareTextBlock_lbl2">Earnings Per Share [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl2" xlink:title="label: EarningsPerShareTextBlock to us-gaap_EarningsPerShareTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl">Basic and diluted loss per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:title="label: EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract to us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl1">Weighted average common shares outstanding:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl1" xlink:title="label: EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract to us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl2" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl2">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl2" xlink:title="label: EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract to us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="EarningsPerShareBasicAndDilutedAbstract" xlink:title="EarningsPerShareBasicAndDilutedAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl">Basic and diluted loss per share:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:title="label: EarningsPerShareBasicAndDilutedAbstract to us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl1">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl1" xlink:title="label: EarningsPerShareBasicAndDilutedAbstract to us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_EarningsPerSharePolicyTextBlock_lbl">Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:title="label: EarningsPerSharePolicyTextBlock to us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerSharePolicyTextBlock_lbl1">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl1" xlink:title="label: EarningsPerSharePolicyTextBlock to us-gaap_EarningsPerSharePolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl">Caladrius Biosciences, Inc. common stockholders - basic (in usd per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl1">Caladrius Biosciences, Inc. common shareholders - basic (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareBasic_lbl2" xml:lang="en-US" id="us-gaap_EarningsPerShareBasic_lbl2">Earnings Per Share, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl2" xlink:title="label: EarningsPerShareBasic to us-gaap_EarningsPerShareBasic_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareAbstract_lbl">Earnings Per Share [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:title="label: EarningsPerShareAbstract to us-gaap_EarningsPerShareAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl">Caladrius Biosciences, Inc. common stockholders - diluted (in usd per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl1">Caladrius Biosciences, Inc. common shareholders - diluted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EarningsPerShareDiluted_lbl2" xml:lang="en-US" id="us-gaap_EarningsPerShareDiluted_lbl2">Earnings Per Share, Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl2" xlink:title="label: EarningsPerShareDiluted to us-gaap_EarningsPerShareDiluted_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl">U.S. federal corporate income tax rate (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate to us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl">Expected weighted-average period in years of compensation cost to be recognized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl">Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_EmployeeStockOptionMember_lbl1" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl1">Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl1" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeStockOptionMember_lbl2" xml:lang="en-US" id="us-gaap_EmployeeStockOptionMember_lbl2">Stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl2" xlink:title="label: EmployeeStockOptionMember to us-gaap_EmployeeStockOptionMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl">Share-based Compensation [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl1">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl">Salaries, employee benefits and related taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1">Employee-related Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" xlink:title="label: EmployeeRelatedLiabilitiesCurrent to us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl">Unrecognized compensation cost</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl1" xml:lang="en-US" id="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl1">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl1" xlink:title="label: EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized to us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:label="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:title="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl">Salaries, employee benefits and related taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl" xlink:title="label: EmployeeRelatedLiabilitiesCurrentAndNoncurrent to us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl1">Employee-related Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl1" xlink:title="label: EmployeeRelatedLiabilitiesCurrentAndNoncurrent to us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityComponentDomain_lbl1" xml:lang="en-US" id="us-gaap_EquityComponentDomain_lbl1">Equity Component [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl1" xlink:title="label: EquityComponentDomain to us-gaap_EquityComponentDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_EquityAbstract_lbl" xml:lang="en-US" id="us-gaap_EquityAbstract_lbl">Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:title="label: EquityAbstract to us-gaap_EquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl1" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl1">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl1" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" id="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:title="label: FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl1" xml:lang="en-US" id="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl1">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl1" xlink:title="label: FairValueByFairValueHierarchyLevelAxis to us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresAbstract_lbl">Fair Value Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:title="label: FairValueDisclosuresAbstract to us-gaap_FairValueDisclosuresAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US" id="us-gaap_FairValueByMeasurementFrequencyAxis_lbl">Measurement Frequency [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:title="label: FairValueByMeasurementFrequencyAxis to us-gaap_FairValueByMeasurementFrequencyAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueByMeasurementFrequencyAxis_lbl1" xml:lang="en-US" id="us-gaap_FairValueByMeasurementFrequencyAxis_lbl1">Measurement Frequency [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl1" xlink:title="label: FairValueByMeasurementFrequencyAxis to us-gaap_FairValueByMeasurementFrequencyAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl1" xml:lang="en-US" id="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl1">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl1" xlink:title="label: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:title="label: FairValueMeasurementsFairValueHierarchyDomain to us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="FairValueMeasurementsRecurringMember" xlink:title="FairValueMeasurementsRecurringMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementsRecurringMember_lbl">Recurring</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:title="label: FairValueMeasurementsRecurringMember to us-gaap_FairValueMeasurementsRecurringMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementsRecurringMember_lbl1" xml:lang="en-US" id="us-gaap_FairValueMeasurementsRecurringMember_lbl1">Fair Value, Recurring [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl1" xlink:title="label: FairValueMeasurementsRecurringMember to us-gaap_FairValueMeasurementsRecurringMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US" id="us-gaap_FairValueMeasurementFrequencyDomain_lbl">Measurement Frequency [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:title="label: FairValueMeasurementFrequencyDomain to us-gaap_FairValueMeasurementFrequencyDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueMeasurementFrequencyDomain_lbl1" xml:lang="en-US" id="us-gaap_FairValueMeasurementFrequencyDomain_lbl1">Measurement Frequency [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl1" xlink:title="label: FairValueMeasurementFrequencyDomain to us-gaap_FairValueMeasurementFrequencyDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueDisclosuresTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FairValueDisclosuresTextBlock_lbl1">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl1" xlink:title="label: FairValueDisclosuresTextBlock to us-gaap_FairValueDisclosuresTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US" id="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl">Schedule of Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xlink:title="label: FairValueAssetsMeasuredOnRecurringBasisTextBlock to us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl1" xml:lang="en-US" id="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl1">Schedule of Fair Value of Assets Measured on Recurring Basis</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl1" xlink:title="label: FairValueAssetsMeasuredOnRecurringBasisTextBlock to us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl2" xml:lang="en-US" id="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl2">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl2" xlink:title="label: FairValueAssetsMeasuredOnRecurringBasisTextBlock to us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel1Member_lbl">Level 1</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl" xlink:title="label: FairValueInputsLevel1Member to us-gaap_FairValueInputsLevel1Member_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel1Member_lbl1" xml:lang="en-US" id="us-gaap_FairValueInputsLevel1Member_lbl1">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl1" xlink:title="label: FairValueInputsLevel1Member to us-gaap_FairValueInputsLevel1Member_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel2Member_lbl">Level 2</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xlink:title="label: FairValueInputsLevel2Member to us-gaap_FairValueInputsLevel2Member_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel2Member_lbl1" xml:lang="en-US" id="us-gaap_FairValueInputsLevel2Member_lbl1">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl1" xlink:title="label: FairValueInputsLevel2Member to us-gaap_FairValueInputsLevel2Member_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl1" xml:lang="en-US" id="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl1">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl1" xlink:title="label: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" id="us-gaap_FairValueInputsLevel3Member_lbl">Level 3</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xlink:title="label: FairValueInputsLevel3Member to us-gaap_FairValueInputsLevel3Member_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FairValueInputsLevel3Member_lbl1" xml:lang="en-US" id="us-gaap_FairValueInputsLevel3Member_lbl1">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl1" xlink:title="label: FairValueInputsLevel3Member to us-gaap_FairValueInputsLevel3Member_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US" id="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl">U.S. Federal</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:title="label: FederalIncomeTaxExpenseBenefitContinuingOperations to us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl1" xml:lang="en-US" id="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl1">Federal Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl1" xlink:title="label: FederalIncomeTaxExpenseBenefitContinuingOperations to us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:title="FinanceLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl">Finance Minimum Lease Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: FinanceLeaseLiabilitiesPaymentsDueAbstract to us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl1" xml:lang="en-US" id="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl1">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl1" xlink:title="label: FinanceLeaseLiabilitiesPaymentsDueAbstract to us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="FinancialInstrumentAxis" xlink:title="FinancialInstrumentAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US" id="us-gaap_FinancialInstrumentAxis_lbl">Financial Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl" xlink:title="label: FinancialInstrumentAxis to us-gaap_FinancialInstrumentAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FinancialInstrumentAxis_lbl1" xml:lang="en-US" id="us-gaap_FinancialInstrumentAxis_lbl1">Financial Instrument [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl1" xlink:title="label: FinancialInstrumentAxis to us-gaap_FinancialInstrumentAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl">Furniture and fixtures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_FurnitureAndFixturesMember_lbl1" xml:lang="en-US" id="us-gaap_FurnitureAndFixturesMember_lbl1">Furniture and Fixtures [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl1" xlink:title="label: FurnitureAndFixturesMember to us-gaap_FurnitureAndFixturesMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember_lbl">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:title="label: GeneralAndAdministrativeExpenseMember to us-gaap_GeneralAndAdministrativeExpenseMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GeneralAndAdministrativeExpenseMember_lbl1" xml:lang="en-US" id="us-gaap_GeneralAndAdministrativeExpenseMember_lbl1">General and Administrative Expense [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl1" xlink:title="label: GeneralAndAdministrativeExpenseMember to us-gaap_GeneralAndAdministrativeExpenseMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrantsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_GrantsReceivable_lbl" xml:lang="en-US" id="us-gaap_GrantsReceivable_lbl">Grants awarded</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl" xlink:title="label: GrantsReceivable to us-gaap_GrantsReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrantsReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_GrantsReceivable_lbl1" xml:lang="en-US" id="us-gaap_GrantsReceivable_lbl1">Grants awarded</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl1" xlink:title="label: GrantsReceivable to us-gaap_GrantsReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_GrantsReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_GrantsReceivable_lbl2" xml:lang="en-US" id="us-gaap_GrantsReceivable_lbl2">Grants Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrantsReceivable" xlink:to="us-gaap_GrantsReceivable_lbl2" xlink:title="label: GrantsReceivable to us-gaap_GrantsReceivable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl">Net loss before benefit from income taxes and noncontrolling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1">Pre-tax book income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl2" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl2">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl2" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationDomain_lbl">Income Statement Location [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xlink:title="label: IncomeStatementLocationDomain to us-gaap_IncomeStatementLocationDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeStatementLocationDomain_lbl1" xml:lang="en-US" id="us-gaap_IncomeStatementLocationDomain_lbl1">Total share-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl1" xlink:title="label: IncomeStatementLocationDomain to us-gaap_IncomeStatementLocationDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureAbstract_lbl">Income Tax Disclosure [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:title="label: IncomeTaxDisclosureAbstract to us-gaap_IncomeTaxDisclosureAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="IncomeTaxAuthorityNameDomain" xlink:title="IncomeTaxAuthorityNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityNameDomain_lbl">Income Tax Authority, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:title="label: IncomeTaxAuthorityNameDomain to us-gaap_IncomeTaxAuthorityNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityNameDomain_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityNameDomain_lbl1">Income Tax Authority, Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl1" xlink:title="label: IncomeTaxAuthorityNameDomain to us-gaap_IncomeTaxAuthorityNameDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementLocationAxis_lbl">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:title="label: IncomeStatementLocationAxis to us-gaap_IncomeStatementLocationAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementLocationAxis_lbl1" xml:lang="en-US" id="us-gaap_IncomeStatementLocationAxis_lbl1">Income Statement Location [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl1" xlink:title="label: IncomeStatementLocationAxis to us-gaap_IncomeStatementLocationAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityAxis_lbl">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:title="label: IncomeTaxAuthorityAxis to us-gaap_IncomeTaxAuthorityAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityAxis_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityAxis_lbl1">Income Tax Authority [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl1" xlink:title="label: IncomeTaxAuthorityAxis to us-gaap_IncomeTaxAuthorityAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="IncomeTaxAuthorityNameAxis" xlink:title="IncomeTaxAuthorityNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityNameAxis_lbl">Income Tax Authority, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:title="label: IncomeTaxAuthorityNameAxis to us-gaap_IncomeTaxAuthorityNameAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityNameAxis_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityNameAxis_lbl1">Income Tax Authority, Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl1" xlink:title="label: IncomeTaxAuthorityNameAxis to us-gaap_IncomeTaxAuthorityNameAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl">Pre-tax book income - United States</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl1">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic to us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeStatementAbstract_lbl">Income Statement [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:title="label: IncomeStatementAbstract to us-gaap_IncomeStatementAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityDomain_lbl">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:title="label: IncomeTaxAuthorityDomain to us-gaap_IncomeTaxAuthorityDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxAuthorityDomain_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxAuthorityDomain_lbl1">Income Tax Authority [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl1" xlink:title="label: IncomeTaxAuthorityDomain to us-gaap_IncomeTaxAuthorityDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxDisclosureTextBlock_lbl1">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl1" xlink:title="label: IncomeTaxDisclosureTextBlock to us-gaap_IncomeTaxDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl">U.S. Federal benefit at statutory rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" xlink:title="label: IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate to us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl">Total</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl1">Income Tax Expense (Benefit), Continuing Operations, by Jurisdiction [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl1" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl">Benefit from income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl1">Tax provision (benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefit_lbl2" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefit_lbl2">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl2" xlink:title="label: IncomeTaxExpenseBenefit to us-gaap_IncomeTaxExpenseBenefit_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" xlink:title="label: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl">Valuation allowance for deferred tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:title="label: IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance to us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xlink:title="label: IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance to us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="IncomeTaxReconciliationOtherAdjustments" xlink:title="IncomeTaxReconciliationOtherAdjustments" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl">Other true ups</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:title="label: IncomeTaxReconciliationOtherAdjustments to us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl1">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl1" xlink:title="label: IncomeTaxReconciliationOtherAdjustments to us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:title="IncomeTaxReconciliationPriorYearIncomeTaxes" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl">Return to actual</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" xlink:title="label: IncomeTaxReconciliationPriorYearIncomeTaxes to us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl1">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl1" xlink:title="label: IncomeTaxReconciliationPriorYearIncomeTaxes to us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl">Permanent non deductible expenses for U.S. taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" xlink:title="label: IncomeTaxReconciliationNondeductibleExpense to us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxReconciliationNondeductibleExpense" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" xlink:title="label: IncomeTaxReconciliationNondeductibleExpense to us-gaap_IncomeTaxReconciliationNondeductibleExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="IncomeTaxesPaid" xlink:title="IncomeTaxesPaid" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US" id="us-gaap_IncomeTaxesPaid_lbl">Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:title="label: IncomeTaxesPaid to us-gaap_IncomeTaxesPaid_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaid_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeTaxesPaid_lbl1" xml:lang="en-US" id="us-gaap_IncomeTaxesPaid_lbl1">Income Taxes Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl1" xlink:title="label: IncomeTaxesPaid to us-gaap_IncomeTaxesPaid_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:label="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:title="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl">Less - net income attributable to noncontrolling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:to="us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl" xlink:title="label: IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity to us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl1" xml:lang="en-US" id="us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl1">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:to="us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl1" xlink:title="label: IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity to us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl">Changes in operating assets and liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1">Increase (Decrease) in Other Operating Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl">Prepaid and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" xlink:title="label: IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets to us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl1" xml:lang="en-US" id="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl1">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl1" xlink:title="label: IncreaseDecreaseInStockholdersEquityRollForward to us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_InterestPaidNet_lbl" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl">Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InterestPaidNet_lbl1" xml:lang="en-US" id="us-gaap_InterestPaidNet_lbl1">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl1" xlink:title="label: InterestPaidNet to us-gaap_InterestPaidNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="InvestmentIncomeNet" xlink:title="InvestmentIncomeNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US" id="us-gaap_InvestmentIncomeNet_lbl">Investment income, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:title="label: InvestmentIncomeNet to us-gaap_InvestmentIncomeNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentIncomeNet_lbl1" xml:lang="en-US" id="us-gaap_InvestmentIncomeNet_lbl1">Investment Income, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl1" xlink:title="label: InvestmentIncomeNet to us-gaap_InvestmentIncomeNet_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:title="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl">Investments Classified by Contractual Maturity Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:title="label: InvestmentsClassifiedByContractualMaturityDateTableTextBlock to us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl1">Schedule of Available-for-Sale Securities by Contractual Maturity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl1" xlink:title="label: InvestmentsClassifiedByContractualMaturityDateTableTextBlock to us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl2" xml:lang="en-US" id="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl2">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl2" xlink:title="label: InvestmentsClassifiedByContractualMaturityDateTableTextBlock to us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="InvestmentsFairValueDisclosure" xlink:title="InvestmentsFairValueDisclosure" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US" id="us-gaap_InvestmentsFairValueDisclosure_lbl">Marketable securities - available for sale</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl" xlink:title="label: InvestmentsFairValueDisclosure to us-gaap_InvestmentsFairValueDisclosure_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsFairValueDisclosure_lbl1" xml:lang="en-US" id="us-gaap_InvestmentsFairValueDisclosure_lbl1">Investments, Fair Value Disclosure</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl1" xlink:title="label: InvestmentsFairValueDisclosure to us-gaap_InvestmentsFairValueDisclosure_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US" id="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:title="label: InvestmentsDebtAndEquitySecuritiesAbstract to us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US" id="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl">Share-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:title="label: IssuanceOfStockAndWarrantsForServicesOrClaims to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl1" xml:lang="en-US" id="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl1">Equity-based compensation expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl1" xlink:title="label: IssuanceOfStockAndWarrantsForServicesOrClaims to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl2" xml:lang="en-US" id="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl2">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl2" xlink:title="label: IssuanceOfStockAndWarrantsForServicesOrClaims to us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl">Operating Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeasesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeasesTextBlock_lbl1">Lessee, Operating Leases [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl1" xlink:title="label: LesseeOperatingLeasesTextBlock to us-gaap_LesseeOperatingLeasesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl2" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl2">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl2" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl">Total lease payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDue to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl">Less: Amounts representing interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityUndiscountedExcessAmount to us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl1">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearFour to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl">2022</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear to us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl">2025</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl1">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl2" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl2">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl2" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearThree to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl">Schedule of Future Minimum Lease Payments Under Lease Agreements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl1">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityMaturityTableTextBlock to us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl">2024</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1">2023</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl2" xml:lang="en-US" id="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl2">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl2" xlink:title="label: LesseeOperatingLeaseLiabilityPaymentsDueYearTwo to us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl">Leasehold improvements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeaseholdImprovementsMember_lbl1" xml:lang="en-US" id="us-gaap_LeaseholdImprovementsMember_lbl1">Leasehold Improvements [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl1" xlink:title="label: LeaseholdImprovementsMember to us-gaap_LeaseholdImprovementsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LeasesAbstract_lbl" xml:lang="en-US" id="us-gaap_LeasesAbstract_lbl">Leases [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:title="label: LeasesAbstract to us-gaap_LeasesAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_Liabilities_lbl" xml:lang="en-US" id="us-gaap_Liabilities_lbl">Total liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_Liabilities_lbl1" xml:lang="en-US" id="us-gaap_Liabilities_lbl1">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Liabilities" xlink:to="us-gaap_Liabilities_lbl1" xlink:title="label: Liabilities to us-gaap_Liabilities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="LiabilitiesAbstract" xlink:title="LiabilitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAbstract_lbl">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:title="label: LiabilitiesAbstract to us-gaap_LiabilitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAbstract_lbl1">Liabilities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl1" xlink:title="label: LiabilitiesAbstract to us-gaap_LiabilitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1">LIABILITIES, NON-CONTROLLING INTERESTS AND EQUITY</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl2" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl2">Liabilities and Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl2" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl">Total liabilities, non-controlling interests and stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesAndStockholdersEquity_lbl1">Liabilities and Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl1" xlink:title="label: LiabilitiesAndStockholdersEquity to us-gaap_LiabilitiesAndStockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrent_lbl1">Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl1" xlink:title="label: LiabilitiesCurrent to us-gaap_LiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl">Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_LiabilitiesCurrentAbstract_lbl1" xml:lang="en-US" id="us-gaap_LiabilitiesCurrentAbstract_lbl1">Liabilities, Current [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl1" xlink:title="label: LiabilitiesCurrentAbstract to us-gaap_LiabilitiesCurrentAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="MarketableSecuritiesTextBlock" xlink:title="MarketableSecuritiesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MarketableSecuritiesTextBlock_lbl" xml:lang="en-US" id="us-gaap_MarketableSecuritiesTextBlock_lbl">Schedule of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl" xlink:title="label: MarketableSecuritiesTextBlock to us-gaap_MarketableSecuritiesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MarketableSecuritiesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_MarketableSecuritiesTextBlock_lbl1">Marketable Securities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesTextBlock" xlink:to="us-gaap_MarketableSecuritiesTextBlock_lbl1" xlink:title="label: MarketableSecuritiesTextBlock to us-gaap_MarketableSecuritiesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="MarketableSecuritiesPolicy" xlink:title="MarketableSecuritiesPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US" id="us-gaap_MarketableSecuritiesPolicy_lbl">Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:title="label: MarketableSecuritiesPolicy to us-gaap_MarketableSecuritiesPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MarketableSecuritiesPolicy_lbl1" xml:lang="en-US" id="us-gaap_MarketableSecuritiesPolicy_lbl1">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl1" xlink:title="label: MarketableSecuritiesPolicy to us-gaap_MarketableSecuritiesPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="MarketableSecurities" xlink:title="MarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MarketableSecurities_lbl" xml:lang="en-US" id="us-gaap_MarketableSecurities_lbl">Marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl" xlink:title="label: MarketableSecurities to us-gaap_MarketableSecurities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MarketableSecurities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MarketableSecurities_lbl1" xml:lang="en-US" id="us-gaap_MarketableSecurities_lbl1">Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecurities" xlink:to="us-gaap_MarketableSecurities_lbl1" xlink:title="label: MarketableSecurities to us-gaap_MarketableSecurities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MinorityInterest_lbl" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl">Non-controlling interests</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MinorityInterest_lbl1" xml:lang="en-US" id="us-gaap_MinorityInterest_lbl1">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl1" xlink:title="label: MinorityInterest to us-gaap_MinorityInterest_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="MoneyMarketFundsMember" xlink:title="MoneyMarketFundsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_MoneyMarketFundsMember_lbl" xml:lang="en-US" id="us-gaap_MoneyMarketFundsMember_lbl">Money market funds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl" xlink:title="label: MoneyMarketFundsMember to us-gaap_MoneyMarketFundsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_MoneyMarketFundsMember_lbl1" xml:lang="en-US" id="us-gaap_MoneyMarketFundsMember_lbl1">Money Market Funds [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl1" xlink:title="label: MoneyMarketFundsMember to us-gaap_MoneyMarketFundsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:title="NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl">Schedule of Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" xlink:title="label: NonvestedRestrictedStockSharesActivityTableTextBlock to us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl1">Schedule of Restricted Stock Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl1" xlink:title="label: NonvestedRestrictedStockSharesActivityTableTextBlock to us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl2" xml:lang="en-US" id="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl2">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl2" xlink:title="label: NonvestedRestrictedStockSharesActivityTableTextBlock to us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl">Net cash (used in) provided by financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivities to us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl">Cash flows from financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl">Net cash used in operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivities to us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl">Cash flows from investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl">Cash flows from operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl">Net cash used in investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xml:lang="en-US" id="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" xlink:title="label: NetCashProvidedByUsedInInvestingActivities to us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl">Net loss attributable to Caladrius Biosciences, Inc. common stockholders</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NetIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_NetIncomeLoss_lbl1">Net Income (Loss) Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl1" xlink:title="label: NetIncomeLoss to us-gaap_NetIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl">New Accounting Pronouncements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" xlink:title="label: NewAccountingPronouncementsPolicyPolicyTextBlock to us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="NewJerseyDivisionOfTaxationMember" xlink:title="NewJerseyDivisionOfTaxationMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewJerseyDivisionOfTaxationMember_lbl" xml:lang="en-US" id="us-gaap_NewJerseyDivisionOfTaxationMember_lbl">New Jersey</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewJerseyDivisionOfTaxationMember" xlink:to="us-gaap_NewJerseyDivisionOfTaxationMember_lbl" xlink:title="label: NewJerseyDivisionOfTaxationMember to us-gaap_NewJerseyDivisionOfTaxationMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewJerseyDivisionOfTaxationMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewJerseyDivisionOfTaxationMember_lbl1" xml:lang="en-US" id="us-gaap_NewJerseyDivisionOfTaxationMember_lbl1">New Jersey Division of Taxation [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewJerseyDivisionOfTaxationMember" xlink:to="us-gaap_NewJerseyDivisionOfTaxationMember_lbl1" xlink:title="label: NewJerseyDivisionOfTaxationMember to us-gaap_NewJerseyDivisionOfTaxationMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:label="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="NewYorkStateDivisionOfTaxationAndFinanceMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl" xml:lang="en-US" id="us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl">New York</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:to="us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl" xlink:title="label: NewYorkStateDivisionOfTaxationAndFinanceMember to us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl1" xml:lang="en-US" id="us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl1">New York State Division of Taxation and Finance [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:to="us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl1" xlink:title="label: NewYorkStateDivisionOfTaxationAndFinanceMember to us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl">Total other (expense) income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpense_lbl1">Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl1" xlink:title="label: NonoperatingIncomeExpense to us-gaap_NonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="NonoperatingIncomeExpenseAbstract" xlink:title="NonoperatingIncomeExpenseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpenseAbstract_lbl">Other income (expense):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:title="label: NonoperatingIncomeExpenseAbstract to us-gaap_NonoperatingIncomeExpenseAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" xml:lang="en-US" id="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" xlink:title="label: NonoperatingIncomeExpenseAbstract to us-gaap_NonoperatingIncomeExpenseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl">Non- Controlling Interest in Subsidiary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_NoncontrollingInterestMember_lbl1" xml:lang="en-US" id="us-gaap_NoncontrollingInterestMember_lbl1">Noncontrolling Interest [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl1" xlink:title="label: NoncontrollingInterestMember to us-gaap_NoncontrollingInterestMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl">Operating lease liabilities, current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl1">Operating lease liabilities - current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrent_lbl2">Operating Lease, Liability, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl2" xlink:title="label: OperatingLeaseLiabilityCurrent to us-gaap_OperatingLeaseLiabilityCurrent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl">Weighted average discount rate for operating leases (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl1">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl1" xlink:title="label: OperatingLeaseWeightedAverageDiscountRatePercent to us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl">Operating lease liabilities, noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1">Operating Lease, Liability, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xlink:title="label: OperatingLeaseLiabilityNoncurrent to us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl">Future Minimum Lease Payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl1">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl1" xlink:title="label: OperatingLeaseLiabilitiesPaymentsDueAbstract to us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl">Operating lease liabilities, noncurrent, balance sheet line item</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:title="label: OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList to us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl1">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl1" xlink:title="label: OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList to us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl">Right-of-use assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAsset_lbl1">Operating Lease, Right-of-Use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl1" xlink:title="label: OperatingLeaseRightOfUseAsset to us-gaap_OperatingLeaseRightOfUseAsset_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl">Weighted average remaining lease term for operating leases (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl1">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl1" xlink:title="label: OperatingLeaseWeightedAverageRemainingLeaseTerm1 to us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl">Present value of lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingLeaseLiability_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl1">Operating lease liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl1" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiability_lbl2" xml:lang="en-US" id="us-gaap_OperatingLeaseLiability_lbl2">Operating Lease, Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl2" xlink:title="label: OperatingLeaseLiability to us-gaap_OperatingLeaseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl">Operating lease liabilities, current, balance sheet line item</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" xlink:title="label: OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList to us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl1">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl1" xlink:title="label: OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList to us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityAbstract_lbl">Operating Lease Liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:title="label: OperatingLeaseLiabilityAbstract to us-gaap_OperatingLeaseLiabilityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseLiabilityAbstract_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseLiabilityAbstract_lbl1">Operating Lease, Liability [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl1" xlink:title="label: OperatingLeaseLiabilityAbstract to us-gaap_OperatingLeaseLiabilityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl">Right-of-use assets, balance sheet line item</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList to us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl1" xml:lang="en-US" id="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl1">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList to us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl">Operating Expenses:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpensesAbstract_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpensesAbstract_lbl1">Operating Expenses [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl1" xlink:title="label: OperatingExpensesAbstract to us-gaap_OperatingExpensesAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingExpenses_lbl" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl">Total operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingExpenses_lbl1" xml:lang="en-US" id="us-gaap_OperatingExpenses_lbl1">Operating Expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl1" xlink:title="label: OperatingExpenses to us-gaap_OperatingExpenses_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl">Operating loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingIncomeLoss_lbl1" xml:lang="en-US" id="us-gaap_OperatingIncomeLoss_lbl1">Operating Income (Loss)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl1" xlink:title="label: OperatingIncomeLoss to us-gaap_OperatingIncomeLoss_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsLineItems_lbl">Income Taxes [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:title="label: OperatingLossCarryforwardsLineItems to us-gaap_OperatingLossCarryforwardsLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLossCarryforwardsLineItems_lbl1" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsLineItems_lbl1">Operating Loss Carryforwards [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl1" xlink:title="label: OperatingLossCarryforwardsLineItems to us-gaap_OperatingLossCarryforwardsLineItems_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwardsLineItems_lbl2" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsLineItems_lbl2">Operating Loss Carryforwards [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl2" xlink:title="label: OperatingLossCarryforwardsLineItems to us-gaap_OperatingLossCarryforwardsLineItems_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLossCarryforwardsTable_lbl" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsTable_lbl">Operating Loss Carryforwards [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:title="label: OperatingLossCarryforwardsTable to us-gaap_OperatingLossCarryforwardsTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwardsTable_lbl1" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwardsTable_lbl1">Operating Loss Carryforwards [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl1" xlink:title="label: OperatingLossCarryforwardsTable to us-gaap_OperatingLossCarryforwardsTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwards_lbl">Net operating loss carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:title="label: OperatingLossCarryforwards to us-gaap_OperatingLossCarryforwards_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OperatingLossCarryforwards_lbl1" xml:lang="en-US" id="us-gaap_OperatingLossCarryforwards_lbl1">Operating Loss Carryforwards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl1" xlink:title="label: OperatingLossCarryforwards to us-gaap_OperatingLossCarryforwards_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" id="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:title="label: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl">Total other comprehensive loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:title="label: OtherComprehensiveIncomeLossNetOfTax to us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl1" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl1">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl1" xlink:title="label: OtherComprehensiveIncomeLossNetOfTax to us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl">Unrealized loss on marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:title="label: OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax to us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl1" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl1">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl1" xlink:title="label: OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax to us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:title="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl">Other comprehensive loss:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" xlink:title="label: OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract to us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl1" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl1">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl1" xlink:title="label: OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract to us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAssetsNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAssetsNoncurrent_lbl1">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl1" xlink:title="label: OtherAssetsNoncurrent to us-gaap_OtherAssetsNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl">Available for sale securities - net unrealized loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:title="label: OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax to us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl1" xml:lang="en-US" id="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl1">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl1" xlink:title="label: OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax to us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl">Other long-term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherLiabilitiesNoncurrent_lbl1">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl1" xlink:title="label: OtherLiabilitiesNoncurrent to us-gaap_OtherLiabilitiesNoncurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl">Other expense, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:title="label: OtherNonoperatingIncomeExpense to us-gaap_OtherNonoperatingIncomeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xml:lang="en-US" id="us-gaap_OtherNonoperatingIncomeExpense_lbl1">Other Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl1" xlink:title="label: OtherNonoperatingIncomeExpense to us-gaap_OtherNonoperatingIncomeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl">Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xml:lang="en-US" id="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1">Other Accrued Liabilities, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" xlink:title="label: OtherAccruedLiabilitiesCurrent to us-gaap_OtherAccruedLiabilitiesCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ParentMember_lbl" xml:lang="en-US" id="us-gaap_ParentMember_lbl">Total Caladrius Biosciences, Inc. Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ParentMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ParentMember_lbl1" xml:lang="en-US" id="us-gaap_ParentMember_lbl1">Parent [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ParentMember" xlink:to="us-gaap_ParentMember_lbl1" xlink:title="label: ParentMember to us-gaap_ParentMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl">Tax withholding payments on net share settlement equity awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" xlink:title="label: PaymentsRelatedToTaxWithholdingForShareBasedCompensation to us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="PaymentsToAcquireMarketableSecurities" xlink:title="PaymentsToAcquireMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquireMarketableSecurities_lbl">Purchase of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:title="label: PaymentsToAcquireMarketableSecurities to us-gaap_PaymentsToAcquireMarketableSecurities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquireMarketableSecurities_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquireMarketableSecurities_lbl1">Purchase of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl1" xlink:title="label: PaymentsToAcquireMarketableSecurities to us-gaap_PaymentsToAcquireMarketableSecurities_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquireMarketableSecurities_lbl2" xml:lang="en-US" id="us-gaap_PaymentsToAcquireMarketableSecurities_lbl2">Payments to Acquire Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl2" xlink:title="label: PaymentsToAcquireMarketableSecurities to us-gaap_PaymentsToAcquireMarketableSecurities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl">Purchases of property and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xml:lang="en-US" id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" xlink:title="label: PaymentsToAcquirePropertyPlantAndEquipment to us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_PlanNameDomain_lbl">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl" xlink:title="label: PlanNameDomain to us-gaap_PlanNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameDomain_lbl1" xml:lang="en-US" id="us-gaap_PlanNameDomain_lbl1">Plan Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl1" xlink:title="label: PlanNameDomain to us-gaap_PlanNameDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PlanNameAxis_lbl" xml:lang="en-US" id="us-gaap_PlanNameAxis_lbl">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:title="label: PlanNameAxis to us-gaap_PlanNameAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PlanNameAxis_lbl1" xml:lang="en-US" id="us-gaap_PlanNameAxis_lbl1">Plan Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl1" xlink:title="label: PlanNameAxis to us-gaap_PlanNameAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockMember_lbl" xml:lang="en-US" id="us-gaap_PreferredStockMember_lbl">Series B Convertible Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:title="label: PreferredStockMember to us-gaap_PreferredStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockMember_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockMember_lbl1">Preferred Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl1" xlink:title="label: PreferredStockMember to us-gaap_PreferredStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl">Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at March 31, 2022 and December 31, 2021, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_PreferredStockValue_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl1">Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at December 31, 2021 and December 31, 2020, respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl1" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockValue_lbl2" xml:lang="en-US" id="us-gaap_PreferredStockValue_lbl2">Preferred Stock, Value, Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl2" xlink:title="label: PreferredStockValue to us-gaap_PreferredStockValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl">Preferred stock, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl1">Preferred stock, shares authorized (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl1" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesAuthorized_lbl2" xml:lang="en-US" id="us-gaap_PreferredStockSharesAuthorized_lbl2">Preferred Stock, Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl2" xlink:title="label: PreferredStockSharesAuthorized to us-gaap_PreferredStockSharesAuthorized_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl">Preferred stock, par value (in usd per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1">Preferred stock, par value (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockParOrStatedValuePerShare_lbl2" xml:lang="en-US" id="us-gaap_PreferredStockParOrStatedValuePerShare_lbl2">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl2" xlink:title="label: PreferredStockParOrStatedValuePerShare to us-gaap_PreferredStockParOrStatedValuePerShare_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl">Preferred stock, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl1">Preferred stock, shares outstanding (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl1" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_PreferredStockSharesOutstanding_lbl2">Preferred Stock, Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl2" xlink:title="label: PreferredStockSharesOutstanding to us-gaap_PreferredStockSharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl">Preferred stock, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_PreferredStockSharesIssued_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl1">Preferred stock, shares issued (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl1" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockSharesIssued_lbl2" xml:lang="en-US" id="us-gaap_PreferredStockSharesIssued_lbl2">Preferred Stock, Shares Issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl2" xlink:title="label: PreferredStockSharesIssued to us-gaap_PreferredStockSharesIssued_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl">Preferred Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:title="label: PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract to us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1">Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1" xlink:title="label: PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract to us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl">Prepaid and other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xml:lang="en-US" id="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1">Prepaid Expense and Other Assets, Current</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" xlink:title="label: PrepaidExpenseAndOtherAssetsCurrent to us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromWarrantExercises_lbl">Net proceeds from warrant exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:title="label: ProceedsFromWarrantExercises to us-gaap_ProceedsFromWarrantExercises_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromWarrantExercises_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromWarrantExercises_lbl1">Proceeds from Warrant Exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl1" xlink:title="label: ProceedsFromWarrantExercises to us-gaap_ProceedsFromWarrantExercises_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl">Net proceeds from issuance of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1">Net proceeds from issuance of capital stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2" xml:lang="en-US" id="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2">Proceeds from Issuance of Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2" xlink:title="label: ProceedsFromIssuanceOfCommonStock to us-gaap_ProceedsFromIssuanceOfCommonStock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl">Sale of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:title="label: ProceedsFromSaleAndMaturityOfMarketableSecurities to us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl1">Sales of marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl1" xlink:title="label: ProceedsFromSaleAndMaturityOfMarketableSecurities to us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl2" xml:lang="en-US" id="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl2">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl2" xlink:title="label: ProceedsFromSaleAndMaturityOfMarketableSecurities to us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_ProceedsFromStockOptionsExercised_lbl">Proceeds from exercise of options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:title="label: ProceedsFromStockOptionsExercised to us-gaap_ProceedsFromStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_ProceedsFromStockOptionsExercised_lbl1">Proceeds from exercise of options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xlink:title="label: ProceedsFromStockOptionsExercised to us-gaap_ProceedsFromStockOptionsExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProceedsFromStockOptionsExercised_lbl2" xml:lang="en-US" id="us-gaap_ProceedsFromStockOptionsExercised_lbl2">Proceeds from Stock Options Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl2" xlink:title="label: ProceedsFromStockOptionsExercised to us-gaap_ProceedsFromStockOptionsExercised_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProfitLoss_lbl" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_ProfitLoss_lbl1" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl1">Net loss</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl1" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProfitLoss_lbl2" xml:lang="en-US" id="us-gaap_ProfitLoss_lbl2">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl2" xlink:title="label: ProfitLoss to us-gaap_ProfitLoss_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProjectMember" xlink:label="ProjectMember" xlink:title="ProjectMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProjectMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ProjectMember_lbl" xml:lang="en-US" id="us-gaap_ProjectMember_lbl">Project [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProjectMember" xlink:to="us-gaap_ProjectMember_lbl" xlink:title="label: ProjectMember to us-gaap_ProjectMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ProjectMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ProjectMember_lbl1" xml:lang="en-US" id="us-gaap_ProjectMember_lbl1">Project [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProjectMember" xlink:to="us-gaap_ProjectMember_lbl1" xlink:title="label: ProjectMember to us-gaap_ProjectMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentLineItems_lbl">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:title="label: PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentLineItems_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentLineItems_lbl1">Property, Plant and Equipment [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl1" xlink:title="label: PropertyPlantAndEquipmentLineItems to us-gaap_PropertyPlantAndEquipmentLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:title="label: PropertyPlantAndEquipmentDisclosureTextBlock to us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1" xlink:title="label: PropertyPlantAndEquipmentDisclosureTextBlock to us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl">Useful life (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1">Property, Plant and Equipment, Useful Life</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" xlink:title="label: PropertyPlantAndEquipmentUsefulLife to us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentAbstract_lbl">Property, Plant and Equipment [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:title="label: PropertyPlantAndEquipmentAbstract to us-gaap_PropertyPlantAndEquipmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl">Schedule of Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:title="label: PropertyPlantAndEquipmentTextBlock to us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" xlink:title="label: PropertyPlantAndEquipmentTextBlock to us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl">Long-Lived Tangible Asset [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1">Long-Lived Tangible Asset [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1" xlink:title="label: PropertyPlantAndEquipmentByTypeAxis to us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentImpairment" xlink:label="PropertyPlantAndEquipmentImpairment" xlink:title="PropertyPlantAndEquipmentImpairment" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentImpairment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentImpairment_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentImpairment_lbl">Long-lived Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentImpairment" xlink:to="us-gaap_PropertyPlantAndEquipmentImpairment_lbl" xlink:title="label: PropertyPlantAndEquipmentImpairment to us-gaap_PropertyPlantAndEquipmentImpairment_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentImpairment_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentImpairment_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentImpairment_lbl1">Property, Plant and Equipment, Impairment [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentImpairment" xlink:to="us-gaap_PropertyPlantAndEquipmentImpairment_lbl1" xlink:title="label: PropertyPlantAndEquipmentImpairment to us-gaap_PropertyPlantAndEquipmentImpairment_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl">Long-Lived Tangible Asset [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1">Long-Lived Tangible Asset [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1" xlink:title="label: PropertyPlantAndEquipmentTypeDomain to us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl1">Property and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentNet_lbl2">Property, Plant and Equipment, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl2" xlink:title="label: PropertyPlantAndEquipmentNet to us-gaap_PropertyPlantAndEquipmentNet_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl">Property and Equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:title="label: PropertyPlantAndEquipmentPolicyTextBlock to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" xlink:title="label: PropertyPlantAndEquipmentPolicyTextBlock to us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl">Property and equipment, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xml:lang="en-US" id="us-gaap_PropertyPlantAndEquipmentGross_lbl1">Property, Plant and Equipment, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl1" xlink:title="label: PropertyPlantAndEquipmentGross to us-gaap_PropertyPlantAndEquipmentGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="ResearchAndDevelopmentAbstract" xlink:title="ResearchAndDevelopmentAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentAbstract_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentAbstract_lbl">Research and Development [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl" xlink:title="label: ResearchAndDevelopmentAbstract to us-gaap_ResearchAndDevelopmentAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl">Research and Development Costs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:title="label: ResearchAndDevelopmentExpensePolicy to us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" xlink:title="label: ResearchAndDevelopmentExpensePolicy to us-gaap_ResearchAndDevelopmentExpensePolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl" xlink:title="label: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl1">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl1" xlink:title="label: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpense_lbl">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:title="label: ResearchAndDevelopmentExpense to us-gaap_ResearchAndDevelopmentExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpense_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpense_lbl1">Research and Development Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl1" xlink:title="label: ResearchAndDevelopmentExpense to us-gaap_ResearchAndDevelopmentExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:title="ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl">Research Funding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" xlink:title="label: ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock to us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl1">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl1" xlink:title="label: ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock to us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember_lbl">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:title="label: ResearchAndDevelopmentExpenseMember to us-gaap_ResearchAndDevelopmentExpenseMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentExpenseMember_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentExpenseMember_lbl1">Research and Development Expense [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl1" xlink:title="label: ResearchAndDevelopmentExpenseMember to us-gaap_ResearchAndDevelopmentExpenseMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:label="ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:title="ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl">Progress payment amortized to related research and development over estimated award period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:to="us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl" xlink:title="label: ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred to us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl1" xml:lang="en-US" id="us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl1">Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:to="us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl1" xlink:title="label: ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred to us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl">Restricted Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockMember_lbl1" xml:lang="en-US" id="us-gaap_RestrictedStockMember_lbl1">Restricted Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl1" xlink:title="label: RestrictedStockMember to us-gaap_RestrictedStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl">Restricted Stock Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xml:lang="en-US" id="us-gaap_RestrictedStockUnitsRSUMember_lbl1">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xlink:title="label: RestrictedStockUnitsRSUMember to us-gaap_RestrictedStockUnitsRSUMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl">Accumulated Deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsMember_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsMember_lbl1">Retained Earnings [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl1" xlink:title="label: RetainedEarningsMember to us-gaap_RetainedEarningsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl">Accumulated deficit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US" id="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1">Retained Earnings (Accumulated Deficit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xlink:title="label: RetainedEarningsAccumulatedDeficit to us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl">Options vested or expected to vest, weighted average remaining contractual term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl1">Options, Vested and expected to vest, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl2" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl2" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl">Expected term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl">Expiration period (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl">Options outstanding, weighted average remaining contractual term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1">Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl2" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl2" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl">Options exercisable, weighted average remaining contractual term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl">Total fair value of shares vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1" xml:lang="en-US" id="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1" xlink:title="label: SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 to us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="SaleOfStockPricePerShare" xlink:title="SaleOfStockPricePerShare" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US" id="us-gaap_SaleOfStockPricePerShare_lbl">Price of shares sold (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:title="label: SaleOfStockPricePerShare to us-gaap_SaleOfStockPricePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SaleOfStockPricePerShare_lbl1" xml:lang="en-US" id="us-gaap_SaleOfStockPricePerShare_lbl1">Sale of Stock, Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl1" xlink:title="label: SaleOfStockPricePerShare to us-gaap_SaleOfStockPricePerShare_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="SaleOfStockConsiderationReceivedOnTransaction" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US" id="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl">Gross price for stock transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:title="label: SaleOfStockConsiderationReceivedOnTransaction to us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl1" xml:lang="en-US" id="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl1">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl1" xlink:title="label: SaleOfStockConsiderationReceivedOnTransaction to us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US" id="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl">Number of shares sold (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:title="label: SaleOfStockNumberOfSharesIssuedInTransaction to us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xml:lang="en-US" id="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1">Number of shares sold (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" xlink:title="label: SaleOfStockNumberOfSharesIssuedInTransaction to us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl2" xml:lang="en-US" id="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl2">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl2" xlink:title="label: SaleOfStockNumberOfSharesIssuedInTransaction to us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xml:lang="en-US" id="us-gaap_SaleOfStockNameOfTransactionDomain_lbl">Sale of Stock, Name of Transaction [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:title="label: SaleOfStockNameOfTransactionDomain to us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SaleOfStockNameOfTransactionDomain_lbl1" xml:lang="en-US" id="us-gaap_SaleOfStockNameOfTransactionDomain_lbl1">Sale of Stock [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl1" xlink:title="label: SaleOfStockNameOfTransactionDomain to us-gaap_SaleOfStockNameOfTransactionDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl">Schedule of Assumptions in Calculating Fair Values of Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1">Schedule of Fair Value of Share-based Compensation Awards</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl2" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl2">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl2" xlink:title="label: ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock to us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl">Schedule of Stock Options and Warrants Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl1">Schedule of Stock Option and Warrants Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl2" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl2">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl2" xlink:title="label: ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl">Schedule of Restricted Stock Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl1">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock to us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl">Schedule of Restricted Stock Units Activity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:title="label: ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl1">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl1" xlink:title="label: ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock to us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl">Schedule of Benefit from Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:title="label: ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock to us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" xlink:title="label: ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock to us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl">Schedule of Components Deferred Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock to us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl">Schedule of Reconciliation of Effective Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" xlink:title="label: ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock to us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl">Schedule of Provision for Income Taxes Based on Loss from Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" xlink:title="label: ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock to us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl">Schedule of Available-for-sale Securities Reconciliation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock to us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl1">Schedule of Available-for-Sale Securities Reconciliation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl1" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock to us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl2" xml:lang="en-US" id="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl2">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl2" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock to us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl">Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl2" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl2">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl2" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesTable to us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl1">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl1" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesTable to us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl">Schedule of Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" xlink:title="label: ScheduleOfAccruedLiabilitiesTableTextBlock to us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl1">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl1" xlink:title="label: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesLineItems to us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl1">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl1" xlink:title="label: ScheduleOfAvailableForSaleSecuritiesLineItems to us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl1">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl1" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl">Schedule of Share-Based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1">Schedule Share-based Compensation Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl2" xml:lang="en-US" id="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl2">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl2" xlink:title="label: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock to us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:title="label: ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl1">Property, Plant and Equipment [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl1" xlink:title="label: ScheduleOfPropertyPlantAndEquipmentTable to us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" xlink:title="label: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl" xlink:title="label: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl1">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl1" xlink:title="label: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ScheduleOfStockByClassTable_lbl" xml:lang="en-US" id="us-gaap_ScheduleOfStockByClassTable_lbl">Schedule of Stock by Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:title="label: ScheduleOfStockByClassTable to us-gaap_ScheduleOfStockByClassTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ScheduleOfStockByClassTable_lbl1" xml:lang="en-US" id="us-gaap_ScheduleOfStockByClassTable_lbl1">Schedule of Stock by Class [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl1" xlink:title="label: ScheduleOfStockByClassTable to us-gaap_ScheduleOfStockByClassTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl">General and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xml:lang="en-US" id="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1">Selling, General and Administrative Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" xlink:title="label: SellingGeneralAndAdministrativeExpense to us-gaap_SellingGeneralAndAdministrativeExpense_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl">Vesting terms (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1">Vesting terms (years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl">Stock Options, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl">Granted (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl">Forfeited (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1">Options, Forfeited (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl">Risk-free interest rate - minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="ShareBasedCompensationAwardTrancheTwoMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl">Share-based award tranche two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:title="label: ShareBasedCompensationAwardTrancheTwoMember to us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl1">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl1" xlink:title="label: ShareBasedCompensationAwardTrancheTwoMember to us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl">Share-based award tranche one</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:title="label: ShareBasedCompensationAwardTrancheOneMember to us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" xlink:title="label: ShareBasedCompensationAwardTrancheOneMember to us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="ShareBasedCompensationAwardTrancheThreeMember" xlink:title="ShareBasedCompensationAwardTrancheThreeMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl">Share-based award tranche three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" xlink:title="label: ShareBasedCompensationAwardTrancheThreeMember to us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl1">Share-based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationAwardTrancheThreeMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl1" xlink:title="label: ShareBasedCompensationAwardTrancheThreeMember to us-gaap_ShareBasedCompensationAwardTrancheThreeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl">Expected volatility - maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl">Expired (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1">Options, Expired (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl">Exercised (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1">Options, Exercised (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl">Risk-free interest rate - maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl">Schedule of Fair Value of Shares Vested and Weighted Average Estimated Fair Values of Shares Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl">Expected volatility - minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl">Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1">Options, Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl">Expected dividend yield</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl">Warrants, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Weighted average estimated fair value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl">Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl">Valuation Assumptions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl">Number of shares authorized for issuance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl">Expired (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl1">Options, Expired (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl">Number of shares available for future grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl">Forfeited (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1">Options, Forfeited (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl">Options, Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl">Weighted Average volatility</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl">Stock Options, Weighted Average Contractual Term and Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl">Exercisable (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1">Options, Vested (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl">Options, outstanding, ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1">Options, outstanding, beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl">Vested or expected to vest (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1">Options, Vested and expected to vest (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl">Options, outstanding, ending balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1">Options, outstanding. beginning balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl">Options outstanding, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1">Options, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl">Weighted average estimated fair value of shares granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1">Weighted average estimated fair value of shares granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl">Exercisable (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1">Options, Vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl">Stock Options, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl">Options vested or expected to vest, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl1">Options, Vested and expected to vest, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl">Vested or expected to vest (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1">Options, Vested and expected to vest (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl">Options exercisable, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl1">Options, Vested, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl2" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl2">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl2" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl">Stock Options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl1">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl1" xlink:title="label: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl">Award Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1">Award Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" xlink:title="label: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US" id="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl">Share-Based Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:title="label: ShareBasedCompensationOptionAndIncentivePlansPolicy to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xml:lang="en-US" id="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" xlink:title="label: ShareBasedCompensationOptionAndIncentivePlansPolicy to us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_SharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl">Ending Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl1">Beginning Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SharesOutstanding_lbl2" xml:lang="en-US" id="us-gaap_SharesOutstanding_lbl2">Shares, Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl2" xlink:title="label: SharesOutstanding to us-gaap_SharesOutstanding_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl">Summary of Significant Accounting Policies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:title="label: SignificantAccountingPoliciesTextBlock to us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1">Significant Accounting Policies [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" xlink:title="label: SignificantAccountingPoliciesTextBlock to us-gaap_SignificantAccountingPoliciesTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="SoftwareAndSoftwareDevelopmentCostsMember" xlink:title="SoftwareAndSoftwareDevelopmentCostsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US" id="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl">Software</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:title="label: SoftwareAndSoftwareDevelopmentCostsMember to us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl1" xml:lang="en-US" id="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl1">Software and Software Development Costs [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl1" xlink:title="label: SoftwareAndSoftwareDevelopmentCostsMember to us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xml:lang="en-US" id="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl">State and local</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" xlink:title="label: StateAndLocalIncomeTaxExpenseBenefitContinuingOperations to us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl1" xml:lang="en-US" id="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl1">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl1" xlink:title="label: StateAndLocalIncomeTaxExpenseBenefitContinuingOperations to us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl">State</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StateAndLocalJurisdictionMember_lbl1" xml:lang="en-US" id="us-gaap_StateAndLocalJurisdictionMember_lbl1">State and Local Jurisdiction [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl1" xlink:title="label: StateAndLocalJurisdictionMember to us-gaap_StateAndLocalJurisdictionMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfFinancialPositionAbstract_lbl">Statement of Financial Position [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:title="label: StatementOfFinancialPositionAbstract to us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:title="StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl">Statement of Comprehensive Income [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:title="label: StatementOfIncomeAndComprehensiveIncomeAbstract to us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementClassOfStockAxis_lbl1" xml:lang="en-US" id="us-gaap_StatementClassOfStockAxis_lbl1">Class of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl1" xlink:title="label: StatementClassOfStockAxis to us-gaap_StatementClassOfStockAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StatementTable_lbl" xml:lang="en-US" id="us-gaap_StatementTable_lbl">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementTable_lbl1" xml:lang="en-US" id="us-gaap_StatementTable_lbl1">Statement [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementTable" xlink:to="us-gaap_StatementTable_lbl1" xlink:title="label: StatementTable to us-gaap_StatementTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StatementLineItems_lbl" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementLineItems_lbl1" xml:lang="en-US" id="us-gaap_StatementLineItems_lbl1">Statement [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl1" xlink:title="label: StatementLineItems to us-gaap_StatementLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfCashFlowsAbstract_lbl">Statement of Cash Flows [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:title="label: StatementOfCashFlowsAbstract to us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl">Statement, Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementEquityComponentsAxis_lbl1" xml:lang="en-US" id="us-gaap_StatementEquityComponentsAxis_lbl1">Equity Components [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl1" xlink:title="label: StatementEquityComponentsAxis to us-gaap_StatementEquityComponentsAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StatementOfStockholdersEquityAbstract_lbl">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:title="label: StatementOfStockholdersEquityAbstract to us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl">Proceeds from option exercises (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1">Exercised (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2">Options, Exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3" xlink:title="label: StockIssuedDuringPeriodSharesStockOptionsExercised to us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl">Net proceeds from issuance of common stock and warrants (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:title="label: StockIssuedDuringPeriodSharesNewIssues to us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1">Stock issued (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesNewIssues to us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl2">Stock Issued During Period, Shares, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesNewIssues to us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl">Number of shares issued (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1">Number of shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl2">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl">Share-based compensation (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:title="label: StockIssuedDuringPeriodSharesShareBasedCompensation to us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesShareBasedCompensation to us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl">Shares issued under ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:title="label: StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans to us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl1">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans to us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="StockIssuedDuringPeriodSharesOther" xlink:title="StockIssuedDuringPeriodSharesOther" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesOther_lbl">Shares issued upon exercise of warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:title="label: StockIssuedDuringPeriodSharesOther to us-gaap_StockIssuedDuringPeriodSharesOther_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodSharesOther_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodSharesOther_lbl1">Stock Issued During Period, Shares, Other</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesOther to us-gaap_StockIssuedDuringPeriodSharesOther_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl">Proceeds from option exercises</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:title="label: StockIssuedDuringPeriodValueStockOptionsExercised to us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1" xlink:title="label: StockIssuedDuringPeriodValueStockOptionsExercised to us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl">Net proceeds from issuances of common stock and warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1">Net proceeds from issuance of common stock and warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl2">Stock Issued During Period, Value, New Issues</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl2" xlink:title="label: StockIssuedDuringPeriodValueNewIssues to us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl">Share-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:title="label: StockIssuedDuringPeriodValueShareBasedCompensation to us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl1">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl1" xlink:title="label: StockIssuedDuringPeriodValueShareBasedCompensation to us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl">Value of shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl1" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl1">Value of shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl1" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl2" xml:lang="en-US" id="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl2">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl2" xlink:title="label: StockIssuedDuringPeriodValueRestrictedStockAwardGross to us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl">Total Caladrius Biosciences, Inc. stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquity_lbl1">Stockholders' Equity Attributable to Parent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1" xlink:title="label: StockholdersEquity to us-gaap_StockholdersEquity_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl">Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl">Total stockholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1">Ending Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2">Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl2" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xml:lang="en-US" id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl">Stockholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_StockholdersEquityAbstract_lbl1" xml:lang="en-US" id="us-gaap_StockholdersEquityAbstract_lbl1">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl1" xlink:title="label: StockholdersEquityAbstract to us-gaap_StockholdersEquityAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventMember_lbl">Subsequent event</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventMember_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventMember_lbl1">Subsequent Event [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl1" xlink:title="label: SubsequentEventMember to us-gaap_SubsequentEventMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventTypeDomain_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain_lbl">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeDomain_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventTypeDomain_lbl1">Subsequent Event Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl1" xlink:title="label: SubsequentEventTypeDomain to us-gaap_SubsequentEventTypeDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventLineItems_lbl">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:title="label: SubsequentEventLineItems to us-gaap_SubsequentEventLineItems_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventLineItems_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventLineItems_lbl1">Subsequent Event [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl1" xlink:title="label: SubsequentEventLineItems to us-gaap_SubsequentEventLineItems_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis_lbl">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTypeAxis_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventTypeAxis_lbl1">Subsequent Event Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl1" xlink:title="label: SubsequentEventTypeAxis to us-gaap_SubsequentEventTypeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsAbstract_lbl">Subsequent Events [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:title="label: SubsequentEventsAbstract to us-gaap_SubsequentEventsAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventTable_lbl">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:title="label: SubsequentEventTable to us-gaap_SubsequentEventTable_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventTable_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventTable_lbl1">Subsequent Event [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl1" xlink:title="label: SubsequentEventTable to us-gaap_SubsequentEventTable_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsequentEventsTextBlock_lbl1" xml:lang="en-US" id="us-gaap_SubsequentEventsTextBlock_lbl1">Subsequent Events [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl1" xlink:title="label: SubsequentEventsTextBlock to us-gaap_SubsequentEventsTextBlock_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="SubsidiarySaleOfStockAxis" xlink:title="SubsidiarySaleOfStockAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US" id="us-gaap_SubsidiarySaleOfStockAxis_lbl">Sale of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:title="label: SubsidiarySaleOfStockAxis to us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SubsidiarySaleOfStockAxis_lbl1" xml:lang="en-US" id="us-gaap_SubsidiarySaleOfStockAxis_lbl1">Sale of Stock [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl1" xlink:title="label: SubsidiarySaleOfStockAxis to us-gaap_SubsidiarySaleOfStockAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl">Supplemental Disclosure of Cash Flow Information:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xml:lang="en-US" id="us-gaap_SupplementalCashFlowInformationAbstract_lbl1">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl1" xlink:title="label: SupplementalCashFlowInformationAbstract to us-gaap_SupplementalCashFlowInformationAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US" id="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl">Financial Instruments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:title="label: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl1" xml:lang="en-US" id="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl1">Financial Instruments [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl1" xlink:title="label: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl">Treasury stock, at cost; 11,080 shares at March 31, 2022 and December 31, 2021</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="us-gaap_TreasuryStockValue_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl1">Treasury stock, at cost; 11,080 shares at December 31, 2021 and December 31, 2020 respectively</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl1" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl1" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockValue_lbl2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockValue_lbl2" xml:lang="en-US" id="us-gaap_TreasuryStockValue_lbl2">Treasury Stock, Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl2" xlink:title="label: TreasuryStockValue to us-gaap_TreasuryStockValue_lbl2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" xlink:label="TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" xlink:title="TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl">Treasury Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" xlink:to="us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl" xlink:title="label: TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract to us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl1">Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" xlink:to="us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl1" xlink:title="label: TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract to us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl">Treasury stock (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockShares_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockShares_lbl1">Treasury Stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl1" xlink:title="label: TreasuryStockShares to us-gaap_TreasuryStockShares_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl">Treasury Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_TreasuryStockMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_TreasuryStockMember_lbl1" xml:lang="en-US" id="us-gaap_TreasuryStockMember_lbl1">Treasury Stock [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl1" xlink:title="label: TreasuryStockMember to us-gaap_TreasuryStockMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_UseOfEstimates_lbl" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl">Use of Estimates</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_UseOfEstimates_lbl1" xml:lang="en-US" id="us-gaap_UseOfEstimates_lbl1">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl1" xlink:title="label: UseOfEstimates to us-gaap_UseOfEstimates_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:label="USStatesAndPoliticalSubdivisionsMember" xlink:title="USStatesAndPoliticalSubdivisionsMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl" xml:lang="en-US" id="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl">Municipal debt securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="USStatesAndPoliticalSubdivisionsMember" xlink:to="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl" xlink:title="label: USStatesAndPoliticalSubdivisionsMember to us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl1" xml:lang="en-US" id="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl1">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="USStatesAndPoliticalSubdivisionsMember" xlink:to="us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl1" xlink:title="label: USStatesAndPoliticalSubdivisionsMember to us-gaap_USStatesAndPoliticalSubdivisionsMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_VestingAxis_lbl" xml:lang="en-US" id="us-gaap_VestingAxis_lbl">Vesting [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingAxis" xlink:to="us-gaap_VestingAxis_lbl" xlink:title="label: VestingAxis to us-gaap_VestingAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VestingAxis_lbl1" xml:lang="en-US" id="us-gaap_VestingAxis_lbl1">Vesting [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingAxis" xlink:to="us-gaap_VestingAxis_lbl1" xlink:title="label: VestingAxis to us-gaap_VestingAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_VestingDomain_lbl" xml:lang="en-US" id="us-gaap_VestingDomain_lbl">Vesting [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingDomain" xlink:to="us-gaap_VestingDomain_lbl" xlink:title="label: VestingDomain to us-gaap_VestingDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_VestingDomain_lbl1" xml:lang="en-US" id="us-gaap_VestingDomain_lbl1">Vesting [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VestingDomain" xlink:to="us-gaap_VestingDomain_lbl1" xlink:title="label: VestingDomain to us-gaap_VestingDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantMember_lbl" xml:lang="en-US" id="us-gaap_WarrantMember_lbl">Warrants</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantMember_lbl1" xml:lang="en-US" id="us-gaap_WarrantMember_lbl1">Warrant [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantMember" xlink:to="us-gaap_WarrantMember_lbl1" xlink:title="label: WarrantMember to us-gaap_WarrantMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingTerm_lbl">Warrants expiration term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:title="label: WarrantsAndRightsOutstandingTerm to us-gaap_WarrantsAndRightsOutstandingTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WarrantsAndRightsOutstandingTerm_lbl1" xml:lang="en-US" id="us-gaap_WarrantsAndRightsOutstandingTerm_lbl1">Warrants and Rights Outstanding, Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl1" xlink:title="label: WarrantsAndRightsOutstandingTerm to us-gaap_WarrantsAndRightsOutstandingTerm_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl">Diluted shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xlink:title="label: WeightedAverageNumberOfDilutedSharesOutstanding to us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl">Basic shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xlink:title="label: WeightedAverageNumberOfSharesOutstandingBasic to us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl">Weighted average common shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xml:lang="en-US" id="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" xlink:title="label: WeightedAverageNumberOfSharesOutstandingAbstract to us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:label xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_CounterpartyNameAxis_lbl" xml:lang="en-US" id="srt_CounterpartyNameAxis_lbl">Counterparty Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl" xlink:title="label: CounterpartyNameAxis to srt_CounterpartyNameAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_CounterpartyNameAxis_lbl1" xml:lang="en-US" id="srt_CounterpartyNameAxis_lbl1">Counterparty Name [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl1" xlink:title="label: CounterpartyNameAxis to srt_CounterpartyNameAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_MaximumMember_lbl" xml:lang="en-US" id="srt_MaximumMember_lbl">Maximum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:title="label: MaximumMember to srt_MaximumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_MaximumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MaximumMember_lbl1" xml:lang="en-US" id="srt_MaximumMember_lbl1">Maximum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MaximumMember" xlink:to="srt_MaximumMember_lbl1" xlink:title="label: MaximumMember to srt_MaximumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_MinimumMember_lbl" xml:lang="en-US" id="srt_MinimumMember_lbl">Minimum</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:title="label: MinimumMember to srt_MinimumMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_MinimumMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_MinimumMember_lbl1" xml:lang="en-US" id="srt_MinimumMember_lbl1">Minimum [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MinimumMember" xlink:to="srt_MinimumMember_lbl1" xlink:title="label: MinimumMember to srt_MinimumMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_RangeMember_lbl" xml:lang="en-US" id="srt_RangeMember_lbl">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl" xlink:title="label: RangeMember to srt_RangeMember_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_RangeMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeMember_lbl1" xml:lang="en-US" id="srt_RangeMember_lbl1">Statistical Measurement [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeMember" xlink:to="srt_RangeMember_lbl1" xlink:title="label: RangeMember to srt_RangeMember_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_RangeAxis_lbl" xml:lang="en-US" id="srt_RangeAxis_lbl">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:title="label: RangeAxis to srt_RangeAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_RangeAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RangeAxis_lbl1" xml:lang="en-US" id="srt_RangeAxis_lbl1">Statistical Measurement [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RangeAxis" xlink:to="srt_RangeAxis_lbl1" xlink:title="label: RangeAxis to srt_RangeAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:label xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xml:lang="en-US" id="srt_RepurchaseAgreementCounterpartyNameDomain_lbl">Counterparty Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:title="label: RepurchaseAgreementCounterpartyNameDomain to srt_RepurchaseAgreementCounterpartyNameDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="srt_RepurchaseAgreementCounterpartyNameDomain_lbl1" xml:lang="en-US" id="srt_RepurchaseAgreementCounterpartyNameDomain_lbl1">Counterparty Name [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl1" xlink:title="label: RepurchaseAgreementCounterpartyNameDomain to srt_RepurchaseAgreementCounterpartyNameDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:label xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_LegalEntityAxis_lbl" xml:lang="en-US" id="dei_LegalEntityAxis_lbl">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:title="label: LegalEntityAxis to dei_LegalEntityAxis_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LegalEntityAxis_lbl1" xml:lang="en-US" id="dei_LegalEntityAxis_lbl1">Legal Entity [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl1" xlink:title="label: LegalEntityAxis to dei_LegalEntityAxis_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:label xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="dei_EntityDomain_lbl" xml:lang="en-US" id="dei_EntityDomain_lbl">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityDomain" xlink:to="dei_EntityDomain_lbl" xlink:title="label: EntityDomain to dei_EntityDomain_lbl" />
    <link:label xlink:type="resource" xlink:label="dei_EntityDomain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityDomain_lbl1" xml:lang="en-US" id="dei_EntityDomain_lbl1">Entity [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityDomain" xlink:to="dei_EntityDomain_lbl1" xlink:title="label: EntityDomain to dei_EntityDomain_lbl1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFilerCategory_lbl" xml:lang="en-US" id="dei_EntityFilerCategory_lbl">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:title="label: EntityFilerCategory to dei_EntityFilerCategory_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:label xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntitySmallBusiness_lbl" xml:lang="en-US" id="dei_EntitySmallBusiness_lbl">Entity Small Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:title="label: EntitySmallBusiness to dei_EntitySmallBusiness_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MarketableSecuritiesMember" xlink:label="MarketableSecuritiesMember" xlink:title="MarketableSecuritiesMember" />
    <link:label xlink:type="resource" xlink:label="clbs_MarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MarketableSecuritiesMember_lbl" xml:lang="en-US" id="clbs_MarketableSecuritiesMember_lbl">Marketable Securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesMember" xlink:to="clbs_MarketableSecuritiesMember_lbl" xlink:title="label: MarketableSecuritiesMember to clbs_MarketableSecuritiesMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MarketableSecuritiesMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MarketableSecuritiesMember_lbl1" xml:lang="en-US" id="clbs_MarketableSecuritiesMember_lbl1">Marketable Securities [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesMember" xlink:to="clbs_MarketableSecuritiesMember_lbl1" xlink:title="label: MarketableSecuritiesMember to clbs_MarketableSecuritiesMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MarketableSecuritiesMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MarketableSecuritiesMember_lbl2" xml:lang="en-US" id="clbs_MarketableSecuritiesMember_lbl2">Marketable securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MarketableSecuritiesMember" xlink:to="clbs_MarketableSecuritiesMember_lbl2" xlink:title="label: MarketableSecuritiesMember to clbs_MarketableSecuritiesMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_TreasuryStockPolicyPolicyTextBlock" xlink:label="TreasuryStockPolicyPolicyTextBlock" xlink:title="TreasuryStockPolicyPolicyTextBlock" />
    <link:label xlink:type="resource" xlink:label="clbs_TreasuryStockPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_TreasuryStockPolicyPolicyTextBlock_lbl" xml:lang="en-US" id="clbs_TreasuryStockPolicyPolicyTextBlock_lbl">Treasury Stock, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockPolicyPolicyTextBlock" xlink:to="clbs_TreasuryStockPolicyPolicyTextBlock_lbl" xlink:title="label: TreasuryStockPolicyPolicyTextBlock to clbs_TreasuryStockPolicyPolicyTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_TreasuryStockPolicyPolicyTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_TreasuryStockPolicyPolicyTextBlock_lbl1" xml:lang="en-US" id="clbs_TreasuryStockPolicyPolicyTextBlock_lbl1">Treasury Stock, Policy [Policy Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockPolicyPolicyTextBlock" xlink:to="clbs_TreasuryStockPolicyPolicyTextBlock_lbl1" xlink:title="label: TreasuryStockPolicyPolicyTextBlock to clbs_TreasuryStockPolicyPolicyTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_TreasuryStockPolicyPolicyTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_TreasuryStockPolicyPolicyTextBlock_lbl2" xml:lang="en-US" id="clbs_TreasuryStockPolicyPolicyTextBlock_lbl2">Treasury Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TreasuryStockPolicyPolicyTextBlock" xlink:to="clbs_TreasuryStockPolicyPolicyTextBlock_lbl2" xlink:title="label: TreasuryStockPolicyPolicyTextBlock to clbs_TreasuryStockPolicyPolicyTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CLBS16TreatmentOfCMDMember" xlink:label="CLBS16TreatmentOfCMDMember" xlink:title="CLBS16TreatmentOfCMDMember" />
    <link:label xlink:type="resource" xlink:label="clbs_CLBS16TreatmentOfCMDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_CLBS16TreatmentOfCMDMember_lbl" xml:lang="en-US" id="clbs_CLBS16TreatmentOfCMDMember_lbl">CLBS16 Treatment Of CMD</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CLBS16TreatmentOfCMDMember" xlink:to="clbs_CLBS16TreatmentOfCMDMember_lbl" xlink:title="label: CLBS16TreatmentOfCMDMember to clbs_CLBS16TreatmentOfCMDMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_CLBS16TreatmentOfCMDMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_CLBS16TreatmentOfCMDMember_lbl1" xml:lang="en-US" id="clbs_CLBS16TreatmentOfCMDMember_lbl1">CLBS16 Treatment Of CMD [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CLBS16TreatmentOfCMDMember" xlink:to="clbs_CLBS16TreatmentOfCMDMember_lbl1" xlink:title="label: CLBS16TreatmentOfCMDMember to clbs_CLBS16TreatmentOfCMDMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_CLBS16TreatmentOfCMDMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_CLBS16TreatmentOfCMDMember_lbl2" xml:lang="en-US" id="clbs_CLBS16TreatmentOfCMDMember_lbl2">CLBS16 Treatment of CMD</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CLBS16TreatmentOfCMDMember" xlink:to="clbs_CLBS16TreatmentOfCMDMember_lbl2" xlink:title="label: CLBS16TreatmentOfCMDMember to clbs_CLBS16TreatmentOfCMDMember_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_CLBS16TreatmentOfCMDMember_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_CLBS16TreatmentOfCMDMember_lbl3" xml:lang="en-US" id="clbs_CLBS16TreatmentOfCMDMember_lbl3">CLBS16 Treatment Of CMD</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CLBS16TreatmentOfCMDMember" xlink:to="clbs_CLBS16TreatmentOfCMDMember_lbl3" xlink:title="label: CLBS16TreatmentOfCMDMember to clbs_CLBS16TreatmentOfCMDMember_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SeriesDPreferredStockCendMember" xlink:label="SeriesDPreferredStockCendMember" xlink:title="SeriesDPreferredStockCendMember" />
    <link:label xlink:type="resource" xlink:label="clbs_SeriesDPreferredStockCendMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_SeriesDPreferredStockCendMember_lbl" xml:lang="en-US" id="clbs_SeriesDPreferredStockCendMember_lbl">Series D Preferred Stock, Cend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesDPreferredStockCendMember" xlink:to="clbs_SeriesDPreferredStockCendMember_lbl" xlink:title="label: SeriesDPreferredStockCendMember to clbs_SeriesDPreferredStockCendMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_SeriesDPreferredStockCendMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_SeriesDPreferredStockCendMember_lbl1" xml:lang="en-US" id="clbs_SeriesDPreferredStockCendMember_lbl1">Series D Preferred Stock, Cend [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesDPreferredStockCendMember" xlink:to="clbs_SeriesDPreferredStockCendMember_lbl1" xlink:title="label: SeriesDPreferredStockCendMember to clbs_SeriesDPreferredStockCendMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_SeriesDPreferredStockCendMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_SeriesDPreferredStockCendMember_lbl2" xml:lang="en-US" id="clbs_SeriesDPreferredStockCendMember_lbl2">Cend Series D preferred stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SeriesDPreferredStockCendMember" xlink:to="clbs_SeriesDPreferredStockCendMember_lbl2" xlink:title="label: SeriesDPreferredStockCendMember to clbs_SeriesDPreferredStockCendMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CendTherapeuticsIncMember" xlink:label="CendTherapeuticsIncMember" xlink:title="CendTherapeuticsIncMember" />
    <link:label xlink:type="resource" xlink:label="clbs_CendTherapeuticsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_CendTherapeuticsIncMember_lbl" xml:lang="en-US" id="clbs_CendTherapeuticsIncMember_lbl">Cend Therapeutics, Inc</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CendTherapeuticsIncMember" xlink:to="clbs_CendTherapeuticsIncMember_lbl" xlink:title="label: CendTherapeuticsIncMember to clbs_CendTherapeuticsIncMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_CendTherapeuticsIncMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_CendTherapeuticsIncMember_lbl1" xml:lang="en-US" id="clbs_CendTherapeuticsIncMember_lbl1">Cend Therapeutics, Inc [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CendTherapeuticsIncMember" xlink:to="clbs_CendTherapeuticsIncMember_lbl1" xlink:title="label: CendTherapeuticsIncMember to clbs_CendTherapeuticsIncMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_CendTherapeuticsIncMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_CendTherapeuticsIncMember_lbl2" xml:lang="en-US" id="clbs_CendTherapeuticsIncMember_lbl2">Cend</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CendTherapeuticsIncMember" xlink:to="clbs_CendTherapeuticsIncMember_lbl2" xlink:title="label: CendTherapeuticsIncMember to clbs_CendTherapeuticsIncMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialTerminationFeeReceivable" xlink:label="MergerAgreementPotentialTerminationFeeReceivable" xlink:title="MergerAgreementPotentialTerminationFeeReceivable" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl" xml:lang="en-US" id="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl">Merger Agreement, Potential Termination Fee Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialTerminationFeeReceivable" xlink:to="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl" xlink:title="label: MergerAgreementPotentialTerminationFeeReceivable to clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl1" xml:lang="en-US" id="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl1">Merger Agreement, Potential Termination Fee Receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialTerminationFeeReceivable" xlink:to="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl1" xlink:title="label: MergerAgreementPotentialTerminationFeeReceivable to clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl2" xml:lang="en-US" id="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl2">Potential termination fee receivable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialTerminationFeeReceivable" xlink:to="clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl2" xlink:title="label: MergerAgreementPotentialTerminationFeeReceivable to clbs_MergerAgreementPotentialTerminationFeeReceivable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl" xml:lang="en-US" id="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl">Merger Agreement, Expected Ownership In Company, Counterparty Stockholders, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:to="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl" xlink:title="label: MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage to clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl1" xml:lang="en-US" id="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl1">Merger Agreement, Expected Ownership In Company, Counterparty Stockholders, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:to="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl1" xlink:title="label: MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage to clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl2" xml:lang="en-US" id="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl2">Expected post-merger ownership in Company by Cend stockholders (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:to="clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl2" xlink:title="label: MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage to clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementMinimumNetCashThreshold" xlink:label="MergerAgreementMinimumNetCashThreshold" xlink:title="MergerAgreementMinimumNetCashThreshold" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementMinimumNetCashThreshold_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MergerAgreementMinimumNetCashThreshold_lbl" xml:lang="en-US" id="clbs_MergerAgreementMinimumNetCashThreshold_lbl">Merger Agreement, Minimum Net Cash Threshold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementMinimumNetCashThreshold" xlink:to="clbs_MergerAgreementMinimumNetCashThreshold_lbl" xlink:title="label: MergerAgreementMinimumNetCashThreshold to clbs_MergerAgreementMinimumNetCashThreshold_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementMinimumNetCashThreshold_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MergerAgreementMinimumNetCashThreshold_lbl1" xml:lang="en-US" id="clbs_MergerAgreementMinimumNetCashThreshold_lbl1">Merger Agreement, Minimum Net Cash Threshold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementMinimumNetCashThreshold" xlink:to="clbs_MergerAgreementMinimumNetCashThreshold_lbl1" xlink:title="label: MergerAgreementMinimumNetCashThreshold to clbs_MergerAgreementMinimumNetCashThreshold_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementMinimumNetCashThreshold_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MergerAgreementMinimumNetCashThreshold_lbl2" xml:lang="en-US" id="clbs_MergerAgreementMinimumNetCashThreshold_lbl2">Minimum net cash threshold at closing per agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementMinimumNetCashThreshold" xlink:to="clbs_MergerAgreementMinimumNetCashThreshold_lbl2" xlink:title="label: MergerAgreementMinimumNetCashThreshold to clbs_MergerAgreementMinimumNetCashThreshold_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockPricePerShare" xlink:label="PurchaseOfPreferredStockPricePerShare" xlink:title="PurchaseOfPreferredStockPricePerShare" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_PurchaseOfPreferredStockPricePerShare_lbl" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockPricePerShare_lbl">Purchase Of Preferred Stock, Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockPricePerShare" xlink:to="clbs_PurchaseOfPreferredStockPricePerShare_lbl" xlink:title="label: PurchaseOfPreferredStockPricePerShare to clbs_PurchaseOfPreferredStockPricePerShare_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockPricePerShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_PurchaseOfPreferredStockPricePerShare_lbl1" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockPricePerShare_lbl1">Purchase Of Preferred Stock, Price Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockPricePerShare" xlink:to="clbs_PurchaseOfPreferredStockPricePerShare_lbl1" xlink:title="label: PurchaseOfPreferredStockPricePerShare to clbs_PurchaseOfPreferredStockPricePerShare_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockPricePerShare_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_PurchaseOfPreferredStockPricePerShare_lbl2" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockPricePerShare_lbl2">Series D original issue price (in usd per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockPricePerShare" xlink:to="clbs_PurchaseOfPreferredStockPricePerShare_lbl2" xlink:title="label: PurchaseOfPreferredStockPricePerShare to clbs_PurchaseOfPreferredStockPricePerShare_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AgreementAndPlanOfMergerAndReorganizationMember" xlink:label="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="AgreementAndPlanOfMergerAndReorganizationMember" />
    <link:label xlink:type="resource" xlink:label="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl" xml:lang="en-US" id="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl">Agreement And Plan Of Merger And Reorganization</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementAndPlanOfMergerAndReorganizationMember" xlink:to="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl" xlink:title="label: AgreementAndPlanOfMergerAndReorganizationMember to clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl1" xml:lang="en-US" id="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl1">Agreement And Plan Of Merger And Reorganization [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementAndPlanOfMergerAndReorganizationMember" xlink:to="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl1" xlink:title="label: AgreementAndPlanOfMergerAndReorganizationMember to clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl2" xml:lang="en-US" id="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl2">Merger Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AgreementAndPlanOfMergerAndReorganizationMember" xlink:to="clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl2" xlink:title="label: AgreementAndPlanOfMergerAndReorganizationMember to clbs_AgreementAndPlanOfMergerAndReorganizationMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialExpenseReimbursement" xlink:label="MergerAgreementPotentialExpenseReimbursement" xlink:title="MergerAgreementPotentialExpenseReimbursement" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialExpenseReimbursement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MergerAgreementPotentialExpenseReimbursement_lbl" xml:lang="en-US" id="clbs_MergerAgreementPotentialExpenseReimbursement_lbl">Merger Agreement, Potential Expense Reimbursement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialExpenseReimbursement" xlink:to="clbs_MergerAgreementPotentialExpenseReimbursement_lbl" xlink:title="label: MergerAgreementPotentialExpenseReimbursement to clbs_MergerAgreementPotentialExpenseReimbursement_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialExpenseReimbursement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MergerAgreementPotentialExpenseReimbursement_lbl1" xml:lang="en-US" id="clbs_MergerAgreementPotentialExpenseReimbursement_lbl1">Merger Agreement, Potential Expense Reimbursement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialExpenseReimbursement" xlink:to="clbs_MergerAgreementPotentialExpenseReimbursement_lbl1" xlink:title="label: MergerAgreementPotentialExpenseReimbursement to clbs_MergerAgreementPotentialExpenseReimbursement_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialExpenseReimbursement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MergerAgreementPotentialExpenseReimbursement_lbl2" xml:lang="en-US" id="clbs_MergerAgreementPotentialExpenseReimbursement_lbl2">Potential expense reimbursement per agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialExpenseReimbursement" xlink:to="clbs_MergerAgreementPotentialExpenseReimbursement_lbl2" xlink:title="label: MergerAgreementPotentialExpenseReimbursement to clbs_MergerAgreementPotentialExpenseReimbursement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreEquityOfferingValueAfterConversion" xlink:label="PreEquityOfferingValueAfterConversion" xlink:title="PreEquityOfferingValueAfterConversion" />
    <link:label xlink:type="resource" xlink:label="clbs_PreEquityOfferingValueAfterConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_PreEquityOfferingValueAfterConversion_lbl" xml:lang="en-US" id="clbs_PreEquityOfferingValueAfterConversion_lbl">Pre-Equity Offering Value After Conversion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreEquityOfferingValueAfterConversion" xlink:to="clbs_PreEquityOfferingValueAfterConversion_lbl" xlink:title="label: PreEquityOfferingValueAfterConversion to clbs_PreEquityOfferingValueAfterConversion_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_PreEquityOfferingValueAfterConversion_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_PreEquityOfferingValueAfterConversion_lbl1" xml:lang="en-US" id="clbs_PreEquityOfferingValueAfterConversion_lbl1">Pre-Equity Offering Value After Conversion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreEquityOfferingValueAfterConversion" xlink:to="clbs_PreEquityOfferingValueAfterConversion_lbl1" xlink:title="label: PreEquityOfferingValueAfterConversion to clbs_PreEquityOfferingValueAfterConversion_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_PreEquityOfferingValueAfterConversion_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_PreEquityOfferingValueAfterConversion_lbl2" xml:lang="en-US" id="clbs_PreEquityOfferingValueAfterConversion_lbl2">Pre-Equity Offering Value After Conversion</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreEquityOfferingValueAfterConversion" xlink:to="clbs_PreEquityOfferingValueAfterConversion_lbl2" xlink:title="label: PreEquityOfferingValueAfterConversion to clbs_PreEquityOfferingValueAfterConversion_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialTerminationFeePayable" xlink:label="MergerAgreementPotentialTerminationFeePayable" xlink:title="MergerAgreementPotentialTerminationFeePayable" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialTerminationFeePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MergerAgreementPotentialTerminationFeePayable_lbl" xml:lang="en-US" id="clbs_MergerAgreementPotentialTerminationFeePayable_lbl">Merger Agreement, Potential Termination Fee Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialTerminationFeePayable" xlink:to="clbs_MergerAgreementPotentialTerminationFeePayable_lbl" xlink:title="label: MergerAgreementPotentialTerminationFeePayable to clbs_MergerAgreementPotentialTerminationFeePayable_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialTerminationFeePayable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MergerAgreementPotentialTerminationFeePayable_lbl1" xml:lang="en-US" id="clbs_MergerAgreementPotentialTerminationFeePayable_lbl1">Merger Agreement, Potential Termination Fee Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialTerminationFeePayable" xlink:to="clbs_MergerAgreementPotentialTerminationFeePayable_lbl1" xlink:title="label: MergerAgreementPotentialTerminationFeePayable to clbs_MergerAgreementPotentialTerminationFeePayable_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementPotentialTerminationFeePayable_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MergerAgreementPotentialTerminationFeePayable_lbl2" xml:lang="en-US" id="clbs_MergerAgreementPotentialTerminationFeePayable_lbl2">Potential termination fee payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementPotentialTerminationFeePayable" xlink:to="clbs_MergerAgreementPotentialTerminationFeePayable_lbl2" xlink:title="label: MergerAgreementPotentialTerminationFeePayable to clbs_MergerAgreementPotentialTerminationFeePayable_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockAggregatePrice" xlink:label="PurchaseOfPreferredStockAggregatePrice" xlink:title="PurchaseOfPreferredStockAggregatePrice" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockAggregatePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_PurchaseOfPreferredStockAggregatePrice_lbl" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockAggregatePrice_lbl">Purchase Of Preferred Stock, Aggregate Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockAggregatePrice" xlink:to="clbs_PurchaseOfPreferredStockAggregatePrice_lbl" xlink:title="label: PurchaseOfPreferredStockAggregatePrice to clbs_PurchaseOfPreferredStockAggregatePrice_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockAggregatePrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_PurchaseOfPreferredStockAggregatePrice_lbl1" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockAggregatePrice_lbl1">Purchase Of Preferred Stock, Aggregate Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockAggregatePrice" xlink:to="clbs_PurchaseOfPreferredStockAggregatePrice_lbl1" xlink:title="label: PurchaseOfPreferredStockAggregatePrice to clbs_PurchaseOfPreferredStockAggregatePrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockAggregatePrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_PurchaseOfPreferredStockAggregatePrice_lbl2" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockAggregatePrice_lbl2">Aggregate price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockAggregatePrice" xlink:to="clbs_PurchaseOfPreferredStockAggregatePrice_lbl2" xlink:title="label: PurchaseOfPreferredStockAggregatePrice to clbs_PurchaseOfPreferredStockAggregatePrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl" xml:lang="en-US" id="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl">Merger Agreement, Expected Ownership In Company, Company Stockholders, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:to="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl" xlink:title="label: MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage to clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl1" xml:lang="en-US" id="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl1">Merger Agreement, Expected Ownership In Company, Company Stockholders, Percentage</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:to="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl1" xlink:title="label: MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage to clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl2" xml:lang="en-US" id="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl2">Expected post-merger ownership in Company by Company stockholders (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:to="clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl2" xlink:title="label: MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage to clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_GrossProceedsOnTransaction" xlink:label="GrossProceedsOnTransaction" xlink:title="GrossProceedsOnTransaction" />
    <link:label xlink:type="resource" xlink:label="clbs_GrossProceedsOnTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_GrossProceedsOnTransaction_lbl" xml:lang="en-US" id="clbs_GrossProceedsOnTransaction_lbl">Gross Proceeds On Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProceedsOnTransaction" xlink:to="clbs_GrossProceedsOnTransaction_lbl" xlink:title="label: GrossProceedsOnTransaction to clbs_GrossProceedsOnTransaction_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_GrossProceedsOnTransaction_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_GrossProceedsOnTransaction_lbl1" xml:lang="en-US" id="clbs_GrossProceedsOnTransaction_lbl1">Gross Proceeds On Transaction</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProceedsOnTransaction" xlink:to="clbs_GrossProceedsOnTransaction_lbl1" xlink:title="label: GrossProceedsOnTransaction to clbs_GrossProceedsOnTransaction_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_GrossProceedsOnTransaction_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_GrossProceedsOnTransaction_lbl2" xml:lang="en-US" id="clbs_GrossProceedsOnTransaction_lbl2">Potential gross proceeds</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GrossProceedsOnTransaction" xlink:to="clbs_GrossProceedsOnTransaction_lbl2" xlink:title="label: GrossProceedsOnTransaction to clbs_GrossProceedsOnTransaction_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockShares" xlink:label="PurchaseOfPreferredStockShares" xlink:title="PurchaseOfPreferredStockShares" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_PurchaseOfPreferredStockShares_lbl" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockShares_lbl">Purchase Of Preferred Stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockShares" xlink:to="clbs_PurchaseOfPreferredStockShares_lbl" xlink:title="label: PurchaseOfPreferredStockShares to clbs_PurchaseOfPreferredStockShares_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_PurchaseOfPreferredStockShares_lbl1" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockShares_lbl1">Purchase Of Preferred Stock, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockShares" xlink:to="clbs_PurchaseOfPreferredStockShares_lbl1" xlink:title="label: PurchaseOfPreferredStockShares to clbs_PurchaseOfPreferredStockShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseOfPreferredStockShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_PurchaseOfPreferredStockShares_lbl2" xml:lang="en-US" id="clbs_PurchaseOfPreferredStockShares_lbl2">Number of shares purchased</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseOfPreferredStockShares" xlink:to="clbs_PurchaseOfPreferredStockShares_lbl2" xlink:title="label: PurchaseOfPreferredStockShares to clbs_PurchaseOfPreferredStockShares_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:label="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="MergerAgreementTransactionExpensesThresholdForRatioAllocation" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl" xml:lang="en-US" id="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl">Merger Agreement, Transaction Expenses Threshold For Ratio Allocation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:to="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl" xlink:title="label: MergerAgreementTransactionExpensesThresholdForRatioAllocation to clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl1" xml:lang="en-US" id="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl1">Merger Agreement, Transaction Expenses Threshold For Ratio Allocation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:to="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl1" xlink:title="label: MergerAgreementTransactionExpensesThresholdForRatioAllocation to clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl2" xml:lang="en-US" id="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl2">Transaction expenses threshold for allocation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:to="clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl2" xlink:title="label: MergerAgreementTransactionExpensesThresholdForRatioAllocation to clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CendSeriesDPreferredStockPurchaseAgreementMember" xlink:label="CendSeriesDPreferredStockPurchaseAgreementMember" xlink:title="CendSeriesDPreferredStockPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl" xml:lang="en-US" id="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl">Cend Series D Preferred Stock Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CendSeriesDPreferredStockPurchaseAgreementMember" xlink:to="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl" xlink:title="label: CendSeriesDPreferredStockPurchaseAgreementMember to clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl1" xml:lang="en-US" id="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl1">Cend Series D Preferred Stock Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CendSeriesDPreferredStockPurchaseAgreementMember" xlink:to="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl1" xlink:title="label: CendSeriesDPreferredStockPurchaseAgreementMember to clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl2" xml:lang="en-US" id="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl2">Cend Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CendSeriesDPreferredStockPurchaseAgreementMember" xlink:to="clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl2" xlink:title="label: CendSeriesDPreferredStockPurchaseAgreementMember to clbs_CendSeriesDPreferredStockPurchaseAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:label="OptionsVestedweightedAverageRemainingContractualTerm" xlink:title="OptionsVestedweightedAverageRemainingContractualTerm" />
    <link:label xlink:type="resource" xlink:label="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl" xml:lang="en-US" id="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl">Options, Vested, weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OptionsVestedweightedAverageRemainingContractualTerm" xlink:to="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl" xlink:title="label: OptionsVestedweightedAverageRemainingContractualTerm to clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl1" xml:lang="en-US" id="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl1">Options, Vested, weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OptionsVestedweightedAverageRemainingContractualTerm" xlink:to="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl1" xlink:title="label: OptionsVestedweightedAverageRemainingContractualTerm to clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl2" xml:lang="en-US" id="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl2">Options, Vested, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OptionsVestedweightedAverageRemainingContractualTerm" xlink:to="clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl2" xlink:title="label: OptionsVestedweightedAverageRemainingContractualTerm to clbs_OptionsVestedweightedAverageRemainingContractualTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:label="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:title="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" />
    <link:label xlink:type="resource" xlink:label="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl" xml:lang="en-US" id="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl">Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:to="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl" xlink:title="label: LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock to clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl1" xml:lang="en-US" id="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl1">Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:to="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl1" xlink:title="label: LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock to clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl2" xml:lang="en-US" id="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl2">Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:to="clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl2" xlink:title="label: LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock to clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:label="WeightedAverageExercisePriceWarrantsExercisable" xlink:title="WeightedAverageExercisePriceWarrantsExercisable" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl">Weighted Average Exercise Price, Warrants Exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExercisable" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl" xlink:title="label: WeightedAverageExercisePriceWarrantsExercisable to clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl1" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl1">Weighted Average Exercise Price, Warrants Exercisable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExercisable" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl1" xlink:title="label: WeightedAverageExercisePriceWarrantsExercisable to clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl2" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl2">Warrants exercisable (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExercisable" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl2" xlink:title="label: WeightedAverageExercisePriceWarrantsExercisable to clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl3" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl3">Warrants, Vested, Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExercisable" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl3" xlink:title="label: WeightedAverageExercisePriceWarrantsExercisable to clbs_WeightedAverageExercisePriceWarrantsExercisable_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsExpired" xlink:label="WarrantsExpired" xlink:title="WarrantsExpired" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WarrantsExpired_lbl" xml:lang="en-US" id="clbs_WarrantsExpired_lbl">Warrants Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsExpired" xlink:to="clbs_WarrantsExpired_lbl" xlink:title="label: WarrantsExpired to clbs_WarrantsExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WarrantsExpired_lbl1" xml:lang="en-US" id="clbs_WarrantsExpired_lbl1">Warrants Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsExpired" xlink:to="clbs_WarrantsExpired_lbl1" xlink:title="label: WarrantsExpired to clbs_WarrantsExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsExpired_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="clbs_WarrantsExpired_lbl2" xml:lang="en-US" id="clbs_WarrantsExpired_lbl2">Warrants expired (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsExpired" xlink:to="clbs_WarrantsExpired_lbl2" xlink:title="label: WarrantsExpired to clbs_WarrantsExpired_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsExpired_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="clbs_WarrantsExpired_lbl3" xml:lang="en-US" id="clbs_WarrantsExpired_lbl3">Warrants, Expired (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsExpired" xlink:to="clbs_WarrantsExpired_lbl3" xlink:title="label: WarrantsExpired to clbs_WarrantsExpired_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsExercised" xlink:label="WarrantsExercised" xlink:title="WarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WarrantsExercised_lbl" xml:lang="en-US" id="clbs_WarrantsExercised_lbl">Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsExercised" xlink:to="clbs_WarrantsExercised_lbl" xlink:title="label: WarrantsExercised to clbs_WarrantsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WarrantsExercised_lbl1" xml:lang="en-US" id="clbs_WarrantsExercised_lbl1">Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsExercised" xlink:to="clbs_WarrantsExercised_lbl1" xlink:title="label: WarrantsExercised to clbs_WarrantsExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsExercised_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="clbs_WarrantsExercised_lbl2" xml:lang="en-US" id="clbs_WarrantsExercised_lbl2">Warrants exercised (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsExercised" xlink:to="clbs_WarrantsExercised_lbl2" xlink:title="label: WarrantsExercised to clbs_WarrantsExercised_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsExercised_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="clbs_WarrantsExercised_lbl3" xml:lang="en-US" id="clbs_WarrantsExercised_lbl3">Warrants, Exercised (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsExercised" xlink:to="clbs_WarrantsExercised_lbl3" xlink:title="label: WarrantsExercised to clbs_WarrantsExercised_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsGranted" xlink:label="WarrantsGranted" xlink:title="WarrantsGranted" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsGranted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WarrantsGranted_lbl" xml:lang="en-US" id="clbs_WarrantsGranted_lbl">Warrants Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsGranted" xlink:to="clbs_WarrantsGranted_lbl" xlink:title="label: WarrantsGranted to clbs_WarrantsGranted_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsGranted_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WarrantsGranted_lbl1" xml:lang="en-US" id="clbs_WarrantsGranted_lbl1">Warrants Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsGranted" xlink:to="clbs_WarrantsGranted_lbl1" xlink:title="label: WarrantsGranted to clbs_WarrantsGranted_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsGranted_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WarrantsGranted_lbl2" xml:lang="en-US" id="clbs_WarrantsGranted_lbl2">Warrants granted (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsGranted" xlink:to="clbs_WarrantsGranted_lbl2" xlink:title="label: WarrantsGranted to clbs_WarrantsGranted_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsGranted_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WarrantsGranted_lbl3" xml:lang="en-US" id="clbs_WarrantsGranted_lbl3">Warrants, Granted (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsGranted" xlink:to="clbs_WarrantsGranted_lbl3" xlink:title="label: WarrantsGranted to clbs_WarrantsGranted_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsCanceled" xlink:label="WarrantsCanceled" xlink:title="WarrantsCanceled" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsCanceled_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WarrantsCanceled_lbl" xml:lang="en-US" id="clbs_WarrantsCanceled_lbl">Warrants Canceled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsCanceled" xlink:to="clbs_WarrantsCanceled_lbl" xlink:title="label: WarrantsCanceled to clbs_WarrantsCanceled_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsCanceled_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WarrantsCanceled_lbl1" xml:lang="en-US" id="clbs_WarrantsCanceled_lbl1">Warrants Canceled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsCanceled" xlink:to="clbs_WarrantsCanceled_lbl1" xlink:title="label: WarrantsCanceled to clbs_WarrantsCanceled_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsCanceled_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="clbs_WarrantsCanceled_lbl2" xml:lang="en-US" id="clbs_WarrantsCanceled_lbl2">Warrants forfeited (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsCanceled" xlink:to="clbs_WarrantsCanceled_lbl2" xlink:title="label: WarrantsCanceled to clbs_WarrantsCanceled_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsCanceled_lbl3" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:title="clbs_WarrantsCanceled_lbl3" xml:lang="en-US" id="clbs_WarrantsCanceled_lbl3">Warrants, Forfeited (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsCanceled" xlink:to="clbs_WarrantsCanceled_lbl3" xlink:title="label: WarrantsCanceled to clbs_WarrantsCanceled_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CommonStockWarrantsShares" xlink:label="CommonStockWarrantsShares" xlink:title="CommonStockWarrantsShares" />
    <link:label xlink:type="resource" xlink:label="clbs_CommonStockWarrantsShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_CommonStockWarrantsShares_lbl" xml:lang="en-US" id="clbs_CommonStockWarrantsShares_lbl">Common Stock Warrants, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWarrantsShares" xlink:to="clbs_CommonStockWarrantsShares_lbl" xlink:title="label: CommonStockWarrantsShares to clbs_CommonStockWarrantsShares_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_CommonStockWarrantsShares_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_CommonStockWarrantsShares_lbl1" xml:lang="en-US" id="clbs_CommonStockWarrantsShares_lbl1">Common Stock Warrants, Shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWarrantsShares" xlink:to="clbs_CommonStockWarrantsShares_lbl1" xlink:title="label: CommonStockWarrantsShares to clbs_CommonStockWarrantsShares_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_CommonStockWarrantsShares_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="clbs_CommonStockWarrantsShares_lbl2" xml:lang="en-US" id="clbs_CommonStockWarrantsShares_lbl2">Warrants outstanding, beginning balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWarrantsShares" xlink:to="clbs_CommonStockWarrantsShares_lbl2" xlink:title="label: CommonStockWarrantsShares to clbs_CommonStockWarrantsShares_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_CommonStockWarrantsShares_lbl3" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="clbs_CommonStockWarrantsShares_lbl3" xml:lang="en-US" id="clbs_CommonStockWarrantsShares_lbl3">Warrants outstanding, ending balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockWarrantsShares" xlink:to="clbs_CommonStockWarrantsShares_lbl3" xlink:title="label: CommonStockWarrantsShares to clbs_CommonStockWarrantsShares_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsvested" xlink:label="AggregateIntrinsicValueWarrantsvested" xlink:title="AggregateIntrinsicValueWarrantsvested" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsvested_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_AggregateIntrinsicValueWarrantsvested_lbl" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsvested_lbl">Aggregate Intrinsic Value, Warrants vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsvested" xlink:to="clbs_AggregateIntrinsicValueWarrantsvested_lbl" xlink:title="label: AggregateIntrinsicValueWarrantsvested to clbs_AggregateIntrinsicValueWarrantsvested_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsvested_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_AggregateIntrinsicValueWarrantsvested_lbl1" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsvested_lbl1">Aggregate Intrinsic Value, Warrants vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsvested" xlink:to="clbs_AggregateIntrinsicValueWarrantsvested_lbl1" xlink:title="label: AggregateIntrinsicValueWarrantsvested to clbs_AggregateIntrinsicValueWarrantsvested_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsvested_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_AggregateIntrinsicValueWarrantsvested_lbl2" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsvested_lbl2">Warrants exercisable, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsvested" xlink:to="clbs_AggregateIntrinsicValueWarrantsvested_lbl2" xlink:title="label: AggregateIntrinsicValueWarrantsvested to clbs_AggregateIntrinsicValueWarrantsvested_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsvested_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_AggregateIntrinsicValueWarrantsvested_lbl3" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsvested_lbl3">Warrants, Vested, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsvested" xlink:to="clbs_AggregateIntrinsicValueWarrantsvested_lbl3" xlink:title="label: AggregateIntrinsicValueWarrantsvested to clbs_AggregateIntrinsicValueWarrantsvested_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:label="AggregateIntrinsicValueWarrantsOutstanding" xlink:title="AggregateIntrinsicValueWarrantsOutstanding" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl">Aggregate Intrinsic Value, Warrants Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsOutstanding" xlink:to="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl" xlink:title="label: AggregateIntrinsicValueWarrantsOutstanding to clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl1" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl1">Aggregate Intrinsic Value, Warrants Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsOutstanding" xlink:to="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl1" xlink:title="label: AggregateIntrinsicValueWarrantsOutstanding to clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl2" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl2">Warrants outstanding, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsOutstanding" xlink:to="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl2" xlink:title="label: AggregateIntrinsicValueWarrantsOutstanding to clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl3" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl3">Warrants Outstanding, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsOutstanding" xlink:to="clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl3" xlink:title="label: AggregateIntrinsicValueWarrantsOutstanding to clbs_AggregateIntrinsicValueWarrantsOutstanding_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:label="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:title="WeightedAverageRemainingContractualTermwarrantoutstanding" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl">Weighted Average Remaining Contractual Term warrant outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:to="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl" xlink:title="label: WeightedAverageRemainingContractualTermwarrantoutstanding to clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl1" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl1">Weighted Average Remaining Contractual Term warrant outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:to="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl1" xlink:title="label: WeightedAverageRemainingContractualTermwarrantoutstanding to clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl2" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl2">Warrants outstanding, weighted average remaining contractual term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:to="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl2" xlink:title="label: WeightedAverageRemainingContractualTermwarrantoutstanding to clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl3" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl3">Warrants, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:to="clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl3" xlink:title="label: WeightedAverageRemainingContractualTermwarrantoutstanding to clbs_WeightedAverageRemainingContractualTermwarrantoutstanding_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:label="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:title="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl">Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:to="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl" xlink:title="label: WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest to clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl1" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl1">Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:to="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl1" xlink:title="label: WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest to clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl2" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl2">Warrants vested or expected to vest, weighted average remaining contractual term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:to="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl2" xlink:title="label: WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest to clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl3" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl3">Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:to="clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl3" xlink:title="label: WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest to clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:label="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:title="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl">Aggregate Intrinsic Value, Warrants vested and expected to vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:to="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl" xlink:title="label: AggregateIntrinsicValueWarrantsvestedandexpectedtovest to clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl1" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl1">Aggregate Intrinsic Value, Warrants vested and expected to vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:to="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl1" xlink:title="label: AggregateIntrinsicValueWarrantsvestedandexpectedtovest to clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl2" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl2">Warrants vested or expected to vest, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:to="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl2" xlink:title="label: AggregateIntrinsicValueWarrantsvestedandexpectedtovest to clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl3" xml:lang="en-US" id="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl3">Warrants, Vested and expected to vest, Aggregate Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:to="clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl3" xlink:title="label: AggregateIntrinsicValueWarrantsvestedandexpectedtovest to clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsVested" xlink:label="WarrantsVested" xlink:title="WarrantsVested" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsVested_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WarrantsVested_lbl" xml:lang="en-US" id="clbs_WarrantsVested_lbl">Warrants, Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsVested" xlink:to="clbs_WarrantsVested_lbl" xlink:title="label: WarrantsVested to clbs_WarrantsVested_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsVested_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WarrantsVested_lbl1" xml:lang="en-US" id="clbs_WarrantsVested_lbl1">Warrants, Vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsVested" xlink:to="clbs_WarrantsVested_lbl1" xlink:title="label: WarrantsVested to clbs_WarrantsVested_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsVested_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WarrantsVested_lbl2" xml:lang="en-US" id="clbs_WarrantsVested_lbl2">Warrants exercisable (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsVested" xlink:to="clbs_WarrantsVested_lbl2" xlink:title="label: WarrantsVested to clbs_WarrantsVested_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsVested_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WarrantsVested_lbl3" xml:lang="en-US" id="clbs_WarrantsVested_lbl3">Warrants, Vested (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsVested" xlink:to="clbs_WarrantsVested_lbl3" xlink:title="label: WarrantsVested to clbs_WarrantsVested_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:label="WeightedAverageRemainingContractualTermwarrantsvested" xlink:title="WeightedAverageRemainingContractualTermwarrantsvested" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl">weighted Average Remaining Contractual Term, warrants vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermwarrantsvested" xlink:to="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl" xlink:title="label: WeightedAverageRemainingContractualTermwarrantsvested to clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl1" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl1">weighted Average Remaining Contractual Term, warrants vested</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermwarrantsvested" xlink:to="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl1" xlink:title="label: WeightedAverageRemainingContractualTermwarrantsvested to clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl2" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl2">Warrants exercisable, weighted average remaining contractual term (in years)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermwarrantsvested" xlink:to="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl2" xlink:title="label: WeightedAverageRemainingContractualTermwarrantsvested to clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl3" xml:lang="en-US" id="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl3">Warrants, Vested, Weighted Average Remaining Contractual Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageRemainingContractualTermwarrantsvested" xlink:to="clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl3" xlink:title="label: WeightedAverageRemainingContractualTermwarrantsvested to clbs_WeightedAverageRemainingContractualTermwarrantsvested_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsOtherDisclosuresAbstract" xlink:label="WarrantsOtherDisclosuresAbstract" xlink:title="WarrantsOtherDisclosuresAbstract" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WarrantsOtherDisclosuresAbstract_lbl" xml:lang="en-US" id="clbs_WarrantsOtherDisclosuresAbstract_lbl">Warrants Other Disclosures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="clbs_WarrantsOtherDisclosuresAbstract_lbl" xlink:title="label: WarrantsOtherDisclosuresAbstract to clbs_WarrantsOtherDisclosuresAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsOtherDisclosuresAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WarrantsOtherDisclosuresAbstract_lbl1" xml:lang="en-US" id="clbs_WarrantsOtherDisclosuresAbstract_lbl1">Warrants Other Disclosures [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="clbs_WarrantsOtherDisclosuresAbstract_lbl1" xlink:title="label: WarrantsOtherDisclosuresAbstract to clbs_WarrantsOtherDisclosuresAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsOtherDisclosuresAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WarrantsOtherDisclosuresAbstract_lbl2" xml:lang="en-US" id="clbs_WarrantsOtherDisclosuresAbstract_lbl2">Warrants, Weighted Average Contractual Term and Intrinsic Value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="clbs_WarrantsOtherDisclosuresAbstract_lbl2" xlink:title="label: WarrantsOtherDisclosuresAbstract to clbs_WarrantsOtherDisclosuresAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:label="WeightedAverageExercisePriceWarrantsExpired" xlink:title="WeightedAverageExercisePriceWarrantsExpired" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl">Weighted Average Exercise Price, Warrants Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExpired" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl" xlink:title="label: WeightedAverageExercisePriceWarrantsExpired to clbs_WeightedAverageExercisePriceWarrantsExpired_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl1" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl1">Weighted Average Exercise Price, Warrants Expired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExpired" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl1" xlink:title="label: WeightedAverageExercisePriceWarrantsExpired to clbs_WeightedAverageExercisePriceWarrantsExpired_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl2" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl2">Warrants expired (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExpired" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl2" xlink:title="label: WeightedAverageExercisePriceWarrantsExpired to clbs_WeightedAverageExercisePriceWarrantsExpired_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl3" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl3">Warrants, Expired (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExpired" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExpired_lbl3" xlink:title="label: WeightedAverageExercisePriceWarrantsExpired to clbs_WeightedAverageExercisePriceWarrantsExpired_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueOptionExercised" xlink:label="AggregateIntrinsicValueOptionExercised" xlink:title="AggregateIntrinsicValueOptionExercised" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueOptionExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_AggregateIntrinsicValueOptionExercised_lbl" xml:lang="en-US" id="clbs_AggregateIntrinsicValueOptionExercised_lbl">Aggregate Intrinsic Value, Option Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueOptionExercised" xlink:to="clbs_AggregateIntrinsicValueOptionExercised_lbl" xlink:title="label: AggregateIntrinsicValueOptionExercised to clbs_AggregateIntrinsicValueOptionExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueOptionExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_AggregateIntrinsicValueOptionExercised_lbl1" xml:lang="en-US" id="clbs_AggregateIntrinsicValueOptionExercised_lbl1">Aggregate Intrinsic Value, Option Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueOptionExercised" xlink:to="clbs_AggregateIntrinsicValueOptionExercised_lbl1" xlink:title="label: AggregateIntrinsicValueOptionExercised to clbs_AggregateIntrinsicValueOptionExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_AggregateIntrinsicValueOptionExercised_lbl2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:title="clbs_AggregateIntrinsicValueOptionExercised_lbl2" xml:lang="en-US" id="clbs_AggregateIntrinsicValueOptionExercised_lbl2">Options exercised, aggregate intrinsic value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AggregateIntrinsicValueOptionExercised" xlink:to="clbs_AggregateIntrinsicValueOptionExercised_lbl2" xlink:title="label: AggregateIntrinsicValueOptionExercised to clbs_AggregateIntrinsicValueOptionExercised_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_Sharesvestedandexpectedtovest" xlink:label="Sharesvestedandexpectedtovest" xlink:title="Sharesvestedandexpectedtovest" />
    <link:label xlink:type="resource" xlink:label="clbs_Sharesvestedandexpectedtovest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_Sharesvestedandexpectedtovest_lbl" xml:lang="en-US" id="clbs_Sharesvestedandexpectedtovest_lbl">shares, vested and expected to vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Sharesvestedandexpectedtovest" xlink:to="clbs_Sharesvestedandexpectedtovest_lbl" xlink:title="label: Sharesvestedandexpectedtovest to clbs_Sharesvestedandexpectedtovest_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_Sharesvestedandexpectedtovest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_Sharesvestedandexpectedtovest_lbl1" xml:lang="en-US" id="clbs_Sharesvestedandexpectedtovest_lbl1">shares, vested and expected to vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Sharesvestedandexpectedtovest" xlink:to="clbs_Sharesvestedandexpectedtovest_lbl1" xlink:title="label: Sharesvestedandexpectedtovest to clbs_Sharesvestedandexpectedtovest_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_Sharesvestedandexpectedtovest_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_Sharesvestedandexpectedtovest_lbl2" xml:lang="en-US" id="clbs_Sharesvestedandexpectedtovest_lbl2">Warrants vested or expected to vest (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Sharesvestedandexpectedtovest" xlink:to="clbs_Sharesvestedandexpectedtovest_lbl2" xlink:title="label: Sharesvestedandexpectedtovest to clbs_Sharesvestedandexpectedtovest_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_Sharesvestedandexpectedtovest_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_Sharesvestedandexpectedtovest_lbl3" xml:lang="en-US" id="clbs_Sharesvestedandexpectedtovest_lbl3">Warrants, Vested and expected to vest (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Sharesvestedandexpectedtovest" xlink:to="clbs_Sharesvestedandexpectedtovest_lbl3" xlink:title="label: Sharesvestedandexpectedtovest to clbs_Sharesvestedandexpectedtovest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:label="WeightedAverageExercisePriceWarrantsExercised" xlink:title="WeightedAverageExercisePriceWarrantsExercised" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl">Weighted Average Exercise Price, Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExercised" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl" xlink:title="label: WeightedAverageExercisePriceWarrantsExercised to clbs_WeightedAverageExercisePriceWarrantsExercised_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl1" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl1">Weighted Average Exercise Price, Warrants Exercised</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExercised" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl1" xlink:title="label: WeightedAverageExercisePriceWarrantsExercised to clbs_WeightedAverageExercisePriceWarrantsExercised_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl2" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl2">Warrants exercised (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExercised" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl2" xlink:title="label: WeightedAverageExercisePriceWarrantsExercised to clbs_WeightedAverageExercisePriceWarrantsExercised_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl3" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl3">Warrants, Exercised (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsExercised" xlink:to="clbs_WeightedAverageExercisePriceWarrantsExercised_lbl3" xlink:title="label: WeightedAverageExercisePriceWarrantsExercised to clbs_WeightedAverageExercisePriceWarrantsExercised_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:label="WeightedAverageExercisePriceWarrantsGranted" xlink:title="WeightedAverageExercisePriceWarrantsGranted" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl">Weighted Average Exercise Price, Warrants Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsGranted" xlink:to="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl" xlink:title="label: WeightedAverageExercisePriceWarrantsGranted to clbs_WeightedAverageExercisePriceWarrantsGranted_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl1" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl1">Weighted Average Exercise Price, Warrants Granted</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsGranted" xlink:to="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl1" xlink:title="label: WeightedAverageExercisePriceWarrantsGranted to clbs_WeightedAverageExercisePriceWarrantsGranted_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl2" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl2">Warrants granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsGranted" xlink:to="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl2" xlink:title="label: WeightedAverageExercisePriceWarrantsGranted to clbs_WeightedAverageExercisePriceWarrantsGranted_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl3" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl3">Warrants, Granted (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsGranted" xlink:to="clbs_WeightedAverageExercisePriceWarrantsGranted_lbl3" xlink:title="label: WeightedAverageExercisePriceWarrantsGranted to clbs_WeightedAverageExercisePriceWarrantsGranted_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:label="WeightedAverageExercisePriceWarrantsCanceled" xlink:title="WeightedAverageExercisePriceWarrantsCanceled" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl">Weighted Average Exercise Price, Warrants Canceled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsCanceled" xlink:to="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl" xlink:title="label: WeightedAverageExercisePriceWarrantsCanceled to clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl1" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl1">Weighted Average Exercise Price, Warrants Canceled</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsCanceled" xlink:to="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl1" xlink:title="label: WeightedAverageExercisePriceWarrantsCanceled to clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl2" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl2">Warrants forfeited (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsCanceled" xlink:to="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl2" xlink:title="label: WeightedAverageExercisePriceWarrantsCanceled to clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl3" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl3">Warrants, Forfeited (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsCanceled" xlink:to="clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl3" xlink:title="label: WeightedAverageExercisePriceWarrantsCanceled to clbs_WeightedAverageExercisePriceWarrantsCanceled_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="WeightedAverageExercisePriceWarrantsOutstanding" xlink:title="WeightedAverageExercisePriceWarrantsOutstanding" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl">Weighted Average Exercise Price, Warrants Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsOutstanding" xlink:to="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl" xlink:title="label: WeightedAverageExercisePriceWarrantsOutstanding to clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl1" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl1">Weighted Average Exercise Price, Warrants Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsOutstanding" xlink:to="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl1" xlink:title="label: WeightedAverageExercisePriceWarrantsOutstanding to clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl2" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl2" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl2">Warrants outstanding, beginning balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsOutstanding" xlink:to="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl2" xlink:title="label: WeightedAverageExercisePriceWarrantsOutstanding to clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl3" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl3" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl3">Warrants outstanding, ending balance (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsOutstanding" xlink:to="clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl3" xlink:title="label: WeightedAverageExercisePriceWarrantsOutstanding to clbs_WeightedAverageExercisePriceWarrantsOutstanding_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:label="WarrantsWeightedAverageExercisePriceRollForward" xlink:title="WarrantsWeightedAverageExercisePriceRollForward" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl" xml:lang="en-US" id="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl">Warrants Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl" xlink:title="label: WarrantsWeightedAverageExercisePriceRollForward to clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl1" xml:lang="en-US" id="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl1">Warrants Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl1" xlink:title="label: WarrantsWeightedAverageExercisePriceRollForward to clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl2" xml:lang="en-US" id="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl2">Warrants, Weighted Average Exercise Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl2" xlink:title="label: WarrantsWeightedAverageExercisePriceRollForward to clbs_WarrantsWeightedAverageExercisePriceRollForward_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:label="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:title="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:to="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl" xlink:title="label: WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest to clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl1" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl1">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:to="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl1" xlink:title="label: WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest to clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl2" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl2">Warrants vested or expected to vest (in dollars per share)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:to="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl2" xlink:title="label: WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest to clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl3" xml:lang="en-US" id="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl3">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:to="clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl3" xlink:title="label: WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest to clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:label="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:title="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl">Effective Income Tax Rate Reconciliation, Section 382 NOL Limitation, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount to clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl1" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl1">Effective Income Tax Rate Reconciliation, Section 382 NOL Limitation, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount to clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl2" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl2">Section 382 NOL Limitation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl2" xlink:title="label: EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount to clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:label="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:title="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl">Effective Income Tax Rate Reconciliation, Change in State Deferred, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount to clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl1" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl1">Effective Income Tax Rate Reconciliation, Change in State Deferred, Amount</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount to clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl2" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl2">Change in state deferred</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl2" xlink:title="label: EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount to clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:label="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:title="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl">Effective Income Tax Rate Reconciliation, Sale Of State Net Operating Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl" xlink:title="label: EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses to clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl1" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl1">Effective Income Tax Rate Reconciliation, Sale Of State Net Operating Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl1" xlink:title="label: EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses to clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl2" xml:lang="en-US" id="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl2">Sale of New Jersey State NOLs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:to="clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl2" xlink:title="label: EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses to clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_DeferredTaxAssetsRightOfUseLiability" xlink:label="DeferredTaxAssetsRightOfUseLiability" xlink:title="DeferredTaxAssetsRightOfUseLiability" />
    <link:label xlink:type="resource" xlink:label="clbs_DeferredTaxAssetsRightOfUseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_DeferredTaxAssetsRightOfUseLiability_lbl" xml:lang="en-US" id="clbs_DeferredTaxAssetsRightOfUseLiability_lbl">Deferred Tax Assets, Right Of Use Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiability" xlink:to="clbs_DeferredTaxAssetsRightOfUseLiability_lbl" xlink:title="label: DeferredTaxAssetsRightOfUseLiability to clbs_DeferredTaxAssetsRightOfUseLiability_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_DeferredTaxAssetsRightOfUseLiability_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_DeferredTaxAssetsRightOfUseLiability_lbl1" xml:lang="en-US" id="clbs_DeferredTaxAssetsRightOfUseLiability_lbl1">Deferred Tax Assets, Right Of Use Liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiability" xlink:to="clbs_DeferredTaxAssetsRightOfUseLiability_lbl1" xlink:title="label: DeferredTaxAssetsRightOfUseLiability to clbs_DeferredTaxAssetsRightOfUseLiability_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_DeferredTaxAssetsRightOfUseLiability_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_DeferredTaxAssetsRightOfUseLiability_lbl2" xml:lang="en-US" id="clbs_DeferredTaxAssetsRightOfUseLiability_lbl2">Right of use liability</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsRightOfUseLiability" xlink:to="clbs_DeferredTaxAssetsRightOfUseLiability_lbl2" xlink:title="label: DeferredTaxAssetsRightOfUseLiability to clbs_DeferredTaxAssetsRightOfUseLiability_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_DeferredTaxAssetsAccumulatedDepreciation" xlink:label="DeferredTaxAssetsAccumulatedDepreciation" xlink:title="DeferredTaxAssetsAccumulatedDepreciation" />
    <link:label xlink:type="resource" xlink:label="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl" xml:lang="en-US" id="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl">Deferred Tax Assets, Accumulated Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsAccumulatedDepreciation" xlink:to="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl" xlink:title="label: DeferredTaxAssetsAccumulatedDepreciation to clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl1" xml:lang="en-US" id="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl1">Deferred Tax Assets, Accumulated Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsAccumulatedDepreciation" xlink:to="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl1" xlink:title="label: DeferredTaxAssetsAccumulatedDepreciation to clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl2" xml:lang="en-US" id="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl2">Accumulated depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DeferredTaxAssetsAccumulatedDepreciation" xlink:to="clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl2" xlink:title="label: DeferredTaxAssetsAccumulatedDepreciation to clbs_DeferredTaxAssetsAccumulatedDepreciation_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NetDeferredTaxAssetsAndLiabilitiesGross" xlink:label="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:title="NetDeferredTaxAssetsAndLiabilitiesGross" />
    <link:label xlink:type="resource" xlink:label="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl" xml:lang="en-US" id="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl">Net Deferred Tax Assets And Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:to="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl" xlink:title="label: NetDeferredTaxAssetsAndLiabilitiesGross to clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl1" xml:lang="en-US" id="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl1">Net Deferred Tax Assets And Liabilities, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:to="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl1" xlink:title="label: NetDeferredTaxAssetsAndLiabilitiesGross to clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:title="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl2" xml:lang="en-US" id="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl2">Net deferred tax assets and liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:to="clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl2" xlink:title="label: NetDeferredTaxAssetsAndLiabilitiesGross to clbs_NetDeferredTaxAssetsAndLiabilitiesGross_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:label="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl">Operating Loss Carryforwards, Annual Available, Five Years, Net Unrealized Built In Gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:to="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl" xlink:title="label: OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain to clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl1" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl1">Operating Loss Carryforwards, Annual Available, Five Years, Net Unrealized Built In Gain</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:to="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl1" xlink:title="label: OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain to clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl2" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl2">Possible additional NOLs for five years resulting from Net Unrealized Built-in Gain rules</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:to="clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl2" xlink:title="label: OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain to clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" />
    <link:label xlink:type="resource" xlink:label="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl" xml:lang="en-US" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl">Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:to="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl" xlink:title="label: ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross to clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl1" xml:lang="en-US" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl1">Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:to="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl1" xlink:title="label: ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross to clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl2" xml:lang="en-US" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl2">Proceeds from sale of NOLs, gross</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:to="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl2" xlink:title="label: ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross to clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:label="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="OperatingLossCarryforwardsSetToExpireWrittenDown" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl">Operating Loss Carryforwards, Set To Expire, Written Down</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:to="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl" xlink:title="label: OperatingLossCarryforwardsSetToExpireWrittenDown to clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl1" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl1">Operating Loss Carryforwards, Set To Expire, Written Down</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:to="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl1" xlink:title="label: OperatingLossCarryforwardsSetToExpireWrittenDown to clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl2" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl2">Write down of NOLs set to expire unutilized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:to="clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl2" xlink:title="label: OperatingLossCarryforwardsSetToExpireWrittenDown to clbs_OperatingLossCarryforwardsSetToExpireWrittenDown_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:label="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="OperatingLossCarryforwardsBeforeWriteDown" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl">Operating Loss Carryforwards, Before Write Down</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsBeforeWriteDown" xlink:to="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl" xlink:title="label: OperatingLossCarryforwardsBeforeWriteDown to clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl1" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl1">Operating Loss Carryforwards, Before Write Down</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsBeforeWriteDown" xlink:to="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl1" xlink:title="label: OperatingLossCarryforwardsBeforeWriteDown to clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl2" xml:lang="en-US" id="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl2">Net operating loss carryforwards, prior to write down</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLossCarryforwardsBeforeWriteDown" xlink:to="clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl2" xlink:title="label: OperatingLossCarryforwardsBeforeWriteDown to clbs_OperatingLossCarryforwardsBeforeWriteDown_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" />
    <link:label xlink:type="resource" xlink:label="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl" xml:lang="en-US" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl">Proceeds From Sale Of Net Operating Losses, NJEDA Program</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:to="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl" xlink:title="label: ProceedsFromSaleOfNetOperatingLossesNJEDAProgram to clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl1" xml:lang="en-US" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl1">Proceeds From Sale Of Net Operating Losses, NJEDA Program</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:to="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl1" xlink:title="label: ProceedsFromSaleOfNetOperatingLossesNJEDAProgram to clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl2" xml:lang="en-US" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl2">Proceeds from sale of NOLs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:to="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl2" xlink:title="label: ProceedsFromSaleOfNetOperatingLossesNJEDAProgram to clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl3" xml:lang="en-US" id="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl3">Net proceeds from sale of NOLs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:to="clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl3" xlink:title="label: ProceedsFromSaleOfNetOperatingLossesNJEDAProgram to clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LossOnSaleOfNetOperatingLosses" xlink:label="LossOnSaleOfNetOperatingLosses" xlink:title="LossOnSaleOfNetOperatingLosses" />
    <link:label xlink:type="resource" xlink:label="clbs_LossOnSaleOfNetOperatingLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_LossOnSaleOfNetOperatingLosses_lbl" xml:lang="en-US" id="clbs_LossOnSaleOfNetOperatingLosses_lbl">Loss On Sale Of Net Operating Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnSaleOfNetOperatingLosses" xlink:to="clbs_LossOnSaleOfNetOperatingLosses_lbl" xlink:title="label: LossOnSaleOfNetOperatingLosses to clbs_LossOnSaleOfNetOperatingLosses_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_LossOnSaleOfNetOperatingLosses_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_LossOnSaleOfNetOperatingLosses_lbl1" xml:lang="en-US" id="clbs_LossOnSaleOfNetOperatingLosses_lbl1">Loss On Sale Of Net Operating Losses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnSaleOfNetOperatingLosses" xlink:to="clbs_LossOnSaleOfNetOperatingLosses_lbl1" xlink:title="label: LossOnSaleOfNetOperatingLosses to clbs_LossOnSaleOfNetOperatingLosses_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_LossOnSaleOfNetOperatingLosses_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_LossOnSaleOfNetOperatingLosses_lbl2" xml:lang="en-US" id="clbs_LossOnSaleOfNetOperatingLosses_lbl2">Loss on sale of NOLs</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LossOnSaleOfNetOperatingLosses" xlink:to="clbs_LossOnSaleOfNetOperatingLosses_lbl2" xlink:title="label: LossOnSaleOfNetOperatingLosses to clbs_LossOnSaleOfNetOperatingLosses_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_BusinessTextBlock" xlink:label="BusinessTextBlock" xlink:title="BusinessTextBlock" />
    <link:label xlink:type="resource" xlink:label="clbs_BusinessTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_BusinessTextBlock_lbl" xml:lang="en-US" id="clbs_BusinessTextBlock_lbl">The Business [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessTextBlock" xlink:to="clbs_BusinessTextBlock_lbl" xlink:title="label: BusinessTextBlock to clbs_BusinessTextBlock_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_BusinessTextBlock_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_BusinessTextBlock_lbl1" xml:lang="en-US" id="clbs_BusinessTextBlock_lbl1">The Business [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessTextBlock" xlink:to="clbs_BusinessTextBlock_lbl1" xlink:title="label: BusinessTextBlock to clbs_BusinessTextBlock_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_BusinessTextBlock_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_BusinessTextBlock_lbl2" xml:lang="en-US" id="clbs_BusinessTextBlock_lbl2">The Business</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BusinessTextBlock" xlink:to="clbs_BusinessTextBlock_lbl2" xlink:title="label: BusinessTextBlock to clbs_BusinessTextBlock_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:label="OperatingLeaseRightOfUseAssetAbstract" xlink:title="OperatingLeaseRightOfUseAssetAbstract" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl" xml:lang="en-US" id="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl">Operating Lease, Right-Of-Use Asset</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAbstract" xlink:to="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl" xlink:title="label: OperatingLeaseRightOfUseAssetAbstract to clbs_OperatingLeaseRightOfUseAssetAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl1" xml:lang="en-US" id="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl1">Operating Lease, Right-Of-Use Asset [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAbstract" xlink:to="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl1" xlink:title="label: OperatingLeaseRightOfUseAssetAbstract to clbs_OperatingLeaseRightOfUseAssetAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl2" xml:lang="en-US" id="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl2">Right-of Use Assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OperatingLeaseRightOfUseAssetAbstract" xlink:to="clbs_OperatingLeaseRightOfUseAssetAbstract_lbl2" xlink:title="label: OperatingLeaseRightOfUseAssetAbstract to clbs_OperatingLeaseRightOfUseAssetAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NumberOfOfficesUnderOperatingLeases" xlink:label="NumberOfOfficesUnderOperatingLeases" xlink:title="NumberOfOfficesUnderOperatingLeases" />
    <link:label xlink:type="resource" xlink:label="clbs_NumberOfOfficesUnderOperatingLeases_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_NumberOfOfficesUnderOperatingLeases_lbl" xml:lang="en-US" id="clbs_NumberOfOfficesUnderOperatingLeases_lbl">Number Of Offices Under Operating Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOfficesUnderOperatingLeases" xlink:to="clbs_NumberOfOfficesUnderOperatingLeases_lbl" xlink:title="label: NumberOfOfficesUnderOperatingLeases to clbs_NumberOfOfficesUnderOperatingLeases_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_NumberOfOfficesUnderOperatingLeases_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_NumberOfOfficesUnderOperatingLeases_lbl1" xml:lang="en-US" id="clbs_NumberOfOfficesUnderOperatingLeases_lbl1">Number Of Offices Under Operating Leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOfficesUnderOperatingLeases" xlink:to="clbs_NumberOfOfficesUnderOperatingLeases_lbl1" xlink:title="label: NumberOfOfficesUnderOperatingLeases to clbs_NumberOfOfficesUnderOperatingLeases_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_NumberOfOfficesUnderOperatingLeases_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_NumberOfOfficesUnderOperatingLeases_lbl2" xml:lang="en-US" id="clbs_NumberOfOfficesUnderOperatingLeases_lbl2">Number of offices under operating leases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberOfOfficesUnderOperatingLeases" xlink:to="clbs_NumberOfOfficesUnderOperatingLeases_lbl2" xlink:title="label: NumberOfOfficesUnderOperatingLeases to clbs_NumberOfOfficesUnderOperatingLeases_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" />
    <link:label xlink:type="resource" xlink:label="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xml:lang="en-US" id="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl">Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl" xlink:title="label: IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities to clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl1" xml:lang="en-US" id="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl1">Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl1" xlink:title="label: IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities to clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl2" xml:lang="en-US" id="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl2">Accounts payable, accrued liabilities and other liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:to="clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl2" xlink:title="label: IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities to clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:label="OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:title="OfferingPeriodsEmployeeStockPurchasePlanTerm" />
    <link:label xlink:type="resource" xlink:label="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl" xml:lang="en-US" id="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl">Offering Periods, Employee Stock Purchase Plan, Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:to="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl" xlink:title="label: OfferingPeriodsEmployeeStockPurchasePlanTerm to clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl1" xml:lang="en-US" id="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl1">Offering Periods, Employee Stock Purchase Plan, Term</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:to="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl1" xlink:title="label: OfferingPeriodsEmployeeStockPurchasePlanTerm to clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl2" xml:lang="en-US" id="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl2">Term of offering period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:to="clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl2" xlink:title="label: OfferingPeriodsEmployeeStockPurchasePlanTerm to clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:label="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:title="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl">Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Exercise Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:to="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl" xlink:title="label: EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate to clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl1" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl1">Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Exercise Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:to="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl1" xlink:title="label: EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate to clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl2" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl2">Purchase price measurement as percent of closing price on exercise date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:to="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl2" xlink:title="label: EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate to clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:label="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:title="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl">Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:to="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl" xlink:title="label: EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee to clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl1" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl1">Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:to="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl1" xlink:title="label: EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee to clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl2" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl2">Maximum annual contribution per employee</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:to="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl2" xlink:title="label: EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee to clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:label="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:title="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl">Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:to="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl" xlink:title="label: EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent to clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl1" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl1">Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:to="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl1" xlink:title="label: EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent to clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl2" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl2">Maximum annual contribution per employee as percent of annual salary</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:to="clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl2" xlink:title="label: EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent to clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:label="NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:title="NumberofOfferingPeriodsEmployeeStockPurchasePlan" />
    <link:label xlink:type="resource" xlink:label="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl" xml:lang="en-US" id="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl">Number of Offering Periods, Employee Stock Purchase Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:to="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl" xlink:title="label: NumberofOfferingPeriodsEmployeeStockPurchasePlan to clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl1" xml:lang="en-US" id="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl1">Number of Offering Periods, Employee Stock Purchase Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:to="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl1" xlink:title="label: NumberofOfferingPeriodsEmployeeStockPurchasePlan to clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl2" xml:lang="en-US" id="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl2">Number of offering periods</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:to="clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl2" xlink:title="label: NumberofOfferingPeriodsEmployeeStockPurchasePlan to clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:label="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:title="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl">Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Enrollment Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:to="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl" xlink:title="label: EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate to clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl1" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl1">Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Enrollment Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:to="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl1" xlink:title="label: EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate to clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl2" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl2">Purchase price measurement as percent of closing price on enrollment date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:to="clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl2" xlink:title="label: EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate to clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EquityIncentiveCompensationPlan2018Member" xlink:label="EquityIncentiveCompensationPlan2018Member" xlink:title="EquityIncentiveCompensationPlan2018Member" />
    <link:label xlink:type="resource" xlink:label="clbs_EquityIncentiveCompensationPlan2018Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EquityIncentiveCompensationPlan2018Member_lbl" xml:lang="en-US" id="clbs_EquityIncentiveCompensationPlan2018Member_lbl">Equity Incentive Compensation Plan 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentiveCompensationPlan2018Member" xlink:to="clbs_EquityIncentiveCompensationPlan2018Member_lbl" xlink:title="label: EquityIncentiveCompensationPlan2018Member to clbs_EquityIncentiveCompensationPlan2018Member_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EquityIncentiveCompensationPlan2018Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EquityIncentiveCompensationPlan2018Member_lbl1" xml:lang="en-US" id="clbs_EquityIncentiveCompensationPlan2018Member_lbl1">Equity Incentive Compensation Plan 2018 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentiveCompensationPlan2018Member" xlink:to="clbs_EquityIncentiveCompensationPlan2018Member_lbl1" xlink:title="label: EquityIncentiveCompensationPlan2018Member to clbs_EquityIncentiveCompensationPlan2018Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EquityIncentiveCompensationPlan2018Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EquityIncentiveCompensationPlan2018Member_lbl2" xml:lang="en-US" id="clbs_EquityIncentiveCompensationPlan2018Member_lbl2">2018 Plan</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EquityIncentiveCompensationPlan2018Member" xlink:to="clbs_EquityIncentiveCompensationPlan2018Member_lbl2" xlink:title="label: EquityIncentiveCompensationPlan2018Member to clbs_EquityIncentiveCompensationPlan2018Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMember" xlink:label="EmployeeStockPurchasePlanMember" xlink:title="EmployeeStockPurchasePlanMember" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EmployeeStockPurchasePlanMember_lbl" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMember_lbl">Employee Stock Purchase Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMember" xlink:to="clbs_EmployeeStockPurchasePlanMember_lbl" xlink:title="label: EmployeeStockPurchasePlanMember to clbs_EmployeeStockPurchasePlanMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EmployeeStockPurchasePlanMember_lbl1" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMember_lbl1">Employee Stock Purchase Plan [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMember" xlink:to="clbs_EmployeeStockPurchasePlanMember_lbl1" xlink:title="label: EmployeeStockPurchasePlanMember to clbs_EmployeeStockPurchasePlanMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlanMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EmployeeStockPurchasePlanMember_lbl2" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlanMember_lbl2">ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlanMember" xlink:to="clbs_EmployeeStockPurchasePlanMember_lbl2" xlink:title="label: EmployeeStockPurchasePlanMember to clbs_EmployeeStockPurchasePlanMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2017Member" xlink:label="EmployeeStockPurchasePlan2017Member" xlink:title="EmployeeStockPurchasePlan2017Member" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2017Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EmployeeStockPurchasePlan2017Member_lbl" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2017Member_lbl">Employee Stock Purchase Plan 2017 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2017Member" xlink:to="clbs_EmployeeStockPurchasePlan2017Member_lbl" xlink:title="label: EmployeeStockPurchasePlan2017Member to clbs_EmployeeStockPurchasePlan2017Member_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2017Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EmployeeStockPurchasePlan2017Member_lbl1" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2017Member_lbl1">Employee Stock Purchase Plan 2017 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2017Member" xlink:to="clbs_EmployeeStockPurchasePlan2017Member_lbl1" xlink:title="label: EmployeeStockPurchasePlan2017Member to clbs_EmployeeStockPurchasePlan2017Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2017Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EmployeeStockPurchasePlan2017Member_lbl2" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2017Member_lbl2">2017 ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2017Member" xlink:to="clbs_EmployeeStockPurchasePlan2017Member_lbl2" xlink:title="label: EmployeeStockPurchasePlan2017Member to clbs_EmployeeStockPurchasePlan2017Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2017AmendedMember" xlink:label="EmployeeStockPurchasePlan2017AmendedMember" xlink:title="EmployeeStockPurchasePlan2017AmendedMember" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl">Employee Stock Purchase Plan 2017 Amended [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2017AmendedMember" xlink:to="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl" xlink:title="label: EmployeeStockPurchasePlan2017AmendedMember to clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl1" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl1">Employee Stock Purchase Plan 2017 Amended [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2017AmendedMember" xlink:to="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl1" xlink:title="label: EmployeeStockPurchasePlan2017AmendedMember to clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl2" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl2">Amended 2017 ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2017AmendedMember" xlink:to="clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl2" xlink:title="label: EmployeeStockPurchasePlan2017AmendedMember to clbs_EmployeeStockPurchasePlan2017AmendedMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2012Member" xlink:label="EmployeeStockPurchasePlan2012Member" xlink:title="EmployeeStockPurchasePlan2012Member" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2012Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_EmployeeStockPurchasePlan2012Member_lbl" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2012Member_lbl">Employee Stock Purchase Plan 2012 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2012Member" xlink:to="clbs_EmployeeStockPurchasePlan2012Member_lbl" xlink:title="label: EmployeeStockPurchasePlan2012Member to clbs_EmployeeStockPurchasePlan2012Member_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2012Member_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_EmployeeStockPurchasePlan2012Member_lbl1" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2012Member_lbl1">Employee Stock Purchase Plan 2012 [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2012Member" xlink:to="clbs_EmployeeStockPurchasePlan2012Member_lbl1" xlink:title="label: EmployeeStockPurchasePlan2012Member to clbs_EmployeeStockPurchasePlan2012Member_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_EmployeeStockPurchasePlan2012Member_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_EmployeeStockPurchasePlan2012Member_lbl2" xml:lang="en-US" id="clbs_EmployeeStockPurchasePlan2012Member_lbl2">2012 ESPP</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EmployeeStockPurchasePlan2012Member" xlink:to="clbs_EmployeeStockPurchasePlan2012Member_lbl2" xlink:title="label: EmployeeStockPurchasePlan2012Member to clbs_EmployeeStockPurchasePlan2012Member_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:label="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:title="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" />
    <link:label xlink:type="resource" xlink:label="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl" xml:lang="en-US" id="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl">Restricted Stock And Restricted Stock Units Issued [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:to="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl" xlink:title="label: RestrictedStockAndRestrictedStockUnitsIssuedAbstract to clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl1" xml:lang="en-US" id="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl1">Restricted Stock And Restricted Stock Units Issued [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:to="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl1" xlink:title="label: RestrictedStockAndRestrictedStockUnitsIssuedAbstract to clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl2" xml:lang="en-US" id="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl2">Restricted Stock and Restricted Stock Units</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:to="clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl2" xlink:title="label: RestrictedStockAndRestrictedStockUnitsIssuedAbstract to clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProgressPaymentOnGrantAwardCashReceived" xlink:label="ProgressPaymentOnGrantAwardCashReceived" xlink:title="ProgressPaymentOnGrantAwardCashReceived" />
    <link:label xlink:type="resource" xlink:label="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl" xml:lang="en-US" id="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl">Progress Payment On Grant Award, Cash Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressPaymentOnGrantAwardCashReceived" xlink:to="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl" xlink:title="label: ProgressPaymentOnGrantAwardCashReceived to clbs_ProgressPaymentOnGrantAwardCashReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl1" xml:lang="en-US" id="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl1">Progress Payment On Grant Award, Cash Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressPaymentOnGrantAwardCashReceived" xlink:to="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl1" xlink:title="label: ProgressPaymentOnGrantAwardCashReceived to clbs_ProgressPaymentOnGrantAwardCashReceived_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl2" xml:lang="en-US" id="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl2">Progress payment received on grant award</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ProgressPaymentOnGrantAwardCashReceived" xlink:to="clbs_ProgressPaymentOnGrantAwardCashReceived_lbl2" xlink:title="label: ProgressPaymentOnGrantAwardCashReceived to clbs_ProgressPaymentOnGrantAwardCashReceived_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_FundingAmountAwarded" xlink:label="FundingAmountAwarded" xlink:title="FundingAmountAwarded" />
    <link:label xlink:type="resource" xlink:label="clbs_FundingAmountAwarded_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_FundingAmountAwarded_lbl" xml:lang="en-US" id="clbs_FundingAmountAwarded_lbl">Funding Amount Awarded</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FundingAmountAwarded" xlink:to="clbs_FundingAmountAwarded_lbl" xlink:title="label: FundingAmountAwarded to clbs_FundingAmountAwarded_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_FundingAmountAwarded_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_FundingAmountAwarded_lbl1" xml:lang="en-US" id="clbs_FundingAmountAwarded_lbl1">Funding Amount Awarded</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FundingAmountAwarded" xlink:to="clbs_FundingAmountAwarded_lbl1" xlink:title="label: FundingAmountAwarded to clbs_FundingAmountAwarded_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_FundingAmountAwarded_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_FundingAmountAwarded_lbl2" xml:lang="en-US" id="clbs_FundingAmountAwarded_lbl2">Total funding amount awarded</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FundingAmountAwarded" xlink:to="clbs_FundingAmountAwarded_lbl2" xlink:title="label: FundingAmountAwarded to clbs_FundingAmountAwarded_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MilestonePaymentOnGrantAwardCashReceived" xlink:label="MilestonePaymentOnGrantAwardCashReceived" xlink:title="MilestonePaymentOnGrantAwardCashReceived" />
    <link:label xlink:type="resource" xlink:label="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl" xml:lang="en-US" id="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl">Milestone Payment On Grant Award, Cash Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePaymentOnGrantAwardCashReceived" xlink:to="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl" xlink:title="label: MilestonePaymentOnGrantAwardCashReceived to clbs_MilestonePaymentOnGrantAwardCashReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl1" xml:lang="en-US" id="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl1">Milestone Payment On Grant Award, Cash Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePaymentOnGrantAwardCashReceived" xlink:to="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl1" xlink:title="label: MilestonePaymentOnGrantAwardCashReceived to clbs_MilestonePaymentOnGrantAwardCashReceived_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl2" xml:lang="en-US" id="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl2">Milestone payment received on grant award</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="MilestonePaymentOnGrantAwardCashReceived" xlink:to="clbs_MilestonePaymentOnGrantAwardCashReceived_lbl2" xlink:title="label: MilestonePaymentOnGrantAwardCashReceived to clbs_MilestonePaymentOnGrantAwardCashReceived_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_FundingOfGrantAwardCashReceived" xlink:label="FundingOfGrantAwardCashReceived" xlink:title="FundingOfGrantAwardCashReceived" />
    <link:label xlink:type="resource" xlink:label="clbs_FundingOfGrantAwardCashReceived_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_FundingOfGrantAwardCashReceived_lbl" xml:lang="en-US" id="clbs_FundingOfGrantAwardCashReceived_lbl">Funding Of Grant Award, Cash Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FundingOfGrantAwardCashReceived" xlink:to="clbs_FundingOfGrantAwardCashReceived_lbl" xlink:title="label: FundingOfGrantAwardCashReceived to clbs_FundingOfGrantAwardCashReceived_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_FundingOfGrantAwardCashReceived_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_FundingOfGrantAwardCashReceived_lbl1" xml:lang="en-US" id="clbs_FundingOfGrantAwardCashReceived_lbl1">Funding Of Grant Award, Cash Received</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FundingOfGrantAwardCashReceived" xlink:to="clbs_FundingOfGrantAwardCashReceived_lbl1" xlink:title="label: FundingOfGrantAwardCashReceived to clbs_FundingOfGrantAwardCashReceived_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_FundingOfGrantAwardCashReceived_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_FundingOfGrantAwardCashReceived_lbl2" xml:lang="en-US" id="clbs_FundingOfGrantAwardCashReceived_lbl2">Funding of grant award</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FundingOfGrantAwardCashReceived" xlink:to="clbs_FundingOfGrantAwardCashReceived_lbl2" xlink:title="label: FundingOfGrantAwardCashReceived to clbs_FundingOfGrantAwardCashReceived_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:label="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:title="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" />
    <link:label xlink:type="resource" xlink:label="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl" xml:lang="en-US" id="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl">Amortization Of Accrued Grant Funding Liability To Offset Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:to="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl" xlink:title="label: AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense to clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl1" xml:lang="en-US" id="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl1">Amortization Of Accrued Grant Funding Liability To Offset Expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:to="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl1" xlink:title="label: AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense to clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl2" xml:lang="en-US" id="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl2">Amortization of accrued grant funding to offset expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:to="clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl2" xlink:title="label: AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense to clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl" xml:lang="en-US" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl">Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:to="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl" xlink:title="label: SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod to clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl1" xml:lang="en-US" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl1">Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:to="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl1" xlink:title="label: SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod to clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl2" xml:lang="en-US" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl2">Maximum shares allowed in Accelerated Purchase as percent of shares traded during specified period (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:to="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl2" xlink:title="label: SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod to clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AtTheMarketOfferingAgreementMember" xlink:label="AtTheMarketOfferingAgreementMember" xlink:title="AtTheMarketOfferingAgreementMember" />
    <link:label xlink:type="resource" xlink:label="clbs_AtTheMarketOfferingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_AtTheMarketOfferingAgreementMember_lbl" xml:lang="en-US" id="clbs_AtTheMarketOfferingAgreementMember_lbl">At The Market Offering Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AtTheMarketOfferingAgreementMember" xlink:to="clbs_AtTheMarketOfferingAgreementMember_lbl" xlink:title="label: AtTheMarketOfferingAgreementMember to clbs_AtTheMarketOfferingAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_AtTheMarketOfferingAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_AtTheMarketOfferingAgreementMember_lbl1" xml:lang="en-US" id="clbs_AtTheMarketOfferingAgreementMember_lbl1">At The Market Offering Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AtTheMarketOfferingAgreementMember" xlink:to="clbs_AtTheMarketOfferingAgreementMember_lbl1" xlink:title="label: AtTheMarketOfferingAgreementMember to clbs_AtTheMarketOfferingAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_AtTheMarketOfferingAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_AtTheMarketOfferingAgreementMember_lbl2" xml:lang="en-US" id="clbs_AtTheMarketOfferingAgreementMember_lbl2">ATM Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AtTheMarketOfferingAgreementMember" xlink:to="clbs_AtTheMarketOfferingAgreementMember_lbl2" xlink:title="label: AtTheMarketOfferingAgreementMember to clbs_AtTheMarketOfferingAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:label="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" />
    <link:label xlink:type="resource" xlink:label="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl" xml:lang="en-US" id="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl">Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:to="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl" xlink:title="label: RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty to clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl1" xml:lang="en-US" id="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl1">Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:to="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl1" xlink:title="label: RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty to clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl2" xml:lang="en-US" id="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl2">Maximum beneficial ownership allowable per agreement (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:to="clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl2" xlink:title="label: RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty to clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:label="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl" xml:lang="en-US" id="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl">Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:to="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl" xlink:title="label: SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase to clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl1" xml:lang="en-US" id="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl1">Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:to="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl1" xlink:title="label: SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase to clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl2" xml:lang="en-US" id="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl2">Maximum obligation per directed purchase transaction for Regular Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:to="clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl2" xlink:title="label: SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase to clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:label="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:title="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl" xml:lang="en-US" id="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl">Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:to="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl" xlink:title="label: SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent to clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl1" xml:lang="en-US" id="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl1">Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:to="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl1" xlink:title="label: SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent to clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl2" xml:lang="en-US" id="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl2">Commission on gross proceeds due to third party (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:to="clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl2" xlink:title="label: SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent to clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl" xml:lang="en-US" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl">Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:to="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl" xlink:title="label: SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase to clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl1" xml:lang="en-US" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl1">Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:to="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl1" xlink:title="label: SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase to clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl2" xml:lang="en-US" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl2">Maximum shares allowed in Accelerated Purchase as percent of shares in Regular Purchase (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:to="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl2" xlink:title="label: SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase to clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl3" xml:lang="en-US" id="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl3">Maximum shares allowed in Accelerated Purchase as percent of shares In Regular Purchase (percent)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:to="clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl3" xlink:title="label: SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase to clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:label="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl" xml:lang="en-US" id="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl">Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:to="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl" xlink:title="label: SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase to clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl1" xml:lang="en-US" id="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl1">Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:to="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl1" xlink:title="label: SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase to clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl2" xml:lang="en-US" id="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl2">Number of shares allowable to direct for Regular Purchase (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:to="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl2" xlink:title="label: SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase to clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl3" xml:lang="en-US" id="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl3">Number of shares allowable to direct for Regular Purchase (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:to="clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl3" xlink:title="label: SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase to clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:label="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl" xml:lang="en-US" id="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl">Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:to="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl" xlink:title="label: SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement to clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl1" xml:lang="en-US" id="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl1">Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:to="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl1" xlink:title="label: SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement to clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl2" xml:lang="en-US" id="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl2">Aggregate offering amount authorized per agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:to="clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl2" xlink:title="label: SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement to clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:label="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl" xml:lang="en-US" id="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl">Purchase Agreement, Accelerated Purchase Specified Stock Floor Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:to="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl" xlink:title="label: PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice to clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl1" xml:lang="en-US" id="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl1">Purchase Agreement, Accelerated Purchase Specified Stock Floor Price</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:to="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl1" xlink:title="label: PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice to clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl2" xml:lang="en-US" id="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl2">Accelerated purchases specified floor price threshold for directed purchases</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:to="clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl2" xlink:title="label: PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice to clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:label="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="StockIssuedDuringPeriodSharesIssuedAsConsideration" />
    <link:label xlink:type="resource" xlink:label="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl" xml:lang="en-US" id="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl">Stock Issued During Period, Shares, Issued As Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:to="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl" xlink:title="label: StockIssuedDuringPeriodSharesIssuedAsConsideration to clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl1" xml:lang="en-US" id="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl1">Stock Issued During Period, Shares, Issued As Consideration</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:to="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl1" xlink:title="label: StockIssuedDuringPeriodSharesIssuedAsConsideration to clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl2" xml:lang="en-US" id="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl2">Commitment shares issued as consideration per agreement (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:to="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl2" xlink:title="label: StockIssuedDuringPeriodSharesIssuedAsConsideration to clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl3" xml:lang="en-US" id="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl3">Commitment shares issued as consideration per agreement (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:to="clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl3" xlink:title="label: StockIssuedDuringPeriodSharesIssuedAsConsideration to clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_TermOfAgreement" xlink:label="TermOfAgreement" xlink:title="TermOfAgreement" />
    <link:label xlink:type="resource" xlink:label="clbs_TermOfAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_TermOfAgreement_lbl" xml:lang="en-US" id="clbs_TermOfAgreement_lbl">Term Of Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfAgreement" xlink:to="clbs_TermOfAgreement_lbl" xlink:title="label: TermOfAgreement to clbs_TermOfAgreement_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_TermOfAgreement_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_TermOfAgreement_lbl1" xml:lang="en-US" id="clbs_TermOfAgreement_lbl1">Term Of Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfAgreement" xlink:to="clbs_TermOfAgreement_lbl1" xlink:title="label: TermOfAgreement to clbs_TermOfAgreement_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_TermOfAgreement_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_TermOfAgreement_lbl2" xml:lang="en-US" id="clbs_TermOfAgreement_lbl2">Term of agreement (in months)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TermOfAgreement" xlink:to="clbs_TermOfAgreement_lbl2" xlink:title="label: TermOfAgreement to clbs_TermOfAgreement_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_InstitutionalPurchaseAgreementMember" xlink:label="InstitutionalPurchaseAgreementMember" xlink:title="InstitutionalPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="clbs_InstitutionalPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_InstitutionalPurchaseAgreementMember_lbl" xml:lang="en-US" id="clbs_InstitutionalPurchaseAgreementMember_lbl">Institutional Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InstitutionalPurchaseAgreementMember" xlink:to="clbs_InstitutionalPurchaseAgreementMember_lbl" xlink:title="label: InstitutionalPurchaseAgreementMember to clbs_InstitutionalPurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_InstitutionalPurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_InstitutionalPurchaseAgreementMember_lbl1" xml:lang="en-US" id="clbs_InstitutionalPurchaseAgreementMember_lbl1">Institutional Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InstitutionalPurchaseAgreementMember" xlink:to="clbs_InstitutionalPurchaseAgreementMember_lbl1" xlink:title="label: InstitutionalPurchaseAgreementMember to clbs_InstitutionalPurchaseAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_InstitutionalPurchaseAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_InstitutionalPurchaseAgreementMember_lbl2" xml:lang="en-US" id="clbs_InstitutionalPurchaseAgreementMember_lbl2">Institutional Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="InstitutionalPurchaseAgreementMember" xlink:to="clbs_InstitutionalPurchaseAgreementMember_lbl2" xlink:title="label: InstitutionalPurchaseAgreementMember to clbs_InstitutionalPurchaseAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LincolnParkAgreementMember" xlink:label="LincolnParkAgreementMember" xlink:title="LincolnParkAgreementMember" />
    <link:label xlink:type="resource" xlink:label="clbs_LincolnParkAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_LincolnParkAgreementMember_lbl" xml:lang="en-US" id="clbs_LincolnParkAgreementMember_lbl">Lincoln Park Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkAgreementMember" xlink:to="clbs_LincolnParkAgreementMember_lbl" xlink:title="label: LincolnParkAgreementMember to clbs_LincolnParkAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_LincolnParkAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_LincolnParkAgreementMember_lbl1" xml:lang="en-US" id="clbs_LincolnParkAgreementMember_lbl1">Lincoln Park Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkAgreementMember" xlink:to="clbs_LincolnParkAgreementMember_lbl1" xlink:title="label: LincolnParkAgreementMember to clbs_LincolnParkAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_LincolnParkAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_LincolnParkAgreementMember_lbl2" xml:lang="en-US" id="clbs_LincolnParkAgreementMember_lbl2">Lincoln Park Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LincolnParkAgreementMember" xlink:to="clbs_LincolnParkAgreementMember_lbl2" xlink:title="label: LincolnParkAgreementMember to clbs_LincolnParkAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:label="H.C.WainwrightSalesAmendedAgreementMember" xlink:title="H.C.WainwrightSalesAmendedAgreementMember" />
    <link:label xlink:type="resource" xlink:label="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl" xml:lang="en-US" id="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl">H.C. Wainwright Sales Amended Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="H.C.WainwrightSalesAmendedAgreementMember" xlink:to="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl" xlink:title="label: H.C.WainwrightSalesAmendedAgreementMember to clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl1" xml:lang="en-US" id="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl1">H.C. Wainwright Sales Amended Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="H.C.WainwrightSalesAmendedAgreementMember" xlink:to="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl1" xlink:title="label: H.C.WainwrightSalesAmendedAgreementMember to clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl2" xml:lang="en-US" id="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl2">H.C. Wainwright Sales Amended Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="H.C.WainwrightSalesAmendedAgreementMember" xlink:to="clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl2" xlink:title="label: H.C.WainwrightSalesAmendedAgreementMember to clbs_H.C.WainwrightSalesAmendedAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AdditionalPurchaseAgreementMember" xlink:label="AdditionalPurchaseAgreementMember" xlink:title="AdditionalPurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="clbs_AdditionalPurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_AdditionalPurchaseAgreementMember_lbl" xml:lang="en-US" id="clbs_AdditionalPurchaseAgreementMember_lbl">Additional Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPurchaseAgreementMember" xlink:to="clbs_AdditionalPurchaseAgreementMember_lbl" xlink:title="label: AdditionalPurchaseAgreementMember to clbs_AdditionalPurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_AdditionalPurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_AdditionalPurchaseAgreementMember_lbl1" xml:lang="en-US" id="clbs_AdditionalPurchaseAgreementMember_lbl1">Additional Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPurchaseAgreementMember" xlink:to="clbs_AdditionalPurchaseAgreementMember_lbl1" xlink:title="label: AdditionalPurchaseAgreementMember to clbs_AdditionalPurchaseAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_AdditionalPurchaseAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_AdditionalPurchaseAgreementMember_lbl2" xml:lang="en-US" id="clbs_AdditionalPurchaseAgreementMember_lbl2">Additional Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdditionalPurchaseAgreementMember" xlink:to="clbs_AdditionalPurchaseAgreementMember_lbl2" xlink:title="label: AdditionalPurchaseAgreementMember to clbs_AdditionalPurchaseAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_January2021PurchaseAgreementMember" xlink:label="January2021PurchaseAgreementMember" xlink:title="January2021PurchaseAgreementMember" />
    <link:label xlink:type="resource" xlink:label="clbs_January2021PurchaseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_January2021PurchaseAgreementMember_lbl" xml:lang="en-US" id="clbs_January2021PurchaseAgreementMember_lbl">January 2021 Purchase Agreement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="January2021PurchaseAgreementMember" xlink:to="clbs_January2021PurchaseAgreementMember_lbl" xlink:title="label: January2021PurchaseAgreementMember to clbs_January2021PurchaseAgreementMember_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_January2021PurchaseAgreementMember_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_January2021PurchaseAgreementMember_lbl1" xml:lang="en-US" id="clbs_January2021PurchaseAgreementMember_lbl1">January 2021 Purchase Agreement [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="January2021PurchaseAgreementMember" xlink:to="clbs_January2021PurchaseAgreementMember_lbl1" xlink:title="label: January2021PurchaseAgreementMember to clbs_January2021PurchaseAgreementMember_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_January2021PurchaseAgreementMember_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_January2021PurchaseAgreementMember_lbl2" xml:lang="en-US" id="clbs_January2021PurchaseAgreementMember_lbl2">January 2021 Private Placement</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="January2021PurchaseAgreementMember" xlink:to="clbs_January2021PurchaseAgreementMember_lbl2" xlink:title="label: January2021PurchaseAgreementMember to clbs_January2021PurchaseAgreementMember_lbl2" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreferredStockLiquidationPreferenceShare" xlink:label="PreferredStockLiquidationPreferenceShare" xlink:title="PreferredStockLiquidationPreferenceShare" />
    <link:label xlink:type="resource" xlink:label="clbs_PreferredStockLiquidationPreferenceShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_PreferredStockLiquidationPreferenceShare_lbl" xml:lang="en-US" id="clbs_PreferredStockLiquidationPreferenceShare_lbl">Preferred Stock, Liquidation Preference, Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreferenceShare" xlink:to="clbs_PreferredStockLiquidationPreferenceShare_lbl" xlink:title="label: PreferredStockLiquidationPreferenceShare to clbs_PreferredStockLiquidationPreferenceShare_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_PreferredStockLiquidationPreferenceShare_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_PreferredStockLiquidationPreferenceShare_lbl1" xml:lang="en-US" id="clbs_PreferredStockLiquidationPreferenceShare_lbl1">Preferred Stock, Liquidation Preference, Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreferenceShare" xlink:to="clbs_PreferredStockLiquidationPreferenceShare_lbl1" xlink:title="label: PreferredStockLiquidationPreferenceShare to clbs_PreferredStockLiquidationPreferenceShare_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_PreferredStockLiquidationPreferenceShare_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_PreferredStockLiquidationPreferenceShare_lbl2" xml:lang="en-US" id="clbs_PreferredStockLiquidationPreferenceShare_lbl2">Preferred stock, liquidation value</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreferenceShare" xlink:to="clbs_PreferredStockLiquidationPreferenceShare_lbl2" xlink:title="label: PreferredStockLiquidationPreferenceShare to clbs_PreferredStockLiquidationPreferenceShare_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_PreferredStockLiquidationPreferenceShare_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_PreferredStockLiquidationPreferenceShare_lbl3" xml:lang="en-US" id="clbs_PreferredStockLiquidationPreferenceShare_lbl3">Preferred stock, liquidation preference (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockLiquidationPreferenceShare" xlink:to="clbs_PreferredStockLiquidationPreferenceShare_lbl3" xlink:title="label: PreferredStockLiquidationPreferenceShare to clbs_PreferredStockLiquidationPreferenceShare_lbl3" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreferredStockSharesDesignated" xlink:label="PreferredStockSharesDesignated" xlink:title="PreferredStockSharesDesignated" />
    <link:label xlink:type="resource" xlink:label="clbs_PreferredStockSharesDesignated_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="clbs_PreferredStockSharesDesignated_lbl" xml:lang="en-US" id="clbs_PreferredStockSharesDesignated_lbl">Preferred stock, shares designated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesDesignated" xlink:to="clbs_PreferredStockSharesDesignated_lbl" xlink:title="label: PreferredStockSharesDesignated to clbs_PreferredStockSharesDesignated_lbl" />
    <link:label xlink:type="resource" xlink:label="clbs_PreferredStockSharesDesignated_lbl1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="clbs_PreferredStockSharesDesignated_lbl1" xml:lang="en-US" id="clbs_PreferredStockSharesDesignated_lbl1">Preferred stock, shares designated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesDesignated" xlink:to="clbs_PreferredStockSharesDesignated_lbl1" xlink:title="label: PreferredStockSharesDesignated to clbs_PreferredStockSharesDesignated_lbl1" />
    <link:label xlink:type="resource" xlink:label="clbs_PreferredStockSharesDesignated_lbl2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="clbs_PreferredStockSharesDesignated_lbl2" xml:lang="en-US" id="clbs_PreferredStockSharesDesignated_lbl2">Preferred stock, shares designated</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesDesignated" xlink:to="clbs_PreferredStockSharesDesignated_lbl2" xlink:title="label: PreferredStockSharesDesignated to clbs_PreferredStockSharesDesignated_lbl2" />
    <link:label xlink:type="resource" xlink:label="clbs_PreferredStockSharesDesignated_lbl3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="clbs_PreferredStockSharesDesignated_lbl3" xml:lang="en-US" id="clbs_PreferredStockSharesDesignated_lbl3">Preferred stock, shares designated (shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreferredStockSharesDesignated" xlink:to="clbs_PreferredStockSharesDesignated_lbl3" xlink:title="label: PreferredStockSharesDesignated to clbs_PreferredStockSharesDesignated_lbl3" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>clbs-20220726_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 22.7.2.5062 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://caladrius.com/role/SubsequentEventsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#SubsequentEventsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationCompensationCostNotYetRecognizedQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationSharebasedCompensationExpenseQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityStockOptionsAndWarrantsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityEquityIssuancesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesBalanceSheetPresentationQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesNarrativeQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesNarrativeQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeLossPerShareQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeLossPerShareQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/BusinessQ1Details" xlink:type="simple" xlink:href="clbs-20220726.xsd#BusinessQ1Details" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesNarrativeFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesNarrativeFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/ResearchFundingFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#ResearchFundingFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationValuationAssumptionsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationCompensationCostNotYetRecognizedFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationSharebasedCompensationExpenseFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityStockOptionsAndWarrantsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityEquityIssuancesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityEquityPlanFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesBalanceSheetPresentationFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesNarrativeFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesNarrativeFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/LossPerShareFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#LossPerShareFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentNarrativeFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentNarrativeFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentSummaryFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesContractualMaturitiesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesSummaryFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/BusinessFyDetails" xlink:type="simple" xlink:href="clbs-20220726.xsd#BusinessFyDetails" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeLossPerShareQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeLossPerShareQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesQ1Tables" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/LossPerShareFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#LossPerShareFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesFyTables" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesQ1Policies" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesFyPolicies" />
  <link:roleRef roleURI="http://caladrius.com/role/SubsequentEventsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#SubsequentEventsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ContingenciesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ContingenciesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeLossPerShareQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeLossPerShareQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/BusinessQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#BusinessQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ContingenciesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ContingenciesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/IncomeTaxesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#IncomeTaxesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ResearchFundingFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ResearchFundingFy" />
  <link:roleRef roleURI="http://caladrius.com/role/SharebasedCompensationFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#SharebasedCompensationFy" />
  <link:roleRef roleURI="http://caladrius.com/role/StockholdersEquityFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#StockholdersEquityFy" />
  <link:roleRef roleURI="http://caladrius.com/role/OperatingLeasesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#OperatingLeasesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/AccruedLiabilitiesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#AccruedLiabilitiesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/FairValueMeasurementsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#FairValueMeasurementsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/LossPerShareFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#LossPerShareFy" />
  <link:roleRef roleURI="http://caladrius.com/role/PropertyAndEquipmentFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#PropertyAndEquipmentFy" />
  <link:roleRef roleURI="http://caladrius.com/role/AvailableforsalesecuritiesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#AvailableforsalesecuritiesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#SummaryOfSignificantAccountingPoliciesFy" />
  <link:roleRef roleURI="http://caladrius.com/role/BusinessFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#BusinessFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfCashFlowsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfEquityQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfComprehensiveLossQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfOperationsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsQ1Parentheticals" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsQ1" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfCashFlowsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfEquityFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfEquityFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfComprehensiveLossFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedStatementsOfOperationsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsFyParenthetical" />
  <link:roleRef roleURI="http://caladrius.com/role/ConsolidatedBalanceSheetsFy" xlink:type="simple" xlink:href="clbs-20220726.xsd#ConsolidatedBalanceSheetsFy" />
  <link:roleRef roleURI="http://caladrius.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="clbs-20220726.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFilerCategory" xlink:title="presentation: CoverAbstract to EntityFilerCategory" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="EntitySmallBusiness" xlink:title="EntitySmallBusiness" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntitySmallBusiness" xlink:title="presentation: CoverAbstract to EntitySmallBusiness" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: AssetsCurrentAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="MarketableSecurities" xlink:title="MarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="MarketableSecurities" xlink:title="presentation: AssetsCurrentAbstract to MarketableSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OtherLiabilitiesNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesCurrentAbstract to Liabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockValue" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockValue" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="presentation: StockholdersEquityAbstract to AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="MinorityInterest" xlink:title="presentation: StockholdersEquityAbstract to MinorityInterest" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract to PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreferredStockLiquidationPreferenceShare" xlink:label="PreferredStockLiquidationPreferenceShare" xlink:title="PreferredStockLiquidationPreferenceShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="PreferredStockLiquidationPreferenceShare" xlink:title="presentation: PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract to PreferredStockLiquidationPreferenceShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract to PreferredStockParOrStatedValuePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreferredStockSharesDesignated" xlink:label="PreferredStockSharesDesignated" xlink:title="PreferredStockSharesDesignated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="PreferredStockSharesDesignated" xlink:title="presentation: PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract to PreferredStockSharesDesignated" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract to PreferredStockSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract to PreferredStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract to CommonStockParOrStatedValuePerShare" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract to CommonStockSharesAuthorized" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract to CommonStockSharesIssued" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract to CommonStockSharesOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" xlink:label="TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" xlink:title="TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" xlink:to="TreasuryStockShares" xlink:title="presentation: TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract to TreasuryStockShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentExpense" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="presentation: OperatingExpensesAbstract to SellingGeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="OperatingExpenses" xlink:title="presentation: OperatingExpensesAbstract to OperatingExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OperatingExpensesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="NonoperatingIncomeExpenseAbstract" xlink:title="NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="InvestmentIncomeNet" xlink:title="InvestmentIncomeNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="InvestmentIncomeNet" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to InvestmentIncomeNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to OtherNonoperatingIncomeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to NonoperatingIncomeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NonoperatingIncomeExpenseAbstract" xlink:title="presentation: IncomeStatementAbstract to NonoperatingIncomeExpenseAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeStatementAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeStatementAbstract to IncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ProfitLoss" xlink:title="presentation: IncomeStatementAbstract to ProfitLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:label="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:title="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:title="presentation: IncomeStatementAbstract to IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="EarningsPerShareBasicAndDilutedAbstract" xlink:title="EarningsPerShareBasicAndDilutedAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareBasicAndDilutedAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: EarningsPerShareBasicAndDilutedAbstract to EarningsPerShareBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareBasicAndDilutedAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: EarningsPerShareBasicAndDilutedAbstract to EarningsPerShareDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasicAndDilutedAbstract" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasicAndDilutedAbstract" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:title="StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="ProfitLoss" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:label="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:title="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="presentation: OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract to OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="OtherComprehensiveIncomeLossNetOfTax" xlink:title="presentation: OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract to OtherComprehensiveIncomeLossNetOfTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:label="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:title="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:label="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:title="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="ComprehensiveIncomeNetOfTax" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to ComprehensiveIncomeNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfEquityFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="PreferredStockMember" xlink:title="presentation: ParentMember to PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="CommonStockMember" xlink:title="presentation: ParentMember to CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: ParentMember to AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="AccumulatedOtherComprehensiveIncomeMember" xlink:title="presentation: ParentMember to AccumulatedOtherComprehensiveIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="RetainedEarningsMember" xlink:title="presentation: ParentMember to RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="TreasuryStockMember" xlink:title="presentation: ParentMember to TreasuryStockMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="ParentMember" xlink:title="presentation: EquityComponentDomain to ParentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="NoncontrollingInterestMember" xlink:title="presentation: EquityComponentDomain to NoncontrollingInterestMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="ProfitLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to ProfitLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesShareBasedCompensation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueShareBasedCompensation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesNewIssues" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueNewIssues" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesStockOptionsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueStockOptionsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProfitLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IssuanceOfStockAndWarrantsForServicesOrClaims" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="DepreciationAndAmortization" xlink:title="DepreciationAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationAndAmortization" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationAndAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="PaymentsToAcquireMarketableSecurities" xlink:title="PaymentsToAcquireMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireMarketableSecurities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireMarketableSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSaleAndMaturityOfMarketableSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquirePropertyPlantAndEquipment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromStockOptionsExercised" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="SupplementalCashFlowInformationAbstract" xlink:title="SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="InterestPaidNet" xlink:title="InterestPaidNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="InterestPaidNet" xlink:title="presentation: SupplementalCashFlowInformationAbstract to InterestPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="IncomeTaxesPaid" xlink:title="IncomeTaxesPaid" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SupplementalCashFlowInformationAbstract" xlink:to="IncomeTaxesPaid" xlink:title="presentation: SupplementalCashFlowInformationAbstract to IncomeTaxesPaid" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="SupplementalCashFlowInformationAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to SupplementalCashFlowInformationAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: AssetsAbstract to CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="MarketableSecurities" xlink:title="MarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="MarketableSecurities" xlink:title="presentation: AssetsAbstract to MarketableSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="PrepaidExpenseAndOtherAssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PrepaidExpenseAndOtherAssetsCurrent" xlink:title="presentation: AssetsAbstract to PrepaidExpenseAndOtherAssetsCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsAbstract to AssetsCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract" xlink:label="LiabilitiesAbstract" xlink:title="LiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAbstract" xlink:to="AccountsPayableCurrent" xlink:title="presentation: LiabilitiesAbstract to AccountsPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: LiabilitiesAbstract to AccruedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesAbstract to LiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAbstract to OtherLiabilitiesNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="Liabilities" xlink:title="Liabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAbstract" xlink:to="Liabilities" xlink:title="presentation: LiabilitiesAbstract to Liabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="CommitmentsAndContingencies" xlink:title="CommitmentsAndContingencies" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="StockholdersEquityAbstract" xlink:title="StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="PreferredStockValue" xlink:title="PreferredStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="PreferredStockValue" xlink:title="presentation: StockholdersEquityAbstract to PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityAbstract to CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityAbstract to AdditionalPaidInCapital" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="TreasuryStockValue" xlink:title="presentation: StockholdersEquityAbstract to TreasuryStockValue" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityAbstract to RetainedEarningsAccumulatedDeficit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="presentation: StockholdersEquityAbstract to AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="StockholdersEquity" xlink:title="StockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquity" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquity" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest" xlink:label="MinorityInterest" xlink:title="MinorityInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="MinorityInterest" xlink:title="presentation: StockholdersEquityAbstract to MinorityInterest" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: StockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="PreferredStockSharesAuthorized" xlink:title="PreferredStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="PreferredStockSharesAuthorized" xlink:title="presentation: StatementOfFinancialPositionAbstract to PreferredStockSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreferredStockLiquidationPreferenceShare" xlink:label="PreferredStockLiquidationPreferenceShare" xlink:title="PreferredStockLiquidationPreferenceShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="PreferredStockLiquidationPreferenceShare" xlink:title="presentation: StatementOfFinancialPositionAbstract to PreferredStockLiquidationPreferenceShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: StatementOfFinancialPositionAbstract to PreferredStockParOrStatedValuePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreferredStockSharesDesignated" xlink:label="PreferredStockSharesDesignated" xlink:title="PreferredStockSharesDesignated" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="PreferredStockSharesDesignated" xlink:title="presentation: StatementOfFinancialPositionAbstract to PreferredStockSharesDesignated" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="PreferredStockSharesIssued" xlink:title="PreferredStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="PreferredStockSharesIssued" xlink:title="presentation: StatementOfFinancialPositionAbstract to PreferredStockSharesIssued" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="PreferredStockSharesOutstanding" xlink:title="PreferredStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="PreferredStockSharesOutstanding" xlink:title="presentation: StatementOfFinancialPositionAbstract to PreferredStockSharesOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StatementOfFinancialPositionAbstract to CommonStockParOrStatedValuePerShare" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StatementOfFinancialPositionAbstract to CommonStockSharesAuthorized" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StatementOfFinancialPositionAbstract to CommonStockSharesIssued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: StatementOfFinancialPositionAbstract to CommonStockSharesOutstanding" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="TreasuryStockShares" xlink:title="presentation: StatementOfFinancialPositionAbstract to TreasuryStockShares" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="OperatingExpensesAbstract" xlink:title="OperatingExpensesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="ResearchAndDevelopmentExpense" xlink:title="presentation: OperatingExpensesAbstract to ResearchAndDevelopmentExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="SellingGeneralAndAdministrativeExpense" xlink:title="SellingGeneralAndAdministrativeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="SellingGeneralAndAdministrativeExpense" xlink:title="presentation: OperatingExpensesAbstract to SellingGeneralAndAdministrativeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="OperatingExpenses" xlink:title="OperatingExpenses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingExpensesAbstract" xlink:to="OperatingExpenses" xlink:title="presentation: OperatingExpensesAbstract to OperatingExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingExpensesAbstract" xlink:title="presentation: IncomeStatementAbstract to OperatingExpensesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="NonoperatingIncomeExpenseAbstract" xlink:title="NonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="InvestmentIncomeNet" xlink:title="InvestmentIncomeNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="InvestmentIncomeNet" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to InvestmentIncomeNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to OtherNonoperatingIncomeExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="NonoperatingIncomeExpense" xlink:title="NonoperatingIncomeExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonoperatingIncomeExpenseAbstract" xlink:to="NonoperatingIncomeExpense" xlink:title="presentation: NonoperatingIncomeExpenseAbstract to NonoperatingIncomeExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NonoperatingIncomeExpenseAbstract" xlink:title="presentation: IncomeStatementAbstract to NonoperatingIncomeExpenseAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeStatementAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeStatementAbstract to IncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="NetIncomeLoss" xlink:title="NetIncomeLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="NetIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to NetIncomeLoss" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:title="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract to EarningsPerShareBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract to EarningsPerShareDiluted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="WeightedAverageNumberOfSharesOutstandingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingBasic" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfSharesOutstandingBasic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: WeightedAverageNumberOfSharesOutstandingAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfSharesOutstandingAbstract" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfSharesOutstandingAbstract" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:title="StatementOfIncomeAndComprehensiveIncomeAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="ProfitLoss" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="OtherComprehensiveIncomeLossNetOfTax" xlink:title="OtherComprehensiveIncomeLossNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="OtherComprehensiveIncomeLossNetOfTax" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to OtherComprehensiveIncomeLossNetOfTax" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="ComprehensiveIncomeNetOfTax" xlink:title="ComprehensiveIncomeNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="ComprehensiveIncomeNetOfTax" xlink:title="presentation: StatementOfIncomeAndComprehensiveIncomeAbstract to ComprehensiveIncomeNetOfTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="StatementOfStockholdersEquityAbstract" xlink:title="StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="StatementTable" xlink:title="StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="StatementEquityComponentsAxis" xlink:title="StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="EquityComponentDomain" xlink:title="EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember" xlink:label="ParentMember" xlink:title="ParentMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="PreferredStockMember" xlink:title="PreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="PreferredStockMember" xlink:title="presentation: ParentMember to PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="CommonStockMember" xlink:title="CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="CommonStockMember" xlink:title="presentation: ParentMember to CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="AdditionalPaidInCapitalMember" xlink:title="AdditionalPaidInCapitalMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="AdditionalPaidInCapitalMember" xlink:title="presentation: ParentMember to AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="AccumulatedOtherComprehensiveIncomeMember" xlink:title="AccumulatedOtherComprehensiveIncomeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="AccumulatedOtherComprehensiveIncomeMember" xlink:title="presentation: ParentMember to AccumulatedOtherComprehensiveIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="RetainedEarningsMember" xlink:title="RetainedEarningsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="RetainedEarningsMember" xlink:title="presentation: ParentMember to RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember" xlink:label="TreasuryStockMember" xlink:title="TreasuryStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ParentMember" xlink:to="TreasuryStockMember" xlink:title="presentation: ParentMember to TreasuryStockMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="ParentMember" xlink:title="presentation: EquityComponentDomain to ParentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="NoncontrollingInterestMember" xlink:title="NoncontrollingInterestMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityComponentDomain" xlink:to="NoncontrollingInterestMember" xlink:title="presentation: EquityComponentDomain to NoncontrollingInterestMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementEquityComponentsAxis" xlink:to="EquityComponentDomain" xlink:title="presentation: StatementEquityComponentsAxis to EquityComponentDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementEquityComponentsAxis" xlink:title="presentation: StatementTable to StatementEquityComponentsAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="StatementLineItems" xlink:title="StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="IncreaseDecreaseInStockholdersEquityRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="ProfitLoss" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to ProfitLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="StockIssuedDuringPeriodSharesShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesShareBasedCompensation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="StockIssuedDuringPeriodValueShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueShareBasedCompensation" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueShareBasedCompensation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesNewIssues" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="StockIssuedDuringPeriodValueNewIssues" xlink:title="StockIssuedDuringPeriodValueNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueNewIssues" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueNewIssues" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodSharesStockOptionsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="StockIssuedDuringPeriodValueStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockIssuedDuringPeriodValueStockOptionsExercised" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockIssuedDuringPeriodValueStockOptionsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="SharesOutstanding_2" xlink:title="SharesOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="SharesOutstanding_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to SharesOutstanding" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="presentation: IncreaseDecreaseInStockholdersEquityRollForward to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementLineItems" xlink:to="IncreaseDecreaseInStockholdersEquityRollForward" xlink:title="presentation: StatementLineItems to IncreaseDecreaseInStockholdersEquityRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementTable" xlink:to="StatementLineItems" xlink:title="presentation: StatementTable to StatementLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfStockholdersEquityAbstract" xlink:to="StatementTable" xlink:title="presentation: StatementOfStockholdersEquityAbstract to StatementTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProfitLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to ProfitLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="IssuanceOfStockAndWarrantsForServicesOrClaims" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IssuanceOfStockAndWarrantsForServicesOrClaims" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="DepreciationAndAmortization" xlink:title="DepreciationAndAmortization" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DepreciationAndAmortization" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DepreciationAndAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="AccretionAmortizationOfDiscountsAndPremiumsInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingAssets" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:label="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:title="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="PaymentsToAcquireMarketableSecurities" xlink:title="PaymentsToAcquireMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireMarketableSecurities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireMarketableSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="ProceedsFromSaleAndMaturityOfMarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSaleAndMaturityOfMarketableSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromStockOptionsExercised" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/BusinessFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_BusinessTextBlock" xlink:label="BusinessTextBlock" xlink:title="BusinessTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="BusinessTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to BusinessTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:label="CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:title="CashCashEquivalentsAndMarketableSecuritiesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:title="presentation: InvestmentsDebtAndEquitySecuritiesAbstract to CashCashEquivalentsAndMarketableSecuritiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="PropertyPlantAndEquipmentDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentDisclosureTextBlock" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/LossPerShareFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueDisclosuresTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: EquityAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ResearchFundingFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="ResearchAndDevelopmentAbstract" xlink:title="ResearchAndDevelopmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:label="ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:title="ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:title="presentation: ResearchAndDevelopmentAbstract to ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxDisclosureTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ContingenciesFy">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/BusinessQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_BusinessTextBlock" xlink:label="BusinessTextBlock" xlink:title="BusinessTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="BusinessTextBlock" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to BusinessTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="AvailableForSaleSecuritiesAbstract" xlink:title="AvailableForSaleSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:label="CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:title="CashCashEquivalentsAndMarketableSecuritiesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to CashCashEquivalentsAndMarketableSecuritiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeLossPerShareQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="EarningsPerShareTextBlock" xlink:title="EarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="EarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueDisclosuresTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="LesseeOperatingLeasesTextBlock" xlink:title="LesseeOperatingLeasesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeasesTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: EquityAbstract to StockholdersEquityNoteDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxDisclosureTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ContingenciesQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="CommitmentsAndContingenciesDisclosureAbstract" xlink:title="CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CommitmentsAndContingenciesDisclosureAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: CommitmentsAndContingenciesDisclosureAbstract to CommitmentsAndContingenciesDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SubsequentEventsQ1">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="SubsequentEventsTextBlock" xlink:title="SubsequentEventsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventsTextBlock" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="ConsolidationPolicyTextBlock" xlink:title="ConsolidationPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ConsolidationPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ConsolidationPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="CashAndCashEquivalentsPolicyTextBlock" xlink:title="CashAndCashEquivalentsPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="CashAndCashEquivalentsPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to CashAndCashEquivalentsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ConcentrationRiskCreditRisk" xlink:title="presentation: AccountingPoliciesAbstract to ConcentrationRiskCreditRisk" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="MarketableSecuritiesPolicy" xlink:title="MarketableSecuritiesPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="MarketableSecuritiesPolicy" xlink:title="presentation: AccountingPoliciesAbstract to MarketableSecuritiesPolicy" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="PropertyPlantAndEquipmentPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="PropertyPlantAndEquipmentPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to PropertyPlantAndEquipmentPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentImpairment" xlink:label="PropertyPlantAndEquipmentImpairment" xlink:title="PropertyPlantAndEquipmentImpairment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="PropertyPlantAndEquipmentImpairment" xlink:title="presentation: AccountingPoliciesAbstract to PropertyPlantAndEquipmentImpairment" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="presentation: AccountingPoliciesAbstract to ShareBasedCompensationOptionAndIncentivePlansPolicy" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="EarningsPerSharePolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to EarningsPerSharePolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_TreasuryStockPolicyPolicyTextBlock" xlink:label="TreasuryStockPolicyPolicyTextBlock" xlink:title="TreasuryStockPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="TreasuryStockPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to TreasuryStockPolicyPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="ResearchAndDevelopmentExpensePolicy" xlink:title="ResearchAndDevelopmentExpensePolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ResearchAndDevelopmentExpensePolicy" xlink:title="presentation: AccountingPoliciesAbstract to ResearchAndDevelopmentExpensePolicy" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to NewAccountingPronouncementsPolicyPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="BasisOfAccountingPolicyPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="BasisOfAccountingPolicyPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="UseOfEstimates" xlink:title="UseOfEstimates" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="UseOfEstimates" xlink:title="presentation: AccountingPoliciesAbstract to UseOfEstimates" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="ConsolidationPolicyTextBlock" xlink:title="ConsolidationPolicyTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ConsolidationPolicyTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to ConsolidationPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="ConcentrationRiskCreditRisk" xlink:title="ConcentrationRiskCreditRisk" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ConcentrationRiskCreditRisk" xlink:title="presentation: AccountingPoliciesAbstract to ConcentrationRiskCreditRisk" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="ShareBasedCompensationOptionAndIncentivePlansPolicy" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:title="presentation: AccountingPoliciesAbstract to ShareBasedCompensationOptionAndIncentivePlansPolicy" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="PropertyPlantAndEquipmentTextBlock" xlink:title="presentation: AccountingPoliciesAbstract to PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="presentation: InvestmentsDebtAndEquitySecuritiesAbstract to ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="MarketableSecuritiesTextBlock" xlink:title="MarketableSecuritiesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="MarketableSecuritiesTextBlock" xlink:title="presentation: InvestmentsDebtAndEquitySecuritiesAbstract to MarketableSecuritiesTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:title="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:title="presentation: InvestmentsDebtAndEquitySecuritiesAbstract to InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="PropertyPlantAndEquipmentTextBlock" xlink:title="PropertyPlantAndEquipmentTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="PropertyPlantAndEquipmentTextBlock" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/LossPerShareFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:label="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:title="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="presentation: EquityAbstract to ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:title="NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:title="presentation: EquityAbstract to NonvestedRestrictedStockSharesActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:title="presentation: EquityAbstract to ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesFyTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:title="presentation: IncomeTaxDisclosureAbstract to ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="AvailableForSaleSecuritiesAbstract" xlink:title="AvailableForSaleSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock" xlink:label="MarketableSecuritiesTextBlock" xlink:title="MarketableSecuritiesTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="MarketableSecuritiesTextBlock" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to MarketableSecuritiesTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:title="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeLossPerShareQ1Tables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsQ1Tables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="FairValueAssetsMeasuredOnRecurringBasisTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsMeasuredOnRecurringBasisTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesQ1Tables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="ScheduleOfAccruedLiabilitiesTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to ScheduleOfAccruedLiabilitiesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesQ1Tables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:label="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:title="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:title="presentation: LeasesAbstract to LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityQ1Tables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:title="presentation: EquityAbstract to ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:label="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:title="NonvestedRestrictedStockSharesActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:title="presentation: EquityAbstract to NonvestedRestrictedStockSharesActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:label="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:title="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:title="presentation: EquityAbstract to ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationQ1Tables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:label="DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:title="DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/BusinessFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProjectMember" xlink:label="ProjectMember" xlink:title="ProjectMember" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CLBS16TreatmentOfCMDMember" xlink:label="CLBS16TreatmentOfCMDMember" xlink:title="CLBS16TreatmentOfCMDMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProjectMember" xlink:to="CLBS16TreatmentOfCMDMember" xlink:title="presentation: ProjectMember to CLBS16TreatmentOfCMDMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="ProjectMember" xlink:title="presentation: CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis to ProjectMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="presentation: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="GrantsReceivable" xlink:title="presentation: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to GrantsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="presentation: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="AccountingPoliciesAbstract" xlink:title="AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="SoftwareAndSoftwareDevelopmentCostsMember" xlink:title="SoftwareAndSoftwareDevelopmentCostsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="SoftwareAndSoftwareDevelopmentCostsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to SoftwareAndSoftwareDevelopmentCostsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="PropertyPlantAndEquipmentUsefulLife" xlink:title="PropertyPlantAndEquipmentUsefulLife" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentUsefulLife" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentLineItems" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccountingPoliciesAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="presentation: AccountingPoliciesAbstract to ScheduleOfPropertyPlantAndEquipmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="DebtSecuritiesAvailableForSaleTable" xlink:title="DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="FinancialInstrumentAxis" xlink:title="FinancialInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="CorporateDebtSecuritiesMember" xlink:title="presentation: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to CorporateDebtSecuritiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="MoneyMarketFundsMember" xlink:title="MoneyMarketFundsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="MoneyMarketFundsMember" xlink:title="presentation: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to MoneyMarketFundsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:label="USStatesAndPoliticalSubdivisionsMember" xlink:title="USStatesAndPoliticalSubdivisionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="USStatesAndPoliticalSubdivisionsMember" xlink:title="presentation: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to USStatesAndPoliticalSubdivisionsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentAxis" xlink:to="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="presentation: FinancialInstrumentAxis to TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="FinancialInstrumentAxis" xlink:title="presentation: DebtSecuritiesAvailableForSaleTable to FinancialInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleSecuritiesDebtSecurities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="presentation: DebtSecuritiesAvailableForSaleTable to ScheduleOfAvailableForSaleSecuritiesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="DebtSecuritiesAvailableForSaleTable" xlink:title="presentation: InvestmentsDebtAndEquitySecuritiesAbstract to DebtSecuritiesAvailableForSaleTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="DebtSecuritiesAvailableForSaleTable" xlink:title="DebtSecuritiesAvailableForSaleTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="BalanceSheetLocationAxis" xlink:title="BalanceSheetLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="BalanceSheetLocationDomain" xlink:title="BalanceSheetLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember" xlink:label="CashAndCashEquivalentsMember" xlink:title="CashAndCashEquivalentsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetLocationDomain" xlink:to="CashAndCashEquivalentsMember" xlink:title="presentation: BalanceSheetLocationDomain to CashAndCashEquivalentsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MarketableSecuritiesMember" xlink:label="MarketableSecuritiesMember" xlink:title="MarketableSecuritiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetLocationDomain" xlink:to="MarketableSecuritiesMember" xlink:title="presentation: BalanceSheetLocationDomain to MarketableSecuritiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BalanceSheetLocationAxis" xlink:to="BalanceSheetLocationDomain" xlink:title="presentation: BalanceSheetLocationAxis to BalanceSheetLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="BalanceSheetLocationAxis" xlink:title="presentation: DebtSecuritiesAvailableForSaleTable to BalanceSheetLocationAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleSecuritiesDebtSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DebtSecuritiesAvailableForSaleTable" xlink:to="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="presentation: DebtSecuritiesAvailableForSaleTable to ScheduleOfAvailableForSaleSecuritiesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="DebtSecuritiesAvailableForSaleTable" xlink:title="presentation: InvestmentsDebtAndEquitySecuritiesAbstract to DebtSecuritiesAvailableForSaleTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:title="InvestmentsDebtAndEquitySecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="presentation: InvestmentsDebtAndEquitySecuritiesAbstract to AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to AvailableForSaleSecuritiesDebtSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="presentation: InvestmentsDebtAndEquitySecuritiesAbstract to AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="ScheduleOfPropertyPlantAndEquipmentTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="PropertyPlantAndEquipmentByTypeAxis" xlink:title="PropertyPlantAndEquipmentByTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="PropertyPlantAndEquipmentTypeDomain" xlink:title="PropertyPlantAndEquipmentTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="FurnitureAndFixturesMember" xlink:title="FurnitureAndFixturesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="FurnitureAndFixturesMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to FurnitureAndFixturesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="ComputerEquipmentMember" xlink:title="ComputerEquipmentMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="ComputerEquipmentMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to ComputerEquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="LeaseholdImprovementsMember" xlink:title="LeaseholdImprovementsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentTypeDomain" xlink:to="LeaseholdImprovementsMember" xlink:title="presentation: PropertyPlantAndEquipmentTypeDomain to LeaseholdImprovementsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentByTypeAxis" xlink:to="PropertyPlantAndEquipmentTypeDomain" xlink:title="presentation: PropertyPlantAndEquipmentByTypeAxis to PropertyPlantAndEquipmentTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentByTypeAxis" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentByTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="PropertyPlantAndEquipmentLineItems" xlink:title="PropertyPlantAndEquipmentLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="PropertyPlantAndEquipmentGross" xlink:title="PropertyPlantAndEquipmentGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentGross" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentLineItems" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: PropertyPlantAndEquipmentLineItems to PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="PropertyPlantAndEquipmentLineItems" xlink:title="presentation: ScheduleOfPropertyPlantAndEquipmentTable to PropertyPlantAndEquipmentLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="ScheduleOfPropertyPlantAndEquipmentTable" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to ScheduleOfPropertyPlantAndEquipmentTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/PropertyAndEquipmentNarrativeFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="PropertyPlantAndEquipmentAbstract" xlink:title="PropertyPlantAndEquipmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PropertyPlantAndEquipmentAbstract" xlink:to="Depreciation" xlink:title="presentation: PropertyPlantAndEquipmentAbstract to Depreciation" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/LossPerShareFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="FairValueMeasurementsRecurringMember" xlink:title="FairValueMeasurementsRecurringMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementFrequencyDomain" xlink:to="FairValueMeasurementsRecurringMember" xlink:title="presentation: FairValueMeasurementFrequencyDomain to FairValueMeasurementsRecurringMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="FairValueMeasurementFrequencyDomain" xlink:title="presentation: FairValueByMeasurementFrequencyAxis to FairValueMeasurementFrequencyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByMeasurementFrequencyAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByMeasurementFrequencyAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="AssetsFairValueDisclosureAbstract" xlink:title="AssetsFairValueDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="InvestmentsFairValueDisclosure" xlink:title="InvestmentsFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsFairValueDisclosureAbstract" xlink:to="InvestmentsFairValueDisclosure" xlink:title="presentation: AssetsFairValueDisclosureAbstract to InvestmentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsFairValueDisclosureAbstract" xlink:to="AssetsFairValueDisclosure" xlink:title="presentation: AssetsFairValueDisclosureAbstract to AssetsFairValueDisclosure" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="AssetsFairValueDisclosureAbstract" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to AssetsFairValueDisclosureAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:label="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:title="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to EmployeeRelatedLiabilitiesCurrentAndNoncurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to OperatingLeaseLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to OtherAccruedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="AccruedLiabilitiesCurrentAndNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="AccruedLiabilitiesCurrentAndNoncurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to AccruedLiabilitiesCurrentAndNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesNarrativeFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NumberOfOfficesUnderOperatingLeases" xlink:label="NumberOfOfficesUnderOperatingLeases" xlink:title="NumberOfOfficesUnderOperatingLeases" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="NumberOfOfficesUnderOperatingLeases" xlink:title="presentation: LeasesAbstract to NumberOfOfficesUnderOperatingLeases" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: LeasesAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: LeasesAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:label="OperatingLeaseRightOfUseAssetAbstract" xlink:title="OperatingLeaseRightOfUseAssetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseRightOfUseAssetAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseRightOfUseAssetAbstract to OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseRightOfUseAssetAbstract" xlink:to="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:title="presentation: OperatingLeaseRightOfUseAssetAbstract to OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseRightOfUseAssetAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseRightOfUseAssetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseLiabilityAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseLiabilityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="OperatingLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseLiabilitiesPaymentsDueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01" />
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="PlanNameAxis" xlink:title="PlanNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="PlanNameDomain" xlink:title="PlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EquityIncentiveCompensationPlan2018Member" xlink:label="EquityIncentiveCompensationPlan2018Member" xlink:title="EquityIncentiveCompensationPlan2018Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="EquityIncentiveCompensationPlan2018Member" xlink:title="presentation: PlanNameDomain to EquityIncentiveCompensationPlan2018Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMember" xlink:label="EmployeeStockPurchasePlanMember" xlink:title="EmployeeStockPurchasePlanMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlanMember" xlink:title="presentation: PlanNameDomain to EmployeeStockPurchasePlanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2012Member" xlink:label="EmployeeStockPurchasePlan2012Member" xlink:title="EmployeeStockPurchasePlan2012Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlan2012Member" xlink:title="presentation: PlanNameDomain to EmployeeStockPurchasePlan2012Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2017Member" xlink:label="EmployeeStockPurchasePlan2017Member" xlink:title="EmployeeStockPurchasePlan2017Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlan2017Member" xlink:title="presentation: PlanNameDomain to EmployeeStockPurchasePlan2017Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlan2017AmendedMember" xlink:label="EmployeeStockPurchasePlan2017AmendedMember" xlink:title="EmployeeStockPurchasePlan2017AmendedMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameDomain" xlink:to="EmployeeStockPurchasePlan2017AmendedMember" xlink:title="presentation: PlanNameDomain to EmployeeStockPurchasePlan2017AmendedMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PlanNameAxis" xlink:to="PlanNameDomain" xlink:title="presentation: PlanNameAxis to PlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="PlanNameAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to PlanNameAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="VestingAxis" xlink:title="VestingAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="VestingDomain" xlink:title="VestingDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="ShareBasedCompensationAwardTrancheOneMember" xlink:title="ShareBasedCompensationAwardTrancheOneMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheOneMember" xlink:title="presentation: VestingDomain to ShareBasedCompensationAwardTrancheOneMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="ShareBasedCompensationAwardTrancheTwoMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheTwoMember" xlink:title="presentation: VestingDomain to ShareBasedCompensationAwardTrancheTwoMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:label="ShareBasedCompensationAwardTrancheThreeMember" xlink:title="ShareBasedCompensationAwardTrancheThreeMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingDomain" xlink:to="ShareBasedCompensationAwardTrancheThreeMember" xlink:title="presentation: VestingDomain to ShareBasedCompensationAwardTrancheThreeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="VestingAxis" xlink:to="VestingDomain" xlink:title="presentation: VestingAxis to VestingDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="VestingAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to VestingAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:label="NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:title="NumberofOfferingPeriodsEmployeeStockPurchasePlan" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="NumberofOfferingPeriodsEmployeeStockPurchasePlan" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to NumberofOfferingPeriodsEmployeeStockPurchasePlan" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:label="OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:title="OfferingPeriodsEmployeeStockPurchasePlanTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="OfferingPeriodsEmployeeStockPurchasePlanTerm" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to OfferingPeriodsEmployeeStockPurchasePlanTerm" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:label="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:title="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:label="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:title="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:label="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:title="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:label="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:title="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: EquityAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="SubsidiarySaleOfStockAxis" xlink:title="SubsidiarySaleOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LincolnParkAgreementMember" xlink:label="LincolnParkAgreementMember" xlink:title="LincolnParkAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="LincolnParkAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to LincolnParkAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_H.C.WainwrightSalesAmendedAgreementMember" xlink:label="H.C.WainwrightSalesAmendedAgreementMember" xlink:title="H.C.WainwrightSalesAmendedAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="H.C.WainwrightSalesAmendedAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to H.C.WainwrightSalesAmendedAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AtTheMarketOfferingAgreementMember" xlink:label="AtTheMarketOfferingAgreementMember" xlink:title="AtTheMarketOfferingAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="AtTheMarketOfferingAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to AtTheMarketOfferingAgreementMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_InstitutionalPurchaseAgreementMember" xlink:label="InstitutionalPurchaseAgreementMember" xlink:title="InstitutionalPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="InstitutionalPurchaseAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to InstitutionalPurchaseAgreementMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AdditionalPurchaseAgreementMember" xlink:label="AdditionalPurchaseAgreementMember" xlink:title="AdditionalPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="AdditionalPurchaseAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to AdditionalPurchaseAgreementMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_January2021PurchaseAgreementMember" xlink:label="January2021PurchaseAgreementMember" xlink:title="January2021PurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="January2021PurchaseAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to January2021PurchaseAgreementMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain" xlink:title="presentation: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="SubsidiarySaleOfStockAxis" xlink:title="presentation: ScheduleOfStockByClassTable to SubsidiarySaleOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:label="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:label="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="StockIssuedDuringPeriodSharesIssuedAsConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="presentation: ClassOfStockLineItems to StockIssuedDuringPeriodSharesIssuedAsConsideration" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockNumberOfSharesIssuedInTransaction" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="SaleOfStockPricePerShare" xlink:title="SaleOfStockPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockPricePerShare" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockPricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="SaleOfStockConsiderationReceivedOnTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockConsiderationReceivedOnTransaction" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_TermOfAgreement" xlink:label="TermOfAgreement" xlink:title="TermOfAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="TermOfAgreement" xlink:title="presentation: ClassOfStockLineItems to TermOfAgreement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:label="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:label="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:label="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="presentation: ClassOfStockLineItems to RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:label="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="presentation: ClassOfStockLineItems to PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:label="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:title="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="presentation: ClassOfStockLineItems to StockIssuedDuringPeriodSharesNewIssues" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="ProceedsFromIssuanceOfCommonStock" xlink:title="ProceedsFromIssuanceOfCommonStock" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="ProceedsFromIssuanceOfCommonStock" xlink:title="presentation: ClassOfStockLineItems to ProceedsFromIssuanceOfCommonStock" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:title="presentation: ClassOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:title="presentation: ClassOfStockLineItems to ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="WarrantsAndRightsOutstandingTerm" xlink:title="WarrantsAndRightsOutstandingTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="WarrantsAndRightsOutstandingTerm" xlink:title="presentation: ClassOfStockLineItems to WarrantsAndRightsOutstandingTerm" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:title="presentation: ClassOfStockLineItems to ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="StockIssuedDuringPeriodSharesOther" xlink:title="StockIssuedDuringPeriodSharesOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesOther" xlink:title="presentation: ClassOfStockLineItems to StockIssuedDuringPeriodSharesOther" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="ProceedsFromWarrantExercises" xlink:title="ProceedsFromWarrantExercises" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="ProceedsFromWarrantExercises" xlink:title="presentation: ClassOfStockLineItems to ProceedsFromWarrantExercises" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="ClassOfStockLineItems" xlink:title="presentation: ScheduleOfStockByClassTable to ClassOfStockLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfStockByClassTable" xlink:title="presentation: EquityAbstract to ScheduleOfStockByClassTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to StockIssuedDuringPeriodSharesStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueOptionExercised" xlink:label="AggregateIntrinsicValueOptionExercised" xlink:title="AggregateIntrinsicValueOptionExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="AggregateIntrinsicValueOptionExercised" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to AggregateIntrinsicValueOptionExercised" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CommonStockWarrantsShares" xlink:label="CommonStockWarrantsShares" xlink:title="CommonStockWarrantsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="CommonStockWarrantsShares" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to CommonStockWarrantsShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsGranted" xlink:label="WarrantsGranted" xlink:title="WarrantsGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="WarrantsGranted" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to WarrantsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsExercised" xlink:label="WarrantsExercised" xlink:title="WarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="WarrantsExercised" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to WarrantsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsCanceled" xlink:label="WarrantsCanceled" xlink:title="WarrantsCanceled" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="WarrantsCanceled" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to WarrantsCanceled" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsExpired" xlink:label="WarrantsExpired" xlink:title="WarrantsExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="WarrantsExpired" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to WarrantsExpired" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CommonStockWarrantsShares" xlink:label="CommonStockWarrantsShares_2" xlink:title="CommonStockWarrantsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="CommonStockWarrantsShares_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to CommonStockWarrantsShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_Sharesvestedandexpectedtovest" xlink:label="Sharesvestedandexpectedtovest" xlink:title="Sharesvestedandexpectedtovest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="Sharesvestedandexpectedtovest" xlink:title="presentation: EquityAbstract to Sharesvestedandexpectedtovest" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsVested" xlink:label="WarrantsVested" xlink:title="WarrantsVested" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="WarrantsVested" xlink:title="presentation: EquityAbstract to WarrantsVested" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:label="WarrantsWeightedAverageExercisePriceRollForward" xlink:title="WarrantsWeightedAverageExercisePriceRollForward" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="WeightedAverageExercisePriceWarrantsOutstanding" xlink:title="WeightedAverageExercisePriceWarrantsOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsOutstanding" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:label="WeightedAverageExercisePriceWarrantsGranted" xlink:title="WeightedAverageExercisePriceWarrantsGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsGranted" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:label="WeightedAverageExercisePriceWarrantsExercised" xlink:title="WeightedAverageExercisePriceWarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsExercised" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:label="WeightedAverageExercisePriceWarrantsCanceled" xlink:title="WeightedAverageExercisePriceWarrantsCanceled" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsCanceled" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsCanceled" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:label="WeightedAverageExercisePriceWarrantsExpired" xlink:title="WeightedAverageExercisePriceWarrantsExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsExpired" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsExpired" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="WeightedAverageExercisePriceWarrantsOutstanding_2" xlink:title="WeightedAverageExercisePriceWarrantsOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsOutstanding_2" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="WarrantsWeightedAverageExercisePriceRollForward" xlink:title="presentation: EquityAbstract to WarrantsWeightedAverageExercisePriceRollForward" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:label="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:title="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:title="presentation: EquityAbstract to WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:label="WeightedAverageExercisePriceWarrantsExercisable" xlink:title="WeightedAverageExercisePriceWarrantsExercisable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="WeightedAverageExercisePriceWarrantsExercisable" xlink:title="presentation: EquityAbstract to WeightedAverageExercisePriceWarrantsExercisable" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsOtherDisclosuresAbstract" xlink:label="WarrantsOtherDisclosuresAbstract" xlink:title="WarrantsOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:label="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:title="WeightedAverageRemainingContractualTermwarrantoutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to WeightedAverageRemainingContractualTermwarrantoutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:label="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:title="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:label="WeightedAverageRemainingContractualTermwarrantsvested" xlink:title="WeightedAverageRemainingContractualTermwarrantsvested" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="WeightedAverageRemainingContractualTermwarrantsvested" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to WeightedAverageRemainingContractualTermwarrantsvested" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:label="AggregateIntrinsicValueWarrantsOutstanding" xlink:title="AggregateIntrinsicValueWarrantsOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="AggregateIntrinsicValueWarrantsOutstanding" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to AggregateIntrinsicValueWarrantsOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:label="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:title="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to AggregateIntrinsicValueWarrantsvestedandexpectedtovest" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsvested" xlink:label="AggregateIntrinsicValueWarrantsvested" xlink:title="AggregateIntrinsicValueWarrantsvested" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="AggregateIntrinsicValueWarrantsvested" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to AggregateIntrinsicValueWarrantsvested" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="WarrantsOtherDisclosuresAbstract" xlink:title="presentation: EquityAbstract to WarrantsOtherDisclosuresAbstract" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:label="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:title="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: RestrictedStockAndRestrictedStockUnitsIssuedAbstract to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="presentation: RestrictedStockAndRestrictedStockUnitsIssuedAbstract to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: RestrictedStockAndRestrictedStockUnitsIssuedAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="presentation: RestrictedStockAndRestrictedStockUnitsIssuedAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="RestrictedStockAndRestrictedStockUnitsIssuedAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to RestrictedStockAndRestrictedStockUnitsIssuedAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: EquityAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="presentation: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="IncomeStatementLocationAxis" xlink:title="presentation: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to IncomeStatementLocationAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems to AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:title="presentation: ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable to EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/ResearchFundingFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="ResearchAndDevelopmentAbstract" xlink:title="ResearchAndDevelopmentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="GrantsReceivable" xlink:title="presentation: ResearchAndDevelopmentAbstract to GrantsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_FundingAmountAwarded" xlink:label="FundingAmountAwarded" xlink:title="FundingAmountAwarded" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="FundingAmountAwarded" xlink:title="presentation: ResearchAndDevelopmentAbstract to FundingAmountAwarded" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_FundingOfGrantAwardCashReceived" xlink:label="FundingOfGrantAwardCashReceived" xlink:title="FundingOfGrantAwardCashReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="FundingOfGrantAwardCashReceived" xlink:title="presentation: ResearchAndDevelopmentAbstract to FundingOfGrantAwardCashReceived" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MilestonePaymentOnGrantAwardCashReceived" xlink:label="MilestonePaymentOnGrantAwardCashReceived" xlink:title="MilestonePaymentOnGrantAwardCashReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="MilestonePaymentOnGrantAwardCashReceived" xlink:title="presentation: ResearchAndDevelopmentAbstract to MilestonePaymentOnGrantAwardCashReceived" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProgressPaymentOnGrantAwardCashReceived" xlink:label="ProgressPaymentOnGrantAwardCashReceived" xlink:title="ProgressPaymentOnGrantAwardCashReceived" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="ProgressPaymentOnGrantAwardCashReceived" xlink:title="presentation: ResearchAndDevelopmentAbstract to ProgressPaymentOnGrantAwardCashReceived" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:label="ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:title="ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" xlink:title="presentation: ResearchAndDevelopmentAbstract to ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:label="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:title="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentAbstract" xlink:to="AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" xlink:title="presentation: ResearchAndDevelopmentAbstract to AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="CurrentFederalTaxExpenseBenefit" xlink:title="CurrentFederalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentFederalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="CurrentStateAndLocalTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentStateAndLocalTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="CurrentIncomeTaxExpenseBenefit" xlink:title="CurrentIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="CurrentIncomeTaxExpenseBenefit" xlink:title="presentation: CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract to CurrentIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="DeferredFederalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredFederalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredFederalIncomeTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="DeferredStateAndLocalIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract to DeferredIncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="FederalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:to="FederalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract to FederalIncomeTaxExpenseBenefitContinuingOperations" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:label="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:to="StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract to StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract to IncomeTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:label="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:label="IncomeTaxReconciliationNondeductibleExpense" xlink:title="IncomeTaxReconciliationNondeductibleExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="IncomeTaxReconciliationNondeductibleExpense" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to IncomeTaxReconciliationNondeductibleExpense" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:label="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:title="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:label="IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:title="IncomeTaxReconciliationPriorYearIncomeTaxes" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to IncomeTaxReconciliationPriorYearIncomeTaxes" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="IncomeTaxReconciliationOtherAdjustments" xlink:title="IncomeTaxReconciliationOtherAdjustments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="IncomeTaxReconciliationOtherAdjustments" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to IncomeTaxReconciliationOtherAdjustments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:label="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:title="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:label="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:title="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract to IncomeTaxExpenseBenefit" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:label="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract" xlink:label="DeferredTaxAssetsGrossAbstract" xlink:title="DeferredTaxAssetsGrossAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="DeferredTaxAssetsOperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsOperatingLossCarryforwards" xlink:title="presentation: DeferredTaxAssetsGrossAbstract to DeferredTaxAssetsOperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_DeferredTaxAssetsRightOfUseLiability" xlink:label="DeferredTaxAssetsRightOfUseLiability" xlink:title="DeferredTaxAssetsRightOfUseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsRightOfUseLiability" xlink:title="presentation: DeferredTaxAssetsGrossAbstract to DeferredTaxAssetsRightOfUseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:title="presentation: DeferredTaxAssetsGrossAbstract to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:title="DeferredTaxAssetsGoodwillAndIntangibleAssets" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:title="presentation: DeferredTaxAssetsGrossAbstract to DeferredTaxAssetsGoodwillAndIntangibleAssets" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_DeferredTaxAssetsAccumulatedDepreciation" xlink:label="DeferredTaxAssetsAccumulatedDepreciation" xlink:title="DeferredTaxAssetsAccumulatedDepreciation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsAccumulatedDepreciation" xlink:title="presentation: DeferredTaxAssetsGrossAbstract to DeferredTaxAssetsAccumulatedDepreciation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:label="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:title="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:title="presentation: DeferredTaxAssetsGrossAbstract to DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="DeferredTaxAssetsOther" xlink:title="DeferredTaxAssetsOther" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsOther" xlink:title="presentation: DeferredTaxAssetsGrossAbstract to DeferredTaxAssetsOther" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="DeferredTaxAssetsGross" xlink:title="DeferredTaxAssetsGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsGross" xlink:title="presentation: DeferredTaxAssetsGrossAbstract to DeferredTaxAssetsGross" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxAssetsGrossAbstract" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxAssetsGrossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract" xlink:label="DeferredTaxLiabilitiesAbstract" xlink:title="DeferredTaxLiabilitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:label="DeferredTaxLiabilitiesLeasingArrangements" xlink:title="DeferredTaxLiabilitiesLeasingArrangements" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesLeasingArrangements" xlink:title="presentation: DeferredTaxLiabilitiesAbstract to DeferredTaxLiabilitiesLeasingArrangements" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="DeferredIncomeTaxLiabilities" xlink:title="DeferredIncomeTaxLiabilities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredTaxLiabilitiesAbstract" xlink:to="DeferredIncomeTaxLiabilities" xlink:title="presentation: DeferredTaxLiabilitiesAbstract to DeferredIncomeTaxLiabilities" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesAbstract" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxLiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NetDeferredTaxAssetsAndLiabilitiesGross" xlink:label="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:title="NetDeferredTaxAssetsAndLiabilitiesGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="NetDeferredTaxAssetsAndLiabilitiesGross" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to NetDeferredTaxAssetsAndLiabilitiesGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="DeferredTaxAssetsValuationAllowance" xlink:title="DeferredTaxAssetsValuationAllowance" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxAssetsValuationAllowance" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxAssetsValuationAllowance" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="DeferredTaxAssetsLiabilitiesNet" xlink:title="DeferredTaxAssetsLiabilitiesNet" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="DeferredTaxAssetsLiabilitiesNet" xlink:title="presentation: ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract to DeferredTaxAssetsLiabilitiesNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:title="presentation: IncomeTaxDisclosureAbstract to ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesNarrativeFyDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="DomesticCountryMember" xlink:title="presentation: IncomeTaxAuthorityDomain to DomesticCountryMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="presentation: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="presentation: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="presentation: OperatingLossCarryforwardsTable to IncomeTaxAuthorityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="IncomeTaxAuthorityNameAxis" xlink:title="IncomeTaxAuthorityNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="IncomeTaxAuthorityNameDomain" xlink:title="IncomeTaxAuthorityNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="NewJerseyDivisionOfTaxationMember" xlink:title="NewJerseyDivisionOfTaxationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="NewJerseyDivisionOfTaxationMember" xlink:title="presentation: IncomeTaxAuthorityNameDomain to NewJerseyDivisionOfTaxationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="CaliforniaFranchiseTaxBoardMember" xlink:title="CaliforniaFranchiseTaxBoardMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="CaliforniaFranchiseTaxBoardMember" xlink:title="presentation: IncomeTaxAuthorityNameDomain to CaliforniaFranchiseTaxBoardMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:label="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="NewYorkStateDivisionOfTaxationAndFinanceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="presentation: IncomeTaxAuthorityNameDomain to NewYorkStateDivisionOfTaxationAndFinanceMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityNameAxis" xlink:to="IncomeTaxAuthorityNameDomain" xlink:title="presentation: IncomeTaxAuthorityNameAxis to IncomeTaxAuthorityNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityNameAxis" xlink:title="presentation: OperatingLossCarryforwardsTable to IncomeTaxAuthorityNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:title="presentation: OperatingLossCarryforwardsLineItems to EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:label="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="OperatingLossCarryforwardsBeforeWriteDown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="presentation: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsBeforeWriteDown" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwards" xlink:title="presentation: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwards" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:label="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="OperatingLossCarryforwardsSetToExpireWrittenDown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="presentation: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsSetToExpireWrittenDown" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:label="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="presentation: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="presentation: OperatingLossCarryforwardsLineItems to ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="presentation: OperatingLossCarryforwardsLineItems to ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LossOnSaleOfNetOperatingLosses" xlink:label="LossOnSaleOfNetOperatingLosses" xlink:title="LossOnSaleOfNetOperatingLosses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="LossOnSaleOfNetOperatingLosses" xlink:title="presentation: OperatingLossCarryforwardsLineItems to LossOnSaleOfNetOperatingLosses" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="OperatingLossCarryforwardsLineItems" xlink:title="presentation: OperatingLossCarryforwardsTable to OperatingLossCarryforwardsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="OperatingLossCarryforwardsTable" xlink:title="presentation: IncomeTaxDisclosureAbstract to OperatingLossCarryforwardsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/BusinessQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:title="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:label="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProjectMember" xlink:label="ProjectMember" xlink:title="ProjectMember" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CLBS16TreatmentOfCMDMember" xlink:label="CLBS16TreatmentOfCMDMember" xlink:title="CLBS16TreatmentOfCMDMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ProjectMember" xlink:to="CLBS16TreatmentOfCMDMember" xlink:title="presentation: ProjectMember to CLBS16TreatmentOfCMDMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="ProjectMember" xlink:title="presentation: CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis to ProjectMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:title="presentation: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to SubsequentEventTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AgreementAndPlanOfMergerAndReorganizationMember" xlink:label="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="AgreementAndPlanOfMergerAndReorganizationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AgreementAndPlanOfMergerAndReorganizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to BusinessAcquisitionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CendTherapeuticsIncMember" xlink:label="CendTherapeuticsIncMember" xlink:title="CendTherapeuticsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RepurchaseAgreementCounterpartyNameDomain" xlink:to="CendTherapeuticsIncMember" xlink:title="presentation: RepurchaseAgreementCounterpartyNameDomain to CendTherapeuticsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CounterpartyNameAxis" xlink:to="RepurchaseAgreementCounterpartyNameDomain" xlink:title="presentation: CounterpartyNameAxis to RepurchaseAgreementCounterpartyNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="CounterpartyNameAxis" xlink:title="presentation: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to CounterpartyNameAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantsReceivable" xlink:label="GrantsReceivable" xlink:title="GrantsReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="GrantsReceivable" xlink:title="presentation: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to GrantsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="presentation: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="presentation: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:label="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="MergerAgreementTransactionExpensesThresholdForRatioAllocation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="presentation: ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems to MergerAgreementTransactionExpensesThresholdForRatioAllocation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:title="presentation: ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable to ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:title="presentation: OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract to ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="AvailableForSaleSecuritiesAbstract" xlink:title="AvailableForSaleSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="ScheduleOfAvailableForSaleSecuritiesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="FinancialInstrumentAxis" xlink:title="FinancialInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="CorporateDebtSecuritiesMember" xlink:title="CorporateDebtSecuritiesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="CorporateDebtSecuritiesMember" xlink:title="presentation: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to CorporateDebtSecuritiesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="MoneyMarketFundsMember" xlink:title="MoneyMarketFundsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="MoneyMarketFundsMember" xlink:title="presentation: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to MoneyMarketFundsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:label="USStatesAndPoliticalSubdivisionsMember" xlink:title="USStatesAndPoliticalSubdivisionsMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="USStatesAndPoliticalSubdivisionsMember" xlink:title="presentation: TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain to USStatesAndPoliticalSubdivisionsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentAxis" xlink:to="TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:title="presentation: FinancialInstrumentAxis to TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="FinancialInstrumentAxis" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesTable to FinancialInstrumentAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesLineItems to AvailableForSaleSecuritiesDebtSecurities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:title="presentation: ScheduleOfAvailableForSaleSecuritiesTable to ScheduleOfAvailableForSaleSecuritiesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="ScheduleOfAvailableForSaleSecuritiesTable" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to ScheduleOfAvailableForSaleSecuritiesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="AvailableForSaleSecuritiesAbstract" xlink:title="AvailableForSaleSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="CashEquivalentsAtCarryingValue" xlink:title="CashEquivalentsAtCarryingValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="CashEquivalentsAtCarryingValue" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to CashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecurities" xlink:label="MarketableSecurities" xlink:title="MarketableSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="MarketableSecurities" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to MarketableSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="CashCashEquivalentsAndShortTermInvestments" xlink:title="CashCashEquivalentsAndShortTermInvestments" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="CashCashEquivalentsAndShortTermInvestments" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to CashCashEquivalentsAndShortTermInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract" xlink:label="AvailableForSaleSecuritiesAbstract" xlink:title="AvailableForSaleSecuritiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract to AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:label="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:title="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="AvailableForSaleSecuritiesDebtSecurities" xlink:title="AvailableForSaleSecuritiesDebtSecurities" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="AvailableForSaleSecuritiesDebtSecurities" xlink:title="presentation: AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract to AvailableForSaleSecuritiesDebtSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AvailableForSaleSecuritiesAbstract" xlink:to="AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:title="presentation: AvailableForSaleSecuritiesAbstract to AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeLossPerShareQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="EarningsPerShareAbstract" xlink:title="EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="AntidilutiveSecuritiesNameDomain" xlink:title="AntidilutiveSecuritiesNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember" xlink:label="WarrantMember" xlink:title="WarrantMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="WarrantMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to WarrantMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: AntidilutiveSecuritiesNameDomain to RestrictedStockUnitsRSUMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="AntidilutiveSecuritiesNameDomain" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis to AntidilutiveSecuritiesNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:title="presentation: AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:title="presentation: ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable to AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareAbstract" xlink:to="ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:title="presentation: EarningsPerShareAbstract to ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/FairValueMeasurementsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="FairValueDisclosuresAbstract" xlink:title="FairValueDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:label="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="FairValueByFairValueHierarchyLevelAxis" xlink:title="FairValueByFairValueHierarchyLevelAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="FairValueMeasurementsFairValueHierarchyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="FairValueInputsLevel1Member" xlink:title="FairValueInputsLevel1Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel1Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel1Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="FairValueInputsLevel2Member" xlink:title="FairValueInputsLevel2Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel2Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="FairValueInputsLevel3Member" xlink:title="FairValueInputsLevel3Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementsFairValueHierarchyDomain" xlink:to="FairValueInputsLevel3Member" xlink:title="presentation: FairValueMeasurementsFairValueHierarchyDomain to FairValueInputsLevel3Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByFairValueHierarchyLevelAxis" xlink:to="FairValueMeasurementsFairValueHierarchyDomain" xlink:title="presentation: FairValueByFairValueHierarchyLevelAxis to FairValueMeasurementsFairValueHierarchyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="FairValueByFairValueHierarchyLevelAxis" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to FairValueByFairValueHierarchyLevelAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="FairValueByMeasurementFrequencyAxis" xlink:title="FairValueByMeasurementFrequencyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="FairValueMeasurementFrequencyDomain" xlink:title="FairValueMeasurementFrequencyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="FairValueMeasurementsRecurringMember" xlink:title="FairValueMeasurementsRecurringMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueMeasurementFrequencyDomain" xlink:to="FairValueMeasurementsRecurringMember" xlink:title="presentation: FairValueMeasurementFrequencyDomain to FairValueMeasurementsRecurringMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueByMeasurementFrequencyAxis" xlink:to="FairValueMeasurementFrequencyDomain" xlink:title="presentation: FairValueByMeasurementFrequencyAxis to FairValueMeasurementFrequencyDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="FairValueByMeasurementFrequencyAxis" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to FairValueByMeasurementFrequencyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="InvestmentsFairValueDisclosure" xlink:title="InvestmentsFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="InvestmentsFairValueDisclosure" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to InvestmentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="AssetsFairValueDisclosure" xlink:title="AssetsFairValueDisclosure" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="AssetsFairValueDisclosure" xlink:title="presentation: FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems to AssetsFairValueDisclosure" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:title="presentation: FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable to FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FairValueDisclosuresAbstract" xlink:to="FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:title="presentation: FairValueDisclosuresAbstract to FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/AccruedLiabilitiesQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:label="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:title="AccruedLiabilitiesCurrentAndNoncurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="EmployeeRelatedLiabilitiesCurrent" xlink:title="EmployeeRelatedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="EmployeeRelatedLiabilitiesCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to EmployeeRelatedLiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to OperatingLeaseLiabilityCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="OtherAccruedLiabilitiesCurrent" xlink:title="OtherAccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="OtherAccruedLiabilitiesCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to OtherAccruedLiabilitiesCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="AccruedLiabilitiesCurrent" xlink:title="AccruedLiabilitiesCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="AccruedLiabilitiesCurrent" xlink:title="presentation: AccruedLiabilitiesCurrentAndNoncurrentAbstract to AccruedLiabilitiesCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesNarrativeQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_NumberOfOfficesUnderOperatingLeases" xlink:label="NumberOfOfficesUnderOperatingLeases" xlink:title="NumberOfOfficesUnderOperatingLeases" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="NumberOfOfficesUnderOperatingLeases" xlink:title="presentation: LeasesAbstract to NumberOfOfficesUnderOperatingLeases" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:title="presentation: LeasesAbstract to OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="OperatingLeaseWeightedAverageDiscountRatePercent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseWeightedAverageDiscountRatePercent" xlink:title="presentation: LeasesAbstract to OperatingLeaseWeightedAverageDiscountRatePercent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLeaseRightOfUseAssetAbstract" xlink:label="OperatingLeaseRightOfUseAssetAbstract" xlink:title="OperatingLeaseRightOfUseAssetAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="OperatingLeaseRightOfUseAsset" xlink:title="OperatingLeaseRightOfUseAsset" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseRightOfUseAssetAbstract" xlink:to="OperatingLeaseRightOfUseAsset" xlink:title="presentation: OperatingLeaseRightOfUseAssetAbstract to OperatingLeaseRightOfUseAsset" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseRightOfUseAssetAbstract" xlink:to="OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:title="presentation: OperatingLeaseRightOfUseAssetAbstract to OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseRightOfUseAssetAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseRightOfUseAssetAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="OperatingLeaseLiabilityAbstract" xlink:title="OperatingLeaseLiabilityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="OperatingLeaseLiabilityCurrent" xlink:title="OperatingLeaseLiabilityCurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityCurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="OperatingLeaseLiabilityNoncurrent" xlink:title="OperatingLeaseLiabilityNoncurrent" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrent" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:label="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:title="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLeaseLiabilityAbstract" xlink:to="OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:title="presentation: OperatingLeaseLiabilityAbstract to OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="OperatingLeaseLiabilityAbstract" xlink:title="presentation: LeasesAbstract to OperatingLeaseLiabilityAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="LeasesAbstract" xlink:title="LeasesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:title="FinanceLeaseLiabilitiesPaymentsDueAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:title="presentation: FinanceLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:title="presentation: FinanceLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:title="presentation: FinanceLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:title="presentation: FinanceLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="LesseeOperatingLeaseLiabilityPaymentsDue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityPaymentsDue" xlink:title="presentation: FinanceLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityPaymentsDue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:title="presentation: FinanceLeaseLiabilitiesPaymentsDueAbstract to LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="OperatingLeaseLiability" xlink:title="OperatingLeaseLiability" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="OperatingLeaseLiability" xlink:title="presentation: FinanceLeaseLiabilitiesPaymentsDueAbstract to OperatingLeaseLiability" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LeasesAbstract" xlink:to="FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:title="presentation: LeasesAbstract to FinanceLeaseLiabilitiesPaymentsDueAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01" />
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="ScheduleOfStockByClassTable" xlink:title="ScheduleOfStockByClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="SubsidiarySaleOfStockAxis" xlink:title="SubsidiarySaleOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LincolnParkAgreementMember" xlink:label="LincolnParkAgreementMember" xlink:title="LincolnParkAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="LincolnParkAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to LincolnParkAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AtTheMarketOfferingAgreementMember" xlink:label="AtTheMarketOfferingAgreementMember" xlink:title="AtTheMarketOfferingAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="AtTheMarketOfferingAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to AtTheMarketOfferingAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain" xlink:title="presentation: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="SubsidiarySaleOfStockAxis" xlink:title="presentation: ScheduleOfStockByClassTable to SubsidiarySaleOfStockAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="ClassOfStockLineItems" xlink:title="ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:label="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:label="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="StockIssuedDuringPeriodSharesIssuedAsConsideration" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesIssuedAsConsideration" xlink:title="presentation: ClassOfStockLineItems to StockIssuedDuringPeriodSharesIssuedAsConsideration" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockNumberOfSharesIssuedInTransaction" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockNumberOfSharesIssuedInTransaction" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="SaleOfStockPricePerShare" xlink:title="SaleOfStockPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockPricePerShare" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockPricePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="SaleOfStockConsiderationReceivedOnTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockConsiderationReceivedOnTransaction" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockConsiderationReceivedOnTransaction" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_TermOfAgreement" xlink:label="TermOfAgreement" xlink:title="TermOfAgreement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="TermOfAgreement" xlink:title="presentation: ClassOfStockLineItems to TermOfAgreement" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:label="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:label="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:label="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" xlink:title="presentation: ClassOfStockLineItems to SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:label="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" xlink:title="presentation: ClassOfStockLineItems to RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:label="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" xlink:title="presentation: ClassOfStockLineItems to PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="StockIssuedDuringPeriodSharesNewIssues" xlink:title="StockIssuedDuringPeriodSharesNewIssues" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockLineItems" xlink:to="StockIssuedDuringPeriodSharesNewIssues" xlink:title="presentation: ClassOfStockLineItems to StockIssuedDuringPeriodSharesNewIssues" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfStockByClassTable" xlink:to="ClassOfStockLineItems" xlink:title="presentation: ScheduleOfStockByClassTable to ClassOfStockLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfStockByClassTable" xlink:title="presentation: EquityAbstract to ScheduleOfStockByClassTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to StockIssuedDuringPeriodSharesStockOptionsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OptionsVestedweightedAverageRemainingContractualTerm" xlink:label="OptionsVestedweightedAverageRemainingContractualTerm" xlink:title="OptionsVestedweightedAverageRemainingContractualTerm" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="OptionsVestedweightedAverageRemainingContractualTerm" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to OptionsVestedweightedAverageRemainingContractualTerm" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CommonStockWarrantsShares" xlink:label="CommonStockWarrantsShares" xlink:title="CommonStockWarrantsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="CommonStockWarrantsShares" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to CommonStockWarrantsShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsGranted" xlink:label="WarrantsGranted" xlink:title="WarrantsGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="WarrantsGranted" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to WarrantsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsExercised" xlink:label="WarrantsExercised" xlink:title="WarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="WarrantsExercised" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to WarrantsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsCanceled" xlink:label="WarrantsCanceled" xlink:title="WarrantsCanceled" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="WarrantsCanceled" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to WarrantsCanceled" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsExpired" xlink:label="WarrantsExpired" xlink:title="WarrantsExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="WarrantsExpired" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to WarrantsExpired" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CommonStockWarrantsShares" xlink:label="CommonStockWarrantsShares_2" xlink:title="CommonStockWarrantsShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="CommonStockWarrantsShares_2" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward to CommonStockWarrantsShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_Sharesvestedandexpectedtovest" xlink:label="Sharesvestedandexpectedtovest" xlink:title="Sharesvestedandexpectedtovest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="Sharesvestedandexpectedtovest" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to Sharesvestedandexpectedtovest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsVested" xlink:label="WarrantsVested" xlink:title="WarrantsVested" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="WarrantsVested" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to WarrantsVested" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsWeightedAverageExercisePriceRollForward" xlink:label="WarrantsWeightedAverageExercisePriceRollForward" xlink:title="WarrantsWeightedAverageExercisePriceRollForward" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="WeightedAverageExercisePriceWarrantsOutstanding" xlink:title="WeightedAverageExercisePriceWarrantsOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsOutstanding" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsGranted" xlink:label="WeightedAverageExercisePriceWarrantsGranted" xlink:title="WeightedAverageExercisePriceWarrantsGranted" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsGranted" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsGranted" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExercised" xlink:label="WeightedAverageExercisePriceWarrantsExercised" xlink:title="WeightedAverageExercisePriceWarrantsExercised" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsExercised" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsExercised" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsCanceled" xlink:label="WeightedAverageExercisePriceWarrantsCanceled" xlink:title="WeightedAverageExercisePriceWarrantsCanceled" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsCanceled" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsCanceled" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExpired" xlink:label="WeightedAverageExercisePriceWarrantsExpired" xlink:title="WeightedAverageExercisePriceWarrantsExpired" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsExpired" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsExpired" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsOutstanding" xlink:label="WeightedAverageExercisePriceWarrantsOutstanding_2" xlink:title="WeightedAverageExercisePriceWarrantsOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsWeightedAverageExercisePriceRollForward" xlink:to="WeightedAverageExercisePriceWarrantsOutstanding_2" xlink:title="presentation: WarrantsWeightedAverageExercisePriceRollForward to WeightedAverageExercisePriceWarrantsOutstanding" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="WarrantsWeightedAverageExercisePriceRollForward" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to WarrantsWeightedAverageExercisePriceRollForward" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:label="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:title="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageExercisePriceWarrantsExercisable" xlink:label="WeightedAverageExercisePriceWarrantsExercisable" xlink:title="WeightedAverageExercisePriceWarrantsExercisable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="WeightedAverageExercisePriceWarrantsExercisable" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to WeightedAverageExercisePriceWarrantsExercisable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WarrantsOtherDisclosuresAbstract" xlink:label="WarrantsOtherDisclosuresAbstract" xlink:title="WarrantsOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:label="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:title="WeightedAverageRemainingContractualTermwarrantoutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="WeightedAverageRemainingContractualTermwarrantoutstanding" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to WeightedAverageRemainingContractualTermwarrantoutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:label="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:title="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_WeightedAverageRemainingContractualTermwarrantsvested" xlink:label="WeightedAverageRemainingContractualTermwarrantsvested" xlink:title="WeightedAverageRemainingContractualTermwarrantsvested" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="WeightedAverageRemainingContractualTermwarrantsvested" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to WeightedAverageRemainingContractualTermwarrantsvested" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsOutstanding" xlink:label="AggregateIntrinsicValueWarrantsOutstanding" xlink:title="AggregateIntrinsicValueWarrantsOutstanding" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="AggregateIntrinsicValueWarrantsOutstanding" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to AggregateIntrinsicValueWarrantsOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:label="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:title="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="AggregateIntrinsicValueWarrantsvestedandexpectedtovest" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to AggregateIntrinsicValueWarrantsvestedandexpectedtovest" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AggregateIntrinsicValueWarrantsvested" xlink:label="AggregateIntrinsicValueWarrantsvested" xlink:title="AggregateIntrinsicValueWarrantsvested" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="WarrantsOtherDisclosuresAbstract" xlink:to="AggregateIntrinsicValueWarrantsvested" xlink:title="presentation: WarrantsOtherDisclosuresAbstract to AggregateIntrinsicValueWarrantsvested" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="WarrantsOtherDisclosuresAbstract" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract to WarrantsOtherDisclosuresAbstract" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:title="presentation: EquityAbstract to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="EquityAbstract" xlink:title="EquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="RangeAxis" xlink:title="RangeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="RangeMember" xlink:title="RangeMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="MinimumMember" xlink:title="MinimumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MinimumMember" xlink:title="presentation: RangeMember to MinimumMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="MaximumMember" xlink:title="MaximumMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeMember" xlink:to="MaximumMember" xlink:title="presentation: RangeMember to MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RangeAxis" xlink:to="RangeMember" xlink:title="presentation: RangeAxis to RangeMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="RangeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EquityAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: EquityAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="IncomeStatementLocationAxis" xlink:title="IncomeStatementLocationAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="IncomeStatementLocationDomain" xlink:title="IncomeStatementLocationDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="ResearchAndDevelopmentExpenseMember" xlink:title="ResearchAndDevelopmentExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="ResearchAndDevelopmentExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to ResearchAndDevelopmentExpenseMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="GeneralAndAdministrativeExpenseMember" xlink:title="GeneralAndAdministrativeExpenseMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationDomain" xlink:to="GeneralAndAdministrativeExpenseMember" xlink:title="presentation: IncomeStatementLocationDomain to GeneralAndAdministrativeExpenseMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementLocationAxis" xlink:to="IncomeStatementLocationDomain" xlink:title="presentation: IncomeStatementLocationAxis to IncomeStatementLocationDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="IncomeStatementLocationAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to IncomeStatementLocationAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="AllocatedShareBasedCompensationExpense" xlink:title="AllocatedShareBasedCompensationExpense" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="AllocatedShareBasedCompensationExpense" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to AllocatedShareBasedCompensationExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="RestrictedStockUnitsRSUMember" xlink:title="RestrictedStockUnitsRSUMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockUnitsRSUMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockUnitsRSUMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="RestrictedStockMember" xlink:title="RestrictedStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="RestrictedStockMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to RestrictedStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:title="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="AwardTypeAxis" xlink:title="AwardTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="EmployeeStockOptionMember" xlink:title="EmployeeStockOptionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="EmployeeStockOptionMember" xlink:title="presentation: ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain to EmployeeStockOptionMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AwardTypeAxis" xlink:to="ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:title="presentation: AwardTypeAxis to ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="AwardTypeAxis" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to AwardTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:title="presentation: ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems to ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:title="presentation: ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable to ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:title="presentation: DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract to ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/IncomeTaxesQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="IncomeTaxDisclosureAbstract" xlink:title="IncomeTaxDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="OperatingLossCarryforwardsTable" xlink:title="OperatingLossCarryforwardsTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="IncomeTaxAuthorityAxis" xlink:title="IncomeTaxAuthorityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="IncomeTaxAuthorityDomain" xlink:title="IncomeTaxAuthorityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="DomesticCountryMember" xlink:title="DomesticCountryMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="DomesticCountryMember" xlink:title="presentation: IncomeTaxAuthorityDomain to DomesticCountryMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="StateAndLocalJurisdictionMember" xlink:title="StateAndLocalJurisdictionMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityDomain" xlink:to="StateAndLocalJurisdictionMember" xlink:title="presentation: IncomeTaxAuthorityDomain to StateAndLocalJurisdictionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityAxis" xlink:to="IncomeTaxAuthorityDomain" xlink:title="presentation: IncomeTaxAuthorityAxis to IncomeTaxAuthorityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityAxis" xlink:title="presentation: OperatingLossCarryforwardsTable to IncomeTaxAuthorityAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="IncomeTaxAuthorityNameAxis" xlink:title="IncomeTaxAuthorityNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="IncomeTaxAuthorityNameDomain" xlink:title="IncomeTaxAuthorityNameDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewJerseyDivisionOfTaxationMember" xlink:label="NewJerseyDivisionOfTaxationMember" xlink:title="NewJerseyDivisionOfTaxationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="NewJerseyDivisionOfTaxationMember" xlink:title="presentation: IncomeTaxAuthorityNameDomain to NewJerseyDivisionOfTaxationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:label="CaliforniaFranchiseTaxBoardMember" xlink:title="CaliforniaFranchiseTaxBoardMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="CaliforniaFranchiseTaxBoardMember" xlink:title="presentation: IncomeTaxAuthorityNameDomain to CaliforniaFranchiseTaxBoardMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:label="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="NewYorkStateDivisionOfTaxationAndFinanceMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityNameDomain" xlink:to="NewYorkStateDivisionOfTaxationAndFinanceMember" xlink:title="presentation: IncomeTaxAuthorityNameDomain to NewYorkStateDivisionOfTaxationAndFinanceMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxAuthorityNameAxis" xlink:to="IncomeTaxAuthorityNameDomain" xlink:title="presentation: IncomeTaxAuthorityNameAxis to IncomeTaxAuthorityNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="IncomeTaxAuthorityNameAxis" xlink:title="presentation: OperatingLossCarryforwardsTable to IncomeTaxAuthorityNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="OperatingLossCarryforwardsLineItems" xlink:title="OperatingLossCarryforwardsLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsBeforeWriteDown" xlink:label="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="OperatingLossCarryforwardsBeforeWriteDown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsBeforeWriteDown" xlink:title="presentation: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsBeforeWriteDown" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="OperatingLossCarryforwards" xlink:title="OperatingLossCarryforwards" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwards" xlink:title="presentation: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:label="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="OperatingLossCarryforwardsSetToExpireWrittenDown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsSetToExpireWrittenDown" xlink:title="presentation: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsSetToExpireWrittenDown" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:label="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" xlink:title="presentation: OperatingLossCarryforwardsLineItems to OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" xlink:title="presentation: OperatingLossCarryforwardsLineItems to ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:label="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" xlink:title="presentation: OperatingLossCarryforwardsLineItems to ProceedsFromSaleOfNetOperatingLossesNJEDAProgram" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_LossOnSaleOfNetOperatingLosses" xlink:label="LossOnSaleOfNetOperatingLosses" xlink:title="LossOnSaleOfNetOperatingLosses" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsLineItems" xlink:to="LossOnSaleOfNetOperatingLosses" xlink:title="presentation: OperatingLossCarryforwardsLineItems to LossOnSaleOfNetOperatingLosses" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingLossCarryforwardsTable" xlink:to="OperatingLossCarryforwardsLineItems" xlink:title="presentation: OperatingLossCarryforwardsTable to OperatingLossCarryforwardsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureAbstract" xlink:to="OperatingLossCarryforwardsTable" xlink:title="presentation: IncomeTaxDisclosureAbstract to OperatingLossCarryforwardsTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://caladrius.com/role/SubsequentEventsQ1Details">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="SubsequentEventsAbstract" xlink:title="SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="SubsequentEventTable" xlink:title="SubsequentEventTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="SubsequentEventTypeAxis" xlink:title="SubsequentEventTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="SubsequentEventTypeDomain" xlink:title="SubsequentEventTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="SubsequentEventMember" xlink:title="SubsequentEventMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeDomain" xlink:to="SubsequentEventMember" xlink:title="presentation: SubsequentEventTypeDomain to SubsequentEventMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTypeAxis" xlink:to="SubsequentEventTypeDomain" xlink:title="presentation: SubsequentEventTypeAxis to SubsequentEventTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventTypeAxis" xlink:title="presentation: SubsequentEventTable to SubsequentEventTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="SubsidiarySaleOfStockAxis" xlink:title="SubsidiarySaleOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="SaleOfStockNameOfTransactionDomain" xlink:title="SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CendSeriesDPreferredStockPurchaseAgreementMember" xlink:label="CendSeriesDPreferredStockPurchaseAgreementMember" xlink:title="CendSeriesDPreferredStockPurchaseAgreementMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SaleOfStockNameOfTransactionDomain" xlink:to="CendSeriesDPreferredStockPurchaseAgreementMember" xlink:title="presentation: SaleOfStockNameOfTransactionDomain to CendSeriesDPreferredStockPurchaseAgreementMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsidiarySaleOfStockAxis" xlink:to="SaleOfStockNameOfTransactionDomain" xlink:title="presentation: SubsidiarySaleOfStockAxis to SaleOfStockNameOfTransactionDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsidiarySaleOfStockAxis" xlink:title="presentation: SubsequentEventTable to SubsidiarySaleOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="LegalEntityAxis" xlink:title="LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="EntityDomain" xlink:title="EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_CendTherapeuticsIncMember" xlink:label="CendTherapeuticsIncMember" xlink:title="CendTherapeuticsIncMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityDomain" xlink:to="CendTherapeuticsIncMember" xlink:title="presentation: EntityDomain to CendTherapeuticsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LegalEntityAxis" xlink:to="EntityDomain" xlink:title="presentation: LegalEntityAxis to EntityDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="LegalEntityAxis" xlink:title="presentation: SubsequentEventTable to LegalEntityAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="StatementClassOfStockAxis" xlink:title="StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="ClassOfStockDomain" xlink:title="ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_SeriesDPreferredStockCendMember" xlink:label="SeriesDPreferredStockCendMember" xlink:title="SeriesDPreferredStockCendMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ClassOfStockDomain" xlink:to="SeriesDPreferredStockCendMember" xlink:title="presentation: ClassOfStockDomain to SeriesDPreferredStockCendMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementClassOfStockAxis" xlink:to="ClassOfStockDomain" xlink:title="presentation: StatementClassOfStockAxis to ClassOfStockDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="StatementClassOfStockAxis" xlink:title="presentation: SubsequentEventTable to StatementClassOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="BusinessAcquisitionAxis" xlink:title="BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="BusinessAcquisitionAcquireeDomain" xlink:title="BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_AgreementAndPlanOfMergerAndReorganizationMember" xlink:label="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="AgreementAndPlanOfMergerAndReorganizationMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAcquireeDomain" xlink:to="AgreementAndPlanOfMergerAndReorganizationMember" xlink:title="presentation: BusinessAcquisitionAcquireeDomain to AgreementAndPlanOfMergerAndReorganizationMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BusinessAcquisitionAxis" xlink:to="BusinessAcquisitionAcquireeDomain" xlink:title="presentation: BusinessAcquisitionAxis to BusinessAcquisitionAcquireeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="BusinessAcquisitionAxis" xlink:title="presentation: SubsequentEventTable to BusinessAcquisitionAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="CounterpartyNameAxis" xlink:title="CounterpartyNameAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="RepurchaseAgreementCounterpartyNameDomain" xlink:title="RepurchaseAgreementCounterpartyNameDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RepurchaseAgreementCounterpartyNameDomain" xlink:to="CendTherapeuticsIncMember" xlink:title="presentation: RepurchaseAgreementCounterpartyNameDomain to CendTherapeuticsIncMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CounterpartyNameAxis" xlink:to="RepurchaseAgreementCounterpartyNameDomain" xlink:title="presentation: CounterpartyNameAxis to RepurchaseAgreementCounterpartyNameDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="CounterpartyNameAxis" xlink:title="presentation: SubsequentEventTable to CounterpartyNameAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="SubsequentEventLineItems" xlink:title="SubsequentEventLineItems" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" xlink:title="presentation: SubsequentEventLineItems to MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:label="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" xlink:title="presentation: SubsequentEventLineItems to MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:label="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="MergerAgreementTransactionExpensesThresholdForRatioAllocation" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementTransactionExpensesThresholdForRatioAllocation" xlink:title="presentation: SubsequentEventLineItems to MergerAgreementTransactionExpensesThresholdForRatioAllocation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementMinimumNetCashThreshold" xlink:label="MergerAgreementMinimumNetCashThreshold" xlink:title="MergerAgreementMinimumNetCashThreshold" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementMinimumNetCashThreshold" xlink:title="presentation: SubsequentEventLineItems to MergerAgreementMinimumNetCashThreshold" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialTerminationFeePayable" xlink:label="MergerAgreementPotentialTerminationFeePayable" xlink:title="MergerAgreementPotentialTerminationFeePayable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementPotentialTerminationFeePayable" xlink:title="presentation: SubsequentEventLineItems to MergerAgreementPotentialTerminationFeePayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialTerminationFeeReceivable" xlink:label="MergerAgreementPotentialTerminationFeeReceivable" xlink:title="MergerAgreementPotentialTerminationFeeReceivable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementPotentialTerminationFeeReceivable" xlink:title="presentation: SubsequentEventLineItems to MergerAgreementPotentialTerminationFeeReceivable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_MergerAgreementPotentialExpenseReimbursement" xlink:label="MergerAgreementPotentialExpenseReimbursement" xlink:title="MergerAgreementPotentialExpenseReimbursement" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="MergerAgreementPotentialExpenseReimbursement" xlink:title="presentation: SubsequentEventLineItems to MergerAgreementPotentialExpenseReimbursement" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockShares" xlink:label="PurchaseOfPreferredStockShares" xlink:title="PurchaseOfPreferredStockShares" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="PurchaseOfPreferredStockShares" xlink:title="presentation: SubsequentEventLineItems to PurchaseOfPreferredStockShares" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="PreferredStockParOrStatedValuePerShare" xlink:title="PreferredStockParOrStatedValuePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="PreferredStockParOrStatedValuePerShare" xlink:title="presentation: SubsequentEventLineItems to PreferredStockParOrStatedValuePerShare" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockPricePerShare" xlink:label="PurchaseOfPreferredStockPricePerShare" xlink:title="PurchaseOfPreferredStockPricePerShare" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="PurchaseOfPreferredStockPricePerShare" xlink:title="presentation: SubsequentEventLineItems to PurchaseOfPreferredStockPricePerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PurchaseOfPreferredStockAggregatePrice" xlink:label="PurchaseOfPreferredStockAggregatePrice" xlink:title="PurchaseOfPreferredStockAggregatePrice" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="PurchaseOfPreferredStockAggregatePrice" xlink:title="presentation: SubsequentEventLineItems to PurchaseOfPreferredStockAggregatePrice" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_PreEquityOfferingValueAfterConversion" xlink:label="PreEquityOfferingValueAfterConversion" xlink:title="PreEquityOfferingValueAfterConversion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="PreEquityOfferingValueAfterConversion" xlink:title="presentation: SubsequentEventLineItems to PreEquityOfferingValueAfterConversion" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:type="locator" xlink:href="clbs-20220726.xsd#clbs_GrossProceedsOnTransaction" xlink:label="GrossProceedsOnTransaction" xlink:title="GrossProceedsOnTransaction" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventLineItems" xlink:to="GrossProceedsOnTransaction" xlink:title="presentation: SubsequentEventLineItems to GrossProceedsOnTransaction" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventTable" xlink:to="SubsequentEventLineItems" xlink:title="presentation: SubsequentEventTable to SubsequentEventLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SubsequentEventsAbstract" xlink:to="SubsequentEventTable" xlink:title="presentation: SubsequentEventsAbstract to SubsequentEventTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>logo_caladrius.jpg
<TEXT>
begin 644 logo_caladrius.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M&GR=>,P+QDZ;EB\51HPBU*CAJGL54FVFI3J17.TDK<J:75-:W_BVG_X);_\
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M &('C+_U'=2K\3P7^^83_L)H?^G8'O2V?H_R/XJO^#6O_D[?]IG_ +(O:_\
MJ>Z?7]#'_!>G_E$U^UO_ -@_X/?^M!_">OYY_P#@UK_Y.W_:9_[(O:_^I[I]
M?U0?\%0?@CJW[17_  3^_:J^$?A^WEO/$7B#X6:CK'ARQA4O+J/B+P)J.F_$
M#0-,C YW:EJ_A:RL PSM^T;MK8VG^A/$O$T<%X\9)C,1-4\/A,SX*Q->I)VC
M"C0JX"K5G)]%&$)2;Z)'S.40E4X;G3@FY5*&80BDKMRE4Q$4DENVVE8_(O\
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MDKIV:N.7X=8&.75(NMAXTE2M4:YI1C\,FXJ-III-2BHM22:LT?Q"?##X@?\
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M:^./B[PB?BC>^+/BG_PD_P#PDOQ7U_1]:_T;XK>-;31!>Z;'XJL4M@/#MOI
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MB6YUC^SM-F31K" DM>7^IO;6UI&KO<2(JDUX)\2/%'PW\#_MFZGKOQ7LK?\
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??"4U1PD)TL-0@ZE.C>356M?FKU)3G*I*,;M**2__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>logo_caladriusx1.jpg
<TEXT>
begin 644 logo_caladriusx1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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ME.#Z29AGE>CB,CQ=6A5A6IM4K3IR4HW]O2TNF[/NGJC]1/\ @V\_Y1I^#O\
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MXKFD[:VBG)[)-Z'+#B#*)M)8R";ZSC4@M;;RE!);ZW>FO17/ZPJ*^!?V4/\
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M$!C2YA)#K_&K^W=^P7^TK_P2._:#\*:GIOC74Y-&N[V;Q%\%/CMX,%[X?FU
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MU*S+<RVL@XK]5**_G:IQYQK5Q3QL^+.(GB>?VBJ1SC'P497O:%.G7C2A"_\
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M^.V1V.--^$V,CVR<?6OK?_@V3_Y,&U__ ++!XJ_E%7R/_P '7_\ R(W[%/\
MV,WQV_\ 3;\)J^N/^#9/_DP;7_\ LL'BK^45?M6/_P"4:,E_['M7_P!7^;'@
M4?\ DK,7_P!@,?\ TC#'[._MGDC]CS]K @D$?LT_'4@C@@CX7>*<$'L17\!W
M_! 3_E*%\&_^P7X\_P#3)-7]^'[:'_)G?[6/_9M/QV_]5=XJK^ __@@)_P I
M0O@W_P!@OQY_Z9)J/"#_ )-CXL?]BZO_ .JC&AG?_(WR'_K]4_\ 3E _TAJ*
M**_F@^J"ORF_X+<_\HP/VK/^Q,TW_P!2;1:_5FORF_X+<_\ *,#]JS_L3--_
M]2;1:^HX(_Y+/A/_ +*3)/\ U988Y<=_N>*_[!ZW_IN1_,S_ ,&K_P#R>U\>
M?^S6-<_]6U\)J_L=_;3_ &B;+]D_]EKXU?M 7EO'>2_#GP7?:GI-C*V([WQ!
M>20Z5H$$BC#RP_VM?VDMS%&5DDM8IU1XS\Z_QQ?\&K__ ">U\>?^S6-<_P#5
MM?":OZ?O^"S'PN\2?%S_ ()O_M+>&?"=M<7^NV/A6R\46NG6J-)-?P>&]9L-
M2U&%44$L(M-CN[Q@ <BU.!G%?L7BWA<'CO&W+L%F+4<!BZW"^&QCD^6+PU:5
M&G6C*5URQE"4HRG=<B;E?0\/(93AP_STE>I".+E!6O><9U'%6ZZI:=3^&']D
M[]G?X_\ _!9;]MS5=.\9?$.]&L>(_P"TO'OQ4^)&L13:RO@[P59W<43Q:-I!
MN;:-ECGO;+0_#FC17%G91W5W;?:)883<7%?V>?!+_@@+_P $T/@]I%E:ZI\'
M-5^,7B"VCC%QXL^*WC+Q!J-]=R@ R,VB>%[KPIX12%I 3''_ ,(])(D>U'GF
M(9V_E"_X($_MI_"S]C;]L'7'^-.JP>%_ WQA\!7/PVN/%]_F/3O"FLMKVBZ]
MI-_J\F-T&F7%WHZZ9=SL/+LQ>"[E C@8U_H@>&_%GACQEI=KK?A/Q#HOB72+
MVWANK74=#U*SU.SGM[A!)#*D]G-,FV1&##)!YP0""*]CQXXDXSR+/<)D^58K
M,<AX7I9;A%E[RB57+\/B9J+C7A/%87V4I.A*,:,<)[54Z5*-.:I?O>>?/PWA
M<#B,++%584L3C95JGMIUDJM2#YKQM&?-R\T;2YTDY-O72R^&9_\ @E)_P3FN
M+46<G['_ ,&1"%*9B\/S6\^",'_2X+V*ZW>C>=N!Y!!YKY ^-_\ P;S?\$U?
MBY8W0\,_#CQ;\#]>FBD,>N_"WQSK3)]J()ADN=$\=R>-=$-NC;1+;:;9:6TL
M094GAE;SA^XM%?@^#XYXSR^M&OA.*N(*52+OKFV-J4Y/M4HU:U2C56GPU*<H
MOL?25,#@JL7"IA,/.+W3HT_31\MT^S3370_A+\=_\&\7[;G[.'[2_P (];_9
MF\?:?\1?![^/M#O-.^*MA<+X#\3_  SBL]1@N9-6\5Z--J=V9+:RMT8B[\-7
M^J7%ZRD?V1:AQ$/[LE#!5#-N8* S8V[F  +;<G&3DXR<9QDTZBNWC'C_ #[C
MFGDRS[ZG5Q&34,30AC*&&CA\1B_K,Z4YU,7[-JE*450@H1HTJ-.+=22AS5),
MRP.6X;+O;+"J<(5YQG*G*<IP@XQY?<4KM)[N[;>BO:,4O\G_ /8_*>+/VSO@
M#/XB;SCK/QP\'7VIO<;G,ES+XDMKUWEX#,S7(#$X!W<\=O\ 6 K_ "F?C3X-
MUC]C;]NOQMX5O;>>UNO@-^T->-:#RVB:]T?PEXU^V:9>6RG!-KJ^CVUO=6CC
MY9;6ZC=?E<5_J-?!GXFZ#\9_A/\ #OXK>&+VVU#0_'_A#0O$]E<VDBRP?\32
MPAN+BW#H2OF6=VT]I,N<I-!(A *FOV[Z2=.6+AP1G6&]_+<3@,;3HU8:TE*N
ML%BJ*37NKVM!\T5UC2=KJ+M\_P *?NXYCAJC_?TL2G43^)Z2@VUO93A+7NST
MRBBBOY:/KPIDDB1(\LKK''&C222.P1$1 6=W9B%554%F8D  $D@"GU\@?\%
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M;?\ !KG^W[>PBZO_ (N?LJV]W,JR-#-XY^*]S,CG&5N)T^#+IYBC.3$\ZD@
M.0<AEW_P;3_\%+_",#7?AKXM?L\W\T67BM?"OQ6^*>F7S%<E0CZG\*M!M%D)
M VYO%4$Y+J.:_O>HK\Y7TA/$._OU,EJ0O_"GE,.2W\ONU8RM_P!O7\STUPQE
M2^&.(C+^:.(FI/UZ?<D?Y@/[<7[#7_!1+]D?P9X;N_VMK;Q<WPMU7QA#H?A+
M4KWXO6'C[PE=>,?[&UF^MTT[08_%.HZEIU__ &'9:T\6H7?A_3U%J+FU%RKS
MF"3^FO\ X-6?^35OVD/^R\Z;_P"H%HM:O_!U#_R9M\ O^SFM)_\ 56?%*LK_
M (-6?^35OVD/^R\Z;_Z@6BU^D\5<48WC#P#Q.=YAAL#A<56SC"T:E++J-2AA
MFL/F]*G&:IU*U>2G.*3J/VG*Y7<8Q6B\K!8.G@>)G0I3JS@L)*:=:?/-<\$[
M<UE=+97N_-G]+OQ+_P"2<^/O^Q+\4?\ IDOJ_P U'_@C?_RE(_91_P"RK2_^
MFS6*_P!*[XE_\DY\??\ 8E^*/_3)?5_FH_\ !&__ )2D?LH_]E6E_P#39K%?
M.>!__)%>+/\ V)%_ZJ\[.S/_ /D99!_V&/\ ]/84_P!.2OYX_P#@L?\ \%L;
M/]A74?\ AG[X"Z9HOC+]HV_TBVU+Q%J>MF2Y\+_"O3M6MUN-)&I6%K-!<:QX
MIU&QFBU2TTHW-G:6-A<:??7<]U]I^PC^AJ1MB._]U&;_ +Y!/]*_RS_C%?:M
M^V#_ ,%*/'1\27MQ-)\:/VJ-8TN=Y)7WV'A[6/B#/86^G6S,2T4.D^'_ "["
MPC4A88;6"- %0 ?*>"/!>4<4YWFF89_26)RCAO PQU;!R;]EB<15E4]A'$*+
M4IX>E3P^(JSI)I59PIPFW2=2$^S/\=7P>&HTL*^7$XRLJ%.>GN)_%)7NE)MQ
MBG9\O,WND?4'@'P__P %D/\ @JYK6I>(?#'B+XW?$7PW)=R0ZGXAN/%R_#'X
M1Z>^]?,M8$2_\,^&=2ELE>,2V6CV6LZO#$4>:%MV]OJS3/\ @V)_X*(>)84U
M/Q%\3_V9])NY\M+:Z[\0_B;J>K1L1N/GR:?\)M3LF)8X+1ZE+R&(W#!;^YOX
M/?"7P1\#/AIX-^%/PZT/3_#WA'P3H.GZ%I6GZ=:PVL/EV5ND4EU*D*H)+J\F
M$EU=3OF2:XFDD=BS$UZ77K9E]('/Z&(J8?A+)\AR#)Z,Y0P=&&71J8B5"+<8
M2K<LZ>&A*<4G[.CAX*G?DYYM<[QI\-86<4\=B,7C*SM*I*=>2@Y:744O>Y;K
M2\FVNRT7\$[_ /!L3_P45T)7NM#^,7[,#2Q@%(]*^)'Q<T^]<C)Q&7^#5K N
M.Q:[3FOE?]I3_@E/_P %8OV8/A9XW\6_$!_$.N_!;P[I N?'>J>$/CO%J?A:
M#1#>VMNK:GX8UCQ%H6KZI9F]EM +:'PY?,KE)7@58RZ?Z0%?G#_P5W_Y1L_M
M<_\ 9,1_ZDWA^NKAOQXXVS'/LER[,</D&-H8_-LNP5657+)0JTZ>*QE&A.I1
MG1Q--1JPC-RIRE&<5-)RC)*Q-?AO+X4*LJ4\72<:<Y+DQ#M>,6[-2C)-.UFN
MVUC^3/\ X-A_^3Z?&_\ V1G7O_2ZUK^TK]MR_O-+_8R_:TU'3]XOK+]FKXY7
M%J\9Q)#-%\,O$[)<(><-;D>>/^N=?Q:_\&P__)]/C?\ [(SKW_I=:U_==\4_
M!%K\3?AC\1OAO?.(K+X@^ _%_@B\E(R([7Q7X?U'0;AR.X2&_=B.^,5R>.M:
MGAO%?"8BM_"H8+(:U7K^[I5ZDYZ=?=BR^&DY9+"*=G*>)2?9N<DG\F?YK/\
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MLW9=(PA*3?1)MZ(Y,PDHX'%RD[)8:LVWT7LY'\^7_!J__P GM?'G_LUC7/\
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M?@:1;:W\:_C=X<@MSMFL?B1\-](<$1X!2XF\6^"?[17&,,1=QOZM7TG\,O\
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MGU[=C=_1.CI(B21NLD<BJ\<B,'1T<!E=&4E65E(*L"00002#7^;C_P %H/\
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MS^,?P>\2Z'H>HQ,9;:ZB\2Z!*VF74+QAF=)UFA>(JI8[UXS7\3_P*_X-WO\
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M;E_FM?EM;7X_F=_]OJVN59MS?R_5'>]MK\WR_0_9;_@ZA_Y,V^ 7_9S6D_\
MJK/BE65_P:L_\FK?M(?]EYTW_P!0+1:_"/7O^"3/_!9;]H_5(M0^+7P^^*GB
M34C+YRZG\8_'\M_-%-(I1I6N=5U+5)4DVNRNX^;:6&3D@_U7_P#!"[]@KX]_
ML#? +XL>!_V@+7PO8^)?'OQ.L_&.DV?A?7T\00V^DP^%]-T@K?726ULD-V;J
MUE)@"OM3!+G-?6\70X>X7\&:W!F'XMR//LUCF>&Q489=BJ$IU%4S.EB:JIT*
M>(KSE&A3NY5&XW2YG&.QPX)8K%Y^\PG@<3A:#PSIIUX<K34$E?16<NBU]=&?
ML5\2_P#DG/C[_L2_%'_IDOJ_S4?^"-__ "E(_91_[*M+_P"FS6*_TP/&6E76
MN^$/%6B6/E_;=8\.:WI=IYK^7%]JO]-N;6W\Q\-LC\V5-[X.U<G!QBOXU_\
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M\A9\0_\ !QUK2^5#<_MI#>H4&SU:_P!/?!;:"LD.J6[*V[C<K!O4XKSCQ?\
M\$_O^"Z?[2Q%I\8?"O[2GC"UNBJM%\7/B+J6H:>B%@Z*\.KZ_J$4<*$!E01;
M8\#"C %=.1^#V#R7.<JS7,_$;@NE1RS,<#F$J=''4ZM6M]3Q-+$^RBJM?#QC
M[14^3GO+DYE+DG:S5;.ZE6G4IT<HS2<IPG!.>'=.*YHM)N3YN_8]O_X-A_\
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MAEH'PB^"G@W2O!'@?P["$M-,TR ))=W3*BW&IZI=MFYU+5+PHKW=_>2S7,[
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MA'>4I0:C%>;>A^-?_!J3_P @;]KG_L)_#K_TEUFO[!:_GV_X(5_\$VOVD/\
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M[*4X1O?V_P#X(%_L+Z[^Q_\ LC2^+_B)I,FC_%?]H2_TOQMKVE7<7EZAX?\
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M(=)N I%Q93*<5_4;%%%!%%!!&D,,,:10Q1J$CBBC4)''&B@*B(BA450 J@
M 5S^)7&O#%/A3)_#?@FM6Q^4956AB,=F]922QE:DZTU3H<T*;J*IB,14Q%:M
M&G3I*4*5+#\U/F965Y?BWC:^;9C&%/$5X>SIX>#35&G[BO)IM<W+!1T;WDW9
MRLI****_!#Z(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-O NEW'B+QCJ-OEU6Y_LVS5_L-K(R.L-UJ#VMO,T<HCE8PR;?'=2_;8UWPE
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@:5.G+!>WYL34JJ--5\1B/K"A.I[&DU2H4:;Y^12/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>logo_cend.jpg
<TEXT>
begin 644 logo_cend.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MA6%OIGCC0(I)5CDU/4[*U6/3_$<$"L9;B*.&SO&13Y#E@$;J]"_X->_B[<:
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M:>/J.FG.M]9J.$;*3<HSERJST=K+?30_I%'_  =(Q* J_L;,%   'QH4  #
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MTNWO)4PK7D-P-D;!HTQ?V0_^2DZW_P!B/J7_ *?O#5?8_P#P7/\ %^C>,?\
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M2^KPIT\%3J6:?+5E"=:LX/5-4JE&6NDT=%7/ZTHM4J$*4G]J4G4:\TN6"O\
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M]1\0:)86L:EY+F\U6QMH$0#)9I9ITC50.22P&*_R7K#4=0TJZBOM+O[S3;V
M[H;RPNI[.ZA;UBN+=XYHSP.4<'BNPUCXI_$[Q#9/INO_ !&\>:YITB['T_6/
M%_B#4[)T'17M;W49X&48'RF,CVKR<9X)X:IB9SP6>5</A)3;C1KX-8BK2@W?
MD5:.(HJIRJZ4I4XO:]W=O6GG[4$JF'O-+5PG:,GIJDXMQOKI>5M'?H?WA?MI
M_P#!>G]DW]E?7]*\%_#R)OVF?&G]K00^+[+X=^)+"Q\,^#M&5T%_+<^,I;#5
MM*U;Q*JETL_#6EI,%G@FCUS5=!_T8W7U?^R-_P %5?V,OVRK.WMOAS\3+7PQ
MXY:*-KSX8_$<VGA/QK:R, '6SMKB[FTSQ!;QN0K7GA[4M3@3?&)S!*XB'^:H
MJL[*B*SN[!41069F8X554 EF8D   DDX S7]*O\ P2$_X(K^/_BUXQ\(_M(_
MM2>&]9\"_"'PW?:;XG\%^!-42?2?$WQ+U"SFBO=-N=3LF\J^T?P8)$BEG$ZV
M]]KT7[B!(;&5KF9<1^'/!>0Y Z^,S'&8/%T(3<,:ZD*M?'XAI.-"& DXTIJ]
ME"%!T94XOGKUY1C*96$S3'8K$\L*,)TFUS12:5*%[.3J][:^\G=Z1BMC^W$$
M$9!R#R".A'K7\ ?_  <0_P#*27Q5_P!DE^%'_IGO*_O[5550J@*J@*JJ %50
M,  #@ #@ < <"OX!/^#B'_E)+XJ_[)+\*/\ TSWE?)>#O_)65O\ L3XS_P!2
M,$=F=_[B_P#K[3_4^,_^"5?_ "D6_8]_[+9X7_\ 0KBO],BO\S?_ ()5_P#*
M1;]CW_LMGA?_ -"N*_TR*]'QK_Y'F4?]BJ7_ *EUS+(/]TJ_]A$O_3=(*_S#
M/^"CG_)]?[5'_98_%G_I4M?Z>=?YAG_!1S_D^O\ :H_[+'XL_P#2I:OP3_Y'
M&<_]BVE_ZE0%G_\ NU'_ *_K_P!-S/TO_P"#;[_D_75O^R.^,?\ T;I]?TC_
M /!<+]EW4OVGOV"/'L'A;2Y=6\??!G6=)^-'@^QM4+WE^OABWU#3/%^F6ZQA
MIIY+GP/KGB*ZL["))&O]8T_28%C\SRY(_P";C_@V^_Y/UU;_ +([XQ_]&Z?7
M]X,L4<T<D,R)+%*CQ2Q2*'22.12CHZL"K(ZDJRD$,"01@US>).8U\H\0L%F>
M'LZV!PN68F$6VHS]G4K.5*36O)5AS4YV^S)FF5THULK]E/X:GMH/NN:35UYI
MZI]&DS_([(*DJP(8$@@@@@@X((/((/!!Y!K^K;_@B1_P6+\#_"OP1HO['_[5
MGB:/PUX9T":6#X,?%?69V_LC1M,OKCSO^%>^+KID/]G:997DT\_AC7;F0VEA
M;7#Z)>O;:?:Z6UOY+_P6,_X(R^+_ (1^*_%'[3'[+OA34?%/PC\17M_X@\>>
M O#]BUYJWPVU"Y=[O4=3TS3+16N+SPA-(TMRZV<$CZ&#()8UL$$L7\T1!!((
M((."#P01U!'8BOV&K3X>\2.'8Q]I[3#U7"HG3E%8S+,;&+TDFI>SK04IPDIQ
M=.M2E)QYH3C(\%/%93BGIKJG>_LZU.Z>C^2=UK"6_9_ZRFD_$?X>Z]IEMK6B
M>.?"&JZ1>6\=U:ZE8>(](NK*>VF4/%/'<PWCQ-'(I#(P;!!!%?E-_P %$O\
M@L3^SM^QUX"\1Z'X$\7^'OBK^T)?Z=>V/A#P1X7U*TUFP\/:M-');P:]XXU&
MR-W9:9INDRG[8-)D9M1UJ2%+&&&&WFGOK7_/AL?%'B;3+.33]-\1:[I]A-_K
M;&QU?4+2SEYS^\MH+B.%^>?F0\\UL?#WX=>//BWXST+X??#7PIKGC?QOXHOH
M]/T/PYX?LI=0U34;N4\A(HP1'#$NZ:ZN[AXK2T@22YNYX8(Y)%^*P'@WE6"Q
M2Q>9YO5QN"P\O:O#O#PP=.<*?OVQ-=UZMJ22?M5!4^:-_P!Y!'HU,]J5(\E#
M#\M66BDY.I9O3W(**YG?:_6UXLS_ !IXP\1_$+Q?XI\>>,-4N=<\5^,_$.L>
M*?$NLWC![O5==U[4+C5-5U"X< !IKN^NIYY" !N<X &!7T'^R'_R4G6_^Q'U
M+_T_>&J\Q^.OP6\;?L[_ !7\8?!CXCV]G9^.O EUIVG>)[*PNEOK6PU2^T73
M=9EL%NT58[B2Q74DM+F6+="US#+Y+R1;)&]._9#_ .2DZW_V(^I?^G[PU7ZQ
MBYT:F4SJ89PEAYX:G.A*E;V<J,E"5)T^73D<'%PMIRVMH>1AE*.,IQFFIJJU
M-/=23:DGYWO?S/\ 4@HKYX^*7[5WP!^"WB1/"/Q-^($?ACQ#)I=KK2:>_AOQ
MAJV=,O);J"VNC=Z%X?U.Q422V5ROE-<B=/*+21(KH6R_AY^V/^S=\5O%>E>"
M/ 'Q*B\0>)];%V=+TQ/"WC?3_M8L;.XU"Z*WNK>&K#3HQ%9VL\W[Z[CWB,I'
MOD9$;_/:?&/"-/,O[&J<5<-T\X^LPP7]E3SS+(YE]<J3C3IX3ZC+%+%?69U)
MPIPH>R]K*<HQC!RDD_M_K%#G]G[>C[3FY>3VD.?F;LH\O-S<U]+6O<H?M%?L
M0?LG_M861M?C]\#/ OC^]6#[/;>)KC3I-%\;V$(5@D6G^.?#D^D>+K.WC9MX
MLX=96R=P#+;2 8K\@?'_ /P;3_L2^(;N>\\#?$/XZ_#PSL[+IAU_PSXLT6T!
M?<L=I%JOAFVUKRT4E/\ 3-?O9& 1C)N#F3]Y_B;\3?"WPD\+/XQ\8S7L&BIJ
MFCZ.TEA9O?7'VW7-0ATRP46\;*QC:ZN(UEDSB)"7;@&O0:^[RKC/.<KK5LNR
MK/\ %4*N$HX>O6R^&*]K'#T<7+$0PU66#JNI3I0Q$\+B8TI^S2J.A52;=-VF
MIAL+7D_:T:52:2;<H1<TG=*\K<UGRM+76S/YB=._X-@_V=8;D/JO[2'Q>O[3
MS=QM['PYX2TRX,.#^[%U,=4C$F=I\W[(5P"/*Y!7[.^"_P#P0&_X)R_".]M=
M5UGX?^,/C5JMG*EQ;3?%_P 97.J:7',C$CS?#/A*S\'^&M3MR#M:SU[2M7M7
M7&^)B 1^U%%>MBN.^+\93=*MG^8*$E9JA4AA&UV<L)"C-I]4Y:JZ=[LSA@,%
M!WCAJ-TTTW!2LUJFN:]FO(P?#'A7POX)T+3O"_@SPWH/A+PSH]NMII'AWPSI
M&GZ#H>EVJLS+;:=I.E6]K865NK,S"&VMXHPS,0N6).]117R<I2G*4IR<I2;E
M*4FY2E)N[<F[MMO5MN[>YV;;!7/^*?"7A;QSH&I^%?&GAO0O%OAC6K26QUCP
M]XETFPUS1-4LIU*36NH:7J4%S97<$BDAXIX70CJ*Z"BG&4H2C.$I1G%J491;
MC*,D[J49*S33U3333U0'XS?%S_@@C_P3=^*VJ7.LV7PN\3_"74+V66:[_P"%
M1^-=1T#2Y)91C-MX<\00>*O#.DQ1G#16NB:-IMHA&/LY4E3X)I__  ;3_L!V
M=XMQ=>./VG-5@1U9;"\\?_#Z*WD48+)<2:?\)K*[<,01FWN+5E4D [L./Z%*
M*^FH\:\64*:I4^(,T4%'E2GBIU9**V2G5<YJVRM)66BT.66!P<GS/"T&][^S
M@K^J22?S/SJ_9T_X)0?L#_LO:A9>(/AM^S]X8U'QE8,DUKXX^(LU_P#$CQ/9
MW<4D<D5_I,WB^XU/2_#>H1&)!'>>%]+T2=%\P!\S3&3]%       ,  8 'H
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M2G&$$M>2"C%*_7EC:U[/6VMBP0&!5@"",$$ @@]00>"#Z&OS!_:3_P"".O[
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MK5Y$ZZUI6J6Q7[,C:;?12PP7%K+-!>0"*YB<QRJ3]707]C=646I6UY;3Z?-
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8=Z=.G*2G*$7);-J[TV]6KNS>JN[6/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ny20004343x2_ex99-1img01.jpg
<TEXT>
begin 644 ny20004343x2_ex99-1img01.jpg
M_]C_VP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$" @(" @(" @(" @,# P,# P,# P,! 0$! 0$! @$! @(" 0(" P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M __=  0 8O_N  Y!9&]B90!DP     '_P  1" /Q PP# !$  1$! A$!_\0
MNP !  (# 0$! 0$!          <(!08)"@0# @$+ 0$! 0$!
M     0(#!!   00# 0 !  <$! L% P41!@,$!0<  @@!"1$2$Q05%E@7&)?7
M&CFWUADZ5W=X>9:HM=35"B$B,9@C)%DE,S0W.$%6=I6S)S(VMK@F0E%4-5*)
M$0$  @$!!@,)  ,!  ,!  ,  1$"(1(Q05%A\!-QT0,B,H&1H;'!X2-#\4(S
M4G)B4X+"_]H # ,   $1 A$ /P#W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]#W
M\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# _]'W\8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M_]+W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]/W\8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# _]3W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M$:B#7UXG$HOE-&C-J@TC6/WA7U!LENNMLI6,LIRFY73^]-?L/O7WEO\ =O\
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M\^\>22:?OC!$F<XS/NNM>&# 8# 8# 8# 8# 8# 8# 8# 8# 8# __]+W\8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MJ/DLJHLMI]Z\;[:H:FMK+9V>"ZV&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8'__U/?Q@,!@,!@,!@,")+VN<3Y[J8SM\T:$$M#"+)E]U&@^,3FS8X*9^7CQ
M<%KD!@E7<>E/V#9)O-1\# 1^SA#5],2+9#U1/[3Z^I8BYIS<BOFXXNG:\CK*
M@];0EX69M\AJ>#CV$&%+3DRR"J4A;UL&X(]E[8.J"E*UZ-3/X;+S.ZVBR,^U
M68I-5M_L=U3?AY73 (?.?R#K+ T9+B]K0[8Q#ZE.Y2?:3?-A_ UR,7-:>E6"
MTY8#NI.BK#<,AV-<.6LK,3,<C)P<2S?M6+A[K/+IPWH\/)8 ]^32HJ>&JS+[
MQJJ]:7@;;(&K<0<FT55;YVG73A =1<7F61 );AG, =41)4>"HX]WFT&$^V(R
M^'8;Q7BKK;[(D83.ZGQ17RCT80T>_O@;KV[)8;A9ZJ DG@WT/6P/.@UF6?&I
M2,G6%D2UF6D$UY61A4*CMLR+_2&=C(MA*/6K%H\?.W**.XV)NM&!D?E.#H)"
MS-R3E/J\?=U*TN&?,(UUYRU*.$03G>.&']_6&P>#/4<[#/1JI%#L?:/V_CK6
M:DGTTFWAV$DHTE/& V.L??T;/)?)E6+,GJP9C:1Z(*-NA2 X'>8Y88AZ@D6/
M1RU>1LO*$\U74<K<[4H'PUFSB]%OQTPCA>'\8O6\CNYTC/5GJ0V)YQHU?K;Y
M6ZJXVL$J K*H;H2>;BZ(%ZF>"$CR^T!261L8"N2QAL<''EC],5X0J%SF!Y^+
MDM(AY&LI)X_C6S5DBZ5F8+63&.$Y1<3#[K ^7#D.L+'.JZ,9$ZC=:[L&&KHA
M._1V*VKWR1F >^"':<93>Q&F_<#$-8?.9)7#]SLST4:V*CI$[)>Z:N7;81AE
M,7#433YB>>ZY)?RL>UC<H5*>$LT->MC,AY<#);Q4*KR/LZSI#T/+.EH0]\;U
MN+SL4HX:_A/XJ0:3#-P--)QDKZZT$>SF=W[;ISO\JE!=+W-7%%@@=8[8RLBH
MFMS-W*A%SL;P(L+R.Q>K%(ECVF;]M%XBI(1HEJOM),&T@.LG$M&QCV2;3+KR
M-T$X3$7+7XKYB.1ILC;"T2C:#V3FRZP@0$W2&1WQC9A0([T$\!HX"?*&.B$M
MKT.']&09+7JZWK5">'6SUXKNS\T;:.AX>3>FGR65H_J"]KE9TGT$O"4;6,!>
M.H[Y'TRF56W2125V0*#EH5(DM=:8[)1,[O4TZ^914W)0).\9-D?L(M1R]8MW
M(V)N(TU:^!?*Q1)STFMRLK75QB-G1YMY7)&N0*T;*BH6;,Z4*[W)8$YF:^O
MX6#U181!IAONN_;H-9F0BGOD&K*M6;ITB-B:VN#'!_RJ!%B@\*?5_P L]5ED
M81G],UC!PJ7G+@T:NS"[05&P8!@_!SKJ$5*1="#@7S-1^O,M8Y%PV?(R$7M(
MQ/BL@D-BIJ9A,9?W<-P)SL#B=#W[;?KVU)VB!0IKQ.CVXN=W<("LX;G-9"ZM
MBWA7\[K(@HJ)3CF5F)%A'BZ"\$]8ZRBDCHDT5)&.EW"NL5\U?&;U@7.I9.TQ
M1^#WY1G.!"/SXR,*S;>P+N<)1[A\@D.F\^Q<A-/S<?/QQ?,Z./6;>0%)5",V
ME=M6/WXOAY?9J<9\Z7(<H#"AL@"]"+[&8P6S\$+P8C71S./Y2+A968K8#C92
MN;7,04B/>B' J218*QB9E_I(38A/Q[]6-=0[U)*+X>71:.M/D;HJX[)A*TJ\
M?M U=FFS1]619##P[N"VD&L"0H%K/LD-GW!>WVT J,E1G1(K>2J$8JB[F(AA
M'(R,G*LF2U9G"8WMOGNZJ5&/2-S/,CQC B;OIS:>)TQYG)Q#,8Y"CF&]WGB+
M>(FI"?DA(?*I)(91]:L5I!P1[>-/NFOFVBNPV9[ZK!54>$EBC*L^44Y95'O]
M9-5D@(6J^J=^3/&.C)@[1GDMJ>M"VAMM&.U7F[?1%S(H2.BS57[5JFGZBHJ2
M8KC:2\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8$97-358="U:<4I= ;%6!5U
MCP3@;,Q":^\ZL9>*<;IK>>:NF#AG)QD@Q=H).6;UHNW>L7B*3ANJDNDFIJ6)
MF)N-[D1_1O\ X9_T?K?^H3J+^=6&O$]IS_'HVN+_ .S]_$_!CDZ'0O.1C#B)
M1N@H2BT7U-US'CA$HV^C[MO.P;2]D8R7W;_1Y]3UPDI[I]'_ '?1EN8BN"3G
ME,W._P H]&J?T;_X9_T?K?\ J$ZB_G5D7Q/:<_QZ.E')W&W-7#E8N*<Y9JZ.
MJFO7I+)&,C#-)HI)GLL42[6/8OIN8(S6<)":6>[Q\2U;:>N'BFJ+9LDDGYHG
MIKKX9F9RFYWK.80P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P/__5]_& P& P& P& P($Z(J/G2U EO(=1"E>%M5U,_D;
M8D6UP*L%JE@E!L5(V3TQL&#)'28#,PHD/3#Y[HH0-W3")<))R2?B+MFW<H%B
M9B?=WN4\1SU\ U>!\F*1A]Q^,"P;'2%#37BO9_K9P+:V& =*5[(UU*D+V\O9
MJ$(S(#Z!L%KL@LZ2E'NFR*_GNRP_#JQ<;OVL\_HMY$<B?'98CAK:"+82N%:-
M@8NV'9V3]#V%<R4T#6)7=7PL"6&T^6VD6MSBL30#Y]&WK#\;5?P+_>#VE$==
MW:KQVM4VLXT5O(></A"OH=;!IN<<X7XV*JS'9(0D+"[.GKG.H>G0"Q)I2.DJ
M9L,PO(IL.MZV;6'$O8Z27$I.+C))6/VC'^SA%IJU2+M>TCG'R3ZUK3XSK+&+
M-!1.S*Q>"E_]*E4O;0Y4G6Y4+QMM=*6D#K11F"&+2K[AA?"J:/@8,<*OP9Q]
MK'2*+%T[4C-]]7"WI+SC7E')LI?1/Q[EFL=!E$X![IC=V6Y5CF$;=%EH^C+7
M+U":Q5^VWSM8,7"V?&)'ZEL$CV.F7%9$*<C&+QWK-%"(UCM6Z.I+RCZ?AHDC
M3GQ<!!"'&D[8E6CDF*V<= -4[D77I>R@*WM5E9]<F5CU=2HW,W-J+580Q=AU
M=!-I87%VD9ZT;HK1"S/1@_?LG1;SG_C-6)[\7=H6!ZSL.Y.=9ZRKD+8Z+B81
MSU"PCR4N/9JL(.HAMF!CL;:#%TB:>5W:$>UA=8-NB_:+$R3YC]F^E/'+@1MQ
M&ET^1C\8/QAV8%SC$<Y[J8E#B.)WJXTDP8J(O-#=[5A280,MM894(%Z$B>6R
M*GSJ;1F"*:=O2[\?T<>OWVSY#WW0;><<4U2? ?*L\16T7D=?D9467C5=NT?9
MA.6W%=I6035/7G^5/VCUK&3!%8LG(!X:^V"H_:,80JD<@.;:+;0^K#UV[]7)
MM9,@PX:YICW9C*Z"!@_([ "SVO#$TG;KO,EL&=#[. JCK0VB'-AD-D2APE^+
M"5$BNB;A*03=,7\5^(M5$)%R[=.!M2TIA\9'!,,1010,\P5L%R O: +=(RP
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M$VO85)V2*@%C<LV8;A#J>\_ BLN">'JQYJOTG=QEK<P7Q7!*_3L:A1F2#T)
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M#O<=\CE76BCE1594SG$1.B^F&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8$>5E453TJ.*!]-UA7E2B2TFYFE1:L@H; QQ
M68>HM6[R64A!:,BHS>3=MV2.BJ_J7JJFB.FNVWOFNOGA9F9WI#PA@/\ SP,%
M^5QK_P"]V"__ !2P_P"7P7)^5QK_ .]V"_\ Q2P_Y?!<L"4U;61R.38<;5R"
M& B2QKJ&(Q8I$1\@')^(?);(/8J;@Y:/=QDK&O$=O=%4%TE$E-???-M??/\
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M2Q9!%\\0Q#L4:+$R! /Z[2;F1BOO#KQM]T+6&L<-.215^VOEZ(S+[J,<IU,
M!AG"US.5NULN@NRB.RH8?NN^(6*%R:QT09MI2T--4I192CK807*FXP3M)^&D
MI1+5",]08>#9PY_A/->=F=HF_-919\I5 B.F(MTNTYK(I8/I"Y;VBQO6I8J,
MKOJ"XXNDJQL):T;9$&?5PX5B@_%0$IJZCX1LVE7KQXF@]U\K,XXW7"N_LT>I
M#3OF3A+JO*W*V-FYI8-W?&?%BM!M6'0,7#U&%S(9S63=&[C.@Y;FD"0#@"86
M64I3CUG%LT7CP=D6Q.M,1.B,/%%G9TB.4_M"J-[_ "R%I34MG&M7*1'E6559
M-@3@0$<]=/A846$-@T#Q%/PC<P 6/0$I,6$4T,3WW8S5 66=2WI2Y )-DPCF
M1'ZS?P,6L(TCO?W\_KN)IV7\N'H])$=<<[ CEM!0)-NP8E''73VLS:"D,Y[G
MGA<WAX':^APEJU"PPOF8 ;Z!DPPDIV!F;9C4WKY19-!@]I&.'&?O'3U^S.G_
M &3\IHO; +2L#SR)$;Q_<C*N"VY&_)/4.]4RP0>B]3.X"T0I_ V@6#PDG29-
M8TEJ5-3 @BX@BCQAU[&3#!_LNP8Q(QPF+OASA'G.?9GR9J1%>)&W-YH_FBF>
MYR:ELF=<P=3P\O:$L45YRB/=#2"6LJ4Q8!R,WHQ4D,)Y55Y#-1 W>PKAC!L&
M\K[(.W)9QPX3WK]72'A6^NG+2%WT5UY6NH)9[EL%$XPN)T5<=6A3P8(.?>=K
M+,(*:].R2S8R#,J[M6X)@2W2<D2#F96'7NS9@FK&2J;6L91$3[NY?_#)@,!@
M,!@,!@,!@?_2]_& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P.<GR#*]/B[.JSOEM,_GRV>_:7S/+C N
MG+S N(K=)##&*K+I4P$V"OC22:<]W>$#"KZ26T2WA ^<(G'CE!'9QHN;QV=V
M3G7,]9_*N&LQ1H#T?/3 K53"<A)8;G^5^E"HU-SIG0?8"P32AM:A";3TQ9<2
M-GM,@&TU<@VQ;#97,GS#Q)=FFV>,Y:-;.''\^7=)IO/H#Y F?*_'E]#P=^*=
M$LK1NV4L*N*>YR[7E:M/F471G4,750*=4\7#M6="UX-'QFS$V?XT7QZ<,-DK
MMK+[:OH]%MLXJ1&.U,<*Z=&QEEU]B=+<Y?*Q7<;'3%0V-SH,6G2U6DG/K.5;
M6\477 0]D6O!N 1=Q-&KYFC8O.IG4/L?Y&M4)V,(IV;\8/METXU9D(C&)QGA
M/?JL0=,[[$^KH6R8D]MWRK5OCVNQ"1%WE=&UM4Z#7D%6+1TJ&%CBK:T3@3JR
MK2*8 BG=-8-*4]GY6/AEVL1LVV4=;;F8K9KC<.8-O1?5X_!] 15?E'7EK1,1
MT/-V$U(7+/Y5*/)+3]LB([C;P'- 2H.C]Y$P,&\WDSP FFQJ#PXQ5YBS:QD1
M**-_/=5W$;BM+K=TZ?GZK3PP)VO[U76-AVF;6W!B]5\L\BL;40#IV\R&O;5O
MFP [K"I[3!ABDJ_CIBG95'2U30-+20W6VV>!;$7BME-DHIZ[?-*GN[,Q'.?T
MJQR,;_)&V+/C^TZ2A.J8FO.4P8D@^D"!P&6^32/2[BW^2K;N(4(3P<AHV>,;
M'G.<V(R%"+W=PR>2,I:T[*-$T=I%!!/:-91AK57/KW\E@+5MOJ>G^J>_RP+J
MN\S:4C4Z-1YMF)QA\@-O48W'BD-Y?#2Y*'YNJT)9\VDPL*%\T4SI!-C16ZM%
MGLTD?L1U\V0^AQ68B)B-WVZ]\FL-^S_E-*XNO")MS_L)O8R8Y+(38"C^1NBO
M&I2PN'DRTB:R:IDS&PIN&EQZ0C^I("'A'DS$P;B+JZ,G89V22C[9 AC&T79P
MY\^/7T^K+5%U=\OEAP40L4U)SV'2"S+G5B_EXOD7N=Q%*3=W]/R-9FTIZ+7@
M5<UFL(RY[IB)WG25ALB_;*>NFTDG,)1RGJ'A)QPCGQXQR2I8]4'O4NOQ,= 7
M/5ELPMIPA3&VA=-<BIET0%5U5AY#<A7T913\BJR*.(Z&&W\-?#B-B6DA,ME)
MS9%[I!.'KAL\6;.*D3L[41N_J&.>NIOEE=UUSR0'O/8A"11)K#MS"K)'F_J5
M>T@L0%>GZ&YZDX8JM6Q>C2::7.BNJ;+F[":SLW#/%4HL2>.'B,BFHY?M8U./
ML[FI_').%4]:?($0\?MK:MJF@D$N:2O6 #YR("^8>T3K]BU32HP.RLQ/D_.I
M/#UA==XE8L8/%Q]R[ )*0%G&CA.6:2+AHPD$=:DXX[51NKG#ZZ,Z([^MZ;FX
M/H.G7//5=F//9\]WE "D[2>VK2=J0U \=FWKN.,7Q0=BEIN79[?)_$P<2R%&
MCQ62K[=NGO)+(O4O"3&,;M9OU[^;GA;%_P#9X/STF S_ ![6=Q<Y ]5](6'9
MYEW#6/R#W6VON6IIA.DP24PPM=(?8Y9SRV66A&4LL/W!)1;!5?==B.S.[1LC
M,KQN(QF;O7I7?T31,]H_*HQ&@0_!Z='Y8>EZOL.''1QQP?U^)BLP51%S<IP[
M"S3L!B9>Q.AZE@P^JK)-?8<8]9J/BI((DY"-TE/)2*:0Y-G#=/YCJF\>ZN^4
M=V?CZ4S1E;K5_P"3%&H$20_R_P!0MG$M$3KSA2$N%Z*'1Y9 5+1#;[?IP\EX
M=6<!&;Z!CJND6TM&KN$I!6/J;.%;]?EU]/NK'S]V%\N,#2O-(6I0<<5R38CK
MH$M2WND.<.]!(G9LF0Q[X7 A(,C(Q<=H%%@J+,TU_;EWCT*R>.W6Z*K9!5/Z
M5(LXX7.OWCOY+W3#GMVV>4.+[6.YDKK:]'?47(=E6W5% 5\:5NTTJ0NN,*BK
M"J.W!\O(K&L'T? @$F>/BISI(1#5QO%;^NVJ3#5=#>L^[&4Q&ZI?WQ/;L(SM
M>YU"&2ZOKX=O6]VM8<WTIU0,=B/R+=Y7-;VH:%UBP)1TM#2.P_"VU$5U-RR,
M/$2FXQ PD1!>./N! 0*17HRC3AI'"E,W,O9A-Y9YC!M_E"#^>I?J)2&E*F1A
MOD!WO^#!1?G#I6"$[2%"&P&:]L(!MS=+Z#+ST;!I%Z/#\9'#3H@2CFLJ3,D(
MUT]VZZ,:B:7.WJ?K>7L8$^1F2L:19<[4_ UB,:_)='-M^IFC&RM;HZ< ['JK
M5\Z%.692PCW9)U%5DN\'&PJ!,WK.,<+S$)';TTN*JOEW;H99T_T<U .%XWGW
MRQ;H.@*]:[%+HFK=C+HYBA;.%/.,;9EIHSN*2\ILTF(88EBH@@'[G74<E8MJ
M=Z(0;G=I*-''C$S%:WI%?MSD%>V_E?J4E'@5YR"7V*,PYET::W+[,T[U%8YJ
MD)P'2%V6B[CZ N_9F)UG9P^\Y[&] ZN8F98BQ(\('P^JVAG<2LFVWC>SA,7?
M+ER6WK_J'Y0YB;Z&B#J@J.%Y"M^1XZSZP'?V;]1-=SKH=6H:C/WP9^U60C]N
M>YBOM;!*R4,V:LRQ$V9NX/625BMV6RNNM9F,-->*)8GY#_D,.0V,M"M.8H<D
M%+'J^P;KIN!:4+>I'K.4J0T[>EW<[V1/V\)GLG7:9LXV@@$%G:P:H;F,S/3C
MJ8B]FS!1LQ2&SC=3/??%+^_:O::XGUG=2]3#5?4K0/,?2]T5ZA:_.W05?F5H
ME0+:_4\'3<<\6L S GHI&ZU'3(J0$<8X'_Q5]J4I+-MXULX;?0-G&XCC,^B)
M(KMSY.I^,BIB"I4?>!\9*.5RFPY7@3KX5>D@4^DN+H!Z1!E%$-Z,[:CY&HW'
M0%B2JL9[K,R%D1]5NDX%%AH]U?HC9P[F.O?S:38?R2_)K7?L=.ON1H%P$J1$
M6/MI2;H6^@1P:W-:L<'U;0X/&;D=@[* R$]?=I@4U(?B#607W@3"6$T/LR:O
MR%\ZBQAA/'7OO_JZ'3G3W9-5E-O0==U^WE? L/J?VLD6?&'4=\1%IS)O/B@\
M:64_L.F+ 0@0L.K63GWGXF#H,IT[\B(=>79ZR"*B#52LXQC._P#,.<=@7S\F
MD+Q)*CE6\U0?.L82UL+ U?UYSQPYU(Q/JQ+2+E*E[.*(0%A*\LR.EZYU);IN
M EAX0M>C49"UV^ 73&;2E9&1TW8QN(PVM9O7GU="[1O;N4)Z<,!NJ:31FZ:1
MNX'3()PDK.^3U<TKJ3V^-X!FEZW*V]J1X)6+F!C;YLV956CX&0A%]J[?++Q^
MKM&=D5JQ$8[.N^O7^?5$UHWW\A5$W!U^N"UN06A5I)8,X]I94@Y\Z"MC:MYB
M($?CI"(E\U_9R>[21C04^M;%@R[N(%H%&:CWXE/2#+\951>1OA8C&8B]_P#U
MJD+V[\I*PO$%Q-S-"P<63 =7KOFD;R%U$1$E1DTM!_'E*VB:S(6UM-N;6^.C
M6O2UJ[- R,C1THV5K!=EJZ>/6T@GJ79PY_?S](^K42+K3Y2*!X:HZTJUY>+N
MI;8.SKL%2QQ,PJ6](:Q1Q1MT*:693TSK64V4*6D!5?*<["Q)$P4)*)R$@A+O
MPZ+2<_\ C\;2$-G"<JF:C3\,@1]$?+/54OTK9XS1C"RH:R+.CM:HIXMJ:_I-
M]2<<^XXKZRX<B>S@*>'3:?KFNIF%7&2R"$H%5\5V9M*?@SILY?-HK45A-1T_
M??R69Y7Z0^14ZLP%:]"U#5L56)"8,ZQG7-:T5U&%.X][YRNUO)S>"!;?SH,G
M(FK7UFMW(-K#3(+&OV,XX2:;R;A=#W[U6<HQB--_RYNN.&# 8# 8# 8# 8#
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ME<S 8# 8# 8# 8# _]3W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MU9(M1LEKY\-J:>.7K5Q]=76:K.Q,W,:WU6FE;:^38<OPI_ >R0:P*1%+#K]
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MS;"'4]$[%S5575&?(U,_,!39QR=5QG9A$SY3JP2J(;)H%:MN0+(FI&&B^:Z
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MXEO;0TJ)-G)Q6S:&EAV8392;&1:**HC[+6L8SC$:U>OX;)Q(T^3_ /;-(O\
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M;,77.S'UHR(A:9;3"^LEJP1CGGK^LX[%>]OOJKZ=5/\ *2:V738-8#FU+%J
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M: + )S='EWKJL@3M.T) >O>RP*?L$2OFZ ,HDIS6?1+)+8(2F6\&VDVC"/\
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MX'9,\^/2@58*  E-58HWF_PW>1GD$9))9C&OOLU4_#>$Q&_G$_1!%DP?R_\
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MZ=PT#*O'K5*-=I?:Q[&IE.,^?\A64/%OFU$:A$@J-G+8E[!&J1)QQT4V-/\
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MC-$O2_0VX@W/YRK=K$)$):O.;6->Z-_(DGTCG;EZML\5>ODW>NE9RV:J-_\
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M6]JC ^+HAYI:QB&]$&EK%[%L^E$"=Y73 <E)%1A)P\LE'J1AK_'%3I]^:=Y
M=^:^9CKJ5C+-LD=D5[(M28I^(=5O\?L+Y!5]!4_U5)T6+)&VAC;R5@HGEFH5
M2P,MI<7$)"(?JO?(M\K$[.7[>I_CT_O3^M,5I_YB _M.SSD-FRDX'']:U;65
M<VY8?O&K:KC@>$4#NP)U#HH2#&8?<$2N+G%MSL:(+ ,)%JN%6[+\P;O6:2CM
M>%^SG&+_ &M]P*'_ "9(F+:6[;NH_(0^!IZ%T:CT[4''E7+&5MD9Y9.Y7X9,
M*$.[Z>_9UT&L1W2&>0Q' 1TH@^^EY'[/$'/UJSEL?^=_S01YQO8HH.<PU,MR
ML0V'&!7R*=$="/+\0+:*-K;I"JD^SY;HFMGD.:W+;$+8FSOHE5L.>F;R'<RD
M]L+-)9H\:[2CAGIJ7:C6;X?I/'< L1]@4-S4F/\ $ECV SM.>#S<JG"B"Y\$
M.B^/@)9K FLN_%A^]+6K^1 >BB75JV'VJ\1)??@UWLXDW/BKJ*;1<@3'W9G7
M^J$E_#E\NJ<NJM9KAM>P'EL0-"U"?%L<3<L$I816I%%O5J_0OR.5C'VE;0Y
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MKD@MB6A'R=9(HFLA"Z-U6:L@^35?[B-C6>%]>K%OX;YH1D* =-"VSK'.Y:A
MJ8*581I\?L+"C-W$6MR*WF(E?L^.C:BK@"C'(2C5+D?3DX1S-MWJA<N^CMO=
M-A_COI?7OS27PO9G?Y/T[9=/=-V ,D+:G:U5/[:8CC2H7$.,V[<\G #56TM#
M2 # (2\;7@S!4T8V- M9=PJ=[!5GB/A,X\>I^M]Z91CLW'??Z5KN1W\[R5<5
M<G0T=;^UM-8H@<7"XLM/XTI:OI\\EX*!A9*'!6\!/")"&4J&RWWR< )-WN0%
MLHMZHP*X]%OJW7WBQX5ZU7S65HJG>[V_84(8]#3%MV:.UA2O4->#-H%'G'4'
M4\QI8<US&_K%P)"=0,A>XM[!)XZN)14PV)(=(<:2[132'\;QZ[?16LS..S4;
M_GU93X_:_P#DD#@H+@>O9--[%S=$6Q"3]<,(3EX8#*-. @Z#A:A ^L6U!C8V
MLN.G50/I9V^T=.I>/BUXIL@EM'_7\;JC.<)^']JQU-6?S&4A7W(E+#+LXD0J
MNBSG.%-II=3B(@7B:1A*EXFA+2J(TT?> THX%A,G=6^E#$XU[)%_FL T0<(3
M*<DQEF\:F?9S,SQ^?7^--N^I/FAL/FDII<Q?VO9RUCU(1P,V[#WWQ\#I.]/3
MSGKD75V%6>]FH8#&&U!#EOR5TQJCX,1:'.OJ$1NBY>LO4GFQ8GV<97'/KSG^
M+N=,QORV;=#S\=S:0""7.<T]@D8TA?-Z;4)Q*.N8%':>EWD(P+H?604>\;G@
M9(V\KK))3"9NV,=8!#5SK':1Z%8C8K7?W^=RG]84;\SM(5SRA2P#9\]%5H$A
M_.[FQY;>L>-[<-A.2;CY7$V)SZRAYRT>?XF0HL*3'H?5\2I3$P>KKRB>\:[D
M4]'?C6-3/LYF9G?KS^JP#BP?D*YBXZNRW^EK3]FS&NZ@Y:O2.D"]ESG&O9VV
M69O*RO2W&(6SJH-CX)\C9D4-PH0'/5V+^;>3ASKI&2B[Q-ONUJ5C.51NN?Y+
M%_8?-&//XM19Z[/Y ?:4A.%J,<CR+!UB>"4,&<[3MZAU<IR"<39T-TB76JVL
MB&C-YQPSKIL&N8_?200F-=9#0?X^[[K[K%M)#Y!IVO.=Y4H@;4"YF9N*^)"\
MABL'G'#VXA.O9&UB]SS7 SS^Q7Q/1;NOH*J5F#<Q6%W,B8J.4F>S!5=;V1WW
M)[MSY=7/NF>=_E%M'L+ASH#K0/(W,515O]./2%^53O+49+@%7V=S33+ 1'/&
M=!%RD/8\5%7=Z71C"8UC6DX^8M4GS^-C$UD6^D:F<(QF,>-<^:7;!C/FK)#O
MI],#(SFO@M,V-I/G;Z67"$HVTAANM.W/R /PLU,1A3/D5?639$-22TC^:H4?
M*(?2:>L-'NS=E(3"M2/#TO\ ?3^I,IBI^]S'LRQ;%O9:T@D:9T!V-4M='^DG
MR0XKX'?6=T;6LW1#N@H8+8$=K/UVE*5]&OYM6T8>7T;$S%9%'5=FK]FX$SCL
MU'..??T4_K*@?F8JJJ2\QKHML&.NFTF51P!\+V\ZY$M.29RP5P'40(9= ,9K
M4A;ZF=O^WS6&XY 1TJ8H#LHDJA(3J'FB[V5TBS/LYG7=\^:]/*XS\HL-9@+.
M]&VD4G]>K&#,(,!@DKKDRL&FE:(<KM2':YGP]3I+:)/$V<ZZF8^CSN+C3J8A
M-F+M9VVCT&7V"C:LY;%:;_GS]'7'#!@,!@,!@,!@,!@?_];W\8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# Y<]V41TX>WC0%U<[.Y15[1=.=-[Q\<DG1CQ!K9E@/Z,%A]Z+,;B'I-)I
M:CVJ%CGP;E?7+*(9R[1LSEW24')R[*5-XS$1,3QF% R3G+Y29JU![H)N+2:]
MF0$D-?A)-.$?-2%E-ZY$8CY4@D>_&AZ"F4J(<=$LZ>Z#KYNI]W9[@:QO(^*[
M_7AFC_=O&KPJN'_/MHD#QC\\ODNSB8B9A=@R=+#=1(I/T.4M+-":[MR;):4J
MI$JC02.4 92Q^2Q0>A[H+/PEN^AS"8GW@W%[NF:"#)I3_'WWQW)?ZMYF[=M/
MM4;(ZUM2[A:E(T@H&Q0\S@9;F64#J0( ZF.[J\M5B(UY9@_+SSTG+92Q@CQR
MZD(.?;O&T\XV]=_5B(]O$$C+&,=:O_C!U..?+F8UKVHGTXM RI(=\KSD10-'
M^U/RR[IR$N>7J7QLPA8RRD[F+B*PTY0M?+,BB+/@YJ+;//-_N#]>(\\U<PG8
MB8K=?5^I/"_+_ 3J4N.%)L8PA+;=D2#P#BH_B*%8U_6HATO Q=/AP\5S\+&R
ML*,6KS3)R,B0S3UJ?$<2ZBT$&D>W>N-]?!&Q]NO+U:K6@O\ +M4I--SDQ,WU
M=P!7%K&\>C61*3\*.Y_H8 .;<[7D4;!&2EXP$9@:?AXY)4N[CXN2) F.8POD
MQ'MH3W=NV9)"=B8X1/SZ?U]P4*?+"1L.>9*[)GH)@>!MT4P1W7#5C.<(0](%
M=9.*--1DNAX=I[ZE8Y(HA:1#%O+&CYE75C[HV?.0?799M#_5I.QK55\^_+[L
M%4@9\Q[8<JZOR"0EJH8,Q*CQ.QY #B>%6(+7L4RL?E&*E=^9H)J*%3MI+#5%
MHVGX:,RJ&>0.DXC')A;?9GXVU\+/AW?K]^_-<GBF7^0&-FYJ/[*%S E;S8'R
MTRB2)GMS!#"858B5#SJO2#I"&K@M5,YL=4MP6;^NI5PHLHO,E;=E"#[2 B7<
MTY,Y;/\ YZ\W2K#!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@?_]?W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# TV?L:O12:8#92=AHT12HX5F,7 SY
M/"0\U)"()Y#^G!4PBY%\W?/!P-\(6'XJ^33V:QWWYO\ >-T_MD_K"I0\OV9Q
M^U7EFKGJWFQNY@ **M6=;KWG6"*\+5\Y'1LQ"61+(J%&JD<!3$3,LW3686\T
MCG#9VBJFMMHKIML79RY2PL!WAPZ5.@MB+]E\I$CVR2OT$KMG =$5#,.CXX\=
M03'T-"V\<8.%2DK\>E$8C^',?%WGVLBUT^S^LX2\W&SERELY/UUR@$FQ76IG
MT]SR(V,!L(R5.  GNFMH V#(N:1@W$-)%8K*DK2='6$LW)HU1LL\0137TD&V
MVGNWBZ7NXV<IUJ:;.3=!T&%0AD2F5X5 )#E<ET97]A3Y-909 P@(>S32 ?PX
M092LK--&(N72S$KBUFT:^40>KHR37?1/;5PC[N*F=SY)OI/G49?V)$D=^TJ/
MRE0R(#$6S&S=I@T4_J^6M;=)*KHNQ&;^=;N J1LE5PGK (26K968VWU\::K>
M^^?2*GDV!S<]/,K%:5 \M>M6EM/_ ,.^X5<Y.A="Q7OXO!F!/$_= E64T)7/
MXH-5[/R+?ZC7;[=C!R"^GUDF;G=,5-7P25A# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_]#W\8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# Y-?*
MCRW*=81=!5W5UY5C2/0;\EM06'E#DF_""<\YTM*IR"K^MA6MX1DSDY\A*8VN
MBME.--VS;UNPEHB/6=+MDO\ VVIO"=FYG=W2%J(X!(V5WBDF"EO-4SRU3G=7
M1W48W8E;D,U.7U)DY:$V=1I/R>8QC<9<A4('U.0%CZ$E7/A/(/G+$6CXAQ$L
M5VJJFD6<M.-U$(HY^^.SJ&HS'XX9.L;;H:9=</T'ORGUI#AEKIQ#E])S=A4I
M<1%!,DR7E.ZU9J.=!L&V=[Q:^M<D[GQY'+MYJ-;K;[JEG*)B;C?-QW_ULMI?
M&$;E_P C'0?6701A12W"1RR*24J$"HN>-2*-BYC@P=Y*-)6:8O*F'(T1<MVD
M9)KJ2[JP):$2@5/I\A4)+;60:$C.L8QCXOZV]Y\31<4_%A3? YT2@\Z=N;=I
M2SNJCQZ3FL^RM!\ROJ M/H2=9%LT,[&)44E \@^:0^TJT8Z*;Z-6RJK)JGKL
MD-OW]ISQ2^ _N$]W+(FX.E^=%&E^+5-9/4AQO 6E:+^QK>II7JN%#H%&N%=:
M;1>UTR";X'T$'BA4R?-) 3;N-62GNB?TF_%QC=&[<MNG\>?R'P'6%'=QR4_R
M795MUA6W.L-8D$6W';X*.G!I6?,_8%"VH7:F<?S@:OXEE.R?0T=/Q^JD2ILI
M]B];+^M_LD5W)G;QV=G6G?O\_ OY%_:C^=1+]F?Y2_/W[1?S'#_D7\B_@_YA
M_.OYN^^?E_\ *7Y?_P#?OQ+[Q]S^Y_\ MOM/L_\ Q97*INN+:4E4ETDUT%$U
MD5D]%45DM]5$E4E-?-TU$U-/?=%$U-/?/==O/??/?/<#],!@,!@,!@,#"R9(
M.PLB.P\Q/PL3+%\FZA1.+DY5BPD2B880DJ3/HD=9.ETG,W)LQN"?2"J#;555
M-BS77VU\214WU#-8&%DR0=A9$=AYB?A8F6+Y-U"B<7)RK%A(E$PPA)4F?1(Z
MR=+I.9N39C<$^D%4&VJJJ;%FNOMKXDBIOJ&:P& P,3'3\%+OIZ,B9J)E)(6D
MV\*3Q\=(LWKX<F'<+$DC6)GFC995>'DW([/,7Z:#C5-7=D]07\U]263VV!&S
M\%,NIUC#S43+/1>6T@"9G&R+-\Z'9U2'B").%G6[5956(EE!^?8/M6SCQ-;U
MF];K>:_9K)[;!^<^2#HG':S!3/PHU$[2<'"ZRD_*L8:.VF">;CQD:B=7LBNV
M;>R9"22[2/8H?6^U=OG22"6NRJFFFP9K 8# 8# 8&G)6& +IP2J)R'+)%!;.
M (THD30JB9$=#'I/J2!4%OJ^]UEBT>V"9GQ]&M_5'C3V(>_:IZ_=5_LQ4MQP
M&!A8PD'9J1(H>'GX66EA"3:0I9%QDJQ?R(O,/X2*)F,21,FJZKF$DW@W.L9!
M)!SJDJHQ>(+ZZ^I+)[[!FL!@,!@,!@,!@,!@,!@,#__1]_& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MAS=-M 4N//IM+61BXL6^ZM=XMJQ81ZM2<L9B=.]&WS/.=FQ'R*5YTT:7 /O
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M,0HRW80GX1Y'L4VZ@G+&8J(=<L,& P& P& P& P&!__2]_& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M 8# _]3W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]7W\8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# _];W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]?W\8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# _]#W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]'W\8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# _]+W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]/W\8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# _]3W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]7W\8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# _];W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]?W
M\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# _]#W\8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M_]'W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]+W\8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# _]/W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]3W\8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# _]7W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _];W\8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# _]?W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]#W\8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# _]'W\8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _]+W\8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# _]/W\8# P9./,"T;(125<3C2+)H.6'I)T,$Y($DC
M9A-,'$:\<#QD&RT"8"4XBW<[;-).*?,I)@X\T7:KHKIZ*:AYW*]<UT!1M*L.
MH>J.B*KYL-K$^35N6VC9O?G4X QD;9HKL.,J+EZM9;H@BO*(*02.;4(V*EH\
M>9$L:T+G4,H_?(/7K'Q52.LW.Z(NHX=-4T%W2O0//?('(_:A.I;%F)"L=<=2
M%X-),YEA.W*%7)[-17&-E6 $-DV#%K<U@677=70V[ATT;+0N]CS>OBS9-5RB
MX)43E./?7OHA>PB"QZ'V*JOMOK.UW_;E/5UR+!\6B*%XV*/1G6A_+P@[^U,O
MTIWTQC83HUK:O02Y)!E;::A21.O UHR=L](K3ZBGA8J=8CW=;Z- OUCY0SJQ
M]DKZN:'!XKY3A6AG3CH[Y6NX*'K"/IC3XXVUS-1 AZ/=V1:);6,4ZNDC4DM9
M!DR7?3$G]SB7"WK/U'1N6-8W:[/*.;K9V19R#CXX>P9JD[7;-S:O>6K :M#*
MI[7D3,DKLX<4,P/A)ZRL:.DFICL3^"Q="$$9).E&DM(1TDQD_/JZO$5-JYXQ
M[\7S<?GOR+=6!]A[V&3I&D\OS3Q1TUR]+4Y$0);XTZ#^46M+=Y7J]:7B0V)6
M65.A:Q#FVPJ/"'#=F_<IIDDLDP65W67T4CIL17G/VU0"9]!=.-N-8CFV(MWJ
MLVOCF#H*]&CRP#4KZUY:Z3MB@I'AWJ3H:F[Q-((J&:[N0_\ R.:#,LTA!>;:
M-8<_EJP3CG:Z39YL[U+$8[5Z5,=.<=_-U(Y]O&>,OD3O.-MFZ[)1HG6ZHAGQ
M-Y%&DE%4I;MCDG'= %Y^$3LO%$^VA"Y@0N<])0H*=MVH[(JS!#.-T9:3C=%H
M.L3'N16_C]>^]_.J2ZLL01Z%Z">O>BI,?'PGHVXMK;D$>WK5L+P" !/YD./Z
M[$$+EHHQ?Q5;\/"4)S_.D<7![0BRS(]#7<DY?[MTF:B.T:V=-W#E_P#S/U75
MZ-Z<&2RR[L,P;JN6WMIJTYS?_&'7M2]!3#>K^F&!$K'($#T=K<&-VU=]4-#*
MY/)T4-%)"**M @9BV\BA['*;^K^DC'2+C36WP6U;XLRHSY%BR6ZB/(#Y%P@7
M^0/\HT1YUG:H+*@M=@9':$=SP2@')K&R8$*TA5:+B16=CS9L)*OI%9_O*_?M
M5UMM4J1&L:>[IW;X"N[8D:JZE[&M7IBQW5WB/2,KOUGQT1=/GW/5S&MY3T:'
M1ZE3<\A=9V8U>3,#3T=(Q\B"UI%+2 79HU)H24B\D)*1TGW$*UF(C2M);?V_
M=QV ?*3S^,1%JR(_#KC_  ]K&5HRZ@.@2=+DK1ZHOBLK6] >1F6VE9]2:R J
MK$?G*0E]TI  '(Y.98:K*I>:IDQB\/KPZ<U=>+>QA4*I_@*R;=ZUK<?BR&^-
M(GI<U)_DNLSH1HM*S/"?1LY&PG14;>[L=%^7RJ4L^'9.=:\8.7D,TFVB'K=5
M1P@E[J:RQUF(CARZPV%,C.+J'ZY!*;ZXN9K\C-PK=6"76521G2-D2"% .=.?
M>F) 0FGE *&KX.YN!:DZ8@ZX8AA-$PPKN7Q>['5R\D6A"^4=$TC68]S2N_)K
M/&/8/2/6O8K",?$-PP%3=TC5 ]N5O#-)TQC&/.-/<?VO:-;VI7<2T_$O&L1$
M] '-35V@5,TEDF,E''SY-9%W]Z5\\+EC&./"XT^K=;NZ-ZHJWNJ\#T*,;,-J
M@Y])^E2NV:.;D,](Q4SSTPICXIXHPF 4=6>J1K8NH16XB"Q(=NS0]>2'K*9B
M67FCB>6W])$1./6?ZBWMCH2VQ?C;XTRK:Z22!-#CXS[?L%66F^S;AYD)SSH6
M+IOD>2 "6&V %U'75]^,YTHEW4!69$LC'FCMX\2<.D]O??=RXQ&U.G_KEY_1
M;P:[4%H=(%1,>K!YA)4?\I'6S?JJ.G[GB&4Y4_.3TN[4K^H?VZP*Y+[) E+I
MF<R L8CV:2;P313>)V2VT230WTK.S/+_ ,Q7V0KS?T'*G/R #6IQ?L// !NY
MM OY\8GWR$7-23 [%YWO_OX:!R&@>?A'67K'M:'GZM%1-O&LYA=O%,1=O#.8
MM5PT=M\BS'N[OMTCZ)HZ>MO2%NGK!-WT+9(;V8#VW2</P!SC%7M8 ?"7 #2E
M6T!,L$HKF6,*X("Z&";!NHC.8,S)I(<(EQ:+9OM]73'R"0<HDQC2-/=XMQ^+
MBP+4F.B.SAVUC(^D&LT1FI?54&<7+9%M1Q +BW<G=54SAF%1E@O-XVGT1N)%
MA@4?!HRC[",(V'A)79?9Q.;MVU,XC9BN](<PN ^Z9,/)>9I>^.O(^)JI\:TE
M,6V;G'<1/==7M"H_XE[E\)!*X;)N:9A=:?M>7M2LH&3F*B4W4@0^23AW$8HL
MM(?7\C>6.^HUUX=8[M-,'WKTS+WKV8?5G+]"$8]U;2/7,9PN+SE'7A^QP3M#
MC^N'TAS1+T%/G5>QE3VC*]?@,$;V&JS&Y*56DOP=BU?)M_-$_$B;,5$36DQ?
MS]$O7_;(4. /-&_QQ=8W+?#<LZ<?#O19" =5V%V-;8_7'O)G0I!8CV,";2MH
MYCQRSA05AG!/!B&L:W0\*HEDJB//W;9O&JDB-9VXB-/+BE3Y++:=#7$_/Q!R
MC?5D[ Q+7W1R8C; )<IT0E1D+0?QR=8E8*3/[5<$<F8&4XQ+!J)F4)22?NY#
MR=9(.]U/7B6N_E3"/>U[UA0VR>K.\UNA=:A?DUY#UFTJ>\_4)T&UJA%:8_-8
M:RH[Y-".S>EZ.K5Y)IAA&5VG04 (65#PWC:75CBEI&QF["7DH1)@XC48XU>E
M3?Z7W^1>\G3GDSF*@^+KEOQ9UTK%*D@-T?0#/H?I^V1>C*"#HTY\M5P151#V
MS=!HR,K=>UZ%3\F^2?>/6AJZUDW&OBBGNU9PCWIG+@QO,_7(G?'5?+]I2%LI
MG!GT=5L(R?<P!?5%GBICQ':0A3%@N;J&[DXKBRN.!;%K30Y$YJ&<&)="^3XN
M;>Q[)+5VBO'N(F$XU$QPC[_-'R,O<\1 75:=HFM@@?/1C\C5Q53<G0#'N#IR
M1)@;FH.ZDO 6U:-*DF68U5/&H##S0T+";\S!21&28ASUW*K.8M1#U9 NFZ-]
M<NGW?;S]U:" _73\+3[%?S_*9E$=6A/'1+;G1CTT'[DFTH/XSEX2!JZV['+Y
M2>Z0(1^\#NS88=D594BFTOID(IFZW:M/$DR3'N[O>TO[_P 8L1ZRHNXZ)^.1
M]>?<CH8Y_<\:$J5\7-777Y%4SY;N42KWDUT.UG;M\558@T6M+;1#SHXFM0J5
ME_%I]\BHX>1[Q9@AKJ6<9B9J-;Y<-5*;8[&[>I(7K*5LTXNAC+5,)<$?+-?3
M;:1*8B7(:,*X/G#ECH7F";B&CQ5J/1,A9[BQ3V5%]V6L;%O4-=6C/[)%OKX:
MC'&=U<8_J^H;84U270H@YN7K"-E+DM6K;)M.0 K&ZSM+[G\=Q465/=71Y4^Z
M'XMC;L!0&U>.@)&47C69,4/(25$_N<+%LW2+-6+=P)F8N-(T_/SYO0:EM]=)
M/?[1-7ZR>FWVJ7GT)*?6U\]^T3\^NI]">_T_3K_XMO\ N]_\_?\ SRN3],!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@?_]3W\8# 8# 8# 8&L#86)AZY0Z%QZ*@G
M!J3NS0M7C6J;94B+'T=%Q#PAEM]//-GDHXBX1FWV5W]]V^Q;)Z?_ *.GGG@;
M/@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,")[WN$<Y\I6U[T+XP@FA:H*^++'(H@4;Q;LFDX8.A'D[(,!]
MK-R\!#N)AVU9;:-]'3YFWV5VU\463U^G?PL1<TH-:_RS5#1\/*?M7HOH<&L8
M9D9C0UIDB5YOBS82&8>OU;/_ #OL6/.C4*-.(>:$&ZZL7&B9@0D\JZ9/VC6*
M5=14JBR-1A,[IBDAV1\A\%4MJ$51'/,G2T81-8>-EZ\?M5N:)F(NC8IOBL.<
MJZBPC2'Z3?3X;(V?9%M1GD+Z?, MM^'M9)T]69IQ;_[ D8W%Q,,C6??T)<-C
M0-95SS;T:13NK#[Y;3W[7G&'B.>7#*^+HYP)8JT5)[HJ+DB-^)6;S\5).]@-
MJ:-7+*/3=,%GJ;IKZL)QJ+F83=471FMH67:%03].VO2U@5</@QH[A+0=4[)Z
ME8!9$_98P&G K(TU;EMQND/+3523:/W666BIA#[OILJRTT5T]]),5%\%(4_E
MU!GE/S]V1/(O7LP)"H&%VV0L6N_(S,F84_:4<N\IVRV<+-=;16Q)&V\]B96-
M@H:)4?EFTM#N&;R):+*L=7AK8UJX^_HDIW\EH(O>I?SJ$4#?UGV4,RYP-Q<4
M&R_+S!V9D]:-A:0/(>*&S_I<'.P]A 1)6B[3GC"(&!>51U2\C)-ZK)0R<F38
MTNXIN-??(-6!]%<HO]JQO,2>]?VE<M35]$D H)RJ I.T>TM!X42]B'%?G9Q5
MD:-$255/-QIQ%S\PL2-G;=VP179:/G+(3C,7T3O3'1(5>A3T )B4(=Q#_G&Y
M'-'FC@V%'(DVG"MF#!1ZXEPIO)+:R\T%[QIRV1:RBS5HA)*(J.&7WF/4:/7)
M)BJZPGO"& P& P& P& P,3/S\$*04T4%$U$C8R-Q,C/D1%/R+.'@H""AV:TC
M+S4U+R*S>/BHF*CVZB[ERNHFB@BGMOOMKKK[[X$)V'UKRK46LOO:_3//M8:#
M\T/#<]O8=S5R%:PA$7#CDQ$X"7V)"2-\C9HG$62TK'-5OJ+O8U+=RCKNCKMO
MX6,9G=$L5+=H\=0"]F-9WK'FB%<TJ]:QMR-Y:]JMCEZED7T^D*,F%F)/"I%0
M#>O"E;2-22E?&BBDAOJWU\]6]\T]&SERE]!UV-R)5PU7QG9G5'.%=A]M13N<
MJLL.KPK(1&K,A&"$0Y?3%?3L^3Q\69Q3)L0,%%7$<JY13T>M]MMO/%D_=ALY
M3NB6[K7S1K<1:V O<]3H ;V1)HAD;+6*()B+N6"HPGFC*+:DF\QK#.)$2A@F
M9=R:&BWJK!K$/55]=-&J^R8J=W%^@C>E)6 <G%8 =Q56;656*R;>RJ\$;"$B
M0YKU=9=1LD@<"4-+O9\365<I;)ZZOV[?;;?7W7S_ +_/?/!4QK.Y':7:?'#B
MO9^W$.L^9UZH$RE$&*;.2OBK5*]&C5RDW7;A\^::%6PW#%*Z+M+?2/<N4W>^
MJNGOB?OFWGOHV<KJIMF7G5_+4=- PW(=*T Q(K/#_P!H=:0+RXZ[:S5A@'W"
M3E/SR#1:Y'H^+0_\,A7CG\38)N&7V#193[3ZB6_NHV<N4L/6O:/'5S/IR+I_
MK'FBUY,8'WQ82QU:WM5IT^'A:,^I^)$LXT%RJ4<1(_'_ &FOV[QQJFV2^MY]
M;?SZ?,$XY1OB6P5_U+S);+" EJKZ,HBRXLK,'M>"TE7]O5^9,"4_CAE^:2 -
M /!PADF\P8, Z)=2RT8WV4>I1C95ULGX@GOOJ)B8WP^\YZ0YWJ\'3LZR[ZI>
MNZU6*9$&2L(YM('$@=4UAY.=A)</3+)^=CX#<IBID7DVCF/\<>NT'4<Z2W3U
MW05UT$1,Z1&K^F71W/,E8;2HHZ^*9?VP_%$#MC6#*T AU8;T'=1NDRV,F@4A
M.*$CD4<PZFKM.1T;;,]VVWBOBGNGOFV"IJ^#$!O5O+EC5\86U7O25!'=55YL
MZU/[,#;BKPHKX&V8L$)5]J8&<(1/AP9V9Q;E)RKX]<H?9MU-5-OHTV\]]&S,
M353;,V+T7SY3[8D>6U>U-U<T#4Q-4O=6+9X2$MA1(]<330&4)%R6<C$H),S=
M#<BE$^NO4O)%1@YU;_:>H*^:B(F=T,HWN^EG< \*VMO5>Y%XZOHBVI D;GXH
MM ,*J(/)G:!LUY,)RVT<UKZ;U')#UG-;J:QKGQ@X^S6V^P4^J*E^(3>]'V68
MGM=US<M4G]@56_\ (JSP4)L,1*C&MY/UX]C_ "-/1B"F'\V'O_9"-<(?8R"#
M=3[9NII]'UM-O/!,3&L[D;R_;?&(_&FDQ/\ 77,,'$5N;(5I8DK+WY54;&@5
MC.?9W5L &CYZ5H-18V<;"\GYI%/MD'^_L<Z^A+W[!7Z@V<N4MRE>EN<H$Y Z
MQG+_ *3AK*M.,CIJL:]E;5!8XYL:'F/7'D1+ 8F[GD9\OC)3UJK]V7CV[A)?
M[/?ZFVWU??H%3OK1@?>O^2_&5JR?O47.OD;1#]K%7A(>W96GC*FI-]-.!ME'
M6J[_ #-]A7C]X1-%6"2,OLS44>I;H:^>JZ^Z>#9RY3JQ?G;?&.SVMHW7KKF'
M:1N9%@XI^/\ +\JKU[:R$J2O0R,7K9KX5_;G2,D81KB)0VB]76JTDW4:Z?2O
MIMIX-G+E*2A&]*2L Y.*P [BJLVLJL5DV]E5X(V$)$AS7JZRZC9) X$H:7>S
MXFLJY2V3UU?MV^VV^ONOG_?Y[YX*F-9W)4PA@,#_U??Q@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,""^G:95Z+YTO*A$"9,+6N6J3JM$2]6#V)DAE4S')"!3G5!W29'=IQ
M.+W?>+>M/'[+UQYI]3[=+ZWU]2Q-3$N7]^_$S9'29&\M"T^FZYG;H(8R3'ID
MBWYJ+V]>@,>Q8P+6I#?G "8=2L26H[[H9^B0R0H9S)09JQLD:SFZ;+5!UJV3
MC<9Q&D1HM[:G%+RQE^LB14\$9D\Z+5Y_A@J3LZN2TE&:8KWGG<?)@T8C&%87
M12%B21'%7$]+SB'(88L%G\"1D+-PWUVWA]=WM9C*JZ*XC/Q/1(JSYPA61E2L
MGI25D)W'/6\4\V299US(GTEU!.=5FL5473A!?,A/U#59H6S:T ]AY.*,YAV+
M.GK9]-/GCU5_X7;W]?IR3'5/Q[QX_9MU6U9QD-(E%R%E9&<NQXW'[KX3'9<G
MK&5MV70-+51K7IHQ)+F.S=:X721,XEY76%GD(N,^]Q*BS--?"3EI4??5BJJ^
M,>N:FI'G.DH,SE'D75UJ4C:MYD$NTGR2;Z5D.?!)YK5PW*O#4W+7]>!(C;L.
M*E$5!LG#V$A6PY^%1S-JB[V<(%G.9F9:.[^,X[8]'7_T> =*0]>'5Q#%[,(0
M_AZ9GG=Y1D[;0%&!X)'6E9CJ]=16WJ=YWDH=C)A@HD)CCF.4B8]+67\\3>*/
MQMZ1$QHN$KR:'10UQD#@4EL&@_&!L-D89 >12,GM/#HGSW:_/\,+.':+R(3B
M5DXRS-9!1]J@X^T58>I?8>?;^JI&=K?U]6_UA36M;V/TA8.I%M,>]"6@)V5O
M$^Q/C#P3V%Z+J2E/(;1]Y)//9S5]I5?DE]X]1:?9^OO4/L]OL?ME!,W$=(3=
MA# 8# 8# 8# 8%<.QZ_++8Y$ZIJP"C-9LYLOG"\:_#(;=]'QFLN6&58DXZ.Q
MFTE+.F,5':OYB212]7<KHMT?K_74WTT\]V\+C-91,[K<BI#ESKFI*WY9K(1K
M"[9V=Y=Z:F;&).C.9"GD!2XN@QFR>:K["96V)V,[7/Y(3<W<L:&K"'L3V=2<
M)/TGGXF-./--_&,&;O&9F><=[N_WDTN:NUWHW>U;0,!<0Y)/OD.@.D:GE+;U
MX[,^4AT.]^1]CT0H;! [5-F@O6A/(HUNXVFB"!,)R-]<KMW#"'6:J[MM/1>-
MQ.F[K>[Z+NEW)A.&\M4715>.W=CS8)U7S+<9G/R'Y?%/Q9.&[-".A[Q+6$+L
M\9PH]"M/K3;Z-@&*BOK)BFC',]5]DTO-S.U>5SRG\.<G1'QV=?&U-G[$9,[.
M*W1+U!\FA["\V24QRY&5*.BO0]5]^#%1V#!E2=?P-O*3QC-W0-^*LI4Z?H1^
MY&YV<Q[9%I]$?&XRQOY1^G3#F(0N$#O^_H"/K2U*UY8E9PY.8"+N4CI DU?7
M<=VN2EQN6\\K5/95A',53-EN9R2(I&*/M8R2BY20:IQ3)DVW>L&E8FIB/_LY
M]<V<-])\LL.-^D34&E.CK8JZH!^G[&YXJ]2J *2K<>@Z;W!:SG@!>RKLBZML
M&VZQ=RY'"D1&],8M.=@C)_O'-4$F+&*WC<Y1-Q&D6UT X&ZJ@KPKBXEPG8<
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MOV#?37ZJ**>G_A_\OI^GWTL991I$Z/XK/XO.#Z=/1>SJVY^B!@Z"Y-.9&9]
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ML5Y1)/06(H--QX[5C4/??5O%-M?L_P#P^Z^>^_22,IC<K?\ X''XV/TP0?\
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M0#$B%\4H>1;=2"E!EXQ0=(3ROW SE=:S;M1A@P&!_]?W\8# 8# 8# 8# 8#
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M1_!/G ;8[%^F]6C9.01U;)(Z:[HJ[:IIG32]O?$XL]#6M6MW\OL;4[<"QJN
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MV0=H>H-/MG+CQ-7Q<FU/VKOZ*X:?%W6$: = 58)WKT0%UYU1;]O6YT$+Q"M
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MS_O/@J>3]VO7'*+YPBT9=.<]/';C?5)NU:W16[APNKM_^BFBBD2[J*[[>_\
MEYKY[[[@J>2P**R3A))=!5-=!=/19%9'?51)9)37S=-5)33W;11-33;SW7;S
MWWSWSWZ?,(_3 8# _]'W\8# @3JFY%N=>8NBK_;QB,VZI"C+7MII"N-E-$)A
MY78).EK2*7W2W34T1DG,1JCOMYMK[KKO[[]/GT?3X7&+F(>:#XS/AMYV^0;G
M88^03Y+W!]UKT+U=[-6$OX06?8@6+@0IL13$8*CPZUK4F#9'ZFL6QU7\;[./
M(R.1629,VB*;;U1>.N><XSLX:1"2)#XT_P#LT4847 )N:174<4%"GLY<!-'G
MWR!RU9 Z=6P2Q)8<+(W!%&[VJ'1H'P[=11\/M9IQ.HJ:;(^M/MM?4_!M>U^O
MDW8-^)#_ +.=847S#-!E"-I^+[*1GUN;GK2X>WM$K%U%@&>LXA3W^\V<AN&N
M8@*&'[I9&?\ (I759MLT^K]\^JW]J;?M8O7=Y/TC_B,_[.;*VU?U%QM%Q;VV
M.70V"L"]@QO=W:>[X#$22 V*(J54>>6K^%$6V\%YHNNVB7#]TS^V1T<))*+H
MZ;C;]K43>D^2M,3R1_V5*<!G5A1E82R\(V7JY%"'4DODT:6+-H77(;152S G
M4;R8;VL9C5@R?FK>+E8F%>QCE91+35?ZRJ?F\6_;;O1OK7X_O^R^OQQ,M85<
MR?CJ@#65F_B;"R^_'J:0=<-^RG+@"]<HMCI5TTE)"_81X-/8M7325A7C5522
M;-&VFRW@VO;=T^T]^.K_ +,O6TG.0)/1TLJ3#UNF=%R(>)%'R+V&;JV97(6#
M6&>Q$.$U\5DY810H<'67 O9*<CV;J!9^2B*:KW5;WU/41E[6>X;3U#\6O_9O
M>,W0"RZ/Y\E@)Q9D2>$ EK'FOR$6"FJ/5>F*+V$13[BLS4Q;A8\(-S:,5?/Y
MK:/:(I.?=_5/J)+>IU(S]KENG\(_)>"?^R[B@LU,I.KF[R"?6';E7QWHQ87R
M"&LS)E5"R/X9<;B+& TUGB>3"Z[<;:;R9,W9J#2+95-Q]_\ 6ZJ:NT7:]M/<
M)6AOB<_[.,36R!4D(T.W-[!LJO(.V!5N!VYW(<B?E=%,$0DPD6%%EB-ES-:
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M]'$^&/\ 1O\ [PW57\\<'BY\S^CB?#'^C?\ WANJOYXX/%SYG]'$^&/]&_\
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MR17<.-*SE..4[6MNLF&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M]?-?#I$S/LIOF]46'(P/.'67^-%]$?ZL"$_M+HS#K_I^;T>8<C 8'__5]_&
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M?GNJDGLEHHHGINNIZDAKOOKKLLKXDJOZFEKM[YZHIXBCOO\ 5\^GWZNFWO\
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M7Z1#F.;MI."G8?[WN+QUW?3Z</1IM4\;_(E7-'MQJ$K#IP-G'=4NQ\/@0_L
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M1@>S/19>^.[\ )R L#JB@W'-]B&OD=Q_S0+D+KRMTZAHZ-;C T?P$M!M'4?
M)ME](O;WQW(*>;OW-9SK2JW?N5+W!]U)7W(,)-U-%=PJ=R/I'GF)[KG+)A>S
MR>!!YAVWE7-V$7*HY8?-?9/-\Q#K6>TVB?/V,UD91+,8D]'FC31HV:/&T:K&
M<M:V>&[^?=^$O9WRT0H0QL10VNPGF2$X JF-A$'Y9&]1 #K)3ABG+@MCJBD
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MQ,56D_MVFY,;]&# [T=7ETFUBVDI7!R,Q5,V:?U^#@I(7!LUS+2)C+(L&M9
M5>!A#'#%RD!-%M'36-V<HZM?&#M=T[9JN%*YY5I,<E=OBA.^K" 6+!#J.2Z
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MXJD$SCN,B7C!(N2EXC9!X)C#6JW<^L]5B.GK0ZW';?Z#9!93TN,MQX)KQ2A
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M16.U:S"B3I(S-;6-U7]5F>DOR;T '2V]$N^F"^MKRO\ ZVL@BDBWGQN,V#0
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MA&-)B!.'UEW(F,(TTX?OJ^NS[9^1TI:UN"IKW45[V9,6L/\ 5]=WCQX4[\X
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MIFK;1ZX6Y@8"\C4:= 4"@XYW'G/:38JB?)0G7;REX5V7'1ULH;_:B.D-7LI
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ME2!NW;KMHU)2&5C<S-7LZ>GRZIBHCAKG:::<O5<'?)MRY=M<P[2<C*'%1B"
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M+G/XO"WGRSN?B-#HD:+*UHV:A3Q4/=4'M$V"567%<(A?!2D@C:Z=P2#(> '
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M>WGAG.8G*:7ZPR8'*.]G\K1GR8UCTT6UW=1/2\[P]9U!K%=+T7;W0CP<LO\
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MTJIR'*CS2_G;JRR$AL7G<BBFZX%Z7PL6KZQ6G'\2TD&KA01[/*=S\KV^7/\
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MNK?ONMNOJ^H0YZ, U>1[%YL+!.IR^DQRPA(CDK?KZT1LH4CK[M.EA"9%)-E
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M]?DG*XJ>]WHNQADP& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M)?EL2C.N:BH4:YBOXQ K?DNBJP RV&A:<2?VE<-!W#$U@4R5?.B#H8=2AJI
M/!0UW(5RB.A)1QXTC'<4BZ9./M%1&'NS-QP;+%_,#2/M#"EU3]5W#][GG85
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M.M$'BK8DXUO4=HOY;IBQ#&NFEA<RV4$"MU<W4Q;5=_A<I3LR[A;#/P;LNU'
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M.=%)23G)*Y8Q#)%@U7(#0UER Q+9I5!#79U)2K][(O5O=EG"ZJV^^^Q&>P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M0[\(W]4_PQ_F0C/^-3>%]I\<NI^&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MV:ZBFGXG,/G7T?;NU]U!<RD'"& P& P& P& P& P& P& P& P& P& P& P&
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M*-_5J?(%_H7]-_V,F6&L/CCS0[\(W]4_PQ_F0C/^-3>%]I\<NI^&# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M,LDX07]6\0716];K;-U_$E-%/4%]=--]D%O-/??4UM=%-??==OHV\\V\]_\
MN^8&N!AR%6,/MRVO3 6/!5V_G(IJ3!A!$E ^YDQB=DA8ECF\S".WT<L_'B:&
M>1SY'53U1H_:+-U?-%4M]-15;VTX'G#K+_&B^B/]6!"?VET9AU_T_-Z/,.1@
M,#__TO?Q@,"B7RC?U:GR!?Z%_3?]C)EAK#XX\T._"-_5/\,?YD(S_C4WA?:?
M'+J?A@P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M7E"UP8RE1!I'LAK %-C,8%\Y#X"9V<E(.W\C)6=3016^O,Q6OV>_OTNT//\
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M<\]S(MZ$IM!&ZVBU=#4M&=&2:4I=T$1LO2D;L;=&K0VE?(V>&B125@/RTK6
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M#4 133^ TBFKQJW1:DRC"M*NOWN0=TI'=M]+>VK0Q#)=-+!!/<<G#V\#I\R
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MI>:@V[1MT$.B$>-;QDG-&'-A>0'UC5W%O;0BK3OP($87XL0,0';VAY!DC-
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M1$'I#&N&"4ELW\9*/6ZB&JGJNFVO@J:O@V_ 8# 8# 8# 8# 8# 8# 8# 8#
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M+4 ^^,P?";0>K5R+V_-AC&R"'M1@XTD".#T4)UEG+IV@_P!HURJZ4K,Y8_\
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MUX_ADY1.6AHU.Q.4S-;Y_77S31\B5&=]]'1=IM0O\\1^K+XV:GG"-\ 7/UD
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MTY-3(D&QDBX8$.DC..F9%YYX,IPN=W]YK4A_,O?-ELS$EMUUT\ /CDSYW9,
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M?=S68G&+\_U+\K@YIZJ-.<?CL*I@.LJR.G.7ZXL*5LL7ANIB>J)4BLI]PI<
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M O(/(1DLZ:P327*B!XNW8IK+ZLF^^B'VJOV?VFQG*=J;6*PA@4>N_EFT"CI
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M+M1$34:SWR=$<,F!YPZR_P :+Z(_U8$)_:71F'7_ $_-Z/,.1@,#_]?W\8#
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M5D=E@W-57OE"+HTGLL2[GLJMBG87HD;EKKZ#Y\&+BNT/K]5]L*\K'=+U8P+
M1@-SZY6\%0\6E&;+QKJ0CVTNC*)5FL;X57?%S&5Z=^3@ '*JK[TXZZAKQ(Z%
M*(P(J8AY6ART:*= [XKX>UV-A[6Z=T>5%A;TBQ[;;3,6_&WQ2\=N46":;Z T
M1VU=RL;K";G2K_?HM6F^^3:;MYI7K2T>IPV#<'FE6S-^>TM6$Q(R-<UM;7RL
MN(4]]&Y^BW/.L$0V$(@E/H2LW%",?K(,96'VT^KJ]9?6)[E7IW7];?PSU#V=
M8'5%/!'44O=045V5S3?EIV)S86<]1%>TZ#N0:5Y%;53-U%;4I3@P6G!&_A;<
ME]C**W-)_P ')Y]Y&O647NV:^.:F48Q'N\_5!G*767R,G?5%<1%B0?<+?GV:
M*AM5(<LSE9T#F3UO8<(X]G&]N64_^-BEJF#@WGMX,:;R<$RG(B1DE2796'.2
MOV.3AW,6<<(QX7WU[Y/QM^[OD%/.D[/%A]QWR!\Z5Y?U:$SN6B>=-'TZTA*X
M[MJJK2@<KCR'X*B$K"ILMI4MES5FG#EEL2TQ!C;1Y(/&##R;AG](C&N%_P \
M_1H\A:_RH5*&7('5T5]MV-98$_Z#2J%F><E0I.,6X0^=!=EZFTX;6BAR]%0;
M5N!4;!UD65FC#2,4/%L]/;PT;K.,=]H4>BQ&$U=5Y^2TYH3_ "H5'+7$_"#Z
M[.C' ^P-:SJ\2/Z#IB'$"";C?C@5O\:NUS,UA2M>S;N3DNPF&H3HUTE41O?9
MUO$>M_9+[-PF9]R:W1_WT15S-V9W0%W1K&]A61)->; ^L;.[!*K&)Z@+8(\9
M455$!8M6%5-'PX8</<567)F#FTSP++(-Z/5A%.IYI!+L&.SO3=TB[+..,Q[N
M_=WK*9NO+J^2,<Z^M 5J3]HHM2$)3LB]JUL T:7W&E9<[O1-D3$7)0[UCQ=8
M-:P5KZ=([043NU,+J#8;P5BUM?8/U>5;SC>IC&&SKO[Z_I4U7I'YI793"LWD
M7: GJD"HZ6%&Z\UE,W];S9G9:/1172<8.\/G5<R-D458FJR%3M2NWX]E808'
MPNWHX32!:WEW<:KV??\ WZZ)BO>[.Y9RN[1H>F2+N,Y(+ ?G,I3-PE'&TU6A
MA+40X^/&U739D8FS?E>I:RJ"RM^X!MJR082<<+E^J+R/]9I>,W:2VQ(C&[FO
MKU]&M2UT_)=-KP8O5%D=M[%I'88&!ENQ_P -"X\#U;S)+'-%C0MU %GIKR0'
MQQETH5ADWO+F@C*.W[,:=311XL,02(NAX@*PXUNY\>2^G:W2%C,.48<@Y()>
MDSXZ;W<:4$\L6F*@T+"1L>4JA;X38CRSX%/C#J'9@"^6W5;F#?3 W62\<J0*
MLT&SR-C7.[U*LXQ&U[U57?&',H6,ODBNBX*&/S=QU_4]Y2%?:!Y[#P')@]'5
M)S&"WAU/\:T=+2E1V+8?,\^%&QZ6T&@:312S)Y0U5#'T/(I[,(C2+W]7C<QA
M$5%5Y]);D3FGRU0M7UX0IEW4YU8\IS<+W:X\4H0"AO:]O0RX_P#D=1GJJV#Z
M[I(4A"=H'6H&U<KY F30A42*)*.VV33]>,6N@]R^%7^X_K?)FS/D6!CU\YDI
M_KXFB!.QZ]KKQ:!H=K+EG0@.+]<_(D&^;1Z@WRL><[541%5-L:U()TJW%0V"
ME89G&-ER$?UEH^40)6%<.XC^M9 RCY#*\%>C_)JW/D$)X:E/S5"CS/\ =NK5
MP:6%8MC_ "!]$!.IM %3[A*V)NP <$YVB@XI4W Q,LC6L-..%HZ,=(-V44W'
MNS6[N/-'->6W\DL)#21!==E_(0!.+.$J@L<KG*DX=9W//B-BK\.5-O"!0%63
MSD$Z8"P?8703,\;FS%9AK("TD)CS=WZ.^D;F3F"S&'"OKU=6N#+;Z&>0ND!V
MP7DK+J>ZR7I4W"Z D@"$' FL*MY]M.#KF4; 96'UM&OYD']_:,+.&\V43$N]
MFT)EJO';K(^+;;5C*(_\_#"I_-UG?(A8MF<YP)N:=2Q(;+$]#$'3DN:<KU[5
MZ87:B5&]>'/2G-@A*$_/$.SE.6H:S@&L(6,,(_R<D'NI$NUBK DW;C55C%F,
M8B=W=?UH=ZG/R"F4E:T#$G/90FQ&;0+R2R&%;\T0S:*J.O:S^0BAXB@EN53;
M;FF>ENE'-H\2."PP*8IC(64[<2L2DT<-(3[905DRQ&/3N/7R0Q*$WR?<_"-C
M"=/^7VV!"_H*PCIC,25"N9>3I>"L'J#Y1I2>2 -JYXDZDL0F&C*0$*=F7*$A
M7A[)-HLL6W0>P<7*LI2&+[DU=77ZCKYK1%M7=I=)_'S9L+T8=VO)V;:_8=;#
M4E6P?2M;L!P-H(>[;#P2<CPL+L+GCTJ-Z@G:>:N"IVZ/HN6WD85+3\21_"MY
M%DZ,WC&6FZOTJ*8//D>FSF,A4->L$[!J_I?M@NY=#7//*I'1>P3Y3OR)0U,7
M0?W@1TM+-1HN8682C0N-B,J9,1W826A5VL"Z;/47+8U[E<*J+^R5K'Z4[NN-
MOUL[C5^]Z9K)>MKB9<8Q5?<2FHZ<VW9[3G.OO%PZVG!!S*1V_2 I#6CL^<!Y
M"FN%.YR1EY))"=]_"6#=(D1C%;KXZ]7UP]]?)I9O>0G2@HZ['J[F>>N(WC;+
MLHUYJ#O=:\@:G6LA)I"@I:9<,"=8LZONM>*CO8N:5,+3DW<8HR7\D89ZLNR7
M%81C<U==\?1<O@KJ"\C2-L,.ZA-UW-OL9*Z:RJ6)0!X1FQL6-X+2K:C^H^DO
M)@*%FXM$IGO3AXLCY$NG2#-J@FT1CFB.WC]NA6<XB-V[UW.459W;\E=G"5?]
M)@&O1%]SK'X\3.;#;;M7G%E3\L/WI=OO$<[>(W6PN(\NPL'8(2!C\._(:WD=
M0PU]+G[:08LOS,@R^S6C<QA&FD:^J2-^JOE0W?U\+>2'3T4I,UW;;<ZM;;C6
MX#  B&2#RTRBG#0>&D?BA ;-VN)./@!\,(WLK",&6\P\5EXRJG<.JV>[#9PZ
M?7^]\UDZOZ ^44KNPHTT"S2&#DN6&!36M97C7I=%.2<RDN/:P.AUZ5GP5PN'
M4Y#W>EU;*S0\3LWMJ#+=.-0<H-*^8;M&TB_J3&%?/]^?+_J!P#I'O<C*+8*J
MZ/\ KV\X;F7]H\K+1=E\OQU4V:6)!H%\4W1Q?SQ.TC$TA3L+^TNTAHDM8;K]
MP^'O2'=C.;+PLB[T^SD%X3&/37^_Q97DBR/E&*.IV(!TO*3PH /JJBY.?0VJ
MZ>:P<<[,^?:W.GDM7QO <1.Z64L.KNB":?%4TB.X$U'H[#:^+A*KQ'R:ER3&
M&S<;^^OZ4%#DNW:KX!>\5ZUQTY.EED5:?D&[7SD:1^ZO*PMKXR;@+[$$"^SJ
MVHD>!8NV5._5MVBJ$Z_2LN7>/&?KQ>2V?KN')KW9SVM-_/KZ?)9_HH.Z\".0
MZR>U%)=< )6RZ3^6A*7!:,KV=G" C]M/SOPHYO)2Z+@ZS,+*@1R3//RLA!3K
M)S#Q31,I1?[.4WGX+)1]3'9VM:W1^E?+Y<?)+5W8=PG-5;]:'+5 C/H'>P9N
MI):1A:BHBU8GXXSI%M04V&\.=*Q1JY6,A<@%E8YD"V/)P\7$2#]XR2E$)687
MBX[,XZUW?5<KJCH'Y!A$)X;C:\5OEO;A76U%3?0AY4O,!M8U R,N3&-9CEPO
M9NL)'B2PKOBB,>@9"9GFXS-S]&+1T9[MXHZ?R3?:)3K.,8ZW5>?]]4@Q-T=D
MN:,X#(=ICJ#8Y*[WF@*\X%_SNY1/K+&=;<=5['6,?2R_"0X+4+2\=$[:%.S,
MC#JB(),,WUU2FF\PT4UDQ6-SNJN^/J@JNNJ^[+-/Z9B;&4[=H^E8:C>88F^K
M+".")UQ8\AV.L'6.K;(="B!YRG8SA]1Q3/\ K7\QE\$-N8&$?PT:A'24<REE
MG2\6<<8B:J[GCP62^*W]XRE:OK.B>AU+LGX!3GWE%]6#PWHY>#WK4Y, B\7U
MET/*SE>UG 1\(+5! 4W#Z;29HLI*)2\\W8OY15[+1#-2LYU,S,<Y5T/;L[U;
M7O?DW7;OL,<KDFM_67XZ#V'+)4:AUT&,%&<_5F753T7(6=1A@4<G<V>D@M*/
MHD@2>U\TE&1'/3[:5<>,FWBD:B,:BZOCWQ17"/?E@GN<YN+=&/5;6:)*$VI2
M% 7M4B3$A'"5#XKF-V:W!Y9Y35KJX5K*GNQHQ0%<R$N1KL4G\FX9)IHS.C5R
MV+[FUPK^^BR72UC=_.F 4'\MV3T_%%A1SKRRQH(I).3(.2'[,M(_L<U#^ICW
ML>6-.9FD=S\64?3K>!+X>'D-ZR9.IU=='6.(OI4'&IG&,?\ U6_G^.Y02+W]
M\R5O^2?D@*W%SW!'ST3N48E&?.H.],JLJ^^>J.?*+KZAUXTX #"*7LBCJ4&[
M/L0W\EV+J2B/9N']>;>QJ&OVA:]G'7_C!= =!?,R/H:#U5-+%2E!:G;FC!HF
MD^?":>D;I- 6X>N*[_.!)!5WPM;U>1EH2-1 %=EP@R?%50B,E.36OJ;,FC)+
M\,BA$>SX][NOJNVU.^P($8^0H)5N?H\CGJHCJN2H2^RCDV469[[OER2"((*O
MJXKSAF/E;6L7389T<DA*-0]LA>N\XPE8N+8-4G8YK4K'3=]?[Z*:0L]\BX!!
M'E\5LTZSAU>B;W T[*J8PH>M"XIK6OWOQR\WDE@=-PL/"\ZP101]!!QN!2@\
MVADT4@:;+$/P5$50D-_N_L7W9TFM(_>Y-"'1G?T>U!!>:'>D3"+MPPJ<4K,L
M>\F2B,](UC!_(%=@O:A_T:U'*6@(7GHIL#@W<%DG;<@8".J;QPY7C(R)D-'K
M)D2L>GUZ>J.?C"ANJ/+OXYC>@HCIB%?4QPY;M92]?'?/;\(H6F(E5CPXPIQD
M'75M3@KZ?65:0H%R<B3Q<H7$<C!3<<^8:LXG5GOHZ+GLU-5O]7H]RN1@,!@,
M!@,!@,!@,!@,!@><.LO\:+Z(_P!6!"?VET9AU_T_-Z/,.1@,#__2]_& P*)?
M*-_5J?(%_H7]-_V,F6&L/CCS0[\(W]4_PQ_F0C/^-3>%]I\<NI^&%5NWKU,.
M9^4KKO, $T30PKX42D8.(>HL7$.R<2$S%P2I:3H29A7<:J&@+254G9K5P0P"
M'L3&N/M))AK]+M(N,7E3@ZI\XE[M)2LQ9)#FXF+SX+LG4@;C<8%$@I6"$#.6
M4Z$NJ)XNI_NZ\D3FD(FJPC0C-!D2;3L8,KMY*'4L3:7:>--XZ^''7OY=\EO^
M4.K.A)CKPNB9J^N?^G.=[HZ,A:@%#"GA8TCX2.*HGX[@SHQT95!,..AKH"(*
MF7JH2\8.1]#:5=.">5>R?LNGY[LQVK.6,;.Z8FOVAVQ/E,OP;O6T 5A9G-S6
M+K&P[DK\CF4 K0JHVI0_;KGBBF0JSKCL<9Z FGQ84T;4-U$I =PBDE4RT"^:
M.FTS'M(Y.-GU8L815Z]Q/?%K?/78UCW7;E<]42E=\&&LF/2/.U'%-UU]SB4Z
M6[9 ETCW;U7Q["D5(7Y,7402U>U?"L*LARG\ ?L"1.31EGZ?CMK]HCOH)QB(
MV=>XB4C]-_*OT!25S=;A(,ESW:?M'E! &0M&0(M*_MYK(2:\[47;+#KJ[9Z>
MZ.$0^0YWA#BTGT+)M]XP,;[:MD?JD:'J;]5L3'")B)GO7=YHUJ;Y7NP2VOYF
MZK')>)0:J!SL.N^9==!N#'K4-[(&"2O]#K<ZJA6N?D*)JJL(]+4""%UU!! H
M,IT;3TF]6_I4^B-&#\LX8Q-:W5]Z),%ODIZ]M:6C 2LWO*C8T+[.K(==2LI6
M%G%T-S;)%P#W0=G_ #!>0Y =#0;TFZ1J%ER? ^2KUI*C;?SPOT45@FS;\-<R
M0G#&-9NO^:_=4Z%^3$BN"R(<1I9&J*SCKEG./NAK91J,%BZ@NJ#L8@Z-^/,&
M.A:T".'Z0*++N&.*@&[W42\GR"L06+E89@V;1DA/,TG.Z99PJ-=^OXE>[XD>
MZ;IO(0K^I>C%A" (:UI&B!22,BAT1LS._+CM\$+;QJR.$9DR+7ZQN9,>.1"-
M+3?5))X[?3,L[>M_6C1D[:H5GVF,1-QS[^ZKO?/=!9RV27Y2_-D 0U)R11G/
M)YSC);4MS@=#M;UWT]<])V38-?'8UT#7P UJJK9:KK+?U@(L8%$ACY!Y.V@]
M758[.(QFMY&L<=JIGXIG[=_A9J.L;J BJCEY*L;BV@;++?EH[ K1<IM=F>V6
M'K5B*N>^U(H1- \>LBM)\R#1Z#"(SR&A_P P1S)N]C(W;S?5-MIKY6:C6]VS
M'Z5=F?E-Z.N&,H\?^_5:#2UCV/\ 'EH4U?6"!]"WL)"=E*</7-8/0BY4]L7[
M-?ELO,[;GZ?UCO1KZ7$AK]FK./%/92,9QK8B+^?[^_%'Y/\ +7TT(GMEV#&V
M#SN3RLX+\V \O6:NT4-UWQ*0SDS\B91/5_T2VN3M6F:N3Z$3?TP,"1%-/S:N
M]7.\M'[LH:14:Q<9-#8C=Y_/=T7AI3Y$.H2H]YD=W/)<MUV#=)]&]*4O#U")
MC+HYO>+\ID\0KP:C8Z:1ZL8Q]AQ"TK'R;@E.A 6)86 1WBU5XM.*?.9J/,SC
MC%U=Q$-?.>_^YQDCNXH9[\M>U35\5WW:D*)N*3N!]8DO6G!'2HU1<P 2)LET
MA&#:)[<4,4^23 B2@/8^#78^I;PLEHZ^NT&SCNUO3[PCB,^5N9G]8D\36Y#&
M2Z.BN"ZNZHE=A5,NLZ$-[=\ZW7MWF,6")*_ZO)3NR*M. V,WC@M&7E"2"83!
M ]1A"%_]E&JEV/.M:^R5@?M"UZ*XRJ\@(K;Y6<2P?W_;/(%B-8&JHT63#*YK
MFWKCKD8J&G.<VO3(2^E+7C(D0'EXD9CYQ]/1H,X]5:0!*^9)ZRM39B<N.ZU1
MV?S(]5#H&&[NS+EB>L!7GV6)]ZD,Z],O+Z+) <^,&![.;]'O_P I6X"C7M/D
M%WR#P*<QT:)L&WJ\6Z292^KOQPVC(UX>-\:O]T[H\LWV8FL]<-+WJ6U%)7M3
MUM&(.CO6\+*5LPM *&Z^H6QW5B"U3&%D6F8P\2*(=%0$'-J>3DNT;RJJ.WJZ
M/C]LWUKG,<8W=^CFS\??2-_3-#=L]@]%W2F3+!]'\_%$1H^"3UR.5_\ @?!=
M5="&I#[5@]:D;7\HTEBNT'3N0;#<&*3$@NW<).)11I[%-(2-91&U&,=Z]][Y
M-"OD6M0TX"JKI=Z3\Z5W/'?29S2!CT,70R4[RU4P&'W/:P/%W>9P 'TN11'H
M^:0E?Q40@DPME[",BDH:[_CKJ.1]W6ILQM5KN[[I##?Y->F20E3 P"P>.BTM
M*K+7K+5O!578I*\YVT9=[4!R(!6!=(U!=1++ET#UA5-MR5G@++5^&::0T7YJ
MPD2J/\6F=8NQ'7N+:%1_R[WC:->"!"1W;P8(PILKS^N:=); =@:T#R)+VN"=
MGEY13-_QLWU+#H2]H#DUS2)0*:[DR"4]']DL-E&&WNT0C/"<(B>/KN?)8/S'
M=#5K0KWH$\8TB!O7QU2< &<^3%/%Z9=,>/N/J#Z5NT)EK=L7J6EAZ,-E9Z]]
M8H?20&7A&U2@UM$!8E=+KIQ@CV<3-1WK3\1#Y(NHQ*]N@*IM+J'E08A1?H)>
MLY"TK=JA6#J[D<8>6A\D+\8DKIA&-^ DQ(25IC'.0'$#:DV:BK'Q@9P"J"<B
M\W^U(QL8U$Q$[OKN]>^%R^'>]NC>C;U'Q:V VMP<%.ZDDB>'!H4$L"'LJOCL
M2Y\^/>YBB.,3@LL!>.(XYU,=FRT2C'ZAP^_C_P NI;+K+**KIIU,L8B+C??K
MZ*6UKV99EC=@U0]K -^/1QT/T4:)UI<5D0?.A+,7WQ0)#;2ZB&1Y5ZP+X:^F
M9:=71.05))-(?Z7(A%-I$4EU=X1=E[&JZ19QB,9NZC[]868N[Y-;'J?L#H"F
M53SFYJ"TV_F6#NMO:Z/R[H\9 (KX]B[KZ1ZC(THB[8..(Z>&;+'6HBYBV@]&
M^N]I))'\<:2"C)%_4C")QB=;GUI0H4[0ONP1VP^I:99?'_SP6-HFCYGI'J.+
MYEB"LJM85D_DHMGE)(NG;* NM)L*BZ>$*+HAN1DNCLR.6;5EN\0CR!LWU;3#
M.-3C&Z;G_E\DYVO\MO6M81A]NYAN<G/WVX'PW7Y=(![4!"JRKZ/N3Y'*D:*6
MV1WEVI2M7%4L42_$@\V0EU34 :-W)MMJTCI=XV8Q<H2,,9Y]UTZM0OOY,>Q$
M^8R@W-RSG2EVEV0_R+5Q7P'641*DG2X:1<_P).'5^X$BV)ZQBO#'UB40SY_.
M6$$C)%%C7T1*ZD8E&/'$W'%C#':K6:KO<W^S/D6[,HTVD@*SK/Y6&5J_F!RN
MR:W9VK#*#H6/96*<?$JDG;E@#)+>J1HVVJ$3[8+FV^Z=B0\1+_A^C]ZFT\^A
M%H2,<9BXON_1?9QW45I?'!<'3[61IV4OZJ.9;+O/6"9Z2OM?D<..O+;AJDNI
M(#1-W=@1-#= >U&]G!K[:9V<.XGQ9!*06<-'"NM9V??KA;DE;/R)6S5=K"?0
MX%YSI9$R:CEZT26=7U&'"@WR];0%7ET<@J5]T 1,;,[#K$9G1RK_ "R2NNX=
M2>NIG&QY=)R.S&1\:O5&3F-QA$Q7EIQX_P#=S)$?SDWK'$2+#8PXV%F<91\1
M9ELL)J-!R24JPM@D>>U+#!JO5B_D2@WO5KN7UMF27$G.L76\05L6J"HI)&"_
MGW5T(]G'7?WP=%>=/D$O6Y[G[G IT4HT-'.<V5ZZABI18-6B\R#2U2V@:U^'
M.+XB8CI.R;@9 MLBPZW+?S#,5U7$?$1_VZ+/V?:*,9EU6)QB(B==7.<I^9KI
M"#$R@^96KRM"0L?R6]M5I8-EU?NGS^37O6AIV<.2%"53X ]7S:TZ9=!R5,L6
M0M,M[++H>3CA5W(Q4>HM(Z,O8WX<;M=_HZB\P=C]#VA<IZ(6>QJ+P'G8SM2:
MI[0""S4=*Q"/X\Z3&N?EV]DSQ+9!E"';^Q$C-K*ME(V*'DH_QDLGMHZ\7TV;
MUB<8B+C?I]X0MPUW3U?;DWSC[;+VI""N;7F*]I!XA&5B3#-P(62\^-2KNX9R
MUR [:V4M6LG!SI%+SD)O QH-!ZLO5&BJ3O;Q-1OL7+&(NM_]I!M3]\W-S^>7
M\#W?:E5%)5;?9$3!\Z-SQQ8XY+&;69^2TUXOM^LZR%S2^2^(DV]+TD(P1#'Q
M0<RA6\7I,)/)5G)K[OY.0BSC$[N7ZMN7('6-X!?QZ65=118&Q,7Q5F\)AREE
M= R90;!52BUS\I?'/&6=<-@IN# 6EW-?5C(6R2'9"CK.0C==9-^X>R4<FL\D
MFXRQC:KS_,M*+_E9Z:;SK,3JJT>&;=-RNS@JFX<$&:YL5\3UP-%)[1@*(]SV
M(W'^IB1.=Y8OQ"R$YL.BX_[BHG'FPPFF336[>256$88\;JNX\V-D?ENZ*A;=
M(JJF[AX1BXV.O#HJF[*M"0K.QXX:X:BJ'O\  ZE"+3ZUBG_5J";P=ZB9D#QF
M)M/Q4,193BS/;R0E6B$KZR&Q%7KNCY^3XWGRZ=.Q]#V=>I88\HUO P5N@- 4
MSZ^I,HFHJ\S*0YOTZ!=6=$&%F=Q\X5R)5;=HOI[-@S>5GD'B$*Y;MO74U**M
MD'8V,;K7=WPE&XQ\QO7;4TB8Q7;G<N>6Y8@@;0%?$WE85 ^KNO3_ )[X@MFN
M* _-UU=G4K$^&5E1O1A!^#$6B!',R,H&R;N/$9*/=N6XJ7P\>O=]._S>3MKY
M([SYUN&Y ( 1HA=>OJ\-Y<6J@Y%S69MPFCX#CZXNC6/4.KP;M& ;..<HNV*\
MCZP?1_D&V55(7:OOI"S<*1[!Z9QPB8COCN_;<_D7[FO'BEG0<''6)RTP-"RA
MNE[$)7MJ5U8#.,OFW.>Q*I9(9HOGX3A[XC)<),K\)CA\UA6CR3-Y!EYJB@W;
MS+O3Q)Y3#&,KW[X5^H[Y0.B>C^HE*%J<OYR>"3N]PP1;V#,T=**S@Z%R%>=T
M'A:&$-;!G=AF31)^R<\FQT6WE2SP#DT5)1R[7#/6OK'9>+.$1%S=UZ=.J J'
M^5/NIGSP[N$SEN;.B&%>;3-03(<!U!80K;I->8W\;9QVO)1!4615[FPD.$8A
M90NWKXAAT!'1VI):OG'U(E9+6.U+.&-UKW--S&/E7[1+:[NVR]2+A4, :%JF
MLCZ1L(A4K$K@[21LSHDZK/65%)>L?DP+^?0B:@ X!?LF@;*6L\>SIAHU;;S$
M4A(I:($V,8J-;GODA\W^3OLNA>:;GM6-*PD_C9^R>D+GH:1)*UL.&-!X$JGY
M':SJ,CK*UF)_814HL(&8=<WC&%BXUD.288/QOW/1VL\\2>M"QAC.5>7X=$P/
MO:_S[C:Z+;!C+EBW+%$^E>;J#JF[:Z!K VYC/6M^.^2&$X2Z!J5WDQA*?LC)
M.AIP?D]&1AIJM*#&_BOK%WJ^C&59V8C*INJG]N>%[_+H>\.US"U& BW(Z9/6
M&UZ $[SR$T%I4H;,M0_I3IGGX(M"LH![V%#D0[7TW-4_I)RXJ-"-CN6?OWS6
M0F8A!\Q?ZQJ/9[4ZWW'DF@G^1OL?EJ&/@(B%.4)V(J=OM5H>A3U'D=/@M=MA
M&3^.A%2P)!G9W7L77K:J@.LNXG'FT"](@B*:[!'KAV41,:\6WBB;..6NNO\
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M^8RU*U)^W.F_\IX/_M'&?\QBI*D_;G3?^4\'_P!HXS_F,5)4G[<Z;_RG@_\
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M85R52U<&,(<P$69C*U6M/)F 4GA]MLNCHL@K[KK]*:J2GFJFM-OI#JWA@P&
MP& P& P& P& P& P&!R%^2X)(2*S^4&8G<5_4=)V873%32!S6_4+3E>L-$77
ML;,0H^9%VW.G0[DLM@E?[K-@0=4;PC.:=_?FWLD@ZV:I.#>&Z?2U&(X?YL3(
MV023?+G\MS<K?VW*TW]X![)M:PZW@S96Y#:G <2.;>8\/1%?UX>ELR&;^;0\
MV[9?9.-_?6;B1C=F<J^->]OJ*I_D:TY)F*JF;LC?EL^;MU6@W&0)(2D.D9T%
MJN,@90'2%@#ELDPZIP]H3CU(3H;$.W[4Z>LD ]=%HMYI)>[I*:ZCWKJL;^3*
M @=SN9CEFDTE\JGS-UXSJ97I]Z5M[%L69&'2@9R-8,'75O6&/:.>9=TR<4CI
M8KB?4?N&SA]LJ]49;M])"/DVC(:\L>'W?3N(\KZ2OL3M\N_S,^[HG=@5Y(RN
MDU;"@M S%6GC"K3DA*#-/C?81%*MA[)?;P.AK)/F@<]EV$BU:R:ZT7):-1[W
M+%]MN<\2-;%EGP$1WS\L!A$5&3\@ ):1_OE!,&DG8?6EX#-8- ]DP]YLEMEW
MM;@QA$ELDKLKHDY;S,>S1_\ :*NEV0B;X1QX<FC2#;EA)"#E67S"?+"R&WK>
M5*GDT>VE:%<ZD=21-0VW;RMMT8G.\0J,^@0=:!J9TX1F(!SZ-.8W?U=O+K.U
M8N/E1[W*.^^^&?K4.H6X;DK*DZW^37YR)PCL^'L^39R,S)V'7L4(N:O&ZC-7
MD;825F<F!LR$ZE 3=$)*Q#]^T1BGC9XSU^]:K2D0F_$W$7,8HSM<%,:E961=
M<WV7\I[OBRG+T9\^V5>##NB*D;B:%.EA#M.%9H&<WP7%TXD=5B!V^2?@<DJV
M,42A;:*DUF$$]^Q:)ORQKI4;5<DREP9Q^$>V5Y.?-G\H"W[(9Y^-V'Z-W]L:
MZC\I&<]$75#[ZNP9S3/ZS$8C1PG(2OW]AZZ8[O&WL3JM[,[:1^Q/>_\ K#_?
M0+EY.)&)=[\O?S&0_A25E ;Y"$)98XV9A\H$28/#F<C;8#/\A1IQ2(:)O[/&
M=9(B,8^"@&29'%*K/=$I%GNN/>Y8HY:L*0L(5(W_ #E\D_S>WL:1]3S]QC(F
MUF+GKX=+A&$CCN3CG7MMFO#K.L@]M8/M8SK 3?34@QBR289>,V;G???Z^HUC
M?&,+_"'QN-#T3&#D0^4_Y5IP3-!V%+!>;:].AVC68'2*-;3$)*MM'%&H.-6\
MA&O$E=/%---_-=_/K:^>_3YX9VJTJ/HV+_!82_\ \3KY7O\ U0!'\D<&WTCZ
M'^"PE_\ XG7RO?\ J@"/Y(X-OI'T/\%A+_\ Q.OE>_\ 5 $?R1P;?2/H?X+"
M7_\ B=?*]_ZH C^2.#;Z1]#_  6$O_\ $Z^5[_U0!'\D<&WTCZ'^"PE__B=?
M*]_ZH C^2.#;Z1]#_!82_P#\3KY7O_5 $?R1P;?2/H?X+"7_ /B=?*]_ZH C
M^2.#;Z1]#_!82_\ \3KY7O\ U0!'\D<&WTCZ'^"PE_\ XG7RO?\ J@"/Y(X-
MOI'T8$I^*I=P-$",M\E7RKRT9O#2?W^+<]0!'B$@TU9K;+LUO?V'[_53<)Z^
MZ^^_5]^CZ?I^C!M](^CF#1=4D92) A/T/V'\R%6;6[SF!=35''\]=G6?VE(%
M57F3T0BI:,D12M^&!&U8VP:[DK#'O9UI'C,Q"-F<VW<)RZNNCO5M&YZ1COK=
M3*"R7(!;X8/(SY6OG<=0(Y- + >GX0LO8S;65!6)0X[T3%G8#% O*I,2R8/!
M5V1)+ST@NQ;(C^JC):1];-9B%7D">]RQ=&8/XK6!-"0Y(/?*I\M<U $$5'SD
M',1O9D,[CI:'EFB+^,DV#I&J-DG+)^R<:*I*:^^Z[Z;^>^>_1[BF=OI'T97_
M  2+G_XH/R\?^L2*_E-BC;Z1]#_!(N?_ (H/R\?^L2*_E-BC;Z1]$_\ ,O L
M;S9:#RUW76/:_1L\L!$%>1D5U'=L9:PX,1!00AA).2 PP0!AIW$S<@\ X]-1
M;5QLFHAI[KNGM[YIMI4G*XJHA?G#)@,!@,!@,!@,!@,!@,!@><.LO\:+Z(_U
M8$)_:71F'7_3\WH\PY& P/_1]_& P*L=S5>47=Q5UU380VU>FMJ\S7I7@>R4
M4T23>E)C6)./CS)153;5-%-W+OT4]M_??/-?-OI_^YAK&:RB>KD9\#'>O,$W
M\>=(4.66Z!5;>?.$/-51:E36<50H$;0<H.%,YHTE$8(K>Q,A(1,C&+H;J+HI
M[Z-'OJS1;W1='?3PW[3&=J^$NU7[SG-GZA*/_BP!?]?PYU/)J![>]"F C.#8
M]V)7M5S,LV3086 !670TB7#*NCE!?9[!LK/A[' G#E9)'9';R2A)!'Q)7;W5
M/53S1301$\G&NY>2:B"==+#XN[%K]MTG.#1L$%MRV!V?0=,R2T!89K=5LV [
M6BAGBKH<&E_VFVQ=CF5F8V*'1%-CM#1>T&[B=FV^JJG2,IG3*/=\OZE]+A_X
M]'W.P=S^1]D12S4;F!(M?DT#<E"M5)<M&N.!/BAUJN-E,"9"\D"SE8B:;EZ/
M2[27CY%XX7;R'CV+76CMU)M97==W;ZX3B7X]1FN*RK49[:]%X^K(Z[FD'+"E
MF\<B;ET^NJ_*\Z?3FORP,TS$UH*N:EO.JH"<$68U P4.S\C]63]E(QVZC3<;
M65W6_P _)]Z_&/QVS-;VU7ASV,QLY>Z]1IZ>&EB6CR80S$F4"G5-M]BQ9:L&
M>56TI62<JW%<TI][AY 4>BKZ%1;QR\4HAXX\<C:RNZW>E,M;M%\FEE,<R<XA
M?2'.T;4-32EP#EA:LK Y]IX@DJWO#F+HJ@#*9!!ZEJW@*;@[!0D[U]F4FK06
MAX5PNDMMOJGOO[XH(G*)G*8F_P"PE1>I^%H(JI0CH[JBN.7(RE0X[KIK7_/9
M/R",5R>5_9Q76AD>BAH+E57FR<<@33-51NR\@,JCLSKJJY]3>Z**ZJ:$O+C%
MWYHJB>3N#5PWGH M#O8^N08Y7@2@:HM&3ZVK*C)L)B""OP:JHU'0QXYB^9C.
M97#JW%92%CUW\@Y7=1YC.IRF\CXNQ]CR[65S,1OZ>K#K\=<*2-80%)$'R"%Q
M-4%?TS:-&4V!SEZ<J+(4L&VD&SM:N%0LN:5.RL<AD0RL9W8>@TBV:)8QO'M6
MJCEH[>H:.\4;65W6JXLD7U?)4]&5A_A-Y!F5LY%P[DKZ;F/"CBUR6/</I5UZ
M/3D%*4%(T)I#Z-)%)GYZQ"&3S9LR1]W<;+[.5G!G6[K\JQ!7,'"-1Q8[I0W<
M+RBC$1V\8#5E@MW<TSY;%A;FF.?*1G:X5B;9KVRJWFPTE@.7@R3<^24 ]DD)
MR,]<LGC5-39#Q34Y93OB^_ZQ<1QK\9<37 '6^W2T#*-ZTNCF&^0LLD;[ISPR
MA3WE6M*AJ(/]2D(Z*CHI2!. 6G&;4G9;LMDGVTD]4:?<=_N7K(;6=W7"?NF7
MIVI?CVZV/ *PK7Z#KOR8K^INDZ78LQN[*KC(J>">I:ZTJ^PD"E)YY*/99W#C
M"CK\#]\<)(,'#]TINDOXK[KX3&<L8J([AHX/S7\==? @Q7P_U! ?A S7G)]>
M:OY"_:C?3<XGR'T$0]-AA>0OU&/FCXTL&URJ0=%KG1-%L_1<[:,F\?O]"G@F
M<IUKG]]$N$XMPX6,+/CY+IP'21MGIFI>K"79G=M3IJM;&IE&C4!6+AMEDG&C
M8/=Z<_PGWYLMJX>*^KO/LW2/VJ/B!/>Y<*[^JN$+Q=\8T'$T<P;])#Z\GSW=
MU-7G7I:XOJG-"O67I6J:#J2+!9N28Q3)"3J\TB>: ^4(8C[%/[_/12#U)9OL
MV9:-36UGKIOCO\MVLWGC@:XK:L2R+'Z^C"01M&6("8MH;>Z>?(RJ'!@4\J/^
M,)XK93<,(Q][,7\A0<LZCMF>AK^#^/%_ONK+QRFBHD2)RB*B-?[;_-J%XS)9
MJ*(+J[[E^BI:-D*^0<+6Y=/+:+,@KJLYR5-1RF":&JZLJSA)RMY"S7,:33OJ
MS;V?)I$=BFLO*/8AOO&+*+RX13(4N(<ZT3>]9303U!1ZE!TWS[>U3UT/$5\
M<N7CFUZ7A5UF,JV'HN/AQ^)@:7H\6J1G"BWWF5EY;>/>ILEO$DHM)P^$W,;M
M9E?K]YSFS]0E'_Q8 O\ K^&:GD?O.<V?J$H_^+ %_P!?P5/(_><YL_4)1_\
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MJSC622?FVWONWOU?I]]^G#%92V?]YSFS]0E'_P 6 +_K^"IY'[SG-GZA*/\
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0!@,!@,!@,!@,!@,!@,#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ny20004343x2_ex99-1img02.jpg
<TEXT>
begin 644 ny20004343x2_ex99-1img02.jpg
M_]C_VP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$" @(" @(" @(" @,# P,# P,# P,! 0$! 0$! @$! @(" 0(" P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M __=  0 8O_N  Y!9&]B90!DP     '_P  1" /Q PP# !$  1$! A$!_\0
MQ0 !  (# 0$! 0$           <(!@D*!00# @$! 0$! 0$
M   ! @,$$   !@,  0 '! 0- 00$ 1T" P0%!@<  0@)$1(3%!466!<8&I<Y
MM];7"ADA(B,D.G=X>:BUU90E)C$V)S(U-R@S-#A!0D11N"E#262(Q$9'2E)6
M665G:'5VA8FV\!$! 0 " 0,"! 4$ @(" P$!  $"$1(A,5$300,R87$B@:&Q
MP4.1T?!"\5+A(V(S<H*2HO_:  P#   !$0(1 #\ [^,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@?_0[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_1[^,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@?_2[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_3[^,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@?_4[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_5[^,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@?_6[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_7[^,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@?_0[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_1
M[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_2[^,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@?_3[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_4[^,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@?_5[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_6[^,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@?_7[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_0[^,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@?_1[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_2[^,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@?_3[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_4[^,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@?_5[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_6[^,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@?_7[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_0
M[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_1[^,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@?_2[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_3[^,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@?_4[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_5[^,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@?_6[^,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_7[^,!@,!@,!@,!@,!
M@,!@,!@,!@<N4"[VZNIUNZ$20F21^TYC;G\))M;@6%#Z1?++FL4JNJ9O5B%S
MBC/#"665(G:-1N#RQF3GI&A)OX8%*H6DE$$&J0JR([7'&Z\<-L_J[RN=R!F=
M7#N.&<G.->&>6>4>(ZTR*Q8;A9YJ]64W[E?PJ[8&IE<^>V*'PE-\)3A4,:\I
M_7*PA&,"U-LW12<EPQ]M[X[1?7/FG[=B_+'%/>'1=9\MR7G?JJ<3^K7>MJ*8
M;A9[TB\DBR"X#F:6M*J4SN;L#K'5ZJHUFES<!M/-0$C)%[^,2GU4Y;\/'=QF
M]Q<_E+R*]:S2T_'RV=&PGG/[-_)O4%J6I2::C0V07-*4,KNLV&YT<?M9\EC]
M(8U/ O$#>@)CU3<DCXD3UZ4XDXP@T(VLY88ZNM[C68_>0GRT=)\L>.'J=IF7
M)O/<"ZD[NY6IJ(L5<Q>\'>:RF5N-HV)!Y:BN;:ZT6QJ0\^O;_ Q&*XTT*U3V
M[M@P$&.Z/?M=&1OCA+9UMD;'+=\H5PU1V!7M0-DDYWN&KUW5/.''UGLU<T=U
M6.6P>Q+J;8<P2!W?.CO;/7+<*D<8L.0*5!4"6JUK^8PDEZ&K]]V: NL3"7'?
M7>M^W_:O?//E?\@4WIO@3IJV83R"FIKMOL5RXO1QJ QBXD=DQ^3/LIN.$P6T
MPKGZU'F-)XTT26J5!;NQC+4+%B8G1R9<GVLT4AC5PQEN,WN3:WGAPM7L*VCN
M_E?3]O06T&^L_(%TC24=31^'2Y@71=]K5[9FQ[9X>K?K"E2)LHU*WGH_EIC,
M2F.[<8-6):YKQF!,U6?B3&:UX<ZO2?>O9%)UEYD4;ST)>I4.MGM;INH^2Y^B
MM:>%RJA+6Y=ZGKV02.J*ZD::2$.U=0F<\Y6&>-"W-XR$@"8HK)) $HTX&1UF
M.-X])VZ_V=!/5OD5ZUA=I^09LYRA/.?V;^,BH*KM2[$UY!L@R:7698E9OUSK
M(_5+Y$WZ/1J!A9X&RC3$*G%(_B6O7H3A3@"/8BJY8X8ZF][JB+'UIUC=SWYT
M)?/9;6T\Y@@WCNKJY8WSG,(I;S$2RPR]N-+KM^LX&QNT6N6,/<0='&+C+26>
MYIA)G1_= !-93(^!.0 N-<9..N^_Y7=X"[!Z9Z-F=?492<5YYJ^D>6N6_'@^
MWJ1.6RZIK.I@=TISZQ6K\NT8^*[)W\M,L(A8 HB'"5*9>XK' K^M&FB$:<&I
MGC)UN]VU@? /F(NOL'HJH(LYU"T"I+HC[?=QLV(4CU#&I#SN"JQOKQ7IMQ7=
M8D:34+:Y=K1>+K"M?*@D&VAY&2D.T,S>P;AE\.8SZQ3_ ,U_0=N5;W';K?'I
MQV^BA<!\2S7<<4:.4[]E]71&KKK/Z7L^%,5]W!#VBQ(RU2FO&1*8D2OWLV61
M+%)!2(@Q-[L'9I)?AR7'V^9+UN^7SJ*C7\F@(6365U6;S?QYS)8ENR47/_5E
MR'=>W39E:!ECLS4I*.?(X1"*7CDJ2-X5+?))>D$W*%SI[$",!2)8(D3#&];V
MM^G1\EP^9_LY5SQU]V30=;\V1.C>8+QJ?G@JL[^BMO*+Y>9K+E-+IYI('9,V
M6%6Z5I;F9;;'NB)I-:$ZP84IRHQ1OW4U*,3X>.YC=[JT]O\ E(MBN.Q(?6\7
M=:)M.C'KM*IN,Y6Q0JCNLW"90"4V>_,\)4'2GK+3>'D=NL6%R=V"J<(1_/=]
M(/Z'VP56AZ#69A+CN[WK?M_VK^]>5WR#+Y;8R>%5SQ\C@!OE/G?B>J)^E2"[
M7"5(K>3W$27#+5L2,L4K3L[E6K11S8O(=2$;LUN+E+3TQJ;2)" 24^-<,?KO
MCM3BEYQ)8/#94"U8+5\_GLM_A;T7@<Q]S=;?9(3&YX\MM8_%K%K9-$[#@KXH
M-89 @,5L;9*CI"R!+, 6YH',103,+?IVX+E\T^6+O2:55X]^G;M@?)GV#]L=
MH*>,38E63#;C/;#,\/<ON"%1"S4#U)K)E$2;&5M?JI5%.;0>D7*5))03R%1/
MO>B$1+ACNXS>Y-OIA7EB[BF4+X&Z7!$N2F_FOOWON*\QPN#BCUO'WO7U5.]@
MV3"U#U(7M19+=$7Z<N*:O#U'O25I(;6<T9)1J1;M5Z4U3AC+<>NY-K/=]6CV
M7%O)QXIZGH:XH!!JNNU7TZ"1PF4PV:OS9,'FL*:?99+C[-^6[)B&I,PHXBN1
M;AR!.!%MJE #7%><X)PIT11,9CPRM[]&KWQ2=:=6\K<.^+;XI&Z"?^2^DNV;
M%X];&E,DG^NA43_;M[](/+39HY0*2$5R@C['.8XYHU+,)E4JSFY*0<6L"8J$
M!+&\\<<LLN_*3:[O /F(NOL'HJH(LYU"T"I+HC[?=QLV(4CU#&I#SN"JQOKQ
M7IMQ7=8D:34+:Y=K1>+K"M?*@D&VAY&2D.T,S>P;,Y?#F,^L8)Y]>OW^&OU'
M<AUKUJKXYFDDKR[^GI7;3/91]4O9A%7U]+&;GVJ")(0\,XUC1=]['E(7)($1
MF](&@X\01%E#"*GP\?\ E9M)44\T"\JN>">FIH@KPKE#J+E^_G:SY(6A>DLS
MK;KCG" .5@RF#GR0B2JXDDA<R1PB2M[.B&T&.QZUO ;LTL)@4VX>GUL]Y?T1
M9:_EH[)K:AXM8JMPY*)N2*\8Q'JZ_.>&CFOMFW99&ETQ+F\Y:8?))33+Y+8+
MS)'UE9)&-,G?IXXFI=O0UBI4!&V[)& 3#'?OK>O927R(W:V7127G<<D=:1J&
M*?D?P4S,^2H'^R'B72I':,P@,T;F67I9).WFMV\N!Z6&I$ XM'8S[V \TURT
MO4;+.+-X35Q_-MRF/D^LF*=[UU0[*ZT3:-'SOJD?)3XV06JNF03RKYQ]G<CD
MQBF4]-NB /*;W-F*0QP13O 6[8I(@1*"S-C'[-6-+7/A..^N];_WW:TO$?UI
MU-RMP_XAVZ0L//\ *N2.J+VD_*[$SLB>PD_2,/F,ZLR['1FG[J_J7X<">HH&
M5Q]PTM;TS 6-N;@IO7<#33Q")C>>.-RR[\I%4$EK-T@Y\\/%MHZK@L70D<N_
MPD60#JQCDEW+(,I,C4%L4"Y ?)I;;\HO(":8*FHQ2XGE3$IQ(/6G?#5+>6!*
M6F-:_%E/KBV"\FW=WE)NLN,JMI"?T5!:@?? U271-?\ /#W#KGDU7QO3@DIZ
M)(T2I4[7\*72&Q6^R#-HVZ0.CJJVD@GI0J +'8Y2\&&,ICQMO?DN_P"/KR<W
M'W%:'/D#3PVMXX0W\ARBX.UBR&"8@=H#?*.YGVA8U5,$$IF"I)$25DMK:5NQ
MZ1Y ]+!LZ5.$"@(A>W-K.6$QE^_1\'5OD5ZUA=I^09LYRA/.?V;^,BH*KM2[
M$UY!L@R:7698E9OUSK(_5+Y$WZ/1J!A9X&RC3$*G%(_B6O7H3A3@"/8BACAC
MJ;WNJS0APM+JCSJ\[VA)#J@<*S;_ !>UYUG3<+E];3E5**O@=K6<YLRLQG6'
MV:G;6'I,3^XA1+Y&!MTU*8L'2 ;0!65I4*+=3X=GORTQ[R@OO74T\GLAH3F)
MZ['>I:?XMF*PZ6@_.728*4KN#]#*^E;4B;#==V1^46="Z]DU=-C442C>RSVM
M\6N("D*()( [ H(+AQX;NN[W[>\JGD YN?NU6>2P#ENRH;XX85R$T7F_F"M-
M@L&T++ZIYR@!,7400IH4.$7(86KJ&4'N+TJ5H6[14%!I*F3[<?2L#288W7?=
MW^B8;9\AW?=!O77E'V.V\5NM]<Y<@Q;NR*3>/-%LL-'S"I4\U>HC8E1RU!)[
M2^/06TA'L9P(X[&O!R1PV(HXUK  W8"HDQQNK-ZMTQRK?+KTE8= \_\ <3E"
MJ&BO*%V=_MW.#[$Q-LN?[BI[GV4.RFLXM85E2MGLXV)LED$VZD!\50#9-)TK
M,X(MEE&F'>VT+A);CUW(VD^/7I*R.O.>CNB)TPQ*.1BQK6MU10Z&+('M$H6\
M\1^=N\3JF1RTU[?7D;G+9>T,0W8Y6E*;49R5:G]DB)UK8C*QG)C=1R/<)=R=
MG(N$9YSK,^@[ZL/I3R"MM&K.';4FMKRB73N+FW)?DUY,N8+)8,CEILKB)=4:
MJXZ2(](SB]MQBSWO>T_M/>S([Y88\MZZ3O\ NV&\2^03I"+>./@YG8NBH'/.
MAK&8>RY;,S>CJF[2[CO^9QFM>J9[#H0^I(ES$:]6:7#FQL2*VUQD#T8-&W$H
MDA*0DX!)Q11C+&<KTZ=/$?O0GDL['NCL>J+]>9?!(IS8X>'F2]N3KG!HB,_D
MI!<<@]IL47LL<:4)[$;BG6]WF=1IQ#''E2A-;FN(*2VPQM6. U#B:+AC,=>_
M+3V*I\XO4LPK29V.YU/74D;WWA?IGJ:"K(ISAV/!X;1%CTY3CG<,!JZY[+M1
M$SU[>D?G+4W'D;?H8Y,:$Y4A&4F,WI6A-,%^'CO7U^C-TW7=YOW0_B,O?K&O
MN3HXNO"I/(/?E83.(S"_V--1_/Z3C2A[8;2)ZN<;"9Z[62MY<E;EJ6*76/R5
MJ;&A(B&SB2+2E2Q0.,UE,=^W[L,GOD=NGH6BO(?SI:6ZGFD<E7A[[ ZAK:TJ
MFY[ZTYZ83F=BB)U>KF5!KJ=$GW=,8? 3](O:I=%_8M)Y2<T BM",+WH<)++/
M_*3V2;QGWCT!!)QX].4YS&H%1G-$NY.XLB]1VM9=1W%*#.I9U).78A*Y'"*M
MNB,RQCJ*LIM''8(FQ.S2!N<%+F)&:829ZYR=.(98SKE.N6[^[)O)Q![AM/RP
M>(6JU+Q2+S34@=>G["C5?V)7$WE2#YUIJ!P23RB3S@EKM*-MC\_LS M+-K]8
MD3(3(V^;4'+=.2<_1)9,-3#*^[ZZ1\KG4TX2\0=&3BMZ"3<C=_=2R/F2LH'%
M"K*+Z6JI68_VA'8%,IX^.[RJA4S1+EU8*1/J9 PM(&<DXH?O)NQ["6+AC-SK
MRD_):3Q&]<=F]S4<AZ8Z#B?-\.J.<)9,S5>WU*38R:?N<GK^T9S )H^RMOE<
MCE+"R110?&PI&U&0L4KQ'(CE9Q@2EA*5+6?B8XXW4WMSXVC;'?EF,1"VUK3J
M*Y9#4G\)TI2FJHCZR,V#$&IKMFOD;<:VQIF>%]AS8,/YF"M<DQ3<S!0K7Y$8
M>M6*')68?HH,=9,9V[<&S:U?,'T_SJIZDHJXH;0S[T12G7'(G.46LZM*[OUY
MI849Z[J5]NMFFTBI:./=BWA)WBNH9"74I:U,CD UX<3TI*/8-AW[<Q/AXW5F
M]:OZ-I/C?ZQLCKZC);-K8KX<&FE?W1/ZB4NJ2O;7JN)VHS1<IB>HO;D!K^[F
MIJL^*Q*91N4I/50NWO"E(O3JB1'"V7L(:QGC,;T[:<\7/GEK.D7E;BUP.'6X
MI-SWU3TG=_&+'RGNS/?H]4,!B356<:Y=Z(0UBLD&T<7?[LMB-/H'9<,@@XIM
M="AZV9I665N.MP_!K763?^5WV#RO=G%W$8[2B$<PJ^:@^::4^)8IE8&.U6Z\
MCB%<N=F"$VN9(W&?.D!2FL"72$3JETUG!=S-G[("VZT6#9GACKWWQV,'E>[.
M+N(QVE$(YA5\U!\TTI\2Q3*P,=JMUY'$*Y<[,$)M<R1N,^=("E-8$ND(G5+I
MK."[F;/V0%MUHL&QPQU[[X[9C6/EDZ!F?$_BPZ,=XG2*6Q.X_(BS<F6BPH6&
M:DQIDJ]9<'1->N,BKEK4V.J?&V9)&NJ6<?O;BN=VXM6L/V)'L!I!95+A.64]
MI&=U'Y1;)G'?55\_$/E%6[S[T!:'4E9U[-*BIOJ&,FPM9S]%IQ/&LY?T38J;
M[NE^.CA'X08@?D$+V 3([*->@U0F![0PEPDQWUW->%;_ !ZR>20G^"Z.LRAL
MA?(E,(EP_P![R>*2N,.R]ADD8DC"]](NK%(8\^M2A(Z,KXRNB0I2D5IC2U"9
M06 PL81AUO1<_P#\WYQJF<>W.REWC(*XZ)Z/OY+UU%2+'ZC=KX+M&4HKC,XZ
MBO$P.^8^]+[0*=03QP2.TMF[3"Q*1K->L07[@ SV6M)BHZ<<>?+7X>WY[TOZ
M/S,]'5M":LJ:KX\T6-,Z1\??&-PV**S*1Z[OZS.GK5N.D&N>'0R*6!2"%VC=
M6.;JTIRA&RV;C7)E[ZX&A]D(*-::68].;W>V[XZ,Y5^>*Z9/:4W<ZPHX*^JJ
MRN:L:F?J)<.9>R)/T;*V]]:X MMB;);<AL1.HNK5-:CF2LU/&I"W&/3HC:!&
M;"F$L1@,'IR3KWUYFE;9YT5UZM\=GF<G/5<GI?IN*TCY&FJE6. .S)?\#;FV
M7Q+H;D5M4HH@_0#HF-3&)47%0R$E=&&%(Z%NY+P4<H='-Q3JCT0RR3GC,>G1
M;JP?+%WI!X+WETV&!\F+^9N$?(>X\F2"*F,-N)KJLVO$UJU97ARE@? 62HA<
M:G;*DM9M5#<53>I;7$1IP0-Z3W36E9)AC;,>N[&:3#RK]>_;.0Z0>'\U(^9]
M>9*OO$VJ9)7'K7<KU-5_,+*SV7:R22-DZ8X$ MP":M"R(QM.PH?5*./&OUZ2
M1DX8Z]]\=MYM1 OH!-C[OI342A0.W9Z.H@U$BF2,E-0NUY&JO36.*9+UPUMN
MA; FB?CVS2=F$>((4A6@!V(=<[KV2[A# 8# 8# 8# 8# 8# 8# 8# __T._C
M 8# 8# 8# 8# 8# 8# 8# 8%+_XO3C_WCWK[(?Z?[Z'\87[3Y_M#_P"3 ^&?
M!_M>]7YU]3_V;_1_ /1\K_\ S7PWUOYV&N67Z:_(!X]./R_=_4J'T>Z]H+/(
M61_W_M#?L^P%_OWO=O?RS7?K>U^)'_\ 8 O3%P^O_-;=>@/H'++]-?DH7XS_
M  M4;R71W.N^A*YKZS>JZ;;[$)<9FRSRVIS4"5UFDIE>]/\ "ZVGQ[!7K;(U
M4 =$#>N=2XB@<SC4XO6.-]4)PS6?Q+E;KY5Z*#\<G%O,4^+LZD*/;(=,T+*]
MQN.."F76'+VZ!1V2KRG*0L-6QJ;RZ21BIV5[6E:&J2QI&U$'ZV((P[",>A&;
MGEETK_=^.7C/[K,,XLU318.;JY>B)+ 8*7/K1+=X;)4DM=YRBDD:LLN;!M5F
MD*"4ORQ2G7$/8%1&E BBS D^@O0YY;Y>[$-^*K@K[2FJVPT2(J<LMF5O=+:L
M(M*YT[$3<-3*(ZIA=J&0HBQ2X0KL4LV+(OBCT<W&.,@  T#J<M H4!-'/+6M
M]&=1_P >G'\6J;GNC&&H?<:LY6N]%T?0L7^?[05?(ESM\EG4O1S+XVLFJB12
MCV,BLI[4?#GE6XM0O??9B2[*)( 4.66[?>Q(U2\H4)1=DW';-40E7#IK?TE5
M32VCDDUGZ^-2F8KU1BUTEA<">)2XP&.25Z4CT)>O:FQ"J7^H7I0,T)9>@DN5
MLU?9!EB>+KA&V:HM&D;#H5)):QN;HV4];6+'%-@6LD.>>AYH,0Y/9#?(6V=(
MI/%E;J$P90D#0M0M)9!IA):4!1I@!%F>4NY>NM,AOSQR<6].SXRSKOH]LF,S
M7,K)&Y&X)I=8<0;I['8TO-<H\PVE&H1+HW&+8961:;L:5+)4;J01K00@#H(
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M4FBM:0E[YKM2BI,JX1L$Y:[_ !WH#J>.DT4VIZR>1IG;X*W0V23R^2F!O.)
M4O/6Q5\V#V@"4^S83X?]]]?LPV*>77H*8QNC9^W5C5*6#UHPT@B\E:DQLF:Q
M945BVITXZ\KRE@JT\J8IBF,NK9)7\EDSNE="9$J)C@F\6Q^H/:L\O"=9[^S-
M**\L=MWE9JJG6FLX V3>Q.MJI1\[!$7(W B6>/*?L<[L$WHN2)$TC#H4E65W
M14OTE5IE1#0E>G1D3FI3M>G3A4N$DW[:_59#HWICL1KZSM*@^=0\R-,4I_BV
MO^L'QXNZ-6-(9#*'J16;?L,75TUBA]F09MCC.[M53IC 2 \A?\"4;,V<A<@*
MR@(XDF.MW??2J\6\HW3UBL]NW!$(11K34C;(_'W55+025,%@_/KQ:GD(IKE&
M:QEPM6RTL\1QZ'P*G)3TAHQSVFBJA8^MY04A0FU21M2KJW#&=.N^OZ/?O_R9
M]&\9I;O'>L8HNV]<IR*A7:VUE3M<FJA=;-5]3L]E,%8"J.+V#:4_*AUI5Y:E
M>&&21H7/$D*<8@(;BE,1FA]AD)A,M:WU_A[4Q\B'4%2NPJ,L5DYU?>FK=A?$
M[YRH*O&V;JZCGSYT7/U%9764K4*+&<7251J@W%H52$Q<A7MGOD:4)#A! (>Q
M['#&]9OCUVC&2^7#H!LW7]71^MZ:>>C(_95D4ITRQNP)PP5] [$7]85YQWS:
MYM[FG?WYTC$/M&36FBG!@UVW0Q1$F=<F3F%K#TZ@!>$[]>/M_;=?5U;U%WO$
M9<CYFW;7/\2MN']$>-)_-N2N:/LT,,L2I.MNK%5.)(@_UFZ](*WVOEL9E];.
M9<C;]2UW^=(DKT2D4L)Z@P]-4QF/?KK52/"/)/T+,.BU4.9*F=)S5L:Z\7\=
M2EE@W'/:"UV],3F.ZEL+I<[JA*R/O+$/@T3LM(J6*H>J-7J447(&H42,*P&T
M@H7":^NM]XN-<-W=&R'J;?*7-2BDX0\Q2@&#H6P+*O.'3JRVQ8V3>>3FO8/
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MIG5$C6!;=*420TDO/)$]S^.V(V+8O-<:BE>UC$N<ZAZZ6]Z3<:F73=YG+MT
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M\%;NJMN6Q6"RF=/4'ALNL M\4)')V:6Y$XGMFRT'MM(B"$Y8N>5FGZ0KQ_\
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M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_U._C 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8'_U>_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_UN_C 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8'_U^_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_T._C 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8'_T>_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_TN_C 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8'_T^_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_U._C
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8'_U>_C 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_
MUN_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_U^_C 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8'_T._C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_T>_C 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8'_TN_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_T^_C 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8'_U._C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_U>_C 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8'_UN_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_U^_C 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8'_T._C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_T>_C 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8'_TN_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_T^_C
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8'_U._C 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_
MU>_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_UN_C 8&+S>%Q6R(7+Z[G3(BDL)GL
M7?X7,8XXA&)OD$5E+4K8Y"R+PE&%&B1.K2N.(-T$01; 9OT;UO\ ET.W5J__
M (BGQ)?0_5/_ %\Z_:[#?J9^5J^7N"./N+5DR<.7*(B%-K;!3,B.9*8R<^GF
MOR6-FN9[(0K$].[K[,MO->50@Z*]GZVS=^MZWH#Z"7+++N@:Q?#5XQ+9GTSM
M"Q./*RE$^L.4/DTFLE6JI>0MD,JDKBH=WY[6EH9,D2:6NKFK-/-V66 (C!BW
MZ/Y<+/B9R:EZ/;ISQ&^-[GVS(G<=-\FUS [,@JU0Y1*7-2F6'N+&O5MRQI/5
M)"G.1KD.SAM[@<7K8RA^KZ_I#Z!:UO1+GE9JWHD'ICQQ<0]CS)DL'IKG6#V]
M-(W&28:R2*1FR AP01=,ZNCVG92QLKTUEF(B'9[5G@T8$>PC4#]&_0+T8)GE
MCTE5Q_B*?$E]#]4_]?.OVNPOJ9^5V[^Y&YMZEJ]CI;H"HXO9U6QIX9) P0Q]
MTXDM;0\QMI<F%C<$ FI>W+"#VUF>%28OT&^K[$\8=ZWK>&9E<;N=U)/XBGQ)
M?0_5/_7SK]KL->IGY79K#D/FNF*'>N8:PJ&+1"@Y$VS)G?:Q;PN)\?=FRPDZ
MQ)-$:_;@N6."DJ0I7 XH_P!8_>_9C]4.PZUK6C-RMN[W4F_B*?$E]#]4_P#7
MSK]KL->IGY6CYA\?O&W&#O+'[E^@H;3KS.6YM:)6XQHU]4*7EL:%*A8W(E W
MIX=?9D)E2H9GH*]3UA;UZWI]4/H)<LLN]0E9/AO\8]OV!,K3LGCZLI58%A21
MWE\TDRU3+DZV029^6&N+R\K2F^2HT>ECDN/&<;LLH&A&#V+T>G>_26?$SDU+
MT??4GB#\:U$V1$;>J7D>MH59$"=0OD0E;<HEBA>PNX"#DQ;@C*<Y&N1;4E%*
M!^H(90_4%OUM>@6M;T+GG9JWHD[IKQT<2]DRQ@G/3G.\(M^71>/:B;"_R0Q_
M3N#=' N2YX SEF,KRUA-1EN;FH."$S0]@&</T;UZV_229Y8])5;/XBGQ)?0_
M5/\ U\Z_:["^IGY78O#D+FKI.HF&AKQJ"*V+4$661UPCD$>0N!#,RK8DU*F2
M-J&[;6N0+4PVAG7')BO5-UKV)H@[].M[PS,K+N=U)_XBGQ)?0_5/_7SK]KL-
M>IGY77J/D'FFAZ1?>;ZCI^*0BCI03+$\BKAL X'L3T3.D(VR7%N.W%<M7J@O
MK</9!WK';_HO0$/JAUK6C-RMN[W4H_B*?$E]#]4_]?.OVNPUZF?E9SF/QZ<7
M<9R"32KF'GV%4](IBS)8_)7B-F/RA:ZLJ-;IQ3MIQCT\.OLDH%P F["5H'KC
M '8O3ZH?02Y99=ZA^S_#MXS+GL.8VO9_(-9RZP[ ?U\HF4H7*):F7/\ (74[
M:AR=EI3=)$2+2M<H%LPT0"@:&,6Q;UZ=[WLL^)G)J7H_NK/#UXT*3L2'VS5O
M(=:0^Q( ^)))#I2@42U2N8'Y +8T+HB*<I(M1;5I#-^L6(90_4'K0M>@6M;T
M+\3.S5O1+/3?COXK[+DD;F'3O/<)N"3Q%C.C<<>I(8_)US6PGKSG0QK*,97A
MJT:D^(*##0A,T/U!F"V'T>MOTDF66/:JS_Q%/B2^A^J?^OG7[787U,_*Z]Q\
M@<T] TNP\[W'3\4GE*1;Y6^7*\=0.!#&R_)+<)IBOPW;:N0KDOP1K&).3ZIV
MOZ$6P"].M[ULS,K+N=U*/XBGQ)?0_5/_ %\Z_:[#7J9^5UZ6Y!YIYVIQ_P"?
MJ5I^*5_34I.DRB1U^T <#V5[.F382S2<QRVYKEZU4)Y:4Y:8WUCM_P!" (=>
MC6M:T9N5MW>ZE'\13XDOH?JG_KYU^UV&O4S\K*\R>.SBCC642&:\Q\\PFH)7
M*V ,7D#[&S'Y0O<H\%Q2NWPDTQZ>70)203DA).$$O0-C&4#8M[]77H)<LLN]
M19:_A^\:=XV-+[;M;D6M9G8T^>#Y!,)4X*)8F7OSTJ 6!2Y+"FV1HD6E2C16
MMF" 4#UQ>D6_2+>][+/B9R:EZ/FK/PY>,JG+!AMJUIQ_6<3L&OI"V2R&2=$H
MERA;'Y&RJ0+&EX1%.,E6(MK&]64$TH1A0] ,#H6M>G6MZ%^)G9JWHF;IWQ\<
M9=FO<6DG3_/\+N%^A34N8XNZR0Q]3JVAH<58%ZQO(,97AJ]JF-6%Z,]4W0_4
M%O>P^CUA>DDRRQ[56#^(I\27T/U3_P!?.OVNPOJ9^5V+6Y"YJN^C&/FBUJ@B
MLSHF-(X@WQ^M7(+@0P,Z* I"$$.3M^V]<C<$P&!"F 21ZIVM^RUZHO6#O>MF
M9E9=SNI/_$4^)+Z'ZI_Z^=?M=AKU,_*[-$<A\U\QU2_4=0U0Q:MJGE#D_O$A
MA#(%Q.:7ESE#2A8I L<!.BYP6*371F;$Z8SUC=Z]B2$.M:UK#-RMN[W4F_B*
M?$E]#]4_]?.OVNPUZF?E9#F;QR\1\;R]]GW,G.T(J"8R:-F1!\D,<-?U#@X1
MDUS;GDYF,,>GET 4C.=6A*>/180;$,@'IWOU=:PESRRZ6]$<6_XA_&U?EE2V
MX+?Y*K><65.W$#O+I:YJ98G<'US C3(-+5A39(T*+1^TJ,L(M@*!ZVP^MOTB
MWO>RS/.34O1Y5<>&WQBU'/X9:5<\>UE%I_7DF99E"Y,B4R]0MC\HCJ\AT8WI
M$4ODRM'M:V.*8LXK9A0]!, '?H].M8+\3.S5O1.?3_ 7'7:#E$'?J&A8=<;G
M D+LVQ!;)37T@]C0/IZ%4[)4PV5X:O:$K%#:2/>C?7]40/YOJ^L+TDF66/95
MC^(I\27T/U3_ -?.OVNPOJ9^5V[)Y&YMM^@FCENR:CB\KY^8&:%1]EJ]?IQ)
MCS6S5R6VE0AO1"0+TCB01'"6A. CU3]"]0K01;%K8M;,S*R[G=23^(I\27T/
MU3_U\Z_:[#7J9^5W>>>2><.4*U>:?YWJ6,U96DB?G>4/D1C_ ,2.;75_?VEJ
M87AT6B=E[BK.4KV9C2)A^DWU?9)P!UK7H_E,W*V[O=2+^(I\27T/U3_U\Z_:
M[#7J9^5C.9_'!P_QQ-'JQ.9>=(/4,VD4740MYD<<.D)[@NBJMU:'Q4R&">7I
MT*+1*'9A1GCT (1"&F!Z=^C7HPESRRZ6L$NCQ)>./HBSI7<UT\H5W8%GSA2A
M62R8.ZJ6$.3VJ;6EO8D)ZLMLD:%#HPAI:TY/I 4#U@EZV+TBWO>RS/*34O1C
M]>>&CQA51/879]>\=UE&)[7<I89M"I*B53 Y;'I7%W1*]1]\1%KI.J2;6-+J
MB*/*V86,.C"P[]&_1@OQ,[-6]$_=1<'<A]IG0I1U)1<2N4^N2I"3"39,>^D#
MCQ4J&RCD):/;*[M7KA<QQY%L?M?:>C:</J^KZ1>DDRRQ[*H?Q%/B2^A^J?\
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M7ZB8/H#K?K;V9N5RN[W4@'X+/$F8,9@N'ZH]88A#%ZJV< #ZPM^G?J@!+0@
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M%^.E#=CTT1F,.G,;_,VOJ(Z?*QV(G<%;N94H8^2)GVU#<=?!MC6/'>NO_O\
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M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# YPZR_M1?1'^6
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M =[%Z-:WO1>-UO5TL!A# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M=1CE*T/&C7_1#:2<=I$?R=U+R^3!;:DJI(0 P2TZL9M%8?*0AWH  )V8\8S
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MSF2=3,'8+BL(7GB5!/)$8:E]4H!>B05RRRRW9=MD#4[M+ZB+<F1T;GAN.$8
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M?HU/(%_@OZ;_ %,S+#6'SS[H=\(WZ)_AC^Y!L_WI[POQ/GK:?A@P& P& P&
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MTIYR(G:,1[%^,U+6J:V>5./IMV@W0RF.MZQZ6KFRZZA4>>7!QC)]SU?&S&V
MS]ID2%&V.[:I:5QC<%R(5E>^$#+V96;\/6O%NNR/Y'YWYO%ZIYNLR1\*.5?(
M^R9:B9^87NX>G:XK*IIA$4L+CLCDUAV-:B^(N@:8937B0:2QA(\M/Q&5-Y.W
M HE*$6D^HOIS=F^S>S3$SE=B57!IQ.(>RP&5RAA3.[Q$8W/VFTX\SGJ1&;*+
M8[$8VYH:I@TJDNBSTZXE*FT:4:'TE@%K8=5SO2]$G80P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P.<.LO[47T1_E@,GZRZ,PZ_T?S='F'(P&!_
M_]?OXP&!1+RC?HU/(%_@OZ;_ %,S+#6'SS[H=\(WZ)_AC^Y!L_WI[POQ/GK:
M?A@P& P& P& P& P& P& P& P& P& P& P& P& P& P& P-+TH\(O+U]]3=-
M]2]L$(.L'^[GJ"E5?%'MKE]=L?/U>P&-FQM!"6$44LTW4M5O)7L5#BXGDH@G
M*B-FE)"1GJ!&G3U+,9CCT10K\&21OX5[B\?$#Z;4Q*A>H[QCUQ4RUKJB/E!_
M+K:WV? ;'>JZ;SEEM(5UG1QPU7:)$B,.4LAJ 0S51NEAYQVS!ZGXIEKK%JNF
MO&A]XSI+H/H3[:OD[[=_%C:_C0^4?LX^8?E7[3YX_P W^VKX_P#/C'\<^!_'
M/=?ESW)'[S[+VGQ0KUO9A),]23Z[(WXT/EZ>>(J;_;5[W_%6TA95-?#/LX]W
M^W?[0^;83SW\Q^^_/A_V8?!_D[XO[G[*1>\>\^Z^W+]G[R,<_F^J@\T\"5MO
MO&4U\>D5\CDKB''QLV.EU1UH9S;#WQ_AJ!5:>[7.A5DST%D,SW;L42296J<$
M99 8TH*>1)U1QJ@A,%",UZDY<M?B9E>?@E>;>,[4BC1V6OA=/=L6E,;SG,<5
M<X5Y,[;9;-D&D[HQ,R:_W63HY:IHR+2UF:E1<13)&TX3<B-0$.B4*U4<,3XF
MM=.L;-:)XU^Q3L[O+KK[1_F;[[?W7?\ T??*'P;[,ONVU4\5E_YL^:'7YS^<
M_BOOW_LQI^'>S]C_ %KUO:A,7+>,Q\(SNGQP1B]NPK4Z<FM@B/B%N^-N:>.J
M3T^7#@B-^!3BUG&R72RD\^%*=:"I*1N0VXII^#:V$P(56EVMZT3H3+6.OKM3
M.FO!>@J/F[E&CA]/.DOE_/?DCJCR*SZW'NK5!CG=+[5"!?'&FM1LBRUG19"D
MIT, UMQ;L-U>M)=MXC0H1Z4>R*-7XF[;KO-)2=?$>^L/0]TVO1W1L/K6K>C;
M@W>EP5%->1Z>N]_W83T!N#8JZL;9FKDF<*_068:VA-<B3VEY$0H--.1C3G""
M8"'/IJSK/J.OB/?6'H>Z;7H[HV'UK5O1MP;O2X*BFO(]/7>_[L)Z W!L5=6-
MLS5R3.%?H+,-;0FN1)[2\B(4&FG(QISA!, .?35G6?58JW>%9O*^_JA[\I_H
MC[(I=%*7:^:;A@+W4C19[!;M )+D2W(Y1)C=5<NB:^KI8[NWO";;Z46[B(+$
M0("7^B- IK,RG'C8JYRQX:_NS_Q5/_PCOG7^+)^_+_\ B@^6_MM^^?\ ,/\
M^]!^^S;[-OCW_P"W_C'LO_G'UOYIJY[WT[Z_1$'D"\4\<D9_D%ZP=+#O602N
M^K0X*O&IHUS70Z2R+FH.T>/HDXTJQ3*)QE7/"1782X-5A+W9Q0IR6%8@:R5
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MC,+ZG6W7MIMYLN.R>7UQ/XE"9PMK&9RB$RJ.Q&RFUG;9"XU[)WMB7MK!.$#
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M ;98_IJ)=TEL/TBD1DP#(M.HE!A)X$6T0D@0 T:$X0JYWCO\.]+(X0P& P&
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M5<4EO1L.\T4/\KLMY8CEJ0]H;V"&MZEQ0+*'@-E2$]MK@EX;TFTRW9QBHML
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MX;NK2:>I;)W$7L$#<F]HK5F_S2BQ;UO6AJWLS# 8# 8# 8# 8# 8# 8# 8#
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M?(S\N\S1X%J%L'.M%,9=ZG$*+N+9ZCK]L!<9Z8]V5)C[4 BCY ;".3JG]>8
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M_2DG89%7MCQB$\\PZ5-SK4<M:%K3(877;&5(H3&:L=E1;@<,EV)0N.TQ@]C
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M_>GO"_$^>MI^&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# YPZR_M1?1'^6 R?K+HS#K_1_-T>8<C 8'
M_]#OXP&!1+RC?HU/(%_@OZ;_ %,S+#6'SS[H=\(WZ)_AC^Y!L_WI[POQ/GK:
M?A@P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M'C"TS:VHY=R6"LP559/#&=(B;7A3I")_/FJ2UXB:@%#6K='$&(1*DX#RBQG
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M.L>?7_I.&ODZYS?.CJHC<+A-YL4<9MR)YW6\LB5B3]L=U*-A#M7L)HDX!%[
M$(]F'$ ,%^'9-]+IFE >6.FNH;=3UY1= ]AS^M%<]E-;)NM6FCBM\HFR>(%K
MA.NA62;+@/Z=G&H0^[$.!K(6B-5G$DZ-T8:$.Q<+)NV;\>[:3A@P& P& P&
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M\BIUX=W1@:+8U=-;;K1U?61F>I&],C;.]27Y77.[1'HTXKU28I4,Y.B0*3S
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M+PJ"#3*TU*%%6,2F-EPR,R:QECFJ*0MJ2!L+T](G67J7!<H 206WE*!FFC"
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MW L %,?7KTJL(P&$C$ P&]DXW>IU2I&+RI2;S^951#+@JV76E7199M@UK&+
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M/$&+DS7S_>S)VG'XA.S71,["5O!LG;)Y!"C68H9[D H*4"U(6% =I-&N4_\
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M]YC9X/)4E(N2*6(F54XOP$DH<%A13HI/,0BJ<I9K>NWE \0HZWN'^>TSQ<]
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M,VYNM^F9;5<8?O%.Z7U7CS;W0]MW38C;-2+KJG[L3?5MI([+2)E+?62M)MC
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MY7!G-=4+N^J(VQ>R< -I1QZAN5JS2W"SM[?N^13WF\0CA?ISIB=P-ID-L\:
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MEQ/ F6;(/%HO8N.4[O/ZD[1@7*4OYNA\QA=LRM7TA;HZI9EE<U+:UBHHT:3
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M[_PE0KR"\<*4J98AO..NA3DRTM(8Z!F9Y<\JIJS]"RQ7!*D65VA:HZL6V/\
M,DR;U#8H+82W$UF6)S2W(*,18]!)PR\,XA/7?.]C:HWY+L0M[,Z0^TC['$Q<
M7FB-;*?L@ LW9OOR%QCB-9#?DM2A&E7?'"VWV:\1:/7I5'%$C)<;-_1$XO)-
MQON1JXNCLV3O2XM\F$39'2,T??LJAU@3> IW-3+*[J"?QNKW6"W79C4%F5 U
M&HBXO;\H/(&20D,-UZF%X9*[47Y)W-U\8,E\C=SQ)[>$K=7TOMY/6]8\^WO$
M%[;'4$<+D,>A0!RTJ;N$[;DP!!+<;00D((#[N8:O'[FWH52G1;A^/C'YL_EK
MIIIO.S8Q;QTCK*GFCGOEVZ8(^/E ]&(ILT N*3WO'+'>KN;S8&H/J2MH>K@4
M;)(>Y(U1QJ(,=O:'+CREB/U!PNNG?:YP>U^8S+HW0)5G%G6,"4D0$T1,1GIU
M>$64J8-2E)5*FZ"HL.F4MNK(X+2TF)F/X9&:GWZX$0M89XW6_9E\RZ<HVOS[
M\32Z=%-!_,%0,U]7J7\ E*[<#J>0-UE.S1+#MMK&L"_A6-U02,W2)JVN<0:;
MO0-.'9Z;1PU;KZH>_C%>//M1,IS5K.(YLFL6&5(YC*JNXS82P658\?CLFKJ&
M2BTRZ_'5T4?+ :I4B^!%.3RE^+JAFI$FSE2=2247AEK?LAVYO)?4L4OJA*+K
M.5L,@=I/U7(J(O1WDL+LIKA,0CL'H2Z[*L8<,MY:V1ZHWR<5G,H1'T,D2I'9
MY''R'(PAQ2)CS23"BS"ZW?"1->3WAP%>3>U5MUG,L#K]NK]_?'R25?<D8&Y0
M^U)TU5G7=B01GD->MC[:-5RV=/:5M22N,IG>.".-].UH2PC&$G#+>M=5?;@Z
M3\=LE=; O1-5E;27IJD*@G$_9;>O3B:^&W=0/==4V_WBT1:VKH5\W.\PI9_:
MH.V:?3XN8:1-@,QH3T+.>:H3%GQ9,NW_ !OU6(N'R6<;\]#>DER6RK9%,+A\
M5F=DND1JF[[-AM:MLT:MO$4!8<VKNM)/&J\<I@@![=E;7]2V.SLG,)&F2F>V
M*T.I,,KV97!._N3+*N0^@X;:"USLTB>VG5.D"JM;88XLLM*DEKXCM2M&JRW^
M"M=9O%@PTF.*UREE2/!SD-H !R*),;SB5)@N.4F_9'#9V1XYYM-IG=1<PJ]7
M/:%K:6*55U2.K7UF?4E.(IA\K3!?4%K2B#-QUHU698)8&Q4HA+B\LRE[&4E]
M8:LPLL0XYZU[5X-.=@UMV+U=:%!L\49Y?4]/4=S1?Z -ITQ9%?V;&;O?K?N5
M0V[?X#>$<BK]'38LTUE$Y-&50V!$N(/6A<$ZHXLU((DMQN.._=:*R^L^=Z<=
M[38K0LYIA+E2U)M_15DE/C=($Z=AIMU>Y;&T,Q2KP-!C?)/;2"$."+;>UFK7
M4M5I.6-,$:U%I09F-O9#EG=\4;'(S3SY!K(B+X9<I/.4]AYCC&;B>4$EI:^K
MBK^LF)\CH:XK>9N>YU./G;2:(,ZXA&-S=@[]XVG0I'%4E+,:U^+_ "I<U]&3
MKE^+V50;X\4I93YVLMU%K>Y ORRK,%=7&-U59 ZD>*3@.ZG<G&:OZUKDKX].
MI+ PO;O$5:;:)8H;5S6Z$[C7"S>KUZ>_E?7IOO>NJ@X'L_N6J-*;CBK#5\LE
MU<!CT3G[VV2"2M:-X1M*&8I8Y&ULB@L<;Y4V"22!<ZIV\ABT2?I<:E&6+U:S
M,;<N->_77:52D4):5HVU::02OF"/-R[J20!YZOJA2H*X+*UC5P>UW1EL))';
M\?+-KJ9-C@!N&<[KPZ4>R%OWG1B<L7&[U/= -!]W6G:G2%<TX_Q> (H[,+'\
ML$,<7%G0R(EZ3H.#^H:LI2J%2(Y;)5R$M7)HG.51\A]H08!2XEE&(PH2=#3C
M+<9)O[?JLJH[\Y-274X<^*;15D6>SV<P4L]HC*WM8,/8;8E\;:)9"Z^?[4W!
M_LJ8I3.F9\(VPI5;T28^*M')$&E"M.H(*)QRUOV>&?Y(.,4RN?IS[A-+3US&
M+6F#L_?9K;8HA*&.BVUQ>+C'4,W# Q0^^72M&UH5&O+="%TA<4&DX]&D!$'>
MM#ADD'?:7+/VCO=2!NN'FV'&^?0]4OT=3F.*D;50 CB2=60M<B$!C.4V^JI)
M.VEVH^(:2*"5.T_NYQ1@R<;K?MO3$H!Y!N0[/FA-?PNVC'&2J6ET=40'"O;2
MC;&XJ(]#4-@RR)M<NDT)9XDZ65!8<XE+I#$TZXV3QXO8@N2!*868 );CE'O5
MIV_S%;5!OW4D/L=61SW'&PY[76Q.*^LVJXFM9$[<E<C7N-*[1AL./F+*'2P*
M72MH+6IQ.8#6_0]KB3DX!<;+Q]U#^ZN^.7)3QQ9#TR5ZU="KD5H4552^FK\X
MXOZ>M\,E5R6)$HW#YA<W.DDK)@L9LC&F!_4O$<&X)68F9+$Q#4QKCW)>C*--
M8XWEX_-<DWH3FWD:MJ-KZ2>QA0Y!76WJ(5I1W+]QHA(HQ&&]A4SB8(N<JTAM
M@3ND:SC+E)TNW';Z24DC9K@2D<%NE.]B&9U<K:E#[UE ?*?SS]H1'RM]X;[J
M?Q3Y?EO_ +__ +:_N[?9[[E\!^(^W^V/_L?XA['X3_\ /?O7N/\ 6<)QOZ;4
M3XY\NG.-W\XTI8]V6/'*NLR9T&JMZ>Z5P"V8+3.E\&B )5<[?6-G3QA-@4Z%
M6*8I08[MC1)'QT9RR!@5ZT,HS>C66%EU.R4)+Y0J#:)USC"F6%=*R'?0]JRF
MJTJ\WDCK"+K(:X1FHI!;&G!UBTGHQME+D6Z($#?[(I.DUL#.X'/I@PL[:O5%
M#A>O;I]8C.-^7.C&S=)H+1(DXV^PN)9CVA,[MJ>E^FYG0<?AD 25\X2!<P/B
MNCT$G7PW;-+EJT]U<$3?\#&B2MSH6G='9N2'#A?;SI8#L/R%47QU6,HG$HU+
M9S*6RA)UT1%:W@D)GDB>)=7T"<(4Q.SXJ>X]$7YB@L>32*QV)*K='LQ&D0%+
M]J3MZ((4#+)CC<K^;YU/D I..2FPASR8)XG#(]!^<'J+11UJSHEFZ/<Y9T"_
MW>S1V)N%"R&H&F<.$AEVZF%J.1YD1NDK/$C<AKFU&0%"8J'&^W=_3EY-.+6Q
M% CQ6C)W1WLQQLYCA\"C%%] S"W%DGIA9"T=JPMUI>*58\VU%9[ ]V"T'.3
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MF;'.8_+62MFT\AP->&=2QJ52HT21U $E/A<<L9JW>XE>@^$;3JOI"N;C?Y1
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M9&FQ2X"S]E\FTURNA;&V")EZ"HFVG$]]I&R2MB4J3LY,F2+TMV@+"U:TUA2
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M0Q*RDM .B4<<W(W._EL=+1#;BJW3T5[*W IPM_N8VM<C0B3E;5 *#%X3G_\
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M&I6A&W,C,,H3K%:N0K7#9^U SW92J- (HD92<DS;O\GKR>C(?++VJ+H5S62
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M48JPO+?C3$$OC^J-';1-C%36W_DE)=SMTV@YR%*(_JAD/1SZI7.CQ<I+<"(
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MQ.WO:HY"K(.;05>'74O:I*L3R3V?3A$S@-G\JMR;IF+S;C]D9JD@]]I93 [
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MT$@*9T+:U9Q1 ZN7P[C-^&Y##F8'.'67]J+Z(_RP&3]9=&8=?Z/YNCS#D8#
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MTLSLN_HFNT./(5.)7"+&KZP+2YKM.OH."KF&QZ%701 Z*ZN(.$K;JYE41M"
M6E5<WB3"X&&*FDAXCRXUE5*#S4!B8:A1LPDRU-7K&&3+B%?*9K4EJM?7?4D$
MN6J*IL6FMVU&$G+#M)["A5H3* SV4$3MBL;E^>5N2OU)*T:#$IK Q,.DI) B
M0A]D/8,'+VU-,)@GC1KZ(RI&ZR&_ND[3@C9T7,>L6ND9V\4NVU2DOV96:Z7,
M?/%A%7TA6\]DPH[:;J)\9VYY?W%J;%Y! RDVM$@#HO.^)O6GK'>/5I=QR5XF
MG5?7$_L!;3,]H.N;5DLMIY'/Z'KBSUL96SPJIU</I"*L&YE)10QI IE$E;I)
M)A%MQ.O?];#O>R<O$FBO_'3 HASF]<H2FZKNM>C#H_"62"Q&3-?.-<F4\MKN
M2)II$)A6CWS;SU1+TFFS1.&MN>P.+P>\&;=FTE5Z/:C5;4"YW?+IM@%A>*JO
M;/CJQ!,.E^I7:9R2UX%;]DVDYJN;Y!)+;>ZG:QME31>PH-*>;GZAU=;5J(T2
MULC[?#FYL&["$X*RU2W>S]EF=G:1G=H< NUNN%"R"9=M]<*Y?SP\2:40V4:8
M^*U8'>9R :HEOG4J@;SQR[5(LFT%8UAK9'G-%'D"MI2&FF%#][4*51I)EK>I
M.OW_ ,ISKVO>BXO<VU<MO938M L5#16(,K3*&*NT]I3:\S)S*G:;VQ8*^ U-
M7,:9TJ6#EL;4TH&'25L/,-<#E#>4:6F-&2V:[==H*N#QMU7<EH3JR'.W+_B#
M;:=E<^7!:-6P>2UZAKFP+&YC<X&NJI_D&WZL)'/R4B!)7#6D5M*%_1,BH)7O
M>T87()*XHLSLFNB0&#A.FH[%*+AJ5TGBMEY]Z@M[K.&%N+LP*#7.QKJ7=&+Y
M4R2H08P22Y0=$=T[( H4A $BPL"5!HY6?[)1M4.5Z_6:8/1'CAJGG^UZPM*-
M6I?<H3T95,_HZC:SG4KA3K6U1U-83S"GM="HHB:*[8):O2,*B"(R&U6\O#JY
M%(/51G*3TJ5O*1"YVS73J\/HOQD5;T:Z=%FN=V]'U?%NM&".LO1%?U+)ZR9H
MW92N(PA+7<9?EKS+:DFMBL"ELB+<C2F-K0^M\><0I=;7MJK9ZO:@LSLUTG1(
M[OQ+5#;4[I!D6[0D#<@Z\6]Z)&QH?H83+'NZ4O2YO71$/:UK\V,D6*B#E91>
MFPA*M-1C"TC"4<YE'>LX!)RN_P M?PBWQC<A*^6J\O>322#FUM-^G.FK@O\
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M?S<:8C''%87II]N4$QO4(P&N-9XXZ]]ZVW-X<S 8# 8# 8# 8# 8# 8# 8#
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MXTX/:I@3[)]8E&6(8]B+SR_V1.-M<W4]=\&B=>6-'GIP8("_1^501?'I_8D
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MOGZ/)*WFEMV! 'ZOK;N:K["ALGOF:/EA7&?'+3K>P8K9;2TV-+9$J4NC62[
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M[0OQQDM55GS ]);AO."7_/J,9VB>$=(3^ QV)U0G;ZW)>)4&%E?'D9LC+VD
M6E  !9.&$MWVVL0_]C>2BVG/RBSV/]/)^:FGB7A+DGJIDIB.TY0MH(T=I61Q
MT]= 3VN!3B3QF4K'.!N,IAKJB5*OB#DK#[PE-;EA*<DPI43CA-=-[M_=NGE/
M2%B/?BJD?7C">@AEL._CZ=^D&52U(4;JV12Q%_.2BSFX]M;)&F=F]R0,4E.
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MRM')%->ZCD 98PF LVZ-RI<0C6@:G$D*LQ1L 51I,I_\>I-?B=)CYHVPJX>
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M73?J&4F%<LQ>L>9JY@<*21R*E-BSHI^J=GMWI-Z-E136*8GKX$YSQIBVT G
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MGM/GTB._.W.W96JJAXL&\7RD3)SXV^)[0YELA9UM/^3JXE-Z6A3B:96U9KA
MX12EB1?JJ5I[/7Z0*8*X*TA!+6D) G3F"<!FIBS''VGO?;:W=)]*7ZW]\V?"
M+5ZW7VI8-@4O><F.DE07)<+E4OCN>:[YW1KG1GZ(XX<H*P4XYQIBG)1PX[*
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M"$[?M4BLLPH?\X&\KE>ETRG 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MH2]1<ZJ;2,FCK6Y=:I[LK0Z?CL1B.3)GN! AQ<F%(A31G4+22U37I-[\G&:
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M-+6?)W)N>5"0( !2AV/1)9,<\9K=WUM_1FUW>+?M26]8]-IW%);,SI;H[L6
M](1FV*N>^&VLB"-D95U^OB1,XD5WPM=U)'%]+F1 "1O00\QR:7)M2 )V0 2M
M<(\DSQXSS)]?^BU_&9VR8R==5Q6=,MC>E5^6%#Y':HLN/R[G7W*W:E5MS RM
MW/C'#K012QJ99A6+@1\>2IIFQDPU4I;"R F"";_*)GCTM_\ '2\W"K3>W#+5
M3M .7/%R2V7=L=;=!W#8RZQ9=2S>DYSA14#B$AF\Y?-\OUZZT$PI)%+D@=,\
M3;53>4K='@[V"S7\XDHSEK+KN=(_.Q.4>FFKRWLG3/.-23"*PF?3"L@=76O9
M\_Y[EU V94L)I]-%B0UA6HOB73%:W?'E82VQ$K2%HF568F,/4FB3*# F"93A
MQK5/SGRGT+P''.0)ATGSI2ML#@OCFZ,Y_GU"VCT/S3'C:)E+QUM9ESAN=R',
M9<XLDEKZ:0.4-S,[+(@>[.Z4D(B1IQF:"F,-W*9;DM[S]D=^.+QX7K<'+<,M
M-10++,89-? QTMSG3SY*UU9;4#Z1L;KWIBP( QLC3*WTA^C2M_KR>H%J>0FI
MDC.!*X>H-> 7M !+EG)EK?\ RG[.C3QQ6!>3!%J^XPM#G^1PC[G_ !;Q9#[%
MN5_EFG)OE-^/-*Q[YWJZ)I$,>51J8$UXG:=#=9"TR5U1;6*BR- ](O:;KEE)
M\TO>UI-K[QJ=L0D[@NF5_$\+<UO*'E6UTS9_<;5;5(B?+>I=[M*6R];+=1Y=
M)FFSCC]LKPWE/+<M1EK_ /NZU!1)5>Q'^ZQTN>/6[[X]DY\V<;>1%^[8XSN#
MIZ@&B+12H[&ZX-N\<76<.L]$%1NVZ2M:,0H^I8=4\.;>C)9$G^0NK42\?/D@
M>W0UU. L&W%%A.5D$RRQXV8WQY5WAOC+\A4-Y.\?4';:5>(S8/!5B]0LDX9H
MA*>+YL]WPQ7J6XBB%TUJWWV78-+K10AA.$P&-\V RO)*9><-'H'L"3,+<\>5
M\77ELU4<H]<4;XCZ2YBYN@@9;:$)FT/5S"!W$OYYL&QVNJA7L[V<]-M?*I>U
MIN5%]MP!*J;MQL+P3N,MI;<'18SE"=,,PQRQN>[V_P!_-1#F#Q>]9%=8\K6!
MT+SW\0J&"^0#R!]%3,%AS#EV2*(_!+CX^YXCE#R:0Q*ED\'KY9)5MZP!8!2A
MBL7(3MSP@&M&G"C,(<%)K+/'C9+UU/+[HGXYNP*<NN(7DGY+9;HK6EO*=Y.+
MAB_+26QJ'8RY'SQU?$H#'J)M:!(IC*2JJCZ>O7"+K5A+ XJV=Z0[6?T:4D8A
M"".>-FM]>,ZK'<D\.=05_P"+CRR4!*>>V6G[7ZDL?R$2BA:-C=@US((Z5'[Y
MIE#&:EC#!+6B2[BS.R[>@;:DNW<]J-2D)PFJRDI>];U4RRESQN]R:5!N3P_]
M'LK%RPX5%2>D<=?/&[%N5.J:JI!-Q&AGB&[WI''U%Q6#)'3I*,/E?R5?8Q91
M#<\2Z-O&Y<$R-IC$RA02(OUHU/B3KN^^YW6+N3QL](BMXI)!:F#/X;;'@T=/
M&J_VI()Y5H7FKN@0-4Q2-EKVH%>OCD@FY*]G="&Q6[1EJ6K!F*!^JG+2;%H!
MF9S77_RVAN*<0^0>>EV";..2%-5? _X.G:7C)A:=?>E$2]58/1:0R.D1I*1J
M,3D])&&.=F$*36]8O."A3)B="<5"(XS2<);EC[7_ );6-X_\52FL>R^5+(L+
MDNIV>J(1X>H735KKS6ZG'A";W&KG4.+L@R21YI<W)TFLZ>:^"[)U\LVD7M[@
ME$(C;B:(18-DRSWC9+UY?H\!I\<'5DL_@YB'@&5P=L8>MVR O!#7#)+,88]E
MMKXR])/%C,;$CG;)('V'(CWZMPA;DQY3G[JE*7Z3GF%%Z.  <\?5Y?\ '_T]
MJ_\ B#H#ISHV[[V>>-F6%L,Z\&5H\N5Q!)9+.?I.L@'5[_;5J/$=K9L.99>X
M,S0[&Q22)CPR)%LJ/D%+1$B<0F!.+",<IC-;_P"7Z*?0KQ9=0E5Y?R&\^6[D
MFSC)*C\*959 I/H7F2*V:UW9QIR3)8%;,K0/%FS9YK=S+JRS5@&]6E?RAH7X
MM8)4V[6@*">$U<YTU?/ZU9+R1Q+HZ(?P<&?Q3KA+"3NB4"'GLFRT,11Q9MC!
MB];V_4RQE1K28.SH89\<W%U2$M].:4?PT]W][-3!&2,&Q&<->K^'M_Z1S>OC
MO[)NSG#S .<2Y6:J0D7:$Y\?::A^4FVRZ."M;6OEB8UD*SY\KD\/E+?4; 3,
M6IN5+$A G4EQ,)9_5-) I-(*,+,L9<>O;?5FO4OC/N"+3OR,PCG3A>E[BJ3N
MZA:AJVA7QJD5)U1$>+GV(0N4126'KX;(4['(D3*HGC]NP"#8>F<SED@] E!'
MMQC.+&.<LF[JS]6)SKQQ=H$=W\U]<(Z!8;7B7'QG&U-/\2<K @+3+^P4]8UI
M,(U->U%(%EJ,L,23^B9'+2S(4@DNVUX5DIAC$ G7LB!B9X\;COOO\OH]SFKG
MN2N?FJNRE6H;.^<C\JV_8WD6C8VM<B<&]KZ$Z\K6*5PVP)8D:R3$S ="Y6VV
M"\H$0SPBT+6C?8E;UK1@M_\ CW_RLU_9Z'EHY&\C_3\WZ[A=04:CDU83BL:J
M04#+:_=>)(<.0O490M;O-$%]S&]HC(.C"Y*V2PE0"( ASK%VE*0$LQ2X$F&G
M#P8988R;O7\UG.7N4>FJ7\GET6;7E23"K.1K9EO0MAWDLNN?\]V6DL:U)K(D
MJJ%3WE[5>?$;RK-LE!Z?:Q[99:>D0$(1Z) 2)041[,SEE+A)>[3S&^7+ZZW7
M>4^D:3Y0ASTNG7FZFCL;W.ZSRM(^\<\$U%9=;SJ1$;CSPO+M-U5L\;5#TS:8
M4*\A1J4.H#MD#* %0=.4QU;?^/9<"6^)2]Y'".V+%^[U73Y>,F\R;AUA"XQ,
MY-7@5'4O$$6G,!L%KHUTG*1=)"(5"; E('5U^!O(VS>W5"2:X)R_20/1GG-R
M;Z<=?:ODL'QK]77;:SI=R[E6/U/7MR>53QKWK)>43K!I%W%75!\PP&<PJ^K9
MFNXE(2JP=W2QARLDU8RL2][=UA276MEJ![WO8F>,FM]>-ZO20>+GHMC?7&3Q
M_G2-L\B_$C0_M!L>VJ2T^W.:;@I@.95&IBB6)I:2>ACB(\:\6HF#8) +8Q>A
MK%ZP?2.<\_\ #7YJ>>+;F.].B^2O&2@@O(D2@\)I_P @DCZRF?;PY[4Z=;-X
M!5=U6XTRBNE,12J55VG2R7+$P8P,@: #(8T,J(TU5ZIGJIS6>4F66[[:TMU_
M%W]AL4W4P5EYC3BA[5_"%ZY\C+/;C-8='((XJY17SU[?')O1QM1.F^>MZ^J4
M0MGGLXVT!A^W'T-A*H?O 0&>6.N__#7YO:X>YYD1WF!Z$J5*>RO7*G!MK77U
MC4IS(ZH7]H;[?\@<,@1#9 E9  B+:1U:C:I^H1D^L-0D/<O6V$(!)S1C*_\
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MC4\@7^"_IO\ 4S,L-8?//NAWPC?HG^&/[D&S_>GO"_$^>MI^&# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# YPZR_M1?1'^6 R?K+HS#K_1_-T>8<C 8'_]+OXP&!1+RC?HU/(%_@OZ;_
M %,S+#6'SS[H=\(WZ)_AC^Y!L_WI[POQ/GK:?A@P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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/!@,!@,!@,!@,!@,!@?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>sig_backbay.jpg
<TEXT>
begin 644 sig_backbay.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M6'^5;X6_M;_M%?\ !QUK7QA_9[^'WCCPO^PE^PSX)DTS0_C]X1T[Q'HWC/\
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MOM'E?:/*C\_R=WD^=M'F^5O^?RM^[R]_S;<;N<U)17D/[04'Q<N?@)\;[;X
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M,NHWT@EFOM9\1:]=P6]K%J/B;Q5KEWJ7B3Q-JBVUN-2U[5=0O1! LXA3W6@
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M>(_B+:WGV77M32]T67Q)IEI;ZC+J&HM>:Q;:U'I.A '0:[_P0[\#?!S]H_\
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M\9^-[K0["ZMM$,?@OPLEEHUUXPU/QT ?S8_L*_L\?\%3/^"FGPJ\#^$/A_\
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M+\/_ !1+X1U36O"'@F[5CI,V@6%LVJ:AHPCT[7/$NL6XE2;]"/V+_P#@G/\
ML?\ [ /AW5M%_9E^$6E>$M:\3[7\;_$C6[R_\7_%7QW-_H\DA\4_$'Q'/?\
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M\$LAX@\3>#_V=/V1OA]XJ\0?#W6/VNO#/A?Q"VDW_P =/VEO%?AO4='\4_\
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M>UOQ%\'_ ((?L ^+?&WPP^)_[/G@Q/BAXHOM%^#NF^&_AU+X5^,OBSXAZ_\
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M$OQ!M?A_X(\63WD]S/\ :?$%M\.]*T;X@WE\LER;B:[7XEQFZO/.N)8MEP\
M .H_X*2?\%0?BS\=?B+X:_X)L?\ !&_QKX/^*_[6WQ.MO$-S\7_C9X,U_2M9
M\#?LU?"_1+1[;Q'>GXB6DE_X4T'QS+>7,-A=Z];SZUJG@21(M T?2&^*OBWP
M2NE_R]?\$ZOV3_\ @H-JG_!53PO\,?@5<_#_ $3]J+]D[XK^//&'[6O[9Z^.
M_$?QU\-7MEX\;3=.\:Z/\5=9E\8W7A7QUJ,%C)XD\#:9\//#5OX=^(/B7Q]X
M@^(4?COQ39)X=OO$7PS_ *KOB]_P;E_LYZE\:/#WQ4_8]^/OQZ_X)XZ+?> -
M*^%GQG\"_LL^)M8\.1?%?P/I$M@R0Q>([GQ&-0\-ZYK4.DZ(/%UWJ]KXX\.>
M+-3T'2O%>L^$I_&=QXD\1^(OV._9,_9!_9[_ &(?@YH?P+_9M^'FE^ / ND2
M27]\T!>^\1^+_$=U'%'J?C#QSXFNS)JWBOQ5J@@@CN-5U2XE^R6%MI^AZ1!I
MGA[2=(TFP /Y"?\ @OY\4/\ @H#\=D\3^)M/F^(O[*'[./P(_:;\-?L^_LE_
M"&73?'6B_M"?MZ_M1VWB[2(G^)_@OPKX7W->?"_PQ8:5KWBOX*^-IYGT[5WL
M]!'AFQU+Q=X]>'P7_3%\9/\ @H1\,/\ @G_^QW\&?BQ_P4+\<Z+X.^-NL_"+
MP6WBKX9>#CI_B#QW\1_C?9^"= F^(WA7X3^$-,N+9=>AM_&U[-IIUL2:5X(\
M/IJ6D7/B3Q%X?TJ]@O*R/^"E_P#P2R^%?_!2S3_@->^+/B;\3_@C\2_V;_B!
M>>._A7\6_A%JB:;XR\-OK!T.?7K#3I+IC:V-[<ZMX2\&>(-&\3VJ1^(/#&N>
M%=.NM&O(;>ZU:SU'\^OB-_P;!?L5?&VZNO$WQZ_:;_X*"?&_XI7UKH]A=?&#
MXH?M ^$_&OQ!&G:-!?P6VD6^I^*/A-K-J=''VY&AL]3L]4FLA86B6-Y;K-JO
M]I@'XF_M_P#Q8_X*E_\ !6W]H/\ 9A_8Z\56+_L>_#+]J[Q*^O>"_P!CF&XN
M;CXH^&/@'X-N_P"UM2_:=_;#M-^B:S%93BSUG4_AQ\.-:.@V6L7GPYU"2P\$
MZ3KMEX4\:_$?^N'P7^UK_P $_?V23^SC^P3H'[2/@G4OB!H&G?"_]FKX4_"'
M0O$=Y\7_ (N!_#VB:)X*\)6GCC1?A[8>)=:\*)'I5G9WNO>+/&UAX8\,:3IM
MOJ.O:KJ&E:'I]Y<VGX\ZG_P:H?LT^,_BUJOQ/^*O[:_[</Q+N-:LK"WU;4/$
M/CCP1>?$W6Y-,T[2M*L8?$'Q2UGP5KU[JVDVVFZ5;Z7!IW_"/VMS;:3;Z;I]
MGJ=LFFQ/)]G?&7X<?L7_ /!#3]DK6O$O[&G[,?@ZU_:*^)^IZ-\!/V=M"L=*
MO?&OQG^//Q\^)MRMEX&\(:SX[\076I>.M>\-VFK6LWCC7O#3^)-.\-VFDZ#J
M6G^&+'3-5O\ 1K"X /VI\->-O!GC1O$2>#O%WACQ8_A#Q-J?@OQ8GAK7]*UU
MO"_C'14MI-8\)^(ETN[NCHGB;28[RS?4]!U(6VJ6"75LUU:Q+/$6Z>OSA_X)
M8?L-S_L%_LGZ%\./%^O3>-OCU\2O$>M?'/\ :@^(MUJ-UK%SXX_: ^(\=C>>
M.+]-5O&,^H:;H@L]/\*Z5J)AL6UVUT/_ (2B^T^UUK7]6#_H]0!^?_\ P47_
M ."C'P(_X)P? G6/BM\5=6LM:\=:I9WUA\&?@EINK6UOX^^,WC<"&WT_0/#F
MFK'>ZC!H5K?WNGMXP\7KI5]IWA32[E)Y8-0U>]T30M8X/_@FI^R7\1OA!X8^
M('[3_P"U9)I?B#]O']L34]*^(W[1>MZ?'&=(^'&DVFGQ6?PU_9O^'\8DNCI?
M@+X+^%5LM >$:GKMWK7BM=<U2^\4^);&+P_=6GX::)_P;,?'?]J#]H3XD_M#
M?\%0?V^O''Q+\3ZAX@UEOAW/\ -1EMO%EGH\6M3:OX-OV\5_$GP0?#?PQTO0
M)+J]-M\(/AU\-;GPSH4URC>&O&FGP6[6]S^@>G?\$B/^"@?PYNE_X4=_P78_
M; T/3+5Y7TZR^//PT\*?M/7$'F.T"1WEUX[\<:1;:C!%I(AMH[:338;>+4TD
MUBWB@>86D0!_0)7GGQ6^+/PT^!OP_P#$_P 5/B_XX\-?#GX=^#=+N=8\2^+O
M%NJVFCZ-IEE:Q/*QDNKN2,374^SR;'3[837^HW;PV5A;7-W/#"_XM+_P28_;
MQ\:RW*?''_@N5^V=X@L+_P#LU;V'X#> O 7[,E\$M;:>WO1INH^$M9\3'1WN
MP;5X9+"VB,,D5Q/?#5;JY2XMORM^('_!JA\3?C;^USK/C'XZ?\%!?B=\4?V8
MX1I]SH.O?$#5O$'Q)_:YU33C=*+[P%K/B?QA;S?#[1!86(":?\2K*#Q#!J%T
MBM-\'])A(10#]*?^"=_PZ\3_ /!27]HI?^"R'[1VB:IIGP]TR#Q/X!_X)G?
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MS,V6(!U=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5P?B;X6_#3QIXL^'_CSQ?\
M/_!GBCQO\*+_ %S5/AAXOU_PUH^K^)OA[J/B;2&T#Q'>^"]<O[.?4O#5SKVB
MM_9>L2Z/<VC:E9)%;WAFCAB"=Y10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'RG^W5XZ^*OPQ_8O_
M &J_B%\#-'UG7/C)X/\ V?OBQK_PPL?#UC;ZKK4?CC3_  5K,WAS5=-T>Z26
M/6[G0M3%OKB:'';W=WK0TXZ78V5[>W=O:3?RP?L4_%[Q=_P4-_86_9?_ ."6
MW_!.CPS\6_@Y\%=)^&FB:;_P4N_;'\5Z%+H=EH$_B6WTWQ9\=OAC\%/$<NJZ
MTWB[XI?&WQWXG\<?;3J-O#!I?@S4[>-=.N?"NI:OJ'AO^TNH+:UMK.$6]I;P
M6L"O+(L%M#'!"KSRO/,XCB54#S3R232L%S)+(\CDN[$@'E?P&^!OPR_9I^#?
MPX^ OP:\,VGA#X9?"OPMIWA+PCH5HJDPV%@C-/?ZC<A$DU/7M;OY;S7/$FN7
M>_4=?\0:CJ>M:G-<:A?W,\GK=%% !1110 4444 %?D3>?\$'?^"3>I_&;7OC
MQK/['G@_7?'GB3QG?_$#5;37/&/Q1U;X>3^*M6U:YUS6+MOA)?>.)OA=)I6J
MZE<O+=>%+CPA/X1CMT33[+0K33_,M9/UVHH RM"T+0_"^BZ3X;\,Z-I7AWP[
MH.G6>D:'H.A:=::1HNC:3I\"6MAI>DZ7I\-O8Z=IUC:Q16UG96<$-M;01I##
M$D:*HU:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
4* "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124387072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-4/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CALADRIUS BIOSCIENCES, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000320017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127725952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (FY) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,747<span></span>
</td>
<td class="nump">$ 24,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">2,181<span></span>
</td>
<td class="nump">1,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">90,700<span></span>
</td>
<td class="nump">96,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">91,463<span></span>
</td>
<td class="nump">97,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">697<span></span>
</td>
<td class="nump">1,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">2,104<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,801<span></span>
</td>
<td class="nump">4,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,222<span></span>
</td>
<td class="nump">5,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at December 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, authorized 500,000,000 shares; issued 59,800,792 and 19,389,413 shares, at December 31, 2021 and December 31, 2020, respectively; and outstanding, 59,789,712 and 19,378,333 shares, at December 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">546,580<span></span>
</td>
<td class="nump">545,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 11,080 shares at December 31, 2021 and December 31, 2020 respectively</a></td>
<td class="num">(708)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(457,242)<span></span>
</td>
<td class="num">(453,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(425,550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Caladrius Biosciences, Inc. stockholders' equity</a></td>
<td class="nump">88,495<span></span>
</td>
<td class="nump">92,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="num">(254)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">88,241<span></span>
</td>
<td class="nump">92,000<span></span>
</td>
<td class="nump">$ 110,014<span></span>
</td>
<td class="nump">32,242<span></span>
</td>
<td class="nump">$ 20,553<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, non-controlling interests and stockholders' equity</a></td>
<td class="nump">$ 91,463<span></span>
</td>
<td class="nump">$ 97,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127810480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (FY) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PreferredStockLiquidationPreferenceShare', window );">Preferred stock, liquidation preference (shares)</a></td>
<td class="nump">0.001<span></span>
</td>
<td class="nump">0.001<span></span>
</td>
<td class="nump">0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PreferredStockSharesDesignated', window );">Preferred stock, shares designated (shares)</a></td>
<td class="nump">825,000<span></span>
</td>
<td class="nump">825,000<span></span>
</td>
<td class="nump">825,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (shares)</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued (shares)</a></td>
<td class="nump">60,544,144<span></span>
</td>
<td class="nump">59,800,792<span></span>
</td>
<td class="nump">19,389,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding (shares)</a></td>
<td class="nump">60,533,064<span></span>
</td>
<td class="nump">59,789,712<span></span>
</td>
<td class="nump">19,378,333<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract', window );"><strong>Treasury Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (shares)</a></td>
<td class="nump">11,080<span></span>
</td>
<td class="nump">11,080<span></span>
</td>
<td class="nump">11,080<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PreferredStockLiquidationPreferenceShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Liquidation Preference, Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PreferredStockLiquidationPreferenceShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PreferredStockSharesDesignated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred stock, shares designated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PreferredStockSharesDesignated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761123858352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (FY) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 17,680<span></span>
</td>
<td class="nump">$ 9,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">11,370<span></span>
</td>
<td class="nump">9,892<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">29,050<span></span>
</td>
<td class="nump">19,145<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(29,050)<span></span>
</td>
<td class="num">(19,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income, net</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(75)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before benefit from income taxes and noncontrolling interests</a></td>
<td class="num">(28,974)<span></span>
</td>
<td class="num">(19,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">(1,508)<span></span>
</td>
<td class="num">(10,872)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(27,466)<span></span>
</td>
<td class="num">(8,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Less - net income attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Caladrius Biosciences, Inc. common stockholders</a></td>
<td class="num">$ (27,466)<span></span>
</td>
<td class="num">$ (8,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic and diluted loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Caladrius Biosciences, Inc. common shareholders - basic (in dollars per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Caladrius Biosciences, Inc. common shareholders - diluted (in dollars per share)</a></td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares</a></td>
<td class="nump">55,313<span></span>
</td>
<td class="nump">15,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares</a></td>
<td class="nump">55,313<span></span>
</td>
<td class="nump">15,440<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124372384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (FY) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (27,466)<span></span>
</td>
<td class="num">$ (8,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Available for sale securities - net unrealized loss</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive loss</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(27,523)<span></span>
</td>
<td class="num">(8,156)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders</a></td>
<td class="num">$ (27,523)<span></span>
</td>
<td class="num">$ (8,165)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057157536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity (FY) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Caladrius Biosciences, Inc. Stockholders' Equity</div></th>
<th class="th"><div>Series B Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Non- Controlling Interest in Subsidiary</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,529,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 20,553<span></span>
</td>
<td class="nump">$ 20,816<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 438,911<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (417,400)<span></span>
</td>
<td class="num">$ (708)<span></span>
</td>
<td class="num">$ (263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(8,141)<span></span>
</td>
<td class="num">(8,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuance of common stock and warrants</a></td>
<td class="nump">18,728<span></span>
</td>
<td class="nump">18,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">18,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">19,389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">32,242<span></span>
</td>
<td class="nump">32,496<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">458,748<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(425,550)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(8,063)<span></span>
</td>
<td class="num">(8,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,841,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuance of common stock and warrants</a></td>
<td class="nump">85,457<span></span>
</td>
<td class="nump">85,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">85,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Proceeds from option exercises</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">59,510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Mar. 31, 2021</a></td>
<td class="nump">110,014<span></span>
</td>
<td class="nump">110,268<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">544,601<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(433,613)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">19,389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="nump">32,242<span></span>
</td>
<td class="nump">32,496<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">458,748<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(425,550)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(27,466)<span></span>
</td>
<td class="num">(27,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,757<span></span>
</td>
<td class="nump">1,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,888,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuance of common stock and warrants</a></td>
<td class="nump">$ 85,500<span></span>
</td>
<td class="nump">85,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">85,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="nump">7,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Proceeds from option exercises</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">59,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">92,000<span></span>
</td>
<td class="nump">92,254<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">545,988<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(453,016)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(4,226)<span></span>
</td>
<td class="num">(4,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 593<span></span>
</td>
<td class="nump">593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">60,544,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 88,241<span></span>
</td>
<td class="nump">$ 88,495<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 546,580<span></span>
</td>
<td class="num">$ (196)<span></span>
</td>
<td class="num">$ (457,242)<span></span>
</td>
<td class="num">$ (708)<span></span>
</td>
<td class="num">$ (254)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129309920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (FY) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (27,466)<span></span>
</td>
<td class="num">$ (8,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Equity-based compensation expense</a></td>
<td class="nump">2,005<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization/accretion on marketable securities</a></td>
<td class="nump">2,514<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other current assets</a></td>
<td class="num">(453)<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(150)<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities', window );">Accounts payable, accrued liabilities and other liabilities</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="num">(2,839)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(22,245)<span></span>
</td>
<td class="num">(8,823)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(179,775)<span></span>
</td>
<td class="num">(34,799)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Sales of marketable securities</a></td>
<td class="nump">124,939<span></span>
</td>
<td class="nump">27,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(54,896)<span></span>
</td>
<td class="num">(7,277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Tax withholding payments on net share settlement equity awards</a></td>
<td class="num">(248)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of capital stock</a></td>
<td class="nump">85,500<span></span>
</td>
<td class="nump">18,728<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="nump">85,276<span></span>
</td>
<td class="nump">18,580<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="nump">8,135<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">16,512<span></span>
</td>
<td class="nump">14,032<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">24,647<span></span>
</td>
<td class="nump">16,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057203456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Q1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 12,747<span></span>
</td>
<td class="nump">$ 24,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">2,181<span></span>
</td>
<td class="nump">1,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">90,700<span></span>
</td>
<td class="nump">96,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">91,463<span></span>
</td>
<td class="nump">97,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">697<span></span>
</td>
<td class="nump">1,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">2,104<span></span>
</td>
<td class="nump">2,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,801<span></span>
</td>
<td class="nump">4,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,222<span></span>
</td>
<td class="nump">5,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at March 31, 2022 and December 31, 2021, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, authorized 500,000,000 shares; issued 60,544,144 and 59,800,792 shares at March 31, 2022 and December 31, 2021, respectively; and outstanding, 60,533,064 and 59,789,712 shares at March 31, 2022 and December 31, 2021, respectively</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">546,580<span></span>
</td>
<td class="nump">545,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">458,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 11,080 shares at March 31, 2022 and December 31, 2021</a></td>
<td class="num">(708)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(457,242)<span></span>
</td>
<td class="num">(453,016)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(425,550)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Caladrius Biosciences, Inc. stockholders' equity</a></td>
<td class="nump">88,495<span></span>
</td>
<td class="nump">92,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="num">(254)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">88,241<span></span>
</td>
<td class="nump">92,000<span></span>
</td>
<td class="nump">$ 110,014<span></span>
</td>
<td class="nump">32,242<span></span>
</td>
<td class="nump">$ 20,553<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, non-controlling interests and stockholders' equity</a></td>
<td class="nump">$ 91,463<span></span>
</td>
<td class="nump">$ 97,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124389664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Q1) (Parentheticals) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PreferredStockLiquidationPreferenceShare', window );">Preferred stock, liquidation value</a></td>
<td class="nump">0.001<span></span>
</td>
<td class="nump">0.001<span></span>
</td>
<td class="nump">0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PreferredStockSharesDesignated', window );">Preferred stock, shares designated</a></td>
<td class="nump">825,000<span></span>
</td>
<td class="nump">825,000<span></span>
</td>
<td class="nump">825,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">60,544,144<span></span>
</td>
<td class="nump">59,800,792<span></span>
</td>
<td class="nump">19,389,413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">60,533,064<span></span>
</td>
<td class="nump">59,789,712<span></span>
</td>
<td class="nump">19,378,333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (shares)</a></td>
<td class="nump">11,080<span></span>
</td>
<td class="nump">11,080<span></span>
</td>
<td class="nump">11,080<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PreferredStockLiquidationPreferenceShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Liquidation Preference, Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PreferredStockLiquidationPreferenceShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PreferredStockSharesDesignated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred stock, shares designated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PreferredStockSharesDesignated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129274144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations (Q1) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 3,278<span></span>
</td>
<td class="nump">$ 5,076<span></span>
</td>
<td class="nump">$ 17,680<span></span>
</td>
<td class="nump">$ 9,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,342<span></span>
</td>
<td class="nump">3,010<span></span>
</td>
<td class="nump">11,370<span></span>
</td>
<td class="nump">9,892<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">6,620<span></span>
</td>
<td class="nump">8,086<span></span>
</td>
<td class="nump">29,050<span></span>
</td>
<td class="nump">19,145<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(6,620)<span></span>
</td>
<td class="num">(8,086)<span></span>
</td>
<td class="num">(29,050)<span></span>
</td>
<td class="num">(19,145)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment income, net</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">151<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(148)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before benefit from income taxes and noncontrolling interests</a></td>
<td class="num">(6,705)<span></span>
</td>
<td class="num">(8,063)<span></span>
</td>
<td class="num">(28,974)<span></span>
</td>
<td class="num">(19,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">(2,479)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,508)<span></span>
</td>
<td class="num">(10,872)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to Caladrius Biosciences, Inc. common stockholders</a></td>
<td class="num">$ (4,226)<span></span>
</td>
<td class="num">$ (8,063)<span></span>
</td>
<td class="num">$ (27,466)<span></span>
</td>
<td class="num">$ (8,150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Basic and diluted loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Caladrius Biosciences, Inc. common stockholders - basic (in usd per share)</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Caladrius Biosciences, Inc. common stockholders - diluted (in usd per share)</a></td>
<td class="num">$ (0.07)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.50)<span></span>
</td>
<td class="num">$ (0.53)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares</a></td>
<td class="nump">60,560<span></span>
</td>
<td class="nump">42,117<span></span>
</td>
<td class="nump">55,313<span></span>
</td>
<td class="nump">15,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares</a></td>
<td class="nump">60,560<span></span>
</td>
<td class="nump">42,117<span></span>
</td>
<td class="nump">55,313<span></span>
</td>
<td class="nump">15,440<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124358304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Q1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (4,226)<span></span>
</td>
<td class="num">$ (8,063)<span></span>
</td>
<td class="num">$ (27,466)<span></span>
</td>
<td class="num">$ (8,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Available for sale securities - net unrealized loss</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive loss</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders</a></td>
<td class="num">$ (4,352)<span></span>
</td>
<td class="num">$ (8,122)<span></span>
</td>
<td class="num">$ (27,523)<span></span>
</td>
<td class="num">$ (8,165)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127471376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Q1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Caladrius Biosciences, Inc. Stockholders' Equity</div></th>
<th class="th"><div>Series B Convertible Preferred Stock</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Non- Controlling Interest in Subsidiary</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">10,529,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 20,553<span></span>
</td>
<td class="nump">$ 20,816<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 438,911<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (417,400)<span></span>
</td>
<td class="num">$ (708)<span></span>
</td>
<td class="num">$ (263)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(8,141)<span></span>
</td>
<td class="num">(8,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,117<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuances of common stock and warrants</a></td>
<td class="nump">18,728<span></span>
</td>
<td class="nump">18,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="nump">18,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">19,389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">32,242<span></span>
</td>
<td class="nump">32,496<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">458,748<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(425,550)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(8,063)<span></span>
</td>
<td class="num">(8,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,841,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuances of common stock and warrants</a></td>
<td class="nump">85,457<span></span>
</td>
<td class="nump">85,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">85,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Proceeds from option exercises</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">59,510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Mar. 31, 2021</a></td>
<td class="nump">110,014<span></span>
</td>
<td class="nump">110,268<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">544,601<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(433,613)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">19,389,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="nump">32,242<span></span>
</td>
<td class="nump">32,496<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">458,748<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(425,550)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(27,466)<span></span>
</td>
<td class="num">(27,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,757<span></span>
</td>
<td class="nump">1,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Net proceeds from issuance of common stock and warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,888,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Net proceeds from issuances of common stock and warrants</a></td>
<td class="nump">$ 85,500<span></span>
</td>
<td class="nump">85,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">85,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="nump">7,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Proceeds from option exercises</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">59,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">92,000<span></span>
</td>
<td class="nump">92,254<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">545,988<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(453,016)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(4,226)<span></span>
</td>
<td class="num">(4,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,226)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">743,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 593<span></span>
</td>
<td class="nump">593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Proceeds from option exercises (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">60,544,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 88,241<span></span>
</td>
<td class="nump">$ 88,495<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 546,580<span></span>
</td>
<td class="num">$ (196)<span></span>
</td>
<td class="num">$ (457,242)<span></span>
</td>
<td class="num">$ (708)<span></span>
</td>
<td class="num">$ (254)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127790944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Q1) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (4,226)<span></span>
</td>
<td class="num">$ (8,063)<span></span>
</td>
<td class="num">$ (27,466)<span></span>
</td>
<td class="num">$ (8,141)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Share-based compensation</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">597<span></span>
</td>
<td class="nump">2,005<span></span>
</td>
<td class="nump">1,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Accretion on marketable securities</a></td>
<td class="nump">515<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="nump">2,514<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other current assets</a></td>
<td class="num">(969)<span></span>
</td>
<td class="num">(1,763)<span></span>
</td>
<td class="num">(453)<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities', window );">Accounts payable, accrued liabilities and other liabilities</a></td>
<td class="num">(1,786)<span></span>
</td>
<td class="nump">834<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="num">(2,839)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(5,642)<span></span>
</td>
<td class="num">(7,975)<span></span>
</td>
<td class="num">(22,245)<span></span>
</td>
<td class="num">(8,823)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(26,546)<span></span>
</td>
<td class="num">(75,911)<span></span>
</td>
<td class="num">(179,775)<span></span>
</td>
<td class="num">(34,799)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Sale of marketable securities</a></td>
<td class="nump">20,456<span></span>
</td>
<td class="nump">10,821<span></span>
</td>
<td class="nump">124,939<span></span>
</td>
<td class="nump">27,542<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(6,090)<span></span>
</td>
<td class="num">(65,090)<span></span>
</td>
<td class="num">(54,896)<span></span>
</td>
<td class="num">(7,277)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Tax withholding payments on net share settlement equity awards</a></td>
<td class="num">(168)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="num">(148)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">85,457<span></span>
</td>
<td class="nump">85,500<span></span>
</td>
<td class="nump">18,728<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(168)<span></span>
</td>
<td class="nump">85,297<span></span>
</td>
<td class="nump">85,276<span></span>
</td>
<td class="nump">18,580<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(11,900)<span></span>
</td>
<td class="nump">12,232<span></span>
</td>
<td class="nump">8,135<span></span>
</td>
<td class="nump">2,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">24,647<span></span>
</td>
<td class="nump">16,512<span></span>
</td>
<td class="nump">16,512<span></span>
</td>
<td class="nump">14,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 12,747<span></span>
</td>
<td class="nump">$ 28,744<span></span>
</td>
<td class="nump">$ 24,647<span></span>
</td>
<td class="nump">$ 16,512<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124994064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Business (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_BusinessTextBlock', window );">The Business</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 1 &#8211; The Business</span></div>

<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Overview</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Caladrius&#8221; or the
            &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The Company is developing what are intended to be first-in-class therapeutics based on the characteristics of
            naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its technology is intended to leverage these cells to enable the body's natural repair mechanisms using formulations unique to each medical
            indication.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's leadership team has decades of collective
            biopharmaceutical product development experience in a variety of therapeutic categories. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The
            Company&#8217;s current product candidates include:</div>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA<sup>&#174;</sup> (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow on Phase
                    2b study (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA<sup>&#174;</sup> (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the
                    treatment of critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan. HONEDRA&#174; was the recipient of orphan drug designation in March 2021 from the U.S. Food
                    and Drug Administration (&#8220;FDA&#8221;) for Buerger's disease; and</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, the subject of a study designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients
                    with chronic kidney disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">On April&#160;26, 2022, the Company and Cend Therapeutics, Inc., a Delaware corporation (&#8220;Cend&#8221;), entered into an Agreement and Plan
                    of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, a wholly-owned subsidiary of Caladrius will
                    merge with and into Cend, with Cend surviving as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;), subject to the terms of the Merger Agreement and stockholder approval of the transaction. Under the exchange ratio formula, as of
                    immediately after the Merger, the former Cend stockholders are expected to own approximately 50% of the outstanding shares
                    of Caladrius Common Stock and the Company&#8217;s stockholders as of immediately prior to the Merger are expected to own approximately 50%
                    of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on our net cash balance at the time of closing and the amount of any transaction expenses of Cend in excess of $250 thousand at the time of closing. See Note 12 below for more information regarding the Merger and related transactions.</div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Ischemic Repair (CD34 Cell Technology)</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The CD34+ cell was discovered as a result of the deliberate search
            for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building
            new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same
            capability.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's proprietary cell technology using autologous (a
            patient&#8217;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is
            restricted or reduced. Through the administration of CD34+ cells, Caladrius seeks to promote the development and formation </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">of new microvasculature and thereby increase blood flow to the impacted area. The
            Company believes that a number of conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology including but not limited to Buerger's disease, CLI, CMD, and DKD.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">XOWNA<sup>&#174;</sup> for Treatment of Coronary
            Microvascular Dysfunction</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In 2017, with the assistance of a $1.9 million grant from the National Institutes of Health (Award Number&#160;R44HL135889), the Company initiated its program for XOWNA<sup>&#174;</sup> for the
            treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled
            patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian
            Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr.
            Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, the Company commenced enrollment in its Phase 2b FREEDOM Trial of XOWNA<sup>&#174;</sup>, a double-blind, randomized and placebo-controlled clinical trial designed to
            further evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in
            January 2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment, including supply chain disruptions affecting the availability of qualified catheters used in the diagnosis of CMD and/or administration of XOWNA<sup>&#174;</sup>.
            Protocol amendments to the initial FREEDOM Trial protocol, as agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of subject enrollment.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">HONEDRA<sup>&#174;</sup> for Treatment of Critical
            Limb Ischemia</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's randomized, open-label, registration-eligible study of
            HONEDRA<sup>&#174;</sup> in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA<sup>&#174;</sup> study's enrollment, however, has been significantly curtailed by the
            COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of 2020 and 2021. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19 delays,
            coupled with the unpredictability of the timing of site enrollment re-initiation, Caladrius suspended further enrollment and is focusing its efforts on consummating a partnership for the product in Japan. Such a partnership may become the basis
            for the completion of development and registration of HONEDRA<sup>&#174;</sup> in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or exploration
            of the possibility of submitting the existing data to Japan's Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) under Japan's regenerative medicine regulations, which allow for conditional approval of innovative regenerative medicine
            products. Despite receipt from FDA in March 2021 of orphan designation in the U.S. for CLBS12 as a potential treatment for Buerger's disease, based on a response from the FDA in October 2021 regarding a development plan for U.S. registration
            the Company decided not to pursue United States development in Buerger's disease at this time.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">CLBS201 for Treatment of Diabetic Kidney Disease</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Progressive kidney failure is associated with attrition of the
            microcirculation of the kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, the Company
            has elected to move forward with a Phase 1b, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol is expected to include six subjects in total with the first two
            subjects sequentially dosed and followed for a two-week safety observation period. Clearance by the independent Data Safety Monitoring Board (&#8220;DSMB&#8221;) overseeing the study will then permit the treatment of the next four patients, with all
            patients being followed for safety and therapeutic effect. A read-out of data will occur after at the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201 will be its ability to demonstrate a
            therapeutic effect that will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate. As announced recently, the Company has treated the first patient in the
            CLBS201 proof-of-concept study and targets treatment completion for all six subjects during the third quarter of 2022.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Additional Out-licensing Opportunities and
            Pipeline Diversification</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's broad intellectual property portfolio of cell therapy
            assets includes notable programs available for out-licensing in order to continue their clinical development. The Company's current long-term strategy focuses on advancing its therapies through development with the ultimate objective of
            obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to
            realize potentially meaningful value increases within its own proprietary pipeline if it is successful in advancing its product candidates to their next significant development milestones.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the Company further desires to diversify its pipeline of
            development products candidates and is exploring a range of strategic transactions in furtherance of that goal. The Company has taken, and intends to continue to take, active steps to identify assets and/or companies for acquisition and/or
            partnership that would enhance and de-risk its current development portfolio. Such assets could target indications beyond cardiovascular disease as well as product categories outside of cell therapy. The range of possible transactions includes
            an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute the shares of its existing stockholders. There can be no assurance
            that this exploration of strategic alternatives will result in Caladrius entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Coronavirus Considerations</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which
            causes COVID-19, was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects. Despite the FDA approval
            of multiple COVID-19 vaccines in late 2020, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, the
            Company implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. The Company's clinical study of HONEDRA<sup>&#174;</sup> in Japan has experienced
            significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 2021 covering Tokyo and other regions in response to an increased number of COVID-19 infections. With the Company's expectation that COVID-19 in
            Japan would continue to impact negatively clinical site operations and enrollment of patients in the HONEDRA<sup>&#174;</sup> clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory
            authorities regarding the submission of patient data already accrued. Caladrius' phase 2b trial of XOWNA<sup>&#174;</sup> in the U.S. has also experienced delays in enrolling patients as a result of COVID-19.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying unaudited Consolidated Financial Statements have
            been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim
            financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated
            Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of March&#160;31, 2022, and the results of its
            operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2021
            and 2020 included in our 2021 Form 10-K. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">assumptions believed to be reasonable under the circumstances, the results of which
            form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly,
            actual results could differ from those estimates and assumptions.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 1 &#8211; The Business</span></div>

<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">OVERVIEW</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Caladrius&#8221; or the
            &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The Company is developing what are intended to be first-in-class therapeutics based on the characteristics of
            naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its technology is intended to leverage these cells to enable the body's natural repair mechanisms using formulations unique to each medical
            indication.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's leadership team has decades of collective
            biopharmaceutical development experience. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The Company's current product candidates include:</div>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA<sup>&#174;</sup> (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow-on Phase
                    2b study (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA<sup>&#174;</sup> (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the
                    treatment of critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan. HONEDRA&#174; was the recipient of orphan drug designation in March 2021 from the U.S. Food
                    and Drug Administration (&#8220;FDA&#8221;) for Buerger's disease; and</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients with chronic kidney
                    disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Ischemic Repair (CD34 Cell Technology)</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The CD34+ cell was discovered as a result of the deliberate search
            for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building
            new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same
            capability.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's proprietary cell technology using autologous (a
            patient&#8217;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is
            restricted or reduced. Through the administration of CD34+ cells, Caladrius seeks to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. The Company believes that a number of
            conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology including, but not limited to, Buerger's disease, CLI, CMD, and DKD.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">XOWNA<sup>&#174;</sup> for Treatment of Coronary
            Microvascular Dysfunction</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In 2017, with the assistance of a $1.9 million grant from the National Institutes of Health (Award Number&#160;R44HL135889), the Company initiated its program for XOWNA<sup>&#174;</sup> for the
            treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled
            patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian
            Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr.
            Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, the Company commenced enrollment in its Phase 2b FREEDOM Trial of XOWNA&#174;, a </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">double-blind, randomized and placebo-controlled clinical trial designed to further
            evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in January
            2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment. Protocol amendments to the initial FREEDOM Trial protocol, as agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of
            subject enrollment.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">HONEDRA<sup>&#174;</sup> for Treatment of Critical
            Limb Ischemia</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's randomized, open-label, registration-eligible study of
            HONEDRA<sup>&#174;</sup> in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA<sup>&#174;</sup> study's enrollment, however, has been significantly curtailed by the
            COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of the past 18 months. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19
            delays, coupled with the unpredictability of the timing of site enrollment re-initiation, Caladrius suspended further enrollment and is focusing its efforts on consummating a partnership for the product in Japan. Such a partnership may become
            the basis for the completion of development and registration of HONEDRA<sup>&#174;</sup> in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or
            exploration of the possibility of submitting the existing data to Japan's Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) under Japan's regenerative medicine regulations, which allow for conditional approval of innovative regenerative
            medicine products. Despite receipt from FDA in March 2021 of orphan designation in the U.S. for CLBS12 as a potential treatment for Buerger's disease, based on a response from the FDA in October 2021 regarding a development plan for U.S.
            registration the Company decided not to pursue United States development in Buerger's disease at this time.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">CLBS201 for Treatment of Diabetic Kidney Disease</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Progressive kidney failure is associated with attrition of the
            microcirculation of the kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, the Company
            has elected to move forward with a Phase 1, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol, as approved by an Institutional Review Board (the &#8220;IRB&#8221;), is expected
            to include six subjects in total with the first two subjects sequentially dosed and followed for a two-week safety observation period. Clearance by the independent Data Safety Monitoring Board (&#8220;DSMB&#8221;) overseeing the study will then permit the
            treatment of the next four patients, with all patients being followed for safety and therapeutic effect. A read-out of data will occur after at the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201
            will be its ability to demonstrate a therapeutic effect that will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Additional Out-licensing Opportunities and
            Pipeline Diversification</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's broad intellectual property portfolio of cell therapy
            assets includes notable programs available for out-licensing in order to continue their clinical development. The Company's current long-term strategy focuses on advancing its therapies through development with the ultimate objective of
            obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to
            realize potentially meaningful value increases within its own proprietary pipeline if it is successful in advancing its product candidates to their next significant development milestones.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the Company further desires to diversify its pipeline of
            development products candidates and is exploring a range of strategic transactions in furtherance of that goal. The Company has taken, and intends to continue to take, active steps to identify assets and/or companies for acquisition and/or
            partnership that would complement its current development programs and de-risk its overall development portfolio. Such assets potentially could target indications beyond cardiovascular disease as well as product categories outside of cell
            therapy. The range of possible transactions includes an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">the shares of its existing stockholders. There can be no assurance that this
            exploration of strategic alternatives will result in Caladrius entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Coronavirus Considerations</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which
            causes COVID-19, was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects. Despite the FDA approval
            of multiple COVID-19 vaccines in late 2020, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, the
            Company implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. The Company's clinical study of HONEDRA<sup>&#174;</sup> in Japan has experienced
            significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 and re-implemented from January&#160;7, 2021 through March&#160;21, 2021 covering Tokyo and other regions in response to an increased number of COVID-19
            infections. Due to reported increases in COVID-19 cases and a low rate of vaccination in Japan, States of Emergency were renewed on April&#160;25, 2021 through May&#160;11, 2021 and then re-implemented in Tokyo from July&#160;12, 2021 through September&#160;30,
            2021. With the Company's expectation that</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">COVID-19 in Japan would continue to impact negatively enrollment of
            patients in the HONEDRA<sup>&#174;</sup> clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory authorities regarding the submission of patient data already accrued. Caladrius'
            phase 2b trial of XOWNA<sup>&#174;</sup> in the U.S. has also experienced delays in enrolling patients as a result of COVID-19.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying consolidated financial statements have been prepared
            in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments
            about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimate and assumptions in determining stock-based awards values. Accordingly, actual results could differ from
            those estimates and assumptions.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_BusinessTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Business [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_BusinessTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125094144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 2 &#8211; Summary of Significant Accounting Policies</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition to the policies below, the Company's significant
            accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included in its 2021 Form 10-K. There were no changes to these policies during the three months ended March&#160;31, 2022.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Concentration of Risks</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of
            priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Share-Based Compensation </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the
            date of grant.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 2 &#8211; Summary of Significant Accounting Policies</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Cash and Cash Equivalents</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Cash and cash equivalents include short-term, highly liquid,
            investments with maturities of ninety days or less when purchased.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Concentration of Risks</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">credit risk from these financial instruments. The goals of the Company's investment
            policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Marketable Securities</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company determines the appropriate classification of its
            marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash
            equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity.
            Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of
            securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the
            impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and
            whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and
            this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Property and Equipment</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The cost of property and equipment is depreciated over the estimated
            useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The estimated useful
            lives of property and equipment are as follows:</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">10
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer equipment</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Software</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Life of lease</div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Long-lived Assets</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Long-lived assets consist of property and equipment. The assets are
            amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the
            asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result
            from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair
            value of the assets.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Share-Based Compensation </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be
            forfeited. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Loss Per Share</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Basic loss per share is based on the weighted effect of all common
            shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to
            common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding.
            Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Treasury Stock</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Treasury stock purchases are accounted for under the cost method
            whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Research and Development Costs </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Research and development (&#8220;R&amp;D&#8221;) expenses include salaries,
            benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the
            costs associated with research and development activities when incurred.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">To further drive the Company&#8217;s cell therapy initiatives, the Company
            will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#8217;s research and development programs. The Company accounts for such grants as a deduction to the
            related expense in research and development operating expenses when earned.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">New Accounting Pronouncements</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In October 2019, the FASB issued ASU 2019-12, which affects general
            principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and
            interim periods within those fiscal years, beginning after December&#160;15, 2020. The Company believes that the adoption of this new accounting guidance has not had a material impact on its financial statements and footnote disclosures. </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125049456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale-Securities (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Available-for-Sale-Securities</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 3 &#8211; Available-for-Sale-Securities</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$62,770</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;">$(162)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$62,608</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$53,135</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(65)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$53,070</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 10pt;">6,578</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 10pt;">6,578</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">17,267</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(34)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">17,233</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,263</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(5)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,258</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,615</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(196)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(70)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are
            generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash equivalents</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;">$10,647</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$21,129</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">70,323</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes our portfolio of available-for-sale
            securities by contractual maturity (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 19.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$86,615</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;">$86,419</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,615</span></div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 3 &#8211; Available-for-Sale-Securities</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or debt marketable securities in the Company's Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$53,135</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(65)</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$53,070</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 5pt;">8,406</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 5pt;">(<span style="text-indent: 0pt;">7</span>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$<span style="padding-left: 5pt;">8,399</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 10pt;">7,591</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 10pt;">7,591</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,263</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(5)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,258</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">14,753</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(6)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">14,747</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(70)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,750</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(13)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are generally
            based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale debt securities on the Company's Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$21,129</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$12,676</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">18,061</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the Company's portfolio of
            available-for-sale securities by contractual maturity (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$91,522</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$91,452</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$30,750</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$30,737</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,750</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125308896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (FY)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 4 &#8211; Property and Equipment</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Property and equipment consisted of the following (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 12.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 8.33pt;">26</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 8.33pt;">26</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer equipment</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">314</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">254</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">90</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">90</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, gross</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">430</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">370</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated depreciation</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(368)</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(313)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">62</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">57</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company&#8217;s results included depreciation expense of approximately
            $0.1 million and $0.1
            million for the years ended December&#160;31, 2021 and 2020, respectively.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761131305504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss Per Share</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 4 &#8211; Income (Loss) Per Share</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For the three months ended March&#160;31, 2022 and 2021, the Company
            incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At March&#160;31, 2022 and 2021, the Company excluded
            the following potentially dilutive securities (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 17.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2,640</span></div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">1,022</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrants</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">1,460</span></div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">798</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 5 &#8211; Loss Per Share</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For the years ended December&#160;31, 2021 and 2020, the Company incurred
            net losses and therefore no common stock equivalents were utilized in the calculation of loss per share as they are anti-dilutive in the periods presented. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At December&#160;31, 2021 and 2020, the Company excluded the
            following potentially dilutive securities (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 13.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2,132</span></div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 7.5pt;">964</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrants</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2,638</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">604</span></div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 7.5pt;">340</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125038912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 5 &#8211; Fair Value Measurements</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The fair value of financial assets and liabilities that are being
            measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price).
            The Company is required to classify fair value measurements in one of the following categories:</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 1 inputs are defined as quoted prices (unadjusted) in active
            markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 2 inputs are defined as inputs other than quoted prices
            included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 3 inputs are defined as unobservable inputs for the assets or
            liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
            requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth by level within the fair value
            hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands).</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 6 &#8211; Fair Value Measurements</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Fair value of financial assets and liabilities that are being
            measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price).
            The Company is required to classify fair value measurements in one of the following categories:</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 1 inputs are defined as quoted prices (unadjusted) in active
            markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 2 inputs are defined as inputs other than quoted prices
            included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 3 inputs are defined as unobservable inputs for the assets or
            liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
            requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's financial assets and liabilities that were accounted
            for at fair value on a recurring basis as of December&#160;31, 2021 and December&#160;31, 2020 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The carrying values of cash, cash equivalents, accounts payable and
            accrued expenses approximate fair value at December&#160;31, 2021 and December&#160;31, 2020, due to the short maturity nature of these items.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761131305376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 6 &#8211; Accrued Liabilities</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities as of March&#160;31, 2022 and December&#160;31, 2021 were
            as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salaries, employee benefits and related taxes</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;">$1,005</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">$2,034</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities &#8212; current</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="padding-left: 12.5pt;">205</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="padding-left: 12.5pt;">229</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">894</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">326</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,104</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,589</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 7 &#8211; Accrued Liabilities</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities were as follow (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 13.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salaries, employee benefits and related taxes</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2,034</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,716</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities - current</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">229</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">370</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">326</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">400</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,589</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,486</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125121472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 7 &#8211; Operating Leases</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company has operating leases for two offices with terms that expire in 2023 and 2025, respectively. The Company estimates its incremental borrowing rate at lease commencement to
            determine the present value of lease payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or
            reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases includes options for the Company to
            extend the lease term and/or sub-lease space in whole or in part.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of Use Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_ce1d736a988a4564aff92c00256cdd92"><span style="-sec-ix-hidden:Fact_2bb6a876105046b48a849d6ac8adfc37">Other assets</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$667</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$724</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Right-of-Use Asset</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$667</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$724</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_394d33db98754a5dbaa2063579daa0be"><span style="-sec-ix-hidden:Fact_01cbbf57a5d5461f83158b26769ed161">Accrued liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;">$205</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$229</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_646cbb0a67a54f629dc6c425eb143706"><span style="-sec-ix-hidden:Fact_52d14b2a09d54c84bb4a3b7e7f351e66">Other long-term liabilities</span></span> </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">421 </span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">485 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Operating Lease Liabilities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$626</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$714</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of March&#160;31, 2022, the weighted average remaining lease term
            for our operating leases was 2.3 years, and the weighted average discount rate for our operating leases was 9.625%. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of March&#160;31, 2022 were as follows (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years ended</div>
                </td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">181<br/>
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">217<br/>
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">190</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">143</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease payments</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">731</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Amounts representing interest</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(105) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">626</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 8 &#8211; Operating Leases</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company adopted ASU No. 2016-02, Leases (Topic 842) on January&#160;1,
            2019 and recognized leases with duration greater than 12 months on the balance sheet using the modified retrospective approach. The Company has operating leases for two offices with terms that expire in 2023 and 2025, respectively. The Company estimates its incremental borrowing rate at lease commencement to determine the present value of lease
            payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic
            842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases includes options for the Company to extend the lease term and/or sub-lease
            space in whole or in part.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of Use Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_6c255ea4f7c24c48b604a925c0f5819f"><span style="-sec-ix-hidden:Fact_02a6f0c3111348a5b2e0df82b435956e">Other assets</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$724</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$574</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Right-of-Use Asset</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$724</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$574</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_d2023c19465a459a9ecb0fec411ae9c3"><span style="-sec-ix-hidden:Fact_f6a138b4447e4c69840c11bceb8fe65d">Accrued liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$229</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$370</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_b65fe760104b4546b3abaa579a18c88c"><span style="-sec-ix-hidden:Fact_3980d08cb35e4c0087f62256aa859a67">Other long-term liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">485</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">254</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Operating Lease Liabilities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$714</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$624</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, the weighted average remaining lease term
            for our operating leases was 2.50 years, and the weighted average discount rate for our operating leases was 9.625%. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of December&#160;31, 2021 were as follows (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years ended</div>
                </td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 3.33pt;"><span style="text-indent: 0pt;">286</span></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">217 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">190 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">143</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease payments</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">836</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Amounts representing interest</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(122)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">714</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125231520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 8 &#8211; Stockholders' Equity</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Equity Issuances</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Purchase Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In March 2019, the Company and Lincoln Park Capital Fund, LLC
            (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company&#8217;s
            common stock having an aggregate value of up to $26.0 million, subject to certain limitations and conditions set forth in the
            Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional 181,510
            shares of common stock as commitment shares.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the Purchase Agreement, Lincoln Park purchased 250,000 shares of common stock, at a price of $4.00
            per share, for a total gross purchase price of $1.0 million (the &#8220;Initial Purchase&#8221;) upon commencement. Thereafter, as often as every
            business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase
            Agreement the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to 100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln Park&#8217;s obligation under any single such purchase will not exceed $2.5 million, unless the Company and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;).
            If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase
            Agreement, the Company may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of (i) 300% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) 30% of
            the total number of shares of the Company&#8217;s common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement. Under certain circumstances and in accordance with the Purchase Agreement, the
            Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company controls the timing and amount of any sales of its common
            stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the
            floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than 9.99% of its common stock.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Purchase Agreement does not limit the Company&#8217;s ability to raise
            capital from other sources at the Company&#8217;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating
            conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of March&#160;31, 2022, the Company had not made any sales of common
            stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase. The agreement expired on April&#160;1, 2022.</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">At The Market Offering Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June&#160;4, 2021, the Company entered into an At The Market Offering
            Agreement (the &#8220;ATM Agreement&#8221;) with HCW, as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $50.0 million. During the three months ended March&#160;31, 2022 and since inception the Company had not issued any shares under the ATM Agreement. Having received a listing deficiency notice from Nasdaq on February&#160;18, 2022 after the Company&#8217;s shares traded below $1.00
            for 30 consecutive trading days, the Company will not be permitted to sell additional shares under the ATM Agreement until it re-establishes timely compliance. Compliance may be reestablished by various mechanisms, including stock price
            appreciation at or above $1.00 for a requisite period of time and reverse stock split.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Stock Options and Warrants</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the three months ended March&#160;31, 2022:</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">2,131,849<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">5.64</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">7.97<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">21,356,600<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.84</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">4.37<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the period:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;">540,600 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;">0.91 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 30pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 17.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(9,565)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;">1.90 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(23,275)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">26.00 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,639,609</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">4.51</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.83<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at March&#160;31, 2022 or expected to vest in the future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,594,630<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">4.57</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.80<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,408,083</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">7.36</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">6.41<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Restricted Stock</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock for services as follows ($ in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,061,175 </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">300,450 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 25pt; border-bottom: 3pt double #000000; min-width: 45pt;">973</span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">478</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The vesting terms of restricted stock issuances are generally
            between <span style="-sec-ix-hidden:Fact_09a53c4a1103459dacf922bb1b50b09c">one</span> to four years.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock units for services as follows ($ in thousands, except share data):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock units issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,379,860 </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">458,245 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock units issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,265</span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">729</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock issued
            for services in the three months ended March&#160;31, 2022 and 2021 was $0.92 and $1.59 per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms
            of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 9 &#8211; Stockholders' Equity</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Equity Plans</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company has used long-term incentive plans for the purpose of
            granting equity awards to employees of the Company, including officers, and nonemployees, including consultants and nonemployee members of the Company's board of directors (collectively, the &#8220;Participants&#8221;). The Participants may receive awards
            as determined by a committee of independent members of the Company's board of directors or, to the extent authorized by such committee with respect to certain Participants, a duly authorized employee (collectively, the &#8220;Committee&#8221;). The
            incentive plan currently used by the Company is the 2018 Equity Incentive Compensation Plan (the &#8220;2018 Plan&#8221;), as adopted by the stockholders of the Company in June 2018, and subsequently increased by the stockholders of the Company in June
            2021 with 6,000,000 shares authorized for issuance thereunder and in June of 2020 with 2,500,000 shares authorized for issuance thereunder, plus any shares awarded under the 2015 Equity Compensation Plan (the &#8220;2015 Plan&#8221;) or the Amended and Restated 2009
            Equity Compensation Plan (the &#8220;2009 Plan&#8221;) that are not issued due to their subsequent forfeiture, cancellation, or other settlement thereof. Concurrent with the adoption of the 2018 Plan, no future awards will occur under the 2015&#160;Plan or the
            2009 Plan. The awards that may be made under the 2018 Plan include: (a) incentive stock options and nonqualified stock options, (b) shares of restricted stock, (c) restricted stock units, and (d) other kinds of equity-based compensation awards.
            All stock options under the 2015 Plan and 2009 Plan were granted and the 2018 Plan are granted at the fair market value of the common stock at the grant date. Stock options vest either on the date of grant, ratably over a period determined at
            time of grant, or upon the accomplishment of specified business milestones, and generally expire&#160;2, 3, or 10 years from the grant date
            depending on the status of the recipient as a nonemployee, employee or director of the Company. As of December&#160;31, 2021, there were 5,585,661
            shares available for future grants under the 2018 Plan. No additional awards may be made under the 2015 Plan or the 2009 Plan.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company adopted an employee stock purchase plan effective
            January&#160;1, 2013 and authorized 50,000 shares under the plan (the &#8220;2012 ESPP&#8221;). The plan has&#160;two six-month offering periods per year under which eligible
            employees may contribute up to 15% of their compensation toward the purchase of the Company's common stock per offering period (with
            a $25,000 cap per calendar year). The employee's purchase price is equal to (i) 85% of the closing price of a share of the Company's common stock on the enrollment date of such offering period or (ii) 85% of the closing price of a share of the Company's common stock on the Exercise Date of such Offering Period, whichever is lower. In May 2017, the Company's stockholders
            approved an amendment and restatement to the 2012 ESPP (the &#8220;2017 ESPP&#8221;) in order to effect an increase of authorized shares from 50,000
            to 100,000. In June 2018, the Company's stockholders approved an amendment to the 2017 ESPP (the &#8220;Amended 2017 ESPP&#8221;) in order to
            effect an increase of authorized shares from 100,000 to 500,000. During the year ended December&#160;31, 2021, 47,132 shares were
            issued under the Amended 2017 ESPP. At December&#160;31, 2021, the Company had 300,577 shares of the Company's common stock available for
            future grant in connection with this plan.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Equity Issuances</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Purchase Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In March 2019, the Company and Lincoln Park Capital Fund, LLC
            (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company&#8217;s
            common stock having an aggregate value of up to $26.0 million, subject to certain limitations and conditions set forth in the
            Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional 181,510
            shares of common stock as commitment shares.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the Purchase Agreement, upon commencement Lincoln Park
            purchased 250,000 shares of common stock, at a price of $4.00 per share for a total gross purchase price of $1,000,000 (the &#8220;Initial
            Purchase&#8221;) upon commencement. Thereafter, as often as every business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase Agreement, the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to
            100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln
            Park&#8217;s obligation under any single such purchase will not exceed $2,500,000, unless the Company and Lincoln Park mutually agree to
            increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;). If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such
            Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of
            (i) 300% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) 30% of the total number of shares of the Company&#8217;s common stock traded during a specified period on the applicable purchase date as set forth in the
            Purchase Agreement (each, an &#8220;Accelerated Purchase&#8221;). Under certain circumstances and in accordance with the Purchase Agreement, the Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company controls the timing and amount of any sales of its common
            stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the
            floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than 9.99% of its common stock.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Purchase Agreement does not limit the Company&#8217;s ability to raise
            capital from other sources at the Company&#8217;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating
            conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The
            Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, the Company had not made any sales of common
            stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase. In addition, the Company may not direct Lincoln Park to make Accelerated Purchases under the Purchase Agreement if the stock is below the specified floor price
            of $1.00.</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Common Stock Sales Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2018, the Company entered into a common stock sales
            agreement with H.C. Wainwright &amp; Co., LLC (&#8220;HCW&#8221;) as sales agent, which was subsequently amended in August 2018 (the &#8220;Sales Agreement&#8221;), in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and
            sell shares of its common stock, having an aggregate offering price of not more than $25.0 million.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company provided HCW with customary indemnification rights, and
            HCW was entitled to a commission at a fixed commission rate equal to 3.0% of the gross proceeds per share sold.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On February&#160;12, 2021, the Company suspended the use of the
            at-the-market transactions facility and terminated the continuous offering pursuant to the Sales Agreement.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of the termination of the Sales Agreement on February&#160;12, 2021,
            the Company had sold an aggregate 3,784,912 shares of its common stock pursuant to the Sales Agreement for net proceeds of $9.5 million since inception. For the year ended December&#160;31, 2021, the Company had not issued any shares under the Sales Agreement.</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">At The Market Offering Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June&#160;4, 2021, the Company entered into an At The Market Offering
            Agreement (the &#8220;ATM Agreement&#8221;) with HCW, as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $50.0 million. During the twelve months ended December&#160;31, 2021, the Company had not issued any shares under the ATM Agreement. Having received a listing deficiency notice from Nasdaq on February&#160;18, 2022 after the Company&#8217;s shares traded below $1.00 for 30
            consecutive trading days, the Company will not be permitted to sell additional shares under the ATM Agreement until it re-establishes timely compliance. Compliance may be reestablished by various mechanisms, including stock price appreciation
            at or above $1.00 for a requisite period of time and reverse stock split.</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Registered Direct Offerings</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2021, the Company entered into a Securities Purchase
            Agreement (the &#8220;Institutional Purchase Agreement&#8221;) with certain institutional investors (the &#8220;Institutional Purchasers&#8221;). Pursuant to the terms of the Institutional Purchase Agreement, the Company sold to the Institutional Purchasers in a
            registered direct offering an aggregate of 24,906,134 shares of its common stock and warrants to purchase an aggregate of 12,453,067 shares of its common stock at a combined purchase price equal to $2.45 per share and associated warrant. Each warrant features an exercise price equal to $2.90
            per share, is exercisable immediately upon issuance and will expire five years from the issuance date. Additionally, in a concurrent
            non-brokered registered direct offering, the Company entered into a Securities Purchase Agreement (the &#8220;Additional Purchase Agreement&#8221;) with certain accredited investors (the &#8220;Additional Purchasers&#8221;). Pursuant to the terms of the Additional
            Purchase Agreement, the Company sold to the Additional Purchasers an aggregate of 1,632,652 shares of its common stock and warrants
            to purchase an aggregate of 816,326 shares of its common stock at a combined purchase price equal to $2.45 per share and associated warrant. Each warrant features an exercise price equal to $2.90 per share, is exercisable immediately upon issuance and will expire five years
            from the issuance date. In connection with the registered direct offerings, the Company received gross proceeds of approximately $65.0
            million.</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Private Placement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January 2021, the Company entered into a securities purchase
            agreement (the &#8220;January Private Placement&#8221;) with certain investors (the &#8220;January Purchasers&#8221;). Pursuant to the terms of the January Private Placement, the Company agreed to sell to the January Purchasers an aggregate of 12,500,000 shares of its common stock at a purchase price equal to $2.00 per share, along with warrants to purchase an aggregate of 6,250,000
            shares of its common stock. In connection with the January Private Placement, the Company received gross proceeds of $25.0 million.
            Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.90 per share. The warrants are exercisable immediately upon issuance and will expire <span style="-sec-ix-hidden:Fact_b33f9ae5fcb543bd9c7f792ce5439476">five and one-half years</span> from the issuance date.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Warrant Exercises</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January 2021, the Company issued 801,148 shares of common stock for net proceeds of $1.8
            million in connection with warrant exercises associated with the April&#160;23, 2020 securities purchase agreement and the May&#160;25, 2020 securities purchase agreement.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Stock Options and Warrants</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the year ended December&#160;31, 2021:</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2020</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;">963,700</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$14.64</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">5.86</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt;">2,638,355</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.18</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">4.98</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the Year:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">1,314,790</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">1.32</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">19,519,393</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.90</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(7,250)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">3.28</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="padding-left: 6.67pt;">(3)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(801,148)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.19</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(29,842)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">2.18</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 4.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(109,549)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$34.12</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$</span><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">2,131,849</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">5.64</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">7.97</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at December&#160;31, 2021 or expected to vest in the
                    future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,120,643</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">5.66</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.96</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Exercisable at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,122,783</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">9.26</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">6.70</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Restricted Stock</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock for services as follows ($ in thousands, except share data):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">612,950</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">156,184</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">877.7</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">512.3</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock issued
            for services in the years ended December&#160;31, 2021 and 2020 was $1.43 and $3.28 per share, respectively. The fair value of the restricted stock was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms of restricted stock
            issuances are generally between <span style="-sec-ix-hidden:Fact_71e638d2f8944c3b8762be6c9f077488">one</span> to four years.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock units for services as follows ($ in thousands, except share data):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Units Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">458,245</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">325,853</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Units Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">728.6</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">863.0</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock units
            issued for services in the years ended December&#160;31, 2021 and 2020 was $1.59 and $2.65 per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms
            of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125143920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 9 &#8211; Share-Based Compensation</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Share-Based Compensation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We utilize share-based compensation in the form of stock options,
            restricted stock, and restricted stock units. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;">$218</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;">$<span style="padding-left: 5pt;">96</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">542 </span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">501 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total share-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$760</span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$597</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total compensation cost related to non-vested awards not yet
            recognized and the weighted-average periods over which the awards were expected to be recognized at March&#160;31, 2022 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unrecognized compensation cost</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;">$<span style="padding-left: 2.5pt;">814</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">444</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;">$1,004</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"><span style="padding-left: 5pt;">1.77 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">0.96 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><span style="padding-left: 10pt;">2.25 </span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the three months ended March&#160;31, 2022 and 2021 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total fair value of shares vested</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$<span style="padding-left: 2.5pt;">377</span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$<span style="padding-left: 2.5pt;">397</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average estimated fair value of shares granted</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$0.62</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$1.08</div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Valuation Assumptions</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The fair value of stock options and warrants at the date of grant was
            estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant
            and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 10 &#8211; Share-Based Compensation</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Share-based Compensation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company utilizes share-based compensation in the form of stock
            options, restricted stock, and restricted stock units. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the years ended December&#160;31, 2021 and 2020 ($ in thousands):</span></div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;">$<span style="padding-left: 7.5pt;">760</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;">$<span style="padding-left: 7.5pt;">179</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,245</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,086</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total share-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,005</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$1,265</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total compensation cost related to unvested awards not yet recognized
            and the weighted-average periods over which the awards are expected to be recognized at December&#160;31, 2021 were as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unrecognized compensation cost</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;">$<span style="padding-left: 2.5pt;">757</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">149</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">546</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"><span style="padding-left: 5pt;">1.64</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">1.57 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">1.70</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the years ended December&#160;31, 2021 and 2020 were as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total fair value of shares vested</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<span style="padding-left: 2.5pt;">757</span></div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<span style="padding-left: 2.13pt;">536</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average estimated fair value of shares granted</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">0.91</span></div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2.11</span></div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Valuation Assumptions</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The fair value of stock options at the date of grant was estimated
            using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and
            exercise of options for all employees.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The range of assumptions made in calculating the fair values of
            stock options was as follow:</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term - minimum (in years)</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term - maximum (in years)</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility - minimum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">79%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">75%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility - maximum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">84%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">79%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted Average volatility</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">81%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">75%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected dividend yield</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate - minimum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">0.63%</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">0.40%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate - maximum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">1.16%</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">1.71%</div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125092688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Funding (FY)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research Funding</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 11 &#8211; Research Funding</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">California Institute of Regenerative Medicine
            Grant Award</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2017, the California Institute for Regenerative Medicine
            (&#8220;CIRM&#8221;) awarded the Company funds of up to $12.2 million to support The Sanford Project: T-Rex Study, a prospective, randomized,
            placebo-controlled, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of CLBS03 as a treatment for recent-onset type 1 diabetes. The funding is based upon the achievement of certain milestones related to the proportion of
            subjects enrolled in California, as well as manufacturing and development costs incurred in California. Based on the actual number of subjects enrolled in California, the total amount of funding was revised to $8.6 million, of which $8.2 million
            has been received through the grant project period completion.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company received $5.7 million in initial funding in May 2017, a $1.9 million
            milestone payment in December 2017, a $0.3 million progress payment in March 2018, and a $0.2 million progress payment in May&#160;2019, of which the total was amortized over the estimated award period through July 2020 as a reduction to the related research and
            development expenses, with the final true up payment of $46 thousand received in September 2020 and recorded as a reduction to the
            related research and development expenses. During the year ended December&#160;31, 2021 and December&#160;31, 2020 the Company amortized and recognized $0.0







            million and $1.6 million in credits, respectively, to research and development related to CIRM funds received.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125039040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 10 &#8211; Income Taxes</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In assessing the realizability of deferred tax assets, including the
            net operating loss carryforwards (&#8220;NOLs&#8221;), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets. Based on its assessment,
            the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021 and 2020, the Company had approximately $281 million and $264 million,
            respectively of federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on
            January&#160;25, 2021. As a result, $169 million of the $281 million of federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $112 million of remaining federal NOL. The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact
            to the balance sheet or income statement. Losses incurred before the ownership change on January&#160;25, 2021 will be subject to an annual limitation of $173k under Internal Revenue Code Section 382, while losses incurred after January&#160;25, 2021
            will not be subject to limitations. The Company may be able to utilize additional NOLs of approximately $1.1 million per year for the
            first five years after this ownership change as a result of the application of the Net Unrealized Built-in Gain rules.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021 and 2020 the Company had State NOLs available
            in New Jersey of $97 million and $99
            million, respectively, California of $70 million and $70 million, respectively, and New York City of $13 million and $13 million, respectively, to offset future taxable income expiring from 2031 through 2041. In accordance with Section 382 of the Internal Revenue
            code, the usage of the Company&#8217;s NOLs would be limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences
            become deductible.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company applies the FASB&#8217;s provisions for uncertain tax
            positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest
            benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with uncertain tax positions as a component of income tax
            expense.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of March&#160;31, 2022, management does not believe the Company has any
            material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in future
            periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For years prior to 2018, the federal statute of limitations is closed
            for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from date of filing.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2021, the Company received preliminary approval from the
            New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) to participate in the Technology Business Tax Certificate Transfer Program (the &#8220;Program&#8221;). The Program permits qualified companies to sell a percentage of their New Jersey net operating
            losses (&#8220;NJ NOLs&#8221;) to unrelated profitable corporations. On February&#160;22, 2022, the Company received final approval from NJEDA to sell $2.5
            million of its NJ NOLs related tax benefits (&#8220;NJ NOL Tax Benefits&#8221;), which was subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.3 million. The gross proceeds of $2.5 million have been
            recorded as a benefit from income taxes and the loss on sale of NJ NOLs of $0.1 million recorded in other income (expense) in the
            consolidated financial statements.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 12 &#8211; Income Taxes</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) for income taxes is based on loss from
            operations before provision for income taxes and noncontrolling interests as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pre-tax book income</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">United States</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$(28,974)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$(19,013)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(28,974)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(19,013)</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) from income taxes was as follows ($ in
            thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 15.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>


</table>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) for income taxes is determined by applying
            the U.S. Federal statutory rate of 21% to income before income taxes, and the components are set forth below ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">U.S. Federal benefit at statutory rate</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;">$<span style="padding-left: 5pt;">(6,085)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;">$<span style="padding-left: 5pt;">(3,993)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Permanent non deductible expenses for U.S. taxes</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">320</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 30.83pt;">5</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Change in state deferred</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">622</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">5,122</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Return to actual</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">2,277</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other true ups</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">1,407</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">387</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Section 382 NOL Limitation</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 8.33pt;">35,438</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sale of New Jersey State NOLs</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 10pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 5pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Valuation allowance for deferred tax assets</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(33,979)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(1,521)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tax provision (benefit)</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Deferred income taxes at December&#160;31, 2021 and 2020 consist of the
            following ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 19.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred Tax Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated net operating losses (tax effected)</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 3.33pt;">36,281</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 3.33pt;">68,286</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right of use liability</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">201</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">176</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt;">3,086</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt;">5,025</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intangibles</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">97</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">131</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated depreciation</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">26</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">19</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued payroll</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">176</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">167</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">526</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">526</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax assets</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">40,393</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">74,330</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred Tax Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right of use asset</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(204)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(161)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax liabilities</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(204)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(161)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">40,189</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">74,169</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Valuation allowance</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(40,189)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(74,169)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net deferred tax asset</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In assessing the realizability of deferred tax assets, including the
            net operating loss carryforwards (NOLs), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets. Based on its assessment,
            the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, and 2020, the Company had approximately $281 million and $264 million,
            respectively, of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on
            January&#160;25, 2021. As a result, $169 million of the $281 million of Federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $112 million of remaining Federal NOL. The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact
            to the balance sheet or income statement. Losses incurred before the ownership change on January&#160;25, 2021 will be subject to an annual limitation of $173k under Internal Revenue Code Section 382, while losses incurred after January&#160;25, 2021
            will not be subject to limitations. The Company may be able to utilize additional NOLs of approximately $1.1 million per year for the
            first five years after this ownership change as a result of the application of the Net Unrealized Built-in Gain rules.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021 and 2020, the Company had State NOLs
            available in New Jersey of $97 million and $99 million, respectively, California of $70 million and $70 million, respectively, and New York City of $13
            million and $13 million, respectively, to offset future taxable income expiring from 2031 through 2041. In accordance with Section
            382 of the Internal Revenue code, the usage of the Company&#8217;s state NOLs would be limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period
            when those temporary differences become deductible.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company applies the FASB&#8217;s provisions for uncertain tax
            positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest
            benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant taxing authority. The Company recognizes interest and penalties associated with certain tax positions as a component of income tax
            expense.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, management does not believe the Company has
            any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in
            future periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For years prior to 2018 the federal statute of limitations is closed
            for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from date of filing.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2021, the Company received preliminary approval from the
            New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) to participate in the Technology Business Tax Certificate Transfer Program (the &#8220;Program&#8221;). The Program permits qualified companies to sell a percentage of their New Jersey net operating
            losses (&#8220;NJ NOLs&#8221;) to unrelated profitable corporations. On April&#160;12, 2021, the Company received final approval from NJEDA to sell a portion of our NJ NOLs, which were subsequently sold to a qualifying and approved buyer pursuant to the Program
            for net proceeds of $1.4 million. The $1.5
            million of our NJ NOL related tax benefits (&#8220;NJ NOL Tax Benefits&#8221;) have been recorded as a benefit from income taxes and the loss on sale of $0.1
            million recorded in other income (expense) in the consolidated financial statements.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124295472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (FY)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 11 &#8211; Contingencies</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Contingencies</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, the Company is subject to legal proceedings and
            claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a
            material adverse effect on the Company's financial condition or operating results.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 13 &#8211; Contingencies</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, the Company is subject to legal proceedings and
            claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a
            material adverse effect on the Company's financial condition or operating results.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129183360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Business (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_BusinessTextBlock', window );">The Business</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 1 &#8211; The Business</span></div>

<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Overview</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Caladrius&#8221; or the
            &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The Company is developing what are intended to be first-in-class therapeutics based on the characteristics of
            naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its technology is intended to leverage these cells to enable the body's natural repair mechanisms using formulations unique to each medical
            indication.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's leadership team has decades of collective
            biopharmaceutical product development experience in a variety of therapeutic categories. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The
            Company&#8217;s current product candidates include:</div>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA<sup>&#174;</sup> (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow on Phase
                    2b study (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA<sup>&#174;</sup> (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the
                    treatment of critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan. HONEDRA&#174; was the recipient of orphan drug designation in March 2021 from the U.S. Food
                    and Drug Administration (&#8220;FDA&#8221;) for Buerger's disease; and</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, the subject of a study designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients
                    with chronic kidney disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">On April&#160;26, 2022, the Company and Cend Therapeutics, Inc., a Delaware corporation (&#8220;Cend&#8221;), entered into an Agreement and Plan
                    of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, a wholly-owned subsidiary of Caladrius will
                    merge with and into Cend, with Cend surviving as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;), subject to the terms of the Merger Agreement and stockholder approval of the transaction. Under the exchange ratio formula, as of
                    immediately after the Merger, the former Cend stockholders are expected to own approximately 50% of the outstanding shares
                    of Caladrius Common Stock and the Company&#8217;s stockholders as of immediately prior to the Merger are expected to own approximately 50%
                    of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on our net cash balance at the time of closing and the amount of any transaction expenses of Cend in excess of $250 thousand at the time of closing. See Note 12 below for more information regarding the Merger and related transactions.</div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Ischemic Repair (CD34 Cell Technology)</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The CD34+ cell was discovered as a result of the deliberate search
            for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building
            new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same
            capability.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's proprietary cell technology using autologous (a
            patient&#8217;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is
            restricted or reduced. Through the administration of CD34+ cells, Caladrius seeks to promote the development and formation </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">of new microvasculature and thereby increase blood flow to the impacted area. The
            Company believes that a number of conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology including but not limited to Buerger's disease, CLI, CMD, and DKD.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">XOWNA<sup>&#174;</sup> for Treatment of Coronary
            Microvascular Dysfunction</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In 2017, with the assistance of a $1.9 million grant from the National Institutes of Health (Award Number&#160;R44HL135889), the Company initiated its program for XOWNA<sup>&#174;</sup> for the
            treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled
            patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian
            Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr.
            Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, the Company commenced enrollment in its Phase 2b FREEDOM Trial of XOWNA<sup>&#174;</sup>, a double-blind, randomized and placebo-controlled clinical trial designed to
            further evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in
            January 2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment, including supply chain disruptions affecting the availability of qualified catheters used in the diagnosis of CMD and/or administration of XOWNA<sup>&#174;</sup>.
            Protocol amendments to the initial FREEDOM Trial protocol, as agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of subject enrollment.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">HONEDRA<sup>&#174;</sup> for Treatment of Critical
            Limb Ischemia</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's randomized, open-label, registration-eligible study of
            HONEDRA<sup>&#174;</sup> in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA<sup>&#174;</sup> study's enrollment, however, has been significantly curtailed by the
            COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of 2020 and 2021. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19 delays,
            coupled with the unpredictability of the timing of site enrollment re-initiation, Caladrius suspended further enrollment and is focusing its efforts on consummating a partnership for the product in Japan. Such a partnership may become the basis
            for the completion of development and registration of HONEDRA<sup>&#174;</sup> in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or exploration
            of the possibility of submitting the existing data to Japan's Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) under Japan's regenerative medicine regulations, which allow for conditional approval of innovative regenerative medicine
            products. Despite receipt from FDA in March 2021 of orphan designation in the U.S. for CLBS12 as a potential treatment for Buerger's disease, based on a response from the FDA in October 2021 regarding a development plan for U.S. registration
            the Company decided not to pursue United States development in Buerger's disease at this time.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">CLBS201 for Treatment of Diabetic Kidney Disease</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Progressive kidney failure is associated with attrition of the
            microcirculation of the kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, the Company
            has elected to move forward with a Phase 1b, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol is expected to include six subjects in total with the first two
            subjects sequentially dosed and followed for a two-week safety observation period. Clearance by the independent Data Safety Monitoring Board (&#8220;DSMB&#8221;) overseeing the study will then permit the treatment of the next four patients, with all
            patients being followed for safety and therapeutic effect. A read-out of data will occur after at the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201 will be its ability to demonstrate a
            therapeutic effect that will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate. As announced recently, the Company has treated the first patient in the
            CLBS201 proof-of-concept study and targets treatment completion for all six subjects during the third quarter of 2022.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Additional Out-licensing Opportunities and
            Pipeline Diversification</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's broad intellectual property portfolio of cell therapy
            assets includes notable programs available for out-licensing in order to continue their clinical development. The Company's current long-term strategy focuses on advancing its therapies through development with the ultimate objective of
            obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to
            realize potentially meaningful value increases within its own proprietary pipeline if it is successful in advancing its product candidates to their next significant development milestones.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the Company further desires to diversify its pipeline of
            development products candidates and is exploring a range of strategic transactions in furtherance of that goal. The Company has taken, and intends to continue to take, active steps to identify assets and/or companies for acquisition and/or
            partnership that would enhance and de-risk its current development portfolio. Such assets could target indications beyond cardiovascular disease as well as product categories outside of cell therapy. The range of possible transactions includes
            an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute the shares of its existing stockholders. There can be no assurance
            that this exploration of strategic alternatives will result in Caladrius entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Coronavirus Considerations</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which
            causes COVID-19, was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects. Despite the FDA approval
            of multiple COVID-19 vaccines in late 2020, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, the
            Company implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. The Company's clinical study of HONEDRA<sup>&#174;</sup> in Japan has experienced
            significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 2021 covering Tokyo and other regions in response to an increased number of COVID-19 infections. With the Company's expectation that COVID-19 in
            Japan would continue to impact negatively clinical site operations and enrollment of patients in the HONEDRA<sup>&#174;</sup> clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory
            authorities regarding the submission of patient data already accrued. Caladrius' phase 2b trial of XOWNA<sup>&#174;</sup> in the U.S. has also experienced delays in enrolling patients as a result of COVID-19.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying unaudited Consolidated Financial Statements have
            been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim
            financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated
            Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of March&#160;31, 2022, and the results of its
            operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2021
            and 2020 included in our 2021 Form 10-K. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">assumptions believed to be reasonable under the circumstances, the results of which
            form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly,
            actual results could differ from those estimates and assumptions.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 1 &#8211; The Business</span></div>

<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">OVERVIEW</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Caladrius Biosciences, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Caladrius&#8221; or the
            &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The Company is developing what are intended to be first-in-class therapeutics based on the characteristics of
            naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its technology is intended to leverage these cells to enable the body's natural repair mechanisms using formulations unique to each medical
            indication.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's leadership team has decades of collective
            biopharmaceutical development experience. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The Company's current product candidates include:</div>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">XOWNA<sup>&#174;</sup> (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow-on Phase
                    2b study (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#8220;CMD&#8221;);</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">HONEDRA<sup>&#174;</sup> (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the
                    treatment of critical limb ischemia (&#8220;CLI&#8221;) and Buerger&#8217;s disease is being sought based on the current results of a clinical trial executed in Japan. HONEDRA&#174; was the recipient of orphan drug designation in March 2021 from the U.S. Food
                    and Drug Administration (&#8220;FDA&#8221;) for Buerger's disease; and</div>
                </td>

  </tr>


</table>

<table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;">


  <tr>

    <td style="width: 20pt; text-align: left; vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div>
                </td>

    <td style="vertical-align: top;">
                  <div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CLBS201, designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients with chronic kidney
                    disease related to type 2 diabetes (diabetic kidney disease or &#8220;DKD&#8221;).</div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Ischemic Repair (CD34 Cell Technology)</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The CD34+ cell was discovered as a result of the deliberate search
            for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building
            new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same
            capability.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's proprietary cell technology using autologous (a
            patient&#8217;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is
            restricted or reduced. Through the administration of CD34+ cells, Caladrius seeks to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. The Company believes that a number of
            conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology including, but not limited to, Buerger's disease, CLI, CMD, and DKD.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">XOWNA<sup>&#174;</sup> for Treatment of Coronary
            Microvascular Dysfunction</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In 2017, with the assistance of a $1.9 million grant from the National Institutes of Health (Award Number&#160;R44HL135889), the Company initiated its program for XOWNA<sup>&#174;</sup> for the
            treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled
            patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian
            Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr.
            Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, the Company commenced enrollment in its Phase 2b FREEDOM Trial of XOWNA&#174;, a </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">double-blind, randomized and placebo-controlled clinical trial designed to further
            evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in January
            2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment. Protocol amendments to the initial FREEDOM Trial protocol, as agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of
            subject enrollment.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">HONEDRA<sup>&#174;</sup> for Treatment of Critical
            Limb Ischemia</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's randomized, open-label, registration-eligible study of
            HONEDRA<sup>&#174;</sup> in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA<sup>&#174;</sup> study's enrollment, however, has been significantly curtailed by the
            COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of the past 18 months. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19
            delays, coupled with the unpredictability of the timing of site enrollment re-initiation, Caladrius suspended further enrollment and is focusing its efforts on consummating a partnership for the product in Japan. Such a partnership may become
            the basis for the completion of development and registration of HONEDRA<sup>&#174;</sup> in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or
            exploration of the possibility of submitting the existing data to Japan's Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) under Japan's regenerative medicine regulations, which allow for conditional approval of innovative regenerative
            medicine products. Despite receipt from FDA in March 2021 of orphan designation in the U.S. for CLBS12 as a potential treatment for Buerger's disease, based on a response from the FDA in October 2021 regarding a development plan for U.S.
            registration the Company decided not to pursue United States development in Buerger's disease at this time.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">CLBS201 for Treatment of Diabetic Kidney Disease</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Progressive kidney failure is associated with attrition of the
            microcirculation of the kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, the Company
            has elected to move forward with a Phase 1, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol, as approved by an Institutional Review Board (the &#8220;IRB&#8221;), is expected
            to include six subjects in total with the first two subjects sequentially dosed and followed for a two-week safety observation period. Clearance by the independent Data Safety Monitoring Board (&#8220;DSMB&#8221;) overseeing the study will then permit the
            treatment of the next four patients, with all patients being followed for safety and therapeutic effect. A read-out of data will occur after at the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201
            will be its ability to demonstrate a therapeutic effect that will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Additional Out-licensing Opportunities and
            Pipeline Diversification</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's broad intellectual property portfolio of cell therapy
            assets includes notable programs available for out-licensing in order to continue their clinical development. The Company's current long-term strategy focuses on advancing its therapies through development with the ultimate objective of
            obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to
            realize potentially meaningful value increases within its own proprietary pipeline if it is successful in advancing its product candidates to their next significant development milestones.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition, the Company further desires to diversify its pipeline of
            development products candidates and is exploring a range of strategic transactions in furtherance of that goal. The Company has taken, and intends to continue to take, active steps to identify assets and/or companies for acquisition and/or
            partnership that would complement its current development programs and de-risk its overall development portfolio. Such assets potentially could target indications beyond cardiovascular disease as well as product categories outside of cell
            therapy. The range of possible transactions includes an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">the shares of its existing stockholders. There can be no assurance that this
            exploration of strategic alternatives will result in Caladrius entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Coronavirus Considerations</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2019, a novel strain of coronavirus (SARS-CoV-2), which
            causes COVID-19, was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects. Despite the FDA approval
            of multiple COVID-19 vaccines in late 2020, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, the
            Company implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. The Company's clinical study of HONEDRA<sup>&#174;</sup> in Japan has experienced
            significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 and re-implemented from January&#160;7, 2021 through March&#160;21, 2021 covering Tokyo and other regions in response to an increased number of COVID-19
            infections. Due to reported increases in COVID-19 cases and a low rate of vaccination in Japan, States of Emergency were renewed on April&#160;25, 2021 through May&#160;11, 2021 and then re-implemented in Tokyo from July&#160;12, 2021 through September&#160;30,
            2021. With the Company's expectation that</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">COVID-19 in Japan would continue to impact negatively enrollment of
            patients in the HONEDRA<sup>&#174;</sup> clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory authorities regarding the submission of patient data already accrued. Caladrius'
            phase 2b trial of XOWNA<sup>&#174;</sup> in the U.S. has also experienced delays in enrolling patients as a result of COVID-19.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying consolidated financial statements have been prepared
            in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments
            about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimate and assumptions in determining stock-based awards values. Accordingly, actual results could differ from
            those estimates and assumptions.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_BusinessTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Business [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_BusinessTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124300208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 2 &#8211; Summary of Significant Accounting Policies</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In addition to the policies below, the Company's significant
            accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included in its 2021 Form 10-K. There were no changes to these policies during the three months ended March&#160;31, 2022.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Concentration of Risks</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of
            priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Share-Based Compensation </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the
            date of grant.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 2 &#8211; Summary of Significant Accounting Policies</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Cash and Cash Equivalents</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Cash and cash equivalents include short-term, highly liquid,
            investments with maturities of ninety days or less when purchased.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Concentration of Risks</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">credit risk from these financial instruments. The goals of the Company's investment
            policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Marketable Securities</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company determines the appropriate classification of its
            marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash
            equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity.
            Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of
            securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the
            impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and
            whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and
            this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Property and Equipment</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The cost of property and equipment is depreciated over the estimated
            useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The estimated useful
            lives of property and equipment are as follows:</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">10
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer equipment</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Software</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Life of lease</div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Long-lived Assets</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Long-lived assets consist of property and equipment. The assets are
            amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the
            asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result
            from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair
            value of the assets.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Share-Based Compensation </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be
            forfeited. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Loss Per Share</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Basic loss per share is based on the weighted effect of all common
            shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to
            common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding.
            Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Treasury Stock</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Treasury stock purchases are accounted for under the cost method
            whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Research and Development Costs </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Research and development (&#8220;R&amp;D&#8221;) expenses include salaries,
            benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the
            costs associated with research and development activities when incurred.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">To further drive the Company&#8217;s cell therapy initiatives, the Company
            will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#8217;s research and development programs. The Company accounts for such grants as a deduction to the
            related expense in research and development operating expenses when earned.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">New Accounting Pronouncements</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In October 2019, the FASB issued ASU 2019-12, which affects general
            principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and
            interim periods within those fiscal years, beginning after December&#160;15, 2020. The Company believes that the adoption of this new accounting guidance has not had a material impact on its financial statements and footnote disclosures. </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124310272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale-Securities (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Available-for-Sale-Securities</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 3 &#8211; Available-for-Sale-Securities</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$62,770</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;">$(162)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$62,608</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$53,135</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(65)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$53,070</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 10pt;">6,578</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 10pt;">6,578</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">17,267</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(34)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">17,233</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,263</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(5)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,258</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,615</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(196)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(70)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are
            generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash equivalents</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;">$10,647</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$21,129</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">70,323</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes our portfolio of available-for-sale
            securities by contractual maturity (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 19.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$86,615</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;">$86,419</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,615</span></div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 3 &#8211; Available-for-Sale-Securities</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or debt marketable securities in the Company's Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$53,135</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(65)</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$53,070</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 5pt;">8,406</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 5pt;">(<span style="text-indent: 0pt;">7</span>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$<span style="padding-left: 5pt;">8,399</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 10pt;">7,591</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 10pt;">7,591</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,263</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(5)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,258</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">14,753</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(6)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">14,747</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(70)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,750</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(13)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are generally
            based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale debt securities on the Company's Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$21,129</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$12,676</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">18,061</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the Company's portfolio of
            available-for-sale securities by contractual maturity (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$91,522</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$91,452</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$30,750</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$30,737</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,750</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126512704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Income (Loss) Per Share</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 4 &#8211; Income (Loss) Per Share</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For the three months ended March&#160;31, 2022 and 2021, the Company
            incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At March&#160;31, 2022 and 2021, the Company excluded
            the following potentially dilutive securities (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 17.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2,640</span></div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">1,022</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrants</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">1,460</span></div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">798</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 5 &#8211; Loss Per Share</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For the years ended December&#160;31, 2021 and 2020, the Company incurred
            net losses and therefore no common stock equivalents were utilized in the calculation of loss per share as they are anti-dilutive in the periods presented. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At December&#160;31, 2021 and 2020, the Company excluded the
            following potentially dilutive securities (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 13.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2,132</span></div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 7.5pt;">964</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrants</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2,638</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">604</span></div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 7.5pt;">340</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124310400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 5 &#8211; Fair Value Measurements</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The fair value of financial assets and liabilities that are being
            measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price).
            The Company is required to classify fair value measurements in one of the following categories:</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 1 inputs are defined as quoted prices (unadjusted) in active
            markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 2 inputs are defined as inputs other than quoted prices
            included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 3 inputs are defined as unobservable inputs for the assets or
            liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
            requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth by level within the fair value
            hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands).</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 6 &#8211; Fair Value Measurements</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Fair value of financial assets and liabilities that are being
            measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price).
            The Company is required to classify fair value measurements in one of the following categories:</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 1 inputs are defined as quoted prices (unadjusted) in active
            markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 2 inputs are defined as inputs other than quoted prices
            included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 3 inputs are defined as unobservable inputs for the assets or
            liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement
            requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's financial assets and liabilities that were accounted
            for at fair value on a recurring basis as of December&#160;31, 2021 and December&#160;31, 2020 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The carrying values of cash, cash equivalents, accounts payable and
            accrued expenses approximate fair value at December&#160;31, 2021 and December&#160;31, 2020, due to the short maturity nature of these items.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126511856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 6 &#8211; Accrued Liabilities</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities as of March&#160;31, 2022 and December&#160;31, 2021 were
            as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salaries, employee benefits and related taxes</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;">$1,005</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">$2,034</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities &#8212; current</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="padding-left: 12.5pt;">205</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="padding-left: 12.5pt;">229</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">894</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">326</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,104</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,589</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 7 &#8211; Accrued Liabilities</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities were as follow (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 13.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salaries, employee benefits and related taxes</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2,034</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,716</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities - current</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">229</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">370</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">326</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">400</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,589</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,486</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126567680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Operating Leases</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 7 &#8211; Operating Leases</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company has operating leases for two offices with terms that expire in 2023 and 2025, respectively. The Company estimates its incremental borrowing rate at lease commencement to
            determine the present value of lease payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or
            reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases includes options for the Company to
            extend the lease term and/or sub-lease space in whole or in part.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of Use Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_ce1d736a988a4564aff92c00256cdd92"><span style="-sec-ix-hidden:Fact_2bb6a876105046b48a849d6ac8adfc37">Other assets</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$667</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$724</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Right-of-Use Asset</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$667</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$724</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_394d33db98754a5dbaa2063579daa0be"><span style="-sec-ix-hidden:Fact_01cbbf57a5d5461f83158b26769ed161">Accrued liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;">$205</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$229</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_646cbb0a67a54f629dc6c425eb143706"><span style="-sec-ix-hidden:Fact_52d14b2a09d54c84bb4a3b7e7f351e66">Other long-term liabilities</span></span> </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">421 </span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">485 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Operating Lease Liabilities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$626</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$714</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of March&#160;31, 2022, the weighted average remaining lease term
            for our operating leases was 2.3 years, and the weighted average discount rate for our operating leases was 9.625%. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of March&#160;31, 2022 were as follows (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years ended</div>
                </td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">181<br/>
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">217<br/>
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">190</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">143</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease payments</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">731</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Amounts representing interest</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(105) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">626</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 8 &#8211; Operating Leases</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company adopted ASU No. 2016-02, Leases (Topic 842) on January&#160;1,
            2019 and recognized leases with duration greater than 12 months on the balance sheet using the modified retrospective approach. The Company has operating leases for two offices with terms that expire in 2023 and 2025, respectively. The Company estimates its incremental borrowing rate at lease commencement to determine the present value of lease
            payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic
            842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases includes options for the Company to extend the lease term and/or sub-lease
            space in whole or in part.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of Use Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_6c255ea4f7c24c48b604a925c0f5819f"><span style="-sec-ix-hidden:Fact_02a6f0c3111348a5b2e0df82b435956e">Other assets</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$724</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$574</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Right-of-Use Asset</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$724</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$574</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_d2023c19465a459a9ecb0fec411ae9c3"><span style="-sec-ix-hidden:Fact_f6a138b4447e4c69840c11bceb8fe65d">Accrued liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$229</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$370</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_b65fe760104b4546b3abaa579a18c88c"><span style="-sec-ix-hidden:Fact_3980d08cb35e4c0087f62256aa859a67">Other long-term liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">485</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">254</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Operating Lease Liabilities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$714</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$624</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, the weighted average remaining lease term
            for our operating leases was 2.50 years, and the weighted average discount rate for our operating leases was 9.625%. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of December&#160;31, 2021 were as follows (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years ended</div>
                </td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 3.33pt;"><span style="text-indent: 0pt;">286</span></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">217 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">190 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">143</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease payments</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">836</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Amounts representing interest</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(122)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">714</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125238592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 8 &#8211; Stockholders' Equity</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Equity Issuances</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Purchase Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In March 2019, the Company and Lincoln Park Capital Fund, LLC
            (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company&#8217;s
            common stock having an aggregate value of up to $26.0 million, subject to certain limitations and conditions set forth in the
            Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional 181,510
            shares of common stock as commitment shares.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the Purchase Agreement, Lincoln Park purchased 250,000 shares of common stock, at a price of $4.00
            per share, for a total gross purchase price of $1.0 million (the &#8220;Initial Purchase&#8221;) upon commencement. Thereafter, as often as every
            business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase
            Agreement the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to 100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln Park&#8217;s obligation under any single such purchase will not exceed $2.5 million, unless the Company and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;).
            If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase
            Agreement, the Company may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of (i) 300% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) 30% of
            the total number of shares of the Company&#8217;s common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement. Under certain circumstances and in accordance with the Purchase Agreement, the
            Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company controls the timing and amount of any sales of its common
            stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the
            floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than 9.99% of its common stock.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Purchase Agreement does not limit the Company&#8217;s ability to raise
            capital from other sources at the Company&#8217;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating
            conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of March&#160;31, 2022, the Company had not made any sales of common
            stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase. The agreement expired on April&#160;1, 2022.</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">At The Market Offering Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June&#160;4, 2021, the Company entered into an At The Market Offering
            Agreement (the &#8220;ATM Agreement&#8221;) with HCW, as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $50.0 million. During the three months ended March&#160;31, 2022 and since inception the Company had not issued any shares under the ATM Agreement. Having received a listing deficiency notice from Nasdaq on February&#160;18, 2022 after the Company&#8217;s shares traded below $1.00
            for 30 consecutive trading days, the Company will not be permitted to sell additional shares under the ATM Agreement until it re-establishes timely compliance. Compliance may be reestablished by various mechanisms, including stock price
            appreciation at or above $1.00 for a requisite period of time and reverse stock split.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Stock Options and Warrants</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the three months ended March&#160;31, 2022:</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">2,131,849<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">5.64</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">7.97<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">21,356,600<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.84</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">4.37<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the period:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;">540,600 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;">0.91 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 30pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 17.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(9,565)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;">1.90 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(23,275)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">26.00 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,639,609</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">4.51</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.83<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at March&#160;31, 2022 or expected to vest in the future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,594,630<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">4.57</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.80<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,408,083</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">7.36</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">6.41<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Restricted Stock</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock for services as follows ($ in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,061,175 </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">300,450 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 25pt; border-bottom: 3pt double #000000; min-width: 45pt;">973</span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">478</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The vesting terms of restricted stock issuances are generally
            between <span style="-sec-ix-hidden:Fact_09a53c4a1103459dacf922bb1b50b09c">one</span> to four years.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock units for services as follows ($ in thousands, except share data):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock units issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,379,860 </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">458,245 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock units issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,265</span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">729</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock issued
            for services in the three months ended March&#160;31, 2022 and 2021 was $0.92 and $1.59 per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms
            of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 9 &#8211; Stockholders' Equity</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Equity Plans</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company has used long-term incentive plans for the purpose of
            granting equity awards to employees of the Company, including officers, and nonemployees, including consultants and nonemployee members of the Company's board of directors (collectively, the &#8220;Participants&#8221;). The Participants may receive awards
            as determined by a committee of independent members of the Company's board of directors or, to the extent authorized by such committee with respect to certain Participants, a duly authorized employee (collectively, the &#8220;Committee&#8221;). The
            incentive plan currently used by the Company is the 2018 Equity Incentive Compensation Plan (the &#8220;2018 Plan&#8221;), as adopted by the stockholders of the Company in June 2018, and subsequently increased by the stockholders of the Company in June
            2021 with 6,000,000 shares authorized for issuance thereunder and in June of 2020 with 2,500,000 shares authorized for issuance thereunder, plus any shares awarded under the 2015 Equity Compensation Plan (the &#8220;2015 Plan&#8221;) or the Amended and Restated 2009
            Equity Compensation Plan (the &#8220;2009 Plan&#8221;) that are not issued due to their subsequent forfeiture, cancellation, or other settlement thereof. Concurrent with the adoption of the 2018 Plan, no future awards will occur under the 2015&#160;Plan or the
            2009 Plan. The awards that may be made under the 2018 Plan include: (a) incentive stock options and nonqualified stock options, (b) shares of restricted stock, (c) restricted stock units, and (d) other kinds of equity-based compensation awards.
            All stock options under the 2015 Plan and 2009 Plan were granted and the 2018 Plan are granted at the fair market value of the common stock at the grant date. Stock options vest either on the date of grant, ratably over a period determined at
            time of grant, or upon the accomplishment of specified business milestones, and generally expire&#160;2, 3, or 10 years from the grant date
            depending on the status of the recipient as a nonemployee, employee or director of the Company. As of December&#160;31, 2021, there were 5,585,661
            shares available for future grants under the 2018 Plan. No additional awards may be made under the 2015 Plan or the 2009 Plan.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company adopted an employee stock purchase plan effective
            January&#160;1, 2013 and authorized 50,000 shares under the plan (the &#8220;2012 ESPP&#8221;). The plan has&#160;two six-month offering periods per year under which eligible
            employees may contribute up to 15% of their compensation toward the purchase of the Company's common stock per offering period (with
            a $25,000 cap per calendar year). The employee's purchase price is equal to (i) 85% of the closing price of a share of the Company's common stock on the enrollment date of such offering period or (ii) 85% of the closing price of a share of the Company's common stock on the Exercise Date of such Offering Period, whichever is lower. In May 2017, the Company's stockholders
            approved an amendment and restatement to the 2012 ESPP (the &#8220;2017 ESPP&#8221;) in order to effect an increase of authorized shares from 50,000
            to 100,000. In June 2018, the Company's stockholders approved an amendment to the 2017 ESPP (the &#8220;Amended 2017 ESPP&#8221;) in order to
            effect an increase of authorized shares from 100,000 to 500,000. During the year ended December&#160;31, 2021, 47,132 shares were
            issued under the Amended 2017 ESPP. At December&#160;31, 2021, the Company had 300,577 shares of the Company's common stock available for
            future grant in connection with this plan.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Equity Issuances</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Purchase Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In March 2019, the Company and Lincoln Park Capital Fund, LLC
            (&#8220;Lincoln Park&#8221;) entered into a purchase agreement (the &#8220;Purchase Agreement&#8221;) and a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company&#8217;s
            common stock having an aggregate value of up to $26.0 million, subject to certain limitations and conditions set forth in the
            Purchase Agreement (the &#8220;Offering&#8221;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional 181,510
            shares of common stock as commitment shares.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Pursuant to the Purchase Agreement, upon commencement Lincoln Park
            purchased 250,000 shares of common stock, at a price of $4.00 per share for a total gross purchase price of $1,000,000 (the &#8220;Initial
            Purchase&#8221;) upon commencement. Thereafter, as often as every business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase Agreement, the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to
            100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln
            Park&#8217;s obligation under any single such purchase will not exceed $2,500,000, unless the Company and Lincoln Park mutually agree to
            increase the maximum amount of such single purchase (each, a &#8220;Regular Purchase&#8221;). If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such
            Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln Park in an &#8220;accelerated purchase&#8221; to purchase an additional amount of common stock that may not exceed the lesser of
            (i) 300% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) 30% of the total number of shares of the Company&#8217;s common stock traded during a specified period on the applicable purchase date as set forth in the
            Purchase Agreement (each, an &#8220;Accelerated Purchase&#8221;). Under certain circumstances and in accordance with the Purchase Agreement, the Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company controls the timing and amount of any sales of its common
            stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the
            floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than 9.99% of its common stock.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Purchase Agreement does not limit the Company&#8217;s ability to raise
            capital from other sources at the Company&#8217;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating
            conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The
            Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, the Company had not made any sales of common
            stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase. In addition, the Company may not direct Lincoln Park to make Accelerated Purchases under the Purchase Agreement if the stock is below the specified floor price
            of $1.00.</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Common Stock Sales Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2018, the Company entered into a common stock sales
            agreement with H.C. Wainwright &amp; Co., LLC (&#8220;HCW&#8221;) as sales agent, which was subsequently amended in August 2018 (the &#8220;Sales Agreement&#8221;), in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and
            sell shares of its common stock, having an aggregate offering price of not more than $25.0 million.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company provided HCW with customary indemnification rights, and
            HCW was entitled to a commission at a fixed commission rate equal to 3.0% of the gross proceeds per share sold.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On February&#160;12, 2021, the Company suspended the use of the
            at-the-market transactions facility and terminated the continuous offering pursuant to the Sales Agreement.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of the termination of the Sales Agreement on February&#160;12, 2021,
            the Company had sold an aggregate 3,784,912 shares of its common stock pursuant to the Sales Agreement for net proceeds of $9.5 million since inception. For the year ended December&#160;31, 2021, the Company had not issued any shares under the Sales Agreement.</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">At The Market Offering Agreement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On June&#160;4, 2021, the Company entered into an At The Market Offering
            Agreement (the &#8220;ATM Agreement&#8221;) with HCW, as sales agent, in connection with an &#8220;at the market offering&#8221; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $50.0 million. During the twelve months ended December&#160;31, 2021, the Company had not issued any shares under the ATM Agreement. Having received a listing deficiency notice from Nasdaq on February&#160;18, 2022 after the Company&#8217;s shares traded below $1.00 for 30
            consecutive trading days, the Company will not be permitted to sell additional shares under the ATM Agreement until it re-establishes timely compliance. Compliance may be reestablished by various mechanisms, including stock price appreciation
            at or above $1.00 for a requisite period of time and reverse stock split.</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Registered Direct Offerings</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2021, the Company entered into a Securities Purchase
            Agreement (the &#8220;Institutional Purchase Agreement&#8221;) with certain institutional investors (the &#8220;Institutional Purchasers&#8221;). Pursuant to the terms of the Institutional Purchase Agreement, the Company sold to the Institutional Purchasers in a
            registered direct offering an aggregate of 24,906,134 shares of its common stock and warrants to purchase an aggregate of 12,453,067 shares of its common stock at a combined purchase price equal to $2.45 per share and associated warrant. Each warrant features an exercise price equal to $2.90
            per share, is exercisable immediately upon issuance and will expire five years from the issuance date. Additionally, in a concurrent
            non-brokered registered direct offering, the Company entered into a Securities Purchase Agreement (the &#8220;Additional Purchase Agreement&#8221;) with certain accredited investors (the &#8220;Additional Purchasers&#8221;). Pursuant to the terms of the Additional
            Purchase Agreement, the Company sold to the Additional Purchasers an aggregate of 1,632,652 shares of its common stock and warrants
            to purchase an aggregate of 816,326 shares of its common stock at a combined purchase price equal to $2.45 per share and associated warrant. Each warrant features an exercise price equal to $2.90 per share, is exercisable immediately upon issuance and will expire five years
            from the issuance date. In connection with the registered direct offerings, the Company received gross proceeds of approximately $65.0
            million.</div>

<div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Private Placement</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January 2021, the Company entered into a securities purchase
            agreement (the &#8220;January Private Placement&#8221;) with certain investors (the &#8220;January Purchasers&#8221;). Pursuant to the terms of the January Private Placement, the Company agreed to sell to the January Purchasers an aggregate of 12,500,000 shares of its common stock at a purchase price equal to $2.00 per share, along with warrants to purchase an aggregate of 6,250,000
            shares of its common stock. In connection with the January Private Placement, the Company received gross proceeds of $25.0 million.
            Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.90 per share. The warrants are exercisable immediately upon issuance and will expire <span style="-sec-ix-hidden:Fact_b33f9ae5fcb543bd9c7f792ce5439476">five and one-half years</span> from the issuance date.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Warrant Exercises</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January 2021, the Company issued 801,148 shares of common stock for net proceeds of $1.8
            million in connection with warrant exercises associated with the April&#160;23, 2020 securities purchase agreement and the May&#160;25, 2020 securities purchase agreement.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Stock Options and Warrants</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the year ended December&#160;31, 2021:</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2020</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;">963,700</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$14.64</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">5.86</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt;">2,638,355</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.18</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">4.98</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the Year:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">1,314,790</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">1.32</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">19,519,393</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.90</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(7,250)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">3.28</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="padding-left: 6.67pt;">(3)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(801,148)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.19</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(29,842)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">2.18</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 4.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(109,549)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$34.12</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$</span><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">2,131,849</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">5.64</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">7.97</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at December&#160;31, 2021 or expected to vest in the
                    future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,120,643</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">5.66</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.96</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Exercisable at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,122,783</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">9.26</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">6.70</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Restricted Stock</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock for services as follows ($ in thousands, except share data):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">612,950</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">156,184</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">877.7</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">512.3</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock issued
            for services in the years ended December&#160;31, 2021 and 2020 was $1.43 and $3.28 per share, respectively. The fair value of the restricted stock was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms of restricted stock
            issuances are generally between <span style="-sec-ix-hidden:Fact_71e638d2f8944c3b8762be6c9f077488">one</span> to four years.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock units for services as follows ($ in thousands, except share data):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Units Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">458,245</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">325,853</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Units Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">728.6</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">863.0</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The weighted average estimated fair value of restricted stock units
            issued for services in the years ended December&#160;31, 2021 and 2020 was $1.59 and $2.65 per share, respectively. The fair value of the restricted stock units was determined using the Company&#8217;s closing stock price on the date of issuance. The vesting terms
            of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125238592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 9 &#8211; Share-Based Compensation</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Share-Based Compensation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We utilize share-based compensation in the form of stock options,
            restricted stock, and restricted stock units. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;">$218</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;">$<span style="padding-left: 5pt;">96</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">542 </span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">501 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total share-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$760</span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$597</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total compensation cost related to non-vested awards not yet
            recognized and the weighted-average periods over which the awards were expected to be recognized at March&#160;31, 2022 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unrecognized compensation cost</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;">$<span style="padding-left: 2.5pt;">814</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">444</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;">$1,004</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"><span style="padding-left: 5pt;">1.77 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">0.96 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><span style="padding-left: 10pt;">2.25 </span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the three months ended March&#160;31, 2022 and 2021 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total fair value of shares vested</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$<span style="padding-left: 2.5pt;">377</span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$<span style="padding-left: 2.5pt;">397</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average estimated fair value of shares granted</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$0.62</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$1.08</div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Valuation Assumptions</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The fair value of stock options and warrants at the date of grant was
            estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant
            and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 10 &#8211; Share-Based Compensation</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Share-based Compensation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company utilizes share-based compensation in the form of stock
            options, restricted stock, and restricted stock units. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the years ended December&#160;31, 2021 and 2020 ($ in thousands):</span></div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;">$<span style="padding-left: 7.5pt;">760</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;">$<span style="padding-left: 7.5pt;">179</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,245</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,086</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total share-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,005</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$1,265</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total compensation cost related to unvested awards not yet recognized
            and the weighted-average periods over which the awards are expected to be recognized at December&#160;31, 2021 were as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unrecognized compensation cost</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;">$<span style="padding-left: 2.5pt;">757</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">149</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">546</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"><span style="padding-left: 5pt;">1.64</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">1.57 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">1.70</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the years ended December&#160;31, 2021 and 2020 were as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total fair value of shares vested</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<span style="padding-left: 2.5pt;">757</span></div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<span style="padding-left: 2.13pt;">536</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average estimated fair value of shares granted</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">0.91</span></div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2.11</span></div>
                </td>

  </tr>


</table>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Valuation Assumptions</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The fair value of stock options at the date of grant was estimated
            using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#8217;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and
            exercise of options for all employees.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The range of assumptions made in calculating the fair values of
            stock options was as follow:</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term - minimum (in years)</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term - maximum (in years)</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility - minimum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">79%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">75%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility - maximum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">84%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">79%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted Average volatility</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">81%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">75%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected dividend yield</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate - minimum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">0.63%</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">0.40%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate - maximum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">1.16%</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">1.71%</div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057255408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 10 &#8211; Income Taxes</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In assessing the realizability of deferred tax assets, including the
            net operating loss carryforwards (&#8220;NOLs&#8221;), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets. Based on its assessment,
            the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021 and 2020, the Company had approximately $281 million and $264 million,
            respectively of federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on
            January&#160;25, 2021. As a result, $169 million of the $281 million of federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $112 million of remaining federal NOL. The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact
            to the balance sheet or income statement. Losses incurred before the ownership change on January&#160;25, 2021 will be subject to an annual limitation of $173k under Internal Revenue Code Section 382, while losses incurred after January&#160;25, 2021
            will not be subject to limitations. The Company may be able to utilize additional NOLs of approximately $1.1 million per year for the
            first five years after this ownership change as a result of the application of the Net Unrealized Built-in Gain rules.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021 and 2020 the Company had State NOLs available
            in New Jersey of $97 million and $99
            million, respectively, California of $70 million and $70 million, respectively, and New York City of $13 million and $13 million, respectively, to offset future taxable income expiring from 2031 through 2041. In accordance with Section 382 of the Internal Revenue
            code, the usage of the Company&#8217;s NOLs would be limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences
            become deductible.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company applies the FASB&#8217;s provisions for uncertain tax
            positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest
            benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with uncertain tax positions as a component of income tax
            expense.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of March&#160;31, 2022, management does not believe the Company has any
            material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in future
            periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For years prior to 2018, the federal statute of limitations is closed
            for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from date of filing.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In December 2021, the Company received preliminary approval from the
            New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) to participate in the Technology Business Tax Certificate Transfer Program (the &#8220;Program&#8221;). The Program permits qualified companies to sell a percentage of their New Jersey net operating
            losses (&#8220;NJ NOLs&#8221;) to unrelated profitable corporations. On February&#160;22, 2022, the Company received final approval from NJEDA to sell $2.5
            million of its NJ NOLs related tax benefits (&#8220;NJ NOL Tax Benefits&#8221;), which was subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.3 million. The gross proceeds of $2.5 million have been
            recorded as a benefit from income taxes and the loss on sale of NJ NOLs of $0.1 million recorded in other income (expense) in the
            consolidated financial statements.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 12 &#8211; Income Taxes</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) for income taxes is based on loss from
            operations before provision for income taxes and noncontrolling interests as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pre-tax book income</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">United States</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$(28,974)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$(19,013)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(28,974)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(19,013)</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) from income taxes was as follows ($ in
            thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 15.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>


</table>

<div><br/>
          </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) for income taxes is determined by applying
            the U.S. Federal statutory rate of 21% to income before income taxes, and the components are set forth below ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">U.S. Federal benefit at statutory rate</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;">$<span style="padding-left: 5pt;">(6,085)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;">$<span style="padding-left: 5pt;">(3,993)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Permanent non deductible expenses for U.S. taxes</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">320</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 30.83pt;">5</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Change in state deferred</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">622</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">5,122</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Return to actual</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">2,277</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other true ups</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">1,407</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">387</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Section 382 NOL Limitation</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 8.33pt;">35,438</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sale of New Jersey State NOLs</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 10pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 5pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Valuation allowance for deferred tax assets</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(33,979)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(1,521)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tax provision (benefit)</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Deferred income taxes at December&#160;31, 2021 and 2020 consist of the
            following ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 19.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred Tax Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated net operating losses (tax effected)</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 3.33pt;">36,281</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 3.33pt;">68,286</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right of use liability</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">201</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">176</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt;">3,086</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt;">5,025</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intangibles</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">97</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">131</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated depreciation</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">26</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">19</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued payroll</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">176</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">167</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">526</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">526</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax assets</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">40,393</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">74,330</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred Tax Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right of use asset</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(204)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(161)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax liabilities</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(204)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(161)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">40,189</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">74,169</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Valuation allowance</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(40,189)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(74,169)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net deferred tax asset</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In assessing the realizability of deferred tax assets, including the
            net operating loss carryforwards (NOLs), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets. Based on its assessment,
            the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, and 2020, the Company had approximately $281 million and $264 million,
            respectively, of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on
            January&#160;25, 2021. As a result, $169 million of the $281 million of Federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $112 million of remaining Federal NOL. The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact
            to the balance sheet or income statement. Losses incurred before the ownership change on January&#160;25, 2021 will be subject to an annual limitation of $173k under Internal Revenue Code Section 382, while losses incurred after January&#160;25, 2021
            will not be subject to limitations. The Company may be able to utilize additional NOLs of approximately $1.1 million per year for the
            first five years after this ownership change as a result of the application of the Net Unrealized Built-in Gain rules.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021 and 2020, the Company had State NOLs
            available in New Jersey of $97 million and $99 million, respectively, California of $70 million and $70 million, respectively, and New York City of $13
            million and $13 million, respectively, to offset future taxable income expiring from 2031 through 2041. In accordance with Section
            382 of the Internal Revenue code, the usage of the Company&#8217;s state NOLs would be limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period
            when those temporary differences become deductible.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company applies the FASB&#8217;s provisions for uncertain tax
            positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest
            benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant taxing authority. The Company recognizes interest and penalties associated with certain tax positions as a component of income tax
            expense.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of December&#160;31, 2021, management does not believe the Company has
            any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in
            future periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For years prior to 2018 the federal statute of limitations is closed
            for assessing tax. The Company&#8217;s state tax returns remain open to examination for a period of three to four years from date of filing.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In February 2021, the Company received preliminary approval from the
            New Jersey Economic Development Authority (&#8220;NJEDA&#8221;) to participate in the Technology Business Tax Certificate Transfer Program (the &#8220;Program&#8221;). The Program permits qualified companies to sell a percentage of their New Jersey net operating
            losses (&#8220;NJ NOLs&#8221;) to unrelated profitable corporations. On April&#160;12, 2021, the Company received final approval from NJEDA to sell a portion of our NJ NOLs, which were subsequently sold to a qualifying and approved buyer pursuant to the Program
            for net proceeds of $1.4 million. The $1.5
            million of our NJ NOL related tax benefits (&#8220;NJ NOL Tax Benefits&#8221;) have been recorded as a benefit from income taxes and the loss on sale of $0.1
            million recorded in other income (expense) in the consolidated financial statements.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125316400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 11 &#8211; Contingencies</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Contingencies</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, the Company is subject to legal proceedings and
            claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a
            material adverse effect on the Company's financial condition or operating results.</div>
<span></span>
</td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 13 &#8211; Contingencies</span></div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">From time to time, the Company is subject to legal proceedings and
            claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a
            material adverse effect on the Company's financial condition or operating results.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125234176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Q1)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">
<div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><span style="text-decoration: underline;">Note 12 &#8211; Subsequent Event</span></div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Cend Merger Agreement</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On April&#160;26, 2022, the Company and Cend Therapeutics, Inc., a
            Delaware corporation (&#8220;Cend&#8221;), entered into an Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger
            Agreement, a wholly-owned subsidiary of Caladrius will merge with and into Cend, with Cend surviving as a wholly-owned subsidiary of the Company (the &#8220;Merger&#8221;), subject to the terms of the Merger Agreement and stockholder approval of the
            transaction. Under the exchange ratio formula, as of immediately after the Merger, the former Cend stockholders are expected to own approximately 50%
            of the outstanding shares of Caladrius Common Stock and the Company&#8217;s stockholders as of immediately prior to the Merger are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on the Company&#8217;s net cash balance at the time of closing and the amount
            of any transaction expenses of Cend in excess of $250 thousand at the time of closing.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Consummation of the Merger is subject to certain closing conditions,
            including, among other things, approval by the stockholders of the Company and Cend, and the Company&#8217;s satisfaction of a minimum net cash threshold at closing, expected to be approximately $64.9 million assuming a closing at the end of the third quarter of 2022, and as described further in the Merger Agreement. The Merger Agreement contains certain termination rights for
            both the Company and Cend, and further provides that, upon termination of the Merger Agreement under specified circumstances, the Company may be required to pay Cend a termination fee of $1.0 million, Cend may be required to pay the Company a termination fee of $4.0
            million, or in some circumstances reimburse the other party&#8217;s expenses up to a maximum of $1.0 million.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">At the effective time of the Merger, the Company&#8217;s Board of Directors
            is expected to consist of nine members, four of whom will be designated by the Company, four of whom will be designated by Cend and one member who will be mutually agreed between the Company and Cend.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Stock Purchase Agreement</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In order to provide Cend with capital for its development programs
            prior to the closing of the Merger, the Company and Cend entered into a Series D Preferred Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;), pursuant to which the Company agreed to purchase from Cend 1,135,628 shares of Series D Preferred Stock, $0.00001 par
            value per share (the &#8220;Series D Preferred Stock&#8221;), of Cend at a purchase price per share equal to $8.8057 per share (the &#8220;Series D
            Original Issue Price&#8221;), or approximately $10 million in the aggregate. The Series D Preferred Stock ranks senior to Cend&#8217;s common
            stock and the other series of preferred stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of Cend. The Series D Preferred Stock has a liquidation preference equal
            to the Series D Original Issue Price plus an amount equal to any accrued and unpaid dividends to the date of payment and will participate with Cend&#8217;s common stockholders and other preferred stockholders thereafter on an as-converted basis. The
            Series D Preferred Stock shall vote with the common stock on an as-converted basis on any matters presented to the stockholders of Cend. Each share of Series D Preferred Stock is convertible, at the option of the holder thereof, into such
            number of shares of Cend common stock as is determined by dividing the Original Issue Price by the conversion price in effect at the time of conversion, which conversion price shall be the Original Issue Price as appropriately adjusted for
            stock splits, stock dividends, combinations, and subdivisions of Cend common stock, and as adjusted pursuant to a weighted-average antidilution adjustment. The Series D Preferred Stock will automatically convert into shares of Cend common stock
            upon the closing of a firm-commitment underwritten initial public offering implying a pre-equity offering value of at least $250
            million, resulting in at least $50 million of gross proceeds to Cend.</div>

<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Collaboration Agreement</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In connection with such Purchase Agreement, Cend entered into a
            Collaboration Agreement (the &#8220;Collaboration Agreement&#8221;), pursuant to which the Company agreed to collaborate with Cend on certain developmental and clinical activities prior to the closing of the Merger. Under the Collaboration Agreement, the
            Company and Cend will form a joint steering committee (the &#8220;Committee&#8221;) comprised of individuals from both entities. The Committee will meet regularly and be responsible for monitoring ongoing studies and making recommendations for development
            activity and trial planning. Cend has agreed to pay each member of the Committee from the Company an hourly consulting fee for such service.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127304272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (FY) (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying unaudited Consolidated Financial Statements have
            been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim
            financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated
            Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of March&#160;31, 2022, and the results of its
            operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2021
            and 2020 included in our 2021 Form 10-K. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying consolidated financial statements have been prepared
            in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">assumptions believed to be reasonable under the circumstances, the results of which
            form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly,
            actual results could differ from those estimates and assumptions.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments
            about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimate and assumptions in determining stock-based awards values. Accordingly, actual results could differ from
            those estimates and assumptions.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Cash and Cash Equivalents</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Cash and cash equivalents include short-term, highly liquid,
            investments with maturities of ninety days or less when purchased.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Risks</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Concentration of Risks</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of
            priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Concentration of Risks</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">credit risk from these financial instruments. The goals of the Company's investment
            policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Marketable Securities</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company determines the appropriate classification of its
            marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash
            equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity.
            Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of
            securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the
            impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and
            whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and
            this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Property and Equipment</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The cost of property and equipment is depreciated over the estimated
            useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. <span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The estimated useful
            lives of property and equipment are as follows:</span></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">10
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer equipment</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Software</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Life of lease</div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentImpairment', window );">Long-lived Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Long-lived Assets</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Long-lived assets consist of property and equipment. The assets are
            amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the
            asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result
            from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair
            value of the assets.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Share-Based Compensation </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the
            date of grant.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Share-Based Compensation </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be
            forfeited. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Loss Per Share</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Basic loss per share is based on the weighted effect of all common
            shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to
            common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding.
            Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_TreasuryStockPolicyPolicyTextBlock', window );">Treasury Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Treasury Stock</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Treasury stock purchases are accounted for under the cost method
            whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Research and Development Costs </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Research and development (&#8220;R&amp;D&#8221;) expenses include salaries,
            benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the
            costs associated with research and development activities when incurred.</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">To further drive the Company&#8217;s cell therapy initiatives, the Company
            will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#8217;s research and development programs. The Company accounts for such grants as a deduction to the
            related expense in research and development operating expenses when earned.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">New Accounting Pronouncements</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In October 2019, the FASB issued ASU 2019-12, which affects general
            principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and
            interim periods within those fiscal years, beginning after December&#160;15, 2020. The Company believes that the adoption of this new accounting guidance has not had a material impact on its financial statements and footnote disclosures. </div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_TreasuryStockPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_TreasuryStockPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for assessing and recognizing impairments of its property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126571184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Q1) (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying unaudited Consolidated Financial Statements have
            been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim
            financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated
            Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#8217;s financial position as of March&#160;31, 2022, and the results of its
            operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2021
            and 2020 included in our 2021 Form 10-K. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Basis of Presentation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The accompanying consolidated financial statements have been prepared
            in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">assumptions believed to be reasonable under the circumstances, the results of which
            form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly,
            actual results could differ from those estimates and assumptions.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Use of Estimates</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments
            about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimate and assumptions in determining stock-based awards values. Accordingly, actual results could differ from
            those estimates and assumptions.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Principles of Consolidation</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.</div>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Risks</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Concentration of Risks</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of
            priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Concentration of Risks</div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of </div>

<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">credit risk from these financial instruments. The goals of the Company's investment
            policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</div>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Share-Based Compensation </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the
            date of grant.</div>
<span></span>
</td>
<td class="text">
<div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Share-Based Compensation </div>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be
            forfeited. The fair value of the Company&#8217;s restricted stock and restricted stock units is based on the closing market price of the Company&#8217;s common stock on the date of grant.</div>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125337600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The estimated useful
            lives of property and equipment are as follows:</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">10
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer equipment</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Software</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Life of lease</div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Property and equipment consisted of the following (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 12.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 8.33pt;">26</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 8.33pt;">26</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer equipment</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">314</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">254</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">90</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">90</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, gross</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">430</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">370</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated depreciation</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(368)</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(313)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">62</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">57</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761123840720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale-Securities (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-Sale Securities Reconciliation</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$62,770</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;">$(162)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$62,608</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$53,135</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(65)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$53,070</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 10pt;">6,578</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 10pt;">6,578</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">17,267</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(34)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">17,233</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,263</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(5)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,258</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,615</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(196)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(70)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or debt marketable securities in the Company's Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$53,135</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(65)</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$53,070</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 5pt;">8,406</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 5pt;">(<span style="text-indent: 0pt;">7</span>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$<span style="padding-left: 5pt;">8,399</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 10pt;">7,591</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 10pt;">7,591</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,263</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(5)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,258</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">14,753</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(6)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">14,747</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(70)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,750</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(13)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are
            generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash equivalents</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;">$10,647</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$21,129</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">70,323</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are generally
            based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale debt securities on the Company's Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$21,129</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$12,676</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">18,061</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Available-for-Sale Securities by Contractual Maturity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes our portfolio of available-for-sale
            securities by contractual maturity (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 19.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$86,615</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;">$86,419</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,615</span></div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the Company's portfolio of
            available-for-sale securities by contractual maturity (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$91,522</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$91,452</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$30,750</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$30,737</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,750</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125308112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The estimated useful
            lives of property and equipment are as follows:</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">10
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer equipment</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Software</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3
                    years</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements</div>
                </td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Life of lease</div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Property and equipment consisted of the following (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 12.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture and fixtures</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 8.33pt;">26</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 8.33pt;">26</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Computer equipment</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">314</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">254</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">90</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">90</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, gross</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">430</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">370</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated depreciation</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(368)</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(313)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">62</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">57</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124311744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At March&#160;31, 2022 and 2021, the Company excluded
            the following potentially dilutive securities (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 17.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2,640</span></div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">1,022</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrants</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">1,460</span></div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">798</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At December&#160;31, 2021 and 2020, the Company excluded the
            following potentially dilutive securities (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 13.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2,132</span></div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 7.5pt;">964</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrants</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2,638</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">604</span></div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 7.5pt;">340</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761123856976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Fair Value of Assets Measured on Recurring Basis</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth by level within the fair value
            hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands).</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's financial assets and liabilities that were accounted
            for at fair value on a recurring basis as of December&#160;31, 2021 and December&#160;31, 2020 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761123856976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities as of March&#160;31, 2022 and December&#160;31, 2021 were
            as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salaries, employee benefits and related taxes</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;">$1,005</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">$2,034</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities &#8212; current</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="padding-left: 12.5pt;">205</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="padding-left: 12.5pt;">229</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">894</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">326</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,104</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,589</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities were as follow (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 13.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salaries, employee benefits and related taxes</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2,034</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,716</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities - current</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">229</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">370</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">326</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">400</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,589</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,486</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125376208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock', window );">Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of Use Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_ce1d736a988a4564aff92c00256cdd92"><span style="-sec-ix-hidden:Fact_2bb6a876105046b48a849d6ac8adfc37">Other assets</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$667</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$724</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Right-of-Use Asset</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$667</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$724</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_394d33db98754a5dbaa2063579daa0be"><span style="-sec-ix-hidden:Fact_01cbbf57a5d5461f83158b26769ed161">Accrued liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;">$205</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$229</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_646cbb0a67a54f629dc6c425eb143706"><span style="-sec-ix-hidden:Fact_52d14b2a09d54c84bb4a3b7e7f351e66">Other long-term liabilities</span></span> </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">421 </span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">485 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Operating Lease Liabilities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$626</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$714</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of Use Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_6c255ea4f7c24c48b604a925c0f5819f"><span style="-sec-ix-hidden:Fact_02a6f0c3111348a5b2e0df82b435956e">Other assets</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$724</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$574</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Right-of-Use Asset</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$724</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$574</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_d2023c19465a459a9ecb0fec411ae9c3"><span style="-sec-ix-hidden:Fact_f6a138b4447e4c69840c11bceb8fe65d">Accrued liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$229</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$370</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_b65fe760104b4546b3abaa579a18c88c"><span style="-sec-ix-hidden:Fact_3980d08cb35e4c0087f62256aa859a67">Other long-term liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">485</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">254</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Operating Lease Liabilities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$714</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$624</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Lease Agreements</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of March&#160;31, 2022 were as follows (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years ended</div>
                </td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">181<br/>
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">217<br/>
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">190</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">143</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease payments</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">731</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Amounts representing interest</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(105) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">626</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of December&#160;31, 2021 were as follows (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years ended</div>
                </td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 3.33pt;"><span style="text-indent: 0pt;">286</span></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">217 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">190 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">143</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease payments</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">836</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Amounts representing interest</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(122)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">714</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057943136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options and Warrants Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the three months ended March&#160;31, 2022:</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">2,131,849<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">5.64</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">7.97<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">21,356,600<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.84</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">4.37<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the period:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;">540,600 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;">0.91 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 30pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 17.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(9,565)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;">1.90 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(23,275)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">26.00 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,639,609</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">4.51</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.83<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at March&#160;31, 2022 or expected to vest in the future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,594,630<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">4.57</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.80<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,408,083</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">7.36</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">6.41<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the year ended December&#160;31, 2021:</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2020</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;">963,700</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$14.64</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">5.86</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt;">2,638,355</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.18</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">4.98</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the Year:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">1,314,790</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">1.32</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">19,519,393</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.90</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(7,250)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">3.28</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="padding-left: 6.67pt;">(3)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(801,148)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.19</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(29,842)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">2.18</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 4.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(109,549)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$34.12</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$</span><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">2,131,849</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">5.64</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">7.97</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at December&#160;31, 2021 or expected to vest in the
                    future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,120,643</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">5.66</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.96</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Exercisable at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,122,783</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">9.26</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">6.70</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock for services as follows ($ in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,061,175 </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">300,450 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 25pt; border-bottom: 3pt double #000000; min-width: 45pt;">973</span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">478</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock for services as follows ($ in thousands, except share data):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">612,950</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">156,184</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">877.7</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">512.3</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock units for services as follows ($ in thousands, except share data):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Units Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">458,245</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">325,853</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Units Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">728.6</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">863.0</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124322192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;">$218</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;">$<span style="padding-left: 5pt;">96</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">542 </span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">501 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total share-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$760</span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$597</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the years ended December&#160;31, 2021 and 2020 ($ in thousands):</span>
<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;">$<span style="padding-left: 7.5pt;">760</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;">$<span style="padding-left: 7.5pt;">179</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,245</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,086</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total share-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,005</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$1,265</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total compensation cost related to unvested awards not yet recognized
            and the weighted-average periods over which the awards are expected to be recognized at December&#160;31, 2021 were as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unrecognized compensation cost</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;">$<span style="padding-left: 2.5pt;">757</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">149</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">546</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"><span style="padding-left: 5pt;">1.64</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">1.57 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">1.70</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of Fair Value of Shares Vested and Weighted Average Estimated Fair Values of Shares Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the years ended December&#160;31, 2021 and 2020 were as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total fair value of shares vested</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<span style="padding-left: 2.5pt;">757</span></div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<span style="padding-left: 2.13pt;">536</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average estimated fair value of shares granted</div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">0.91</span></div>
                </td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2.11</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions in Calculating Fair Values of Stock Options</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the three months ended March&#160;31, 2022 and 2021 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total fair value of shares vested</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$<span style="padding-left: 2.5pt;">377</span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$<span style="padding-left: 2.5pt;">397</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average estimated fair value of shares granted</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$0.62</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$1.08</div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The range of assumptions made in calculating the fair values of
            stock options was as follow:</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term - minimum (in years)</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term - maximum (in years)</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility - minimum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">79%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">75%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility - maximum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">84%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">79%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted Average volatility</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">81%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">75%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected dividend yield</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate - minimum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">0.63%</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">0.40%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate - maximum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">1.16%</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">1.71%</div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127780112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (FY) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes Based on Loss from Operations</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) for income taxes is based on loss from
            operations before provision for income taxes and noncontrolling interests as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pre-tax book income</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">United States</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$(28,974)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$(19,013)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(28,974)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(19,013)</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Benefit from Income Taxes</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) from income taxes was as follows ($ in
            thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$</span><span style="padding-left: 15.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">U.S. Federal</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 15.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">$<span style="padding-left: 20.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">State and local</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 30.83pt;">$(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Effective Income Taxes</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) for income taxes is determined by applying
            the U.S. Federal statutory rate of 21% to income before income taxes, and the components are set forth below ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Years Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">U.S. Federal benefit at statutory rate</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;">$<span style="padding-left: 5pt;">(6,085)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;">$<span style="padding-left: 5pt;">(3,993)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Permanent non deductible expenses for U.S. taxes</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">320</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 30.83pt;">5</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Change in state deferred</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">622</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">5,122</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Return to actual</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">2,277</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other true ups</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 13.33pt;">1,407</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 20.83pt;">387</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Section 382 NOL Limitation</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 8.33pt;">35,438</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 25.83pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sale of New Jersey State NOLs</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 10pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 5pt;">(10,872)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Valuation allowance for deferred tax assets</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(33,979)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(1,521)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tax provision (benefit)</div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">(1,508)</span></div>
                </td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$(10,872)</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components Deferred Income Taxes</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Deferred income taxes at December&#160;31, 2021 and 2020 consist of the
            following ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 19.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred Tax Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated net operating losses (tax effected)</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 3.33pt;">36,281</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 3.33pt;">68,286</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right of use liability</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">201</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">176</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Share-based compensation</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt;">3,086</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 13.33pt;">5,025</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intangibles</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">97</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">131</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated depreciation</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">26</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 25.83pt;">19</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued payroll</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">176</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt;">167</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">526</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">526</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax assets</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">40,393</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">74,330</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred Tax Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right of use asset</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(204)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;">$</span><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(161)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax liabilities</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(204)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(161)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">40,189</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 8.33pt;">74,169</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Valuation allowance</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(40,189)</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;">(74,169)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net deferred tax asset</div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 35.83pt;">$</span><span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;">&#8212;</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124324816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Available-for-Sale-Securities (Q1) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Available-for-sale Securities Reconciliation</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$62,770</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;">$(162)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$62,608</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$53,135</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(65)</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$53,070</div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 10pt;">6,578</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 13.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 10pt;">6,578</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">17,267</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(34)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">17,233</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,263</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(5)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,258</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,615</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$(196)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(70)</span></div>
                </td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or debt marketable securities in the Company's Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div>
                </td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Corporate debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$53,135</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;">$(65)</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$53,070</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<span style="padding-left: 5pt;">8,406</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 5pt;">(<span style="text-indent: 0pt;">7</span>)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$<span style="padding-left: 5pt;">8,399</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Money market funds</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt;">18,124</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 10pt;">7,591</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 8.33pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 10pt;">7,591</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Municipal debt securities</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,263</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(5)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">20,258</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">14,753</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;">(6)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">14,747</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(70)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,750</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 18.33pt;">$(13)</span></div>
                </td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Marketable Securities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are
            generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash equivalents</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;">$10,647</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$21,129</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">70,323</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Estimated fair values of available-for-sale securities are generally
            based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale debt securities on the Company's Consolidated Balance Sheets (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$21,129</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$12,676</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">18,061</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Investments Classified by Contractual Maturity Date</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes our portfolio of available-for-sale
            securities by contractual maturity (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 19.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$86,615</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;">$86,419</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,615</span></div>
                </td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$86,419</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the Company's portfolio of
            available-for-sale securities by contractual maturity (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortized <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div>
                </td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$91,522</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$91,452</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;">$30,750</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;">$30,737</div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Greater than one year</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,522</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$91,452</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,750</span></div>
                </td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$30,737</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126503520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share (Q1) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At March&#160;31, 2022 and 2021, the Company excluded
            the following potentially dilutive securities (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 17.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2,640</span></div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">1,022</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrants</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">1,460</span></div>
                </td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">798</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At December&#160;31, 2021 and 2020, the Company excluded the
            following potentially dilutive securities (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 13.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt;">2,132</span></div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 7.5pt;">964</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrants</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21,357</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2,638</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted Stock Units</div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">604</span></div>
                </td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 7.5pt;">340</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129673792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Q1) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table sets forth by level within the fair value
            hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands).</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$75,772</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company's financial assets and liabilities that were accounted
            for at fair value on a recurring basis as of December&#160;31, 2021 and December&#160;31, 2020 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2020</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 1</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 2</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Level 3</div>
                </td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;">&#8203;</td>

    <td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets: </div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Marketable securities - available for sale</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$70,323</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 32.5pt;">$18,061</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129737008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Q1) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities as of March&#160;31, 2022 and December&#160;31, 2021 were
            as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salaries, employee benefits and related taxes</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;">$1,005</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">$2,034</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities &#8212; current</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="padding-left: 12.5pt;">205</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="padding-left: 12.5pt;">229</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">894</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">326</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,104</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,589</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities were as follow (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 13.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Salaries, employee benefits and related taxes</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2,034</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,716</div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities - current</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">229</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt;">370</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">326</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">400</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,589</span></div>
                </td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,486</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761056458128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating Leases (Q1) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock', window );">Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of Use Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_ce1d736a988a4564aff92c00256cdd92"><span style="-sec-ix-hidden:Fact_2bb6a876105046b48a849d6ac8adfc37">Other assets</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$667</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$724</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Right-of-Use Asset</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$667</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$724</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_394d33db98754a5dbaa2063579daa0be"><span style="-sec-ix-hidden:Fact_01cbbf57a5d5461f83158b26769ed161">Accrued liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;">$205</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$229</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_646cbb0a67a54f629dc6c425eb143706"><span style="-sec-ix-hidden:Fact_52d14b2a09d54c84bb4a3b7e7f351e66">Other long-term liabilities</span></span> </div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">421 </span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">485 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Operating Lease Liabilities</div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$626</span></div>
                </td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$714</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Right-of Use Assets:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_6c255ea4f7c24c48b604a925c0f5819f"><span style="-sec-ix-hidden:Fact_02a6f0c3111348a5b2e0df82b435956e">Other assets</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$724</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 20pt;">$574</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Right-of-Use Asset</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$724</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$574</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating Lease Liabilities:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_d2023c19465a459a9ecb0fec411ae9c3"><span style="-sec-ix-hidden:Fact_f6a138b4447e4c69840c11bceb8fe65d">Accrued liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$229</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;">$370</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="-sec-ix-hidden:Fact_b65fe760104b4546b3abaa579a18c88c"><span style="-sec-ix-hidden:Fact_3980d08cb35e4c0087f62256aa859a67">Other long-term liabilities</span></span><br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">485</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">254</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total Operating Lease Liabilities</div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$714</span></div>
                </td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$624</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Lease Agreements</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of March&#160;31, 2022 were as follows (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years ended</div>
                </td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">181<br/>
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">217<br/>
                    </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">190</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">143</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease payments</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">731</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Amounts representing interest</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(105) </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">626</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Future minimum lease payments under the lease agreements as of December&#160;31, 2021 were as follows (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years ended</div>
                </td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">$</span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 3.33pt;"><span style="text-indent: 0pt;">286</span></span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2023</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">217 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">190 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">143</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease payments</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 8.33pt;">836</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Amounts representing interest</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;">(122)</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Present value of lease liabilities</div>
                </td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 23.33pt;">$</span><span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;">714</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126847152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Q1) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option and Warrants Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the three months ended March&#160;31, 2022:</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands)</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">2,131,849<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">5.64</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">7.97<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">21,356,600<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.84</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">4.37<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the period:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;">540,600 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;">0.91 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 30pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 17.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(9,565)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 10pt;">1.90 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(23,275)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">26.00 </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212; </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,639,609</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">4.51</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.83<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at March&#160;31, 2022 or expected to vest in the future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,594,630<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">4.57</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.80<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested at March&#160;31, 2022</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,408,083</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">7.36</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">6.41<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.13<br/>
                    </span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the activity for stock options and
            warrants for the year ended December&#160;31, 2021:</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrants </div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years) </div>
                </td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value (In <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Thousands) </div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2020</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 7.5pt;">963,700</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$14.64</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">5.86</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt;">2,638,355</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.18</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;">4.98</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;">$&#8212;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes during the Year:<br/>
                  </div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">1,314,790</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">1.32</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">19,519,393</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.90</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 14.17pt;">(7,250)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">3.28</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="padding-left: 6.67pt;">(3)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(801,148)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$2.19</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 9.17pt;">(29,842)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;">$<span style="padding-left: 5pt;">2.18</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;">$<span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expired</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 4.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;">(109,549)</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$34.12</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$</span><span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Outstanding at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 40pt;">2,131,849</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">5.64</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">7.97</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 1pt solid #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Vested at December&#160;31, 2021 or expected to vest in the
                    future</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">2,120,643</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">5.66</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">7.96</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Exercisable at December&#160;31, 2021</div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 40pt;">1,122,783</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$</span><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;">9.26</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">6.70</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">21,356,600</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 22.5pt;">$2.84</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 17.5pt;">4.37</span></div>
                </td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 15pt;">$&#8212;</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock for services as follows ($ in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,061,175 </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">300,450 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 25pt; border-bottom: 3pt double #000000; min-width: 45pt;">973</span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">478</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock for services as follows ($ in thousands, except share data):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">612,950</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">156,184</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of Restricted Stock Issued</div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">877.7</span></div>
                </td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">512.3</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock units for services as follows ($ in thousands, except share data):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of restricted stock units issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,379,860 </span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">458,245 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Value of restricted stock units issued</div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 45pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;">1,265</span></div>
                </td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 37.5pt;">$</span><span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;">729</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126847024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Q1) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule Share-based Compensation Expense</a></td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span>
<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;">$218</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;">$<span style="padding-left: 5pt;">96</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">542 </span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;">501 </span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total share-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$760</span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 20pt;">$597</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text"><span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The following table summarizes the components of share-based compensation expense for the years ended December&#160;31, 2021 and 2020 ($ in thousands):</span>
<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Research and development</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;">$<span style="padding-left: 7.5pt;">760</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;">$<span style="padding-left: 7.5pt;">179</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,245</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;">1,086</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total share-based compensation expense</div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$2,005</span></div>
                </td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"><span style="border-bottom: 3pt double #000000; min-width: 27.5pt;">$1,265</span></div>
                </td>

  </tr>


</table>

<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total compensation cost related to unvested awards not yet recognized
            and the weighted-average periods over which the awards are expected to be recognized at December&#160;31, 2021 were as follows ($ in thousands):</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unrecognized compensation cost</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;">$<span style="padding-left: 2.5pt;">757</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">149</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">546</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"><span style="padding-left: 5pt;">1.64</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">1.57 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">1.70</span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Total Compensation Cost Related to Nonvested Awards</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total compensation cost related to non-vested awards not yet
            recognized and the weighted-average periods over which the awards were expected to be recognized at March&#160;31, 2022 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units</div>
                </td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Restricted <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unrecognized compensation cost</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;">$<span style="padding-left: 2.5pt;">814</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;">$<span style="padding-left: 2.5pt;">444</span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;">$1,004</div>
                </td>

  </tr>

  <tr>

    <td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Expected weighted-average period in years of compensation
                    cost to be recognized</div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"><span style="padding-left: 5pt;">1.77 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"><span style="padding-left: 5pt;">0.96 </span></div>
                </td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><span style="padding-left: 10pt;">2.25 </span></div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value of Share-based Compensation Awards</a></td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the three months ended March&#160;31, 2022 and 2021 were as follows (in thousands):</div>

<table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div>
                </td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total fair value of shares vested</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$<span style="padding-left: 2.5pt;">377</span></div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$<span style="padding-left: 2.5pt;">397</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted average estimated fair value of shares granted</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$0.62</div>
                </td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;">$1.08</div>
                </td>

  </tr>


</table>
<span></span>
</td>
<td class="text">
<div style="display:none;"><br/></div>
<div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The range of assumptions made in calculating the fair values of
            stock options was as follow:</div>

<div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> <br/></div>

<table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;">


  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Options</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br/>
                  </div>
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,</div>
                </td>

  </tr>

  <tr class="header">

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2021</div>
                </td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;">&#8203;</td>

    <td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2020</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term - minimum (in years)</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term - maximum (in years)</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 12.5pt;">6</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility - minimum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">79%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">75%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility - maximum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">84%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">79%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted Average volatility</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">81%</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">75%</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected dividend yield</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"><span style="padding-left: 7.5pt;">&#8212;</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate - minimum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">0.63%</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">0.40%</div>
                </td>

  </tr>

  <tr>

    <td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate - maximum</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">1.16%</div>
                </td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;">&#8203;</td>

    <td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;">
                  <div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;">1.71%</div>
                </td>

  </tr>


</table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126917600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Business (FY) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_CLBS16TreatmentOfCMDMember', window );">CLBS16 Treatment Of CMD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants awarded</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_CLBS16TreatmentOfCMDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_CLBS16TreatmentOfCMDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057194896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (FY) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129128992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Summary (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 86,615<span></span>
</td>
<td class="nump">$ 91,522<span></span>
</td>
<td class="nump">$ 30,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">86,419<span></span>
</td>
<td class="nump">91,452<span></span>
</td>
<td class="nump">30,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">62,770<span></span>
</td>
<td class="nump">53,135<span></span>
</td>
<td class="nump">8,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">62,608<span></span>
</td>
<td class="nump">53,070<span></span>
</td>
<td class="nump">8,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">6,578<span></span>
</td>
<td class="nump">18,124<span></span>
</td>
<td class="nump">7,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">6,578<span></span>
</td>
<td class="nump">18,124<span></span>
</td>
<td class="nump">7,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">Municipal debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">17,267<span></span>
</td>
<td class="nump">20,263<span></span>
</td>
<td class="nump">14,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 17,233<span></span>
</td>
<td class="nump">$ 20,258<span></span>
</td>
<td class="nump">$ 14,747<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057938944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Classification on Consolidated Balance Sheets (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">$ 86,419<span></span>
</td>
<td class="nump">$ 91,452<span></span>
</td>
<td class="nump">$ 30,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,129<span></span>
</td>
<td class="nump">12,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=clbs_MarketableSecuritiesMember', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,323<span></span>
</td>
<td class="nump">$ 18,061<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=clbs_MarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=clbs_MarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127284880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Contractual Maturities (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Less than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,522<span></span>
</td>
<td class="nump">$ 30,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Greater than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 86,615<span></span>
</td>
<td class="nump">91,522<span></span>
</td>
<td class="nump">30,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,452<span></span>
</td>
<td class="nump">30,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Greater than one year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total estimated fair value</a></td>
<td class="nump">$ 86,419<span></span>
</td>
<td class="nump">$ 91,452<span></span>
</td>
<td class="nump">$ 30,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761056280064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Summary (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 430<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(368)<span></span>
</td>
<td class="num">(313)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125340528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Narrative (FY) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761123747824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (FY) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of loss per share</a></td>
<td class="nump">2,640<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of loss per share</a></td>
<td class="nump">21,357<span></span>
</td>
<td class="nump">21,357<span></span>
</td>
<td class="nump">21,357<span></span>
</td>
<td class="nump">2,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computation of loss per share</a></td>
<td class="nump">1,460<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129193808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (FY) (Details) - Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">$ 75,772<span></span>
</td>
<td class="nump">$ 70,323<span></span>
</td>
<td class="nump">$ 18,061<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="nump">18,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="nump">18,061<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="nump">18,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057935168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent', window );">Salaries, employee benefits and related taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,034<span></span>
</td>
<td class="nump">$ 1,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">$ 894<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 2,486<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761124464096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Narrative (FY) (Details) - office<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_NumberOfOfficesUnderOperatingLeases', window );">Number of offices under operating leases</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term for operating leases (in years)</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate for operating leases (percent)</a></td>
<td class="nump">9.625%<span></span>
</td>
<td class="nump">9.625%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_NumberOfOfficesUnderOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Offices Under Operating Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_NumberOfOfficesUnderOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057864688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Balance Sheet Presentation (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OperatingLeaseRightOfUseAssetAbstract', window );"><strong>Right-of Use Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 667<span></span>
</td>
<td class="nump">$ 724<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Right-of-use assets, balance sheet line item</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, noncurrent</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease liabilities, current, balance sheet line item</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease liabilities, noncurrent, balance sheet line item</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLeaseRightOfUseAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLeaseRightOfUseAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057866480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Future Minimum Lease Payments Under Lease Agreements (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Future Minimum Lease Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">731<span></span>
</td>
<td class="nump">836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Amounts representing interest</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 624<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057066528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Equity Plan (FY) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>offering_period </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 01, 2013 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clbs_EquityIncentiveCompensationPlan2018Member', window );">2018 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future grant</a></td>
<td class="nump">5,585,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clbs_EquityIncentiveCompensationPlan2018Member', window );">2018 Plan | Stock options | Share-based award tranche one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clbs_EquityIncentiveCompensationPlan2018Member', window );">2018 Plan | Stock options | Share-based award tranche two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clbs_EquityIncentiveCompensationPlan2018Member', window );">2018 Plan | Stock options | Share-based award tranche three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlanMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan', window );">Number of offering periods | offering_period</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm', window );">Term of offering period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent', window );">Maximum annual contribution per employee as percent of annual salary</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee', window );">Maximum annual contribution per employee | $</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate', window );">Purchase price measurement as percent of closing price on enrollment date</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate', window );">Purchase price measurement as percent of closing price on exercise date</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2012Member', window );">2012 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2017Member', window );">2017 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2017AmendedMember', window );">Amended 2017 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future grant</a></td>
<td class="nump">300,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under ESPP</a></td>
<td class="nump">47,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Enrollment Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Exercise Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Offering Periods, Employee Stock Purchase Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering Periods, Employee Stock Purchase Plan, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clbs_EquityIncentiveCompensationPlan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clbs_EquityIncentiveCompensationPlan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2012Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2012Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2017AmendedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=clbs_EmployeeStockPurchasePlan2017AmendedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761055301328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Equity Issuances (FY) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">36 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 12, 2021</div></th>
<th class="th"><div>Jun. 04, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of capital stock</a></td>
<td class="nump">$ 65,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 85,457,000<span></span>
</td>
<td class="nump">$ 85,500,000<span></span>
</td>
<td class="nump">$ 18,728,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares issued upon exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">801,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Net proceeds from warrant exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember', window );">Lincoln Park Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement', window );">Aggregate offering amount authorized per agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration', window );">Commitment shares issued as consideration per agreement (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross price for stock transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_TermOfAgreement', window );">Term of agreement (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase', window );">Number of shares allowable to direct for Regular Purchase (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase', window );">Maximum obligation per directed purchase transaction for Regular Purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase', window );">Maximum shares allowed in Accelerated Purchase as percent of shares in Regular Purchase (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod', window );">Maximum shares allowed in Accelerated Purchase as percent of shares traded during specified period (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty', window );">Maximum beneficial ownership allowable per agreement (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice', window );">Accelerated purchases specified floor price threshold for directed purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember', window );">H.C. Wainwright Sales Amended Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement', window );">Aggregate offering amount authorized per agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent', window );">Commission on gross proceeds due to third party (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,784,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember', window );">ATM Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement', window );">Aggregate offering amount authorized per agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_InstitutionalPurchaseAgreementMember', window );">Institutional Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (shares)</a></td>
<td class="nump">24,906,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="nump">$ 2.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants issued</a></td>
<td class="nump">12,453,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="nump">$ 2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AdditionalPurchaseAgreementMember', window );">Additional Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (shares)</a></td>
<td class="nump">1,632,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="nump">$ 2.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants issued</a></td>
<td class="nump">816,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="nump">$ 2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_January2021PurchaseAgreementMember', window );">January 2021 Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants expiration term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Number of shares per each warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase Agreement, Accelerated Purchase Specified Stock Floor Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Issued As Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_TermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_TermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_H.C.WainwrightSalesAmendedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_InstitutionalPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_InstitutionalPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AdditionalPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_AdditionalPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_January2021PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_January2021PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127677312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Options and Warrants (FY) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options, Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, outstanding, beginning balance (in shares)</a></td>
<td class="nump">2,131,849<span></span>
</td>
<td class="nump">963,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,314,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares)</a></td>
<td class="num">(9,565)<span></span>
</td>
<td class="num">(29,842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (shares)</a></td>
<td class="num">(23,275)<span></span>
</td>
<td class="num">(109,549)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, outstanding, ending balance (in shares)</a></td>
<td class="nump">2,639,609<span></span>
</td>
<td class="nump">2,131,849<span></span>
</td>
<td class="nump">963,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested or expected to vest (shares)</a></td>
<td class="nump">2,594,630<span></span>
</td>
<td class="nump">2,120,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Exercisable (shares)</a></td>
<td class="nump">1,408,083<span></span>
</td>
<td class="nump">1,122,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Stock Options, Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, outstanding. beginning balance (in dollars per share)</a></td>
<td class="nump">$ 5.64<span></span>
</td>
<td class="nump">$ 14.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0.91<span></span>
</td>
<td class="nump">1.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">1.90<span></span>
</td>
<td class="nump">2.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in dollars per share)</a></td>
<td class="nump">26.00<span></span>
</td>
<td class="nump">34.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">4.51<span></span>
</td>
<td class="nump">5.64<span></span>
</td>
<td class="nump">$ 14.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested or expected to vest (in dollars per share)</a></td>
<td class="nump">4.57<span></span>
</td>
<td class="nump">5.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Exercisable (in dollars per share)</a></td>
<td class="nump">$ 7.36<span></span>
</td>
<td class="nump">$ 9.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Options, Weighted Average Contractual Term and Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, weighted average remaining contractual term (in years)</a></td>
<td class="text">7 years 9 months 29 days<span></span>
</td>
<td class="text">7 years 11 months 19 days<span></span>
</td>
<td class="text">5 years 10 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options vested or expected to vest, weighted average remaining contractual term (in years)</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">7 years 11 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable, weighted average remaining contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueOptionExercised', window );">Options exercised, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options vested or expected to vest, aggregate intrinsic value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Warrants, Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_CommonStockWarrantsShares', window );">Warrants outstanding, beginning balance (in shares)</a></td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">2,638,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsGranted', window );">Warrants granted (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,519,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsExercised', window );">Warrants exercised (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(801,148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsCanceled', window );">Warrants forfeited (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsExpired', window );">Warrants expired (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_CommonStockWarrantsShares', window );">Warrants outstanding, ending balance (in shares)</a></td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">2,638,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_Sharesvestedandexpectedtovest', window );">Warrants vested or expected to vest (shares)</a></td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">21,356,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsVested', window );">Warrants exercisable (shares)</a></td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">21,356,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsWeightedAverageExercisePriceRollForward', window );"><strong>Warrants, Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding', window );">Warrants outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsGranted', window );">Warrants granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExercised', window );">Warrants exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsCanceled', window );">Warrants forfeited (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExpired', window );">Warrants expired (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding', window );">Warrants outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">2.84<span></span>
</td>
<td class="nump">2.84<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest', window );">Warrants vested or expected to vest (in dollars per share)</a></td>
<td class="nump">2.84<span></span>
</td>
<td class="nump">2.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExercisable', window );">Warrants exercisable (in dollars per share)</a></td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsOtherDisclosuresAbstract', window );"><strong>Warrants, Weighted Average Contractual Term and Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding', window );">Warrants outstanding, weighted average remaining contractual term (in years)</a></td>
<td class="text">4 years 1 month 17 days<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest', window );">Warrants vested or expected to vest, weighted average remaining contractual term (in years)</a></td>
<td class="text">4 years 1 month 17 days<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermwarrantsvested', window );">Warrants exercisable, weighted average remaining contractual term (in years)</a></td>
<td class="text">4 years 1 month 17 days<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsOutstanding', window );">Warrants outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest', window );">Warrants vested or expected to vest, aggregate intrinsic value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsvested', window );">Warrants exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueOptionExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Option Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueOptionExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants vested and expected to vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CommonStockWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Warrants, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CommonStockWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_Sharesvestedandexpectedtovest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shares, vested and expected to vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_Sharesvestedandexpectedtovest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Canceled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Other Disclosures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants, Vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Weighted Average Exercise Price [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Canceled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Vested And Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term warrant outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermwarrantoutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermwarrantsvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>weighted Average Remaining Contractual Term, warrants vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermwarrantsvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127616064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted Stock and Restricted Stock Units (FY) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract', window );"><strong>Restricted Stock and Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of shares issued (shares)</a></td>
<td class="nump">1,061,175<span></span>
</td>
<td class="nump">300,450<span></span>
</td>
<td class="nump">612,950<span></span>
</td>
<td class="nump">156,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Value of shares issued</a></td>
<td class="nump">$ 973,000<span></span>
</td>
<td class="nump">$ 478,000<span></span>
</td>
<td class="nump">$ 877,700<span></span>
</td>
<td class="nump">$ 512,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value</a></td>
<td class="nump">$ 0.92<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract', window );"><strong>Restricted Stock and Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract', window );"><strong>Restricted Stock and Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract', window );"><strong>Restricted Stock and Restricted Stock Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of shares issued (shares)</a></td>
<td class="nump">1,379,860<span></span>
</td>
<td class="nump">458,245<span></span>
</td>
<td class="nump">458,245<span></span>
</td>
<td class="nump">325,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Value of shares issued</a></td>
<td class="nump">$ 1,265,000<span></span>
</td>
<td class="nump">$ 729,000<span></span>
</td>
<td class="nump">$ 728,600<span></span>
</td>
<td class="nump">$ 863,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="nump">$ 2.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted Stock And Restricted Stock Units Issued [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057372848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Share-Based Compensation Expense (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 2,005<span></span>
</td>
<td class="nump">$ 1,265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">760<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 542<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
<td class="nump">$ 1,245<span></span>
</td>
<td class="nump">$ 1,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057939632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Compensation Cost Not Yet Recognized (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 814<span></span>
</td>
<td class="nump">$ 757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">1 year 9 months 7 days<span></span>
</td>
<td class="text">1 year 7 months 20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 444<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">11 months 15 days<span></span>
</td>
<td class="text">1 year 6 months 25 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 1,004<span></span>
</td>
<td class="nump">$ 546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">2 years 3 months<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761056287808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (FY) (Details) - Stock Options - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of shares vested</a></td>
<td class="nump">$ 377<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
<td class="nump">$ 757<span></span>
</td>
<td class="nump">$ 536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value of shares granted (in dollars per share)</a></td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 1.08<span></span>
</td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761056980576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Valuation Assumptions (FY) (Details) - Stock Options<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility - minimum</a></td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility - maximum</a></td>
<td class="nump">84.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted Average volatility</a></td>
<td class="nump">81.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate - minimum</a></td>
<td class="nump">0.63%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate - maximum</a></td>
<td class="nump">1.16%<span></span>
</td>
<td class="nump">1.71%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Valuation Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129121520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Funding (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">41 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>May 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_FundingAmountAwarded', window );">Total funding amount awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_FundingOfGrantAwardCashReceived', window );">Funding of grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MilestonePaymentOnGrantAwardCashReceived', window );">Milestone payment received on grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_ProgressPaymentOnGrantAwardCashReceived', window );">Progress payment received on grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred', window );">Progress payment amortized to related research and development over estimated award period</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense', window );">Amortization of accrued grant funding to offset expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Accrued Grant Funding Liability To Offset Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_FundingAmountAwarded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funding Amount Awarded</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_FundingAmountAwarded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_FundingOfGrantAwardCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Funding Of Grant Award, Cash Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_FundingOfGrantAwardCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MilestonePaymentOnGrantAwardCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone Payment On Grant Award, Cash Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MilestonePaymentOnGrantAwardCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProgressPaymentOnGrantAwardCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Progress Payment On Grant Award, Cash Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProgressPaymentOnGrantAwardCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057311584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Loss from Operations Before Provision for Income Taxes (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Pre-tax book income - United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,974)<span></span>
</td>
<td class="num">$ (19,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Pre-tax book income</a></td>
<td class="num">$ (6,705)<span></span>
</td>
<td class="num">$ (8,063)<span></span>
</td>
<td class="num">$ (28,974)<span></span>
</td>
<td class="num">$ (19,013)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057329824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Benefit from Income Taxes (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">U.S. Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax provision (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">U.S. Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,508)<span></span>
</td>
<td class="num">(10,872)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax provision (benefit)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,508)<span></span>
</td>
<td class="num">(10,872)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations', window );">U.S. Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State and local</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,508)<span></span>
</td>
<td class="num">(10,872)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax provision (benefit)</a></td>
<td class="num">$ (2,479)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,508)<span></span>
</td>
<td class="num">$ (10,872)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057368368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Income Tax Reconciliation (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. Federal benefit at statutory rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,085)<span></span>
</td>
<td class="num">$ (3,993)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Permanent non deductible expenses for U.S. taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount', window );">Change in state deferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">622<span></span>
</td>
<td class="nump">5,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Return to actual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,277<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other true ups</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,407<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount', window );">Section 382 NOL Limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,438<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses', window );">Sale of New Jersey State NOLs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,508)<span></span>
</td>
<td class="num">(10,872)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33,979)<span></span>
</td>
<td class="num">(1,521)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax provision (benefit)</a></td>
<td class="num">$ (2,479)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1,508)<span></span>
</td>
<td class="num">$ (10,872)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change in State Deferred, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Sale Of State Net Operating Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Section 382 NOL Limitation, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127475312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components of Deferred Income Taxes (FY) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred Tax Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Accumulated net operating losses (tax effected)</a></td>
<td class="nump">$ 36,281<span></span>
</td>
<td class="nump">$ 68,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_DeferredTaxAssetsRightOfUseLiability', window );">Right of use liability</a></td>
<td class="nump">201<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">3,086<span></span>
</td>
<td class="nump">5,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_DeferredTaxAssetsAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Accrued payroll</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">526<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">40,393<span></span>
</td>
<td class="nump">74,330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred Tax Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use asset</a></td>
<td class="num">(204)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(204)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_NetDeferredTaxAssetsAndLiabilitiesGross', window );">Net deferred tax assets and liabilities</a></td>
<td class="nump">40,189<span></span>
</td>
<td class="nump">74,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(40,189)<span></span>
</td>
<td class="num">(74,169)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_DeferredTaxAssetsAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Accumulated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_DeferredTaxAssetsAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_DeferredTaxAssetsRightOfUseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Right Of Use Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_DeferredTaxAssetsRightOfUseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_NetDeferredTaxAssetsAndLiabilitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Deferred Tax Assets And Liabilities, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_NetDeferredTaxAssetsAndLiabilitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127636528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (FY) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 22, 2022</div></th>
<th class="th"><div>Apr. 12, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal corporate income tax rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain', window );">Possible additional NOLs for five years resulting from Net Unrealized Built-in Gain rules</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram', window );">Proceeds from sale of NOLs</a></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross', window );">Proceeds from sale of NOLs, gross</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_LossOnSaleOfNetOperatingLosses', window );">Loss on sale of NOLs</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OperatingLossCarryforwardsBeforeWriteDown', window );">Net operating loss carryforwards, prior to write down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.0<span></span>
</td>
<td class="nump">$ 264.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OperatingLossCarryforwardsSetToExpireWrittenDown', window );">Write down of NOLs set to expire unutilized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New Jersey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.0<span></span>
</td>
<td class="nump">99.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_LossOnSaleOfNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss On Sale Of Net Operating Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_LossOnSaleOfNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Annual Available, Five Years, Net Unrealized Built In Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLossCarryforwardsBeforeWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Before Write Down</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLossCarryforwardsBeforeWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLossCarryforwardsSetToExpireWrittenDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Set To Expire, Written Down</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLossCarryforwardsSetToExpireWrittenDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Net Operating Losses, NJEDA Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761127630544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The Business (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 26, 2022</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Merger Agreement | Cend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage', window );">Expected post-merger ownership in Company by Cend stockholders (percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage', window );">Expected post-merger ownership in Company by Company stockholders (percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation', window );">Transaction expenses threshold for allocation</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_CLBS16TreatmentOfCMDMember', window );">CLBS16 Treatment of CMD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrantsReceivable', window );">Grants awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Expected Ownership In Company, Company Stockholders, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Expected Ownership In Company, Counterparty Stockholders, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Transaction Expenses Threshold For Ratio Allocation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=clbs_AgreementAndPlanOfMergerAndReorganizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=clbs_AgreementAndPlanOfMergerAndReorganizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=clbs_CendTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=clbs_CendTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_CLBS16TreatmentOfCMDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_CLBS16TreatmentOfCMDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057674384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">$ 86,615<span></span>
</td>
<td class="nump">$ 91,522<span></span>
</td>
<td class="nump">$ 30,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(196)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">86,419<span></span>
</td>
<td class="nump">91,452<span></span>
</td>
<td class="nump">30,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">62,770<span></span>
</td>
<td class="nump">53,135<span></span>
</td>
<td class="nump">8,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">62,608<span></span>
</td>
<td class="nump">53,070<span></span>
</td>
<td class="nump">8,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">6,578<span></span>
</td>
<td class="nump">18,124<span></span>
</td>
<td class="nump">7,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">6,578<span></span>
</td>
<td class="nump">18,124<span></span>
</td>
<td class="nump">7,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">Municipal debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">17,267<span></span>
</td>
<td class="nump">20,263<span></span>
</td>
<td class="nump">14,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Fair Value</a></td>
<td class="nump">$ 17,233<span></span>
</td>
<td class="nump">$ 20,258<span></span>
</td>
<td class="nump">$ 14,747<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761055289408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 10,647<span></span>
</td>
<td class="nump">$ 21,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Marketable securities</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="nump">$ 18,061<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total</a></td>
<td class="nump">$ 86,419<span></span>
</td>
<td class="nump">$ 91,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057860576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis', window );">Less than one year</a></td>
<td class="nump">$ 86,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost</a></td>
<td class="nump">86,615<span></span>
</td>
<td class="nump">$ 91,522<span></span>
</td>
<td class="nump">$ 30,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Estimated Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue', window );">Less than one year</a></td>
<td class="nump">86,419<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">Greater than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total estimated fair value</a></td>
<td class="nump">$ 86,419<span></span>
</td>
<td class="nump">$ 91,452<span></span>
</td>
<td class="nump">$ 30,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129130256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income (Loss) Per Share (Q1) (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">2,640<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">21,357<span></span>
</td>
<td class="nump">21,357<span></span>
</td>
<td class="nump">21,357<span></span>
</td>
<td class="nump">2,638<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">1,460<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761055829424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Q1) (Details) - Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">$ 75,772<span></span>
</td>
<td class="nump">$ 70,323<span></span>
</td>
<td class="nump">$ 18,061<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="nump">18,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="nump">18,061<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">75,772<span></span>
</td>
<td class="nump">70,323<span></span>
</td>
<td class="nump">18,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Marketable securities - available for sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value disclosure</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761129105216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Salaries, employee benefits and related taxes</a></td>
<td class="nump">$ 1,005<span></span>
</td>
<td class="nump">$ 2,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">894<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 2,104<span></span>
</td>
<td class="nump">$ 2,589<span></span>
</td>
<td class="nump">$ 2,486<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761125035632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Narrative (Q1) (Details) - office<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_NumberOfOfficesUnderOperatingLeases', window );">Number of offices under operating leases</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term for operating leases (in years)</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate for operating leases (percent)</a></td>
<td class="nump">9.625%<span></span>
</td>
<td class="nump">9.625%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_NumberOfOfficesUnderOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Offices Under Operating Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_NumberOfOfficesUnderOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761055301232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Balance Sheet Presentation (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OperatingLeaseRightOfUseAssetAbstract', window );"><strong>Right-of Use Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 667<span></span>
</td>
<td class="nump">$ 724<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Right-of-use assets, balance sheet line item</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Operating Lease Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, noncurrent</a></td>
<td class="nump">421<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease liabilities, current, balance sheet line item</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">Accrued liabilities<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease liabilities, noncurrent, balance sheet line item</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLeaseRightOfUseAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLeaseRightOfUseAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126221760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Operating Leases - Future Minimum Lease Payments (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Minimum Lease Payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">$ 286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">190<span></span>
</td>
<td class="nump">217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">731<span></span>
</td>
<td class="nump">836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Amounts representing interest</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 626<span></span>
</td>
<td class="nump">$ 714<span></span>
</td>
<td class="nump">$ 624<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761055241488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Equity Issuances (Q1) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 04, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember', window );">Lincoln Park Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement', window );">Aggregate offering amount authorized per agreement</a></td>
<td class="nump">$ 26,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration', window );">Commitment shares issued as consideration per agreement (in shares)</a></td>
<td class="nump">181,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares sold (in shares)</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price of shares sold (in dollars per share)</a></td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Gross price for stock transaction</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_TermOfAgreement', window );">Term of agreement (in months)</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase', window );">Number of shares allowable to direct for Regular Purchase (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase', window );">Maximum obligation per directed purchase transaction for Regular Purchase</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase', window );">Maximum shares allowed in Accelerated Purchase as percent of shares In Regular Purchase (percent)</a></td>
<td class="nump">300.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod', window );">Maximum shares allowed in Accelerated Purchase as percent of shares traded during specified period (percent)</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty', window );">Maximum beneficial ownership allowable per agreement (percent)</a></td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice', window );">Accelerated purchases specified floor price threshold for directed purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember', window );">ATM Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement', window );">Aggregate offering amount authorized per agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Stock issued (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase Agreement, Accelerated Purchase Specified Stock Floor Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Issued As Consideration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_TermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_TermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_LincolnParkAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_AtTheMarketOfferingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057609456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Options and Warrants (Q1) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Stock Options, Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, outstanding, beginning balance (in shares)</a></td>
<td class="nump">2,131,849<span></span>
</td>
<td class="nump">963,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options, Granted (in shares)</a></td>
<td class="nump">540,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options, Forfeited (in shares)</a></td>
<td class="num">(9,565)<span></span>
</td>
<td class="num">(29,842)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options, Expired (in shares)</a></td>
<td class="num">(23,275)<span></span>
</td>
<td class="num">(109,549)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options, outstanding, ending balance (in shares)</a></td>
<td class="nump">2,639,609<span></span>
</td>
<td class="nump">2,131,849<span></span>
</td>
<td class="nump">963,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options, Vested and expected to vest (in shares)</a></td>
<td class="nump">2,594,630<span></span>
</td>
<td class="nump">2,120,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Options, Vested (in shares)</a></td>
<td class="nump">1,408,083<span></span>
</td>
<td class="nump">1,122,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Stock Options, Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, outstanding. beginning balance (in dollars per share)</a></td>
<td class="nump">$ 5.64<span></span>
</td>
<td class="nump">$ 14.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options, Granted (in dollars per share)</a></td>
<td class="nump">0.91<span></span>
</td>
<td class="nump">1.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options, Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options, Forfeited (in dollars per share)</a></td>
<td class="nump">1.90<span></span>
</td>
<td class="nump">2.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options, Expired (in dollars per share)</a></td>
<td class="nump">26.00<span></span>
</td>
<td class="nump">34.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options, outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">4.51<span></span>
</td>
<td class="nump">5.64<span></span>
</td>
<td class="nump">$ 14.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options, Vested and expected to vest (in dollars per share)</a></td>
<td class="nump">4.57<span></span>
</td>
<td class="nump">5.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Options, Vested (in dollars per share)</a></td>
<td class="nump">$ 7.36<span></span>
</td>
<td class="nump">$ 9.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Options, Weighted Average Contractual Term and Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">7 years 9 months 29 days<span></span>
</td>
<td class="text">7 years 11 months 19 days<span></span>
</td>
<td class="text">5 years 10 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Options, Vested and expected to vest, Weighted Average Remaining Contractual Term</a></td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
<td class="text">7 years 11 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OptionsVestedweightedAverageRemainingContractualTerm', window );">Options, Vested, Weighted Average Remaining Contractual Term</a></td>
<td class="text">6 years 4 months 28 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options, Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Options, Vested and expected to vest, Aggregate Intrinsic Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options, Vested, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Warrants, Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_CommonStockWarrantsShares', window );">Warrants outstanding, beginning balance (in shares)</a></td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">2,638,355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsGranted', window );">Warrants, Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,519,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsExercised', window );">Warrants, Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(801,148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsCanceled', window );">Warrants, Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsExpired', window );">Warrants, Expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_CommonStockWarrantsShares', window );">Warrants outstanding, ending balance (in shares)</a></td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">2,638,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_Sharesvestedandexpectedtovest', window );">Warrants, Vested and expected to vest (in shares)</a></td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">21,356,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsVested', window );">Warrants, Vested (in shares)</a></td>
<td class="nump">21,356,600<span></span>
</td>
<td class="nump">21,356,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsWeightedAverageExercisePriceRollForward', window );"><strong>Warrants, Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding', window );">Warrants outstanding, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsGranted', window );">Warrants, Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExercised', window );">Warrants, Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsCanceled', window );">Warrants, Forfeited (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExpired', window );">Warrants, Expired (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding', window );">Warrants outstanding, ending balance (in dollars per share)</a></td>
<td class="nump">2.84<span></span>
</td>
<td class="nump">2.84<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest', window );">Weighted Average Exercise Price, Warrants Vested And Expected To Vest</a></td>
<td class="nump">2.84<span></span>
</td>
<td class="nump">2.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageExercisePriceWarrantsExercisable', window );">Warrants, Vested, Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WarrantsOtherDisclosuresAbstract', window );"><strong>Warrants, Weighted Average Contractual Term and Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding', window );">Warrants, Outstanding, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 1 month 17 days<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
<td class="text">4 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest', window );">Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 1 month 17 days<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_WeightedAverageRemainingContractualTermwarrantsvested', window );">Warrants, Vested, Weighted Average Remaining Contractual Term</a></td>
<td class="text">4 years 1 month 17 days<span></span>
</td>
<td class="text">4 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsOutstanding', window );">Warrants Outstanding, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest', window );">Warrants, Vested and expected to vest, Aggregate Intrinsic Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_AggregateIntrinsicValueWarrantsvested', window );">Warrants, Vested, Aggregate Intrinsic Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value, Warrants vested and expected to vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_CommonStockWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock Warrants, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_CommonStockWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OptionsVestedweightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Options, Vested, weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OptionsVestedweightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_Sharesvestedandexpectedtovest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>shares, vested and expected to vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_Sharesvestedandexpectedtovest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Canceled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Other Disclosures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants, Vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WarrantsWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Weighted Average Exercise Price [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WarrantsWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Canceled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Granted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Price, Warrants Vested And Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermwarrantoutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term warrant outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermwarrantoutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_WeightedAverageRemainingContractualTermwarrantsvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>weighted Average Remaining Contractual Term, warrants vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_WeightedAverageRemainingContractualTermwarrantsvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057661568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted Stock and Restricted Stock Units (Q1) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of shares issued</a></td>
<td class="nump">1,061,175<span></span>
</td>
<td class="nump">300,450<span></span>
</td>
<td class="nump">612,950<span></span>
</td>
<td class="nump">156,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Value of shares issued</a></td>
<td class="nump">$ 973,000<span></span>
</td>
<td class="nump">$ 478,000<span></span>
</td>
<td class="nump">$ 877,700<span></span>
</td>
<td class="nump">$ 512,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value</a></td>
<td class="nump">$ 0.92<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
<td class="nump">$ 3.28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of shares issued</a></td>
<td class="nump">1,379,860<span></span>
</td>
<td class="nump">458,245<span></span>
</td>
<td class="nump">458,245<span></span>
</td>
<td class="nump">325,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Value of shares issued</a></td>
<td class="nump">$ 1,265,000<span></span>
</td>
<td class="nump">$ 729,000<span></span>
</td>
<td class="nump">$ 728,600<span></span>
</td>
<td class="nump">$ 863,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.59<span></span>
</td>
<td class="nump">$ 2.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting terms (years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057278704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Share-Based Compensation Expense (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 760<span></span>
</td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 2,005<span></span>
</td>
<td class="nump">$ 1,265<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">760<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 542<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
<td class="nump">$ 1,245<span></span>
</td>
<td class="nump">$ 1,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126574432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Compensation Cost Not Yet Recognized (Q1) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 814<span></span>
</td>
<td class="nump">$ 757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">1 year 9 months 7 days<span></span>
</td>
<td class="text">1 year 7 months 20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 444<span></span>
</td>
<td class="nump">$ 149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">11 months 15 days<span></span>
</td>
<td class="text">1 year 6 months 25 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost</a></td>
<td class="nump">$ 1,004<span></span>
</td>
<td class="nump">$ 546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Expected weighted-average period in years of compensation cost to be recognized</a></td>
<td class="text">2 years 3 months<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761126861616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Q1) (Details) - Stock Options - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total fair value of shares vested</a></td>
<td class="nump">$ 377<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
<td class="nump">$ 757<span></span>
</td>
<td class="nump">$ 536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average estimated fair value of shares granted</a></td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 1.08<span></span>
</td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761057627312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Q1) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Feb. 22, 2022</div></th>
<th class="th"><div>Apr. 12, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain', window );">Possible additional NOLs for five years resulting from Net Unrealized Built-in Gain rules</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross', window );">Proceeds from sale of NOLs, gross</a></td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram', window );">Net proceeds from sale of NOLs</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_LossOnSaleOfNetOperatingLosses', window );">Loss on sale of NOLs</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OperatingLossCarryforwardsBeforeWriteDown', window );">Net operating loss carryforwards, prior to write down</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.0<span></span>
</td>
<td class="nump">$ 264.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_OperatingLossCarryforwardsSetToExpireWrittenDown', window );">Write down of NOLs set to expire unutilized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">169.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New Jersey</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.0<span></span>
</td>
<td class="nump">99.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
<td class="nump">70.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_LossOnSaleOfNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss On Sale Of Net Operating Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_LossOnSaleOfNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Annual Available, Five Years, Net Unrealized Built In Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLossCarryforwardsBeforeWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Before Write Down</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLossCarryforwardsBeforeWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_OperatingLossCarryforwardsSetToExpireWrittenDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Set To Expire, Written Down</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_OperatingLossCarryforwardsSetToExpireWrittenDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Net Operating Losses, NJEDA Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewJerseyDivisionOfTaxationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139761055151488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Q1) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th"><div>Apr. 26, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Merger Agreement | Cend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage', window );">Expected post-merger ownership in Company by Cend stockholders (percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage', window );">Expected post-merger ownership in Company by Company stockholders (percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation', window );">Transaction expenses threshold for allocation</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementMinimumNetCashThreshold', window );">Minimum net cash threshold at closing per agreement</a></td>
<td class="nump">64,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementPotentialTerminationFeePayable', window );">Potential termination fee payable</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementPotentialTerminationFeeReceivable', window );">Potential termination fee receivable</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_MergerAgreementPotentialExpenseReimbursement', window );">Potential expense reimbursement per agreement</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Cend Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PurchaseOfPreferredStockPricePerShare', window );">Series D original issue price (in usd per share)</a></td>
<td class="nump">$ 8.8057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PurchaseOfPreferredStockAggregatePrice', window );">Aggregate price</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PreEquityOfferingValueAfterConversion', window );">Pre-Equity Offering Value After Conversion</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Cend Purchase Agreement | Cend Series D preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_PurchaseOfPreferredStockShares', window );">Number of shares purchased</a></td>
<td class="nump">1,135,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Cend Purchase Agreement | Cend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_clbs_GrossProceedsOnTransaction', window );">Potential gross proceeds</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_GrossProceedsOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross Proceeds On Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_GrossProceedsOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Expected Ownership In Company, Company Stockholders, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Expected Ownership In Company, Counterparty Stockholders, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementMinimumNetCashThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Minimum Net Cash Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementMinimumNetCashThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementPotentialExpenseReimbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Potential Expense Reimbursement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementPotentialExpenseReimbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementPotentialTerminationFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Potential Termination Fee Payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementPotentialTerminationFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementPotentialTerminationFeeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Potential Termination Fee Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementPotentialTerminationFeeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Merger Agreement, Transaction Expenses Threshold For Ratio Allocation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PreEquityOfferingValueAfterConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Equity Offering Value After Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PreEquityOfferingValueAfterConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PurchaseOfPreferredStockAggregatePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase Of Preferred Stock, Aggregate Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PurchaseOfPreferredStockAggregatePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PurchaseOfPreferredStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase Of Preferred Stock, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PurchaseOfPreferredStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_clbs_PurchaseOfPreferredStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase Of Preferred Stock, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">clbs_PurchaseOfPreferredStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>clbs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=clbs_AgreementAndPlanOfMergerAndReorganizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=clbs_AgreementAndPlanOfMergerAndReorganizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=clbs_CendTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=clbs_CendTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=clbs_CendSeriesDPreferredStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=clbs_CendSeriesDPreferredStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=clbs_SeriesDPreferredStockCendMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=clbs_SeriesDPreferredStockCendMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=clbs_CendTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=clbs_CendTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>ny20004343x2_s4a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:clbs="http://caladrius.com/20220726"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="clbs-20220726.xsd" xlink:type="simple"/>
    <context id="c20220101to20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210101to20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210331_StatementEquityComponentsAxis_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_ParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20171231_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_CLBS16TreatmentOfCMDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">clbs:CLBS16TreatmentOfCMDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_BalanceSheetLocationAxis_MarketableSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clbs:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_BalanceSheetLocationAxis_MarketableSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">clbs:MarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20200630_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2017AmendedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c20200630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c20170531_PlanNameAxis_EmployeeStockPurchasePlan2017Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="c20210630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="c20130101_PlanNameAxis_EmployeeStockPurchasePlan2012Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2012Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2013-01-01</instant>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_PlanNameAxis_EquityIncentiveCompensationPlan2018Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EquityIncentiveCompensationPlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2017AmendedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_PlanNameAxis_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">clbs:EmployeeStockPurchasePlan2017AmendedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="c20210604_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-04</instant>
        </period>
    </context>
    <context id="c20180831_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="c20210201to20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:InstitutionalPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="c20210101to20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:January2021PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="c20210201to20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AdditionalPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:January2021PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AdditionalPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:InstitutionalPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="c20211231_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20180801to20180831_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="c20180201to20210212_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2021-02-12</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:H.C.WainwrightSalesAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210201to20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="c20210101to20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c20170228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <instant>2017-02-28</instant>
        </period>
    </context>
    <context id="c20170501to20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="c20170501to20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c20171201to20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="c20180301to20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="c20190501to20190531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2019-05-01</startDate>
            <endDate>2019-05-31</endDate>
        </period>
    </context>
    <context id="c20200901to20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_IncomeTaxAuthorityAxis_DomesticCountryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:NewJerseyDivisionOfTaxationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c20210412to20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2021-04-12</startDate>
            <endDate>2021-04-12</endDate>
        </period>
    </context>
    <context id="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">clbs:CendTherapeuticsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">clbs:AgreementAndPlanOfMergerAndReorganizationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-26</instant>
        </period>
    </context>
    <context id="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20220101to20220331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220331_AwardTypeAxis_RestrictedStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="c20220222to20220222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
        </entity>
        <period>
            <startDate>2022-02-22</startDate>
            <endDate>2022-02-22</endDate>
        </period>
    </context>
    <context id="c20220426to20220426_StatementClassOfStockAxis_SeriesDPreferredStockCendMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">clbs:SeriesDPreferredStockCendMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-26</startDate>
            <endDate>2022-04-26</endDate>
        </period>
    </context>
    <context id="c20220426_StatementClassOfStockAxis_SeriesDPreferredStockCendMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">clbs:SeriesDPreferredStockCendMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-26</instant>
        </period>
    </context>
    <context id="c20220426to20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-26</startDate>
            <endDate>2022-04-26</endDate>
        </period>
    </context>
    <context id="c20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-26</instant>
        </period>
    </context>
    <context id="c20220426to20220426_LegalEntityAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000320017</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">clbs:CendSeriesDPreferredStockPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">clbs:CendTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-26</startDate>
            <endDate>2022-04-26</endDate>
        </period>
    </context>
    <unit id="U001">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="U002">
        <measure>shares</measure>
    </unit>
    <unit id="U003">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U004">
        <measure>clbs:office</measure>
    </unit>
    <unit id="U005">
        <measure>pure</measure>
    </unit>
    <unit id="U006">
        <measure>clbs:offering_period</measure>
    </unit>
    <dei:DocumentType
      contextRef="c20220101to20220331"
      id="Fact_574737c10f394a5e9755cec5ab7de35d">S-4/A</dei:DocumentType>
    <dei:AmendmentFlag
      contextRef="c20220101to20220331"
      id="Fact_238daff061ab46d2b2b8895981147e5d">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="c20220101to20220331"
      id="Fact_1e5a71510c134de08f66144992d105ec">CALADRIUS BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="c20220101to20220331"
      id="Fact_45344d3f03804fa3b37d56200e0fd1d6">0000320017</dei:EntityCentralIndexKey>
    <dei:EntityFilerCategory
      contextRef="c20220101to20220331"
      id="Fact_007e9f44cc7f42e49d97494af57fd318">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="c20220101to20220331"
      id="Fact_930baf0bc2aa4049af949a4c079e0d95">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220101to20220331"
      id="Fact_38b1318e52f545ca93da974d8d454a22">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="c20211231"
      id="Fact_ce1d736a988a4564aff92c00256cdd92">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="c20211231"
      id="Fact_02a6f0c3111348a5b2e0df82b435956e">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="c20201231"
      id="Fact_6c255ea4f7c24c48b604a925c0f5819f">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="c20211231"
      id="Fact_394d33db98754a5dbaa2063579daa0be">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="c20211231"
      id="Fact_f6a138b4447e4c69840c11bceb8fe65d">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="c20201231"
      id="Fact_d2023c19465a459a9ecb0fec411ae9c3">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="c20211231"
      id="Fact_646cbb0a67a54f629dc6c425eb143706">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="c20211231"
      id="Fact_3980d08cb35e4c0087f62256aa859a67">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="c20201231"
      id="Fact_b65fe760104b4546b3abaa579a18c88c">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"
      id="Fact_b33f9ae5fcb543bd9c7f792ce5439476">P5Y6M</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMember"
      id="Fact_71e638d2f8944c3b8762be6c9f077488">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="c20220331"
      id="Fact_2bb6a876105046b48a849d6ac8adfc37">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="c20220331"
      id="Fact_01cbbf57a5d5461f83158b26769ed161">http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="c20220331"
      id="Fact_52d14b2a09d54c84bb4a3b7e7f351e66">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember_RangeAxis_MinimumMember"
      id="Fact_09a53c4a1103459dacf922bb1b50b09c">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4f706008f38d42959f3a25816f2cc4fe"
      unitRef="U001">24647000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_6378aac9e58f4fea95e25dd057172a8d"
      unitRef="U001">16512000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e3655d3ae41748f58d389f81a77fb1ae"
      unitRef="U001">70323000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_683953c60e604540b28da57081dea267"
      unitRef="U001">18061000</us-gaap:MarketableSecurities>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_eb7b2e3784214f05b76b6111e65e73c0"
      unitRef="U001">1212000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d5bc1d43587f45c5b1ef4145a0566e55"
      unitRef="U001">758000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d6d8d76dc08247b496911bfc8f97e9ce"
      unitRef="U001">96182000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_a144fbad57804481a4221185804aaa36"
      unitRef="U001">35331000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_707d1fda3f1c4a608d6bdea5dd4f2d36"
      unitRef="U001">62000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20201231"
      decimals="-3"
      id="Fact_fa17bd27a2f04b989da8ebc8c0170ce9"
      unitRef="U001">57000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_98273a1d047b4a9a8d56dcaddea2a39b"
      unitRef="U001">764000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_25e379a136d24676a004bb6e7bfe5169"
      unitRef="U001">614000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3fb5a146fd154ba2a1c0650c472bb324"
      unitRef="U001">97008000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20201231"
      decimals="-3"
      id="Fact_ab0568f2465b48359beeded821b4e24d"
      unitRef="U001">36002000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1640881b842e480ba3a072b6f2029ab1"
      unitRef="U001">1934000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_6ef9e9b08be041c7a5ecd8fb12f4f31c"
      unitRef="U001">1020000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5ed45443ed0e46ddbe8811138498eff3"
      unitRef="U001">2589000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f9ec3ba46b8f41409b6f06688721cd4b"
      unitRef="U001">2486000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3d3736e6b29f4edcbb3cb791b8e129ef"
      unitRef="U001">4523000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_da3fb9521a34406f9b64deeb9b1e1374"
      unitRef="U001">3506000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_23362d668b574881b7d85cd923fa4f09"
      unitRef="U001">485000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_c26325949fa44f3a84661818092fb27b"
      unitRef="U001">254000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7db2082ad1cd43e0b533473318e45221"
      unitRef="U001">5008000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_0e373271491b4106b874a7cc4f2353be"
      unitRef="U001">3760000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20211231"
      id="Fact_bc88fa29a7ec4335a446b74a37c6ad33"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20201231"
      id="Fact_f94401450b7545d1adac90a25bf513f5"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_6d53c4b9bb6b4298989039f32e41af54"
      unitRef="U002">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20201231"
      decimals="0"
      id="Fact_af982deb5f3c4feab633b46acc86213e"
      unitRef="U002">20000000</us-gaap:PreferredStockSharesAuthorized>
    <clbs:PreferredStockLiquidationPreferenceShare
      contextRef="c20211231"
      decimals="INF"
      id="Fact_7592194032a04eb3a35e47fa09b28789"
      unitRef="U002">0.001</clbs:PreferredStockLiquidationPreferenceShare>
    <clbs:PreferredStockLiquidationPreferenceShare
      contextRef="c20201231"
      decimals="INF"
      id="Fact_fa8d1a7fdecc49a59ea71521fcd429a6"
      unitRef="U002">0.001</clbs:PreferredStockLiquidationPreferenceShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="2"
      id="Fact_16d68f7576c747528355ea1d379a7112"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20201231"
      decimals="2"
      id="Fact_8d1388b139ca44dfb6d6d290d01637e8"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <clbs:PreferredStockSharesDesignated
      contextRef="c20211231"
      decimals="0"
      id="Fact_375e5aad2e87477099601b0602cb27e9"
      unitRef="U002">825000</clbs:PreferredStockSharesDesignated>
    <clbs:PreferredStockSharesDesignated
      contextRef="c20201231"
      decimals="0"
      id="Fact_1fb7c1d33df34e4583cdec13f62e9fe9"
      unitRef="U002">825000</clbs:PreferredStockSharesDesignated>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20211231"
      decimals="0"
      id="Fact_084b3dd56ca74f6c80711979cdae2f1d"
      unitRef="U002">10000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20201231"
      decimals="0"
      id="Fact_532b4b451fb646ea9b7ea414fbbe8920"
      unitRef="U002">10000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20211231"
      decimals="0"
      id="Fact_e919c4a7164d4088873f18dc238481a8"
      unitRef="U002">10000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20201231"
      decimals="0"
      id="Fact_ebe439019aef4b23a4847d7936613490"
      unitRef="U002">10000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_edc8b55ab509407780034d85b80fb46b"
      unitRef="U001">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_903c2a46a2c34f63b6ba618c7b21d3bd"
      unitRef="U001">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="3"
      id="Fact_d880fb6637d04cb1be0f769c987e7a3b"
      unitRef="U003">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20201231"
      decimals="3"
      id="Fact_389c6a22fc1b4024b38dc8198339ec9f"
      unitRef="U003">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_fd90a8b140a6404680d368679a9d807f"
      unitRef="U002">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20201231"
      decimals="0"
      id="Fact_7ab39bc2ef4b4623a21635097659e3ab"
      unitRef="U002">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20211231"
      decimals="0"
      id="Fact_9a1d58e9963e474a9e71ecb911b28b5f"
      unitRef="U002">59800792</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20201231"
      decimals="0"
      id="Fact_9678c9f8fbfe4118a3b2eda52a5e0b32"
      unitRef="U002">19389413</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20211231"
      decimals="0"
      id="Fact_e11a9d842b49451aba7b1e36932fe2c0"
      unitRef="U002">59789712</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20201231"
      decimals="0"
      id="Fact_8ba042e48fb54d30885de180554068f2"
      unitRef="U002">19378333</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_dfacaf548a3d477fb6352817a4ff2583"
      unitRef="U001">60000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d4d452d3ccb847a6a080bd65b3bf130a"
      unitRef="U001">19000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20211231"
      decimals="-3"
      id="Fact_83652405c70a4878a84d0b5ceb88303b"
      unitRef="U001">545988000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20201231"
      decimals="-3"
      id="Fact_a279eb5da21f449c9ca2c9d16c9633ed"
      unitRef="U001">458748000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="c20211231"
      decimals="0"
      id="Fact_4f4f0c29bd934259af3bded25b69240f"
      unitRef="U002">11080</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="c20201231"
      decimals="0"
      id="Fact_c199f4f2659443589d5dcf6b1dfef9c3"
      unitRef="U002">11080</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_74ef592640f2497f8e167f529aacf63a"
      unitRef="U001">708000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_3537ddd33e16469fb85bc3f1b68ba439"
      unitRef="U001">708000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ebf72b39945e45a58ac184f82bdddea9"
      unitRef="U001">-453016000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f1674e69496b4e8885eaf7ba6bcc8b49"
      unitRef="U001">-425550000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7781b99bfeef447da87264b2336d82b5"
      unitRef="U001">-70000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e7e731cc56b844a18f0cf1b0492657be"
      unitRef="U001">-13000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e2048f15debe46ac9163edd69a19bb36"
      unitRef="U001">92254000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_db4fcc1e5ede4db49701e983f83dd3f8"
      unitRef="U001">32496000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_fcf386360cc741a581c325589014403c"
      unitRef="U001">-254000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_49e2837febff4cd68e245cf46ef2bd1f"
      unitRef="U001">-254000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bed677ed1b4a4a269ff073a1c07d35f0"
      unitRef="U001">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_0ec0862a02a14f51a4cec34ba252bb4d"
      unitRef="U001">32242000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2ac4c6c46ce7469a8f458d58bfad643c"
      unitRef="U001">97008000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20201231"
      decimals="-3"
      id="Fact_7adb937a3a124489bb8e3d41df48ca10"
      unitRef="U001">36002000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_730faa7e6b3f43408d243b8c791b4132"
      unitRef="U001">17680000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_f2a01141bc2047ecbc0ada85ad877d48"
      unitRef="U001">9253000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a5e36dc3271c44d6869f04e8485d501f"
      unitRef="U001">11370000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_cd1828acfff64bcfafc171c6cee6b785"
      unitRef="U001">9892000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_103d07189e574bf8a528e6327fbdafa4"
      unitRef="U001">29050000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1c15296560574b2abd997f5ddcba0ef8"
      unitRef="U001">19145000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a3edfaeb80f648a7a3063f217081ccf0"
      unitRef="U001">-29050000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6f9c869ee53a4c08a23f3a350d972ce3"
      unitRef="U001">-19145000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_94543b28727e4ead8444a28ad9b0bc43"
      unitRef="U001">151000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_68ca4e57cb894ffd921da26f612116c5"
      unitRef="U001">132000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_64bc85c642e54e13892df11752bad7ae"
      unitRef="U001">-75000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_8dc1eb0e36674ad49994890145cedad0"
      unitRef="U001">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_631d87ba9b0f4c8fa99bd852d73fb505"
      unitRef="U001">76000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_39d4c910b9f54dfcad84a94c5a69edee"
      unitRef="U001">132000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_cea1751ec8264e0fab4159ef1c541039"
      unitRef="U001">-28974000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_10e6afd265074312a2c66913dbd2a2d6"
      unitRef="U001">-19013000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_4b4162348e694020928d9d72bb20f378"
      unitRef="U001">-1508000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_4bdfd548e6a04061b57185daf84e3ee9"
      unitRef="U001">-10872000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d2b382715bc04cf78438b8531f4a331d"
      unitRef="U001">-27466000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1ef46c6f074f4233a024b03ed5d073b6"
      unitRef="U001">-8141000</us-gaap:ProfitLoss>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7c9980801d484652aa56a7a8965e2bd2"
      unitRef="U001">0</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_dfd5ec91616641bdba866d4a20e98631"
      unitRef="U001">9000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_225353637d1c462f978bca02951b5f77"
      unitRef="U001">-27466000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_14a0e7dfdfb84fe79cd2912b6ae8f49d"
      unitRef="U001">-8150000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_49097c908e0b408c934cfc7e9483ca44"
      unitRef="U003">-0.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_5c6129726dec4068a1a7f8df694589e4"
      unitRef="U003">-0.50</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_bd0ee92921ed4b74863d83403df1989f"
      unitRef="U003">-0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20200101to20201231"
      decimals="2"
      id="Fact_b8b890886bf144b0b5dd2576084e96f7"
      unitRef="U003">-0.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9c14e7c4c6834fefbb34231147b27533"
      unitRef="U002">55313000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_4f2bbd568d8d49939ee3e141b458fe30"
      unitRef="U002">55313000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_5e22c4d818c646438c3ceea17c04d483"
      unitRef="U002">15440000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2b8a4c373e8044fa88ba0c3a4bf823f6"
      unitRef="U002">15440000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d22fc70c05564d3ab4deb7d3c7dea574"
      unitRef="U001">-27466000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9c6e3f7ed45b42d3abd751ee15de1326"
      unitRef="U001">-8141000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_0074a9e7da334317ae2e9b14af6b6550"
      unitRef="U001">-57000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6a3c6a4118084fa4a75b352ec6586a4c"
      unitRef="U001">-15000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_562579d47dd64d9a801c5a8072959d28"
      unitRef="U001">-57000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9367449a5e41435681ac373cc0da0e4e"
      unitRef="U001">-15000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_49ee771c1b444a1a8115d077af97aa3b"
      unitRef="U001">-27523000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_40265068c9e149e29254719db7821059"
      unitRef="U001">-8156000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_623e6308b6fe4c778412cc79b6e94bc6"
      unitRef="U001">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6d24eb6dc80a44ba9fa2f96db60c69d6"
      unitRef="U001">9000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_877b093471984c3d8bb262ef4e3f397e"
      unitRef="U001">-27523000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_91ae8e4d37ee4741a31162df6689fe72"
      unitRef="U001">-8165000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c20191231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_0c7b759d82704a499c273446c199041e"
      unitRef="U002">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_b76bd8c3167443c0a3fef4b35f4f5be3"
      unitRef="U001">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_583c6553a96043c2bb252e2e7381dab5"
      unitRef="U002">10529000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_afe7866be25c41328ccb7902bcb84afc"
      unitRef="U001">11000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_6ca80407112a40e79e977d0f834b7eff"
      unitRef="U001">438911000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_338963560d724e8187a66a70ab6cf90b"
      unitRef="U001">2000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_ad138ddc9aa4490497473bea2f3bce31"
      unitRef="U001">-417400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_367ea42980f4498fb63c4ce96656c6ff"
      unitRef="U001">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_64bd9c91ebed481aa822e9158878dc4c"
      unitRef="U001">20816000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_1e85a7a521824bf6b3c14951b3bfd6bc"
      unitRef="U001">-263000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20191231"
      decimals="-3"
      id="Fact_03ad501f382047b48cab6fedd16999cc"
      unitRef="U001">20553000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_531653fcc05845278c0ce40a4c0bea11"
      unitRef="U001">-8150000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_a9b62c8a608540b0abeb55a5cb604644"
      unitRef="U001">-8150000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_686ccf36a7b142b0be25471a76a98c45"
      unitRef="U001">9000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_a796cc30b38c438991d07dc52da3de97"
      unitRef="U001">-8141000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_53d056c9721047d0ab3755d406fa81ce"
      unitRef="U001">-15000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_637c104d7b4046c78b73a0a38f47aebd"
      unitRef="U001">-15000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_90035d8c91ef45c4ad2e26e4fff7322c"
      unitRef="U001">-15000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_876940d4bd7d4c4ebbdd5f3a134edc2e"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f2e882059d254bf49a29c42d77c76318"
      unitRef="U002">53000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_eb7904cefa704d9e9102e39652d1b9ad"
      unitRef="U001">1117000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_cb5204845652402a9d115a1a153578a3"
      unitRef="U001">1117000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_4a4fca8a325e47b7bca70d79a2b20efc"
      unitRef="U001">1117000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a39d50320e524251851329a19c744ebb"
      unitRef="U002">8807000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_3ded4b6a4599410c8cef86fa5aa87822"
      unitRef="U001">8000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_09540c5bb61b43478415cfb1395572fe"
      unitRef="U001">18720000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20200101to20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_52744e2ec4024edfa0fb4721fcf7f0de"
      unitRef="U001">18728000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_94507d8dc29c4d3e9a5aeddb90f17d2c"
      unitRef="U001">18728000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_7049e91b284448fd9573fde55ab66f36"
      unitRef="U002">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_e9b39c0971aa45c9b4ca89d4010d532d"
      unitRef="U001">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_ad3897fb537b4bd9a16c54cb23538ab7"
      unitRef="U002">19389000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a915f1ef9b2c4fc3bc082f4ba67f95e2"
      unitRef="U001">19000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_1c94de6bb36a416b9063ee7d6a7cd40f"
      unitRef="U001">458748000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_70fe314411eb4682a64e233c078d93c7"
      unitRef="U001">-13000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_bedbd1510fea4c808fda91640f15aaac"
      unitRef="U001">-425550000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_020265c442914faa8ea689662bff9f4d"
      unitRef="U001">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_b57ada58dc824f24ba0121e12c699b86"
      unitRef="U001">32496000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_43c142ac6266466885664619558c9491"
      unitRef="U001">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_614a83f7fdea4a739d80e5d25eb02be7"
      unitRef="U001">32242000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_9fa0bbdae9e347ccb158544503dc70ef"
      unitRef="U001">-27466000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_fa310e0c51584f7c9551dfc5f716f136"
      unitRef="U001">-27466000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_2598fa8f236a427dbfffe1633d57f747"
      unitRef="U001">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c9bd8f45c672423bad760052cfd519ea"
      unitRef="U001">-27466000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_798afd7a6dea4242a5507ff8e3784db5"
      unitRef="U001">-57000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_cb8c118dfddc410d8526169795341135"
      unitRef="U001">-57000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_cdc527d2278645a498bb462da4630691"
      unitRef="U001">-57000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_1082b8af81da449bb507e2b298edf145"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_3eb6f8f76b0c44f582fea0e8251ac767"
      unitRef="U002">517000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_ac92670e90f64c169a33b79dff2886d7"
      unitRef="U001">1757000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_12c071a2cd874faabaef3a6dcefd9f32"
      unitRef="U001">1757000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_b1edbc11d234455da20d728b0c6133ac"
      unitRef="U001">1757000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_063180016d024d9faf268ca6a5664217"
      unitRef="U002">39888000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_6555ae291a084d1e9345c2313c2edd44"
      unitRef="U001">41000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_80bf964946184af0b5ddd0eb58cdc7ed"
      unitRef="U001">85459000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_0f3bf2e8fd924732941c6ed400d80d30"
      unitRef="U001">85500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_26ff2b72514043949857ab4e63cc1eb9"
      unitRef="U001">85500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_d40434ee5b264fda830c533bfd53563a"
      unitRef="U002">7000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_a878b9ce8fc54a978a1ebb68bddbab8e"
      unitRef="U001">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_34fb4b523ac841aa886a97a53e557325"
      unitRef="U001">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_6b64f2b4e0db4e20996412873177a705"
      unitRef="U001">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_97516d87cde14951b57fa8e281ddf98c"
      unitRef="U001">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_5edbd4050fe346fe9f9a1a99179de06d"
      unitRef="U002">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_122bfbf6faef487093ccf00a494c85fb"
      unitRef="U001">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_45429c52e2bb42299d4415c37fe07a89"
      unitRef="U002">59801000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_95b3c390bd6040108c9d1cea976acc3a"
      unitRef="U001">60000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_6bc13017326f4c9fa237097c8eedd080"
      unitRef="U001">545988000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_2895e3c3735a4daa9b4c0d490d79db0d"
      unitRef="U001">-70000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_a75e3deadd0441ae8d3f68b65e3a56f2"
      unitRef="U001">-453016000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_786f23a6d57c47b0be7734a3d296ed5d"
      unitRef="U001">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_c918c6c1f3284dfe87f61a56d8d6a5dd"
      unitRef="U001">92254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_46c0d6d77639459ba33b5d395d57c1ef"
      unitRef="U001">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bbbe99c3621545b9a85bcb09283017ff"
      unitRef="U001">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bf03ebf94b9f4727b31baec9a405b35e"
      unitRef="U001">-27466000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_20c6e284064c4e0f8199385a58f04129"
      unitRef="U001">-8141000</us-gaap:ProfitLoss>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_d4a53a5cff8441acb5d3910920954b1a"
      unitRef="U001">2005000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_242207e22694449db81e695d94117499"
      unitRef="U001">1265000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:DepreciationAndAmortization
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_0c576bc2c77a4319bf54d0c2518128c6"
      unitRef="U001">55000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_153aacbbca73492291cda31cecb8fbff"
      unitRef="U001">63000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_789a8138e4444ef8bf5dfe922b6a74e8"
      unitRef="U001">-2514000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_4bcfdd08dde14ba98a95e62e03789ed4"
      unitRef="U001">-307000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3012079badca4f80b30fa16b4d6181cc"
      unitRef="U001">453000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d3c543bdc0a24d0a853905706c53394b"
      unitRef="U001">-56000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_93eb6a33392341429a557fa7a89e54b2"
      unitRef="U001">150000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_896ebf9e347e4796b63c124405a3a327"
      unitRef="U001">-466000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c47c62e50f2940838ef6f49dea6795e6"
      unitRef="U001">1250000</clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities>
    <clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e078b771973e45d883e99519e3a565a6"
      unitRef="U001">-2839000</clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7a2545d8217c4c5498f2e010c8f5512c"
      unitRef="U001">-22245000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e2b03c50319d464e9d65fbbef2a95fd7"
      unitRef="U001">-8823000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_315c1814b88e41cea718fdbf41f5db12"
      unitRef="U001">179775000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9835bf08c2e04281b225159d1c39879d"
      unitRef="U001">34799000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_29a661688e4747f7932f45418d0acae8"
      unitRef="U001">124939000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_86cb338ef5a94cc389f9839a740815bf"
      unitRef="U001">27542000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_559bb51d54cb4becabb0e0b8443b9c95"
      unitRef="U001">60000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_90da396232a74d18acaee3910e261f79"
      unitRef="U001">20000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_bf3b613563d844fcb73f41b0cbc82af1"
      unitRef="U001">-54896000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_bff14723fe4540c7a7bc15951b323439"
      unitRef="U001">-7277000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_80cba98b0ead4813b72d8a0c9ab70e4b"
      unitRef="U001">24000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b3c3565fbfb5422892f77da1bc9c13c8"
      unitRef="U001">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_67c57a1fb3994d0eae09d61ac7616aca"
      unitRef="U001">248000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_69ef8d25198a43cb9dab2b3cd1fac980"
      unitRef="U001">148000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_401be99e6e9a4cb1b3270dcedb69b34f"
      unitRef="U001">85500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_2b3a54317fcf47d696208828814c72cb"
      unitRef="U001">18728000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9de717464f6545e096a0a486505179a4"
      unitRef="U001">85276000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_5764c4c42b494d5980ae420c24c4ea23"
      unitRef="U001">18580000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_247506825b084cd885e11b852be4f300"
      unitRef="U001">8135000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_37b4e94358064de3ae5e12eba01a0432"
      unitRef="U001">2480000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_fa7f30af90a14de4b511e9fabb9268b2"
      unitRef="U001">16512000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20191231"
      decimals="-3"
      id="Fact_f15e36ab2cb4460eaba449576af17781"
      unitRef="U001">14032000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b48b47c4cc7445aaa7ccb63de4e67621"
      unitRef="U001">24647000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_83a854bf9276448d8a86bb7e733c740f"
      unitRef="U001">16512000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_9931cc7c059e4002b85bb5745973f798"
      unitRef="U001">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_b5c819360e1d4be58dd427cb806a8214"
      unitRef="U001">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ef712ddf72bf4ddb82bf0211337ec7ae"
      unitRef="U001">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_1945a96c1fdd42988bfd4c8f9e9a7e65"
      unitRef="U001">0</us-gaap:IncomeTaxesPaid>
    <clbs:BusinessTextBlock
      contextRef="c20210101to20211231"
      id="Text_5985e66aba6949ca8a068d74294d0c4a">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 1 &#x2013; The Business&lt;/span&gt;&lt;/div&gt;

&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;OVERVIEW&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Caladrius Biosciences, Inc. (&#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;Caladrius&#x201d; or the
            &#x201c;Company&#x201d;) is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The Company is developing what are intended to be first-in-class therapeutics based on the characteristics of
            naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its technology is intended to leverage these cells to enable the body's natural repair mechanisms using formulations unique to each medical
            indication.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's leadership team has decades of collective
            biopharmaceutical development experience. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The Company's current product candidates include:&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"&gt;XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt; (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow-on Phase
                    2b study (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#x201c;CMD&#x201d;);&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"&gt;HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the
                    treatment of critical limb ischemia (&#x201c;CLI&#x201d;) and Buerger&#x2019;s disease is being sought based on the current results of a clinical trial executed in Japan. HONEDRA&#xae; was the recipient of orphan drug designation in March 2021 from the U.S. Food
                    and Drug Administration (&#x201c;FDA&#x201d;) for Buerger's disease; and&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"&gt;CLBS201, designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients with chronic kidney
                    disease related to type 2 diabetes (diabetic kidney disease or &#x201c;DKD&#x201d;).&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"&gt;Ischemic Repair (CD34 Cell Technology)&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The CD34+ cell was discovered as a result of the deliberate search
            for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building
            new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same
            capability.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's proprietary cell technology using autologous (a
            patient&#x2019;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is
            restricted or reduced. Through the administration of CD34+ cells, Caladrius seeks to promote the development and formation of new microvasculature and thereby increase blood flow to the impacted area. The Company believes that a number of
            conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology including, but not limited to, Buerger's disease, CLI, CMD, and DKD.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;"&gt;XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt; for Treatment of Coronary
            Microvascular Dysfunction&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In 2017, with the assistance of a $1.9 million grant from the National Institutes of Health (Award Number&#160;R44HL135889), the Company initiated its program for XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt; for the
            treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled
            patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian
            Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr.
            Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, the Company commenced enrollment in its Phase 2b FREEDOM Trial of XOWNA&#xae;, a &lt;/div&gt;

&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;double-blind, randomized and placebo-controlled clinical trial designed to further
            evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in January
            2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment. Protocol amendments to the initial FREEDOM Trial protocol, as agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of
            subject enrollment.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; for Treatment of Critical
            Limb Ischemia&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's randomized, open-label, registration-eligible study of
            HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; study's enrollment, however, has been significantly curtailed by the
            COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of the past 18 months. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19
            delays, coupled with the unpredictability of the timing of site enrollment re-initiation, Caladrius suspended further enrollment and is focusing its efforts on consummating a partnership for the product in Japan. Such a partnership may become
            the basis for the completion of development and registration of HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or
            exploration of the possibility of submitting the existing data to Japan's Pharmaceuticals and Medical Devices Agency (&#x201c;PMDA&#x201d;) under Japan's regenerative medicine regulations, which allow for conditional approval of innovative regenerative
            medicine products. Despite receipt from FDA in March 2021 of orphan designation in the U.S. for CLBS12 as a potential treatment for Buerger's disease, based on a response from the FDA in October 2021 regarding a development plan for U.S.
            registration the Company decided not to pursue United States development in Buerger's disease at this time.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;CLBS201 for Treatment of Diabetic Kidney Disease&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Progressive kidney failure is associated with attrition of the
            microcirculation of the kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, the Company
            has elected to move forward with a Phase 1, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol, as approved by an Institutional Review Board (the &#x201c;IRB&#x201d;), is expected
            to include six subjects in total with the first two subjects sequentially dosed and followed for a two-week safety observation period. Clearance by the independent Data Safety Monitoring Board (&#x201c;DSMB&#x201d;) overseeing the study will then permit the
            treatment of the next four patients, with all patients being followed for safety and therapeutic effect. A read-out of data will occur after at the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201
            will be its ability to demonstrate a therapeutic effect that will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;"&gt;Additional Out-licensing Opportunities and
            Pipeline Diversification&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's broad intellectual property portfolio of cell therapy
            assets includes notable programs available for out-licensing in order to continue their clinical development. The Company's current long-term strategy focuses on advancing its therapies through development with the ultimate objective of
            obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to
            realize potentially meaningful value increases within its own proprietary pipeline if it is successful in advancing its product candidates to their next significant development milestones.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In addition, the Company further desires to diversify its pipeline of
            development products candidates and is exploring a range of strategic transactions in furtherance of that goal. The Company has taken, and intends to continue to take, active steps to identify assets and/or companies for acquisition and/or
            partnership that would complement its current development programs and de-risk its overall development portfolio. Such assets potentially could target indications beyond cardiovascular disease as well as product categories outside of cell
            therapy. The range of possible transactions includes an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute &lt;/div&gt;

&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;the shares of its existing stockholders. There can be no assurance that this
            exploration of strategic alternatives will result in Caladrius entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Coronavirus Considerations&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In December 2019, a novel strain of coronavirus (SARS-CoV-2), which
            causes COVID-19, was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects. Despite the FDA approval
            of multiple COVID-19 vaccines in late 2020, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, the
            Company implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. The Company's clinical study of HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; in Japan has experienced
            significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 and re-implemented from January&#160;7, 2021 through March&#160;21, 2021 covering Tokyo and other regions in response to an increased number of COVID-19
            infections. Due to reported increases in COVID-19 cases and a low rate of vaccination in Japan, States of Emergency were renewed on April&#160;25, 2021 through May&#160;11, 2021 and then re-implemented in Tokyo from July&#160;12, 2021 through September&#160;30,
            2021. With the Company's expectation that&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;COVID-19 in Japan would continue to impact negatively enrollment of
            patients in the HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory authorities regarding the submission of patient data already accrued. Caladrius'
            phase 2b trial of XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt; in the U.S. has also experienced delays in enrolling patients as a result of COVID-19.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Basis of Presentation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The accompanying consolidated financial statements have been prepared
            in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;).&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Use of Estimates&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments
            about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimate and assumptions in determining stock-based awards values. Accordingly, actual results could differ from
            those estimates and assumptions.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Principles of Consolidation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.&lt;/div&gt;
</clbs:BusinessTextBlock>
    <us-gaap:GrantsReceivable
      contextRef="c20171231_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_CLBS16TreatmentOfCMDMember"
      decimals="-5"
      id="Fact_c07d90e653b940b3ba1e2d50080b964d"
      unitRef="U001">1900000</us-gaap:GrantsReceivable>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_6c65e5604e594013b182c526fa6246a5">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Basis of Presentation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The accompanying consolidated financial statements have been prepared
            in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;).&lt;/div&gt;
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="c20210101to20211231"
      id="Text_e633129383ff47cba9687b59dd0f55af">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Use of Estimates&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments
            about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimate and assumptions in determining stock-based awards values. Accordingly, actual results could differ from
            those estimates and assumptions.&lt;/div&gt;
</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_4f1d7b3a412f407abc76f7b042d960c8">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Principles of Consolidation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.&lt;/div&gt;
</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="c20210101to20211231"
      id="Text_74b32556132f4e5c8c40f5c02fedf852">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 2 &#x2013; Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;Cash and Cash Equivalents&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Cash and cash equivalents include short-term, highly liquid,
            investments with maturities of ninety days or less when purchased.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Concentration of Risks&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of &lt;/div&gt;

&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;credit risk from these financial instruments. The goals of the Company's investment
            policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"&gt;Marketable Securities&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company determines the appropriate classification of its
            marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash
            equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity.
            Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of
            securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the
            impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and
            whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and
            this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"&gt;Property and Equipment&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The cost of property and equipment is depreciated over the estimated
            useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. &lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;The estimated useful
            lives of property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Furniture and fixtures&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;10
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Computer equipment&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;3
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Software&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;3
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Leasehold improvements&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;Life of lease&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"&gt;Long-lived Assets&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Long-lived assets consist of property and equipment. The assets are
            amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the
            asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result
            from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair
            value of the assets.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"&gt;Share-Based Compensation &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be
            forfeited. The fair value of the Company&#x2019;s restricted stock and restricted stock units is based on the closing market price of the Company&#x2019;s common stock on the date of grant.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;Loss Per Share&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Basic loss per share is based on the weighted effect of all common
            shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to
            common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding.
            Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"&gt;Treasury Stock&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Treasury stock purchases are accounted for under the cost method
            whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"&gt;Research and Development Costs &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Research and development (&#x201c;R&amp;amp;D&#x201d;) expenses include salaries,
            benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the
            costs associated with research and development activities when incurred.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;To further drive the Company&#x2019;s cell therapy initiatives, the Company
            will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#x2019;s research and development programs. The Company accounts for such grants as a deduction to the
            related expense in research and development operating expenses when earned.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"&gt;New Accounting Pronouncements&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In October 2019, the FASB issued ASU 2019-12, which affects general
            principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and
            interim periods within those fiscal years, beginning after December&#160;15, 2020. The Company believes that the adoption of this new accounting guidance has not had a material impact on its financial statements and footnote disclosures. &lt;/div&gt;
</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_827707f29d164046bf9342bdde1907dd">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;Cash and Cash Equivalents&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Cash and cash equivalents include short-term, highly liquid,
            investments with maturities of ninety days or less when purchased.&lt;/div&gt;
</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="c20210101to20211231"
      id="Text_126ac2df768748838e6b3bb17a12cdc1">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;Concentration of Risks&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of &lt;/div&gt;

&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;credit risk from these financial instruments. The goals of the Company's investment
            policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.&lt;/div&gt;
</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="c20210101to20211231"
      id="Text_63837709f05346b99fa20eff3cbfefef">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"&gt;Marketable Securities&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company determines the appropriate classification of its
            marketable securities at the time of purchase and reevaluates such designation at each balance sheet date. All of the Company's marketable securities are considered as available-for-sale and carried at estimated fair values and reported in cash
            equivalents and marketable securities. Unrealized gains and losses on available-for-sale securities are excluded from net income and reported in accumulated other comprehensive income (loss) as a separate component of stockholders' equity.
            Other income (expense), net, includes interest, dividends, amortization of purchase premiums and discounts, realized gains and losses on sales of securities and other-than-temporary declines in the fair value of securities, if any. The cost of
            securities sold is based on the specific identification method. The Company regularly reviews all of its investments for other-than-temporary declines in fair value. The Company's review includes the consideration of the cause of the
            impairment, including the creditworthiness of the security issuers, the number of securities in an unrealized loss position, the severity and duration of the unrealized losses, whether the Company has the intent to sell the securities and
            whether it is more likely than not that it will be required to sell the securities before the recovery of their amortized cost basis. When the Company determines that the decline in fair value of an investment is below its accounting basis and
            this decline is other-than-temporary, it reduces the carrying value of the security it holds and records a loss for the amount of such decline.&lt;/div&gt;
</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_4de7f5965bee4c51b551e85c88c8b791">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"&gt;Property and Equipment&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The cost of property and equipment is depreciated over the estimated
            useful lives of the related assets. Depreciation is computed on the straight-line method. Repairs and maintenance expenditures that do not extend original asset lives are charged to expense as incurred. &lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;The estimated useful
            lives of property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Furniture and fixtures&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;10
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Computer equipment&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;3
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Software&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;3
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Leasehold improvements&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;Life of lease&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="c20210101to20211231"
      id="Text_f71b903b428f43a08c9b19af21e40bbc">&lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;The estimated useful
            lives of property and equipment are as follows:&lt;/span&gt;
&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Furniture and fixtures&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 6pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;10
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Computer equipment&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;3
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Software&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;3
                    years&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Leasehold improvements&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.89%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 11.03%; text-align: center; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;"&gt;Life of lease&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Property and equipment consisted of the following (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 12.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Furniture and fixtures&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 8.33pt;"&gt;26&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 8.33pt;"&gt;26&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Computer equipment&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;314&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;254&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Leasehold improvements&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;90&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;90&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Property and equipment, gross&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;430&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;370&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Accumulated depreciation&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(368)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(313)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;62&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;57&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"
      id="Fact_0ff85d8d023d419bbc4e61f704d188b8">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      id="Fact_68960595f3b84957be069a5f964a1e15">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_SoftwareAndSoftwareDevelopmentCostsMember"
      id="Fact_845970771e18468b8c58fddbf87e73e6">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentImpairment
      contextRef="c20210101to20211231"
      id="Text_32d9c6b10a3c49d4b54b40c0c9c0b470">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"&gt;Long-lived Assets&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Long-lived assets consist of property and equipment. The assets are
            amortized on a straight line basis over their respective useful lives. The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset exceeds the fair value of the
            asset. If other events or changes in circumstances indicate that the carrying amount of an asset that the Company expects to hold and use may not be recoverable, the Company will estimate the undiscounted future cash flows expected to result
            from the use of the asset and/or its eventual disposition, and recognize an impairment loss, if any. The impairment loss, if determined to be necessary, would be measured as the amount by which the carrying amount of the assets exceeds the fair
            value of the assets.&lt;/div&gt;
</us-gaap:PropertyPlantAndEquipmentImpairment>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="c20210101to20211231"
      id="Text_318a78ee4c2e42b8aee525a0ee5c470d">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"&gt;Share-Based Compensation &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. Stock based compensation expense also includes an estimate, which is made at the time of the grant, of the number of awards that are expected to be
            forfeited. The fair value of the Company&#x2019;s restricted stock and restricted stock units is based on the closing market price of the Company&#x2019;s common stock on the date of grant.&lt;/div&gt;
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_229949e280c14aba98bf907574ba6736">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;Loss Per Share&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Basic loss per share is based on the weighted effect of all common
            shares issued and outstanding and is calculated by dividing net loss attributable to common stockholders by the weighted average shares outstanding during the period. Diluted loss per share is calculated by dividing net loss attributable to
            common stockholders by the weighted average number of common shares used in the basic loss per share calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities outstanding.
            Diluted loss per share is not presented as such potentially dilutive securities are anti-dilutive to losses incurred in all periods presented.&lt;/div&gt;
</us-gaap:EarningsPerSharePolicyTextBlock>
    <clbs:TreasuryStockPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_1f28623617d745e28008a273615b8b4f">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"&gt;Treasury Stock&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Treasury stock purchases are accounted for under the cost method
            whereby the entire cost of the acquired stock is recorded as treasury stock. Gains or losses on the subsequent reissuance of shares are credited or charged to additional paid in capital.&lt;/div&gt;
</clbs:TreasuryStockPolicyPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="c20210101to20211231"
      id="Text_3a733640beae417da568782acdc215f0">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"&gt;Research and Development Costs &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Research and development (&#x201c;R&amp;amp;D&#x201d;) expenses include salaries,
            benefits, and other headcount related costs, clinical trial and related clinical manufacturing costs, contract and other outside service fees including sponsored research agreements, and facilities and overhead costs. The Company expenses the
            costs associated with research and development activities when incurred.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;To further drive the Company&#x2019;s cell therapy initiatives, the Company
            will continue targeting key governmental agencies, congressional committees and not-for-profit organizations to contribute funds for the Company&#x2019;s research and development programs. The Company accounts for such grants as a deduction to the
            related expense in research and development operating expenses when earned.&lt;/div&gt;
</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="c20210101to20211231"
      id="Text_79edd43165384ef0806f28ffed73354a">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"&gt;New Accounting Pronouncements&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In October 2019, the FASB issued ASU 2019-12, which affects general
            principles within Topic 740, Income Taxes. The amendments of ASU 2019-12 are meant to simplify and reduce the cost of accounting for income taxes. For public business entities, the amendments in this Update are effective for fiscal years, and
            interim periods within those fiscal years, beginning after December&#160;15, 2020. The Company believes that the adoption of this new accounting guidance has not had a material impact on its financial statements and footnote disclosures. &lt;/div&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="c20210101to20211231"
      id="Text_5d4fd5c63958430b94f34dacee0c9be1">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 3 &#x2013; Available-for-Sale-Securities&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or debt marketable securities in the Company's Consolidated Balance Sheets (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 36.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gains&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Losses&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gains&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Losses&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Corporate debt securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$53,135&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;$(65)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;$53,070&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;8,406&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;$&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 5pt;"&gt;(&lt;span style="text-indent: 0pt;"&gt;7&lt;/span&gt;)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;8,399&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Money market funds&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;18,124&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;18,124&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;7,591&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;7,591&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Municipal debt securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;20,263&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;"&gt;(5)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;20,258&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;14,753&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;"&gt;(6)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;14,747&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,522&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 18.33pt;"&gt;$(70)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,750&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 18.33pt;"&gt;$(13)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,737&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Estimated fair values of available-for-sale securities are generally
            based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale debt securities on the Company's Consolidated Balance Sheets (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;$21,129&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;$12,676&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Marketable securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,737&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table summarizes the Company's portfolio of
            available-for-sale securities by contractual maturity (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Amortized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Amortized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less than one year&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;$91,522&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;$91,452&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;$30,750&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;$30,737&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Greater than one year&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,522&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,750&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,737&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_bce55a7d69734b0a921be48c0cdf5d1c">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or debt marketable securities in the Company's Consolidated Balance Sheets (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 36.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 36%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gains&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Losses&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gains&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Losses&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Corporate debt securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$53,135&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;$(65)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;$53,070&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;8,406&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;$&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 5pt;"&gt;(&lt;span style="text-indent: 0pt;"&gt;7&lt;/span&gt;)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;8,399&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Money market funds&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;18,124&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;18,124&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;7,591&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;7,591&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Municipal debt securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;20,263&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;"&gt;(5)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;20,258&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;14,753&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;"&gt;(6)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;14,747&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 24.15%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,522&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 18.33pt;"&gt;$(70)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,750&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 18.33pt;"&gt;$(13)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.96%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,737&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_4f6a006f37454e2f87b726182ab053c2"
      unitRef="U001">53135000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_a013835e16a24ee7b18b286c3f43b626"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_8cb167fc3ea8466cae4e25619ae8ad9f"
      unitRef="U001">65000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_e9dde7478dae4b87b2600e6c7d794879"
      unitRef="U001">53070000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_456ff69a43c54083bf3863ed4c6b22ce"
      unitRef="U001">8406000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_f838abf3f4384fd38d1148ab5b3d1f5e"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_cd4a0efd57974e14b47a6fdbee1bdd9d"
      unitRef="U001">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20201231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_b6c3e3f4057a466286e31fccff2aaf72"
      unitRef="U001">8399000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_e7cdb35e9ef041599e6beb949a5a8b75"
      unitRef="U001">18124000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_ae9be37dd04b4adab6696c3fa854976a"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_eab6b32ae877479c8d284a91060df678"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_364b2ebe8d2a419f89795e2b67d880aa"
      unitRef="U001">18124000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_6dbede363ee745cb9ee9ddb57c5bb8e0"
      unitRef="U001">7591000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_322205b05da14f109864a9fa58b3a873"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_e9877634089e4a90924f1431c3db4b5c"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20201231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_05d842e6624f4166a9b606de55b37b11"
      unitRef="U001">7591000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_e9db045922854f7a8d5d9a7ba3a6993a"
      unitRef="U001">20263000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_93b4ee110f3e491999e8e7a9eae11138"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_6d3e955ea652446d910f3915907d87be"
      unitRef="U001">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_839ae07e39824f32be6f7159feec21e4"
      unitRef="U001">20258000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_c46c0d7372b145cb9e0a4fca3912cd0e"
      unitRef="U001">14753000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_e4cd0db5a8304ed6a4a98ecf3543cdbc"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_946db39cee594db190b657c31e628fa9"
      unitRef="U001">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20201231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_a8f1baa0d57746acb8568d6d86090782"
      unitRef="U001">14747000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231"
      decimals="-3"
      id="Fact_cee7c256b5ff4ac4bd45af4321910772"
      unitRef="U001">91522000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20211231"
      decimals="-3"
      id="Fact_31627a9c41ac4102bc5313a42b772796"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20211231"
      decimals="-3"
      id="Fact_235f44ca7718427c8e07d41d9c25d31b"
      unitRef="U001">70000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_728be5e175024741876a5f0f9d27e6c6"
      unitRef="U001">91452000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20201231"
      decimals="-3"
      id="Fact_6a37753ac68348499bfe416d638f2e53"
      unitRef="U001">30750000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b8808b68675c4fd1be637cb0ad6dfe44"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20201231"
      decimals="-3"
      id="Fact_45c8ddd8c3204f51964a023404c83609"
      unitRef="U001">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_9f991d96ce6646b2a11879a2f43fdb93"
      unitRef="U001">30737000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="c20210101to20211231"
      id="Text_6fe93092e0dc4c69a973fbaaa52e0e92">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Estimated fair values of available-for-sale securities are generally
            based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale debt securities on the Company's Consolidated Balance Sheets (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Cash and cash equivalents&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;$21,129&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;$12,676&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Marketable securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,737&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember"
      decimals="-3"
      id="Fact_726b5c2b40014e67a078058b0b762424"
      unitRef="U001">21129000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20201231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember"
      decimals="-3"
      id="Fact_09448f97990c4340b2f65a165ad82281"
      unitRef="U001">12676000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231_BalanceSheetLocationAxis_MarketableSecuritiesMember"
      decimals="-3"
      id="Fact_e677502ff0b94f7db6d25276efc4c769"
      unitRef="U001">70323000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20201231_BalanceSheetLocationAxis_MarketableSecuritiesMember"
      decimals="-3"
      id="Fact_34dab8df743b42599400dba14741a2ea"
      unitRef="U001">18061000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ac6d86f796b740eb842d3c82de536313"
      unitRef="U001">91452000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_15a02c15eabd4427af4965a2e7b636da"
      unitRef="U001">30737000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_e752d9d60f254d4aab37fa5c31e58e77">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table summarizes the Company's portfolio of
            available-for-sale securities by contractual maturity (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.49%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Amortized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Amortized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less than one year&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;$91,522&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;$91,452&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;$30,750&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;$30,737&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Greater than one year&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 56.41%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,522&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,750&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.65%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$30,737&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="c20211231"
      decimals="-3"
      id="Fact_456602eda8094cbba26bced12d37485c"
      unitRef="U001">91522000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3d339753562d4b1da7d5eb5994a682aa"
      unitRef="U001">91452000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e5cfe8d682ed431495e8390018db47b6"
      unitRef="U001">30750000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_1d3bb9ebb6164f018bbfc12a59d27c73"
      unitRef="U001">30737000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6ef41cdc8da5496990d6e2009c1a3830"
      unitRef="U001">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f9b65bd75dbb4a63befad5be9c0c43c6"
      unitRef="U001">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="c20201231"
      decimals="-3"
      id="Fact_3c86a4942b8942cca3302133cd8929b7"
      unitRef="U001">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_5aee6a1c48f944679fcb354165ac7ca4"
      unitRef="U001">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ddf5fc3c587446ae88edcf7d75e3a424"
      unitRef="U001">91522000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9d2bf1c68bbc4f7199893a18c152c04f"
      unitRef="U001">91452000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20201231"
      decimals="-3"
      id="Fact_d67d8eeb3a71471bbfe2a397713c60f8"
      unitRef="U001">30750000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_f73f17ee3681431ca33d0eb7192ff33d"
      unitRef="U001">30737000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_75249614e9124de690b3161233efff92">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 4 &#x2013; Property and Equipment&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Property and equipment consisted of the following (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 12.68%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Furniture and fixtures&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 8.33pt;"&gt;26&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 8.33pt;"&gt;26&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Computer equipment&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;314&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;254&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Leasehold improvements&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;90&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;90&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Property and equipment, gross&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;430&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;370&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Accumulated depreciation&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(368)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(313)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Property and equipment, net&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.99%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;62&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.98%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 8.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;57&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company&#x2019;s results included depreciation expense of approximately
            $0.1 million and $0.1
            million for the years ended December&#160;31, 2021 and 2020, respectively.&lt;/div&gt;
</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"
      decimals="-3"
      id="Fact_e1b11e6f0c53445b8a0e6113b9148414"
      unitRef="U001">26000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20201231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember"
      decimals="-3"
      id="Fact_bc92b7343d6f47e79291807e7161ee57"
      unitRef="U001">26000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      decimals="-3"
      id="Fact_9894d70910d04b9788c6ad0925acbeb6"
      unitRef="U001">314000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20201231_PropertyPlantAndEquipmentByTypeAxis_ComputerEquipmentMember"
      decimals="-3"
      id="Fact_3d4d25b263934113bf68bf9fcfe1ac51"
      unitRef="U001">254000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact_94dd6e1c15384bee8985c181882fdf65"
      unitRef="U001">90000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20201231_PropertyPlantAndEquipmentByTypeAxis_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact_3b2c5fb9547a42d09a6188c2c3985c7d"
      unitRef="U001">90000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c2100f16fd0f40f792d7e158a892f3b7"
      unitRef="U001">430000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_fc68981667e8408e8ae2620817164a5d"
      unitRef="U001">370000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20211231"
      decimals="-3"
      id="Fact_58067a54839b40959f7c90bcb1168334"
      unitRef="U001">368000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="c20201231"
      decimals="-3"
      id="Fact_e7fb274a65d540159cd79b99dba04298"
      unitRef="U001">313000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5b80a3fa7f794365a54363691f5efeb2"
      unitRef="U001">62000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20201231"
      decimals="-3"
      id="Fact_c433e68b926446d797bbb39fae5bb7c4"
      unitRef="U001">57000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_6f7eefc1ebb6479ba427a5e608700adc"
      unitRef="U001">100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_267c7e3809864e678f9fe8a3c3ff1216"
      unitRef="U001">100000</us-gaap:Depreciation>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20210101to20211231"
      id="Text_723cb341442c46e78a690abce25cfcfd">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 5 &#x2013; Loss Per Share&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;For the years ended December&#160;31, 2021 and 2020, the Company incurred
            net losses and therefore no common stock equivalents were utilized in the calculation of loss per share as they are anti-dilutive in the periods presented. &lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;At December&#160;31, 2021 and 2020, the Company excluded the
            following potentially dilutive securities (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 13.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;2,132&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;964&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;21,357&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2,638&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Restricted Stock Units&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;604&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;340&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="c20210101to20211231"
      id="Text_c8821af336b240808865388e49e0c2ab">&lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;At December&#160;31, 2021 and 2020, the Company excluded the
            following potentially dilutive securities (in thousands):&lt;/span&gt;
&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 13.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;2,132&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;964&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;21,357&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2,638&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Restricted Stock Units&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;604&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.18%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;340&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_53247c0acc2246788447ce1f207c2175"
      unitRef="U002">2132000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_fa4b68d6316d409187911305766024b7"
      unitRef="U002">964000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_bd9f8e086282423ba5e98d4385e76249"
      unitRef="U002">21357000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_ebf91115c32a425182441c9892dd5b44"
      unitRef="U002">2638000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20211231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_b462dace2b64448f9743fdf354d8c1a4"
      unitRef="U002">604000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20200101to20201231_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_0334ac8068074577bc1435dfe00f953c"
      unitRef="U002">340000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="c20210101to20211231"
      id="Text_420d16aedfe84c4d853738a5eb588d1a">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 6 &#x2013; Fair Value Measurements&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Fair value of financial assets and liabilities that are being
            measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price).
            The Company is required to classify fair value measurements in one of the following categories:&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Level 1 inputs are defined as quoted prices (unadjusted) in active
            markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Level 2 inputs are defined as inputs other than quoted prices
            included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Level 3 inputs are defined as unobservable inputs for the assets or
            liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement
            requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's financial assets and liabilities that were accounted
            for at fair value on a recurring basis as of December&#160;31, 2021 and December&#160;31, 2020 were as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Assets: &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Marketable securities - available for sale&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The carrying values of cash, cash equivalents, accounts payable and
            accrued expenses approximate fair value at December&#160;31, 2021 and December&#160;31, 2020, due to the short maturity nature of these items.&lt;/div&gt;
</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="c20210101to20211231"
      id="Text_6149aa0fca2f4b61a4bf3aceeab81215">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's financial assets and liabilities that were accounted
            for at fair value on a recurring basis as of December&#160;31, 2021 and December&#160;31, 2020 were as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 29.25%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Assets: &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Marketable securities - available for sale&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 38.46%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$18,061&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_7c74b49d67b14a18846867761c363bb6"
      unitRef="U001">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_e2787236eb884ee3877f30bb6821d2d8"
      unitRef="U001">70323000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_ba7f5584341743cc95490ade7e76dd9c"
      unitRef="U001">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_920b038e5a8e4f30b24d3c8063c6f4d9"
      unitRef="U001">70323000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_bc43c2c990184e21a020bf5658199108"
      unitRef="U001">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_b3441a7073ed44d7b6bd1552d5defa2f"
      unitRef="U001">18061000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_63570e6bab2b41b393eae0b78fe966b4"
      unitRef="U001">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20201231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_d0dba4f25d654470b98ca7ba85ec28af"
      unitRef="U001">18061000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_5ce05cd546f74cc3a7430f07c8e3588d"
      unitRef="U001">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_e0ba9f4c22474911a9f23e8590a7faa3"
      unitRef="U001">70323000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_76550c631f394de4b625791a002ca58c"
      unitRef="U001">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_2a43a90c108d48f89aa1b01f66c9d73a"
      unitRef="U001">70323000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_3479db8585644a3c821f051d1ff3b705"
      unitRef="U001">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_1406e2c746ef4d909cc7e9b2f6941f14"
      unitRef="U001">18061000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20201231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_8b3df2273c81480998e76400d1da0b8d"
      unitRef="U001">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20201231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_4e357f72eec94d2ea5da9a9332f11b52"
      unitRef="U001">18061000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_c359572323ac433c9e47c072a7299a6e">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 7 &#x2013; Accrued Liabilities&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Accrued liabilities were as follow (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 13.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Salaries, employee benefits and related taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$2,034&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$1,716&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Operating lease liabilities - current&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;229&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;370&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;326&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;400&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,589&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,486&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_f406e2bc20ad4d7cab0e783bd7d2f3c0">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Accrued liabilities were as follow (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 13.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Salaries, employee benefits and related taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$2,034&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$1,716&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Operating lease liabilities - current&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;229&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;370&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;326&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;400&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 84.62%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,589&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.91%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,486&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_888d94298e7146f1957da1c5827f646c"
      unitRef="U001">2034000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_ce6edc46432f460ba5fa708433eb357d"
      unitRef="U001">1716000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0e76dfb74fa242a5bd8da8b28c11fecc"
      unitRef="U001">229000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b92b07fc06904e7e9403f12610f58464"
      unitRef="U001">370000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f1c0213ec134467ab906c450a1dad975"
      unitRef="U001">326000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_656176357d8b4b5d852d86ec92d11105"
      unitRef="U001">400000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_040f6a657bce4a69bb9daa2344d97e08"
      unitRef="U001">2589000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_5ffee8d9a4c94ca2b139b38dd2f699df"
      unitRef="U001">2486000</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20210101to20211231"
      id="Text_0b621830e7394dddaa3c6667885f9486">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 8 &#x2013; Operating Leases&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company adopted ASU No. 2016-02, Leases (Topic 842) on January&#160;1,
            2019 and recognized leases with duration greater than 12 months on the balance sheet using the modified retrospective approach. The Company has operating leases for two offices with terms that expire in 2023 and 2025, respectively. The Company estimates its incremental borrowing rate at lease commencement to determine the present value of lease
            payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or reassessed after the adoption of Topic
            842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases includes options for the Company to extend the lease term and/or sub-lease
            space in whole or in part.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Right-of Use Assets:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_6c255ea4f7c24c48b604a925c0f5819f"&gt;&lt;span style="-sec-ix-hidden:Fact_02a6f0c3111348a5b2e0df82b435956e"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;$724&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;$574&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total Right-of-Use Asset&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$724&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$574&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Operating Lease Liabilities:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_d2023c19465a459a9ecb0fec411ae9c3"&gt;&lt;span style="-sec-ix-hidden:Fact_f6a138b4447e4c69840c11bceb8fe65d"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;$229&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;$370&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_b65fe760104b4546b3abaa579a18c88c"&gt;&lt;span style="-sec-ix-hidden:Fact_3980d08cb35e4c0087f62256aa859a67"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;485&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;254&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total Operating Lease Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$714&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$624&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of December&#160;31, 2021, the weighted average remaining lease term
            for our operating leases was 2.50 years, and the weighted average discount rate for our operating leases was 9.625%. &lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Future minimum lease payments under the lease agreements as of December&#160;31, 2021 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Years ended&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Operating &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Leases&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;$&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 3.33pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;217 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2024&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;190 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2025&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;143&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total lease payments&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;836&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less: Amounts representing interest&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(122)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Present value of lease liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;714&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <clbs:NumberOfOfficesUnderOperatingLeases
      contextRef="c20211231"
      decimals="0"
      id="Fact_f6a380f3a060413d81efb9c92718f7b5"
      unitRef="U004">2</clbs:NumberOfOfficesUnderOperatingLeases>
    <clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_5f8538b0aa4a4baaa0a1984e1c7ab6c6">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Right-of Use Assets:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_6c255ea4f7c24c48b604a925c0f5819f"&gt;&lt;span style="-sec-ix-hidden:Fact_02a6f0c3111348a5b2e0df82b435956e"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;$724&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;$574&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total Right-of-Use Asset&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$724&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$574&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Operating Lease Liabilities:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_d2023c19465a459a9ecb0fec411ae9c3"&gt;&lt;span style="-sec-ix-hidden:Fact_f6a138b4447e4c69840c11bceb8fe65d"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;$229&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;$370&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_b65fe760104b4546b3abaa579a18c88c"&gt;&lt;span style="-sec-ix-hidden:Fact_3980d08cb35e4c0087f62256aa859a67"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;485&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;254&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total Operating Lease Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$714&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.73%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$624&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5df9a28676794aff96ae4e657138eeae"
      unitRef="U001">724000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20201231"
      decimals="-3"
      id="Fact_b0614e88506b43edb9f39c7b60b63269"
      unitRef="U001">574000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_dd73741a45e44d18828d31bb7e09673e"
      unitRef="U001">724000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20201231"
      decimals="-3"
      id="Fact_86aff1f5f68d4c80b69310a131b9afde"
      unitRef="U001">574000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_51cd0e33d9c04689ab189e48dbea2085"
      unitRef="U001">229000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_1456fdc201464fbfaea48f821d9fce66"
      unitRef="U001">370000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_0ccc6158c0914d07902bc3e2987930d7"
      unitRef="U001">485000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20201231"
      decimals="-3"
      id="Fact_9dc9788c5d3d41c7bceba397df4eaedb"
      unitRef="U001">254000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ddda62b1fd5a4ca2b6ba46a50909de85"
      unitRef="U001">714000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20201231"
      decimals="-3"
      id="Fact_69cc25e6f76141468db8f84783716627"
      unitRef="U001">624000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20211231"
      id="Fact_0fcb3ba4efe4406196bf2e965c92155a">P2Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20211231"
      decimals="5"
      id="Fact_a9cd80ee680c402c869fc4bfa782a741"
      unitRef="U005">0.09625</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_f1c4e57e90d44ff4a0bab570608d2cd6">&lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Future minimum lease payments under the lease agreements as of December&#160;31, 2021 were as follows (in thousands):&lt;/span&gt;
&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Years ended&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Operating &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Leases&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"&gt;$&lt;/span&gt;&lt;span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(204, 238, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-left: 3.33pt;"&gt;&lt;span style="text-indent: 0pt;"&gt;286&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;217 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2024&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;190 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2025&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;143&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total lease payments&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;836&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less: Amounts representing interest&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(122)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Present value of lease liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;714&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e5dbbea9ea2b47209bf645a66a665673"
      unitRef="U001">286000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20211231"
      decimals="-3"
      id="Fact_54dce5ad4ae14a27a34579bd33a92b3c"
      unitRef="U001">217000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20211231"
      decimals="-3"
      id="Fact_28f50b875fa0474bbddfedf21c05ec87"
      unitRef="U001">190000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c20211231"
      decimals="-3"
      id="Fact_b81bd856f6db45e7b1f324065ecdae81"
      unitRef="U001">143000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_00c58c2e419e485cbf712926c6841409"
      unitRef="U001">836000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f1bf7cb268c447cc8c9a8990ca6c3dad"
      unitRef="U001">122000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_93ace6af18e44f1d9268b653c7b2dcd9"
      unitRef="U001">714000</us-gaap:OperatingLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_bb4adc1ff8a144bdb166370f51f46e58">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 9 &#x2013; Stockholders' Equity&lt;/span&gt;&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;"&gt;Equity Plans&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company has used long-term incentive plans for the purpose of
            granting equity awards to employees of the Company, including officers, and nonemployees, including consultants and nonemployee members of the Company's board of directors (collectively, the &#x201c;Participants&#x201d;). The Participants may receive awards
            as determined by a committee of independent members of the Company's board of directors or, to the extent authorized by such committee with respect to certain Participants, a duly authorized employee (collectively, the &#x201c;Committee&#x201d;). The
            incentive plan currently used by the Company is the 2018 Equity Incentive Compensation Plan (the &#x201c;2018 Plan&#x201d;), as adopted by the stockholders of the Company in June 2018, and subsequently increased by the stockholders of the Company in June
            2021 with 6,000,000 shares authorized for issuance thereunder and in June of 2020 with 2,500,000 shares authorized for issuance thereunder, plus any shares awarded under the 2015 Equity Compensation Plan (the &#x201c;2015 Plan&#x201d;) or the Amended and Restated 2009
            Equity Compensation Plan (the &#x201c;2009 Plan&#x201d;) that are not issued due to their subsequent forfeiture, cancellation, or other settlement thereof. Concurrent with the adoption of the 2018 Plan, no future awards will occur under the 2015&#160;Plan or the
            2009 Plan. The awards that may be made under the 2018 Plan include: (a) incentive stock options and nonqualified stock options, (b) shares of restricted stock, (c) restricted stock units, and (d) other kinds of equity-based compensation awards.
            All stock options under the 2015 Plan and 2009 Plan were granted and the 2018 Plan are granted at the fair market value of the common stock at the grant date. Stock options vest either on the date of grant, ratably over a period determined at
            time of grant, or upon the accomplishment of specified business milestones, and generally expire&#160;2, 3, or 10 years from the grant date
            depending on the status of the recipient as a nonemployee, employee or director of the Company. As of December&#160;31, 2021, there were 5,585,661
            shares available for future grants under the 2018 Plan. No additional awards may be made under the 2015 Plan or the 2009 Plan.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company adopted an employee stock purchase plan effective
            January&#160;1, 2013 and authorized 50,000 shares under the plan (the &#x201c;2012 ESPP&#x201d;). The plan has&#160;two six-month offering periods per year under which eligible
            employees may contribute up to 15% of their compensation toward the purchase of the Company's common stock per offering period (with
            a $25,000 cap per calendar year). The employee's purchase price is equal to (i) 85% of the closing price of a share of the Company's common stock on the enrollment date of such offering period or (ii) 85% of the closing price of a share of the Company's common stock on the Exercise Date of such Offering Period, whichever is lower. In May 2017, the Company's stockholders
            approved an amendment and restatement to the 2012 ESPP (the &#x201c;2017 ESPP&#x201d;) in order to effect an increase of authorized shares from 50,000
            to 100,000. In June 2018, the Company's stockholders approved an amendment to the 2017 ESPP (the &#x201c;Amended 2017 ESPP&#x201d;) in order to
            effect an increase of authorized shares from 100,000 to 500,000. During the year ended December&#160;31, 2021, 47,132 shares were
            issued under the Amended 2017 ESPP. At December&#160;31, 2021, the Company had 300,577 shares of the Company's common stock available for
            future grant in connection with this plan.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;Equity Issuances&lt;/div&gt;

&lt;div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Purchase Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In March 2019, the Company and Lincoln Park Capital Fund, LLC
            (&#x201c;Lincoln Park&#x201d;) entered into a purchase agreement (the &#x201c;Purchase Agreement&#x201d;) and a registration rights agreement (the &#x201c;Registration Rights Agreement&#x201d;), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company&#x2019;s
            common stock having an aggregate value of up to $26.0 million, subject to certain limitations and conditions set forth in the
            Purchase Agreement (the &#x201c;Offering&#x201d;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional 181,510
            shares of common stock as commitment shares.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Pursuant to the Purchase Agreement, upon commencement Lincoln Park
            purchased 250,000 shares of common stock, at a price of $4.00 per share for a total gross purchase price of $1,000,000 (the &#x201c;Initial
            Purchase&#x201d;) upon commencement. Thereafter, as often as every business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase Agreement, the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to
            100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln
            Park&#x2019;s obligation under any single such purchase will not exceed $2,500,000, unless the Company and Lincoln Park mutually agree to
            increase the maximum amount of such single purchase (each, a &#x201c;Regular Purchase&#x201d;). If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such
            Regular Purchase, and subject to certain conditions and limitations in the Purchase Agreement, the Company may direct Lincoln Park in an &#x201c;accelerated purchase&#x201d; to purchase an additional amount of common stock that may not exceed the lesser of
            (i) 300% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) 30% of the total number of shares of the Company&#x2019;s common stock traded during a specified period on the applicable purchase date as set forth in the
            Purchase Agreement (each, an &#x201c;Accelerated Purchase&#x201d;). Under certain circumstances and in accordance with the Purchase Agreement, the Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company controls the timing and amount of any sales of its common
            stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the
            floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than 9.99% of its common stock.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Purchase Agreement does not limit the Company&#x2019;s ability to raise
            capital from other sources at the Company&#x2019;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating
            conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The
            Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of December&#160;31, 2021, the Company had not made any sales of common
            stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase. In addition, the Company may not direct Lincoln Park to make Accelerated Purchases under the Purchase Agreement if the stock is below the specified floor price
            of $1.00.&lt;/div&gt;

&lt;div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Common Stock Sales Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In February 2018, the Company entered into a common stock sales
            agreement with H.C. Wainwright &amp;amp; Co., LLC (&#x201c;HCW&#x201d;) as sales agent, which was subsequently amended in August 2018 (the &#x201c;Sales Agreement&#x201d;), in connection with an &#x201c;at the market offering&#x201d; under which the Company from time to time may offer and
            sell shares of its common stock, having an aggregate offering price of not more than $25.0 million.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company provided HCW with customary indemnification rights, and
            HCW was entitled to a commission at a fixed commission rate equal to 3.0% of the gross proceeds per share sold.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;On February&#160;12, 2021, the Company suspended the use of the
            at-the-market transactions facility and terminated the continuous offering pursuant to the Sales Agreement.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of the termination of the Sales Agreement on February&#160;12, 2021,
            the Company had sold an aggregate 3,784,912 shares of its common stock pursuant to the Sales Agreement for net proceeds of $9.5 million since inception. For the year ended December&#160;31, 2021, the Company had not issued any shares under the Sales Agreement.&lt;/div&gt;

&lt;div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;At The Market Offering Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;On June&#160;4, 2021, the Company entered into an At The Market Offering
            Agreement (the &#x201c;ATM Agreement&#x201d;) with HCW, as sales agent, in connection with an &#x201c;at the market offering&#x201d; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $50.0 million. During the twelve months ended December&#160;31, 2021, the Company had not issued any shares under the ATM Agreement. Having received a listing deficiency notice from Nasdaq on February&#160;18, 2022 after the Company&#x2019;s shares traded below $1.00 for 30
            consecutive trading days, the Company will not be permitted to sell additional shares under the ATM Agreement until it re-establishes timely compliance. Compliance may be reestablished by various mechanisms, including stock price appreciation
            at or above $1.00 for a requisite period of time and reverse stock split.&lt;/div&gt;

&lt;div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Registered Direct Offerings&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In February 2021, the Company entered into a Securities Purchase
            Agreement (the &#x201c;Institutional Purchase Agreement&#x201d;) with certain institutional investors (the &#x201c;Institutional Purchasers&#x201d;). Pursuant to the terms of the Institutional Purchase Agreement, the Company sold to the Institutional Purchasers in a
            registered direct offering an aggregate of 24,906,134 shares of its common stock and warrants to purchase an aggregate of 12,453,067 shares of its common stock at a combined purchase price equal to $2.45 per share and associated warrant. Each warrant features an exercise price equal to $2.90
            per share, is exercisable immediately upon issuance and will expire five years from the issuance date. Additionally, in a concurrent
            non-brokered registered direct offering, the Company entered into a Securities Purchase Agreement (the &#x201c;Additional Purchase Agreement&#x201d;) with certain accredited investors (the &#x201c;Additional Purchasers&#x201d;). Pursuant to the terms of the Additional
            Purchase Agreement, the Company sold to the Additional Purchasers an aggregate of 1,632,652 shares of its common stock and warrants
            to purchase an aggregate of 816,326 shares of its common stock at a combined purchase price equal to $2.45 per share and associated warrant. Each warrant features an exercise price equal to $2.90 per share, is exercisable immediately upon issuance and will expire five years
            from the issuance date. In connection with the registered direct offerings, the Company received gross proceeds of approximately $65.0
            million.&lt;/div&gt;

&lt;div class="h5" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In January 2021, the Company entered into a securities purchase
            agreement (the &#x201c;January Private Placement&#x201d;) with certain investors (the &#x201c;January Purchasers&#x201d;). Pursuant to the terms of the January Private Placement, the Company agreed to sell to the January Purchasers an aggregate of 12,500,000 shares of its common stock at a purchase price equal to $2.00 per share, along with warrants to purchase an aggregate of 6,250,000
            shares of its common stock. In connection with the January Private Placement, the Company received gross proceeds of $25.0 million.
            Each warrant is exercisable for one share of common stock and features an exercise price equal to $2.90 per share. The warrants are exercisable immediately upon issuance and will expire &lt;span style="-sec-ix-hidden:Fact_b33f9ae5fcb543bd9c7f792ce5439476"&gt;five and one-half years&lt;/span&gt; from the issuance date.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Warrant Exercises&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In January 2021, the Company issued 801,148 shares of common stock for net proceeds of $1.8
            million in connection with warrant exercises associated with the April&#160;23, 2020 securities purchase agreement and the May&#160;25, 2020 securities purchase agreement.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;Stock Options and Warrants&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table summarizes the activity for stock options and
            warrants for the year ended December&#160;31, 2021:&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Warrants &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Shares &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Exercise &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Price &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Remaining &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Contractual &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Term &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(Years) &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Aggregate &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Intrinsic &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value (In &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Thousands) &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Shares &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Exercise &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Price &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Remaining &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Contractual &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Term &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(Years) &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Aggregate &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Intrinsic &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value (In &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Thousands) &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Outstanding at December&#160;31, 2020&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;963,700&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$14.64&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;5.86&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;2,638,355&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$2.18&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;4.98&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Changes during the Year:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;1,314,790&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;1.32&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;19,519,393&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$2.90&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Exercised&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 14.17pt;"&gt;(7,250)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;3.28&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="padding-left: 6.67pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 9.17pt;"&gt;(801,148)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$2.19&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Forfeited&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 9.17pt;"&gt;(29,842)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;2.18&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$&lt;span style="padding-left: 7.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expired&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 4.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;"&gt;(109,549)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;$34.12&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Outstanding at December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 40pt;"&gt;2,131,849&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;5.64&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;"&gt;7.97&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 45pt;"&gt;21,356,600&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;"&gt;4.37&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Vested at December&#160;31, 2021 or expected to vest in the
                    future&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;2,120,643&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;5.66&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;7.96&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.37&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Exercisable at December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;1,122,783&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;9.26&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;6.70&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.37&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;Restricted Stock&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock for services as follows ($ in thousands, except share data):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Number of Restricted Stock Issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;612,950&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;156,184&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Value of Restricted Stock Issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;877.7&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;512.3&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The weighted average estimated fair value of restricted stock issued
            for services in the years ended December&#160;31, 2021 and 2020 was $1.43 and $3.28 per share, respectively. The fair value of the restricted stock was determined using the Company&#x2019;s closing stock price on the date of issuance. The vesting terms of restricted stock
            issuances are generally between &lt;span style="-sec-ix-hidden:Fact_71e638d2f8944c3b8762be6c9f077488"&gt;one&lt;/span&gt; to four years.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Restricted Stock Units&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock units for services as follows ($ in thousands, except share data):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Number of Restricted Stock Units Issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;458,245&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;325,853&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Value of Restricted Stock Units Issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;728.6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;863.0&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The weighted average estimated fair value of restricted stock units
            issued for services in the years ended December&#160;31, 2021 and 2020 was $1.59 and $2.65 per share, respectively. The fair value of the restricted stock units was determined using the Company&#x2019;s closing stock price on the date of issuance. The vesting terms
            of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.&lt;/div&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20210630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member"
      decimals="0"
      id="Fact_c759c721ee1a45d68b8bc0e8a110e6c0"
      unitRef="U002">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20200630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member"
      decimals="0"
      id="Fact_23464e3a0e2143c586d80b037d108676"
      unitRef="U002">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheOneMember"
      id="Fact_a823c34997084d4f96fd461efc8a856a">P2Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheTwoMember"
      id="Fact_ba47942c4b8b4453ba1c95bbdb1449a9">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_PlanNameAxis_EquityIncentiveCompensationPlan2018Member_VestingAxis_ShareBasedCompensationAwardTrancheThreeMember"
      id="Fact_9f7619d354ff49f2bbece96a2c86b136">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20211231_PlanNameAxis_EquityIncentiveCompensationPlan2018Member"
      decimals="0"
      id="Fact_916ccc7e7ac8432d91a1b597a2b741c9"
      unitRef="U002">5585661</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20130101_PlanNameAxis_EmployeeStockPurchasePlan2012Member"
      decimals="0"
      id="Fact_c93184c18e654253b3eb21328b9e5e89"
      unitRef="U002">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <clbs:NumberofOfferingPeriodsEmployeeStockPurchasePlan
      contextRef="c20211231_PlanNameAxis_EmployeeStockPurchasePlanMember"
      decimals="0"
      id="Fact_ebc9a86f63244666ab7561cf22e8712f"
      unitRef="U006">2</clbs:NumberofOfferingPeriodsEmployeeStockPurchasePlan>
    <clbs:OfferingPeriodsEmployeeStockPurchasePlanTerm
      contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember"
      id="Fact_bc88eea52bba4afe8e57ce2ac2d7fa7b">P6M</clbs:OfferingPeriodsEmployeeStockPurchasePlanTerm>
    <clbs:EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent
      contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember"
      decimals="2"
      id="Fact_1bce556ff3ec4e16be7dd91bd19449c2"
      unitRef="U005">0.15</clbs:EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent>
    <clbs:EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee
      contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember"
      decimals="0"
      id="Fact_cf5108515df34b47b2b5030167076995"
      unitRef="U001">25000</clbs:EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee>
    <clbs:EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate
      contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember"
      decimals="2"
      id="Fact_844e364645b04413bcd41ada8116b8e2"
      unitRef="U005">0.85</clbs:EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate>
    <clbs:EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate
      contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlanMember"
      decimals="2"
      id="Fact_55dc02cb978547dca5bf7dbafc381f47"
      unitRef="U005">0.85</clbs:EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20130101_PlanNameAxis_EmployeeStockPurchasePlan2012Member"
      decimals="0"
      id="Fact_1d4eca76d4444c00a995cdef7811d989"
      unitRef="U002">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20170531_PlanNameAxis_EmployeeStockPurchasePlan2017Member"
      decimals="0"
      id="Fact_07925e4729d44d0c919e796665faac04"
      unitRef="U002">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20170531_PlanNameAxis_EmployeeStockPurchasePlan2017Member"
      decimals="0"
      id="Fact_68b774efe9ae439f9ff6c6b02517358c"
      unitRef="U002">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c20200630_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember"
      decimals="0"
      id="Fact_6845fb42314142898a73992413743e27"
      unitRef="U002">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c20210101to20211231_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember"
      decimals="0"
      id="Fact_0fcc18f3b17140828e128bb1f214de34"
      unitRef="U002">47132</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c20211231_PlanNameAxis_EmployeeStockPurchasePlan2017AmendedMember"
      decimals="0"
      id="Fact_dba8399dc2e446caabd136e446a8963a"
      unitRef="U002">300577</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="-5"
      id="Fact_66a7f3d0ac88431db3afbfaa5c1e9554"
      unitRef="U001">26000000.0</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="0"
      id="Fact_8ab9a5fc006c4eb4b9d03b0856bfca58"
      unitRef="U002">181510</clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="0"
      id="Fact_e7da65c020ee4761850ebe8d00c47abc"
      unitRef="U002">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="2"
      id="Fact_2a72a9576fdc48359710a3e5be9169a1"
      unitRef="U003">4.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="0"
      id="Fact_6ecb6ab329cc465f96f08ca274197f74"
      unitRef="U001">1000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <clbs:TermOfAgreement
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      id="Fact_e042a7577a1f403882b7216ae9091b11">P36M</clbs:TermOfAgreement>
    <clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="0"
      id="Fact_a8f945086f174f438fd3fc32c11fcf49"
      unitRef="U002">100000</clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase>
    <clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="0"
      id="Fact_e7642eb5d1fa400a88de05fc64f1de55"
      unitRef="U001">2500000</clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase>
    <clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="2"
      id="Fact_0fd6b3b305c54e73bde553be87eefbab"
      unitRef="U005">3</clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase>
    <clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="2"
      id="Fact_9e97bb44e83d4f98a4eca743a4452b27"
      unitRef="U005">0.30</clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod>
    <clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="4"
      id="Fact_3554504aee5b43198ca2307f912e66eb"
      unitRef="U005">0.0999</clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty>
    <clbs:TermOfAgreement
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      id="Fact_697a4c6fcc29443fa2c7fafda651baea">P36M</clbs:TermOfAgreement>
    <clbs:PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice
      contextRef="c20211231_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="2"
      id="Fact_63586193418244568da72357fdc61282"
      unitRef="U003">1.00</clbs:PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement
      contextRef="c20180831_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"
      decimals="-5"
      id="Fact_e6a696402f4d4201b0875ec9126a018d"
      unitRef="U001">25000000.0</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <clbs:SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent
      contextRef="c20180801to20180831_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"
      decimals="INF"
      id="Fact_3b9038d0c5ab4263adfd56a4c45fd092"
      unitRef="U005">0.030</clbs:SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20180201to20210212_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"
      decimals="0"
      id="Fact_a9bba5b722994263bf2b52b2a2912f84"
      unitRef="U002">3784912</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20180201to20210212_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"
      decimals="-5"
      id="Fact_b57d8fa888994a5383dcf0da2edfd8bf"
      unitRef="U001">9500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20210101to20211231_SubsidiarySaleOfStockAxis_H.C.WainwrightSalesAmendedAgreementMember"
      decimals="INF"
      id="Fact_1a9e8ef56db44374a677acf8e1f682b8"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement
      contextRef="c20210604_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember"
      decimals="-5"
      id="Fact_bde3ee5ecea94965baf3d97124ff66a6"
      unitRef="U001">50000000.0</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20210101to20211231_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember"
      decimals="INF"
      id="Fact_4537ae8bcc984db39c97e0f6421c2f61"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c20210201to20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember"
      decimals="0"
      id="Fact_f385172f2f454219b33cc44a1977c140"
      unitRef="U002">24906134</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember"
      decimals="0"
      id="Fact_321e6a5c12114e80a946d3cfa23ef6c5"
      unitRef="U002">12453067</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember"
      decimals="2"
      id="Fact_1d83aa645cfe4fe58ea6b689cccc29fd"
      unitRef="U003">2.45</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember"
      decimals="2"
      id="Fact_c3ec86402acb4e128aa867d3c03f213b"
      unitRef="U003">2.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20210228_SubsidiarySaleOfStockAxis_InstitutionalPurchaseAgreementMember"
      id="Fact_ccfb91448a71459ba2d4b5a6d3cf4b9e">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c20210201to20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember"
      decimals="0"
      id="Fact_bc3ae37710b24150902c51cf20b2d019"
      unitRef="U002">1632652</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember"
      decimals="0"
      id="Fact_67eb5fd9e23a479f89427131471b699c"
      unitRef="U002">816326</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember"
      decimals="2"
      id="Fact_cf361ad7aa554c948ed209be91ddc873"
      unitRef="U003">2.45</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember"
      decimals="2"
      id="Fact_c775eb2435d44c2783312eeac89deb03"
      unitRef="U003">2.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="c20210228_SubsidiarySaleOfStockAxis_AdditionalPurchaseAgreementMember"
      id="Fact_10a45e4044584cf2868d0d0de058f041">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210201to20210228"
      decimals="-5"
      id="Fact_4123f26b1a3548e6a3a9ef0c8a4af353"
      unitRef="U001">65000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c20210101to20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"
      decimals="0"
      id="Fact_7055f20014cc471f9de48349828f65b6"
      unitRef="U002">12500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"
      decimals="2"
      id="Fact_2bb20140396c4ca2aee2a526057a6629"
      unitRef="U003">2.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"
      decimals="0"
      id="Fact_505c077889c24a81a63c3f770083b9e5"
      unitRef="U002">6250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210101to20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"
      decimals="-5"
      id="Fact_91da2f3a0ff64f75945e95318cda8c2a"
      unitRef="U001">25000000.0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"
      decimals="INF"
      id="Fact_3aee704d8d3549a2b7f73203607b62fb"
      unitRef="U002">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c20210131_SubsidiarySaleOfStockAxis_January2021PurchaseAgreementMember"
      decimals="2"
      id="Fact_f735d335cb45445bb36530947488731f"
      unitRef="U003">2.90</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c20210101to20210131"
      decimals="0"
      id="Fact_cb40ce79b3264e2baa488f261bfe12fe"
      unitRef="U002">801148</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="c20210101to20210131"
      decimals="-5"
      id="Fact_d960e8030d9549cca5cccfee3023da14"
      unitRef="U001">1800000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_60bd97bd4dd94834ba342e2043ec665a">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table summarizes the activity for stock options and
            warrants for the year ended December&#160;31, 2021:&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Warrants &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Shares &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Exercise &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Price &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Remaining &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Contractual &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Term &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(Years) &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Aggregate &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Intrinsic &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value (In &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Thousands) &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Shares &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Exercise &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Price &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Remaining &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Contractual &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Term &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(Years) &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Aggregate &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Intrinsic &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value (In &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Thousands) &lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Outstanding at December&#160;31, 2020&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;963,700&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$14.64&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;5.86&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;2,638,355&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$2.18&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;4.98&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Changes during the Year:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;1,314,790&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;1.32&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;19,519,393&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$2.90&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Exercised&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 14.17pt;"&gt;(7,250)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;3.28&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="padding-left: 6.67pt;"&gt;(3)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 9.17pt;"&gt;(801,148)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$2.19&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Forfeited&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 9.17pt;"&gt;(29,842)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;2.18&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$&lt;span style="padding-left: 7.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expired&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 4.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;"&gt;(109,549)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;$34.12&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Outstanding at December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 40pt;"&gt;2,131,849&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;5.64&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;"&gt;7.97&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 45pt;"&gt;21,356,600&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 17.5pt;"&gt;4.37&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Vested at December&#160;31, 2021 or expected to vest in the
                    future&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;2,120,643&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;5.66&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;7.96&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.37&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Exercisable at December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;1,122,783&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;9.26&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;6.70&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.37&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20201231"
      decimals="0"
      id="Fact_c95c49e85a074f7fb62c3ce92eef26c8"
      unitRef="U002">963700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20201231"
      decimals="2"
      id="Fact_8c1d67bf688848349fc930367a3170d2"
      unitRef="U003">14.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20200101to20201231"
      id="Fact_65ca0397ffbf4956bc0c2633d5a77ba8">P5Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20201231"
      decimals="-3"
      id="Fact_ca1bcd1904e449e38666d36917b8ac13"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <clbs:CommonStockWarrantsShares
      contextRef="c20201231"
      decimals="0"
      id="Fact_f6f189ee2782442097c8a911f6546a15"
      unitRef="U002">2638355</clbs:CommonStockWarrantsShares>
    <clbs:WeightedAverageExercisePriceWarrantsOutstanding
      contextRef="c20201231"
      decimals="2"
      id="Fact_06c40717fe604b47ab1b5d8b87289d0b"
      unitRef="U003">2.18</clbs:WeightedAverageExercisePriceWarrantsOutstanding>
    <clbs:WeightedAverageRemainingContractualTermwarrantoutstanding
      contextRef="c20200101to20201231"
      id="Fact_f69e7dba954748e5bde828143a5bf5ea">P4Y11M23D</clbs:WeightedAverageRemainingContractualTermwarrantoutstanding>
    <clbs:AggregateIntrinsicValueWarrantsOutstanding
      contextRef="c20201231"
      decimals="-3"
      id="Fact_6fdd0797c21543ffbb778b5664d59d45"
      unitRef="U001">0</clbs:AggregateIntrinsicValueWarrantsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_c0ab60d384bb40b2b130cc02f8ef65ab"
      unitRef="U002">1314790</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_2f75ba876fa94fbf8da906ccbfdabad1"
      unitRef="U003">1.32</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsGranted
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_a04135c9803848fba608df2cc06a9f9e"
      unitRef="U002">19519393</clbs:WarrantsGranted>
    <clbs:WeightedAverageExercisePriceWarrantsGranted
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_c944ea82f45a4d26b2008f6245941d2f"
      unitRef="U003">2.90</clbs:WeightedAverageExercisePriceWarrantsGranted>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_6a190d8ad60242d68845f0769b6f4e7d"
      unitRef="U002">7250</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_1d29bfc0247943c6889deb100f4a552a"
      unitRef="U003">3.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <clbs:AggregateIntrinsicValueOptionExercised
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_eb811c3a3f2945d59cea000dbf9cc5aa"
      unitRef="U001">3000</clbs:AggregateIntrinsicValueOptionExercised>
    <clbs:WarrantsExercised
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_a68eeb75a6b846d6890291193b7c7456"
      unitRef="U002">801148</clbs:WarrantsExercised>
    <clbs:WeightedAverageExercisePriceWarrantsExercised
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_5deebe117fd64767a72035ee735e31a1"
      unitRef="U003">2.19</clbs:WeightedAverageExercisePriceWarrantsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_fc7ed8e5778b4a3d8d1703f8cbb94c77"
      unitRef="U002">29842</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_ecede4bcec77467d9192db227bb26756"
      unitRef="U003">2.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsCanceled
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_49354ddd68124ac68d1a8b8997e0b895"
      unitRef="U002">0</clbs:WarrantsCanceled>
    <clbs:WeightedAverageExercisePriceWarrantsCanceled
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_0878c5a3a920418e80f643708d00fd27"
      unitRef="U003">0</clbs:WeightedAverageExercisePriceWarrantsCanceled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_65bffdc772604e5298b93954f1c4a08b"
      unitRef="U002">109549</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c20210101to20211231"
      decimals="2"
      id="Fact_4a8b298c85bb4d9fbfeb9f7c050066de"
      unitRef="U003">34.12</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsExpired
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_59fd299600b848f389c98db878b42ef8"
      unitRef="U002">0</clbs:WarrantsExpired>
    <clbs:WeightedAverageExercisePriceWarrantsExpired
      contextRef="c20210101to20211231"
      decimals="0"
      id="Fact_9c34828fa73d4df9a11be655267d66c8"
      unitRef="U003">0</clbs:WeightedAverageExercisePriceWarrantsExpired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231"
      decimals="0"
      id="Fact_698d0f4e5a0e4a9f8a193ffaabfcaa3a"
      unitRef="U002">2131849</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20211231"
      decimals="2"
      id="Fact_243e291de021455c9bf4fbbce94b0c94"
      unitRef="U003">5.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20210101to20211231"
      id="Fact_b4d4c38991654b37998b9da5c54a4f96">P7Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4df992263e264ff39a0d5cd2166b7aac"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <clbs:CommonStockWarrantsShares
      contextRef="c20211231"
      decimals="0"
      id="Fact_a96e3f771f654e21a74cc4c534b0d84a"
      unitRef="U002">21356600</clbs:CommonStockWarrantsShares>
    <clbs:WeightedAverageExercisePriceWarrantsOutstanding
      contextRef="c20211231"
      decimals="2"
      id="Fact_b7aa650b35c24870b78338674fb3432d"
      unitRef="U003">2.84</clbs:WeightedAverageExercisePriceWarrantsOutstanding>
    <clbs:WeightedAverageRemainingContractualTermwarrantoutstanding
      contextRef="c20210101to20211231"
      id="Fact_138e888156a5406da6111898e707e120">P4Y4M13D</clbs:WeightedAverageRemainingContractualTermwarrantoutstanding>
    <clbs:AggregateIntrinsicValueWarrantsOutstanding
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ddebfe0bbfc24d8eb8c4896634fc372c"
      unitRef="U001">0</clbs:AggregateIntrinsicValueWarrantsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c20211231"
      decimals="0"
      id="Fact_f666aca26c324190b06087e8e360f967"
      unitRef="U002">2120643</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c20211231"
      decimals="2"
      id="Fact_955aea8673fb4c0ca5f2aa22dcca5db5"
      unitRef="U003">5.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="c20210101to20211231"
      id="Fact_716e65638da34e7cb70506afb7bba0fd">P7Y11M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_74cde875d1244b50827eb2a8894717c7"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <clbs:Sharesvestedandexpectedtovest
      contextRef="c20211231"
      decimals="0"
      id="Fact_b17c6a8f163b480eae67f50a2ae39b2c"
      unitRef="U002">21356600</clbs:Sharesvestedandexpectedtovest>
    <clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest
      contextRef="c20211231"
      decimals="2"
      id="Fact_0cf7d4cee38d424c88eba8c0324f3da1"
      unitRef="U003">2.84</clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest>
    <clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest
      contextRef="c20210101to20211231"
      id="Fact_9694fb91d338444c9721bbd7084658bc">P4Y4M13D</clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest>
    <clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6a6207285909497d90f30ef83cd65e5a"
      unitRef="U001">0</clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c20211231"
      decimals="0"
      id="Fact_cbcdd0acffb24d83b16f8c1107b41412"
      unitRef="U002">1122783</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c20211231"
      decimals="2"
      id="Fact_0df883a8d2394f7fb52dac927ffe668d"
      unitRef="U003">9.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="c20210101to20211231"
      id="Fact_df8698535139450095374bf459b8078f">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_a99e84727afd4cecbaa2a8e21a28c8ee"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <clbs:WarrantsVested
      contextRef="c20211231"
      decimals="0"
      id="Fact_beaa0d293b5a407cb6ca981a449c6090"
      unitRef="U002">21356600</clbs:WarrantsVested>
    <clbs:WeightedAverageExercisePriceWarrantsExercisable
      contextRef="c20211231"
      decimals="2"
      id="Fact_a36dac770f534990993d44031476b736"
      unitRef="U003">2.84</clbs:WeightedAverageExercisePriceWarrantsExercisable>
    <clbs:WeightedAverageRemainingContractualTermwarrantsvested
      contextRef="c20210101to20211231"
      id="Fact_f01c165cba8c480cbd4ae3aa5bfa16a7">P4Y4M13D</clbs:WeightedAverageRemainingContractualTermwarrantsvested>
    <clbs:AggregateIntrinsicValueWarrantsvested
      contextRef="c20211231"
      decimals="-3"
      id="Fact_33d9b69a445a4c96ade5802394669aec"
      unitRef="U001">0</clbs:AggregateIntrinsicValueWarrantsvested>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_98b6d60a9c2f40a1bb1230e3776be2e3">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock for services as follows ($ in thousands, except share data):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Number of Restricted Stock Issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;612,950&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;156,184&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Value of Restricted Stock Issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;877.7&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;512.3&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_eaa4d9e46e964ffbb51e140de682ecf3"
      unitRef="U002">612950</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_60f0a6afc38c4eea902a29dd1d6d8c0f"
      unitRef="U002">156184</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="-2"
      id="Fact_aeb9bb45dfc8457f80089a522d17f48c"
      unitRef="U001">877700</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="-2"
      id="Fact_5070987804ea44a6893bb8f5c5343add"
      unitRef="U001">512300</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_f3e202588b0d461f9fe02b24e3d8a743"
      unitRef="U003">1.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_7b607d44f6e348a9b487a48fe1017eb1"
      unitRef="U003">3.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMember"
      id="Fact_54d125464c7348188d8dffd623964bf1">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_2b435b8ebfd44098b15928c6f17fc81c">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;During the years ended December&#160;31, 2021 and 2020, the Company issued
            restricted stock units for services as follows ($ in thousands, except share data):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Number of Restricted Stock Units Issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;458,245&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;325,853&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Value of Restricted Stock Units Issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;728.6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.76%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 10pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;863.0&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_12cb7ab0c8ff45a2bf962857c85c7b49"
      unitRef="U002">458245</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_ebf90454c84c46b5a13d38cc5edad594"
      unitRef="U002">325853</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-2"
      id="Fact_cd58779a54e6422ab97edfbf1f376011"
      unitRef="U001">728600</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-2"
      id="Fact_8e3e43f9b9ec4bf1b39fef85b80b7d29"
      unitRef="U001">863000.0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_ca8d47fcb59f4be79f23249edf5ec899"
      unitRef="U003">1.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20200101to20201231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="2"
      id="Fact_9404cd5e872c448e9e28e411f9a8aab0"
      unitRef="U003">2.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      id="Fact_d9de68b84e1a4f9abfde569b6b39e6ec">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="c20210101to20211231"
      id="Text_4aa7b79d118741bbbd43513722b76b97">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 10 &#x2013; Share-Based Compensation&lt;/span&gt;&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;"&gt;Share-based Compensation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company utilizes share-based compensation in the form of stock
            options, restricted stock, and restricted stock units. &lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;The following table summarizes the components of share-based compensation expense for the years ended December&#160;31, 2021 and 2020 ($ in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year Ended December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Research and development&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;$&lt;span style="padding-left: 7.5pt;"&gt;760&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;$&lt;span style="padding-left: 7.5pt;"&gt;179&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;General and administrative&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;1,245&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;1,086&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total share-based compensation expense&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,005&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$1,265&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Total compensation cost related to unvested awards not yet recognized
            and the weighted-average periods over which the awards are expected to be recognized at December&#160;31, 2021 were as follows ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Restricted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Units&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Restricted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Unrecognized compensation cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;757&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;149&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;546&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Expected weighted-average period in years of compensation
                    cost to be recognized&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1.64&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1.57 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1.70&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the years ended December&#160;31, 2021 and 2020 were as follows ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total fair value of shares vested&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;757&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.13pt;"&gt;536&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Weighted average estimated fair value of shares granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;0.91&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;2.11&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;Valuation Assumptions&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The fair value of stock options at the date of grant was estimated
            using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#x2019;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant and
            exercise of options for all employees.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The range of assumptions made in calculating the fair values of
            stock options was as follow:&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected term - minimum (in years)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected term - maximum (in years)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected volatility - minimum&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;79%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;75%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected volatility - maximum&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;84%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;79%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Weighted Average volatility&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;81%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;75%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected dividend yield&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Risk-free interest rate - minimum&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;0.63%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;0.40%&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Risk-free interest rate - maximum&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;1.16%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;1.71%&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="c20210101to20211231"
      id="Text_fa997cf0755d458d82281d530d0eb974">&lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;The following table summarizes the components of share-based compensation expense for the years ended December&#160;31, 2021 and 2020 ($ in thousands):&lt;/span&gt;
&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.57%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year Ended December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Research and development&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;$&lt;span style="padding-left: 7.5pt;"&gt;760&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;$&lt;span style="padding-left: 7.5pt;"&gt;179&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;General and administrative&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;1,245&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;1,086&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total share-based compensation expense&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,005&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.25%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.03%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.39pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$1,265&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Total compensation cost related to unvested awards not yet recognized
            and the weighted-average periods over which the awards are expected to be recognized at December&#160;31, 2021 were as follows ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Restricted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Units&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Restricted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Unrecognized compensation cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;757&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;149&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;546&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Expected weighted-average period in years of compensation
                    cost to be recognized&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1.64&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1.57 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1.70&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20211231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_1837aad33c424822b36190f23f0d81c8"
      unitRef="U001">760000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20200101to20201231_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_168db0dddb24414eafd2ba50696e4dee"
      unitRef="U001">179000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20211231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_7c1d6e6f554f4280b51dd0aed3b2f354"
      unitRef="U001">1245000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20200101to20201231_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_0b766f7a8a6943c6a1aaaf75850e06b9"
      unitRef="U001">1086000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_89f0daaf9fa740e0a670e0a4931a4d7e"
      unitRef="U001">2005000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_52739c813e67496cbca430675d5e3103"
      unitRef="U001">1265000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_0c74cd9c02dd4f328f6ce7ef4cd49fb2"
      unitRef="U001">757000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_1092abbdda424ac5bd7ae1156c097da1"
      unitRef="U001">149000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c20211231_AwardTypeAxis_RestrictedStockMember"
      decimals="-3"
      id="Fact_691b0b364c6c41d480e6ac220fc29ec7"
      unitRef="U001">546000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_0565468c292f44f6aa812253543f9810">P1Y7M20D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      id="Fact_df6d52c88cd54740913c20ae1c4337c3">P1Y6M25D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20210101to20211231_AwardTypeAxis_RestrictedStockMember"
      id="Fact_38790f596c3a48f9ac2e6699586431ec">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_1b3fcad8f78b4965a0fb931565ad9130">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the years ended December&#160;31, 2021 and 2020 were as follows ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 16.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.73%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total fair value of shares vested&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;757&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.13pt;"&gt;536&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Weighted average estimated fair value of shares granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.81%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;0.91&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.38%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.73%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;2.11&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_4599da3b18c84ec6bbd43decc61587c0"
      unitRef="U001">757000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_0a5e6a923ac5464cab7d5c51768afe9d"
      unitRef="U001">536000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_60912d6289a84b9e8e265eabf5cd30ee"
      unitRef="U003">0.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_2a294da650c44c31bff41ddf4f942866"
      unitRef="U003">2.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_1e8e93c2b2e84f9c8facfb3fd3dbcd50">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The range of assumptions made in calculating the fair values of
            stock options was as follow:&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 16.12%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Year Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected term - minimum (in years)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected term - maximum (in years)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;6&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected volatility - minimum&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;79%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;75%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected volatility - maximum&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;84%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;79%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Weighted Average volatility&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;81%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;75%&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expected dividend yield&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Risk-free interest rate - minimum&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;0.63%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;0.40%&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Risk-free interest rate - maximum&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;1.16%&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 3.48%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 4.58%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.97pt; text-align: left;"&gt;1.71%&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"
      id="Fact_cbf3add653bf43c79b878a7bca78d954">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MinimumMember"
      id="Fact_29114b76d3444fb0aea1a5f7b4ed47dd">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"
      id="Fact_a84ee38e6534461493437567a7df1c9f">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember_RangeAxis_MaximumMember"
      id="Fact_412161404f1947899496da68ee558cfd">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_0f0d5582236640ad910b0d52e45ab5e9"
      unitRef="U005">0.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_8874663df04044f3af68897a0fc264eb"
      unitRef="U005">0.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_c1c1978ac37945ea978bb902e70def7b"
      unitRef="U005">0.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_b4ec743db684449998f3881945dac292"
      unitRef="U005">0.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_8280381ecdd644d6b17d0adac09ee879"
      unitRef="U005">0.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_a2e41cbe01084be4b78a5100929558a8"
      unitRef="U005">0.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_915a0ec5ceb049e99876f94e41803ac8"
      unitRef="U005">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="0"
      id="Fact_faa62ed5ecd0401aae1c9d23af6c2d21"
      unitRef="U005">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_49ad1b684bea411197d16283874f1599"
      unitRef="U005">0.0063</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_c7f857e6f9a64b698f656bde9b6a2c66"
      unitRef="U005">0.0040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_d9236ab85fd345f88b1b3c011229193e"
      unitRef="U005">0.0116</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="c20200101to20201231_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="4"
      id="Fact_cf162e9dc3d941eab545c5abed779ea3"
      unitRef="U005">0.0171</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_cc2807baa95649d39447418d6b5fb83b">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 11 &#x2013; Research Funding&lt;/span&gt;&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;"&gt;California Institute of Regenerative Medicine
            Grant Award&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In February 2017, the California Institute for Regenerative Medicine
            (&#x201c;CIRM&#x201d;) awarded the Company funds of up to $12.2 million to support The Sanford Project: T-Rex Study, a prospective, randomized,
            placebo-controlled, double-blind Phase 2 clinical trial to evaluate the safety and efficacy of CLBS03 as a treatment for recent-onset type 1 diabetes. The funding is based upon the achievement of certain milestones related to the proportion of
            subjects enrolled in California, as well as manufacturing and development costs incurred in California. Based on the actual number of subjects enrolled in California, the total amount of funding was revised to $8.6 million, of which $8.2 million
            has been received through the grant project period completion.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company received $5.7 million in initial funding in May 2017, a $1.9 million
            milestone payment in December 2017, a $0.3 million progress payment in March 2018, and a $0.2 million progress payment in May&#160;2019, of which the total was amortized over the estimated award period through July 2020 as a reduction to the related research and
            development expenses, with the final true up payment of $46 thousand received in September 2020 and recorded as a reduction to the
            related research and development expenses. During the year ended December&#160;31, 2021 and December&#160;31, 2020 the Company amortized and recognized $0.0







            million and $1.6 million in credits, respectively, to research and development related to CIRM funds received.&lt;/div&gt;
</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:GrantsReceivable
      contextRef="c20170228"
      decimals="-5"
      id="Fact_dea1076357e6459a8a9378ba010c81da"
      unitRef="U001">12200000</us-gaap:GrantsReceivable>
    <clbs:FundingAmountAwarded
      contextRef="c20170228"
      decimals="-5"
      id="Fact_5b83c13637974f6bbdd2e35b14c77ac3"
      unitRef="U001">8600000</clbs:FundingAmountAwarded>
    <clbs:FundingOfGrantAwardCashReceived
      contextRef="c20170501to20200930"
      decimals="-5"
      id="Fact_17b4e63edd02475ba0fde2fa81775d1b"
      unitRef="U001">8200000</clbs:FundingOfGrantAwardCashReceived>
    <clbs:FundingOfGrantAwardCashReceived
      contextRef="c20170501to20170531"
      decimals="-5"
      id="Fact_de924e3ef605480abd6c1128dd3feb5d"
      unitRef="U001">5700000</clbs:FundingOfGrantAwardCashReceived>
    <clbs:MilestonePaymentOnGrantAwardCashReceived
      contextRef="c20171201to20171231"
      decimals="-5"
      id="Fact_80e139b124d04353a4b9350fc892a626"
      unitRef="U001">1900000</clbs:MilestonePaymentOnGrantAwardCashReceived>
    <clbs:ProgressPaymentOnGrantAwardCashReceived
      contextRef="c20180301to20180331"
      decimals="-5"
      id="Fact_bd939843ef1d4e9da1cda6d4d604c78e"
      unitRef="U001">300000</clbs:ProgressPaymentOnGrantAwardCashReceived>
    <us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
      contextRef="c20190501to20190531"
      decimals="-5"
      id="Fact_e150742d18094f53a76a14278b0ad5c6"
      unitRef="U001">200000</us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred>
    <us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
      contextRef="c20200901to20200930"
      decimals="-3"
      id="Fact_038a0ce93d824ba88bd544f5e42b1995"
      unitRef="U001">46000</us-gaap:ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred>
    <clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense
      contextRef="c20210101to20211231"
      decimals="-5"
      id="Fact_07ff10a33f7b4e67954f28b462ddca81"
      unitRef="U001">0</clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense>
    <clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense
      contextRef="c20200101to20201231"
      decimals="-5"
      id="Fact_64daed7437b74c4386d326e8a0449e14"
      unitRef="U001">1600000</clbs:AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_5cad08bc886b4ccd857affebec7e757e">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 12 &#x2013; Income Taxes&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The provision (benefit) for income taxes is based on loss from
            operations before provision for income taxes and noncontrolling interests as follows ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Years Ended December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Pre-tax book income&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;United States&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;$(28,974)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;$(19,013)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(28,974)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(19,013)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The provision (benefit) from income taxes was as follows ($ in
            thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Years Ended December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Current&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;U.S. Federal&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 15.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 20.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;State and local&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 30.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 15.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;U.S. Federal&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 15.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 20.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;State and local&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;"&gt;(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 30.83pt;"&gt;$(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;U.S. Federal&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 15.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 20.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;State and local&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;"&gt;(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 30.83pt;"&gt;$(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div&gt;&lt;br/&gt;
          &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The provision (benefit) for income taxes is determined by applying
            the U.S. Federal statutory rate of 21% to income before income taxes, and the components are set forth below ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Years Ended December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;U.S. Federal benefit at statutory rate&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;(6,085)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;(3,993)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Permanent non deductible expenses for U.S. taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;320&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 30.83pt;"&gt;5&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Change in state deferred&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;622&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;5,122&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Return to actual&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;2,277&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Other true ups&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;1,407&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;387&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Section 382 NOL Limitation&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;35,438&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Sale of New Jersey State NOLs&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Valuation allowance for deferred tax assets&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(33,979)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(1,521)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Tax provision (benefit)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Deferred income taxes at December&#160;31, 2021 and 2020 consist of the
            following ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 19.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred Tax Assets:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Accumulated net operating losses (tax effected)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 3.33pt;"&gt;36,281&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 3.33pt;"&gt;68,286&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Right of use liability&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;201&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;176&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Share-based compensation&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;3,086&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;5,025&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Intangibles&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;97&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;131&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Accumulated depreciation&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;26&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;19&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Accrued payroll&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;176&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;167&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;526&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;526&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred tax assets&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;40,393&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;74,330&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred Tax Liabilities:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Right of use asset&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(204)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(161)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred tax liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(204)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(161)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;40,189&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;74,169&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Valuation allowance&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(40,189)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(74,169)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Net deferred tax asset&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In assessing the realizability of deferred tax assets, including the
            net operating loss carryforwards (NOLs), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets. Based on its assessment,
            the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of December&#160;31, 2021, and 2020, the Company had approximately $281 million and $264 million,
            respectively, of Federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on
            January&#160;25, 2021. As a result, $169 million of the $281 million of Federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $112 million of remaining Federal NOL. The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact
            to the balance sheet or income statement. Losses incurred before the ownership change on January&#160;25, 2021 will be subject to an annual limitation of $173k under Internal Revenue Code Section 382, while losses incurred after January&#160;25, 2021
            will not be subject to limitations. The Company may be able to utilize additional NOLs of approximately $1.1 million per year for the
            first five years after this ownership change as a result of the application of the Net Unrealized Built-in Gain rules.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of December&#160;31, 2021 and 2020, the Company had State NOLs
            available in New Jersey of $97 million and $99 million, respectively, California of $70 million and $70 million, respectively, and New York City of $13
            million and $13 million, respectively, to offset future taxable income expiring from 2031 through 2041. In accordance with Section
            382 of the Internal Revenue code, the usage of the Company&#x2019;s state NOLs would be limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period
            when those temporary differences become deductible.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company applies the FASB&#x2019;s provisions for uncertain tax
            positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest
            benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant taxing authority. The Company recognizes interest and penalties associated with certain tax positions as a component of income tax
            expense.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of December&#160;31, 2021, management does not believe the Company has
            any material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in
            future periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;For years prior to 2018 the federal statute of limitations is closed
            for assessing tax. The Company&#x2019;s state tax returns remain open to examination for a period of three to four years from date of filing.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In February 2021, the Company received preliminary approval from the
            New Jersey Economic Development Authority (&#x201c;NJEDA&#x201d;) to participate in the Technology Business Tax Certificate Transfer Program (the &#x201c;Program&#x201d;). The Program permits qualified companies to sell a percentage of their New Jersey net operating
            losses (&#x201c;NJ NOLs&#x201d;) to unrelated profitable corporations. On April&#160;12, 2021, the Company received final approval from NJEDA to sell a portion of our NJ NOLs, which were subsequently sold to a qualifying and approved buyer pursuant to the Program
            for net proceeds of $1.4 million. The $1.5
            million of our NJ NOL related tax benefits (&#x201c;NJ NOL Tax Benefits&#x201d;) have been recorded as a benefit from income taxes and the loss on sale of $0.1
            million recorded in other income (expense) in the consolidated financial statements.&lt;/div&gt;
</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_763d9d5c90ad4bcd8b9349cbb0cbe23c">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The provision (benefit) for income taxes is based on loss from
            operations before provision for income taxes and noncontrolling interests as follows ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Years Ended December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Pre-tax book income&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;United States&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;$(28,974)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;$(19,013)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(28,974)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(19,013)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7ec859f1f49140e9bed0d556473da11b"
      unitRef="U001">-28974000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_c5f7ea68c6984af69124e92b021a8290"
      unitRef="U001">-19013000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_4061714876fc429d8e90160953c6f0e9"
      unitRef="U001">-28974000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_326af574c6134271b3975a73b09832da"
      unitRef="U001">-19013000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_bc58dfcf8de142af92ae460a9419a088">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The provision (benefit) from income taxes was as follows ($ in
            thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Years Ended December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Current&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;U.S. Federal&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 15.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 20.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;State and local&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 30.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 15.83pt; border-bottom: 3pt double #000000; min-width: 30.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;U.S. Federal&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 15.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 20.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;State and local&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;"&gt;(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 30.83pt;"&gt;$(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;U.S. Federal&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 15.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;$&lt;span style="padding-left: 20.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;State and local&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 30.83pt;"&gt;(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 30.83pt;"&gt;$(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.3%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.48%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_6a964e02a3a346eabb8a99070e6e94b2"
      unitRef="U001">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_3df7902d001f4e188ec62c0c0b606e7f"
      unitRef="U001">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1784700f45154042b3f8e54489eb25ab"
      unitRef="U001">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_9eb5959ed295462fa0a3c16eb0a8b187"
      unitRef="U001">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3b4c8066d8a34a12b18c84b974f44f10"
      unitRef="U001">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_3a49a75b59da4215ab9255e787c73d0c"
      unitRef="U001">0</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ad3e60c75dd947ed83a22c4d04d3c592"
      unitRef="U001">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_078bbb2a7c2840488b2912cb072823be"
      unitRef="U001">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_c6bea8bd712544d2856fb081d979d733"
      unitRef="U001">-1508000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d852cd6c031140cd8002b0ffe4ce3eaa"
      unitRef="U001">-10872000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_cd45b460699c4123ab38ab0e67f7515e"
      unitRef="U001">-1508000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6dda46dae47643efbd06d3180b11936d"
      unitRef="U001">-10872000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_a93d7562020d46f5b5c9c0f8de7f0d25"
      unitRef="U001">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_5ddb512cf7c24528b59a41858db211cd"
      unitRef="U001">0</us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7a97e5a84b424edbab8659c79fdeb870"
      unitRef="U001">-1508000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_40edc4b1bbb64d1183572ba9d60f8f6b"
      unitRef="U001">-10872000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_977d8fdcc2424f2c9a4d5edaaec21d68"
      unitRef="U001">-1508000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_43867bc2583a44738cfec050381e8b7f"
      unitRef="U001">-10872000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_7a19108814244ae79134378c663f6b51">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The provision (benefit) for income taxes is determined by applying
            the U.S. Federal statutory rate of 21% to income before income taxes, and the components are set forth below ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.92%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Years Ended December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;U.S. Federal benefit at statutory rate&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;(6,085)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;(3,993)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Permanent non deductible expenses for U.S. taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;320&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 30.83pt;"&gt;5&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Change in state deferred&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;622&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;5,122&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Return to actual&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;2,277&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Other true ups&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;1,407&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;387&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Section 382 NOL Limitation&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;35,438&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Sale of New Jersey State NOLs&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Valuation allowance for deferred tax assets&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(33,979)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(1,521)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Tax provision (benefit)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;(1,508)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.08%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.38%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.03pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$(10,872)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="c20210101to20211231"
      decimals="INF"
      id="Fact_4c5e79801ceb4e0bb9d9719121723553"
      unitRef="U005">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_b4264b71f88f4548a7b237174a308dc1"
      unitRef="U001">-6085000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_695894dd606e4bf68c5fd62b306c7cd8"
      unitRef="U001">-3993000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_1554a8751f1543d5b07d69eb8a0db17d"
      unitRef="U001">320000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_cfcbf5bdbeaa4d8a955b089bcfa1b7a6"
      unitRef="U001">5000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <clbs:EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_7abfcba57916404eb9a17451db3f5221"
      unitRef="U001">622000</clbs:EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount>
    <clbs:EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_bfe8a46784a340a0b52a10b9ebe47892"
      unitRef="U001">5122000</clbs:EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_086cd7285ded40f7b6276046e23dbe1d"
      unitRef="U001">2277000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_94c59636aa4046bda0f511084f70173e"
      unitRef="U001">0</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_563f6465139f4ef1bc02fab42236a746"
      unitRef="U001">1407000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_e3db77eeb42143a0aa7d4ea301537b1a"
      unitRef="U001">387000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <clbs:EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_241d3560132b440d8139bac3a61736ff"
      unitRef="U001">35438000</clbs:EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount>
    <clbs:EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_006d6565417e4495a18b2086c1ead76b"
      unitRef="U001">0</clbs:EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount>
    <clbs:EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_ee2cc2eb2c074e7d890ff5b28dc1c30e"
      unitRef="U001">-1508000</clbs:EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses>
    <clbs:EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_6ff86479e4ca47df95cb4e080ed0c428"
      unitRef="U001">-10872000</clbs:EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_18195f66ee9f43ad804ebfd5ecc9d6a9"
      unitRef="U001">-33979000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_bb95f1133a6f44be944e9e64c73c8ffc"
      unitRef="U001">-1521000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20211231"
      decimals="-3"
      id="Fact_3fca542e11da4eb3a6a47e34cef7e763"
      unitRef="U001">-1508000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20200101to20201231"
      decimals="-3"
      id="Fact_d271067274664b8bad370e5140f46eff"
      unitRef="U001">-10872000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="c20210101to20211231"
      id="Text_cdcc5a120a1545baa09ad8dac351cb7e">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Deferred income taxes at December&#160;31, 2021 and 2020 consist of the
            following ($ in thousands):&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"&gt; &lt;br/&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 19.19%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2020&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred Tax Assets:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Accumulated net operating losses (tax effected)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 3.33pt;"&gt;36,281&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;$&lt;span style="padding-left: 3.33pt;"&gt;68,286&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Right of use liability&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;201&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;176&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Share-based compensation&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;3,086&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;5,025&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Intangibles&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;97&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;131&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Accumulated depreciation&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;26&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 25.83pt;"&gt;19&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Accrued payroll&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;176&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt;"&gt;167&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;526&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;526&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred tax assets&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;40,393&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;74,330&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred Tax Liabilities:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Right of use asset&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(204)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(161)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Deferred tax liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(204)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(161)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;40,189&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;74,169&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Valuation allowance&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(40,189)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 35.83pt;"&gt;(74,169)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Net deferred tax asset&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.66%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.94%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.65%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 20.83pt; border-bottom: 3pt double #000000; min-width: 35.83pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="c20211231"
      decimals="-3"
      id="Fact_81a4e28922d64ca2a6699029ca6878ea"
      unitRef="U001">36281000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="c20201231"
      decimals="-3"
      id="Fact_780b755b514e4fb4921d7b5e98fa6eed"
      unitRef="U001">68286000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <clbs:DeferredTaxAssetsRightOfUseLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_02f68960c941414bb560fbfb40f75ca9"
      unitRef="U001">201000</clbs:DeferredTaxAssetsRightOfUseLiability>
    <clbs:DeferredTaxAssetsRightOfUseLiability
      contextRef="c20201231"
      decimals="-3"
      id="Fact_3b8e153831ca4eb985bb33105a62b55a"
      unitRef="U001">176000</clbs:DeferredTaxAssetsRightOfUseLiability>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="c20211231"
      decimals="-3"
      id="Fact_7abb3519a588484bb10705186949e6a4"
      unitRef="U001">3086000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="c20201231"
      decimals="-3"
      id="Fact_2871b734bf1a4333aaf8eaa674663bd3"
      unitRef="U001">5025000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_38a5a5ee0bfa4fbb942446c3ad278bca"
      unitRef="U001">97000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="c20201231"
      decimals="-3"
      id="Fact_35569933e40e4be2ab79bc7b14a8d40e"
      unitRef="U001">131000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <clbs:DeferredTaxAssetsAccumulatedDepreciation
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e127febe803344a4b6286155b02892f3"
      unitRef="U001">26000</clbs:DeferredTaxAssetsAccumulatedDepreciation>
    <clbs:DeferredTaxAssetsAccumulatedDepreciation
      contextRef="c20201231"
      decimals="-3"
      id="Fact_5fec75f0c7bc498b8cb425f0baa10acc"
      unitRef="U001">19000</clbs:DeferredTaxAssetsAccumulatedDepreciation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e4ae5bcfde9d41558f85dff393266b0a"
      unitRef="U001">176000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="c20201231"
      decimals="-3"
      id="Fact_db005b280d46481b9dc6a3d20a4ed192"
      unitRef="U001">167000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="c20211231"
      decimals="-3"
      id="Fact_94a8046c787c42deaf6f91cfb13f9119"
      unitRef="U001">526000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="c20201231"
      decimals="-3"
      id="Fact_722d26ecdf1144a5853597ae7ffcfcb3"
      unitRef="U001">526000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3491b0fce14e438f990404c837c7cf85"
      unitRef="U001">40393000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_04f345defc114c47be1038e9b4688cec"
      unitRef="U001">74330000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="c20211231"
      decimals="-3"
      id="Fact_02746c7a4acb4480b6c880b7ea251404"
      unitRef="U001">204000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="c20201231"
      decimals="-3"
      id="Fact_1cb73e245e2f4ac4977a019c5b0f1125"
      unitRef="U001">161000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_4752f069dfc442cb8f5a754e21dfd00a"
      unitRef="U001">204000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="c20201231"
      decimals="-3"
      id="Fact_083a661fdd0e486b901563b308b3f5cf"
      unitRef="U001">161000</us-gaap:DeferredIncomeTaxLiabilities>
    <clbs:NetDeferredTaxAssetsAndLiabilitiesGross
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ca162b26b960421696fb9d230ce7eec1"
      unitRef="U001">40189000</clbs:NetDeferredTaxAssetsAndLiabilitiesGross>
    <clbs:NetDeferredTaxAssetsAndLiabilitiesGross
      contextRef="c20201231"
      decimals="-3"
      id="Fact_27fa6afe69bc4f37b62815c3bbc4a0f4"
      unitRef="U001">74169000</clbs:NetDeferredTaxAssetsAndLiabilitiesGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e505a6c875174a9c8439bf775315eddc"
      unitRef="U001">40189000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="c20201231"
      decimals="-3"
      id="Fact_56df7cc09efe4b8f99929fe6d0eab6c3"
      unitRef="U001">74169000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_37af15d050184f85a0051063fd07a773"
      unitRef="U001">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="c20201231"
      decimals="-3"
      id="Fact_bba483577a23445987d530959fb545e8"
      unitRef="U001">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <clbs:OperatingLossCarryforwardsBeforeWriteDown
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_78669cb620e14f3096217f1549768fd4"
      unitRef="U001">281000000</clbs:OperatingLossCarryforwardsBeforeWriteDown>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20201231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_bff9fcff02c04a59ab7b79c272da07de"
      unitRef="U001">264000000</us-gaap:OperatingLossCarryforwards>
    <clbs:OperatingLossCarryforwardsSetToExpireWrittenDown
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_8a74aa290a464a4e8a056fecd5d71c3c"
      unitRef="U001">169000000</clbs:OperatingLossCarryforwardsSetToExpireWrittenDown>
    <clbs:OperatingLossCarryforwardsBeforeWriteDown
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_af7b5970411e41fc988ca7c6f6fc8819"
      unitRef="U001">281000000</clbs:OperatingLossCarryforwardsBeforeWriteDown>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_155ba48613ab4761bf176826ac21fd9d"
      unitRef="U001">112000000</us-gaap:OperatingLossCarryforwards>
    <clbs:OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain
      contextRef="c20211231"
      decimals="-5"
      id="Fact_e45ff6d65cf04983a8f0ea22163a596d"
      unitRef="U001">1100000</clbs:OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember"
      decimals="-6"
      id="Fact_fdd6531d6ba444659bf7ded9618d1a11"
      unitRef="U001">97000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember"
      decimals="-6"
      id="Fact_ee794425524d40c2aa649fc73be70859"
      unitRef="U001">99000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember"
      decimals="-6"
      id="Fact_7eda14f514a94ff692420188c8b0b3f1"
      unitRef="U001">70000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember"
      decimals="-6"
      id="Fact_a11a795210f14b1c9a0bc0db9410d337"
      unitRef="U001">70000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember"
      decimals="-6"
      id="Fact_001bc190b26b490d978933e7ecf2210f"
      unitRef="U001">13000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember"
      decimals="-6"
      id="Fact_b6ac782837dd437eaabbd861774e9cc7"
      unitRef="U001">13000000</us-gaap:OperatingLossCarryforwards>
    <clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram
      contextRef="c20210412to20210412"
      decimals="-5"
      id="Fact_2b01f0528f7f484ca0fcb3c4ac5f9722"
      unitRef="U001">1400000</clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram>
    <clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross
      contextRef="c20210412to20210412"
      decimals="-5"
      id="Fact_c3f189976e7941dcb77203dfb7d55140"
      unitRef="U001">1500000</clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross>
    <clbs:LossOnSaleOfNetOperatingLosses
      contextRef="c20210412to20210412"
      decimals="-5"
      id="Fact_ff274cc2689a4fc38ff23ce9a649bbbe"
      unitRef="U001">100000</clbs:LossOnSaleOfNetOperatingLosses>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="c20210101to20211231"
      id="Text_60158982f36c491b976269b60b6cee13">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 13 &#x2013; Contingencies&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;From time to time, the Company is subject to legal proceedings and
            claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a
            material adverse effect on the Company's financial condition or operating results.&lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_a92d52bd48704b04aa1637757d94381b"
      unitRef="U001">12747000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_3d402322e3624bb6973668b3e7c3f23d"
      unitRef="U001">24647000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="c20220331"
      decimals="-3"
      id="Fact_caa05e7c13db4479803a6e4d67ac7989"
      unitRef="U001">75772000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_62aaab255aa54287874bfa8e327ae528"
      unitRef="U001">70323000</us-gaap:MarketableSecurities>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_5674f0942a2845a98f4066f58d10a786"
      unitRef="U001">2181000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_dcfa7d18ba6149d4982a9c568f0b12d9"
      unitRef="U001">1212000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_eb072c7bb64d4a0cbb7807bc5b60cc85"
      unitRef="U001">90700000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_20d38c87ff584747898d90d526d6d0bf"
      unitRef="U001">96182000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20220331"
      decimals="-3"
      id="Fact_c67213a5e30440e58258d8c264edc966"
      unitRef="U001">55000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ef7a589bb2bd4efc824c5cf5f163b08b"
      unitRef="U001">62000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f5176358617249e5aa37a21a45758c32"
      unitRef="U001">708000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5127676b958b4992b2e4e4119b7d5e33"
      unitRef="U001">764000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="c20220331"
      decimals="-3"
      id="Fact_fcc6abd236b4468a815c3722c76a9188"
      unitRef="U001">91463000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f5f43ceb828446f5bda8a8ccbdda94f7"
      unitRef="U001">97008000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_9e7d3162c32243f2862c66f265ae648e"
      unitRef="U001">697000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1720291a54c545b8a4af8dace99b84b6"
      unitRef="U001">1934000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_a3bd31d38e06457f92e42643ed559237"
      unitRef="U001">2104000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e010b426aaaf4aeb9c914c909a6b0131"
      unitRef="U001">2589000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_a91467346cd445e893051527e9b3c562"
      unitRef="U001">2801000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_52343e7ebaf34d0da041cdbdb8bd9859"
      unitRef="U001">4523000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_7d58ba0379bc46f5a8ef5890a19cc9c4"
      unitRef="U001">421000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d92b1cabd7174c308d1468fb241b9465"
      unitRef="U001">485000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="c20220331"
      decimals="-3"
      id="Fact_359017941698447a9f9d86c9703820f9"
      unitRef="U001">3222000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_c1694bde392a47cd9d016224298b525f"
      unitRef="U001">5008000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20220331"
      id="Fact_a13d6e059a784c64b8f9f984cbd1840b"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c20211231"
      id="Fact_12c9182086fe42ebb55f6fd7e5311a32"
      unitRef="U001"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_f1f3d89be3b044f59893f8ee1ecbb94e"
      unitRef="U002">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c20220331"
      decimals="0"
      id="Fact_08e7148452f24f5bace1b22b4f4f46a2"
      unitRef="U002">20000000</us-gaap:PreferredStockSharesAuthorized>
    <clbs:PreferredStockLiquidationPreferenceShare
      contextRef="c20220331"
      decimals="INF"
      id="Fact_cca1a9d66bc54d3fbd16472776a3e712"
      unitRef="U002">0.001</clbs:PreferredStockLiquidationPreferenceShare>
    <clbs:PreferredStockLiquidationPreferenceShare
      contextRef="c20211231"
      decimals="INF"
      id="Fact_11f41bf00ae04ce798baa222d05a5cfe"
      unitRef="U002">0.001</clbs:PreferredStockLiquidationPreferenceShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20220331"
      decimals="INF"
      id="Fact_ac3ffe5a2fe64263be8537a9353d7a98"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="INF"
      id="Fact_590e9a1a04f449cdb5641fc4c88c2edf"
      unitRef="U003">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <clbs:PreferredStockSharesDesignated
      contextRef="c20211231"
      decimals="0"
      id="Fact_627301d9e5fc47e08f5098b8a4af5b4e"
      unitRef="U002">825000</clbs:PreferredStockSharesDesignated>
    <clbs:PreferredStockSharesDesignated
      contextRef="c20220331"
      decimals="0"
      id="Fact_351092cb632044feb9b3763672fe9c25"
      unitRef="U002">825000</clbs:PreferredStockSharesDesignated>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20211231"
      decimals="0"
      id="Fact_ee423311a0bd47f9b8af3a81a77825a8"
      unitRef="U002">10000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20220331"
      decimals="0"
      id="Fact_c81e6ff511c54eeea7c451e13c07dc34"
      unitRef="U002">10000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="c20220331"
      decimals="0"
      id="Fact_98421872e02f4c8ab08e339fcbc1b058"
      unitRef="U002">10000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c20211231"
      decimals="0"
      id="Fact_3c81c3eed605441fb12b284206951db0"
      unitRef="U002">10000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_592691232de8430e84ad2ad17c456369"
      unitRef="U001">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_5456918e483840d5bc7e75e027b8e7b9"
      unitRef="U001">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20220331"
      decimals="INF"
      id="Fact_8bf1f54ef57f42fd9b1e7cce47958d3c"
      unitRef="U003">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c20211231"
      decimals="INF"
      id="Fact_637cabc1ffcc48e38534b2868efe4312"
      unitRef="U003">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20211231"
      decimals="0"
      id="Fact_37b9132e1baf4ce3919b998e74227151"
      unitRef="U002">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c20220331"
      decimals="0"
      id="Fact_1de40aeac3ed43ac8f6531b4ecb8d213"
      unitRef="U002">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20220331"
      decimals="0"
      id="Fact_4e979b4882a84ab08282a2ce5841db3a"
      unitRef="U002">60544144</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="c20211231"
      decimals="0"
      id="Fact_c51ee9bcb0484559b7c4ab05b2bb41be"
      unitRef="U002">59800792</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20220331"
      decimals="0"
      id="Fact_c495d895e8754e6694244ba3e2e4a261"
      unitRef="U002">60533064</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c20211231"
      decimals="0"
      id="Fact_95a098b9e85046549cc5c74262cd98de"
      unitRef="U002">59789712</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_b35eefa7876a4830a041fea01c1df0f5"
      unitRef="U001">61000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_2baa38aa9a9e4cd3b47427569db55d5a"
      unitRef="U001">60000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20220331"
      decimals="-3"
      id="Fact_df4216e31e684522b7a4e40e2eae4bf0"
      unitRef="U001">546580000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="c20211231"
      decimals="-3"
      id="Fact_1b9af99ef0454249b13caf24c01162fa"
      unitRef="U001">545988000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="c20211231"
      decimals="0"
      id="Fact_bf16dcde815d421cad5f64795ed91fb4"
      unitRef="U002">11080</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="c20220331"
      decimals="0"
      id="Fact_97aade5c8adc400b94fa29b274410206"
      unitRef="U002">11080</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_792d4eec6e5149e98f6a51b84189e45e"
      unitRef="U001">708000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e990598ccc4845399d77805c8d19c8fc"
      unitRef="U001">708000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f6d1cbdf56b042e2afebe010d3fec426"
      unitRef="U001">-457242000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bff8a12244b04fe98649293806cbd87c"
      unitRef="U001">-453016000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="c20220331"
      decimals="-3"
      id="Fact_9f946afd07ed4530ad71b539fb5b0ddf"
      unitRef="U001">-196000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="c20211231"
      decimals="-3"
      id="Fact_50371cbbfd5f4ed0a82505f23eaf8760"
      unitRef="U001">-70000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_19113624a9204365939d4e67c3afff50"
      unitRef="U001">88495000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_486791862f9c486199e2371711736b8d"
      unitRef="U001">92254000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8b44aa4fa0bb41fb99cf4ea7f5baf0da"
      unitRef="U001">-254000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_04738d5b81194e968778289866620982"
      unitRef="U001">-254000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f143af27082d4f709de49ae6df322740"
      unitRef="U001">88241000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_88b1b7151d5d4453ac68644739d1222a"
      unitRef="U001">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20220331"
      decimals="-3"
      id="Fact_ea85f5d3d06d40c8aee11fca1288571a"
      unitRef="U001">91463000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6e62f249e56b4132be01e1c11b672014"
      unitRef="U001">97008000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_9b685af5a06c4f128959126e0e94c102"
      unitRef="U001">3278000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_125b07ce1a2041c9aa7e67bcd9cad671"
      unitRef="U001">5076000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_3b6d31755b404d72b01539af191e7e47"
      unitRef="U001">3342000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f4b5fc5efd1c422fb869bf25bebdb918"
      unitRef="U001">3010000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_0114ed89967346d5a39fa7002cacea5b"
      unitRef="U001">6620000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f0d638d79ddf46ad9588267a0d61ff37"
      unitRef="U001">8086000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_47c04285c05b47dfbbb242290daa139a"
      unitRef="U001">-6620000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_815d5d1199dc43d990b7f0a89ec582c9"
      unitRef="U001">-8086000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_ba5c65993a95455fbfe79bc4a7b068b4"
      unitRef="U001">63000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c2a518ef34724eb1913f3e976b366cba"
      unitRef="U001">23000</us-gaap:InvestmentIncomeNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_91005a0ffea74ac2b02f0a6a0a5c6ee0"
      unitRef="U001">-148000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e0d67d2a4af74303b4ece42ab179befa"
      unitRef="U001">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_5f81a3cdc644451fac2ccf5da10c93af"
      unitRef="U001">-85000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_3b815887d31b4b3d973f169aa2912f40"
      unitRef="U001">23000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_950608eb2e154e38ba5d93ddfc23cb97"
      unitRef="U001">-6705000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_9f0b0150c19e4e6594cf8ed708558690"
      unitRef="U001">-8063000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_c6aa10d9f2fd4443b5dde3e093e06380"
      unitRef="U001">-2479000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_abc1a881da434d338232055547d8c072"
      unitRef="U001">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_4fbabd2386cf4124adb6dbb4e9466834"
      unitRef="U001">-4226000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_59330b4df26a4017aeb8591fbc6be9f9"
      unitRef="U001">-8063000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_c7e36c6b2f994763a9a61a632dd02cf7"
      unitRef="U003">-0.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_54524011d116485ba8e65ea3108917b0"
      unitRef="U003">-0.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_0a95f1b407514c828036ba36950da11b"
      unitRef="U003">-0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20210101to20210331"
      decimals="2"
      id="Fact_4d4dc74e08f94391b70d3f5e14317b1c"
      unitRef="U003">-0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a46b4a4f1e6f475db7fd7a2ac6c41806"
      unitRef="U002">60560000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_75357b9b25a54e3c968dc4f871dc466a"
      unitRef="U002">60560000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f8793a4126e24c7d9e6bb45127339f25"
      unitRef="U002">42117000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_559e5c5bc9564c2e82d50d7a0a25a3bb"
      unitRef="U002">42117000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_dbf63bf573804684847a5373ea643271"
      unitRef="U001">-4226000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_6221a60e941c463696726b9624606d6d"
      unitRef="U001">-8063000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_cb8bcbff2e7b477081974576a60b1acd"
      unitRef="U001">-126000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_de0556c03f83471f871e9c65609087a8"
      unitRef="U001">-59000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_b9a1f49763214e84b73fc45163888028"
      unitRef="U001">-126000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e71f1124610b493c9892aa8ad8da721c"
      unitRef="U001">-59000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_bb3b6bf362e64ccd93fb24b07c8caf61"
      unitRef="U001">-4352000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4f2678b9b9b244fe9b2d9ba7f7c6bffb"
      unitRef="U001">-8122000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_4fca8c6a083c4c5bbaf30aac8ebbd7a8"
      unitRef="U002">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_f8c0d81f24604bd5955e16b72b300168"
      unitRef="U001">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_edbb46860152428fb9e1fb0c4d1fb1ab"
      unitRef="U002">59801000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_60ff33ea767d487897cda60d97a115df"
      unitRef="U001">60000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_453da17cd12741e9b49026698fec3915"
      unitRef="U001">545988000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_07366bf41d024655a21bc27f669c7eef"
      unitRef="U001">-70000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d96b852c54004b37853b9e6109c8e2bf"
      unitRef="U001">-453016000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_7f0a373a2e534e6baf5d1f462567f7b2"
      unitRef="U001">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_31e8e4aa7c4d484bbf32a38c48f8f907"
      unitRef="U001">92254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_e78904a2f981483abe61a946e67d6c18"
      unitRef="U001">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d8b66a4664954e339957b274eb0918e4"
      unitRef="U001">92000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_aad8d2994d8447778bba8285e0b55659"
      unitRef="U001">-4226000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_89e116e17a694cb3a22a51ff9e21ab2c"
      unitRef="U001">-4226000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_156fc1e9e78c4f8cbc40ea88a24c56ad"
      unitRef="U001">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_bc518076ed18422d87da46a38b6f508a"
      unitRef="U001">-4226000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_30fee710efff45e98425f30738610066"
      unitRef="U001">-126000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_087f97d74e0e4144b1e7c4bb0a86c764"
      unitRef="U001">-126000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_906c83200a1949a29715ff98c496128f"
      unitRef="U001">-126000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_962886faa136415fa96caee40bbd903d"
      unitRef="U002">743000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5096b951c7114538bd605fa4a712389e"
      unitRef="U001">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_01dfdbcd0a5947a0b33139f32dfa8453"
      unitRef="U001">592000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20220101to20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_116d8d8c8d684d0bbb6eec566752e75c"
      unitRef="U001">593000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_5a8c661be1604f7a95058fb4dbf0aeee"
      unitRef="U001">593000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="c20220331_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_df5fa457dd054d4eb63acdaf8d70f884"
      unitRef="U002">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_80da5e5b440d448d931084f8e7d7c4f9"
      unitRef="U001">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5b906777829a4a6db3751d4de2f23152"
      unitRef="U002">60544000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_63b9f6abd3a943f29adb2cc055923b5f"
      unitRef="U001">61000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_367c5f5fdb454ab5a60ebd5702c18dbf"
      unitRef="U001">546580000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_fc9c20211e844cc199dda169ffabd081"
      unitRef="U001">-196000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_d5fefa1b927e41d096b49ae9a8ee9fc9"
      unitRef="U001">-457242000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_a7b17e8a8f094d12ada0201b5c5e39bc"
      unitRef="U001">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_a525dd75038e48e0a279eb9ef17aaf04"
      unitRef="U001">88495000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_7bd51255ba0042b8b1a8c8a29af10b81"
      unitRef="U001">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20220331"
      decimals="-3"
      id="Fact_c411646724c64a29b2ee08d2ba8b78e1"
      unitRef="U001">88241000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_62e2e76477b548c2a2aeaa1805ad0209"
      unitRef="U002">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_221c0660730e4282b08d4802c525a162"
      unitRef="U001">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_bdc76b3ef4bf4fa0adc332fe3a2efa42"
      unitRef="U002">19389000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f67f35610f274410840578d9b9c42103"
      unitRef="U001">19000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7132d791043c4728a24397dd44048e0b"
      unitRef="U001">458748000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_e5d5af1f1ee74c5fb8101d34a8590af2"
      unitRef="U001">-13000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_735a9322fedd46e2a67eafd53e464800"
      unitRef="U001">-425550000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_2740fe7ac6424533990bf1838f8fac5d"
      unitRef="U001">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_3110238813174cc8bd4bf2420c565236"
      unitRef="U001">32496000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6a9b5126c74c4ce4841dae6fb7aaeff5"
      unitRef="U001">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20201231"
      decimals="-3"
      id="Fact_db0d0ea7b2a14c0ab3ed53953ce3e897"
      unitRef="U001">32242000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_05e0b43219e84e8b82ce802ac3ce5354"
      unitRef="U001">-8063000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_afc64f6c996e4b6fbc7a8223db50370b"
      unitRef="U001">-8063000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_949d310b74a048c18cf1a3eaf89cdc4d"
      unitRef="U001">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_25df5b8e00404d7fa3548bf755e6f324"
      unitRef="U001">-8063000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_8b563b7ba2e749dca5812a5290c22315"
      unitRef="U001">-59000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_170b83938a934d329266750f024a6946"
      unitRef="U001">-59000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_156d824ea67648e68602e357dfdd0ae1"
      unitRef="U001">-59000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_0f43fdfb3bcc4714a98c4fd50577175f"
      unitRef="U002">273000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_383d229903c345a28abfd1379ae4e3bc"
      unitRef="U001">413000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_a0baa62d4d3849e69b8f8875c5bfa680"
      unitRef="U001">413000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_598c7bf67b0044fb9095c94fce774b6d"
      unitRef="U001">413000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_37f44177c4cb42ad816314a563dd433a"
      unitRef="U002">39841000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_c7634357dadf451a9114ccfa0cdeda40"
      unitRef="U001">41000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_a93dd26e42834c4f84471f3999ab2fcb"
      unitRef="U001">85416000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_51b8ecbad20c40aeac5b8bbdbf1dfd92"
      unitRef="U001">85457000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_0ac1080dd5fc4f84bfaaeb88f9caaf2b"
      unitRef="U001">85457000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_5e227d81707b4d79b3e6fb1bd51b0498"
      unitRef="U002">7000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_8c6e4972611b47638ee0ca4850458fb8"
      unitRef="U001">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_945ac806b309421f991fc8c50dff0d32"
      unitRef="U001">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c20210101to20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_bb5aa00cb557455d81cc80e10e2b2441"
      unitRef="U001">24000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesOutstanding
      contextRef="c20210331_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_ad8e26f4d5254d52aaf17be9cccbb89b"
      unitRef="U002">10000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_PreferredStockMember"
      decimals="-3"
      id="Fact_b5f7ffab83904a6085cddd9bdcd9f93e"
      unitRef="U001">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_f86915ebe1184d92b03b17d7ea799c17"
      unitRef="U002">59510000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_CommonStockMember"
      decimals="-3"
      id="Fact_7b3fe1d752fd482b8f04d0dbd611ef2c"
      unitRef="U001">60000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_AdditionalPaidInCapitalMember"
      decimals="-3"
      id="Fact_7667e7737b3a48e2853830e285a8d00a"
      unitRef="U001">544601000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_AccumulatedOtherComprehensiveIncomeMember"
      decimals="-3"
      id="Fact_28d1840c7f2c4cee926f9b5a4db80dfa"
      unitRef="U001">-72000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_RetainedEarningsMember"
      decimals="-3"
      id="Fact_2fc7ad3d99b04ac1b81fdf07bbdf8c7b"
      unitRef="U001">-433613000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_TreasuryStockMember"
      decimals="-3"
      id="Fact_371e8961d4f24d2f9cab2af4e9d2c571"
      unitRef="U001">-708000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_ParentMember"
      decimals="-3"
      id="Fact_e2b36fdc4a814c2b8024302539633643"
      unitRef="U001">110268000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331_StatementEquityComponentsAxis_NoncontrollingInterestMember"
      decimals="-3"
      id="Fact_6129063f347949058cc95b23a8406283"
      unitRef="U001">-254000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="c20210331"
      decimals="-3"
      id="Fact_66b9eeacb10d4d04bdccb0fb5ee0bb7b"
      unitRef="U001">110014000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_97e8c893f3eb43a3b5b536eb1de0dc48"
      unitRef="U001">-4226000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_69bc0581a99b4feb919ba5aeb65dabc1"
      unitRef="U001">-8063000</us-gaap:ProfitLoss>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_58088fd0c0144aff9bd00fad15b02b89"
      unitRef="U001">760000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f4a91605ba624b3a9d9ff6d19fffecbc"
      unitRef="U001">597000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:DepreciationAndAmortization
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_11329796d06a40b59d23fc2669de65a8"
      unitRef="U001">7000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_4cda5d0b4f6e484e9a209d6c3fd55a17"
      unitRef="U001">16000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_ac83cd10d58a4dcf9d21ab7df397a17e"
      unitRef="U001">-515000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_501c1f79fdcd48fb9182c65d001d7756"
      unitRef="U001">-323000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_12122b856a5f4e138197fded20b5c6ad"
      unitRef="U001">969000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_2cc93ad31edb42ceb6291d176fe6a523"
      unitRef="U001">1763000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_27261a5e052d4504883c1efc15e2e7c5"
      unitRef="U001">-57000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c348a29f9dc24e2d8148acfd84c7e732"
      unitRef="U001">-81000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_367aab4a8acf459a8d1c0150e0a8a920"
      unitRef="U001">-1786000</clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities>
    <clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_50a22af69b23464c8763e9d0caa98282"
      unitRef="U001">834000</clbs:IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_70b999bc52a54d2b9f6e4c15741e3583"
      unitRef="U001">-5642000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e94abe667af44c28b7c675fcefc20dfb"
      unitRef="U001">-7975000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_01dce1bf32994c94a182b6cce000cc6f"
      unitRef="U001">26546000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_d4fbc033bf8444d199c66d8937cfb621"
      unitRef="U001">75911000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_0caa7e9fa80742fcb0eaa1fca23b3657"
      unitRef="U001">20456000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_d14a037e5f5d4b5292cc108c6b3d0aba"
      unitRef="U001">10821000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_e54f8938bf484a51b37c5b1ed6e5b112"
      unitRef="U001">-6090000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_f9f83f8f859b4497998af6efd8e75156"
      unitRef="U001">-65090000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_3730080c9a6641c7ac8f0e00cd7b12ff"
      unitRef="U001">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_e4e8776b483e495995929f13c8c20593"
      unitRef="U001">24000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_06f2dadb7d214fccac15bb5a6e7dcea8"
      unitRef="U001">168000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_90bd0208290c43da8ad63b559a2e1d19"
      unitRef="U001">184000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_0594d02ef580476d9efa8a2b3457df2d"
      unitRef="U001">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_c300ca71225945eb82595ff4489e481e"
      unitRef="U001">85457000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_0cda345ce1a6480cb70e05710ed61e56"
      unitRef="U001">-168000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_1592af5b4c83459f82f333e842d86e99"
      unitRef="U001">85297000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_0539e4c3f5164bc59ad54f1d613e6030"
      unitRef="U001">-11900000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_9834e35d561841aa9ad5eddf1247a967"
      unitRef="U001">12232000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20211231"
      decimals="-3"
      id="Fact_53250825a03e484abe3ef14ea0bdb4bd"
      unitRef="U001">24647000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20201231"
      decimals="-3"
      id="Fact_8b19c82674f241829de1a18da455780e"
      unitRef="U001">16512000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20220331"
      decimals="-3"
      id="Fact_fd9fa18961544a62b31ee51830047d8d"
      unitRef="U001">12747000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="c20210331"
      decimals="-3"
      id="Fact_bc00d206d9a847bfaa7e8d0564fbe57d"
      unitRef="U001">28744000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <clbs:BusinessTextBlock
      contextRef="c20220101to20220331"
      id="Text_f536e5430175482aa5c7508e577127ca">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 1 &#x2013; The Business&lt;/span&gt;&lt;/div&gt;

&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;Overview&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Caladrius Biosciences, Inc. (&#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;Caladrius&#x201d; or the
            &#x201c;Company&#x201d;) is a clinical-stage biopharmaceutical company dedicated to the development of treatments and reversal of severe diseases. The Company is developing what are intended to be first-in-class therapeutics based on the characteristics of
            naturally occurring CD34+ cells and their ability to stimulate the growth of new microvasculature. Its technology is intended to leverage these cells to enable the body's natural repair mechanisms using formulations unique to each medical
            indication.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's leadership team has decades of collective
            biopharmaceutical product development experience in a variety of therapeutic categories. Its goal is to develop and commercialize products that address important unmet medical needs based on a broad and versatile portfolio of candidates. The
            Company&#x2019;s current product candidates include:&lt;/div&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"&gt;XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt; (CLBS16), the subject of both a completed positive Phase 2a study (ESCaPE-CMD) and an ongoing follow on Phase
                    2b study (FREEDOM Trial) in the United States for the treatment of coronary microvascular dysfunction (&#x201c;CMD&#x201d;);&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"&gt;HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; (CLBS12), recipient of SAKIGAKE designation pursuant to which early conditional approval in Japan for the
                    treatment of critical limb ischemia (&#x201c;CLI&#x201d;) and Buerger&#x2019;s disease is being sought based on the current results of a clinical trial executed in Japan. HONEDRA&#xae; was the recipient of orphan drug designation in March 2021 from the U.S. Food
                    and Drug Administration (&#x201c;FDA&#x201d;) for Buerger's disease; and&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"&gt;CLBS201, the subject of a study designed to assess the safety and efficacy of CD34+ cell therapy as a treatment for patients
                    with chronic kidney disease related to type 2 diabetes (diabetic kidney disease or &#x201c;DKD&#x201d;).&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"&gt;


  &lt;tr&gt;

    &lt;td style="width: 20pt; text-align: left; vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#x2022;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td style="vertical-align: top;"&gt;
                  &lt;div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"&gt;On April&#160;26, 2022, the Company and Cend Therapeutics, Inc., a Delaware corporation (&#x201c;Cend&#x201d;), entered into an Agreement and Plan
                    of Merger and Reorganization (the &#x201c;Merger Agreement&#x201d;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, a wholly-owned subsidiary of Caladrius will
                    merge with and into Cend, with Cend surviving as a wholly-owned subsidiary of the Company (the &#x201c;Merger&#x201d;), subject to the terms of the Merger Agreement and stockholder approval of the transaction. Under the exchange ratio formula, as of
                    immediately after the Merger, the former Cend stockholders are expected to own approximately 50% of the outstanding shares
                    of Caladrius Common Stock and the Company&#x2019;s stockholders as of immediately prior to the Merger are expected to own approximately 50%
                    of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on our net cash balance at the time of closing and the amount of any transaction expenses of Cend in excess of $250 thousand at the time of closing. See Note 12 below for more information regarding the Merger and related transactions.&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;"&gt;Ischemic Repair (CD34 Cell Technology)&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The CD34+ cell was discovered as a result of the deliberate search
            for a cell capable of stimulating the development and/or repair of blood vessels. All tissues in the body maintain their function by replacing cells over time. In addition to the maintenance function, the body must also be capable of building
            new blood vessels after injury. A CD34+ cell is an endothelial progenitor cell that has the ability to stimulate new blood vessel formation at the level of the microvasculature. No other native cell discovered to date has demonstrated this same
            capability.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's proprietary cell technology using autologous (a
            patient&#x2019;s own naturally occurring) CD34+ cells has led to the development of therapeutic product candidates designed to address diseases and conditions caused by ischemia. Ischemia occurs when the supply of oxygenated blood to healthy tissue is
            restricted or reduced. Through the administration of CD34+ cells, Caladrius seeks to promote the development and formation &lt;/div&gt;

&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;of new microvasculature and thereby increase blood flow to the impacted area. The
            Company believes that a number of conditions caused by underlying ischemic injury can be improved through its CD34+ cell technology including but not limited to Buerger's disease, CLI, CMD, and DKD.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"&gt;XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt; for Treatment of Coronary
            Microvascular Dysfunction&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In 2017, with the assistance of a $1.9 million grant from the National Institutes of Health (Award Number&#160;R44HL135889), the Company initiated its program for XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt; for the
            treatment of CMD, a disease that afflicts as many as 1.6&#160;million patients in the United States alone, with no current targeted treatment options. That study, the ESCaPE-CMD Trial, was a Phase 2a proof-of-concept open label study that enrolled
            patients at the Mayo Clinic in Rochester, MN and Cedars-Sinai Medical Center in Los Angeles, CA. Those data showed a positive therapeutic effect with a statistically significant improvement in angina frequency, coronary flow reserve, Canadian
            Cardiovascular Society Angina Class and Seattle Angina Questionnaire scores, as well as an acceptable safety profile. The full data set from that study was presented at the SCAI 2020 Scientific Sessions Virtual Conference on May&#160;14, 2020 by Dr.
            Timothy Henry, FACC, of the Christ Hospital in Cincinnati, Ohio. In December 2020, the Company commenced enrollment in its Phase 2b FREEDOM Trial of XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt;, a double-blind, randomized and placebo-controlled clinical trial designed to
            further evaluate the efficacy and safety of intracoronary artery delivery of autologous CD34+ cells in subjects with CMD and without obstructive coronary artery disease. While early enrollment proceeded to plan with the first patient treated in
            January 2021, the impact of the COVID-19 pandemic contributed to a general slowing of enrollment, including supply chain disruptions affecting the availability of qualified catheters used in the diagnosis of CMD and/or administration of XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt;.
            Protocol amendments to the initial FREEDOM Trial protocol, as agreed to by the FDA, were implemented with the goal of enhancing breadth and speed of subject enrollment.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"&gt;HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; for Treatment of Critical
            Limb Ischemia&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's randomized, open-label, registration-eligible study of
            HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; in Japan for the treatment of CLI and Buerger's disease has, to date, demonstrated positive trends in both safety and efficacy. The HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; study's enrollment, however, has been significantly curtailed by the
            COVID-19 pandemic's impact in Japan, including the States of Emergency in Japan that have persisted for much of 2020 and 2021. Due to the significant and continued operational and financial burden incurred as a result of these COVID-19 delays,
            coupled with the unpredictability of the timing of site enrollment re-initiation, Caladrius suspended further enrollment and is focusing its efforts on consummating a partnership for the product in Japan. Such a partnership may become the basis
            for the completion of development and registration of HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; in Japan and may include the completion of enrollment of the four remaining no-option CLI subjects stipulated in the original protocol, if necessary, and/or exploration
            of the possibility of submitting the existing data to Japan's Pharmaceuticals and Medical Devices Agency (&#x201c;PMDA&#x201d;) under Japan's regenerative medicine regulations, which allow for conditional approval of innovative regenerative medicine
            products. Despite receipt from FDA in March 2021 of orphan designation in the U.S. for CLBS12 as a potential treatment for Buerger's disease, based on a response from the FDA in October 2021 regarding a development plan for U.S. registration
            the Company decided not to pursue United States development in Buerger's disease at this time.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"&gt;CLBS201 for Treatment of Diabetic Kidney Disease&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Progressive kidney failure is associated with attrition of the
            microcirculation of the kidney. Pre-clinical studies in kidney disease and injury models have demonstrated that protection or replenishment of the microcirculation results in improved kidney function. Based on these observations, the Company
            has elected to move forward with a Phase 1b, open-label, proof-of-concept trial evaluating CLBS201 dosed via intra-renal artery injections in subjects with DKD. This protocol is expected to include six subjects in total with the first two
            subjects sequentially dosed and followed for a two-week safety observation period. Clearance by the independent Data Safety Monitoring Board (&#x201c;DSMB&#x201d;) overseeing the study will then permit the treatment of the next four patients, with all
            patients being followed for safety and therapeutic effect. A read-out of data will occur after at the six-month follow-up visit for all patients. A key criterion for continued development of CLBS201 will be its ability to demonstrate a
            therapeutic effect that will make it competitive in the field of DKD treatment, i.e., kidney function regeneration, as indicated by increased glomerular filtration rate. As announced recently, the Company has treated the first patient in the
            CLBS201 proof-of-concept study and targets treatment completion for all six subjects during the third quarter of 2022.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;Additional Out-licensing Opportunities and
            Pipeline Diversification&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company's broad intellectual property portfolio of cell therapy
            assets includes notable programs available for out-licensing in order to continue their clinical development. The Company's current long-term strategy focuses on advancing its therapies through development with the ultimate objective of
            obtaining market authorizations and entering commercialization, either alone or with partners, to provide treatment options to patients suffering from life-threatening medical conditions. The Company believes that it is well-positioned to
            realize potentially meaningful value increases within its own proprietary pipeline if it is successful in advancing its product candidates to their next significant development milestones.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In addition, the Company further desires to diversify its pipeline of
            development products candidates and is exploring a range of strategic transactions in furtherance of that goal. The Company has taken, and intends to continue to take, active steps to identify assets and/or companies for acquisition and/or
            partnership that would enhance and de-risk its current development portfolio. Such assets could target indications beyond cardiovascular disease as well as product categories outside of cell therapy. The range of possible transactions includes
            an acquisition, merger, business combination, in-license or other strategic transaction, any of which could result in the issuance of securities that could significantly dilute the shares of its existing stockholders. There can be no assurance
            that this exploration of strategic alternatives will result in Caladrius entering into or completing any transaction or that such transaction, if completed, will add to shareholder value.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"&gt;Coronavirus Considerations&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In December 2019, a novel strain of coronavirus (SARS-CoV-2), which
            causes COVID-19, was reported to have surfaced in China. In March 2020, the World Health Organization declared the outbreak of COVID-19 to be a pandemic, and the world's economies began to experience pronounced effects. Despite the FDA approval
            of multiple COVID-19 vaccines in late 2020, there remains uncertainty around the extent and duration of disruption and any future related financial impact cannot reasonably be estimated at this time. In response to the COVID-19 pandemic, the
            Company implemented a universal work from home policy as well as stringent social distancing and other hygiene policies for employees when they must be in the office. The Company's clinical study of HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; in Japan has experienced
            significant delays in enrollment due to the States of Emergency in effect in Japan for most of 2020 2021 covering Tokyo and other regions in response to an increased number of COVID-19 infections. With the Company's expectation that COVID-19 in
            Japan would continue to impact negatively clinical site operations and enrollment of patients in the HONEDRA&lt;sup&gt;&#xae;&lt;/sup&gt; clinical trial, it elected to suspend trial enrollment, seek a development partner and consult with the Japanese regulatory
            authorities regarding the submission of patient data already accrued. Caladrius' phase 2b trial of XOWNA&lt;sup&gt;&#xae;&lt;/sup&gt; in the U.S. has also experienced delays in enrolling patients as a result of COVID-19.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"&gt;Basis of Presentation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The accompanying unaudited Consolidated Financial Statements have
            been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim
            financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated
            Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#x2019;s financial position as of March&#160;31, 2022, and the results of its
            operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2021
            and 2020 included in our 2021 Form 10-K. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"&gt;Use of Estimates&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other &lt;/div&gt;

&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;assumptions believed to be reasonable under the circumstances, the results of which
            form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly,
            actual results could differ from those estimates and assumptions.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Principles of Consolidation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.&lt;/div&gt;
</clbs:BusinessTextBlock>
    <clbs:MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="INF"
      id="Fact_29e40cd7cd1546eebf44cd4060a33333"
      unitRef="U005">0.50</clbs:MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage>
    <clbs:MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="INF"
      id="Fact_5bd885b4388741a3baf10ef2494a7e0e"
      unitRef="U005">0.50</clbs:MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage>
    <clbs:MergerAgreementTransactionExpensesThresholdForRatioAllocation
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-3"
      id="Fact_a4776233846a48d5be5845a46d874496"
      unitRef="U001">250000</clbs:MergerAgreementTransactionExpensesThresholdForRatioAllocation>
    <us-gaap:GrantsReceivable
      contextRef="c20171231_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_CLBS16TreatmentOfCMDMember"
      decimals="-5"
      id="Fact_d035a67a0afe474581a168a8c2e6c434"
      unitRef="U001">1900000</us-gaap:GrantsReceivable>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_9b1454c72db84da6948e2f14b2b9de6d">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"&gt;Basis of Presentation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The accompanying unaudited Consolidated Financial Statements have
            been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC for interim
            financial information. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, the accompanying Consolidated
            Financial Statements of the Company and its subsidiaries, which are unaudited, include all normal and recurring adjustments considered necessary to present fairly the Company&#x2019;s financial position as of March&#160;31, 2022, and the results of its
            operations and its cash flows for the periods presented. The unaudited consolidated financial statements herein should be read together with the historical consolidated financial statements of the Company for the years ended December&#160;31, 2021
            and 2020 included in our 2021 Form 10-K. Operating results for the three months ended March&#160;31, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022.&lt;/div&gt;
</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="c20220101to20220331"
      id="Text_113c5b9d46d0474c960f453df67d3358">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"&gt;Use of Estimates&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The preparation of financial statements in conformity with GAAP
            requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Estimates also affect the
            reported amounts of expenses during the reporting period. The Company bases its estimates on historical experience and other &lt;/div&gt;

&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;assumptions believed to be reasonable under the circumstances, the results of which
            form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. The Company makes critical estimates and assumptions in determining stock-based awards values. Accordingly,
            actual results could differ from those estimates and assumptions.&lt;/div&gt;
</us-gaap:UseOfEstimates>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="c20220101to20220331"
      id="Text_042ed7f892014923857aa12d2e315838">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Principles of Consolidation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Consolidated Financial Statements include the accounts of
            Caladrius Biosciences, Inc. and its wholly owned and majority owned subsidiaries and affiliates. All intercompany activities have been eliminated in consolidation.&lt;/div&gt;
</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="c20220101to20220331"
      id="Text_79b1a489344141aa928e3d11e80d1478">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 2 &#x2013; Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In addition to the policies below, the Company's significant
            accounting policies are described in Note 2 of the Notes to Consolidated Financial Statements included in its 2021 Form 10-K. There were no changes to these policies during the three months ended March&#160;31, 2022.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Concentration of Risks&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of
            priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Share-Based Compensation &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#x2019;s restricted stock and restricted stock units is based on the closing market price of the Company&#x2019;s common stock on the
            date of grant.&lt;/div&gt;
</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="c20220101to20220331"
      id="Text_261863b3249940f2a8dc47ef23a35339">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Concentration of Risks&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company is subject to credit risk from its portfolio of cash,
            cash equivalents and marketable securities. Under its investment policy, the Company limits amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S.
            government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of the Company's investment policy, in order of
            priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.&lt;/div&gt;
</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="c20220101to20220331"
      id="Text_3577991e36d24c7e85bae11716375b73">
&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Share-Based Compensation &lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company expenses all share-based payment awards to employees,
            directors, and consultants, including grants of stock options, warrants, and restricted stock, over the requisite service period based on the grant date fair value of the awards. Consultant awards are remeasured each reporting period through
            vesting. For awards with performance-based vesting criteria, the Company estimates the probability of achievement of the performance criteria and recognizes compensation expense related to those awards expected to vest. The Company determines
            the fair value of option awards using the Black-Scholes option-pricing model which uses both historical and current market data to estimate the fair value. This method incorporates various assumptions such as the risk-free interest rate,
            expected volatility, expected dividend yield and expected life of the options or warrants. The fair value of the Company&#x2019;s restricted stock and restricted stock units is based on the closing market price of the Company&#x2019;s common stock on the
            date of grant.&lt;/div&gt;
</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="c20220101to20220331"
      id="Text_ae17541791d84f628a2c5c9cfdb0faa2">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 3 &#x2013; Available-for-Sale-Securities&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 35.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 35.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gains&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Losses&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gains&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Losses&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Corporate debt securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"&gt;$62,770&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"&gt;$(162)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;$62,608&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$53,135&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;$(65)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;$53,070&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Money market funds&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;6,578&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;6,578&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;18,124&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;18,124&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Municipal debt securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;17,267&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(34)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;17,233&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;20,263&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;"&gt;(5)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;20,258&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,615&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$(196)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,419&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,522&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 18.33pt;"&gt;$(70)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Estimated fair values of available-for-sale securities are
            generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Cash equivalents&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"&gt;$10,647&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;$21,129&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Marketable securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,419&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table summarizes our portfolio of available-for-sale
            securities by contractual maturity (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 19.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Amortized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair Value&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less than one year&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;$86,615&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"&gt;$86,419&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Greater than one year&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,615&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,419&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_e444fe8640ff47e287f03d9ce7334ac5">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table is a summary of available-for-sale securities
            recorded in cash and cash equivalents or marketable securities in our Consolidated Balance Sheets (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 35.45%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 35.44%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gains&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Losses&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gains&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Gross &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Unrealized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Losses&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Corporate debt securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"&gt;$62,770&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"&gt;$(162)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;$62,608&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;$53,135&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;$(65)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;$53,070&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Money market funds&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;6,578&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"&gt;&lt;span style="padding-left: 13.33pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;6,578&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;18,124&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;18,124&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Municipal debt securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;17,267&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(34)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;17,233&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;20,263&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt; border-bottom: 1pt solid #000000; min-width: 18.33pt;"&gt;(5)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;20,258&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 25.64%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,615&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.92pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$(196)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,419&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,522&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.42pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 18.33pt;"&gt;$(70)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.87%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.4%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.07pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_c3765e2699f145d68f348ee45b54f01b"
      unitRef="U001">62770000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_7c3a18d4bcaf44d3aa4663b71ef43acb"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_0ab4767477494e3782991bbb23d519e3"
      unitRef="U001">162000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20220331_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_2771acfefb954fbf8bff71b71c5e7014"
      unitRef="U001">62608000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_867724428db443109cafc7ff05994c85"
      unitRef="U001">53135000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_5b14d845c8844b42bd63ea547007d098"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_e7901d67c6864751bc96ce8935eefafa"
      unitRef="U001">65000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231_FinancialInstrumentAxis_CorporateDebtSecuritiesMember"
      decimals="-3"
      id="Fact_05ccdef4f2a443bb90d128844075522e"
      unitRef="U001">53070000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_fe254bace3d646e182a60b5fa796937e"
      unitRef="U001">6578000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_8d21eed6719445978782550fb4d741f5"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_502c8e6b976246b0bf1060aabd335db3"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20220331_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_9a0be722fe864ce0a7d274c65117e6c2"
      unitRef="U001">6578000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_8ef07fd6ef3c4c8b937520c20a631dff"
      unitRef="U001">18124000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_7a76c00dc0d14332858e9d6779d69d48"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_c2ee3d08249f4243a88b11be29d94d18"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231_FinancialInstrumentAxis_MoneyMarketFundsMember"
      decimals="-3"
      id="Fact_183e46dbf91c486f98867a76d0c9d341"
      unitRef="U001">18124000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_a9e1d0da7d9c4b3eaf852ae748ca2107"
      unitRef="U001">17267000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_203b9516d58340c88dbf075b1b641103"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_5598ff80b800403cad38566d09b05e96"
      unitRef="U001">34000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20220331_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_d224a76050d4410390d01685b11addd4"
      unitRef="U001">17233000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_46b6e5027aa74a398c941f095a6dd430"
      unitRef="U001">20263000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_58d9172128d949f8b7e690bd9e7512a3"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_8aaad14adba74dc3bf2fc7e7ed5163d1"
      unitRef="U001">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231_FinancialInstrumentAxis_USStatesAndPoliticalSubdivisionsMember"
      decimals="-3"
      id="Fact_e3218be46e4d4da5b6bed14906887d6f"
      unitRef="U001">20258000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f479d5a58cac432f86c7bb7b4d54c231"
      unitRef="U001">86615000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20220331"
      decimals="-3"
      id="Fact_ccda01b5f52d4828acab7b5068ac9a6f"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8224419e040740358f3570df73ae1794"
      unitRef="U001">196000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20220331"
      decimals="-3"
      id="Fact_eac66ed9ab044263a95ffc7d2d43b14d"
      unitRef="U001">86419000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231"
      decimals="-3"
      id="Fact_afe66022c30e4679b05daceb19f9c2e7"
      unitRef="U001">91522000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20211231"
      decimals="-3"
      id="Fact_9c1dbd1ea7cd40cca58bddbb57d7fc32"
      unitRef="U001">91522000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c20211231"
      decimals="-3"
      id="Fact_90ab9311abfb497b8506367f86a764a3"
      unitRef="U001">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="c20211231"
      decimals="-3"
      id="Fact_757c6943e3584a0885cb7f7ca9c791e6"
      unitRef="U001">70000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_6289a4d567ad479094b02ef9433c2596"
      unitRef="U001">91452000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="c20220101to20220331"
      id="Text_2b250b4f98284e28b16cb08d8e767bd3">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Estimated fair values of available-for-sale securities are
            generally based on prices obtained from commercial pricing services. The following table summarizes the classification of the available-for-sale securities in our Consolidated Balance Sheets (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Cash equivalents&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"&gt;$10,647&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;$21,129&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Marketable securities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.56pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,419&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$91,452&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_eb157e1c0109422680e40fb53168482e"
      unitRef="U001">10647000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_607a7586232942709403bd0060db3e80"
      unitRef="U001">21129000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecurities
      contextRef="c20220331"
      decimals="-3"
      id="Fact_90db233daaa3430c9d302fdb059a8494"
      unitRef="U001">75772000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_190f90aaae8e4de5b8552a412456944d"
      unitRef="U001">70323000</us-gaap:MarketableSecurities>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="c20220331"
      decimals="-3"
      id="Fact_afb55fccd5d24f308eee90661db83601"
      unitRef="U001">86419000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="c20211231"
      decimals="-3"
      id="Fact_ee5a540da1cc4aecb47d9e48f0797ab6"
      unitRef="U001">91452000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20211231"
      decimals="-3"
      id="Fact_bc49e621160c47a085811484660ba348"
      unitRef="U001">91452000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_81b01e6dca0148e09ce0a3e389ef8550">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table summarizes our portfolio of available-for-sale
            securities by contractual maturity (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 19.31%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Amortized &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.76%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Estimated &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Fair Value&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less than one year&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;$86,615&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"&gt;$86,419&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Greater than one year&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"&gt;&lt;span style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.78%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.96pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,615&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.88%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.76%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.9pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$86,419&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f807c8584d3949a9bbfcc4c552125d39"
      unitRef="U001">86615000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_37a27cfa675e4dfb84c70aec8770894a"
      unitRef="U001">86419000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_5c8aaf1b11974bfdbef0d75d435c3a45"
      unitRef="U001">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c20220331"
      decimals="-3"
      id="Fact_1cd51ec43ffc4caa833b7a5e18ab0c48"
      unitRef="U001">86615000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="c20220331"
      decimals="-3"
      id="Fact_579d0619e9da49fb972f5f8b2400ac94"
      unitRef="U001">86419000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="c20220101to20220331"
      id="Text_73fcadad799946fcb79287451d2040b4">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 4 &#x2013; Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;For the three months ended March&#160;31, 2022 and 2021, the Company
            incurred net losses and therefore no common stock equivalents were utilized in the calculation of diluted loss per share as they are anti-dilutive. &lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;At March&#160;31, 2022 and 2021, the Company excluded
            the following potentially dilutive securities (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 17.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;2,640&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1,022&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;21,357&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;21,357&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Restricted Stock Units&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1,460&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;798&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="c20220101to20220331"
      id="Text_84522f7600ff4a12985a405deb2ceaa9">&lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;At March&#160;31, 2022 and 2021, the Company excluded
            the following potentially dilutive securities (in thousands):&lt;/span&gt;
&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 17.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;2,640&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1,022&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;21,357&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;21,357&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Restricted Stock Units&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1,460&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.83%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.88%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;798&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_3d47e9ca0b654a94a6a2b9411697df47"
      unitRef="U002">2640000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_d3f33c8eebae41c6b6e0759a03063348"
      unitRef="U002">1022000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_e3bf1ad559a84a8f8301b7559c4bae62"
      unitRef="U002">21357000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_WarrantMember"
      decimals="-3"
      id="Fact_81b8b8eeb5e742e19f611be2b821d6ad"
      unitRef="U002">21357000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_4e53a59a95cd441f89cc785686074cbf"
      unitRef="U002">1460000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20210101to20210331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_9f9144234ca34c6ea5c8ef0c19d364ac"
      unitRef="U002">798000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="c20220101to20220331"
      id="Text_fa393a9faca0421a80825f4709604ef7">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 5 &#x2013; Fair Value Measurements&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The fair value of financial assets and liabilities that are being
            measured and reported are defined as the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the principal market at the measurement date (exit price).
            The Company is required to classify fair value measurements in one of the following categories:&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Level 1 inputs are defined as quoted prices (unadjusted) in active
            markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Level 2 inputs are defined as inputs other than quoted prices
            included within Level 1 that are observable for the assets or liabilities, either directly or indirectly.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Level 3 inputs are defined as unobservable inputs for the assets or
            liabilities. Financial assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement
            requires judgment and may affect the valuation of the fair value of assets and liabilities and their placement within the fair value hierarchy levels.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table sets forth by level within the fair value
            hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands).&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Assets: &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Marketable securities - available for sale&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="c20220101to20220331"
      id="Text_477bfde4a3e346319330ab5958b28da5">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table sets forth by level within the fair value
            hierarchy the Company's financial assets that were accounted for at fair value on a recurring basis as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands).&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 32.14%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 1&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 2&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Level 3&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff; white-space: nowrap;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt; white-space: nowrap;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Assets: &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Marketable securities - available for sale&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 30.77%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$75,772&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.41%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.16pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.94%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 32.5pt;"&gt;$70,323&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_7fef356f76e44b2cb05214e36e294d20"
      unitRef="U001">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_1f110618655a4c95948ea1a6c2dc95a6"
      unitRef="U001">75772000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_c5e14725eb5f47a3b6dc657eefea30b1"
      unitRef="U001">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20220331_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_0a41061d314e47d18c7d492d434bcb75"
      unitRef="U001">75772000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_a5c2ce99581e4907942f099a40bc6ac6"
      unitRef="U001">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_cc1e7d890eac4987a7acd0565a47f861"
      unitRef="U001">70323000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_4c1a76c387e94cdb8d20ec7e605aaca8"
      unitRef="U001">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_b3642c409cb24506883ffa0d803e257b"
      unitRef="U001">70323000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_cba70a5b460643669cf2490ae3a085a6"
      unitRef="U001">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_408ee1a0d1d243d7af4000e35c8df7e5"
      unitRef="U001">75772000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20220331_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_f6a84740db724463b1319e779600a2aa"
      unitRef="U001">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20220331_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_4ff83c26030740f8805f70ad7b3eaaeb"
      unitRef="U001">75772000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel1Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_c7b0dcb1da6449e9b3db66474cc0b983"
      unitRef="U001">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel2Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_8a1bc202fd0b4828b3afd2fe9ea71ef4"
      unitRef="U001">70323000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20211231_FairValueByFairValueHierarchyLevelAxis_FairValueInputsLevel3Member_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_3fb9698efc744e02ade5f39475d70922"
      unitRef="U001">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c20211231_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember"
      decimals="-3"
      id="Fact_032ded14f5034f509828766ce91c1972"
      unitRef="U001">70323000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_1515bf9949424cae92e6357367cc464d">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 6 &#x2013; Accrued Liabilities&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Accrued liabilities as of March&#160;31, 2022 and December&#160;31, 2021 were
            as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Salaries, employee benefits and related taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"&gt;$1,005&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"&gt;$2,034&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Operating lease liabilities &#x2014; current&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;205&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;229&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;894&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;326&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,104&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,589&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_0cd42b77435a482fb3bf62e6149e7b04">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Accrued liabilities as of March&#160;31, 2022 and December&#160;31, 2021 were
            as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Salaries, employee benefits and related taxes&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"&gt;$1,005&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"&gt;$2,034&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Operating lease liabilities &#x2014; current&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;205&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;229&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Other&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;894&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;326&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.06pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,104&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$2,589&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_246d2973f4314ad886e85af7144e135b"
      unitRef="U001">1005000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_d30706a42f274cf4bd0df7e39d9e1869"
      unitRef="U001">2034000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_da0777e1b5ac4f828ba7d6248d5e01fd"
      unitRef="U001">205000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f7bd34395b4f4094a5d5df17ea4330c2"
      unitRef="U001">229000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_2a3dd0067cd14d9da5e15c86f0177800"
      unitRef="U001">894000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_aaa07bb834294567b332457a631b05e6"
      unitRef="U001">326000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_ecbaad73bad949ec803ff162188d1dc5"
      unitRef="U001">2104000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_86383e3aa23e441ca2e8efc9bcb466bc"
      unitRef="U001">2589000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="c20220101to20220331"
      id="Text_7db16f5660114739a0035bfb1409223a">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 7 &#x2013; Operating Leases&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company has operating leases for two offices with terms that expire in 2023 and 2025, respectively. The Company estimates its incremental borrowing rate at lease commencement to
            determine the present value of lease payments as most of the Company's leases do not provide an implicit rate of return. The Company recognizes lease expense on a straight-line basis over the lease term. For lease agreements entered into or
            reassessed after the adoption of Topic 842, the Company elected to account for non-lease components associated with its leases and lease components as a single lease component. Each of the Company's leases includes options for the Company to
            extend the lease term and/or sub-lease space in whole or in part.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet were as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Right-of Use Assets:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_ce1d736a988a4564aff92c00256cdd92"&gt;&lt;span style="-sec-ix-hidden:Fact_2bb6a876105046b48a849d6ac8adfc37"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;$667&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;$724&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total Right-of-Use Asset&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$667&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$724&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Operating Lease Liabilities:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_394d33db98754a5dbaa2063579daa0be"&gt;&lt;span style="-sec-ix-hidden:Fact_01cbbf57a5d5461f83158b26769ed161"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;$205&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;$229&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_646cbb0a67a54f629dc6c425eb143706"&gt;&lt;span style="-sec-ix-hidden:Fact_52d14b2a09d54c84bb4a3b7e7f351e66"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;421 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;485 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total Operating Lease Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$626&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$714&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of March&#160;31, 2022, the weighted average remaining lease term
            for our operating leases was 2.3 years, and the weighted average discount rate for our operating leases was 9.625%. &lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Future minimum lease payments under the lease agreements as of March&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Years ended&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Operating &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Leases&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;181&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;217&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2024&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;190&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2025&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;143&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total lease payments&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;731&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less: Amounts representing interest&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(105) &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Present value of lease liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;626&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeasesTextBlock>
    <clbs:NumberOfOfficesUnderOperatingLeases
      contextRef="c20220331"
      decimals="0"
      id="Fact_2f7f1cd0aa374dad983882bfb95f8cd8"
      unitRef="U004">2</clbs:NumberOfOfficesUnderOperatingLeases>
    <clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_3fc91bb115d54959b0b02d44cc7f7d61">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Operating lease liabilities and right-of-use assets were recorded in
            the following captions of our balance sheet were as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;December&#160;31, &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Right-of Use Assets:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_ce1d736a988a4564aff92c00256cdd92"&gt;&lt;span style="-sec-ix-hidden:Fact_2bb6a876105046b48a849d6ac8adfc37"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;$667&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;$724&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total Right-of-Use Asset&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$667&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$724&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Operating Lease Liabilities:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_394d33db98754a5dbaa2063579daa0be"&gt;&lt;span style="-sec-ix-hidden:Fact_01cbbf57a5d5461f83158b26769ed161"&gt;Accrued liabilities&lt;/span&gt;&lt;/span&gt;&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;$205&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;$229&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="-sec-ix-hidden:Fact_646cbb0a67a54f629dc6c425eb143706"&gt;&lt;span style="-sec-ix-hidden:Fact_52d14b2a09d54c84bb4a3b7e7f351e66"&gt;Other long-term liabilities&lt;/span&gt;&lt;/span&gt; &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;421 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;485 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total Operating Lease Liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.61%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.81pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$626&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.35%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 10.08%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.58pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$714&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220331"
      decimals="-3"
      id="Fact_818d5b3b6f26488a843fff1def7368cf"
      unitRef="U001">667000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_59b00c5bf16c4fdab820a35ed46cc91d"
      unitRef="U001">724000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20220331"
      decimals="-3"
      id="Fact_e216ba22b15a47338b8f3adb9511f271"
      unitRef="U001">667000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="c20211231"
      decimals="-3"
      id="Fact_26b8b9387c0b4a08b38e4e10d4375ba3"
      unitRef="U001">724000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_b1b75d4169f54e89ae11b4f25d22c1d5"
      unitRef="U001">205000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_06c6ba22d72643e786778d9fb4ce4c4e"
      unitRef="U001">229000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8d47b144c74d46b992950e148e051a02"
      unitRef="U001">421000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c20211231"
      decimals="-3"
      id="Fact_e32f9a73b5544b6d97e95c1daabad5ea"
      unitRef="U001">485000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220331"
      decimals="-3"
      id="Fact_67b921052da44ea88340a47ede6e6835"
      unitRef="U001">626000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20211231"
      decimals="-3"
      id="Fact_25af6510705b4b7787aa13f9b9193d5b"
      unitRef="U001">714000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="c20220331"
      id="Fact_a1dbc465cd3e4a698838f2e35b0bb755">P2Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="c20220331"
      decimals="5"
      id="Fact_0af2f1879cde4a3a9b8112f3f4a1b487"
      unitRef="U005">0.09625</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_11e72fc091a64eec91ef223e13590ddf">&lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;Future minimum lease payments under the lease agreements as of March&#160;31, 2022 were as follows (in thousands):&lt;/span&gt;
&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Years ended&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Operating &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Leases&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;181&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2023&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;217&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2024&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;190&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;2025&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;143&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total lease payments&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 8.33pt;"&gt;731&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Less: Amounts representing interest&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 23.33pt;"&gt;(105) &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 87.18%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Present value of lease liabilities&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.66%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.89pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 3.33pt; border-bottom: 3pt double #000000; min-width: 23.33pt;"&gt;626&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="c20220331"
      decimals="-3"
      id="Fact_92d5d9ec1b1e40bab7ea0883d5f9e4ad"
      unitRef="U001">181000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="c20220331"
      decimals="-3"
      id="Fact_81436dc3f99f4013aeb6fc6cf9212543"
      unitRef="U001">217000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8c8f71465ea94238af0e83405f1aa5b0"
      unitRef="U001">190000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c20220331"
      decimals="-3"
      id="Fact_89686fa86c6d4404bf89e5bd41bde1b0"
      unitRef="U001">143000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_db178d4728a6486bbdac643638a28289"
      unitRef="U001">731000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="c20220331"
      decimals="-3"
      id="Fact_9fa49193f1314039be228ad6dfe3962a"
      unitRef="U001">105000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="c20220331"
      decimals="-3"
      id="Fact_8c7ffa3cb8f34d4cb0f6c2e9b35bce1b"
      unitRef="U001">626000</us-gaap:OperatingLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_839f7f30e02840f799a4754270238b87">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 8 &#x2013; Stockholders' Equity&lt;/span&gt;&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;Equity Issuances&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Purchase Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In March 2019, the Company and Lincoln Park Capital Fund, LLC
            (&#x201c;Lincoln Park&#x201d;) entered into a purchase agreement (the &#x201c;Purchase Agreement&#x201d;) and a registration rights agreement (the &#x201c;Registration Rights Agreement&#x201d;), pursuant to which the Company has the right to sell to Lincoln Park shares of the Company&#x2019;s
            common stock having an aggregate value of up to $26.0 million, subject to certain limitations and conditions set forth in the
            Purchase Agreement (the &#x201c;Offering&#x201d;). As consideration for entering into the Purchase Agreement, the Company issued to Lincoln Park an additional 181,510
            shares of common stock as commitment shares.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Pursuant to the Purchase Agreement, Lincoln Park purchased 250,000 shares of common stock, at a price of $4.00
            per share, for a total gross purchase price of $1.0 million (the &#x201c;Initial Purchase&#x201d;) upon commencement. Thereafter, as often as every
            business day from and after one business day following the date of the Initial Purchase and over the 36-month term of the Purchase
            Agreement the Company has the right, from time to time, at its sole discretion and subject to certain conditions, to direct Lincoln Park to purchase up to 100,000 shares of common stock, with such amount increasing as the closing sale price of the common stock increases; provided Lincoln Park&#x2019;s obligation under any single such purchase will not exceed $2.5 million, unless the Company and Lincoln Park mutually agree to increase the maximum amount of such single purchase (each, a &#x201c;Regular Purchase&#x201d;).
            If the Company directs Lincoln Park to purchase the maximum number of shares of common stock it then may sell in a Regular Purchase, then in addition to such Regular Purchase, and subject to certain conditions and limitations in the Purchase
            Agreement, the Company may direct Lincoln Park in an &#x201c;accelerated purchase&#x201d; to purchase an additional amount of common stock that may not exceed the lesser of (i) 300% the number of shares purchased pursuant to the corresponding Regular Purchase or (ii) 30% of
            the total number of shares of the Company&#x2019;s common stock traded during a specified period on the applicable purchase date as set forth in the Purchase Agreement. Under certain circumstances and in accordance with the Purchase Agreement, the
            Company may direct Lincoln Park to purchase shares in multiple accelerated purchases on the same trading day.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company controls the timing and amount of any sales of its common
            stock to Lincoln Park. There is no upper limit on the price per share that Lincoln Park must pay for its common stock under the Purchase Agreement, but in no event will shares be sold to Lincoln Park on a day the closing price is less than the
            floor price specified in the Purchase Agreement. In all instances, the Company may not sell shares of its common stock to Lincoln Park under the purchase agreement if it would result in Lincoln Park beneficially owning more than 9.99% of its common stock.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Purchase Agreement does not limit the Company&#x2019;s ability to raise
            capital from other sources at the Company&#x2019;s sole discretion, except that (subject to certain exceptions) the Company may not enter into any Variable Rate Transaction (as defined in the Purchase Agreement, including the issuance of any floating
            conversion rate or variable priced equity-like securities) during the 36 months after the date of the Purchase Agreement. The Company has the right to terminate the Purchase Agreement at any time, at no cost to the Company.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of March&#160;31, 2022, the Company had not made any sales of common
            stock to Lincoln Park under the Purchase Agreement other than the Initial Purchase. The agreement expired on April&#160;1, 2022.&lt;/div&gt;

&lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;At The Market Offering Agreement&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;On June&#160;4, 2021, the Company entered into an At The Market Offering
            Agreement (the &#x201c;ATM Agreement&#x201d;) with HCW, as sales agent, in connection with an &#x201c;at the market offering&#x201d; under which the Company from time to time may offer and sell shares of its common stock, having an aggregate offering price of up to $50.0 million. During the three months ended March&#160;31, 2022 and since inception the Company had not issued any shares under the ATM Agreement. Having received a listing deficiency notice from Nasdaq on February&#160;18, 2022 after the Company&#x2019;s shares traded below $1.00
            for 30 consecutive trading days, the Company will not be permitted to sell additional shares under the ATM Agreement until it re-establishes timely compliance. Compliance may be reestablished by various mechanisms, including stock price
            appreciation at or above $1.00 for a requisite period of time and reverse stock split.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;Stock Options and Warrants&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table summarizes the activity for stock options and
            warrants for the three months ended March&#160;31, 2022:&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Shares&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Exercise &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Price&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Remaining &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Contractual &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Term &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(Years)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Aggregate &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Intrinsic &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value (In &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Thousands)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Shares&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Exercise &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Price&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Remaining &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Contractual &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Term &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(Years)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Aggregate &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Intrinsic &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value (In &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Thousands)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Outstanding at December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;2,131,849&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;5.64&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;7.97&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;21,356,600&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$2.84&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;4.37&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Changes during the period:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;540,600 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;0.91 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Exercised&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 30pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="padding-left: 17.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Forfeited&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 14.17pt;"&gt;(9,565)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;1.90 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expired&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;"&gt;(23,275)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;26.00 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Outstanding at March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;2,639,609&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;4.51&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;7.83&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.13&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Vested at March&#160;31, 2022 or expected to vest in the future&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;2,594,630&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;4.57&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;7.80&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.13&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Vested at March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;1,408,083&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;7.36&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;6.41&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.13&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;"&gt;Restricted Stock&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock for services as follows ($ in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Three Months Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Number of restricted stock issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;"&gt;1,061,175 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;300,450 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Value of restricted stock issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 25pt; border-bottom: 3pt double #000000; min-width: 45pt;"&gt;973&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;478&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The vesting terms of restricted stock issuances are generally
            between &lt;span style="-sec-ix-hidden:Fact_09a53c4a1103459dacf922bb1b50b09c"&gt;one&lt;/span&gt; to four years.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;Restricted Stock Units&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock units for services as follows ($ in thousands, except share data):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Three Months Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Number of restricted stock units issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;"&gt;1,379,860 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;458,245 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Value of restricted stock units issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;"&gt;1,265&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;729&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The weighted average estimated fair value of restricted stock issued
            for services in the three months ended March&#160;31, 2022 and 2021 was $0.92 and $1.59 per share, respectively. The fair value of the restricted stock units was determined using the Company&#x2019;s closing stock price on the date of issuance. The vesting terms
            of restricted stock unit issuances are generally one year, or upon the achievement of performance-based milestones.&lt;/div&gt;
</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="-5"
      id="Fact_1ae19c090a3843e18a20963cbb917b31"
      unitRef="U001">26000000.0</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="0"
      id="Fact_7277d241456c461fa868ce688fb95c14"
      unitRef="U002">181510</clbs:StockIssuedDuringPeriodSharesIssuedAsConsideration>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="0"
      id="Fact_c04787dccaa945ce877513f95af6dc7b"
      unitRef="U002">250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="2"
      id="Fact_0b8f2b03cb804e79b8795a1403dac888"
      unitRef="U003">4.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="-5"
      id="Fact_f781cf82ff6a4d6fac5a8194a2036227"
      unitRef="U001">1000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <clbs:TermOfAgreement
      contextRef="c20190301to20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      id="Fact_18b0cd57f26b44fea64238a9fe4bf3ab">P36M</clbs:TermOfAgreement>
    <clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="0"
      id="Fact_fee15084e7724ec6b61156c466d53b9c"
      unitRef="U002">100000</clbs:SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase>
    <clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="-5"
      id="Fact_debc6322b3a7430db2c5b02670bfbf66"
      unitRef="U001">2500000</clbs:SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase>
    <clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="2"
      id="Fact_8ad80778fad341928dadcbc893335629"
      unitRef="U005">3</clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase>
    <clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="2"
      id="Fact_1f798a75cd1248b59bd5494b038c28e9"
      unitRef="U005">0.30</clbs:SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod>
    <clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty
      contextRef="c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember"
      decimals="4"
      id="Fact_86b49d648dcc4c4eb798954989184bd1"
      unitRef="U005">0.0999</clbs:RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty>
    <clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement
      contextRef="c20210604_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember"
      decimals="-5"
      id="Fact_24da1ea978c44e7f8fe82ce7f768f621"
      unitRef="U001">50000000.0</clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c20220101to20220331_SubsidiarySaleOfStockAxis_AtTheMarketOfferingAgreementMember"
      decimals="INF"
      id="Fact_9111a1959363481084910ab2278cfd04"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_63e51c18b35346ad942fee5577867554">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The following table summarizes the activity for stock options and
            warrants for the three months ended March&#160;31, 2022:&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 35.3%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="10" style="width: 36.37%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Warrants&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Shares&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Exercise &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Price&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Remaining &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Contractual &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Term &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(Years)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Aggregate &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Intrinsic &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value (In &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Thousands)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Shares&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Exercise &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Price&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Weighted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Average &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Remaining &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Contractual &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Term &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;(Years)&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Aggregate &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Intrinsic &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Value (In &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Thousands)&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Outstanding at December&#160;31, 2021&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;2,131,849&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;5.64&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;7.97&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;21,356,600&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;$2.84&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;4.37&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;$&#x2014;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Changes during the period:&lt;br/&gt;
                  &lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 7.5pt;"&gt;540,600 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;0.91 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Exercised&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 30pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="padding-left: 17.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Forfeited&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 14.17pt;"&gt;(9,565)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;1.90 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Expired&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; min-width: 40pt;"&gt;(23,275)&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 27.5pt;"&gt;26.00 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 35pt; border-bottom: 1pt solid #000000; min-width: 45pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; min-width: 22.5pt;"&gt;&#x2014; &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"/&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Outstanding at March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;2,639,609&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;4.51&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;7.83&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.13&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Vested at March&#160;31, 2022 or expected to vest in the future&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;2,594,630&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;4.57&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;7.80&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.13&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 26.71%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Vested at March&#160;31, 2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 40pt;"&gt;1,408,083&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.47pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 27.5pt;"&gt;7.36&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;6.41&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;21,356,600&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 6.93%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.97pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 22.5pt;"&gt;$2.84&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.83%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.91pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 17.5pt;"&gt;4.13&lt;br/&gt;
                    &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 0.41%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.55%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.51pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 15pt;"&gt;$&#x2014;&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20211231"
      decimals="0"
      id="Fact_0a8aac52d9cd4a5cad0ffff69145ddf6"
      unitRef="U002">2131849</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20211231"
      decimals="2"
      id="Fact_1737eb09bbd04772adaf334bac1d0d98"
      unitRef="U003">5.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20210101to20211231"
      id="Fact_d3ceb3b08a9f43928712fedc09c78f6a">P7Y11M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20211231"
      decimals="-3"
      id="Fact_844fe32673da45efa7e31c4bf0fc327f"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <clbs:CommonStockWarrantsShares
      contextRef="c20211231"
      decimals="0"
      id="Fact_7e82ae12b0f144bba0084546451c8f94"
      unitRef="U002">21356600</clbs:CommonStockWarrantsShares>
    <clbs:WeightedAverageExercisePriceWarrantsOutstanding
      contextRef="c20211231"
      decimals="2"
      id="Fact_f8bc7989a5324f5f9520950539dff6f4"
      unitRef="U003">2.84</clbs:WeightedAverageExercisePriceWarrantsOutstanding>
    <clbs:WeightedAverageRemainingContractualTermwarrantoutstanding
      contextRef="c20210101to20211231"
      id="Fact_c8254038903c4304a98d74fd4bab2590">P4Y4M13D</clbs:WeightedAverageRemainingContractualTermwarrantoutstanding>
    <clbs:AggregateIntrinsicValueWarrantsOutstanding
      contextRef="c20211231"
      decimals="-3"
      id="Fact_f05d9de2d4db457f8130aa29f0798a8e"
      unitRef="U001">0</clbs:AggregateIntrinsicValueWarrantsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_98c4797539ce462c8e542b9da65438e0"
      unitRef="U002">540600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_ce30f0b05eb840d9b4d4b2176cfb6210"
      unitRef="U003">0.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsGranted
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_2ff39fb74e9849c59d51f2aff606b5c3"
      unitRef="U002">0</clbs:WarrantsGranted>
    <clbs:WeightedAverageExercisePriceWarrantsGranted
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_3290c15580e141ff82fd77732977ddaf"
      unitRef="U003">0</clbs:WeightedAverageExercisePriceWarrantsGranted>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_69b1e376659e402da005140dee327ffb"
      unitRef="U002">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_170300b359f4424da49a40b4210f8438"
      unitRef="U003">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsExercised
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_5a08277a4d464eb695578ddbba765ddf"
      unitRef="U002">0</clbs:WarrantsExercised>
    <clbs:WeightedAverageExercisePriceWarrantsExercised
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_cf7f53bfb2274af88a509ffe34151539"
      unitRef="U003">0</clbs:WeightedAverageExercisePriceWarrantsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_6123a40f5e7c4a4499d0c0b14e0b1098"
      unitRef="U002">9565</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_947b75f56f6d4c4dae2487cd22837780"
      unitRef="U003">1.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsCanceled
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_0da77c89ee4c4ba5859119fe6808875f"
      unitRef="U002">0</clbs:WarrantsCanceled>
    <clbs:WeightedAverageExercisePriceWarrantsCanceled
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_4fcbb1208f8e45658575e343db91ab80"
      unitRef="U003">0</clbs:WeightedAverageExercisePriceWarrantsCanceled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_2d5eab29ce0646369302427fb1b8a007"
      unitRef="U002">23275</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c20220101to20220331"
      decimals="2"
      id="Fact_b92d7fd7f87e4f0f81d7c32ebdf86beb"
      unitRef="U003">26.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <clbs:WarrantsExpired
      contextRef="c20220101to20220331"
      decimals="INF"
      id="Fact_2934e48abc00426880cfabda6d2cb660"
      unitRef="U002">0</clbs:WarrantsExpired>
    <clbs:WeightedAverageExercisePriceWarrantsExpired
      contextRef="c20220101to20220331"
      decimals="0"
      id="Fact_62d10134ae6b479380f2678fe2067206"
      unitRef="U003">0</clbs:WeightedAverageExercisePriceWarrantsExpired>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c20220331"
      decimals="0"
      id="Fact_7955b42fc9a549c68bd2b84ccd2e9068"
      unitRef="U002">2639609</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c20220331"
      decimals="2"
      id="Fact_26d1923d9fb34844bcb89f7474f302be"
      unitRef="U003">4.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="c20220101to20220331"
      id="Fact_f9b34464d46a4c2d9b011ec3fbc9d82c">P7Y9M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_e2f8cc48b72b47928b6d5d442a7bdb33"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <clbs:CommonStockWarrantsShares
      contextRef="c20220331"
      decimals="0"
      id="Fact_f2b2e0bd329943ada6e86032fce8a6d0"
      unitRef="U002">21356600</clbs:CommonStockWarrantsShares>
    <clbs:WeightedAverageExercisePriceWarrantsOutstanding
      contextRef="c20220331"
      decimals="2"
      id="Fact_c77329a79f1c46c582a4a038a37b816f"
      unitRef="U003">2.84</clbs:WeightedAverageExercisePriceWarrantsOutstanding>
    <clbs:WeightedAverageRemainingContractualTermwarrantoutstanding
      contextRef="c20220101to20220331"
      id="Fact_040892a4b6c24f9aa884d11a899007f1">P4Y1M17D</clbs:WeightedAverageRemainingContractualTermwarrantoutstanding>
    <clbs:AggregateIntrinsicValueWarrantsOutstanding
      contextRef="c20220331"
      decimals="-3"
      id="Fact_7bdc1e6671f942e5bc96120fb0124ad6"
      unitRef="U001">0</clbs:AggregateIntrinsicValueWarrantsOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c20220331"
      decimals="0"
      id="Fact_8b4f9499752649eebb70106e36b2da1b"
      unitRef="U002">2594630</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c20220331"
      decimals="2"
      id="Fact_e1ef9c4ad34d432cb9f8501b421927e8"
      unitRef="U003">4.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="c20220101to20220331"
      id="Fact_852846ced2de4c338e7eba54f2cd8c2a">P7Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_80c70f5a3abd48b8b78826fb9afcf4cf"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <clbs:Sharesvestedandexpectedtovest
      contextRef="c20220331"
      decimals="0"
      id="Fact_8043ad793d9d49c3a3f6850888acad7b"
      unitRef="U002">21356600</clbs:Sharesvestedandexpectedtovest>
    <clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest
      contextRef="c20220331"
      decimals="2"
      id="Fact_5a83379237f74bf1979165ce930727cd"
      unitRef="U003">2.84</clbs:WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest>
    <clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest
      contextRef="c20220101to20220331"
      id="Fact_d4cbe693e6f643d4aff3a97e6cf94128">P4Y1M17D</clbs:WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest>
    <clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest
      contextRef="c20220331"
      decimals="-3"
      id="Fact_af24645ca3ec44d48cbff436e58cb2f3"
      unitRef="U001">0</clbs:AggregateIntrinsicValueWarrantsvestedandexpectedtovest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="c20220331"
      decimals="0"
      id="Fact_fb65b45cae144244b744d8698ac54f63"
      unitRef="U002">1408083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c20220331"
      decimals="2"
      id="Fact_dd51bcffa1dc4385ad9b704234459d9c"
      unitRef="U003">7.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <clbs:OptionsVestedweightedAverageRemainingContractualTerm
      contextRef="c20220101to20220331"
      id="Fact_f13013846887486f9308a317d0936499">P6Y4M28D</clbs:OptionsVestedweightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="c20220331"
      decimals="-3"
      id="Fact_111ddb9096804dcaa9249eca4940b978"
      unitRef="U001">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <clbs:WarrantsVested
      contextRef="c20220331"
      decimals="0"
      id="Fact_8edb830485f44e8e8c7f9b75b29c8ca8"
      unitRef="U002">21356600</clbs:WarrantsVested>
    <clbs:WeightedAverageExercisePriceWarrantsExercisable
      contextRef="c20220331"
      decimals="2"
      id="Fact_fd9ca6c17edc4b0db4868c4f54982564"
      unitRef="U003">2.84</clbs:WeightedAverageExercisePriceWarrantsExercisable>
    <clbs:WeightedAverageRemainingContractualTermwarrantsvested
      contextRef="c20220101to20220331"
      id="Fact_723bdc1fe26c4541a851f6c7b4435dcf">P4Y1M17D</clbs:WeightedAverageRemainingContractualTermwarrantsvested>
    <clbs:AggregateIntrinsicValueWarrantsvested
      contextRef="c20220331"
      decimals="-3"
      id="Fact_f2a084ec6dd8482fb1758049a3a64b3f"
      unitRef="U001">0</clbs:AggregateIntrinsicValueWarrantsvested>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_81c564b83d7e4d9ebd72f19fa4d4f32d">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock for services as follows ($ in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Three Months Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Number of restricted stock issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;"&gt;1,061,175 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;300,450 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Value of restricted stock issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 25pt; border-bottom: 3pt double #000000; min-width: 45pt;"&gt;973&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;478&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_9bce703c58ef42288008446472dff63b"
      unitRef="U002">1061175</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockMember"
      decimals="0"
      id="Fact_a0bc2cff2168465aa03a2c846a293a12"
      unitRef="U002">300450</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember"
      decimals="-3"
      id="Fact_657acf36c64242dabb5fd7f2f1eac707"
      unitRef="U001">973000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockMember"
      decimals="-3"
      id="Fact_99186fdbb105486a9f2be695e7e26190"
      unitRef="U001">478000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember_RangeAxis_MaximumMember"
      id="Fact_34b525dd845144f49e2b68100041c53b">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_6bee3e0c5b2f43b882dab054f4aade40">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;During the three months ended March&#160;31, 2022 and 2021, the Company
            issued restricted stock units for services as follows ($ in thousands, except share data):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 20.35%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Three Months Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Number of restricted stock units issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 45pt;"&gt;1,379,860 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 5.25pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;458,245 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Value of restricted stock units issued&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 9.62%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 45pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 45pt;"&gt;1,265&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.36%; border-bottom: none; font-size: 2pt; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 8.01%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 5.25pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;$&lt;/span&gt;&lt;span style="padding-left: 17.5pt; border-bottom: 3pt double #000000; min-width: 37.5pt;"&gt;729&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_1a388ff54cf14f0cb9deef6e14272f6e"
      unitRef="U002">1379860</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="0"
      id="Fact_11662cd3110041d6969e762ec367fcb1"
      unitRef="U002">458245</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_d4d392900b8d47c5a95f6fe7eed26f76"
      unitRef="U001">1265000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_02a3864b25de46198b6ee2387f8d8163"
      unitRef="U001">729000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_46e20d1b99a447c79251bd50555546e0"
      unitRef="U003">0.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20210331_AwardTypeAxis_RestrictedStockMember"
      decimals="2"
      id="Fact_ac649c9a8f9f45e683ccf673c4f724f1"
      unitRef="U003">1.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      id="Fact_ed1516c9e5b642a494787c97eb066cef">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="c20220101to20220331"
      id="Text_ab0376df24f742d8a04fa7a05b63eb55">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 9 &#x2013; Share-Based Compensation&lt;/span&gt;&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;Share-Based Compensation&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;We utilize share-based compensation in the form of stock options,
            restricted stock, and restricted stock units. &lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;The following table summarizes the components of share-based compensation expense for the three months ended March&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Three Months Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Research and development&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;$218&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;96&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;General and administrative&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;542 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;501 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total share-based compensation expense&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$760&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$597&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Total compensation cost related to non-vested awards not yet
            recognized and the weighted-average periods over which the awards were expected to be recognized at March&#160;31, 2022 were as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Restricted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Units&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Restricted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Unrecognized compensation cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;814&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;444&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"&gt;$1,004&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Expected weighted-average period in years of compensation
                    cost to be recognized&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1.77 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;0.96 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;2.25 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the three months ended March&#160;31, 2022 and 2021 were as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Three Months Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total fair value of shares vested&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;377&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;397&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Weighted average estimated fair value of shares granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;"&gt;$0.62&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;"&gt;$1.08&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;"&gt;Valuation Assumptions&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The fair value of stock options and warrants at the date of grant was
            estimated using the Black-Scholes option pricing model. The expected volatility is based upon historical volatility of the Company&#x2019;s stock. The expected term for the options is based upon observation of actual time elapsed between date of grant
            and exercise of options for all employees. The expected term for the warrants is based upon the contractual term of the warrants.&lt;/div&gt;
</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="c20220101to20220331"
      id="Text_79ade1563cca413a9ab4787ce57c40e3">&lt;span style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"&gt;The following table summarizes the components of share-based compensation expense for the three months ended March&#160;31, 2022 and 2021 (in thousands):&lt;/span&gt;
&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Three Months Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Research and development&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;$218&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;$&lt;span style="padding-left: 5pt;"&gt;96&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;General and administrative&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;542 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt; border-bottom: 1pt solid #000000; min-width: 20pt;"&gt;501 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total share-based compensation expense&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$760&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.02pt; text-align: left;"&gt;&lt;span style="border-bottom: 3pt double #000000; min-width: 20pt;"&gt;$597&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_15bcd3db5f4040c3b70c461bad7de12f"
      unitRef="U001">218000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210331_IncomeStatementLocationAxis_ResearchAndDevelopmentExpenseMember"
      decimals="-3"
      id="Fact_e8750fc045fd451bada12cc07c9d8bdc"
      unitRef="U001">96000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_d0052139ab5e4808befdbcc53d1007e9"
      unitRef="U001">542000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210331_IncomeStatementLocationAxis_GeneralAndAdministrativeExpenseMember"
      decimals="-3"
      id="Fact_1585980d235741069b9ebc2cfb914943"
      unitRef="U001">501000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20220101to20220331"
      decimals="-3"
      id="Fact_a3c1aa9813cf4992950a2ec6984d80d6"
      unitRef="U001">760000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="c20210101to20210331"
      decimals="-3"
      id="Fact_055f765629414fcb9642d9ad718f28b2"
      unitRef="U001">597000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="c20220101to20220331"
      id="Text_2e4a8af45f004fef8e310b4089cf5302">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Total compensation cost related to non-vested awards not yet
            recognized and the weighted-average periods over which the awards were expected to be recognized at March&#160;31, 2022 were as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Options&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Restricted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Units&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Restricted &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Unrecognized compensation cost&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;814&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;444&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"&gt;$1,004&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 71.8%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"&gt;Expected weighted-average period in years of compensation
                    cost to be recognized&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 5.79%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.31pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;1.77 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.3pt; text-align: left;"&gt;&lt;span style="padding-left: 5pt;"&gt;0.96 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 1.24%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.5%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"&gt;&lt;span style="padding-left: 10pt;"&gt;2.25 &lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_b03cf2392fda40cb870169f7da1c6a98"
      unitRef="U001">814000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      decimals="-3"
      id="Fact_88536e6a29e3440d8d946695f96ddb7e"
      unitRef="U001">444000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c20220331_AwardTypeAxis_RestrictedStockMember"
      decimals="-3"
      id="Fact_62a14e3fe70c47e9af96af0c9004093e"
      unitRef="U001">1004000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      id="Fact_85cec763f2af4d2abdd341fcea9794ee">P1Y9M7D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockUnitsRSUMember"
      id="Fact_5d4df826e8f74bada52c47c545ef583d">P0Y11M15D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="c20220101to20220331_AwardTypeAxis_RestrictedStockMember"
      id="Fact_633da930efee40b38ab6bf4ef6ce952d">P2Y3M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="c20220101to20220331"
      id="Text_9fff4a6384fe4abfa30cd50b72d1eea8">
&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Total fair value of shares vested and the weighted average estimated
            fair values of shares granted for the three months ended March&#160;31, 2022 and 2021 were as follows (in thousands):&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" class="fintab" style="margin-top: 4pt; border-collapse: collapse; width: 468pt; margin-left: auto; margin-right: auto;"&gt;


  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 6pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 6pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Stock Options&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td colspan="4" style="width: 18.81%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;Three Months Ended &lt;br/&gt;
                  &lt;/div&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;March&#160;31,&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr class="header"&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;"&gt;&#160;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2022&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 4.25pt; border-bottom: 1px solid #ffffff;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: center; vertical-align: bottom; border-bottom: 1pt solid #000000; padding-top: 4.25pt; padding-bottom: 4.25pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;"&gt;2021&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Total fair value of shares vested&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;377&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 4.25pt; padding-bottom: 3pt; background-color: #CCEEFF;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;"&gt;$&lt;span style="padding-left: 2.5pt;"&gt;397&lt;/span&gt;&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;

  &lt;tr&gt;

    &lt;td style="width: 76.92%; text-align: left; vertical-align: bottom; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"&gt;Weighted average estimated fair value of shares granted&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;"&gt;$0.62&lt;/div&gt;
                &lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td class="gutter" style="width: 2.13%; border-bottom: none; font-size: 2pt; padding-top: 3pt; padding-bottom: 3pt;"&gt;&#x200b;&lt;/td&gt;

    &lt;td style="width: 7.27%; text-align: left; vertical-align: bottom; white-space: nowrap; padding-top: 3pt; padding-bottom: 3pt;"&gt;
                  &lt;div class="fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.77pt; text-align: left;"&gt;$1.08&lt;/div&gt;
                &lt;/td&gt;

  &lt;/tr&gt;


&lt;/table&gt;
</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_5e7d5a685523469c80706cf3bab1e990"
      unitRef="U001">377000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="-3"
      id="Fact_34fed4c3970b45ee8967ab12ba2657fa"
      unitRef="U001">397000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_e193c9c7f5fc46c4851e1a8169a028f1"
      unitRef="U003">0.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c20210101to20210331_AwardTypeAxis_EmployeeStockOptionMember"
      decimals="2"
      id="Fact_7f6c53ebb6534bf5b3070101005eb4e4"
      unitRef="U003">1.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_694bbc021b284f538d33d56f20ed2867">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 10 &#x2013; Income Taxes&lt;/span&gt;&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In assessing the realizability of deferred tax assets, including the
            net operating loss carryforwards (&#x201c;NOLs&#x201d;), the Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to utilize its existing deferred tax assets. Based on its assessment,
            the Company has provided a full valuation allowance against its net deferred tax assets as their future utilization remains uncertain at this time.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of December&#160;31, 2021 and 2020, the Company had approximately $281 million and $264 million,
            respectively of federal NOLs available to offset future taxable income expiring from 2030 through 2036. The Company performed an analysis and determined that they had an ownership change of greater than 50% over a 3-year testing period on
            January&#160;25, 2021. As a result, $169 million of the $281 million of federal NOLs will expire unutilized. The Company wrote off that portion of the deferred tax asset and reduced the corresponding valuation allowance resulting in $112 million of remaining federal NOL. The write off of the deferred tax asset and the corresponding reduction in valuation allowance has no impact
            to the balance sheet or income statement. Losses incurred before the ownership change on January&#160;25, 2021 will be subject to an annual limitation of $173k under Internal Revenue Code Section 382, while losses incurred after January&#160;25, 2021
            will not be subject to limitations. The Company may be able to utilize additional NOLs of approximately $1.1 million per year for the
            first five years after this ownership change as a result of the application of the Net Unrealized Built-in Gain rules.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of December&#160;31, 2021 and 2020 the Company had State NOLs available
            in New Jersey of $97 million and $99
            million, respectively, California of $70 million and $70 million, respectively, and New York City of $13 million and $13 million, respectively, to offset future taxable income expiring from 2031 through 2041. In accordance with Section 382 of the Internal Revenue
            code, the usage of the Company&#x2019;s NOLs would be limited given the change in ownership. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period when those temporary differences
            become deductible.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;The Company applies the FASB&#x2019;s provisions for uncertain tax
            positions. The Company utilizes the two-step process to determine the amount of recognized tax benefit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the consolidated financial statements is the largest
            benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company recognizes interest and penalties associated with uncertain tax positions as a component of income tax
            expense.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;As of March&#160;31, 2022, management does not believe the Company has any
            material uncertain tax positions that would require it to measure and reflect the potential lack of sustainability of a position on audit in its financial statements. The Company will continue to evaluate its uncertain tax positions in future
            periods to determine if measurement and recognition in its financial statements is necessary. The Company does not believe there will be any material changes in its unrecognized tax positions over the next year.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;For years prior to 2018, the federal statute of limitations is closed
            for assessing tax. The Company&#x2019;s state tax returns remain open to examination for a period of three to four years from date of filing.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In December 2021, the Company received preliminary approval from the
            New Jersey Economic Development Authority (&#x201c;NJEDA&#x201d;) to participate in the Technology Business Tax Certificate Transfer Program (the &#x201c;Program&#x201d;). The Program permits qualified companies to sell a percentage of their New Jersey net operating
            losses (&#x201c;NJ NOLs&#x201d;) to unrelated profitable corporations. On February&#160;22, 2022, the Company received final approval from NJEDA to sell $2.5
            million of its NJ NOLs related tax benefits (&#x201c;NJ NOL Tax Benefits&#x201d;), which was subsequently sold to a qualifying and approved buyer pursuant to the Program for net proceeds of $2.3 million. The gross proceeds of $2.5 million have been
            recorded as a benefit from income taxes and the loss on sale of NJ NOLs of $0.1 million recorded in other income (expense) in the
            consolidated financial statements.&lt;/div&gt;
</us-gaap:IncomeTaxDisclosureTextBlock>
    <clbs:OperatingLossCarryforwardsBeforeWriteDown
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_f261d540aa6844c081ebb28872c29cdc"
      unitRef="U001">281000000</clbs:OperatingLossCarryforwardsBeforeWriteDown>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20201231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_505043f6d54c4de48aec3592c9a76ecf"
      unitRef="U001">264000000</us-gaap:OperatingLossCarryforwards>
    <clbs:OperatingLossCarryforwardsSetToExpireWrittenDown
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_fc5d2ac218264a28b32fcf4879144622"
      unitRef="U001">169000000</clbs:OperatingLossCarryforwardsSetToExpireWrittenDown>
    <clbs:OperatingLossCarryforwardsBeforeWriteDown
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_24991f632b864d3086681ceb709f95c5"
      unitRef="U001">281000000</clbs:OperatingLossCarryforwardsBeforeWriteDown>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_DomesticCountryMember"
      decimals="-6"
      id="Fact_6b01f9675067465dadf40b7b966c38af"
      unitRef="U001">112000000</us-gaap:OperatingLossCarryforwards>
    <clbs:OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain
      contextRef="c20211231"
      decimals="-5"
      id="Fact_566942ed8e944079901239f5bbc362f4"
      unitRef="U001">1100000</clbs:OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember"
      decimals="-6"
      id="Fact_1cfe6d0fd4e74b80af58ff74bc45c0b3"
      unitRef="U001">97000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewJerseyDivisionOfTaxationMember"
      decimals="-6"
      id="Fact_dba60e7032b2418eb3b806336095f851"
      unitRef="U001">99000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember"
      decimals="-6"
      id="Fact_32691a24dd0546c1a32106f3e9a96567"
      unitRef="U001">70000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_CaliforniaFranchiseTaxBoardMember"
      decimals="-6"
      id="Fact_d9fdac5678814f24885e5d872d329edc"
      unitRef="U001">70000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20211231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember"
      decimals="-6"
      id="Fact_18d681268a824cfeb89254cea888f438"
      unitRef="U001">13000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="c20201231_IncomeTaxAuthorityAxis_StateAndLocalJurisdictionMember_IncomeTaxAuthorityNameAxis_NewYorkStateDivisionOfTaxationAndFinanceMember"
      decimals="-6"
      id="Fact_1392558620ec48a497c837fcca825f2c"
      unitRef="U001">13000000</us-gaap:OperatingLossCarryforwards>
    <clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross
      contextRef="c20220222to20220222"
      decimals="-5"
      id="Fact_e31e8d594b7840af845611ca2fcaf3cf"
      unitRef="U001">2500000</clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross>
    <clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram
      contextRef="c20220222to20220222"
      decimals="-5"
      id="Fact_e2b69f06156c47eebdbfe94be9216add"
      unitRef="U001">2300000</clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgram>
    <clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross
      contextRef="c20220222to20220222"
      decimals="-5"
      id="Fact_92bda2c6a2a142428b64da0bbb7c558e"
      unitRef="U001">2500000</clbs:ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross>
    <clbs:LossOnSaleOfNetOperatingLosses
      contextRef="c20220222to20220222"
      decimals="-5"
      id="Fact_d100ed3ce9054192a6a3696e953642ee"
      unitRef="U001">100000</clbs:LossOnSaleOfNetOperatingLosses>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="c20220101to20220331"
      id="Text_a32c022d28264fe5a2bf6eeb998b0154">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 11 &#x2013; Contingencies&lt;/span&gt;&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;Contingencies&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;From time to time, the Company is subject to legal proceedings and
            claims, either asserted or unasserted, that arise in the ordinary course of business. While the outcome of pending claims cannot be predicted with certainty, the Company does not believe that the outcome of any pending claims will have a
            material adverse effect on the Company's financial condition or operating results.&lt;/div&gt;
</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="c20220101to20220331"
      id="Text_25ef6d05863f49f08ec6c7fbe5b9df61">
&lt;div class="h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"&gt;&lt;span style="text-decoration: underline;"&gt;Note 12 &#x2013; Subsequent Event&lt;/span&gt;&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"&gt;Cend Merger Agreement&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;On April&#160;26, 2022, the Company and Cend Therapeutics, Inc., a
            Delaware corporation (&#x201c;Cend&#x201d;), entered into an Agreement and Plan of Merger and Reorganization (the &#x201c;Merger Agreement&#x201d;), pursuant to which, among other matters, and subject to the satisfaction or waiver of the conditions set forth in the Merger
            Agreement, a wholly-owned subsidiary of Caladrius will merge with and into Cend, with Cend surviving as a wholly-owned subsidiary of the Company (the &#x201c;Merger&#x201d;), subject to the terms of the Merger Agreement and stockholder approval of the
            transaction. Under the exchange ratio formula, as of immediately after the Merger, the former Cend stockholders are expected to own approximately 50%
            of the outstanding shares of Caladrius Common Stock and the Company&#x2019;s stockholders as of immediately prior to the Merger are expected to own approximately 50% of the outstanding shares of Caladrius Common Stock. The actual allocation will be subject to adjustment based on the Company&#x2019;s net cash balance at the time of closing and the amount
            of any transaction expenses of Cend in excess of $250 thousand at the time of closing.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;Consummation of the Merger is subject to certain closing conditions,
            including, among other things, approval by the stockholders of the Company and Cend, and the Company&#x2019;s satisfaction of a minimum net cash threshold at closing, expected to be approximately $64.9 million assuming a closing at the end of the third quarter of 2022, and as described further in the Merger Agreement. The Merger Agreement contains certain termination rights for
            both the Company and Cend, and further provides that, upon termination of the Merger Agreement under specified circumstances, the Company may be required to pay Cend a termination fee of $1.0 million, Cend may be required to pay the Company a termination fee of $4.0
            million, or in some circumstances reimburse the other party&#x2019;s expenses up to a maximum of $1.0 million.&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;At the effective time of the Merger, the Company&#x2019;s Board of Directors
            is expected to consist of nine members, four of whom will be designated by the Company, four of whom will be designated by Cend and one member who will be mutually agreed between the Company and Cend.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"&gt;Stock Purchase Agreement&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In order to provide Cend with capital for its development programs
            prior to the closing of the Merger, the Company and Cend entered into a Series D Preferred Stock Purchase Agreement (the &#x201c;Purchase Agreement&#x201d;), pursuant to which the Company agreed to purchase from Cend 1,135,628 shares of Series D Preferred Stock, $0.00001 par
            value per share (the &#x201c;Series D Preferred Stock&#x201d;), of Cend at a purchase price per share equal to $8.8057 per share (the &#x201c;Series D
            Original Issue Price&#x201d;), or approximately $10 million in the aggregate. The Series D Preferred Stock ranks senior to Cend&#x2019;s common
            stock and the other series of preferred stock with respect to rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of Cend. The Series D Preferred Stock has a liquidation preference equal
            to the Series D Original Issue Price plus an amount equal to any accrued and unpaid dividends to the date of payment and will participate with Cend&#x2019;s common stockholders and other preferred stockholders thereafter on an as-converted basis. The
            Series D Preferred Stock shall vote with the common stock on an as-converted basis on any matters presented to the stockholders of Cend. Each share of Series D Preferred Stock is convertible, at the option of the holder thereof, into such
            number of shares of Cend common stock as is determined by dividing the Original Issue Price by the conversion price in effect at the time of conversion, which conversion price shall be the Original Issue Price as appropriately adjusted for
            stock splits, stock dividends, combinations, and subdivisions of Cend common stock, and as adjusted pursuant to a weighted-average antidilution adjustment. The Series D Preferred Stock will automatically convert into shares of Cend common stock
            upon the closing of a firm-commitment underwritten initial public offering implying a pre-equity offering value of at least $250
            million, resulting in at least $50 million of gross proceeds to Cend.&lt;/div&gt;

&lt;div class="h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"&gt;Collaboration Agreement&lt;/div&gt;

&lt;div style="display:none;"&gt;&lt;br/&gt;&lt;/div&gt;
&lt;div class="para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"&gt;In connection with such Purchase Agreement, Cend entered into a
            Collaboration Agreement (the &#x201c;Collaboration Agreement&#x201d;), pursuant to which the Company agreed to collaborate with Cend on certain developmental and clinical activities prior to the closing of the Merger. Under the Collaboration Agreement, the
            Company and Cend will form a joint steering committee (the &#x201c;Committee&#x201d;) comprised of individuals from both entities. The Committee will meet regularly and be responsible for monitoring ongoing studies and making recommendations for development
            activity and trial planning. Cend has agreed to pay each member of the Committee from the Company an hourly consulting fee for such service.&lt;/div&gt;
</us-gaap:SubsequentEventsTextBlock>
    <clbs:MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="INF"
      id="Fact_caa53e6f893e4299a293cb1e66e15b50"
      unitRef="U005">0.50</clbs:MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage>
    <clbs:MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="INF"
      id="Fact_d94dbeb384e448cdb97e729182278da3"
      unitRef="U005">0.50</clbs:MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage>
    <clbs:MergerAgreementTransactionExpensesThresholdForRatioAllocation
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-3"
      id="Fact_a047edb98c8649b9bb863ba51659d3ab"
      unitRef="U001">250000</clbs:MergerAgreementTransactionExpensesThresholdForRatioAllocation>
    <clbs:MergerAgreementMinimumNetCashThreshold
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_3371433814c74c9dbb530476b1893855"
      unitRef="U001">64900000</clbs:MergerAgreementMinimumNetCashThreshold>
    <clbs:MergerAgreementPotentialTerminationFeePayable
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_06bef34ba02847b9b6fdb019add49d28"
      unitRef="U001">1000000.0</clbs:MergerAgreementPotentialTerminationFeePayable>
    <clbs:MergerAgreementPotentialTerminationFeeReceivable
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_10e0745448704815b5171f948c490a96"
      unitRef="U001">4000000.0</clbs:MergerAgreementPotentialTerminationFeeReceivable>
    <clbs:MergerAgreementPotentialExpenseReimbursement
      contextRef="c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember"
      decimals="-5"
      id="Fact_07fb86e5d1bb49d8a7744f7f88652e50"
      unitRef="U001">1000000.0</clbs:MergerAgreementPotentialExpenseReimbursement>
    <clbs:PurchaseOfPreferredStockShares
      contextRef="c20220426to20220426_StatementClassOfStockAxis_SeriesDPreferredStockCendMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"
      decimals="0"
      id="Fact_1c6c7e25cd454e65a6727d4e3a014f63"
      unitRef="U002">1135628</clbs:PurchaseOfPreferredStockShares>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c20220426_StatementClassOfStockAxis_SeriesDPreferredStockCendMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"
      decimals="INF"
      id="Fact_f2892699525d4342b715825837569840"
      unitRef="U003">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <clbs:PurchaseOfPreferredStockPricePerShare
      contextRef="c20220426to20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"
      decimals="4"
      id="Fact_70167f542b834833a0fbe91796664811"
      unitRef="U003">8.8057</clbs:PurchaseOfPreferredStockPricePerShare>
    <clbs:PurchaseOfPreferredStockAggregatePrice
      contextRef="c20220426to20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"
      decimals="-6"
      id="Fact_8a4cdda0c0724c4baa4d3d59c3e1c414"
      unitRef="U001">10000000</clbs:PurchaseOfPreferredStockAggregatePrice>
    <clbs:PreEquityOfferingValueAfterConversion
      contextRef="c20220426_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"
      decimals="-6"
      id="Fact_f122d2010a824616a925f6dd2ddceb25"
      unitRef="U001">250000000</clbs:PreEquityOfferingValueAfterConversion>
    <clbs:GrossProceedsOnTransaction
      contextRef="c20220426to20220426_LegalEntityAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember_SubsidiarySaleOfStockAxis_CendSeriesDPreferredStockPurchaseAgreementMember"
      decimals="-6"
      id="Fact_7524974db38d44a791b2efeecf4ba897"
      unitRef="U001">50000000</clbs:GrossProceedsOnTransaction>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>120
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M>ITAWDM9OT5U18NBRO\;H?$UJ8HIOM\@S0#LWPJACQ4S0?./8/H74$L#!!0
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MZG9FW0LFGQ923\P7M.:T+'(L2 X^XQ+7&0'WK3D.OE_]\0.X +_?+\'W'WX
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MN=QO]NO#Z?Y'^<AS\4(W8F1]K(:\)UX=RFS#C5=_RXKB-8$/N^-]?I\NTY*
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M06E!E\,10E-&4%J,HK7UVKA5IMZN^E8G0(_M?06!I/E0VMQ4;28V(>P :-8
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M.P[$-L\Q?[XF&=M?CN#H9>(;?4BEGI@L%R5^(/=$_BCON'J:'+0D-">%H*P
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M5[0AL"F\Y$F/B<WZ2N7L*&**38).6/M"$,T">U3# ]K0B?:&*!?$M *H:A+
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M@/I^PYA\>= O./P>LOP?4$L#!!0    ( )>%^E0M9GGKKP<  !TM   8
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M=F-<_BRN6:IH2M7C"EJNX"+7FN6Y6B3>V&"U=S"QA,Q215.J'AZ"+YL1^ K
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M@Q5*VZRP2@5E _#[3DKSV+$)AKHW_P]02P,$%     @ EX7Z5'44E.6V"P
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M3Y9G_I7J.4A8\ +S=K#ZS?7IRC+%OXO1T['<J2B7393 .;*V$ F+D+ 8"4M
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M?I?GU;<?Z@]M/7SZ\=7_ 5!+ P04    " "7A?I4S%P8^*@&  "L'P  &0
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M5RY=CT[.TG#(+!W2V7Q(9XN!G'5&,-J/8-2;I7<K*MBY6< SE/)2JQI)C2Z
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M# #:UDN(0P D@8.)/['C!UJ-PX/JT V_%<NX7RT[Y0J:J" -KIP]C[R)O54
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M7#&:,6$ ^O<EY^KUQ32POZ"?_@]02P,$%     @ EX7Z5/KD+0?M%   E5$
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M?=IE?W0.K :FY077C7B:]K:D!C)"K V:HPO;^FW?KL# 6*8$L;"*NF 0+FU
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M=:T;0PR83 G1(_:%'LJ(T5%=/4YRJ+$A*T(-WDU,@*!Y4D&6A"!)5!&61(@
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MN@U:+8.O5-1NL+\(_X=8/[+&;62:>F2EJ^<35ODJV"& P\SEO51N+ ]N>)_
MX[K4N;4"9P+Z&)O[$+<0YZ621=QY&WJ2S)ANR@*%6U6ZO4:=">2[0%SY*79$
MI3W&7I"4*J-^8K148P6E:Q LS2LYKH%F:VG<!+!W8XN-"-.$O?EE"B2^AVO)
M(8)-2CLS$[!#2PW4Q;;D&J!M]KPW(1T\$L%]":U.&E2M?%]B/.!L[(4B5::
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MDY/'ZB/B_#7 I:JLH$QT*JZ-VO3/%H2]F7SWPC4;W6Z_""J,! L]$APN:6^
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M.'QI:A8YB,I"A#\BGU];D%B8'G&KN\@NI*;ET:=DA=QF\>&IG &F2J&%(++
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M ;IN><<U?8AN(Z^)8@Z(KI$_"6;&\P">4^K^ QD,+QH_^S=02P,$%     @
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M?@2V>OBN%MX4X>UX8KPW>?C,4-!4Q01T/C5T3]<+%K#\[\/X+U!+ P04
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MXPIW060Q/_3W"9I,C@Y<DNOVQCEHK"3@(&/2TK\LTDAX9D4"$Z4I0WPZ.8%
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M0<&YI]Q23 O*NBNLCEWV/3Y_JI*D[,I(5 Y39*K@P9<(:DLHB8)3%J:2IQ%
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MFH(%:'^JB&)5+WS ZOOR^%]02P,$%     @ EX7Z5*A"[IO2%0  F&<  !D
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MPT5 U4&N!'%5Z);GW/>!92FCAC2?8]= LW.@05PZU2J/!K!F+<IS_$V%%2P
MP%P%#$+8^P*S@?R%;-8\23#1%%9%0-CYK"3[G<2>M8C-M,:?Q<K (^H8"Y#K
M\%UW91T(%_*1%EPZR4&+V2C<;@JA93[,&DS"K6,Z6:"K"'#_4<35L1!@I\^3
M1)Y'56M))M(MEC 3+97UJ2S)#:*H&5M)EXUG'#JST#:,JJYI #"ZM*3]*<I8
MU=;TL8.V?^4A^UJHHX\6!+6DMG#B"3OACQJVME>+1(/W1\$C=039>FVSD_6C
M1I&^ZZ/@??!HP'<J93C9/-(T_ "VBH#H(RGED((F8]7N'.L,3P9::)HHI-R_
M)@_$(.@?=:$%7[6)P9MOU7D&!0'Z4*,5"[3;O=1@FDNNO"P,EZA1[@CRLZ-&
MIY;'ITDVGLWQ-?IL;&/B9?VY8==Y;E$INI[2=NJJ<BYWI5^O#XRKKJK:L2NZ
MUY&".I\"Y6<3@NNY%#A(?4#3VINEO GY3GWF#[I8R#I* F,?DKL T6EZ2KNV
M];!&Z6@Z!JX\T>N5/FVE5HJ),WNVG-GSN5=VX/$K'D948T<KI;7H4I7/#8+O
ML)_35J.*TIE!=6DI'.LH7-72I#T"#*PVJF.]JML.H8CM5KDYZQ\\4><XN$5(
M:JD7HC:X[::_QCF\P6CZ[-6[BXMVY$#CZ.CU.F4RO-&-<?4!&4F9I#@8^=TZ
MIQ-1>!D"0:TZBD+R4 M'N"[RJFUM]HUF(:A*2U7S%*G:[ASH!1XM1=I34M/"
MCIV@Y;0X._9G1(V [VE<P",00ZXPUQLN4?VNU^ ([E^@ 4.,L;EH66'=Z<+
M\W.=PXWCJH5?)!F$+:HQ0:LT!4;=;92M1P^V<'5L\;*Y;'6"?$'+VHJ9>'1%
M_24I:(^CNJ9O4>06=F>E9NA!AV;IE9)HCNY7G<PG*E>&996W2TLM43+8E<Q%
M2S(Q[$@SDN14:P)3CDCU^B$9:@W0HD]F2&F#57=*TD8:@=7P3IAY)S7FBS[F
M9;PQN@/K7CLH.SQAW5FYA4;]@E10+6JP?M.%[4W\$AY:P;)PT3AK[>),#09F
M4]HZN\;:SVRQ,'>_=06P96NMIJTU]0CD.Q"\/1G+KQW]7SOZ_^LZ^GM=\BTL
MK(_J\6^T-A[6XE^EBH8&_XH_E9S?M\&?_?4-_D,R\"5T^%M?1(>_]6 =_F6I
MX$_V]UN?M+^??=']_=8GZ.\?$OTOL+_?^BS]_>J(X,OJ[S<Z02W3%3/.&LSH
M"_;#W@:X4TR^W@;X>AO@ZVV K[<!/OXV@#68RCSP;8 #$M[/?B'@3>TXS8HX
M8'MC#GPP.00YCE"XK8^2T)BHSF]Z5!F/ADFQ] U@E_JN4>U4!?L=D::5GE?=
MY[VJ2S?#;AD2(K)5VPIUT< Y=]COH##72A:^Y?'^*8!S*)UG93K_P_GO=?+=
MN9:@,F4\A&\=JG%="@&=.2LNT:Y3\;>9]W3V5B?BG_^F@_5 -QU(K"MK>NS/
MFC<>FKZWR@J M&J'ZEM)D*]X8!PG(")!L[9!$:I%PS'?2_(PCU16K<^;I=2]
M]9QMPQMU;E,^)6-3%6 G3AV?Z5PU2S%*E WOC [3P>LO]6T'WZ3-LI![Q6I\
M6E0U9HOGC^''8\VHO+:IDFUYH%P"'0*5QF>C0TSL)BA2.M$HZ=L)0SN24]H=
MBF,TM,8)7U>'4M.>K*Z%HH"AQ>Z)O5A.[97GC_GK.U"ER"8!>E041\5?U9>U
MN]=<'/9:GWJ,ER=-!G;L-DR?A%]O0GT!-Z&N1735Z:AZ &9_85>?F+KZ9/U7
M7'UBS:M/UL-=?5)%;5*ZERIT*;5,=J*$<5UE[ZH@T_0U'>U")4A)7FARCQ3H
ME4/3H7C8FA4F>!A/O5AW0LX:G5C=4F_5S*K"O7'$.AY+IX+#,S/*L;F5U336
MX6&ETAU%9SYX!G=N>Y/IF'= ;E;7RKIUG28X\$O3V<1VYXM1<+ER_FM*3SH%
MY\K='_O.=-;P[)3C2YFB3(H*'X>]XA3(T2>V%1S/E22=II='G7W J];WW. I
MKQI+&4T8QV*#BV!/&-:RJ[R(Z(!ZK3L?MF@".BT/U6#5T7%6*7I$#82T\[*]
MQTK2Y/$Z2S\0KX;9=E]%&#@JJ7$Y6 MX +GKAF[$F%7  /-@^:_G&NI;P\)O
M7+(OBO9\XMOSV6C8TQ1L:TRPE][<GOCS+UVJV<-*M34DU6],![9B1(([SK'R
MX9TX'@L/>.9^0SW>@.GQ''(1JXHY+K+P"CER$?&@RBS+=I@[749=EZC8T\@L
MFU)=@NRM-^0K3*I1 ;FO7@RNWCG81M3KD$)#ZJ]JLM*SWIF269Y'Q-AM21O'
MYFM%E8,\Q=S6!Y?6, J#<G8@@4:DK)WC6BUMZR@.1CIX"EDUV?0LR)]03Y56
M5Y1"R!^AK'30F8C'.QYMM3_2=[2K?A\YKBDZ#%^ZGNU-ET/G5\8LT'.6I8*:
M4IR2JJ)"I&GN2HZJ[[?P)[9J*C9H:J->7/9@4C?2[) IG_O*_5C2^_6V_;_W
M'NZZ;=^_);6:3^R%Z9ZB-S7=M9\YR_[ER.%[D!#G+.W)S'"+RG>\I>$:Y*K_
M\$N^:H_L^G(OVGOVQ)O:"\,E\&/F.9/^3;R[/GLK>P;_)BO#W4C_D,OFP[?M
M3Q;H=/N2?\PFCM\7BM[T27_JB?88!J @??VKW-W/(Q?N_96]G/HF;(UR?<AG
MD_X<LZ$W?<(.W+KW7.#9=&5 =3)UO/N+P,>C^A_^A2#U'?3^SH;OWUN#]^\]
MW[7G4]-E9-A[WQ;#WN]CH!]V[Z\:8>)!K 7]]'U[8;R'OW)\TSW\Q:?]>H&1
M[8W>PU>1[4!85=[9=4V!K?5G[^ ?=C_;K%* 2^/*=6]C;\QWHN>0G:UF?6)Z
M0&1O.:VO6A\*\)@M%PO'0'(V\WQG\NFN61_&+G7%VG.FZA[+,;FBC[UB_9DN
M5YLH8@W=J[[?MQ(\I*Q_@F\D^%,2KS8Y(*;ZJP1ZSR>0X2UGDQ&Y'P6+7R6P
M= SFFBWG$\?]2.DGRI87*CY>!V8KI0.^,Y]]_9J!^WW-@/JS%*>-/WX2B^R2
M_B8,5I6*)%=_!Z5Z6OW9F3/Z:RNG]7#U-VM^XMDE9($L$EN8ZCJ+V9'J:2@_
MY.F>_I3*.LWS-*9?=X)O1(8#X/TV3?/R RY0_3&>%_\/4$L#!!0    ( )>%
M^E3;%A[;108  "X9   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;.59
MVV[;.!!]UU<0;E.T0&)+LGS+#4C2=G<?NALD:8MBL0^T-+:)2*)+4G:\7[]#
M2I9E4[:3]+(+[$LB43.',\,S%\FG<R[NY01 D8<D3N598Z+4]+C5DN$$$BJ;
M? HI/AEQD5"%MV+<DE,!-#)*2=SR7;?;2BA+&^>G9NU:G)_R3,4LA6M!9)8D
M5"PN(>;SLX;76"[<L/%$Z876^>F4CN$6U,?IM<"[5HD2L012R7A*!(S.&A?>
M\56@Y8W )P9S6;DFVI,AY_?ZYK?HK.%J@R"&4&D$BO]F< 5QK('0C*\%9J/<
M4BM6KY?H[XWOZ,N02KCB\6<6J<E9H]\@$8QH%JL;/O\5"G\Z&B_DL31_R3R7
M#=H-$F92\:101@L2EN;_Z4,1AXI"W]VBX!<*_F,5VH5"VSB:6V;<>DL5/3\5
M?$Z$ED8T?6%B8[31&Y;J4[Q5 I\RU%/GMQ,JX.@2 Q&1*YX@.20U\7W]_LN;
MTY;"+;1@*RS@+G,X?PM<FWS@J9I(\BZ-(*K1O]JM[_D[ %KH6^F@OW3PTM^)
M^(&*)FE[A\1W?;_.H-WJ;R$LU;T=YK3+>+<-7GMGO(<FWM=T@?F@R(40-!V#
MN?[S8BB50'+_51?\'#NHQ]8)?RRG-(2S!F:T!#&#QOFK%U[7/:ES_#N!K84A
M*,,0[$+?2KLZIW<C_<X5D %Y]:+O>]X)V<KGK0\^ \D4B]G?0&3E<,*J#$N)
MF@#119/P$<&L#.\)G^IG\M#!\"C!0H5:YLDAH6E$-E=)EC(LN.3. ,58/EDZ
M)HH.8RAJ*)H@S3YZ;YXB':39;9M5\*"OC5E&34T$ $GR_ &=/P39'TY*^AN[
M-)'):^,1SR2NR#?'C@Z?VSXAQ7_GSD!54W$%90D;Z)I%S[E!XA@UO7$$,VP:
M4T/S3>F7OM>W%\F@Z_P"*0@:&P0:805D.C]T[;?D.X%M1L?UG#NN$&!O&*WM
M>UW77NP,>B0'7 ,)N51XY#'5YZTX27EZ-$,&X!V=4Q%)7%%D 0K9$O)QBF<=
M&9_TP<U-LX'HB,[0US&0*0C&48?C/9E/&$90RQ5(<Q!@K Z+S89 JJAJ\]B-
M I4%[>3>T[\U?/TCY[<5@IL5L7/!CYK8>\6<CVG%2#MX]NGWO:!F-0AJ5KU#
MUPV<=\N8; FHSN,%$M*D5=4"QUA@17)S&Z_9ZUF+;G/0M=G?]#L%34:4"3*C
M<09E,DNRI,8& <C27GS,$LTE9Z4N*_IC[!A:_AFI_TUD^%&%8G^H;"*T:PX#
M5P<]Y_/6<-9OL8RFA>8VN[;!+[VFVR>?$"-G[X7$\EWDBBGNZUM4>X4Y!4QB
MO9_4B:K/+D+#M*2Q I]*9V5N)DV30*G+F(;W1[?AA,>:"0:/3#'!M$#"(XCS
MUE+6A1G'8H1]32T(DR2O>QFV%3+!"LI1$0->D4$#]#:Z-=)T8=II[T3FYF\@
M*\ VN&3>TK/U/?A03PQY?! 9YYD,MT.O$":F4RTW!#4'2-?==W2 X %$R*19
M7<+K[6@<$TBF,5\ R%TVE1%>-RIOK:D9KXPYD+?SJDJS;E)ZQ 3BN8\=08;V
M@[M5X)>SB'S:,.(LAQ%K[/BWAI&\SN:E"(=H2(;8RI:#]+(:N>3U2[*G_GQ!
MH**R5''JBHM75US<)TPAI+;E$Z\W>,H<XAWZ0:=FU>UWGSV+^-C@;$SL>WZW
M\YAY)$MKIY%*MW.>.8W0?<.(??I6"]I+@O_(1-+KU+4<+QC4K':"[D\82+KV
M,.0U:ZS$T<7]F0/)(]/_&YGP XK%<R:1>EITVMWO-HG@D%EC;]/SGCN';!D]
M*N?\?QL]-"F=)XP>YIN-V:$2]X1&H!F,'H:9=K (X7K2..N'H>->YL#/9_R[
MM> >Z:^,+,D2\V)@TOB-I6>_\'1M&/KP33 5@JQLVI3O#0[LM<[!-I3"I$V-
M?E"#,CA89>]%D;T5- O#VV-)Q&8LPH)(%@QB.\,-[?V3;>O.#9/W1R/]LL6P
M0NAY#AF(]-T>&WQY:=LVN<W /=B%MB5&7M/KVFC85KR#NN^!K<HGZ03$V'RI
ME]CCLE3E7Z?+U?+'@ OS#;RU$L]_2<#WR3'#-(EAA*INL]=I$)%_G<]O%)^:
M#]Q#KA1/S.4$,!&%%L#G(XX3>G&C-RA_(CG_!U!+ P04    " "7A?I40353
M+\L$  #%"@  &0   'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6R%5F%OXS8,
M_9Y?0?B*PQV0)K;3IKTV"="TZ]9A'8KFMF$8]D&QZ5@[6_(D.6GNUX^48S?=
MI3V@:"R9?'HD'VE--MI\L3FB@Z>R4'8:Y,Y5%\.A37(LA1WH"A6]R;0IA:.E
M60UM95"DWJDLAG$8CH>ED"J83?S>@YE-=.T*J?#!@*W+4ICM' N]F091T&X\
MRE7N>&,XFU1BA0MTOU4/AE;##B65)2HKM0*#V32XBB[F)VSO#7Z7N+%[S\"1
M++7^PHN[=!J$3 @+3!PC"/I9XS46!0,1C7]WF$%W)#ON/[?HMSYVBF4I+%[K
MX@^9NGP:G >08B;JPCWJS4^XB^>4\1)=6/\?-HWM:!Q 4ENGRYTS,2BE:G[%
MTRX/>P[GX2L.\<XA]KR;@SS+&^'$;&+T!@Q;$QH_^%"]-Y&3BHNR<(;>2O)S
MLT>T*$R2PVVM4JE6\.'VSX^3H2-H-A@F.YAY Q._ A/%<*^5RRW\H%),7P(,
MB5-'+&Z)S>,W$6\P&< HZD,<QM$;>*,NT)''&WTO4*%2N,$UR;$B<3GXZVII
MG2%U_'TH[ ;TY# H=\R%K42"TX!:PJ)98S![_RX:AY=O4#[I*)^\A?Y-;0[Q
M>QOA5^T0H@C>OSN/H^@2OJGVM2@D=;:2 NZ4==+5Y* S,ERA0B.X9> >4YD0
M<N]'(RAA5QMA4C*'6UR:FCJ92A2=]<'E>!B/-EX!_,#$XO#R^N[QWC]&EQ]!
M,#ZF#9XN*Z&VD!%?R\3J"IR&HR@>Q-0.1<&=31NVKBIM''PFGX50=&(*#T;_
M0[U_ 9^/'_$)%JY.MWT04!EM*_33H \44:I+^173?J\JJ))+?9R0DHTN"MJ#
M5-?+ H^7E%E"S*G_(8:$5C(1!3@C^;\&7(NB%A0KD[8B0[?U0L,L(\-DR]2O
M?YDOPA$(2QP<#5#GY<?),9C0X[%6EJ:PVU94,TBE6*)#._ Q9;MZ2>MG4$IY
MX,#IC4AR26KV6'1(@L;1*.;<( T/A9;0"V*6,DUVH/ Y59PXG?5LO>0D64#5
MA SD_%S%/M/=T,SDWU*H.J-&J0U3X?#2O3Y*M"48J9+:F/_##&#N67><74UY
M4W6Y1,.LO\N"O9QVY"1*73>AMCG9"(YQ+6T3X]'Y8-Q*H\]VFUR2XFF[4TR/
MZ@A+1.4S3SI@L1E=KW)_T,K+O&KD Q4:J5,*KZP*Y+0U%6F5V2$<G0[..DE*
M_I..U=&53L&]:'M%D(0'GSH^7;6@$EN?3;*F"8@^09U+.!AU)Q"]%8T<N^]Q
M[WN;S,_[OCS>)?Z.BZ?T:2]3S[GFS%*^22Q?N7AKXL(OB:HLO:1\J[89:E/X
M<UTP9APV4B<QU,T7>"? 5H]F;R+W]I6$3W3EL&C[]"UT#9],*M]N-?($:/D3
MY:.3,1GHVG*\72THL 56KDT?4VE>:S]9#O+J'>(%AW@-X*9I 6:V)5N2+<-V
M!6L_6[MOS<O=\,5@>TYORW"E_)(J%_;:RO$[$LQX7U\)!2 =)8GX[L990?.-
M@GDU@+U)P!-W-U7;K T.?;*&>U>+$LW*7Z L=0,U87/+Z':[.]I5<S5Y-F\N
M>*3.E506"LS(-1R<G09@FDM3LW"Z\A>5I79T[?&/.=TST; !O<\T?<YV"SZ@
MN[G._@-02P,$%     @ EX7Z5)NXNW3_#   1C8  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL[5MM<]LV$O[.7X%QW8X]H]@B9<MVG'C&<>I>.FF:
MB9/>=&[N T1"$BX4H0*D9?77W[,+DJ)$RD[2W+6YRY=8?,%B7Y_=Q89/%L:^
M=U.E<G$W2S/W=&>:Y_/'AX<NGJJ9= =FKC(\&1L[DSDN[>30S:V2"2^:I8=1
MOS\\G$F=[5P\X7NO[<434^2ISM1K*UPQFTF[?*92LWBZ$^Y4-][HR32G&X<7
M3^9RHFY4_F[^VN+JL*:2Z)G*G#:9L&K\=.<R?'QU1._S"[]HM7"-WX(D&1GS
MGBY>)$]W^L202E6<$P6)/[?J2J4I$0(;OY4T=^HM:6'S=T7]FF6'+"/IU)5)
M_ZZ3?/ITYW1')&HLBS1_8Q9_4Z4\QT0O-JGC?\7"OSL8[(BX<+F9E8O!P4QG
M_J^\*_706'#:W[(@*A=$'[I@4"X8L*">,Q;KN<SEQ1-K%L+2VZ!&/U@WO!K2
MZ(RL>)-;/-58EU^\R&(S4^*MO%-.[%W_NO_D, =9>G@8ER2>>1+1%A(#\9/)
M\JD3WV>)2CK67]V_/HSN(7 (>6JAHDJH9]&]%'^2]D ,PIZ(^E'4Q=#]RY^K
MN%X>WL/.H-;Q@.D-'M2Q>*Y=G!I76"7^<3ERN84;_[-+Y9[B43=%"NW';BYC
M]70'L>N4O54[%]]]$P[[YUWB?B9B:\(?U<(?W4=]S<&Z!+U_]2N3*Q'VQ7??
MG$9A>"[6W/4%4, YY9S.)B*?*J"*3/7O<J13G2^%&5,\*VM5(G+HGM[-74_H
M+$Z+I%P39$!*8**5.=V!;9R(I;5+ .1"V@1!07M'_?-7/[]T_#,\W^_Q=E=F
M-I?9LF0"#-%->2MU*D>I$G/C-&&4D%DB,C61?*%N=:*R6(G<".5R#2120H\!
MH^.QCK7*<C$N<G(0\,QTM)=YH=-4C)28J(RX):&,*'+(^CO>R9U0=]JQ$!U2
M'XAGP+I$ #CI5<\QP#CO!4U)IM*)N37$8B(D&,&6MS(MI(?<%)@OB7<Y07YP
M.=,B!7;LB#^D#VTK<3RKGI)5E&"<*$#,YO@I9(ZW-98@11R(2T?60QRJV4C9
M.A99D_C17]?_5(+9.?B^8VVF2[$;G89 RS1EMK%H-QH>53=Z ;Q\KCA_I.PF
M8Y5 I:D@$S<,"/V:\1C";+&(NIMK2PH?6S,#7X,^V+*FF$SI8G@@WC:8A(M1
MSB6]$DLR73J(2[PE*E<6T$[JF[(>5"E3)LP"QG93/1?Q5&831=Q.X.9802]G
MXKC_K3"WN))B\&BI)&XK[P784!NR>/"CS ID:!$=>S6R?B6,X)#K>F(W')[5
MR@)]4NV: C<UQ)[(PL.J6>F"R;JX"TN1"_5YF>;&Y@WR;7]A3>!.$;,:E(B-
M)3.9C".URPD]__04_K,;(HTT&/8>QL99L>Y97%A=LG8_-VTNF#_F CMVL43Q
MDQFAH8,X#^ _1&,D4W[HJS)C*_=Q.<Q(,7@@7AK&#SPHF)&1@J\H7MWV@$QL
M&K3&!E>,_@7')L]E+\-KJ4CU3.>R4O]N>#)X#[-!*0!0^!%<4;Q1MRHKR'J)
M$C=EA34XC7IB,=5P^'2#/SDF!]QD(V V,I-OL+)BP*T[R4PNZ=4JV"HPDTFB
MZ>W*W\#U1GB'!ROOA)\+=GRHC!%]K"V@:4Q@2_==R2W#2TN;<A4)E3M@KU3'
MLNFOKV"X=YE/+Q#_6:'3_!%\X >"+ENDRCV,62W(NB'[;V!. 'JO4/O^""X5
M8]/NV<DZDIV=!160B2:0]<05V(,2,BUYX4E_?>'J>G,A/:9=?T7%+:[*W+D;
M#M;7KZXWUW\T4(8-H#P"'E$FCQ%K"0?*0N?3IA=65MATUR"&N_I44#CIP;&A
M9*X93LY="5JF2"FPO#?"B!,PG_D@]ZZ@&W#K_93@A?-S65A4+M&5[N!<B4)O
ME5 &+X 83+I,UA6*=FHG*6Q5P)28O9@R9\;A734#=E*4)7J,7:ET<,%(^94>
MCT!K/:[8@\MZY/KRYEFM"<[MU( YCI95^@5+@:]76D%:1J6GEB_,(Y>K.5$"
M(XY,7^<O'STS4V2YA^#83#(.&-+3"*H8:X#=-<4I;M3[B1F L5+!#,#W*-7O
MX5B/*,,](CR!MR@W-6G2:^[1V$"7E@0UD^J$RZ.QSN!.&OY2(RV;B5Y,I9T@
M3P8E4SY)31D,6NF5F=%30\ET##%\)BBA@"U=^PD\(4]Y)^_$OBA-U:W$'7:6
M F9%_EFNZ[B6A# 6FX,UCCGXDP1MQ16;@2PD%U->,UU#E2P"G -L*6^&TLO(
MPHA#]-]U?84V*9[6?5(/<)PABIC[Q"A7(CD\Z59M@!<5+LN 1+:DWVW,L%9]
MX%GU6T'U@N:,,%.2>R"?],<I)PKR?Q0-64XD4QF_)QX=6F 0;M3TLMZ 4J%$
M)9^3^:D4[;+X1EE"&0I> G<K? GNT[BOH+?)@1L^= ,?H!MNC^J]%(AUYX5B
M@U:UPC;FR!TS18&$"%_GM,L"=M4%^/19ZM\#F*MV*K*-T%M)PJ4B:3I3=SFG
M1Q^//E'.(9PEV:)^>.I#K:J>B.>"RZ9F.B?^J9]524!XTNC&Y-V:.#4"L>S,
ME%70*$CX2HUZL(P-<B>A5 ^93+,N9,<, VRUL2DJGCFE4, SP,)+L@GGDSH1
M4Q)>[Q>@'07P1W@A-C7M9I>^PH S>()41S3R\/=P&3/3,:@BXYDYV_FRBN55
MB_CC]\\OJQZ1^)Q+E+VQGK.#>8AZJ^)I9E(S6:*,@*X(1.EDX J>I\=4=^ =
M*S,'L!>OK9E8.1-[M++<I+Q7;>/57+TX)Y>$"_Q64"V@(6/,0G,V,, G> ]K
M-(8$JY2)+JTA[5I+')2UWTI&T>R$N6Z#OZ4,35 AT)23&[(Y):XRH?R<B6LU
MLKY<C"K Z30*Q4FZ80Y6;"W ;G1P'#1J?1*X9$M4G#0RSB;OK.YGY;-51X]*
M%VBX +:A='6 *V@(M2;R"7?:LM3IDMR;0MQS2,5ZL82IYH5U!<.\K_HKBY /
MDT(Y8:J$@1<"U+64M]_$TL'#QCO'=?TUE0" D5)90)%MN3LGH*_2%RMI!?3*
MU0T,'VB @I,I&[O2$^W0;U31-5T*18*:BMQ>F33V2P<.'LRQ!UU'4!]RS!-U
M'_.0?NK"1>R5,N^S9M=D!AB-JE,.EIO4$I2>3&A5ME4K8BT2?%1C,LH0UJ2I
M;RY]0N;<.C;4Z\&C=KTZ# K/+''[CP-BO3\X%^7?X%=&)S[17&L*@M>H;]@[
MC7E?;;ZYF!N'CIO]X%W&Q2OW#J[URNY>=-H[.SG:[W@2GO7ZX6"_Q>@'K-EN
M@I;?4?QLZBGX)#U]N$ZNJ"E%Y&T^W+Q^=W"#;%<FM):PWOFB\^U/ M^QD8^D
M)NZ@L8U"M?Y3]GQ(J.=5+_*G2[\7]H[[IVTWV@O[O=.3J,OSMJS8W;ID\_JM
MR;?8X4L7_:-@KW&$./+M'Z4I/MI=D]U7<09)V)854Q1^2QFK)%@"9)-\KW$6
M5G85B'#+O0[Q@EYD1+/ /P*)'P%_36FJ[(<F8T.PMB7WAKW^Z7&'OL7>H'=V
M!EQ\#0U*;IJ0 !JMM2@3H&^9F0&O]TU2@ZC?NG<<7-6'"[[T3;;%ZS"*VLM[
M810%;[A2YB(DSHL.]XMZT<G)5M3YF=-Y;M'P%/,VVV'OJ-]>/#@]"9I',%0W
MO5P=)+9>/^X=#4ZWLG!351^K(K-Q^O71T?1+Q]$K&:?K7*9%9 ![GYQU4>\=
M1^%^0-5A5]QU>,Z#,5R#\WJ1D=]W3$CUE7;5:63@,RD5(@\'V"<&5<TEB7[)
M:GO\(*9>QG$Q*WRQW9ZA4<- 1E#C,9Q()5WJ&PQ[-&5H/QB>XL$PX/]10&HH
M')W:54< ;1':-,*387 S!4H]\@4A01=B>(OO AF&':'7CXZ#%^B2L@G!0-N3
MSMI1$P["-<4D"BTF'=MT[1NU-PW/:#DB%:V47%(%VB5:^][PI(SREA0=F^#>
MRN3W1,I1OS<X&[1NGQSU!H/^A]<EY%0O2^NA#7W8L];L[L<Q';$7];LJ5L3D
M$#&\)EZZVKP=])UD/)$.?82G9UWZ"(=GG9C4HNM)=&SHB>P'KSJ'J9]2L_RW
MIN.$X%_GX7_./+SWGQB(]VBKZZ\3\0<FXM=?[D3\^NM$_.M$_"\P$6^#UJHI
M"%:@\R$C\6V3Z<\^$@_^_)%X<,](7'S@2-RMNJ\O:# >/#08%U\'XU_F8)R'
M*I]K-O[')^,=E=9'#,>#M>'L__YP/"C#]_]H./YES\97H]BOL_&_Q&S\$LZ5
MBC#JW6>1AP?CLME5D!N4#-7#;0J2SSG=#CJGV^'!T?IT&W?6!O8KUCYY7K\:
MB8L_.A*G.7CPT7/PAU/J0=?7$X>-3W5F"KF6OF "4%#>]E_MU'?KCZ0N^=N@
MP]7K_@NKGY"JZ= @56,L[1^<'.\(Z[]:\A>YF?.'/R.3YV;&/Z=* K/H!3P?
M&V24\H(VJ#\=N_@W4$L#!!0    ( )>%^E0@NU#-& ,  " )   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;.U634_;0!"]\RM&1J*MA.+8"11!$@E"
M47N@0J 6554/F_4XWK(?[NZ:P+_O[#JX"0H1AQYZZ"7V[LY[,_-F,^/1PM@[
M5R%Z>%!2NW%2>5\?IZGC%2KF>J9&32>EL8IY6MIYZFJ+K(@@)=.\WS],%1,Z
MF8SBWI6=C$SCI=!X9<$U2C'[>(;2+,9)ECQM7(MYY<-&.AG5;(XWZ+_45Y96
M:<=2"(7:":/!8CE.3K/CZ3#81X.O A=NY1U")C-C[L+B4S%.^B$@E,A]8&#T
MN,<I2AF(*(Q?2\ZD<QF J^]/[!<Q=\IEQAQ.C;P5A:_&R5$"!9:LD?[:+#[B
M,I^#P,>-=/$7%JWM09X ;YPW:@FF")30[9,]+'58 1SU7P#D2T#^6L!@"1C$
M1-O(8EKGS+/)R)H%V&!-;.$E:A/1E(W0H8HWWM*I()R?3(WV0L]1<X$.WEY\
M>S=*/?&&TY0O.<Y:COP%C@%<$DOEX(,NL-B GV['9_D6@I02ZK+*G[(ZR[<R
M7C+;@T&V#WD_SS<%M!U^CKR#9UO"&70B#R+?X$61E1*>[KYWP'0!ZZ*?"\>E
M<8U%^'XZ<][2U?ZQJ0JMD^%F)^'O?NQJQG&<T/_9H;W'9+*WFQWV3S8I\)?(
MUO08=GH,M[&O7[I-F6Z'?S8>(<M@;_<HS[*39W*NKRZL4>"I[X W\;D/OD(R
M4C73CR <]:_93^HIX5SBG$FHK>&(!7'$:NUPR81R^X""D!:8(SD\%F L-/II
M%6B9!V:%0Q Z.C&62*@U C>-I6U3PJQQE(QS/;BMA,36K/'<J'A,O3GXA=8E
M<*:U\3!#BHD"XL'K@J( 3CZI0_O']6P*0QFW""GP'MN8GOD(AL_\+(244#$"
ML!WJC&@%R<"*>PQ18UD&>8Q>=?7&04FYD<9DR0VQQ:9,DM!\L2P4@'J\HU[J
M>IMNWVL*/'BAP/]+^H^5M.T!Z<H04FCG<3:[()3V[3SJ=KOQ?QJG7OK'O/UV
MH/8]%]I1\4J"]GOO#Q*P[3QN%][4<:3-C*<!&5\K^H1!&PSHO#1T@Y:+X*#[
M*)K\!E!+ P04    " "7A?I4,OQ90^T4  "540  &0   'AL+W=O<FMS:&5E
M=',O<VAE970R-RYX;6SM7&ESY#:2_<Y?@=#,SK1C5+JZ??81H:.][K7[&,G'
M1&SL!Q2)JD*+)&B"5'7YU\]["8#%*E7+/;NVP^M1A*.E8A% WODRD=:3I6NO
M_<*83KVKRMH_W5MT7?/%X:'/%Z;2_L UIL8W,]=6NL/'=G[HF];H0A95Y>')
MT=$GAY6V]=ZS)_+L3?OLB>N[TM;F3:M\7U6Z79V9TBV?[AWOI0>7=K[H^.#P
MV9-&S\V5Z;YKWK3X=#CL4MC*U-ZZ6K5F]G3O]/B+\T=\7U[XWIJE'_VNR,G4
MN6M^>%$\W3LB0:8T><<=-'[<F'-3EMP(9/P8]]P;CN3"\>]I]R^%=_ RU=Z<
MN_('6W2+IWN?[:G"S'1?=I=N^96)_'S,_7)7>OE7+>.[1WLJ[WWGJK@8%%2V
M#C_UNRB'#UEP$A><?.B"AW'!0V$T4"9L7>A./WO2NJ5J^39VXR\B&UD-;FQ-
M+5YU+;ZU6-<]^W9AU%GO\=1[]>#OQQ\].>RP+;\\S.,69V&+D_=L\5"]='6W
M\.IY79ABQ_KSN]<?G]RQP2'X&9@Z24R=G=RYXTO='JB'Q_OJY.CD9!=!=R^_
M,/FP_/@.<AX.,GXH^SU\SWZOV[FN[4^:=KNOSEWM76D+'<RX+M2;UGA3=^&!
MFZDO;:WKW.I27>&A@<]T7OWWZ=1W+:S^?W9I*!#P:#<!C 1?^$;GYNE>P[/:
M&[/W["]_.O[DZ/$NZ?Q"FVW(ZM$@JT=W[;YAC[L8O7OU*]<9=:S^\J?/3HZ/
M'ZL-XWY] U(95\YUJ8O6]EZ=6>=S:^K<^'WUHH;6'W#IR='CI=F7W[!)?-+[
M[2>N;[<?#5NGYZY5W<)DZ6M7-;I>Q2\_4M8KK7(P87-=3GR'L*FFUC4+C0"5
MF[[C<Y6'50A.!3YWIE"=XZYX<(,HW- ^:#8=HG@7C(56U>+;UF,]OO+\'0NL
M-PAY_D D$ZDA%7$G6\_5<J$[I?&RK3M#?^1I4Z-FMO7=Q-:3O-20)LYO=2,D
M>HFCA8+QDJH<U,-,36N]?.EF6:V[OM5EN5(NS_NVY3GG%P\?_4WEB-^!7"RU
MK=)36]INQ3.QNNI+\"N[SF%'W8*\U%!A9?/6W6B?\X6^-0?J!;CN3+ZH7>GF
MPM.8_I+\4[K8RIMX*IZ;6D_+<,#4%:N_>A5)A?0:#7HJ; G?]957M*.Y8M[D
MH7!5/*KMC[V1C72^P,M44)G96A2%5S8$C=U+Y%DH96$;$*LKM="4?8Z'E!,T
M74IZNS'9;3-H6E?T>;>A=?.N@9QIP& 7MG2C\0GBHS6L%:1H-7.'KWP0U-QA
M/RL2B+N)"F!HE6D9>.Q/)IU'5=,BBJ*E%]FJ<6VG<79?5P 9D6=HQ10C0]!J
MVCI=R+9BAIV%G+ETAMCGA%E\QR@8S3$;.<?QIX^]HJ&0Q\3W^GWPFI=]8;X(
M?O7)X^P?KW]X=0HG//[TT>/AX5>O7SV_N+SU^/R;LZN3(T1W:MWWT[>0..G1
ML+B^H)MY.Z^#W<#233!VY?6,DB5#9C8#S[F(>6W&4>)XA5X].",M1C7@GXZ9
M+2V,.%^T#BZOKFU1FU7R2IA<.7CWJC'J!-_HJ2'##\)OM]=@[QA;+KZ^2''E
M8.#U=:U.F]:6ZN23D P#U\GSR<PYG(3R'[PY1,)]\' !@I8,!;EKH;J0GU*$
MY+ITX#X<"0X/VN%TD!I.G;=&$E=(<*6N,PCKI6GGII5'E\:-LJ)Z0++BSO&M
M88OU*4W?^IZVAT.6"YLO0&7EX)6.L@<LZD %&. !2;,Q5M("_4P'[ BI+36\
MK(V. @9A6\&GO1&504TVQ+-M<BB9Y0*>NIJX)>T$)WD+!;7!((;LLK1EF55<
MK43MI$KD0]'MAV<B?=\C,=TPNHCIW+'Y6'FW1;86U!;SD$KET_IM?H*T.I=?
MX]R"ZFD:!M<R+0#JJ'V0W('ZKN8K?&S>,32".3&,%!CWR0-"OJT8&6#/"/IZ
MUL4UX>Q@A%R QT$"Z^.])!\&MCPZ P01:'IGJ[#AQT?_D8A#88*\">U!>AX!
MT_AL0PF0%BP$0 H'I#RCMD/-YO$BJ3']\"#F<3<6WP<1F;V72/5>(D/*@+A[
M:  YTX5,(M;$/#Q2K2[>HD 0'0Z!%Z $L9C1TB_P%(Z'W(#X+8I$^261MW22
MRY(XX$-]@!"TJY&ZA</:1W*-V"_USIB()W\^^?@(&[C><Z?=AQRH*V-4P&4G
MH!]5HT3$R@G$"&5HJ CGNA4)C:4L.":&Q35=3&-2SR(@7H9$_8"!6+$<5-\.
M,."CD'[7(7K)?&M][FXD6HF[01LH^9(]%::T4P1#T(L(V^:+C-3JL#S7C> %
M(JJ(3A+!XZP,J@^Q*$((O#PMG6,>1#8I0?LIDX7UOI=4-J /Q:*[T^$)%L[Z
M.FAANN)>I<YY6, N9$!$#4G43,X2O9*-RD:F%MVG7?9'Y\!J8%I><-V(IVEO
M2VH@(\3:H#FZL*W?]NT*#(QE2A +JZ@+!N'2!J0R-[7M((.8&&$;A#IB;+L0
MWO:!:FT7T:R(X(:(=!O^O7(Q!P"_(;"'<T>:)M+A00%PP=E82XE5+4"_UY7)
M1!!"VS9J S\-<16#<&!H#30#*M1]QX_P!/5 9S';#^&%L6$'!/YH P.3LO+]
MV'Z$YG8 H@W,$I%: OL1V@T)+M<]8\64(%E\2 _>I -Q2%T+4T=\U#2EI![W
M;@6EBLR"IG#4PNBR6ZRB,6._#"=WK96@*!X 0DU!>;:NGR^" 105"AZ1?ZQW
M1V+8'T5%;\RU8%0P7+E8!VSYV<A0WE,:I"C7&G)<YZW@IL#"C-$H"AS 5@O=
M",]Z Y$R:ED<FY"PJOMJ&K##3K'V3)'EBG9A4Y0*GD.5T>=P%F@4ZPMRL8#9
M8R0Y*F0$ZG*O:=^IVG6JM)6-2>>LES#YUT'9$-\W+_#/RXL @@ *#]08'#-:
M /Q^&N&'Z,-[R^R4FX""_WQ\\#FD6)84ZKPEW)I! ?+N*Q$U7/P%',AV?1=2
MPU=B!^K!*=!BH5X%\5P^>O35-\<//_[LL\\_VH2=4']GQ9+(-Z-%BUJ(<7:#
MU,T?FVA^RT-!9>$J5"W 56QP3DK Y7*?266PM FT.+<,=0'G Z1L[;GY(]8)
M0M>W YH'MQ<)BW\=L/A%Q.)OR @\C_$GPO29MB5MD#'2>Y<'K@,:[. HR7#9
M(Q##S6V;Q_(R!;NPU0&[1)/4*Q 6;$@?6Q5!0)EB;94KC$26&[,=]+3459T9
M\# 3#&*V7XPBCKI%4LB5<NQ@PXG5F&<.U-FH&\ 29<H>4:B8-^P@8\B3?FZP
MY@K;4=IB1$%&ZLV"/!U/-]6*D]UL@O_@?[EID"%:YAT#T-J'E)R45SC2<H/(
MAHS8Z@DJ2L*J%MF,=O@V"$ 8BL#*AZ/%<[YE<J"<'!NS^'V,^&(1JKQ]MU[+
MY.TZ7:[=2_HFJENZ;'C)FQ][2-E*.@@4AE &M+<T$M-802[=9(D0F"K/D1P5
MJWZ'N'I> J.(ZR+N2!1#[&G8]H 2V0]65V'Q2R?YF*(Y<Y1O*N,NKEZ>#?TH
M)DM$W81I@I\(\.R8$' J0D^L"48.P0>U><>ZJ5_7NC'$@,F4$#UB7^BAC!@=
MU=7C)(<:&[(BU.#=Q 0(FB<59$D(DD0584F$"%#$I&(C.1XPZ1MHWMM0@H..
M@31N>PV;S>&!E&0M;\"88#L]Z-I*OLF8$@1GU!K!F)%K*9W=9B*XFRRN]#67
M2TL/(42@2D2 ,VO*0L++UQ=K\>XK>V!0C&\Y&0.;J4T;6\J:AI>:@Z,T5ZAY
MZ5!DP7T!)VV9<BY)A0P(#6I ?Z1H;)CCN'*U&:D%M)$64XR,.8HQ4IX:*K>]
M,MB/:%8C3W5^9#:40&FZ)'MJ9\.1BKY-9@B(!H/]L1>OI838R #Y$?3"V5[W
MW:2T.>^6L.9UPSY3SR03T$_VQC:&K6*$:EJXG<7VW%86"2TK0F=IP_4!RL+J
MH>?-UM6HW9.Q1]0-/2G/'"V .N8U4'"#+""/R*G;H-4R^$I%[0;[B_!_B/4C
M:]Q&IJE'5KIZ/F&5KX(= CC,7-Y+Y<;RX(;W"3RN2YU;*W FH(^QN0]Q"W%>
M*EG$G;>A)\F,Z:8L4+A5I=MKU)E O@O$E9]B1U3:8^P%2:DRZB=&2S564+H&
MP=*\DN,::+:6QDT >S>VV(@P3=B;7Z9 XGNXEAPBV*2T,S,!.[340%UL2ZX!
MVF;/>Q/2P2,1W)?0ZJ1!U<KW)<8#SL9>*%)E"MB5T3QBUI>*^<8,WA8R!U-C
M%S#_N&YHD@G:63S.]SD+:>YCMW6T ^('F&K;$&D)]\6,Z\V&,' ;$#C(]QN%
MX:97S_I6M,"JH0U;%]$Q5N'X1"PT/MY]: F/Z!*\(9FQ#/E%$XW-8Y$LQHA(
M."[>R6XD(:%.T0*[TIM:DO"#D%GOI^894IO?]!4G;^S'^V <:1IYPS('DJ'H
MG[$H#Y<IM'X)._F/O0T*CR]DR1BE1R^!V_4EC7H16BDUT\.DM?Y:1)4\<$-,
M*58<J*L^7R0*<MDHA$*UOB-@5EPYUFCL?Z32I5T#NF"9_+DVB]3/E]82W64K
M*@4Y#HJ 57N!OEMZ""$KT_58$ONJBFVZ:;H[@]2FMHX^;.L8P,2#0]F]4]/[
MTD_"\=*KC?S'=DO,>BP<DQ%X V&&H"V"#^^/+)UH"7@Z5H+K1AKU8-[QNHG]
MM5$O3Z3 _G4HNVIIZ/=B=9D<(=5_,-T!<Z]905%CVM!0"-W<$?'K,G4(=]+;
MC2;&U"8=MLU^FEP'XEQ/L]B0E)VE=49ZPU1X(3A3^(RM60DX@'VN1=Z[L:WT
M#FL:0!MM"4Y_@50N%1B2\N?L5M>.O1/R9>M0M:Z7/[@ZO;R:G+OO)R>HTD11
MF92RV/GU]R\N)MR";3,4"##K 'VEHH @9SJ7GK\Z1]C3$G%>LF?&#'T48LX/
MKH428X$XO@CGO1?,/ (+F/$40?1:X%8\-UX\:D1] %K4(OM#QW+)79'_#.(
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MV..].JGM:XUZF@)83V?@P\Y!#!I_-C6LA]CA#;=>LEU;2"@+90\^][4$ 6
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M #>A8!$;V;R6*.+TOF^X&;PR#6&/";T?4/LW'E#['<RG!7MO(M-3AIPAA(:
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MX OXG@.LZ0,/&/X2X[-_ E!+ P04    " "7A?I4#N#N/C<.  !T+   &0
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M!]NZC8T#RC0BEP+"J1WMP6Y4=^U+8OZ(S0%6C>3XH)/6I-:%RPOZ =C-?\'
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MYC\)S)2C WA.4G<?B$'_HO'S?P-02P,$%     @ EX7Z5"Y4"0Y"!0  )AD
M !D   !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL[5EM;]LV$/[N7T&H19<
M:JPW2W9>#"3NRP8T0]:TW8=A'VCY;!.51)>DDGJ_?D?)4=Q0DJ,D0S9@7VSI
M>/?PCKP[/J:/K[GX*I< BGQ/DTR>6$NE5H?]OHR7D%)YP%>0X<B<BY0J?!6+
MOEP)H+/"*$WZGN.$_92RS!H?%[(+,3[FN4I8!A>"R#Q-J5B?0<*O3RS7NA%\
M9(NETH+^^'A%%W )ZO/J0N!;OT*9L10RR7A&!,Q/K%/W<!)H_4+A"X-KN?5,
M="13SK_JEU]F)Y:C'8($8J41*'Y=P0221 .A&]\VF%8UI3;<?KY!?U?$CK%,
MJ80)3WYG,[4\L886F<&<YHGZR*]_ADT\ XT7\T06G^2ZU TBB\2Y5#S=&*,'
M*<O*;_I]LPY;!D.GP<#;&'CW-? W!GX1:.E9$=8;JNCX6/!K(K0VHNF'8FT*
M:XR&97H7+Y7 489V:GQZ15E"IPF\QHQX?4GQX1+B7##%0)*]W]S]X[[">;1V
M/]Y@GI687@.F3\YYII:2O,UF,*NQG[3;NUX+0!\#K*+T;J(\\UH1SZDX(+YK
M$\_QO#J'VLW?0%R9NRWN^-6B^P6>WX@W5>1VF6WRXRY(W 7RQ^E4*H%9_F?=
M!I3X03V^KOQ#N:(QG%A8VA+$%5CC5R_<T#FJ"_Z)P'Y8BJ!:BJ -O3W_ZB)O
MA_N5*R ^>?5BZ+GN$6G/[D]+('.>8"-CV8(HK4>8)/2FI1$^)]3<&5DA] 3$
M7&"*$I:1F,HEH=FL?(!O.;M"[4Q)P@56K/@*Y0RWYMJ*YX),>"9YPF94(=(9
M36@6 [G4)8T5B#IJR7.)R'+_L*<C<_PCLOGN86;'RRJUR=UAS%Q(IR"J[#4
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M5Q J4#2 &UWCN(EM('&[V +;-IN@VX?%/M#2V")"D2I)Q?%^?8?495U8]KI
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MI"]WXO"2 WCOJ!),K/5.I?^^66JC4,[_#-6[@4N'X>P5O](5S6#FXQW6H)[
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MQ4FZ80Y6;"W ;G1X$C1J?1*X9$M4G#0RSB;OK.[GY;-51X]*%VBX +:A='6
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MO_?^( ';SN-VX4T=1]K,>!J0\;6B3QBTP8#.2T,W:+D(#KJ/HLEO4$L#!!0
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M #L0%9K<NJB++K)ABZ22 G([&9P-"@2I&];'R<79Y#=(,H;IC$=0. E=.F(
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M[2U +E%J>8K26G:\&UFV:D)77LT!7PA%"5ODEAR08H4U5=B3 ZB!NZ%\R(:
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MM%%4R5@#%9%T\A*EP4 UU#(>]>!8CJ*N8*G&#"%TO155*UQPL),6BNPW' W
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MW/]*Q,\ ,LH-2K7"U-/Y8\0]ZW]XP7]HS)9_NP!U>&,J_I,P7%D:@.?$=?Q
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M/3_SB*K'9[TPLG03:"D-SC/WFN,_#E#6 ?=7$C5L%C9 ^Q]F\AM02P,$%
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M>(1@4>6 5RZ,S-V,M)0&)R[WF>!,#,H>P/VUE&:WL KJ*7O^#U!+ P04
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M=V]R:W-H965T<R]S:&5E=#0Y+GAM;,58;4_C.!#^GE]A=6$%$K1)VJ8M"Y6
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M0<*6%RVWM1ZXC^<+J0:ZX_.<SF$"\DM^Q_&M6Z-$<0J9B%E&.,PN6I?NV=5
MK=<+OL:P%!O/1'DR9>R[>OD07;0<91 D$$J%0/'O!UQ#DB@@-..?"K-5JU2"
MF\]K]/?:=_1E2@5<L^3/.)*+B]:P12*8T2*1]VSY.U3^]!5>R!*A?\FR7!N,
M6B0LA&1I)8P6I'%6_M/':A\V!(;.#@&O$O"TW:4B;>4-E71\SMF2<+4:T=2#
M=E5+HW%QIH(RD1QG8Y23XP]9R%(@#_01!&F__]8A[0<Z34!TSKL2\=6J;EAA
M7958W@XLUR,?6287@KS+(HBV ;IH6&V=M[;NRMN+> /A*?%=FWB.Y^[!\VMO
M?8WG'_26W,0B3)@H.)"_+J="<LR/OTT^EX@],Z*JF3.1TQ N6E@4 O@/:(U?
MOW(#Y^T>>WNUO;U]Z.,)UF!4)$#8C-QQ]B/6M8"E2+;B=H5I&1&<N65"D!EG
M*?F< Z<J[X7)I_U:'Q9 \EI;>PH9S&+9T7KC4J_4>F.A*T*K3M:J+5:K)E-
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MS]\?F-P1A_^[ZWO((*C)(#B:#.X!R3:,DUASM!IY-YN!;HX.<L-^+3]S;D2
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M:/T)Z[+\<O.TO/S^]9'R>8QWY@1F*.J<#O BQLMO2N6+9+G^CC-E4K)4/RZ
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MUN!XA&!1Y8!7+HS,W8RTE 8G+O>9X$P,RA[ _;649K>P"NHI>_8/4$L#!!0
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M"UZ[S7\>70C)(9'_,NUQ ^&;(51Q[XL%2>EA'ZI74'Y)^Z/GS]S0>6GR[X'
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MK@1@?<J87 W4#=;'X:-_ %!+ P04    " "7A?I4#(,U*F@%  "M%   &0
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M*^#W*>=J\Z(7*&\HQW\!4$L#!!0    ( )>%^E10M_T>DP(  #<(   9
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M:HTME, "EZFXI9OWT @*%%],4U[]HDT=._(M%)=<T*P!RQ5D)*__\4-CQ Y
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M@F95<P4X :8"Y/B"4O'84?<,[454^ =02P,$%     @ EX7Z5$]'ICQC @
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M=K IQ0,]_(:Z@&:*+Z,EUT]PZ&P]!V0-%[3JP'($%2;M&[YTB1@ )(\9$'2
MX!00G0&$'2 \!<1G %$'B"[U,.L .G2WC5TG+H$"KI>,'@!3UI)-?>CL:[3,
M%R9JHFP%DW^QQ(GU1\HYN$<,; O($'CS_J^WX$V"!,0E?PO> :ZZ^?&%"?BC
MH V').=+5TC_BL7-.E]WK:_@C*\0?*)$%!RD)$>Y 9],X_U@@L"5@??1!\?H
M[X))QD^078'0_P4$7A 8!K2Y'.Z;XIF&)RB;A*>7P[V)9(3]5 @U7W2&;RMH
M]@1^K]4"-JH["5<5[8;7,$,K1Y8LCM@S<M8__^3'WJ^FS-HD2VR2I9;(1AI$
MO0:19@_/:'!+!,YQV:CJ";8H:Q@66"Z\]"4K&SGGP8[1"FQH53<"ZDI+=R"%
MC&"R'Z[COS]*8O!!H(K_8Y(RLBFE3;+$)EEJB6PDY:R7<C:YG)24[WHM^:N6
M:*1E-M:R5/6XECKJBFN2KO4::Z]J&_"\#N)(KO_GH21?&_FZP@V-$@.3'YX8
MI5\;7<=1;S/*3-QG)I[,S!?(&"3"6&,FD=\Z,6V2)3;)4DMDH_3/^_3/?X@:
M,[<II4VRQ"99:HEL).6BEW+Q76K,PE099O.3(G.157*156JPBL.%N<Y<]]FY
MGLS. ^*"X4S(-+1[F\\$FZO.),^W3E6;9(E-LM02V4@,WWL]:7@_1-WIAF%)
M3:MLB56VU!;;6-#!T='_+M6G<SO:O43QZ1;'8#6_7IP4'X-1[$4GM<=@% YV
M5&UVW,$9NT)LKR\WN RN(:(]8_6]_07*K;XV..F_\V\VOJ$_41<N^DS_2M_>
MULACYAX3#DJTDZZ\J[G<D['V J1M"%KK$_XC%8)6^K- ,$=,&<C_.TK%L:$<
M]-=0Z_\!4$L#!!0    ( )>%^E1E"VPR@0,  /<2   9    >&PO=V]R:W-H
M965T<R]S:&5E=#8V+GAM;+58VV[;.!3\%4);+!*@&XF2+;M9VT 3(FB!+1 D
M;1=]9.1CFX@D>DG:;O]^24F1K9JAXI1]B769&6E&Y.$))SLN'N4*0*'O15[*
M:;!2:GT9AC);04'E!5]#J>\LN"BHTJ=B&<JU #JO2$4>QE&4A@5E93";5-=N
MQ6S"-RIG)=P*)#=%0<6/*\CY;AK@X.G"'5NNE+D0SB9KNH1[4%_6MT*?A:W*
MG!502L9+)& Q#=[C2X)30Z@07QGLY,$Q,E8>.'\T)Q_GTR R;P0Y9,I(4/VS
MA6O(<Z.DW^._1C1HGVF(A\=/ZC>5>6WF@4JXYOF_;*Y6TV <H#DLZ"97=WSW
M 1I#0Z.7\5Q6?]&NQH[2 &4;J7C1D/4;%*RL?^GW)H@# AX\0X@;0OQ20M(0
MDI<2!@UA4"536ZER(%31V43P'1(&K=7,015FQ=;V66F^^[T2^B[3/#6[H4R@
MKS3? /H$5&X$Z(^J)#J[^7:.S@@HRG)YCOY"=Y!MA&#E4A]_N2?H[,TY>H-8
MB3ZO^$;2<BXGH=(O9&3#K'GX5?WP^)F'?Z+B B7X+8JC.+;0K]UT EE+QQ8Z
M>3D]ZM)#G6(;9=Q&&5=ZR3-Z[Z4$)2]M,=3$@9UHIO:E7-,,IH&>NQ+$%H+9
MGW_@-/K;%HI/,>))K!-8T@:6N-3-YW_4 ^PA!R3-Z&**@=3#BV[UH*LNZ[J&
M),W!EFFM/:RT377;SD;#T4@/H^UA6!94E,1)%T6.47@<I;A%=>P-6GL#I[UZ
M/+Q%"S/%MM44FS.9Y=S,,INC6B[M<61!61P=HQR.AJVCH=/1/["%'-FFVI63
M>.H(]RE&/(EU DO;P-+7EH349V ^Q8@GL4Y@HS:PT6\L":.C01_]-'EZ$<2%
MZ%@:MY;&?LO N-=%+X*X$!T7[UH7[UXP]6V+])63>.I(]BE&/(EU L/1OK.*
M7COY&Z:GS+RJ$5]JW=0.^E'\&RM (]ZWAMI@ED74 G.LHGC?*&)G6W5Z26CT
M>FU98#9;QS"7K7T[A]W]7%TC$JL!)_/D >]3C?A2ZZ:V[Q+QX-5EPME@GIR:
M3S7B2ZV;VKX3Q>Y6]!?+Q+!WC>V'$">DZVO?,&)G>_6*TI >_>]R9*470IR0
MVDIXL,E@MH3T%UBR4J(<%IH378PT6=2[+/6)XNMJW^&!*\6+ZG %= [" /3]
M!>?JZ<1L9;1[7;/_ 5!+ P04    " "7A?I4AG-T1\,"  "<"   &0   'AL
M+W=O<FMS:&5E=',O<VAE970V-RYX;6RM5FM/VS 4_2M6AB:0@+Q#86DD:(4V
M:=,0'9NF:1_<Y+:Q<.S,=EOX][.3-$K;$('$E\2/>X[//;FV$V^X>)0Y@$)/
M!65R;.5*E5>V+=,<"BS/>0E,SRRX*+#27;&T92D 9Q6HH+;G.)%=8,*L)*[&
M[D02\Y6BA,&=0')5%%@\WP#EF['E6MN!>[+,E1FPD[C$2YB!>BCOA.[9+4M&
M"F"2<(8$+,;6M7LUC4Q\%?"3P$9VVLAD,N?\T72^9&/+,8* 0JH, ]:O-4R
M4D.D9?QK.*UV20/LMK?LMU7N.I<YEC#A]!?)5#ZV1A;*8(%75-WSS6=H\@D-
M7\JIK)YH4\=&CH72E52\:,!:04%8_<9/C0\=@!N\ / :@/=:@-\ _-<"@@80
M5,[4J50^3+'"22SX!@D3K=E,HS*S0NOT"3.??::$GB4:IY+K-!4KR-!7@N>$
M$D5 HN/;WR?H> H*$RI/T!EZF$W1\=$).D*$H1\Y7TG,,AG;2@LP-';:+'93
M+^:]L-@W+,Z1[YXBS_&\'OAD&#Z%M(6[/?#IZ^'.+MS6KK76>:UU7L7GO\&Z
M/]=SJ80NYK]][M1\03^?V>!7LL0IC"V]@R6(-5C)QP]NY'SJ\^H]R:;O1+;C
MH]_ZZ ^Q)S-,L=#FG2(H2LJ? = <&"R(DDC7F3Y<*%;:9X6?H+?H!NG?:FM-
M%E9DYLQ<)Y[C![&][MIU&.1>N%$;M&-#T-H0#-KPO02!%6%+1$$?9(AVRNI,
M'P5" %-]Z0<]BL-=P9,Z)NK&>)=[21W&^!=.?TYAFU,XG)/*0?1I#@\TCR[W
M3)Z$AWJ\:$_S84S@O* Y:C5'@YJWV[KC?U\&@R1O+;KH\!.&H_WOTQ,4C/:+
MSNY<!>;>UD?NDC"I:VJA8<[YA<:+^BZL.XJ7U>TPYTK?-54SU[\/($R GE]P
MKK8=<^&T/R3)?U!+ P04    " "7A?I4!JY<SY "  #D!@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970V."YX;6RM56UKVS 0_BN'!Z.%+7YKTJY+#&U*66'K
M2LM6QM@'Q3['HK;D27+2_ON=9-<DG1,ZV!=;.MWSW#UWUGFZENI!%X@&'JM2
MZ)E7&%.?^KY."ZR8'LD:!9WD4E7,T%8M?5TK9)D#5:4?!<'$KQ@77C)UMAN5
M3&5C2B[P1H%NJHJIIW,LY7KFA=ZSX98O"V,-?C*MV1+OT'RK;Q3M_)XEXQ4*
MS:4 A?G,.PM/YV/K[QR^<USKC358)0LI'^SF*IMY@4T(2TR-96#T6N$<R](2
M41J_.TZO#VF!F^MG]DNGG;0LF,:Y+.]Y9HJ9=^)!ACEK2G,KUY^PT^,23&6I
MW1/6K>]QX$'::".K#DP95%RT;_;8U6$#$(UW *(.$+T A,<[ '$'B)W0-C,G
MZX(9EDR57(.RWL1F%ZXV#DUJN+!=O#.*3CGA3/*U1L4,%TOXC%0-#>_AFBEK
M6B$<7/XXA(,+-(R7^I".9)[S%*>^H<@6[Z==E/,V2K0CRA>F1A"'[R *HF@
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M4C72P'6 >CYG3+X-=.M5M>;17U!+ P04    " "7A?I4S[CY$08'  !30@
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M@MCW^L-01QZ5VC]-:JC_!:51*(VA:*;4M?_E66V4P@7UR+'K8GMLV\L?*"V
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M%K/H,=J>HXZ2^2N11.LAJ&;6FA3)_ME)*-'F!ZHYJ.:BFH=J/JH%E":'LBF
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M#]5\5 LH34Y24] 8J@L:[SSP7NNO''A7WX?.F4([&*AFHYJ#:BZJ>:CFHUI
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M$1N1-2[$E06A.>+BE"Y-MJ88)953GIFV9?EFCM+"F$VJL0<ZFY -S]("/U#
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MD[PZ7&&48%H:B.L+0OC'23E!NW$Y^P]02P,$%     @ EX7Z5+CK(V-L P
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MYM;$(C&LZ2Z3U^SP'BJ#1HHO8IG0O^10R3H6B79"LKP"HP9Y6I1/>E<YX@B
M/-T KP)X;<#P$<"@ @S: /\1P+ "#)^ZPZ@":-/MTG;MN(!*NIAQ=B!<22.;
M&FCO:S3Z*RU4HMQ(CF]3Q,G%34(YO%JBJV.R8CGFGZ Z@J_(HZ_".S4&<O;V
M^SDY"T#2-!/GB/AR$Y"SY^?D.4D+\CEA.T&+6,QLB8JJ[>RH4FI9*N4]HM2
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M%B3+BF+8 RU=6T(D4B-I.]ZO'TG)M!7+:@,(RXLM2O<>W7/(0_-ZO&'\220
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M:H7V;:']UD(_/A=J(U=%;LQ&"_$%60-7/QRH )ZR6.\>6R!<(+8X)H(D0W-
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M2.Y%KM>*?,L32-H /JJI)87ODN9A+^(=Q)=D0+^2, BI@]#B>/>@A\Z@CO#
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M_+ QVU.SVZC9?:N:-O6Z_R[>._>Z^RZ.+5877B_<MXHM5K9X+6:V>-V=\E
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MGZL ^7U)J=B]J KJ^Z+Q_U!+ P04    " "7A?I4,YR> <,#  #,#0  &0
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M(%ES0?.Z6(X@3XO=._Y>-V*O 'H'"E!=@$XM<.L"]]0"KRZH6FWOI%1]B+'
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M!'8G@JZJ+?(G*@3-J\,EP7/"2H#\?D&I>#TI=]V;OV6F_P%02P,$%     @
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M?CSM%_%$%I]D5<5:!HERJ7A:B3&#E&7E-WVI.&P(;/> P*D$SGL%O4K0>Z_
MK01N0:;<2L$AI(H&0\%71.AH=-.# F:AQNVS3/_L8R5PE:%.!9=+RA(Z2> 4
MC]#IF.)@#%$NF&(@R2G97R<;ZY,UN>:9$OCKY30AMU3IE34Y_FV?D.,0%(KE
M"=H\CD-R?'1"C@C+R$/,<TFSJ1R:"K>@$S&C*MVK,EWG0+JW5)R1GOV%.);C
M-,BOV^4A1+7<;I"'[Y=;VW(3N=?PG1J^4_CU#L%/N5#L'TR1HE1--$J]VZS7
M5\*%7- (1@;6O 2Q!"/X_,GVK:]-;+HT"SLRV^+6J[GUVMR#7R E43'-",^
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M1TP%R/<[2L6QH1+T%U/K_P%02P,$%     @ EX7Z5)SD/OZM P  2Q0  !D
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MQ?/R< TD V$ ^OZ2<_5\8K:'FOW#V3]02P,$%     @ EX7Z5'XCK@3) @
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MAE!9!SK/I31/&SOI^A];\@=02P,$%     @ EX7Z5#31 #HW P  DPT  !D
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MYAL4@GS-%[%$F%^T*6(="T4K(5E:@-4,4D+S?_Q8&+$%\'H' %X!\%X+:!>
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M<R95?Y7?KE7+#%P'J.=+QN3K0#=951,>_ 502P,$%     @ EX7Z5/9>E3F
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M<8<=%T@):X;W8O#E+<NX9#L>Y\!.\-+/U9IE(*L;XW3((R/^6(\JV+R$%6/
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M#;+8 7_?"+2C7BF^IVJ^T%O\ U!+ P04    " "7A?I4]@99>70#  ";&
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MKWI[@-Y>]?8 O;WJ[0%Z>]7; _0.JG< Z!U4[P#0.ZC> :!W4+T#0.^@>@>
MWJ'ZLQ*@=U"] T#OH'H'@-Y!]0X O8/J'0!Z1]4[ O2.JG<$Z!U5[PC0.ZK>
M$:!W5+TC0.^H>D> WK':; +0.ZK>$:!W5+TC0.^H>D> WDGU3@"]D^J= 'HG
MU3L!]$ZJ=P+HG53O!- [J=X)H'=2O1- [U1M%@3HG53O!- [J=X)H'=6O3-
M[ZQZ9X#>6?7. +VSZIT!>F?5.P/TSJIW!NB=5>\,T#NKWAF@=ZXV>P/TSJIW
M!NA=5.\"T+NHW@6@=U&]"T#OHGH7@-Y%]2X O8OJ70!Z%]6[ /0NJG<!Z%U4
M[P+0NU2'=0!ZFZX^K@/PVW35@9T.(+CIJB,[W7<:/DZ?^WZ\%7VMJX#O%'NZ
M?+:_??]U^76QOC=7I-O[C/'I+U!+ P04    " "7A?I4T37\65\"  #7.0
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M4$L! A0#%     @ EX7Z5 =!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "7A?I4B J3Q.X    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" "7A?I4F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( )>%^E0 <GABR@(  !T(   8
M      " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" "7A?I4A,>$-;4'  ! +0  &               @($-"P  >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ EX7Z5%6S50_' P  5!$  !@
M             ("!^!(  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( )>%^E1 _7Q<Z 0  &(3   8              " @?46  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "7A?I4]+*LR5D#  !H
M"@  &               @($3'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ EX7Z5&O8V]*^"P  #WD  !@              ("!HA\
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( )>%^E37@NB"
M @8  !L9   8              " @98K  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    " "7A?I4+69YZZ\'   =+0  &
M@('.,0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ EX7Z
M5.JR"TZE P  H@X  !@              ("!LSD  'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( )>%^E1.;KX3DP4  -D9   9
M      " @8X]  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ EX7Z5+O:H&U? P   PL  !D              ("!6$,  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "7A?I4=124Y;8+   )>0
M&0              @('N1@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( )>%^E3,7!CXJ 8  *P?   9              " @=M2  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ EX7Z5/KD+0?M
M%   E5$  !D              ("!NED  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    " "7A?I4*T03_C8.  !T+   &0
M@('>;@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( )>%
M^E2@_![<4 4  "H9   9              " @4M]  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ EX7Z5$/P>EP@ P  AP<  !D
M         ("!TH(  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    " "7A?I4JSM#=Y(#  !_"@  &0              @($IA@  >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( )>%^E0O\X(3F04  (D8
M   9              " @?*)  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ EX7Z5&$*5HT6 P  /0D  !D              ("!PH\
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "7A?I4T^5N
MJN8%  !K%@  &0              @($/DP  >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( )>%^E2H0NZ;TA4  )AG   9
M  " @2R9  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
MEX7Z5-L6'MM%!@  +AD  !D              ("!-:\  'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    " "7A?I40353+\L$  #%"@  &0
M            @(&QM0  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( )>%^E2;N+MT_PP  $8V   9              " @;.Z  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ EX7Z5""[4,T8 P
M( D  !D              ("!Z<<  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    " "7A?I4,OQ90^T4  "540  &0              @($X
MRP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( )>%^E0.
MX.X^-PX  '0L   9              " @5S@  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ EX7Z5"Y4"0Y"!0  )AD  !D
M     ("!RNX  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M" "7A?I4H\XH*I #  "1"@  &0              @(%#]   >&PO=V]R:W-H
M965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( )>%^E1;=(GSF04  (D8   9
M              " @0KX  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L!
M A0#%     @ EX7Z5/6CQ%H6 P  /0D  !D              ("!VOT  'AL
M+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " "7A?I4JKPXTN8%
M  !K%@  &0              @($G 0$ >&PO=V]R:W-H965T<R]S:&5E=#,S
M+GAM;%!+ 0(4 Q0    ( )>%^E0__9O9TA4  )AG   9              "
M@40' 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ EX7Z
M5+M.UO5$!@  +AD  !D              ("!31T! 'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    " "7A?I4HALO^_\,  !&-@  &0
M        @('((P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( )>%^E3+]CT-%P,  " )   9              " @?XP 0!X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ EX7Z5%SE;  ?"0  IA@
M !D              ("!3#0! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    " "7A?I4,"!.>1D2   *0P  &0              @(&B/0$
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( )>%^E3(JFA<
MRPD  %XF   9              " @?)/ 0!X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ EX7Z5%4AF\T; P  SP<  !D
M ("!]%D! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " "7
MA?I48A(>J(<%  "@&@  &0              @(%&70$ >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( )>%^E3X5YDT"@,  ,4'   9
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M970T-RYX;6Q02P$"% ,4    " "7A?I4;)%(U@0&  #8'@  &0
M    @('-= $ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M )>%^E1$1=R)3P4  '84   9              " @0A[ 0!X;"]W;W)K<VAE
M971S+W-H965T-#DN>&UL4$L! A0#%     @ EX7Z5 N0JJ6V!0  Y!,  !D
M             ("!CH ! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"
M% ,4    " "7A?I4FLLGUXD%  ".&@  &0              @(%[A@$ >&PO
M=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( )>%^E08+)"G%P,
M -P(   9              " @3N, 0!X;"]W;W)K<VAE971S+W-H965T-3(N
M>&UL4$L! A0#%     @ EX7Z5$V0!$U^ P  !@X  !D              ("!
MB8\! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "7A?I4
MG8_(%Q4#   ,"0  &0              @($^DP$ >&PO=V]R:W-H965T<R]S
M:&5E=#4T+GAM;%!+ 0(4 Q0    ( )>%^E2=3P-[!@0  '$/   9
M      " @8J6 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%
M  @ EX7Z5,VQRP,&!@  &A\  !D              ("!QYH! 'AL+W=O<FMS
M:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "7A?I4#(,U*F@%  "M%
M&0              @($$H0$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+
M 0(4 Q0    ( )>%^E10M_T>DP(  #<(   9              " @:.F 0!X
M;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ EX7Z5 R$E^"K
M @  3PD  !D              ("!;:D! 'AL+W=O<FMS:&5E=',O<VAE970U
M.2YX;6Q02P$"% ,4    " "7A?I4','4&:@$  !Q&0  &0
M@(%/K $ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( )>%
M^E3JT.I-%@,  '4-   9              " @2ZQ 0!X;"]W;W)K<VAE971S
M+W-H965T-C$N>&UL4$L! A0#%     @ EX7Z5.T&H+P% P  IPL  !D
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M=#8V+GAM;%!+ 0(4 Q0    ( )>%^E2&<W1'PP(  )P(   9
M  " @9'% 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @
MEX7Z5 :N7,^0 @  Y 8  !D              ("!B\@! 'AL+W=O<FMS:&5E
M=',O<VAE970V."YX;6Q02P$"% ,4    " "7A?I4+-0;[ST#  "4#0  &0
M            @(%2RP$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4
M Q0    ( )>%^E0K"!@J%0,  *8+   9              " @<;. 0!X;"]W
M;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ EX7Z5,^X^1$&!P
M4T(  !D              ("!$M(! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX
M;6Q02P$"% ,4    " "7A?I4%C:(Y'$-   <LP  &0              @(%/
MV0$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( )>%^E2Q
M<^OT@@@  #8]   9              " @??F 0!X;"]W;W)K<VAE971S+W-H
M965T-S,N>&UL4$L! A0#%     @ EX7Z5,*9MJ6C!   Q!P  !D
M     ("!L.\! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )>%^E2E5[_2G00  "X?   9              "
M@2L# @!X;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ EX7Z
M5+1.2"[E @  3 D  !D              ("!_P<" 'AL+W=O<FMS:&5E=',O
M<VAE970X,"YX;6Q02P$"% ,4    " "7A?I4@ZJ@&<H#  "\%   &0
M        @($;"P( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0
M   ( )>%^E1<!)]*300  #L2   9              " @1P/ @!X;"]W;W)K
M<VAE971S+W-H965T.#(N>&UL4$L! A0#%     @ EX7Z5#.<G@'# P  S T
M !D              ("!H!," 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q0
M2P$"% ,4    " "7A?I4];>'GCL%   %(@  &0              @(&:%P(
M>&PO=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( )>%^E02%)#\
MF@,  ,@0   9              " @0P= @!X;"]W;W)K<VAE971S+W-H965T
M.#4N>&UL4$L! A0#%     @ EX7Z5"GJ^KVZ!   HAD  !D
M ("!W2 " 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4    " "7
MA?I4)-7'1ZX"   #"   &0              @('.)0( >&PO=V]R:W-H965T
M<R]S:&5E=#@W+GAM;%!+ 0(4 Q0    ( )>%^E3NSMHP_@(  %8+   9
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M970Y,BYX;6Q02P$"% ,4    " "7A?I4--$ .C<#  "3#0  &0
M    @(%L.0( >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    (
M )>%^E3;6^G@$@,  ) +   9              " @=H\ @!X;"]W;W)K<VAE
M971S+W-H965T.30N>&UL4$L! A0#%     @ EX7Z5/9>E3F !0  1B$  !D
M             ("!(T " 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q02P$"
M% ,4    " "7A?I4Y+.:$TX(  !S/   &0              @(':10( >&PO
M=V]R:W-H965T<R]S:&5E=#DV+GAM;%!+ 0(4 Q0    ( )>%^E0Y;%"^T@0
M #4=   9              " @5]. @!X;"]W;W)K<VAE971S+W-H965T.3<N
M>&UL4$L! A0#%     @ EX7Z5)?DPE6, P  T1   !D              ("!
M:%," 'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6Q02P$"% ,4    " "7A?I4
MN4RZ[+ #   ;$   &0              @($K5P( >&PO=V]R:W-H965T<R]S
M:&5E=#DY+GAM;%!+ 0(4 Q0    ( )>%^E2?51Q +@,  ) )   :
M      " @1); @!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0
M   ( )>%^E2]+A#PT@0  #0@   :              " @7A> @!X;"]W;W)K
M<VAE971S+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( )>%^E2Q(O HL04  *TG
M   :              " @8)C @!X;"]W;W)K<VAE971S+W-H965T,3 R+GAM
M;%!+ 0(4 Q0    ( )>%^E3V!EEY= ,  )L8   -              "  6MI
M @!X;"]S='EL97,N>&UL4$L! A0#%     @ EX7Z5)>*NQS     $P(   L
M             ( !"FT" %]R96QS+RYR96QS4$L! A0#%     @ EX7Z5&L\
M->69!@  34,   \              ( !\VT" 'AL+W=O<FMB;V]K+GAM;%!+
M 0(4 Q0    ( )>%^E3M2,2UY (  /$[   :              "  ;ET @!X
M;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( )>%^E31-?Q9
M7P(  -<Y   3              "  =5W @!;0V]N=&5N=%]4>7!E<UTN>&UL
64$L%!@    !N &X /!X  &5Z @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>208</ContextCount>
  <ElementCount>322</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>57</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>010000 - Statement - Consolidated Balance Sheets (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedBalanceSheetsFy</Role>
      <ShortName>Consolidated Balance Sheets (FY)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>010100 - Statement - Consolidated Balance Sheets (FY) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (FY) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>020000 - Statement - Consolidated Statements of Operations (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy</Role>
      <ShortName>Consolidated Statements of Operations (FY)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>030000 - Statement - Consolidated Statements of Comprehensive Loss (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (FY)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>040000 - Statement - Consolidated Statements of Equity (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedStatementsOfEquityFy</Role>
      <ShortName>Consolidated Statements of Equity (FY)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>050000 - Statement - Consolidated Statements of Cash Flows (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy</Role>
      <ShortName>Consolidated Statements of Cash Flows (FY)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>060000 - Statement - Consolidated Balance Sheets (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedBalanceSheetsQ1</Role>
      <ShortName>Consolidated Balance Sheets (Q1)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>060100 - Statement - Consolidated Balance Sheets (Q1) (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Q1) (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>070000 - Statement - Consolidated Statements of Operations (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1</Role>
      <ShortName>Consolidated Statements of Operations (Q1)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>080000 - Statement - Consolidated Statements of Comprehensive Loss (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Q1)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>090000 - Statement - Consolidated Statements of Equity (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1</Role>
      <ShortName>Consolidated Statements of Equity (Q1)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100000 - Statement - Consolidated Statements of Cash Flows (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1</Role>
      <ShortName>Consolidated Statements of Cash Flows (Q1)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>110100 - Disclosure - The Business (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/BusinessFy</Role>
      <ShortName>The Business (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>110200 - Disclosure - Summary of Significant Accounting Policies (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy</Role>
      <ShortName>Summary of Significant Accounting Policies (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>110300 - Disclosure - Available-for-Sale-Securities (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesFy</Role>
      <ShortName>Available-for-Sale-Securities (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>110400 - Disclosure - Property and Equipment (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/PropertyAndEquipmentFy</Role>
      <ShortName>Property and Equipment (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>110500 - Disclosure - Loss Per Share (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/LossPerShareFy</Role>
      <ShortName>Loss Per Share (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>110600 - Disclosure - Fair Value Measurements (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/FairValueMeasurementsFy</Role>
      <ShortName>Fair Value Measurements (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>110700 - Disclosure - Accrued Liabilities (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AccruedLiabilitiesFy</Role>
      <ShortName>Accrued Liabilities (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>110800 - Disclosure - Operating Leases (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesFy</Role>
      <ShortName>Operating Leases (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>110900 - Disclosure - Stockholders' Equity (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityFy</Role>
      <ShortName>Stockholders' Equity (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>111000 - Disclosure - Share-Based Compensation (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationFy</Role>
      <ShortName>Share-Based Compensation (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>111100 - Disclosure - Research Funding (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ResearchFundingFy</Role>
      <ShortName>Research Funding (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>111200 - Disclosure - Income Taxes (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesFy</Role>
      <ShortName>Income Taxes (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>111300 - Disclosure - Contingencies (FY)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ContingenciesFy</Role>
      <ShortName>Contingencies (FY)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>111400 - Disclosure - The Business (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/BusinessQ1</Role>
      <ShortName>The Business (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>111500 - Disclosure - Summary of Significant Accounting Policies (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1</Role>
      <ShortName>Summary of Significant Accounting Policies (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>111600 - Disclosure - Available-for-Sale-Securities (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesQ1</Role>
      <ShortName>Available-for-Sale-Securities (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>111700 - Disclosure - Income (Loss) Per Share (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeLossPerShareQ1</Role>
      <ShortName>Income (Loss) Per Share (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>111800 - Disclosure - Fair Value Measurements (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/FairValueMeasurementsQ1</Role>
      <ShortName>Fair Value Measurements (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>111900 - Disclosure - Accrued Liabilities (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AccruedLiabilitiesQ1</Role>
      <ShortName>Accrued Liabilities (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>112000 - Disclosure - Operating Leases (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesQ1</Role>
      <ShortName>Operating Leases (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>112100 - Disclosure - Stockholders' Equity (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityQ1</Role>
      <ShortName>Stockholders' Equity (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>112200 - Disclosure - Share-Based Compensation (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationQ1</Role>
      <ShortName>Share-Based Compensation (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>112300 - Disclosure - Income Taxes (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesQ1</Role>
      <ShortName>Income Taxes (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>112400 - Disclosure - Contingencies (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ContingenciesQ1</Role>
      <ShortName>Contingencies (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>112500 - Disclosure - Subsequent Events (Q1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SubsequentEventsQ1</Role>
      <ShortName>Subsequent Events (Q1)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>120200 - Disclosure - Summary of Significant Accounting Policies (FY) (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (FY) (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>121500 - Disclosure - Summary of Significant Accounting Policies (Q1) (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies</Role>
      <ShortName>Summary of Significant Accounting Policies (Q1) (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>130200 - Disclosure - Summary of Significant Accounting Policies (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables</Role>
      <ShortName>Summary of Significant Accounting Policies (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>130300 - Disclosure - Available-for-Sale-Securities (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesFyTables</Role>
      <ShortName>Available-for-Sale-Securities (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/AvailableforsalesecuritiesFy</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>130400 - Disclosure - Property and Equipment (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/PropertyAndEquipmentFyTables</Role>
      <ShortName>Property and Equipment (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/PropertyAndEquipmentFy</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>130500 - Disclosure - Loss Per Share (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/LossPerShareFyTables</Role>
      <ShortName>Loss Per Share (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/LossPerShareFy</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>130600 - Disclosure - Fair Value Measurements (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/FairValueMeasurementsFyTables</Role>
      <ShortName>Fair Value Measurements (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/FairValueMeasurementsFy</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>130700 - Disclosure - Accrued Liabilities (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AccruedLiabilitiesFyTables</Role>
      <ShortName>Accrued Liabilities (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/AccruedLiabilitiesFy</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>130800 - Disclosure - Operating Leases (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesFyTables</Role>
      <ShortName>Operating Leases (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/OperatingLeasesFy</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>130900 - Disclosure - Stockholders' Equity (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityFyTables</Role>
      <ShortName>Stockholders' Equity (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/StockholdersEquityFy</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>131000 - Disclosure - Share-Based Compensation (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationFyTables</Role>
      <ShortName>Share-Based Compensation (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/SharebasedCompensationFy</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>131200 - Disclosure - Income Taxes (FY) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesFyTables</Role>
      <ShortName>Income Taxes (FY) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/IncomeTaxesFy</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>131600 - Disclosure - Available-for-Sale-Securities (Q1) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables</Role>
      <ShortName>Available-for-Sale-Securities (Q1) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/AvailableforsalesecuritiesFy</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>131700 - Disclosure - Income (Loss) Per Share (Q1) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeLossPerShareQ1Tables</Role>
      <ShortName>Income (Loss) Per Share (Q1) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/IncomeTaxesFy</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>131800 - Disclosure - Fair Value Measurements (Q1) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/FairValueMeasurementsQ1Tables</Role>
      <ShortName>Fair Value Measurements (Q1) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/FairValueMeasurementsFy</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>131900 - Disclosure - Accrued Liabilities (Q1) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AccruedLiabilitiesQ1Tables</Role>
      <ShortName>Accrued Liabilities (Q1) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/AccruedLiabilitiesFy</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>132000 - Disclosure - Operating Leases (Q1) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesQ1Tables</Role>
      <ShortName>Operating Leases (Q1) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/OperatingLeasesFy</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>132100 - Disclosure - Stockholders' Equity (Q1) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityQ1Tables</Role>
      <ShortName>Stockholders' Equity (Q1) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/StockholdersEquityFy</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>132200 - Disclosure - Share-Based Compensation (Q1) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationQ1Tables</Role>
      <ShortName>Share-Based Compensation (Q1) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://caladrius.com/role/SharebasedCompensationFy</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>140100 - Disclosure - The Business (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/BusinessFyDetails</Role>
      <ShortName>The Business (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/BusinessFy</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>140200 - Disclosure - Summary of Significant Accounting Policies (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>140300 - Disclosure - Available-for-Sale-Securities - Summary (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails</Role>
      <ShortName>Available-for-Sale-Securities - Summary (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>140302 - Disclosure - Available-for-Sale-Securities - Classification on Consolidated Balance Sheets (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails</Role>
      <ShortName>Available-for-Sale-Securities - Classification on Consolidated Balance Sheets (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>140304 - Disclosure - Available-for-Sale-Securities - Contractual Maturities (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails</Role>
      <ShortName>Available-for-Sale-Securities - Contractual Maturities (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>140400 - Disclosure - Property and Equipment - Summary (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails</Role>
      <ShortName>Property and Equipment - Summary (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>140402 - Disclosure - Property and Equipment - Narrative (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/PropertyAndEquipmentNarrativeFyDetails</Role>
      <ShortName>Property and Equipment - Narrative (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>140500 - Disclosure - Loss Per Share (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/LossPerShareFyDetails</Role>
      <ShortName>Loss Per Share (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/LossPerShareFyTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>140600 - Disclosure - Fair Value Measurements (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/FairValueMeasurementsFyDetails</Role>
      <ShortName>Fair Value Measurements (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/FairValueMeasurementsFyTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>140700 - Disclosure - Accrued Liabilities (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AccruedLiabilitiesFyDetails</Role>
      <ShortName>Accrued Liabilities (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/AccruedLiabilitiesFyTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>140800 - Disclosure - Operating Leases - Narrative (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesNarrativeFyDetails</Role>
      <ShortName>Operating Leases - Narrative (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>140802 - Disclosure - Operating Leases - Balance Sheet Presentation (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails</Role>
      <ShortName>Operating Leases - Balance Sheet Presentation (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>140804 - Disclosure - Operating Leases - Future Minimum Lease Payments Under Lease Agreements (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails</Role>
      <ShortName>Operating Leases - Future Minimum Lease Payments Under Lease Agreements (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>140900 - Disclosure - Stockholders' Equity - Equity Plan (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails</Role>
      <ShortName>Stockholders' Equity - Equity Plan (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>140902 - Disclosure - Stockholders' Equity - Equity Issuances (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails</Role>
      <ShortName>Stockholders' Equity - Equity Issuances (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>140904 - Disclosure - Stockholders' Equity - Stock Options and Warrants (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails</Role>
      <ShortName>Stockholders' Equity - Stock Options and Warrants (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>140906 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails</Role>
      <ShortName>Stockholders' Equity - Restricted Stock and Restricted Stock Units (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>141000 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails</Role>
      <ShortName>Share-Based Compensation - Share-Based Compensation Expense (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>141002 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails</Role>
      <ShortName>Share-Based Compensation - Compensation Cost Not Yet Recognized (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>141004 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails</Role>
      <ShortName>Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>141006 - Disclosure - Share-Based Compensation - Valuation Assumptions (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails</Role>
      <ShortName>Share-Based Compensation - Valuation Assumptions (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>141100 - Disclosure - Research Funding (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/ResearchFundingFyDetails</Role>
      <ShortName>Research Funding (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/ResearchFundingFy</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>141200 - Disclosure - Income Taxes - Loss from Operations Before Provision for Income Taxes (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails</Role>
      <ShortName>Income Taxes - Loss from Operations Before Provision for Income Taxes (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>141202 - Disclosure - Income Taxes - Components of Benefit from Income Taxes (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails</Role>
      <ShortName>Income Taxes - Components of Benefit from Income Taxes (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>141204 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails</Role>
      <ShortName>Income Taxes - Effective Income Tax Reconciliation (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>141206 - Disclosure - Income Taxes - Components of Deferred Income Taxes (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails</Role>
      <ShortName>Income Taxes - Components of Deferred Income Taxes (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>141208 - Disclosure - Income Taxes - Narrative (FY) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesNarrativeFyDetails</Role>
      <ShortName>Income Taxes - Narrative (FY) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>141400 - Disclosure - The Business (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/BusinessQ1Details</Role>
      <ShortName>The Business (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/BusinessFy</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>141600 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details</Role>
      <ShortName>Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>141602 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details</Role>
      <ShortName>Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>141604 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details</Role>
      <ShortName>Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>141700 - Disclosure - Income (Loss) Per Share (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeLossPerShareQ1Details</Role>
      <ShortName>Income (Loss) Per Share (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/IncomeTaxesFyTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>141800 - Disclosure - Fair Value Measurements (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/FairValueMeasurementsQ1Details</Role>
      <ShortName>Fair Value Measurements (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/FairValueMeasurementsFyTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>141900 - Disclosure - Accrued Liabilities (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/AccruedLiabilitiesQ1Details</Role>
      <ShortName>Accrued Liabilities (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/AccruedLiabilitiesFyTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>142000 - Disclosure - Operating Leases - Narrative (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesNarrativeQ1Details</Role>
      <ShortName>Operating Leases - Narrative (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>142002 - Disclosure - Operating Leases - Balance Sheet Presentation (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details</Role>
      <ShortName>Operating Leases - Balance Sheet Presentation (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>142004 - Disclosure - Operating Leases - Future Minimum Lease Payments (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details</Role>
      <ShortName>Operating Leases - Future Minimum Lease Payments (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>142100 - Disclosure - Stockholders' Equity - Equity Issuances (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details</Role>
      <ShortName>Stockholders' Equity - Equity Issuances (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>142102 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details</Role>
      <ShortName>Stockholders' Equity - Stock Options and Warrants (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>142104 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details</Role>
      <ShortName>Stockholders' Equity - Restricted Stock and Restricted Stock Units (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>142200 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details</Role>
      <ShortName>Share-Based Compensation - Share-Based Compensation Expense (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>142202 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details</Role>
      <ShortName>Share-Based Compensation - Compensation Cost Not Yet Recognized (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>142204 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details</Role>
      <ShortName>Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>142300 - Disclosure - Income Taxes (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/IncomeTaxesQ1Details</Role>
      <ShortName>Income Taxes (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/IncomeTaxesFyTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="ny20004343x2_s4a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>142500 - Disclosure - Subsequent Events (Q1) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://caladrius.com/role/SubsequentEventsQ1Details</Role>
      <ShortName>Subsequent Events (Q1) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://caladrius.com/role/SubsequentEventsQ1</ParentRole>
      <Position>102</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-4/A" original="ny20004343x2_s4a.htm">ny20004343x2_s4a.htm</File>
    <File>clbs-20220726.xsd</File>
    <File>clbs-20220726_cal.xml</File>
    <File>clbs-20220726_def.xml</File>
    <File>clbs-20220726_lab.xml</File>
    <File>clbs-20220726_pre.xml</File>
    <File>ny20004343x2_ex23-1.htm</File>
    <File>ny20004343x2_ex23-2.htm</File>
    <File>ny20004343x2_ex99-1.htm</File>
    <File>ny20004343x2_ex99-8.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>logo_caladrius.jpg</File>
    <File>logo_caladriusx1.jpg</File>
    <File>logo_cend.jpg</File>
    <File>sig_backbay.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="967">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="7">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>126
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ny20004343x2_s4a.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "contextCount": 208,
   "dts": {
    "calculationLink": {
     "local": [
      "clbs-20220726_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "clbs-20220726_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ny20004343x2_s4a.htm"
     ]
    },
    "labelLink": {
     "local": [
      "clbs-20220726_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "clbs-20220726_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "clbs-20220726.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 510,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 15,
    "http://xbrl.sec.gov/dei/2021q4": 7,
    "total": 22
   },
   "keyCustom": 74,
   "keyStandard": 248,
   "memberCustom": 17,
   "memberStandard": 37,
   "nsprefix": "clbs",
   "nsuri": "http://caladrius.com/20220726",
   "report": {
    "R1": {
     "firstAnchor": null,
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://caladrius.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "070000 - Statement - Consolidated Statements of Operations (Q1)",
     "role": "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1",
     "shortName": "Consolidated Statements of Operations (Q1)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142204 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Q1) (Details)",
     "role": "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details",
     "shortName": "Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "clbs:OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142300 - Disclosure - Income Taxes (Q1) (Details)",
     "role": "http://caladrius.com/role/IncomeTaxesQ1Details",
     "shortName": "Income Taxes (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U003",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142500 - Disclosure - Subsequent Events (Q1) (Details)",
     "role": "http://caladrius.com/role/SubsequentEventsQ1Details",
     "shortName": "Subsequent Events (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220426_BusinessAcquisitionAxis_AgreementAndPlanOfMergerAndReorganizationMember_CounterpartyNameAxis_CendTherapeuticsIncMember_SubsequentEventTypeAxis_SubsequentEventMember",
      "decimals": "-5",
      "lang": null,
      "name": "clbs:MergerAgreementMinimumNetCashThreshold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "080000 - Statement - Consolidated Statements of Comprehensive Loss (Q1)",
     "role": "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1",
     "shortName": "Consolidated Statements of Comprehensive Loss (Q1)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20191231_StatementEquityComponentsAxis_PreferredStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "090000 - Statement - Consolidated Statements of Equity (Q1)",
     "role": "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1",
     "shortName": "Consolidated Statements of Equity (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100000 - Statement - Consolidated Statements of Cash Flows (Q1)",
     "role": "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1",
     "shortName": "Consolidated Statements of Cash Flows (Q1)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:BusinessTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110100 - Disclosure - The Business (FY)",
     "role": "http://caladrius.com/role/BusinessFy",
     "shortName": "The Business (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110200 - Disclosure - Summary of Significant Accounting Policies (FY)",
     "role": "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy",
     "shortName": "Summary of Significant Accounting Policies (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110300 - Disclosure - Available-for-Sale-Securities (FY)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesFy",
     "shortName": "Available-for-Sale-Securities (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110400 - Disclosure - Property and Equipment (FY)",
     "role": "http://caladrius.com/role/PropertyAndEquipmentFy",
     "shortName": "Property and Equipment (FY)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110500 - Disclosure - Loss Per Share (FY)",
     "role": "http://caladrius.com/role/LossPerShareFy",
     "shortName": "Loss Per Share (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110600 - Disclosure - Fair Value Measurements (FY)",
     "role": "http://caladrius.com/role/FairValueMeasurementsFy",
     "shortName": "Fair Value Measurements (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010000 - Statement - Consolidated Balance Sheets (FY)",
     "role": "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
     "shortName": "Consolidated Balance Sheets (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110700 - Disclosure - Accrued Liabilities (FY)",
     "role": "http://caladrius.com/role/AccruedLiabilitiesFy",
     "shortName": "Accrued Liabilities (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110800 - Disclosure - Operating Leases (FY)",
     "role": "http://caladrius.com/role/OperatingLeasesFy",
     "shortName": "Operating Leases (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "110900 - Disclosure - Stockholders' Equity (FY)",
     "role": "http://caladrius.com/role/StockholdersEquityFy",
     "shortName": "Stockholders' Equity (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111000 - Disclosure - Share-Based Compensation (FY)",
     "role": "http://caladrius.com/role/SharebasedCompensationFy",
     "shortName": "Share-Based Compensation (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111100 - Disclosure - Research Funding (FY)",
     "role": "http://caladrius.com/role/ResearchFundingFy",
     "shortName": "Research Funding (FY)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111200 - Disclosure - Income Taxes (FY)",
     "role": "http://caladrius.com/role/IncomeTaxesFy",
     "shortName": "Income Taxes (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111300 - Disclosure - Contingencies (FY)",
     "role": "http://caladrius.com/role/ContingenciesFy",
     "shortName": "Contingencies (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:BusinessTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111400 - Disclosure - The Business (Q1)",
     "role": "http://caladrius.com/role/BusinessQ1",
     "shortName": "The Business (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111500 - Disclosure - Summary of Significant Accounting Policies (Q1)",
     "role": "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1",
     "shortName": "Summary of Significant Accounting Policies (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111600 - Disclosure - Available-for-Sale-Securities (Q1)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesQ1",
     "shortName": "Available-for-Sale-Securities (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "010100 - Statement - Consolidated Balance Sheets (FY) (Parenthetical)",
     "role": "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
     "shortName": "Consolidated Balance Sheets (FY) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111700 - Disclosure - Income (Loss) Per Share (Q1)",
     "role": "http://caladrius.com/role/IncomeLossPerShareQ1",
     "shortName": "Income (Loss) Per Share (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111800 - Disclosure - Fair Value Measurements (Q1)",
     "role": "http://caladrius.com/role/FairValueMeasurementsQ1",
     "shortName": "Fair Value Measurements (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "111900 - Disclosure - Accrued Liabilities (Q1)",
     "role": "http://caladrius.com/role/AccruedLiabilitiesQ1",
     "shortName": "Accrued Liabilities (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "112000 - Disclosure - Operating Leases (Q1)",
     "role": "http://caladrius.com/role/OperatingLeasesQ1",
     "shortName": "Operating Leases (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "112100 - Disclosure - Stockholders' Equity (Q1)",
     "role": "http://caladrius.com/role/StockholdersEquityQ1",
     "shortName": "Stockholders' Equity (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "112200 - Disclosure - Share-Based Compensation (Q1)",
     "role": "http://caladrius.com/role/SharebasedCompensationQ1",
     "shortName": "Share-Based Compensation (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "112300 - Disclosure - Income Taxes (Q1)",
     "role": "http://caladrius.com/role/IncomeTaxesQ1",
     "shortName": "Income Taxes (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "112400 - Disclosure - Contingencies (Q1)",
     "role": "http://caladrius.com/role/ContingenciesQ1",
     "shortName": "Contingencies (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "112500 - Disclosure - Subsequent Events (Q1)",
     "role": "http://caladrius.com/role/SubsequentEventsQ1",
     "shortName": "Subsequent Events (Q1)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "120200 - Disclosure - Summary of Significant Accounting Policies (FY) (Policies)",
     "role": "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies",
     "shortName": "Summary of Significant Accounting Policies (FY) (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "020000 - Statement - Consolidated Statements of Operations (FY)",
     "role": "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
     "shortName": "Consolidated Statements of Operations (FY)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "121500 - Disclosure - Summary of Significant Accounting Policies (Q1) (Policies)",
     "role": "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies",
     "shortName": "Summary of Significant Accounting Policies (Q1) (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": null
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130200 - Disclosure - Summary of Significant Accounting Policies (FY) (Tables)",
     "role": "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables",
     "shortName": "Summary of Significant Accounting Policies (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130300 - Disclosure - Available-for-Sale-Securities (FY) (Tables)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesFyTables",
     "shortName": "Available-for-Sale-Securities (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130400 - Disclosure - Property and Equipment (FY) (Tables)",
     "role": "http://caladrius.com/role/PropertyAndEquipmentFyTables",
     "shortName": "Property and Equipment (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130500 - Disclosure - Loss Per Share (FY) (Tables)",
     "role": "http://caladrius.com/role/LossPerShareFyTables",
     "shortName": "Loss Per Share (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130600 - Disclosure - Fair Value Measurements (FY) (Tables)",
     "role": "http://caladrius.com/role/FairValueMeasurementsFyTables",
     "shortName": "Fair Value Measurements (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130700 - Disclosure - Accrued Liabilities (FY) (Tables)",
     "role": "http://caladrius.com/role/AccruedLiabilitiesFyTables",
     "shortName": "Accrued Liabilities (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130800 - Disclosure - Operating Leases (FY) (Tables)",
     "role": "http://caladrius.com/role/OperatingLeasesFyTables",
     "shortName": "Operating Leases (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "130900 - Disclosure - Stockholders' Equity (FY) (Tables)",
     "role": "http://caladrius.com/role/StockholdersEquityFyTables",
     "shortName": "Stockholders' Equity (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "131000 - Disclosure - Share-Based Compensation (FY) (Tables)",
     "role": "http://caladrius.com/role/SharebasedCompensationFyTables",
     "shortName": "Share-Based Compensation (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "030000 - Statement - Consolidated Statements of Comprehensive Loss (FY)",
     "role": "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy",
     "shortName": "Consolidated Statements of Comprehensive Loss (FY)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "131200 - Disclosure - Income Taxes (FY) (Tables)",
     "role": "http://caladrius.com/role/IncomeTaxesFyTables",
     "shortName": "Income Taxes (FY) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "131600 - Disclosure - Available-for-Sale-Securities (Q1) (Tables)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables",
     "shortName": "Available-for-Sale-Securities (Q1) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "131700 - Disclosure - Income (Loss) Per Share (Q1) (Tables)",
     "role": "http://caladrius.com/role/IncomeLossPerShareQ1Tables",
     "shortName": "Income (Loss) Per Share (Q1) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "131800 - Disclosure - Fair Value Measurements (Q1) (Tables)",
     "role": "http://caladrius.com/role/FairValueMeasurementsQ1Tables",
     "shortName": "Fair Value Measurements (Q1) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "131900 - Disclosure - Accrued Liabilities (Q1) (Tables)",
     "role": "http://caladrius.com/role/AccruedLiabilitiesQ1Tables",
     "shortName": "Accrued Liabilities (Q1) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "clbs:LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "132000 - Disclosure - Operating Leases (Q1) (Tables)",
     "role": "http://caladrius.com/role/OperatingLeasesQ1Tables",
     "shortName": "Operating Leases (Q1) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "132100 - Disclosure - Stockholders' Equity (Q1) (Tables)",
     "role": "http://caladrius.com/role/StockholdersEquityQ1Tables",
     "shortName": "Stockholders' Equity (Q1) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "132200 - Disclosure - Share-Based Compensation (Q1) (Tables)",
     "role": "http://caladrius.com/role/SharebasedCompensationQ1Tables",
     "shortName": "Share-Based Compensation (Q1) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20170228",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:GrantsReceivable",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140100 - Disclosure - The Business (FY) (Details)",
     "role": "http://caladrius.com/role/BusinessFyDetails",
     "shortName": "The Business (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140200 - Disclosure - Summary of Significant Accounting Policies (FY) (Details)",
     "role": "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails",
     "shortName": "Summary of Significant Accounting Policies (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231_PropertyPlantAndEquipmentByTypeAxis_FurnitureAndFixturesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20191231_StatementEquityComponentsAxis_PreferredStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "040000 - Statement - Consolidated Statements of Equity (FY)",
     "role": "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
     "shortName": "Consolidated Statements of Equity (FY)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140300 - Disclosure - Available-for-Sale-Securities - Summary (FY) (Details)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails",
     "shortName": "Available-for-Sale-Securities - Summary (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140302 - Disclosure - Available-for-Sale-Securities - Classification on Consolidated Balance Sheets (FY) (Details)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails",
     "shortName": "Available-for-Sale-Securities - Classification on Consolidated Balance Sheets (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231_BalanceSheetLocationAxis_CashAndCashEquivalentsMember",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140304 - Disclosure - Available-for-Sale-Securities - Contractual Maturities (FY) (Details)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails",
     "shortName": "Available-for-Sale-Securities - Contractual Maturities (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140400 - Disclosure - Property and Equipment - Summary (FY) (Details)",
     "role": "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails",
     "shortName": "Property and Equipment - Summary (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140402 - Disclosure - Property and Equipment - Narrative (FY) (Details)",
     "role": "http://caladrius.com/role/PropertyAndEquipmentNarrativeFyDetails",
     "shortName": "Property and Equipment - Narrative (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140500 - Disclosure - Loss Per Share (FY) (Details)",
     "role": "http://caladrius.com/role/LossPerShareFyDetails",
     "shortName": "Loss Per Share (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140600 - Disclosure - Fair Value Measurements (FY) (Details)",
     "role": "http://caladrius.com/role/FairValueMeasurementsFyDetails",
     "shortName": "Fair Value Measurements (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140700 - Disclosure - Accrued Liabilities (FY) (Details)",
     "role": "http://caladrius.com/role/AccruedLiabilitiesFyDetails",
     "shortName": "Accrued Liabilities (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "clbs:NumberOfOfficesUnderOperatingLeases",
      "reportCount": 1,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140800 - Disclosure - Operating Leases - Narrative (FY) (Details)",
     "role": "http://caladrius.com/role/OperatingLeasesNarrativeFyDetails",
     "shortName": "Operating Leases - Narrative (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140802 - Disclosure - Operating Leases - Balance Sheet Presentation (FY) (Details)",
     "role": "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
     "shortName": "Operating Leases - Balance Sheet Presentation (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "050000 - Statement - Consolidated Statements of Cash Flows (FY)",
     "role": "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
     "shortName": "Consolidated Statements of Cash Flows (FY)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140804 - Disclosure - Operating Leases - Future Minimum Lease Payments Under Lease Agreements (FY) (Details)",
     "role": "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails",
     "shortName": "Operating Leases - Future Minimum Lease Payments Under Lease Agreements (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140900 - Disclosure - Stockholders' Equity - Equity Plan (FY) (Details)",
     "role": "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails",
     "shortName": "Stockholders' Equity - Equity Plan (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210630_PlanNameAxis_EquityIncentiveCompensationPlan2018Member",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210201to20210228",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140902 - Disclosure - Stockholders' Equity - Equity Issuances (FY) (Details)",
     "role": "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
     "shortName": "Stockholders' Equity - Equity Issuances (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20210131",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140904 - Disclosure - Stockholders' Equity - Stock Options and Warrants (FY) (Details)",
     "role": "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
     "shortName": "Stockholders' Equity - Stock Options and Warrants (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "140906 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (FY) (Details)",
     "role": "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
     "shortName": "Stockholders' Equity - Restricted Stock and Restricted Stock Units (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141000 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (FY) (Details)",
     "role": "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails",
     "shortName": "Share-Based Compensation - Share-Based Compensation Expense (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141002 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (FY) (Details)",
     "role": "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
     "shortName": "Share-Based Compensation - Compensation Cost Not Yet Recognized (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141004 - Disclosure - Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (FY) (Details)",
     "role": "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails",
     "shortName": "Share-Based Compensation - Fair Value of Shares Vested and Weighted Average Estimated Fair Value of Shares Granted (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141006 - Disclosure - Share-Based Compensation - Valuation Assumptions (FY) (Details)",
     "role": "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
     "shortName": "Share-Based Compensation - Valuation Assumptions (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20170228",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:GrantsReceivable",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141100 - Disclosure - Research Funding (FY) (Details)",
     "role": "http://caladrius.com/role/ResearchFundingFyDetails",
     "shortName": "Research Funding (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20170228",
      "decimals": "-5",
      "lang": null,
      "name": "clbs:FundingAmountAwarded",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "060000 - Statement - Consolidated Balance Sheets (Q1)",
     "role": "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1",
     "shortName": "Consolidated Balance Sheets (Q1)",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141200 - Disclosure - Income Taxes - Loss from Operations Before Provision for Income Taxes (FY) (Details)",
     "role": "http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails",
     "shortName": "Income Taxes - Loss from Operations Before Provision for Income Taxes (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141202 - Disclosure - Income Taxes - Components of Benefit from Income Taxes (FY) (Details)",
     "role": "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails",
     "shortName": "Income Taxes - Components of Benefit from Income Taxes (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141204 - Disclosure - Income Taxes - Effective Income Tax Reconciliation (FY) (Details)",
     "role": "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails",
     "shortName": "Income Taxes - Effective Income Tax Reconciliation (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141206 - Disclosure - Income Taxes - Components of Deferred Income Taxes (FY) (Details)",
     "role": "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails",
     "shortName": "Income Taxes - Components of Deferred Income Taxes (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141208 - Disclosure - Income Taxes - Narrative (FY) (Details)",
     "role": "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
     "shortName": "Income Taxes - Narrative (FY) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20210101to20211231",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U005",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20170228",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:GrantsReceivable",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141400 - Disclosure - The Business (Q1) (Details)",
     "role": "http://caladrius.com/role/BusinessQ1Details",
     "shortName": "The Business (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141600 - Disclosure - Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Q1) (Details)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
     "shortName": "Available-for-Sale-Securities - Schedule of Available-for-Sale Securities Reconciliation (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141602 - Disclosure - Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Q1) (Details)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details",
     "shortName": "Available-for-Sale-Securities - Classification of Available-for-Sale Securities (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141604 - Disclosure - Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Q1) (Details)",
     "role": "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details",
     "shortName": "Available-for-Sale-Securities - Available-for-Sale Securities by Contractual Maturity (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141700 - Disclosure - Income (Loss) Per Share (Q1) (Details)",
     "role": "http://caladrius.com/role/IncomeLossPerShareQ1Details",
     "shortName": "Income (Loss) Per Share (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "060100 - Statement - Consolidated Balance Sheets (Q1) (Parentheticals)",
     "role": "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals",
     "shortName": "Consolidated Balance Sheets (Q1) (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331_FairValueByMeasurementFrequencyAxis_FairValueMeasurementsRecurringMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141800 - Disclosure - Fair Value Measurements (Q1) (Details)",
     "role": "http://caladrius.com/role/FairValueMeasurementsQ1Details",
     "shortName": "Fair Value Measurements (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "141900 - Disclosure - Accrued Liabilities (Q1) (Details)",
     "role": "http://caladrius.com/role/AccruedLiabilitiesQ1Details",
     "shortName": "Accrued Liabilities (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "clbs:NumberOfOfficesUnderOperatingLeases",
      "reportCount": 1,
      "unitRef": "U004",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142000 - Disclosure - Operating Leases - Narrative (Q1) (Details)",
     "role": "http://caladrius.com/role/OperatingLeasesNarrativeQ1Details",
     "shortName": "Operating Leases - Narrative (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142002 - Disclosure - Operating Leases - Balance Sheet Presentation (Q1) (Details)",
     "role": "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details",
     "shortName": "Operating Leases - Balance Sheet Presentation (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142004 - Disclosure - Operating Leases - Future Minimum Lease Payments (Q1) (Details)",
     "role": "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details",
     "shortName": "Operating Leases - Future Minimum Lease Payments (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U001",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20190331_SubsidiarySaleOfStockAxis_LincolnParkAgreementMember",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "clbs:SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142100 - Disclosure - Stockholders' Equity - Equity Issuances (Q1) (Details)",
     "role": "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details",
     "shortName": "Stockholders' Equity - Equity Issuances (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20211231",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142102 - Disclosure - Stockholders' Equity - Stock Options and Warrants (Q1) (Details)",
     "role": "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details",
     "shortName": "Stockholders' Equity - Stock Options and Warrants (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U002",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331_AwardTypeAxis_RestrictedStockMember",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
      "reportCount": 1,
      "unitRef": "U002",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142104 - Disclosure - Stockholders' Equity - Restricted Stock and Restricted Stock Units (Q1) (Details)",
     "role": "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details",
     "shortName": "Stockholders' Equity - Restricted Stock and Restricted Stock Units (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220101to20220331",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142200 - Disclosure - Share-Based Compensation - Share-Based Compensation Expense (Q1) (Details)",
     "role": "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details",
     "shortName": "Share-Based Compensation - Share-Based Compensation Expense (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20004343x2_s4a.htm",
      "contextRef": "c20220331_AwardTypeAxis_EmployeeStockOptionMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unitRef": "U001",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "142202 - Disclosure - Share-Based Compensation - Compensation Cost Not Yet Recognized (Q1) (Details)",
     "role": "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details",
     "shortName": "Share-Based Compensation - Compensation Cost Not Yet Recognized (Q1) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 57,
   "tag": {
    "clbs_AdditionalPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Purchase Agreement",
        "label": "Additional Purchase Agreement [Member]",
        "terseLabel": "Additional Purchase Agreement"
       }
      }
     },
     "localname": "AdditionalPurchaseAgreementMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_AggregateIntrinsicValueOptionExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Option Exercised",
        "label": "Aggregate Intrinsic Value, Option Exercised",
        "negatedTerseLabel": "Options exercised, aggregate intrinsic value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueOptionExercised",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsOutstanding": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants Outstanding",
        "label": "Aggregate Intrinsic Value, Warrants Outstanding",
        "terseLabel": "Warrants Outstanding, Aggregate Intrinsic Value",
        "verboseLabel": "Warrants outstanding, aggregate intrinsic value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsOutstanding",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants vested",
        "label": "Aggregate Intrinsic Value, Warrants vested",
        "terseLabel": "Warrants, Vested, Aggregate Intrinsic Value",
        "verboseLabel": "Warrants exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsvested",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AggregateIntrinsicValueWarrantsvestedandexpectedtovest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value, Warrants vested and expected to vest",
        "label": "Aggregate Intrinsic Value, Warrants vested and expected to vest",
        "terseLabel": "Warrants, Vested and expected to vest, Aggregate Intrinsic Value",
        "verboseLabel": "Warrants vested or expected to vest, aggregate intrinsic value"
       }
      }
     },
     "localname": "AggregateIntrinsicValueWarrantsvestedandexpectedtovest",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AgreementAndPlanOfMergerAndReorganizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement And Plan Of Merger And Reorganization",
        "label": "Agreement And Plan Of Merger And Reorganization [Member]",
        "terseLabel": "Merger Agreement"
       }
      }
     },
     "localname": "AgreementAndPlanOfMergerAndReorganizationMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Accrued Grant Funding Liability To Offset Expense",
        "label": "Amortization Of Accrued Grant Funding Liability To Offset Expense",
        "terseLabel": "Amortization of accrued grant funding to offset expense"
       }
      }
     },
     "localname": "AmortizationOfAccruedGrantFundingLiabilityToOffsetExpense",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/ResearchFundingFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_AtTheMarketOfferingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At The Market Offering Agreement",
        "label": "At The Market Offering Agreement [Member]",
        "terseLabel": "ATM Agreement"
       }
      }
     },
     "localname": "AtTheMarketOfferingAgreementMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_BusinessTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Business [Text Block]",
        "label": "The Business [Text Block]",
        "terseLabel": "The Business"
       }
      }
     },
     "localname": "BusinessTextBlock",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/BusinessFy",
      "http://caladrius.com/role/BusinessQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clbs_CLBS16TreatmentOfCMDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CLBS16 Treatment Of CMD",
        "label": "CLBS16 Treatment Of CMD [Member]",
        "terseLabel": "CLBS16 Treatment of CMD",
        "verboseLabel": "CLBS16 Treatment Of CMD"
       }
      }
     },
     "localname": "CLBS16TreatmentOfCMDMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/BusinessFyDetails",
      "http://caladrius.com/role/BusinessQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_CendSeriesDPreferredStockPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cend Series D Preferred Stock Purchase Agreement",
        "label": "Cend Series D Preferred Stock Purchase Agreement [Member]",
        "terseLabel": "Cend Purchase Agreement"
       }
      }
     },
     "localname": "CendSeriesDPreferredStockPurchaseAgreementMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_CendTherapeuticsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cend Therapeutics, Inc",
        "label": "Cend Therapeutics, Inc [Member]",
        "terseLabel": "Cend"
       }
      }
     },
     "localname": "CendTherapeuticsIncMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_CommonStockWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrants, Shares",
        "label": "Common Stock Warrants, Shares",
        "periodEndLabel": "Warrants outstanding, ending balance (in shares)",
        "periodStartLabel": "Warrants outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockWarrantsShares",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_DeferredTaxAssetsAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Accumulated Depreciation",
        "label": "Deferred Tax Assets, Accumulated Depreciation",
        "terseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "DeferredTaxAssetsAccumulatedDepreciation",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_DeferredTaxAssetsRightOfUseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Right Of Use Liability",
        "label": "Deferred Tax Assets, Right Of Use Liability",
        "terseLabel": "Right of use liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsRightOfUseLiability",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change in State Deferred, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Change in State Deferred, Amount",
        "terseLabel": "Change in state deferred"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeinStateDeferredAmount",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Sale Of State Net Operating Losses",
        "label": "Effective Income Tax Rate Reconciliation, Sale Of State Net Operating Losses",
        "terseLabel": "Sale of New Jersey State NOLs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationSaleOfStateNetOperatingLosses",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Section 382 NOL Limitation, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Section 382 NOL Limitation, Amount",
        "terseLabel": "Section 382 NOL Limitation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationSection382NOLLimitationAmount",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_EmployeeStockPurchasePlan2012Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan 2012 [Member]",
        "label": "Employee Stock Purchase Plan 2012 [Member]",
        "terseLabel": "2012 ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2012Member",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_EmployeeStockPurchasePlan2017AmendedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan 2017 Amended [Member]",
        "label": "Employee Stock Purchase Plan 2017 Amended [Member]",
        "terseLabel": "Amended 2017 ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2017AmendedMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_EmployeeStockPurchasePlan2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan 2017 [Member]",
        "label": "Employee Stock Purchase Plan 2017 [Member]",
        "terseLabel": "2017 ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2017Member",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee",
        "label": "Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee",
        "terseLabel": "Maximum annual contribution per employee"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployee",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee, Percent",
        "label": "Employee Stock Purchase Plan, Maximum Annual Contribution Per Employee, Percent",
        "terseLabel": "Maximum annual contribution per employee as percent of annual salary"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMaximumAnnualContributionPerEmployeePercent",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Member]",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Enrollment Date",
        "label": "Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Enrollment Date",
        "terseLabel": "Purchase price measurement as percent of closing price on enrollment date"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnEnrollmentDate",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Exercise Date",
        "label": "Employee Stock Purchase Plan, Purchase Price, Percent Of Closing Price On Exercise Date",
        "terseLabel": "Purchase price measurement as percent of closing price on exercise date"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanPurchasePricePercentOfClosingPriceOnExerciseDate",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_EquityIncentiveCompensationPlan2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Compensation Plan 2018 [Member]",
        "label": "Equity Incentive Compensation Plan 2018 [Member]",
        "terseLabel": "2018 Plan"
       }
      }
     },
     "localname": "EquityIncentiveCompensationPlan2018Member",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_FundingAmountAwarded": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funding Amount Awarded",
        "label": "Funding Amount Awarded",
        "terseLabel": "Total funding amount awarded"
       }
      }
     },
     "localname": "FundingAmountAwarded",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/ResearchFundingFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_FundingOfGrantAwardCashReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funding Of Grant Award, Cash Received",
        "label": "Funding Of Grant Award, Cash Received",
        "terseLabel": "Funding of grant award"
       }
      }
     },
     "localname": "FundingOfGrantAwardCashReceived",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/ResearchFundingFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_GrossProceedsOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross Proceeds On Transaction",
        "label": "Gross Proceeds On Transaction",
        "terseLabel": "Potential gross proceeds"
       }
      }
     },
     "localname": "GrossProceedsOnTransaction",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_H.C.WainwrightSalesAmendedAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "H.C. Wainwright Sales Amended Agreement [Member]",
        "label": "H.C. Wainwright Sales Amended Agreement [Member]",
        "terseLabel": "H.C. Wainwright Sales Amended Agreement"
       }
      }
     },
     "localname": "H.C.WainwrightSalesAmendedAgreementMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities",
        "label": "Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities",
        "terseLabel": "Accounts payable, accrued liabilities and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_InstitutionalPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Institutional Purchase Agreement",
        "label": "Institutional Purchase Agreement [Member]",
        "terseLabel": "Institutional Purchase Agreement"
       }
      }
     },
     "localname": "InstitutionalPurchaseAgreementMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_January2021PurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2021 Purchase Agreement",
        "label": "January 2021 Purchase Agreement [Member]",
        "terseLabel": "January 2021 Private Placement"
       }
      }
     },
     "localname": "January2021PurchaseAgreementMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]",
        "label": "Lessee, Operating Lease, Balance Sheet Presentation [Table Text Block]",
        "terseLabel": "Schedule of Operating Lease Liabilities and Right-of-Use Assets on Balance Sheet"
       }
      }
     },
     "localname": "LesseeOperatingLeaseBalanceSheetPresentationTableTextBlock",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFyTables",
      "http://caladrius.com/role/OperatingLeasesQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clbs_LincolnParkAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lincoln Park Agreement [Member]",
        "label": "Lincoln Park Agreement [Member]",
        "terseLabel": "Lincoln Park Agreement"
       }
      }
     },
     "localname": "LincolnParkAgreementMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_LossOnSaleOfNetOperatingLosses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss On Sale Of Net Operating Losses",
        "label": "Loss On Sale Of Net Operating Losses",
        "terseLabel": "Loss on sale of NOLs"
       }
      }
     },
     "localname": "LossOnSaleOfNetOperatingLosses",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_MarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities",
        "label": "Marketable Securities [Member]",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Agreement, Expected Ownership In Company, Company Stockholders, Percentage",
        "label": "Merger Agreement, Expected Ownership In Company, Company Stockholders, Percentage",
        "terseLabel": "Expected post-merger ownership in Company by Company stockholders (percent)"
       }
      }
     },
     "localname": "MergerAgreementExpectedOwnershipInCompanyCompanyStockholdersPercentage",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Agreement, Expected Ownership In Company, Counterparty Stockholders, Percentage",
        "label": "Merger Agreement, Expected Ownership In Company, Counterparty Stockholders, Percentage",
        "terseLabel": "Expected post-merger ownership in Company by Cend stockholders (percent)"
       }
      }
     },
     "localname": "MergerAgreementExpectedOwnershipInCompanyCounterpartyStockholdersPercentage",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_MergerAgreementMinimumNetCashThreshold": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Agreement, Minimum Net Cash Threshold",
        "label": "Merger Agreement, Minimum Net Cash Threshold",
        "terseLabel": "Minimum net cash threshold at closing per agreement"
       }
      }
     },
     "localname": "MergerAgreementMinimumNetCashThreshold",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_MergerAgreementPotentialExpenseReimbursement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Agreement, Potential Expense Reimbursement",
        "label": "Merger Agreement, Potential Expense Reimbursement",
        "terseLabel": "Potential expense reimbursement per agreement"
       }
      }
     },
     "localname": "MergerAgreementPotentialExpenseReimbursement",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_MergerAgreementPotentialTerminationFeePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Agreement, Potential Termination Fee Payable",
        "label": "Merger Agreement, Potential Termination Fee Payable",
        "terseLabel": "Potential termination fee payable"
       }
      }
     },
     "localname": "MergerAgreementPotentialTerminationFeePayable",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_MergerAgreementPotentialTerminationFeeReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Agreement, Potential Termination Fee Receivable",
        "label": "Merger Agreement, Potential Termination Fee Receivable",
        "terseLabel": "Potential termination fee receivable"
       }
      }
     },
     "localname": "MergerAgreementPotentialTerminationFeeReceivable",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_MergerAgreementTransactionExpensesThresholdForRatioAllocation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Merger Agreement, Transaction Expenses Threshold For Ratio Allocation",
        "label": "Merger Agreement, Transaction Expenses Threshold For Ratio Allocation",
        "terseLabel": "Transaction expenses threshold for allocation"
       }
      }
     },
     "localname": "MergerAgreementTransactionExpensesThresholdForRatioAllocation",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_MilestonePaymentOnGrantAwardCashReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Payment On Grant Award, Cash Received",
        "label": "Milestone Payment On Grant Award, Cash Received",
        "terseLabel": "Milestone payment received on grant award"
       }
      }
     },
     "localname": "MilestonePaymentOnGrantAwardCashReceived",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/ResearchFundingFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_NetDeferredTaxAssetsAndLiabilitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Deferred Tax Assets And Liabilities, Gross",
        "label": "Net Deferred Tax Assets And Liabilities, Gross",
        "totalLabel": "Net deferred tax assets and liabilities"
       }
      }
     },
     "localname": "NetDeferredTaxAssetsAndLiabilitiesGross",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_NumberOfOfficesUnderOperatingLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Offices Under Operating Leases",
        "label": "Number Of Offices Under Operating Leases",
        "terseLabel": "Number of offices under operating leases"
       }
      }
     },
     "localname": "NumberOfOfficesUnderOperatingLeases",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesNarrativeFyDetails",
      "http://caladrius.com/role/OperatingLeasesNarrativeQ1Details"
     ],
     "xbrltype": "integerItemType"
    },
    "clbs_NumberofOfferingPeriodsEmployeeStockPurchasePlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Offering Periods, Employee Stock Purchase Plan",
        "label": "Number of Offering Periods, Employee Stock Purchase Plan",
        "terseLabel": "Number of offering periods"
       }
      }
     },
     "localname": "NumberofOfferingPeriodsEmployeeStockPurchasePlan",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "clbs_OfferingPeriodsEmployeeStockPurchasePlanTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Offering Periods, Employee Stock Purchase Plan, Term",
        "label": "Offering Periods, Employee Stock Purchase Plan, Term",
        "terseLabel": "Term of offering period"
       }
      }
     },
     "localname": "OfferingPeriodsEmployeeStockPurchasePlanTerm",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_OperatingLeaseRightOfUseAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset",
        "label": "Operating Lease, Right-Of-Use Asset [Abstract]",
        "terseLabel": "Right-of Use Assets:"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAbstract",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Annual Available, Five Years, Net Unrealized Built In Gain",
        "label": "Operating Loss Carryforwards, Annual Available, Five Years, Net Unrealized Built In Gain",
        "terseLabel": "Possible additional NOLs for five years resulting from Net Unrealized Built-in Gain rules"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsAnnualAvailableFiveYearsNetUnrealizedBuiltInGain",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_OperatingLossCarryforwardsBeforeWriteDown": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Before Write Down",
        "label": "Operating Loss Carryforwards, Before Write Down",
        "terseLabel": "Net operating loss carryforwards, prior to write down"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsBeforeWriteDown",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_OperatingLossCarryforwardsSetToExpireWrittenDown": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Set To Expire, Written Down",
        "label": "Operating Loss Carryforwards, Set To Expire, Written Down",
        "terseLabel": "Write down of NOLs set to expire unutilized"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSetToExpireWrittenDown",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_OptionsVestedweightedAverageRemainingContractualTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options, Vested, weighted Average Remaining Contractual Term",
        "label": "Options, Vested, weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Vested, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "localname": "OptionsVestedweightedAverageRemainingContractualTerm",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_PreEquityOfferingValueAfterConversion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-Equity Offering Value After Conversion",
        "label": "Pre-Equity Offering Value After Conversion",
        "terseLabel": "Pre-Equity Offering Value After Conversion"
       }
      }
     },
     "localname": "PreEquityOfferingValueAfterConversion",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_PreferredStockLiquidationPreferenceShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Liquidation Preference, Share",
        "label": "Preferred Stock, Liquidation Preference, Share",
        "terseLabel": "Preferred stock, liquidation value",
        "verboseLabel": "Preferred stock, liquidation preference (shares)"
       }
      }
     },
     "localname": "PreferredStockLiquidationPreferenceShare",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_PreferredStockSharesDesignated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock, shares designated",
        "label": "Preferred stock, shares designated",
        "terseLabel": "Preferred stock, shares designated",
        "verboseLabel": "Preferred stock, shares designated (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesDesignated",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgram": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Net Operating Losses, NJEDA Program",
        "label": "Proceeds From Sale Of Net Operating Losses, NJEDA Program",
        "terseLabel": "Net proceeds from sale of NOLs",
        "verboseLabel": "Proceeds from sale of NOLs"
       }
      }
     },
     "localname": "ProceedsFromSaleOfNetOperatingLossesNJEDAProgram",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross",
        "label": "Proceeds From Sale Of Net Operating Losses, NJEDA Program, Gross",
        "terseLabel": "Proceeds from sale of NOLs, gross"
       }
      }
     },
     "localname": "ProceedsFromSaleOfNetOperatingLossesNJEDAProgramGross",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_ProgressPaymentOnGrantAwardCashReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Progress Payment On Grant Award, Cash Received",
        "label": "Progress Payment On Grant Award, Cash Received",
        "terseLabel": "Progress payment received on grant award"
       }
      }
     },
     "localname": "ProgressPaymentOnGrantAwardCashReceived",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/ResearchFundingFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Agreement, Accelerated Purchase Specified Stock Floor Price",
        "label": "Purchase Agreement, Accelerated Purchase Specified Stock Floor Price",
        "terseLabel": "Accelerated purchases specified floor price threshold for directed purchases"
       }
      }
     },
     "localname": "PurchaseAgreementAcceleratedPurchaseSpecifiedStockFloorPrice",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_PurchaseOfPreferredStockAggregatePrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Of Preferred Stock, Aggregate Price",
        "label": "Purchase Of Preferred Stock, Aggregate Price",
        "terseLabel": "Aggregate price"
       }
      }
     },
     "localname": "PurchaseOfPreferredStockAggregatePrice",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_PurchaseOfPreferredStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Of Preferred Stock, Price Per Share",
        "label": "Purchase Of Preferred Stock, Price Per Share",
        "terseLabel": "Series D original issue price (in usd per share)"
       }
      }
     },
     "localname": "PurchaseOfPreferredStockPricePerShare",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_PurchaseOfPreferredStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Of Preferred Stock, Shares",
        "label": "Purchase Of Preferred Stock, Shares",
        "terseLabel": "Number of shares purchased"
       }
      }
     },
     "localname": "PurchaseOfPreferredStockShares",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty",
        "label": "Registration Rights Agreement, Maximum Beneficial Ownership Allowable For Counterparty",
        "terseLabel": "Maximum beneficial ownership allowable per agreement (percent)"
       }
      }
     },
     "localname": "RegistrationRightsAgreementMaximumBeneficialOwnershipAllowableForCounterparty",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_RestrictedStockAndRestrictedStockUnitsIssuedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock And Restricted Stock Units Issued [Abstract]",
        "label": "Restricted Stock And Restricted Stock Units Issued [Abstract]",
        "terseLabel": "Restricted Stock and Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockAndRestrictedStockUnitsIssuedAbstract",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement",
        "label": "Sale Of Stock, Aggregate Offering Amount Authorized Per Agreement",
        "terseLabel": "Aggregate offering amount authorized per agreement"
       }
      }
     },
     "localname": "SaleOfStockAggregateOfferingAmountAuthorizedPerAgreement",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase",
        "label": "Sale Of Stock, Amount Per Agreement, Allowable To Direct Counterparty To Purchase, Regular Purchase",
        "terseLabel": "Number of shares allowable to direct for Regular Purchase (in shares)",
        "verboseLabel": "Number of shares allowable to direct for Regular Purchase (shares)"
       }
      }
     },
     "localname": "SaleOfStockAmountPerAgreementAllowableToDirectCounterpartyToPurchaseRegularPurchase",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent",
        "label": "Sale Of Stock, Commission On Gross Proceeds Due To Third Party Upon, Percent",
        "terseLabel": "Commission on gross proceeds due to third party (percent)"
       }
      }
     },
     "localname": "SaleOfStockCommissionOnGrossProceedsDueToThirdPartyUponPercent",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase",
        "label": "Sale Of Stock, Maximum Amount Per Agreement Per Transaction For Direct Counterparty Purchase, Regular Purchase",
        "terseLabel": "Maximum obligation per directed purchase transaction for Regular Purchase"
       }
      }
     },
     "localname": "SaleOfStockMaximumAmountPerAgreementPerTransactionForDirectCounterpartyPurchaseRegularPurchase",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase",
        "label": "Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares In Regular Purchase",
        "terseLabel": "Maximum shares allowed in Accelerated Purchase as percent of shares In Regular Purchase (percent)",
        "verboseLabel": "Maximum shares allowed in Accelerated Purchase as percent of shares in Regular Purchase (percent)"
       }
      }
     },
     "localname": "SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesInRegularPurchase",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period",
        "label": "Sale Of Stock, Maximum Shares Allowed In Accelerated Purchase As Percent Of Shares Of Stock Traded During Specified Period",
        "terseLabel": "Maximum shares allowed in Accelerated Purchase as percent of shares traded during specified period (percent)"
       }
      }
     },
     "localname": "SaleOfStockMaximumSharesAllowedInAcceleratedPurchaseAsPercentOfSharesOfStockTradedDuringSpecifiedPeriod",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "percentItemType"
    },
    "clbs_SeriesDPreferredStockCendMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D Preferred Stock, Cend",
        "label": "Series D Preferred Stock, Cend [Member]",
        "terseLabel": "Cend Series D preferred stock"
       }
      }
     },
     "localname": "SeriesDPreferredStockCendMember",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "clbs_Sharesvestedandexpectedtovest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "shares, vested and expected to vest",
        "label": "shares, vested and expected to vest",
        "terseLabel": "Warrants, Vested and expected to vest (in shares)",
        "verboseLabel": "Warrants vested or expected to vest (shares)"
       }
      }
     },
     "localname": "Sharesvestedandexpectedtovest",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_StockIssuedDuringPeriodSharesIssuedAsConsideration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Issued As Consideration",
        "label": "Stock Issued During Period, Shares, Issued As Consideration",
        "terseLabel": "Commitment shares issued as consideration per agreement (in shares)",
        "verboseLabel": "Commitment shares issued as consideration per agreement (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedAsConsideration",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_TermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Of Agreement",
        "label": "Term Of Agreement",
        "terseLabel": "Term of agreement (in months)"
       }
      }
     },
     "localname": "TermOfAgreement",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_TreasuryStockPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Policy [Policy Text Block]",
        "label": "Treasury Stock, Policy [Policy Text Block]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockPolicyPolicyTextBlock",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "clbs_WarrantsCanceled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Canceled",
        "label": "Warrants Canceled",
        "negatedLabel": "Warrants, Forfeited (in shares)",
        "negatedTerseLabel": "Warrants forfeited (shares)"
       }
      }
     },
     "localname": "WarrantsCanceled",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Exercised",
        "label": "Warrants Exercised",
        "negatedLabel": "Warrants exercised (shares)",
        "negatedTerseLabel": "Warrants, Exercised (in shares)"
       }
      }
     },
     "localname": "WarrantsExercised",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Expired",
        "label": "Warrants Expired",
        "negatedLabel": "Warrants expired (shares)",
        "negatedTerseLabel": "Warrants, Expired (in shares)"
       }
      }
     },
     "localname": "WarrantsExpired",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Granted",
        "label": "Warrants Granted",
        "terseLabel": "Warrants, Granted (in shares)",
        "verboseLabel": "Warrants granted (shares)"
       }
      }
     },
     "localname": "WarrantsGranted",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Other Disclosures",
        "label": "Warrants Other Disclosures [Abstract]",
        "terseLabel": "Warrants, Weighted Average Contractual Term and Intrinsic Value"
       }
      }
     },
     "localname": "WarrantsOtherDisclosuresAbstract",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_WarrantsVested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants, Vested",
        "label": "Warrants, Vested",
        "terseLabel": "Warrants, Vested (in shares)",
        "verboseLabel": "Warrants exercisable (shares)"
       }
      }
     },
     "localname": "WarrantsVested",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "clbs_WarrantsWeightedAverageExercisePriceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Weighted Average Exercise Price [Roll Forward]",
        "label": "Warrants Weighted Average Exercise Price [Roll Forward]",
        "terseLabel": "Warrants, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "WarrantsWeightedAverageExercisePriceRollForward",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsCanceled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Canceled",
        "label": "Weighted Average Exercise Price, Warrants Canceled",
        "terseLabel": "Warrants, Forfeited (in dollars per share)",
        "verboseLabel": "Warrants forfeited (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsCanceled",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Exercisable",
        "label": "Weighted Average Exercise Price, Warrants Exercisable",
        "terseLabel": "Warrants, Vested, Weighted Average Exercise Price (in dollars per share)",
        "verboseLabel": "Warrants exercisable (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExercisable",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Exercised",
        "label": "Weighted Average Exercise Price, Warrants Exercised",
        "terseLabel": "Warrants, Exercised (in dollars per share)",
        "verboseLabel": "Warrants exercised (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExercised",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Expired",
        "label": "Weighted Average Exercise Price, Warrants Expired",
        "terseLabel": "Warrants, Expired (in dollars per share)",
        "verboseLabel": "Warrants expired (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsExpired",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Granted",
        "label": "Weighted Average Exercise Price, Warrants Granted",
        "terseLabel": "Warrants, Granted (in dollars per share)",
        "verboseLabel": "Warrants granted (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsGranted",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Outstanding",
        "label": "Weighted Average Exercise Price, Warrants Outstanding",
        "periodEndLabel": "Warrants outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Warrants outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsOutstanding",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest",
        "label": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest",
        "terseLabel": "Weighted Average Exercise Price, Warrants Vested And Expected To Vest",
        "verboseLabel": "Warrants vested or expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceWarrantsVestedAndExpectedToVest",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest",
        "label": "Weighted Average Remaining Contractual Term, Warrants Vested and Expect to Vest",
        "terseLabel": "Warrants, Vested and expected to vest, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Warrants vested or expected to vest, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermwarrantoutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Term warrant outstanding",
        "label": "Weighted Average Remaining Contractual Term warrant outstanding",
        "terseLabel": "Warrants, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Warrants outstanding, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermwarrantoutstanding",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "clbs_WeightedAverageRemainingContractualTermwarrantsvested": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "weighted Average Remaining Contractual Term, warrants vested",
        "label": "weighted Average Remaining Contractual Term, warrants vested",
        "terseLabel": "Warrants, Vested, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Warrants exercisable, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualTermwarrantsvested",
     "nsuri": "http://caladrius.com/20220726",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r43",
      "r45",
      "r100",
      "r101",
      "r211",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r210",
      "r221",
      "r256",
      "r258",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r421",
      "r469",
      "r470",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r210",
      "r221",
      "r256",
      "r258",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r421",
      "r469",
      "r470",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r210",
      "r221",
      "r246",
      "r256",
      "r258",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r421",
      "r469",
      "r470",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r210",
      "r221",
      "r246",
      "r256",
      "r258",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r421",
      "r469",
      "r470",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r44",
      "r45",
      "r100",
      "r101",
      "r211",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AccruedLiabilitiesFy",
      "http://caladrius.com/role/AccruedLiabilitiesQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r30",
      "r387"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization/accretion on marketable securities",
        "negatedTerseLabel": "Accretion on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://caladrius.com/role/AccruedLiabilitiesQ1Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AccruedLiabilitiesQ1Details",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r434",
      "r460"
     ],
     "calculation": {
      "http://caladrius.com/role/AccruedLiabilitiesFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.",
        "label": "Accrued Liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AccruedLiabilitiesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r28",
      "r188"
     ],
     "calculation": {
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r19",
      "r49",
      "r50",
      "r51",
      "r454",
      "r475",
      "r476"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r48",
      "r51",
      "r58",
      "r59",
      "r60",
      "r103",
      "r104",
      "r105",
      "r346",
      "r471",
      "r472",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r17",
      "r296",
      "r387"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r293",
      "r294",
      "r295",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid in Capital",
        "verboseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r260",
      "r289",
      "r298"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails",
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share",
        "verboseLabel": "Anti-dilutive securities excluded from computation of loss per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Details",
      "http://caladrius.com/role/LossPerShareFyDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Details",
      "http://caladrius.com/role/LossPerShareFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Details",
      "http://caladrius.com/role/LossPerShareFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Details",
      "http://caladrius.com/role/LossPerShareFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r95",
      "r144",
      "r146",
      "r150",
      "r174",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r341",
      "r347",
      "r367",
      "r385",
      "r387",
      "r429",
      "r453"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r42",
      "r95",
      "r174",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r341",
      "r347",
      "r367",
      "r385",
      "r387"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r358"
     ],
     "calculation": {
      "http://caladrius.com/role/FairValueMeasurementsFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Assets, fair value disclosure"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r158"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r155",
      "r181"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails",
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Greater than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r159",
      "r162",
      "r448"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Greater than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year",
        "verboseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Remainder of Fiscal Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "verboseLabel": "Greater than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "Greater than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r159",
      "r161",
      "r447"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r153",
      "r156",
      "r181",
      "r433"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated Fair Value",
        "totalLabel": "Total estimated fair value",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesAvailableforsaleSecuritiesByContractualMaturityQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails",
      "http://caladrius.com/role/AvailableforsalesecuritiesContractualMaturitiesFyDetails",
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r262",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r255",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r255",
      "r257",
      "r334",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of California.",
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "auth_ref": [
      "r424",
      "r425",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by project.",
        "label": "Project [Axis]",
        "terseLabel": "Project [Axis]"
       }
      }
     },
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessFyDetails",
      "http://caladrius.com/role/BusinessQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r25",
      "r87"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r9",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Available-for-Sale-Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesFy",
      "http://caladrius.com/role/AvailableforsalesecuritiesQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r80",
      "r87",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r80",
      "r368"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r93",
      "r95",
      "r118",
      "r119",
      "r120",
      "r122",
      "r124",
      "r132",
      "r133",
      "r134",
      "r174",
      "r199",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r219",
      "r220",
      "r224",
      "r228",
      "r367",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Number of shares per each warrant"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Number of shares called by warrants issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r36",
      "r197",
      "r435",
      "r459"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r198",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ContingenciesFy",
      "http://caladrius.com/role/ContingenciesQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in usd per share)",
        "verboseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized",
        "verboseLabel": "Common stock, shares authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "verboseLabel": "Common stock, shares, issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r16",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares, outstanding",
        "verboseLabel": "Common stock, shares, outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r16",
      "r387"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value, authorized 500,000,000 shares; issued 60,544,144 and 59,800,792 shares at March 31, 2022 and December 31, 2021, respectively; and outstanding, 60,533,064 and 59,789,712 shares at March 31, 2022 and December 31, 2021, respectively",
        "verboseLabel": "Common stock, $0.001 par value, authorized 500,000,000 shares; issued 59,800,792 and 19,389,413 shares, at December 31, 2021 and December 31, 2020, respectively; and outstanding, 59,789,712 and 19,378,333 shares, at December 31, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r54",
      "r56",
      "r57",
      "r67",
      "r442",
      "r465"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r54",
      "r56",
      "r66",
      "r339",
      "r340",
      "r351",
      "r441",
      "r464"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r54",
      "r56",
      "r65",
      "r338",
      "r351",
      "r440",
      "r463"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r137",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Risks"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r92",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r247",
      "r254",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r317",
      "r324"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "U.S. Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r317",
      "r324",
      "r326"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income tax provision (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r317",
      "r324"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r318",
      "r324"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "U.S. Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r85",
      "r96",
      "r318",
      "r324",
      "r325",
      "r326"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred income tax provision (benefit)"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r12",
      "r13",
      "r308",
      "r430",
      "r452"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 2.0,
       "parentTag": "clbs_NetDeferredTaxAssetsAndLiabilitiesGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r96",
      "r318",
      "r324"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r309"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 1.0,
       "parentTag": "clbs_NetDeferredTaxAssetsAndLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred Tax Assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r311"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Accumulated net operating losses (tax effected)"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Accrued payroll"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r310"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred Tax Liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r315",
      "r316"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r85",
      "r186"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentNarrativeFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r85",
      "r186"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationFy",
      "http://caladrius.com/role/SharebasedCompensationQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r262",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Schedule of Total Compensation Cost Related to Nonvested Awards"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r68",
      "r108",
      "r109",
      "r110",
      "r111",
      "r112",
      "r116",
      "r118",
      "r122",
      "r123",
      "r124",
      "r128",
      "r129",
      "r356",
      "r357",
      "r443",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Caladrius Biosciences, Inc. common stockholders - basic (in usd per share)",
        "verboseLabel": "Caladrius Biosciences, Inc. common shareholders - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Basic and diluted loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Basic and diluted loss per share",
        "verboseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r68",
      "r108",
      "r109",
      "r110",
      "r111",
      "r112",
      "r118",
      "r122",
      "r123",
      "r124",
      "r128",
      "r129",
      "r356",
      "r357",
      "r443",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Caladrius Biosciences, Inc. common stockholders - diluted (in usd per share)",
        "verboseLabel": "Caladrius Biosciences, Inc. common shareholders - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r125",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Income (Loss) Per Share",
        "verboseLabel": "Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1",
      "http://caladrius.com/role/LossPerShareFy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r98",
      "r304",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal corporate income tax rate (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://caladrius.com/role/AccruedLiabilitiesQ1Details": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Salaries, employee benefits and related taxes"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AccruedLiabilitiesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r434",
      "r460"
     ],
     "calculation": {
      "http://caladrius.com/role/AccruedLiabilitiesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Employee-related Liabilities",
        "terseLabel": "Salaries, employee benefits and related taxes"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AccruedLiabilitiesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Compensation [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r290"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Expected weighted-average period in years of compensation cost to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Stock options",
        "terseLabel": "Stock Options",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Details",
      "http://caladrius.com/role/LossPerShareFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r58",
      "r59",
      "r60",
      "r103",
      "r104",
      "r105",
      "r107",
      "r113",
      "r115",
      "r131",
      "r175",
      "r235",
      "r242",
      "r293",
      "r294",
      "r295",
      "r320",
      "r321",
      "r355",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r471",
      "r472",
      "r473",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r358",
      "r359",
      "r360",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r358",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets Measured at Fair Value on Recurring Basis",
        "verboseLabel": "Schedule of Fair Value of Assets Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyTables",
      "http://caladrius.com/role/FairValueMeasurementsQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r212",
      "r214",
      "r215",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r359",
      "r394",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r358",
      "r359",
      "r361",
      "r362",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFy",
      "http://caladrius.com/role/FairValueMeasurementsQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r212",
      "r247",
      "r248",
      "r253",
      "r254",
      "r359",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r212",
      "r214",
      "r215",
      "r247",
      "r248",
      "r253",
      "r254",
      "r359",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r212",
      "r214",
      "r215",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r359",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r363",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r212",
      "r214",
      "r215",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r394",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r364",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r96",
      "r303"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations.",
        "label": "Federal Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "U.S. Federal"
       }
      }
     },
     "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Minimum Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r164",
      "r165",
      "r171",
      "r172",
      "r173",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r183",
      "r184",
      "r185",
      "r213",
      "r233",
      "r354",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails",
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrantsReceivable": {
     "auth_ref": [
      "r41"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants.",
        "label": "Grants Receivable",
        "terseLabel": "Grants awarded",
        "verboseLabel": "Grants awarded"
       }
      }
     },
     "localname": "GrantsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessFyDetails",
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/ResearchFundingFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": {
     "auth_ref": [
      "r336",
      "r338"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less - net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r97",
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Pre-tax book income - United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r62",
      "r144",
      "r145",
      "r148",
      "r149",
      "r151",
      "r428",
      "r437",
      "r444",
      "r467"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Pre-tax book income",
        "totalLabel": "Net loss before benefit from income taxes and noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1",
      "http://caladrius.com/role/IncomeTaxesLossFromOperationsBeforeProvisionForIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r191",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails",
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails",
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r98",
      "r305",
      "r307",
      "r312",
      "r322",
      "r329",
      "r331",
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesFy",
      "http://caladrius.com/role/IncomeTaxesQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r99",
      "r114",
      "r115",
      "r143",
      "r303",
      "r323",
      "r330",
      "r468"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Benefit from income taxes",
        "totalLabel": "Tax provision (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1",
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails",
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Continuing Operations, by Jurisdiction [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsByJurisdictionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Valuation allowance for deferred tax assets"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "U.S. Federal benefit at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Permanent non deductible expenses for U.S. taxes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other true ups"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Return to actual"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesEffectiveIncomeTaxReconciliationFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r82",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r78",
      "r81",
      "r89"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "verboseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r71",
      "r73"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment income, net"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Investments Classified by Contractual Maturity Date",
        "verboseLabel": "Schedule of Available-for-Sale Securities by Contractual Maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesFyTables",
      "http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r358"
     ],
     "calculation": {
      "http://caladrius.com/role/FairValueMeasurementsFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Marketable securities - available for sale"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/FairValueMeasurementsFyDetails",
      "http://caladrius.com/role/FairValueMeasurementsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Equity-based compensation expense"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Lease Agreements"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFyTables",
      "http://caladrius.com/role/OperatingLeasesQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details",
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details",
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details",
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details",
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1DetailsCalc01": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Amounts representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details",
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFy",
      "http://caladrius.com/role/OperatingLeasesQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r32",
      "r95",
      "r147",
      "r174",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r342",
      "r347",
      "r348",
      "r367",
      "r385",
      "r386"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r22",
      "r95",
      "r174",
      "r367",
      "r387",
      "r432",
      "r457"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, non-controlling interests and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "verboseLabel": "LIABILITIES, NON-CONTROLLING INTERESTS AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r95",
      "r174",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r342",
      "r347",
      "r348",
      "r367",
      "r385",
      "r386",
      "r387"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      },
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOfAvailableforsaleSecuritiesQ1Details",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesFyTables",
      "http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r40",
      "r95",
      "r174",
      "r199",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r367",
      "r431",
      "r456"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r80",
      "r83",
      "r86"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r52",
      "r55",
      "r60",
      "r63",
      "r86",
      "r95",
      "r106",
      "r108",
      "r109",
      "r110",
      "r111",
      "r114",
      "r115",
      "r121",
      "r144",
      "r145",
      "r148",
      "r149",
      "r151",
      "r174",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r357",
      "r367",
      "r438",
      "r461"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net loss attributable to Caladrius Biosciences, Inc. common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewJerseyDivisionOfTaxationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New Jersey.",
        "label": "New Jersey Division of Taxation [Member]",
        "terseLabel": "New Jersey"
       }
      }
     },
     "localname": "NewJerseyDivisionOfTaxationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of New York.",
        "label": "New York State Division of Taxation and Finance [Member]",
        "terseLabel": "New York"
       }
      }
     },
     "localname": "NewYorkStateDivisionOfTaxationAndFinanceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r242",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non- Controlling Interest in Subsidiary"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other (expense) income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Activity",
        "verboseLabel": "Schedule of Restricted Stock"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityFyTables",
      "http://caladrius.com/role/StockholdersEquityQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating Expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r144",
      "r145",
      "r148",
      "r149",
      "r151"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Future Minimum Lease Payments"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetailsCalc01": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Operating lease liabilities",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details",
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsQ1Details",
      "http://caladrius.com/role/OperatingLeasesFutureMinimumLeasePaymentsUnderLeaseAgreementsFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]",
        "terseLabel": "Operating Lease Liabilities:"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://caladrius.com/role/AccruedLiabilitiesFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      },
      "http://caladrius.com/role/AccruedLiabilitiesQ1Details": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      },
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities - current",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AccruedLiabilitiesFyDetails",
      "http://caladrius.com/role/AccruedLiabilitiesQ1Details",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease liabilities, current, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease liabilities, noncurrent, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Right-of-use assets, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationFyDetails",
      "http://caladrius.com/role/OperatingLeasesBalanceSheetPresentationQ1Details"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r381",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate for operating leases (percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesNarrativeFyDetails",
      "http://caladrius.com/role/OperatingLeasesNarrativeQ1Details"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r380",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term for operating leases (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/OperatingLeasesNarrativeFyDetails",
      "http://caladrius.com/role/OperatingLeasesNarrativeQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r313"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "verboseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r33"
     ],
     "calculation": {
      "http://caladrius.com/role/AccruedLiabilitiesFyDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent",
       "weight": 1.0
      },
      "http://caladrius.com/role/AccruedLiabilitiesQ1Details": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AccruedLiabilitiesFyDetails",
      "http://caladrius.com/role/AccruedLiabilitiesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r46",
      "r47",
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized loss on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r53",
      "r56",
      "r58",
      "r59",
      "r61",
      "r64",
      "r235",
      "r369",
      "r374",
      "r375",
      "r439",
      "r462"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r46",
      "r49"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Available for sale securities - net unrealized loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Caladrius Biosciences, Inc. Stockholders' Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Tax withholding payments on net share settlement equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities",
        "negatedTerseLabel": "Purchase of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r262",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in usd per share)",
        "verboseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized",
        "verboseLabel": "Preferred stock, shares authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r15",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "verboseLabel": "Preferred stock, shares issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding",
        "verboseLabel": "Preferred stock, shares outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r15",
      "r387"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at March 31, 2022 and December 31, 2021, respectively",
        "verboseLabel": "Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 0.001 share of common stock, $0.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at December 31, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r4",
      "r23",
      "r24"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Net proceeds from issuance of common stock",
        "verboseLabel": "Net proceeds from issuance of capital stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Sales of marketable securities",
        "verboseLabel": "Sale of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r76",
      "r292"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of options",
        "verboseLabel": "Proceeds from exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Net proceeds from warrant exercises"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r52",
      "r55",
      "r60",
      "r79",
      "r95",
      "r106",
      "r114",
      "r115",
      "r144",
      "r145",
      "r148",
      "r149",
      "r151",
      "r174",
      "r199",
      "r200",
      "r201",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r338",
      "r344",
      "r345",
      "r350",
      "r351",
      "r357",
      "r367",
      "r444"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsQ1",
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfComprehensiveLossQ1",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProjectMember": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Planned program of work.",
        "label": "Project [Domain]",
        "terseLabel": "Project [Domain]"
       }
      }
     },
     "localname": "ProjectMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessFyDetails",
      "http://caladrius.com/role/BusinessQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r28",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r192",
      "r479",
      "r480",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentFy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r27",
      "r187"
     ],
     "calculation": {
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentImpairment": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for assessing and recognizing impairments of its property, plant and equipment.",
        "label": "Property, Plant and Equipment, Impairment [Policy Text Block]",
        "terseLabel": "Long-lived Assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r10",
      "r11",
      "r189",
      "r387",
      "r450",
      "r458"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1",
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r26",
      "r189",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r10",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentFyTables",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r10",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life (in years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessFyDetails",
      "http://caladrius.com/role/BusinessQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government.",
        "label": "Research and Development Arrangement with Federal Government, Customer Funding to Offset Costs Incurred",
        "terseLabel": "Progress payment amortized to related research and development over estimated award period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ResearchFundingFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r300",
      "r422",
      "r484"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails",
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "terseLabel": "Research Funding"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ResearchFundingFy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Details",
      "http://caladrius.com/role/LossPerShareFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r18",
      "r242",
      "r296",
      "r387",
      "r455",
      "r474",
      "r476"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r103",
      "r104",
      "r105",
      "r107",
      "r113",
      "r115",
      "r175",
      "r293",
      "r294",
      "r295",
      "r320",
      "r321",
      "r355",
      "r471",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Gross price for stock transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock, Name of Transaction [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares sold (in shares)",
        "verboseLabel": "Number of shares sold (shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price of shares sold (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AccruedLiabilitiesFyTables",
      "http://caladrius.com/role/AccruedLiabilitiesQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Details",
      "http://caladrius.com/role/LossPerShareFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share",
        "verboseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Tables",
      "http://caladrius.com/role/LossPerShareFyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesClassificationOnConsolidatedBalanceSheetsFyDetails",
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Available-for-sale Securities Reconciliation",
        "verboseLabel": "Schedule of Available-for-Sale Securities Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesFyTables",
      "http://caladrius.com/role/AvailableforsalesecuritiesQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r160",
      "r163",
      "r166",
      "r167",
      "r168",
      "r169",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes Based on Loss from Operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesFyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Components Deferred Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesFyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Effective Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesFyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r260",
      "r288",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r260",
      "r288",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule Share-based Compensation Expense",
        "verboseLabel": "Schedule of Share-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationFyTables",
      "http://caladrius.com/role/SharebasedCompensationQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Benefit from Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesFyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r28",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/PropertyAndEquipmentSummaryFyDetails",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "auth_ref": [
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.",
        "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessFyDetails",
      "http://caladrius.com/role/BusinessQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r262",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details",
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Units"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityFyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r269",
      "r278",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option and Warrants Activity",
        "verboseLabel": "Schedule of Stock Options and Warrants Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityFyTables",
      "http://caladrius.com/role/StockholdersEquityQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Share-based Compensation Awards",
        "verboseLabel": "Schedule of Assumptions in Calculating Fair Values of Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationFyTables",
      "http://caladrius.com/role/SharebasedCompensationQ1Tables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r37",
      "r93",
      "r132",
      "r133",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r228",
      "r233",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting terms (years)",
        "verboseLabel": "Vesting terms (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Warrants, Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "terseLabel": "Valuation Assumptions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility - maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility - minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate - maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate - minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Weighted Average volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationSharebasedCompensationExpenseQ1Details",
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for future grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Stock Options, Weighted Average Contractual Term and Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (shares)",
        "negatedTerseLabel": "Options, Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Options, Forfeited (in shares)",
        "negatedTerseLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average estimated fair value of shares granted",
        "verboseLabel": "Weighted average estimated fair value of shares granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Shares Vested and Weighted Average Estimated Fair Values of Shares Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationFyTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options, Outstanding, Aggregate Intrinsic Value",
        "verboseLabel": "Options outstanding, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r271",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options, outstanding, ending balance (in shares)",
        "periodStartLabel": "Options, outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Stock Options, Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options, outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Options, outstanding. beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Stock Options, Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Options, Vested, Aggregate Intrinsic Value",
        "verboseLabel": "Options exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Options, Vested (in shares)",
        "verboseLabel": "Exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in dollars per share)",
        "verboseLabel": "Options, Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Options, Vested and expected to vest, Aggregate Intrinsic Value",
        "verboseLabel": "Options vested or expected to vest, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options, Vested and expected to vest (in shares)",
        "verboseLabel": "Vested or expected to vest (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options, Vested and expected to vest (in dollars per share)",
        "verboseLabel": "Vested or expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r259",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationCompensationCostNotYetRecognizedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details",
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Exercised (in dollars per share)",
        "verboseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Expired (in dollars per share)",
        "verboseLabel": "Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Forfeited (in dollars per share)",
        "verboseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options, Granted (in dollars per share)",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based award tranche one"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Three [Member]",
        "terseLabel": "Share-based award tranche three"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Share-based award tranche two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r262",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r284",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationValuationAssumptionsFyDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Options outstanding, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options, Vested and expected to vest, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Options vested or expected to vest, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of shares vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedFyDetails",
      "http://caladrius.com/role/SharebasedCompensationFairValueOfSharesVestedAndWeightedAverageEstimatedFairValueOfSharesGrantedQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r91",
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFy",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r96",
      "r303",
      "r323"
     ],
     "calculation": {
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesComponentsOfBenefitFromIncomeTaxesFyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeTaxesNarrativeFyDetails",
      "http://caladrius.com/role/IncomeTaxesQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r93",
      "r95",
      "r118",
      "r119",
      "r120",
      "r122",
      "r124",
      "r132",
      "r133",
      "r134",
      "r174",
      "r199",
      "r203",
      "r204",
      "r205",
      "r208",
      "r209",
      "r219",
      "r220",
      "r224",
      "r228",
      "r235",
      "r367",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r39",
      "r58",
      "r59",
      "r60",
      "r103",
      "r104",
      "r105",
      "r107",
      "r113",
      "r115",
      "r131",
      "r175",
      "r235",
      "r242",
      "r293",
      "r294",
      "r295",
      "r320",
      "r321",
      "r355",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r375",
      "r471",
      "r472",
      "r473",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Statement, Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r131",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r15",
      "r16",
      "r235",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares issued under ESPP"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r235",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Stock issued (shares)",
        "verboseLabel": "Net proceeds from issuance of common stock and warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Shares issued upon exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r235",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Number of shares issued",
        "verboseLabel": "Number of shares issued (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r15",
      "r16",
      "r235",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r15",
      "r16",
      "r235",
      "r242",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (shares)",
        "negatedTerseLabel": "Options, Exercised (in shares)",
        "terseLabel": "Proceeds from option exercises (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsFyDetails",
      "http://caladrius.com/role/StockholdersEquityStockOptionsAndWarrantsQ1Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r15",
      "r16",
      "r235",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Net proceeds from issuances of common stock and warrants",
        "verboseLabel": "Net proceeds from issuance of common stock and warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r15",
      "r16",
      "r235",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Value of shares issued",
        "verboseLabel": "Value of shares issued"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsFyDetails",
      "http://caladrius.com/role/StockholdersEquityRestrictedStockAndRestrictedStockUnitsQ1Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r15",
      "r16",
      "r242",
      "r261",
      "r279"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r39",
      "r235",
      "r242"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Proceeds from option exercises"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r16",
      "r20",
      "r21",
      "r95",
      "r152",
      "r174",
      "r367",
      "r387"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Caladrius Biosciences, Inc. stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r59",
      "r95",
      "r103",
      "r104",
      "r105",
      "r107",
      "r113",
      "r174",
      "r175",
      "r242",
      "r293",
      "r294",
      "r295",
      "r320",
      "r321",
      "r336",
      "r337",
      "r349",
      "r355",
      "r367",
      "r369",
      "r370",
      "r375",
      "r472",
      "r473",
      "r494"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r94",
      "r220",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r234",
      "r242",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityFy",
      "http://caladrius.com/role/StockholdersEquityQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r376",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r376",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r376",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r376",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/BusinessQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r388",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SubsequentEventsQ1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails",
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesQ1Details",
      "http://caladrius.com/role/SubsequentEventsQ1Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosure of Cash Flow Information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfCashFlowsFy"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r164",
      "r165",
      "r171",
      "r172",
      "r173",
      "r213",
      "r233",
      "r354",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r38",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfEquityQ1"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Number of Shares and Restriction Disclosures [Abstract]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockNumberOfSharesAndRestrictionDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r38",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFyParenthetical",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1Parentheticals"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r38",
      "r243",
      "r244"
     ],
     "calculation": {
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 11,080 shares at December 31, 2021 and December 31, 2020 respectively",
        "negatedTerseLabel": "Treasury stock, at cost; 11,080 shares at March 31, 2022 and December 31, 2021"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedBalanceSheetsFy",
      "http://caladrius.com/role/ConsolidatedBalanceSheetsQ1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r247",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "Municipal debt securities"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/AvailableforsalesecuritiesScheduleOfAvailableforsaleSecuritiesReconciliationQ1Details",
      "http://caladrius.com/role/AvailableforsalesecuritiesSummaryFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r135",
      "r136",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesFyPolicies",
      "http://caladrius.com/role/SummaryOfSignificantAccountingPoliciesQ1Policies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityPlanFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/IncomeLossPerShareQ1Details",
      "http://caladrius.com/role/LossPerShareFyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants expiration term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/StockholdersEquityEquityIssuancesFyDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r117",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r116",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsFy",
      "http://caladrius.com/role/ConsolidatedStatementsOfOperationsQ1"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(a)(32))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6806780-109447"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "http://asc.fasb.org/subtopic&trid=2197926"
  },
  "r486": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r487": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r488": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r489": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r490": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r491": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r492": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r493": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>127
<FILENAME>0001140361-22-027000-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-027000-xbrl.zip
M4$L#!!0 " @( +*%^E0                1    8VQB<RTR,#(R,#<R-BYX
M<V3M75MSXS:R?M^J\Q]X_+*S#[(L6W.M.%OR+>LM>^38FN3D:8LB(0D5BM0
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MEYLS7B&CYL_JLU_; 7#6AR&.Z6*MGN-,A/[5R^2H^V?4?8-.KZIRV$=@IFT
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MLJ$9VGA$BGW@-WMJ(--!C\D<T8N"D$RF_VQV45:I@S[=AOD==:BJ5[V#?DX
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M/HCS$;-YFJ=1N8.1\TYZYE0!>9;\+ S- RT>C^YZ+-"Y8R<IM8Q0#/^='2/
M-].Q-(?T0,-L7QV)'@B-,(C31+$BT]KK^-&=UH9_AKU6ZLEXQOP:O;C(OW3Q
MXA%X #Z75@*5-3OCLP^F,I?O80!P3 Q,MSG0D5[AN[[(H31"BF8Z,:%^B,"N
M%'=E*%;X1F(V,B"0V$T;7VV)0X%7+QT\7;9(S2C%'&W$2Y.MF X5;SKB7B]7
M0;0&@!F<#7#T*T6G)X/36EBA5;N#<87,[H_IJK"1LU6A0_/9S-E#]%+?PRY[
MQ_>\A312)'UK,<$UQ>93W4]]F2YZW(12_ILND.;Q]V408;K,3"^.P^L014%
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MOG0J=W2%BY_U1M4^ 2]!+->_AIVLTAMCQSYIQ _S__G_ 5!+!P@9FW$TS18
M ,(T 0!02P,$%  (" @ LH7Z5                !4   !C;&)S+3(P,C(P
M-S(V7V-A;"YX;6SM75ESW#B2?M^(_0]:S;,L2[UM3SO:,Z'#ZE6$Y%)+\L[N
MTP3%0JFXS2(T($M2S:]?@$<5#QP)$%5,:O30;;N8R L?$C?RU[^^+N*]9\+2
MB"9?]X\^?-S?(TE(IU'R^'5_F1X$:1A%^W_]R[__VZ__<7#P&TD("S(RW7M8
M[9TR&DQ9-'TD>S>WDUD4D[WCXP^?/QQ_^/GCI^/:YX,#43R.DC^^B/\]!"G9
MXV*3],MK&GW=GV?9TY?#PY>7EP\O/WV@[/'P^./'H\/_N;ZZ"^=D$1Q$29H%
M24CV]SC]ES3_\8J&09;K7"O^^L#BBL%/AVM92@KQKX.*[$#\='!T?/#3T8?7
M=+I?JB@^ X14Y*\=^M*FHU]^^>4P_[HFY8PB#>NUV=Q[>WN%_QB-R2V9[8D_
M?]Q>KDN'02R<O4P_A'1Q*+X>3IY$5?%ZO")<O_1BF2T9N8Z2:+%<Y#_=!*L%
M2;+T]Z-SD@51G)X%<?CQB*N7B\I63^3K?AHMGF)2_39G9/9U/XP?4NZMX^./
MGX\_"5_]R5W6X:Z,VXU9S@:=A"%;DNE5%#Q$<91%I)_F6G:N*C[SXL%#3&:4
MI4%,4A(N6<Z[_>5N_>5T=4:3C 5AM@SBZR 3/Z_Z6;8%+;P[Y"P.TC2:146,
MFLS4JFW)%TX*.+KADO<7"W(?O'*Q=/%$$]$B)K-S,B.,D6GM\\6JA[%.8OJ;
M]&TV(V$6/9/U;[<DI$G(FU7N6U\V6<CQ6T^GO$^?1=D%HXLM5Y51TK8[@Q_)
ME+#\EY-'1DC^VUK\#GH_D/Q!G3"<^;X,/^44?-!T-R<DNV$\)"99_W9J+\/;
M,*"7WEIVCBI>!!'[[R!>DFON"U[3_0%DXNBHZ VCO-JRU4DR_?:/9?0DV-XM
M%XN K7JI"^/K?TS1&<+T1H>S+._&^:@7&^Z.!G"_I#2.IF(*?,?;? '5R4ST
M<HS,29+R#OR*IGQ4Y6*!%7O/)I0ACG_UJWN3KV^_!^G\(J8O')M>_5UGNVVH
M>%9=QGYK4/&K>Y.O!Z7K_;0'73OLZBIR5<)EG*M_Q?_=$$5>,\+'/M-*F%#4
MU89<9"4TIF%#4"Q6Q2AK&B7DI%Q0OKHT"]*'?(EIF1X\!L'3(;?VZ)#$65K]
M(NP_.OAX5*Z#_:G\^>^U003O^>XR&OXQIS$?T:6B%\S6WN4AF,1?]Z'D690)
M9YC)#P>SG+>I193E(.6ZB;Z1CP0)GYJ1M&4T@+*T5TO9-+6&K!/6M#I@8<67
M_[4!J^YZ8DEQF(K>4' [B'C3J\K/^*S,HM:HC;$U"[[LF43L971/RYHR3OQU
M_UBL5;^0Z'&>E0O7PR&D9I.Z&:@1/Z3JDVS.)V4;7;[3A ^;&'=]RQ(S86F8
MCA %LNL@!ENEPK" JXX);K2>2:M:3=#%[IF\:G=I3W>6*S?+2%=:IZ%#@=^V
MUA1NF@K%);4 LX850BQS;>F2=Q,WP4I,_905KR':U+J4"'&5FXV"U;>43UG9
M1X;*1A##G5$OS-?@'*GIQH&9>LQA/1!KL *Z99?-OZOU91+&2W%\X8:RO&:R
MC$4/RTQ@^YZ*GEFL;=&8Z_)XF62$D;0=+OPR+5WOB^EPOKZ.$LIRO:5>4WTN
M[>]^'JXQ>:Y@:C2^T>[\2!>MLRL580]M7"DPK@W@6@VX%6O("9E^"UC"ZR/E
M_>=R(2J73,_)+ JC=L. %RCMA13 U'CJ#<':6$/3$#"'\"R!_S,BX-^S?#MK
ME1N5[V^U@*$F*'TC(\!:\49C !4MXU%6['_6*_9@X)J]8>6A$V75:BA*=T@I
ML%:NV1Q [4J9(!Q3UL)+OK#3V%(I#JZ(C97O))O,[H/7[ES3I?1F$FI7&BMB
M^KD!@"9K 272/F%"VG0:"1N#^":(II?)6? 494'<1I2>JD*.B@HM0D!F09"@
M8E36^$^(:EQL;-!$V6VH/M<VC9J?L5:NP1! K78Y .<VXYY(&B=#6YI*RN2.
M?!EL*\LXUBMHOK1 &,Q.TI1D[0W/YH]5YU3^.+2NBNT!V;>&Y@@VN?CH^8EW
M;]]>G_@0AW"XY:,>G5D6)39S$G.)X1J_7'7J8FFC&3<(RYF*F1_"!GD=L#](
M'D<V]SO:J[0:DFJE5DJ"L-H!MNCK6<X X1JJ.) H#L+P/T0?\AS$^=&8["Q@
M;,6[">E8TJ9,-<"$E4&(!1=K]>  <D0X2&IUP53?PTF\D,^JI-$.TSI-=0[_
M)@Z2K'X8G\_Y.UVAF73=!^I(,56JA5&*.M9S0!@':_VP_IR:BJ9^1*U+@ZEV
M(68HJE51U#!@^?6P;?45__<.3C@KCX /!C,._\T*8@M>TF]E?;2^#1H:9U$F
MT;[[81/VUA^&TWOC/7%)M#CWN^1][086I^)V#ZG?FWW-6,"A'24!6UUR(*6@
M,QX[D%1Z=JN2!@S%U95(94O14%1A6$:!P*1RXJ<TJ/V];<[F^Y#'%%+">QXQ
MA#TGSR2F><=>:M8YH0"@71].T-(.UX6J:X?:6=CH53M<BP,)6FX(Q\IW) \<
MQ?L],=?[9+J(DBC-A''/1 X+NT+581U@(:1 <;+9C!@H6X1['+HP3LU!4>Z;
M#:]\P-KE(6M#LF,?N_3$+L8,%-)O-GRZ1:T:=5/7!F&$XQ;0IJKRH&:DJ\;R
M:KJ!Y[]02V'$]1DQV.9=MCJS!=32UD;S419:SZ0U;!$ND5PFS[SEBO%(H6MW
M,4Q#L9ZR2"B0(\!L%;S:I;P0+O3NJ$-R:E=;[I;Z-\I=5I1DV87N<@VB43,;
M90JL;U$)A..$M1TE7LI'R:3+0TJJQM*.A HGTDSF&%$B82!K;$./T^5+M%2S
M^MGL&NK%RVV2=3&TB-:U8-T)HV^<O',EQR=+\#(HA"5"4&W!5WHX^A%H:K@H
MMH-DKQD->7:W?<)<<0< 0+DYT:NF'/28LDHMA_NTGKB97>9R@W:7,02""^K;
M7XU@HF%='KKN)QDZ'$ "9@^7Q;?$W0SVL5T?=[A+Y7!SR.76% 8O_$@8">+H
MGV3Z7S06M?I;$"5"Z4FR.9MXPJ*4?SKG_^353EA$IY:>\R7&X.W^8@;<[[ !
M'=V9JYO[*  =U^N76]$-X6K8MB*QIHZA5Q@]JZ:K6NFE1TP+U#[/)KT1>,'6
M);8 (H>5#20N!XZ7?=_X<A\_][KUI:H4')/TVFO)@]Z0:!W5O^4>9%'(M2V/
M\C=_J%$6G1NO(?'^!#DGQ9_K&OOV&LZ#Y)'<<IN+-!WM.< @PFMW-G8I?, M
M?I()]7G0>HXX;D]7/U*1]V5]0N%$Y$^177JR+[@YT LN^-ZC.BRIVE:+S2(^
MD/<(5OC%DYPDKY*%Z#S^F=LXF9U':?%T(V_A-XPLHN4BW6Q==R[F]F)2>QK5
MA<G80.;%63T Z2H?XVM)YX2/B<(BBY4X^5BSJ 51 &7I6BWEV, &-[L'HK1"
M$-YE[HY)\AGOQCK9XP-VA38[DZ!"8X.5DS-Z( PJ3_80DW.,ZF;L$+](T--Z
MYKA\Y;HZ<%S=\5<_Y.^1HQ)W#AS'#\J^;O2*6 =E2CA_1AT[RQ<MJF29TI<M
MC("W8:+$.(S)^&'MX"RO2(;)ESV;.O1X\3)-ER+ET626OYW$5?Y;P%@@<@)2
M=D?8<Q22=,+.XB!:=$#K4K;"JEW9T4&TAVOZ(--.+,+#NP.M[M$>ZU;-->N=
MZI\?SK;0&^%RBT+]BRCA0'989]04U*\S2@L.N,Y8YO&])?FSJ_?T/GC]6Y3-
MY\4>LFC/\X"14PZ0J=@)X1V.;);?ETVUANG,!EWDU@&$>G,8)(A+-,G71YTU
MP'@@C!L=$C+-C\]NNJ>SS8.CW65T&/UF==U$/SH(6KJ@#];,HA N5]6USK6<
M/.5'L;^]$A9&Z6:758(I+;T$4PKZ,6,*X@)/F%*(PGC\ =O TSR0P3GPE.J-
M,(@HU"]V>!P&GIJ"^H&GM.#P \][>A)RA# ">.C4JDQK2&DH@R[0ZNJ9NKD"
M$FPE8NN#18,XZ L?@_7B/ [Q '4=9$+EU60& 9UK>5DO#RL_.C#V=%$?8-J+
MQGA^MMV\E*]XFB*BL: J+&H*C@Z.KD[Q&2 U,F6CE*'O5Z,;EYK'.3C'I5*]
M#2$'Q9'?S57CWX_>GVE]?^ZTN>.[J^=.1W+]?RN/N#B\"O#^CLN(WG$QX,WJ
M*1<%5AQ><T'1^70>A1BR#_H7>A0"[P5NA'?2MGAC]/WV)]YJ[WV3T_(VRDX#
M\LES$,5BA82/(U(^&TK7"R5WPG-L=;$Z%ZFZXW2X>+S64>Q)<QW/R4-6N])>
MG'H7F]1I=AJD4>>2C&/QZGJ,=?$!+Q7I==VDU_V-<21N7@P0N"R&DI+DQSYY
MPGP*Y3E@;A=73-'M.+29-<92N?QRDA^E$/9.;<LV5C5M-,#>5$R!;'6QMP%>
MH%N\XU,M%^$>L&OC$B^X^ [+4IX]PW*+Y]M M@^'#A:66TJ9]F61##G%"A<+
MPFP9Q.4F'O_Q?0 ZX@%H,TQO*O5DEA$V2<C]G-'EX_R"SYG^EP2L:8U5C^S(
M&]1M6_-^&Q'0IX.W/ "P5FYT ]6-A>*0=I1P$X5=/AJ,F:%E*]$Q?-M- ^S*
MG;4'G48(MX#&,5O#XQ%%15\$$9,E$/?#K$\XJ#'#$PJ,<'$- 2K7:9N_2AOG
M9E_38G1-WMRS]\4ZF*^GL>*;;P&V#MUZ8P HA.F$5G5TL'YJ$,]N#"1%_6;_
M#YK-7D\ZZ#-MU1)+_;4E_O>82)Y=@I[;]<UV\Y2;)[:#9CLR@X9NS87MA$E*
M7<HGW3SI@/1.K5S=?+$1VM8;Q*;67A+C1Y^5N5:8,G'&='I@W8%>DR!=LN(T
M%X(^JG@*9ZV=>&(QID+!=A@VT55Q54V'(2LHP%(8<2=7*,3FG0Y;C15&+6UM
M#CY5[)L91.5L,37,\I&SVJ-F&%IE1ZFS)6,DCW+BE'+QC^Y(R:)0[4E;2*$!
M#UY6[^9<B:LFE:*K,ZD/8,3584L#\8"-UZXJJ:7AS98,DM5(AJZ0@7"GX-OB
M*:8K0LJG6^P:E%OATL>VA<<$MEZ.<02?K4R$RW?%VX,JBV6'QXW$]6/C&N(Q
M@<O*<-=(9I!A.!FUTP%*,^JFIYPB"<G=G)#LAI&4ZYO+03!J4?0/L"X:UC>_
M#T1VG [.4%F]1AZ*DA9##5317:ZR<G0!IM>#!,<8PATGL'&"/50D8P$46Q:M
M<'ZQS/B4^#I*HL5RD?]4O8_P@W-E^2\GCXR@63"Z(GSF3Q1.KW0_[VPQVA8K
M00 O-ES#A^HH-M+N7ZBC8UJE+?VS+CU<B+!& .WKG$8$@;(2(<5:+,*9KXT-
M%W3)>L"R7MP!ET7QMPM,B7MV@LQ"KBPGTHB@><\EN_8EG?(N0;,H_W;1*7/0
M;@)G(1CA)22H%=_YV._^A<3/Y)HFV;R]S]N7C25:NVS>)F@-[MHZ=KOR,6UG
M^9E>G'&-/@[XKLC[) /!VAKV@ $SUCD>*-F/;;#/6WJ9.%,D0@HYZ<E"_,NF
M\9AX0%J2FL>X<.?#4=OII=3",751M3?8Q%,P-"D>MBJ?X<H3'VPH$*QX54G$
M8&^N :G7F5P-U$,FKBU4NR <.D%L9SVL4,L)ID+#A0EHI5)'#S3"@4%8D<X6
M)@3A-DFE>OZFW4DRO>*R+,%E4[0%,5C140'-P1NN<(.)0C@^&N"YS%V:!ZD7
MV9NH+?O[LBD=Y,YFN'8':&^>O--H>YHVYRX.8?O3]U, :+HS*-WNP@ U''M[
M! I$%T$(QQWET1%83P CKAZL-1 /;G,CE !-AY5I>L!49L#W2V'U2=W,;[YN
MJA4E&A10!,(P7FI>1@0@DDS430RIJ4>$'J#);KA1,T>ZR%,D EF_]<M_NR4A
M3<(HCK"<7,4Z/PCCAU3H?/SQ\_&G7&/QR]\E'N6QI.G5LSP12Y3D8:::P$D7
M?CUQJ^X]].6&>M3EUU?0(5AOJ0@WV17!H#B9/_V_97E_4-4$8:7:3=)4"C7V
MW&R'8@S,O<32SSZPU".^W0D*FOSTY^/ODZNK:!$5UR"<(QR(GT6,,_!#C33?
M_O(9YPQR2W1^PA_IBH!]F52QFA,4EZK%=>G"ICBF+^*R#RP(.C#4QT<KAJ@!
M[=UC/:.JE> 2TG_&#^GO5$P1EKR!/L2D= 8,N[J2>I#*2XX1C0 ?](2=7 +"
MA0:%_C<LHDR<':W-+F'XTI74XTM><HSX OB@)[[D$A">0%?HK[#XI%IS$7.K
M)==IU1B?P!#8C[<>HZZ\QXAB+W[LB7-7'7QNB_29.@4QF<SRA0*1>&M]EHSR
M(4@[GGKC9S-UTO-#C5K?_O(Z==+++='Y&=GR<?V,8.>L"JH#@NM1?.U)B>Y3
MGT#JUL$E);6_T,'9=:2)_:F-0-EKAI:E-DFH8:6&/ZBVUD]FO9Y(58?NMBFJ
MKNM+^7.;)NT-Q53V*(L-?Y!.43'4V7CIV;FFE/J1.3-WG^NIVX(^_TOU6]GU
MB*C,_RPJ,YF6/5%:O=)4_VP"G1?F*FCV9#XJ /MTI"O,>^J </G6W<2[><#(
M:9"*)"(; DGZF6V*Z-TP="+>9O, .W7KC42G"<(]W8ZAC3G&6<#8:D;92\"F
MQG&4N:0*V+J2H\(KV 6N,-0)0'B"LVL9I=.7*(YY@[E,LB!Y%,O:Q2?C,-U<
M5#EXUQ4=%<#@3G!%F%:"SW5AZ+SH5HB9S'ZHKU#;%%%!1%ID5- P&^T*"2EG
MA%M0W6@I3L(8NZTZD;*'*HA&!0B98<[]3L'+L-XXA&-L%[.D4=64U@(H1!Y0
M09DM4-R2KMFC:#4Z4M7]Z ;I\-8V-1*W\?EPZH0Q<;Q#=G[1NEPWAIC*#1]6
MM/5*W9V@O[9:8]5J.B8AP-8TDD $:%5]PY%<!#0QTZ ]G6*SA;IN9.C[P*8T
MX4*P%,0A?JVX\:2B_<$ZY&<-+?#4\U A $LVIP>5K7*WR7:J-)0SRM(@)NDZ
M#>59'*1I-(O"7-!DUJ;<)*S\_6CP#=^S()V+_T3"L6>N7)*WX;LY9=D]88M:
M^J-6>[ O6-V.LR@X7("X#M@?O&X>ZM75\H".I+153C+@]3_[2J,@0YOW_\!2
M1-.7<T<XC6Z;E.7KC'P()LM##".N-0D=\=@ 8V5\#^B8Y&"Z1:KN+]3]P^E*
MO$G @C!;!G&9V7B%H-.PS2,-RLVMC"WP8OC3F=_2F M_+%];KZ6F[IO/',[8
M,J$YA/';S&AN[=)F!J<MI#2':(2PXP2;1Q9!)-[RG<PNHI1[,W_ZO6_# #&U
M;10&IF^T0=BX<ON-P: -PE6'MFE-X\NDX>* 1)J=!FEDZC^AQ17@-A?'XRGK
MB&CM3(\2?/6PYBH9,K* T>>CRS4Z6QMN3*IZZ8-E*KZUSMA?J[+C[J-[_A=L
M34Y.WEU+@JJ':AK?R;2*83X.3,0+344+3K^+(&W$F\Y9:JZP[>1+'VF*]/>L
MU"J(^$]$[2'W]! 0,>9>;Z$$3%]="C;3(\>*K<5PN  X8^KJP?FG$(P WK-,
MO6>9>L\R]9YE"B7NWK-,[;HC>D]ZB*T[>D\4C"3G*J)$P9B>$7-,3^^"SDYR
M>^O2;QB9'>?L!I="+,+9^GOZ:LR 19N^>C0SC<H8Z5:("XBUC&Q@K&#T!H$,
M<=EVH:S0P'4*4GX0_WO@XO[R_U!+!PA7?U:6+A8  !M> 0!02P,$%  (" @
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M'73X^#*K5-I8M]*!X:^7K7SB45>@0(/1IVF$,;M 0AG-LWK.W1-"*(O!W1,
M>0AW2:9P];1!/&T0!S)SFC:(#V6#>$P74^I#TA7<#%J<'6)5L=+$XF)CVB/6
M5+;')K&8<AA]$$\^[N:7NJ $$</OQRH]+$"!<GM51%CD_+!V2QVXO[,!%P
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MI%6+.1K1U6O:V&EF+-Y;>YQ/U0M6C4^!I!AVA30H59V?#MB2-WO?JL$SC(,
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MK&1!/2TC[><N['__</K#;X3[-T17N%1*7&:)E;O;N%YI$X-ZHP!#7SN88\.
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MUR2[I*+<W75EN?8ZMULNU"6IY<T<7<OLXU:.1)8P.N#I4MAT*6SX</1TY?5
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M/=#40;]K@+8F40&FP98][FS*SDMO@U%>ZVG(O]J]#/GICWKF#$%V3EF1:IW
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ME13Q)M[N6'%&+_=7#7[XOM[N6!7WD?WN/.I=4=_P]2'*$E;,Y1<TJ[[7D]B
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M*'^I(9NO[UA.DCRR!VW?J+Z^O2OS=![P=1_H44D_D(U5U6SNY\W 8YY:#LN
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M5Z,^2L$>]?'"LH&7B21<[-6<>B([AR7J,F1H*:@8. @5!]WUG!3ZFPJ2GC.
MQ",*'M65?E20ID<(;^+QCU&C?($!TMDSB%'J,,H9GI/%Q%G".3V \D)0Z<"<
M8[8) $ZJ"21_0JUW%WF8NH<NZMA(4\@X%M1F%^YAB,GF\B[-BBN:W9\ECS0O
M[F$'9S0=E>=/Q1V]G+X3N9KB<2BU:_/C=E)CJRL>W?Q<-(2']HB<;N @!^-$
M-O3GX>2>)T6HYV.A*K=X\-0< BV[';%"ZIYT.KX<,!L=\\1%\[R):!OE^?G-
M7UEVC)+B//L2W]X5GW=\?>S\ICV%>AIMMW3S[JENE]<-1]D)QUJ3LERMN:J$
MFW_\60Q*/$I)0?"PJMKS<V;Y7<1^8K(NFY/K)_*M[D#B/-_1N4^@(8$U]8*8
M@0ZY&>Z)$T:,\S,++RGCQ.*95CQ]<RN<5O7G),U(V6!!6LIUGN XW=.N,;CO
M,7=B#Y)YLA(@*.J%4"Q<%NGZCT]Q0L\*>B\I <1M^HE]V 9'5/I6?25AH1>
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M]AW"H[>7B@8QMHFYS5="]U8YO:7W%/0VC*^?B+!0XO99B11=,ZT(LE Z' $
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M43(;AN*)&ZQR^BOE#[(Q3D3L6T2WE-_%?)\F%3-RDNZ*O&#480YFO@@C#)X
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M3[BI6\Q,$/WXIJ8C,6")M$^/*!K+7B&$)[!:-_;X60X!U#0)90<"$4DRP46
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M7EBP5]I^[Y>$):/E!#,P!:#!1OOX[]D_\B)>"T7:R9+]*>?6TO3GCQK?GO*
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MM%"LW.(,@4+XI8=K--[YTU^+@+Y!<D&NGTC79&#;<2%245=$!,/%$(L%6 D
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MMX442*VM+FAV'R7\_I8D34C;J'G[4UZNDY:/JA4!'4DS@).>\+IQ!O%=9 3
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MPOM47_WS=!$]54L%._J917SUC6X?Z6]I4MP-9]RN9A1R#S/C@:\0QY.D"(-
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M:O5*DW"3;J<ZX L&'QE7+:=[P^Z&T[ZV^T2U=>-PMLV$00 8Y7;/)%\T_:>
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MAX],BA>D_C6_UO\;M";;8LM C4W!%9P. Q08H+U>.#.)WEHJ[4AC\X U%LH
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M:S>L-<;ML)1J:-E?/2#Q!!(48=^.0C2?AS+EE(ZKB*FJ(9!0;]A%2":Q79_
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M>K2I7=_#77]T/GRD:*!/C92 K*SJAM7A^E((FM=6A?#>=!-8I-;C-N*QKO.
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M:'B7AS^^\CP$'."YSX")WZWY*4[H64'O!<4NL$,K5]H.[@C7N/ A;#"7&CI
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MF;U)IY\E;"WV67K]##94ZGX3+"J5GF;9(NEZ=ETI:FT9K A58A2. @%19+C
M,QI@\X6<2K0-5VPZ?J>$L8=3"D"O:!A6[B*\<! [; BXH3B4$P+K=;:C%@_L
M03N.DY2V(QZ]-:Y\IBF8:R#'(<;Z'*]Z=)\>"H;14."(*6TPI%)*:VQ(. WR
M/"EV?>0FH%L\X ZSTQBY(<_RO(-9GZ"\H3F4%.4X,51/M1"-H^]]84_:$,+Q
MF3+QPIMF?4LR1T1=V@I'Z3")XF4M"SPO1?#C9PG+QPP7*20?I09B:-,2WL^F
MUBOCG<%YN)0/I=:2+EQ\BA-Z5M#[W&+5>M378.6ZTW>"9;^]MUE6L(?>75<
M^_96[^EUT=&GA6@E\"OO0\I.X0B1 ; ,UP&%XVV^%+@W8[H<./ _-<(G7=P>
M>4:%]_(5W^#1G@O@@22Y#_</V_2)LBBSQWA-Q3?XGVS+8,JLS0\+WR;QW^F&
MY>TX9>WR0K.%Z\''^!H=3!]X%X+@1>7SXAWT*(&WB"#[U;^"I'Y4=5/>)G8:
M/<1%M.7FF#S>ISO6.K!IAP_FB"\>\0-4Z84D>.XD-Y5@?Y]0)<''Y4'X$<ZB
M!Y!W$KT*PC2"H+^BZ, 4X7F5;_H+#_WX\57&^;@J$3<RK\]+^8EU4A&7'^>H
M-+VZ=:EKL]'R9R;5P(OC_*'3LV)K;ISS\;U"U@1?3T]Y"G4V3>AN.W6KO%=%
MF ";STT2,)^>\A">AX>H/$4YFQP<X\WU0CQ:=^C*H7V<ZE"5(Y"'JRZR](%F
MQ=,%8U]QDFP^_&T7/W#4JQ?F8=U&DS1=-S0M53ORN"(.<@P3.X"IX4VS9?L%
M*7N48K7O$]IR%!! 0IF!#ZY,--06Q!H \3HA?CTLW\*<8H&7U>&OB(4O<_J!
M;""+D9*$VM9@^;NGMDU=HY5O@E>G*22[HSSF;!=-*!PC\9@)<2*#J0V&+\%2
MH6!AH&N37#\1X=R!&PY-OK"H(-0W1!3*],_1A5@@4>(.B<L>J@*DJ"8C\O*5
MR?,R65O*A$KE0(JA+S2G#!!WK&![3Q_I-BU+MLXW.4V3(HO6Q55Z0;.;-+O_
MF&;GQ1U+S>IJ",OPJ!QR-XRFH:ZA>"R(D$*#"2F*L\$;["J+Y2RM8[._5-J8
MY22M#9<OOJE,AR:E:(P0:BDF%F5:ZNI#+*8XD0=%:@^5$598TS%Z^4KI^2FM
MK8_"Y70@%=)ED:[_>/=TNHUR3<DC;3E>TAFWQ)O8#6W[7':1^ +.OX2]^Q,J
MWH1/F,I&H=%?/N#BZ8YJ9*3SEV$GR8Q$;-LOJGPL ,C\.$!J.$E_]IC23XH=
M0#6O+-,M,WK[*TUH%FU9=CG9W,=)G!?\19:/M#X[,51HHTZ-6 ,[N3(,Y 9?
MPDW<*JD'-[2J&Y4%8-1K-C/YS/"1NHS>@)&@_CUR&GB<#)IX><#()0XN>7:H
M&B](%Z']#H$<TIP J;+DX1&J\Z84W5JN;"FW_#]_H7G!OF1U\&HY3#P>3#?I
M"=6TJU(@!N/CB1/\\)32@^UN5?^-L+1^GY,W<4*>V.PZ_W%F,?*![M0_J@:Z
MANBEIW[HT0=&4N1'0#Q$-R5)ER.6OE+4 5.'R='P,BG>,QD> IN2GX,G+V2'
M,Y1G,Q;U$8V&Z)7Y5X9; ?(P&3[O@Q2V7^;\@3?,SW=%7K"I+?M*?Z7Q[5U!
M-R>L?(YNV5R,9NLXIQ=9O*9?TNWV)LUX1ZSYC', KK,>AP#F4G3KD/$7"^?Z
M"EX2Q/_?WK?_MK$C:_XKQ/ZR9P"?V9&SV'OG+B# >9W-;!(;B><,%L'%15NB
M[,:1NSW=+2>9OW[)?JD??+/X:%F_Y*$FJTKB]Q6+1;+:SJAULWO0"KE 75_4
M=D9=;U1W7^CD8,]7B"D$A % \XRQ+2"SD>4OL4@7!I=4#F9^?/YK!1(&]]YO
M8(34%:)O5W=E?>8C]%[K"_:*T OL!;O%96XZM%_Y-]*P*C]DS=+DMR(O9T6^
MW6D "L:9&@)/50R;H@NG^3:ZG&]X6M?U ^+U?REI]\5F/!5@#^B])3B#]<X,
M99#NE_M=XN1R-'&EP+X 1 :.#!LM*,W:+"G]A&@Z.P< X)Z"=X@[^N)>WVN_
MU/N\V.&T.A /UGTS4>2I&YHY4J\:MX&K=ST1 !L<X@B*FZ]@-8^X,&G==J+Q
M(ID;MF1)EA0E>L(%JL/'V*-'5\S4F3T<HEUS9@&V1&O:<?(K+-!1>3Z&X^@;
MQ.:H2#3<A[)GEQ6CRS*-AD_,9WDX<N3 :G_'DAP9'YN_4CS>)*X],UB^#TP8
MKN&7O=M]HI[0]$C5B7G"91[->I^DQ>_)_H"ORO+PV'SY+VGYQ_L"XP\9B==P
M67U)*OPIS=+'PR/4)H^A6MN='VVUH5+(FH;&LT=D9KB3?+.)*6O:X-<=:4&F
MG:8)*D@;]"MZ;)I%/L= $PXBK6P!9J!4LZ8%(/EGHV^]('\3?A_+T.A8G W,
MCA=5C&K-:*#Z E'EB&I'G7I$]5^@3V<_%H D+\N1Q;B[1K_*+?FRFP=\^SW_
MA!_O<*$6SHIZBB-2=D\W3IZERU=<*-!MX&VYTD;^,FF.\37M4/4]C]*C";$C
M=TJR055R*RPA"IZ!K]LO@%T'&B*]@.A5><]NVP^1CNA;TS7.P\J.8*TW70+C
M.O))ZSK#AI/6K*?RI#7HZ9SSO:X D]94MQWMQ]($DU:>Q9FR%F)'B]W,0=4E
M=R]$C]P3W7X![''2FND%1*_.I$4Z+F;2@H2U\:0%@>O()ZU;HL]TVF+T55]M
M#?NZ#U>/VD*LN&;:+:/6B3S1JHLVC9WK+!SIA:CLX=6.48]B-*/4J7[?@/:Y
M IMK!D6SUBJ,=EW,E 8-<_.U&!#.8YS:S+*EM-3DIL+;W_,]$;-/JY]UOC3Y
MX7I+74FQBTUUB>*8MKF$IL:]L:YBNK?=+KDQZZX)>N[;T(WUIDF4_M4E[5QM
M22D#VN&>E- &9[M2"M]\49XGSBUV);/C<3MNM]E[EW;4W^VSG]U:(+:\/+\6
M=Z@L.VQ+OEY:U)V"W&8U5 ]UFU5;?>C[%IH&QWB;U>PK.+UT86+2NNYTJA?#
M3'D)>1W" NO MR$T+0&]#6'T*RS0345VE]7P&\3FIH9W6<\.*SZ'Y>HFZ\(\
M5@0W60VLCN<FJZ'QL7DKZ)NL Q->SDW6A7I"5S=9%^8)X[[)*O_"S=<)E$LP
M4 Z72=!2'GZVTS WSBR"_A=P/-WI&K3N/CK9D-R$C[#3D"'*P><@#3N 9R#M
M7V!QKBFZS(&!_7&YIG'6X.RDXG)2[G(&B_%24>0+-&V.*5M@8'I<'@H^4] :
M\)+R!(OS?.YR!(OQ?''G!ZS+&+@_EJN@UENEJQB/Y H,C?M KMSPL,5GAH=Q
M!96N3N[DF@KAO%:(\7H85V"!WP(QL1[$E1@;YS%<!:-C<3:A*EV=_5@ DKPL
M1Q;WR5O>%_V89OA#A1_!7MHW$V@;OPX$AIHI>A/BB3FG)CEQ\&,E]IX;?:,2
M42TRSENT)OB&<+-,A 'YSUXVB&><6!H%)<.'93-SW/,1(I0Z$U(/7_$S<IE1
M"/,-?9/D8_WP+8FY^MCL-KG;XUO\HWI-OM0?4 $,I"U.WD^L;4M4;S_5M#Z>
MB OPV_A[J:J)?>NOFP>\/>PQRG?#I3;Y7ZVY1+^3U0^M )1M&;M2994^)O23
M8]=RT+=]2?-")QM0Y^#L1:T6''/Y1E=-L]R]^]7H]UFZ%PT?)$-^DZA=J/,W
M6,^\;MT$4;.&'OM;;1JBMJ':N*7&^"?K=KV\27O)?G>9ZQF-T@WNWZ:EI-AC
MZ:\8WZ@E-#6>-8BIZ:%K\ S?J\4I_75R[Z)1HYWG&CE>WZLEM,%WB9Q8WZTE
M-3=\W&YL=CQN)UCIK[-;"\26E^?7X@Z596>/A2L%IS=U]35#7=/5T1SZAHFZ
MK3%>T-6VWND%$TUKUFW._#3OO!G0#_+:AQFN@:]\J!L!>M]#][LORP=%=A-7
MW_B(?-#P#N[9&\7BC5S=O5V$.XK@UJV>P?%<N=6W.R)7!'W95F%W[:1NVB[*
MP[FZ8[L(#W<ZMVN[W,7;]#G=XFQ+,Q<^MKQ8^ESN=(WUQ9AF'EJXC'TMAL7>
M\\HS&XZ[6-OV$?J9XOU2C[5I<\AU?I<'4P]9W:%JY\G<^?=<@M.(>TN*96UP
MC^%I ZI36V\_G9V18_B?NC>*>T>)]PW?_?.05C\_9&55'.J@_+IZP,7M0Y*U
M4?CG/'NN3[!_R??[]WE!.T%%HU;*;4-30^6AIAPC<^,)6FW,=S(?F1NT_D=2
MU$O3B_::QD*G#COV0<PCUI@&FE.,[ "98"Q^@<4YHO"!L)7I<7DAF!"Y48\&
M^E%M *J(!<>L;V\$^>>A?D'U\8K:-VH8:BU;ZI6)!;M"Z/AZ@;[P1"-OS>L@
MWH)R0[N<Q^O:=D4[@VI^DP5%^6;?+,S4:V+KNM\.3=KM4-Q?\=[1?-0S;7JJ
MLZ2I9_ R@5J0RM?4JFFBGUG7Z'<[)=>Z@'6+X;=:C%_UNMHQO4%^]NK+\.K>
M5TRGXM9/=)UUM=VF]!_)_FU:;O9Y>2"ST]4=:9]L*F^K*B4KG*^A)%9$.ZT+
M[5[0^DCE>X29M>66]?LBISH1JE'4R[2GC'=?<YS0(#\SFL)OLES_M8!%B-)W
MB-1Y>5U@'*U! W/0M\Z@D]U%69(#];Y*6(('7>8*@'6*ZRK;?L+50[[-]_G]
M3^AH7U^CBX/V/(TQG9IEVQA/Q*YML[?#LP(KUK1M.WD=.RQT5C'@DJLSKG*P
M.CSDRE;N[)BKZ+LNPX&$#YGU[8W >[@\?%]7P1[H77[,NPCOY.,,?C3N:9DQ
M:G.N[GK7G*J[.I"O5J3_PF!'[67R;>-/OOQ0DP7/HGAB2XF%3N8"H<[U\71G
M63]'2=\ [?("I82 21;]K7YC$D"X9A7< ?EAGBH0KRO^'C&R.GS )[/..Z5A
M@KG9H>^CDK,GL,3JTEW!,L.MZ_XN9UK4??J3$% !EUP#T/NNF!H"OW^%89-R
MV/77QC]G^)Z>FG42>$FM=/G"%)[6=?V EHIK8J_8B\-9 !_PI2(2I,&^*82A
M#/+]']SO$B>;U<*M,9UO7;]Q3F!K %(/*T'V]$XS=&8X'/I.@>(>RC.:&>:O
M#*.Y?0%XK5A64;6JXD#+\=CYV3D P/84G,,R*QM.UHS/2;JG[RM[GQ?UX7)'
M>6V>&N#T]EQ-)/FPJ6'1)KLYAOI(D#%5,U+?7;LZ\[T[5(<"HWO:8:&>694J
M#E)?(EBZ28!--;K(@[&_5<2>(+H$.<_(4&[ 5;I\Y$I^._L0<$"?EA-9=$Z=
M?)$=3NELZ2JG+M  E%-G:@B\0F?89)A3=YZ$XYOJ<JW.T[IN'YQ,:EV$?\"U
MM01PL$MKAC+(I37WN\1):I/4>@!"N\ZJ<]4>L^H#;I]*7CTLO1WEU</P.WQ>
MG6-8-'EU@7T!F V<5Q]H.96\>ECGX"BO'L8Y+#.OSBS? KS 8@L'6EM-A0=V
MT&-SXLF7B\QSZ9D9"MEOLSR)6(N#=$!/RL<7K \=ZX%TGZQO$!UIPZ>VA:;Y
M92Q,&EM0$.\SKFAZ>S"QGMV ,6*7ZP>6F:=F72><U+_[/=\3:?NT^NGZY8M*
MBET4AY HCNF*M]#4>"(V4].]W?F6&[.>53I][ALMU,.;D\[5/6UE.#N\K2VT
MP=FE;85OOBB_$S[H-#8['J?C]F6/,X=V-.#47OL8N5?S480B4K>VS#C99WED
MGT60XRYUO*R"QJ'+%JL7)_Y:Y9L_CCF-V;SP)L_JUH=DCVYQ\5B7*OI /DNS
M,MTLNL*_]^J;@8H4>RND&7_!X>64%0Y>/-AOB>"3+P(<K;-QE&^-Q]LL.LK\
MO7ZQXU6V[5ZO?IO3C][]P,4F+>D!Z4F4W3[!-T4Z<Y]Q& ,4I]H:$W@*LC,_
MND@7Y.NXG,< #%P/&M=;_=M\OT^*$CWAHMGV7_BN/Q"_ 6<O.); SFYV=D%.
M?Q"_T.)=H5:X3F3<Y;%[0]=A/82%Q_-/C;2S3UR(3W04\I^24PQ_0M[^.T1S
MF![FJ\3M#H&/Z+<>E29;.Y,H0>C'M"Y.;Q8C8]N9AFK;SMXW-N_KZ++ *7G?
M15]!N#Y4946(FV;WS9UVX"P,5SY08H4A/_!4.+-(-_WQ5!_-?)<YO0S*L]+E
MO,76>0S,\^/S"X3KO]%=LJ>UZD_GL@*?$(!^7XA!6$\^4P7IG#G?(T:&:ZWJ
M&XI_K9*B\DYRUXMUCE(.S>_P?9IE9Z:[P>+2J1Y^8<LT*YJU*M<Z[P0'7E%>
M#WU$H^7L#"S!NG1GL.AU%F>9.?BBX;?&-8UQNS6N;$R<F4]%\W77AN&V@_2^
M4(#TIXZ!ZS9CF1<(#Q*6S^33E[0OI$MX]YE) ]IX24PJVN4A,:GU"RW>-VJM
MJD.=&]+\/G'[1L9..=W7.;O)A;I)O]OGB_23X;,,]M\AFI0$S%>)VT?ZW#X?
M94)>XO;YHKVOW^WS17K?1:=UPN1OPB1JEI*1<91Z\;TM'SC+HI5.4=["/[45
M0\#)*7BJ),!LLZ3DAZLLA_^S Z&3&H;9BX$O^C/GG,'9'06%^TOR1^&3#$O,
M)D24-@B7'W@Y*8!E^"_W)RHB]%^GLDSOJP'5Q8#<+<S9>N"7XE,]\4PR8\LB
M/.D@L]73;,+0W06QX_5T<G]?U*^)0FE?TNIY^26MY*1QX^;Y^'3FU\<J'7ER
MUO>*V2O$M<<O-3685QBN;4<AX57O%TZJU%T\?L']@C608XAJ43HW+\9E*-O*
M8$[!Y5+S[$W<HOK4O,FBEXCC%Z-,5L/UP[=DANTK1P,O' VU.WF;FX+VJ-X<
M);4WPJ6GV3?P]P(J-8N.;QI)VF0D+JOTD;[(&.UH+?]Z=4I?,E5OKI3HOCB^
M>N[4]EY,*>SL_51:O'#Y_BJI(>Y><*7X&RS/G\6U:#;\ I'YLY6Q0SM[KH ,
M>,FN*_P"WL#H:);UAK9'YK: 4P#S%X7.MISK)H@:,GAET]D'!F322_:!BTX[
MR,O/.2G+IJO66QG\2(JXJ1H:86I!T_2PA4J'=>!&!>N;^'KA*0%MEGDM_>FZ
M,IRJ!7ZK>4941T['V+C6^[J6Q^)D.&7@S\XF!))?EK<)OU+7L3::);JNT;%X
MFF 5UD^A6-Y27%FPXNAA7=FB%]R#$PQ?\OW^?5[0A^[.@3.4P!\"'RF)YT37
MP*SHW@$G--/3<:ZIXNG[C6LYY;)]N80*;@Y=<8#G[,#50)^CTU:S;Q0MRZ-Y
M&['8Q# 4!W[_\$ 1^D95H5;7PE\\'(/3<'_HV[O7.,67"P^^;7\/PND=/VL[
MO-5-YMH19R)";OER=EN4OTO80G<BV_H[B,_<6LDG>R71GN->J] IT,5W_3F.
M27Y+SPE_ER4[P47L!JE_E6B=H&(QY).]@GDZ?C!8&>38'6&T^U)JYL>^4:7^
M+:)U@L&J'9^=:N1.-5AUX]B=ZJ)WR.3?W.>15/Z+TWRE4>(^DLI\5=KBDB2A
MCZ2R31&^)NJ4#XWQ2>=UZ@ET0G5F@=]Y)?X3JDQCEY:3"'Y"E6.+^NN7SAXH
M!+Q?E@M:0GI@.<=6N4;'XGZ"K?5/^-AJ=*XLV+(]K"L[Q47YX'QNT-,/ZG9X
MNTFZL-,/<LN7L[!7_BYA;VLHG7[ P\L5+^NX@P:IO5[ B.6X@]PDOS<T%GC<
M0<WZ1:06U+]*M%YOGGQX:9MP"W1YP>[3QN[SHDU=J)D?>RY#_5M$Z^^"7=(]
M.]7(G6JPF[VQ.]533*)<W955D6PJ/ZF2J3:W"9&CMCCGPLZ^Z.X'J]D;8&H;
M63"^,7R2L\>,+^[G"!8HO4P$G6(/[G[\'>-W#M%<*U:T-;!G +YH+ AMT;=.
M[\(O'<?I?_PN[P,YH+@O)I>\+UC_<4L,)%_NAK#]<_*(W^:/29KIAI(6*E3C
M1R,5KN<% Z/\1XKF1EI- J9JU_5S1!N@;\WGL7MF&_CKN&-+N&FZ8 -M6G[7
M^-M$RFI_(9Z%@2$HO3ISVAW83H/4$4903?A'K/U 0)15Z3.F9I<W^3[=_%0*
MD)0D".,?B00GCE"HTU/THF*#OB>32VT7G:]GB\X8G94:O*2^2'F\53R-4)C<
MD2C8$@;SCN=V)?T. #])L_3IDT&&Y5L[=K?X1X5>$S?\1Y0SMR\R:,V[KMD0
M?M8<5FMCS8FLY\,9;_P<@MM#B;JSU5/]UIYWV58Z8S&T2.DYZ[-^UY0^?)V0
MCAL<V:4HYM!-"<3[M1GL&#:=87\NQP46M+QX X:O55)4VG!0<M?S3NO7^#[-
MLA/#A,AE:H$"Z$345"SL2266=&TH="=[QC52EPH T6D4+0"$/;V1WF?I+MTD
M9$&[V>0',B%G]_5<G.*21D=U<#2=!+4Z=3.C8B=;,BBI@5_QZ:@5,D==T/KK
MX?$Q*7[25]\.NJ%C/]1U#$PR/;SD-J,Y8:-2_Q%%-31Z@RK<0DU+)0Q.Z7),
MC$[T+9YUF >H\D('AU@-NZ;*=]5W,O&1-5_WS[?X&>_S)[H6?Y.75?D)LXH7
MZ?;K9AKU?K8,5M4$/]]H:A9264O6NFL3F*C:X,@MQVW"5E41(\+JZ?6)3K@I
M1E<K&#171VS6AZ+Z_PRZH+H/^M;T"CW9>,,P;\IQ#N*P$T^55-3,CT3'_D.V
MR1_Q;?*#GGC*2OP:9WB7$GOIK'D@$^?U$R[J#&4YG8<LQ733DK$86S]@J!A^
MTK(S1.@H;$2OZ]ZUSZ!PW ?V"K9PRV&'?N(R#"6./(B550'9 #=)6AKAB@JK
M(1=J :B1@(@(U,I O[12_G2!CH+04=*9/Z(Y-S"!XIF1_W8HTG*;;JAI[ 6@
M6FO6_,IJ#>DXYO+=SI9<?<J>@".AX7M$C!6,,X^8XL$0T&_>D<LRG@[WH'(S
MZ?!U62**,84,&\:R]'(".167;XVY\ Z<KO.N=^_3+,DV:;*_R<NT/M/!N;*K
MT67HRJ5=(*@G4:+KU*7T4],GI:"*F'7?DFX0]6U1USB>.V(Z )D24F, &:24
M])XQ4TE;%.QLHD+B2>C9JP(_D,@P?<;MIU*BZO2><U:M-QQ]5?0Y8K*&:D52
M*TL<\WO4NENT1<AP+62QR:X[W%S>JPCBN !U&R+P!F_V25E>[^JR!%<_4F9^
M4]1NRO!Y.R@N3R6[650)-"F1E-EW77]:G\6HRS]\HT]BX1UW9%D,$PT"ATO3
M+DS6L.6ZA [LTDFDQ1@WJQ,'CFA)9(6<.)9!M[0T$\^?CAY.G6C[$ K^M3AW
M[G(H7@GKQPZ#..5;_6DLV!X/#PO0LQ^5 ^*Z'1.Y PG@(PWOW4:B]89Y=1+C
M+/-6"@,=AU_ZF&;X _DG-]:;-9CZIT$#*.3V(MWYJ:D*)1"/.PUQ3)^@^E$L
M8)Z/&PO0S%^:@^F^+1/7$TE.H #OR&;B]7&P.CT@R+R;!A+B\'+7NS=)^?!^
MGW\OY3DM;M-Y HO1%"Y;-1/N*#7%TZ.8AV)WGR2=2!M4-XHQU<0?<'9>23@P
MW"32K!<G8\21'@&+WOWSD%8_:2(KSVBQ"U&*2-1VRB-V6R@BL:2[BRL$VI3X
MQ.U_)-0%:AJA8ZNX<@'"L6=12C9$'$ZQNC%)Q9?O&F3P$8M(DQ7"2!SS4G E
MBV^L@15+U%,GPA[R_9;XK\96>?@C[S./@T1]X (BOA9'D9%4H6*())$SCI6&
MC?][Y^HCC)H4<,(.G]2&D1M'\;MS BJ9OI!,)99]*,L#WKX]%/1.7E-UH;[]
M73]LJ["VY?WQ=D9;4P$]A_4%6!-:5Z6#:,W0!#'?C82N;XI\@_&V1)1A**_;
M="^NPV5$)3#,L99#C?[4*>C*&GL(,TN"P%\MCOQK@_^L?OV'N(R/L17P%*"!
M9S] O[QXK'.#4_]@!R@Y8Z17K2;-&.VW;IR^M("-H=3CN_H&V#^[>GZYG #P
MGQ?<\0/_5W!+&5/U\)!_!?M.BW=]@$1(TQCP<CGS*A[.O(IV/?49?Z\?S5/6
M.IU4UDV#3B[]1Z]&=WVD\FYQ'<7&SF(L:/T95^AIM!I*R=.Z$&"^0YO\\9'X
MBK(^^T;O#!&/0-Q&M90ETAQ*JKQG#K0&U?O^RO2>:/2&8N!W16OIA4'QJGNK
M6UJW7L)Z!@B8)NL62V0Z7I^,=,'5R=12"8/*RPZ536O4-&_CI@O45=LD?9H6
MP6_FNX>KR3K#$JYA"WB*S/R"RZI(Z>N]FJ/3--C^K<A+K5A)*D0E=A((<4EU
MKEK?L97,$&-_(!:\_GRH;QB3.*N9L!8T?\EQI^H@E%"@X2^X\I3]A\2B8)3P
M&*A)[7!#B167$V<JF(1ZCKG@.!04ZO83&DI-<,,#Q=#Q**.]G=8F[&HY9\:8
M1)N.&1-O-,I^'XS6T0>A!*6S#QP)3C<$F#H]GWX0V6"^*\"7.MH5V QW!9:1
MUI- 33FW+QU[G=P^4YAZ<E]@2QC\ QZC-=;O /S="\C*=G(]3J?,+;#C+MD%
M2G:$Y^A]7NQP6AV"%]D.RA"C$Q.N*!+XZ*_ YG>/3_O\)\9UHQM"T@=B?_U.
M-9VI52Y%97H527'I8OAZ_4ZS4CN,O8U$<N=PVO3.(=L2-_+NZ\U-Q Y$ 7*J
M3D1M_#7\"%^@LB^1V12.#WZF7;D-CLBP4EO:=D+:A6TG!M5RSK0QFW^=\R;>
M>?BZ>F!4,%;MH#*[MAU<.HY:A=\Y<ZC2V",<A4QGPJ?!L7N:\^V.ET3,\#$P
M5,D\&SH-VM9]E1DZT.0%BW[FJY$Z>R JSD)U^]/%HLD<8@C&&&>&WY/]H9G(
MS&Y\R?N+YPU1?S?4Y6OT-:M(+3#@MD2FY+)7E/16@):<[6JCK<1]OB@%5R"S
M(P367<]:<NW@0)?,:77GBW8]U?8_WH-YJ2S0FP(=TB#:"5+S"#^[C\)$Z/P
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M:_BWM:B]G%;6D+MF!GP-+4^TAZRNUEMGA9T7D;<5OT=691QD#&2_,58LV2F
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M=056",R!$#'V"";2>J]@;DH(2L!$>#;:P<FP.K/!%@P1T,$R^#-5"Q@ VI@
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M$/ QAPXO)J+U1GMU,L,M#324QALLV!C(=!1N3#3HC3LCGQ1AT*$% &G@H00
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M.JDN-71DR987:K*<^#05U?Z6$1K6Z#LO9>&2D*.5T[T6<RB)AA\]U2)U5UK
ME;HH7?PH>B45L7)/I&Y<4&XYCO!US'#'*FDD?Z:5#72BY)6K0%Q5OX_@6\<6
M=^PB07;'GZ3ASV;('Q)B(WSFCP A4?(GGJBX#>,A@^.)2(@8N1<9S.NT%L05
M,8^-<N.$ACJ )OH^F;=@CS4%.8CC8H ,T'UU&500+S8R-0961A!K3ZQQSD>P
MR/M,2 U\+8"1(</S@1FQ1.D3DYSS4B-FGZ3)V^9ELD^*GV<RRI&U #(Z*'B0
M[U1/_TSH;=I]5 I!I[O]56!U;8Z*)&@;(+DEK"EO<&-8[U1H##>(#9"6 XP^
MZVJQNJ3)/6-=$WQ#'K(>@[YF4+"OSF@W&?B < >I]J"G$KST@[YZ4-!/BT(,
MST9'40;",ZR%!2(\P3JBP](9&:0]#5/ CTLS)8,<F)Y(#G=F:V1(9(>F6;8Y
M.K@U5P5Y^+*7OOCCEVQ&P)SFXD(1\CC72 G0@2Z&X1$1.H9#U$RC?%$9]B#U
MF<MV*%P<F8,>J9Y9$\VA:J9EOBAM=[#Z2.&E'ZWV2F$GQZN]4!AVL?+/0UK]
M_)!1U>DS?I,_TO(<=0A,+;S\R^K?/V&ZH)HN173[=0L-]7Y6?DI5#?PB05,S
MW\EH"5HWS5'?'@T[U*$!HEW0MZ93X#+K^O#);49VPG%5$4<&ZRGUAER@:%A7
M)0QF5V?0B@?5*VIM T,=79!AGZY>&.R2D*T&9OBM"$^@Y(5+;D'IZ=PL,\!1
M:RT][0H1S(B%>SRCJA:X*'07YC!B<?>*") ?=I'%(^*."B=4H&(/N0+7QRX5
MXPR5_B\48]H'%[5!YNRXH9, 04V;#=1(,/#NZ\W-R2%)^]2=-I+\S.\DIO@W
MO3E^WD,VSP][."''48&_^7ZF4Y\E$Q%BGTP;Q^Z8&="04HH]=HJL.G:6,VNJ
MR ,2'0<$<V6V&)0%!B\#A+I1@CD*744+8RT^(H:Y1ELL-FF$?T,1AP_V4-,-
M(\RAYB^<N"(3ZA9O]:,*9D>5X&+2T1FE1GK\AAHLU68,FTM2\/EMIR7X?C:*
ME'C)'5\-=HYDJ)&4H=8?A#W$*$R=0.!5BEA>*'I-XA@(^+J,:F;*? 4W3,5
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MDA*O_S]02P<(V0%C 9'8  !XUP\ 4$L#!!0 " @( +*%^E0
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MB"J%$(?#>%6966.HLA"Z/Y\C=/D\[!B, PB((2XD,"&$PQ5E"^!"#FP<6'B
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M5!DF.!-4<9@ZHKPEQTNJQ/S8I'KH?72[,R#+P-[B;U&<1EGV%J>/9<9FQ@X
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M$R;0)6HL]&/'KJ1DIEEFI9+6Y8G(#<KDJ)158F*27RE01 *U8 */_*:<[7Y
M5J^RTF<HCQ]3RCQ@KAP6%LR5[<*!HD@BM;FYLMU$Z!&_+/EH#GD0PKH%!>AJ
M"@:-+*:TYE#5D _]:),EVW)7Y$644A\@ %:,T@)L=4H'#3"^W.90UFDC]./)
M5B0;</6E4&,8*3B!=9>Z_'K0 [4SXAS4-_A)7!F DD.X!>S$@,L[&EY<]T6P
M1ZH#X9CK,4DI'IR"6XG!Y#0$H]X:3.?LT4\(\1=@D*(\,(6Y]%*0V!"L6(NN
M7T/%5B?VMY*O!RE!"5;\=%,B& #)Y=/##9-NXR0UXHUW>"ZW5T*^W"R?45:V
MX#01<A6PN>>+<PHG*=7)GLXHY?#N?Z5D^A90F4R2ER-'6JZY^<\OYS):/T=D
M@-.$O&?H!26X3(A7<]@3%%1V'Z,O+.O,5,D["ZL)VK547/)57+Z0;.@7"N]0
M&8#V&TJ)#A(BY&*]C=.8RE_$+XB-*;5*S2D]L)+?*-,270%N4/JAGR(.E""S
MSS*[[#MP9 (I8(1!RD;*GB-J4+;<8.D/%##&(<S4XG3R<.Q%.]S.X0VO88G^
M &N7" (@7)'4H=$F-<+B>G%_Y1JGN"M7DV^=O4(&EV^>*Y:7=_E&U O*R[PH
M%6NLI\2X)?:['48)=P^V@[L'0X3KC@TI\>J=* ;1X$TGO>'(%;]O14&%VSGD
M!(7#0)*2R!J@DM$/?=T+A194Q<$#RB*6Y#":\'I9=?H&+XX A$._4G58]ET0
M=5=9U'9$W(,']P1M<(9:+R6>OQ+9B=QQ&F5OET1K.>C.YQ%:ZOAJ+;7D\T X
MGHK!0\@J2Z$_H;,7NC8K)RA%FT'^&4FI_O.N_5+^ U8FFB+8&.1"#[DD^PVN
M?X/YK5DR=;_Y# 61&/ )NTMD1/BC%_:A29#41-2=1'F\HJ<S<;)K4M2<Q?DJ
MP?DNXY[_C:12]X$V%<_4!U$.1'2'HVELAV*8V-U1I]DH'96<QD+WG_3%JC4A
M 5BO% =B^U)3 AE;=&LPVS<7^*/N@,G3C(D'3[/:S84>$/X%Q8]/1,+%"]F]
M/*+KW?8!9<O-( B0,Q/K5J_[1[VZ_YIBS<E:=15UY'H.UX8"'J>?[AA7Y8(.
M?L760Y_E.>+6IDX6?*U96PQF?NTIP1FH(VN YK<__?7$R(D*O)!0;\?DW1]/
M@J4[26:IX\)ES'0KE+WJM_)ME4$67'E&(Y7:P^1&L-I.'S_?Q 7#&S?\<'C8
M?/_!AXL02OV#!8)QKT) 6JB?/=]3#GVUP,L:_3G-4)30ZXO_A1-JT7Z+XI2*
MO$SOT&J75?G;LC@GG\[(/]-'LK>*\9J3']QV,^TX#BO-A#@"CJ3TT>/)'I^A
M1Z1H9.+72#CO?<Y]XR- (?N^,30S\_ '^XXK0T .( $E#[=Y^25#A!]<]-&H
M$S9E,NS DSU(E2O6DXV'PN.'"G6&FPP_GT3<,WA/TZ?S).Y\[(M6?_1 ADJM
M=#3AE")M\1KW=TR@LGT)V64=G@5V^3G#6[*VZI\$BLHTYX#L,@XWNJ4A_X2H
M8Z:_U65\:C:[G4^^I"IC2R$HPDQ*QI;JB#,H4^^#C&-,2;KS8IO0,)U80R#T
M+?GI(5D'$P#<[\.D*-YVO4P&<;\S:NOO]%Y0]H ]Z';.XY9,"(#*BI\/]18:
M*K*)82*A%'HD/.#M-S9X5.O!7^GS%U2:,DL !J<:>E;>_A.83&2)"W$>&_46
M,R!IQ #AD0@]O+N3%XH)!4$)5L8M;T$@ET., &9]&UENCQEI*=P78N%&JQ<\
MR:)4KNP[%$)?T;.O S''#:3HX7JIH*B_Z% 0$8@6,<7 HU]@[B8,<]=P_,PL
MTF7<+)NDC?'H0J-=GR16<^UQ5%G2K-XU%-(*W:;MQ;LB"YSRTB//33HHT/>-
MM@HXO=I(IVITAJK_OTR'WO9;8F N</8UROJ7)C1K'ZY"JM5VV.V2^%%9]*-/
M,:"ZG8;E8@X""E4:*JT'-XI3PV(\EV$19+QEA0=V8WZ>.0!\VW^S66=0F'W(
M66-%Z--("C2D<P0J@2&=&LABA'0&ZQ<6!2 M7J(XH8.#R'X7):@51[?^GUV5
M,4PCL$R'+"#X3(ULB(BVI-31X\$<7Z$[ODM55:]PM&-,J_59<YD4E>%91%&E
MQEF+$ST*[96(*H40A\-X59E98ZBR$+H_GR-T^3K6&(P#"(@A+B0P(83#%64+
MX$(.0G^63SBHK]'7\M/0@:52"6*J6Y4FA%VQ0NP:Y%:K^JD:?(D $HU,19"R
MZP!L[30A*E2'58LZ!&BPKP"*5T;TX_*Y3)!X_HJR59P/,@OI$P"M@]D$)H1B
MN*(LKX+9'(3^1*%P8:0/;WE]R!)X\N &J\GN E@([6!?2%0^M?O]XSLYMQL(
M:O'D3N?%Q.K X3Q=N\>0OP=W0[3.1W>F5>K=X9WVZ1UO,+F(0+H:Q,;@L<$D
MG+BD?4MUWFFU%J8?\37L"<4PKQ:!J40<@FXI8ZYZ)5?;^;0[>JUIFD2@)W?8
M3Z/\Z2+!7WW)G[7G1WY[G5MT>&F=4=1I7GK*STV&7V+2@R=OG\GZ_C+=/RJW
M6!7Q2W66R7EY39O (<.],H$YQD3UE2/]7H*'F:@W,K7D88?S_OP>WR*R7%O%
M">J\:7"/QXTWFTWL+\C::,)A)'.>[Z)TA>H9=I&NOT19%A'Q:, &RE[B%=F?
M9J=)% ^"MK7J-E',:G6=&0>KD,+C=-BU,#8X+9?_:AR&;J;.$.%Z%5?82M>+
M+=UN_L4*8P"4K#M*6'*RT(;KYSA %O(3>O*_Q8ILSDO)6F+1-,_Y"N_H/:)T
M?9.A;;S;YH?G7OL&?1R1P\U_+2*3'0=&M'J<(:++JD84]*_5Z$G1(]WIWOO@
MRABW$3C"XM/$EL(.FZ&;SZ&/<R]NG0B&L^50K\B]QL>OZ)->R/A_CN+U6=W'
MS9.Q:9749)'G:#"MC"/"U1>,B$>G,E)D,-WY&KJ2';_P&&%[^V$,:*S[H5.
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M<YAC,?"[:K? 2/T*;9L!&WZ'(_:6A5D1'\/4=[O:G!3E\+3!?>C^J1&*)?L
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M30" O+P[X5N9)AD<]B2'%1X^L,4L["Z@ =Q_6%'D7@B"K!UJY63T0]\*<94
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M^449(K\$"A&VI&,@\DL/(L=W<.M 9+$M]T+J2&%6A "F5S$TW(CD'@6?'N'
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M(5/N'E*O*$Z#XJ=+"() ;4VHPTZE*?_<XQ+N84%EXXC ,.A?&)I!/.I$K!G
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MA&HH[$/'[(A&[$X5FPW\Q6.%(V-@E\C#'N1M0OMARB$+ITF4Y_$F7M4A(/S
MA3E4P7FHPFF4/YW_N8M?"&<T-J<H$[C&Z>,_HV37CT^ %=ZG0A07#L1R*,FL
M8RYD#83N6ZR.RZ@:N.LZ49'FE)-9)! , >3300Z;;.B[:SH>^F,B7=\]X:P@
MFY?M9?J"\C)IY3"[JVK%EJ6"5@P$<=JZT+5@T,9&G"4.W*;>K'CX*YR3MR9L
M=1<EGZ*"_OPV+WN<+WO$&]BZH_J>?V75*- "N2JDM/Q7Z"VBY]/$!M#CZYR,
M,OKXE/+YF2'JBDH'4_=PDE"!HM2M-%;AT$D&P+3<&Z7!K/Z2>_0;4\<>CC@A
MC3]21=Q_Q?=/&=X]/M$WX<P-2?465(>E2@OO:&AJ*][5\%1A6'^7X^L0G4-*
MCCUR1H68&!\6X) 3(WLGK_IQC)F#K*IU-K4CVP_=:P<5_R**L])1.7)SQ*6C
MN!A@T/%?B<R%Z5X2DWNA 5$36Z 640^-"Q1G8W<]/-7J31L#/D=O=%K\O1?C
MQ%U1CAY;8,*F]C+O;XRIJMC%. /P&/IQS!RJ=?Q1,/J4<#3&&0>*\[9#9;UJ
M<\O!:-NDE3GRL5KUNC"-<[U!V=T3Z4</SL?.HRPEEGW/$F=W(RM6@X%?S(LK
M7VD1K^-D5Y")ZP"Y]@-S-#_=KLGHTQ=&DLC$(/'AI3$CQ!W.K>/X/WEC$V"D
M53E"2\T,;K,EW[J*^\8"M+A0:2-?5#!E"K?/"7Y#J,Q.N7SFOF@D+=<80WXY
M=VL$:'=AN)R]%8"D!3K_"RB'OF/_$M%$;NP7'YG?:B7VO@4!$)$\ZJ#H40M]
M.WF+R-(GIFEP2Y1_3N,BO[W[S 0&J.SA80!1V2" HR*O.I DU -/\G&,!0Y6
MGM<AO62$QW+[*.5M.DE!3.XJN-UJ8WG,O=]E0"(^" Q)$OHJ9*1RKC@94$R3
M-;.3NO(B;\HX&19;^KB$675W:9K1=4,SU.EO",'Q1I&I9Z,3XE7G2K(9;N<I
MTLX4R3-RGL^'5Y.Y+RUU56/+;MMN3_/8Z5V@-L)&P+>L]T<]GU"4[[(J@;X'
MYR-[OL[B?)5@RAKOYA"D:)/66UC48>KRAJ^K.'J(DQ*$=8>LE^DM!69&<%>&
M:7Y.\4..LO(]N<N48+.;G9]U6F*+?%^KQLA[T!,G;_L__RM&&7TYXNV*OAO!
MRBFO5*FO-4DE#W31M@U#7IGG$UIU^YJ!U?5 0262\[+3/C ]C8"2?>%9)=VE
MN-7J3JPB>"^/K4J#9>I444.A^Q58PGT$ ^TC&&@?IP4TMN 6@/9Q*J<G+.%^
M @/M)S#0?IH6T-B"6P#:3Q,Y35%<,>%Q"PI.1PC;[O0 K$W]62;QI3M,;Q"P
MYN*8TV.&V.OTK82MR2P=3MY:*+[(T)\[E*[>Q+L968WA5H9?PP,5L)@#[UXX
M-01[ED$-OU20[P>.>(('5!%MW 95W%LY0*_R9ARQ N0S?J\][BPS:"?P<P,5
MH\+1O7@ <N=X7G,\U0^:F8KF[<[MP*GBJ!,[GZ?)[-,6>8[*;&AB#9("USC-
M.@H=G)CU#;])VOT9P@QM=QW0RCG'.%3H:116N%:1K+![0V(4%UA1/1P#8H(G
M:CUDO(2^':CT)(>LM%P3U\(O-SV@0I5B&:,"-D;,:SY<I3S*6L7"M';$58T9
M[J?B/A0=^6.+>!)V.X.I3A<:8R;@N)/%:I7M4!O$'@2=#)DZ)7U"9*Y&TZK^
M!R<1D5;E9AI5K.S^MMXM*E\3&G+<4PNX?._VGJ"\NR!8O2[&ZEKHA;$JM=N^
MZ2=H+_25[/(9940_Z>,5L:%[F_K&1B&L<*U\6>$ \:<D_UCPR1H+W?FR+)Y0
MQE5+'WF@P@WR)(5#1)Z*_*.1)VG,QK+7BP4*="T"778$";5CH4P.,)W7Z%R_
M/M&UVODUO19.P^(]6)=7'''6W>R/=5?W/VH,W57RD%/&/O[XR\>?2[;H+[]?
M[^BYW'*SW&SB%2(;-IH-L:O"'J,*-6KN036<#52.XK&.I-TAV:5,AQR(XK16
MM%]0_/A$UNZ+%_+K(ZI2;C8?Z;,W'X1K7'AUYJH74MU#Y(W4@0R&ZN2#7^N*
M)*:.+GJK\9;L,6]0MI+MN^#5(9AD5@\-DW(=C,(DD[S)5;#;1<H)*9&NT-T3
M0L5-JYUYS<)<LW2U=TN1LMQ\SJLS!0ZK2G68PY9;QQ>KUF-010$J@CLT3FJ=
M.+!98J&[!@K4U-!N#9H(_XDDH8!W1%]E8!+-H)X2(Q9'R0W.8ZK$<VH4\_@A
M05=QK@1'=:H0X*I0G0C$M15I8S"H,!-X$@'H*@HV#ZDMG;@TI[6OW/OC01,^
MM[3XK,2_2?Y='!!!^V[<B9"D%84CH,G,[GL)#QYC&,"&Y<48:Y</&&9<L4TA
MK=W M'PP>Q%A (/!*F@P68*0G8<I/ !.;84-;4'&DP7-J@%N0D;,OU;V'QHS
MM<;60^?LTV<S>YA)3 ^8,92AJX1W,FP,J-+\RD-C\/S;Q/?MLNVDVHZ=02W@
M=XIZ9QL7NV*7H4]Q&F]WV_*GF^C-E_1\3D\W3-VA+,<DZB I1GFCY3/ND[/J
M%9O;CPH5W>GE"N4Y0IR1UO#*? %T@(.QA/:8T2?D[HZ*.DJP09WU[J: F:%6
M=@P3H3M+0;(3?5T3\W[_%24OZ!-.BZ=^L-=8,BK(9Y*9(N[E^K*.>B8+H3N8
MH)+7[]!J0KU76Q'A^]H3!39;.\? \[[ET*/CE00F+??OO&O7UX%R57_*8&9H
MZ&APKMH.W2,%%5D3QYKPG2QJ'8!UE./'BS,&H:2?TW4=@(K6YZ\K4I3YX,XH
M&A#T\FE,"<I 35G#-;_]&N3_K@#R7RN0I^B17F"^]\(>3_L@5@^1.F>R:IB3
M'<_^;#:(Q NON;:+4>9 5R$<<'H1=5_Z:92L?MQ?:K+ 4ODHZA-.B$[S\S]W
M!,'5?R_S?$>[Q >W?L41Q^W-_MBD[>A]=&>D#X\[E1H_>3M-HCQG/8L#*%E+
M)RSI4-3=0QZOXRA[NXOVS#$R.DO+-6+RRSD4\L *?6IVN;G/HC0G(".#DIF\
M&5ZA$1M0P=PE'&)(5CA);Z+LC\4CV:92,\1,P"POV"Q]!07=/10([P6L(&OO
M.3]I(^6B54#<V7$%!QV+XOX)?2*<HF*Y(=S05&Y"E, K-#D? !4"08VR[#KH
M@302^*T+^?R -<QJ3]F\-LH'&0&T T_##5EL8/A4W5,NGWBI7CY1PV^6''-A
M4,I8"W/%R64M+%.KDE/&G$UO*_V1F [JT=B;DM)#LM@53SB+_T+K&Y3MK0M_
M7:-%9KC:423C;.R(>Q$;4TUW4#%;[5DKQ=9\6VV4,M -*%J?[2C[A-T8K\NW
M;?/J]T5^BE-B/<K]-!ZLM;4)-&C4(. Q#L>J XI C79"#U)HKQ'J;$!M>2_3
MUII!L".$5F7L#>55/4:FO@K4K2*@A=!C#5K2WF3QBB97*:7E(X]9;(BR7K$@
M$"4231T]/6JA'^*W).M8Y%NT0O$+3?T-,ESPND-,0>H& 31E):BC#]*$C<L:
M8Y9Q--?8<L/;-W"^UAH:?/47"&)!@%T](*)Q-FUW3=[:792;B?868I$D^"O=
MUM_CLSA#J^*T/&[/B%:+MWM\L\M63S25!7K<)5'6_%.PD33< F./::P%?X%I
M7Z$:.U-CC.@?LUL?()^B5WJB.Y25_-VRV!<X&TJL/%8L-C8<-E8:"V($V5>S
M^F"RPE,]KG[Q=UQ5^[?2;M -W&*U0@E=&:%U(\4BK[-*[C=[J>IX,MD(=QR9
M:22D\6-!K=KCQ@PO]7CYVZ3&2TV &)%UX\N[>T:K>!.7ON,8KVT,('BK)D<4
MI-6)#S%EQ1]SS$&8JP?AK[X,0F(E8AIS5N[6:0*__' X7RGB!*5H$]/<"\NO
M*>'A*7[>KX3)A-V>JGM#S0KMNE\-T_9WV-A4(G!P&&:A.4CQYA1O/Z#W.[WA
M8-\/Y%(]%PG&6>EG[4'>!*FZ<\:1\A?0!E4$Q.^X%ANXAGOP)SKLO$9?RT^#
MD%>E2I##Z%8E?\&I);:)0^<6[09PH3XN"XS4@H06*45I<0@&'EO(N36 5<+O
MNVKL4BR1*:(4\"V6X961\I?E,Z5.WX#^0A_I\B,CU"2NCE!3=D)FT_4IWCZC
M-*\'"-'Q8SGQGKP=BM0WB!9?HVQ=]\@_44Z?7DG7YZ]D.J;7%C']B:.4([76
MS&VV6PNWVY:[(B^B=$VFM%N<)&3!3S\:[BUQ(X8ZB=?()/JFBBJRURU=^N9[
MI*'O;F%C%\+8?F_TUE-6Y"D7%.;ET%^&/%?+["+*"O=[L9&*^:U<KERF;->V
M%>*&!G*?^#R*]?HAE"'<%R+X\&G1[KV]K3A_1=DJSM%@=&H3@'A7. 2F/,K&
MZO-H(TF#48WP;A\3OHQ5*M'B!L4T]X2M.4_0@J&)C]G"E,>E]1X)90ID2J(1
MCM\=V<$/ZO/7Y[@Z3+0UJ 4M&!K4S!;F03VB1T(9U$Q)-"XT3'&Z/KJSZ?>/
ML[O))W?3H#]"&=5\AY/&O9;*X72>LJ?J@! $/2$Q"R6^>]\LFB32&8951ZK0
M'WFPI'K;\X=JLW:/_J8TUQS14FAV8G"V RYG\*Y5.YJJW6DTBN68UH3;K%UK
MPFAVMB;6.G$JUH0A9_"91<RMV;X@&NU.U/:"LN@1-?[Y,C"8KN<VMB-=%!DP
MOPD&,S#Y_G;3R6YZ-N"I8\3@,;N+5>A5:TX2H 8,[W3%DK^3.)Y<*3S"I.$Q
MWS+4^)AL>39 1^[=((R02>DGOVN6*:O1AQ,KI-6X*4.DV/ALBX[?QY,P1XH*
MF/S.6Z8O1L#,,6V29O.FK))R\[-=<M'/D[!,RBH(/HOL>%L^B/LY[GI)JWES
M*R;%YF?;Y**?)V&;E%7@+)WP[,&6MVHS1&\V0>Y\V,<+]?/8BST'!QX[.%#O
M1#2XXWH=B2>_1!\=,'7$V=$,,T<+0)SH3.H^D,B'$V$O@A7G)?RX\"SWMDN1
MF:.%.\ZVR[6.)VF[P-+K[P4(N0<\ >NU6*]C^D>4G,7Y*L$Y]2M;RMH&:LN0
M[9&TY;C#'N2"/2AO+VX1?2V:_'Z*TU+,7930)Y\^LKK1#0?MSCTV!\'.)K!A
M@WWH6+,3B%#P_?1Q;($G<0%PA-*4]PL\77XP;)?,,V;(7)ED;+9BSF 0F'$S
MJ0=G 9><9Q\Z(GZ%B=&S-F-(U(#0(S']$6Q M4<>:WH<3S[H#W[2<4E4$Z=Y
MO/IGE.PL'E>SVS%_/-UO9_J#]EB=Y&(6M2/6?&@G6V L'A^S,DF65?,PFH^C
M'=5Q^9C-R[$Z.3#S,T+L^5Q.=C;@U#S!^3C::=QLGIQW\C3,$T1L_:,W+][V
M"NB(6.78+;@38(EP-<I^#A1E@A?DCH0_X"MTMKF9Q*&+CH(J75^F1!$[^F.^
M+)Y0=O\4I<<\P#?#Q=B%S%@NIMC]USA]*0>/A>?;1C5NO;/9C9L[8R#\;G%:
M/O+Q)<K*[!0EI_WG=J7E:DT(RH6WBAD'#0S7FJ$%B1:_Y<NT?#X=IT/BP+;A
MLLRG,GC)B/.U5O;@ZSL$IEA#KN$XX,ZWD]F&0=Y36MSO/0@&_1"6,1!:?O]J
M- P]>O9*@L?3*%VAA O'_N<>&@^?WS$8.3KR!8L']AR^TR2UBL]Q)K")G:\#
MBUA_?<<09&O(%P3NN7/]II"M'<W@XOB\IP'M:6Q=N+>XJWF7U^,-N;G&N&=-
M^%R.A2Y[QTN:6G#F)>88W&I,58Q&Z1K5SNT"TY]87CI9V;93C5_VW0\\H!K]
M&B=\IGW=XU>G-IS%;/=C;RW;?'S/2!4JRAMH]KET%O,LP:(LU0K[:$2S=@_-
MX-H&Q18TV;#5"A+KBZU7NQ%;M;:S4:[;O7BLBKK#5Y&-<MBI-N_I801 #,Y!
MA7I-!7BZ/^"P#$W(Z84E6/I[- %@GGMLH5-7 9 ^''=8AB3L+,,2*,<=5#B'
M)>_T0J.J B@]./6PC$G0D88E2(XZKW".2,Y)AGI-)2/I^@3$NHF4'V]8,Y#Z
M9Q?.P6ALIS-PU,]['8"2G.UVYD,*(QXH/>^'=RXJL!@ASK><"'D-<R>AI&#X
MN)3>]: RU@7^#+ Q(H6XGFC=7]/W [1KJWL"JMKS0-)5=5"#IR.&C8N1)DY8
M2LGE=XR@Q7MG*/SBUH8^+['/UXHE#-U4J--AFP,5.LZW&=+N'8Y@;3VQ]Q<\
M#AB#3J5EWV)(@*)TY^&HF8<+P"IQ%$DU*$M(3@G5*MJS!G )$YZ?T$B&;1TP
M,\HX]VAH&>8]C2G!5Z@?VP9YWZIO9S6<;!9R/Z1ZQ5K5*A6#P)^V)M1!I]*4
M;SXA">^PF-)Q1& (]"\*U2 :=>)(#2!3%@GJC3,%)(<.*'4P."7('0=A[S<+
MD_E#%*"_PQ^_E)3O.7>2U30XUG(JC>72Y*[P/W\8=/L5^:'ZQOS4@01Z+1"9
M!?<]VP'%*DJB=1;O\N]7>%LQ4-YH>\()$2"OU'!+#%T6TSFT_+9(U[U?/J=Q
MD?_CPQDJHCC)OW66(H@-UWK.Y&"Y E+_H\,T1ZLGM-XE:+F1@I?[DO@]X]3%
M.-WF'I4YNNZ47G%!FEF\QOV;O,QOS9JJ^\WCY%A<W1]$2-<W291>1UMTAJEK
MH0\@BTU $UUI->&N5WIF\A/:/J"LIU9AF5HOG#+^+AG'0 '#=**X"-3@B"X@
M.)R$GDJ1-7_?WGV& )1=E@W4?MGW EBACIP M\^1C5.+(_8G>TZ&;$O&3U+=
M_NMP MIR:'%@P^ <<_P97WQB\<*L-\A,-5]ZA;K->C85Y%G1F@;(O_I3 /GI
M]ULJ+6.I._B],>N'WQTPRIZ5AE_:S+)G'-OL?HK3>+O;,AEF?JM9[GUS-DQ9
M2L5BUKL#K46 #I5>Q1"'RJ?HE=^EK&]-EW:_>=>E M;%7=JM&/@Z8FCPL,BT
M,#333/N=2O-L/9RM>7.+Q9FZU:2S*!W7R<^OXA1=%FC;G^K-$1R;I+Q%T*%^
MZ2;I,L]W:'VVR^+T\:;*Z% F%>K[ORG7OV4X'^AT%)%&CYI$_-U;PY&$#>G0
MT 'AGL%R7Z?)F&>+'E,CHSP)'SDP8#3$XT)&8]K#0DF#1QP5,K[>[70L/5<N
M,[_DEVFEQU[(9_GQ+"K0111G1M_9L\67]1=,E/F:BD'P1Z/VC8P_LK[;Y\K+
M_] ;#WL;_\&4[1&0'FL^F*3?NP60Z]NK0<QDUT:H>>@>%N-;>HNN&1.\VK#%
M?L166@K5DD9+FFO7Y*[WV/&/5*Z'ONSL7^E5P#1''H0^'J)0EYLVA[<HH8]A
MG.*\?I[@H=5CO/OG9HC5J!M+; [%?%>AF)<I&8GHC@SFDM$KVA3E?7A:#2A9
M*T98TCM1F=&7H+)B<;V(AT1D8GQ:I.LS]((2_$SYJXTH+_@,6N,0@B:OX6S2
MAW4CUA&\.[L+&ZH#Q.0-A.Z\_@VE9"N?$!D7ZVV<QG1.*>(7)(*<4IU:]\ Z
M_L-.1WA%X &;"#RR #(Y836S#M)S$X\@(3Q'* SWS_#UA,6-L9")T,WQ',5@
M^1I34E)':[88M87MZ5"M4G/Q"5AI(KY6+1W9\*)"&9GM^^P?#7P%9<@)=31_
MZCA^9_^KV/_:_3LOKG'Q+U3<HA5^3.._T'IVP<XNV-D%.]^&GV_#>WL;_GS[
MG. WA,IHP"H A^F DY9K<G;PR_F[[1AYT1BJF^-<,A9P$[JK8KXA;Q:X\PUY
MMP"><X],+/=(J&%/<^J&L/IK3MW@K8F?CU..M&%!V4N\0FQAKG%:)8(M^<[O
M<1$E,F<5;\-CJYW^ALE\._XN!Y3.>8[5$_]_>U?;V[8-A'_17E!T[?9E@.,F
M0XLT-I(,0S\5BDT[Q!PI(26WWJ\?24NV3/'EJ)>0=/4E<>*[(^_X\$CQCJ<A
M0D,#]CUV1SF8:?;W$:XR4OZ+T\GW8OPT/O24US0^^H'N8Q:5<] H%'GL<8P_
MC_'G,?X\QI^/NA_N )?&.;ZL57XY)<WQ$S=X@T/<)QXCU6.D>HQ4CY'J,5(]
M1JK/.H[R0T>JQWC*&$\9XRFQ'1..\917L&_CR:K9^P>Y]V6UIOTC5U6MZ?!\
MI2Q$-& S];$8I)EP]P3N!8J&'X?!BA4-TO4?UD?ZK6_HMXKA6*O0XZ@%5<RL
M8]W!6,_2QWC*&$\9XRD_9CQE7]'@/OF.0GA%[*$WQ^'5Q#4 E"?UEC24_K9J
MLV?$*ZNDZ^N,TFE"R&Z5D7UD7Q%G %*7*ENI?5?58J,Q*?+'C/ :A[K:83HB
M>5PEHI!T,Q0+TY-I]?-_],YZP$N]+J99D>9DISQV-])4@40UC>=Z0(8AR6!Z
MJ8H -:7RU4<C+?H'4%X:9Y(N>66<S:>"8+K$"VV$!DA]>,>$A3IH^+CI"@>2
M56[D&U/+6I"!_:G-I*>UN53B(H]M0/<02I-:0Q<6Z6K+GD=DHJD7CXB!]C4R
MH7;M/Q*&IB=PCZ,-4YI)_6E[@[Y]XO#:?<!;3!G&9RO6R42[F('I2[T!] $Y
M774:@:O.-A]\FA8 D!Z[ZY@F&\S\9(J3*Y*D;"0HM\=%QORF$F1@^M+@ /K@
M0>:JLQO( -)COVS.YM&7C/PK=HK-J<3VCE<X9:JK"^ZV8S[Z."?FX+'8R1K.
MWL^IJ<AOG@/V1LJ-*3#]22]>O3,]HYRF3OM^S0:UA[W_47+L_E6O?B.693W.
M;7!8CW2O.R4/+38/E.OUYM?W;]X)K?A_#"I=(/8)_<-&D,V/;_*^WYG/JEZ#
M+\!YU!RTK+TIH%/KNA[R=F@L]BVS7E4P%L'@.P>T#0LOC][;V77=H?P^N_S^
MC/?S(4>IDP<SLUNQI&./'V$@P_2,.UV;WEX!ZHS&29H6R6:R3?"&;Y*N\!9]
M00FA-RC_.R6(/9;^AY87!=[D']._FB=L_0NV(MA=</S8[FC,GE'OWILA7L79
M93[,2;9 :$FOV##=)3S[AO7]1&%$;SY=?I@PPC5)GE0OK.\DHQR8EC)B 70?
M)FJ%W98-ES!]&RM,.R*T(SC/%Y<^('E XV^AH)'W<9;J^BYA#T9<&M1&' NN
MG)1NA2);"R5FWIW_(:'[X97S:2&HB7,Y\#9DL!JM;4^2-C1AMG+\><UWQ0-%
M+P63=[GE&=P!)#?+7=)D-MO(JFPX+9G'[+_3/BD+IAA(U)IY3UF6^Z,N:&*A
MTN@60I&39I?4E4IL='H5_2?S2)U29Z.::-3*>8];VP<E@RDFW:[2B149IVIQ
MD4=);?.W:4?M#+#:\E""0R_PS*S9N!T(\I9F0QYN[^EDQ1[IXHKA)4[(;O_8
M(<KC:)8>(UW->6GH/"IY[ K/")BM[DF2TD2DL*O7(3!#I3: H;]G]2G;IMXA
M@A'],*\P)]J>%V3QF% T61,D;A6J$_Q:LE?Y?L[L_EP$?!RSSG:1/(FU:9$9
MZ-SD&3AMLQ_)6DR_IA-7MB$\.4#V&=C8MC!"?#E\:=1("R/IBJ+%S^ML^\L2
M8;%DO+SE'W_:?Q1.E?WY]1JMD\UEFJMOBVJ^K4XXY6]?I\O[%I4+F.JKJA3A
MR5?]+DKWCX@DSZC(\8)^3!?:U<=(5UMF-'3>9I;2K!E<I],959=6+08:*9%[
M)-WTR8Q(/;66)$/4=#SAC=Q&-J]M=D$P7]V0X2V5I<^[P'Q[--TDE!H>7VQT
M]?N_:CJ/%WAJ?5%Z>SU!Y4L5!/UY?N4&ECLS]1$8C+H:$!NUM_EJ,'KFJN7I
M[&U*%OLLF\38_9]UBF8 I$M^4"=3++<*6;';T+;S![I!X,Y?+\U;2EA/+O>B
MH#A%E$X6+P6FXITVBE7%0E4:4TL5EGK\(T'JN R8WJ"R1-_?\G,X(BE+1<]6
MGQ%9(\+^O$7,/$F*_]-?J6[)7;U&P)7;FVN #V'6U2BGWL/:L*@C[=I@Y([:
MYCDR]SEGMWJY[@$$1VY=VS((\]NP15 KRUNZJ7J-H"2OK0_L+WEM8/_Z*BI%
M(<(LJZTO8B*IGC:4)*^KR2UZED_0Y6XI5SIGOL-+TL%\WJ:%NVZMC[; 39WW
MN9=QLF3MT28]+RI:V;\^'BP]<CO;'#[ :<&\O5J0MUSN83*7KG4OL["0J?.7
M:F3][?G+W6$%Z\OOSVB1H^7L6\H,^HB?/Z:\S&Z2[NH#)IY/'[,-&RPZ1V3!
MAWLM)P\.(+FT2Z^20YEJ31!D0]K0.$NOZ[GTO?;!6Y9/=_B+7WTC'R#4'?1&
MH>>"=[CE!H&ZL?G0;ME+>M42-;B**47TGO%3K@E__32WU&0C&F D9G"WDZ7&
MM*NLF*#<R4ZM$>S::F@7\B5U/N,4/Q5/-RB?)O3QH(D9H18F-12U3#%A#J9Y
M:W!IQ8=VC5WJ]SS+V4^<;.X1><*I4/P*H7FR4UR!:<6KQI2--R9H.=FA-<)L
MK81V$1W6_5NT0'C;&FM-=B>XU=G/ '%::_0-NGI#H5TYUVE0KOFW"#\]%*QA
M_B40<R96"][4K%%B#6"%[CA3-S+$%?5.13;*$]#9ZC1Q1KQKJ5'T!41<%="P
M$ >-'"=-X5BQB2W1\3[6@U+ICD9"9D0DP2S%2_K8L[105$:5$].A/ N,*6R4
MM='< 6U \27J?@_=)\T)7FA!Y,)C\5 23]@0:J%W=W\E22\!]$?H )JLV2J]
M9C- ]!^((#63!4(R4Y08,FK>'42R^.IX-9@H NONY4N!\]ULQ?J"T[7PFY,5
M:VV:I5O69O,<U8GGN)9!>,+&4 N]G58RB/0*0<&<T(O*>E7MLUE:.[>58&,G
M+&UF(@P:(& -X:@PB:R@$&ME*L?B#4V3=ZC>4!,6>44U:QTG11D,UT.GTQ<:
M*X6]3@VO\AO^@[]P^<__ 5!+!PC*^CEH(H<  +M@"@!02P,$%  (" @ LH7Z
M5                !(   !L;V=O7V-A;&%D<FEU<RYJ<&>TNP=8D]W6-OC0
MI?=>%9 F(+U*;'0ATCN1)B7202($\BI-0.25*EWI'2D!1"!"* ("TGM)$)$F
MB04BA##QG/_[SIGK.M?,?///;*Z'9V5E[YV]UMYKK?M..5\XWP#83 R,#0 *
M"@K@/?D/.#\ U._Z!(8%AOH$!HFI*%P%-&\:FU$=,%AZA08^" _S#0P R(WM
M3U^  J#XK_LYEG'#^-8MR%U+L('Q'7WRA # ^"D@,,"+DMS!/R LQ-+PIIB]
M@Z,8W0Q !W #G  C<-'-(S0(^%_-6/^66"BYTS_F^^]V-/?/1]/R1G?%Q(#_
M66/S] KU($]WFRR'N9-?G"QWD&4N=VO+6V3Y(P!<8/+T]_0$ /H%LOZI]S_Z
M,-S[T\?[W_H\"/?W)>O#_NC]O=Q"R?)3LBSA#@TBZQCJ_NA#_CGV_3_D?QL;
MYN7A0];/D/5,#\.]R*_%L$&6$R/"_HQE]/G3WR,HY(\,)\O2'CYNY#Z,963Y
MRC_7_X\F\,<W8F0GJ2MIJ:O+*\LKB47XAOG<O'OK?^B4_[OV9X_^*4F\ @#6
M. !HF_ (#WGX3QWUGW\T  / "G !_( (( Y( _* ,J !Z #7 7W !  #UH #
MX IX #Z /Q "1 !PX#&0 *0 ?P-90!Y0#)0!U4 #T RT UU +S (C *?@%E@
M&=@ MH ]  << :?D TE'P4S!2<%/(4HA22%'H4RA2:%'H4]QA\*2PH'B'H4W
M10!%. 6<(I8BA2*=(H_B-44U11/%6XI>BF&*28I%"@S%#L5WBA-**DHF2BY*
M8<K+E(J4FI0W*$TIK2E=*+TI@RDC*>,HGU.^I"RAK*-LH^RE'*6<I=R@W*/\
M1050,5+Q4%VDDJ?2I+I%!:9RI+I/%4(50Y5,E4U50M5 U4DU1#5-M4&U3_6;
MFI::DUJ,6IY:A]J(VH;:@SJ8.H;Z&74>=15U&W4_]30UAAI'3:)AIA&BD:/1
MIC&FL:?QIHF@2:#)IJF@0=(,T,S2;-$<T=+2\M!*T6K0&M$ZT/K11M$^HRVD
M;:1]3SM)NTG[BXZ.CI].CNX:'9C.C2Z,+H$NEZZ.#D4W1;=%1[C >$'T@O(%
M@PN.%P(N/+F0?:'F0L^%J0O;%T[IV>@EZ;7IP?2>](_HT^C+Z#OI)^BWZ$\9
MV!FD&*XQ6#/X,3QF>,G0P## L,+P@Y&1\1*C%J,%HR_C7XPO&=\P?F#$,/YF
MXF"29;K%Y,P4SO2<J9+I/=,BTP]F9N;+S->9'9G#F)\S5S.CF=>8"2R<+ HL
MQBR>+ B6?)8VEBF6;ZSTK)*L-UA=62-9LUE;6"=8]]GHV2ZSW6)S8XMARV=[
MRS;/]HN=DUV)'<SNS_Z,O89]F/TK!QW'90Y]#D^..(Y2#C3')B<5ISCG+4X/
MSEC.,LX!SBTN6BXI+F,N/ZX4KGJN<2X<-P>W*K<M-XP[G[N;>X.'BN<RCS'/
M YXTGF:>.9X37F'>&[Q>O$F\#;Q3O,=\@GS7^;SXDOD:^6;Y3OC%^/7YH?PO
M^-OY5P6H!60%+ 0B!(H$!@3V!;D$=00]!),%FP67A"B%9(4LA:*$2H4^"OT2
M%A$V% X2SA5&"^^+\(A<%_$3R13I$=D1Y135$_45S11%B>Z*<8O=$'L@]E*L
M7PQW4>BBT<7PBZ\OCE\\O21UR>;2DTN-EU;%&<0UQ>^+9XKWB>,D1"7,). 2
MM1)+DO22FI(^DCF20Y+'EZ4NVUU.O-Q^^:L4GY2Q5*14K=2*-+,T2#I8ND1Z
M1H961E,&*E,H\TF64E9-UD<V7W9"CE).7<Y7KE!N\@K-%:TK 5=*KLS+,\G?
MD'\H7RN/4>!1N*/P1*%=X9NBA**CX@O%(4725;6K#ZZ675U6XE R47JBU*GT
M75E6V4,Y7WE&A5G%0 6ATJ&"5Y53]5(M4EU0XU0S4TM4ZU,[4]=0#U%O4-_1
MD-"XIU&@,:_)I7E7\YGF!RT:K9M:"*TNK=_:ZMIAVLW:ASKR.E"=&IVONE*Z
M7KIENIO7+EUSN_;ZVH:>F-X]O5=Z&Z"+(#=0"0A[7?RZY_6*Z]LW9&[XW:B[
M\>WFU9LA-Y$WCV]IWXJ^]?XVU6W#V\FWQ_4Y]&WT\_37#"X9>!O4&N ,U0RC
M#-\;T1B9&KTPFC<6-O8PKC;&F6B81)OTFS*96IGFF6+OR-X)N=-I1FEF8I9A
MMF(N:1Y@W@X&P,;@#/#J7:F[P7??6=!:W+7(M_ABJ60)MQRRXK2"6-58'5G?
MM$ZS7K:1M@FWZ;-EM76VK;8]MKMMEVZW8:]H'VT_ZB#@X.O0X4CG:.M8X?C+
M2=\IRVG+6<TYP7G.1<H%YC+L*N#ZP+4;P@IQ@[3<H[EG=Z_F'M$-[%;B]LO=
MV+W '>=QRR/'8\_SNF>FYX[7-:]TK^W[U^ZGW__J?<T[PWO'!^23[;/O>\LW
MSQ?O9^17['<,!4,KH></[!XT^E_PO^?_-H C !K0'R@2" N<#)(+2@C:"-8.
MS@K&A9B&5(12A+J$=H1QD0O+QW#I\/APS$.]A_D/"1&V$2TP=E@ [.,CV4=)
MC[8C#2++HZBC/*+ZX!?AC^&8Z!O1KV,H8MQC^A#BB#C$UE^&?U4]9G@,?3SV
MY.J3]"<_8^UB.^.$X_Z*VXPWC*]-8$D(29A/U$DL?DK]U/?I>))*4FX2*=DS
M>23E:DIV"O&9Q[.15*74EZGGS^\_'T]33ROZF_;O@+_G7H!>5*6SIT>F;V:8
M9;1EBF4F9_[,@F0-9ZMF%^<PY(3G;+R\\[(C5R+W[UQBGD_>;/[-_,8"H8*D
M@N-"S\*IHNM%#<7"Q2G%)Z]\7RV\-GS=5G*Y)+N4MO1AZ9<RV[*A<LWRZ@J!
MBI2*L\J RHTJRZK^:HWJZAJAFK1:RMKPVITZY[I/];?K.QKD&UXW\C2FO '>
MA+_9;;K7--=LVMS7HMG2T"K96H#D1":W4;0]:L.U^[1O=#AT3+XU>=O7J=.)
M?*?PKK+K8E=^-W=W6@]#3US/.2H2]>M]T/O]7N_>S3Y(WS+:'CW3;]$_/F Z
M\&'08! ]=&,(]>':AZYA[>&W(YHC[:/JHVT?U3XBQ]3&D./JXVT3&A,=G[0^
M=4[J3O9,@:9ZIV]/#\X8SXS.FL].SMG,+<P[SV\L>"Y\77RPB%]ZN'2Z_-<*
MS4KR*MMJ]IK06LFZS'KCAOI&-^8VYB/6"KN\Z;&Y]SGT,W$K[@OSE^QMT>WJ
MK\I?NW8,=C[M.NUN[07MG>XG'+ ?%'R3_M9Z>/WP(\X>MX4/P9]_?_:#_T?E
M3]6??;_N_EH[\C\Z/4XF\!.J?FO^'CJQ.]D^C2#2$5^>R9QUDDQ)*^?^Y^?_
MADD4_F"V?^&1VU[WW<(?A(G] 2JW A\$AH>(606Y>7B)R?\7L/O_!Z>XYP)
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MF$OY\8O7%\1O-O5R6T[B)%3<0Y[0,_#P\O$+2%Z6DI:15553U]#4TKYU6]_
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M-NT\>0_9_B&!61$=HSI[X#CR25K$YM64OSM%VV^Q[+O+$TL@$HO]6:&'O]W
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M#WRLBV!"T.M285EI5MH7B!:EK!0[ZA%K5_&T+>$EX C>Q ;DJO:1L"+$E-G
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MYZ473:X>^O3:\H>8O6FM;M>Z%XLO+Y^RUS2E!?/@7'[48D=+/A)FQ:OI:7(
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M%$FTY(">*&6SX,ZW3@[FB3Y!#N3=[SQXJ="H7Y8'X9JM 1JG?7(\^Z,T)4(
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MK-1]4SX^X'^OT;FY![OBA[N'[X>XX&^.[W_$]YE<+,VU\?TO $!&Y>;GY@8
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M*=]3?J;<I/Q#Q4 E3J5-]9 JE"J-"D;UB6J)ZI2:FEJ8^@ZU/74(=1IU-?4
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M9CXM/E^^MWR#?$A^+O[[_*'\)?R3_%<W16Y:W7Q^$W[SNP"%@(J AT"60+\
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MX"&)/<5^_@LL.&")\F+I@PQ2!-'SIA:=1!GZ<2Z:LG[G#JHGGW>L7A++/??
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M2)("M>XMEI(2=++!^X6SJ%]I6DFG#^8.CWP;7/E>FT=P&YLP_YE&F6#)MG$
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M&C;-*A/['B2\'4-+RY^U.8 YR]Z[J]*N9?^[P--LR*&A&C*'98.Z'2^M;^$
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M=)SE8=:1K;,>W%;@TH"*LJYSC#RF6@M0L66@W:ETY(8I7L\^L0S<1IQ.%#>
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M8$'.&^R *ST ?\ :]5$Q.:ROD[A($R":3CNL'V8U?AVG^5K=I_(2X$:(ULG
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MNIU[LZZ)07NZK^[#IH57A*M8NP&=E'YO.*=RM??8+7"'EI?T,*3]8A&S?4I
MNM)Y:;*P:0@:QP36MSQ7#:I*98R<MK\$A'\?._@[%E8'G&?3:R:KD<MX3#OK
MQS@#.F]T79[AB4OM@I>H25/;@X,?W_<(<S\T&9]%;?5T2[6VQ4DFAS5+:ZE^
M+%+(X7#Q8%<('.!__H[=?WC8/(U2H WYIN7E*V@?Z.J\M>VB];R=1RT+HKR
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M@Z7YXQ9F*7U@L'\GQ5M3[T11ECYM&* UJ1GB]O@H(2!14W7EOVLLQY'< 73
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M2=2XNO8 P2J]%VLHU9X3%EUIE*I>S&;'I$[WH@,(4QFB>M,_%2ME'W0C=ZI
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M").C1GE7UOFQM:O&%%8O&XOZZH5*RPN'<:&&P]*2JN'.7P9BXYS#'<10P]/
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M2TK* H'N,M+_&HI'B</(1%M8["]^ "#) (";5"SVN@B+O<'%3K & 'W!V#5
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MEKY?);.\XFLO4CUO;66"V@30="H7M3>QM2"X$+(NO12%(]Z!XV]2$PJI"["
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M_R4D4(EHN0W9/5*&3+<M>2GJC!N-RV0+-\VN3CR7!96:XJ"MWM _PIB1208
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M#U73XZ]J?IPPTFJXN[O$6CPD<W>^!^#K*Q+(W0CC'O$.:#L1 T*U['*18N9
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M'!IL>BQ>%=4O-4MKG0QI%@8+F]DO+:V>"^:<SK)!&LD:QK&PD)8@>1?MW?\
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M?VDW1E!R=Z=.G*2G*$7);-J[TV]6KNS>JN[6/__94$L'"*?$<G>Q50  "ED
M %!+ P04  @(" "RA?I4                %P   &YY,C P,#0S-#-X,E]E
M>#(S+3$N:'1MM55M;YLP$/X^:?_A1J1UDT)>V-*M"8W4IK3+E)*(I*KVT8 !
MJ\1&MFF3_?H9 TU:EJJ=-!3(<?8]]]R;L1.Y3L?OWP'8"4:AEI0LB4SQV.Z6
M_Y7R@VG"C 28"AR"9$,XYPR%G(0QADM"$0T(2F')TEP21D4;IC3H0&FLKPL6
MY&M,)00<(ZE <D%HO ^S\.8123%85N=;Q^H,>L?6GOV$95M.XD1"_^1D "98
M/<O:-S?-,I1N%8OMLW +0FY3?&I$C$HS0FN2;H=PM")K+,#%#^"Q-:)';=":
M-@C,230"O5N0WW@(_5XF1R#Q1IHH)3$=0HHCI0E8RO@06CU]C0SP8ZTZ-5J1
MO@S-IK[MD-S7J51B36L?5^568EXY/TRU9%H2-<9U@NR$UY@)+K(TA*_9ID$3
M?!3<Q9SE-#2?+ZT1CPDUB_"&@'+)'E6\!"QU/N,A5G:44:S"UN1/C9*\H;0B
M0:%B40E[# ^$K<%5)'81]Y-R/52!^"P-U09GDQ"?2+"^=/IVM]@QMGV^P^_N
M4ESE^_#R9.XN'7<%\TN8NA?.PE$/]>HY5]/ERO&<"UC<G,^F$SB;3.8W[FKJ
M7L'EU+O>1]$N/K;ZQ[U10WV+(4'W&(@0N6IUEG/@.&-<0ECT?C/6U]6[+B>/
M_4_68-"&GOI]5KFI:>BL7",>)&J*VGI$VO! 9*+<BPP'LDZ 9" 3K/"H8"G1
MI"!Z'&,AE:(85@$L@@E*BQG+!9P3)@*":8#K 5< $A&JK G5B!Z.B9 <%:<
M+&L<0#2$!6>:0RXZ<%OZ+I8J*KG A;-"1!'CVDQA*.0J<V]QT-;O3Y%5$>KH
M*5HK+P)4-Z$LPX@+4!.!>9D3E&GLCZWOEM4;.9L,<RDZ^K7?+'65^G^LJ/&L
M274!NZ(+5]Z9:LC5C[GGKN8NS&:+U_9>X>D7XW=MJ*7&EI]YN@7KN&R0QBKL
M*#767CAOK#>>-W\[^_[3&=2, PZ=#2]E]H6\/+?82>5M=XNO4?%5ZE8?W3]0
M2P<($;6DA_,"  !]!P  4$L#!!0 " @( +*%^E0                7
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MA[E?,#M=S :KI*!1G3QYK(";_" /,\:M%M+%6C:7X-*@PU- "!2%Z=BY$P0
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M)%D*INB)9;%[/"A)C(G8"UUSH@H;Y0)U\#L(263N.BY?W:&(0[S[T^0I],4
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M94=/$JN)5*F0/$)<UOES=3TJ75SUA[_+P_;Q=;__:[?WE8S&\KASLSR .Z7
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MLHDXF<N5E)1Q)QD8GJR X<GF_)V?J*M6I%/2^=/5G*=-@-@U%/@" F)DI^A
MI^E&P]1"7@9Q+67JD50[JI5<+DADQ^HDP[73%5P[C>+:P+1M;:(S</3^:[J6
MP?%-%+ULPC39,%SX\@UC&+"F&L8*I^[0X)<=]4JJ7=5*T9\CA=SI#,:EB\Z_
M;[OC/\C@6NZ1L7QYG>YC/E(+2:DO($Z[L&Y1)<SEM5HI%CH/RKD$!W:T!ET
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M2($ONO@%\J=K6N[<_Z:_N$/DB8T5.$'+MHEE_@"F&Z9QC$^R0UT/7$/L'WW
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M*C4V6ZEQU(Q*C6-7J;'GE1HU&89T&&<C>>.B^H45T@7%<X+"-ISTR^FP[17
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M[I[XAGMB3H>P5?!)%9:&I]:&I<NQM/1MR[L)>L/*VGC/PU@](>7GK1G=MJ^
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MCL O[ >59]$]32F3XT\DT*22Y>:;(6?HGQ,,!$4,=(0##Z^@.>U"F) &%PY
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M^OI<&Z%4O%H'BB%/Q,M.@K!2"YH; 5V!9^-/H_E,IB8-5VVAXU)RX13ZU77
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MY9:,U*O.L7K+_)[1\QV=[*( ^FO.:5UG)!?2$$GH>Z.0")L.B-79ZX;Q9!B
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M\H3R*/,-W5(K/O$MP! BAW2,YF+J2+K6H\I?[6/*"25:AJ-!#-*_U/'ONH/
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M2PEQ4H6*!7/:A)IN&:7]PHK2;,!;\QY!Y]$$4AXT+RCI'+9/O1NPR-,9=H7
MK#Y\X\LHB'+_+DXHM_BR#I$%+XLK=JH7QOKD9/W]49$(<;$HCV>,6$+)TUU
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M4$U,J-6C6/Y% QD',QQ:/QP0?'1*.1E?-D8Q.O7ZQF/@&3-9)Y?6S!I)JY!
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MUS>?[F%R5Y\_OKO]!/_Q_O;3Y:>K6YC]]>7#Y>O,JNB_;"SB;F3H$6&$_HO
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M#=JT:,(1MB/LG1#VI7\\Z$3'MB-L1]@/(>RA?]'?NKNE(]&K+D4G'Q+8ZDI
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M3PCN7W]8-!*4) 4FTWK9AORS9/V5?T\9G-4?6%<94F&+>AC5_I7]0>MFZV9
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MTDISMKSW_N+NA=< .U#$XDZV9.L!/T00,RE_A_3-ROTVZ%SYIV> _?MP_$K
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M;J00M#,'PQ?T71L+_""X6:(?5 !X _JU],7S%][+."X 51_%(DES#_".!5)
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M%(V["F(TA/2ZN $'8VG\\JD;93#2=N7FP7H$MLG!+@>S$>QP)7U[WJ<0Y&
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M4HV>]_?D%BOR_=*T7R[8EE>7-DDH"+Q \:'YGM]+A>%K3NEKS4%:2)Z#@^]
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M>E1;]ID&BW 245&!U$KP6HZ.Z>5(*T<FK.>A T@7[75#4/,$?C1J\6+!B(@
MLJKI*F^V:@5X7":+?G<N2LE83L:?A%$AYSR))8^20K&9AG*)^-J@F/:I:Y!&
MX1=Q&V9"K[&DG7K&8F23K)YT0M2.,H%K8N*X\$?-YE*WQ[/M =DTHD1<AV,.
MR"E&:KQ<'7?&[@H#?Y4[7[G#C&Z7 G3E%4_,S:$E-;!\"%.#4LJX2IETPKM5
M!1<6I4F(N>0]IN4-ZK.8J3$,W8;OU,(QFIIJ*4T9@ O7&!"*!"FDV$RM(WJ>
MO4!I#<'Z%1&Y]NZK-T_8,''P"!30P$.N&KM:C7VYNVKLYCIA5XV]VVKLR[94
M8Y^X:NR6[F;:PD[;:H736DNMT2JRQ7FIB>7B)U0<6M/B VX2RH<II0O_8'-+
M6FA@T:,^)"55UHQ@5H74 " KN%9C(OTU"LJ.(:_<:Q]PDUB0ZFFW8!JH)/A:
MP)5NML]?KJV6JWO";HZF?#G-)<;7;Y57J+J'8FPDU6TWP/06"YS5!%?+FM,&
M7M-58(2]= 2E3>'] K;:).3*@D ??+W-B9NMDPT2I72^*HW0.' P--$\Y;K>
MVEM+M%B%#Z?]_]"+88SOKUDV53<,=_'H:C-@6:*<E44M,N4<@J%8*4U(%:?+
MC<Q8L7,/(M5"-<RG(\2<J]7%'#RNJC0<W]S)>M&/2"N<';:W2P63/\"=[TH6
M;ENG^S5<AA2"S=.[_%7U(YIXE(-N3&(FVU,6$C0.?5;]MM:VM!P^/ UNDI0>
MP\FND:#2=$Y-81_]V"K6K8^=-1?TRBI5W9-?YWP%6S>E\!7H/?":5N\M]L+Y
M0G"YGZY^:RX.H(V#7RI\&(S_+$*V(NV:%E7VP,O6Z4+,F:'3$#1[B#74DP(Y
MG2K<,I%CZA&NG19F^S+BILN"Y89$8SA<68/(95KWE6=[:MOW*IW4\UZ66='J
M?/2F,?/&.CKB$*RU%-IU)H+%Z4F3FX#546DBP!<! )Z'SBQ&)5P8?4@FE8HD
M(-E(K+@_NEK.'?C6<'%SX@2(Z5DX"K5#G"4@,\*<JGW"&/X1\+^!NP%IP34-
MPDR92Z7-LJI:\ XN1*/<O)QRW/]<58H%$9?B 3OE1K-7(_^C"I&%J&NO5/?E
MY[,PG:@]9[LE12"+F*L3[<-;M*A'29<2BHJ4U8WH=$UFZ-)#UARJ6GF#C=G
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M6"D+W&AI8W8S%%+DN(;"AR!NBY?R&M\Y.NF+2)&.??ZU[R79YO-6 *7 *4\
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MQR=%@.]-"E5EV\ )REHL^<IG5Q\U*YV2JE5&0L1VI\=Z-G[II?+7?,Y,4Q1
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MOWS]7Z\K<7QB=I.QM##/C&C,M$AER;PA]B5S5G9X<4AF5?A;+T^##Y"RS>3
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MPPSZ;C[,8:^FR^!><UP^@2NNX57)1(U4UDNWL[*<EA9WX9)QZFC5N^Q4QUJ
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M5K<BD0[M^4A\#)\R#8RP)0UE7@(7R^.%KH9EV=< "L 057 Y+(J<CZ5V?GQ
M3@'M9G/A'O^BOZIV&SD.&$^RJ[4J+AHXSM$H%0&BTD$Y&H14 #2=[@?$AV2(
MY/6'H>.^4&^4AB5[^I"3'N&5<V-<@.)-X)YEVI.XI4R%EHQ5HVZ,>"[<4B]R
M=[GV5*7^1!G7'2*"%%WF<-*8+=]Y_02:Y/SP"""E\'V,!")91\0??34L2<D&
M14\],YX0V9BP2$[JAC9[A.+N@).-!W8&5).:O*GZZ_O^#%Z@C#_"[A0/ -%
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MGGR7C!#]]NEW@7<$'D^^)6DK5'X4).2B/A3L5E4HJOS-#Y#,+"S\X%7%A>G
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M_P$%!9*$@&:6^X?LOTED@5-KTP<4,]=HPHIU\[O#H:6/=$/X.&TU($2XPP>
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M%*N]T[@3"< KHFSCS$>&Z5"4JNK@!X(&-B-CY"7)28HATMVTT]#23G%9/&7
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MT!V=61,BE@ OF\.<&^$LPP"^''N[.X!NJ!WM=KL]7%E7TRY5F)FZJLO.<0A
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MW9R<!!JC^H:925:;J?.B4/N82)>GA4).M07W%;U3\M>PBEZNV'G'1ZEJV*=
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M@*'E9,^,B@@'\+T?4[-#;'4TPD!G87"+L\%:DN"RL4@[]K#=\/ #H,YN((#
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MLT>,5Z)T\G-D6SA5F8922FO%2B)D,=P*E$W?EC1MW \>DY"1G@(UBF.P&4X
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M& @8JE,Z_@S]*!X&H\,^'TIJ?H,*\O>-JHQM#PGAAF\.F1?TO* O:T'CB>U
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M[F[OO7I[_2<MX,NN/;QA?& \3$%'4=!;WKN^::*SX_:BK7F7%897,"/BOE&
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M[P&7L=M0E0YFP4S/$^TE@E2E#T42C"[O'#> #!L\Q^W+U0W*&*E7<(6ASMQ
MTU(+HKD0C]Z"MPR@P.U0[[!6$,%%<\\0I5LF'@BK(9#JM&$IO(U"C9+_@C%G
MA0Q<?5M,Y I1#0O[PBE)PNTI?[XH\Z/YZF=86I0XS1L1)C4&&)XD&9"Q@.B2
M\ 0U^+X#'$T@XG1$3MG>^J8K=ZJM_& &#LPH6,Z:8\EEKB7XJ/97_-G-N"LQ
MZ?(KD;1-E4-N3 .U.]_$@KF4T<.3=7LPV!E@V^UP1-8)]&_2E,?$!0@O--@
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M)ID6X[['B$""18'YP43)A[%ZI\$13Y'8(>#9$])!-*)-V3NS]$37,&)[N_J
M8S">BQH;3"$?%061:B+7[6KLA:@@6HU':4><5IU="C>M$XEESPZ_#V2PW0 5
M0XIG7=5E4E.4?'@B4V/_N:65(Q3?JMCO\B$1\X,, DKP4:06;SK$!DJ;%0UQ
MC0&U".^MRCU2Q?QOE+*XK5E@S]]:\HY$7+XF)5".N,/WCAZN1Z)Z9(%UH3_,
M%0^)DQ.<9,[PK*'3HX@1_MZ^I9UD':^&PR"!RJ$&G0=84@'Q,;_UM/ZKHYQQ
MW!DE4&30TN4XP3#O>SII2 E-L34/&VV_GIQT\M9.)!C$5AN[.?6;!=X.<;B.
M4)I"M? B4UD$SWFC(1X%4T3C?#DV?10Y.(2@,8CP2B"VJQO/*7+G6261N01/
M#:3D :Z4=NPYTT'[/>[(?;LU"3=(2@GB7Q(3.1>CT?L KJ47S^Z]4Q+9TJL:
MCOD1I@)"6FQL8Q@K'=*LCXR[4JH!0>H<2>/]Z4-%;7TU;+*4&\(G(=I">!#_
M%,S-$]Z(T+(J,^%#67&P<"?DC]0]G^9,N87+YDF>;LA.NSY(.?.WT7Z:?G0#
MAISHG:3N@MR)9'J.^A29_=".WPKP^"O*784;,C5)$E>.]UG"MLB0YS5^'&+,
MZ2GCT#F66+L#0S%K\!L"B%=T9M6-*E6?>5])$>5U8HDLW1FAXL4B+JQP-++F
MUX,O54,W*(M"]MZ&:]K$?*/H-">U"#)R#I#R@?&=))F;FQ9\B("P# ]LJF+S
M0BIUSKL9=TN[!8,DC[4RI Q5XQC9032H%$&PG]G[5@^6B.!F/Z&LS[=S@*9"
M3U*/,<$U,"3[LRORW>J>'"U*98:AC3NH[=Y?5^$N$'&9J>PLCTXZ#':>PG%8
M^FB&]8X58?FVO0/^<=\5C/G.>E#)\SA1FVA><#9.*T0O/6WMIKTCPBSUUO;!
M\534><C,VY_> P/M2V<<L1WP?>DM[=?Q <BJ*,<^Q66'%%=.! H>%H];B3F=
MUC1#YZSCNC2QC.@$4[?7R\&1:)N;EA3IT]4SY28/X!+[8H'R\ZQ]WZM@0%N*
MGZ!-R[Z+9Q,&*5>QM:35(WYJ$M/M!X@=V%"#%'C^K%6#(AI5[]^C>:2J( \>
M+5\XBX"",/4V)NB T&"IPHOTXVV;UH0\PS.%_V[[:XB>GW2^X4(2SZ,1N4DG
M'2G9BU:;$B0+[%/V@ZLS\PFV,R52QD/_6T__0A6FRMH)",$ +2&5Y)! #J0Y
MJ,S6,>>VXZ6LZ!0AM0S[C1VI-> +7"]>NAP#5+&(=[UE*KOPW<$1\ZAQ+"8$
M+H4O@X JPY;E9+S><GRNL9=2N,/Z]'FDCW/V'4QX\HJW$"D)"$E]A>S^%-]Q
M/LF1Z"?+('Q]4H[$4:-Q"JKV07,\>S94%G:HQY!/C8S.C?@[L#NZ3'!=S19!
M)@>( ;=EX?D %;002QQ? K@9H?##&3.J*WGE I4)E$)8'YWS=$B(-IC,79H_
M]!4UJ%?67, 5)6FY26?6Q@9V6Q%L(6]SOSGT=LK+AJ)>=VUHL1D;6%4XGHDG
M%WJ:; !K+O21LE AR3*(9>4X0JO3)EQ(D16[)>A"T?J'O(##"F8A 6L-(9$,
M!E?,T'=\FERHK--1:(T6[U'*]G*F/6 )%R/'*%7@E#-B($-OS%LU[^P76'?2
M4Z1:%[U"!XRUH::2.X7+,N"9BU>&7=9&*%MB,)WD#U43+K;T7L_*?"GDS+/2
MNZ-Z9UW3/+MPRPXT.I8I(^G,0?J'3O0'C](+3[[X= \S.7CHS=CJV80OSX2Y
M LA.9&BWL\7.%GM9%CN5Z9(8+-IW UBS=^J\-IX1&5P;57"(XW.EL_G/YO\T
MS)^A&KKYRP6KB#2Q;LF?8LTS8C)&3+YX/,1D'LLW(R8?%S'YXF(0DU_,B,G?
MA9A\E',UAX><C]8/[VCM#."QN+#/^O!036G*[K!0 K4Y5&%,B+R8'<?9NB_*
MNK&QT E#I]7N3.65=)YLG 1XAGQ^ .I4 .V,PRZ/BYD;K.?5<'FK@3":(Y00
M36\, W=]?4?ZJJ6#623@-F4%I5V/C-X>G$2X=+ RKBLN80:<^KD12'#N<[-T
M G4_BB?!_8JS.0%[SS1:)ARK'.,[@W<0.Z/Z.>%O)2(FCL'ON$Q(@!4B@T-D
MA?VPT6 D_*QT:OJRL=;NYGY7 @4@6B@ XNS +V>0T)XU5SVFYA0,)QP&P>38
M"X67*>-M?FF(60]KS@220QJ\:<C.]>)-W80O;S]- ,]:8UK"Q%WMFAJT0CLW
M% MV*H=@U-"G7$F&)IJO$ W#$"*PL!N<M@'"#*?SJ&</9@6Y-=TLG@1$E:Q,
MGGO0ZTQWZN6O72ZU^XQJKZ18&?/O ;18V!Y,M_.-V=1H% Y(.$T\\;DE&#<5
M,-SD?)'+I6'Q5X^FO8]R*%/>NV[M/MN&0<;DP174+8+ \S\?:?$ :/[SSZ[O
MWS"HE)!UQY*"*9?4)&?/U.:0*LYZF,O4H?F$ELD]AN'8FPNV6(Z)9)W@<;0M
M5V_1'W'WF 3E,IRO=[C34^*:;M4(M@V!S( T06I4#JL9OJ@O)M_/(,SDFC?8
MF9B].#7](;'']>('P.M<]?8"T0 DU^5-_&C;8MA"9RVBI%Z>J(<.,@7$HMF$
MA&O9XZP@ I\2=PKNY&J[F[+AQAU"^'S[\T_L1D "GU3P["3_;(A$9.).\5$>
MW!8N&5]1VO-6#$+'$Y\!_[)9.V](@.URVA(/D<+^+XT&50G*CF])KTQP=H^.
M/.<9@52>$$L'X/JHL:5.9ISH= #6MP2UZ' $$'M:DLLA"$"Q4GE.WU]+"$YX
M\[H!2)5=<\H8=F4_(%ZUNT7(G^^[5=XF3UMOKPHHU+*#7M0&CS4UD(J\3)R[
M8^_X!$Z!?,7FO#/ ':I-VUR=LRF$<XP6S#V9E=E9NT$)2<=PR#W"(@J%\,85
M_&/L<M!7+SR?]2K(!:3=0QK$7%^K MP5DPT#2:?>4SRTOJ'$SU$P*<5:D1M&
MS9)X(@ 1]WW;M+2D>-!4LAO[(9A^:=;<FN9FV!P*/CC>N2)_TR/R^,QSR)V&
M$R3ZR. /-B8&Q<AF& +L'69&'>Y)\8T8UXO7_A&BW2MX#FGXZM73,Q&/O>I;
MHR3G-<"<#A$\Q\=A!:%.#?[W!OE\[-H8&S[PKQ??,0447)&4[&$#:@@MNJB(
MFXISXQ&L.QTR >)S-!PV.QWSO>UHQL>8O8 =O<X^;0]=L6 TP5(;A%*M7&SL
M%D6I3OLAX;0*FN$::#B@EC[*?/*E2*<!NHQQ8Q;P\U-<G;]H'KGUI(W3D)[9
MWCJ9+%'-$?9&UJS1[CEAK)X"._:O: (3Y_6E,'M-,*SIE4T8:]IT' '=O=X1
M+>80LW"UV,#D5BZTOHU+ZCF(WSY^_*#YS;%W@=T" 4=/JZGG)@S/IN63CLPA
M)FN\66S&'=!@<>L!D67%(TI7=Z\KKZ,Z['E"Z&K*Z1>W"8CD#GMXE>T!%]F[
MH3/H@] ZPL;-N(EH&#K*9V& "\\DZPQM+9D_W A,19M'Q[-\UJX+>V/:$=HP
M^0.:4I]1) U<@AZ:"P7I"+V<9SD"0B9KO[2OXUZ:37G++'W6!>RA8?/4>U$7
M[#9]OQ_JMP9P_ 49JMT6[(QN89U ")-]L>Q:0T=D1'4+),,%>Q1+;I R$$;-
MQ4:+?7W;#KD'>JFR611X4K-O. )X"$!RI%QA0A1CG,H>P1V3V("';W"T5635
MFP%P&L2&)]U=\2LR18\$JCQ+_$(X.47(WV//)95HSWP>_FW#DH0PN+;! >S$
M=D#!@[?F1!UBN?TE?'V8JQI8<GC0?FS[8;(%$YT?"$'.=37 G:!#RC6-EOV3
M/H]>HOA0^O9MFI[W<9I.\HK=JV,@-<BS%K:+RT[35S+ER$FNA^^3HR[XRLPK
M>!HE]]?'0\GE\5LS2NYQ47)_O1B4W)<S2N[#YA64]'.KR)[./TCKQ@X@*5!2
M63@\-Q1'Q7V21%/9H3IFN]H9,X3(&?OGO7T?Q^P!-!']D"35K0N^,R6D5M;C
M5GE1D+!WV70(;3OGS\"+F@Z9'?IV52.G-=[C/N%<$61S727*Y;@H9/9YGXS^
M[31W.%4IL-X*969XFUZB=\[@:G\1UQ>[=A"-34R.=O7D$%Z:X0[HM'RLM9_*
MLARS(.$=@0)RRE[.KJIUF$V'3%U)DREP)#0W%+2HK(AU6>WO>N(SLQ.$\6L[
MM'8!VF_+,Z^,*Y0B.:/@!!Q",:%UA-J"OR')O&SH4FSAQ^)8_PRNXYT#0,2!
M 0RLM.Y77'H*6"20WI+IR8'LC P0F:N;%9&>5]UXTQ?,ZB/\F,S/TCEV9BPT
M4 B3&C1Q28R]@8)(WNOB"91:_:V!]451K7VY<!C"X  \;UGS8/\V7&*%-"KB
M.I(W_8ADV(@;:B@8*XX\#[S?B"Q_M+*DZ@V>/H\\4PT1A:H " RTZDVP#M&5
MB;USI P@,FWXCNB MS$F.ZM,$]( G!1T%RIR(B9WC?**8N9Z\<K.]16>]1@*
MJBFEQT5V#::6]^P*V,NUX\RZ9IQW0"I3Y<DTL&6_8^9 3V&44!I8N^-KQ@NB
MK'=@Q+IJC\D;7H_$TMKMPN%9VN,%HNQ"50Q=;H<-2= ' 7SL0R_MY)A3,*_R
M_3]?8?AG_S_*+MEYKW9J8BEV5G6X9(]N G:,'DG+WN%@4^X;&>85[P,_2.'6
MF<L#PC(<F&R1LU9/,=S&%^W'I7T9VE)@F#6=H!VREWL;&/[[OSW__-G7SS\M
M%B^>O7CNBEN .@"II(CX+$J"_%@>PN_;9:!"]\E9SRIWZ)WER(1&F=8<P5VH
MI,$E;+=G\\]XBMBGN3)0KE9\*9#+Z0P(I26X"&8Q*B/7"<>Y%P(P'FM&^LG^
M(T-8B@"5;,I)]J,EK$,AI&50/5X!L];-:'])&2NZ.F9ZN[KGTC:?)\%IDLGN
M!71)LC#PW)HX5K#*[5MGJ5T\+5/5,"&P;!T/=@XN'G@\-%3A,$=Z.,<>S T"
M>3SL$S"@PQ&N8G8:HP9,>?<(](6#J!,6-#R!]GLBZ6[L0HT?VAD9K:B$-RW<
ML<R[FG+XLL,!D "O:W]!!XMDR\.],#9Z!YUC"N&CZ:H^A1>JC+'4J?&2F+07
MX!T32"9;:A=4J2.>20)D1/DWA5S0@)P/^'S+05F]4^+2F"1G$A-/5BW5A&%8
M7V_ 3WNQC/UJSW5O#RVL"Q1!HA%GDGS.Z*N\:SBH5.$T3Z 4@' EW)8WR#5*
M5RM7&U#3J5RE(-F="L7WOJFQE!58G'7M[-KNCUMJ. S3Q)]/\=S]GE&M1-E=
M..#<R0DNG&^BI'.2:(W#? SK,CH^6O^0S,8IBI$;!<&&>Q0Q0*V$) F)IBJ[
MZJI=7ZT@N[#:F%U+X/=#()B#'[=1WPHX)H$/D$6&H/KL[H-==?Y$8%Z&GG>V
M *H^[N&'YR\^<[>X#@<@>V&EF^ )Q7W87Q'-7V_?HAJW1"BKJE?MVYJXY1"/
M@N-KS0_X^VYL%#W0.JKLAGV0*\%:')<LK4 O.]$JF$(987BIO@<IA?V6 GO=
M<1(&7>:V;L?HN*$!>'[,F#B54M4]\%S0.%$]N&[66Q2=0,\.\BN0MUC62$N>
MB;)= <9>'9\\W1/DT8ET4N(L51'&_$7ZUDQ:)I7JRNQKUA=;6W/"! E].7S]
M9=>6L//D-"UH>T(8;1_$C0ZEC6S]>@\M5S8P ]R(7-?IE\->.\+Y^590+]&
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M1?9_,6'!O>D]==7E%[ GI(,\!O!*V]5$8L&3"33MPB(SRA%BL(?M3 AZ0K;
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MG0UYWN*M:;F5(\K9. \IXPPKNJICWBH>B :\BH"&@7 6-/+L'$6BEAD/*;/
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M%K->S/JRS%K(\64N4T6@B'5"$7@/PP#<$D%T:;CG;@((8['ZQ>HOS^I5G,1
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M4W]@US5UM[#I++9^>;;NW#S9<D!@:T$DGG=MHRE3/U:ZT.E08_4OU:84?5U
M7R9W3A)[BFA0 SLE%"RL4I^H4N=1(/$B1=/*BG"8V@"B8;!<XY%X*\L%W!,Y
MSR10!\^/XMOZF'0'5H(Z@#C"JQ;G<X4Y6OWW#&HG@N=<K2+Y9U3<JBT:RBEG
M@@0@&&.(\1?Q<UL :^C59]J6!NGR4$2#@E_"1 H&"MZ>G<$(E%)VQV1Q([\\
M,B_!XX7A6B]>KB,L@(P*:)!G:6@'S$#IT@4P0 "L];:BI2H 5W+A8$$@5+(M
M@'S<->1C+@&^I7$E?I?>M!2Q8?"UGIU)&9G2 9HZQ;7*[92^=UWYGH7\$Z#;
MW [/F C^E1KE2F?$ZR)H6D!+]BZM=/\F=[&B^0>9G[KM^K<&R/V;X ,?4Z@]
M.QR2I4JZ?"3DHTQ^I!TRVD,90%MLDHIN4SQ8F+<+<+>=%F+SZ#(=O>+YP"-V
MP\@<6VZKG\7!S>'83Q"+]*,??H,KH>U&#!1YC@W0,+'7A70/S>O-%O;\L1%J
MWX+F ]JD5>J L\U/Q5=/PYBHO#%LS3TC\7OA$'Q8[]6STP0P8%]E-$')U^XG
M]S+2*<),QFVL-8T8PBU[F_07%KH7RN\)4DK@R'+3$V)IG Z$]SD=<8XE+"@4
M=;!O!QL.1L;<.R2P/ZAN&$'%U0(TV,S S30"P%E3/+"O!$SI(Z.KU5?N*2:!
MZ744SZP$?@HTV)8+&I$X.E.7N$7!+$&98@%SIUOR6>EFY,'B[I:FGFRDD"G0
M3H>YV':9I&V^2^T:N>-RY\P$2S38-7(Y8=/=^D<2:)WB45/+T96^H3F-&#ZU
M1BPW'>58IA>7BR2J=WJ@M<[7-Z/O$&5LBDG\0",7*%YP<5!CV-%LS^OH$MVC
MG!LRU106ABB&7'#XADYVS%3YY?-K-B\P9;#&XB[^JT7GZH>1M12=G:S[KMS*
M?F5\0[P" <"L9N!!@1C(3;<XPG(;4E;$"$4P2)YD4&@SX@.W/B@G]^Z:U6S3
M%SK;Q\?$6 \4L(D4APC)L'U].5'-P+WD;[W6V"NLW.H#&7']\MM7,J'Z86BX
M,<,O@_)<@.E\KEG[Y- */->%;XKO<Q9PQB^%060P<A%.TB4^3Y(4YW7.-RM>
M6F:LQ2FD$I_>F^(XPLD?KW,8J?+&GG44X6"[Q\M?K;YI>9Z&2+@(N,R,!@'4
M;&&;:*"$@0F)3:ACK#>N;F]=C;>4D 2&LM3QB)$.Y2'C*9Q31GRM&6^\"I*8
MV -XLZ<)-R;+#+Y[BRQLJ#!'2\17+0IKG;,:29'HWC:5)]D<N *]A;/S?FSF
MAZB5';X0I_YVSY?2#3D_2OAK^>HFR]FZO4G#;""Y33Z6^!J<J?71O0EZ;SN)
M<'C!TYS+(^C[_ &E3)'.)A7;#-\D4&%]#!MSWLLTJNDYT5G!O@]5-<:KX?X9
M@UN")QA(*FO@ZH2-:]SI<W .RSV .RWC50CV2-R:Y)-W8K#J6D8,5[K3OYU7
M1.Y]!I]?.]-'N,R*7>%@F2.$N-_@WF#SJ^=PC\EKBF,XF$86U>2.0O\JW8*5
M^$V.0X9IP"P7EW'B=T;!!6(\JE<<B6DN, :6;=F<!J4)9#]9MAA3F=S]N4]4
M[$+]D?:P \J>25J$DF^/-DXY!*/E>T#I2%;"CX8*<<$V(J!0A.\#L@4N\XC%
M7/VBSWE3.P,Z-Q6-B@:]BV&BK5T+:)DW.6:4,0-)DXL4KC\KK]N.-J@)S3S7
M,L,#;LQ:]DDRVZV=Y=[P%DK\S]7J1W$Q[S")[I_=>+3$)&FQ?*#3\2$8!SK?
MOOHYJ\;CR?S<F!2)]KB6RHIPO-[O#.-E$'\2T\"(=\%[ME['6QIQ/J":&)W!
MIC[H"2D-^:P?@O0,>,+0(:U6GN,V%_'TVG8)0EC['L]\M7KE+RO3VXGKGL<+
MWE%;2T%J!NL;A*Z/=AH!88YS%L_D5.,-R^1 DH0,1R^^FXN5SE,(R+S\N7T0
M,]QP*= 3#6A),%Z!4!_,LG84ACZ%7E5MDAZ_*<Q,W$(?>#]4[:/'@ZKE050+
M5.UQH6H?70Q4[=,%JG:A]($_IZ+_<U@&N:C_:H5MI>79'T&91P<XG<L<$K%V
M;^SL$99HK'2-$"^H)#PDG]+C'#-C(*W8E0-U_*(9\^A4ZRM$?R;6M%5,Y1K&
M5?W0)-2(B;JPWG?=-M0K[BH.(] 4$8%,2O04\R ?@Z%3>^\;IQ=IROZHH="R
M-SZBX+P[R>%S4=-J;;]LE"^K!\S<DF1TZ0FNW#>L:S!@;Z3H/_B*61'@=]P7
M7]=RK\SW:!OCAH+27)+Q>-#,(;B@:+5 <617/7,W2)3HK1!-L4I8GP0J+K^B
MX*LMTQ)A* %HQ5,B*1VC(3.</2-HMTV5S)9.ZP/X#G@7W*#W/J.*IFJH>6Y3
M7[ QM:]*%$+;$A-<!!$ACM],M,KL#S:[L=R=B3_(ZLSPPP>&,+4Q?NT9RZBY
M]>3\@)1[M7<WM9J@:?5-DB-?<QJ.;B$I03*I%>I\^ZHY O(@!&#,OB7R'Y(E
M'DMG1!%=NW5#M]!,(+VX ^,P9NZPG6C</-)<!"_#EK5U0BU82M[@B7?7=COD
M"QCJ0U;&B*@'-DR7#CFCO*XE%31(C2WJ_=95@A0^DKK;;*I&Z3*>L'O[PO@N
M^)-S3H><A91#B4ZNKY*>@G-8FTT'_DR7Y27YC47I>.T,[,"S6185";D)M''Y
M."5/>$G;A]QO$;UL=[LEL3#P4>=<!IV;V\I=T]DEEP]0&'];\38W7X$Z.)W+
MZ)474HAPQ]M12@*Y\R!MB\:'0Z[/I"=ZH$/-GNER9!>YX]SJ+H8+^[ZOVSS$
ME-%KJ*$? ZN/^^[V6;![6C?Y!E,N+VT%%WPFE5?4"M<[$_#P.GIR,;6'!)1U
M7W3!"A2GNQR@?>]-R0NXJ;>FAJ;7;3LE;S.6IF<6)_FB>+$14_AQ/ZFBF%%$
MDW,636@*$>)G?[1XX5PA@AVV'D3N(Y0BT/',2G=IVR;BHA%X0!RU9?>_W1*7
MC])Y?XR2C^B_<KMN]:,[0M]FXGAO66X+)("QQPC%BWB/+8'XC-1=HET3W.;W
MP-U!:A29QN_1!YLFN&37$$J?])JWVYYRIZD]5*-7BFR!/>4;JH?P-46XK$9:
MB$&.QX8Y,,FLSAB>G!@>-F/JC(;Z"A&BII)W7$D<#?WQ6,*\W&5GK0GG-@R@
M%&G/'==48O9 GD^]18H'103R#.PSE]G2K#"[JWK(N"K=@C!N/"ZO-+4+A;\Q
MDT+S#=)\1$? E5RJ]:UND 2^8%APB2"7M<'D';),N)ZOQ*INURCL?EI#/;BP
M\ 1*H4ZY. (^@=G$2/<Q3'KHR=NA'[TU3LBOU+D7DQ[47H Q.M+H3>D1GG8F
M4H]AOITAO?0B8'L$A;$AH0Y]D>P2AU;\JO*W6A#-;#X^C.P^ \X9XO =IA!=
M^9Z3SYL3%>K3H(V#!KWW>DR@YEA@]:_GGLPH/(:I^G\PM(.X@O1HZ.:#G132
M$:![8J[\^XQ#A.<2H_>+Y.S;!WA(%WV;,@KF[,%(2<*V+V_/?75-(4VBG@?G
M:']G,+&9-)_8^M%:!B JW^M)%I1RMH?<*VT.NM]X'>8W;]"!O^L@*)/91KY'
M=FN\7+:0*<>,EC3O0[TN]<Q?O9Y)M/$^8XF;N2$7\:>__??X/9Z%-4R#(DV=
MR03]F9QI40'IMB0"0B-L>)I59[*?97^"V&]XGZA/9D(:C"_!"=+' [8HZ&YR
M"=&TS377),^20O35S9#C3R&>[A0*;5YWJU/O/!2PTE)E](5;,M>NA1ZO2 >-
MG9^R\LYN[9Y@1^<2A K#TU'XZQ%(UM\)@$!8=FW13\)J<W1DWU/5DU9*!$:-
M%R!%IKJ :WP6=LT<Z0'R1O>!74T:+(!NR$@$K=ZZ"@ CKE43_&];.ZN@@_2,
M:P^\N?+  ]>)P@J=M2;2[K.V[OYTZ.2L]4H!47L_-0 =A*K=B9V,Q.T"[IKY
M=YMR:C?[!!5]5YB1N^?W"C+>+Q&]QQSHUI)*;@@ISD01A!J+0XD%JG _5.&/
MCP=5R#?1%ZC"XT(5_G@Q4(7/%JC" E5PN^F[, "#P([9)<[,$R58S?OK\C5W
M4W^:W)>)*(L%>]/ EJTTIP(9]TPWG6\1T4>17-AO?I+#(>_U?A[^2N(WF7\_
M"<PX,WHO R4H6_*-Y:?06I/NV>\JI M<8FYP8M5KGCF]]^7G3(O"'8%5MM4U
MJU.$T)I;=&?FD=)D42UH8$[VZEU)\69H4&E0B>PV1P/*X?/L!1069GP&7ERW
M'H <V2\'O^A0BW0#M]UCQ?B8K<E'JDDX>28_X[F6#L'WY,)UI#.OHL7ATB/&
M_W@$);Y'G0^4R;U(P$\F7ZCISWKN^'?N)X+A?S#S/U3.X7CS&KD:U?%*A/-T
M>[D!O*@+'P#+U,.<#<7.!*O289<<4AA8:)GOR-F>0JFA*\*5J?.O..>@*''!
M9&:\IMTT#MRJG#UQMFDL.5*D[W&'2*E,*-2C5D2C#T(-I!9/;>\KC()MRD%;
MK"106ID1-M,#W>QI9M/3/H<*^2"BIZ)D,G9/OXSBH20\\9$?$#!F8';;]UF+
MB=]8G7H&M1#9Y/%<*EQBM ^C3G_H5L0%+I=6&Z5C&!6R[A-W*L+,($_JR,9,
M##J<7[F9"C]8+Y DMS1(#?'E\H'XR:,TU3Q1JAIKT5I,6!)3G,@W#K(8>$3^
M$5V'SR#T9)@+880,],C+)-XT-N+6M[7,NQ2Y:1QO81C]I!*&U=G'2<7! -_B
M:C-*#K3L>(8_8&M+&8!-BTZ6K  @W;#,3<NPIQ[HO?/JFVJ;XTAQOA=3T.->
MLG0OL*MMS_-AF%Z>6(6J[:\N57-/U/SR^?ON\"QAB0Y.FE?9K=VG>8M??CO@
MYS*71.4H,<'ACCC]/EQK$:<!_BRX>WUETS+#SG9>Q;*33GGO8"(%X0H*@X4Z
MAQ7NQOU"R0Z$*\S9G7UF5R?I4V_+<E-+V%$:UAVY%>UV\4&\\!E)L"=X-KYJ
MLVPR=N;=6U(2)V2:+UC99&)LZF\J]Z^E3%:[ )7$PE=W,.-DF2=")]N?Y%HE
M+U???_GM#SBZ>S3H0S1^+T#?SG^Q,E[F7!;8"(Z9Z\F=ZL7JN#\-SCC*-L'M
M<K<FC66M13=R94B>H^,/,H5IJ )TV>T+=UXALHW(70^5.]*WAEB# +8#CC;#
M_@6!/L'Q\EV-7=<,21'>I$QXQH<-6ZJ)5,/]:SM#%\;\LY+8T6\V)?69*5<Z
MEINWY37^:)^\"/Q<-_S<(O-9$$577UY7\ALCM-B*D&455.#OB)O,[6V,Q;))
M.U-Y6U5'B8,>UEV,'4_@^,'2SYQB&B8%J])V2A)@4*94<7PZ#!Q$[NP>$71,
MW*FIB3KN8+E5Z"F!3KB6G$XT8I6L)?CF-+XSX<KFK]^^*59__8\WN.A?7[^)
M;K;P0S!9&J.<_K9*T=#=!W3"?S#NTVM>(_)UQT0W#2  8AJ[V/G>3V)@<DYC
M-%C.V*M#A+3F@=9=#]7BS:E0]N/XF\!Z_(Q%EXUP<S]PM>6,9:>>0,LJ#SN?
MBOB4+"2_9T,@C/?UL*BB_:*'[.^>Y%6/&O8WK=2OU+O,3/LA0V^*UN% TY[F
M7HY14I9T=^A_-UWC,C8J:/$-;'EKZ&6<^RZ;19!GM6RF"]M,\5XQM*R$C6LP
MWM)/1]YKMT \&L=?MRSQB3*43G'QF)JB=7=4.C6G-I\5,S"L_D>GR+;&AY>]
MLNR5R]HK%.9QE"L<,"$)" $<6$ $ -V&*O@T,+D??4PS&K1W0IYU6_94Y(1D
M5>O"X!CUGM\O'%>I>%4(K".-K.X=09SDZLNV6K;596TKRG:'L"%0&K$E-TTS
MH[H"#1<@'PVQX&+9BV5?EF5'U9(\$Y:IC<PK$Q@J(22!*3W&^<EB\XO-7Y;-
M$WD(9=0<;KB?CJ-4G$B4  G[HE)[QWM=;/BWM^&^VDU#-)=D.S306DE1&,+F
M:%HE/O3/#WHJN_<P#2!71TQS+BF^Z72F,LQ?+#*TOPU@_D^/!YC/0[D7P/SC
M N;_="F ^8^?+X#Y189V.<1_G4-<6R]#5?_=P\)''F\O>%J-3WD@<GKE[N7>
MNR!KA)GXGO[1HH6YV/_EV7_=_C2U&Q^=JFV'2MNFOJD;D"GV($]L C!M4<*$
MK%<Z8![P2EE\M<KM>:H5JEZR9H=,+6C9)UZHK%S=X.?4VQ*P*N!4-E9=K1#*
M\3M%UAY"H6Z% :S@9B T*%9M.8H7%>Y\=^'LC:^"=*.+>T1C2/4-">'3*#U,
MO K)3$<ITSU5+11 &5"Z%TL**&DB[&DZ#!X;/=%M>1QE?$ %5#QO9U2D\QV:
M[JC;I'5&E_Z.OF'5 M&O!BF.?&ENG"DT0@FI&C\_2.6Z@>ET,K- .D#E!Y1X
MMLDCKOWTB(J9<G*)6SA&NJ:7CR?^V?0BBKC,;U6:[ ?P$)R?38)W$RULZ>S=
M#E;X"QO2K>*^7M?*]AK/176[W3/T Y^LAM0W7N'Q/F@AZ6*$\H8"G6O"GDXL
M#P8#!5>N"ZW2A>9U<Q^-UXQ+V[0#="+"\P^L*XCM&2BC15\WM5?L?=C[YYY1
MXQUF%;].Z$:7]<&HT*X) $3, VN237(^<G"')KL(<[,[ORI K@:"J82QE"<6
MM;3$P>>@Y*=#=5 *95J0WITOX R!UEW[[. <:%5N9T!*W%AI.LYR7P7T(0+X
MS[L)>0MF^FO'335Y;!4_\1<TU3"X%J*7.+_%"!*\:RJ9=8N?WS0PPN&J7Z--
M]<BGQX;E#8AO(K*BGV<SNVI+C"WV1"/ZL8;P_W1+-'3&\1)F!31@0K';/71)
MQ*^,1VY5W*5LW&E'#R^[(+<'<KX#WT!?7K4_=?#OP'PJ51=?G\[4JKT&[A@P
M<G\%?^&82,W#SZO!!!-Z/12[:$ (/:JAPL#3IJ\J@!'Z8]?S7.=873.BFAAO
MPVGH#+ALZ4,VYF3J.;1QXT<7?95J&^\XZ8UY<A8<U2B1;B8:BFHJ<\Q+L!+I
M1;E[H'K/S#.?TZLUV[50K3P67GJ0X<2"M\K@TN05J^,54.D5O.J,^LKO_82N
M6^5O 8BZE/@X&B\5WL5XX3@<:T[/4B\WL("\5U]]B,[L_#U/[:Z\Z7BB@(90
M#3J^A@"?153?<>M'L*1O)#[<5RZIVF]*8.= <N3BW+%&F)O()M.06UZE)Z5U
M#Z#LS "])U&ZXQ[)1;7,T".D1I;/.>@917=C9OJD9QT?V*)1+YQH]RFE/\$8
MZ<<P;\E ,/*C?&CDYR7%C(H[7D7\9O6]L$X"1N1OZRUY$SA]'@P],9H ?T2H
MD9GJIB$H,%5I FF3+["O1<I@DJ<B^]&4(YGV6%&+P.:A.I]O\ P\#LL#_'28
M":(THF+PRW.U^L'MP/CY_>1K&)8RJ2P#(1J=$0_T8K/Y<WX;$HEA'MY?.4R9
M\P8WY 'ND\XDW -05R1&E:L7<=Z1^G4V-7.^1Q@*PSR[3B3)G&V1!(VTT\M-
M-:%TE(8&>F.TH0?KH&00AOXU1"I\<D"] ,P2?._L8YK\38+5C8<T5'V2'+WZ
MDDSV&9/+@T/>\*>**7KFV#:=>,3;FFT<H>E(C\?[:,P*:LX,]5H(CAL7"(U[
M$=86#@@F?5 "CY@S3=P/V0K1!DBZ[KV31_S#SI)Q .4P\'OOE<SKZ$L+\$\^
M9/8UPJ!S7I3&NJ;C? G<SG*!VH%CJHC)/A?)**$(67F.KH4#8B%K._^2GZ)#
MSOD^H;GA^?8Y/4(1M$ "46-/1M+-\I1PW!_+4\=B\-YY,X]^CXT0*/C@_Q(%
MV!$JTYY%G,SF 2<T&6*TS4TD<?2J(3J!"9UM9.;N2OR7>EMXH1;94/(8Q"!.
M1<L-]S]:5F.8D[HP#4D)0L1S-IR*MAK9\[MF;[?5D<D]9/WX1:HP9^?G7,WZ
M^+AF'LJ,&$^,XA _7Z_+'F8B ^-FLLBRQ.<KDY1J6]UQM^]OZ([X<QS9$MXI
M%""Z_MHE67\7]<357\-W63*7\/MSHPOO^*YODY\A"*Q:9D>T7UTH[[0@:ZN
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M"!5&P !$'='#1+Q@,I;^"5;F?E1OPUH2!LKJ\9+0B_9D].-9A.9=KTFAF3,
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MV=8]@UAEF)]&SBES8V3I@+827A>?9()! #3NH#UC,^OTNFS+;5+/_X!'RN5
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MI<"@9&R(^D)8$Q\WGEQJUO;6@AN5 VJ=B.#N$S-4-2Y'I1 @S);;48/S"N_
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M/((2H8:[5\<+-(&<#U+(IPK['6Z9X2?=NJ%D7ZI@1U*/!6FWE,3F[)"?YQ?
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MF"+V7A'Q8W?; L*.S_#)]&ML[053E6*J7CP:INH<VF<!53TRJ.K%Q8"J/EY
M54\55/7'>Z 9ZX:+Z.AB;:6.S!3KW:ZXYSPIA$&_"4S.G#7$WOJ#ZNKZJE!D
M$XX'A/,?XB@\=S#2H53O3C@9XS0*H33]>3IBB,W=(S7_WG+VA/)Q&9(_2I:8
M_.&M5MKUW^1;3,Z(_N>&!M24G$[@&=NJ(7''$U;%Y,/(ML,*Q0\NRS44V4)D
M4^HY;U;X4 + [6F^T_3S3).CG)>J)37<D2]:74]UPT!DR6A( 8)"&J\?_8^6
MJS]?.GE+@/V/!]B4SQ\P3B3PJ]777";ZQC2T?ZPV^Y8X+GF4\DLH"<DDP&MM
M7<OGO,S@\\^P<;_^YL<O7W]=Z*19W><>'8""(^O1Q)(_!H7@YPLYY;;H/,NF
MKT)UJ6X>*Q-:%83":!GA]Q"6N&]U&Y0Z!@;#H6,-_B8#OD!!-YJ \%R8&?OF
M-MX!_WRFNAE0!H0GP+H9&0MR@:$20R,/!+ISG@&;W<L^^/=51,Y.^$9ORLV)
M#&0S]>2MO#2&*12]SW<$/^;U#ZM81>Q*7KU('7$*=Z:7A^%A8>?/EI)1WU5#
M94>J,T69&G6HOOA2F\S1R!Q:YNVQ,5Q3-8B%%=S!T/4NO_*H$=RF O!.K!C9
M^.\WDSM2T.%>Z4]^U#YEB=#_?$9+R@F#T32,#B)^:%]PAV::OT452]CI &8>
M$':<^@$3DTE]GV]P*0(M9]1EG5'6_M_L3T.](0&V-Q(*_C"1$&-;<6U6:T2A
M'/]**L=4TK[O3%$%K4C!Y4R_8:<:+1S[DD*75T(2U*#,& M+^I!!5Y#8!_/T
M^!;"O(FCHN&O]W6S[:L@P>;/:"5&?B,%IP\8^"E'8>A8?\ASH4#=EFW++E[T
M5JU7Q\'A.:YPMI[MNDBWBPZ1G?CNF[*9&#*"*^@K&U8?;*N=5MP5S[WM!#".
MDV:@L+T[$K3/)1?XV[';.N>%O[!3V]=TU##.G).9D4KK$#]2X9 (>DGEL,#9
MP@A3T0-R47]%%T8KQX4^YF;O"57J [U?L-' V%5:YFKUI:IEGI&M970AOP;D
M5K[/-,A4MUV?.U967W#;M<_\C1MA8T7=A'_C,6C"Y./Q6B 2&?Q)W^\^M+C_
MQ?U?EOL/@1$I$E:]A]:(YM#4@@C8*J RX(!=[;KORBWFUD0VBI''+O3?5!:.
MP\,988C@;)ANM2ZAF*0W-BQD@,O^N;S]4[HLJ+LF$0O):)A.'O,Y.9A_0&O.
M?Y^T79\%Q*Q% 17G-FA^%YW9M9;_#GIK""!BG3?-VOS0@L7\$. ]!KL7?H($
M(P@NDEA/9P<\XD$!$T,P=H/U)1D+P.EZD%PT0R"FXGBNSB%T@UM?2DUUV^Q#
MF?$YU77\7'5 _7B !J_)<@4R"R6?,.-O9V1X?83IGG!JD8";*:+KJ=X*&XT2
M!Y$^[PT$:>-?HS^<\:)]=YB:ZW(,):<,(@0/%DCO=-YD""2*5F]$XZ)<S<?2
M]?GQ*X^Z'ES2[5[6^46%5M%,V!&9/P=R,L@D2GY>XO;<PUNQ>#6]J'9C$=,T
M5/E6?]_$C;O5=;V3\<ICU0XSX9,('LQ)$,Q3 TE9G>U\T785ZD&:RBC,[7/C
M$YINP_J-RA$4R&BNO7KRV>0I55?$5K0M[YN*S]-S7HNM1+]32EM2%)'JEI_/
MBI*;VA0)ZWXS'2@@WHB8##[$/FA;TS !XVX W9$!V3928*9&J.="(<<#)!%*
M^.7AC.WS9#LE E 6.@BWB\BXR_8169R%K]7/,-/\JDH*$271%MT2?QSH="GL
MU;G3C8AF,ZL3O1IN6WN=I'B-*.7B8N=)*/!<;NC'GLWXJB]B$UAC4TZ\Z7"'
M(T3%18E2;D5G\NK6UDCU9@T_6.731FZ&43<0O3>!$S"60P6/J$F,@Z9Q3Z-5
M1HLZK\<4ZA]-5])-QPO@<_DR\ /13INH<D(\6@>#WZ>):E"M=:SZ=L>4:=?;
MZ.(I3M!_*0I5AF%.*<'GU*A1 "$';4WB7S+-CDE><P['+\$4J(U#OFLDF'L&
M+CQ!7L]Z<P,)L/ZE B)4.XH$X'#!N/S5CGC2O[;NMJE,$CK*9R<>HC$'7[W*
MBY!A].$LBVQ(M^)%\!QW=JAF3^A0&BGE,EG7LDA&A\Y(,+>KU3>9^X@5T QG
MEKP-K;6<?ZT^V/1;UL92.M=,8"Z9018\6A&],P"G>>U-_!A>>KP.Z2"^WZ'W
MF(:??,]Q@0+EC>ZTW[L+.];]2*Z7CXCDRD.,%B37(R.Y7EX,DNN3!<GU5)%<
M#XL0HG'& ,W54U84/%.Z7&2@X7 (0_Y4^9A%I^30<<I*MFL.1YN0:/N[,"WQ
M<DN$IYR34;!0AF:TEAARG78_DH")!E1/KKN>8QN+1;A_WG0VMV!R?&*?CH :
M\9/K<$)(B;,#Q$4L^*HY<@0/06),Y&)D_#1A T&Y#3&ZVM6DW*)W%^#1E[&Z
M9JC$=5]5.HRE/#?AATRXBE@,8RQA?"7#-15,H_"D2;2.NN#Q"KBGF1@$3F,;
M+FVF-X$7NF<UV%TM#R>QA_/%+0^?<<ZO%F.U:US$XE+@AJ-SY=Q(Z<H\S-R2
MM\VXSO'M&0Z*T89ZTH'-BB4_Q9R %$2$>%9' Y$"4H\W'6[V[QIC82K7Z<R9
MF.48=DE,MNTVB8/]S"$UMK'V'-&_#BW"J8\V/W-W$25K.TAY;DL 2GY)G#N2
MN0;ND%'8M'B?SN0?8NH]FA,;]O5N5JMH;^J^DR$NS2AD*G\]U<U6*B2B ]9W
M[I*2J+\C0EGD.TS6/,S&W")^*YHB/[I?_FER#F>K3+;X-Z[75'$14GC!SC@$
M93<2#D"D#&+'/-EN46&HHYZ82W]R;]T%T:!K2#(1KH ];<JX;]VS=. P]PY.
MB9I"?[QS$63KWLB ZH4,',*',ND/T;%U(RPS+W[NJ;BD_NNOG;(($M:WQBE*
MYR>W#$2$Q]<I(_'GI[CF7X6*2E*E3U&.[ J"TGET/E#(J:#OV3'B0@.W\.36
MXX# G/D\O,@RU_Y,?P*TE?^(L) X9&4)C-;?N#874\4K*L5E+8K(I/N\G^8I
MJSG8L+&&7^X 5D0ECQP[H_?@B2QMZEU,J;P+F=8T]=Y/<$\H=:59L)8ZC-3,
MC%_,0]]%_ )3-9304VC*-06 5/X"R^T6Q.AZMNW='QJ,2 "G.[C?<P=K0:.\
MY>A/01<NNR.%.7WVY=_+?DOWK6^/KW9;ND//G:SGJC4))CB^%$*^ICP<<'[Z
M"T>=PSV1M>NW!83:W!OWY;;N2BY ^TN=OS$>%0?I865N"<_CR1#YXT9:0(/=
M;&54U;SLNK'[.[]F*HQ0-<AZQBKB-J6O*X.R  -Q^Y./=88DUS#/_0UO)J[=
MWW&IA-DF6J[9"[.O*/B$B$=@)[EBN&XT&$[_1+_)40I?@>JSE0^ON9,IJ\.@
M:^5/38)%^)?$$%+N2*205+6\@\GH*7J65PWAUJ]9,LE'ILXLN_ZM\ZF*I+:-
M56Z](ZK$&4'*/[40]W4"3HQ7T\?ADH+Q*Q"1"-B/M.4C@MW4I+);WUC2N(?B
MAMZ;EJ>5@]8K<>".J3*F:47H@ZM%U=YPB'$+E_%!>_@&<!E8[QLL<M91&KMW
M]<;]_][37MB&/=-(43O/9SJY23!N0,''RDR$]P_!HQ5F=2CBS[JSWR*.>=R8
M9?_RG_[\/7I_!J2;$+!+[H-XP#C8RP_BWG\W!^IQV!1F;H"^J=Y2:5F.<>F]
MQ-:)Z+>ZI@&FAE=,&7W0Y:="4*@HN;LGTM44("34GEQWB<HMM'?ZB@GAT7Z3
MH43?K(KOKHAO(O]U3]'1YE]-9NT5N[_ZJ7.+3\S@(V(NN-=XJ=(W^5ZO+!-X
MJ 32VNT<=^#;'JVO^)73-4/&QR%6QQ.*6F6$YJ-"P!O*+(]Y,77T9ZBFZ60/
MHJ[I;^@MSBAXY5ZN5J]LU9E;%QU-1AQ5_H^!3''MB)#C/<%E/-TNUZ@W>_>F
M!5C'E--TYVU%)4] ?]KK9T2?PT><6W)Z587(10G^QJ_LUB6V4@^LWKFDDZG)
MN\W;O7,  +;#IY/,8U*FXJ#U"2<P$8^B))FTQ>,P+$ @"5SD]H<TA3U:Q&^7
MI#1NJ?2YYG;=N0-=6:Z1!KK@@$@DGS$ZT[ J.^-^=[4*I1Z_4P6/$NJ3=%MX
M>P8'H3SRI'+L-[/>$(U:!#A)XRREY4)#M!,ICCBS(=:"70 %E@0+S((U:XM0
M&$%[JZ.R=R-28>[N>);:;M5=[$IN%&,ERV<]@BX#I$YB[O;,[ATH,P_H-[?1
M2#W/Q%= !!V(KA*5<4Y0"_X%FL<\AFE,=TO.+ 3))A(D!ITJ);/,7EA:]FG+
M_J-';-GG>\E+R_Z16_8?74S+_M.E9?_[;ME[&:DD30BPK'O]?DS[K)7)I.I.
MN5IAQAK\7!_E#>ZK0<.R$/+_HC;SNY_Q"39,H$ST"6R(22P2?:41IE7 18U3
MPCH16^$"(H?NB+^0#?EIG#+>,,N\Z+(7+GDO^'(HD5Y4#TC=4[1RQO&#UNJT
MJAKR_'1QJ^J=%B?TO[XBXA#[_4A'?L;7KTN:&R.NFT@O1K$U!67O[75EA'A#
MAK;K-E.D4UQN.%V1[_;)Z$WHXA2*\O:RN@39$E8PSO%H;+UOA?9K+NZG_RF"
MJ[13&X>U=E6D6D"&95H9W'ZH\.AR>^ZK59.[6B;6%P]T\1X(RMBIOE/0":3>
M"N7]M>(AT?RAJF/R&?2:CYD?EVOG'PB+=G;:,O8BH)>M2G%"/(M$_BFY188'
M<N6P9.)=EY-,!NLZOW0B956AX+=LTF637O(FU1ZY%S,%)A-G=2$$E_3G3/>@
M"-*/ M4!/.V,=%1FY$O_N^?87W;0LH,N:P?93)"8K5B ULHZ6KJ%54_U*S0/
M+&+6;QXS5D<B&>9 -#EI=Q<CT_GO7O;.LG<N:^^<25)5F<:C;G#TT&A ?#S0
M6$I#Z2=-C7C:?]EADI[JI, ]'SJ7KW+WD6>"$OJ$DE@/9+"6>!JHR(F$4L98
M@.-#QD9<;X0KNC8)'A^U/U7=D2@R_BYB@C=N?1 ]/NB6S]X= 3B@<^X;W7.4
MTVEQ!XL[N"QW0) VJ)=@_ _;:5V-MU75"HZSW:Z2XY;WDG;))<.DGZ.V&VDK
M&OZCJ/R4W_@_IR8E*J4@S-&Q! )%-B>[_2FA[=>U4,/$Y1X+^O S25%%>MFU
MRZZ]K%V;= X%IZ(;D#7I"RBY^1\5 L;235+RG!QJ/0&ZMBG!8HKCB^O6.^Y6
MV@V<W[WGBLJH]09RD4Q^N9 7)F:W;+%+VF(:)PL3TJ9[1G_*!XA>JB1W; WV
MH!HR8QMF6[M+Z!3>X4Q/@RF%!=-;0IL+1_8MPMR($4R&XF\JCM1EU,SOU8HO
MDGVDA08,4QO4.N(75_@Y:N"_AAG\-W+.=HZ5.>7N!%0"->MAV!C@R$<]=<3@
MI;H"&=RWAWV#SED9MIB"H!Y64ZN?C:;"F7U IIH.81C"PVCM0):@.@E'O'$+
M!$"ZG=OG")$^3GC01@8/XP4(5(O9*?\P"6ZFBW@ :UUY5CW:7D7 MD0(4?/X
M9H&QD PSV.P)@BUAZTW%'=6@@=-6=&QBBA*[^*=IH!'C:IBM+B.B\=#HA,),
MF&:1P#K5;?SDLV&!,[!68TCG!C R+5O[!CA:?T ;^@PVUO 77E?$C7'<Z_2<
M_ISJS9N8VOY6)DC[0_0F$_OO.T#5>0ZX;#=,)];RIM)P_+<G</@9HR5G@*T/
MG"V!4 QO;:KH)X,UTO^G%Q6O)[_!RC?#AG':*M=TTFD#9Q>#]^-KBW9P$"U.
MJ2,V94\"6=,HS?Z(4&32D>)#Y78.H?4W9++;JMPV3.J2PK[5$0GVV.C;^WE]
M>O=]<G35Z2CAW'*?(H _?OMN-?&PS ])G:+5=$1-S/>-#,5BUZM7-C$,T]C$
M2U4.7BN"IN#J<9*M^_K[[PQ#C.&?9?!%(#S@!/SUM]_)F.C<=QD;%1,Z0@;B
M/4Q4F/=22HAZO%I]A;I;23,%8E')I.]?2II$7KUR%N.NF)@*N:XOB&#W!V8Q
MW$0*'/Q$KYJ-,X3PJV_$O,PO7F6([)Z&@?&^'+P0-0XH'N4@C:GM=:7:%_&J
MLGTP^H=&#OB7R P2 \MO<>=:!NK&K';EC3-/_-1EJA%<-:2J<I2FIYT]RD)@
MP5$QSPYME9&2XV(ZYN%&]U5Y4ZL[G3L^#-A")+&#3(4_$1]DK,5\'#?894?(
MAI9\IQR8)1][DBC7O:&F='&$C3K#,^!-08.1F[M!P3'<N!#&CG4R>!.3 SUT
M_^F8CZF5T8A+.9;Z%J!=WM-@<^J,'_8-+J9J)5003A?057*<>EOUF"PC<4@P
M0N,ML@,<H;)"<S>[76X?+M,IZ73*'Q]Q.B4_-K%,ISSR=,H?+V8ZY;-E.N7W
M/9WRGQ55Y/85G2]RZ-3 Q#IOR[S&S,(P3$*[[W)A)JG?"5T"._G:\Z*GHY-T
MZFTV;N<%6L*X/CQV;FD*H90S/#I=[Z>)34$%4 VDZ!3!;<M^Z^D'[Z D"#P3
M/<]>\Z/*0T1?*$\>TU3(B3B+'<H^83L$HU.\ 'CDO[Y^X\,=_E#@XZ2+&ZT+
MD6/T<A5???$J%%UZ)6^!0(%-F@S9](X;U[F$7L]A$TU=K;[/7\;H0KH'IR?0
M0Y]D1^MN"ZU@UB@5#DH<[_'C8SV1D!R="1$W9Y/)74QLZ5FE/9UI/F$E&JV4
M1<M8EKO?F!T+489_?@IFF"^(\M2Z34JS2;P2C0:[_ 2&1M^BH1*]),Y5Y1W-
M,H^[7EAN<%Z576VI,;FK=477E7QY5H:.IGD;K=/$=$;.%1 1P*F;I)HF:::^
M5"%#/7/;"$]URD<*9?+"9FEZ>N^I0DSRND",%(^TGW\Y0@WH'9!2"$;*'[HA
MA$M*I1LW?_WVS6PW2NZ@>.2&2 IH[FY-A/ [8(U7Q#$+LHSXYE2P0&Q7_AJO
M!6_LF4&?8>2+6-U1&MKT4TVLD0:[%FY.[RLRJDF*2H!BSS(86[D+M<-<14:&
M_=-Q_CF-O6R86C1':(OMTESQ[,X6V?'!*_6@2@K(]YRIWFI#Y04,NCX6G<DH
MN(#1_PEF]:]4T<FOG6R"F3>8Y7AN*> !U-PE9[<?BE]8((Y"NYG5&G#6T '-
MJ9[7&)7L7389F'N3<@[7T6.$LW5-FN7>[BMTI)GFDR<%W>G5$;]!L'^J"*2#
MA4D!H6NO.W#I^:6@WR=F$O^#3"TQ7H,?,]8** UU*)"HQXPH>%*A.@G:6JIR
M9 GTDLX@3T?AV&0U5R;H.H5O"PZ/M<)F\Q3\M1"4BMH ON(0MVVD_<)E"3E\
M))::ES?"AJ_V9;.[KZC\,^K(5JSTKK)RO>-U\33 $,HBT47$#_S/J[^YB]>,
MZ'/!Z-23 Q"P0AP2X%I2DJ[Y1?3=H1[2J-9,MAF)FG*[K_IJ9GG6OA#M6K&:
M69A+/LV_/BIL<8GV >$)B[H2^ ->G%<@AHF<+<-+O2AN&9$4_*P^G[CQN%@?
MO^FT<I_;8/.R5SA+?6](NT$:;IG-Y'M)6+7[&F2^YD3! :U4LN^&,<QH"".1
MKEK@L@X<Y!I!QFNB#45/O"BOXRF>,#\X%\::QP(=0A:8;TJEJW]W+3!>,[%D
MX2$=9D)#XMRQ3T2^>&#./5^C]&< AD^3"'+$SB0=[)7;#%./S5.V,I'*^0R=
M-:W,GX5G%#L&91K1-B86*^7JCMR*]ZAEZ\D J;WNDH)T=8(1Q>L 1\?D7P.R
MRES*%@K@3Z C^@\P)B?YC.U**>T4^?WASM2;4C,;#O()36;<16<#&U@@/54D
MA7P37%6(Z--HW2M3VJ]*&;0#2F .H#U[8D"50GII Q%]"J:!OG;;E[?L>YG+
M]6X?_21#W&_H82F(C%!,S<F3 N>Q5U7-I&#)MJ/F@3.BVD<#8SK*:C:^2>KX
M$[8MHP%'FL@Z<PNO,9=<AE+/53B-G7OI)M +DKQ 3<":FDLVC%0A>U5#U<B8
M+N:-=U#65.W!4;#4U^2V5H/+V(FH#-?#)W8U*7I4_4 ,J,V5%OZ2RDW@G+%E
MGI]=EN*#8E=#RCH6*C%UFS-AT6SS,>Z'E]B$2V=C*NR] E"GGB@ 91>)V"81
M"@ZI(9!Q ",O])M1LWCGC.#9#NHHA3.7S=OR&MD%<E7AD)WAV:M-C>V+-CPW
M,,-9PG/.OH"P2PL+&ZE)KH2_.OZ)@6@ALKVCLG#'*AU+B*B<TH!F]D)/QB;$
MSQDF&#GTZOYLY*2#KBDJ*;^?8S"<3YH:EP>()X]H:+R;!1HY(96X]Y7,XL@[
M(Q9Y&8DW1R@<O/4N,TJO+.0Z4"$"GO[WG8%IV&5B['Q5[R&Q[]7J![-&R'O#
M+I0<D!++<%S1[;G7V'G:CL0_J+R3?26WK G$(J(NA6UH,JL:"3KI]9V(DMI_
ME*F_K3)$V #G'8D[%-LQ0UCXH)70H*VX^T352Q8*'YQ%^1TO/QV ]=^519;$
M6IMF8'4293:1W0EA&-:6#F!*I3RG3*;:*"8GHXC$#.TI"[.*<LP3E3L839<^
M>=HG_],C]LGS#=RE3_[(??(_74J?_)/G2Y_\0OOD/X<=_N>TTR.)'^^!$88]
MXRJ"B1Y[:';$QTDLMQ+T!HPH">:XW&7:RHYE#BH1XA7A**P, 753WAKT[;JR
M"B"B^?$4\\+D%.3)4T',YJK=D<2-RIY3&Y A?WY\.ZTAA/<R*&HTJWQS]K45
ME#$]S"J27F)L,0D-J/3&"NF,,5TZ?7&V!R;1W'^U-16"?QAA)$&&2+0_BBC%
M2:(]%1]24:*9]I!BB^GG&041E\%%8BB>!5\XYY/G56D4(XM$%DLAS75AE)'H
MON*[0?@YE_2Q&1# )J@A5(.+O];5UL))3!LJ'=[@(GES>D\AH$1J15>*.I/9
MA4J20A<*BI9#]O)F>S/=OBEB]6P5%&=3_8*-A5H,TEI-80BJURD6D8SMY(62
M?$Y]IAEL!CAF>D<EX$'U%HJN@IP](U<DSLJKF#F'(JU^R2NT.W!&N"CU&)&"
MD0<(L?A9>XJ%:.)U,#HVJ! \^,6^/E_W2)1NLIMX$*D?%[/PT\[UX./+V$_#
M/#))>7YJ'\I+G+X8H8G$)]CD9#;R4]PWYL.2L!<RY7/'1,\G[WM"9;5ST*@@
M0W'![ZTHR&E+G4R$,N3++^;_0\HYSG[W[L*@/-,Q%@%UOZU.H1XY'RJ@1A!D
MG9U7J.'NJ4<3?2C QNHA:3HC<!K19-:3HJ^HJTE_DSO*E$7/C5W&HY->O"72
M(9;!F-.3CZQ,R4X9YR26D(6S3*XN_!FKS;ZE((@;*C$(*T6&;B>JA1!. /8P
M!)"_^5IY<^:US=\9=P&%N3) 1%$+%Y<\KW:?-<;04[S_:F<Q'#^$#W[5R433
M;%)D[[RQ^[9B]67_]FV]^G[JAJ;<CW6Q^O:+8O5%>5.[8*UQ&7/2J'[C'"?.
M3"[Z?/D='P=?EWU?K_[]7__YY<M//^^=,^<_.9-T7^&.._>%=;5;?>>+4=]1
MKZ'JKW+?K_LH^F+OL>1\(%K1@:SQIJ;^*)1?>QJV05T;6C -M7&%6>90>0S=
M7J".?^G<,3D+,[[ J$O79]JX+J 9=((F?+.$26E]MWJ'BMH-Q?AX5*K%H>1/
MSB."-,G/S[SP<GM3,XR5_9%[[<9&W?%&[;EZE!8& "AY%=U0G-;"Y%FN#0ZD
M^\.#JWJ7=EJ\_]%ICXNHS4:G)K]Q4'EE$*9V3K'(M<'2SIH_D:%LR,?R4_37
MKV#]7U0;;*Y__><7'S___*,7Q>KE\Y<O>(_M2\QK5<3OTC3/ )3PMJ_^D"H\
MW$K?$V1T-KD>-HM!?(@8Z'W)]Q]B(>@_F$T62=N98?H5_#S.>N0^=."'6SB_
MJ]Z[+E!Z$HT[]II+R>Y P=T_9L^CO79DMO(?$Y<R"/3;HU*$:R*T#N!367);
M*1@D9S*#G=@P!C1NCT8?8^.<+!NR3-]#L4%Z<(?FH'-??ULU:70VV"\S+4D2
M[WIWU,D,FP)^Q9F*Q,&\]&@SQ6(2[K+5=C:0L4*KC@Q]X'98.*K]0;RHG/RB
M3NMW3P:$R*K>G; I!&Z//RM/"OZBW)F:4APZYU)DHX8=X5W60BNWF/EEF?FK
M[0TCABR0( V@&3]>#Z"Z.LW.47>NC8047ZQ[L>[+LFX?W<^(?B$@8XU8A:DJ
MC$"X^+0YV;0^FA*@#<"(4FAV*@SU'.HDMPZK"(IRNZ^;2IH3G@<N0:6' 0D[
M%B%J0#U+X9B8+0)_+7R+R^Z\O-U9'[(SJU&"$J<C!NBOW"H0EW$[%SGB:1@K
MP4F'EN%"9S@KZ$J?*"RNG?6Z:];E?I1FTBPU4S<\*$QEU@*5+^>:BM6\U&L<
ML+SOE9$KYX2QF-^D,8UX&(]PIN!]=GDS]8;[#N;2H6];'@AQK1P A@R:2.?1
MS=N6)[?PS[9T38LC"(!T&40L[;A*DA_[;T'5Q3:"N)6J[:! !/0$2U#<N.5F
M9'-BD@4IE>X4K=Q1,:;B;BZ_4)B%%[03UCLRD!D.W8\"D>5 DBXP$(;J?4Q4
MIA5;);222C3.317$TLMH&=D>^^9KJ9Y-I)&!O2DS'%TD"-^(:IP=6)A?N:)1
MTK["I-":)G$-@I_P$"D4/:YT_YRGGBWVNLK,ZY+]\W31B?3_ZF'A6'H =O3C
M1\2.YD&-"W;TD;&C'U\,=O3%@AV]4.SH(W$L8:J4RO(T;ZSZ%8HQX]9AZ&3;
MWF'2^ZP]OB$^'0*I<R9^BL/K:634T]8&- \:DS<M7AR=H">RYTL\+<]* YA)
MI 'V1YE?5YZG%).1G)7W4<J>H3O663!EI<91')-1WWUDF]E  Q:1UQ"Q:=ME
M(^16[3-W@5C0L>Y>%2*4),.//IL$2I7[QPY@U$87WI)MRKACTSS%"#,!]^0L
MWK:;3%!$AFI 0U'//UD_7 #<W2,:PM-Q$%2G7W/+C@HX .V>\:[;6D]ULP7?
M!71-HPX9,:,=#MV6<:2,[RLQC_2>X".,H)4$.6LK^G?2JR)<0BSG,9^V2Q Y
M^:T!OA<F<7.+0R&ZWIC2J-LV\!Q'.&^'7G>_P33RKSN[_HT?_S)X5()U3D@W
MG2-9@TLMQ7Q<E\3-#&/W-L"H7IL'10C4 .VW7'0$4![?A_']*;H%^ 2WI[ ,
M;IW(0],0ON"QYV\@F;>E?4.]^;8Z2TQ1B03"V9/#4RC1?=!M$+C9N0\2INOY
M5IC8-MIY&+/U$X(Y:FMYI\,$]JQSW\[27)"\JJB6LZF<V^')=/Q+& ZA7]A1
M\"S97SCNIE:Q2_&S;YEK(159+N)<UF (,/=:-H+C4/J$Y!4(5Y<8MLNV*SJ4
MJNO0@2(I0DJT&:1CO\G\"Q%D7!/2QTZ%T_@IDQ6WUZS6(18A,!.YFX)XKYU9
M$2Z(0/$TD)F'>//*K2@O8M9+]PTT>\K<D/PD9GB6//7@#'[T!'.,N,<1<JC
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M8\2YC=Y&0(KTVMOA-E (;FOMD7 OIAN4/=)W]FA)0_D+-1/+:A.W 5P$L!5
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MB&RW1%K-?XI&4+5J=+;#%I#?,@6X*+C2W'#0;:#5&V0X&L<E9"JDG@VF'!K
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MNAE==&F\H+W\=-O#EIPX/&)J(7?@5.?&N['E7"S5;J4QLO[TIH:J4EWFW!H
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MX40T!P7U' TR19(LH^%P/26B\X_GYF*X8YC6.Y?& ;.F"VZY^\VLC*7X#'7
MT#9;]E_($!4$Y[0SJ6;J]$7G36Y39:P2[*1'T60S./'YNJ.4/P/PH5\7QE3,
MT0/!:H6[-98I@,T1J(*-=BN%BQYKZ1<XX;DQC@./A0W\[%%]3K2_3-OJVIW&
MK6%J,2N!)0 8L/*JTJ'/8GV[0ZQ./4?V0O:5E91YA]W-U0@\]#!5.XXE#EF=
M;9>+LO=HYBC-O I$*;3O:,QI(_:Z$KM6"&X D2X+<@IHR.F64U$W1(@6+!&[
M-T.K$JBEF*[W;:2: A\86LE$>U:8\[(.@K<<[,F T=U'FH0TM4A<?26BVBW#
MZ:Z%9_P0Y>A$#:/<82?$FQT_W>B]A@VP<H =+],VY]TC-A%HT+(HM0/T[MD3
M4,[V_$"CT^>>C7]A->+_UKVY; 5<Q0NDR4Y>N(W^(D>&RR!@R4['[%A@M43V
M%H*^(E91]>MPX++]D\ZV.-8M:CGBVJXEW.[.5>LU-ZZV@53S#<(D$E',?Q5T
MTY:<XF=@6"MAFFUS5J%@W+W(1&0!JH?2JAR=>:0C4.(&QY0<A LI=TZ-3 C8
M8<1B^+?Q,19;(VR@0=DBJ%?C'!J1#11W"=%I]((]7D3AKACU]=T1Z0C9HUG,
M.#&GG/7/:"<\_XSZ',T-G7NV)<)&AXXH[U6^IVCF_0JJXS#<RC'?^ \^\/N\
MD13P"K3C]9S6@>*TOM*BZ>X)CQEX=22IQ+ZB!YWNFO,[E1D'9<;[UUAFC->_
MIC+C-9<9[W_E,N.CVZL\AS3 5&K\SRDUGKR*E1K?__(L.?GUUW^<O$Q>/7OV
M'JJ-L+HG+T^>OGWQCW?).[/L?__E]<NGS][^T<7''>\_HL2W^$7GQVXUGKY_
M$UF-ISCB!)X+[?(;Z)8_P-@(4FLG1'KPB@3=>M1(Z ;ITWS=(:]X0&I(+2)(
M4F4,]/<_W+F39+/5#-[ ]P@2$W,T'] !AUC N 6 L[19AU7LOA=%EI20]KK,
M3V'>O037U)L/_&\0QUAZ/T8DX3A5IMEE_\!_N13H_CF+UY\"T N)5W_O(84-
M+JB:"14L"T!,<:Q$V,B6))>7E[.+HH$($IF7*-_/[S4SZ_27)R]_>@>+]NZ5
M>O  EX<S A>Q6P,;0]ZT0)#CO$&$FL,2\0-_2AD;B&_"*0LC XN  VG.-97P
M_8U#A[14N27<=X_YDW#;/[5T6)"TP9B[B[TL\1P"J\]O9FNJE;B& $%>UY7/
MMN!_ET_7I\S=6Q8-C(/-,>%M;ENTYT$%A,H(O$J#%:!1(]C><]*?]>9:QR0F
M-RQ"_#Q5^.;D5405OK'#Y6*;\A65XL//4(KKK2\%@=T/ _<97ZU#>9[G9=FN
M,]"._^=/=_Z$/Z^!"8-_)O\3_Y/78;LV1YHFWY](DO 4PL]_[9H?P]_+)__:
M+0)GYCB^( G,,86JC/S6/-7@[E]Z*TW$,@L#%G5?7OOA[[O%/@MP$]XP<A)_
M?$_%V6+!V6:T5PC.R!ANDV'W(163O>3TB="&IMAOLMXX\'Z!(VBS^;E44>-)
M/?EW%?15F^S./!KAR3^2^W#"*48WY\@;A8<^^&K-]5[(&P)\QJ_!![EXX$/.
M.*^PFP>VIA3*-F5._XP"@.NZV8C&HH>Y0;OBLZN=1Q34OPPD5?_T/_^'^0"H
MDA\G[?)EM,OQI%UV:A>@? *$H7B+F%1GR"%W7G0HJELGN(6$D?+/R:BY=.ZX
M&]_F!%D@D7VW+HLN5;65U8@N^Y)JZZF,<9P$_> $_>XDZ#=4T-WO?S4W2YY0
MY^M7%O5GDZC'3OI!B/J]2=1'11VYKJG1.7D"\2X=]Q<O7OA31,$K9BKO!&A"
M2Q3&XSO']X4>53)V8^+N-U@W[BH%$&3/85PG\OXT3, -_0M,2;-(S?TO<Y[<
M#25^S^$.,0 [,DV.<-:U&2.B3^XFJB;TY[^;A/_PA/_^)/RCP@\&>KEA )&0
MWG.R%BF',9T/,THB..J(9)D??H8&@;@">']>-U5G[O#RY1O$LV/FWC&C-  '
M[G F+!,R*T[B96',OA?!"\^967_@I&JP?I#DQ,'Q-)^KZL3=(TZ[3O)[</+[
M8))?\<=3XM"NZNKV:2&SN18710OD $BIG3)X369O8%M!U=KND$'G1F4\[$5T
M5LE( FR1M_.F./V,^6NS208/308?3C*X-2961K&HVSE2\IB[O:CF,[.S1X^2
M9T0\] +GEH"</=&"^:;,&-!F F?@Y\A'A _N5?5@U_RTMF97=PT :BJ@G0R&
MMS(6_GYJE@W^;Y+&@Y/&1Y,T[I6Y<E"!>+D6.=BJ' +/#+K.@!^+\ QV.D'8
MMR?_!-A <2CT3$N+J./'@T=$X 12J<(CO)$'_;6>,6P& N')+4T.3PB__\\4
M0BG+4A\6]>BYV48M#S0$]#Z..UP!0Q0T:<;0$HSL]N341_20<-7+/TQ #A2!
M\_;)3T\C$)RW'F'S2 3OKY$7SD](EB^K0["AZL'C;U9=[$H7P5BJ10X0"NSB
ML<U7X]@/SDV%B5DBSL@*Z"!.8R^>4)R,1Y=82J@I$V:@RMB^V+#D*,P/_X0C
MM<C96#!CBA%,R%VY.\4?%5&FT-RCWC($LUP5O8)RG8=</O+/>_@K(EAV;J)E
MA>?^R9$U0X>-FQ*?OWXKO80QEV@'CND*$*'X<GS&4E]I\1P!AXX7!RF8K;53
M5QFU@S;Y[$+FQG]21C'],<9R:J0:-%(]N,9&JGB'S]1(=<V-5 ]N4"/5\=1(
M]5F-5-?BF,8F/DV^Z>2;6M\T@D+$3A%V/O?T,^..R;4[GY&'_0H>W?$.2-F(
MP_X).#/UJ#S#E9V\Z$),2;=)*7T;2BF*F+RJ6HJ+X9>(B:./^Q44T]VOH9CV
MP+I.JFE238>FFJY;-N\Y<*J0EK[K<-[)JUE<+O]>UNV'5#[U;I:\VHAB>E7,
MS[.\3'Z9)4^SBV+1 JW:J]G3&7(TC\%>)S&<Q/ _70SOC\)$QX(8!( .L)Z#
MK.?5@)]V=.Z$]1P\]"2]D_2.2.\#Y> .P:-;"F5?!%"*%)=EW4[8T;&GL0\]
MR?0DTR,R_?"3@M;K0*CJ:3+P"S=+UX.N3BC52>XGN0]S=1"&\@@:(?PGW%N<
M6&P<FSIFM2V;]?5B4Y$DQF7OZG1K72/=*UGX.:F^^.M_FBI]A*J4MN%3\<&'
M"@6^V02$(T:29VR@H0 *XJOV!?NKY-/UVSD\T=VY%TRV3MJ"F,K))69 P%Y-
MDI:;''.]/&-K;&H*SD$RP7"S0(Q2, I' ;5N%J'<\9W9L(Y^%4#KTW_&Z#4!
MT&J6\VG&;(W_K#%%\,:<@>8 :39? _>W[8A?HM*CTS("/Y/Q+A!$P<?<4(DJ
MYOJIY4J3O_7EANNQ]RE#DE*OO4P,Z) _G$8F,0]7S<28S,\^Y%4$?8>LY"@]
M'W'>DWFG^W?O7N=[Z1>9)2>?L0@/[J3W']U-C^]]3TNQ$_!W2:.:T3_%^6]]
MAXH'W_\9)*;Q$ENNP.M+;C'/_&)8.XY+KG):9!C> ->C&8E,1 J:!G)?T8%A
M4:9,' D1KL'G38AXTQA=5ZS-/3QEK%]YVX2(J["R8$^W^DN3GQG]"3).5*=M
M@F@[@5^.3%X<O'X-^I8<%ICF +,?>:@\?&]%_0EF%>[_EVA?M<\[4:'?F.[]
MY]N8ZF55"S+P-K^HYS8#](;\GP-4OTCHB2<4+"S./_]TTMPB.'7L*=(\QM/\
M/"N7>WD'6VEPIX$&^^!P'UXC#C<.$)UPN->,PWUX@W"X=R<<[@T=:+ 3J;OW
M7*--W:/SFWF>U8BKZJ;SZ/@#1R(WZ#?[FC\[Q6H+W )B1G3NF <>1OU$Z<V-
MTL?/G6[8\O2MY(7RBFLF](>YL1BSY%\\^M!\#U(-<*\UD@AL(8SWACCBU%#X
MFOCX]LX NZA:F-.')/CX1PRD>W-L%D14#^_5=A#'TMW\!1BA;P\6HJ!=.,\@
MC5W"S$Q:JX5]%./JMV,[--%L?UE9^^;SM[O#'I$,>V0=1[43,?YC[+Q["@!E
MB0*)> 83<15-7<%:E8"U,(;UC'(].,[6&(.I!C+)T('*D#-GSHI9<6IAO.L&
MIW;##V<T]Q@'RJ'8N*\PYK:#?/U8)<1\>K6&^>-<HP ^ 7![UEFQ,)8-)TCG
MENKQL=@AOBK)J7D&S^#Z(S]&&0VTA<4L;RCZX$K S0AB^!A?9Y+J2:H/5*JA
M&]_8K?4Y)#%K.^KX!4]CL@*^@'P;RB)^4K !E5,(<5%.2/C(.::11S!^G?*8
MR ,-?X+Q2WBER_S4_&?N77CG%?1(9_/:S@RK[S]&H;5CI=H/E"UG'6*+0#BF
MDMX-!!OBK*8NY5=V_&C$H1][?78CV M?]3B,"#S@O+@@1_GHZ(?[WR=KF+#U
M+ ,,944C;2,3NHXEZT_I4.O03P5'&Q,VNQD (&K$6610F*L$J IA79:<-O6'
MO(&,!H!6 _:!TZPRYFV19R7%;<2=8VQ?469-,/&;:IG("B%I>G-LC9%!>%TJ
M:78XE5P2Y3,1.>:M.WG>F%R\!X15K7[S6<+1,4^3/2MP3*^Z&E3!D?O'>^*,
MKU+5 '<PX2]^AG^"(<_^8@P,XY8*#)0\S4?6V#)3RWH EK#!@FG6;&S=P1QX
M8Y_[#I]]Y)N @!S_]BQYJO_&EX1=%YJQUC*1&1$T7KI9\)RQ2V][8V/OW3^6
M? $<8IQR1Z_R["-3.$"2%T?P^*N""T*'R)T0<YRJS@42O%YR!(>GPZO!P!RY
M5L;KBB8)#\@L>5TE@U7A-[>/.C@56YY67YU*AWML<QEPK4')ILDSYN;F&\%C
M(IK"'%1LO/6&>2.LIBS55M%387%'%?7-MX]1N=ZW6GWD_0]RLCVO ')P$1*7
MK4UAL4>,46GRB_H#3D>G5: $3#1'%22Y*OS8)X[D&T,U>(H&[&>&V*E"&714
M4%GB\D$[3Q:O0*N"AY98 Z'R@X.SS1\1L6,T!30ZX*&Y+-I<GUW__<=OU^1K
M\VFH3C!=D5DFNI>_R$. $IQ<7BYW@$=6JMF'VLNK+!WB21Z! =DL8*KENSL'
M0,#(5R[/:TPU!@@@$8ZV7T.6Q:@OQM.8%P.5R_JZPR$%C(7 0X].E@L$"XE2
MBW:;#,%NHJ\,VP43%Z"B,Z4RO^Q)_.8#MA:3D>9K1MU?-@ :J03)$^.;>L*=
MR;F)$,#<@:V#.C9E:/C<ZJ3[)7J89?$!KT<F YGW\<A/><E)(&Z:0- 0Y\I<
MA+6R]BOR@DIGV UE/V+S!$66V(2&SF8\AE],1WTZZC?JJ(^/!Q^67&?).\JT
MTY=&)IK+$/(4O%>CY?-RF8K2=^GX*6TD::,L[G(J, 'XGO5EU>X.58H@33(>
MW4-WB6@U\#8E/I;4+ YPWW&[=&#I,<.XK,NROL2_49T"M:9-.F(V"2[O[FB]
M9'# O<S"34-&?A8F_9]11/KO?0&)H'^:53_ "(LPD#GFB##=2#A;L'5!((MB
MGX[A5Y8*WCP,E3/S:+_5#308\B=WBH(&X((JTS!U"<1B 5;K.G8HMR\3WLQ#
M_-[73;\:PTV?G+: B\+3CMU:0<;)-6Y0YMQ<_A)KDGQ=Q,,'69(E)((1F<8@
M[]A:T-7G&?92J0VPD)SH T/.M>U7N#[R9@A<Q3U+X;\;.9R0Q!OI;VEGR5&:
MW$^3!VGR$-_[$;5GQ9Y=[?'P5:Z6)C'!.#PZIR/7T,'A[?D0^7^%-Z+DWMU9
M\E-T#R'7,]C'UNZ%^45GK@2WV+50P9D)$IC1FR/@"44 ")^$W!<R4KIO[>3G
MDQ>_OGL?Z5W3K_>O(,,=Z5LB)4_9!D['BS(7!V!5FY,W3$?1,]^RU0/ZV67<
M^*3M5AK#E1D(,^^V(A>))$4FJ/, ZOSH&J'.<0SN!'6^9JCSHQL$=;XW09V_
M;:BSY3+[SGHO/%OW$VVCK\>CAE(L#[L16]MJC["$!UX:]5-+8]=8.RSW'$+:
M/=5]L/.LL@]>&:]HA?5 J)88GV*/]MZCX<..D?W>DF_[2^'8;K_S'!7(^#<+
MBI.RB[H ?W%=H]-@[K/(RZ(5#WK$4T(##$_W:]8NLM_-Q]: Q$E>9<V'O)LE
MO[@.Z"N^0?C0L(3!9@!41?P$7FOL_S>[5K98#/:7P7Y9&IMI-WE/!OM)?:;&
M^Z&)&",/+#0A<"96JK*VHY4*>0#]CG!;ZNNR#SE YN?Y+$H,BHCW_5[%7P Y
MIR_"3G2XJ^I&C]U4"Z!ZV=2G4M!,2[[,<D.Y/Z2"FMGP7H=8 OQG-/3B[2\J
M='V)4L$ZCT8&ZJ*2UME(Y.3O&*1G\/IM#K?$!F8"]3B?V$)NXNXY[ __Y5\O
MWO_RR^N73STO.@48QM;@<K;U^P,H2^@L<[X:.UFMEP]O+P; .Q0Q>@-]D*B"
M&=PST/PV.U0C^L/-B@=N,:#!A6-;@OXE%/MFL(=+>BKS)!16"%F*0PKG%KIB
M(US9437[Q>L!_ZS8'E6:#SN)!;42^,BS\$O<C'? S*TEQ6"#R& EE6B(9T_@
MLGB53JSL4,-3PTZUD= U/)J#D/G>KJCYBH%R7 3IB\.876+E U1])R@6?^NK
MG)V4NQ;!J:2/EC!"N.=Y%*[QO0S MM 'OPCX&XYFCSZI$W[/+-TL>9(W@.V1
M>USM70"\U/:GO_&!&V(WF)DAGI>'$O<@&Y&3JP8^VO!ZQ&L./ZGW GNQ,X>)
M2VML%7HW0M\0[2:\E7WG\0/=*KZC38\Y=2'Y2VH^ONWSHX.R!CJ]R8OJLV:1
MA0.RHH_J/>NB7HL&#-GL!B[/U:G7?;;UB',)#W3AGB?(W_Z1#Q>E@C>/)T\'
M.M<;=<O$50IR%]/I>*9AMQMLJ4GW(*IB Q6LQ8Y#N.]8MNT'[!./E200L6G(
M_#<A5E'L5JXR *!9<J9O711J50E$9M>6GL[B#D/C[Q%#P&?,.U;LBH$Q3"D/
MRJ]<ISM"((6PW1G1@"*RR#\!O&XCE!250B[JK=/OC![+H$*'%AS)7'%Q3N8F
M7&4.*VL_X67\EU=FWMX5NW1'[)1[-(DN+YDL!X&CYMB5!4L&3*X#A4ENR.;:
M3,VW5(%\%R-F>4=$(]\ '\N+RO+J*:X]>K%3Z \LRL#U2:V'D":@9>I-SCA?
MQ*$/)RVYLX0M[,SF)]!HS+2,B!,4,[#*@0K":-.+(K],7?\3_>=9DZTL&!X0
MQ+.0$#$7%YMXH_+?>^[W!1W!0TC735%9?QQDY)-9:0:5%TTB<-(T8&((I^T%
M0*MLP5ACOZ6%WH'4Y;QONWI19(#PMR$G/?"B-XYF RL*L36\)B,A8M110;*+
M8R/S_R^9^0G<#GT4P$=M"L!&LS&(DCJ-D$%YO$UANZ8Q3JO3'AP$<UGSO_3R
MYOWV>E=Y=&#!-<<$$%S&=[Y=+V^OS<WRSOBU0*A+3&" 29OW3<1\[/WZ^O')
M,#!<_J0T6M784__-3XC7&U?-2%T!U68T7WQU+,.R(+AVW56>(?C#<ET0O<5@
MZ=89G>%E3DI;GL'>-F4;IR9T?82CVW([FA^ _/F8>'_ACW^^2_^=)NNR;]TF
M">U7?)&_*<7_^E5$\;]&,7R%='&'J.Y/;""TR 1>\ DZ+O7=)O_01WPHFP*&
M(JJX(C;W0H?1U;!'X"ZNZP!R1#GF@HSHRFA> E]_/JL8-;M8#Y6H 2T-JNWQ
M,;>19H1AEF[ :8MM4V#"G NI$#F1 GZA$K#1U" [VOQT(QTKO_6+,Q%93(TQ
MH1\C0*3!IXB*[E3Z'Y3^O[_&TG^\)CV5_J^Y]/_]5R[]?W][A2'G_UN?'4V5
M_QM:^=_A2 @88)N6.#]RKL/[7YZ]>A;9;//[Y-6SMS\_>_LU'"6?4>*:D*Q%
M:TEN)1<U1GK[/I)#<HW3H1']E,AKD;?SIF#:6?'9C;= /F]0!/?S80-N[^1?
MYT69QR))GB@@5KQH^;Z4M9S7D.[TGP#J4\'][6K1CT'8X#*W7(FG0C;VYNJ6
M5;T,S%\ 16S@KJ*\W:;NB3W.4A9D"XA$\V5/$;#Y NQ3DU]]M1$.2N5/R^;A
M6.(50CGZQNHE_9??OB_01Y'-SRDL^L3XO 7_+/](B;,3\F7K=5%Q,N<G8WS,
M_VS<K?QO_)3:5R$7<5'/>PKHS3.YOGV*P3F(HRPL$D5O%9)_P0?]!8'M>V*\
MWN<%3%6$Y7[AWNMSV9]O6,@VXBWN&;+]=/+D[]&P[2?K3_AG\@ CN/>[\M51
MW(HB[>[R; 4<WWV901S3Y)!4&\G8R=<AYLEL=JSM +%Q!G0]):9GP.-+*N/\
MW09-AY\IZ^H,?T*:DLL<$ETF[C!N2&T>VUTA*Z'3#SVLENE=\B4$=L2)>8[Q
MC&Z7N<C*/L?\=X5A45%Q6VQAU!''76]S4(%(3O\<^(:.[MS^>Q"RCJR<OP[A
MJF%U?&FDO46*:?-JJUI%IF9]6M$F\ !]97Q(X4 HV@] 1=;6\\+BY(8+[? (
MF.BJS.N# ;&PJ%3AV,QYZ"ISTN )!O=S*TP.K(GZSHMUFZIDHOL(%=S4[-4#
MDX>8?746@U8:+'?&#'(FBNY+#(K-U?.JA;)WUJQX$UIS_^HL+,-4^9D)FC,&
M4."^KY#IR=Y8Y[F]<^/L17B@N 8#J)T:VP I;B\:"?3QR22)"%=Q\[K.^F(A
M%3P<8L")#WD+(Y5\PM5P7?>,U'&&;6SL#X#MF./9PTPEYB*"HOU'HP=PC!D-
M90 B+GM(S39C/1,JKZ0"\C/POE0*M"G.:J.%6Z1(R2"EJXZS5\+$!5-0G3EX
M%)"R L^*6#I/FSK#QVCP[<WERV*9)S)GC9=#Y"$SWZOIB_*:L&Z@36P51VPE
M++H5CB"53S+'TY1H#;G0"2"&U0I:H/@\G Z,CMP9-Q'0D%ACL7M"NJ-8\")F
MUJOV'W-$><H94P=UMT@<I,B_KI*_94;1-_YLE2-_$%9E5GXNR;8" "6+A$G@
ML W=6(P+R($B(!57I<W*P/4"]$#7^D/T$*^501F''+YUW\S/LS;W/I4F9N?;
MEG8\7^!AXWHSP+<'X)\_']^G=S'K6IJ=.T3HE-F6Y_EIX_:%V>_VV!</#61<
MX[XA2R9K&Z B+.B(#G(+"!,L$5+;8<$%0R,5'6L>NTG"":HV$5LP,ST0F10F
MU#G1O%YY,Q\$FWF(0O;<ZC:JR\G&,5'/%@_3LV8@/N8"$.B<F;\'#I;S<-A,
MI/(YV!.@!NN-+:)6Z#(3:(VS&:L\ ]9TVF)(H3<7U(8]S]ISV*,2;*[9F.+?
M"*4;^)$'N#%#,7LD8O:TF25/LXMBD?QMEKS*_OWO.DW>G,^>SB+[-3\O\N40
M]A>2"("@P,JB54I=1WJF6$B!/9OJ^!D['>09X9=MMRI*GNO3?\+DG2;^-AY(
M62 )]VVD#29.,&/<-LG:?&EE]'./1!"6\7.1(Z4PG@? #9,R('!SN2(J.6.I
M*?MROC%>"[IY;$X%)V3.%PY/Q2?@*P\GK(<E5-!7YH(02^,Z4.1!812<6ICL
M:K:A1\<<BS2P/BD[GESHR7C-W3* <V7^UE)F W82-Y#A1O93TI;!\Q])4,Q7
MS3&EKF3G'6C_R8\VS#N9;VO7@_B&!IL_QX8:RCC%(:GVP:A\/4;@Z?@;,Z&!
MI;7)' CJ(-6DD<97F;$M+(HQ@[?P-IG)S[)DU2.)?06A'8[HAO$/UK2%[1)P
M!HT'C(E QLKA9IO+TU (),9M<1F=ZF;Q=I[@R-U2'<OL3!X@#Z8)U O@VEWT
M$%IL!/*'$\_5BE@7@$Z@70ASQEF]NU^ZR$5'P5G@@5OE'S_IQNS7Y85W%GUI
MC#\U8H'B*M$_Y[;5(HI'#9<JD-Y+ #7SW W2&*C"+FN!0PY?+LB+ZR")O5.8
MS<:M7# TL-AC!R56V#XS$\?P>8H&(:&D9X;:12ET4-&%D1ILPX";Z:!$VAM)
M_OT+6=8S&-*(O0B(#:B#\@"1 !L#U-!.  ^;.3'?@ :Y*_*".;4Q-2),^MB#
ME%5, SN?,YIB *#%#UCQDOD9)IXV;F]=KV;)B?WN4!KMQ_#XVEN;SXXF0,2>
M<_ICSIT'HY\?26-F.J7P]]<O4TI6+ JSB^"LLU:Y//<@A!10D!<9'APRUNYL
M&F%OYD4<NC3A'T+\P]&=:\0_Q OS$_[A>O$/QW=N#O[A>,(_W%#\PS4Q'P3.
ML$O+*<,E.#?F,@7PM@45QS+H@?]C[(FQ5IA^QV0I\J6[JZ+/8GZT!FA98,C"
MU$G@<[74!KOJ2YLC'=J\$NKDYM7R3I>O,NMI8.^H5+W\@A?P6YI8%.C<.'34
M;V^<1^YRA07 .YBWK1%.X*9/T>,?:';BQ!C9DH_ O4% M#VHL)U#:-A]?V&L
MJV#$>0@S3\-DDPY"7%L.[PD56ESF/86]EPHH=M*X6IZ[,C (<.:^I=:KKOX&
MMC&28-^]7Y$M\K?0[9?:B'Y-91X.;CBO$B2,7'Z175_:,YH (V6?< =U]4O%
MX=@E5M+6^P62#%+1-113!UZH2S-Q$DER5NB50C:2,D3*U1RTQ<C['&K4H@_(
M YV"I,05N.$N2VB6SCLJ0:;0V]\P]\&Y*JM&C5>&/'EL11!6W?E#A;8DOU*O
MYQ>;)VW\K6J&6 8L-[*1\.!V+V?J-;%M!ST_"O;UAGO/O*)&$3R5QMV4HK!N
M)DPC[7]AJ7=7X)1R$$V4 7"ZYV6/%>Z%.:"8 T5BE2';CZ7/6?2Y>M?#/)RO
M,LF.?S_478B# OR;F 8+^5(3II2Y@(W*Y^?H483-RFA)-O Z%\4\;S6N$'0'
MD+)BOH3*U2OD#S*?!C<)[L;57AJ*<8J.NRYIMWU!O-0KAZ$S!@:2V7 #6Q7W
M4#;T!GA;;NV#8%^?R_PC,R"QBV/UIED!L]Q&EQ[ZMA_;5.RG)A] M6QS0Q$+
M8,?@8 D1SDUM=GUI-);7A_$$,XNOP/LS6_$ZEE=4)E"GVNVY<QMX6^H7O_=Y
MRW )Y:,N%E!&@.]^R#<H_SD,7R%?%)5R8TQ6Y294L8G5Y0!QTD0^C-4[U!/A
M6J0?RHG@YAM+M+R?6K4JWS\*P"9V@55CS(@O!+>!Q .4.V6DK,UJ&U$[+2I.
MAFY/70=YOVA^;GZ> 6EL)2[3$/=# CZ2W3;[#K:I)$C+R!N,$U@,*1E46SL$
M75>O';FA&5<M(=%(N&7Q,0=&$Z;(QL\?JI.E.OSO#WPL^L^?F_P,3-!/37UI
MPI0GZC@,EG2'(YX&%<IX/6A[5$6.C:XG#>L[^!1!!&'>@KMO.POI P5J-.O@
M"49.J1&/LZP'5G07JC'N:HW '^\$';Q".[;1]39OFH7?' K*@7"@@G EF%L3
MQ-6N+#58=476P=5OYP;#" ]4(UR%LC1D3LH!))-SQ.R3(2/0)E7*2_%G"9&'
M$WR/WB1FM<9/!U;.C</^>Y]UN7/ @Q(CD:4U]G7)H6:>-FPZG4,_^ID. P"O
M66-SY^G&/F]T%4>>#H[ZHLDNOX%C&<D6$'W*G".VRSS_4-KB*Z.XM \N7G$,
MC<(!?0QDS;ZK\YJY145H+[6AJ!9_,7]TOK0RQ+/D1<4H(I@$TVW0KZJ<@IOW
ME#W$ !'Z?3 OF+I7< E)W;)O7O+<A'\-0\A<L==_DZ6%D\2A*(1>9I_3 Y[!
M$"J;V9#ABF&M'^D4*(-)U[/4.V-X@G\($:<')\A&[Y#NA8S&*8"$XW%90(7^
M6@TZJY%)8XF 6N<69P"?1D:%%2"1$,XSM].VO%!6'L?\F<45-QX/#:5W@8:L
MS(5MBCJL"JK'S\W+55X60*& C,S+WA^H^+XV]M^.+;9V11UHKOK2KD.,0S(*
M?0C68?"SZ= G-20[R]8(YFJ#@).8, K$3QNS5,_/S?8@?$NAM' DA='.#9X1
M=ZIH0AH$,;!E9=&!J< C62V<\6?X)H,(>18"/X59O]L67*9@A\LXE"8; ](<
MJIOI;;_5WSOC9&(F@$Z=%A1NT9X/$_7O-63EB3@=*1E)R\/L8A7KSL[$HWU%
M",9-99S!+'DY2YY#YP)XJ^\ZY!M^-4O^;G:"L-E1 "3&-HHS%-XL_F (<K '
MB@Z=U=3E1C&YH$+WVD+J99"[]. Z?JYOK ["W:4+0?IYMFS9X['V_:$]:)DG
M=,,^Z(:CZT,WC)3=)W3#-:,;CFX.NN'NA&[XYM$-GIFTL/M%S]AK/Z[QPYJM
M$-OM;:=9^R&H42 5P+SCKL;6&V] _I2QKX7E^'&(!$X1KGLTUE#K 7#?@'KI
M60\T1R;D>5?/B]P$0&!\;/JZ@OTY<^]IQ/%=ONXH]V"6Y Y9S;8_;4VD3;Z^
M:QZ!9W#A__.G-BWD+\)S8,PV)MJ\]-.\-;OBLGX6\H]15%;-X>=B#N60.0T9
M5<$HEW^^!;?<]5.-^I_HO=@0\#3OS)&L_'1R&%,I=_U*,/-O84&MISN"9L?E
MQ#SE8"F'_MNP1*0"*$E%[H$QA[A)RY;CJ=WGR\."=(\HZC/(4V  V_2EGX#_
MR9427.!<KXIY4>8ZB8.3*J4\FG$5U<]GA50>E-S"40RD!S:4?P0HA>?%FITG
M;"Z5\2%9A,&V%[]C[_HI5/-0WPXPRS\-,<M?\YC&+>'5CRDHU" >=U6GP8&,
M;8M.@L91*#\=Z$+]:H[UR@GT'NCYGZX=/7^8FM!?N>/!$<-L?B[Q]+LR@ZYF
MVPH8*RF&O=-..>&XY!I)&_NUTVXS:&AC12<*-E* \I3HJX;'I^ 3482]1MA*
M';Z336.):O?R\:D=5;7*/F!E4A33BN9D>([:H29V OF(I.;!C:@ON-;"_A_"
M7QF=ZUL7,(B0/@_Z>'OC&EC,+31YIAXW%;@3:\BH$/D#>RY<OK$:2)53U)CE
MO9J9M'-\GI7T%G5U5OL9V]YL;"G<7,#.CPU97 ]",IRV+B_RQ3<AT@Z4=ZWN
M(O*5'(JG>'V6Y>$0X1A11XBO&?$E0<C\U0SP0M_$J7-%Z;T]5J#N719>.7DX
M,,;!XEG#X%J?PGDMBV7',T @N'WQZU,>G 'SL#J&C^952V%Z@-*<,R]>VZ\.
M=0.>FF@ZX@-M/ZBVA_<V#Q)6$<=/==O559#+?F7NFLW/>V/$H8:H\&I(=L/@
MIG!\A+ FIHK1J-R,3-=S20SKK_I-I]N:VX'-YEO8OPB4&I"YU(,K8$9W?JD#
M)A[-@?"%#$ZA)*(X8-M,7J CS GQ%.7K#%SDOC)K?8D> HQ-@<_VQ+5/D HJ
MR0I6YV;&8M>V/6'6;W"(';5>"^21?8E(362C*#>1*LU83X1M31\MI@^]'[^]
M2O<^J>2"1N/1Z4$HJ!]FGQ';RC(;JQ\=WLY%G-^(2^FO9PCQK08)#F?GD0:%
M^F#<Y23Z$>.D6DE0; "7\JSY\*%(WO9U6V;G79$FKYY"V?*IY2U VX<D(DXG
MN(I\A9Z%;9-1?0[0 05 "4K78B6S6%/_&O8W(-X$T2XF #(J.K 1*BWLW2/(
M(*!VW_=>W\1!NG*W"[E""I=)TN@OY$\!/G* X'4,,8,##*,"S-UDG )#'>CF
M3K#MLYS7:S+4U!ZR&% Z/';C+!TH>#C\:FZ1<?X=O:R="[K,78>FZW) >*N.
M]D+P[ <;DP5'QX81@:RYA!YB#\9S((1<PHDV02K/^@;>ZKLF 1V Z[L1J;5"
M,+F;S8MFWA/0$J'6^N8[ _-O8L-<[C78,-#'7LA"S%*V,PU6U0JT<F>#H[Z-
M4,7FG@YS(3V.Q@<RGF[TW!.R[+1@QV1+)X6_A)_>5L%92;>%MA5B@LOL 9<Y
MOD:X3!S',<%EKADN<WQSX#+W)KC,MPV7^8FSR6P&S.E#K>LS]]X1L^!J/#0@
MD9R_\[HE?H6PN&3,0[Z&85K&UP!+S/#Z(1AD?;YI84PA<TI#(V-J22TQN&'Z
MU].RP/8-LT05N+V>_0XBFP&[R&.8P;< 076P>DBMEX#%0400PT6!:7U5M"MC
M<2)HH$%I(X@_@UP.] @+I!W6X!#]A/?$>@)E.#DH&"H#$3!RR0Q;TOR)H2D3
MIFN6]&& BHBIHNK)X[7D#'YW0*4+PH<:JGKRQ8@AGEX_AL16W<.?BE$+D"Z1
M .:5V=)_I\E+$X- DV)];O[W>=XTA5F2G\OZHOU 7WUC@D1 ;<^>S%)+,D]4
M\M"7U>:E%WLDMWAP"EZ?IZ%\EX;-A=">%G9G:PI*+>Q[N*&,Y@D[@5NL0TN0
M=(CB.#A #X=CI8.E5<N8#5KG.+R,0_RV=,+I@^@WXO-Q Z>=VP,<PA+K'' .
MOHFE?R1+[YI0,DHR2J&6R4L>Q]*"?IP5U')LMV:Z>\]&M@G3AL(O@:RO(T]_
M'8F.:\QM? ,G@[DMCLE)&;*9/#.O/X<Y43\;V[I.7KY\8K6D_$D4);:S@.4<
M<JSN(-H]2&_C.;@.WEK>/7(6DOC7?'+U>_+G,-4+C\DT5:H($!A)K\$UK./
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MQ4'YMXWH&80B$4.V0QWKRXNS=8E=.=3!']&V\&Q9\%R1\JTD!<"7QEH-905
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M')F*F_I]D',P)18^\.>CV9T  ]DD?[X7_)+:D-=K(W8T[D^S#)DX=77:-ZU
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MC17T*-4I0P3J.;66$:VIY"" \5DQI;C,#3D;MKR \]G,Y[$FBD(5(AD1P=B
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M7L7Z+JG9-CVH-\;1K<#11R^8?#IMOOWX#O_8:J!TGU.8L>V;$Y]XC@5**9J
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M*BIPM\ZTY==ZS@FUZJ6(EJS>'[FA-U_M:*9E=H.HV")>;E6?E)(VA<7;(3S
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MUX\/_%]M#FY/QAR3$<G/8402=VOQ\)^%H55GB$!Y9  [T\+K^A1/&7)L@@:
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MW^KU:^#^+1Z-UVQUZG7YH-18+49=[H"-,GQ,TAZY RE6?KZ[_8(/OW09?;R
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M/LM,M$_ 3D+G"+T[D" T9/N,\2XP,#'(;1B!:5D@)JY<+P(7C !N.EG3T+I
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M?"?#C!E_XH ],<N9C$%L^><'9C-7)IKI8&S:IN>[7 $2]C)AMH>\GTFFP<R
M_/.'^(R..<-LQZ]A]HPBF7XVI^@,@<; ]5A-$/>,"0.1W>-Y1(_GG <P5KC5
M!H(F,:+PJ3 )P\ /W%2&OA;S#K@C!@VC#2S@[B 0,S=B)+"!LP/3\,4NUFF8
MYH;E!F</<W: AF \D6\#5@"_3>2V)U-^/OX#)+U, <;P/0[]'7SFF>3 >Y?,
MSD<7I#E@VH85# #<@4V# 0<07&D/J 76>@(FR8&G$JHQT^4T>#&9Z2MQ!%<L
MS,3S?/B8#@!23]2T>/).<B:^Y=*A[@"?\METX>V.ZR%,0<';@A98#?T1ARU\
MYX$8N&$I G_0=[[F(;-8<@!I#D1U#C*GO/#MG&HZ^"/P?'%'?#40#\N6!1?B
MN_J)6?4"PT 92D[G;'(YCY/)>A2:S'-33DY-3A]B)6\>7K!$ 4MU..__" 8/
M0L(\6;?!AY#F!B *GHSN#@J^P08\#0VW\WH1SP&-@_4B_-4#X(([Y1J$6::-
ML(Q'$^DEG)TL>A %?.KF<8IS>,S?+9G*U0@($/,,U^PSU&PN%ZT^:(YG+3\G
M7&X%_R5*SO,:%?XN(31SY"ZG%"$4JFC2)PX:/W!KIGJ"6G*;?*2<^@PPP(1N
M Y$513+T!2X3:IQC/9K&560S/UI5(ZFZIK$#[S("UQ503&@X7];H .<U\AM/
MKGK$&SF!-4 4P%P#$3A0O?%A=@]_VFXZ^?1U/'' (,@J/$*^)K0B[3N!J J:
M8S7PRD+^SN8''I4/86> B0Z74#>A>_GJ"5P)JTIRI[&*Q3VH0%-:_?KRZST'
M3&!;C"_R8)HP)@I8AH#J&JY]7ZZ^A"J*+Z+IDI1Y%LG<I2;$.G_V7/[6!' 3
M94@I-9TP$D3YS[^T.XW\?'%QF[!MQKP:*)($%$\ H_G$APD66'0/8!OPPPN6
M8O[@6N2;?N SC'G5$V^("$Z//7X=Z$3))O@.Q91K_LD$(,U72#<(Q5C8:1&7
M\):[ZRN^UGGSWQN_:N"@;13.3H)Z!#G>SJ=25/D9SAB-KK!&<A#=E=33B?5O
M1>L WI0M:6+S5@3N  LU9,!:PQ<HX MH)VIE%@:Y("!FE[,A\!+(S(7@C!H4
MW+=,^!1,@"$ KZCX#9DW"5QPW(6<X.*7K)O$Y5Q.(/R4D0!JNC:.U9G  .'!
MIU+G@G0B7.,12GH]:02AOO<M^'YEW7@?&4<\6-K\P&='_R _W4@"DM(7+CBQ
MGKP8/)F>XV9T9!_#'@*Y-D%_7*;;(J_>O[FYO\(P5@,]^;>BU&Z>Z97FT&NL
MP/G<Y'AYJ\%X!CS:0BUK6N.7+H</!\=R#"7APXV?5>FG:09$BSOA_A"PVB#P
M!XAFXD%QW6VY_'J]L:%?'Z&BVOY\[AH4(8.BO8T^/)@40"2HE@%7>&BC@2KV
MYQA@,_YL)",U%$#*,;S0RF:\TM6$Z\,"9UG8S%>ZS^ #H-<AI+C5E(6M0$SN
M+QUA(S$VP."I#%>L8#;.=WQS%=0=0X/M 1WOIM3WAX'U<%#O\^U14D]R<LE.
MC+4*8I/$\Z8+%:^0[9YK^GJ[_)=7R(9UE(773NZTHJ6I=7H;)6\7\FQ+&\L%
M;1N3,5M.^Q*6TP[Y?UO+)FN=[FXK?<N-T(VJ>W%EN=XNBLN/E,H0JB"]&:1;
M"M)E)51!>C-(MQ6DRTJH@O1FD.ZL!^DM%M6^TE,Y\NT3=YC7*MKS*7;_347)
MSM%4N^Q"7R99V%(COC<+SG(4VKBQW?Y"%45:1<E6 J($1 F($A E((4CK:)D
M*P$IJ8"4QWT\^.VT-Y/KEZ*5UZZW5)>6L!THH/( =ELJ1C]3^%3X+#$^NPJ?
M"I_EQ6?S7.%3X?-@\%D!WZ!,CMZ.W ;<X/+1"R:?3IMOP<.#/TJK9$H<_BBR
MG\L>55.9Y&%+6NL4W))MM3"J(GRJ2+."_&LAO[6N756$3Q5I5I!_)>2;YPKR
MU:)907[/D*^ 0W8H7M>7JR_"Z=++[G255@%54,M45Y7H[?*NG@JA"J& T)9"
MJ$)HF1':++'3K1"J$+H^0N<X#,E/\\\6S=R4Y$_8K)@/)CSYF8-F^1:N;,OF
M!#^2;1IRC/94:]969CL_]J.J Y^P)\V\@]DV[TTAAC6O345K9DX;.3![O=.F
MY_LN,S("1.U[ ]P)3T]ENH'/LG[V^]6T1 E&F".?O*2/#)CM\&9T$]XNR7Z(
M.L-J>Q)6A>%M85@_/@SS!HHAAI>WY-1$QT4\YI-W=%K0E$S!OVKP;QT?_+]<
M?8G0/Z^%J(;]0\L#>740R<Q!).=;/(@D_X0,=1#)E@\B.2_1021-=1!)F0\B
MV?*A(_R$#I3W:C?QQ"'D]>^,^G3&_8U%\^BH_[4+JYP=I$XB"%MNIE>BS?MO
MMAH:2?3&U ^Q-Z:^H#<F3L[]"!S""0O [/%F[:IRL6+M/"GR8;:]<_@"J<QR
MS\E.;5+<P) _T#ZA",:FZA,J1&/-H':O6=X^H9PVU:ZK[ @M09_0BB"E,H0J
M2!?>)[0B2*D,H0K2A?<)K0A2*D.H@O1>^H0> %(J0VA'.SM3D%X?TET%Z;(2
MJB"]&:1["M)E)51!>C-(GRE(EY50!>G-('VN(%U60KO:>5M!>FU(MQJ%'2/Q
MRD165?JZ[FCCJ3A&8C?]?C9,DQ7=\;B29*N.QZ]O5Z8KY%>0;(7\^<COKH;\
MI;V^F]MNAE])I%64;"4@NQ>0K9\644FD591L)2#S7 BMNVJK[%9;0;^"9.=$
M\!3T5_>>WS1KC8Y"?A7)5LA_'?+U6J>QO?[SE8101<E6R'\=\MNUSA9/KJDD
MA"I*MD+^ZY#?J^EZ3R&_@F3GI#45\M>Q\QNU3K>]7E.*\N0XR].:;$=93'[6
MX6[ZYVXH[KOOK%=2PE1GO1742:NI\*GP6=Y\1[=PSU[A4^%S/C[/"_="%#Z/
M#Y^KI\.:7;7 %T78#H(\E0'HJZL9>IJH9VB?M4M2T:!PK' \/_G:W-X1W26%
M06D)4_A<CL_>>>&)(H5/A<^Y*?RSML)G483M("5S8/A<6G7;KC5;+;*)H5J!
MW$R9<F@[2MO$9\VWRIZV*7%F61W)6C+U5M IQ-6#3Q5I5I!_5>C^]$WW3$&^
M6C0KR+\2\N<]!?EJT:P@_[H$V%+7K=<J>WY!"4;14;4*"<;6$F^=7EFV$BO!
M4(*QOTQ)^[RE %\IFA7@7Y5ZZ96X!E@!7@%^ZYLF6[WR%A4KP!>=H3PXP"_U
M@+NU=JMYJ,G+0\E0?KGZ(A*4[;(G*$NKIRH8D2N9QEE]7UFGO#:EPN<AXW/%
M?3NMPENL*GPJ?"[0G^4-0BE\'BP^CRJM=N@X5F7GQY$%4S@^=AR7.VFE\'GL
M^"QWCDGA\]CQ6>Z4T*'C4VT_VTX&9XL)G.2GO_X%+J!]BZ6N^3C[DB071S+_
MP0<HY[G'H;7\C#K)H<05T7>N>"H-?">/DTEF-UOR(+N0F6Y@L3HPU#>I=?(I
M:J"8&E3>=WSLQ&"6A8@#SO]TTCCAG^5,\,]B6/Q/R8(D,:W<F<^"<1M)M%Q
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MP#\Q0Y.OF, E]3Y>4Z=#&.E[T(3/=.K->5!J5D9N^!19T2 GOC%Y 3]^EG:
MQ.1%5BZ$A2\"$6&MA,[OS,QPSF9D^=,)L'\9DR\9O%FRN=W(9?-L0#VD5] Z
M<3SN6+Q'1<95<42_P'C$*^3FR:>/E)B#GT[LJ0Y$MEOMUHO^N]>FOS<;Y_4Q
M%_[?)P^Z#A<"?1>V,7)<H.OC.QK/T&0^;2L"_BX_B,T_<U_!]K%R"-2,E;-A
MEP]B!$KLIY._W]]<@4-[<?GMFMQ\(5<W/^ZO?]S?(;D?WTW2H$JPH8Y1$!">
M>7*<JR3FJH0QN 0GA<27M5YG0X,^7"1F5V@BHT>@ITTWC++RH.,0(U3HC($N
M'X!#Z&#0T,$@%(8/TTI]8+J,!_)JV17MB0D'D\>-'8S9/,I<6V;=0ZL),W#P
M</@4&Z/<VK1$2!E_Y<L17\!SAY-G.HC_QX4)?==YZV36)>84VTX.G?BN# -P
MM>,D++DS)EC&IF20Z>+!9<)^0&\)8P7/X(*C7P7<MB4?O+F4SX_Q&,X31LJ0
M@V!LD2EH0NEES9@58'F88"6 Y<GCW0RXQKQDU 5H1+,C:\6&P>.I<)B$U1X8
M:#<BD/"58*8PDT= .)/L&'?X1L\'N1J!J+,4Q) 5$;!X?4X4\9#,2YK?BTR@
M*OK@,Z8HE?&Z4%SGH6&>99J>MJSIC^(F0B/4C@Q];B-C]$W,5;ZXK:4V$A.:
MHR@2881% Q3!9AE=D-Z(C!ZG\E%A- &>E D_Y(=#%WE#7%H0M_*J3$"(!]HI
M5SH"FW.)ST1+)O#;Q$6&<1=/A DG@0L+/18R+%#<J[$^$Z1<<1X  P]<=IV
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M6/[("1Y&Y-X9#,C/)ACY &=15<"37MQ(F+5)TO*%F_4 )3,<-!CU> .[V(
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MC]!GZ@X\XN##PZ?#W2-Q%P<H'[JXS/2 Z1:V_1F0_I03F?=0L)/'IDWYS<]
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MI-[':^IT""-]3ZCU#(O(G >E9F7DAD^111%A&<[DY0/)H1T@,7F1Q0]A88Q
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MB7:ES99H5UHC%/0![M_*]E]LU3J-=JVM-Q+'"LQIFOC,7&RX2$V+KP<X&</
MQP,T3,\+N*F6I2>:0A-&,1B;-E:*N7%7Q/A-EPZN@/#RJ$5WV/%QQ \!L=@#
M;Z<(?)$]C-&M&3DNXAX;FT=/CUZ/7V>YGQY\JM<Y?!B;X+.GFCL/,RV)$2<
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MJP>B#T3_W3G_@>@?.V2P043_?443 FL\=@QB<UCC(<(3X!.RJ[J[N[L)(8K
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MJ][-(\3M<BA^YV@_>(3!([R=1RC)9W=O+SY\L1L?O-C?4 H*'N%7#<AK\N"
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M2BW/]<\:^&;%7E&[$VA*GIGJ")J;A:M@%FZI*$F<ER+-G[U$JZU"F8/WC:(
M+YPH3UWH5F+:$ZDK";Y4V9RJOFG=/$5U4"CD++444"RMWRL27_H V>'!7MK#
MPZ2HBKO_B1B1M*(^U@0["ZMY#M\%:E=T-4>1E6.$B.Q&$_R)368:;?ZKDF/8
MY@/FI(BO) (N$)5*E+/ 'L[MABW-Q@PL_1(?..I0.FU4-R*P'DRHQQ)$SG,)
MJCX5]:08T:ZY40R8]65+V5A72>>V4"EJ\8#RA-A%VXEL!6-8J)I2.["R%.G>
ME9'(S*SLW]V]G3W[0LG&K]03S:<.#MRG()5KDK:<#?KD"@22#,E4=8FD(Q8Y
MET3-:G9_5XMD,<,1E6@) 86T"%6O:^?@\,[K,DMIUYZ!3 &SOR);AF.XIE:"
M<-<3<@ZPM2M1?I 2-@E))7UI[:Q'+2UYCR$?*A0Z%0J[#U>AT),Z#Q4*#URA
ML+M&%0K[H4+A:5<HS++$$;YMX9V _5%BMSU%JHRM085ZJOF:?U^G@ZP5(N06
M#&HEX%IC3,@DE/B>)7694HL%VH5PQ?@<H.!_"U8569%?/<<V5,RA8;5=K0TL
M)V*_[>JJKI.%^P3[9\:N80.4/=+)U*R6^@P[]-":2T:@(]&B9/M59>':;A_\
M;OJXF9\'3(!0#RE/ZK#"$F1/80;.MO7C19Y<.Q-IQ='U0U1BSGHF1PQ-H$2.
M^M'Q"_1M&GWW\HLR]8IN.]N<[I_IN3:].1W-%7NJLME-K0P\2I%M@Q VGHV)
M[%BY88_MV7%=U#+(,$:7R?:7[D&';7_Y2=$B=@&P[^*TZM@1/#V!"SY;<NNO
MYU#X,-P;D4$$EE?D+L<13N?+4-;D1?Z<B!H?10D[RU<UOS..D.6_XI\\+=,K
M+?\G N+HW8.=R^<@6,.I?#&F]W"5!J?/B5,27)-,GO>< $:_N#F,]DU?G!-%
M]N0>3<NY#*F8(4'DH"?RRNS%&GB,11X;X;HHMZ*@$FITF\@I=,ZZ52:UM /4
MDZOB7;PDF(P^1K)XW')9I/JK5-760);SF6@CD'$S]2-,F -\28@;"\B5*]YG
M]4HYWE6.I]V\W#G_9?.T8,DC!@EQ!#XR2T_XSA5#=AA.2):[2L>U"4VTOP]O
M%/S&A1S:_\J7^-FM\3,? 8S2(=X6H4W(0GUZ&OP?0@Y8\3'>':*=R/BT&0GW
M)J<H4$9U.7E#"#_7..EJR\I+O?EX*<,!SVBOLS27L7>,=%0BBTW,M-!5-ZJ*
M;QDEQ7[< ;AXA2G!936DNVC-'R]]H 147(6:63H."E%"/:5J*C/T,I'1>3H]
M3!80S6#9CHO&E5:6O%NSJH&[JJ9?%^O^?F7>L8EZM/HJD?%6,)P:7+!5AG\-
M+^-H&0;NTG+83!&B9RA,Y8GS+(\6Y,1W6PT:P*:V-GR4NVU-95^66CVX0VH5
M'-Z>"A#.H$L6_^@DTB6WNY?MQA,YG[Z!AEE_%<E]ZC Z$<U%11D(366]#(.\
M:+E4^J5.$6-:*6P;-B<-F(^E81,6_2R98U7 (4'^U#=C&4I!-E5SQRDH.?0D
M4W'CG!UI[?X)<\HYYE%2=1:2-4B"L,R4?/&(5']\U^[)5AB_I=EB(PFLY)(%
M@)F !LT%@HR@_:+Z)&SUX:E75CYW "?XNA3RY!NHR2V@)E7,%&/ZADA2AM=0
MVJF8FC>D]C)  @2*7C.*=BH"'75-!09SU.<,6LK=;^;#0T*%HPB#5,OL816E
M5;_! 1X/+]#7QKX#B"A@:G4VM K)M1O+U0D85>!WG5.K^)!X[ZS(FND@30++
M!99;.Y:C(J(H'4>R749#>:MH@&77NTR#ZD9BL.EDTJQ,J<RP:F88,Z& *!4F
M4"3?*@MD:[([ EW]AY;%49 BI\(,PE9T5Z"*1[86UH#S=HZ/=W;!Z=C:WW$<
MCV<<W6OJ25&2T"A*KI.A!?.OZ[ET^Q'!E*K=L @<?.\:#3]=RZB;9.7:,4KE
M(#GS4=\D%<?S"'88^SUR_Q'PT$C^^MY.'.V>G!S1@4Q(_%W#34HL4#Q-4T/)
M L_J8_'6:\KZ<RDWZ8F^PZ5P8U_L0AG/%)$+LBW(MO62;;F.2%-_%=.MKB%V
MP8[[2)R#> K/%=L=*I"*0_$$ (CN$D.X?ZS-BAQ4;NOP!L;-WCC!(57-5MVW
M3ZG=MX'QL6XNP&33-8@18E=>H?'+98%480&4Z^T^X(AR3^=!7R\T/$#,VA#/
M"E=5PCF-'&2F6^ R=3K;39T'%?%N+S^$8D"5  DV.:2:OGJA^,1<8U"Y7>P\
M.8:W":?D/$T=XLAS>!RDQ,7A_8(*3;G^E3*W2Q)^[1I(>9B4F.DTE+C+I;US
M(HXMEZ4KZ%Z[C1UEYQO)L0&:V(Y.[2)KBCC(159=0*[;7+L76UQ9)JO8'\AO
M8+3AAO6QD246JD=7J![=>\#J47]98Z@>?>#JT;TUJAX]"-6C3[MZM"/)>VI*
M9!8ZMZ2Q494DCLV37%G/CQU3FS3K$;2>1MBQA+:1#0RR'5WBDQQ%A.JCQ_*Q
M]7@T2@G["7SN& ,>23Z/0>W4-UBB0>NS2B/UU!E']7>.0J/.N CS2@O)U3I+
M4I4@K48@4PJKNM3L;]&"=1E!:XDM90_+=0?AY2*:@Q!K-U>J* @/QF#+983C
M>NI4MF+1=G@QN B.^5A.DZD-VTB8?-=ZEREE)R)R!Q.^D_0V*6YB#NH/MLFW
M9<&Z01D+O!Y]3Q^(?DXM7=1]+*/C=K=0NW)L 9X(@:2M;L?[K''<@7L 9G<]
M'*J*9_4J'9:5?&5 L]OOU$S  VBP0@<,0]?Z7V+KR@$S*L2HF^#&25K*J8$8
M;&L,QZQPAFT,OP6&L7W<'JO[%_NT]"'*VFDN1K"^UZ6FMCBQ.9I;IJV'+OJP
M?F*_J+(_WD+QZ\HOBF/2Z(6EOLG8N1PET.XKLB*G'KG=U$?D-RBNA5W<*W^/
M+?1<*^/*WNJ6U9G.#+B6J^TTM#K=>4J/U1$9%;U%:[7UR9H$[)@J<-7O9F6*
MA6(,@20G7PGI\1)P(JU/'J-OLY5 04KS.VAD!8HVRCBGXS3I](G08G60G%L*
MC8'@.+2;4$[C=P&7A,(^BEE14K'11P-7LI&X6FW=>7]<'I=:.GK2B3>L6!]N
MK4_"PTA,<HH2(?A/DC,8(\Y\H9P'_L4J!K/+<6EHD#4C!C9]G:292H(1N(])
M)+WY>!FIX:(\B&8ZRXJY$,J&50_AFMZ616P![^C C@WAY1:7LIJ,6>_Q8KW:
M"W-79!W(.:6S$I%Y:CGD5 ,NX(P_NWX5=V:/[%3%\#2F!JFY2:N)A!R7;>[R
MF)P:N>A4"EN&$VH+N);E=$/8DM:((.Z(<#R.&H@SJ6K2"+ 1#')$6^ N7!<,
MV$0;UU16%R@<<4JA&FU9V7-:(U;&ADR2NDZHUL_@I>F((.<&ZJ:48X?P^61D
MZ[8(E_P,K.>(K1F)G^GIX;"O.4M5K;@GB6?ZN[>!G9[O;PV>2=(R"R;A;D<&
M?0Z$8S)9LTGT!Y:'"VU>Z36>C."/.VZ(<2);<4#X6XX]+Q8+E5K+R")-,X5%
M*" RB1UI>XX.P7E+NE45OKQ@7<K->"<:(Q ^44F<OR>KJ=Y85&BT%I[HJV3X
MN9E%?\!)2(-@ _67&\OV&U 2A\:R'ET);!_*@ [%)=T;<T*KA;&QD(DFCN*
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MC.C%95K7;,Q7G7$V;#XK@T65&92N1Y5HHG(PCU6!Q=Z1GA-P_LO9;]%6:T0
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M>,DIXT#'!DP>,^EMI S>.#X7[WTX+!LY-H9]:4(0M6):4]R+E%D+1V%99T=
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M5/YP(F/ '[DV_9S+C2W 9G?[5CL'^%E85M);I< %"C>Z;*I5^+>H;I>[OKK
M$;)BH;+*]*QR5:QO2^FPZ)A\)5)<**O<#$EMCC0/90@KE"$</6 9@C\_'LH0
M'K@,X6B-RA!>A#*$IU^&H(%R5NK4B+F,K-;E^!+KJ!]%S FOD]X>@J4C_*!(
M=V\VU[Z-I5H,#*<:1\X):/_(!LLK((O$U5@]M;Q4M(H^3#L)G:S0]4(F:4ZI
M7WZ0MB"5UFSCI_441[PK_.;X\G)7=> R;<O(R3[,+FFQ*O/67A2%\C;1D^IB
M3K(A(V96&-F%>:7K!U.;[A&+K3O 8DDG)JF )/'A.,C=[1-5Z)%@71-^ICY4
M!(7[(I&YW Z9=CT&TA$VQ%EU,28H9\4]B.X70'DZ$Q 9K%+-0/1<;["W.O;6
M\0/:6WY#(-A;#VQO'3^NO;6[\UP7SH')M1LLKC6UN);-(Y5&V")!,=DUR/J?
MWIYZKMI&2/KEX\7%6SC4-0#,?[C!JZHUE=(M"BI9:KPI]F]A M$3L>WIQD/D
M![N%HFW(T7L> FG;@HP^55CA..Z8;3"V$@P\.&6<[_0NKLWL;$,!M+9"<_?>
MF55XC*-;996%/5Y=8:UCT([N!0P5/3_$'H&KAV/K^!=F61MJ=S,/3 9H1&J[
M7 X7 )-*;OFR&? 1&%(9B6I8IK-N9XR9RXT1NK)6H4\%&'\G2/>N*_!/,].6
M/JT^B0!&#@)\Y]:XB;&FZM)N$LI$LQ@$2<\86)-4Q=<4!)VCD@7K5@5,PH=!
MY<])6>* &9G!;M6 6'.W1A89Q0HD"C%6)CQ&1G?GJ3\1G?(?J::9G# <.I@C
M^4B4]DKE![%,AU**5)%'R.^+5VN:?NG!"A)"3=A6Y:;T&CF+KX\.Z=&<U^F6
MH!$/$I)599B;$ZV(MX-Y9Y5QII!L,I?1_V*8:/B=,JT^J[VKXBFYIE2#19F'
M4R6IFJN62PPO#_@*I@)*.3QC.BA&J2EY77)ZZ+ :YAW,V_NV)L)3&F;,0$5)
MIB"'T+6K4$#28'M5QJSKX_3NNDF<"LBW-:S$D@A_$"R/2W@DQR2>V$!DJ;@V
M*=1*^%<DB;XE<4WU$L+A- -@O':9BX)4&EEI3E-*9==N@]_OIA?L=]'Z:#AR
M!H;\:,ZD6A7F^1*BQ[?X4>%=/P\.AVL>TV!)=7]2R-%P)BYBGO&=ZU;UA:30
M&=2EISW0UI4>],1Q[#Y8:SHY7E.)1??%:J2HQU539@V8"H3FOQ,MKU=0=:CD
M6/@,!(VIQ/?.N0*?I(-/SL2+67XJ: _$U,2^BJ6Q\E4@N:?55)>46EK7B$E#
MO)1RP<7PY6DV\=W^N@VYNG7\TQYR]<O%.X\I_@N7O7GR3&L?UOI]P;!96=31
M#NI:!$$108JSRFXS @YLIX5EESM^@*C'!"99Q4P*K!CDHG:<$)>.4FGJ:S+<
M_M9G^U6IZ-/9>Y]#IT9-.CN/WDOIMX'$=>HG(,KRMS?(V@#C\59'#=)3DRO4
MKA8:EMT/M2"['>MID=PA%EV+BAK:N0Z?B9$S!FHX*KZV%!@R<%;CP>*P7)VG
M1:"72PD4.7F#:?/#DKQ.K_ACZC6[5X3;ZG3II^)5"3>Z0I/",=SHM7L[NT?1
M!=9!S;&:%>U8^,:'#,OB>DA=96[@  @PT1WZ:B 5J6,4 4]G"A0%_&6P#2II
MH'9:S&Q)U:ZWM^85"[3MU"YU)25-:^?53)NL3F<9S<W82I]Q](0J/'UOI(K$
MSBAV,H^L:ATJ.+(O:M5SA_5LI?8B+J0[$'U$>XF=0XHHFS$?F S!GWB][>##
M3:Y>E8N$VE)0Z?7LSCN5FB,=,R&SEP;)D&O<T5WL&6>-@ZS)U*?2/OT]K -K
M4[*7/%A,8MK/Z1JB0B:ZKH0[E/3:VK5QSD*]U[?@TA3@+N,QK2[S\0X'O+!;
MW%YKL<W,?VU#G??%7\)'N98M]U4&FN/&:-?2T^:D-V..4HTCA8[@>H<<I)+G
M8 >%8O669)!FA*U\K9"\I UNFBM:$P<[+,*7;?HPI!9L<ND//RTU=_[^[+5'
MSYU3AUDAT8G?C\'%:L_J=&_YM3-B76J2)ZD3262H@GGGF(KEQQ11 EI/6=)4
MCO7?^EF$K>=Y5.3.L:?\\W3J;4>E-P!GPD97%1C;K3M<]'A2Q'I9KXJD).!P
M0S7T?MD+VSZ!1#5K(\J#WO5VU#[ZA97H"-S9E)J!1^Z;253CYO5\=^6RW^Y;
MQO=RST9:R7+N&Q7V^.);]# A.C2 48II@R$0N))*9"3.\#QJLR9\MH)'ECAJ
M>:'#*C,P=7BL!>B+8MNZ2M/-T=8'*?D6H3!AA<*$%P]8F.#/F(?"A <N3'BQ
M5H4)>Z$P84T+$QZH%!0CW=3BHQHDS\MM.2OP[]O1V^3?_P8S^\-D^WP[IC_]
M4HHK',/\J@01 Q=8(TAF]-^@1SY''9!S<!WGH O2)'J=(8Q2I?0Y6:*NK3!N
M:1[?.E98@/^-K)J<$8CXK(OR\^<T^M@4599,ZC2.?A7@",'_YI5LD#K'CE7T
M'=\6DP2,B%%T^N]DH#1[UW1H[__<F 6</^^<-VE>'HA!#;@^>TEW<JFHEE+S
M/1=U-DG%&)PE]51I]\;N"7Q NVJDDHS\G5=-A1@(E?J*OHK_+A$N*(</X%>Y
ME8N:I74'H%3I[1,PJ_@'^F'FI;##C]3;>VZ]_RU8>$.PJ>3KURSAL+>S?2\G
MY>S-Z9E'H)X9+ @\E3=YJTVO506#D\$Y&:O(<-'W'4+:0$?&+-Z9?E[H<1V2
M->P&*4;CP?%.%"C[;-!>BNMV,WOG-(?N::;]IXGH,NS#\P*P]4G(.,CE#/QW
M[=N;[[S#1M<S":R%P9!$(LQ(W)!%WHKRV&0SN0(]H%PH\ ME(('/J..M<,#$
M$SCY/XN2JXJ[N&E^Y"LK".6T#'</?-U""??FT[.W/C8UM3J*\;CFJ*^7='.C
M!Q>Z>5.+=Q=@6U=;63YMVFJP%'*"<C+48/ )M@>ZAS28.Y$(69U!(?NB=/U\
M[:T2+D*)2"!6 94&WY;(5;5=3O:3_Q:X_7@HLJS"86;YU=]^V/F!?IYA.8O\
MF5T'^J>\LL5GO$>VX<_N/MMZ$7_^:UW^W/Z]^N1?ZU'+"MWSWQT"@M:H--5O
M856=MW]MJOOA9X)*.-)0"9U7_UB/5MGK.FS&PQ\_<W 9P2K+=C4E_/ :9Q5=
M/C^(C7B^6V4F%<@B#\2,CZ]+R7PG@.,Y@&^Q;,C,.)#E&Y<79[XD)_W)U F=
MROBS'DH_<-(NLAMH)AOHB1]-8[OL>K;ZCNH)5?I88&2P##QF\9DG%%@/TU5(
M&A!6#Y5Y&=V*BHB3?NRPDOW3__Y?\ 'D]9\#^P?VOQO[8XV48A-3X8DI.05:
M)?U:G>**)=#6%,W'4F:8)#XST52,0Q(0#"*G(AGJ,(,5,M[AGTVN%*>?^0N9
M'AY1+HB&52R/>6NL KL(%5:55XG$ Z60"&AW%3SVEJ5*4(RA:BQ$>T#0X(H_
M0;94HU3K?'[#%<[TR_&K"+V*79[S_J_%$JT'RQAC_]Y18C8U&,UE@R!R()DU
MB@_\1D[W ND(ZS593Y-[9!&MAGG)7Q;VI+^O?X3@HV"K71!V0=BMG[#K=1X7
M^8N=8@"=0?I +11HJ- ?8O11B=&**Z&K[7,)M-S#\O=9U27C-I_V+H2J%RN!
MWD^MEO$0;WQUNS=Z(JC\GWLNX_QVRS"F9S(J9K4<6J9AI.V8A(IPW&6!_OB"
M_P"L)767T>J7H*1KKSRN&0Z_C3_7:M&A4AL)0--7C6,C> <Q'L3X&HIQ\265
M]4-+BM):[J:JZ*#,OID4@(5K[Y)JE/Q+\^S;I/PL, *JAR#[&5@';T@IZ#68
MUU)W1'LD<\]B9?\1V=XM)'W^DQ826$V7R3-8N($MR^^E+ QV%,FY(Q@&EO+@
MF568(+=$ R8"]P?N7S?NMSW6 ;?H,KJ'%;)!X'05S4$?K49(6A/&27EN*WV"
M?#[#&XY+-RA&<S_?ZQ+@(;IA(K^2SID*"A'2#_O%,L T20<\.69A,L24]7+%
M S_*S2%;[^ *989'6=B'3,<T2J;)%2-CLWN';KH8RS:W1"+WJ+YU^[5]SCHW
MSL"BU:JMM>D]DZS"L3D$\3TWK^ 93IQ?4B"!22M +TM&%>9AS";0&,]*02D9
MQ,(6W&"L=\H36'2I*XY,J";IS  PNC"%?OG<8\%OI=>Z$AN+O*DE3^TQF]N[
MQ)],:DU#3G7:ZNAJ;W+=<EKSG<T$F;/XVX'*:/N^3OO>NNY>"04F,A^E2,\?
M?S3@MZK327;RCM**L2/'!$D%IG%/%$/9W>YE\SZXO8]1A%P,[6]B:H9JNDXU
MW<D#5M/YR[Q"-=T#5].=K%4UW7ZHIGO:U70.#(*X8Q)]W)1D<QB'I%NQX<^L
M<ZPYJ27NLM0:IMI>K8VF=:B\>4B-?UW:>O*>1MLFQ"XR-JY6@%@P4$-8=X4F
M.MA!-4822?1RY5917B6Y!%Z(G9^2K"<Q7@P;JNJ*4:1/*!H9<V64@MJ(K=DU
M"NZ05F<A'U!H <>EW"V9G_MCE.24X3 TG!K&*$ $HZ(JJSSC*]P I_S<D.,/
M/2?0?8BN *!I"]U&-$)\(5 *9R&YKFBPI92+NH2F,4&.4S_*,E@-GD:K;UIA
MG/.\@29+2GJSQ)Q5\18IUJP/\#BSP;,>C\O8[M^"#E<CN9S@4\99.L3/W84
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MPHK'O_YILX5X"+ANJ@R_1\"U%'\*[3;E1?Z<\X,4TZ2JM$[8C]&6^J9AEPH
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M:TYHT\F==5-KF-W";<0TV8IRY]J+BE5UJ_G:K$@). 24I+B1];MP2DY0Q3V
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M6PD7D<JO,;I9US(NPJA-Y'F)D3WZE$U:-4D)YW/J 9+,AFPK]HU@;4\7\QY
MX)' (^O$(Z1;L#B_ D*W2GQ0*XT*;W]4 ($E((7S3K^V _2K.T*,N+#0" C^
M0W5MZ5[6EM^+A]\W3O@#BZ]*O\X_>DNC'NA!S J<=@3_0GLAK::,DFKUT_)"
M!\(&9N+XEZQ/(,]W>Q/1+] ?N1_P10N;PKVR58$JVO@9#)EAH5?XB.;K0EC<
M$3O W?\=("R$@F=X#/2*.P%6.( 2[OX7H4MHTEL!6.)66!+VG/-O#"C1VGU
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M3VCTPA6<+X1EQ_ZTX[R5@M8['T?8X/I-J-)!<,2N?@.4#8&Q4,]YF<7A6$P
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ME3+*.BNNF9"LHFT6\9YT=O*-$P'"!P(%-YO\*A:!<L8I#YRE^"O6:6+]L+E
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MCJ.>A^G8%\[;KO,JB&8R7F^-Q.9Y239U7VV0II%%=#>NL7UHL+'[:H,T.V'
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M8/6R)(WG=#Q>1)\C7PYN?RI=V!&\$<Q+W\+)U>=C7PZ="@@<.%@$'XT=-YK
MZ7U +;4-N-L%.^G@@C,9!/C?,5UU?(M#+^&4O-@ CT[@S<=G\[+E<X^E"-*Q
M*V*9'Q2>1!Y". +@I2^X/F(+[-E)8^&'P& ('ODANU]Y1GD-?JZ%TNIG+BTD
MC1!)+@#2< R)TFL5_(*K$M-IY ./)Z2MPU6XKPO[OC[ OP9PG3C_@,"-J\@
M'H USL?"AV^'SF"^>C&XR5=R$&<BGJMYZ:<X+[WWK%O:-Q*7F\4QW#;@\2*L
MA;7?R<E( G3>A&X7$-+Q@%"#:#J1!!LQJF :X',JW7$(:#":*W2?=^%]V,?A
MLTYY'VYT,$0_%YST9\+1<\31C]$<_CUWKD2<ALA!]A3O^OG\H_FEXB#[N*T<
MOV$Y-T->,(W]6V10<.O (@&"L%G<MC,$> +8;V62(G[#!51I$&]A(CWZ]S2.
MO,Q- 4GQMPH FC(\.0VB.:\31O!!@%\9)+&??#J8 *&-!-XH?YJV G0(OQHA
M.P!<\8 / C-%O>7 C>!R GK>%<G8&0;1K'*)L9P D2;.[\@5#*+ K=E@HFT*
M.,UDP%>*6(0P,.+ENO^RLC2A(!R;=H!(C0PA3*:!"%,E>R:3C&[93U+Z!G$,
M\_08Q(,+? 3^4H;'K4C<+!"QDV3Q2$9A%ZX>H"Q 7+E(-=:KI6<5UT*T@H_[
M@"%PMW2+,^"'$M# $4$2.1JE< 64?!I!'(17*DE<.5$\ D[\-YV&MC"(8:4$
M-"M4S.BCQ/=2/Y&:6^<,LN,0FB.&=("W^&$%;^2M"#):O0P N 2-5#:/AV]8
M?#J9)ZF<\/5-Q3R*OX^E/QED<<)H[,U#X*IN0EL?P^L#*4-$KBBX)2QSDBB+
M73A2QX%3H-* @/(R"=(".".)++A'7-\-H@3_.(EB$L.A\UV/L6'@!P'>-FPY
M5D0Y]!%^""HMR[^R3%@'_W\IAWA6S7[P\#;15/@4,79"C9#%^97( F#&4Q1*
M.:T1&A:O>TQ?8?[CL8Y3H#X-UIPM)$Q"18K5CUF,#*G !^M$=IVKV(]BY"$#
MX"8AR6V4Y\ #X::FI%08IH/8!>OZQ)&/:T\*&P9,).%BO3@0X2?-]_2?+82%
M@_4],0'8_2SB3Z%,DB(@_EM,P)+Y&1#*V0.[!H 7"A?XG.>\EF$&Q+RO6!4P
MFD\ JJ(DB64B1>R"FAN*8(XL)W5^Y\&DUR"W8F"O@$5OT+8*B>A$4&%JXRCP
M$+(ON_VN,XRCB?,O$4CDZYQL1+^Z_NW]OYS?IB#<0'B\4[1\3D8;[P\?SE>
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MNJ[F^APC.,D8HP]Y/H#697+73CJ+V+-#^(W* $N)W['%N\(/X[DMP$;<@L:
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M@YH$9 [/P'L3U-[44?TXG3M[QX>T^42K=NB1,P\E_F=\YE0_0P)( V/UB8I
M6'6\CO*YAE'YKS- X+$,C(94!%E'HZ%2F6TE,;60V7@:2UBZ5-&[$];Q<VJ1
M$/Y$.%)209_7XHN3N&,P2P*T[Y793;IB"1+*3X4\&W'/+#6, J!K[97$WQ![
M0AM_F@V *^ ]@8!VI>TO*7QI4D8:9$O.GJVQ(B>"*Z!?(4P=, [\"*Q\BP$,
M91RS^P0N39D>K)$7X<#J.3W0>['?5?_83CM6!3\0 ("\GC\$($@*["B$A<V
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MZMQP5YPYD(59DI4S!SI:EPZ!Y(I@B.4H"P0Z[W+5PO*XKY0$I'!9^N(LLG7
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MB_7H&['X#)Y9V:"V!JH8TC;JGG^ W1N16<\>-XJWP/&FZ#R;H]@4L<?(8(
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M99+&OIM*S^''?@O]M/BL(T)//ZX&=A;_'LMI+!,9IDXZEHX8C6(Y$JET1K&
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M+YU&T3Q\\_JU$[3LY/<6$/(ZQ=/A5;K8]GKQYR'^=>V(FR;"XI.'; 2!((E
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M/1#S0(1X'FXT%8Q?707B"DO.KP(.WXWQSPEW G;-W1@PZ\_F<23&S/$8MVU
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M 7U LC!F/&*O3*MKM*VV@2XA2#D((7=#*3TS_L.9Q3,V!V7CH457,L2E9HR
M1NP$_JX6=BD][!*>S1)B!^![!@YG-QQ4#$@F2#]I)E1'4^Y.5*/+J#=(@\.[
M'%1U&+N1L<Y;V3'W+:,-NI3TC(T/NE('(15:VILF[9W=DW:T^'A=P1A!O^\<
M_/4GL]]^RP',8-!=U[\A],-O(-YTO"0\Y!RP5Q3NX_<GX+5P[Y9UV^;^]P/
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MNBER;3JUZ=R*\6G3V? !;KWI3&=0&\\:$]IOF5UM.Q\DN]LIMLKC%=LYNO/
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MXF(U#UOLHSJ4EE_[SA@1BYP?^_$(L9XA-3T6=Q2'".2%3,B#=H&$*]\?@QB
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M^ ^DGWTY^*5N[PH-@!(\%C; 7[52\.?G(#YS\ <CD9-[P)(_SBKS%/U^18S
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M)_F/PQ!'!:,$NQ3/:(PA2,Q8X*MA#"-$/G#Z7HM^XT2_LWNB_TV:MU"*-^D
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MGV&7_VF:G<,T(_7G_&H CP*%QYX]]0.@[-UKOIBC^7+JUH3\1;6:I\_7/'!
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M:.V>/%[>"!?PR[TQ R?G<,K="9N+ ''-]DVKU?OY()'7< I2%;+,=>+X[8F
M5[\F-U3C-TJ8U+62%_26$HD#,'V@ $8")IS$'?JMELC,A= LGOM2R,%N16S,
M;Y$BP4',HVD@Q.$,ACE%JAU_#&-V0=B1NL\\L*=__<GLM]^:IL'P]C'@3$RO
M\0CL8?OG9&@Y6BMHK"8G%+8/O^U;E-Z(IC*[<0 O>* 3@I 'MTD'_X2FD*83
M?S83H#5FR-]3'H%;>;?2F0?^M3,68X--_1L!+2M%8\B!0/N@[:8\! <O KH%
MZ%1V"?K0\>3-ET##A0BNZ19;>&HL)HZW4+6H0@\,QL.4J\0CO%FRQ3YYT"B#
M/H%<8DN&6R,8_DSD6#/Q QC]+4.]@\]P-\_:ZKGF$]#>2VEN:3W:-#W:V4D]
MZD6WAQ-R!A+]:66T9U[%*-7R(+V6T2?5\E12,LHIN@$9_VI'_D@$2BVB5C2'
M&:7(%^Y902>BCLE3C?;B5O"@2M]=*WUG9TF1*D5+<\.DN:NE^0YI!L\(Y 8Q
M3\Y"A6%,?080&O"K#M@2P:D6:+;<?\B(]F\QM-TE1P=X@H3L.XYS0-T&8L8=
M#UNH<'56$>Z@,X&,$Z$DT0F ,:'S0VJ0_4[_ -6'+<(0F27^'8/-)\7E8GP4
M@@_C(K' ?LHO@?H8^S<>QGPPV42;)Y 4\"^FOKN4 >1\&FPF>!@'T,@D\&?T
M]L0)0G15PZC2\5JJB#;K"D[\. !=O=^-IO?U_U+O;MG0E=-W?V_OF9RZ._VW
MOR<#4!ZG[!F> +_WDW?MN[$7 :^6C3_;['[!>4V3 #16#FP%3AXHH0#:8C<*
M\5E)L! 4OP_>ADLY=N, Q*%M&19!!'0@T1QF##!G)U/N79%PG,"/@>]6.=;5
MM!DY6$J1"A5]QBH5X(%"4RD3F! ?<<!"!W0>*)(T$1'"H.<NV;M\PTC!? [Q
M!$ZIH306![EU18!J!&B>Q/A5'('2))T, BPF$V%3@H.03AC*S%B6BRUMUQMF
MUWL[:->E^2+W>F'8.YUEAGWM3(#S@^WWE:HPRMK#6)'HP P^:O%]\T@]G3$@
MJ=E=84*4MG/0 W!OE6??(]=^L%DKE]"*ELX\0E-7I'<-@U?-AE*.HWG)C3OM
MX"=ON7Y?V,0*XZ)X"KR< P$5%B0ENZC7I4%#2S@'18X>UW(4X+03=ZJ<6P>F
M<>Q BV 5%&_07MQF.62DL[A\[JI'OV1">0K^""0]^=OVO3">S=*GB>82T[0]
M:IH]ZFM[M"E[I#0%R-ZU=%C_:%VTV#XH,!M_"?#I:DFT(4B+@ML#]NG+:>(Q
M$@5J >ZM#"JEE8F>F'R(6"/0.7((YZ!(!/O$;!>^AJED4>!P-PETKQ]($N@R
M\,RK>;$NF<A35]Q!9IW3_-7#?QGS^"*6L)H!+V >G\02LN/T;9SN-.@$<GXL
MB;K#"!Y$G^TU/$0<B\/7C@=SK'I+'S!DSE@M (+"2<1;&^"F&>#!#AK@]9>_
M[YOR76-M9TDHM&+!9VGT]QOW8@B_5/377W]A1PYD5%S<B6Y\MF\MS5-O:$'[
MCI3G1@U@FHZK43Q8/?XGM((O%@YN+!+4T5^&YBTR/D?:^*QM?-:-HY[)]M#B
M8\[^#.0JY).46S6PNNI%[4WU1"=&Z#GT9+&*O/0Y(W3)C5;]HU+]NE6M)Y-R
M]I'KV]\/)P$P,BO;S[158=CJEC:4H2"+8$%A['WW_!L/+QWI%I7=:AX5/OWE
M\/ ,).&<@\TSAYW#0]50;JPN>&ZT$61:W >0H3W=4Y!CY>G%^4=L_$,@^/=C
M^&?!T&P7<WCD<(3/'!+TWH"7><-OPR4-Y69E&B2MJ/T/:N+;\Q]O607M (GY
M#[7/(=GG)1&1[*RPZ,W"#%=L;%$_[0'[[V+R!P$])VSN5K*Y;$X3>B6M<S\D
M87T#3I?+<2DUI5]B/.45<G/O_3O.G/$O>]ZM!41V.]W.#^O/L,O_-,W.(2@#
M.\8F_IQ?'<&C0.&Q9T_] "A[]YHOYFB^G+HU(7]1;<3H\S4/'.Y%N)\HF&%J
MB[Z]4=,P\MTQ#0-,S>27O9\NOYZ I3O^\/L9^_J1G7S]<GGVY?("R7WW>IZ'
M5881,%L@.UZT3)(KU<12I8"U+WE[_TQ:H2^WW#SD9( +D592JTT'YSYRQ &U
M/^>W5%.C;&-6W0?,EKXPV!M;^L+)=@2R'VI7Q+S2."0Q1!HOT/Z,M&P XX4P
M H8NTCW"A=CWEHK T](*CT-LP%*P0B\3L#1!V)*UXC-^FQC'21S%6-6#O>#_
M/"P>&O'0"=,2AQLGA <H^9PU?$)NP%![1X"N' 7EOMD\#L(8&X%G'>!<IC@C
MW3Z29\;=>TF>>-O(,^&U@N"R1*]EBE> >MK9>__%][ ZS)DX6 0F)B+ 0BY,
MG@LOE%A[YJ'G1/6!<OH%*_H *VN) ,F@K%H+<6V LBM4%\1.!?BM:65N1VU8
MR$.2-NO9SIRKG5+0&"5<05YQV09$!_!D"ZIX\@K<)J>4-((SBHG9!+Y%+5'Q
MA8KID6^@-HTXM:=$O\4NDYT@'WRL[ -^G#J!L",_"$G@09W(?(/RMO/L2ME#
MH1!1(V9SU[\5%!X4@Y6[AW:?08V$!TW(,K&%4F+.!*0!7I':%>B@:&#LHWX,
M?:RVP&Q#=A0C3 8ZZ/+!'V%K:^7X'%B'C/N@&/>"0CMXH- 25,>^D$&=E"&(
MK!90\0DZAV68*;1(46AMZQ2?D?11&,V# /T)Z6\T4#]_('L-XEIT?0HNPY(1
M4[Z4 O=*'9]73!M0^+50&YO@^RD'/<\N7 C #/;YPW%KJ9>DPHB]]]*"4-!<
MY"Q#Q>JCEYB=J*M R%P/S=+GH"5Y29VB4YG9 6@-)7_9OG+:Y$,9H!\GK:5[
M%4,1D3L,<QA-\[N,<?ET04FKV#=FQ-#%BUQ!9>X+UU:P$(RT3%V]ZG:[>'@,
MF3UL$-CI*#\;C*=P2"TE+\]%0,NO8."+O!GY7AR23WS-72&=W$[OYX10H-QC
M=@RF#YDF6Y-49%+T,+J9$!$]G=)+[48P^2+*]@] Q_4#+H, "!"@$>D-1,O]
M  -P$F:KD&G6IJ"Q@,>A6IY'+4P9,M6UCXG!U B/F4S(%<<?^M#:&"0L$(EP
MKR!$>BO89/+@<BS@M'3ES*+H2@\%70W'BVDO;.2X:0 F62 <\CS05[NEND^8
M2Y@93-#UVYB-):,C%X!P72Y,G2*I+4!MH'<%Z+N&$ RYG7@H1@Z#12:L&:SD
M#[1]:$QYMS!GPIG<^3%-5VN)H*^X0GX-55><O+39WSBVA=ZU1TEGI0VE^L-%
MV;$S 2\6H5FE"0'<7R$>J5:2Q>9(XDZ#^ H%Y1L[CL,H@+%S=@Y!ZN_1N&50
MHGJ<K2L^DIG]5(V2C"W>7*5/#91]\)])IU8.F)<V")^#V(!D>)CG U$,9=8Z
M3+?SC"LV-.*Z@Q31*Z0C73^80O?"4VNDB911]CUDE+A/I(92_H[7JB:RK-OS
M.A5;/_[CXI5UU#6L=MN@!W YA619_=COM5&AJOII%/NIX"[\Z7AA3%)?6AL/
MXSGJ ^B)I#(;[Y!)@I%E*MZ&<NVH:@2I!Y/8 +6*@^L<::M2EZT"AX(D+LSD
M*9N OJ$E=L_/J,4J2J1ZC*8^F,5,<B>-R'BXL$^C4J42=OV%JW<RP+N(H%7*
M"R4@_7)QEAIU['&"F[6 ^Q537C0-:^";$(%9 +00<DCX#7@/" \PE:#[T1NI
M0"K\&WMD%M-D%[P020=1&D0Y)1RB9]I!1!WZI6-,%B:HQ2[BT;]4M"VW_I'U
MF24XSW!4LO#BS,CI>XS7?1O\A<24C4 #XY[%[$/HRJ3%(EA-(,,DF6LOR),*
MK&4UI[L>2W$^%($J%1"HT@-%?QD-6/&YWTGV:RF4*UN+1FPN$X^N(V*2%_KA
M+56Y9$=6W*2&%L8'7V0&_H7OC6-;NIM^'.7;?HO_'_NOU!J2:E0^J,<6.ZA0
MOUVIGN6$1V!X<-T6$54U%-3P^>56RU*^;85KM"Y^U?8T2H]ZX$>AITKHP65>
M^/+XC]-7G<&1,>QT2'')0";='I9?_DU"F:\Y%[R30/X^<K4.7=U!Q^CW!]3?
MA9A'F;#JJ*1&'T6"E,W4#;M3PV;L,.#3CZ^FU6&?)4. [  7)J/*.LBA@Y'I
MF30=-T)\SYV^@I7EV=$=)\HC480M=NRZ1>;(I%D:Y:S+);F[&"4']Q[2'O^7
M\/DVX=]]K=+3Z/542G7.G0([?Y8F *K15$IE$G=SOM0?%\<KO:AG3Q!LB*O'
M\\!Q<_IA#98B #_2!N\4OXE92UF=9VAU$.<I'^?SW>X0B7PBB23TKSJ=CM')
MZ#UR;F1H&HAK1]RHJA4^_E=,)2QR<SH6:B.Q\/])V*JD*[&)RV:])%I;$D9]
M!(YXXP (.?4#8.CGUND:(>5:":*$I50HZ,KUS"6)HCP5A8Q11T4Z=V2!LMTL
M$H>I3']2U% ')XMG*^3Z/+-$N52!ZEJ:4BU-;X.U--5%'KJ69L.U-+U:U=(,
M=2W-=M?2H-*^4Q$;"[M S]Q((X\I)ZH_)V=XZH@)^RS&6$U<-$!?Y9I/F@#(
M)HDRZ7R(' /WEDV$D&L O7:K+9-!^(L!,8;MQJ%<1&+@=8.?0CZ$@4$FY<W5
M\3I@O-*<B7M;17X5!8%P9B.P--),91/.F-3W0IP.<'_<F()5](*@?5J4$*Z8
M3S$J73SH^N4SR,9.&%&(8ONX;(:;3A<K$P?)B))S5F1%?X2.6$1^4+9WUQ_#
M5%\9^)(7SL$ <W6:"=8104@4RC]'P"\/LR@T[30H6H?WDNR0['3!P8Y*Q%/:
M1Y7-EC,C=T*&TD55J9C$O;NS!>5MTNJR@YL4[UY12.N2; "3S-,4GLDD&R(Z
M6*)]0,,MI$2R!]J@Y9%KG!P$#+JG)0%L)LPLJ"P93I$#&9%2V2VYI"/[0)^)
MCG :QP$54U")>(9.582./K.:0Y@[&'A:/99R)RV)EC!5:TCP79*@L7F,Y6.C
M+$LFSD2=M]&K8DN+?9HD-&620F&Q35I4(Y)46HJ7$I1Y@<2'8F_.'1DL@!EU
MPCDE6OD,JW="8(A(UXLS;F6:]'X /C_*3.?,#]+3H"J/15T?K$DV)'%PZ>E2
M=F&1+*G*VM[=4Y(M^2A&02G19:6X2A*Y,W^<UFTD^5.9R\V3E[X0S^7*!F4O
M;7\N5*9/,EK&=EEVYZ92I:W]7"L3H?9,)=HQ:04G//)78@-\?ZKLBB$ 1:1G
MBQ6CTB"*FE[B+[4PZ>EK@: JK8#,C"E7FM,U!Z5#*25Z[:,Z("Q/B(%XFAM9
MHQ#3D5PFVRJ,E92WC(V" >,\)FH67@8ZCX9O$P6B&B@R0YG$@'9%Y >GAC5.
M2TZ10K5LK@XDIE7)V8PV)5-QJBS4 *@,C!X\EFP2J]BCK$2"3LX[2K 5+O+G
M6 -DHS%SW70M5. <Y1=(UU3VV7/ 2GONER0([A:5&F8([JA)LNY]6QK6)'V+
M 5%F>]0[--D%.!,AE>\VLB8)%=,XK8]4&YZ*E4,*QB2C? S@93>!$Z&AI-HS
M@U$ C)!"SN3AI-BD'DS37P"H6[G3*%U44HM,H\#_CM #E17?(LI#@'Q&P*1)
MFHVH",,/KKCG_(? _S]A0?AP>Y0TX(XM:[E;[ \J0. L.X5S>3!>TK-D &K-
M@&,E1%8%(M-F6 ,"'FV(FXN<<+JP@@DC"]7;09FGN*JD$HPH0FF&49*2V/=T
M<9#:I05-==;D3)J4I,/J/FBZ4,8KQHLS$>*V+ML)['@F_>0PU<0+OX;+QU'Y
M@G<C,XBYXK,EZ"E6L"=EM5AD@CUD)S>SX)K,<QSA8KOT DNT$_,(05AC@G63
MJ'+\,,2C/Z463#U'T)OS&.;)9KDS(Q:*E8Y,<2A,D#8DFU9;!3;'0Q(#@@F9
M&A]Z@5#H'! 7E.RL:2E'7_KX^1,PP.2Y?BCCBRG59<FA8PE2YJA[:3PD"_P8
M]SN([$AHGR4&QO$\DV=,M@[> 992A0<:"!1..35)^XK.6M0&/HEN7Y0AG2=E
M2']@V<9EO@PIW>9=6$11V^(;: F^B2L>C&4%@,0D=(T^6ZJSN;0"2W84_$]:
M$[/0'F%AS1-;7?(Z51U6I2E41 *^CK>(U*9R7T[BHV1<YFS0+I=1:H'5IZAC
M76.9HKR;-IO:SY>.9G2&C"4J:E8+!^<6:DVQP'.1+D#W^,KWQTF8.A6%^" 0
M5QAF0"QW19L:9)R5Z-]$V.0&Y2]^<LYL6HN8VSJ!9P@I5Y^L0]5!2JO(*YSY
M=.? 9)@?)GXR:(/<6*625R"GM$8@L)9"&,6FTT-/LN#?3XXU(^66'/N;&S H
M]:2@]K"RH+8\?GGVU'YZ9AI$E8<!EQO=LT6VR404)F%QCK=\G91!ZL)A%:KT
MD*0O-(=@P ''@KB5'W/J.I1*"2CFRPYYGUA=3!.&H$(.Z*^3KQ^^'9=':OL(
MDBN19AW*N&5Y4@H9%IC.=-6L\HSAI*2T8I]]Q2KQ!3FD:HO\K[2#\(O,?"VJ
M&IFJOY!U891-"PMG0)>/?RX//5G +QY#LH1@G,3_R>Q!/"B>X)*$JLFM5S":
M2@1O] #GEZS4W:A#8>V]5SLM/Z4[+5\D5GR _W3O'4WH/A&0*H?<1)]HU5Y"
M.I0(Y1KW#5!HDVP^2&N5*IE1JBM&WF3KI>A5_#;-8/JE8C*3+E> UJG8(U$U
M8>JE)TW(4MHUMT64A[0H%66RW!J/4R&W@'62:J3C^"H&?==1-[BD7R3UV49:
M9\8Z;57(@!UE*KFK*N.L*K=-EQR42@[Z&RPYJ%X+UR4'&RXYZ->JY,!LZYJ#
MFM8<W!E(KE^'P%P'S_52G#7-EC6O..B#W-1C.LEBG4V2ESE3D]LZAF9&'I4!
M%B8-9Q;'3>0.[\@&)9Z/-_5$ 'GP"<M/)8_)7RA@$6KI?7'R,EU%3,:0V[3C
M &O;H\"QT8&E-UL9YR1_C@CE)A>7O/H>KK#XBT, 6NPK!A1%BZ6._RB\G7TQ
MFYA(TJ'I\AVN[B1/%C*J:OF5>W(C?Y-WL)5 : ZK4(@93_9-4+G+NC#D5U>!
MN,+HPXO)U\",4+IFD$M8YQ8)*#NJ9LT)PQ@F+9OO5].ZN.IW 7>($CL&M&@,
MTO4_F92?\1_.+)Z5":GH:W&?A3Q=C=*^2Z2D^M;@-8CZ1-<;T5 J+B]>O"SW
M!^4/O,GD\M)E";FRFE \3N(] U]TLFR7Y$,HB0LXBSQU(HQRRRY))_#<GE*5
MLSK'0R7"<\?RX3%T);F[YHZ;GDD'G83BW['<+8N3"!%VQ4BW3HZJE/GQ&.;-
MP<T2\DZD>ZCSJAW3\L0FS%. .P*. @R+3B^9X4*@D.5+_L2@=03:-"*?BDA[
M<D5+>2(*.\3*^ST6!R,MBUJ4M:DBRP!HJ8-6Y(I&Q;8DN;RU8)8?&-FS5J 7
M9^X(NC9N3&( G9,42:JDE$M5'=W.L\!?' F5,0D\LVDG5?!RC24=>/;UK-F@
MO)H\%E,^Z02+8QD=EXZA@@:3[$UH3\48U\[RYV:5DD:9[DH3XCK 2;6['K<1
MRM)SVLQMI"N6>?9)<:6%OI2/>1TW#RA1CUK@N_I$.]>4$DB^F20<+/$NX3/:
M1ER#X\D255+EDK@@:E [(.[9%.-:SMO" 4*V+G>[2$,+].QHD_,H_W-FO[<L
M#5AD&<K(D/:Q C&YLXV*0%&GQ65[-;)%FRLDJ7(+HM0HI0L0BKW2TG-NJ%?"
M ZAA+M/FGCR"51XD0>G_[*FR$^[@\GOP'23FFKMQ^5BN8J5"=CU8:1=U!NQ*
MW2=SKZO$K.)X!JI]7#KAK?0*]56^@CQN/EIL@%QLO%TQ_<>V+>;JH.J<Z";R
MFJJ 8B75*G^I,$W)(;Z+LSI*AY0LHS!3B88Z5RQ*,19ZT* -R#8/IP8#!8MK
M<;AO5[DJ*N 8*R<>JZNQ9.-$[M7DZH0G.KLW.;$029&DR[2;Q'NR]Q;O<U-Y
M?ZKFIAWJ97PYH;KP5.GMU!\N37X)Y1E'2VG0Q!DS:!,QI\$2T#,O^X".&9K4
M0AT,C93"L>X!4U?2C KE:3! <>6K,H*MU\S?%K&G5-+G"<C7C[3EBZETJ  7
M_&:8-5GDH;[,!KTT%2=2BBYDU+N>_EU$+C)H"!?'\,NE/4=N^U765FV&2SR_
ME(Z%6[^PQ6D]"PAR52B3GBOH1?\3%DL;,VO5J<(@6LCF)U*]:&$GX'6)&Q+
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M$2//6/L\\M"WMK8)R\&7?=.*XG3TA_1=W<D?:9S@L8%Q%:-;P&YB]^OXQ@W
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MG,WLJ48;E/O2BUYEF*(\/8G<C59:R9L5RJQ^\Q*T;7,LPPZ<+3>IVX> 6M;
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MISN(Y0O/'HNYS K/?1=$C9U6FG" %0, 2BR!Z@IBES3;-B%^UAQ><[CD\(%
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MG/;83>.RWMZZL+906-M:7V%M1<5G75B[YL+:UL84UN[7A;4OKK!65DN1R_8
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M @&5\ZCEP94]7$6 -I)>CQX^A412[$D:Z>M\.-X&5B<4U"M7HXX,"'G,@71
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M;>XGLQ6SL6XZ0%=B5Y"\5^^F@7LYUR.7]C?D:*& JEITYLY2G_(D5Z.^S6;
M[_F3-1G""VY#_U9U+2PC?HOB<_W81?*GS.F/I_UECHZ&GI)6!INHFE#EIV0A
M0K8?7\.]&/Q<V/_]&R1#&2,R3C@>IU'L@+GK>R("19%M'(%*?'EF(V:-2=XJ
M,BK_U,[<),,,Y&J0>2S,Y@<./@=E4NJ^=6/UG=TI96\^4V+^0GTQMKO@+#E
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M"HJR]M>?S.YH_HU(QLW7!4Q')CISWAH^%)73'*%X.1W!912]@!'6W%C9M+$
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MX;%"J59$6\=)!R^0DX;:GD-3#EP0'3)$?LALL\B3*D4IFYJ^MXZ^#U\@?6/
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M\-K)+L&538WL,R%(2U1RMB>_%O",;L%7372MG%%-Z'P!4I=-Z3("71[:)7^
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MH!\G&04+G2J?949WX8MH'3,5]>)FEX2ZC#P340\XBIQ)2H56UB<7565P:SK
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M&N:**1N$ KEILRTK(L$=7[!/U#J,)9).#J2%\^=\X>Q#MME:^QQ4'AO0LJ2
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MR#O@G<?;PP) +X"E4GZ0'$[V@7<6*1EY)X"YUZ!#@1)FL9'?'_15O%$?VA=
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M6W16GB'#0ZJ>X:^9O87:U6&9T,[&*K@MT?U# P\_.V])L!^ P]72ZX"^ZA#
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M@*83,YV8:W5BI&K.A@+RV8_"R=<Y_*.$]GJ#,YZW 1DO*"F;8.80#S2365S
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MY5PFA$9SF\.SI=(J7+2 50PDTR9F./SH"79^QA*H^"]=%.,*946SI$YS'J2
MB1TE [__T>&*.$@AD1X:MXR[=ES ;&3;ML  .9_YY?$L$?B*27I%S'AVL"!0
M[1EU-$*\ 0Y-!P1DH6@Z.BP\MU1IJ>4)_!:Z*TH&.!@J8T?B,#GA,BI=P"CY
MXA>C9YG'K=5[>(YU;!LOT7,>MT$!!Y8$99UP'_3^H2H2M" HJS=,E!SO0)-!
MV-IHA<+"2)9#1 !+M02?$;%SSU.L!U3+ D H2D2G=CO8[\T EQY^-D $\-+'
M?9&]@?IF\ PVA\5PEEGM56M<\G0 5!*==986[;I7-:$+=66;H=NG"N;T=HZ.
MLNE(PL]S=T*D-8UY7/W-JGI$M,VZ][7&!+CY747NFX]\8 U[L?R(6S@EN2;!
MO?Z"RS@MIR!CE-;CTYG4T(.Y)(D;W+[)E-) IWI(1".,R'"I1-LS)$V5^GBF
M2P)![<N7BU3:Z-_S(]2]0=SA\?WR,W"7TL*#=)D/)J<C.!W!:W4$Q:^QR!AT
M%&V:%^8]5=S.DI]G+B? :9!96&H/6M7@G6TRZ39)C1W$P& EYYSKG)MGIU2<
MAVJ+%I$8+O 6)4<@L8R]'W5T94*2Q#SDA4:M2?V<C/JO<<>>OR"]KW*Y,8(6
MG]IQV1P%W$5!M0T:8W)V-!VF2,S 7<X Y^#&R258;CCI$>3@>@H4TT5+B<?Y
MZ\I!(>FBH#$J7P&P/J $</%ESIU;_8P!.]LFR;T[CP"(@P2&&XRD0"R>8]J5
M](UL*ZJUQO 9W;"I8^D3.I8>7&''TG@KS=2Q=,4=2P^N2<?2\=VI8^G;[ECJ
MY^G5:(V@P#D[J);19UB]->NS DAQ00?3P?"%U895F.#)Q]&%'&\(2YO$&UIB
MG%>(.7C$F=;$#I.3DC&],)!KBC5&[,XLR7)A'E"S2?L>V<U"RE),(@-B)QY(
M[:L];(S?_/3GIE??T=RLV,]X!VSP:"DCX?[XQODK2?BY^J2O7-**,30YVN0H
MV^?+?D*MV=(IY1S^JNIZ*(?M.FW0$?[W=5YD036T:[C)P&7N9)*A?#I17XKK
MFC,99LRSTBMR@7F3P#A18-8WCQJDJ\[!]+;G!4PAVQ2R?5K(]O'1B*<0T.3(
M\6&&F6@MBV>-+ZVC<B:I<(59*XU!G $W!32>-9'9YU:B%WE7E<-JO,F\5MUM
ML:V%7TL03E+@4#7P/]JJH(->(O=#YRDE4YLW&ZFO"8.53(=-!)3MXM.]^7Y7
M'M3@%;I#8E/P-C;5@@> ZJC3<@$6.RX-D4+5:#9?C3\Z>- P2&J6G('"@CPY
M?C3,=P.PO8Q#X#\L\IT4RJ10KE:A'(\J%%]S"U0*$Z 4^883$ZI"Z*!LK:\7
M?1MZ^,</55\+" 74MF5(AOQQ9B,4=^X( @!,Z^@?;^0^)%F%N%V/\Q;TGN ?
M82?,J2(#YTSG=#JG-_2<WON\<PH !7UB.7I29][CWE,N 9JP.JO3[5JM.OD
M(*8<XJ_0O<C40GI-G+82Y*7),FU318FTC)Z+W0,[[^YZ<5+9G^_9L"$,3CC(
M Y0H^X S=R'!YC[/ ?MCL, ]AE_&<F,'7>_:G-P&(7$U!)N/#R>%,BF4&ZE0
M[CN% MP:6OR!6@L8'!7B*/Y^!+VFZ[^B#ZP\WYL@?\=/E.JJ/S=^SJND0"3\
MMKGV(((?(.\86N@/&ZU44Q^RU-0GDFBQ@O(1T__Y5V<5!E^_/\D^ + *J%=(
M\EW 4V<K5K][% I# F,B2+> )M%W,5C<5$OC'-%)LLW/F;5.2SS-L.#$E2/3
MU2#MS3*>E^P9,<DR+7J6+BH*!8ZKQY0[0'?@:=('?^L:]DYY;G&O'4'$XYG9
MUEFT>'[A)%EJSCT+SER%R\Z<5*0<;IO'^:JO[K%Q(0O!,FM Y:F6"SO4;[0>
MI%#A)K-%$=P[G\D0"Z&&=29,@0O:R5J&3).Y[Q213C\)38@0>>=:4*/ GEZ!
M3,5@&E K&ML#<3[-(4UQ@*HY;>J-S&%J_71F25S.VHZ4)D,U):2+G#X$6CTO
M1>SL&_&+&M14H6J-SU]J0E$K0 IRQJ442+6@ZF9QN P0WL \8R:*#X)Y%I<Q
MJH8JM :NU6%RXM1HL9OU.2^P#/:X/&B2Z<DYUW26EK3GS&R^?U]F"=<4&: ?
M/S\[D4-0@F3J)0%K/:%<P^9(,5-[-M"I[]#"(LOUIZ5KUW31?_KRP<4Z8R-#
M_P0P.M6UXOH;T'329RYP^[35H\=)IL4Z6[S?5CD4BC3$5%R/YK:2RI&A\@/Q
MF78'6"T*G_VBZ9F1CTB+$9'8#3.#$M"1RMF1#N >=A(#DGI<"-SG-_+TR7 !
M:!X_P "E3E&6<WU>$/HW+)$+'1KC&C? IUHD1[\H2?_QW>/[<#+Z< MH<^7C
ME^MIW8=?&V<16\%6E' $<+K2Y3G(C7$@+W% >(;'MF"F6_\QF7?>=IN*&6\7
MXJ,X0ECIAPFNRB4(S<"0V*9; 4^;1K )#%!5CX-N!+=>DSOM6.DG;\B0*LDM
MW^Z6V2]:'?MBMP>,]XCYLAK(;=@B'SRM!(.T8A[^2_BJ#]\>!N3@+A"E _SM
M(OC?]CLTX&#?P"-YPCZUSDL0>DIK0].A"4.R,?ET"@\&[2"9X9I0#Y:=B"72
M8YI !%#%A-3:%FH=,^[:TJOBF-JC0LD(C?2)O &^M/4A(N- CA.YBF3T6(^G
MYVE>L+5DC0Z;EY<"Q=HS[,=Y??Z EMF98Y!.Z2R?=;#MSEL2G&F\ X!R,20#
MUDCL/>=@SL1PL:(2T!\W,/A0)FQ^LAVXI!-OUFO#<SU2G@E_2+U_F#S!WF#3
MF3F.MT:#P ,U^&-M5MQ2)0D:* M\*TW*;C.'*>Z5:<)9&DH>'VZI;R$1C<;N
M1]C((>3Y-LG&2T7D#(A7QR_Z<>9%4EGQPFXIDB&;9:1SC4#4O?L8DU&0[KHD
M7Z7O*MZ (871F 6?,&L#S-K#*\2LC8.I)LS:%6/6'EX7S-K1A%G[MC%K4EII
M6N4XIE]:.WK0W*W.61ZQ("BL+?+B-G2E6&O3]WB(7QJ$T_%\B7!42DB'U#4\
M)R?S&/QH,@;]\@X934LS2 - 6OJI&@XR$5Z4?2T%W[DE, <K+#UYW1MWWZ !
MVV<^%5(A'IY,Z6P<B>MA\KK>KONCC[4K5Z)FK"&3D1:(%!"1L,WTHV'H#OC
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M=%E[?ZP]8?4%J$GNLLN)H#6\V)OK9.L"5VJ)E:A0K9HPO8KS+&77URV<P&V
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M)#<5B]/+FJDGBL\)IUI#& M+X+^*6L/9 :8]] (F$A7DLRWJD&K1*,C83F$
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M*GF$#@G!R*#2.-=G@_%RE^3W8(G)[_:L[";YO>3D]V!%DM_;F^3WBB:_[Y'
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MB^ U-NF<'4#%1?[1E82Q4,249NZ9+M1PY9)U6Y.2VG5 4_PA_=%HM0]+<:>
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MC+)JEKC&CA!:!54*EE@4CT"4Q$E<SN4A01E/D13P4Q&7GG&4JVZ<QF5,Z^N
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M:[#<082!TC1A8A"*$G)"J8;U-"!<[6(E3&G7C(\9H@<A@2D,VV&P&G4>IBK
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M1@41MT6^%=X(JKC.-CWK7.JAS$=L'Y],HEMTH.8,N2S%'*-W6VXXLWK*U3M
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M&#ROC0UK,'_O!D)'6:&DQ08[D 1FA!_\D4JC3FNM?@LW6,1?:CN4$4>VA22
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MT0Y1MGM6K7WL^I5ER9EN7883JNWC(LT_"03->#)][KX(L<,99OT50:,@4BA
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M@GG0MN*T]33ALS@B#,"AWTY4=N8^-M_[ALMH:/K,]G:^Q4RSUM'&/?7M$AH
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M2WB#C88UC(+>]1QLV'57K"=E%_;K@8H)M '(!^N=E.CSBN2.? 3YXCP) $0
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MBR0O;IK/4&+^!RT:TWW'4I(,'CE''90N+=38%8AVO!^0E_E'&T@OR),0YRE
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ME$A!&"U9&KPQS> +HE=MN*QA1UIWE4W=C'9-C'/DAKB)'L+Q1@!VLXU8=J^
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M^IJ#'8%:E:0Q2J$#_""[''-XW 7&/W;B\<X\]A#;E^*V2O1Q1ZF0.;4F^?V
MOZNEP'KB6D*6'05U%-0L"JIWC"&):,K J@E54!VH#%\V8X"^$#MDC372"%=]
MOD*:Z7"]P_5&X;HO0G=!^(RE$]1-4>*ZM-O=$;#\4JZUDP3I%\9Y 6H;/GHS
M#> ?B/PCX8BOKB>2D2L;,.(O5-[KV<>_7KS9&9S4BX@YD(B8!5Y_2W32[)*/
M"RPM"L8+2NM=E:@K_?+X-:< U^83V] IIP1C&@\5Y>UP20F%CKG,([B6361R
M+/5!MZ6CJM<)!S+W"[R!<O.Y+)9*A6;S4&3RAYHS1@+C9KI>D6M!<"4W66#U
MAXN8J+J/RDH *HGB>+9A+NOR.=+JI>U0JI<TJS3LTZ_N^9E2!972AWJ\\SC3
MKS'SIW(/M]\OU]WI!Z0%(9>,%CU=9 .\M\B19H\ $%+-]1;"Q:AJ&9G;P K&
M:S<(B>U'L9/&,4 8?QAA2=L!OQP.$(9]&Q!6V1B]HRA2,2N^L"H-2][BR*I7
MT572A@&'Z>@Z$A2/_H55+-=4_JF4Q=H5%)"Q>ZL^"RQ[)FL_I!5(WZ*+G2IJ
MY9E:6,_U!U7= OI,92DLW! 21Z^H187+TY1B%@PI%)&HQ?=F7ZN!*&;!(%7=
M152$F4V3.)]@9Q@N7=*M<9#HJ-QQ+-!7E6+QZR@K+HK*'.R(!?6[%9/ P\L(
M\&TZC$&D:D0MC*"&0<M8-XBU5<$HIVV8O^@[5URL"1"E@C1-#50F62[DJBF:
ME"?ETN-0F(=,$,-)-B->T4'92<<UPB2Y;N *TFDPYRP D6:JYH*Z[4SCT,=P
MI:;J(,RI&(\KD54\2-<C%LM+51'E*GJW84>^O 3M(*?&06A[22;@^K#7%.F0
M&QQ7"Y\X.T?M4$:/C'WVG3?6;3)G4/36DWNZCK'(TE6%MZJ"3>X5C<"( L!A
M, LRZ=Q$R"0!2Z!E/AZ4%-B/V0O&B"R>PA^D C?E2KUR^!DO!?=E]8PR2@U1
M>;%AX(/X<VD98 $!"%%?^5H72J94FC7=$,IAGB!K,AY5&FNIB\6^=+$6,)6)
M7441D#UC$TG+17X%_:U!2]1<NYZ:9,\SL*EM$%!Q.V*PEKQ3]UIQ\2#"SFA3
M!Z1G3OQ4(@W62N+_,PR;GO(]*T<8;$^XR'QUWQK@1I/$G=$N)PC#(H")=9N$
M_80^!H,?N]=P8H/!]Y>B3*46FL%7*@S4F3@E.2^ O.,9 E.S'5T^.)-:+E\X
M>OQ&8A'+4E>9Z%/<8X ]$]26EVQ*W6G!74JLDUI!$ -&#J'O9B0L78=T\AX3
M%P(:F+U@BS.9(:,69K<%*S6B3 FJM-)HV< L1N5'Z3LK4$"N9T0GK->5]1(L
M:R5:(>C>(%R8;2U?2X3COO-:>&Z>JD)MK*@3 +R43(O4UC:Y-+YDCE.YL-WX
MH:3@5@Y=[HY0I_=5[QK;*\V4LLHQ3>:OLCM%4?\<YQD94VY1OZY*I16K*I_"
MUAJ-H&=1/GQ[?:!4X6NTH*[\K5+^-MA<^=N2NJRN_&W#Y6^#II2_#;ORMX8V
M*K^ES]5]>I=CIZLSU )<3H#_.(*G9$L2\FF ? FRUG>]\N01I2Z)>(9B.$XF
M;B0%IW3H1-+HK.]76#+#C$9+1MV9);"J[X#3(\67'BOUQ[%KU;C=1B#4[W5C
M)M(/DKPHB%>=/KF3B"TYJ>,/%?/KUO,BN0X\:I3EDR<%;;?USEY %"WX$3:K
M\<'>H9YBOFP68CR!7GGVD]*=Y-CMY 8LQ PUQ1BT $&.++* KT4DVU'+'\JN
M!.RX(35L)*BA;BAT:R<,9W#AAVK:PG:65#;)(5.T;4*E&!NM"%1GBGH2 R:F
M!=*P?G;#W7M,Q$(Z1XL<\0'=8=@/#3#K4QQB&@(CW27\$&U65)5_S_U)X<LX
ME^IA&YD 8CTHE_A!*<BU3<*X'0W@TPS-&FY+W+_L.[^>GGY2EHMT6F6Q30R4
MT*=4:(;8OS3\V*>A/1FR8$+XIIK-;5![5I=H$YG[SD?J,*T"#",W#90>+\C"
M95,%Z7?)/F1C/>P4+9O0Z>< *-, 3/Z$L /?F01"#9""/RIVZ6)WICDQ,OO\
MA;=*]L-2SENT'6(V,C2+<;P@\?)92KDNS)4JNS;>A!3.?9/HT$3PTD]2P)@[
M>M'B0+<42T"H" .XM&X9OGP?TCE,+C/=F8]NC=IFHCAP?6H*/@<LJK!"[G3&
M3J@X3^A0IRQ.E9,?[5]@CV-R"((JR\X6U1'*.C[#B1^6'7(U*-B3Q_9X*_M[
M699@:K ;MV!)<\V2$C1^4R\)1BS49C%] ]9RB!\_Q,#4APYWN:M(IUM: L)5
M"G:?B3 5-]PL+N*>7"!,ORZ*AQDC\>\SI%R7^X71/2$2^[KDD FQXAK4!%]L
M1.)%OV;L5ALER\?Q>.<U=T=T+J="9,ZIX;]K(9X:3;.1&<8^(@70:837R!T
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M<LV?17'GT0PXBN*V8RL'RYEL(FMK Q\--YGS5C4V-5K@ME"+1,_#&2@A?A*
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MLQS-? 7VHQLD,Y?J::IU8D]-XC5(Q=B(,+S,L!\<2$#GSV&<=A'/-FWY.S4
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M? 1,#"?,B1!G&= :>#( \5*@]YVW>"XXPYZ#\Q9#/EP].JU_)O-$9]-\X@;
M0O#]SA^7ISWGW;NSU:B :]"P5;@X>%\ U =+V6"PUM4KG,5]6#_S^]3/WX75
M))!M-/X<>_#?7T$?F5<H&0=$NV$:,R!3$04T8E2/(^!!K.K8Q7" (%HZ*YD^
M$_NT0$-S-=)4?$5@S@+XD"?Q7,">C7.[I2$OE[!SY#4[G\(XGTSAQ,D\3N1,
MY#(:+($O#='#_>![Q+]SGCCC>G*ZQ6B!4P:\+PZ5W3),$>M>.;_%PIL"-WF/
M(V C &,.VP_YKSP%HGIM^D>GO_;6>/.E&\7C (YB'WN6AUF@$=H^5ZH.]HH
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MFGO=3&/D-6 T"=]P/B"GSR?XY&?G%$D:KM4EV-![*KH,WE\$HD*2_ZE_':0
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M&0F!COCK.+PF='/2.$\\"F3"&3#;%\'DYV@I GLC2S1FN]4+8PJ&S-!0R*:
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M?X0]0G^8Z6Y#(]EM* PR] 3FZ$"Y(K4-2PF,/J.498!$#;KN!)NS(^KCES1
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MNKN'WE%5*=I;%WGK4UNQOL0/)K/RL+)BV 8\E0:?/YRJOM7FX*A2<4+=7LH
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MJ[+LZS']EMQ18*T^(66_Y2H;?B9$)I/D#&<E(H-5]R)GK^I"QCSR<#4YMIO
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MS(TB9J3CD+PI+(X(6X@-JF6(M#-&4)YR$!TP >9')&RU9SI)#Y;*K61F!8W
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M_0K?,.[N/]_\PS2N/_%__OWS;^]OO][]S;C][S\^WO\_X_S][8>/-Q_O+PI
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M6/&#G:QX>6")EYH%J ,UK=GS[3Z('<\(\KC%P2&+;0] XM882H:;CT,0:L%
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M]'WH^)$S1H?P.$7V>CP.$C]&Y/(XUS?Y9Q+%S+W7FDE20GNMWJ9A5*V:/M%
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M*P6A"LG8=V<\0CV;\OBY^7ACXLT!");9&W8U+^N@N\+^?HH5=WIFV[(U-^O
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M^-J=<4,F3LCWPKA+1F;1., GF(8#^^<YWYT0ZQ7#>1#2&\MP0)U^GP:>]VR
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MH/Y#SJ%7EGAH<1_R-D/VWJ_\+4R:[_ M1>N2[7SL?$,)00U/S2O&N53 V0=
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M&!]H=A1<OA%>-30#2CU["FWY79*^LH@M^U3QTN3!:<3@YFR?V-4-]T0"_I:
M(YECAI$<"E.6<"'FBNY$),:[:( +J(!U4[ME 9:ZQL10CQB6A>__2AX3CWW[
M[O+_TH 0A;"9%WH']F;(D0JX#6YY=*GD"N)='D4TGBX<[MN;]&+_ *1ZQM<$
M7OF5@-8%T^Q3T#(ZG4NK/1CVA45P+8!S"@E]2-?WWHW0;DG0;@1S) $O?<R=
M#R0)_LSV]%T"M@V)P!]H";"@\G6P,^@13[A![4;4?\XV.Q>0&</2@2<=MF^1
M"^XY<[&X^Y-2.R%S=QPO1H-QZQ.?ON"!IT/D@S%BM^YSO[O.OG*=4E* J 2+
M<:\[!<)9H! 34Z-G'SA*'!H'=/-!(,Y^/$:*B-:8>AL3=,<P1)9_;#Y:AA_+
MDD0<']2HL&VI2U9!,F/KE^4&^1;.BKX&X[74<6&+?/DE++,%C<_ I\%=\3W<
MO]7;*N#<782NM6!7*:(.L[@!9U-<(2(7ST82"8QJ'"#4!,<^$UJ"8E!92',6
M3 CB>TL9OT(#T1!EA!DO>=@J]YW'Q&4?+V3%Y,[P#F%/)YQ@#';" FI4H*[O
M;BZ,8;MGINH M=.(PQ%9?A-\#C^F<B;+!I=%!-<V5U:@\8,Y"?EVI$H)#"D"
M1^G'T^(YPD?= +U@O ]^=\"S-CH6RV5CV!5_P#,8T_Q3[\F8S$; 6/R#\+^/
M" KRR&4I' \B"-X>:J$)N[G&(L+%0N'_Y?@)QO;XLS:Z(T6P/)H29#6Z^-(:
MD+*H2%I5/L]J.HO/;:$%M226#PK*<Q$@@U5A6@IP#<<OLE 9/ICE82&42OG;
MC_,",@\\=RP4?/Z)$[@M$WH7HR40?T=29ZD*!:YR9DOC=G@N("APTR["O<6,
M B>G0OF!3N$B#4(*/V1JLLAX/,* 6T>A @2<JM9$GPAW>HE.( OOAE(X$$\
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M>1N7H;_Y3#H:@V7X2&[K1>)8V3:?H-/&<VN?^2G!:H*Q2Y=/_Y+N)/O1#X!
M8'F?OR.AJC0!81X19'L>KYBH*,[7Y8-F"IFG9)3M1W%.%/Z-XGS.27Z3R\X
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M2A#,52X/S'9_:+8[ YYT59T@L'005'D&5+[/>\!GRK'D@VRP7%K#+!)4BY.
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M#V8&"^N%6VC^*RX]87@\$'BW4[B*TRNJU! X:VF(6[-@0H\]<%.QX7B4S.=
MKFAU&S5M+ZZ >JSNIOPSM<_>UM-7K;ACBTW6;JJ:K"EH;G])PB@!C2::GO#:
M\>O,/.2^TVU:8GQ/3;;<'"I:A4RK1%W<R^+6Y3K?YWI3YP^ OUEL+Y:A9F /
M:W7/\S59/;+K9UWJT;[,?3KWAL7OG6=V=/&SA6IG7 (W.K-&?T] &#?E\6W9
M5TL]]TO..I!)YO'2+JH79F4W[<KMSL$S(.(/X/<$WR-=>JM+;VLKO<5D+%E+
M;SEM\I?>7BT.^M*EMZO*4OD5K2/.TN?)X*WZ>N]%HUMKHL/&;!4ENT)EG4BH
M61>-'B3+:6U-(PSGZ[+A7!A(<VBEL^\J VD)VX/B4(6)=QYI:XETDL[ ,CL2
M3-D^^=J'+?32.S7UDL26T %I;E*;J2,5.RLZIN4LLPUZSNX,CE7/279L6RBS
M&S65F;0:2T&U)!D3UZ9[.MV>V;^Z.D;=D^*;JEPHFVBF)1$:Z?72&H<BH]9J
MC.RF=)IRPE&+QMNL^*LK6AG9@RMST.XIKB1?0AZ5/.Q[.B:#JL.\WN.J<1Z2
M2TP\KJUR=2\8]J&U70.T-0RB*\G**RVU@=GN#\WV<7J)1WH9W8I,')KP?7 U
MI.TQ.937*8G ZBYJ6YEDPU:O;ZNN"J6ZQ/94<Y\ST68L>U*XJUODM:AI_LA,
MV[&;9GOBZAUJY;D"RS)_=:U\<5[8A,UW-&FI;&EX6'42=I9M+8:29UG/Q0UR
M63J[4W(8Q<A.+ !FA;H\13H_A0MK8 O9X/0C=MOJ&[=L=ME'6G".:<E?/&"/
M?)TE_2S^5E15FFQ!43*>"N2.$Y'6=HI<;)HQ3,>;BB)<Q_"3V0@V 4OS5Z7P
MDW]A 6^YRH]?H#,LK)A[+AODCF^K?')^"GD!;@12G]P@B6AI)*>;/:MB94OS
MN2N'LO,=<K"(FM<[8QWBY)])%-,"#_YE\@-K$J/<J"[Z:OY2%:M\WSF1.S8\
M;-N03:$KE?QB:4_I$Z"MQPD;TIJ(J7G&U(4S"%&3%\^?Z424!=#T6,@F3CL3
MBZPTFZ;]^VQSA7PZ:::_2^M:?3+."MD+]=THDZ6Z EK&GY= 7D<QPL(Z/\<*
M;&(<Q7(8:[6,]ZZ7(.'IZO,&!9:WLM*>&;95H%-RV586E[_P/5$KL?!"'$/K
M)'R.&QLEQXH; BQ#8QTI)D@2RCW<C3.^.FQ7<2G^P+M,T,($E\[ S;TZZ_J?
MGWZ8C:-D?;B!DJR4G9\TK[H09WDISK)@8A47GM_TQ971ZN \X6F-\L*^Z/**
M!6-JT&]=;69-*92\OM?RBEYKT)6UO(+3)G]YA9YL5L-DLSJ1A(-IDF4NF,1'
MM4VKY<)%M>1*C:2:^+6UGEMUHLVINA64'%+;O2PA&^JZTY"AXK3:@U69[4G?
M'6,ZZ5W!I2ZX_;(JJ69RE!4E>PNK[6AJS%:EPW5:G9HZRP_,X;!SZ'#1CEKN
MN%)3%_480J2'5F'[SEB6EK"]J"%5.'9]16-=F=W.4%4[Z902#_['";%3950(
MG&2V4B&*(:76:2S#15&RF]-8RDG(EH;31HDXMIB!:%MFIW?P5)P]>I#'DK3
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M!<G >8.J967_1VI[!X"@$4CR&769]\<?4& 5GUX,>>#3I/6@W)"8OQ1+J_2
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M-%Q@1>2,HVH+#_-/4ULK.3OMM\7.Q#8Y>N3$'J(N06(ZH?J"Y)Q&:D?H>T/
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MM2]1,,$F1Q63U%)B/6#86<'*2,,G4G*C^XNO#Q78W.5A'&C* ^XM(@O=G$R
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M0L291U*.@JC.7GJU+&TMVW@ Z*_'.1JTU\/6X(697 -)80/>=AX[[!Z?'=N
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M Q7[O-#F>P"DP#+M=S_GZG4$? H^VZS00)RIK.:@5RA -RP3> SQ%LOE'(7
MIEX[R07],2\V^:@&YRL@S9_/')S_&, RXR1OQ8U2/#!)Q\;<X& .JFWG;_A[
M,.>P^0"_%@9^ "H3(!CS1<XA_/W8M,VI9X4^.W87"]=AUX$[^?[(:NVG4[RF
MA8IH 2='O#UJF-CA%/%XB05U@/<N6X;>9&[ZG('V#[_VNP?&8'"H(+P;>FPB
M4-TG5->8WC!,[VI,+\+TJ(V]QO4=PO6>QO4"7.\=](Q!;Z Q?8<PO:\QO0C3
MJ<-J5V/Z#F'ZOL;T DSO&H-^S^AW>AK7=PC7!V\8UX>'1G_09K,0BQ_ON!_P
M*0/$#CQK@C\21K/0L0(1R2HGC8%QV&YKLM@ALAAJLG@^60R-WE"3Q2Z1Q<$;
M)@N1.KT)6;P*7NL.?;D.?;T*._05MX[3'?HJ[M#7JU6'OJ'NT/>L#GTOQQ4>
M*+8?M(;[#S&*>2=&A.#KZ2^CKP6739^S;Z.;F].KZ\+<@-=A?(.G9M9;3O!O
M@WWE=Y9CL&-W#O_^S#W/@O?^8KMW_O<5Z6R7[I*[!KML';> <&R;+6$5T-I
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M56Z91;WTQEZ #S6%+)Y.%9^O][J/QMH&\*T:"8JJ6=K8WYOY/=#9U0$>1Z#
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M-4YFJ+':I;T#M>6--:(\K7;5EY^5>)L':ZL<M(*E%:Q&*%@9E,86<H_O(M$
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MF\_,FO5ZFLLUG.1RK5SV>3A$'<A^5-G[P.)_J=R%9^9W4[1-6N@.QWK8M=W
MCF$&?HPR1',6@5]/)X(4K^"O/RUDC\UWW+V/JH!.,8IBSP@RSPU@.'=A9_"0
M3=')S-RA8F\P#.^Y(L[=*1YL8IS'/\1YG#(W\1%%@X>_!MGWL.L.L^Y$-\)C
MNP,[:>HP/Q7EDD^^85;H?N%I_1A3)0/F@D2][]E#<#XX8&$>9F:I3!?OI^PX
M3'\V&.=AL(7^=E9J;Q;&/XRU&KWJYKTP[# :U>L%K0H,&S\:?GP7I!DN/N)^
MG[Z?C^FBK5VL^6EY7+G'B1B.>Y-5ZL:_'O->XB?B6]LNR,HU")\-NA*>=1L/
M-_[JCFX*)$QK5-[EW3#:NUY8EB^N'Z3IA24)/W=W<;VFW_-[O_L0."QD/[D-
MWVS4@5#@.S7L3F9[JDPM)+SKFZ#DY?H?J6FJ>W=!T[JZVXN:,*_5TS.P8?CN
M?K"VXF\>9Y?C?%ZA%Q[1+:(F[EM$6-3@^_F[WTP6GUTJGE8QS#*8H+G@Z^%Q
M%O@[BJVRNTE5U1F-]=W\-@CR4'>UT.CX;=,"K/<PG2G$>AG<_F'4FFRRZ_\X
MI] _93].">?3Z<GENT=2#HB,0N21+Z<$I1>*771G:L$6@DS))'YVEC,BYP1Y
M<EOL,P\B_WY\=9QY9R/N@GJ8<1X8)RA/V%"&#YRA[N["N(ID]7P<@1I_$"9@
MW)M2QW0EKQY_/W[B[)NY4?TOA0RWW>$PKLO](XN![AJ]%>WK@<SLV,3E>U28
M5?,;U*QOPXH_S-%DX-GUS6 X\]-%)2_6.WQ>A44-+!N,@V+F MU&&ITL2OS>
MN,H#/0J^1/@E-1STBT4*\H[S0@ZE!^/PB!L7?B-?O4%%)?/Q;"4(^; KQ26[
M_TCGX1EV[ K(Y7EDJSS\6A DCF=&U89QFYW3VF@*=:)S%H83OBN,R?6_!)3'
M'\Z/?3K$N&%-ASC=J;K1'^D'N:(;E@]ZV2!@:F8X>5$>.8#M.#L)6ZZ:E$J>
M6:&_W!*8IE,7OJIP38KEB'"-7[GIUV4ZS' <[_TIU=TX&&'#8BZGQ!0_M<1-
M\\-VWD_LD7XDLA7,^)PI*'0Q_#/:&W&ZIQ39'P2;,&[H$UG:B,#+6="9WCB:
M'E.MF=@3 ^/L.)\$U,,OQF$7NT]W^.=PI8;/+\=T <K \@04.K- 790GXGFR
M@]D)/T<]*>0ZSJ[BLLQ\^&%L[EN8[GYX5"=JC@H3-!S%/:L;#>FO71L]@\C&
MJECO"3?<QHUGPL*V.S3!ZIX^<^6PCN<G8&:256\XF)'FJ^J-U>CAFTH-N7'<
M4 O_(RQCUX>](^Q.0>SN;6&_W2KK,OU]9J?O1)OV+Q>,XO#WPE=$)8_F\M2*
M5K,6<>E(XMZM7:_KODXI=(8$P@3'*0O3.,.7Q63.C[^PQ1Z-^P.Q,T_C[FS"
M;$V8-:Q&0$(;O>OR@13\_OCO;D&\/A],-LQ@F^312IKZ+ ^;RQ(7EVZ1T[VX
M<+)O;\?]\.V%!9 O6&?S/YX:89/OBC_I!N'<U I28;@_PI^FOFG!5A,T#>-C
M9W%;?/ET<!/JFCZX?#</3_\1_10P^W70^SHU4PJKL%LX5\$J"]YO_TNDE/F1
M#\?Z?R?;4">*$%WWGON6_>_8?GF$EG5!AL!(;C*&*$<^V5K#YF)*%V:?VXS8
M.D#W\_#G[.^?3RZNL^O_O/Q\<7UYD7W\^*F50[F/1H5OB0HQC7(LVA?%FH5U
M#[@)6PH"$+9SX>(7_L\@_[.3W?]K[S>0JS@RG>EBBM#DSN;R*-+!YO+!)JKP
M8+/\Q"T=;%9\L"F:=+!95K>A20>;<]J=CC#7'F'.KF/))O L9H@O)I,_^X/9
M?Q>O5T_*FUD=G]7,ZA3^^;JPO,:;JL>R+CS.?//4XN$X^_3=5=E1]BH#H=%C
MFK?GFT!.&V==_+:<]75Z\O'D_>?SWZ<KI8='?HA+UNHJ>W=^>75Z?G9Q>G9?
M0.?DXGUV]?N[J_/WYR>?S\^NEH&Z"O.-6>F5=6G>SM6;>1=F*0P\N_K/L[/K
MJV>8NLT=WUP>R=Q3IJKVYNV/YS&8-1@/@[L;(V'?XHEA-KR)CJA5(_73NMR0
MS2KOS!?$V5DAGC6IC/>O?QOE#ZOGE(UYJIOGIG)RC%G%A7C(,:+K4U'G?)G*
M]4V4J]M6[95F9VX^&7@I^QCSZLK$/$SAIAG'F\BVM1B+HX+!(2C2/;*_^>(_
MSQ!T03)P#,2_EP)_I0(N"3.Z%^9><UJKHALRXG)RQ?,;X;5@F#%CI%:P-@(0
MK1$T(3<A=W/D@GU=+WNA17,/G.JN!]:[4)L;UYM$F=^>7%V5^@U/*>6>C*>M
M5ZM*=FZ@V$]S]4MOH+42)PUU 9(6)RVN6XN;L\-N<W>U57OHZ32YY&0XC"V!
MV[*7KEF7_?),!8+5SR0-U>J&[GA)UY*N/<Y;P_>EQAH"6S:Y>5N44WJX;Q=3
M%K^JWNS=RHU6;H]@;+!17*_,>^26MJ( '\.E!+$I#GZ8\-7DS^RW[K=?P@)_
MR)4ITLK[ZC;(.AX>?5'J[I>(F9.^C7^=/0+F9'2J\CS>X?TOU1N[-\71](?P
M@#^(YX !(#P6EB!)I<<*40&91\80'SY:Y%Q\&WV.!^(FQKHAPO!--NYW)^_]
M#D!X:9WIWJI>F,,C'"8PK&D0*OPK7BE0H_]XT_TV^J4_OK6#T?23;]XBTF&$
M__;S_'BVK__31J"T4>8$[K: FV$NE#+24>$#EI6D#E%K >60(R7L,KA!5>"&
MK$,A>AFX6V!S-5KK5AI6_U#YGVZ23_)X?[8MO-M8<FT%@S9:8=?0Y%QVU?W
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M-5(C9_\K*M8GER_.&&26"<\I9X833I' E#H%;6R0Q<,R;[3V>';&4 T4L<%
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MMIE=JY,W _=%#\]Z96*.0=A5+.$\F-"8(@&Y(MXC*NHLIEG1U996Z'UC!4N
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MPCM<TD^NAL%1VL$EE3=;=QLV$5\BOO80WP;L0!U"AE@!A6&$$2P,-BY6_3:
M6")*J&_MB<,.J>])5D=:*&(PQTX 0KP20BM@L"+:"X3]<XNQ;#<T2#N$;'":
M6^$IRNRK?_V7\(%XM77F,_??<?_.TNL9P$P!3IA8U'>(2HW=!]W6O8'Y\\CG
MW5YO%I<[0J,\)GP1>\;%TBF/$H[[?P;JZ;]Y>^5<IHP9W(85^!X4*3#2*'SU
M:! 5I"C7J*)-[KM]U3==U0ORAS=NP^.&QXNAI#2Y"Y/[X>J(/&^2%E[]V]'1
M6?",/L60'CDZFCYF;J@]I_)B<[E9F,99T>\WD7D_^?W5IP_QT>]RI_X\"7\\
MSN?L5]R%CQSI^)DCY<- ?\E4[R_U?;CB07.+<I,OW(.;KCNX^_9K5B)[T(B[
M;YD:CP9AHYQ\E$T4XF8:-$7%;RXL<,F^./W1FS#Y3TWQ.Q>^>3+)M'22ES?W
M>VDGDMX-AMW(9+]DN>NI4?>K>Y!^HN /,Q7G,G"^*IBZ_SVP+B"8X&_PCR'Y
M(S#O40!:X"P _[C[0L('@W0G?7,SR(-<O_VL'M?G;K5L&VK[U9*VBX<(]5>5
M=U5_%.V3P.Z]DKAU,8B;/.X/?[N^/'WS]OKDW<>S[/)#=GIY<7UV<7T5Q?WM
MY[MYE9J9AJ-B!^J/5H&XE"%6\L&MZ@; /0-=L_\N7J_FCS>S*C&[D-7IQ_-G
M:7GTFT[<W)8Y^ZP;^*8F!GWBV(,=<[J*5._!,CJ].OU8@HC3DX\G[S^?_WZ5
MO3N_O#H]/[LX/;OJ9.<7I\?9R<7[[.KW=U?G[\]//I^?72V??2SJ2V.F9"EX
M]C ? 5]7EQ_/WY]<GX7178>__A'A-H'>/SY]/OO/LXNK\_\ZRSY>7AW&B.=\
MA+FG3.GIS=L?S_O9Z&8P'@9S>+B8EC,WU$FQ$^-ZO>B"!8NG2 6*KZ?>Q^3U
MU$DIV/AA0F;%)84_-MG4PD3UU-TPC/3^7POXGD?AA!2F;^63D13O+3IQ*Z+0
M#TOEE(V.Z\Z"TJS,,7VZBOF<QU>Y<HERW7KQ4=-\=*"J2,7Z*=PT!+&);%N+
ML5RX_=M]X79?_.<Y@@XBS/K_\88L2HF"F/3?2Q&_4AF?KBC?6G7=D K_)UC,
M67 )@DOVWAD7HP$3-<>P4^E)U]XXYHD&VTU;MX;2S).SN#.F>;)A>G5DLQB8
MI;Q>?FF9JFY(,?'HHU9M;HJZM$G6>>'$<<T[Y\%J-FAI.DCU%>KK7:@7Y(>\
MO-_*;K?4)Y>@2CYJH-A/[KK-Z\ZP?]TGQT2L4/\M^ZT@;S@P@%)&+%::6*>Y
MQ89;IRA_[AW.IO5;:2DT6BKV4\9& G3]@):&.>RYLX1J@B*B;6Q&[B"U#F+4
ME&XJK32FMLE8WH&&-324L&:V]LN#%0A6N^V25"VIVFXVU4/2M!9L%6VU4U8Y
MW9>C&Y?':X-WN;MQ_6'WJRN<\#KN"^X8HPTVY>N5>7^[6V/1T;:-+^GNKK?+
MPU+=AN^D^SY/>,F.>?)5=7M%,E%PG+-A<*?#%YAQWAUUW7U;RW$_=^&W_CDM
M0]P&UJGEA'A?LNUG!VR#5J^)5ZWK7XF.RT\VEXX3M^DY4MB@I[,FZ*0%R>\/
M*/K/02]*\W?5[<=XV67_Z@%Q)WEW&'[T/KSL?_D4YF1@+]SHTE^K;S-A-0 X
M4=)QJS F&'+ED),:$N699I0^]T+@"\-JE%=?V;#)<&RR;'LQ. Z7*2#?ABE
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M%5!8>,*5T[:QZ7O),CT4F7>9\=<>7JDD&3!MO(<@\RZ3Z-H#D)?'4O>WZTH
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M.'$#V']V(]7M.WNF\G[XWF$-&">(=BA=#H0GH._;*:\\9[=%0-\X,7?G0 _
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M*S/"Q[FY44.7#7R[[ZHWV(%)N4T- \-67LMF]>C5]^("[/7@Q/R_<3=W_WC
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MALT\TRLL*G>]9%J;Y<UWRZNWZQ[33K?3&9LW8H?="S>9(:*\N1QK_)\WX(B
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MHIZ/6 U!_+,LO.\:'F@+]V/)-EMS1%Y/W M7G9J_*:? XZ!6O51DA?=)C&9
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M+D\"5^!3G5E0MG>-(C=6_7Q%_DUYSINB,V57G5%X3E3!]?=;B=9<)./]=E*
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ML-1['C(\[T2?#B&Z4,_9,X=VQ6*.E3JTP?RHSE0PGEMBG N^"T'$"!$\)V$
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MP_#!F=QHKVR>O5KVO!N5P>34[C-/T>?JWV/;GG>CR7^[R:*A3S4!R'!BK#0
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M/Q( "^B,M8P0RS3D%JB@(H!T3O!FA1K%>K>GQEN0'=9T6--A39'B@AR!1KL
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M!SZZV\D,9>*&%7\>);^H=O>6-ZIN*VMWKY?]7)B[<?]B1]=@HL9GK$T\C.N
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M$V16-'5U9SS >236.PF@WK-.8VYW_6F&*KO#9JLLL_<S]H+G#4UDJTZ\)D8
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M*F8FM[,Q?C7#KAB[W4JT;J0=3BMI.Y1YUDX^K15E]QWBL.M%IR@U<Q@KB1*
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M;,Y<_<FI4:#@(L_5X).[=X.%FX\@#O@U7!%E-"$":&9$;-'J%(JS?IOL/8,
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MU!.K%3=!#_?[A>2$S5NS,8_Z=_W>S*M>[Z4WW@-D %%4*LTUEP9Q9!7@=MW
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M%W,9CTQ2U"--DT+3<J)UZ^@M:?.9[IMJN"6@ZOG'U16[.EUA(7*/::AUE$8
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MXXR;- T\(PPG;GQV '3,A'&J"%35B'T-",0<B],JI:-,$XA1O.WEH(%0,XX
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MZOC);,[0?M<SMR4DH\2\'PZ&BXG)D@8:$ "J@/=.<:(,T@!YH)@"T11SKG3
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M(2'7NQ:OO&PIX!SPDKQV2S,.KQF)3K>7\8&@J%(L?CL2 26IAYH 3B$Q @F
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M4@E1IEBUM:'O@?MYEE%UO'Z>D)V3Y2:*73_/\IW;$BXAJ+W]/ O:6M[/,\Y
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M93!A.,,D7FY2UA,*E820&.,5,-991;:'KE\&$_N&#%*/='=(T;68:[0J'#2
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M"CX\O1NLB?>T:Q)MLB07$%+?INIK8SKK<[:E"?4VF5!_<4)E6HR'[.ZE26$
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M'COH.9[9 I&/3,Z)S7'/,/Y,'\-_P%5"C?%6$,(-&=BS$@]D1J-&.99@R-:
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M85K<)(G*7?U)!7*0T[DRG2,;RW[4Z+&8 J:J6\<<AU(B9@1F>A$/PHH,CU%
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MNDWFKN%@^9V9[G*]@4*[X$\-?@WOP[&NQPT]CK7'L1K*OM.)C./NXE@-;9U
MQ,$JH^W]RPNZ1&5RXO>@UN\$M3X:__E0MN[)5,NJR*2CR]51[?+@+.Y-P3Q
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MC^S>@7HN#I3K>U))0G7@^OA7 DY4%(9")420)%I'/STG[V<%XJO^[C__ R[
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M;'=\N57^<W!H)3./J#APJH3)\2QA\M0Z^#N6H:,AY=XHWV-JY."$8BL>VD/
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MJK&B<OJ*%*%OF]1W(DJE+WWN1:"L.S@]U>?LF"UWGT/ZRJ4R=>]2Z$R224F
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M9:N9N+LKWZ@\]?!S9OBQMZQ@>BH ,3/DA$<1L5R?N@YCILT(AS\9"6QFD64
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M"9N&#G$P]=:Q*(UH($GH^A:<'K6X<R!7UA]?<)'J\]_9C_A^?I]S=T,&_@.
M72K'+UY'DWEB8#Y^6L]3&VZ7NEFD1.1O+KTNT7&(N9%741*/1G417<WJTHFG
MI)$8RP*M?/'Y^$\0CN-3\$G0T/FE"!Q]^'IE._44DO6[5'OU;U=7[\?"^,R^
M2<-VKJZRZY2A@X_@S)2*<%?;M/)BBPB>VK=\H]Y]_?P!K_TFD>S/:_C78D?+
MMYC"5ZY"_,X5B^#17AEL], >TQ47JAS+75(3W'DIP_3'KT;#VC'Y[T>6Q9>7
M!>KCO\M"=T3]LG:D#;ZR[*,7)21=M<=O)-PYVV6WNLL%[GZ3!3TM*VSYVO6Z
MIY,T1O9X!9 W D;Y7D]9!(1G"A3&CP1YWZ;V#^N/E/Y!3'H5Q>/Q9"93D_PQ
M_1; 5V&!UV-^-TE@97_]A2V.:+IZ05N2^-<UH=+O+(D9HOP846/4$$!5CW&7
M(%3]^^W-6X#]ZS>_O3=N/AAO;S[=OO]T^Q67^]=?IJ^;($!1E8*[\6P5)VN8
MP%*E]2A1QH1#B79O+]'NMSJ#WQUZ^V?P&_\ Y3 ]:1Z_O]<9!)O&4/$[*>8C
M>1.MRNA73[HQH=\-I;2ER9V01-0.?1_= *">1Y0Q(6F#3KYS0C]CU Q"WW*8
MY-3U0/\W_8"&ONE)YC#F] G]ATOH1]LGW3:M?V#('UQB/@RJ@89@,W:&3/]@
M'_X@YKI,_^THKL_T[S/]M2[59_KWF?ZM(=<^T[_/]&_72;440/M,_S[3O\_T
MOYRU]IG^?:;_)283[I'IK\WX5F92]0FW?;Y_EQ-N3Y/O;S';]Z/(H3RR:&3R
M,!!21JZT*/$(_/>)05+EV_WR]1\'S/NWO6#@NP=*O+T,9N[NRON\_[;#T*GR
M_BW+=0D7MF5A?H9P S>0GDLDMUTOXJ'UQ)RK@P,1=?P!H0<J/VJ/:MO9G,;=
M\_];K+L^M^3<O@J@154 ^Z7FGJ0.0%!A!R0PS= 7U.,."YS(C:0GI2!NY+E'
MU%;W2]"U!L1=EA'MU%2?&^CT%0%]1<"VP&,2L)-=&A)'2.I:@1^Z4A+;]R)?
M^%;3:,Z#::?[ 8]'@N=3&8!)-I><F849_OFD-X/IIO(&IKW#Z<,[$8L3X_N&
M.M?J^542KU2JU<Y)7\8#2XUC3;1Z_Z]Y/'O\.(9'F>.;Z0VL,+F]8^-LUM7?
M5<?MCV/-Q[6&^^K#=[ W'V!GZA.NJ"N)*:PP"!@%'<(+B&.%PC$=^ <^VYQ(
MN'MQSUY3-DRPXY:M2]S]#FXZXRX->,#\*(BH(UW?YCQR/9O3R",T>JIU?[!-
MMX;.,FX:4YGHU,,!<A?.5HN_R]'CT$#&K'(?,M(*2Q/Y14BLT(G'\-$\S;,M
ML\1)U;?=^S4%:)JHS_2/IS@*QIAH'A6POWB;O)I'+Z%2_5-E]%6&[ZIZH+-4
MZDAA.9;+ ^F$+B4X:\[S/1YX,C1=E\O-\RYVDZ[K*G- 7JC"G'I6Z<  Q)Q/
MLV-@_"Z6W]43XPX#?:AKPG9>A?CHH*&,8 UPL?0P!3WE5^6_U>MR@4JM'J.A
MAN7I!165.HW=RPVVK"UH*$M8+C=82:GOXA39:)[(FZA,JU_PF9!\TUFZ1*II
M4^(Y"TW;<T4$,.51(GQFTHAYS 1:M67H. =(/*>.20+I^TX8.C1@9N#YEA#,
ME[X7H(6[E'A^C.*&U3%\8FX_BJ!(52,UPT%]%7!VDC!-77/0,))1K/2S3Q.
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MU"6X_"8![9F2'.-' FND-K5_6'^D] ]BTJLH'H\G,YF:Y(_I-\N$[\(*K\<
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M4;5WN*+JYG+?OJCZL$75?G67CZ3K;5U4;3W3HNJGZ+;'MP".5&I_TM+SK2V
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M;W[[^.[Z]OT[M^'0W[[_],ZX_<_W7ZX_O__'[<>W7P?&QT]OA^=7;3;LPY*
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M:Y3I7:H6TL),T"UKW2;W]_'L7F(V(*8!<K@)/)@<\Q@3"#]-9M+P6ERSO?9
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M.R;H:2:H'&Q:%[Q875!"A=O+X1.M++2R>/%,\)*515GU!-MQ04=S0>5@TZI
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M)*HC_0Z4/ W(>P-Z18^#G#.T,Q;6O[%N"TV;E&4#!([%(<@SPJ2<HFVB!DC
M9K%)=V*1(*IC?#<\S/7<Y+-P"]XG]U%IS(Q\%UYH!P*"A.*$C UNW\>V"R4V
MN)-#B?Q,3(3)*HPI+_< 7T*$,6 ] ,O2LND7,A)F!&NR0E[50*%LYU%-Y,%S
MPP?,XO'"]Z5C39B(3('+1\4=ESS49:H8H9XD?HL($BG6.%]#,)?5"(H+%U>:
MY5(\HO!>?74FFT2/BP*J:40<4B6HFR @7JW(N5J^3]%)F3$2*LB49I ()G);
MUTQ$V-)Z1*_>Y,$U-I4A+R[<^,VJ58RF6Q+>4Z),O.H#<*8@;LPF5A0PV8L
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MA@/<[CCKR.EJ"9P*:RD[6HO!@3L>%7B5<D2%#CO]B(YH(WCV:IVC+8X])9X
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M*V4B"BE%$IHJ#-;YUFG)D(1J-^JS;AGO\B*G^(GK'@C_4I=5:HB]S-/P^K%
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M/%(A'NET11'%^;!O#D9U-P\:EVK;ROD7)[X>6\3I#++.(&NO7[.!9H-CL,'
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MJYN[(9+[^V^S/+ RK(#Y<M&E62;-*W;_E"B&*;'=DX.$%(U>9],D$S<KS 2
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M:W2+L_N5CK"?*2_.C?R9AX4]?"Z-WL+5\]'EQY.[O:']X3W11^SOQQ5.GA'
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MI_ F"[FI@,0<*9'+<)'YEL-38[F;= WGG&>X,T<"!A/4-@CY5$HR9P0FI0!
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MOHN*Y;##7P@9R\8.*+F\NAE>72)>AK??KB_/[^##\ [^\R?"AT/IS^\_KOZ
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M^=!P/F;M?'353'6'\S[KDD2#<R7%1RHY+19A^RPE$@W01UDO5'= [[/R1S1
M'V5Y3_T!O;]"'=$ 74TU3J?1?S.B)2C)D:K*:JU)O:&A9KN6-U4MKN2B6;6X
M4K4]2CR$2(I))!XU6XT6!6TRTJP:D*C5:R4>RH <M0%1+:Z4A5$61GZHR4BS
MLC"JX$K)AQAE6A+)AVIQI21$61!5%*;DXU6:58LK566F)&05S:K-E2I;4Q*R
MBF;5YFIW=7#-AL%+HCIZI]_3E(#(2+/J<K6[NCHP(1D!J6%179L?&2K:Y+VA
MU=57SZ?PJV9%OD]=ZT4+?>(&#C]-DHS^%07A%!XHI))+9D-$958M;?NJGA,4
MWY55R15GMV0%=0IOC;EN MNE"1J/1QCVE4845!BJ+&G84!Z:C;Z2!^%HVU?=
M@J#R4%E]PF;"T )(2)-S/R9A4,;AV(U#!55RQR0PRGHHZZ&$05F/*FO9-I,&
MPVBTE3"(1MN^"MH$%88J"]>4<:@!;4=O'*HJ4U/&07[:]E6K)J@P5%F3IA8E
M:D#;OBK3!)6'2BK0XC=M9AU:O++GY/-I/Y&$[!M*+WVO9$8$VO95JR:HS%39
MFVU#&])KF-+4>AZ3/.RG-$U0>:BFM=MV3E6KT5[3BLPOW<J*B%/@%J-@ 1V=
M^'N1:A?9-T^4+^C<>\[H-2SU4QRE!7']M:#UA3C$M:A&0NU/XEN3__RGT6U^
M;!FZ9C9-X] *\@US=F#U>7#*=U!")Y,$5;X*5H  &!IMY$7W#GTE:FWU#+TU
MZ KB<1P<EO)2OH-T:'T$:KLZC UE*JVX>&?HAC 'FQP<F/)2OH-:C/J(U,YM
MU'S9S=";8*7,UE9;6.H(3'DI5U9*'"O5T@=M0Y:RP(,C5V:94V9,##-F]@:Z
MT6DK,R8[Y<J,55ZVN)E4I54H[\1:,CDX,N6E? ?UC?61J>VJ'[>U5&W=&/3U
M7K.CI$IVRI6EJKR&4EFJ(Y>I'11;UD>FMBO%W';YZIW1U#LJHI*?\AT4;-9'
MIK8LY]S04*7UF._*:FX*.VD:G58FB;?Q*UJF$EG9*=]!O6A]1':[:M(-S6!:
M-[J&Q);O]5G[#:=]O=49O%:,EUXN2DGWP85$7LIW4/Y:'_'>LCAV0^E+:UMW
M9I'GKS!UTY2\1V1G";QX$\P] ZB( UZY>FA]N))%!]9X>Z!M!U6G"G0B3*S(
MM.T@!2L4Z/9]YJ,QZ(B21#UZ9%=>62(3LJL]BE'!6A3:E,*ND\+>K,[PZ*&O
M-+K2Z#6$]5%K](H/Q56X%H6V'=3,R83KR@^S5<@6A;:CU]B5'D*K<"T*;3NH
M'9,)UY4?'JN0+0IM.ZC@D@G9E1_ZJI M"FT[*'22"=E5-L93R!:*MAW4^,B$
M[&I:W'4:_1RTMSJ)6)PJFM(>A2)6:!VD"]TEM>CTGOIB-:+;=LY$;.(I<PLZ
M:61']9\3$)"2DKVO@SCDDZ,C;CNG)$F,U?>:2-(1=YM3DJ1LDKPV2:HF<TK4
ME-&2U6BUVAV].Q@HHR4OV<IHJ99RHF%24K+W=5BN?**T[TYRV/-4G$YR2IB4
M73IXF9ZR2T<K2OLZIU<^4=ISW[C7&VHT&^8V'7/25QB&WNVHA2V)R=[7(<+R
M">N^&]*=]EYK/27):<)*Y%:3O:\SB.43N3TWE#LUFKK9[$G7\$U)G1AEH#61
MNOKU>3/T5F^K(A%Q*E1E*C$VYXM :=&IL=["T##TK%]G]R2@(\WRIC/J!B2T
M/5>CS_@W/;2J/?+:^;KWDMMUJXS<-CZ!\EI'#NLCWWA=>?,CA6Q1:%.]C2KL
ME*%@+0IM2F'726&K;G5*HRN-?NRP/FJ-7G&W.H5K46A3W>JJ[5:GD"T*;4>O
ML2OM5J=P+0IMJEM=A=WJ!J(<4WKDH%:-ZJIM5*?4M2BTJ49UU3:J4\@6A3;5
MJ*[*1G7;>2+B% "5%I?QJBB)*LO6FL\;&FJ.%P2'UC];L5S$HLK]T+ROWG*2
M@;ZV14-*/ Z=+ZN#>-1L+5L4M,E(\[ZZZD@F(;5=\E;BH0R(,B#5=V]3(J0L
MC+(P2CR4A5'%6<)B34::]]5A33+YJ'.1EY(094%4L9B06).1YGWU0I-,/BH_
M(E5)B*PT[ZL!F6024N<*-B4AAZYXJX.$5%$)QU]T\OG4T-OF0.C^7DH^]E@W
M5P?YJ*2>+@E"WB @@I?4M7F)I&BS]X:>6E\]G\*OFA7Y/G6M%RWTB1LXO*\6
M&?TK"L(I/%!(+9?,AHC:K%K:]E4])RB^*ZN2*\YNR0IJ:>MJ"5SBXQ&&?:41
M!16&*DL:-I2']!0[)0\"T;:ON@5!Y:&R^H3-A&%^I(\2!H%H4\9!&8<*JN2.
M26"4]5#60PF#LAY5UK)M)@WIB6Y*& 2B;5\%;8(*0Y6%:\HXU("VHS<.596I
M*>,@/VW[JE435!BJK$E3BQ(UH&U?E6F"RD-5%6BMS<U#>LYE>ZM3O.2$F\BT
M[:L$35!1J++IVH:F(3U\4ID&@6C;5\F9H/)0::NV#04B/>1Q.]L@3C5:>T5O
M/J'*#-DW3Y0OO=Q[SN@U>/13:*2E:_VUT/*%.,2UJ$9"[4_B6Y/__*?1;7YL
M&;IF-DWST#IOVPD[L#H\+-D[*'.31G J7Z;:\#S<-*QL]0R]->@*XCLH.1(C
M4UD3.=JN/F)#44HK(=X9NM$4)2I5DB1&=41-)&GG%FF^"F;H3;!)9JNG)$E>
MLI5-$L0FM?1!VY"E.$^)FC):LAJM5KNC=P<#9;3D)5L9K6I+!3<3IK3RXYU8
MZQE*E,2H)JR)*&U7:+BM76KK9F^@]YH=)4SRDJWL4K55BLHN':TH[:"0L2:B
MM%V-X[;+3N\2(5I>!-!LF&7EPVN_PC#T7D>EXR4F>P=5EC41UBT+,#<T?&FM
MY;O3UJ!,8$LO%J55FA(Y,:HY:R)RVQ5Z;FB\TI+.W=G']!6G8""[K>XK<CV_
M7LFUQ&3OH"JU)G*]9<'JAE*7EJ:N(=B&V6B65;^N_8[>5MF>)>6OV4___F]P
M 0$",M<D[TB^6?B<F=FD\*_;+\Z+82Y,3 OG*IV#>\>S?IV-?=MQL@C:"6YX
M,T7^!3[Z@V:'  PK3_( 1*J(&XNZ(*1SJB/W%\B.>_)Y2*E&+,N;PK2\P%2#
M2(5 3NAIX81JEH?%L $=X5]L@92$\&%LN\2U;.+ ".$+[,P8-'Z_][7?CH'_
M6_/ZZ_"LV]N,385/_S@[NW)'VG?R0+56SSP[BQ^4&ZU#B<_TY:3 RBSU:>5Z
MCIF7P^]?\>%??$I^G<,_<Y9F7S&#2\[N\9HS,H:Q?M"(\T1>@B4/RLW+Q"]H
MJL1^S9X_:B6T RIFSQJ)0@]T?YPKX:"8Q.7=)KNS,,<E>C[^Z038_QJ3OU!X
M<\+F5BF;%RU60B^G=>8%-G8O_:#Y%/N8/M*4?@[SE%?(35#B1+-'GT[<%Q.(
M;+?:K6?SKZ!-_C*;O3.0-]!NS?9?LX<.7 D$GKO6Q/.!L-]_(_,IFBTG;DW,
M#Q<PWT]5SB/Q;8*5\:[G3XE34F3/1C'QZ?C3R3_O;B]./M^=?_EVI=U^U2YN
M;^ZN;NZ&2.[OO\WRJ,KP 28+A,<-EXERJ:*8+ZH7M,*4V&[>K.]:+2_?<M!M
M]!;*:XJ:8F*D. @O+H877]LELWUQ=7.IW?UQ]>/\^]7/N^N+H:Y=WUPLJ-]%
MS7+8\2_4/)0-'F!R>74SO+I$P QOOUU?GM_!A^$=_.=/Q _#TOGP#^WKM]O_
M&=9BS*?7-S"=MS^'YS>7P_>E V"N#=SL..CW@I7^=-(\89]C!XU]3F*D# 'M
MC+<&0W?(+ #:D[\*"BDO3ER+Q5_%95+LN[GWR;12T6TN]=Y"/QTQ)2.,%M:/
M$'I&HS?8?LM2MRP4V/\>M7XY7(JN/-\]5%DDVVUO%1*NY%E5X2JC;6LR%G?@
M/2<5?&/VOZH(-;N-@?D?I6*\%("O[P[<A-T>2KW[Z:1]>+ANIMUB3-^!1T"U
M/^%ADT #]Q4"B/Q.N4HW0QY,T2Q+.RA=LU7Z:?_JYA5*]J9Q#+/1W['&$1ZK
M6RD:LVD:U<)9"KS(1*O"]O;8WFPS^6MV\O"&49Q\_/K!W!9E_!<DF&ACQWL*
MM+'O335O1GT28JJ56*']:(<V#3XL1K+SR173/N]K54M*LLO47/V7M?*Y9"F\
M3(5BA>(=H5@< [ST9,"]F]@J[.D-#37;M;PIU4X=+PC>'UJW+&?O@;7'K@G;
MA7Z0!:M&JV0]IQ2O[U945/" I*-W^I4W%1 4,\(2=M1@;J^[C?)=>JAJO2RA
M0*['JV5AZ41M>LCJ>7J.*BOP\:GEN9;M4,TMFE3\V8*XM6SDFC;SO4<;T_CW
M+]IIA-5!MOM>MKCVH =6RT?S7M6C0-(H9CBKP*O JZ)809VI]8SQ,,0*M7O"
MBVNG,^H&[+1S856+L/I#1B4A&F;7CF97'R32[\WX#E<5SBHT2Q#.KCHSK=GH
M\[$-V@=NVJZ"WC5MZK5[!K&I18, @MN 8I&91MR1-J*/U/%F&/EJ]!E-+0V$
MU4S*A3^X/I-(,"HRW'$BVJR\+85\2).19B4=^W $WM!F20)O0,+DA(1^N;"$
MU3I@4%@3BC"%M=58D\!:2.0$K%FF.R'N [S7=K,KF4% PX#%D(Y-[FU'K6K6
MBN9C]9LELX<*O J\QV9@!;.BYGI6](X\:_?4I6,[Q/HB:C]BZP)A%8NPVD-&
M%2$88JM)C0X:!E_3/&T-*F\T*"AJA"7LJ.%<12X3&-B)T=PVMX*S!)93(%>E
M&J-Z&TZHKUF1[^,")H])A=5!RE<_N.:21P JL=%FHM1V= R&?&B3D68E(?LP
M^T:G6U>S+]C$;67;,TEF8=67L#I*1D4D&&BKL<?M-&;NJY!9H5ERV]E+;6>[
MKJ93'G=H(ZOJ>#ARZD^EL*LJ+#BX_I)'#JJM^S7[6VUQJ!?29*1928>J^SW.
MN/G<L@"(80!#>E%+S"K J($5;O?4KED%9KF-IM%)C&:K9]308*;]LF5QA=8W
MIWY$1V+OCEV#^2+JI[V1O3?M)9T45&.HV7-?[T:?.?JRE2R\F7IKNS8"M0.I
MI&0KV=K'"O6&TI5&Z*>&:;QR7O3\8LFS^*LZ: L&C?4;.F.SR0WZ2AY:A:Z<
M X%[Q@NL#"6"=77>Q,GG@=YJF8(X!@K51XWJ*NQXLE2N=P8]R>VL#.L@:A]G
M#6@^UD4\!=X:T*S 6]=-R/L_+[&ZD/)J/*96J'ECC3Y;K+&'!C$DU:RXR8?G
MLHA32%VSDX-OA:1MWSDUP:!<3;%U;YO$69*6WFJ)3DZPB4S;L0M"E>5:VZ:0
MS8[<X>KQ'*RXY^R2P'Z_.AY4H5@8.$A*MD)QC6-8 =/L&QURZU,24.UT1/E?
M[[$[I;"!JPC+1*I 5/!X-;/LV1(Y^%1@KCF8JUWM[*EN6KN?4C&];K5@)*[2
M4> 5%P@RTJS 6]=(4<S,^)I'%V#Q+ FU>PIWNE@IZXVU&;S0&PFI7]3"SK$L
M[%2X/W;+%<ZNV*TME"@<BRA4$6_V&ZVW+'%V=;/?U^2.4Y>EUCNR;9O:S+13
M=R2.47_#' BZU+0WRO>YVB2=2&SI+A1@ +I.&WG1O4-7>P;OC*;>%.:@^H,C
M4U[*E4Q5[W=L*%.IB_&N;!=NWHEIE3LQ:[^BK?>,KN1>3&=%@8"$N9T=:)65
M'#JPQML#;;O0:0IT DRLR+0IT+T*.G%,B S+!OR+)VH_3$(<AC.J)BH>1K.9
M0Z?4#8F#LL.Z1XQME[B6G>\3H0[JK0?-:N%-)#NIP*O J^RMH(5M<Q-JNR,P
MD1^T,V,]LWH=!!&84(J9YB&\',BZT"S/9?S!P'SFTS'U?8JL]:Q?FNV6#5W#
M>UP*1MASM2<[G,!U9S/?LV@0:#X-*/&MB4;<D3:BC]3Q9FC(A55IPNHM&963
M:+*R=L+YW3JGJW7,IB#99(7F8T3SVJG>E6CN[.[8@^RG?_\WN  []V>N2=Z1
M?+/P.</:>,+;W7Z1,X99&E:F3+AWP':=C7W;<;(SN.LPF#WZ@V9#S&I;>8H'
MC7:O.'$6&$7JSZF.W%^ 3A>"7THAPK6\*<S*"X:[KA<".:&GA1.*IG>$'9Q'
M^!<K"B A?(B#8PB7@Q"^0(L;-(K1<5W9OS6KOP[/NOW-N%3X](^SLRMP=+Z3
M!ZJU>JVSL_A!N=$ZX!$QA30I<#)+?5KLD6/FY?#[5WSX%Y^27^?PSYREV5?,
MX)*S>[SFC(QAK!\TXCR1EV#)@W+S,O$+BT*)#9@]?]1*: =0S)XU$H4>*%=^
M:9=C8A(G@DQV9V&.2\*6^*<38/]K3/Z"I8\)F]NE;%XT"0F]G-:9%]CHLGX
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MD-\$9MR?>7PV^6W)E788:"[!2?.T!;0VM%M7^TKO?<#=2_SR/GLY_)N2K=$
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M.(9GB0>',Z!V N$S/$,(,PB%+70D6L30O8C\A1<(ZXJ0ZP:A+RPC?H'-F?,
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M?=\P[BVV<F84X5N>;3PR9QM1#N+;>B\\QV$@3#*1 CJ:._9H3CUNF)*Y4GF
MF(?(SS2'<URMM8?S)5UR69N;<:U"_F1S$X7,2AU)HY,5^=&-MEN0J2G*TNA)
M&7J6RD;HL5XZYK+_$YMT<=A1=2?><]^W*4C["'Z+[8I9'_B7O]'8.]_"8C9]
M#P":8=P,;C/"!?T,&,;&+&I9?_>RK9C_#_Q&Q*CWS'YB[B> R]AU$!-(\KD
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MW&%Z^2LN0\9'K,PQ)NP'@JT?B$)KX?,%6]+[A+.*?/&$ Q#O!:S3B9!<W!1
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M\^%G<-? !8$(4?6.R'>'* 9MZP+DE\&C ^")/05)!KL&'XK<*"!"0SX7.<>
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M8[^]^"D6Z!:R8"3+E2()@<X-_CV.=(N8)3[)LO"@WJL#"K-$JHU/#AB>PWG
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MS29@W3%@GS88L/>_2R50N4>SG$KL2 U][,H29@+6ET3TVK.2&P6&DT<[\$S
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M_WIEW7RV+FZN[Z^N[^^$W5FD94KC FP5*(X;KE+C0ANQTB+,F>VF3?=/9*!
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MB"MR7^1?69:*VH-F&B95Q)>6IJK5ES+TPOZKU>?&>H79G3XY=B)3M&L)?O.
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M-(^(E5]O>1[*A;,,5_5FS0F!:KMT!\RV0>B.^_@"B$7+F0@R:Y8[=6D,SX:
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M,@+>NFOKY/*-!E&_K.$>UV@97K/3*RGD>7/YQGW^E"@?%XOP$IQ.$_;$L5B
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MV=P5F4_"P5E8.%.$0$A-T2G',0 @W(E>,(C/_PDQM= PABO!W#@S-$<NL1O
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M9PZM7JTT'5!6=SEJD@OPHGJ(Y^_A0R\6Z$\EY_9N6ZDPKV#\^2$HLH5)#4A
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MNJ!=#$<<0H0X]\&:R<M, @1$V1YEA2"O !DKKKPV\O0$.0;F5LY.\ (JB4E
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MMO"#8$Q1(911 ] 0@V\$M&L QIT'*UOY25/Y$R>0/8O*^:7TDU9P4YA9GJ'
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MT;,KP[8_M"JH59"\XFT-3[)]-QD-(#1 *T@50,+R.C],\$EA!*KX!_'4]P_
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MK)5977\E7X_::$Q^_V0@_,.L8<PI)^(3??UU**ALME$&>FB='<O=U5<>T14
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MJT=&#V-'LP!F#<FY\L-*($G=Q2HK+]ASQ(1;-?/,9Q@*MS=KC)'BX+51Y#9
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M0$9I45_C;<K3+'%2#=MRUV@%#9X<)D?X%";>:*ON!> Q!N#QY@D!'FGDP0O
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M]$,'(/Q<:8!J#KMQQ2AWPL*$;<R,1G"R3, ]4]RE1HLH\$DQ%B5\+-FK_-6
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MG+?2P<,"0(U*!1.$P,0U_SCY?/)6E7:?7^9^CE</H!\V;<$\W/,<4$Q F"(
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MJ]HP4_R)&,^)DV+X<3DVKXPT%&=G+YZ=G;^D'@[UAF>I-WSK)H0:9_(5D%[
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M'Q>6YY5;V:B1*/ ME^.N*JJ\Y48X\WW77F3,/A\@3,H6T8$K[\=>:04"C7A
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MQ^[*S"6CP3DK351$4+FV7%C*4"BJ&Q>S9'"H^PBATO!@C*.#"3+Q;HYT9-<
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M<I^['&6J(Z]'\%ZY">OJ6GZ>%;_9.M6I=CDK.U5E=Z!;O^0''?+4,6I&H)U
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MIO2#(N9R0JNQI(0C/@[-G'$R(.,)YF:EO&ZR?ND+AF^ 8Y$!<0ZM86> K2<
MR$#7#>0BJK0IRLVYG/,H\K4%N1O"G5=2%G84QB26BX6^[:P5;)SKAJ(J]*\W
M/%YH*27S2H@^VSD%1077GSQ>Z=I#4H,9+W*M45B6]=A?-A%&<%FK;>"=>I*<
M-D/8('5J9\*DEF&N])PVQ0Y_400I4P733F,Z]/2*_[29@W6TT2WU.L62.G(1
MZ%M!F(SS;&O9C#II'*EW)$#7"TW. LP>3B\!NNULEY:H1S6&.A>2;*!M4?7]
M$>JHA%)D4U\_ Y,*!E *=?3QFEI7CU586:8XKUF02GT3K(>AD^2(#C@$%U6E
M)D5M/<!<H=LY_A&3T5O $9.3%"1$,<F%'!F/E/T^E,._3K:VU+NTML3:$\)]
M#(ADJ>M6B1;&/H!$H"M![B?S!EI4H2ZSA1W1O4A^=O#DRI;02G<!A_1A5+_K
M,L</:/Z*K]C,UK5[8CK+[*>Q/"6O^H?@8#R;WHL+H*_!/&F'QES4',(YT<@Q
MK2>5>=)R'1 #./)1_*)3^!B.1_[<S$K,$,"T! $TDV=(D9XXF";!SUV :_M2
MB(4%7X"H'!B#B3/O>S</&<I%_J5DQB 10X)D L%,7>+1]4N L[\06GTI?IF;
M\,>W.1 4YJMF.HTI& .8N.-CA!7\SZM/OR%9E((^DS]L;=4,T8V4=A%5 36O
M8#WUT]'Y;9_'<Z%VN6,_.,,[@/D8P:LV/FND7-4? 'L+V=*W"')8XH'3P7QC
M]D-M;>6SIYJ@^R8ZR4M(4[QHJ^MK/OQ$I$'.$^U;T+MM/VJ'<B(TOG"-3WWL
M*+O( 2(8&[@:Z/=@KTMT\ .G#B3=NEES7S3W-05>D*6?0T4'J1F_&'\M&_S9
MC&TA85ES6P#VWV,>@[4.L\&_EB  W&!N?L*!N>V;M_@I3Y]8Z20"2R9BD @C
M#C_>9E'ATD2E4 ^ESN"IQL69P;(_5KVWJ7H_WV/5.UV./5:]]USU?OZ$JMZO
MCE7OPZYZ3ZIVLKSE1FY"O6><EX:!Y@9F\B/-B2?_&D.0\J6D LHU))E;J#\B
M2#5(U!#(S[A4X[RK.LN*+^K80A%DH;>/.-:^X:EV*&[(_*'T0]9%Z8/(K?DU
MN3A^?XB9,<SB$AV0U5A.TZS#/W_#J0*%!?S%IU+RUU<H3JVDLT.M]8R201G?
MBV>4ZJU5>4<<!C;7M!OYD%)_[\]%A9P!7LJ.XD/(AE=W^61E-A)2Z7K/*OEH
MFV;.($"\HQ34N"NQ]=,/671(DVV1CLK6):,R,_%M3I)NP0"TY2+GU)*79?<*
M"%:3KE65ATSR[O2>*O\/,3D4M*KZKIG=2:TM02*FRW$3\XC7%,LDEU:7N ^F
MA2$QVP4"@YPS-(^XQ!2JS28&P;AJ0;LK^;&['1;3=NLGRERNVVSIQ5:6WH1X
M&;X^A'$B\1LDI.+.OH,I8O_+C]?(LKC=JK*H<^YK5:0E6!N!_,<&8YFBIU#)
M6RK-:()CHGKC@@;NX%(O!!?1$T$Y@H*HEHOE[(1B W?=O7[]VD.>'\@LMDG^
MY$#J$6="R.[0]Z$6;DB,XKX,*K ;.J?IA_"N\!#8H(3.$\&EKLW"N6;3I14"
M8/2'F@> \V LU6'I?>3[6^F2#,Y?G?XM9+]U-;C<2A 3NXD5JW%=D?2RY@WA
M3 #]=VE;"(H0PM[ZXGQX.WJZ*VE/%*ZIL.CYR=DK::FI[ZJVD0H($[:>!".&
M]-G_!4R<[8J5FS+S-&>O0[(4QE(5R=*_?ZN_8YF?9DY1=;-X41<R9/CY_2E>
M&WCBA?J;[+_'#G'%D%&+'>!,*%>^UCT87#(L:,34Y4F  :?X,Q2NF2]L/595
M>,=EP$\.&QFELXTK7RRE:S#>AK3"28H62R'8!>O&Y5>I#UP1(P(#:]9JV79K
M)C?*X_FRQ2YK"A&2"6LX*SU4^KB-XJL:P7P3,13)YL9L'L9],;_[MSDN2/(L
M\RBJ%/,5VCXS4N4UKI5<>QR5R-5'LP83$<UV1LP#Y/UHYZ?G1 Q*OSHL[1Q.
M:MY2HK A-O 6I,GH(4)2X*T>4E;#= F\[G9UW>.38#":@!"HY=)W A"<:\T:
M\@=!%M3:VK@"?,#X,'=5(UI!)E 6X;R5$]+E*E+32F$MU$#VR4HV+-LM5ZIV
M0.V3P//A@_ CY8L$20 4H/33?=.EC?/;-X[M5BO??,VV[Z<7F!X+@KC)@$3&
MT!W+H6%)E2@=TB"ZZ4&>N*_3)^YK/G$_U-T244*!60[YI![!I^VCJ2JY(47(
M G[ROH,-QNJ+FB91,QQ&Y-E.,06H#"#^U.5^#QZ=P(TY!<G Y7C/T$-<B(D7
M( 3B=&G>P1RP$QH(ICV$_^R[#1IM?WOT\=.$Y[RMW?_N0DV29@8\2UFC^!_C
M971&@VF0W$M,S(!6)21&T(CY+[Z-E^6=WZDB9FCDKO/6P8 )E %6Q'A7E5E<
MREQ/X %G,YMIK.J['/5*I=A,,G1Z-E9O?$>]+:?+3IJC:QA0_AU**V%6%-*9
M[9V]*&:1XH1%6_[)GCI?P.%-(9979B5\HA.[?'J7 :*K*=U;6!DL_\C@!8[=
M0\;@8KP;SN&P&]D6EC"59U,K<4K$Q2QK+("ZF1TYKC/2>4"/@*\B^  UY/(C
M J&DASP%'L%KQVE)7 R(SBA\1]PXX-A%C!<HS+,UAVC4ST^31OW\5#(O2L$'
MA]6?2T?R8-9FFL0@Z,YZ_W;PCDD$A;W10S0@O2?&KKX@$/E%^AN1!@5JQIA%
M_54I)? MS'.<GYZ?.=-GG@-;AN*BMZ9F"P1H\9\$PPW(*;0[IQ,\'\Q3#)!.
M::J45@:?G_VWIPC'&!;S4">*].'\=#NHFE6'Z6C#,A#J_J:!XV2(>[)!WQUR
M"#"@_#8 6%)9+]^NV-:Z](P<.?FWJOU?[+'VGRY*'VO_>Z[]7SRAVG_*Y3[6
M_G^(VO^>SN>S]/E\YNC%?JEJXTUQ9J,"GJ4PYD@<S(UF%SH_V^J@P0-SW#9?
M /$ZK=!-)5^Z9(WS<5Y#UU$%1(1(4%>(]T4_@PTV+<N,?FPARO G2\2*_V"9
M>_J')BZ<:HP\_T-U'WKZJ8FF+8HUE?2@Y]]01_!R#BAB'1MBS)KH&+&C=9">
MX7EZY9WSROL?"* &'SKP=2#F_Z.?N<?K6><\,3GV[!]R  ,]O)AOJM7GJ=;_
M4('7=Q7-Y3&Z \T O$R& ?5*VDXAU*B)H!!R$ <Y><_3D_?<YFJD3,#8YR G
M?&6V[S. DT.PA0152_3QS203I04._#M65EB; *%,K$#3"]8,A?9U+*/PUG/<
M%="54J/=04><FLX!D"0M1*Z^ 4M)I!E4-T*'F=8\I!\]/WTN9N[=W][^?8"B
M&_)$(=D<5"W\.RV(,GG"9'U,<D$=B_.RA1 2%VFT(&U'?,!1P2P>GY=S)+:W
MWZ<!Y#L":A^8W27 5;M%+NN4PI)6#;&]K B"R&X[K0X1$H":&8*%O!ASXA!H
M6M'XHAZ6^9QP9^YYLF@?[O3.#DVQS3L=XI:]2&_9"]ZR[D"F;4A9BSP^Z%#-
MI@J+#%-J?)@M.YL"$X8;+D.V()53<N80)N$CAM*?;2@]]/ON(Y?!.B+=B'8Y
M"F&G LGXVC#]_A<Y0VI?$KR*>0OU?"IB,'C06/<PAR\Y/S("E/RQ-W)$\S;7
M#)TE56="$7RU9..1E=#)D2K#2PPVH"</M86%($&\KRO35M7<R2<$'N$[(B!A
MAJ!/'@J_"*<I0J+Q29DQFPM$&GKS/+,N>%]:3.%TX/1QM:TWCZS8S'OY09 %
MX2LWEUU-G#%,]\$KKI!#W.*7Z2U^Z9QYRL%_\J"Q<0KYG^B>+K!S0V5:S=A!
M&_GDBU0ON<X!5K;C8KRJWM-\^7?"\]!>W3](0_LNK+JZ@+,.P&H_H^YTRE)Y
M#K6^4M.N[[XG9AR"UWV%ER#I2,9IQ.!B?JNXLS"^:21CE+()]!9Z [J\>Z/K
MI\H5,JZ2.P6#,Z]J+0N$\9=<8C5,GJL 1U5R=!CC::O3HN#>^H#"2,9MPR((
M)L;+[O[?;@[,X2H/4903/E1^(GLU,^OGS?_W_ZP;]G__#_SF_R&:PC(S@#%1
MI)I FF&\$)4;E;LGXM+1"!SZ(/KP(9[>'/0.NMYV=S3S>KXRKM3C FMJ5U70
MBV#H"S;0(3/QV+)KHOXB IJ#%-A.N3*6:TG0@&6+Q_-;XXL:OV$1ZR6CGP!T
MXV5WD(.42NU<G$AFYW<I+Z=J'?Y ";?#TSHS]R! OB%S909+LS7OP(B-K==H
M_(B2T=G+IF7XG;4]_J&7^^PML5Q+9)]SK#I.M#,N$P8/)XGC+.1!]@D._ZNI
M@-BOO"MGS1Q]M"N-'U_63"@8)F'$:-]8'D24O!#:"85H&PIFD3ZA7X#7. 9>
M-H6T$EX:#(+SE04W$5*P+$;F@V4K%I#H?Z37"*%S]9JZDL .S2,M2>)K4<WH
MM,K-44+.,];J--V5(R4/38AW;3W"NY]<K^7D$A_6I_<:#.%O#!G^V);/I#G[
M(XZ B!#^I-8!C;&.6 #]2\QJLD0"J,EFAI<W*C;A@<0$!M+U+!<02U ,-YD0
M&Y'Y !=P!(=BT 7CL_ZN\"_JE#._!E#;B/)V!>L$\C7?A)P^6[YB!!V,E)'@
M1ZF  [XI0')&F2GF@P0<T'[Y4*SG.+">#M&^D]$+$H+. BKL>EJO@-L9C'$>
M;T>VXC'"KC6P%'D+ ZO*!P."(&"U#?W61]FWB 5&&3M"-2+:IM.6+[8!6;3W
MS?U_>E+K[N+Q:A;&CLXHN8ILBADNDIR$#Y"5##UGQ(0CNJRE9(@-JORQ+J"W
MBS520@$5.MC:4@ [)I285P#!9%)_\.Z-S9_<(/>;65%F#7N@5  03W"Q;7,Q
MSJ(2AQ>:015-N]_V%#Z(WH</*[.H%"5;X1+I\4H#0'PN=*MRZ=&;(_YB&_S%
MY1[Q%VE@P!%_L6?\Q>73P5]<I-!Q1_S%#X&_>,1!9D\R-N\]2;>;JN56/\Q\
MFF=W)CTHR910V,9B=";"!G/N+]&G48'A('KST#M:3YC'OW4R 7CGBJONQ']V
M1<1CZX^KE7=8]1Q17'5'! 3<!\OHCMH>'DL%$"&WO3F4!L.?1W%3"8GK9))3
MQ',9BQR02E7';_0&+L\J;T&@[+<CP4<OVJ7T\"-]&OB))E!&H;:2ZPX>?>B&
M44H<JS^F,Q8MXMQGUT;"$&XLH(PVJ1336N?0(*HMBDM-7BT+BNN$_^_$_B$\
M$1;JBS4SOAVVJH?-O[=<1 :'IQ%H?F;%%6@FLV2]'SP[GE:^,_XE9 ID#RWC
MJ>],7+& +U)'H?JC(D,+L@D*B$2CFME"2G[7,-^]N5/1+,=2 .^K81_,2KN3
MA<;" 1X;*^PZM<-)>H$:!TM%UQL6.?ACKM[2%GT/D+(5&49BID!BU3\Q,08P
M[F6K&@WU;PYEJ.U(@\D'XOF!,=VEW4*$^\[0!B/'(=*K+',4M"ACLPQW'YME
MB?L)"22:ML7N<KRL)^2W.>V4H5GV;C> Z^MX"0X0N"9\^=W(A7UBE*&!$R)K
MF$D!]A&RL*(=U^$U_M?EZ6EF)@K/@O<C>'8T9\CGV #!O3<B6C&@!Z(F+00J
M)FNFQG;@H^KH3!7F#F95V9."\0R[S#J['X4YX@.?Q^Q?<_!6W4VX8SW.#8_M
MA-R'2;XDD *EI-;]@,&$> J5A5ZO>9)D/0)@X"^Y%X4-.<*<.EJLGK")(E1X
M VN=A2TYG8'J$U'X;E?XO&VFE9E/<P1Q][B@K!R-N9"30BJ*_#PFAN [:Z;W
ME1;=,'^<PF5+GTU<6N8<S1 F1&Z7M526)/,KNKLAA4FP]E4R@ORP=R/O>4.G
MEUGC\:<1O;![U.FT;!U26+4#^RYU_[,\L>K@8[:B\]K\'6/1-]H'$3E1O4?#
M\D]4'3@8J^7&2GL83FL!VG9QHV'PA3WO7K05'(9FU=TU$TP JS#,5QQ@\1C>
M)M083%@T["A'VOJ&):2X,1Q"N-85,A2(!*$#Z6NXN'-3K>= 9K/Z*G-)(E9B
M+L!>W35?@JG](_\Z*&=DF]]@AU_LW"C-#3;Q8F#@UY]*XV,08Q0<7<I"<1<Z
MV%TPU+>EB;N+(.^,:A>',O1VY!=R5@F?8_]QRI68OUU=?01^D2!ES0/I!M%V
MM],RGY2%<? .9P"M'3+':8;T=DB#A[8'R;_)0R"F-I]'(/07-$OW,!^;2)C8
MG$F6BK@(6J[8+6OY5\8%\VN1BU#$-&H2%X[I*OF8?*ILMCI2H^^J;D%HT05H
M/'9.1 *^K=^S+:<SHF;!+0T]VV$/K7231RW##E;LL[?OXSD/9PTFTCU)+7DJ
MR_(/'J@G[WP3R0"![RR5K<!ACPKM!S3FE0[(Y<2!XCJ90) "96^_;5:LX68]
M<]'O";UF.8W:ZQ##;PXPK$LB.0<#2(UE->Y]21?&["M4ZBG >=CS)!Z!L+H=
M]I%C.P_?M1A\,$MA!EM[2;P*1*RC ;"',]TV_5+5QJIQYX 9K 7Y'S%1A@O"
MD-@C-/9"@NLH5L$?Z>,9U4DU50B&0.Q@XI^O=HAQ%2.CBAD:E0QB,HZ4?MC3
MPN\\= Q^:R@/OP9YS] 13'DI@$MFB<(#GT*SAE-2VE9?K-9/RS^F[JL>9B./
MJ,,'OYV8==_[80Q[D9)2%AW/#O@8"QR&6$Q+$+6L*Y3Y#O4*Y?7@4MUR#G)'
MU/X$[6\>!,V]\I'88BM@Q8L] BO2%?\CL&+/P(H73PA8D<*^'X$5/P2PXN'(
MU(F<[N]V TE2![F<6T%-MG$(0?I2A+:_HAP;.V:=[?ER=]%-6:Z+ZX8(,I'3
MF8ZCVQ(\Z:J[Q2*O!B;2@R)!E*./GT DEJ Y/,R>GQ1?Q,7)>:J=18V%D( <
M.UHH.C_7'2U1SUO0#KF'?I:'-IULZ(11/2GA;GYH$XK_[H_H2(E-SD]6$EP/
M.PM ^]V@]$3[Z=08L#[U=MT.<7/<CKT/_%K'SH=OWOEPKCL?^AM7M^][R'9M
M?'";[DFT/7C]P_($)&=$_S21?:KNGY;0S:(4 *@BF/L=6RGVTTKA@23?/*:/
M0B;]+5_Q\ZZ]%/+[?7=2J!69ZJ7X,9?-]\%\)D@3!$_U8\-!@\Q\@ T]PD&W
M QX_*?1\*G$\T/S&"J&Q/;0^IB[I.[S25DZAZM/MVSNB].5G$2[_!X#BAW._
MZQ ?S$8ZXJJ/N.H?%%>=R.^LV;%'\#6LO;\"=LW&<UO0=>KK3Q!RC=<-P$0_
M&N3:+G.]]IV4Y!%\?01?/RFK=01?)V?SB!2(D0(O]X@42)>PCTB!/2,%7CXA
MI$"JK'A$"OP02(%]](/0 0*YN^N:I2"FD!AD!"I(18SYO]<<,'V'BKBX'SX.
M/I%TF!9<U[71NJF?F9,!^+,=_G6;(M_!9)>/+3K?O\/DV*/SZ/Z(8Y/.'IMT
MV'P>:HO.GM'M52K"[&^A"? :87!Y:-TT=W]%,\V699H?J=/&?Z4X#Y9XOT/!
M27S]2UMR$FO';\I17SBPMISJV)>S6U^.TAZ0UIMHL3VJ*T<OQH?WY<2XK!^K
M,^<'7$@^:#JETW9Q\OR$M]L5R2#"*'U F45V/ .%Q\^^KH>'X36.PI04@G.4
M>E.S1,C A9-9X".-U7^8.MS7H[=8NS4<[AO0MAE!%RSTL&1E\DSO&L8V-'5I
MSL&ZR"SING2[!3XY?QUM._V UC,N,/RO)2*.;V]A?>-9K1Z@G$Y%VHPJ89@?
MAE%Q!<Q0'00!(OE(&@;4_?%WO+0!5NS^V'LQSD_;!\IIXGD<*?_D]L0-^-&2
MQO8'8NUM,O8OZI(&AA/@K#='V]]L>;CEN&F^= B<:MK"_(<+R<T_[IOVB_%B
MX&*$>L8W+*RN-^&:G2@*Y0-A031J9), ZS<#P,X^9$S]<4@.,.G+-W.E:K/S
M"V?P< C^-HL_S_;]_B))*$^;%V1F04U,HJQ,C"(JL15)J*=YML1C7.<MND$;
M'@*EO8*A!_UPA1:&5(.Q1TSP/QE)X3CXF2O_<U53C9<K;X(/79:+/L. OUFW
M%3)[0H5ICJJ<NG&3AU#/X#V6.17RZY+D+-4(05H)SD+!+B5L@[N%59KKK,5"
MV U,(!]ZX?6IA<G$&AW]U<S6 A]IXR0@#M?JRYT,KF(HBCHTI&N!(@T6[_+Z
MS#VGPFL,,>9]=\$,<Y")9(;MCW+/8,X5?EUCCU#^#U#I$'G!>$%9.L:GXQ-*
M\P7O8.<I3,/Q.@R/P;B>\.Z6=]?SK@E%H%<'::7ZWPJB0CI<K H8^GBVW<W*
M?EKI4V\O8(:Q"]:OO2ME#V^J,6!([&UR4<IR=5;*$UG;]%U;XKZ1;Y=2P;HX
M$?VKWYK!9\RY+K[[ 'R;3C?NJ/)U@;W^*JU+Z#S&P)])N(\B/&C6V#J]0;0Y
M09/)FJ]'(&'X1NST>0&=BN%^<NU&'<TKP.-<5@(*XN8ES,_*>F(.K?P:18:-
M)<./I_D$\K#Y(@'F :_5!%(3!K/?YE]PXW?+L>B>XVO5S;*>L"(4U;FN )M!
M15E,&35=CE&E_ON'&G8TODQ079 .LN6LT(?.&(4#*5%L]C;HB-(>W^5V6J1H
M:GPL *PA#KRIG\VQHA<>9!O<& ^9F,*<$Q:-S_+R@4\LCUS6UU I-Q?DDYME
M.LW2O&Y@RAV>7#U52D:RYPF"'K3TXT@[F+'6QE]&8J:B:3LNRI'B%G5J')$J
MVR!57NT1J9*&4!R1*GM&JKQZ0DB55"[GB%3Y(9 JVSDW25NM175W#Y$N3\ZU
MJN!#+B QUNA-=&X,Y80HOY:3)?DA ;9U5D*PB>X.SJ[&24M"0[PFJ3GJ;D%5
M4^%&4)?J",\WU>_V1BF3WS3W@%;.V!.L@W#'MBG&J?>'A*07:KR#:J&;R+ C
M_]%WR_PD/9W8F)$(BPC0^QUD%SQ^DF%U4IY0YOZ3P#W$H_[LOCCXGV:!#B:%
MS'E7;D-OD$D6P%TZS0L9WBF\D1,JR[27!A&JN'O.U7M@DHH@](5>T9N\L2QP
M$CUW$!H*\@$DRVU'O5J]85C"VW_,D:VX>)A23V2(QHUY*Z*-$2!]45+!GV!D
MUTU3F"B 'A(.;HNR=S[LVLQ37MQ572,9-D:GS[  "BB?KIQEB@Z"D1J=]NQG
MU9=R)O&\N;-Y+/,L9M!1P[4=_ [- H-AM'$J2MW (Q9M?E^/!A7K$DFDIJ92
M(C8_L@I28HKW!UP9X$O8PX[GMC>+.V-7G#J[,)443Y+_7&;\H.$IG#'CT72D
M"8Z;VTP$HFN"$D5Z2C#(PF1-7LV@00M,! 1BE/YEN$_//(UAXZ4*=685+R=8
MERZ66L1]XQOB$ ;L$V\PP6L>$W#\YF'OF\'P?*14C(U[Z>P;!;VSD(:0MSU;
M=+JE,0$)"\!M.;BMJ3T]V-FTD]6V\VS,-07J0>94=C1GE'DXJ#!&[:5Z&^,6
MFJ;V&YV2])C:E/6^1]">E;95T1N]P?X>+_$V*?'%D/S ?]8!'^]8E?6*?;D]
M5OCP1*@?G+QT7Z7C6T-!UU*4N.]D6#B3!!_]!4QWIY)7WM?K!GJ[$W+"+(V,
M![NQ0K,92R*K7ZM5EIM7S>_,UHZ3D)@8;XA 2'L$:XJ=7*=XO_TRWF6]]JY%
MOD@9XI+67BQ<ND,_48L_UC^YX=3YN"QA)LJ[JED"T8W<O'"'E*1*@EN,3@;_
M-"O06"AC6VZ)B0F^<EU"W]I,]5^KO#-2)O&$3""(QI9\.GZ\U![-3; /H+%X
M\SD AK +4U+FBE/\I/9?#,ITD*M2G$<Y'Q_6SWK4^1'<#4OMF(NS3\U/*5\,
MWLT60:!N0]FSQ+,FV#?V^N!8P](ME[X#>BB):$L&]6&J2B3;.!_6U.9U?QIN
M4SJ5BRG CK0%.5(=.S_&*-[.(<L\9)8P8U=IUR"@AM#" (_0]HL]1W6Q,>0!
MX5WN@3E%7G2+-_%?G5]K1%YF7)@W*Q$@%?RHPN:VP^WLP*DC*3RA<0#IT+OE
M?==2%GRQL '##O=RH!)"S,#[E,W46,//:5P%3\V7LIQ'(Z#\,S+.91$E?.$W
M4""68HC@=.P!L],*X]RN=6=OFT(1W+2J=1*OA/P#ZAOXMHOF4/;[Q"L\Z>FJ
M;LU<0!D&\+G8B8H -L3YD _MN*1B^*P%B"A_+?,C2\+#J1I-G/I'+Q]S(^6&
MS']ZKJT#GT9<X2,P)(.^!O[:<N):T*F99BI%EMCS\-_<L:!ZSLW36BS[*=->
M)LNTE[9,N_!8H]Z6+;B<_FC]2HB-D\$&8ML$RV0/TBV!A(N@;?:$@)AFNE+?
M&N*WJJFRQ9D-5BS^"<)T'[$KT+YF,EFV'<';:,%0T)1DE?%6/D6J>'X6%*JH
M36 >&G+WUR[F?>L8"W5(4S&MPXH8=3D5E2CJJ:?O9]9"1%D2#2[(;JP-*L2W
M2V?F!)CULU$1D#?,3%4=(0WK">0W&TAMDO'_;W&3?9<#? !S?ACWOBSL0WDW
MW'P%(@*DH-Z22,#+_'>I*#R\'U%<O\Y9(&JG')8#<"I3 L5_^5:Y4F1LF%L*
M3J:B#'S/"#1-7!;%R$N!1/@HS,>NW)Q/&N,),7^5:\<*WP[(;6#'38@B8XMB
M-C*4H$-@[)+YV.NY:F2WQ&0W"@WM\8+N[+5W@Q<V8[S]CU\^K(;PRM[*G"\N
MY6,LQZTYC0CPIOP(R#R!GTGIIY/!;PU9'MGZD'BI*9-*$[<7"-FE#R$3YC^,
M4U-[M7>._(7:60XT3'O+@NK\%66/77XA/!6M-?#>WB%+$EDCSSJL:R$(0'@)
MTEC[%8NK23++YD'* 2L.\Q;<H"R* '>?EU>N;F6NM?OO7YZ<!8M/GNZHO[$5
M5N'U'K$*Z2+Z$:NP9ZS"ZR>$54AA$X]8A1\"J["7J"<5]%A(P>#*-1W8HRDX
M3]2Y:,ZT)];JN)\A2FG47)Z<<6#XR6QM$V/3X?]94/]OHC+QUY7[]&F%SWL
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M(>B&:,'L%+LD.:J"!_-FR4X(>5OF?OXHU,V]6SQ4;ZS4(Q YJ6 =K5 >! 5
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MU.WN=*TIPG2(W+A#_-/=?\9&=$N!4+AOB.?54:]93CK"J%72%HZ2P_I_EV>
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M_''H;+0E^BIF%N?LZUFIT+0G&"9; :V7.8[$F.LL)8JUR==E]S9H^G!?,TL
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M\)\Z4.>ZRZM9(F&7"=2SJ4LS%76!L,50$LKAK]SW<370+RK&Y04J3[:Y1R%
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M4U:?HA/R+0& =J.2%<D4_6,Z6*.YP"BN'*0$4<$OJ]J.:9[M,:*H G+:T;^
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M684P^B0;_0._IR9TL%BUZ?9.&#8M/H%,*)"67,S+7-YKH^T[Y[5:;O2Y*[6
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MQ"3+50 *!O;4;<XQ">;2^[=\?52EAB*HJK6*X>3A\ .[A=$:#92GO""WJ E
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MB.T?O"^Y!.$ E@'"!5QL_2?@C:2DA+8AWP7;11A^RW8"^X[F4N1 FR2%C8/
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M47T)VUI2/7GY$FVZ(UVON8N76\&^S;4: ^N[@?5'=QA8WQ_Q/0;6WW%@_=&
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M:+B48A1%1E'DNR<]]P_YF].7UZ^.ATM5!DLZ!D\?[A\5OUNCZ*!)\VT(Q,F
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MUC(ZB \>/8Z?/-Z/:F[J@O/B*E%L@X^OHB!:(X[^<P^Q_0!TU2HZ%WDKHR6
M@UZ/$5P3&65UW<(+\,'LP0?)M$1DB,0,P#K#I2[;*ID+6!!P](16_I\'^WO[
MO%2X4#GBRM(Y%!&= .#$1!M7+=[Q$@@K)1\'HI$%ICD($ R3%G96-'  ='X
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MN[X4_4P#,<]-P(829ZBW//9<#(6USS-S7QO"/'7$ 5"&VVAD%C$G6F%,=7J
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MC%WU,43OO2.DOQX8VMT4?QT^$V?>C='>I>[*PU3,-9F3(<WV-LZ3P_GY8-1
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MNBH'.4OY&"MC@<6]%N\*Y]]6_I;_'(K:UB[)$FCT4% TL]T8LP5L,_'8L!L
M7.2P&.;\.H1ERC?P+D^! J-IF7H$A-S;HIL5_\Q>%"L0[]G?B_;7LA<IUK<%
MWC2@;?+UF^8YWUVK!SF,[4-4GZ#5I9(CT8P-UKB9&"U .XR *5^\<C< 2^N_
MV0P(FIS')YK*HN,5H(JKJ#XE/8)=Y!A:-A57J* @=BBS%WY9(-3K^5T:<FD-
MQN_!]BQ5V6WW[<PU9_ F!? U?P70WS5G&IC6>B-Y\($S<RC:YLZFL\KIT&,!
M@J.QRSKS^HYH'^Y2LX)]-4=NL80N.>$OYX32OX,W^[4759\JMXAF(B;.,2_U
MV[JJ+[]!5_5#G-UPLK1K;&"H+8L9QG>@F-.'\1:3YH;("9T_ZU)2=-+1*X"D
M%IE=J(#2L9ZP@W;*;S:>2%$M[6BPT(UN+Z*1OTR8* %@_63PV;QI>B/TRAB
M%@Q*OT(0C;BU_+X_(M:1L9(6M;F"K:RKF3M(^O8_20$]U<]:>@T!%<=G G1&
MC[#8K:A_]^>T.[81\_L;+.)]",@GZ?=_*_(1 :A_/C]8Z?C=F'!LJ/Z5&=J$
MZ69>L;R;5\9O,#\@=Q%XM$Z_AN3YYH'R+Q]%9_,S@/)I!/<1*'_/0/D_[@]0
M_N((E-]3H/P]$=.\>9O]X\V'MZ_>O\_^\>^OWKWZ\76^#G)%W3F FV^6BC;X
MTMI+"P.9A1D&&;TO"^-69_]QEOV]^)__:?+LI^NSEP#GXI2K*Z4B$O@V$6')
M(4ABW+_S[Y_]L.X/0%=<7(Q 7;>S@!)FSU-E3$(LOUAU9F?D;\'%\_?%LQ:U
M!6FWIO_8FX'=OPWU]/G9^;/?;VM%9;P$RA&6GX@L?Y(P]7[K@Q^GO !%\[EF
M%J_0^=G%=[^/O(1ELRR]@5SHQ=BP/#+<JZ$WBHM2=(^?_' H WO&(]M\INCE
M.PRO@4NY_+??/?WBT8 (8_\I./5QV/U]6,)?^OX_.=[_===L?'F^\OW_K0?V
M[.S\R:=?_^.I.IZJI*1Z<O;L^^.QDB7:5_G_].SBV<-<U2]U)V2%]O&^WN_8
M?@-%\)6.U[V8?W^Y^].W<R _>1AQ/N:CY&/F^-_74RB;,T5[>X /1^O(,3D0
M7?X;7/*U*_25M<X7&-OG:9U].E[WHG7>%HORJ^N=;_Q(?J;O<G!G,AGK?XC*
MZ)"\R@<8$]C;@1U(".Q>+OL' $Q_=0WTS1[%0XF;W<M9_*DMH07EDHCH7UQ7
MY3Q[A2!F0"G]2)GE(RKIJZ"2+NX1E92&RQQ12?>,2OKN*Z.2GA(JJ3S2=^XQ
M*NDWH.]\-4K?^6J_V/B.])U'^LZ',K,C?>=#F<>1OO-(WWFD[]SS,J C?>>1
MOO-(WWFD[SS2=WZS])U'_KV'IJV/[)U']LXC>^=1>AS9.W=F[WSS[OV'7<@[
MX2*T(DF0S*N8:<?TR-ZIV#MQ=?^4A8[5U'>L_E9UT-W9?*HM5N5@-L:&46#Q
MC3N%S&U=LRBAT6W4S-UQ4?KTDX&(1!MP+9'D4:8<:9:.-$M?@69I[^79D5O@
MR"UPY!;8^Q+^O1W8D5O@R"UPO/_?+IKU0(#5QU.U5P,[%(STX51Y'ECM[(,N
MY=[+L1VY!8[< D=N@;TXP(>C=?:IT'8_M<XW7LA]Y!8X<@OLV=B.W )';H'?
M=EOV4Q-]L\&* PF!';D%'O[ #B5N=N06.&AN@5?WVO$D7?1^Y!:X9VZ![[\R
MM\ SXA:8'[D%]IA;8!.10*IZUF,2>)UB$H!?9*^_>JGPSG7!#$'ZZ@/?4..\
M47!OJG&^>'S^7?;J__[\YL-_P0_,&7_SGZ_,<?_[3Z_>OJ=Z]9_^=ODV/XQJ
M[\OW&9,.C T^L \VM3W\_GDR%#[6]E ^$=L#H] R7P&&.8!/ZGWX-;?)S&"C
M9&$C\!6"/;'E'6)%__N__YL0@0]T[Y[M_=YMBTJ%EL/+?A3NK>P"V,?S,Q&F
M4>E26$RI>L\C,K@NA&D ^US[^[OR/KV^&)KEW#^'JK^#'T#O\1L I2Y6Y;(C
MU#^\;;S4"F<Y*Z>,8?T3\1;4E7$<S<#=0%TM55O^"?'_?0^MTKE(HP=@,[QC
M FWHBYNBJA'(NBK;#MHQ(]K9FEXXMVZ80/]M."90Y;$R/ZXF56UFDL/S$5 ]
M,Y?$^'[P'?.I2B;8F0_XB_9JL:J;NQ+6Q2_(>F$>.]3PGHXKQ_'1BZ8OJ37W
M,#6KV3DX[V(%K:7AD_#G3V:ZT 2]S=Z;X5:SJFCOSK(?5S2+J]8\MYPQUX-L
MK3E>=P N=OM!#<?E6^9A;\V??=$/V/_:^RUR/<Q*(S@6U=*5H%W.S#^KSBRY
M^8I9^[@K/91KP"QP3&=8@==64Q@=/C^/?I+]O*Q@45Y*4<=[Z%(N/_UYV:K/
M4_]R6!3ZZN4*FLE7=,#>P6'O<-9%W2&N.KTP9U_QWG]WMJ[7W6XW_V+KFV_6
MUFP;;JR]\)==!F!U?_>H^";'I:+R)N 0F;FO0P]YJ&!8K>J[-"/'_LC/)W^,
ME>&ZTJ7M!9)W#7S)E"W*PBQ3 5=X4?5]66:WU]7T6I5VEG5Y!94=P<6Y+@/Y
M ]>HX#>9)3$;8:]VHJ23"SBSIUJ\FTN>9Q7^N\72MF5#?>CMZ&BOL8ST:]Z+
MK[R?YCA74]04?RMNN^2.TOX8%=>64+G1L=L.N]+$8K!P)X39/TK2CE.M$U<U
M/-E)I\*-PQ8 43UO.1U:<P/- M=F@'@REG>RTUB:B.5%\"^0G"A<X8=&@IZ]
M/\OFY0RI?H+GY*QL9EA^?$=EPUGY<7I=+*^ V23[Y]#T--;NSIS"!=26T'EF
M-;4 7@_XFC]_<]1J.+8S>0C740:SU),QFME(K:69^;#L@6FAS7XQ@^UF%1WL
M6SS#E[?FI'89TA&93]Q61AI-S-_W3]1_Y2,-ZS1ZD'&U:.%9X\>*.?=W=#>]
M78QJ:#@&?VA:?Q@)-;]O6OJWVRH4OJ-;E:CP]XW$;_>,OX!R.W_A<E*&H$C-
M8J&#8$3+^[*]J:90"XG&O-&)N+[^ 3\9EC6:X* L;ZNNW&3_GI(J#1]NN1E.
MJE-*0$^;Y0T+L6:.8FM5EP5LX])L349!S1E(M[Z!JS,OZV:) G#:@CE=+6^:
M^@94S:(!*=X;UZSJAUGY@WF'O&3>%L,L0R*X;%%U1LBVS:JMK/Y!$3L _P2\
MW_RN;/N[X"C]$*Q(99].#I1Y]ZSJKINEN:QW.0K?^5##Z\P<9L.T=S^[J9K:
M>[<1]7D&3CF\ORVO!O[U":ZW&05X+-42)$-;0 K*/0*'W%7FP!90\#@W^K/L
M3N&'D&,P6V!>,:_,^\$MRF:#F1?I*%HX<[SM\,W$YU4/ZW;#,XLG8;[FK\,4
M7$=60HZ(9V37S>N->C5OD!=,K]MF::9CSBJN13UMKILZSV;M<(4SHP60^;$_
M:KQ!GD2!@9IN_5MOF_97F.4<@N_FRS_ @T]N9/L6!5B09OYNP6!/;+6P_*!$
M_Q7LFQRRMH_,;D_KIAN,MO67!'Z)IDQ?D?: 'T!D9UKUPD<83*RX:DLTG8R!
M ;E&=ZO"6:&33E[\TK@>?7!*S16A(FHS%]C527VWZ:KFO);R,6:](N,!]G=:
M#YUQD<^,2]S#'L,6S-CD]F<.9LI58WZ%AG41#U[,'/'A3\!3)F/-J$;GP(,1
M!K\R9[VNP%8[-3Z"\=(Q7&?F42U1>JD]<4N8PY@AH !#5#\M9F8_P9EWB[UF
M'\R=ZS,0E%BG7.,R&D_/C(M%,=8SYZ*3S%."BQ'*VJ0\S"TY SQ-'D9^)$X8
M%@ODL74U<?(TNON:O/W15S4KOJ!1 4;]J$WQ!HX8B,-WY4VY',@%@ -Z_OUW
MSS7-YS=L6XB#/.+>3ZU[[Y,OK59&-CC9YM\7LN6V==Z_G:/JO,C1(SNE#W44
M1#1ORFZ*VIS<?SE[_/@<-!](%'0*Y_&Z[X&E_(47%*:;7,OUE*:.)U 1]GS+
M0D"B]FDI "846I8Y) 7J 2T&\VS61('-5"ZOBBM-YT;V =@ R0 _<4UA/*,C
MG=I9)0L1?3#!E?%L_K^D'^B9(I6^E6-O(Q&\6=M_TX4N@GT&VVWW<;S_.<Q6
M73--E9@YCOXG]#5$$YQ?;% %1^Q<@)U[?:_8N32HZXB=NU_LW!\?[P]V[N*(
MG7M V+DOI5-8AXYX 0ND,Q=)_=6S:%\V;OVRZ@K*5*:M]J8W'B9$0XR-9*8"
M]LW,?H7P!=;99[7GZ\*+BY/R].3)J8O_S,IOUQ@5XVX'4Y1)XA RX2^M]5AS
MLBW!;NU<M*DL0R0*!['20)1+R$B;/:AF R09,;2S;'JCJXNN9(X[;9YRIG):
M4$C4!LHQ3EQ"3 CBD9,.G),,(]DW2;O91;_[UJS"'*8Z*?M;2+,;,27!XW F
M_E+(%[P((T3J:*Z4&556.:\$(W:,>9V]AHBZ@DO9I%J&L F,K$E^DE8YC<GA
MB&*T N:OBP:R V#F]T8+&$/2G-/K+H/DFMEK\UKT"OBM\[99F&EA^-+8"(G7
M!C:G&H-*H%)>6#\8801,S8J;;/95OV$<4$2XJQ!2AJ:MN8T5!2@Y<(A/D@,*
M*M&X^Q0"A#4Q,H1^8V/?<[,>P=FPH^L&N (54RU"W-#X34,?+ #?11=LE,OE
M/_;;$>VO! )P.4V[OMR+0, $^O,41WSR=%_BB%]VY5X759O]O6A_-1[>?T*$
M*K5\.6-NX:C.D/P=UI,"6N;'X[ *E>;8U!EI?U3BLVT7V^@!!BMY2Z#!)$M*
M4W50259UUR53W0>!%@5@*3)*]AB]M*!=(2"+5I,0@FV&WKQD(=DK&,/;_WK_
M"JA:/^;9VZ*;%?\T?_"C>(/-\X$!F'_[WICN]8MB97\[]WZ+4Z%?Y9$2D4PU
MZ:H%'8CH+)$ I&C%VG/BI#.HV=JX2Q!T*&I(A;;5=-V#X& Q8 ?BK1AL4NO)
M," 0Y_@[.+X8)L'P1M/UQB6;HKAM"US<67&':JK$?[GO6%3:+?S/LL$O@&Y8
MN@^=YI3F6S5M3W;B]A<1EOX?L J[1X.,2BO[L,3Q/YH!4B;\M$SFS[DU\TO2
M7#%*=E:6"T2+50!Y6G_N\NR_BNNF^3_9ZVJ):=S#N=KC=YO  *TQDOC< ?<^
M'*/F"AO:!4?;:9U9:4YTFTW,$B*TL1<QP?;E GS[EO 51K4+F[89&>3BG=4)
M#-R[WSC_DH%<]TS):^.\9Y.*8&]&3)O#\:MY/UZ_SF:XO0>.7RI_"?;MAM&%
M^3(W)+P@6=,>T!VA2[)D@SAY4-$@MK_Q?X7(2C/V&%D<'VQ[>I5-8;;_JFEF
MV;R I&02\S\I.M(,A(=E (8%=5K$C_X=&#;TFT5I]O,;SBK_%0&/EP)&&''E
M%8 AX9P&0&.H$ %7M3=NS@J>7@+J8CD5O#AL+M5, +S)U;T4GL_.7AKX]6.X
M3:[H> 7XH6 >VM^:_,)@D'4OWX<4]]<]"2X"\ GVB?.KQTZ0C3\@LC L-6B,
MIC6SF=]Q7,!6-#$"O%E9L)NH4DY<N4Y1V=.+"QV8L[@GA^WKL,1IJ*^H<P[H
M(IS'M^,-CL9#-NP;V#*R=]%V^9N9#B5]NQ?K;=.S@[/SQ4*I-A+IOVT![8,2
MLJS-#4!,9XB)Q#<K^0L=8;$B<1<9C'(V%SD,,'[!R;=K ?/KA'=W1JZH71L2
MX*H2PQPR+JVPLAR*9VVOZ$#@R[O\%:#17BI(7J?>\4!Q"-N?'SZKZVZX+V E
M*+P:VFXH5"O0AXO^^L35DJJ2T6"C[WDY*\/*S&]LO<;!G=3VD<6+<9XLE/E'
M_] =*Z6XNAS3/"/7E9^VHK37-&HO%R:73B+45YCXL "?YR>34VT+ _S.BP>J
MYYX"@+U$IW#9W(+T=9F8\J-QSA"/GDRI&COMZ4EYS*'*7HN?%&PX:3V,XJ0J
MALSR-WBS8@-LM'[.[.?G%[MC"'N]3T9%EE77#=^X*@E7>\S()C,%[B*ML5XS
M>SW/DTCB(QAO6S#>Q?V!\4908D<PWCV#\<[W!XSWY C&.W@PWN?(]T\,FB4@
MWMMHA4^$:'\C1M4[*.K=>4/.GT\>/4GN!3X/?RWKJ^$E_EZD\NB8=7(/0;L8
M?X;5QQ4295"K6S"JEP!*G+:EM*8FW%3YL6RG%:0ZPAK'?=COSPIB[GSM/(\E
MN6-)GT9OVK>T6+[C,"9M! OIB,+@++N"HV]HQ4#<CD7+)/$>AH HM#C[99!\
M?U!1.2*QG^^+Q/["2XS*;V<1'3N<(]O4$K$+*%#?!1W9AKTI<_VZBE.%^#<:
M)5$D058Y2NU%'JQ$E]8]#2,0V8E#7J0B%*=I3]DS@YBRT+TJ%=1(/N;)\5 $
MAV('H$ >PN2#Q(Q/AD&DEAL1 CH']:T)2]H .J]IFX>.LDY%?//K]2E9B2C/
M&:(5#C1/L?LZVQ*4];F*SI6JC.8KDO0(F+S8CWS%_)BOP*U/*,^1S;?( )9+
MBP(87991MF+03YP4774(VG@[OMPG6_/EDDQZ[V/9-%UV8-<J'8 N"4(DPDR,
M)=L*KU417"N"+G^L%L/"*'BCX0$_E2T'*37E'49^).9XYN1/0 !M]O;\2?[L
M\>/<; I_C<BSS%.($,O_OKF%$NDPGQ@ACCXSOPC)3LEJ8+BQ!9"8GQ-\B6!A
M4-]54G9-S0"L2ZU$"82BJ]!0HMAJKTNJ*$)[!<Q8Q)9=/'[\O?"/QZSC\-&+
MQ^?/1C^A2Y6(GAL 6*K:S5M?C"4!=6M0FS.49 48"3HOJQY(T[(I>*1US>!^
MQ\55]GTM)%SF+6:UAQ5]6W;>_.CIX^?Y]X^?DA=\'SMW$-?X@[H>T:50)TEX
MSBU=>& 2)[C#4RO+A3D:81M<L]G0:E/:\X;,%9Q7\QZ+<Q&T?_+L\>_M?8^&
MK[#86,2);.IP@>#/4*#,J[;KS>)#)F%:VJ)*EBSFFNI*U+#J=32E7'Y<59QX
MGABM!%L^+#D<BD@QP>1?%U@VC)S6+EQJ#N)\@',*EX://R6HA7D/KAC\=JY%
M0<HG!8P9_994XAVQZ]P)Z<W="B>M#4@0)GS]Z*5 =XB<S> 7Q;!X54MLWC/4
M/0:'U;A #E!$F(\#$*;!V($['8/-9NVZ.2'E916DQ@I2]WWQ$5<,[%\$T$[,
MR69Q@$642A1BG88]P2 7X 6^-(5TGQP X<.W;0[FC / ,%A@-\<='FRQ<_(
M<WDN,7H"U3\,HT<1X$3Y+/NU+%=J!"@;HV-==&,5N7KY/';M@[,^0F))L_*
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MO\);=,J2@H+X3/@R)ZMCUX "0SJW6YY=G>6PIG.@48>R!NP62@DKR?9B$QN
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MC]$+HBL@J X2]$^&.^"^]H=T2M% /WU6T:2I[4 _FAM-^(=>OW4E6M:-'[:
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M08S-XURO>E?]%?5-7LN+G6+FG;N@ T]GWY!&G^J27#S>VB5YX>(D6)K^QD7
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M2<(D4EHJ5XK*;M:L^JBLIJ[(;<%9%%R:C!K,50>67&Z;VQS-@F)$8%J:J[7
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M49CL0GM;U]/DM\H&Q]8#^3.=6;5MU2:[7#T5&^67%FQ-L_N:NA7\L0K:D2W
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M3&/.5(1])[.Z20AY(-=?V,E*C,'KC1VO7JW2/*B;LRX'2_@]M];ZBO^11G'
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M\:S;VC"P'2>KVBT-]\-Z>_^Y^'7LWKK>O;OS\>RL=C!KNIY6TLR[GVJU$W=
M+ND-(^U#LU;[J)IF>I)HA[XW>/PH7HRBL?/Q_P%02P<(ZXQ*\?Q(#0 .T)8
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MQI;(0-\O#I&Q1UOKFD%FLFP]S<G<69J(A'GVSBQX'*V"Y)_=MM]PZ2SPV"K
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M^LG)V:>FH8@0X%#(*(\(UAUUM=I^V'8IS;;5,W;=-8P2E"'3K(%1XL/D^*X
MIG"/.)3*8=2C>J>#B4Z#[4X2+SCCR3Q$P;YH&B,Y:+"T8#U>\2?KSA5,<D/%
M=DFFMWL.7V3JDD_&N&(P*0)BE<M=U&M-=YE&/A)J6[@8^BA33Q3OI[+G*F>H
M;[,1PH(B<DCI,OMYISC&+=:%@:19S4L..%6R3=>, LC,;#U%!!,1S*]M=YW>
M9))D+O]RJ!7_E+P*]$[$FAQ\R",91Q@:&8EF2Q#%=)"F*=DC39%IP",R#3-D
MO4!IV=0^Z6,6D:4\'4AQ:X<'!)FQ_G :=G$5<"POAA/&(S4Z3GC%\V?-R?G\
MY%4@Y0?[0)%IG<'FD T<R\M)YHZ#PP3'O.6T^BK2&)Z3*%,-!%'\98D>XS4#
M/$JZ%;QGE'81)4^VX#LEM%O-P N'P9OTS(:EM/;-8,_M*G)\P(3;#D(SM06<
MQZ#)&3TZ$7<C.%G,V,HS4X2\";ID*^?@@\@GY)"?!I]=E-(1A,S28&O6(OYI
M^(QK"QC\0NPM"1_BC_Q5BP#1 U<&C[GNK7A7_>Q-#)<$6!40N+@UIK8'AUV6
MM.9SXYQ278F\VBHMAL#N4<EO"@(L':V')=#@W5DH-*W3B8]-P[] 272C]H\[
M8("(<K97Z11UF-8XS;WO+_'BB0>,7.:=L6Q4BLG17R_9+QG,F:,;H(L/JX(C
MFI<2&C+]^"B.P^9V$VFYV(#6L:L^&[9B"//%1Q'RLR4>7.;.2O2F^"J+<^"7
M&1H=492Z%%HU,0_3@TIIJGT?@;QW/1X/&7P/PGB!?S-XQI3 [:7,L_ 7@DE0
M3.@#GZ;&!%$\R7R(=0X+VWQ<C"V!$T5QR,V\0AUD//]\3XQ>!3I) J:IQ&J8
M%9X-2 [3^4NOVUSX1ID2=TC%#S[':P+#Z)(S7)8Q[.D#J:1^MQQQ6#+HR9NK
M;0T_,?PZ8%]MW,&'2/I/@:?$'N[A+/ 4"MYLW8.;<NE<^[RE39I/-0UWQBTR
MQ4[S?N.U&>]L76.+*!M?#KMZ0T<GW,?.O1B5[$5(079231%K1/AY:?'SP\)W
M /5']MR/'-L+M :66X1>*[.5; "1^C%@)G%!MA]-'4"C6@]3]C^F;!^/H:E1
M@A#C?0D- MH&W=;*!F9,\CWKQEW]RB@;H9DZTE4M 8]0/\056O>8;X46WN$7
M:"C?#D8S NY#F$0\"EGH%SQX%'>+I<6*8*9B450%BB^\()C&]<HLP8$NG/DG
MF?$IF E%B+U>@!.=LVNF8,;)A(5C$);NJE<.Z[$+UP_63V4&DUV]RQ>6>^;Y
M;_*^07CDKG"G<+#U1!<N-=@$?@,JDS+P+]#= \H1CK*-X$ :ZR+)*# \SRSW
MCOVC:I*K';\$9*9_8^FY\Z3>[%C1Z:;K:+#Z.Y8^<ZF3F%]I-5J2<2R1LPI<
M7((W+"]V@_&"HP\0[A<+9T-+(E!:ZNK6;-^N#U>*SY/%,L-TLL*)H=(\T5M$
MH:P"R58CPOJ"C3[8TP4-)$VGU%(HYF-"C.HV9JL9[4F$8__-W2J+0JHE$O9+
M6"XS6 V)9S!%U1NKT?Z /\#IY<\\JN!0=.#X:%U1W[Z&M+R^8_ K2'[(.B60
MI A'<.M-W'X[@Z'$\E_R0=FO&24$V<X)B:V8@,\.5D:FLJ!V?^QEU9.Z&9PH
M]C*K2:6;Q''J"?C\HHJR3UIA&\TT(1;*@3Y<(DF3X@R'KV^HJP/WTA/K:_."
M,_EH]:E/<=*"@K84QI/WG^*V/R@)7R&K""8ZEV G7U$BM,Q>TI"]QYJQ(G$9
MN<B1GLZ_Z=Z!-:>BR?3NY9D?_Z'H1-'QVJVF\:5D]FOLFM;X$$2:;!RG!(44
M3Q/&\Y0K*V%BEXE?@JO5%\]S/*8BF=G9;AJ(6WL] "5D1R()KT]:A@U!O\OZ
MRL-FM6N7+S8(IJ-$I3]DA\0!&G]03A@W_,%V+M[XAE8A^W%G4TK,-XZS>+O@
M^&H*&8KY.Y]?;='5:!+<3L&>*XV((N3D%6;2S)J^0: >]VV&>"_% @SK8&B2
MF7R5.ZUV7%.;?C3;F=6-TO<2X(RGR%<; L73&NS8F<TOZ^M''3+M.E:"IIE)
M$H>K5?G"".R:3\T>C2^J%IQ_,7(NG?T;)]$;D:D]%& F-433R!Y_E8U3W2#<
M+5=?(^$C* YE*-G4 !9!<A J0:)QD\\T)PNZ5G"91GY#]?UN4_YC,0/Z,'5D
MD6/PN2UTD[DVW??F4>,&QY%M^YR7X,U8B;Y?[ZR<VT:*BS2+%4)+)(J/4!'M
ML,YUSU-R<0<#5?-=<82Z3F(.*CU\-XP7./5F7G01NB'I^TA Y4NZUS"O?6BV
MZP'!I#2#G+V_^:;N7A)$$WT!9Q.PYP>2OTJ.(1NNH'6$K *7<1FTAHE4BN.R
MN8:T /DT(\]I<>1QT/MYQ[2P\@X>)LE<%<D(D_4DS;F TH?+HNP>IAFM<T,1
MG#/B&4K2P,-MD:VV5;)DRE5DSN-4#G6#]!66R.1DBP*D;:VVXFUPO.AWD-2Q
MM(:\?"I11!N6;980P4A$RBM\"E9Q5F$SC!;:-PT%=C9CTRR&_IIHT/1EK[RE
M5_16])=N?>=UDQ>I$-3P!9>)!R_U+C(%C%O+5',0W8U)O4>=B&7INVZ 8@.D
M#6Y8)&MY4 Y LVFN>QR9TO+',(+'0LO1:+S&O$P54FID49<Y!DDFT2MEE:6P
M^W'H;9'@=XGSN/-=E3<,T&L5@#>>RDVJS]9 KJ8WC<MDZ=3(-E%P&9T<;':K
M 1?+L>B)Y32EM/\?M9Q;6%/7ML=3J2 @I,I-44A;%=R%$*U 6HA)O:)2B-4*
M"$*.18LAAK1'+A%"EH 0+D*VL(46*A'41@5,U80H8&((@;:HJ& BH9+;KG(+
MK"6W5;(2SN+L[WS?>3DOYWSG8:R']3"^.=:<XS?_8UZ6TXCK!DTP82TG R)T
ME<?ON EKJ)%3K:]@_RZO5>Q8@^I/L^JIW%YD2F;A\F5-$*H;IVE+U%Q:(B<[
M<Y5+\VY9K;K,0N:X0X$T7PI3KE4^BO1H$11WN('W8OMGG:GG42D0>?/L=WUZ
M8"U\)UW@P+ZGRLYMZ?(-CF+B=E0=A8\WLCO8_2/\%:A7)^XZSJZ!0$X"FD%K
MK;?D=%2M>ET(G#V:\8H4 IWI0?&KE ]J=JLO]&V2W=1/G?.U@[!S &]CB=_]
MUKK(NF[OGJ(TYK<,VL2*EMI])_XR&1V0=710UP6(^WJP."3 VDSVL_72[A+-
M;M?9Q%VPR++&]GC850K3&^"J/6!-H?CRUAEGOJ]_N82*C3*\9J@RX^47".*R
M14R!YOD0T'G$Z.-&K=4.6Z=6.#S127H0S]BY'Z :LPF4=M/N9)TCDY8:GW_2
MUD-;8^:X61(Y\=:?;+Y_(%^"FFZ"^UC;%S4],1"CEGRQ274356S40M&+MWL]
MO:NKKL %7<2(I [UM7LO99[CO^1(NPDPH4)@.7$,)L[M1IT&GY+YPTV6)$Z&
MV+,7BC02SF50[9% :S42</>MS8U:+/N\3*5-OS=>_Q&(SU=FG&0Q#;H/8&>S
M1OUI#V!ZF(DG&H +0 -MZ09"#KS-$HAL GF/IL[1L!T4L,_ RYL9$9N=E4F^
MDG?)*7'/TV;+O[7%U!R"L"62'Y_I8)[*VSS<(()Y7]>:#JLSU@U92F[CH&0C
M$5DGL7S.B40[[!16>VAZ[A_6)J[O*$Y<_R#T(12AGU=0O&$6&BHI)L,E6G-4
M@TY;Y;2=8(>VIYB$O<WP;&JFC6RSUAVLBKLXFZ6Y-E Y/(9Q9<2A(=?8G@+@
M 6J! $OYIMS-Y-]-@S]AF1>D\>;"MTITD,#\6+@!.MPC7]M!;6&$+6**S1UG
MC"LF.2PZR-LEA3R># NN(>&M9#PT=1[9ZOOC-CB\JZ)-6D( _&7>'+*U'=#?
MHH!Q?;P%!_-U*$?Q ATC!3S4M3;"I%%@\[TE7;KW4$[32FJ3A&>;V!OF6.V:
MQK:!&8(/YW3[P$QO''<+_+LI47,[.">'< $%3$^9\1Z(K_B1:2% %)M+.QI%
M1FI\1/XL=K#N2_B.Q1TY 3.;$QBRY; 9]#+V=07P?4?GU6_TEUX*H:4-W)B,
MY2EME48\]4 ;.%_:+,Q_.MS;U;KP2>*(1N8,'K:Y'+3F<1R;_X +3$053DN;
M*V]_F3;%(D49=*N1'1(8T/,]J6>W/U[$T*'E4N7#@+UPP5G.W6-U);<UQF/?
MCDT_O5^-K\%B,&,4_34!^#6NC.+#_1AFV!S1DN5]%B0JL 78U#JWEHY=9R#
ME%(08@TX"A(G7H+RW>(<UJIA07%U)0T^O -Z+*W9\BIQ7#T]'B_,V[A/[(+;
MQRJ5X<$#HT"O!G%K6MKCR"](%8!'J,[(5MCC#$K?W=8;\A-3I382Q#,S+"FB
M"B0"TBAC6Y-(3&(T=)L/Q1ZMZ28F>4#JJ\LOU&\$0W\$IY4Q-A^XP$C#L0N,
M[MQP**J2G6GIHJU<Q-R:*M.!:;2)MS<YI\!Y%?75O&FJ1P3[5Y3EZET"#"G=
MP#);+]E/3?K<2P78C:Y^]>DNK^))SMX0K,MX[4!8=#$I$:UQ89.R/G!@QB=
ME=UW7@A=[BDA11@)KZ8&M\WML-8O8K[!%=3B'LD'I88W-7KLLM'5^P'.,R\9
MA"M#(C+6?S7&W0+UE=Q^7"LM18[<6O%AA>G(RZ!-EDV%K8*&T0_H];XOTLO]
M'MG]M:20;)RE^>H<DDEU@^NH=4;"1(/E,V2%]6<DQ$*V_0:L.-G/R6BT/1-(
M1>8(IM'\L3\LT,N=8-J9) X!5!5=$K%%>E&Y\,<9<^+$S"I#G4^D:G@[F^-E
MW<I9.AYWGK,%?0*V'L">&P@H=B)G&N%P4]H]L$S!-(J*DES#@&)2%H0SY0KR
MTQUE&U#,4\X']Y:=U#1((<F$EJ[NJD5E#;FV^N(9(W45&SCP,/_=78H>E2Y@
M)*$0  \]H>A#ILK(?@@5W@ 1YEAPWEF3O!#PM*U*+?D9[E6RFGU<<[.5T96C
MY2WEYJ<M!H(]NV OM/U6A!&[DE'OT7];S/B5.2EA;(^8'E]BQW*+!X?9U@81
M>T1:ELW)$9(;+\W>YA_/@ J,/+.=@>*-[/#.+%^.>&KWR(1&_GGMDYO/>X8N
M-MP;F)C=WUQ8V!@WG-"L%<W]X&!DF1<Q4++-"15URYG6*VCBXEZ-JV((%E_D
M4VM3QX&%^?Q%3/(/:4%IY,UPLAY7D+:(D4@(VJPYI5C7R-AZ-#IP]C+5T*,L
M/S42&J]ZJ[R\,Q+[_FB8N::0Q(!P"P:09F:@66*U5E(G3);W1W!B?GX&H=C;
M_C(HGTN%#X.\G9#/6]4BIBP/V=YXJMX)O"2L"*;Q6GTWJ3LV7QR-R<QJFR\C
M,8\;^"OI84S955%J6]&EAM'YFE !/TR >#=8@N$^H[H)HAA%9I'E.R3ROKJY
M&3_+W-5%_@S<\[;K=5K4MN@7XJ8UG!U0Y%$PYF%.$SU4FW:)=5TA!#HIC#/,
M:T.C;;GUPM.UIZG^@[JUW/5<M#W@+NI@0#Q$F*!;ML)AFKE26'!S1/<>)87I
MU'/@(23J!O@4'-GOCY::O(Z/FN&I+J_XF@K)E(LV57V/;4H"^^&J:/#USU57
MQN*!HL#T)S&+F+V_W,=8;X*:\HZUIKW0:G:X:G@-E SOZM(*\I&X>F_-3$M&
M!\'DXX&_IB;Y&S>]F)RL*#$R_<)[B6BR[4M(K7;,.*V)N1,(>8Z.3_-LCL<M
M+GV6Y;;?%KR4?*_Q?O:02=,E6C5.6[^(2<462^/+U7?.F/A:.R,IDUC_F3PJ
M!KJP4%37Z+R=TMD6TWC\#C-3LVL1<[[10I6H)=8XRL@LA@N@LF(/6E5=Q2VC
MZ'_"+<O@E^H\,AAX1D_\]<NS/(4@/SZMA<DR35T8)BY;ETOY GQ3>V=X;,NI
M&.E\6PY;J1J_3J,/N[^8/'3VWP9"<EZ[[51_1H']A!,UT#J#0Q'YPZ6C>I(3
MM;1B"@LWY';XA6P#]WGVL&!]RC[X^VM:.G04";'6V7#=&]O":.=DSO"1TV*'
M\ZG9YF&)4:()B9QRAZN["=C7\5SO4P)4%_8 VH*Y\W"591>@. BP1.LYD1"Y
MP>AR4N;3!]I]53VDJLXFQ0]HY06L(16PFO,!APCV1#[;V/8P5+>"[,,)>0 ^
M+0SYG5C401<JTM3SE"O96<CJ#38G!_#-*&"( !29E-,NV"\E9VG1=^%IL+]3
M()[M\DT6._K\J:E OK^6D+IES[5BYM76JJBB87S41C7>F/?&\R(&^.+26X&'
M+! )AM>A'.]:Q'B0"2@Y::Y<'Y@8^4!-BC1.>8ZUUI++?SX:W_7N3N78Y+XN
MS>&)=Z?3+<=#;%<SP<&XA&.O^U828+$<W,\?ZNF^^X>P!P<'Q9HO&YU1M3KQ
M\B%/3SS7L=SR*>U]26O]\ R]C7]>(G#S\9E42-@G?FDM5FZ,==.YQ(S]&827
M!W _!!2W<&[<4)LFK.\"-PQ0[.#Z<[ZR_F#PSGU:(.)\\;)C!^0_]^!EL"F]
MT?(HOJ\$.<XB*LT?Q,6=JP6ZFC:3=MDWI)?V<W OCG_D;C<CM#GJP'$T,O 0
M3?LW0'\7)\XLN4478--_)5'U.-@OZQ%MU7[G(20 WF-_\\:II(^M#9S8JPG'
M_A@=AW*,?YJOPZU_KQ-,Y#IMWB1Y28JZ>I2SY242;EVAF3YCZ(,_=%#Q\Q9\
MJ_13@VXV9RR*J!7P*M#2.;W;Y@J?O0W?U1F]\A!BFO;2&]&-^*,P<:>:[,7^
M'#^+/[ PMC"I[5.VY9:__O/)ZVYAR@U);][(-* (DNN;LZMK[/-:  7'%M3;
M,+AG?6;$%]9RLB>;UJ5H>=D@S8WHSLY214"NHK*S?@GW<M)?Z!+7$(+\/AW:
MN]GN%9H:]^N#;,^M/\A<;+_%#&^1@?BWB/NVN4?6GX!O7D>JLO&:BT:L*VQG
MS*K SU)*LNMK6/<W+:0FK0)?3N5-G0ZZ)+; ':=J3_Y5X3S]L>T^C'UD<T/9
M"M@CH: G[Z2!;\<A@R(>XJ;7N8S>>#XZC -%A>EU4<[*!7Q^^*_C*=='0T.K
M0W^?G/PHC]@>BLJ^+3A)%K)."A%5@.O,U 6:*T7?0&D%S"Z65,0%LA= "?IC
M:-+YJYJP:Y&M#Z":0HD+L>L@S-KY0H(/]8DUJ*\:(ZT.^R7]';NPY?]\GM[;
MZ^*-CU$%U]$)@;:\.INST+(3YBX'I1?0\$MTX.%PZH7,^!9U73,<J= YA=!\
MV$[[3GN>NCU+<>)$O>@(]T(VJ0EG&5ESX:\#.LL;DD:?E4?W=7D=#-ULM_ W
MT0?6!E1L$?* NUF=?1]P4JV-,C\XQ1"AI+A\:'L.$4K2OEUF?+?O3;5FS[/T
MLA6$#)T[N^JKA+/=50:^"[U66IQ!_[AR.S&J[>+:B']6EU@.H,Q"2]#4EFU4
M5H'\%]&$U8)AQ\:(I;6L8D%K;+?+89,#GQ8YD'S13P;V* 2%WOY%(7QG=ON>
MC536%22N5=H_*2Q=,[NB,?_-"<DL4"@'(UB%WGP^LAT:GYN&I9"7S6F[90^<
M32>D4]RYS[:,:E,46$Q2[]W/(SHI@UG*-*X;C*/6AS.<V\NV'])TKP98@Z+B
MB;1TZ_[&4+VSO@_>O(@Q,Z (!=K7=:#4YI@,R564E3)41Z*%JU+DEDI9SW5F
MLPY"N#Q2XG4M7- 99I[GI4VEW9YQ?D)3+A0);B2>DL82O;R_GL<F!T_OM]NG
MXBK._>L/,/88NW.8]1@'C.L_#BY[OL<=\]7_8+$^D#.:-&@C<"@,;9M@T2Z0
M<HZ$;1CSW01EE75$WD@8C??BS> _<7@@'Y $6&KV_9LTW]V_\D3USK]W5D9M
M_%Z:3"OF;@$%/$#?0A,+NW#VG"\VQ*(:ZGNNDN*6AG@8Y?8A$PN9!99XVR#9
MI?7. &<_P_3CE?O2=C5Y&?>QXPW%]5X#W:6&Q_V8\TW;@%!S B(6<1Q9P@/O
MP7\MU;&H+[5-)U]/=HA+1=%"G<IO>SLQ#=J9I%WM.+04T_N;'4USE4-SU=9F
M),'XY #>23TT=Q@^5ETYYNOXXN3YU'?[H? XL9RQ[]L7#>#\!1D.B?%.*1):
M6:CK+P&%BSP%!_NGY'7@33H?^(P2\ 9./XG^O?<8I.F6N\7M, :PEK'KQP9K
M+4K [AOUZ?/UJY\'\]H[^G^&Q)EJ&0EZ7*D;RWYM^[&11D]R C5]\CN)Y36(
M!]'FE& "X,T;:[,N6S[@/JI>D$X\1\7/7\\K?FI-6@7I5 Z2TE[C/*K1K*'X
M0XFA3/](29R8ZI"D:E0*Q[RWSRL9[6AYWV](:J'C9JY_L=S]JW\9%[.T6(ND
MF'#P9KXY$=5I"IQM!2/[#0_D*;6L(G(0^B9:%@3'[RZB.2.X!_5XVJ-%S%T;
M__;&O!F!#_)=M?,Z,_.CG-R]_8JJ0=V0P@BLU"+[0*UM$1,['8$V,@P>M5 X
MON@72N,D6N5H?E)1D'"6FRA:QERCM4&VU=;O^QE4(?J9[EU4:!HA936/Q!.5
M:^=-L?(!/"?\^B L5,BQ,TV,UU'\KK6'E=F!4F]]D=YNX=-GZ01[5(SO+3>(
M7$=E.)"@U/%DGK\\#X[ZN#, [] YC 6S"H-_:$XWDY^^;R%?OGHJS+[LN$O'
M*M'%%.'H7.G5WJ(@BK-<7W-Q;.DF9I_E.T 1-WEZRFQS9<N47UI+T8HC9[SU
MP6XHZQ'EO.]&+[D;UX_^RS"]M?*)@5!"\0QV]LGJK+RJ_%Y(4YJV.QP1YSP,
M"GC S15;;W+)Z#Q 2A8A]M8ZD@>$G<M!OP U3J<;T8D!,\T8'@I*551M343_
MMSD!NCR:74M0S"3%&69T:W:>ZOC^ELKUNBB.[6?G59Z!M4L->PPX<@#KW]AN
MCX:Q*--%CIS/X%S#DX!.W_=!'"^8M8(=WMGF<2MN9-@'[..)+;D!NU':[K-%
MYOB$1TND$NF%$\7&Q,=/JC_T2?ROSO^_V'=</S@![.^N#X2!I6/K%#"EE,0"
M&Q<QQUZ2U[#E-%#-;X+K#)-7C<R/Q-A5PS#AF/R>X!#X\NG#1NE<TIT@_IE3
MVDN5>UCL;RO6Y&?]X^![>]S_5^;P.R"-K9!]@FQ=.@2=*B^FV07GIAR#?],O
M8@8MQFXYV-FC5(<NW);@*H)1##"VL<\<Z4_/N5:]/>WMS@&5['[M^LSYK.QG
M_14UR2=S<K)8=.([A<4=28*R$'?BG*>U9FF74@=&\U<B"?#G8.Q^F-Y(EX.'
MIH9PJFSW-I_J/$H)<T;GR<F$D\'#7?\^UM;/;C?6=*,,$/3@F&'E'5OHW)4#
M9E-BV-O.MFK1#3;+$GD#W\)L-GC.58/QCT2!9<O%6Q5.'>\ZIC^KV/0U-OC=
M_N!FKT\C-_SZS_8['_K&@NOT+"5A4*C7*?GGY/8=V^@&;!'-"<$+V9&=81Z-
M-[>\BML0/+]0_NONJL,:2?M?K)"^U8R:G%D?H,N[0MB2>N98JM?\MM_&T_];
M%W)W#P,*!T!?E2WH9N:8NN]9?-F41.AM"2D%@.R.B#6D9"@B!CY+*94PX]\>
M4P<-&3;-5_C!B7Z7;HW%$O":PB#21Y3SR=+=_1/B@"C*8TG5K+84\_LS,1[;
MN1!499"O'-'&\CCA5T;5V7MY5T;B,WZ^V#BBC18LBW]%SXZN$2I9R4*Z.O3.
M'F;*R93W0]7/]OY=N7IOZ=68_[QP^?]N=HN#_P%02P<("\#96@15  ";6@
M4$L! A0 %  (" @ LH7Z5!F;<33-%@  PC0! !$
M &-L8G,M,C R,C W,C8N>'-D4$L! A0 %  (" @ LH7Z5%=_5I8N%@  &UX!
M !4                 #!<  &-L8G,M,C R,C W,C9?8V%L+GAM;%!+ 0(4
M !0 " @( +*%^E1I@[@5"D(  ":2!  5                 'TM  !C;&)S
M+3(P,C(P-S(V7V1E9BYX;6Q02P$"%  4  @(" "RA?I4V0%C 9'8  !XUP\
M%0                #*;P  8VQB<RTR,#(R,#<R-E]L86(N>&UL4$L! A0
M%  (" @ LH7Z5,KZ.6@BAP  NV * !4                 GD@! &-L8G,M
M,C R,C W,C9?<')E+GAM;%!+ 0(4 !0 " @( +*%^E1%&PI_NEL  ))?   2
M                  /0 0!L;V=O7V-A;&%D<FEU<RYJ<&=02P$"%  4  @(
M" "RA?I4D;"EMD:#  "(B   %                 #]*P( ;&]G;U]C86QA
M9')I=7-X,2YJ<&=02P$"%  4  @(" "RA?I4I\1R=[%5   *60  #0
M          "%KP( ;&]G;U]C96YD+FIP9U!+ 0(4 !0 " @( +*%^E01M:2'
M\P(  'T'   7                 '$% P!N>3(P,# T,S0S>#)?97@R,RTQ
M+FAT;5!+ 0(4 !0 " @( +*%^E22]:->X0(  !$(   7
M *D( P!N>3(P,# T,S0S>#)?97@R,RTR+FAT;5!+ 0(4 !0 " @( +*%^E1$
M G]!"P(  %L%   7                 ,\+ P!N>3(P,# T,S0S>#)?97@Y
M.2TQ+FAT;5!+ 0(4 !0 " @( +*%^E03N09' 00  !(,   7
M     !\. P!N>3(P,# T,S0S>#)?97@Y.2TX+FAT;5!+ 0(4 !0 " @( +*%
M^E3KC$KQ_$@-  [0E@ 4                 &42 P!N>3(P,# T,S0S>#)?
M<S1A+FAT;5!+ 0(4 !0 " @( +.%^E0+P-E:!%4  )M:   /
M     *-;$ !S:6=?8F%C:V)A>2YJ<&=02P4&      X #@"; P  Y+ 0

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
